FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Ulanski, P
   Janik, I
   Kadlubowski, S
   Kozicki, M
   Kujawa, P
   Pietrzak, M
   Stasica, P
   Rosiak, JM
AF Ulanski, P
   Janik, I
   Kadlubowski, S
   Kozicki, M
   Kujawa, P
   Pietrzak, M
   Stasica, P
   Rosiak, JM
TI Polymeric biomaterials synthesized by radiation techniques - Current
   studies at IARC, Poland
SO POLYMERS FOR ADVANCED TECHNOLOGIES
LA English
DT Article; Proceedings Paper
CT 6th International Symposium on Polymers for Advanced Technologies
CY SEP 02-06, 2001
CL ELAT, ISRAEL
SP ACS, EPF, Israel Chem & Polymer & Plast Soc, Japan Chem & Polymer Soc
DE biomaterial; hydrogel; implant; drug delivery; ionizing radiation
ID INDUCED CROSS-LINKING; AQUEOUS-SOLUTION; POLY(VINYL METHYL-ETHER);
   PULSE-RADIOLYSIS; IRRADIATION; HYDROGELS; CHITOSAN; ALCOHOL); NANOGELS;
   PRODUCT
AB For over 15 years the Institute of Applied Radiation Chemistry in Lodz, Poland, has been involved in studies on new polymeric biomaterials. Some of the technologies developed employ radiation techniques for the synthesis Of crosslinked products (mainly hydrogels), for surface modification and for sterilization. An example of a mature technology of this kind is hydrogel wound dressings, now being produced on a large scale and available on the market in many Central European countries. Another advanced project is a hydrogel system for healing endometrium cancer by precise, local drug delivery. Preliminary clinical tests with over 70 patients have been completed with very good results.
   Current research projects, besides further development of the above mentioned systems, include: a hydrogel-based system for local, controlled drug delivery, polymer materials for encapsulation of living cells and for the construction of hybrid artificial organs, a new approach to the synthesis of polymeric material for intervertebral disc implant, temperature-sensitive membranes and supports for cell cultures; hydrogel phantoms for low-dose, three-dimensional radiation dosimetry; degradation-resistant nanogels and microgels for biomedical purposes (e.g. synovial fluid substitute); hydrogel-based dietary products and adjustment of the molecular weight of biopolymers by ultrasound and ionizing radiation. Copyright (C) 2003 John Wiley Sons, Ltd.
C1 Tech Univ Lodz, Inst Appl Radiat Chem, PL-93590 Lodz, Poland.
RP Ulanski, P (reprint author), Tech Univ Lodz, Inst Appl Radiat Chem, Wroblewskiego 15, PL-93590 Lodz, Poland.
EM ulanskip@mitr.p.lodz.pl
RI Ulanski, Piotr/S-9103-2018; Sanguansri, Luz/B-6630-2011; Kujawa,
   Piotr/D-5142-2013; Kozicki, Marek/M-2744-2018
OI Ulanski, Piotr/0000-0002-4310-3574; Sanguansri, Luz/0000-0003-1908-7604;
   Kozicki, Marek/0000-0002-8396-4344; Kadlubowski,
   Slawomir/0000-0003-0648-5208
CR Charlesby A, 1960, ATOMIC RAD POLYM
   Darwis D, 2002, RADIAT PHYS CHEM, V63, P539, DOI 10.1016/S0969-806X(01)00636-3
   DeRossi D., 1991, POLYM GELS FUNDAMENT
   Funke W, 1998, ADV POLYM SCI, V136, P139
   Gebelein C. G., 1994, BIOTECHNOLOGY BIOACT
   Goosen M. F. A., 1997, APPL CHITIN CHITOSAN
   GORE JC, 1984, PHYS MED BIOL, V29, P1189, DOI 10.1088/0031-9155/29/10/002
   HIRASA O, 1986, KOBUNSHI, V35, P1100
   Janik I, 2000, J CHEM SOC PERK T 2, P2041, DOI 10.1039/b004777p
   KOLODZIEJCZYK M, 2001, 9 BRG WORKSH 62 ICB
   Kozicki M, 2002, RADIAT PHYS CHEM, V65, P133, DOI 10.1016/S0969-806X(02)00209-8
   Kozicki M, 1999, ENG BIOMATER, V2, P11
   KUJAWA P, 1997, 6 INT WORKSH BIOENC
   LIM F, 1980, SCIENCE, V210, P908, DOI 10.1126/science.6776628
   MAEDA H, 1994, J POLYM SCI POL PHYS, V32, P91, DOI 10.1002/polb.1994.090320112
   MARYANSKI MJ, 1993, MAGN RESON IMAGING, V11, P253, DOI 10.1016/0730-725X(93)90030-H
   MUZZARELLI RAA, 1977, CHITIN
   PARK JB, 1992, BIOMATERIALS INTRO
   Peppas N. A., 1986, HYDROGELS MED PHARM, V2
   RAY CD, Patent No. 5824093
   ROSIAK J, 1992, J RADIOAN NUCL CH AR, V159, P87, DOI 10.1007/BF02041021
   ROSIAK J, 1990, RADIAT PHYS CHEM, V36, P747
   Rosiak J. M., 1989, US patent, Patent No. [US4871490, 4871490]
   ROSIAK JM, 1994, J CONTROL RELEASE, V31, P9, DOI 10.1016/0168-3659(94)90246-1
   Rosiak JM, 1999, RADIAT PHYS CHEM, V55, P139, DOI 10.1016/S0969-806X(98)00319-3
   ROSIAK JM, 1988, RADIAT PHYS CHEM, V52, P307
   ROSIAK JM, 1991, ACS S SERIES, V475, P271
   ROSIAK JM, 1996, MED SCI MONIT, V2, P78
   Sabharwal S, 1999, RADIAT PHYS CHEM, V54, P643, DOI 10.1016/S0969-806X(98)00299-0
   Schnabel W., 1981, POLYM DEGRADATION PR
   SHALABY WS, 1994, BIOMEDICAL POLYM
   SILVER F, 1989, BIOCOMPATIBILITY INT, V1
   Spohr R., 1998, New Astronomy Reviews, V42, P189, DOI 10.1016/S1387-6473(98)00004-9
   Stasica P, 2000, ENG BIOMATER, V3, P9
   Ulanski P, 1996, J CHEM SOC PERK T 2, P13, DOI 10.1039/p29960000013
   Ulanski P, 1999, NUCL INSTRUM METH B, V151, P356, DOI 10.1016/S0168-583X(99)00085-3
   Ulanski P, 1998, RADIAT PHYS CHEM, V52, P289, DOI 10.1016/S0969-806X(98)00155-8
   Ulanski P, 2000, J CHEM SOC PERK T 2, P2022, DOI 10.1039/b003952g
   ULANSKI P, 1994, MACROMOL CHEM PHYSIC, V195, P1443, DOI 10.1002/macp.1994.021950427
   Ulanski P, 2002, RADIAT PHYS CHEM, V63, P533, DOI 10.1016/S0969-806X(01)00549-7
   ULANSKI P, 1994, CHITIN WORLD, P572
   ULANSKI P, 2000, ADV CHITIN SCI, V4, P429
   Uludag H, 2000, ADV DRUG DELIVER REV, V42, P29, DOI 10.1016/S0169-409X(00)00053-3
   Wang BL, 1997, LANGMUIR, V13, P6108, DOI 10.1021/la970599p
NR 44
TC 19
Z9 19
U1 0
U2 11
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1042-7147
EI 1099-1581
J9 POLYM ADVAN TECHNOL
JI Polym. Adv. Technol.
PD OCT-DEC
PY 2002
VL 13
IS 10-12
BP 951
EP 959
DI 10.1002/pat.249
PG 9
WC Polymer Science
SC Polymer Science
GA 640GA
UT WOS:000180679000032
DA 2018-10-20
ER

PT J
AU Griesser, HJ
   Hartley, PG
   McArthur, SL
   McLean, KM
   Meagher, L
   Thissen, H
AF Griesser, HJ
   Hartley, PG
   McArthur, SL
   McLean, KM
   Meagher, L
   Thissen, H
TI Interfacial properties and protein resistance of nano-scale
   polysaccharide coatings
SO SMART MATERIALS & STRUCTURES
LA English
DT Article
ID SURFACES; BIOFILMS; MATRIX
AB For many applications, it is essential to be able to control the interface between devices and the biological environment by nanoscale control of the composition of the surface chemistry and the surface topography. Application of molecular thickness coatings of biologically active macromolecules provides predictable interfacial control over interactions with biological media. The covalent surface immobilization of polysaccharides, proteins and synthetic oligopeptides can be achieved via nanometres thick, interfacial bonding layers deposited by gas plasma methods, and the multi-step coating schemes are verified by XPS analyses. Interactions between biomolecular coatings and biological fluids are studied by MALDI mass spectrometry and ELISA assays. Using a colloid-modified AFM tip, quantitative measurement of interfacial forces is achieved. Comparison with theoretical predictions allows elucidation of the key interfacial forces that operate between surfaces and approaching bio-macromolecules. In this way, it is possible to unravel the fundamental information required for the guided design and optimization of biologically active nanoscale coatings that confer predictable properties to synthetic carriers used for the fabrication of bio-diagnostics and biomedical devices. By studying the relationships between interfacial forces and the adsorption of proteins, we have established the key properties that make specific polysaccharide coatings resistant to the adsorption of proteins, which is applicable to biomaterial, biosensor and biochip research.
C1 CSIRO Mol Sci, Clayton, Vic 3169, Australia.
RI McLean, Keith/H-1568-2011; Meagher, Laurence/G-1412-2012; Hartley,
   Patrick/C-1862-2015; Thissen, Helmut/D-3835-2011; McArthur,
   Sally/B-6848-2008; Griesser, Hans/E-5628-2011
OI Meagher, Laurence/0000-0002-2055-6159; Hartley,
   Patrick/0000-0002-2692-2682; McArthur, Sally/0000-0002-4914-6989;
   Griesser, Hans/0000-0003-1072-7863
CR BRYERS JD, 1994, COLLOID SURFACE B, V2, P9, DOI 10.1016/0927-7765(94)80013-8
   CHATELIER R, 1994, Patent No. 9406485
   CHATELIER RC, 1995, LANGMUIR, V11, P4122, DOI 10.1021/la00010a078
   CHATELIER RC, 1993, Patent No. 9302420
   COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431
   CREPON B, 1987, BIOMATERIALS, V8, P248, DOI 10.1016/0142-9612(87)90111-6
   DUCKER WA, 1991, NATURE, V353, P239, DOI 10.1038/353239a0
   FLEER GJ, 1993, POLYM INTERFACES
   GRIESSER HJ, 1989, VACUUM, V39, P485, DOI 10.1016/0042-207X(89)90272-8
   Hartley P. G., 2000, Plasmas and Polymers, V5, P47, DOI 10.1023/A:1009508426115
   HORBETT TA, 1995, AM CHEM SOC S SERIES, V602
   Kingshott P, 1999, ANAL BIOCHEM, V273, P156, DOI 10.1006/abio.1999.4201
   Kingshott P, 1999, CURR OPIN SOLID ST M, V4, P403, DOI 10.1016/S1359-0286(99)00018-2
   KINGSHOTT P, 1999, THESIS U NEW S WALES
   LOFAS S, 1990, J CHEM SOC CHEM COMM, P1526, DOI 10.1039/c39900001526
   Malmsten M, 1998, BIOPOLYMERS INTERFAC
   MARCHANT RE, 1994, J BIOMAT SCI-POLYM E, V6, P549, DOI 10.1163/156856294X00509
   MCARTHUR SL, 2000, THESIS U NEW S WALES
   OSTERBERG E, 1993, COLLOID SURFACE A, V77, P159, DOI 10.1016/0927-7757(93)80112-R
   RATNER BD, 1993, J BIOMED MATER RES, V27, P837, DOI 10.1002/jbm.820270702
NR 20
TC 28
Z9 29
U1 2
U2 19
PU IOP PUBLISHING LTD
PI BRISTOL
PA DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND
SN 0964-1726
J9 SMART MATER STRUCT
JI Smart Mater. Struct.
PD OCT
PY 2002
VL 11
IS 5
BP 652
EP 661
AR PII S0964-1726(02)52618-5
DI 10.1088/0964-1726/11/5/305
PG 10
WC Instruments & Instrumentation; Materials Science, Multidisciplinary
SC Instruments & Instrumentation; Materials Science
GA 612LH
UT WOS:000179076600006
DA 2018-10-20
ER

PT J
AU Spijker, HT
   Busscher, HJ
   van Oeveren, W
AF Spijker, HT
   Busscher, HJ
   van Oeveren, W
TI Influence of abciximab on the adhesion of platelets on a shielded plasma
   gradient prepared on polyethylene
SO THROMBOSIS RESEARCH
LA English
DT Article
DE biomaterial; wettability gradient; platelets; GpIIb-IIIa; adhesion
ID PROTEIN ADSORPTION; IN-VITRO; ACTIVATION; BINDING; SURFACE; RECEPTORS
AB Introduction: Thrombotic effects of biomaterial implants are mediated merely through activation of the platelet glycoprotein IIb-Illa (GpIIb-IIIa) receptor. Consequently, platelet GpIIb-IIIa receptor inhibitors are successfully used during stent implantation procedures to prevent thrombosis. However, currently a new generation of stems contains surface coating, which changes the surface to more hydrophobic or hydrophilic. This change markedly affects the interaction of platelets and may influence the efficiency of GpIIb-IIla inhibitors. Materials and methods: To study the influence of the wettability of biomaterials on the effectiveness of abciximab, 5-cm polyethylene gradients with contact angles of 100 to 40 were made by means of glow discharge. Fresh whole blood with or without abciximab was recirculated over this gradient. Results: Inhibition of platelet adhesion by abciximab was maximal, but not complete, on the hydrophobic and moderate hydrophobic part of the gradient. with contact angles of 55degrees to 90degrees. Percentage inhibition by abciximab was maximal around 60degrees. Conclusions: Intermediate hydrophobicity of currently applied stent materials, such as stainless steel, seems optimal in combination with abciximab. However, on hydrophobic and particularly on hydrophilic materials, abciximab is less effective. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Univ Groningen, Dept Biomed Engn, NL-9713 AV Groningen, Netherlands.
RP van Oeveren, W (reprint author), Univ Groningen, Dept Biomed Engn, Antonius Deusinglaan 1, NL-9713 AV Groningen, Netherlands.
EM w.van.oeveren@med.rug.nl
CR Antoniucci D, 2000, AM J CARDIOL, V85, P821, DOI 10.1016/S0002-9149(99)00874-7
   Coller BS, 1999, THROMB HAEMOSTASIS, V82, P326
   COLLER BS, 1986, J LAB CLIN MED, V107, P384
   Gawaz M, 1996, CIRCULATION, V94, P279, DOI 10.1161/01.CIR.94.3.279
   Gemmell CH, 1998, J BIOMED MATER RES, V42, P611, DOI 10.1002/(SICI)1097-4636(19981215)42:4<611::AID-JBM18>3.0.CO;2-D
   Goodman SL, 1996, J BIOMED MATER RES, V32, P249, DOI 10.1002/(SICI)1097-4636(199610)32:2<249::AID-JBM15>3.0.CO;2-E
   Harmand MF, 1999, BIOMATERIALS, V20, P1561, DOI 10.1016/S0142-9612(99)00051-4
   KIAEI D, 1995, J BIOMED MATER RES, V29, P729, DOI 10.1002/jbm.820290609
   KIM BK, 1974, TRANSFUSION, V14, P130, DOI 10.1111/j.1537-2995.1974.tb04504.x
   Lee JH, 1998, J BIOMED MATER RES, V41, P304, DOI 10.1002/(SICI)1097-4636(199808)41:2<304::AID-JBM16>3.0.CO;2-K
   Marciniak SJ, 2001, THROMB HAEMOSTASIS, V85, P539
   Mintz GS, 2000, CURR INTERV CARDIOL, V2, P316
   Montorsi P, 2000, BRIT J RADIOL, V73, P76, DOI 10.1259/bjr.73.865.10721325
   MUSIAL J, 1985, J LAB CLIN MED, V105, P514
   RUARDY TG, 1997, SURF SCI REP, V27, P1
   SEEGER JM, 1995, J VASC SURG, V22, P327, DOI 10.1016/S0741-5214(95)70148-6
   Spijker H. T., 1997, Cells and Materials, V7, P201
   Spijker HT, 1999, COLLOID SURFACE B, V15, P89, DOI 10.1016/S0927-7765(99)00056-9
   Spijker HT, 2002, BIOMATERIALS, V23, P757, DOI 10.1016/S0142-9612(01)00181-8
   Suzuki H, 1996, PROG HISTOCHEM CYTOC, V30, P1
   Tanaka M, 2000, BIOMATERIALS, V21, P1471, DOI 10.1016/S0142-9612(00)00031-4
   Toes GJ, 1999, BIOMATERIALS, V20, P1951, DOI 10.1016/S0142-9612(99)00100-3
NR 22
TC 4
Z9 4
U1 0
U2 2
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0049-3848
J9 THROMB RES
JI Thromb. Res.
PD OCT 1
PY 2002
VL 108
IS 1
BP 57
EP 62
DI 10.1016/S0049-3848(02)00357-2
PG 6
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA 660BN
UT WOS:000181814200010
PM 12586133
DA 2018-10-20
ER

PT J
AU Palmer, EM
   Beilfuss, BA
   Nagai, T
   Semnani, RT
   Badylak, SF
   van Seventer, GA
AF Palmer, EM
   Beilfuss, BA
   Nagai, T
   Semnani, RT
   Badylak, SF
   van Seventer, GA
TI Human helper T cell activation and differentiation is suppressed by
   porcine small intestinal submucosa
SO TISSUE ENGINEERING
LA English
DT Article
ID INTERCELLULAR-ADHESION MOLECULE-1; EXTRACELLULAR-MATRIX; HUMAN NAIVE;
   DOG-MODEL; INFLAMMATION; RESPONSES; INHIBIT
AB A cell-free biomaterial derived from porcine small intestinal submucosa (SIS) has been used successfully in many models as a xenogeneic scaffolding material without generating immune-mediated inflammatory reactions. We investigated whether this absence of inflammation is due to the presence of porcine transforming growth factor beta (TGF-beta) activity found in SIS that may have immunosuppressive properties on helper T (Th) cell subset activation and differentiation. We used in vitro models for the generation of human Th1 and Th2 cells to investigate the influence of SIS. We found that SIS partially suppressed Th1 cell expansion and secretion of interleukin 12 (IL-12) and interferon gamma (IFN-gamma) in a TGF-beta-dependent manner, but Th1 cell expansion and IFN-gamma secretion could be fully overcome by addition of recombinant IL-12. The suppression by SIS of Th cell activation also involved the induction of Th cell apoptosis. In addition, SIS completely abolished the generation of Th2 cells in vitro, but this effect of SIS was not reversed by neutralizing TGF-beta antibodies. Our results indicate the presence in SIS of factors that can suppress Th cell activation through both the inhibition of IL-12 secretion and the induction of Th cell apoptosis. We established further that these factors include TGF-beta and at least one other factor.
C1 Boston Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02118 USA.
   Univ Chicago, Dept Pathol, Chicago, IL 60637 USA.
   Purdue Univ, Dept Biomed Engn, W Lafayette, IN 47907 USA.
RP Palmer, EM (reprint author), Boston Univ, Sch Publ Hlth, Dept Environm Hlth, 715 Albany St,Talbot 2E, Boston, MA 02118 USA.
CR Allman AJ, 2001, TRANSPLANTATION, V71, P1631, DOI 10.1097/00007890-200106150-00024
   Aoki K, 2001, NAT IMMUNOL, V2, P333, DOI 10.1038/86336
   BADYLAK S, CLIN ORTHOP S, V333, P199
   BADYLAK SF, 1995, J BIOMED MATER RES, V29, P977, DOI 10.1002/jbm.820290809
   BADYLAK SF, 1994, J VASC SURG, V19, P465, DOI 10.1016/S0741-5214(94)70073-7
   Blumberg RS, 1999, CURR OPIN IMMUNOL, V11, P648, DOI 10.1016/S0952-7915(99)00032-1
   Cobb MA, 1996, SURG NEUROL, V46, P389, DOI 10.1016/S0090-3019(96)00202-9
   Cunliffe RN, 2000, GUT, V47, P16, DOI 10.1136/gut.47.1.16
   Fuss IJ, 1999, GASTROENTEROLOGY, V117, P1078, DOI 10.1016/S0016-5085(99)70392-6
   HILES MC, 1995, J BIOMED MATER RES, V29, P883, DOI 10.1002/jbm.820290714
   Hodde JP, 2001, ENDOTHELIUM-NEW YORK, V8, P11, DOI 10.3109/10623320109063154
   King C, 1998, IMMUNITY, V8, P601, DOI 10.1016/S1074-7613(00)80565-8
   Kropp B P, 1995, Urology, V46, P396, DOI 10.1016/S0090-4295(99)80227-1
   Liu FT, 2000, CLIN IMMUNOL, V97, P79, DOI 10.1006/clim.2000.4912
   McPherson TB, 2000, TISSUE ENG, V6, P233, DOI 10.1089/10763270050044416
   McRae BL, 1998, J IMMUNOL, V160, P4298
   McRae BL, 2000, BLOOD, V96, P210
   Palmer EM, 2001, J IMMUNOL, V167, P749, DOI 10.4049/jimmunol.167.2.749
   PAUL WE, 1994, CELL, V76, P241, DOI 10.1016/0092-8674(94)90332-8
   PREVEL CD, 1995, ANN PLAS SURG, V35, P381, DOI 10.1097/00000637-199510000-00009
   Schonherr E, 2000, Dev Immunol, V7, P89, DOI 10.1155/2000/31748
   SEMNANI RT, 1994, J EXP MED, V180, P2125, DOI 10.1084/jem.180.6.2125
   Takeuchi M, 1998, J IMMUNOL, V160, P1589
   TRINCHIERI G., 1998, ADV IMMUNOL, V70, P243
   VoytikHarbin SL, 1997, J CELL BIOCHEM, V67, P478, DOI 10.1002/(SICI)1097-4644(19971215)67:4<478::AID-JCB6>3.0.CO;2-P
NR 25
TC 50
Z9 60
U1 1
U2 3
PU MARY ANN LIEBERT INC PUBL
PI LARCHMONT
PA 2 MADISON AVENUE, LARCHMONT, NY 10538 USA
SN 1076-3279
J9 TISSUE ENG
JI Tissue Eng.
PD OCT
PY 2002
VL 8
IS 5
BP 893
EP 900
DI 10.1089/10763270260424259
PG 8
WC Cell & Tissue Engineering
SC Cell Biology
GA 610AH
UT WOS:000178938200017
PM 12459068
DA 2018-10-20
ER

PT J
AU Ozawa, T
   Mickle, DAG
   Weisel, RD
   Koyama, N
   Ozawa, S
   Li, RK
AF Ozawa, T
   Mickle, DAG
   Weisel, RD
   Koyama, N
   Ozawa, S
   Li, RK
TI Optimal biomaterial for creation of autologous cardiac grafts
SO CIRCULATION
LA English
DT Article
DE congenital cardiac defect; myocardium; tissue engineering; smooth muscle
   cells; biomaterials
ID MUSCLE CELL TRANSPLANTATION; IMPROVES HEART FUNCTION;
   MYOCARDIAL-INFARCTION; TISSUE; STENTS; ARTERY
AB Background-The optimal cardiac graft for the repair of congenital heart defects will be composed of autologous cells and will grow with the child. The biodegradable material should permit rapid cellular growth and delayed degradation with minimal inflammation. We compared a new material, epsilon-caprolactone-co-L-lactide sponge reinforced with knitted poly-L-lactide fabric (PCLA), to gelatin (GEL) and polyglycolic acid (PEA), which are previously evaluated materials.
   Methods-Syngenic rat aortic smooth muscle cells (SMCs, 2X10(6)) were seeded onto GEL, PEA, and PCLA patches and cultured (n=11 per group). The DNA content in each patch was measured at 1, 2, and 3 weeks after seeding. Histological examination was performed 2 weeks after seeding. Cell-seeded patches were employed to replace a surgically created defect in the right ventricular outflow tract (RVOT) of rats (n=5 per group). Histology was studied at 8 weeks following implantation.
   Results-In vitro studies showed that the DNA content increased significantly (P<0.05) in all patches between 1 and 3 weeks after seeding. Histology and staining SMCs for anti-a-smooth muscle actin (alphaSMA) revealed better growth of cells in the interstices of the grafts with GEL and PCLA than the PGA graft. In vivo studies demonstrated that seeded SMCs survived at least 8 weeks after the patch implantation in all groups. PCLA scaffolds were replaced by more cells with larger alphaSMA-positive areas and by more extracellular matrix with larger elastin-positive areas than with GEL and PEA. The patch did not thin and expanded significantly. The GEL and PGA patches thinned and expanded. All grafts had complete endothelialization on the endocardial surface.
   Conclusions-SMC-seeded biodegradable materials can be employed to repair the RVOT. The novel PCLA patches permitted better cellular penetration in vitro and did not thin or dilate in vivo and did not produce an inflammatory response. The cell-seeded PCLA patch may permit the construction of an autologous patch to repair congenital heart defects.
C1 Univ Toronto, Toronto Gen Hosp, Dept Surg, Div Cardiovasc Surg,Toronto Gen Res Inst, Toronto, ON M5G 2C4, Canada.
RP Li, RK (reprint author), Univ Toronto, Toronto Gen Hosp, Dept Surg, Div Cardiovasc Surg,Toronto Gen Res Inst, CCRW 1-815,200 Elizabeth St, Toronto, ON M5G 2C4, Canada.
CR Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964
   Campagnoli C, 2001, BLOOD, V98, P2396, DOI 10.1182/blood.V98.8.2396
   Carrier RL, 1999, BIOTECHNOL BIOENG, V64, P580, DOI 10.1002/(SICI)1097-0290(19990905)64:5<580::AID-BIT8>3.0.CO;2-X
   FREED LE, 1994, BIO-TECHNOL, V12, P689, DOI 10.1038/nbt0794-689
   Hoerstrup SP, 2000, CIRCULATION, V102, P44
   Kim BS, 1998, J BIOMED MATER RES, V41, P322, DOI 10.1002/(SICI)1097-4636(199808)41:2<322::AID-JBM18>3.0.CO;2-M
   Kim BS, 1998, BIOTECHNOL BIOENG, V57, P46
   Kirklin J, 1993, CARDIAC SURG, P964
   Li RK, 2000, J THORAC CARDIOV SUR, V119, P368, DOI 10.1016/S0022-5223(00)70193-0
   Li RK, 1999, CIRCULATION, V100, P63
   Li RK, 1999, J MOL CELL CARDIOL, V31, P513, DOI 10.1006/jmcc.1998.0882
   Li RK, 1996, ANN THORAC SURG, V62, P654
   Li RK, 2000, J THORAC CARDIOV SUR, V119, P62, DOI 10.1016/S0022-5223(00)70218-2
   Mayer JE, 1997, CURR OPIN CARDIOL, V12, P528, DOI 10.1097/00001573-199711000-00005
   MIKOS AG, 1993, J BIOMED MATER RES, V27, P183, DOI 10.1002/jbm.820270207
   Oechslin EN, 1999, J THORAC CARDIOV SUR, V118, P245, DOI 10.1016/S0022-5223(99)70214-X
   Rajasubramanian G, 1994, ASAIO J, V40, pM584, DOI 10.1097/00002480-199407000-00066
   Sakai T, 2001, J THORAC CARDIOV SUR, V121, P932, DOI 10.1067/mtc.2001.113600
   SCOTT SM, 1994, J VASC SURG, V19, P585, DOI 10.1016/S0741-5214(94)70030-3
   Shin'oka T, 2001, NEW ENGL J MED, V344, P532, DOI 10.1056/NEJM200102153440717
   SHINOKA T, 1995, ANN THORAC SURG, V60, P5513
   Shintani S, 2001, CIRCULATION, V103, P2776, DOI 10.1161/hc2301.092122
   Stock UA, 2000, J THORAC CARDIOV SUR, V119, P732, DOI 10.1016/S0022-5223(00)70008-0
   Tamai H, 2000, CIRCULATION, V102, P399
   THOMSON RC, 2000, PRINCIPLES TISSUE EN, P251
   Uemura H, 2000, EUR J CARDIO-THORAC, V17, P543, DOI 10.1016/S1010-7940(00)00410-3
   VANDERHEIJDEN FHWM, 1994, J VASC SURG, V20, P607, DOI 10.1016/0741-5214(94)90285-2
   VanMeter CH, 1996, ANN THORAC SURG, V62, P660
   Watanabe M, 2001, TISSUE ENG, V7, P429, DOI 10.1089/10763270152436481
   Yoo KJ, 2000, ANN THORAC SURG, V70, P859, DOI 10.1016/S0003-4975(00)01630-1
   YOUNG B, 2000, WHEATERS FUNCTIONAL, P65
NR 31
TC 40
Z9 45
U1 0
U2 7
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0009-7322
J9 CIRCULATION
JI Circulation
PD SEP 24
PY 2002
VL 106
IS 13
SU S
BP I176
EP I182
DI 10.1161/01.cir.0000032901.55215.cc
PG 7
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA 599DM
UT WOS:000178318900031
PM 12354729
DA 2018-10-20
ER

PT J
AU Alsberg, E
   Anderson, KW
   Albeiruti, A
   Rowley, JA
   Mooney, DJ
AF Alsberg, E
   Anderson, KW
   Albeiruti, A
   Rowley, JA
   Mooney, DJ
TI Engineering growing tissues
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE bone; cartilage; alginate; adhesion ligands; endochondral ossification
ID SYNTHETIC BIODEGRADABLE POLYMERS; FUNCTIONAL-DIFFERENTIATION;
   BASEMENT-MEMBRANE; CARTILAGE MATRIX; CELL-SHAPE; CHONDROCYTES; CULTURES;
   GROWTH; INVITRO; BONE
AB Regenerating or engineering new tissues and organs may one day allow routine replacement of lost or failing tissues and organs. However, these engineered tissues must not only grow to fill a defect and integrate with the host tissue, but often they must also grow in concert with the changing needs of the body over time. We hypothesized that tissues capable of growing with time could be engineered by supplying growth stimulus signals to cells from the biomaterial used for cell transplantation. In this study, chondrocytes and osteoblasts were cotransplanted on hydrogels modified with an RGD-containing peptide sequence to promote cell multiplication. New bone tissue was formed that grew in mass and cellularity by endochondral ossification in a manner similar to normal long-bone growth. Transplanted cells organized into structures that morphologically and functionally resembled growth plates. These engineered tissues could find utility in treating diseases and injuries of the growth plate, testing the effect of experimental drugs on growth-plate function and development, and investigating the biology of long-bone growth. Furthermore, this concept of promoting the growth of engineered tissues could find great utility in engineering numerous tissue types by way of the transplantation of a small number of precursor cells.
C1 Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.
   Univ Michigan, Dept Otolaryngol Head & Neck Surg, Ann Arbor, MI 48109 USA.
   Univ Michigan, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA.
   Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA.
RP Mooney, DJ (reprint author), Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.
OI Alsberg, Eben/0000-0002-3487-4625
FU NIDCD NIH HHS [T32 DC005356, T32-DC05356]; NIDCR NIH HHS [T32 DE007057,
   R01-DE13033, R01 DE013033, T32-DE07057]; NIGMS NIH HHS [GM08353, T32
   GM008353]
CR Aigner J, 1998, J BIOMED MATER RES, V42, P172, DOI 10.1002/(SICI)1097-4636(199811)42:2<172::AID-JBM2>3.0.CO;2-M
   Alsberg E, 2001, CRIT REV ORAL BIOL M, V12, P64, DOI 10.1177/10454411010120010501
   Alsberg E, 2001, J DENT RES, V80, P2025, DOI 10.1177/00220345010800111501
   ARMSTRONG PB, 1989, CRIT REV BIOCHEM MOL, V24, P119, DOI 10.3109/10409238909086396
   BARCELLOSHOFF MH, 1989, DEVELOPMENT, V105, P223
   Beers M.H., 1999, MERCK MANUAL DIAGNOS
   BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7
   BRIGHTON CT, 1978, CLIN ORTHOP RELAT R, P22
   DENKER AE, 1995, DIFFERENTIATION, V59, P25, DOI 10.1046/j.1432-0436.1995.5910025.x
   FARQUHARSON C, 1995, IN VITRO CELL DEV-AN, V31, P288
   Folch A, 2000, ANNU REV BIOMED ENG, V2, P227, DOI 10.1146/annurev.bioeng.2.1.227
   GIBSON GJ, 1982, J CELL BIOL, V93, P767, DOI 10.1083/jcb.93.3.767
   GUO JF, 1989, CONNECT TISSUE RES, V19, P277, DOI 10.3109/03008208909043901
   HALBAN PA, 1987, DIABETES, V36, P783, DOI 10.2337/diabetes.36.7.783
   HORTON W, 1986, DEV BIOL, V115, P392, DOI 10.1016/0012-1606(86)90258-7
   Iannotti JP, 1994, ORTHOPAEDIC BASIC SC, P185
   ISHAUG SL, 1994, J BIOMED MATER RES, V28, P1445, DOI 10.1002/jbm.820281210
   Isogai N, 1999, J BONE JOINT SURG AM, V81A, P306, DOI 10.2106/00004623-199903000-00002
   IYODA K, 1993, CLIN ORTHOP RELAT R, P287
   JEE WSS, 1987, HISTOLOGY CELL TISSU, P212
   JIKKO A, 1993, DEV BIOL, V156, P372, DOI 10.1006/dbio.1993.1084
   Kale S, 2000, NAT BIOTECHNOL, V18, P954
   Kim SS, 1999, J SURG RES, V87, P6, DOI 10.1006/jsre.1999.5743
   KIM WS, 1994, PLAST RECONSTR SURG, V94, P233, DOI 10.1097/00006534-199408000-00001
   KIM YJ, 1988, ANAL BIOCHEM, V174, P168, DOI 10.1016/0003-2697(88)90532-5
   KUBOTA Y, 1988, J CELL BIOL, V107, P1589, DOI 10.1083/jcb.107.4.1589
   KUETTNER KE, 1982, J CELL BIOL, V93, P743, DOI 10.1083/jcb.93.3.743
   LANDRY J, 1985, J CELL BIOL, V101, P914, DOI 10.1083/jcb.101.3.914
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   MANFRINI M, 1988, Microsurgery, V9, P242, DOI 10.1002/micr.1920090406
   Martin I, 2000, BIORHEOLOGY, V37, P141
   Mundlos S, 1997, FASEB J, V11, P125
   NAKAHARA H, 1992, CLIN ORTHOP RELAT R, P291
   Oberpenning F, 1999, NAT BIOTECHNOL, V17, P149
   PAIGE KT, 1995, PLAST RECONSTR SURG, V96, P1390, DOI 10.1097/00006534-199511000-00024
   PEPPAS NA, 1994, SCIENCE, V263, P1715, DOI 10.1126/science.8134835
   Peters MC, 1998, J BIOMAT SCI-POLYM E, V9, P1267, DOI 10.1163/156856298X00389
   POCKWINSE SM, 1992, J CELL BIOCHEM, V49, P310, DOI 10.1002/jcb.240490315
   Putnam AJ, 1996, NAT MED, V2, P824, DOI 10.1038/nm0796-824
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   SHANNON JM, 1987, BIOCHIM BIOPHYS ACTA, V931, P143, DOI 10.1016/0167-4889(87)90200-X
   Shea LD, 2000, TISSUE ENG, V6, P605, DOI 10.1089/10763270050199550
   Sims CD, 1998, PLAST RECONSTR SURG, V101, P1580, DOI 10.1097/00006534-199805000-00022
   Tzanakakis ES, 2001, CELL MOTIL CYTOSKEL, V48, P175, DOI 10.1002/1097-0169(200103)48:3<175::AID-CM1007>3.0.CO;2-2
NR 44
TC 278
Z9 290
U1 6
U2 45
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD SEP 17
PY 2002
VL 99
IS 19
BP 12025
EP 12030
DI 10.1073/pnas.192291499
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 596VK
UT WOS:000178187000009
PM 12218178
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU Zayats, M
   Raitman, OA
   Chegel, VI
   Kharitonov, AB
   Willner, I
AF Zayats, M
   Raitman, OA
   Chegel, VI
   Kharitonov, AB
   Willner, I
TI Probing antigen-antibody binding processes by impedance measurements on
   ion-sensitive field-effect transistor devices and complementary surface
   plasmon resonance analyses: Development of cholera toxin sensors
SO ANALYTICAL CHEMISTRY
LA English
DT Article
ID QUARTZ-CRYSTAL MICROBALANCE; IMMUNOSENSOR ELECTRODES; COLORIMETRIC
   DETECTION; AMPEROMETRIC DETECTION; ELECTROMAGNETIC-WAVES; SELECTIVE
   ELECTRODES; MONOLAYER INTERFACES; PROTEIN-DETECTION; THIN-FILMS;
   SPECTROSCOPY
AB Impedance measurements on ISFET devices are employed to develop new immunosensors. The analysis of the transconductance curves recorded at variable frequencies, upon the formation of antigen-antibody complexes on the ISFET devices, allows determination of the biomaterial film thicknesses. Complementary surface plasmon resonance measurements of analogous biosensor systems, using Au-coated glass slides as support, reveal similar film thicknesses of the biomaterials and comparable detection limits. A dinitrophenyl antigen layer is immobilized on the ISFET gate as a sensing interface for the anti-dinitrophenyl antibody (anti-DNP-Ab). The anti-DNP-Ab is analyzed with a sensitivity that corresponds to 0.1 mug mL(-1). The assembly of the biotinylated anti-anti-DNP-Ab and avidin layers on the base anti-DNP-Ab layer is characterized by impedance measurements. The development of an ISFET-based sensor for the cholera toxin is described. The anti-cholera toxin antibody is immobilized on the ISFET device. The association of the cholera toxin (CT) to the antibody is monitored by the impedance measurements. The detection limit for analyzing CT is 1.0 x 10(-11) M.
C1 Hebrew Univ Jerusalem, Inst Chem, IL-91904 Jerusalem, Israel.
RP Willner, I (reprint author), Hebrew Univ Jerusalem, Inst Chem, IL-91904 Jerusalem, Israel.
RI Raitman, Oleg/S-3960-2016
CR Abad JM, 1998, ANAL CHIM ACTA, V368, P183, DOI 10.1016/S0003-2670(98)00205-0
   AIZAWA M, 1987, ELECTROCHEMICAL SENS, P269
   ALFONTA L, 2001, BIOSENS BIOELECTRON, V16, P645
   Antonisse MMG, 2000, ANAL CHEM, V72, P343, DOI 10.1021/ac990721k
   ARMSTRONG RD, 1990, ELECTROCHIM ACTA, V35, P1, DOI 10.1016/0013-4686(90)85028-L
   Badia A, 1999, SENSOR ACTUAT B-CHEM, V54, P145, DOI 10.1016/S0925-4005(98)00333-5
   Bardea A, 2000, ELECTROANAL, V12, P1097, DOI 10.1002/1521-4109(200010)12:14<1097::AID-ELAN1097>3.3.CO;2-O
   BARYAKHTAR IV, 1995, SURF SCI, V323, P142, DOI 10.1016/0039-6028(94)00642-3
   Beketov GV, 1998, SENSOR ACTUAT B-CHEM, V48, P432, DOI 10.1016/S0925-4005(98)00081-1
   BERGVELD P, 1989, SENSOR ACTUATOR, V18, P309, DOI 10.1016/0250-6874(89)87038-6
   Bergveld P., 1988, COMPREHENSIVE ANAL C, VXXIII
   Berney H, 1999, SENSOR ACTUAT B-CHEM, V57, P238, DOI 10.1016/S0925-4005(99)00085-4
   Blonder R, 1997, BIOSENS BIOELECTRON, V12, P627, DOI 10.1016/S0956-5663(97)00022-5
   Blonder R, 1996, ANAL CHEM, V68, P3151, DOI 10.1021/ac960290v
   BRECHT A, 1992, SENSOR ACTUAT B-CHEM, V6, P96, DOI 10.1016/0925-4005(92)80038-Y
   BRESLER HS, 1992, ACS SYM SER, V511, P89
   CHARYCH DH, 1993, SCIENCE, V261, P585, DOI 10.1126/science.8342021
   CHOVELON JM, 1991, SENSOR ACTUAT B-CHEM, V3, P43, DOI 10.1016/0925-4005(91)85006-5
   COLLAPICCHIONI C, 1991, SENSOR ACTUAT B-CHEM, V4, P245
   Eijkel JCT, 1997, BIOSENS BIOELECTRON, V12, P991, DOI 10.1016/S0956-5663(97)00054-7
   GOPEL W, 1995, BIOSENS BIOELECTRON, V10, P35, DOI 10.1016/0956-5663(95)96793-X
   HADAS E, 1992, J IMMUNOASSAY, V13, P231, DOI 10.1080/15321819208021229
   HO WO, 1995, BIOSENS BIOELECTRON, V10, P683, DOI 10.1016/0956-5663(95)96959-3
   Ivnitski D, 1996, BIOSENS BIOELECTRON, V11, P409, DOI 10.1016/0956-5663(96)82736-9
   JAWETZ E, 1982, REV MED MICROBIOL, P227
   Jimenez C, 1997, ANAL CHIM ACTA, V351, P169, DOI 10.1016/S0003-2670(97)00332-2
   JINGHONG H, 1996, Z SENS ACTUATORS B, V35, P422
   Katz E, 1996, J ELECTROANAL CHEM, V418, P67, DOI 10.1016/S0022-0728(96)04855-3
   Kharitonov AB, 2000, SENSOR ACTUAT B-CHEM, V70, P222, DOI 10.1016/S0925-4005(00)00573-6
   Kharitonov AB, 2001, SENSOR ACTUAT B-CHEM, V76, P203, DOI 10.1016/S0925-4005(01)00640-2
   Kharitonov AB, 2001, J PHYS CHEM B, V105, P4205, DOI 10.1021/jp0045383
   Knoll W, 1998, ANNU REV PHYS CHEM, V49, P569, DOI 10.1146/annurev.physchem.49.1.569
   Koch S, 1999, BIOSENS BIOELECTRON, V14, P413, DOI 10.1016/S0956-5663(99)00008-1
   Koncki R, 1998, SENSOR ACTUAT B-CHEM, V47, P246, DOI 10.1016/S0925-4005(98)00031-8
   Kruchinin AA, 1996, SENSOR ACTUAT B-CHEM, V30, P77, DOI 10.1016/0925-4005(95)01752-H
   LANG G, 1996, FRESEN J ANAL CHEM, V68, P857
   Lugtenberg RJW, 1998, J ELECTROANAL CHEM, V452, P69, DOI 10.1016/S0022-0728(98)00080-1
   MAMMEN M, 1995, ANAL CHEM, V67, P3526, DOI 10.1021/ac00115a023
   Mirsky VM, 1997, BIOSENS BIOELECTRON, V12, P977, DOI 10.1016/S0956-5663(97)00053-5
   OTTENBACHER D, 1992, SENSOR ACTUAT B-CHEM, V6, P192, DOI 10.1016/0925-4005(92)80054-2
   Pan JJ, 1997, LANGMUIR, V13, P1365, DOI 10.1021/la9602675
   Patolsky F, 1998, J PHYS CHEM B, V102, P10359, DOI 10.1021/jp983700n
   Pavey KD, 1999, J PHARMACEUT BIOMED, V20, P241, DOI 10.1016/S0731-7085(99)00026-6
   Philips JR, 1999, IMMUNOL CELL BIOL, V77, P121, DOI 10.1046/j.1440-1711.1999.00801.x
   Puig-Lleixa C, 1999, ANAL CHIM ACTA, V389, P179, DOI 10.1016/S0003-2670(99)00157-9
   Rishpon J, 1996, ANN NY ACAD SCI, V799, P508, DOI 10.1111/j.1749-6632.1996.tb33247.x
   Sekiguchi T, 2000, SENSOR ACTUAT B-CHEM, V67, P265, DOI 10.1016/S0925-4005(00)00522-0
   Shirshov YM, 1995, P SOC PHOTO-OPT INS, V2648, P118, DOI 10.1117/12.226151
   Simonian AL, 2001, ANAL CHIM ACTA, V442, P15, DOI 10.1016/S0003-2670(01)01131-X
   Soldatkin AP, 2000, ANAL CHIM ACTA, V403, P25, DOI 10.1016/S0003-2670(99)00660-1
   STOYTCHEVA M, 1995, ELECTROANAL, V7, P660, DOI 10.1002/elan.1140070712
   STRIEBEL C, 1994, BIOSENS BIOELECTRON, V9, P139, DOI 10.1016/0956-5663(94)80105-3
   SULEIMAN AA, 1994, ANALYST, V119, P2279, DOI 10.1039/an9941902279
   TERRETTAZ S, 1993, LANGMUIR, V9, P1361, DOI 10.1021/la00029a033
   Volotovsky V, 1998, ANAL CHIM ACTA, V359, P143, DOI 10.1016/S0003-2670(97)00653-3
   Wijayawardhana CA, 1999, ANAL CHIM ACTA, V399, P3, DOI 10.1016/S0003-2670(99)00570-X
   Willner I, 2000, ANGEW CHEM INT EDIT, V39, P1180, DOI 10.1002/(SICI)1521-3773(20000403)39:7<1180::AID-ANIE1180>3.0.CO;2-E
   Willner I, 1999, BIOTECHNOL PROGR, V15, P991, DOI 10.1021/bp990115a
   Willner I, 2001, TRENDS BIOTECHNOL, V19, P222, DOI 10.1016/S0167-7799(01)01634-1
   Willner I, 1999, SENSORS UPDATE, V5, P45
   Zayats M, 2001, ANALYST, V126, P652, DOI 10.1039/b102363m
   Zayats M, 2000, BIOSENS BIOELECTRON, V15, P671, DOI 10.1016/S0956-5663(00)00120-2
NR 62
TC 72
Z9 72
U1 0
U2 21
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0003-2700
J9 ANAL CHEM
JI Anal. Chem.
PD SEP 15
PY 2002
VL 74
IS 18
BP 4763
EP 4773
DI 10.1021/ac020312f
PG 11
WC Chemistry, Analytical
SC Chemistry
GA 594TX
UT WOS:000178068000023
PM 12349981
DA 2018-10-20
ER

PT J
AU Matheson, LA
   Labow, RS
   Santerre, JP
AF Matheson, LA
   Labow, RS
   Santerre, JP
TI Biodegradation of polycarbonate-based polyurethanes by the human
   monocyte-derived macrophage and U937 cell systems
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article; Proceedings Paper
CT 28th Annual Meeting of the Society-for-Biomaterials
CY APR 24-27, 2002
CL TAMPA, FLORIDA
SP Soc Biomat
DE biodegradation; polyurethane; monocyte-derived macrophage; U937 cells;
   hydrolytic activities
ID CHOLESTEROL ESTERASE; DIFFERENTIATION; POLY(URETHANE)S; POLYETHER;
   URETHANES
AB The prominent cell type found on implanted medical devices during the chronic inflammatory response is the monocyte-derived macrophage (MDM). Using an activated in vitro cell system, it was possible to show that MDMs possess esterolytic activities that may contribute to the degradation of polyurethanes. In the present study, the U937 cell line was paralleled to the MDM cell system in order to validate the use of a cell line that could expedite studies on biomaterial biocompatibility and biostability. Using 12-o-tetradecanoylphorbol 13-acetate (PMA), the optimum differentiation time for the U937 cells was 72 h based on biodegradation, dearadative potential, and S-34-methionine uptake. After activation of the cells by resuspending from tissue culture polystyrene plates and reseeding onto a C-14-labeled polycarbonate-based polyurethane (PCNU), both U937 cells and the MDMs elicited comparable radiolabel release (measure of polymer breakdown) and esterase activity (measure of degradative potential) at 48 h, There was no difference in the effect on radiolabel release and esterase activity elicited by both cell types with inhibitors of protein synthesis, esterase activity, and phospholipase A(2). This established that both cell types likely used similar hydrolytic activities and signaling pathways to cause degradation of the PCNU. Immunoblotting demonstrated that both cell systems secreted monocyte-specific esterase and cholesterol esterase enzymes previously shown to degrade PCNUs. The U937 cell system is more convenient and reproducible than MDMs for pursuing possible biological pathways elucidating the mechanism of polyurethane biodegradation. Once established with U937s, the pathways can then be validated with the more physiologically relevant human MDM cell system. (C) 2002 Wiley Periodicals, Inc.
C1 Univ Ottawa, Inst Heart, Ottawa, ON, Canada.
   Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada.
   Univ Ottawa, Dept Surg, Ottawa, ON, Canada.
   Univ Toronto, Fac Dent, Depb Biol & Diagnost Sci, Toronto, ON, Canada.
RP Labow, RS (reprint author), Univ Ottawa, Inst Heart, 40 Ruskin St, Ottawa, ON, Canada.
CR ANDERSON JM, 1993, CARDIOVASC PATHOL, V2, pS33
   APPEL M, 1993, BIOL CELL, V74, P235
   BOYUM A, 1960, J CLIN LAB INVEST, V21, P77
   BOZDECH MJ, 1981, J EXP MED, V153, P182, DOI 10.1084/jem.153.1.182
   BROWN MS, 1983, J CLIN INVEST, V72, P743, DOI 10.1172/JCI111044
   HASS R, 1989, EUR J CELL BIOL, V48, P282
   LABARCA C, 1980, ANAL BIOCHEM, V102, P344, DOI 10.1016/0003-2697(80)90165-7
   Labow RS, 2001, BIOMATERIALS, V22, P3025, DOI 10.1016/S0142-9612(01)00049-7
   LABOW RS, 1994, J BIOMAT SCI-POLYM E, V6, P169, DOI 10.1163/156856294X00293
   Labow RS, 2001, J CELL PHYSIOL, V186, P95, DOI 10.1002/1097-4652(200101)186:1<95::AID-JCP1008>3.0.CO;2-0
   Labow RS, 1999, J BIOMAT SCI-POLYM E, V10, P699, DOI 10.1163/156856299X00595
   Labow RS, 1998, J BIOMED MATER RES, V39, P469, DOI 10.1002/(SICI)1097-4636(19980305)39:3<469::AID-JBM18>3.0.CO;2-5
   Labow RS, 2001, J BIOMED MATER RES, V54, P189, DOI 10.1002/1097-4636(200102)54:2<189::AID-JBM5>3.0.CO;2-8
   LABOW RS, IN PRESS BIOMATERIAL
   Li F, 1997, J BIOL CHEM, V272, P28666, DOI 10.1074/jbc.272.45.28666
   Moore ANJ, 1996, BIOTECHNOL TECH, V10, P523
   NEWCOMBE DS, 1992, LANCET, V339, P539, DOI 10.1016/0140-6736(92)90349-8
   PAPADIMITRIOU JM, 1989, ULTRASTRUCT PATHOL, V13, P343, DOI 10.3109/01913128909048488
   PRUZANSKI W, 1991, INFLAMMATION, V15, P127, DOI 10.1007/BF00917507
   ROSENTHAL MD, 1992, BIOCHIM BIOPHYS ACTA, V1126, P319, DOI 10.1016/0005-2760(92)90247-S
   SABOORI AM, 1990, J BIOL CHEM, V265, P19792
   SANTERRE JP, 1994, J BIOMED MATER RES, V28, P1187, DOI 10.1002/jbm.820281009
   Santerre JP, 1997, J BIOMED MATER RES, V36, P223
   STOKES K, 1995, J BIOMATER APPL, V9, P321, DOI 10.1177/088532829500900402
   SUNDSTROM C, 1976, INT J CANCER, V17, P565, DOI 10.1002/ijc.2910170504
   Tang YW, 2001, J BIOMED MATER RES, V56, P516, DOI 10.1002/1097-4636(20010915)56:4<516::AID-JBM1123>3.0.CO;2-B
   Uphoff CC, 2000, LEUKEMIA LYMPHOMA, V39, P257, DOI 10.3109/10428190009065825
   WYATT TA, 1993, AM J PHYSIOL, V265, P201
NR 28
TC 52
Z9 53
U1 0
U2 7
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD SEP 15
PY 2002
VL 61
IS 4
BP 505
EP +
DI 10.1002/jbm.10286
PG 156
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 568PT
UT WOS:000176551800001
PM 12125674
DA 2018-10-20
ER

PT J
AU Marsh, LH
   Coke, M
   Dettmar, PW
   Ewen, RJ
   Havler, M
   Nevell, TG
   Smart, JD
   Smith, JR
   Timmins, B
   Tsibouklis, J
   Alexander, C
AF Marsh, LH
   Coke, M
   Dettmar, PW
   Ewen, RJ
   Havler, M
   Nevell, TG
   Smart, JD
   Smith, JR
   Timmins, B
   Tsibouklis, J
   Alexander, C
TI Adsorbed poly(ethyleneoxide)-poly(propyleneoxide) copolymers on
   synthetic surfaces: Spectroscopy and microscopy of polymer structures
   and effects on adhesion of skin-borne bacteria
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE biocompatible polymers; bacterial adsorption; biofouling; surface
   analysis; poly(ethyleneoxide)-copoly(propyleneoxide); copolymers
ID SELF-ASSEMBLED MONOLAYERS; PEO TRIBLOCK COPOLYMERS; PROTEIN ADSORPTION;
   BIOMATERIAL SURFACES; POLYSTYRENE SURFACES; PLASMON RESONANCE;
   CONTACT-ANGLE; POLYETHYLENE; MECHANISMS; RESIST
AB Poly(ethyleneoxide)-copoly(propyleneoxide) (PEO-PPO) polymer coatings were evaluated for their resistance to the attachment of the marker organism Serratia marcescens and the skin-borne bacteria Staphylococcus epidemidis. The copolymers were adsorbed onto poly(styrene) films-chosen as simplified physicochemical models of skin surfaces-and their surface characteristics probed by contact angle goniometry, attenuated total reflectance-Fourier transform infrared (ATR-FTIR), atomic force microscopy (AFM), and X-ray photoelectron spectroscopy (XPS). These functional surfaces were then presented to microbial cultures, bacterial attachment was assessed by fluorescence microscopy and AFM, and the structures of the polymer films examined again spectroscopically, Surface characterization data suggest that the adsorbed copolymer was partially retained at the surface and resisted bacterial attachment for 24 h. Quantitative evaluation of cell attachment was carried out by scintillation counting of C-14-labeled microorganisms in conjunction with plate counts. The results show that a densely packed layer of PEO-PPO copolymer can reduce attachment of skin commensals by an order of magnitude, even when the coating is applied by a simple adsorptive process. The work supports the hypothesis that adhesion of microorganisms to biological substrates can be reduced if a pretreatment with an appropriate copolymer can be effected in vivo. (C) 2002 Wiley Periodicals, Inc.
C1 Univ Portsmouth, Sch Pharm & Biomed Sci, Portsmouth PO1 2DT, Hants, England.
   Reckitt Benckiser Healthcare UK Ltd, Kingston Upon Hull HU8 7DS, N Humberside, England.
   Univ W England, Fac Sci Appl, Bristol BS16 1QY, Avon, England.
RP Alexander, C (reprint author), Univ Portsmouth, Sch Pharm & Biomed Sci, White Swan Rd, Portsmouth PO1 2DT, Hants, England.
RI Smith, James/D-2350-2011; Alexander, Cameron/N-7729-2014; Smith,
   James/F-1108-2014
OI Smith, James/0000-0001-8805-3788; Alexander,
   Cameron/0000-0001-8337-1875; Smith, James/0000-0001-8805-3788;
   Tsibouklis, John/0000-0001-5300-357X
CR AMIJI M, 1992, BIOMATERIALS, V13, P682, DOI 10.1016/0142-9612(92)90128-B
   An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   BERGSTROM K, 1992, J BIOMED MATER RES, V26, P779, DOI 10.1002/jbm.820260607
   Bos R, 1999, FEMS MICROBIOL REV, V23, P179, DOI 10.1016/S0168-6445(99)00004-2
   Brady RF, 1997, CHEM IND-LONDON, P219
   BRIDGETT MJ, 1992, BIOMATERIALS, V13, P411, DOI 10.1016/0142-9612(92)90159-L
   Chapman RG, 2001, LANGMUIR, V17, P1225, DOI 10.1021/la001222d
   CHARKOUDIAN JC, 1988, J SOC COSMET CHEM, V39, P225
   EDWARDS DP, 1995, THESIS U PORTSMOUTH
   Elbert DL, 1996, ANNU REV MATER SCI, V26, P365, DOI 10.1146/annurev.ms.26.080196.002053
   Frazier RA, 2000, BIOMATERIALS, V21, P957, DOI 10.1016/S0142-9612(99)00270-7
   Geesin JC, 1996, J BIOMED MATER RES, V33, P1
   Good RJ, 1997, J ADHESION, V63, P5, DOI 10.1080/00218469708015210
   GOOD RJ, 1992, J ADHES SCI TECHNOL, V6, P1269, DOI 10.1163/156856192X00629
   Green RJ, 2000, BIOMATERIALS, V21, P1823, DOI 10.1016/S0142-9612(00)00077-6
   Green RJ, 1998, J BIOMED MATER RES, V42, P165, DOI 10.1002/(SICI)1097-4636(199811)42:2<165::AID-JBM1>3.0.CO;2-N
   Harder P, 1998, J PHYS CHEM B, V102, P426, DOI 10.1021/jp972635z
   Harris J.M., 1992, POLYETHYLENE GLYCOL
   Holland NB, 1998, NATURE, V392, P799
   HOLMBERG K, 1993, J ADHES SCI TECHNOL, V7, P503, DOI 10.1163/156856193X00826
   Hudome SM, 2001, CURR OPIN INFECT DIS, V14, P303, DOI 10.1097/00001432-200106000-00010
   Ista LK, 1996, FEMS MICROBIOL LETT, V142, P59
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P149, DOI 10.1016/0021-9797(91)90043-8
   Jeong JH, 2000, COLLOID SURFACE B, V18, P371, DOI 10.1016/S0927-7765(99)00162-9
   LEE JH, 1988, POLYM SURFACE DYNAMI, P119
   Mavon A, 1997, COLLOID SURFACE B, V8, P147, DOI 10.1016/S0927-7765(96)01317-3
   MERRILL EW, 1993, J BIOMAT SCI-POLYM E, V5, P1
   Morra M, 1997, J BIOMAT SCI-POLYM E, V9, P55, DOI 10.1163/156856297X00263
   MORTON LHG, 1994, INT BIODETER BIODEGR, V34, P203, DOI 10.1016/0964-8305(94)90083-3
   Ong YL, 1999, LANGMUIR, V15, P2719, DOI 10.1021/la981104e
   OSTERBERG E, 1995, J BIOMED MATER RES, V29, P741, DOI 10.1002/jbm.820290610
   Ostuni E, 1999, COLLOID SURFACE B, V15, P3, DOI 10.1016/S0927-7765(99)00004-1
   OTSUKA H, 2000, CURR OPIN COLLOID IN, V6, P3
   PERRIN DD, 1980, PURIFICATION LAB CHE
   PHILLIPS TJ, 1993, J DERMATOL SURG ONC, V19, P794, DOI 10.1111/j.1524-4725.1993.tb00426.x
   Razatos A, 1998, P NATL ACAD SCI USA, V95, P11059, DOI 10.1073/pnas.95.19.11059
   Rijnaarts HHM, 1999, COLLOID SURFACE B, V14, P179, DOI 10.1016/S0927-7765(99)00035-1
   Sanderson NM, 1996, PESTIC SCI, V46, P255, DOI 10.1002/(SICI)1096-9063(199603)46:3<255::AID-PS345>3.0.CO;2-Y
   SCHOTT H, 1971, J PHARM SCI, V60, P1893, DOI 10.1002/jps.2600601233
   Sofia SJ, 1998, MACROMOLECULES, V31, P5059, DOI 10.1021/ma971016l
   Vacheethasanee K, 2000, J BIOMED MATER RES, V50, P302, DOI 10.1002/(SICI)1097-4636(20000605)50:3<302::AID-JBM3>3.0.CO;2-1
   WAGNER CD, 1981, SURF INTERFACE ANAL, V3, P211, DOI 10.1002/sia.740030506
   Wickson BM, 1999, COLLOID SURFACE A, V156, P201, DOI 10.1016/S0927-7757(99)00071-0
NR 43
TC 35
Z9 35
U1 0
U2 7
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD SEP 15
PY 2002
VL 61
IS 4
BP 641
EP 652
DI 10.1002/jbm.10174
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 568PT
UT WOS:000176551800016
PM 12115455
DA 2018-10-20
ER

PT J
AU Ma, ZW
   Gao, CY
   Juan, J
   Ji, J
   Gong, YH
   Shen, JC
AF Ma, ZW
   Gao, CY
   Juan, J
   Ji, J
   Gong, YH
   Shen, JC
TI Surface modification of poly-L-lactide by photografting of hydrophilic
   polymers towards improving its hydrophilicity
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE graft copolymers; modification surfaces; biocompatibility
ID HUMAN-ENDOTHELIAL CELLS; BLOCK-COPOLYMERS; ADHESION; POLYURETHANE;
   POLYETHYLENE; WETTABILITY; ACRYLAMIDE; ADSORPTION; CARTILAGE; MONOMERS
AB Poly-L-lactide (PLLA) has been used to prepare scaffolds to guide tissue regeneration in tissue engineering research. However, one of the limitations to the use of PLLA as an ideal biomaterial is its high hydrophobicity. To improve the hydrophilicity of PLLA, hydrophilic polymers were grafted onto PLLA membrane surfaces through the combination of photooxidization in hydrogen peroxide and subsequent ultraviolet (UV)-induced grafting copolymerization in the monomer solution. Three kinds of modified PLLA membranes (i.e., PLLA-g-polyhydroxyethyl methacrylate, PLLA-g-polyacrylamide, and PLLA-g-polymethacrylic acid) were obtained, resulting in the more wettable PLLA membranes. The occurrence of the grafting polymerization was confirmed by attenuated total reflectance infrared spectroscopy (ATR-IR) and X-ray photoelectron spectroscopy (XPS) analysis. Surface morphology of the modified PLLA membranes was studied by scan electronic microscopy (SEM). (C) 2002 Wiley Periodicals, Inc.
C1 Zhejiang Univ, Dept Polymer Sci & Engn, Hangzhou 310027, Peoples R China.
   Zhejiang Univ, State Key Lab Silicon Mat Sci, Hangzhou 310027, Peoples R China.
RP Gao, CY (reprint author), Zhejiang Univ, Dept Polymer Sci & Engn, Hangzhou 310027, Peoples R China.
OI Gao, Changyou/0000-0001-5084-7208
CR AJAYAGHOSH A, 1992, J APPL POLYM SCI, V45, P1617, DOI 10.1002/app.1992.070450912
   BAMFORD CH, 1994, POLYMER, V35, P2844, DOI 10.1016/0032-3861(94)90316-6
   Bottino FA, 1998, MACROMOLECULES, V31, P7814, DOI 10.1021/ma9700183
   Cao YL, 1997, PLAST RECONSTR SURG, V100, P297, DOI 10.1097/00006534-199708000-00001
   CLARK P, 1992, J CELL SCI, V103, P287
   Fang YE, 1996, J APPL POLYM SCI, V62, P2209, DOI 10.1002/(SICI)1097-4628(19961226)62:13<2209::AID-APP4>3.0.CO;2-N
   FENG XD, 1985, MAKROMOL CHEM, V186, P1533
   FUJIMOTO K, 1993, BIOMATERIALS, V14, P442, DOI 10.1016/0142-9612(93)90147-T
   GERENSER LJ, 1985, POLYMER, V26, P1162, DOI 10.1016/0032-3861(85)90245-9
   Guan JJ, 2000, J APPL POLYM SCI, V77, P2505, DOI 10.1002/1097-4628(20000912)77:11<2505::AID-APP20>3.3.CO;2-L
   Guan JJ, 2000, J BIOMAT SCI-POLYM E, V11, P523, DOI 10.1163/156856200743841
   HAMILTON LM, 1994, J APPL POLYM SCI, V52, P413, DOI 10.1002/app.1994.070520306
   Kokatnur V. R., 1941, J AM CHEM SOC, V63, P1432
   Lampin M, 1997, J BIOMED MATER RES, V36, P99, DOI 10.1002/(SICI)1097-4636(199707)36:1<99::AID-JBM12>3.0.CO;2-E
   Lens JP, 1997, J BIOMAT SCI-POLYM E, V8, P963, DOI 10.1163/156856297X00128
   MATSUDA K, 1990, BIOMATERIALS, V11, P351, DOI 10.1016/0142-9612(90)90113-5
   MIKOS AG, 1994, BIOMATERIALS, V15, P55, DOI 10.1016/0142-9612(94)90197-X
   MISHRA MK, 1982, J APPL POLYM SCI, V27, P1845, DOI 10.1002/app.1982.070270541
   NAKAJIMA K, 1990, POLYM J, V22, P985, DOI 10.1295/polymj.22.985
   SCHINDLER A, 1979, J POLYM SCI POL CHEM, V17, P2593, DOI 10.1002/pol.1979.170170831
   VACANTI CA, 1991, PLAST RECONSTR SURG, V88, P753, DOI 10.1097/00006534-199111000-00001
   VANWACHEM PB, 1987, BIOMATERIALS, V8, P323, DOI 10.1016/0142-9612(87)90001-9
   VANWACHEM PB, 1985, BIOMATERIALS, V6, P403, DOI 10.1016/0142-9612(85)90101-2
   Yuan XY, 1998, J APPL POLYM SCI, V69, P1907, DOI 10.1002/(SICI)1097-4628(19980906)69:10<1907::AID-APP3>3.3.CO;2-0
NR 24
TC 58
Z9 63
U1 1
U2 24
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD SEP 6
PY 2002
VL 85
IS 10
BP 2163
EP 2171
DI 10.1002/app.10803
PG 9
WC Polymer Science
SC Polymer Science
GA 564XA
UT WOS:000176337800014
DA 2018-10-20
ER

PT J
AU Tong, WD
   Eppell, SJ
AF Tong, WD
   Eppell, SJ
TI Control of surface mineralization using collagen fibrils
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE mineralization; collagen; osteoblast; orthopedic biomaterial; atomic
   force microscopy
ID ATOMIC-FORCE MICROSCOPY; NEUTRON-DIFFRACTION; PATTERN-FORMATION;
   CARBOXYL GROUPS; GROWTH; BONE; CRYSTAL; HYDROXYAPATITE; IMMOBILIZATION;
   INSTABILITIES
AB Surface structure in the form of roughness and organized patterning can affect osteoblastic adhesion and proliferation. This study investigates the effect of reconstituted collagen fibrils on the deposition pattern of a homogeneous inorganic mineral (sodium chloride). The patterns were monitored from nanometer to millimeter scales using atomic force and light microscopies. Initially, mineral deposits formed blocks following the contour of the collagen fibrils. At later times, dendritic structures formed. This demonstrates that collagen fibrils can affect the surface deposition pattern of saline minerals. It is also shown that collagen fibril diameter and the stoichiometry of the inorganic and organic phases effect the surface distribution of minerals. (C) 2002 Wiley Periodicals, Inc.
C1 Case Western Reserve Univ, Dept Biomed Engn, Nanoscale Orthoped Biomat Lab, Cleveland, OH 44106 USA.
RP Eppell, SJ (reprint author), Case Western Reserve Univ, Dept Biomed Engn, Nanoscale Orthoped Biomat Lab, 10900 Euclid Ave, Cleveland, OH 44106 USA.
OI Eppell, Steven/0000-0002-0302-1910
CR Anselme K, 2000, J BIOMED MATER RES, V49, P155, DOI 10.1002/(SICI)1097-4636(200002)49:2<155::AID-JBM2>3.3.CO;2-A
   BASELT DR, 1993, BIOPHYS J, V65, P2644, DOI 10.1016/S0006-3495(93)81329-8
   BENJACOB E, 1983, PHYS REV LETT, V51, P1930, DOI 10.1103/PhysRevLett.51.1930
   BONAR LC, 1985, J MOL BIOL, V181, P265, DOI 10.1016/0022-2836(85)90090-7
   BRUCKNER P, 1981, ANAL BIOCHEM, V110, P360, DOI 10.1016/0003-2697(81)90204-9
   CHAPMAN JA, 1990, ELECTRON MICROSC REV, V3, P143, DOI 10.1016/0892-0354(90)90018-N
   CHESMEL KD, 1995, J BIOMED MATER RES, V29, P1101, DOI 10.1002/jbm.820290910
   DEYME M, 1986, J BIOMED MATER RES, V20, P951, DOI 10.1002/jbm.820200710
   Eanes E. D., 1992, CALCIFICATION BIOL S, P1
   GALE M, 1995, BIOPHYS J, V68, P2124, DOI 10.1016/S0006-3495(95)80393-0
   GELMAN RA, 1979, J BIOL CHEM, V254, P180
   GLIMCHER MJ, 1998, METABOLIC BONE DIS C, P23
   GRATZ AJ, 1993, GEOCHIM COSMOCHIM AC, V57, P491, DOI 10.1016/0016-7037(93)90449-7
   Healy KE, 1996, BIOMATERIALS, V17, P195, DOI 10.1016/0142-9612(96)85764-4
   HENCH LL, 2000, 6 WORLD BIOM C KAM H
   HILLNER PE, 1992, ULTRAMICROSCOPY, V42, P1387, DOI 10.1016/0304-3991(92)90454-R
   HODGE AJ, 1967, TREATISE COLLAGEN, V1, P185
   HOLMES DF, 1986, INT J BIOL MACROMOL, V8, P161, DOI 10.1016/0141-8130(86)90020-6
   KESSLER DA, 1988, ADV PHYS, V37, P255, DOI 10.1080/00018738800101379
   KESSLER DA, 1984, PHYS REV A, V30, P2820, DOI 10.1103/PhysRevA.30.2820
   Kieswetter K, 1996, CRIT REV ORAL BIOL M, V7, P329, DOI 10.1177/10454411960070040301
   Kieswetter K, 1996, J BIOMED MATER RES, V32, P55, DOI 10.1002/(SICI)1097-4636(199609)32:1<55::AID-JBM7>3.0.CO;2-O
   Kubinek R, 1998, Sb Lek, V99, P557
   LANGER JS, 1980, REV MOD PHYS, V52, P1, DOI 10.1103/RevModPhys.52.1
   LEE DD, 1991, J MOL BIOL, V217, P487, DOI 10.1016/0022-2836(91)90752-R
   LIU F, 1990, PHYS REV A, V42, P5052, DOI 10.1103/PhysRevA.42.5052
   LOWENSTAM HA, 1989, BIOMINERALISATION, P135
   MARTIN JY, 1995, J BIOMED MATER RES, V29, P389, DOI 10.1002/jbm.820290314
   MASSAS R, 1993, J DENT RES, V72, P1005, DOI 10.1177/00220345930720060201
   Matsumura K, 2000, J BIOMED MATER RES, V50, P512, DOI 10.1002/(SICI)1097-4636(20000615)50:4<512::AID-JBM6>3.3.CO;2-7
   MCPHERSON JM, 1985, COLLAGEN REL RES, V5, P119
   MERGENHAGEN SE, 1960, BIOCHIM BIOPHYS ACTA, V43, P563, DOI 10.1016/0006-3002(60)90488-1
   MULLERKRUMBHAAR H, 1981, ACTA METALL MATER, V29, P145, DOI 10.1016/0001-6160(81)90095-X
   ONUMA K, 1995, J CRYST GROWTH, V154, P118, DOI 10.1016/0022-0248(95)00201-4
   PARK JB, 1992, BIOMATERIALS INTRO
   REVENKO I, 1994, BIOL CELL, V80, P67, DOI 10.1016/0248-4900(94)90019-1
   Rho JY, 1998, MED ENG PHYS, V20, P92, DOI 10.1016/S1350-4533(98)00007-1
   Sato K, 2000, J BIOMED MATER RES, V50, P16, DOI 10.1002/(SICI)1097-4636(200004)50:1<16::AID-JBM3>3.0.CO;2-G
   Sato K, 2001, J COLLOID INTERF SCI, V240, P133, DOI 10.1006/jcis.2001.7617
   SAWADA Y, 1986, PHYS REV LETT, V56, P1260, DOI 10.1103/PhysRevLett.56.1260
   TABATA Y, 1986, BIOMATERIALS, V7, P234, DOI 10.1016/0142-9612(86)90110-9
   WHITE SW, 1977, NATURE, V266, P421, DOI 10.1038/266421a0
NR 42
TC 14
Z9 14
U1 0
U2 4
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD SEP 5
PY 2002
VL 61
IS 3
BP 346
EP 353
DI 10.1002/jbm.10165
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 564ZJ
UT WOS:000176343200002
PM 12115459
DA 2018-10-20
ER

PT J
AU Vehof, JWM
   Takita, H
   Kuboki, Y
   Spauwen, PHM
   Jansen, JA
AF Vehof, JWM
   Takita, H
   Kuboki, Y
   Spauwen, PHM
   Jansen, JA
TI Histological characterization of the early stages of bone morphogenetic
   protein-induced osteogenesis
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE bone morphogenetic protein; bone engineering; scaffold; ectopic;
   osteogenesis
ID BMP-INDUCED OSTEOGENESIS; COATED TITANIUM-MESH; RAT ECTOPIC MODEL;
   ENDOCHONDRAL OSSIFICATION; CELL-DIFFERENTIATION; BIOMATERIAL CARRIERS;
   CALCIUM-PHOSPHATE; HYDROXYAPATITE; PHARMACOKINETICS; PURIFICATION
AB On the basis of currently available knowledge, we hypothesize that the initial bone formation, as induced by bone morphogenetic protein (BMP), is influenced by the chemical composition and three-dimensional spatial configuration of the used carrier material. Therefore, in the current study, the osteoinductive properties of porous titanium (Ti) fiber mesh with a calcium phosphate (Ca-P) coating (Ti-CaP), insoluble bone matrix (IBM), fibrous glass membrane (FGM), and porous particles of hydroxy apatite (PPHAP) loaded with rhBMP-2 were compared in a rat ectopic assay model at short implantation periods. Twelve Ti-CaP, 12 IBM, 12 FGM, and 12 PPHAP implants, loaded with rhBMP-P2, were subcutaneously placed in 16 Wistar King rats. The rats were sacrificed at 3, 5, 7, and 9 days post-operative, and the implants were retrieved. Histological analysis demonstrated that IBM and Ti-CaP had induced ectopic cartilage and bone formation by 5 and 7 days, respectively. However, in PPHAP, bone formation and cartilage formation were seen together at 7 days. At 9 days, in Ti-CaP, IBM, and PPHAP, cartilage was seen together with trabecular bone. At 9 days, in FGM, only cartilage was observed. Quantitative rating of the tissue response, using a scoring system, demonstrated that the observed differences were statistically significant (Wilcoxon rank sum test, p < 0.05). We conclude that IBM, CaP-coated Ti mesh, FGM, and PPHAP provided with rhBMP-2 can indeed induce ectopic bone formation with a cartilaginous phase in a rat model it short implantation periods. Considering the different chemical composition and three-dimensional spatial configuration of the carrier materials used, these findings even suggest that endochondral ossification is present in rhBMP-2-induced osteogenesis, even though the amount of cartilage may differ. (C) 2002 Wiley Periodicals, Inc.
C1 Univ Nijmegen, Med Ctr, Dept Biomat, Coll Dent Sci, NL-6500 HB Nijmegen, Netherlands.
   Hokkaido Univ, Sch Dent, Dept Biochem, Sapporo, Hokkaido 060, Japan.
   Univ Nijmegen, Med Ctr, Dept Plast & Reconstruct Surg, NL-6500 HB Nijmegen, Netherlands.
RP Jansen, JA (reprint author), Univ Nijmegen, Med Ctr, Dept Biomat, Coll Dent Sci, POB 9101, NL-6500 HB Nijmegen, Netherlands.
RI Jansen, John/H-8055-2014; Takita, Hiroko/G-1367-2012
CR BASSET CAL, 1962, NATURE, V190, P460
   Brekke J H, 1996, Tissue Eng, V2, P97, DOI 10.1089/ten.1996.2.97
   CAPLAN AI, 1990, CLIN ORTHOP RELAT R, P257
   Caplan AI, 1987, BONE MINERAL RES, P117
   Doherty MJ, 1998, J BONE MINER RES, V13, P828, DOI 10.1359/jbmr.1998.13.5.828
   Girton TS, 1999, J BIOMED MATER RES, V46, P87, DOI 10.1002/(SICI)1097-4636(199907)46:1<87::AID-JBM10>3.0.CO;2-K
   HALL BK, 1969, LIFE SCI, V8, P533
   IIDA S, 1994, JPN J ORAL BIOL, V36, P249
   Itoh H, 1994, Dent Mater J, V13, P25
   Jansen J A, 1993, Clin Oral Implants Res, V4, P28, DOI 10.1034/j.1600-0501.1993.040104.x
   JANSEN JA, 1994, J BIOMED MATER RES, V28, P1047, DOI 10.1002/jbm.820280909
   JANSEN JA, 1997, P 1 SMITH NEPH INT S
   Jin QM, 2000, J BIOMED MATER RES, V51, P491, DOI 10.1002/1097-4636(20000905)51:3<491::AID-JBM25>3.0.CO;2-1
   Kuboki Y, 1995, CONNECT TISSUE RES, V32, P219, DOI 10.3109/03008209509013726
   Kuboki Y, 1998, J BIOMED MATER RES, V39, P190, DOI 10.1002/(SICI)1097-4636(199802)39:2<190::AID-JBM4>3.0.CO;2-K
   KUBOKI Y, 1992, OSTEOGENESIS INDUCED, P127
   KUBOKI Y, 1998, J DENT RES, V77, P1262
   KUBOKI Y, 1997, P 2 INT C BMP SACR C
   LUYTEN FP, 1989, J BIOL CHEM, V264, P13377
   Mahmood J, 2001, J BIOCHEM-TOKYO, V129, P163, DOI 10.1093/oxfordjournals.jbchem.a002828
   Missana L, 1994, JPN J ORAL BIOL, V36, P9
   MIYAMOTO S, 1992, CLIN ORTHOP RELAT R, P274
   MONMA H, 1987, J MATER SCI, V22, P4247, DOI 10.1007/BF01132015
   Mori S, 1998, BONE, V22, P99, DOI 10.1016/S8756-3282(97)00248-2
   Paquay YCGJ, 1997, BIOMATERIALS, V18, P161, DOI 10.1016/S0142-9612(96)00090-7
   REDDI AH, 1981, COLLAGEN REL RES, V1, P209
   REDDI AH, 1980, ENDOCRINOLOGY, V107, P1291, DOI 10.1210/endo-107-5-1291
   SASANO Y, 1993, ANAT REC, V236, P373, DOI 10.1002/ar.1092360211
   Sasano Y, 1997, ANAT RECORD, V247, P472, DOI 10.1002/(SICI)1097-0185(199704)247:4<472::AID-AR5>3.0.CO;2-T
   TAKAOKA K, 1994, BONE GRAFTS, DERIVATIVES AND SUBSTITUTES, P377
   TRUETA J, 1963, J BONE JOINT SURG BR, V45, P402
   Uludag H, 2000, J BIOMED MATER RES, V50, P227, DOI 10.1002/(SICI)1097-4636(200005)50:2<227::AID-JBM18>3.0.CO;2-2
   Uludag H, 1999, J BIOMED MATER RES, V46, P193, DOI 10.1002/(SICI)1097-4636(199908)46:2<193::AID-JBM8>3.0.CO;2-1
   URIST MR, 1984, P NATL ACAD SCI-BIOL, V81, P371, DOI 10.1073/pnas.81.2.371
   VANDERLUBBE HBM, 1988, STAIN TECHNOL, V63, P171, DOI 10.3109/10520298809107179
   Vehof JWM, 2001, PLAST RECONSTR SURG, V108, P434, DOI 10.1097/00006534-200108000-00024
   Vehof JWM, 2000, BIOMATERIALS, V21, P2003, DOI 10.1016/S0142-9612(00)00094-6
   WANG EA, 1990, P NATL ACAD SCI USA, V87, P2220, DOI 10.1073/pnas.87.6.2220
   Zhang RY, 1999, J BIOMED MATER RES, V44, P446
NR 39
TC 26
Z9 30
U1 0
U2 1
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD SEP 5
PY 2002
VL 61
IS 3
BP 440
EP 449
DI 10.1002/jbm.10216
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 564ZJ
UT WOS:000176343200012
PM 12115469
DA 2018-10-20
ER

PT J
AU Meseguer-Olmo, L
   Ros-Nicolas, MJ
   Clavel-Sainz, M
   Vicente-Ortega, V
   Alcaraz-Banos, M
   Lax-Perez, A
   Arcos, D
   Ragel, CV
   Vallet-Regi, M
AF Meseguer-Olmo, L
   Ros-Nicolas, MJ
   Clavel-Sainz, M
   Vicente-Ortega, V
   Alcaraz-Banos, M
   Lax-Perez, A
   Arcos, D
   Ragel, CV
   Vallet-Regi, M
TI Biocompatibility and in vivo gentamicin release from bioactive sol-gel
   glass implants
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE in vivo gentamicin release; sol-gel glasses; bioactive glasses; in vivo
   bioactivity; SiO2-CaO-P2O5 system
ID DRUG-DELIVERY SYSTEM; COMPOSITES
AB Biomaterial pieces, with suitable osteogenic properties for use in the treatment of bone defects and the capability to avoid bone infections, have been synthesized. These materials are composed exclusively of gentamicin sulfate and bioactive SiO2-CaO-P2O5 sol-gel glass (previously synthesized.). Implant processing was achieved by uniaxial and isostatic pressure of the components mixture. After implanting the pieces into rabbit femur, we studied (i) the antibiotic release, determining the concentration in proximal and distal bone, liver, kidney, and lung as a function of time; and (ii) the bone growth resulting from the glass reactivity in the biologic environment. The results indicate that the implants are good carriers for local gentamicin release in the osseous tissue, exhibiting excellent biocompatibility and bone integration. Moreover, these implants are able to promote bone growth during their resorption process. (C) 2002 Wiley Periodicals, Inc.
C1 Univ Complutense, Dept Quim Inorgan & Bioinorgan, Fac Farm, E-28040 Madrid, Spain.
   Univ Murcia, Fac Med, Lab Cirugia Ortoped Expt, E-30001 Murcia, Spain.
RP Vallet-Regi, M (reprint author), Univ Complutense, Dept Quim Inorgan & Bioinorgan, Fac Farm, E-28040 Madrid, Spain.
RI Arcos, Daniel/L-6167-2014; Vallet-Regi, Maria/M-3378-2014
OI Arcos, Daniel/0000-0002-5367-7272; Vallet-Regi,
   Maria/0000-0002-6104-4889; Meseguer-Olmo, Luis/0000-0003-3858-8148
CR Arcos D, 2001, BIOMATERIALS, V22, P701, DOI 10.1016/S0142-9612(00)00233-7
   Balas F, 2001, J MATER RES, V16, P1345, DOI 10.1557/JMR.2001.0187
   BARZA M, 1978, CLIN PHARMACOKINET, V3, P202, DOI 10.2165/00003088-197803030-00002
   BUCHHOLZ HW, 1970, CHIRURG, V41, P511
   del Real RP, 2000, J BIOMED MATER RES, V52, P1
   Ducheyne P, 1998, MRS BULL, V23, P43
   Hench L.L., 1998, HDB BIOMATERIAL PROP, P355, DOI 10.1007/978-1-4615-5801-9_22
   NOONE P, 1974, BRIT MED J, V1, P477, DOI 10.1136/bmj.1.5906.477
   NORDSTROEM L, 1973, Acta Pathologica et Microbiologica Scandinavica Supplementum, V241, P58
   OTSUKA M, 1995, J BIOMED MATER RES, V29, P33, DOI 10.1002/jbm.820290106
   Ragel CV, 2000, J BIOMED MATER RES, V51, P424, DOI 10.1002/1097-4636(20000905)51:3<424::AID-JBM17>3.0.CO;2-E
   TORHOLM C, 1983, CLIN ORTHOP RELAT R, P99
   Vallet-Regi M, 2000, J BIOMED MATER RES, V51, P23, DOI 10.1002/(SICI)1097-4636(200007)51:1<23::AID-JBM4>3.0.CO;2-B
   Vallet-Regi M, 2001, J CHEM SOC DALTON, P97, DOI 10.1039/b007852m
   vanWachem PB, 1997, J BIOMED MATER RES, V35, P217, DOI 10.1002/(SICI)1097-4636(199705)35:2<217::AID-JBM10>3.0.CO;2-E
   VECSEI V, 1981, CLIN ORTHOP RELAT R, P201
   Zaske D, 1986, TXB CLIN APPL THERAP, P285
NR 17
TC 52
Z9 53
U1 2
U2 12
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD SEP 5
PY 2002
VL 61
IS 3
BP 458
EP 465
DI 10.1002/jbm.10188
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 564ZJ
UT WOS:000176343200014
PM 12115471
DA 2018-10-20
ER

PT J
AU Cheng, NX
   Wang, YL
   Wang, JH
   Zhang, XM
   Zhong, H
AF Cheng, NX
   Wang, YL
   Wang, JH
   Zhang, XM
   Zhong, H
TI Complications of breast augmentation with injected hydrophilic
   polyacrylamide gel
SO AESTHETIC PLASTIC SURGERY
LA English
DT Article
DE breast augmentation; injection biomaterial; complication
AB Since 1997, the hydrophilic polyacrylamide gel (PAAG), an injectable alloplastic biomaterial, imported from the Ukraine has been used for augmentation mammaplasty in China. There were twelve patients with various complications visiting our hospitals after breast augmentation with injected hydrophilic polyacrylamide gel by other clinics, even though such procedures are not performed in our clinical practices. The complications included four cases of PAAG-induced multiple induration and lumps, and one with lactation, three cases of hematoma, two cases of inflammation (infection), and persistent mastodymia, unsatisfactory contour results and abnormal skin sensations in each case. All patients have been treated by removing the injected gel and giving antibiotics. Other procedures included replacement by silicon breast prostheses, mammotomy, and segmental mastectomy. We suggest that the injectable hydrophilic polyacrylamide gel be contraindications for breast augmentation in any young female who is not married, or without a child, with a tendency to hemorrhage, and with little mammary tissue. Some considerations to prevent and manage these complications are discussed.
C1 Guangzhou First Municipal Peoples Hosp, Dept Plast Surg, Guangzhou Med Coll, Guangzhou 510180, Peoples R China.
RP Cheng, NX (reprint author), Guangzhou First Municipal Peoples Hosp, Dept Plast Surg, Guangzhou Med Coll, 602 Renmin N Rd, Guangzhou 510180, Peoples R China.
CR BIRCOLL M, 1987, ANN PLAST SURG, V18, P27
   Chao MJ, 2000, J PRACT AESTH PLAST, V11, P16
   CHEN TH, 1995, BRIT J PLAST SURG, V48, P71, DOI 10.1016/0007-1226(95)90099-3
   ERSEK RA, 1991, PLAST RECONSTR SURG, V87, P219, DOI 10.1097/00006534-199102000-00001
   FANG ZL, 1998, CHIN J MED AESTH COS, V4, P158
   Filatov A V, 1998, Stomatologiia (Mosk), V77, P45
   HANFU L, 1995, AESTHET PLAST SURG, V19, P427
   LEWIS CM, 1980, PLAST RECONSTR SURG, V66, P134, DOI 10.1097/00006534-198007000-00026
   LEWIS CM, 1993, AESTH PLAST SURG, V17, P107
   Niechajev I, 2000, PLAST RECONSTR SURG, V105, P1173, DOI 10.1097/00006534-200003000-00055
   OKUBO M, 1992, AESTHET PLAST SURG, V16, P181, DOI 10.1007/BF00450611
   ORTIZMONASTERIO F, 1972, PLAST RECONSTR SURG, V50, P42, DOI 10.1097/00006534-197207000-00007
   ZHANG YR, 2000, CHIN J MED AESTH CIS, V6, P53
NR 13
TC 83
Z9 92
U1 0
U2 12
PU SPRINGER-VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010 USA
SN 0364-216X
J9 AESTHET PLAST SURG
JI Aesthet. Plast. Surg.
PD SEP-OCT
PY 2002
VL 26
IS 5
BP 375
EP 382
DI 10.1007/s00266-002-2052
PG 8
WC Surgery
SC Surgery
GA 610YT
UT WOS:000178990200011
PM 12432479
DA 2018-10-20
ER

PT J
AU Yang, HH
   Zhu, QZ
   Qu, HY
   Chen, XL
   Ding, MT
   Xu, JG
AF Yang, HH
   Zhu, QZ
   Qu, HY
   Chen, XL
   Ding, MT
   Xu, JG
TI Flow injection fluorescence immunoassay for gentamicin using
   sol-gel-derived mesoporous biomaterial
SO ANALYTICAL BIOCHEMISTRY
LA English
DT Article
DE flow injection immunoassay; sol-gel material; gentamicin
ID IMMUNOAFFINITY CHROMATOGRAPHY; CAPILLARY ELECTROPHORESIS; POLARIZATION
   IMMUNOASSAY; BIOSENSOR; GLASS; ANTIBODIES; ENZYME; PHASE; SERUM
AB Sol-gel-derived mesoporous biomaterials were used for the first time in the flow-injection fluorescence immunoassay system. Anti-gentamicin antibody was immobilized in a mesoporous sol-gel material using tetramethoxysilane as a precursor and poly(ethylene glycol) as a template. The sol-gel glass was used to develop an immumoaffinity column for the flow-injection immunoassay of gentamicin. Little unspecific adsorption of gentamicin on the sol-gel and no antibody leaching under harsh elution conditions were found. The immunoassay is based on the competition between gentamicin and fluorescein isothiocyanate-labeled gentamicin for a limited number of encapsulated antibody binding sites. NaOH solution of 5 x 10(-3) mol/L is used for the regeneration of encapsulated antibody binding sites after each measurement, which allows the immunoreactor to be used for up to 20 times without any loss of reactivity. Sample preconcentration is not needed and a single assay can be performed within 10 min. The calibration for gentamicin has a working range of 250-5000 ng/mL with a detection limit of 200 ng/mL, which is close to that of the fluorescence immunoassay and fluorescence polarization immunoassay using the same reactants. Comparison of the results from this method with that obtained from HPLC showed an excellent correlation. (C) 2002 Elsevier Science (USA). All rights reserved.
C1 Xiamen Univ, Dept Chem, Key Lab Analyt Sci MOE, Xiamen 361005, Peoples R China.
   Xiamen Univ, Dept Mat Sci, Xiamen 361005, Peoples R China.
RP Xu, JG (reprint author), Xiamen Univ, Dept Chem, Key Lab Analyt Sci MOE, Xiamen 361005, Peoples R China.
RI Chen, XL/G-3951-2010
CR Bronshtein A, 2000, CHEM MATER, V12, P2050, DOI 10.1021/cm990780e
   Cichna M, 1997, ANAL CHIM ACTA, V339, P241, DOI 10.1016/S0003-2670(96)00503-X
   DUAN CM, 1994, ANAL CHEM, V66, P1369, DOI 10.1021/ac00081a003
   ELLERBY LM, 1992, SCIENCE, V255, P1113, DOI 10.1126/science.1312257
   Gill I, 1998, J AM CHEM SOC, V120, P8587, DOI 10.1021/ja9814568
   GLEZER V, 1993, J AM CHEM SOC, V115, P2533, DOI 10.1021/ja00059a072
   HARA T, 1994, ANAL CHEM, V66, P351, DOI 10.1021/ac00075a007
   Hartnett AM, 1999, ANAL CHEM, V71, P1215, DOI 10.1021/ac981083t
   HUET D, 1993, ANAL CHIM ACTA, V272, P205, DOI 10.1016/0003-2670(93)80570-B
   Jain TK, 1998, J AM CHEM SOC, V120, P11092, DOI 10.1021/ja973849x
   JOLLEY ME, 1981, CLIN CHEM, V27, P1190
   JOLLEY ME, 1981, CLIN CHEM, V27, P1575
   KRESGE CT, 1992, NATURE, V359, P710, DOI 10.1038/359710a0
   Lee WY, 2000, ANAL CHIM ACTA, V404, P195, DOI 10.1016/S0003-2670(99)00699-6
   Liu ZJ, 2000, ANAL CHEM, V72, P4707, DOI 10.1021/ac990490h
   Lu B, 1997, ANAL CHIM ACTA, V340, P175, DOI 10.1016/S0003-2670(96)00453-9
   Maupas H, 1997, J ELECTROANAL CHEM, V421, P165, DOI 10.1016/S0022-0728(96)04837-1
   Pulido-Tofino P, 2001, ANAL CHIM ACTA, V429, P337, DOI 10.1016/S0003-2670(00)01282-4
   RUZICKA J, 1975, ANAL CHIM ACTA, V78, P145, DOI 10.1016/S0003-2670(01)84761-9
   SCHULTZ NM, 1993, ANAL CHEM, V65, P3161, DOI 10.1021/ac00069a035
   Spitzer B, 2000, J CHROMATOGR A, V880, P113, DOI 10.1016/S0021-9673(99)01311-4
   Sun JH, 2000, CHEM J CHINESE U, V21, P95
   Tao L, 1996, ANAL CHEM, V68, P3899, DOI 10.1021/ac960560+
   Wang BQ, 1999, ANAL CHEM, V71, P1935, DOI 10.1021/ac980940q
   Wang J, 1998, ANAL CHEM, V70, P1171, DOI 10.1021/ac971093e
   Wang J, 1998, J AM CHEM SOC, V120, P5852, DOI 10.1021/ja9742747
   WANG R, 1993, ANAL CHEM, V65, P2671, DOI 10.1021/ac00067a020
   Zuehlke J., 1995, Fresenius' Journal of Analytical Chemistry, V352, P654
NR 28
TC 53
Z9 55
U1 0
U2 10
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0003-2697
J9 ANAL BIOCHEM
JI Anal. Biochem.
PD SEP 1
PY 2002
VL 308
IS 1
BP 71
EP 76
AR PII S0003-2697(02)00222-1
DI 10.1016/S0003-2697(02)00222-1
PG 6
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Chemistry, Analytical
SC Biochemistry & Molecular Biology; Chemistry
GA 602PX
UT WOS:000178514600009
PM 12234465
DA 2018-10-20
ER

PT J
AU Chen, TM
   Wang, HJ
AF Chen, TM
   Wang, HJ
TI Cranioplasty using allogeneic perforated demineralized bone matrix with
   autogenous bone paste
SO ANNALS OF PLASTIC SURGERY
LA English
DT Article
ID INDUCED OSTEOGENESIS; BIOLOGICAL PRINCIPLE; SKULL DEFECTS;
   RECONSTRUCTION; SURGERY; GRAFTS; REPAIR
AB The efficacy of allogeneic perforated demineralized bone matrix with autogenous bone paste in the treatment of full-thickness cranial defects was evaluated in 10 consecutive patients between June 1998 and December 1998. The skull defects resulted from trauma in 9 patients and removal of a cranial tumor in 1 patient. The size of the skull defects ranged from 8 x 6 cm to 11 x 12.5 cm. Follow-up averaged 33 months for all patients. Postimplantation evaluations included serial photographs, repeated physical examination, and three-dimensional computed tomography for all patients. Visual inspection of the implanted biomaterial 6 months later was possible in I patient. The contour of the reconstructed skull was acceptable aesthetically without any secondary depression noted during the follow-up period. Three-dimensional computed tomographic scans taken 2 years after implantation indicated that the allogeneic perforated demineralized bone matrix provided a matrix for new bone formation with remarkable osteoinductive potential for new bone formation. The autogenous bone paste was able to caulk the demineralized bone matrix and fill the contour irregularities and gaps of the reconstructed cranium. The results from this clinical study indicated that allogeneic perforated demineralized bone matrix with autogenous bone paste is a promising alternative to an autogenous bone graft and or alloplastic material for cranioplasty.
C1 Tri Serv Gen Hosp, Natl Def Med Ctr, Div Plast Surg, Dept Surg, Taipei, Taiwan.
   Armed Forces Tao Yuan Gen Hosp, Tao Yuan, Taiwan.
RP Chen, TM (reprint author), POB 30-457, Taipei, Taiwan.
CR BAKAMJIAN VY, 1977, PLAST RECONSTR SURG, V60, P784, DOI 10.1097/00006534-197711000-00023
   EDWARDS MSB, 1987, NEUROSURGERY, V20, P273, DOI 10.1227/00006123-198702000-00013
   GENDLER E, 1986, J BIOMED MATER RES, V20, P687, DOI 10.1002/jbm.820200603
   GLOWACKI J, 1981, LANCET, V1, P959
   HABAL MB, 1978, PLAST RECONSTR SURG, V61, P394, DOI 10.1097/00006534-197803000-00014
   JACKSON IT, 1983, ANN PLAS SURG, V11, P527, DOI 10.1097/00000637-198312000-00014
   MANSON PN, 1986, PLAST RECONSTR SURG, V77, P888, DOI 10.1097/00006534-198606000-00003
   MELLONIG JT, 1992, J PERIODONTOL, V63, P979, DOI 10.1902/jop.1992.63.12.979
   Moss SD, 1995, PEDIATR NEUROSURG, V23, P199
   MULLIKEN JB, 1981, ANN SURG, V194, P366, DOI 10.1097/00000658-198109000-00015
   MULLIKEN JB, 1984, J SURG RES, V37, P487, DOI 10.1016/0022-4804(84)90218-X
   MULLIKEN JB, 1980, PLAST RECONSTR SURG, V65, P553, DOI 10.1097/00006534-198005000-00001
   NICKELL WB, 1972, ARCH SURG-CHICAGO, V105, P431
   OBroin ES, 1997, CLEFT PALATE-CRAN J, V34, P354, DOI 10.1597/1545-1569(1997)034<0353:TMABDC>2.3.CO;2
   OUSTERHOUT DK, 1985, ANN PLAS SURG, V15, P367, DOI 10.1097/00000637-198511000-00001
   PROLO DJ, 1979, NEUROSURGERY, V4, P18, DOI 10.1227/00006123-197901000-00005
   Salyer K E, 1992, J Craniofac Surg, V3, P55, DOI 10.1097/00001665-199209000-00002
   Salyer KE, 1997, PLAST RECONSTR SURG, V99, P1721, DOI 10.1097/00006534-199705000-00038
   Shehadi S I, 1970, Br J Plast Surg, V23, P227, DOI 10.1016/S0007-1226(70)80046-7
   TORIUMI DM, 1990, ARCH OTOLARYNGOL, V116, P676
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   WOLFE SA, 1982, CLIN PLAST SURG, V9, P539
NR 22
TC 34
Z9 35
U1 0
U2 3
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0148-7043
J9 ANN PLAS SURG
JI Ann. Plast. Surg.
PD SEP
PY 2002
VL 49
IS 3
BP 272
EP 277
DI 10.1097/01.SAP.0000015488.91165.B8
PG 6
WC Surgery
SC Surgery
GA 592DN
UT WOS:000177921600007
PM 12351975
DA 2018-10-20
ER

PT J
AU Betre, H
   Setton, LA
   Meyer, DE
   Chilkoti, A
AF Betre, H
   Setton, LA
   Meyer, DE
   Chilkoti, A
TI Characterization of a genetically engineered elastin-like polypeptide
   for cartilaginous tissue repair
SO BIOMACROMOLECULES
LA English
DT Article
ID INVERSE TEMPERATURE TRANSITION; EXTRACELLULAR-MATRIX;
   ARTICULAR-CARTILAGE; MECHANICAL-BEHAVIOR; ENDOTHELIAL-CELLS; IN-VITRO;
   CHONDROCYTES; CULTURE; PURIFICATION; COLLAGEN
AB Elastin-like polypeptides (ELPs) are artificial polypeptides with unique properties that make them attractive as a biomaterial for tissue-engineered cartilage repair. ELPs are composed of a pentapeptide repeat, Val-Pro-Gly-Xaa-Gly (Xaa is any amino acid except Pro), that undergo an inverse temperature phase transition. They are soluble in aqueous solution below their transition temperature (T-t) but aggregate when the solution temperature is raised above their T-t. This study investigates the theological behavior of an un-cross-linked ELP, below and above its T-t and also examines the ability of ELP to promote chondrogenesis in vitro. A thermally responsive ELP with a T-t of 35 degreesC was synthesized using recombinant DNA techniques. The complex shear modulus of the ELP increased by 3 orders of magnitude as it underwent its inverse temperature phase transition, forming a coacervate. or gel-like, ELP phase. Values for the complex shear moduli of the un-cross-linked ELP coacervate are comparable to those reported previously for collagen, hyaluronan, and cross-linked synthetic hydrogels. Cell culture studies show that chondrocytes cultured in ELP coacervate maintain a rounded morphology and their chondrocytic phenotype, characterized by the synthesis of a significant amount of extracellular matrix composed of sulfated glycosaminoglycans and collagen. These results suggest that ELPs demonstrate great potential for use as in situ forming scaffolds for cartilaginous tissue repair.
C1 Duke Univ, Dept Biomed Engn, Durham, NC 27708 USA.
RP Chilkoti, A (reprint author), Duke Univ, Dept Biomed Engn, Box 90281, Durham, NC 27708 USA.
OI Meyer, Dan/0000-0002-1574-1704
CR Ameer GA, 2002, J ORTHOPAED RES, V20, P16, DOI 10.1016/S0736-0266(01)00074-2
   AUSUBEL FM, 1995, CURRENT PROTOCOLS MO
   BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7
   BOYD LM, 2001, ANN BIOMED ENG, V29
   Brun P, 1999, J MATER SCI-MATER M, V10, P683, DOI 10.1023/A:1008960413362
   BUCKWALTER JA, 1993, J BONE JOINT SURG AM, V75A, P1533, DOI 10.2106/00004623-199310000-00015
   BUSCHMANN MD, 1992, J ORTHOPAED RES, V10, P745, DOI 10.1002/jor.1100100602
   Chenite A, 2000, BIOMATERIALS, V21, P2155, DOI 10.1016/S0142-9612(00)00116-2
   CHU CR, 1995, J BIOMED MATER RES, V29, P1147, DOI 10.1002/jbm.820290915
   Elisseeff J, 2000, J BIOMED MATER RES, V51, P164, DOI 10.1002/(SICI)1097-4636(200008)51:2<164::AID-JBM4>3.0.CO;2-W
   FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5
   FREED LE, 1993, J BIOMED MATER RES, V27, P11, DOI 10.1002/jbm.820270104
   GRAY WR, 1973, NATURE, V246, P461, DOI 10.1038/246461a0
   Guilak F, 2001, CLIN ORTHOP RELAT R, pS295
   HAUSELMANN H, 1992, MATRIX, V22, P116
   HAUSELMANN HJ, 1994, J CELL SCI, V107, P17
   HOLLANDER AP, 1994, J CLIN INVEST, V93, P1722, DOI 10.1172/JCI117156
   Iatridis JC, 1997, J ORTHOP RES, V15, P318, DOI 10.1002/jor.1100150224
   KAMADA H, 2001, T ORTHOP RES SOC, V26, P616
   KIM YJ, 1988, ANAL BIOCHEM, V174, P168, DOI 10.1016/0003-2697(88)90532-5
   LeRoux MA, 1999, J BIOMED MATER RES, V47, P46, DOI 10.1002/(SICI)1097-4636(199910)47:1<46::AID-JBM6>3.0.CO;2-N
   LONG MM, 1989, J CELL PHYSIOL, V140, P512, DOI 10.1002/jcp.1041400316
   McPherson DT, 1996, PROTEIN EXPRES PURIF, V7, P51, DOI 10.1006/prep.1996.0008
   Meyer DE, 2002, BIOMACROMOLECULES, V3, P357, DOI 10.1021/bm015630n
   Meyer DE, 1999, NAT BIOTECHNOL, V17, P1112, DOI 10.1038/15100
   Meyer DE, 2001, CANCER RES, V61, P1548
   NETTLES D, 2001, T ORTHOP RES SOC, V26, P202
   NICOL A, 1992, J BIOMED MATER RES, V26, P393, DOI 10.1002/jbm.820260309
   Paige KT, 1996, PLAST RECONSTR SURG, V97, P168, DOI 10.1097/00006534-199601000-00027
   Ragan PM, 2000, ARCH BIOCHEM BIOPHYS, V383, P256, DOI 10.1006/abbi.2000.2060
   SANDBERG LB, 1985, PATHOL BIOL, V33, P266
   Schreiber RE, 1999, ANN NY ACAD SCI, V875, P398, DOI 10.1111/j.1749-6632.1999.tb08522.x
   SETTON LA, 1995, J ORTHOPAED RES, V13, P473, DOI 10.1002/jor.1100130402
   Silverman RP, 1999, PLAST RECONSTR SURG, V103, P1809, DOI 10.1097/00006534-199906000-00001
   Sims CD, 1998, PLAST RECONSTR SURG, V101, P1580, DOI 10.1097/00006534-199805000-00022
   Smeds KA, 2001, J BIOMED MATER RES, V54, P115, DOI 10.1002/1097-4636(200101)54:1<115::AID-JBM14>3.0.CO;2-Q
   Solchaga LA, 1999, J ORTHOPAED RES, V17, P205, DOI 10.1002/jor.1100170209
   SOLURSH M, 1982, DEV BIOL, V94, P259, DOI 10.1016/0012-1606(82)90090-2
   Stile RA, 1999, MACROMOLECULES, V32, P7370, DOI 10.1021/ma990130w
   URRY DW, 1991, J BIOACT COMPAT POL, V6, P263, DOI 10.1177/088391159100600306
   URRY DW, 1992, PROG BIOPHYS MOL BIO, V57, P23, DOI 10.1016/0079-6107(92)90003-O
   URRY DW, 1991, J AM CHEM SOC, V113, P4346, DOI 10.1021/ja00011a057
   URRY DW, 1992, ABSTR PAP AM CHEM S, V203, P202
   URRY DW, 1988, J PROTEIN CHEM, V7, P1, DOI 10.1007/BF01025411
   URRY DW, 1992, SYNTHESES CHARACTERI, V1
   VunjakNovakovic G, 1996, AICHE J, V42, P850, DOI 10.1002/aic.690420323
   Welsh ER, 2000, BIOMACROMOLECULES, V1, P23, DOI 10.1021/bm0002914
   WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0
   ZHU W, 1996, J BIOMECH ENG, V29
   ZHU WB, 1994, J BIOMECH, V27, P571, DOI 10.1016/0021-9290(94)90066-3
NR 50
TC 172
Z9 178
U1 1
U2 58
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD SEP-OCT
PY 2002
VL 3
IS 5
BP 910
EP 916
DI 10.1021/bm0255037
PG 7
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 592XX
UT WOS:000177963100006
PM 12217035
DA 2018-10-20
ER

PT J
AU Cornelius, RM
   Archambault, J
   Brash, JL
AF Cornelius, RM
   Archambault, J
   Brash, JL
TI Identification of apolipoprotein A-I as a major adsorbate on biomaterial
   surfaces after blood or plasma contact
SO BIOMATERIALS
LA English
DT Article
DE apolipoprotein A-I; high-density lipoprotein; adsorption; blood-material
   interactions
ID PROTEIN ADSORPTION; MICROCAPSULES; POLYETHYLENE; MEMBRANES; LIPOSOMES;
   GLASS
AB Apolipoprotein A-I is the major protein component of HDL. It is reported in this communication that apo A-I is a significant component of the protein layer adsorbed from blood or plasma to a variety of biomaterial surfaces, including hydrophobic and hydrophilic polymers, liposomes, a heparinized surface, and a polysulfone hemodialyzer membrane. Evidence in support of this conclusion front SDS-PAGE and immunoblots of proteins eluted from the surfaces after blood or plasma contact is presented. Whether the presence of apo A-I on these surfaces results from the uptake of the free protein or HDL particles remains to be determined. It appears that apolipoprotein A-I and/or HDL deposition may be an important effect in blood-biomaterial interactions generally, and one that has been largely overlooked. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 McMaster Univ, Dept Chem Engn, Hamilton, ON L8S 4L7, Canada.
   McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON L8S 4L7, Canada.
RP Brash, JL (reprint author), McMaster Univ, Dept Chem Engn, 1280 Main W St, Hamilton, ON L8S 4L7, Canada.
CR Archambault J. G., 1998, T SOC BIOMATER, V21, P251
   Babensee JE, 1998, BIOMATERIALS, V19, P839, DOI 10.1016/S0142-9612(97)00242-1
   Bambauer R, 1997, Ther Apher, V1, P49, DOI 10.1111/j.1744-9987.1997.tb00013.x
   BRASH JL, 1986, J BIOMED MATER RES, V20, P1263, DOI 10.1002/jbm.820200904
   BREEMHAAR W, 1984, BIOMATERIALS, V5, P269, DOI 10.1016/0142-9612(84)90071-1
   CHANG PL, 2000, T 6 WORLD BIOM, P1278
   CORNELIUS RM, 1993, J BIOMAT SCI-POLYM E, V4, P291, DOI 10.1163/156856293X00573
   Cornelius RM, 1999, BIOMATERIALS, V20, P341, DOI 10.1016/S0142-9612(98)00174-4
   Gurr M. I., 1991, LIPID BIOCH
   MCINTYRE N, 1991, LIPIDS LIPOPROTEINS
   MULZER SR, 1989, J BIOMED MATER RES, V23, P1483, DOI 10.1002/jbm.820231210
   ODAKA M, 1987, BIOMAT ARTIF CELLS A, V15, P13
   Patsch W, 1996, METHOD ENZYMOL, V263, P3
   Peirone M, 1998, J BIOMED MATER RES, V42, P587, DOI 10.1002/(SICI)1097-4636(19981215)42:4<587::AID-JBM15>3.0.CO;2-X
   Price ME, 2001, BBA-BIOMEMBRANES, V1512, P191, DOI 10.1016/S0005-2736(01)00330-3
   ROSSENEU M, 1992, STRUCTURE FUNCTION A
   Soltys PJ, 2000, BIOMATERIALS, V21, P37, DOI 10.1016/S0142-9612(99)00130-1
   STANISLAWSKI L, 1995, J BIOMED MATER RES, V29, P315, DOI 10.1002/jbm.820290306
   Turbill P, 1996, BIOMATERIALS, V17, P1279, DOI 10.1016/0142-9612(96)88673-X
   VANDAMME HS, 1991, J BIOMAT SCI-POLYM E, V3, P69, DOI 10.1163/156856292X00088
   Yamazaki A, 1999, BBA-BIOMEMBRANES, V1421, P103, DOI 10.1016/S0005-2736(99)00117-0
NR 21
TC 27
Z9 28
U1 1
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD SEP
PY 2002
VL 23
IS 17
BP 3583
EP 3587
AR PII S0142-9612(02)00083-2
DI 10.1016/S0142-9612(02)00083-2
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 568BM
UT WOS:000176522600006
PM 12109682
DA 2018-10-20
ER

PT J
AU Wong, JY
   Weng, ZP
   Moll, S
   Kim, S
   Brown, CT
AF Wong, JY
   Weng, ZP
   Moll, S
   Kim, S
   Brown, CT
TI Identification and validation of a novel cell-recognition site (KNEED)
   on the 8th type III domain of fibronectin
SO BIOMATERIALS
LA English
DT Article
DE fibronectin; cell adhesion; cell spreading; adhesion peptides
ID INTEGRINS; ADHESION; RGD; FEATURES
AB Interactions between cell-surface integrins and extracellular matrix proteins underlie a versatile recognition system providing cells with anchorage, traction for migration or matrix remodeling, as well as signals for polarity, differentiation and growth. Short peptide sequences of fibronectin (FN), most notably RGD found on a loop in the 10th type III domain, are effective in promoting cell adhesion when immobilized to a biomaterial scaffold. Additional sequences (e.g. PHSRN) have been shown to act synergistically to enhance cell adhesion and other cellular processes. Using bioinformatics, we identified a candidate cell-binding peptide sequence, KNEED, located on the loop region of the 8th domain of FN that from in vitro studies appears to participate in cell attachment and spreading. Computational analysis revealed that KNEED exhibits both high solvent accessibility and sequence conservation values across FN sequences from seven species. We demonstrate the importance of the KNEED sequence using a solution-phase competitive inhibition assay utilizing soluble peptides. Results indicate that the presence of soluble KNEED peptides inhibits the attachment and spreading of 3T3 balb/c fibroblasts on FN-coated surfaces in a concentration-dependent manner. As more sequence and crystallographic data become available, computational approaches may aid in the identification of new targets for applications where biorecognition plays a key role. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA.
RP Wong, JY (reprint author), Boston Univ, Dept Biomed Engn, 44 Cummington St, Boston, MA 02215 USA.
RI Wong, Joyce/F-3732-2011
OI Wong, Joyce/0000-0002-3526-6381
CR Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   AOTA S, 1994, J BIOL CHEM, V269, P24756
   BOWDITCH RD, 1994, J BIOL CHEM, V269, P10856
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   CONNOLLY DT, 1986, ANAL BIOCHEM, V152, P136, DOI 10.1016/0003-2697(86)90131-4
   COTRAIT M, 1992, J COMPUT AID MOL DES, V6, P113, DOI 10.1007/BF00129423
   HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9
   KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211
   KIMIZUKA F, 1991, J BIOCHEM-TOKYO, V110, P284, DOI 10.1093/oxfordjournals.jbchem.a123572
   Leahy DJ, 1996, CELL, V84, P155, DOI 10.1016/S0092-8674(00)81002-8
   Leahy DJ, 1997, ANNU REV CELL DEV BI, V13, P363, DOI 10.1146/annurev.cellbio.13.1.363
   LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X
   MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   RAJAGOPALAN P, IN PRESS MAT RES SOC
   Redick SD, 2000, J CELL BIOL, V149, P521, DOI 10.1083/jcb.149.2.521
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   STREETER HB, 1987, J CELL BIOL, V105, P507, DOI 10.1083/jcb.105.1.507
NR 18
TC 21
Z9 22
U1 0
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD SEP
PY 2002
VL 23
IS 18
BP 3865
EP 3870
AR PII S0142-9612(02)00127-8
DI 10.1016/S0142-9612(02)00127-8
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 579EM
UT WOS:000177165700010
PM 12164191
DA 2018-10-20
ER

PT J
AU Hansson, KM
   Tengvall, P
   Lundstrom, I
   Ranby, M
   Lindahl, TL
AF Hansson, KM
   Tengvall, P
   Lundstrom, I
   Ranby, M
   Lindahl, TL
TI Surface plasmon resonance and free oscillation rheometry in combination:
   a useful approach for studies on haemostasis and interactions between
   whole blood and artificial surfaces
SO BIOSENSORS & BIOELECTRONICS
LA English
DT Article
DE surface plasmon resonance; free oscillation rheometry; whole blood
   coagulation; fibrinolysis
ID PROTEIN ADSORPTION; GLYCOPROTEIN IIB/IIIA; PLATELET BINDING;
   COAGULATION; GOLD; SENSOR; SENSITIVITY; EXPOSURE; BLOCKADE; THROMBIN
AB In haemostatic and biomaterial research biological processes at surfaces and in the bulk phase of the surface-contacting medium are important. The present work demonstrates the usefulness of the combination of surface plasmon resonance (SPR), sensitive to changes in refractive index at surfaces, and free oscillation rheometry (FOR), sensitive to rheological properties of the bulk, for simultaneous real-time measurements on coagulation and fibrinolysis of blood plasma and coagulation of whole blood. SFLLRN stimulated coagulation of native whole blood presented a higher SPR signal with different appearance than plasma coagulation, while the FOR signals corresponding to plasma and whole blood coagulation were similar. This indicated that the SPR technique was more sensitive to cell-surface interactions than to Fibrin formation in whole blood during coagulation, while the FOR technique were equally sensitive to coagulation in whole blood and plasma. Spontaneous coagulation of native whole blood in contact with methyl- and hydroxyl-terminated self-assembled monolayers (SAM) on gold and gold surfaces regenerated after coagulation were also studied. The regenerated gold surfaces displayed the shortest coagulation times, although the contact-activation of blood coagulation for these surfaces was low. The methylated and hydroxylated surfaces were comparable in terms of coagulation activation, while the hydroxylated surfaces presented FOR signals that indicated detaching of the coagulum from the surface. The combination of SPR and FOR is well suited for studies of cell- and protein-surface interactions and simultaneous bulk processes. Possible applications are investigations of blood cell defects in patients and monitoring of native whole blood interactions with artificial surfaces. (C) 2002 Elsevier Science B.V. All rights reserved.
C1 Linkoping Univ Hosp, Dept Biomed & Surg, Div Clin Chem, SE-58185 Linkoping, Sweden.
   Linkoping Univ, Forum Scientum Grad Sch, SE-58183 Linkoping, Sweden.
   Linkoping Univ, Dept Phys & Measurement Technol, Div Appl Phys, SE-58183 Linkoping, Sweden.
RP Hansson, KM (reprint author), Linkoping Univ Hosp, Dept Biomed & Surg, Div Clin Chem, SE-58185 Linkoping, Sweden.
CR BOHLIN L, 1998, Patent No. 9854475
   BOHLIN L, 1994, Patent No. 9408222
   Broberg M, 1998, COLLOID SURFACE B, V11, P67, DOI 10.1016/S0927-7765(98)00026-5
   CARR ME, 1995, THROMB HAEMOSTASIS, V73, P499
   DAVIES J, 1994, NANOBIOLOGY, V3, P5
   Eriksson C, 1997, J BIOMED MATER RES, V37, P130, DOI 10.1002/(SICI)1097-4636(199710)37:1<130::AID-JBM16>3.0.CO;2-K
   GAUTAM SK, 1995, BIO-MED MATER ENG, V5, P141
   GEMMELL CH, 1995, J LAB CLIN MED, V125, P276
   Hansson KM, 1999, BIOSENS BIOELECTRON, V14, P671, DOI 10.1016/S0956-5663(99)00050-0
   HUI KY, 1992, BIOCHEM BIOPH RES CO, V184, P790, DOI 10.1016/0006-291X(92)90659-9
   Johansen K, 2000, REV SCI INSTRUM, V71, P3530, DOI 10.1063/1.1287631
   JORGENSON RC, 1993, SENSOR ACTUAT B-CHEM, V12, P213, DOI 10.1016/0925-4005(93)80021-3
   JORGENSON RC, 1994, SENSOR ACTUAT A-PHYS, V43, P44, DOI 10.1016/0924-4247(93)00661-M
   KAIBARA M, 1985, BIORHEOLOGY, V22, P197
   KAIBARA M, 1989, PROGR NEW DIRECTIONS, P63
   Kanagaraja S, 1996, BIOMATERIALS, V17, P2225, DOI 10.1016/0142-9612(95)00311-8
   KINLOUGHRATHBONE RL, 1993, THROMB HAEMOSTASIS, V70, P1019
   Lestelius M, 1997, LANGMUIR, V13, P5900, DOI 10.1021/la970187g
   LESTELIUS M, 1995, J COLLOID INTERF SCI, V171, P533, DOI 10.1006/jcis.1995.1217
   LESTELIUS M, 1994, J BIOMED MATER RES, V28, P871, DOI 10.1002/jbm.820280806
   LIEDBERG B, 1995, BIOSENS BIOELECTRON, V10, pR1, DOI 10.1016/0956-5663(95)96965-2
   Nelson RW, 1997, ANAL CHEM, V69, P4363, DOI 10.1021/ac970538w
   QUICK AJ, 1935, AM J MED SCI, P190
   Ramstrom S, 1999, THROMB HAEMOSTASIS, P292
   RAMSTROM S, 2001, THROMB HAEMOST S JUL
   Ranby M, 1999, BLOOD COAGUL FIBRIN, V10, P173, DOI 10.1097/00001721-199906000-00003
   Ranby M, 1999, CLIN CHEM, V45, P1176
   Sigal GB, 1998, J AM CHEM SOC, V120, P3464, DOI 10.1021/ja970819l
   SODERSTROM J, 2001, THROMB HAEMOST S JUL
   Tam SH, 1998, CIRCULATION, V98, P1085, DOI 10.1161/01.CIR.98.11.1085
   TENGVALL P, 1992, BIOMATERIALS, V13, P367, DOI 10.1016/0142-9612(92)90042-M
   Tengvall P, 1998, BIOMATERIALS, V19, P407, DOI 10.1016/S0142-9612(97)00110-5
   Vikinge TP, 2000, J BIOMED OPT, V5, P51, DOI 10.1117/1.429968
NR 33
TC 23
Z9 23
U1 0
U2 10
PU ELSEVIER ADVANCED TECHNOLOGY
PI OXFORD
PA OXFORD FULFILLMENT CENTRE THE BOULEVARD, LANGFORD LANE, KIDLINGTON,
   OXFORD OX5 1GB, OXON, ENGLAND
SN 0956-5663
J9 BIOSENS BIOELECTRON
JI Biosens. Bioelectron.
PD SEP
PY 2002
VL 17
IS 9
BP 747
EP 759
AR PII S00956-5663(02)00048-9
DI 10.1016/S0956-5663(02)00048-9
PG 13
WC Biophysics; Biotechnology & Applied Microbiology; Chemistry, Analytical;
   Electrochemistry; Nanoscience & Nanotechnology
SC Biophysics; Biotechnology & Applied Microbiology; Chemistry;
   Electrochemistry; Science & Technology - Other Topics
GA 592CQ
UT WOS:000177919500005
PM 12191923
DA 2018-10-20
ER

PT J
AU Carter, DH
   Scully, AJ
   Heaton, DA
   Young, MPJ
   Aaron, JE
AF Carter, DH
   Scully, AJ
   Heaton, DA
   Young, MPJ
   Aaron, JE
TI Effect of deproteination on bone mineral morphology: Implications for
   biomaterials and aging
SO BONE
LA English
DT Article
DE bone salt; anorganic dehydrated bone; hard tissue cryopreservation and
   image enhancement; filamentous mineral and calcified needles and plates;
   bioimplant material; skeletal aging
ID COMPACT-BONE; ENAMEL MATRIX; RAT; CALCIUM; ULTRASTRUCTURE;
   PHOSPHOPROTEIN; DENTIN; CELLS; IMMUNOLOCALIZATION; HYDROXYAPATITE
AB Bone mineral morphology is altered by processing and this is rarely considered when preparing bone as a bioimplant material. To examine the degree of transformation, a commercial, coarsely particulate bone mineral biomaterial produced by prolonged deproteination, defatting, dehydration, and heating (donor material) was compared with similar particles of human bone (recipient material) prepared optimally by low-temperature milling. The two powders were freeze-substituted and embedded without thawing in Lowicryl K4M before sectioning for transmission electron microscopy (TEM) (other aliquots were processed by traditional TEM methods). To maximize resolution, electron micrographs were image-enhanced by digitization and printed as negatives using a Polaroid Sprint Scan 45. In addition to their morphology, the particles were examined for antigenicity (specific by reference to fluorescein isothiocyanate [FITC]-conjugated fibronectin, and nonspecific by reference to general FITC-conjugated immunoglobulins). Results showed that the optimally prepared human bone fragments stained discretely for fibronectin with negligible background autofluorescence. In contrast, the bioimplant fragments stained extensively with this and any other FITC-conjugated antibody and, unlike fresh bone, it also autofluoresced a uniform yellow. This difference was also expressed structurally and, although the bioimplant mineral consisted of rhomboidal plates up to 200 nm across and 10 nm thick, the optimally prepared bone mineral was composed of numerous clusters of 5-nm-wide sinuous calcified filaments of variable density and indeterminate length (which became straight needles 50 nm long and 5 run thick following traditional chemical TEM fixation/staining). It was concluded that the inorganic phase of bone is both morphologically and immunologically transmutable and that, in biomaterials, the transformation is apparently so great that a broad indigenous antigenicity is unmasked, increasing the likelihood of resorption or rejection. This marked change may also provide preliminary insight into a more modest natural aging phenomenon with the localized lateral fusion of calcified filaments into less flexible, more immunologically reactive fenestrated plates. (C) 2002 by Elsevier Science Inc. All rights reserved.
C1 Univ Manchester, Unit Oral Pathol, Turner Dent Sch, Manchester M15 6FH, Lancs, England.
   Univ Leeds, Sch Biomed Sci, Leeds, W Yorkshire, England.
RP Carter, DH (reprint author), Univ Manchester, Unit Oral Pathol, Turner Dent Sch, Higher Cambridge St, Manchester M15 6FH, Lancs, England.
CR Aaron J. E., 1978, Vitamin D, P201
   AARON JE, 1972, ISRAEL J MED SCI, V8, P625
   Aaron JE, 1999, HISTOCHEM J, V31, P455, DOI 10.1023/A:1003707909842
   AARON JE, 1973, CALC TISS RES, V12, P259, DOI 10.1007/BF02013740
   Albeck S, 1996, CONNECT TISSUE RES, V35, P365, DOI 10.3109/03008209609029213
   APPLETON J, 1970, CALC TISS RES, V5, P270, DOI 10.1007/BF02017555
   Arnold S, 1997, CELL TISSUE RES, V288, P185, DOI 10.1007/s004410050805
   Arnold S, 2001, J MICROSC-OXFORD, V202, P488, DOI 10.1046/j.1365-2818.2001.00831.x
   BARCKHAUS RH, 1978, CELL TISSUE RES, V186, P541
   Baskin TI, 1996, J MICROSC-OXFORD, V182, P149, DOI 10.1046/j.1365-2818.1996.135417.x
   Bonucci E, 1995, Connect Tissue Res, V33, P157, DOI 10.3109/03008209509016996
   Boyan BD, 2000, BONE, V27, P341, DOI 10.1016/S8756-3282(00)00347-1
   BOYDE A, 1978, CALC TISS RES, V26, P47, DOI 10.1007/BF02013233
   Boyde A, 1980, METAB BONE DIS REL S, V2, P69
   CARTER DH, 1994, HISTOCHEM J, V26, P103, DOI 10.1007/BF00157958
   CARTER DH, 1991, J HISTOCHEM CYTOCHEM, V39, P599, DOI 10.1177/39.5.1707904
   CARTER DH, 1992, ANAT EMBRYOL, V186, P229
   Carter DH, 1998, HISTOCHEM J, V30, P677, DOI 10.1023/A:1003490506980
   Carter DH, 1997, HISTOCHEM J, V29, P783, DOI 10.1023/A:1026425404169
   Carter DH, 2000, HISTOCHEM J, V32, P253, DOI 10.1023/A:1004059219242
   DAVIES JE, 1991, CELL MATER, V1, P3
   DEBERNARD B, 1986, J CELL BIOL, V103, P1615, DOI 10.1083/jcb.103.4.1615
   EANES ED, 1965, T NEW YORK ACAD SCI, V28, P233, DOI 10.1111/j.2164-0947.1965.tb02877.x
   Filmon R, 2002, BONE, V30, P152, DOI 10.1016/S8756-3282(01)00634-2
   Fincham AG, 1999, J STRUCT BIOL, V126, P270, DOI 10.1006/jsbi.1999.4130
   GAY CV, 1977, CALC TISS RES, V23, P215, DOI 10.1007/BF02012788
   GLIMCHER MJ, 1990, METABOLIC BONE DIS C, P42
   GORSKI JP, 1995, ANN NY ACAD SCI, V760, P12, DOI 10.1111/j.1749-6632.1995.tb44616.x
   GUIZZARDI S, 1995, BIOMATERIALS, V16, P931, DOI 10.1016/0142-9612(95)93118-W
   HARVEY DMR, 1982, J MICROSC-OXFORD, V127, P209, DOI 10.1111/j.1365-2818.1982.tb00414.x
   HAYAT M, 1989, BIOL APPL
   HOBLING HJ, 1995, CONNECT TISSUE RES, V33, P171
   HOHLING HJ, 1989, HDB MICROSCOPIC ANAT, V5, P475
   KANDORI K, 1995, COLLOID SURFACE B, V5, P81, DOI 10.1016/0927-7765(95)98210-E
   LESTER KS, 1890, J ULTRASTRUCT RES, V72, P141
   MARK MP, 1987, J HISTOCHEM CYTOCHEM, V35, P707, DOI 10.1177/35.7.3295029
   MARSH PD, 1995, J IND MICROBIOL, V15, P169, DOI 10.1007/BF01569822
   MCKEE MD, 1990, ANAT REC, V228, P77, DOI 10.1002/ar.1092280112
   Meleti Z, 2000, BONE, V27, P359, DOI 10.1016/S8756-3282(00)00346-X
   Merkx MAW, 1999, BIOMATERIALS, V20, P639, DOI 10.1016/S0142-9612(98)00219-1
   Misra RP, 2000, CELL MOL LIFE SCI, V57, P421, DOI 10.1007/PL00000704
   Morgan A.J., 1979, SCANNING ELECT MICRO, V11, P635
   NYLEN MU, 1972, CALC TISS RES, V9, P95, DOI 10.1007/BF02061948
   Ong JL, 1998, J BIOMED MATER RES, V39, P176, DOI 10.1002/(SICI)1097-4636(199802)39:2<176::AID-JBM2>3.0.CO;2-M
   Oyajobi BO, 1998, J BONE MINER RES, V13, P432, DOI 10.1359/jbmr.1998.13.3.432
   Pautard F.G.E., 1975, Colloques int Cent natn Res scient, VNo. 230, P93
   PAUTARD FGE, 1976, PROGR BIOL CRYSTAL G, V4, P89
   Piattelli M, 1999, INT J ORAL MAX IMPL, V14, P835
   Plate U, 1998, CONNECT TISSUE RES, V38, P149, DOI 10.3109/03008209809017032
   Plate U, 1996, J MICROSC-OXFORD, V183, P102, DOI 10.1046/j.1365-2818.1996.67430.x
   POSNER AS, 1987, BONE MINERAL RES, V5, P65
   RASPANTI M, 1994, BIOMATERIALS, V15, P433, DOI 10.1016/0142-9612(94)90222-4
   Robinson C, 1998, EUR J ORAL SCI, V106, P282, DOI 10.1111/j.1600-0722.1998.tb02188.x
   ROMBERG RW, 1986, BIOCHEMISTRY-US, V25, P1176, DOI 10.1021/bi00353a035
   Schaffler MB, 1995, BONE, V17, P521, DOI 10.1016/8756-3282(95)00370-3
   SCHAFFLER MB, 1994, BONE, V15, P483, DOI 10.1016/8756-3282(94)90271-2
   SCHRAER H, 1977, CALC TISS RES, V23, P185, DOI 10.1007/BF02012785
   SHAHTAHERI MS, 1998, THESIS U LEEDS LEEDS
   Skoglund A, 1997, INT J ORAL MAX IMPL, V12, P194
   Stratmann U, 1997, ANAT EMBRYOL, V195, P289, DOI 10.1007/s004290050048
   TERMINE JD, 1973, CALC TISS RES, V13, P73, DOI 10.1007/BF02013723
   Young M P, 2001, Implant Dent, V10, P149
NR 62
TC 12
Z9 12
U1 0
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 8756-3282
J9 BONE
JI Bone
PD SEP
PY 2002
VL 31
IS 3
BP 389
EP 395
AR PII S8756-3282(02)00840-2
DI 10.1016/S8756-3282(02)00840-2
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 597DF
UT WOS:000178206300006
PM 12231411
DA 2018-10-20
ER

PT J
AU Zoulgami, M
   Lucas-Girot, A
   Michaud, V
   Briard, P
   Gaude, J
   Oudadesse, H
AF Zoulgami, M
   Lucas-Girot, A
   Michaud, V
   Briard, P
   Gaude, J
   Oudadesse, H
TI Synthesis and physico-chemical characterization of a
   polysialate-hydroxyapatite composite for potential biomedical
   application
SO EUROPEAN PHYSICAL JOURNAL-APPLIED PHYSICS
LA English
DT Article
ID CALCIUM-PHOSPHATE; SILICATE
AB New composite materials based on aluminosilicate materials were developed to be used in orthopaedic or maxillo-facial surgery. They are called geopolymers or polysialate-siloxo (PSS) and were studied alone or mixed with hydroxyapatite (HAP). The properties of these materials were investigated for potential use in biological or surgery applications. In this work, the chemistry involved in materials preparation was described. Samples were characterized by some physico-chemical methods like X-ray diffraction (XRD), infrared spectrometry (IR) and electron dispersion X-ray spectrometry (EDX). Results indicate that the mixing hydroxyapatite-geopolymer (PSS) leads to a neutral porous composite material with interesting physico-chemical properties. A preliminary evaluation of its cytotoxicity reveals an harmlessness towards fibroblasts. These properties allow to envisage this association as a potential biomaterial.
C1 LCSIM, Grp Cristallochim & Biomat, UMR 6511, F-35042 Rennes, France.
RP Zoulgami, M (reprint author), LCSIM, Grp Cristallochim & Biomat, UMR 6511, Bat 10B,Campus Beaulieu,263 Ave Gen Leclerc,CS 74, F-35042 Rennes, France.
OI Michaud, veronique/0000-0001-5699-740X
CR DAVIDOVITS J, 1991, J THERM ANAL, V37, P1633, DOI 10.1007/BF01912193
   de Aza PN, 2000, J MICROSC-OXFORD, V197, P60
   Deany I L, 1996, Crit Rev Oral Biol Med, V7, P134
   Ehlers E. G., 1972, INTERPRETATION GEOLO
   Elliott JC, 1994, STUDIES INORGANIC CH, V18
   HENCH LL, 1986, CIBA F SYMP, V121, P231
   Kawasaki A, 1996, J DENT, V24, P429, DOI 10.1016/0300-5712(95)00101-8
   KOKUBO T, 1991, BIOMATERIALS, V12, P155, DOI 10.1016/0142-9612(91)90194-F
   MacDonald SA, 2000, J NON-CRYST SOLIDS, V275, P72, DOI 10.1016/S0022-3093(00)00121-6
   MARQUET V, 1997, POROUS MAT TISSUE EN, V250
   Martens M., 1984, NATURAL LIVING BIOMA, P89
   Miyaji F, 1999, BIOMATERIALS, V20, P913, DOI 10.1016/S0142-9612(98)00235-X
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   PARKES JB, 1992, BIOMATERIALS INTRO
   Shevtsova N. N., 1981, MOSCOW U CHEM BULL, V36, P117
   VANJAARSWELD JGS, 1996, MINER ENG, V10, P659
   Zoulgami M, 2001, BIOMATERIALS, V22, P1933, DOI 10.1016/S0142-9612(00)00384-7
NR 17
TC 11
Z9 11
U1 1
U2 11
PU E D P SCIENCES
PI LES ULIS CEDEXA
PA 7, AVE DU HOGGAR, PARC D ACTIVITES COURTABOEUF, BP 112, F-91944 LES ULIS
   CEDEXA, FRANCE
SN 1286-0042
J9 EUR PHYS J-APPL PHYS
JI Eur. Phys. J.-Appl. Phys
PD SEP
PY 2002
VL 19
IS 3
BP 173
EP 179
DI 10.1051/epjap:2002063
PG 7
WC Physics, Applied
SC Physics
GA 598ZA
UT WOS:000178306400003
DA 2018-10-20
ER

PT J
AU Filmon, R
   Grizon, E
   Cincu, C
   Basle, MF
   Audran, M
   Chappard, D
AF Filmon, R
   Grizon, E
   Cincu, C
   Basle, MF
   Audran, M
   Chappard, D
TI Preparation of a polymer biomaterial (poly (2-hydroxyethyl
   methacrylate)) with an inter-connected macroporosity. An X-ray
   microtomographic and histomorphometric study.
SO JOURNAL OF BONE AND MINERAL RESEARCH
LA English
DT Meeting Abstract
CT 24th Annual Meeting of the
   American-Society-for-Bone-and-Mineral-Research
CY SEP 20-24, 2002
CL SAN ANTONIO, TEXAS
SP American-Soc-Bone-Mineral-Res
C1 Univ Polytehnika Bucharest, Bucharest, Romania.
   LHEA GEROM, Angers, France.
NR 0
TC 1
Z9 1
U1 0
U2 2
PU AMER SOC BONE & MINERAL RES
PI WASHINGTON
PA 2025 M ST, N W, STE 800, WASHINGTON, DC 20036-3309 USA
SN 0884-0431
J9 J BONE MINER RES
JI J. Bone Miner. Res.
PD SEP
PY 2002
VL 17
SU 1
MA SU52
BP S305
EP S305
PG 1
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 592TK
UT WOS:000177952800765
DA 2018-10-20
ER

PT J
AU Pollack, GH
AF Pollack, GH
TI The cell as a biomaterial
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID ACTIN FILAMENT; MUSCLE-CONTRACTION; SKELETAL-MUSCLE; F-ACTIN; FORCE
   GENERATION; MOLECULAR MOTORS; HEAVY-MEROMYOSIN; LENGTH CHANGES; MYOSIN;
   WATER
AB For materials scientists, the cell is evidently a biomaterial - rich with polymers, surface forces, solvent-solute interactions, liquid-crystalline structures, etc. Yet, the language of the materials scientist is as foreign to the biological world as French is to Chinese. Little of the materials scientists' perspective has been brought to bear on the question of biological function. This review aims to begin bridging the gap between the two disciplines-to show that a materials-oriented approach has power to bring fresh insights into an otherwise impenetrably complex maze. In this approach the cell is treated as a polymer gel. If the cell is a gel, then a logical approach to the understanding of cell function is through an understanding of gel function. Great strides have been made recently in understanding the principles of polymer-gel dynamics. It has become clear that a central mechanism is the phase-transition - a major structural change prompted by a subtle change of environment. Phase-transitions are capable of doing work and such work could be responsible for much of the work of the cell. Here, we pursue this approach. We set up a polymer-gel-based foundation for cell behavior, and explore the extent to which this foundation explains how the cell achieves its everyday tasks. (C) 2002 Kluwer Academic Publishers.
C1 Univ Washington, Dept Bioengn 357962, Seattle, WA 98195 USA.
RP Pollack, GH (reprint author), Univ Washington, Dept Bioengn 357962, Seattle, WA 98195 USA.
CR ALBERTS B, 1994, MOL BIOL CELL
   ASAKURA S, 1963, J MOL BIOL, V7, P55, DOI 10.1016/S0022-2836(63)80018-2
   Berry H, 2000, BBA-GEN SUBJECTS, V1524, P110, DOI 10.1016/S0304-4165(00)00144-6
   Block SM, 1996, CELL, V87, P151, DOI 10.1016/S0092-8674(00)81332-X
   Blyakhman FA, 1999, J MUSCLE RES CELL M, V20, P529, DOI 10.1023/A:1005590401721
   CAMERON IL, 1988, PHYSIOL CHEM PHYS M, V20, P221
   CASADEMONT J, 1988, J NEUROPATH EXP NEUR, V47, P618, DOI 10.1097/00005072-198811000-00005
   CLARKE MSF, 1995, CIRC RES, V76, P927, DOI 10.1161/01.RES.76.6.927
   COLLINS EW, 1971, AM J PHYSIOL, V221, P1130
   Cooke R, 1997, PHYSIOL REV, V77, P671
   DEBEER EL, 1998, CELL MOTIL CYTOSKEL, V38, P341
   DOSREMEDIOS CG, 1995, BBA-BIOENERGETICS, V1228, P99, DOI 10.1016/0005-2728(94)00169-6
   FERNANDEZ JM, 1991, BIOPHYS J, V59, P1022, DOI 10.1016/S0006-3495(91)82317-7
   FREYWYSSLING A, 1953, SUBMICROSCOPIC MORPH
   GRANZIER HLM, 1987, J MUSCLE RES CELL M, V8, P242, DOI 10.1007/BF01574592
   HATANO S, 1967, BIOCHIM BIOPHYS ACTA, V140, P109, DOI 10.1016/0005-2795(67)90385-6
   Hatori K, 1998, BIOPHYS CHEM, V75, P81, DOI 10.1016/S0301-4622(98)00184-7
   Hatori K, 1996, BIOPHYS CHEM, V60, P149, DOI 10.1016/0301-4622(96)00008-7
   Hochachka PW, 1999, P NATL ACAD SCI USA, V96, P12233, DOI 10.1073/pnas.96.22.12233
   Hoffman AS, 1991, POLYM GELS, V268, P82
   HOLSTEIN T, 1984, SCIENCE, V223, P830, DOI 10.1126/science.6695186
   HORN RG, 1981, J CHEM PHYS, V75, P1400, DOI 10.1063/1.442146
   Howard J, 1997, NATURE, V389, P561, DOI 10.1038/39247
   HUXLEY AF, 1957, PROG BIOPHYS MOL BIO, V7, P255, DOI 10.1016/S0096-4174(18)30128-8
   HUXLEY H, 1954, NATURE, V173, P973, DOI 10.1038/173973a0
   Huxley HE, 1996, ANNU REV PHYSIOL, V58, P1, DOI 10.1146/annurev.ph.58.030196.000245
   IRVING M, 1995, NATURE, V375, P688, DOI 10.1038/375688a0
   Israelachvili J, 1996, NATURE, V379, P219, DOI 10.1038/379219a0
   ISRAELACHVILI JN, 1988, SCIENCE, V241, P795, DOI 10.1126/science.241.4867.795
   IWAZUMI, 1970, THESIS U PENNSYLVANI
   JACOBS WP, 1994, SCI AM, P100
   JACOBSON RC, 1983, J MUSCLE RES CELL M, V4, P529, DOI 10.1007/BF00712113
   Janmey P A, 2001, Results Probl Cell Differ, V32, P181
   Jarvis SP, 2000, J PHYS CHEM B, V104, P6091, DOI 10.1021/jp001616d
   Jones DS, 1999, INT J PHARM, V179, P167, DOI 10.1016/S0378-5173(98)00337-8
   KAS J, 1994, NATURE, V368, P226, DOI 10.1038/368226a0
   Katayama E, 1998, J MOL BIOL, V278, P349, DOI 10.1006/jmbi.1998.1715
   Kellermayer MSZ, 1996, BBA-BIOENERGETICS, V1277, P107, DOI 10.1016/S0005-2728(96)00089-8
   Kitamura K, 1999, NATURE, V397, P129
   KLENCHIN VA, 1991, BIOPHYS J, V60, P804, DOI 10.1016/S0006-3495(91)82115-4
   KRAUSE TL, 1994, J NEUROSCI, V14, P6638
   LING GN, 1965, ANN NY ACAD SCI, V125, P401, DOI 10.1111/j.1749-6632.1965.tb45406.x
   LING GN, 1976, SCIENCE, V191, P293, DOI 10.1126/science.1082166
   LING GN, 1992, REVOLUTION PHYSL LIV
   MANIOTIS A, 1991, CELL, V67, P495, DOI 10.1016/0092-8674(91)90524-3
   MCINTOSH JR, 1973, J CELL BIOL, V56, P324, DOI 10.1083/jcb.56.2.324
   McNeil PL, 1997, J CELL BIOL, V137, P1, DOI 10.1083/jcb.137.1.1
   MCNEIL PL, 1990, J CELL SCI, V67, P495
   MIKI M, 1994, BIOCHEMISTRY-US, V33, P10171, DOI 10.1021/bi00199a045
   OOSAWA F, 1972, COLD SPRING HARB SYM, V37, P277
   Oplatka A, 1997, CRIT REV BIOCHEM MOL, V32, P307, DOI 10.3109/10409239709082575
   OPLATKA A, 1996, CHEMTRACTS BIOCH MOL, V6, P18
   OSADA Y, 1993, PROG POLYM SCI, V18, P187, DOI 10.1016/0079-6700(93)90025-8
   PASHLEY RM, 1979, J COLLOID INTERF SCI, V71, P491, DOI 10.1016/0021-9797(79)90323-0
   Pollack G H, 2001, CELLS GELS ENGINES L
   POLLACK GH, 1983, PHYSIOL REV, V63, P1049
   Pollack GH, 1996, BIOPHYS CHEM, V59, P315, DOI 10.1016/0301-4622(95)00141-7
   POLLACK GH, 1990, MUSCLE MOL UNCOVERIN
   PRAUSNITZ MR, 1994, BIOPHYS J, V66, P1522, DOI 10.1016/S0006-3495(94)80943-9
   Prochniewicz E, 1996, J MOL BIOL, V260, P756, DOI 10.1006/jmbi.1996.0435
   Rand RP, 2000, CELL MOL LIFE SCI, V57, P1018, DOI 10.1007/PL00000742
   Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109
   Schutt CE, 1998, ACTA PHYSIOL SCAND, V163, P307, DOI 10.1046/j.1365-201X.1998.t01-1-00393.x
   SCHUTT CE, 1993, FEBS LETT, V325, P59, DOI 10.1016/0014-5793(93)81413-T
   SCHWISTER K, 1985, BIOCHIM BIOPHYS ACTA, V816, P332, DOI 10.1016/0005-2736(85)90501-2
   SERPERSU EH, 1985, BIOCHIM BIOPHYS ACTA, V812, P779, DOI 10.1016/0005-2736(85)90272-X
   SOSA H, 1994, BIOPHYS J, V67, P283, DOI 10.1016/S0006-3495(94)80479-5
   SPUDICH JA, 1994, NATURE, V372, P515, DOI 10.1038/372515a0
   TANAKA T, 1992, NATO ASI SERIES H, V64
   TAYLOR SR, 1975, BIOCHEM SOC T, V7, P759
   THOMAS DD, 1987, ANNU REV PHYSIOL, V49, P641
   Tskhovrebova L, 1997, NATURE, V387, P308, DOI 10.1038/387308a0
   TUNG LH, COMMUNICATION
   VERDUGO P, 1992, NATO ASI SERIES H, V64
   Vogler EA, 1998, ADV COLLOID INTERFAC, V74, P69, DOI 10.1016/S0001-8686(97)00040-7
   WIGGINS PM, 1990, MICROBIOL REV, V54, P432
   YAKOVENKO O, IN PRESS AM J PHYSL
   Yanagida T, 2000, PHILOS T ROY SOC B, V355, P441, DOI 10.1098/rstb.2000.0585
   YANAGIDA T, 1984, NATURE, V307, P58, DOI 10.1038/307058a0
   YANAGIDA T, 1978, J MOL BIOL, V126, P507, DOI 10.1016/0022-2836(78)90056-6
   YAWO H, 1985, J NEUROSCI, V5, P1626
   BIOPHYS J, V58, P13
NR 82
TC 9
Z9 10
U1 0
U2 4
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD SEP
PY 2002
VL 13
IS 9
BP 811
EP 821
DI 10.1023/A:1016547409660
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 578DJ
UT WOS:000177101900001
PM 15348544
DA 2018-10-20
ER

PT J
AU Paruchuru, SP
   Wang, XD
   Agrawal, CM
AF Paruchuru, Satya Prasad
   Wang, Xiaodu
   Agrawal, C. M.
TI FINITE ELEMENT SIMULATION OF ELASTIC COMPLIANCE TECHNIQUE FOR
   FORMULATING A TEST METHOD TO DETERMINE THE FRACTURE TOUGHNESS OF BONE
SO JOURNAL OF MECHANICS IN MEDICINE AND BIOLOGY
LA English
DT Article
DE Fracture toughness; stress intensity factor; energy release rate;
   elastic compliance; compact sandwich specimen; finite element analysis
AB Compact Sandwich Specimen (CSS) is the best specimen to test the fracture toughness of bone from small laboratory animals. There exists a direct method to calculate the stress intensity factor (K) of bone using CSS. However, energy release rate (G) is the fundamental measure of fracture toughness of a material. The direct relation between K, G, Young's Modulus (E), and Poisson's ratio (nu), de fined for homogeneous materials may not apply to bone, which has a non-homogeneous microstucture. Therefore, a direct test method is required to calculate G of bone using CSS.
   Elastic compliance technique is used to measure G of a material. This paper presents an experimentally tested and reliable procedure to simulate the elastic compliance technique by finite element analysis. The procedure may eventually be used in formulating the direct test method to calculate G of bone and bone-biomaterial interface, using CSS.
C1 [Paruchuru, Satya Prasad] VR Siddhartha Engn Coll, Dept Mech Engn, Kanuru 520007, Vijayawada, India.
   [Wang, Xiaodu] Univ Texas San Antonio, Coll Engn, San Antonio, TX 78249 USA.
   [Agrawal, C. M.] Univ Texas Hlth Sci Ctr San Antonio, Ctr Clin Bioengn, San Antonio, TX 78229 USA.
RP Paruchuru, SP (reprint author), VR Siddhartha Engn Coll, Dept Mech Engn, Kanuru 520007, Vijayawada, India.
EM paruchuru1@yahoo.co.in; xwang@utsa.edu; agrawal@uthscsa.edu
OI Paruchuru, Satya Prasad/0000-0001-7608-6304
FU Center for Enhancement of Biology-Biomaterial Interface, UTHSCSA, San
   Antonio, USA
FX Center for Enhancement of Biology-Biomaterial Interface, UTHSCSA, San
   Antonio, USA has funded this work.
CR American Society of Mechanical Engineering, 1965, AM SOC MECH ENG PUBL
   Anderson T. L., 1991, FRACTURE MECH FUNDAM
   [Anonymous], E39990 ASTM, P506
   BEHIRI JC, 1989, J BIOMECH, V22, P863, DOI 10.1016/0021-9290(89)90070-5
   BONFIELD W, 1987, J BIOMECH, V20, P1071, DOI 10.1016/0021-9290(87)90025-X
   CURREY JD, 1988, J BIOMECH, V21, P131, DOI 10.1016/0021-9290(88)90006-1
   FLECK NA, 1991, INT J SOLIDS STRUCT, V27, P1683, DOI 10.1016/0020-7683(91)90069-R
   Fondrk N., 1988, J BIOMECH, V21, P623
   Grestle W. H., 1990, ASTM STP, V1074, P509
   Irwin G. R., 1956, SAGAMORE RES C P, V2, P289
   LAKES RS, 1990, J BIOMECH, V23, P967, DOI 10.1016/0021-9290(90)90311-P
   SUO ZG, 1989, MAT SCI ENG A-STRUCT, V107, P135, DOI 10.1016/0921-5093(89)90382-1
   Wang X., 1994, J APPL MAT
NR 13
TC 3
Z9 3
U1 1
U2 3
PU WORLD SCIENTIFIC PUBL CO PTE LTD
PI SINGAPORE
PA 5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE
SN 0219-5194
J9 J MECH MED BIOL
JI J. Mech. Med. Biol.
PD SEP-DEC
PY 2002
VL 2
IS 3-4
BP 473
EP 486
DI 10.1142/S0219519402000526
PG 14
WC Biophysics; Engineering, Biomedical
SC Biophysics; Engineering
GA V26SD
UT WOS:000208564400018
DA 2018-10-20
ER

PT J
AU Louis-Ugbo, J
   Kim, HS
   Boden, SD
   Mayr, MT
   Li, RC
   Seeherman, H
   D'Augusta, D
   Blake, C
   Jiao, AP
   Peckham, S
AF Louis-Ugbo, J
   Kim, HS
   Boden, SD
   Mayr, MT
   Li, RC
   Seeherman, H
   D'Augusta, D
   Blake, C
   Jiao, AP
   Peckham, S
TI Retention of I-125-labeled recombinant human bone morphogenetic
   protein-2 by biphasic calcium phosphate or a composite sponge in a
   rabbit posterolateral spine arthrodesis model
SO JOURNAL OF ORTHOPAEDIC RESEARCH
LA English
DT Article
ID OSTEOINDUCTIVE GROWTH-FACTOR; ABSORBABLE COLLAGEN SPONGES; RAT ECTOPIC
   MODEL; BIOMATERIAL CARRIERS; FUSION MODEL; RHBMP-2; PHARMACOKINETICS;
   AUGMENTATION; REGENERATION; GRAFT
AB The purpose of this study was to characterize the retention kinetics of recombinant human bone morphogenetic protein-2 (rhBMP-2) applied to two calcium-based delivery matrices. Biphasic calcium phosphate (BCP) and a composite containing BCP in an absorbable collagen sponge (BCP/ACS) were evaluated using a spinal fusion model in rabbits. rhBMP-2 labeled with radioactive iodine (I-125) was used as a tracer to assess in vivo retention of rhBMP-2 in the presence of these materials (nine animals per material studied). Over a 36 day study period, animals were assessed for the following: percent administered dose retained at the implant site as measured by scintigraphic imaging (counting) with a gamma camera (all animals), radiography of the implant site (all animals), radioactivity in blood and plasma (all animals), and radioactivity in the urine and feces (three animals for each material). Radioactivity data were corrected for the decay of I-125 and the attenuation between the implant in vivo and the gamma camera.
   Differences observed between the two materials for the area under the retention vs. time profile (AUC; 988%(*)day for BCP vs. 1070%(*)day for BCP/ACS, p = 0.57) and the mean residence time (MRT; 10.2 days for BCP vs. 7.6 days for BCP/ACS, p = 0.06) were not statistically significant. Initial retention/incorporation of rhBMP-2 was slightly higher for rhBMP-2/BCP/ACS than for rhBMP-2/BCP (96.8% vs. 86.0%, p < 0.05). Animals receiving rhBMP-2/BCP showed a longer terminal retention half-life (t(1/2)) than did those receiving rhBMP-2/BCP/ACS (7.5 vs. 4.5 days, p < 0.05). The urinary radioactivity recovery data supported the data obtained by scintigraphy. Over the 36 day collection period, essentially complete recovery of radioactivity (dose) in urine was observed for rhBMP-2/BCP and rhBMP-2/BCP/ACS and the majority of the radioactivity (approximately 95%) was soluble in trichloroacetic acid, suggesting extensive catabolism of rhBMP-2 before renal excretion. Fecal recovery of radioactivity was low, approximately 2-3%.
   In conclusion, rhBMP-2 was retained at the implant site when delivered with either BCP or BCP/ACS based on mean residence time and area under the retention curve vs. time profile. Use of these matrices resulted in detectable rhBMP-2 levels at the surgical site for over a week in contrast to data reported with several other matrices that lasted less time. Systemic catabolism and elimination of the rhBMP-2 was extensive and systemic presence of the protein was negligible. (C) 2002 Orthopaedic Research Society. Published by Elsevier Science Ltd. All rights reserved.
C1 Emory Univ, Sch Med, Dept Orthopaed Surg, Atlanta, GA 30322 USA.
   Emory Univ, Sch Med, Dept Neurosurg, Atlanta, GA 30322 USA.
   Genet Inst Inc, Andover, MA 01810 USA.
   Medron Sofamor Danek, Memphis, TN 38132 USA.
RP Boden, SD (reprint author), 2165 N Decatur Rd, Decatur, GA 30033 USA.
CR Boden SD, 1999, SPINE, V24, P1179, DOI 10.1097/00007632-199906150-00002
   Boden SD, 1998, J SPINAL DISORD, V11, P95
   BODEN SD, 1995, SPINE, V20, P412, DOI 10.1097/00007632-199502001-00003
   Boden SD, 1995, SPINE, V20, P2626, DOI 10.1097/00007632-199512150-00003
   Boden SD, 1999, SPINE, V24, P320, DOI 10.1097/00007632-199902150-00003
   Boden SD, 1995, SPINE, V20, P2633, DOI 10.1097/00007632-199512150-00004
   Fischgrund JS, 1997, J SPINAL DISORD, V10, P467
   Friess W, 1999, INT J PHARM, V187, P91, DOI 10.1016/S0378-5173(99)00174-X
   Friess W, 1999, PHARM DEV TECHNOL, V4, P387, DOI 10.1081/PDT-100101374
   Hollinger JO, 1998, J BIOMED MATER RES, V43, P356, DOI 10.1002/(SICI)1097-4636(199824)43:4<356::AID-JBM3>3.0.CO;2-7
   Hollinger JO, 1998, ADV DRUG DELIV REV, V31, P303
   Murata M, 1999, INT J ORAL MAX SURG, V28, P232, DOI 10.1034/j.1399-0020.1999.283280316.x
   SCHIMANDLE JH, 1995, SPINE, V20, P1326, DOI 10.1097/00007632-199506000-00002
   Uludag H, 2000, J BIOMED MATER RES, V50, P227, DOI 10.1002/(SICI)1097-4636(200005)50:2<227::AID-JBM18>3.0.CO;2-2
   Uludag H, 1999, J BIOMED MATER RES, V46, P193, DOI 10.1002/(SICI)1097-4636(199908)46:2<193::AID-JBM8>3.0.CO;2-1
   Uludag H, 1999, ANN NY ACAD SCI, V875, P369, DOI 10.1111/j.1749-6632.1999.tb08519.x
   URIST MR, 1971, J DENT RES, V50, P1392, DOI 10.1177/00220345710500060601
   WILTSE LL, 1968, J BONE JOINT SURG AM, VA 50, P919, DOI 10.2106/00004623-196850050-00004
   Winn SR, 1999, CLIN ORTHOP RELAT R, pS95
   YASKO AW, 1992, J BONE JOINT SURG AM, V74A, P659, DOI 10.2106/00004623-199274050-00005
   ZERWEKH JE, 1992, J ORTHOPAED RES, V10, P562, DOI 10.1002/jor.1100100411
NR 21
TC 41
Z9 42
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0736-0266
J9 J ORTHOPAED RES
JI J. Orthop. Res.
PD SEP
PY 2002
VL 20
IS 5
BP 1050
EP 1059
AR PII S0736-0266(02)00011-6
DI 10.1016/S0736-0266(02)00011-6
PG 10
WC Orthopedics
SC Orthopedics
GA 600GZ
UT WOS:000178383400024
PM 12382973
DA 2018-10-20
ER

PT J
AU Kumar, RR
   Maruno, S
AF Kumar, RR
   Maruno, S
TI Functionally graded coatings of HA-G-Ti composites and their in vivo
   studies
SO MATERIALS SCIENCE AND ENGINEERING A-STRUCTURAL MATERIALS PROPERTIES
   MICROSTRUCTURE AND PROCESSING
LA English
DT Article
DE hydroxyapatite; biomaterial; composite; implant; functionally graded
   material; coating; bone bonding
ID GRADIENT COMPOSITE; HYDROXYAPATITE; TITANIUM; PRECIPITATION; BONE
AB Hydroxyapatite (HA) was synthesized by the wet chemical method using phosphoric acid (H;PO,) and calcium hydroxide Ca(OH)(2) aqueous solutions. The prepared HA powders were fired at various temperatures ranging from 200 to 1200 C for 2 h to obtain different degrees of crystallinity. The HA powders having different crystallinities were mixed with glass (G) in different weight percentages to form HA-G ceramics. The properties of the HA-G ceramics and the reaction of glass with HA were investigated by X-ray diffraction (XRD), differential scanning calorimetry (DSC) and Fourier transform infra-red spectrometry (FTIR). HA fired at higher temperature showed higher crystallinity and lower solubility. HA slightly reacted with glass and formed a small amount boron containing apatite. HA-G ceramic powders were coated on pure titanium substrate to obtain functionally graded layers of HA-G ceramics. The hydroxyapatite-glass-titanium (HA-G-Ti) composites consisting of HA fired at 400, 800 and 1200 C were implanted in the femur bone of dog to examine the in vivo behavior of the implant. The pull-out strength between the HA-G-Ti composite and the bone demonstrated that the composite using HA fired at 1200 degreesC showed the highest pull-out test value of 20.6 MPa and good biocompatibility. (C) 2002 Elsevier Science B.V. All rights reserved.
C1 Nanyang Technol Univ, Sch Mat Engn, Singapore 639798, Singapore.
   Nagoya Inst Technol, Showa Ku, Nagoya, Aichi 4668555, Japan.
RP Kumar, RR (reprint author), Nanyang Technol Univ, Sch Mat Engn, Singapore 639798, Singapore.
CR BAN S, 1994, J BIOMED MATER RES, V28, P65, DOI 10.1002/jbm.820280109
   BAN SJ, 1995, BIOMATERIALS, V16, P977, DOI 10.1016/0142-9612(95)94904-Y
   FUJISHIRO Y, 1995, J MATER SCI-MATER M, V6, P172, DOI 10.1007/BF00120295
   Ishikawa Tomoji, 1993, Clinical Materials, V14, P277, DOI 10.1016/0267-6605(93)90014-X
   ITO A, 1995, PHOSPHORUS LETT, V24, P24
   ITO A, 1988, J CERAM SOC JPN, V96, P302
   JARCHO M, 1976, J MATER SCI, V11, P2027, DOI 10.1007/BF02403350
   Maruno S., 1999, Materials Science Forum, V308-311, P344
   MARUNO S, 1991, BIOMATERIALS, V12, P225, DOI 10.1016/0142-9612(91)90204-N
   MARUNO S, 1992, NIPPON SERAM KYO GAK, V100, P362
   MARUNO S, 1993, P IMMM93, P305
   MARUNO S, 1992, BIOCERAMICS, V5, P165
   OGINO M, 1980, J NON-CRYST SOLIDS, V38-9, P673, DOI 10.1016/0022-3093(80)90514-1
   RADIN SR, 1993, J BIOMED MATER RES, V27, P35, DOI 10.1002/jbm.820270106
   Rehman I, 1997, J MATER SCI-MATER M, V8, P1, DOI 10.1023/A:1018570213546
   WU JM, 1988, J MATER SCI, V23, P3771, DOI 10.1007/BF00540526
NR 16
TC 24
Z9 26
U1 0
U2 6
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0921-5093
J9 MAT SCI ENG A-STRUCT
JI Mater. Sci. Eng. A-Struct. Mater. Prop. Microstruct. Process.
PD SEP 1
PY 2002
VL 334
IS 1-2
BP 156
EP 162
AR PII S0921-5093(01)01792-0
DI 10.1016/S0921-5093(01)01792-0
PG 7
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Science & Technology - Other Topics; Materials Science; Metallurgy &
   Metallurgical Engineering
GA 580LL
UT WOS:000177236000023
DA 2018-10-20
ER

PT J
AU Ponsonnet, L
   Comte, V
   Othmane, A
   Lagneau, C
   Charbonnier, M
   Lissac, M
   Jaffrezic, N
AF Ponsonnet, L
   Comte, V
   Othmane, A
   Lagneau, C
   Charbonnier, M
   Lissac, M
   Jaffrezic, N
TI Effect of surface topography and chemistry on adhesion, orientation and
   growth of fibroblasts on nickel-titanium substrates
SO MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC AND SUPRAMOLECULAR SYSTEMS
LA English
DT Article; Proceedings Paper
CT 3rd Maghreb/Europe Meeting on Materials and Their Applications for
   Devices and Physical, Chemical and Biological Sensors
CY OCT 29-30, 2001
CL HAMMAMET, TUNISIA
DE NiTi; cell adhesion; cell proliferation; surface roughness; surface
   composition; human fibroblasts
ID HUMAN GINGIVAL FIBROBLASTS; SHAPE-MEMORY METAL; CELL BEHAVIOR; IN-VITRO;
   BIOCOMPATIBILITY; ALLOY; INVITRO; PROLIFERATION; ATTACHMENT; ROUGHNESS
AB Nickel-titanium alloy (NiTi) is a metallic biomaterial known for its mechanical and shape memory properties. These properties suggest that it could be used for medical purposes such as surgical implants. To evaluate the effects of the chemical composition and microtexture of the metal surface on the cellular behaviour, the adhesion, orientation and proliferation of human gingival fibroblasts were studied with substrates having different surface roughnesses. To separate the effects of material roughness and composition on the fibroblast response, we have chosen to compare substrates of different surface roughnesses but of the same chemical composition (NiTi). Moreover, substrates of different surface compositions (Ti6Al4V, cp-Ti, 316L stainless steel) but of similar smooth surface topography were also tested. The texture, chemical state and composition of the surfaces were determined using a surface-tracing instrument for roughness characterisation and X-ray photoelectron spectroscopy (XPS) for chemical analysis. The effect of gamma-sterilisation on the chemical composition was studied. Human gingival fibroblasts attached, spread and proliferated on all titanium-based surfaces. On samples exhibiting the highest roughness, the cells were oriented in a parallel order along the grooves caused by mechanical polishing, whereas on smooth surfaces, they appeared to grow with no specific orientation. We observed low cell proliferation on the NiTi surfaces of the highest roughness. (C) 2002 Elsevier Science B.V. All rights reserved.
C1 Ecole Cent Lyon, Lab Ingn & Fonctionnalisat Surfaces IFoS, F-69131 Ecully, France.
   Univ Lyon 1, Lab Etud Interfaces & Biofilms Odontol, F-69372 Lyon, France.
   Fac Med Monastir, Biophys Lab, Monastir 5000, Tunisia.
   Univ Lyon 1, Lab Sci & Ingn Surfaces, F-69622 Villeurbanne, France.
RP Ponsonnet, L (reprint author), Ecole Cent Lyon, Lab Ingn & Fonctionnalisat Surfaces IFoS, BP 163, F-69131 Ecully, France.
CR Anselme K, 2000, J BIOMED MATER RES, V49, P155, DOI 10.1002/(SICI)1097-4636(200002)49:2<155::AID-JBM2>3.3.CO;2-A
   ASSAD M, 1994, ANN CHIR, V48, P731
   Assad M, 1998, J BIOMED MATER RES, V41, P154, DOI 10.1002/(SICI)1097-4636(199807)41:1<154::AID-JBM18>3.3.CO;2-0
   BLACKSHAW SE, 1988, J PHYSIOL-LONDON, V396, P121, DOI 10.1113/jphysiol.1988.sp016954
   Brunette D M, 1988, Int J Oral Maxillofac Implants, V3, P231
   BRUNETTE DM, 1986, EXP CELL RES, V11, P164
   Castleman L. S., 1981, BIOCOMPATIBILITY CLI, V1, P129
   CLARK P, 1990, DEVELOPMENT, V108, P635
   CLARK P, 1991, J CELL SCI, V99, P73
   CLARK P, 1987, DEVELOPMENT, V99, P439
   CURTIS ASG, 1964, J NATL CANCER I, V33, P15
   DENBRABER ET, 1995, J BIOMED MATER RES, V29, P511, DOI 10.1002/jbm.820290411
   Duerig TW, 1996, BIO-MED MATER ENG, V6, P255
   DUNN G, 1982, CELL BEHAV, P421
   DUNN GA, 1986, J CELL SCI, V83, P313
   DUNN GA, 1976, EXP CELL RES, V1, P101
   Endo K, 1994, Dent Mater J, V13, P228
   HANAWA T, 1991, BONE-BIOMATERIAL INTERFACE, P49
   HORMIA M, 1991, J PERIODONTAL RES, V26, P491, DOI 10.1111/j.1600-0765.1991.tb01800.x
   INOUE T, 1987, J BIOMED MATER RES, V21, P107, DOI 10.1002/jbm.820210114
   Kieswetter K, 1996, J BIOMED MATER RES, V32, P55, DOI 10.1002/(SICI)1097-4636(199609)32:1<55::AID-JBM7>3.0.CO;2-O
   KONONEN M, 1992, J BIOMED MATER RES, V26, P1325
   LOWENBERG BF, 1987, J DENT RES, V66, P1000, DOI 10.1177/00220345870660050101
   MARTIN JY, 1995, J BIOMED MATER RES, V29, P389, DOI 10.1002/jbm.820290314
   McKinney R V Jr, 1988, J Dent Educ, V52, P696
   MEYLE J, 1993, J BIOMED MATER RES, V27, P1553, DOI 10.1002/jbm.820271212
   MOSSMANN T, 1983, J IMMUNOL METHODS, V65, P55
   OHARA PT, 1979, EXP CELL RES, V121, P315
   OSHIDA Y, 1992, Bio-Medical Materials and Engineering, V2, P51
   PUTTERS JLM, 1992, EUR SURG RES, V24, P378, DOI 10.1159/000129231
   Ryhanen J, 1997, J BIOMED MATER RES, V35, P451
   Ryhanen J, 2000, MINIM INVASIV THER, V9, P99, DOI 10.3109/13645700009063056
   Shabalovskaya SA, 1996, BIO-MED MATER ENG, V6, P267
   TAYLOR SR, 1983, J BIOMED MATER RES, V17, P205, DOI 10.1002/jbm.820170202
   TRIGWELL S, 1997, SHAPE MEMORY SUPEREL, P383
   Wataha JC, 1999, J BIOMED MATER RES, V45, P251, DOI 10.1002/(SICI)1097-4636(19990605)45:3<251::AID-JBM13>3.0.CO;2-5
   WEAVER DJ, 1997, BIOMATERIALS, V18, P1115
NR 37
TC 95
Z9 99
U1 3
U2 23
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-BIO S
JI Mater. Sci. Eng. C-Biomimetic Supramol. Syst.
PD SEP 1
PY 2002
VL 21
IS 1-2
SI SI
BP 157
EP 165
AR PII S0928-4931(02)00097-8
DI 10.1016/S0928-4931(02)00097-8
PG 9
WC Materials Science, Multidisciplinary
SC Materials Science
GA 592YD
UT WOS:000177963700024
DA 2018-10-20
ER

PT J
AU Hiller, J
   Mendelsohn, JD
   Rubner, MF
AF Hiller, J
   Mendelsohn, JD
   Rubner, MF
TI Reversibly erasable nanoporous anti-reflection coatings from
   polyelectrolyte multilayers
SO NATURE MATERIALS
LA English
DT Article
ID POLYMER THIN-FILMS; SURFACES; GLASS
AB For nearly two centuries, researchers have sought novel methods to increase light transmission in optical systems, as well as to eliminate unwanted reflections and glare. Antireflection coatings and surfaces have enabled the increasing performance demands of optical components fabricated from glass-based optical materials. With the current trend of technology moving towards optically transparent polymeric media and coatings, the need for antireflection technology and environmentally benign processing methods for polymeric materials independent of shape or size has become quite apparent. We describe an economical, aqueous-based process controlled at the molecular level that simultaneously coats all surfaces of almost any material. Systematically designed nanoporous polymer films are used, which are suitable for optical applications operating at both visible and near-infrared wavelengths. These high-efficiency anti-reflection coatings are created from phase-separated polyelectrolyte multilayer films that undergo a reversible pH-induced swelling transition. Furthermore, such films, easily patterned by an inkjet printing technique, possess potential for pH-responsive biomaterial and membrane applications.
C1 MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA.
RP Rubner, MF (reprint author), MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA.
CR Calvert P, 2001, CHEM MATER, V13, P3299, DOI 10.1021/cm0101632
   CLAPHAM PB, 1973, NATURE, V244, P281, DOI 10.1038/244281a0
   DECHER G, 1992, THIN SOLID FILMS, V210, P831, DOI 10.1016/0040-6090(92)90417-A
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   DOUGLAS T, 1998, NATURE, V393, P6681
   FERREIRA M, 1994, THIN SOLID FILMS, V244, P806, DOI 10.1016/0040-6090(94)90575-4
   Fery A, 2001, LANGMUIR, V17, P3779, DOI 10.1021/la102612
   FRAUNHOFER J, 1888, VERSUCHE URSACHEN AN, P33
   Harris JJ, 1999, J AM CHEM SOC, V121, P1978, DOI 10.1021/ja9833467
   Hattori H, 2001, ADV MATER, V13, P51, DOI 10.1002/1521-4095(200101)13:1<51::AID-ADMA51>3.3.CO;2-6
   Ibn-Elhaj M, 2001, NATURE, V410, P796, DOI 10.1038/35071039
   Macleod H. A., 1969, THIN FILM OPTICAL FI
   Mark J. E., 1999, POLYM DATA HDB
   Mendelsohn JD, 2000, LANGMUIR, V16, P5017, DOI 10.1021/la000075g
   MINOT MJ, 1976, J OPT SOC AM, V66, P515, DOI 10.1364/JOSA.66.000515
   MONACO SF, 1961, J OPT SOC AM, V51, P280, DOI 10.1364/JOSA.51.000280
   Shiratori SS, 2000, MACROMOLECULES, V33, P4213, DOI 10.1021/ma991645q
   SPEIR JA, 1995, STRUCTURE, V3, P63, DOI 10.1016/S0969-2126(01)00135-6
   Uhlmann DR, 1997, J NON-CRYST SOLIDS, V218, P113, DOI 10.1016/S0022-3093(97)00162-2
   Walheim S, 1999, SCIENCE, V283, P520, DOI 10.1126/science.283.5401.520
   Wang TC, 2001, LANGMUIR, V17, P6610, DOI 10.1021/la010755z
   Yang SY, 2002, J AM CHEM SOC, V124, P2100, DOI 10.1021/ja017681y
   YOLDAS BE, 1980, APPL OPTICS, V19, P1425, DOI 10.1364/AO.19.001425
   Zhang H., 2002, HDB POLYELECTROLYTES, V1, P183
NR 24
TC 661
Z9 668
U1 24
U2 299
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1476-1122
J9 NAT MATER
JI Nat. Mater.
PD SEP
PY 2002
VL 1
IS 1
BP 59
EP 63
DI 10.1038/nmat719
PG 5
WC Chemistry, Physical; Materials Science, Multidisciplinary; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 654LM
UT WOS:000181498400026
PM 12618851
DA 2018-10-20
ER

PT J
AU Gamba, PG
   Conconi, MT
   Lo Piccolo, R
   Zara, G
   Spinazzi, R
   Parnigotto, PP
AF Gamba, PG
   Conconi, MT
   Lo Piccolo, R
   Zara, G
   Spinazzi, R
   Parnigotto, PP
TI Experimental abdominal wall defect repaired with acellular matrix
SO PEDIATRIC SURGERY INTERNATIONAL
LA English
DT Article
DE acellular matrix; abdominal-wall defect; diaphragmatic prosthesis
ID CULTURED URETHRAL EPITHELIUM; AUTOLOGOUS GRAFT; DERMAL MATRIX; MUSCLE;
   REGENERATION; GROWTH; RABBIT; HYPOSPADIAS; UROTHELIUM; MYOBLASTS
AB In the surgical repair of congenital abdominal-wall defects (AWD), the ready availability of a nonimmunogenic and non-prosthetic biomaterial that could guide the regeneration of normal tissue is a fascinating possibility. Biomaterials are already in use, but in our experience, an acellular matrix (ACM) can stimulate exact regeneration of the absent tissue. We explored the possibility of using an ACM to repair a muscular AWD in an animal model. Male New Zealand white rabbits (3-4 kg, n = 18) were anesthetized and the abdominal wall was shaved and scrubbed; a vertical incision was made in the left lower quadrant and a large patch of external-oblique muscle was resected (3 x 3 cm). The animals underwent reconstruction with homologous diaphragm acellular matrix (HDAM) grafts that were previously prepared using a detergent enzymatic method. The patches were evaluated histologically at 9 (n = 6), 40 (n = 6), and 90 (n = 6) days post-surgery in each group; moreover, 90 days post-surgery an electromyogram (EMG) (n = 6) of the implanted matrix was recorded. Histologic analysis demonstrated that the HDAM supported fibroblast migration, deposition of newly-formed collagen, and neovascularization. No signs of necrosis, or evidence of skeletal-muscle-cell ingrowth were detected. The EMG revealed minimum muscular electrophysiologic activity, probably due to muscle underlying the patch. The HDAM we employed was thus not able to produce reconstruction of the skeletal muscle, and was progressively remodeled into fibrous tissue. Since the ultimate reason for failure of muscle regeneration is a lack of myogenesis, future studies will use ACMs preconditioned by various regulators of myoblast proliferation and differentiation.
C1 Univ Padua, Dept Pharmaceut Sci, Padua, Italy.
   Univ Padua, Dept Neurol, Padua, Italy.
   Univ Padua, Dept Pediat Surg, Padua, Italy.
RP Gamba, PG (reprint author), Univ Padua, Azienda Ospedurg, Div Chirurg Pediat, Via Giustiniani 3, I-35121 Padua, Italy.
RI gamba, piergiorgio/J-1935-2018
OI gamba, piergiorgio/0000-0003-2068-342X
CR Arnaud E, 1999, Ann Chir Plast Esthet, V44, P357
   ATALA A, 1992, J UROLOGY, V148, P658, DOI 10.1016/S0022-5347(17)36685-5
   BURGE SM, 1990, CRYOBIOLOGY, V27, P153, DOI 10.1016/0011-2240(90)90007-Q
   CHANG KS, 1994, PEDIATR SURG INT, V9, P307, DOI 10.1007/BF01685989
   Cooney DR., 1998, PEDIAT SURG, P1045
   Dalla Vecchia LD, 1999, J PEDIATR SURG, V34, P167, DOI 10.1016/S0022-3468(99)90250-6
   De Angelis L, 1999, J CELL BIOL, V147, P869, DOI 10.1083/jcb.147.4.869
   DeBord JR, 1998, SURG CLIN N AM, V78, P973, DOI 10.1016/S0039-6109(05)70365-0
   FAIRBANKS JL, 1992, J UROLOGY, V148, P663, DOI 10.1016/S0022-5347(17)36686-7
   GAL LR, 1998, BIOCHIM BIOPHYS ACTA, V1402, P39
   Greenawalt KE, 2000, J SURG RES, V94, P92, DOI 10.1006/jsre.2000.6020
   Italiano G, 1997, UROL RES, V25, P137, DOI 10.1007/BF01037930
   LIVESEY SA, 1995, TRANSPLANTATION, V60, P1, DOI 10.1097/00007890-199507150-00001
   Lorenz C, 1996, PEDIATR SURG INT, V11, P456, DOI 10.1007/BF00180082
   Meadows KA, 2000, J CELL PHYSIOL, V183, P330, DOI 10.1002/(SICI)1097-4652(200006)183:3<330::AID-JCP5>3.0.CO;2-N
   MEDDINGS RN, 1993, J PEDIATR SURG, V28, P660, DOI 10.1016/0022-3468(93)90025-G
   MEEZAN E, 1975, LIFE SCI, V17, P1721, DOI 10.1016/0024-3205(75)90119-8
   Parnigotto PP, 2000, UROL RES, V28, P46, DOI 10.1007/s002400050009
   Parnigotto PP, 2000, J PEDIATR SURG, V35, P1304, DOI 10.1053/jpsu.2000.9309
   ROMAGNOLI G, 1993, J UROLOGY, V150, P1204, DOI 10.1016/S0022-5347(17)35728-2
   ROMAGNOLI G, 1990, NEW ENGL J MED, V323, P527, DOI 10.1056/NEJM199008233230806
   Seale P, 2000, DEV BIOL, V218, P115, DOI 10.1006/dbio.1999.9565
   Semsarian C, 1999, BIOCHEM J, V339, P443, DOI 10.1042/0264-6021:3390443
   Sutherland RS, 1996, J UROLOGY, V156, P571, DOI 10.1016/S0022-5347(01)65755-0
   Takami Y, 1996, BURNS, V22, P182, DOI 10.1016/0305-4179(95)00123-9
   van Wachem PB, 1999, BIOMATERIALS, V20, P419, DOI 10.1016/S0142-9612(98)00185-9
   WILSON GJ, 1990, T AM SOC ART INT ORG, V36, P340
   Wilson Gregory J., 1995, Annals of Thoracic Surgery, V60, P353
NR 28
TC 48
Z9 49
U1 0
U2 8
PU SPRINGER-VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010 USA
SN 0179-0358
J9 PEDIATR SURG INT
JI Pediatr. Surg. Int.
PD SEP
PY 2002
VL 18
IS 5-6
BP 327
EP 331
DI 10.1007/s00383-002-0849-5
PG 5
WC Pediatrics; Surgery
SC Pediatrics; Surgery
GA 619ZM
UT WOS:000179508000009
PM 12415348
DA 2018-10-20
ER

PT J
AU Saxena, AK
   Hulskamp, G
   Schleef, J
   Schaarschmidt, K
   Harms, E
   Willital, GH
AF Saxena, AK
   Hulskamp, G
   Schleef, J
   Schaarschmidt, K
   Harms, E
   Willital, GH
TI Gastroschisis: a 15-year, single-center experience
SO PEDIATRIC SURGERY INTERNATIONAL
LA English
DT Article
DE gastroschisis; surgery; SDD implant; complications
ID INTESTINAL ATRESIA; GROWTH-RETARDATION; WALL DEFECTS; OMPHALOCELE;
   MANAGEMENT
AB 70 cases of gastroschisis (GS) were surgically treated at the Pediatric Surgical University Clinic, Winster, from 1984 through 1998. The defect occurred more frequently in males (44) than females (26). The average birth weight was 2,383 g and mean gestational age 36.8 weeks. 9 infants (12.9%) were delivered vaginally and the rest (87.1%) by cesarean section; 34 of the 61 (55.7%) cesarean sections were done solely for prenatal ultrasonic identification of the abdominal-wall defect. 10 infants (14.3%) underwent primary closure; in 19 (27.1%) primary closure of the skin was possible, however, a single solvent-dried dura (SDD) graft was required for fascial enlargement. The remaining 41 infants (58.6%) had extensive defects and required two grafts for optimal closure. 22 patients (31.4%) had associated anomalies, the most common being bowel atresias and undescended testis. 14 (20%) required secondary laparotomies because of bowel-associated complications and 1 (1.4%) for a urinary-bladder perforation. 11 patients (15.7%) had non-bowel-associated complications. The average postoperative trachea intubation time was 3.9 days and the average hospital stay was 75.6 days. The overall mortality was 2.8%. No major complications associated with SDD implants were encountered; only 4 patients (5.7%) had minor complications such as local inflamation and infection and were managed conservatively. The present data support the employment of SDD implants as acceptable biomaterial for the repair of large GS defects.
C1 Univ Munster, Pediat Surg Clin, D-48129 Munster, Germany.
RP Saxena, AK (reprint author), Univ Munster, Pediat Surg Clin, Albert Schweitzer Str 33, D-48129 Munster, Germany.
CR Adra AM, 1996, AM J OBSTET GYNECOL, V174, P540, DOI 10.1016/S0002-9378(96)70424-6
   AMOURY RA, 1977, SURGERY, V82, P373
   BERNSTEIN P, 1940, ARCH PEDIATR, V57, P505
   Brun M, 1996, PEDIATR RADIOL, V26, P723, DOI 10.1007/BF01383389
   CALZOLARI E, 1995, AM J MED GENET, V58, P187, DOI 10.1002/ajmg.1320580218
   CHUN K, 1993, J PEDIATR SURG, V28, P838, DOI 10.1016/0022-3468(93)90339-M
   Cusick E, 1997, Pediatr Surg Int, V12, P34
   DEBEUGNY P, 1990, CHIR PEDIATR, V31, P18
   Dykes E H, 1996, Semin Pediatr Surg, V5, P90
   FRIES MH, 1993, J ULTRAS MED, V12, P583
   GORNALL P, 1989, J PEDIATR SURG, V24, P522, DOI 10.1016/S0022-3468(89)80497-X
   Langer J C, 1996, Semin Pediatr Surg, V5, P124
   Lee SC, 1997, J PEDIATR SURG, V32, P66, DOI 10.1016/S0022-3468(97)90096-8
   MOLENAAR JC, 1993, WORLD J SURG, V17, P337, DOI 10.1007/BF01658701
   MORROW RJ, 1993, PRENATAL DIAG, V13, P111, DOI 10.1002/pd.1970130205
   Nichols C R, 1997, J Matern Fetal Med, V6, P225
   NOVOTNY DA, 1993, J PEDIATR SURG, V28, P650, DOI 10.1016/0022-3468(93)90022-D
   Ramsden WH, 1997, PEDIATR RADIOL, V27, P166, DOI 10.1007/s002470050092
   Raynor BD, 1997, J ULTRAS MED, V16, P13
   SALLER DN, 1994, OBSTET GYNECOL, V84, P852
   SANTULLI TV, 1961, ANN SURG, V154, P939
   SCHUSTER SR, 1967, SURG GYNECOL OBSTETR, V125, P837
   Srinathan SK, 1997, J SURG RES, V68, P1, DOI 10.1006/jsre.1996.4986
   STRINGEL G, 1993, J PEDIATR SURG, V28, P635
   Torfs CP, 1996, TERATOLOGY, V54, P84, DOI 10.1002/(SICI)1096-9926(199606)54:2<84::AID-TERA4>3.0.CO;2-4
   VANHOORN WA, 1985, Z KINDERCHIR, V40, P368
   WELLER U, 1993, MONATSSCHR KINDERH, V141, P665
   YANG P, 1992, AM J MED GENET, V44, P668, DOI 10.1002/ajmg.1320440528
NR 28
TC 23
Z9 25
U1 0
U2 0
PU SPRINGER-VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010 USA
SN 0179-0358
J9 PEDIATR SURG INT
JI Pediatr. Surg. Int.
PD SEP
PY 2002
VL 18
IS 5-6
BP 420
EP 424
DI 10.1007/s00383-002-0799-y
PG 5
WC Pediatrics; Surgery
SC Pediatrics; Surgery
GA 619ZM
UT WOS:000179508000031
PM 12415370
DA 2018-10-20
ER

PT J
AU Emerson, RJ
   Camesano, TA
AF Emerson, RJ
   Camesano, TA
TI Characterization of bacterial and fungal adhesion in biomaterial systems
   using atomic force microscopy.
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
C1 Worcester Polytech Inst, Dept Chem Engn, Worcester, MA 01609 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD AUG 18
PY 2002
VL 224
MA 009-COLL
BP U397
EP U397
PN 1
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA 583RL
UT WOS:000177422201957
DA 2018-10-20
ER

PT J
AU Gouzy, MF
   Sperling, C
   Streller, U
   Salchert, K
   Bohme, F
   Voit, B
   Werner, C
AF Gouzy, MF
   Sperling, C
   Streller, U
   Salchert, K
   Bohme, F
   Voit, B
   Werner, C
TI Immobilization of small synthetic thrombin inhibitors at the surface of
   a polymeric biomaterial.
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
C1 Inst Polymer Res Dresden, Polymer React & Blends, D-01069 Dresden, Germany.
   Inst Polymer Res Dresden, Biocompatible Mat, D-01069 Dresden, Germany.
   Inst Polymer Res Dresden, Polymer Struct, D-01069 Dresden, Germany.
RI Umlauf, Ursula/D-3356-2014; Werner, Carsten/F-8127-2010; Voit,
   Brigitte/D-4755-2009
OI Werner, Carsten/0000-0003-0189-3448; Voit, Brigitte/0000-0002-4531-691X
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD AUG 18
PY 2002
VL 224
MA 711-POLY
BP U477
EP U477
PN 2
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA 583RM
UT WOS:000177422302586
DA 2018-10-20
ER

PT J
AU Sousa, KA
   Phaneuf, MD
   Bide, MJ
   Aggarwal, P
   Alhilali, LM
   LoGerfo, FW
   Quist, WC
AF Sousa, KA
   Phaneuf, MD
   Bide, MJ
   Aggarwal, P
   Alhilali, LM
   LoGerfo, FW
   Quist, WC
TI Development of an infection-resistant anionic dacron biomaterial using
   textile dyeing technology.
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
C1 Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA.
   Univ Rhode Isl, Dept Text, Kingston, RI 02881 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD AUG 18
PY 2002
VL 224
MA 177-CHED
BP U307
EP U307
PN 1
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA 583RL
UT WOS:000177422201495
DA 2018-10-20
ER

PT J
AU Brodbeck, WG
   Patel, J
   Voskerician, G
   Christenson, E
   Shive, MS
   Nakayama, Y
   Matsuda, T
   Ziats, NP
   Anderson, JM
AF Brodbeck, WG
   Patel, J
   Voskerician, G
   Christenson, E
   Shive, MS
   Nakayama, Y
   Matsuda, T
   Ziats, NP
   Anderson, JM
TI Biomaterial adherent macrophage apoptosis is increased by hydrophilic
   and anionic substrates in vivo
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
ID SURFACE-CHEMISTRY; CELL APOPTOSIS; BIOCOMPATIBILITY; POLYURETHANES;
   BIOSTABILITY; EXPRESSION; ADHESION; DEATH
AB An in vivo rat cage implant system was used to identify potential surface chemistries that prevent failure of implanted biomedical devices and prostheses by limiting monocyte adhesion and macrophage fusion into foreign-body giant cells while inducing adherent-macrophage apoptosis. Hydrophobic, hydrophilic, anionic, and cationic surfaces were used for implantation. Analysis of the exudate surrounding the materials revealed no differences between surfaces in the types or levels of cells present. Conversely, the proportion of adherent cells undergoing apoptosis was increased significantly on anionic and hydrophilic surfaces (46 +/- 3.7 and 57 +/- 5.0%, respectively) when compared with the polyethylene terephthalate base surface. Additionally, hydrophilic and anionic substrates provided decreased rates of monocyte/macrophage adhesion and fusion. These studies demonstrate that biomaterial-adherent cells undergo material-dependent apoptosis in vivo, rendering potentially harmful macrophages nonfunctional while the surrounding environment of the implant remains unaffected.
C1 Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44139 USA.
   Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44139 USA.
   Kyushu Univ, Dept Biomed Engn, Fukuoka 8128482, Japan.
   Natl Cardiovasc Ctr, Dept Bioengn, Osaka 5620025, Japan.
RP Brodbeck, WG (reprint author), Case Western Reserve Univ, Sch Med, Inst Pathol, Room 306, Cleveland, OH 44106 USA.
RI Cosgriff-Hernandez, Elizabeth/E-6391-2016
OI Cosgriff-Hernandez, Elizabeth/0000-0002-4701-5600
FU NIGMS NIH HHS [F32 GM020380, GM-20380]; NHLBI NIH HHS [HL-33849,
   HL-55714, R01 HL055714]
CR Anderson JM, 1999, J MATER SCI-MATER M, V10, P579, DOI 10.1023/A:1008976531592
   Brodbeck WG, 2001, J BIOMED MATER RES, V55, P661, DOI 10.1002/1097-4636(20010615)55:4<661::AID-JBM1061>3.0.CO;2-F
   BRODBECK WG, 2001, J LAB CLIN MED, V139, P90
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   DeFife KM, 1999, J BIOMED MATER RES, V45, P148, DOI 10.1002/(SICI)1097-4636(199905)45:2<148::AID-JBM10>3.0.CO;2-U
   DeFife KM, 1997, J IMMUNOL, V158, P3385
   Fabre T, 1999, J BIOMED MATER RES, V44, P429, DOI 10.1002/(SICI)1097-4636(19990315)44:4<429::AID-JBM9>3.0.CO;2-C
   Honma T, 1996, VIRCHOWS ARCH, V428, P165
   Horbett TA, 1993, CARDIOVASC PATHOL, V2, P137, DOI DOI 10.1016/1054-8807(93)90054-6)
   Jenney CR, 2000, J BIOMED MATER RES, V49, P435
   Labow RS, 1997, J BIOMAT SCI-POLYM E, V8, P779, DOI 10.1163/156856297X00317
   MARCHANT R, 1983, J BIOMED MATER RES, V17, P301, DOI 10.1002/jbm.820170209
   MCINNES A, 1988, J EXP MED, V167, P598, DOI 10.1084/jem.167.2.598
   Nakayama Y, 1996, MACROMOLECULES, V29, P8622, DOI 10.1021/ma9606014
   PINCHUK L, 1994, J BIOMAT SCI-POLYM E, V6, P225, DOI 10.1163/156856294X00347
   Shive MS, 2000, P NATL ACAD SCI USA, V97, P6710, DOI 10.1073/pnas.110463197
   SHIVE MS, 2001, J BIOMED MATER RES, V60, P148
   Suggs LJ, 1999, J BIOMED MATER RES, V46, P22, DOI 10.1002/(SICI)1097-4636(199907)46:1<22::AID-JBM3>3.0.CO;2-R
   Wang ZQ, 2001, IMMUNOLOGY, V102, P331, DOI 10.1046/j.1365-2567.2001.01171.x
   ZHAO Q, 1991, J BIOMED MATER RES, V25, P177, DOI 10.1002/jbm.820250205
   ZIATS NP, 1988, BIOMATERIALS, V9, P5, DOI 10.1016/0142-9612(88)90063-4
NR 21
TC 139
Z9 144
U1 0
U2 15
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD AUG 6
PY 2002
VL 99
IS 16
BP 10287
EP 10292
DI 10.1073/pnas.162124199
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 582HC
UT WOS:000177343200015
PM 12122211
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU Bellon, JM
   Jurado, F
   Garcia-Honduvilla, N
   Lopez, R
   Carrera-San Martin, A
   Bujan, J
AF Bellon, JM
   Jurado, F
   Garcia-Honduvilla, N
   Lopez, R
   Carrera-San Martin, A
   Bujan, J
TI The structure of a biomaterial rather than its chemical composition
   modulates the repair process at the peritoneal level
SO AMERICAN JOURNAL OF SURGERY
LA English
DT Article
DE peritoneal interface; laminar prosthesis; reticular prosthesis; behavior
ID ABDOMINAL-WALL DEFECTS; VENTRAL HERNIA; MESH; PROSTHESIS; IMPLANTATION;
   MIGRATION
AB Background: This study was designed to establish whether the spatial structure of a prosthesis conditions its behavior at the peritoneal level.
   Methods: Abdominal defects comprising all,the wall (except skin) were created in rabbits and repaired with a laminar (DM) or reticular (CV-4) ePTFE-prosthesis. Fourteen days postimplant, specimens were obtained for scanning electron and light microscopy. Peritoneal adhesions, resistance to traction, and neoperitoneum thickness were quantified.
   Results: Adhesions to CV-4 were firm and integrated within surrounding tissue; only scarce adhesion formation was observed for DM. Adhesion area was significantly greater (P<0.01) in the CV-4 than in DM (7.00&PLUSMN;2.6; 0.15&PLUSMN;0.08 cm(2)). The neoperitoneum was organized for DM and disorganized for CV-4. This layer was significantly thicker (P<0.05) in DM than CV-4 (455+/-3.4; 70+/-3.1 mum). The CV-4 showed a greater resistance to traction than the DM (26.75+/-3.71; 14.11+/-3.71 N; P<0.05).
   Conclusions: The structure of a biomaterial, rather than its chemical composition, modulates behavior at the peritoneal interface. (C) 2002 Excerpta Medica, Inc. All rights reserved.
C1 Univ Alcala de Henares, Fac Med, Dept Morphol Sci & Surg, Surg Res Lab, Alcala De Henares 28871, Madrid, Spain.
RP Bellon, JM (reprint author), Univ Alcala de Henares, Fac Med, Dept Morphol Sci & Surg, Surg Res Lab, Crta Madrid Barcelona,Km 33-6, Alcala De Henares 28871, Madrid, Spain.
OI Garcia Honduvilla, Natalio/0000-0003-0904-6198; BELLON, JUAN
   M./0000-0002-6071-5011; bujan, Julia/0000-0003-2419-2476
CR AMID PK, 1994, J BIOMED MATER RES, V28, P373, DOI 10.1002/jbm.820280312
   Bellon JM, 1996, J AM COLL SURGEONS, V183, P11
   Bellon JM, 2000, J MATER SCI-MATER M, V11, P25, DOI 10.1023/A:1008981517743
   Bellon JM, 1996, BIOMATERIALS, V17, P1369, DOI 10.1016/0142-9612(96)87276-0
   Bellon JM, 1997, J BIOMED MATER RES, V38, P197
   Bellon JM, 1999, EUR J SURG, V165, P145
   BUJAN J, 2001, EUR SURG RES, V33, P180
   CHEW DK, 2000, SURGERY, V125, pS109
   Chuback JA, 2000, SURGERY, V127, P475, DOI 10.1067/msy.2000.104122
   DEGUZMAN LJ, 1995, ENDOSCOPY, V27, P459, DOI 10.1055/s-2007-1005743
   KAUFMAN Z, 1981, DIS COLON RECTUM, V24, P543, DOI 10.1007/BF02604320
   LICHTENSTEIN IL, 1989, AM J SURG, V157, P188, DOI 10.1016/0002-9610(89)90526-6
   Luijendijk RW, 2000, NEW ENGL J MED, V343, P392, DOI 10.1056/NEJM200008103430603
   Majeski J, 1998, SOUTH MED J, V91, P496, DOI 10.1097/00007611-199805000-00020
   Mauger D. T., 2001, SURG RES, P1201
NR 15
TC 44
Z9 44
U1 3
U2 3
PU EXCERPTA MEDICA INC
PI NEW YORK
PA 650 AVENUE OF THE AMERICAS, NEW YORK, NY 10011 USA
SN 0002-9610
J9 AM J SURG
JI Am. J. Surg.
PD AUG
PY 2002
VL 184
IS 2
BP 154
EP 159
AR PII S0002-9610(02)00907-8
DI 10.1016/S0002-9610(02)00907-8
PG 6
WC Surgery
SC Surgery
GA 585BL
UT WOS:000177503200013
PM 12169360
DA 2018-10-20
ER

PT J
AU Waar, K
   van der Mei, HC
   Harmsen, HJM
   Degener, JE
   Busscher, HJ
AF Waar, K
   van der Mei, HC
   Harmsen, HJM
   Degener, JE
   Busscher, HJ
TI Adhesion to bile drain materials and physicochemical surface properties
   of Enterococcus faecalis strains grown in the presence of bile
SO APPLIED AND ENVIRONMENTAL MICROBIOLOGY
LA English
DT Article
ID IMAGE-ANALYSIS; FLOW CHAMBER; AGGREGATION; INFECTIONS; PROTEIN; ESP
AB The aim of this study is to determine whether growth in the presence of bile influences the surface properties and adhesion to hydrophobic bile drain materials of Enterococcus faecalis strains expressing aggregation substance (Agg) or enterococcal surface protein (Esp), two surface proteins that are associated with infections. After growth in the presence of bile, the strains were generally more hydrophobic by water contact angles and the zeta potentials were more negative than when the strains were grown in the absence of bile. Nitrogen was found in lower surface concentrations upon growth in the presence of bile, whereas higher surface concentrations of oxygen were measured by X-ray photoelectron spectroscopy. Moreover, an up to twofold-higher number of bacteria adhered after growth in bile for E. faecalis not expressing Agg or Esp and E. faecalis with Esp on its surface. E.faecalis expressing Agg did not adhere in higher numbers after growth in bile, possibly because they mainly adhere through positive cooperativity and less through direct interactions with a substratum surface. Since adhesion of bacteria is the first step in biomaterial-centered infection, it can be concluded that growth in bile increases the virulence of E. faecalis.
C1 Univ Groningen, Dept Med Microbiol, NL-9713 GZ Groningen, Netherlands.
   Univ Groningen, Dept Biomed Engn, NL-9713 GZ Groningen, Netherlands.
RP Waar, K (reprint author), Univ Groningen, Dept Med Microbiol, Hanzepl 1,POB 30-001, NL-9700 RB Groningen, Netherlands.
CR Bos R, 1999, FEMS MICROBIOL REV, V23, P179, DOI 10.1016/S0168-6445(99)00004-2
   BUSSCHER HJ, 1995, METHOD ENZYMOL, V253, P455
   BUSSCHER HJ, 1984, APPL ENVIRON MICROB, V48, P980
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Doyle RJ, 2000, MICROBES INFECT, V2, P391, DOI 10.1016/S1286-4579(00)00328-2
   Flahaut S, 1996, APPL ENVIRON MICROB, V62, P2416
   IKE Y, 1983, P NATL ACAD SCI-BIOL, V80, P5369, DOI 10.1073/pnas.80.17.5369
   JACOB AE, 1974, J BACTERIOL, V117, P360
   JETT BD, 1994, CLIN MICROBIOL REV, V7, P462
   Millsap KW, 1999, J COLLOID INTERF SCI, V212, P495, DOI 10.1006/jcis.1998.6054
   MUSCHOLL A, 1993, EUR J BIOCHEM, V214, P333, DOI 10.1111/j.1432-1033.1993.tb17928.x
   Muscholl-Silberhorn A, 1999, MOL MICROBIOL, V34, P620, DOI 10.1046/j.1365-2958.1999.01631.x
   NOORDMANS J, 1993, J COLLOID INTERF SCI, V156, P394, DOI 10.1006/jcis.1993.1128
   ROUXHET PG, 1991, MICROBIAL CELL SURFA, P173
   Shankar V, 1999, INFECT IMMUN, V67, P193
   Toledo-Arana A, 2001, APPL ENVIRON MICROB, V67, P4538, DOI 10.1128/AEM.67.10.4538-4545.2001
   VANDERMEI HC, 2000, SURF SCI REP, V329, P1
   WAAR K, 2001, J INFECT DIS, V185, P1121
   WAAR KH, 2000, MICROBIOLOGY, V148, P1863
   WELLS CL, 1995, CRIT CARE MED, V23, P301, DOI 10.1097/00003246-199502000-00016
   Yu JL, 1996, SCAND J GASTROENTERO, V31, P625, DOI 10.3109/00365529609009140
NR 21
TC 18
Z9 18
U1 1
U2 2
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0099-2240
J9 APPL ENVIRON MICROB
JI Appl. Environ. Microbiol.
PD AUG
PY 2002
VL 68
IS 8
BP 3855
EP 3858
DI 10.1128/AEM.68.8.3855-3858.2002
PG 4
WC Biotechnology & Applied Microbiology; Microbiology
SC Biotechnology & Applied Microbiology; Microbiology
GA 580WV
UT WOS:000177260500024
PM 12147481
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU Bisson, I
   Kosinski, M
   Ruault, S
   Gupta, B
   Hilborn, J
   Wurm, F
   Frey, P
AF Bisson, I
   Kosinski, M
   Ruault, S
   Gupta, B
   Hilborn, J
   Wurm, F
   Frey, P
TI Acrylic acid grafting and collagen immobilization on poly(ethylene
   terephthalate) surfaces for adherence and growth of human bladder smooth
   muscle cells
SO BIOMATERIALS
LA English
DT Article
DE poly(ethylene terephthalate); plasma graft polymerization; acrylic acid
   grafting; collagen immobilization; adherence and growth of human smooth
   muscle cells; tissue engineering
ID POLY(ETHYLENE-TEREPHTHALATE) FILMS; HUMAN UROTHELIUM; TISSUE;
   POLYMERIZATION; CULTURE; RECONSTITUTION; BIOMATERIAL; SURGERY; WALL
AB In tissue engineering, degradable or non-degradable polymer matrices can act as cell-carrier-scaffolds. Cell adhesion and growth on these scaffolds can he promoted by immobilizing extracellular matrix proteins. Therefore, in this study, polymer poly(ethylene terephthalate) (PET) films were surface modified by graft polymerization of acrylic acid, to subsequently allow collagen (types I and III) immobilization and human smooth muscle cell expansion. The surfaces of PET were activated by plasma, followed by acrylic acid graft polymerization, resulting in covalently bound brushes, containing an average of either 0.22 +/- 0.1 or 5.93 +/- 0.87 mug/cm(2) of poly(acrylic acid) (PAA). Subsequent electrostatic adsorption of collagen gave a Surface concentration of 4.96 and 17.2 mug/cm(2),, respectively. as determined using radiolabelled I-125 collagen. Both PET films grafted with 0.22 mug/cm(2) of PAA with or without adsorbed collagen were apt for smooth muscle cell adhesion and proliferation. However, films grafted with 5.93 mug/cm(2) were not. PAA-grafted PET films, onto which serum proteins of the Culture medium adsorbed spontaneously, proved to be better matrices than films oil which collagen has been immobilized. It, therefore, can be speculated that other serum proteins are more important than collagen for the human smooth muscle cell adhesion and growth Oil surface-modified polymer matrices. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 CHU Vaudois, Dept Pediat Surg, Lab Expt Pediat Urol, CH-1011 Lausanne, Switzerland.
   Univ Lausanne, Inst Appl Radiophys, Lausanne, Switzerland.
   Univ Uppsala, Angstrom Lab, Uppsala, Sweden.
   Ecole Polytech Fed Lausanne, Lab Cellular Biotechnol, Lausanne, Switzerland.
RP Frey, P (reprint author), CHU Vaudois, Dept Pediat Surg, Lab Expt Pediat Urol, CH-1011 Lausanne, Switzerland.
RI wurm, florian/D-7224-2013
OI Hilborn, Jons/0000-0001-6947-9601
CR Atala A, 1998, UROL CLIN N AM, V25, P39, DOI 10.1016/S0094-0143(05)70431-6
   Atala A, 1999, UROL CLIN N AM, V26, P157, DOI 10.1016/S0094-0143(99)80013-5
   ATALA A, 1997, SYNTHETIC BIODEGRADA, P149
   ATALA A, 1999, DIAL PED UROL, V22, P7
   BASKIN LS, 1993, J UROLOGY, V149, P190, DOI 10.1016/S0022-5347(17)36037-8
   Elbahnasy AM, 1998, J UROLOGY, V159, P628, DOI 10.1016/S0022-5347(01)63690-5
   Falke G, 2000, WORLD J UROL, V18, P36, DOI 10.1007/s003450050007
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Gupta B, 2001, J APPL POLYM SCI, V81, P2993, DOI 10.1002/app.1749
   Gupta B, 2002, BIOMATERIALS, V23, P863, DOI 10.1016/S0142-9612(01)00195-8
   HORBETT TA, 1993, CARDIOVASC PATHOL, V2, pS147
   HUTTON KAR, 1993, J UROLOGY, V150, P721, DOI 10.1016/S0022-5347(17)35597-0
   Ito Y, 1997, BIOMATERIALS, V18, P197, DOI 10.1016/S0142-9612(96)00119-6
   Kim BS, 1999, EXP CELL RES, V251, P318, DOI 10.1006/excr.1999.4595
   KISMAN OK, 1991, J UROLOGY, V146, P1113, DOI 10.1016/S0022-5347(17)38017-5
   KLEE LW, 1990, J UROLOGY, V144, P1283, DOI 10.1016/S0022-5347(17)39720-3
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee SD, 1996, BIOMATERIALS, V17, P1599, DOI 10.1016/0142-9612(95)00316-9
   MIYATA T, 1992, Clinical Materials, V9, P139, DOI 10.1016/0267-6605(92)90093-9
   Oberpenning F, 1999, NAT BIOTECHNOL, V17, P149
   REZNIKOFF CA, 1983, IN VITRO CELL DEV B, V19, P326
   SANO S, 1993, BIOMATERIALS, V14, P817, DOI 10.1016/0142-9612(93)90003-K
   Scriven SD, 1997, J UROLOGY, V158, P1147, DOI 10.1016/S0022-5347(01)64407-0
   Sugasi S, 2000, J UROLOGY, V164, P951, DOI 10.1016/S0022-5347(05)67224-2
   Temenoff JS, 2000, BIOMATERIALS, V21, P2405, DOI 10.1016/S0142-9612(00)00108-3
   Wilson CB, 1996, WORLD J UROL, V14, pS30
NR 26
TC 127
Z9 134
U1 1
U2 36
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2002
VL 23
IS 15
BP 3149
EP 3158
AR PII S0142-9612(02)00061-3
DI 10.1016/S0142-9612(02)00061-3
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 563RF
UT WOS:000176268800010
PM 12102186
DA 2018-10-20
ER

PT J
AU Knabe, C
   Klar, F
   Fitzner, R
   Radlanski, RJ
   Gross, U
AF Knabe, C
   Klar, F
   Fitzner, R
   Radlanski, RJ
   Gross, U
TI In vitro investigation of titanium and hydroxyapatite dental implant
   surfaces using a rat bone marrow stromal cell culture system
SO BIOMATERIALS
LA English
DT Article
DE titanium; plasma-sprayed coatings; osteoblasts; cell-biomaterial
   interactions; dental implant
ID OSTEOBLAST-LIKE CELLS; SCREW-SHAPED IMPLANTS; PLASMA-SPRAYED COATINGS;
   PROTEIN-KINASE-A; IN-VITRO; HISTOMORPHOMETRIC EVALUATION;
   OSSEOINTEGRATED IMPLANTS; PHOSPHOLIPASE A(2); INTERFACE INVITRO;
   MINIATURE PIGS
AB In this study, rat bone marrow cells (RBM) were used to evaluate different titanium and hydroxyapatite dental implant surfaces. The implant surfaces investigated were a titanium surface having a porous titanium plasma-sprayed coating (sample code Ti-TPS), a titanium surface with a deep profile structure (sample code Ti-DPS), an uncoated tit,11141111 substrate with a machined surface (sample code Ti-ma) and a machined titanium substrate with a Porous hydroxyapatite plasma-sprayed coating (sample code Ti-HA). RBM cells were Cultured on the disc-shaped test substrates for 14 days. The culture medium was changed daily and examined for calcium and phosphate concentrations. After 14 days specimens were examined by light microscopy, scanning electron microscopy, energy dispersive X-ray analysis and morphometry of the cell-covered Substrate Surface. All test substrates facilitated RBM growth of extracellular matrix formation. Ti-DPS and Ti-TPS to the highest degree, followed by Ti-ma and Ti-HA. Ti-DPS and Ti-TPS displayed the highest cell density and thus seem to be well suited for the endosseous portion of dental implants. RBM cells cultured oil Ti-HA showed a delayed growth pattern. This may be related to its high phosphate ion release. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Free Univ Berlin, Univ Hosp Benjamin Franklin, Dept Expt Dent, D-14197 Berlin, Germany.
   Friadent Inc, D-68229 Mannheim, Germany.
   Free Univ Berlin, Univ Hosp Benjamin Franklin, Inst Clin Chem & Biochem, D-12200 Berlin, Germany.
   Free Univ Berlin, Univ Hosp Benjamin Franklin, Inst Pathol, D-12200 Berlin, Germany.
RP Knabe, C (reprint author), Free Univ Berlin, Univ Hosp Benjamin Franklin, Dept Expt Dent, Assmannshauser Str 4-6, D-14197 Berlin, Germany.
CR ADELL R, 1981, INT J ORAL MAXILLOF, V10, P387, DOI 10.1016/S0300-9785(81)80077-4
   ALBREKTSSON T, 1988, J PERIODONTOL, V59, P287, DOI 10.1902/jop.1988.59.5.287
   Anselme K, 1997, J BIOMED MATER RES, V34, P247, DOI 10.1002/(SICI)1097-4636(199702)34:2<247::AID-JBM14>3.0.CO;2-F
   Bowers K T, 1992, Int J Oral Maxillofac Implants, V7, P302
   Boyan BD, 1999, BIOMATERIALS, V20, P2305, DOI 10.1016/S0142-9612(99)00159-3
   BRANEMARK P I, 1969, Scandinavian Journal of Plastic and Reconstructive Surgery, V3, P81
   Buser D, 1999, J BIOMED MATER RES, V45, P75, DOI 10.1002/(SICI)1097-4636(199905)45:2<75::AID-JBM1>3.0.CO;2-P
   BUSER D, 1991, J BIOMED MATER RES, V25, P889, DOI 10.1002/jbm.820250708
   Carr AB, 1997, INT J ORAL MAX IMPL, V12, P598
   Chehroudi B, 1997, J BIOMED MATER RES, V34, P279
   CLAES L, 1976, ARCH ORTHOP TRAUM SU, V85, P155, DOI 10.1007/BF00415453
   Cochran DL, 1999, J PERIODONTOL, V70, P1523, DOI 10.1902/jop.1999.70.12.1523
   Cooper LF, 1999, INT J ORAL MAX IMPL, V14, P37
   CUNE MS, 1994, J PROSTHET DENT, V72, P144, DOI 10.1016/0022-3913(94)90072-8
   Davies JE, 1996, ANAT REC, V245, P426
   DAVIES JE, 1990, J BIOMED MATER RES, V24, P1289, DOI 10.1002/jbm.820241003
   DEBRUIJN JD, 1992, J BIOMED MATER RES, V26, P1365, DOI 10.1002/jbm.820261008
   DeSantis D, 1996, J MATER SCI-MATER M, V7, P21, DOI 10.1007/BF00121185
   ERICSSON I, 1994, CLIN ORAL IMPLAN RES, V5, P202, DOI 10.1034/j.1600-0501.1994.050402.x
   FRAYSSINET P, 1994, J MATER SCI-MATER M, V5, P11, DOI 10.1007/BF00121147
   Gondolph-Zink B, 1998, ORTHOPADE, V27, P96
   GOTTFREDSON K, 1992, CLIN ORAL IMPLAN RES, V3, P77
   Gronowicz G, 1996, J ORTHOPAED RES, V14, P878, DOI 10.1002/jor.1100140606
   Gronthos S, 1997, J BONE MINER RES, V12, P1189, DOI 10.1359/jbmr.1997.12.8.1189
   Grossner-Schreiber B, 1991, Dtsch Zahnarztl Z, V46, P691
   Han CH, 1998, CLIN ORAL IMPLAN RES, V9, P1, DOI 10.1034/j.1600-0501.1998.090101.x
   Hendrich C, 1996, BIOMED TECH, V41, P278, DOI 10.1515/bmte.1996.41.10.278
   Hott M, 1997, J BIOMED MATER RES, V37, P508, DOI 10.1002/(SICI)1097-4636(19971215)37:4<508::AID-JBM9>3.0.CO;2-P
   HULSHOFF JEG, 1995, J BIOMED MATER RES, V29, P967, DOI 10.1002/jbm.820290808
   Hutton J E, 1995, Int J Oral Maxillofac Implants, V10, P33
   *INT STAND BIOL EV, 1994, 10993 ISO INT STAND
   JAFFIN RA, 1991, J PERIODONTOL, V62, P2, DOI 10.1902/jop.1991.62.1.2
   Jemt T, 1992, Int J Oral Maxillofac Implants, V7, P162
   Kettner R, 1997, Mund Kiefer Gesichtschir, V1, P335
   KIEFER H, 1986, BIOL BIOMECHANICAL P, P471
   Kieswetter K, 1996, J BIOMED MATER RES, V32, P55, DOI 10.1002/(SICI)1097-4636(199609)32:1<55::AID-JBM7>3.0.CO;2-O
   Klokkevold PR, 1997, CLIN ORAL IMPLAN RES, V8, P442, DOI 10.1034/j.1600-0501.1997.080601.x
   Knabe C, 1997, BIOMATERIALS, V18, P1339, DOI 10.1016/S0142-9612(97)00078-1
   Lazzara RJ, 1999, INT J PERIODONT REST, V19, P117
   Lincks J, 1998, BIOMATERIALS, V19, P2219, DOI 10.1016/S0142-9612(98)00144-6
   Lohmann CH, 1999, J BIOMED MATER RES, V47, P139, DOI 10.1002/(SICI)1097-4636(199911)47:2<139::AID-JBM4>3.0.CO;2-2
   LOWENBERG B, 1991, CELL MATER, V1, P177
   LOWENBERG BF, 1996, T 5 WORLD BIOM C, P668
   MANIATOPOULOS C, 1988, CELL TISSUE RES, V254, P317
   Matsuo M, 1999, J PERIODONTOL, V70, P1330, DOI 10.1902/jop.1999.70.11.1330
   MICHAELS C M, 1989, Journal of Dental Research, V68, P276
   Mustafa K, 2000, CLIN ORAL IMPLAN RES, V11, P116, DOI 10.1034/j.1600-0501.2000.011002116.x
   Nakashima Y, 1997, J BIOMED MATER RES, V35, P287
   Noth U, 1999, BIOMED TECH, V44, P6, DOI 10.1515/bmte.1999.44.1-2.6
   Ohgushi H, 1996, J BIOMED MATER RES, V32, P333, DOI 10.1002/(SICI)1097-4636(199611)32:3<333::AID-JBM5>3.0.CO;2-T
   Ong J L, 1997, Implant Dent, V6, P19, DOI 10.1097/00008505-199700610-00004
   Ong J L, 1996, Implant Dent, V5, P83, DOI 10.1097/00008505-199600520-00002
   Ozawa S, 1996, BIOMATERIALS, V17, P23, DOI 10.1016/0142-9612(96)80751-4
   PULCO DA, 1991, J BIOMED MATER RES, V25, P711
   Qu J, 1996, Oral Dis, V2, P102
   Schroeder A, 1976, SSO Schweiz Monatsschr Zahnheilkd, V86, P713
   Schwartz Z, 1997, J PERIODONTAL RES, V32, P166, DOI 10.1111/j.1600-0765.1997.tb01399.x
   Smedberg J I, 1993, Clin Oral Implants Res, V4, P39, DOI 10.1034/j.1600-0501.1993.040106.x
   Svehla M, 2000, J BIOMED MATER RES, V51, P15, DOI 10.1002/(SICI)1097-4636(200007)51:1<15::AID-JBM3>3.0.CO;2-9
   TODESCAN R, 1996, T 5 WORLD BIOM C, P721
   TRANQUILLI PL, 1994, J MATER SCI-MATER M, V5, P345, DOI 10.1007/BF00058960
   Trentz OA, 1997, UNFALLCHIRURG, V100, P39, DOI 10.1007/s001130050093
   Vercaigne S, 1998, CLIN ORAL IMPLAN RES, V9, P261, DOI 10.1034/j.1600-0501.1998.090407.x
   Vogel J, 1996, J MATER SCI-MATER M, V7, P495, DOI 10.1007/BF00705431
   Weiner E, 1996, FUTURIST, V30, P25
   Wennerberg A, 1996, BIOMATERIALS, V17, P15, DOI 10.1016/0142-9612(96)80750-2
   Wennerberg A, 1998, CLIN ORAL IMPLAN RES, V9, P11, DOI 10.1034/j.1600-0501.1998.090102.x
   Wennerberg A, 1997, INT J ORAL MAX IMPL, V12, P486
   Zreiqat H, 1999, J BIOMED MATER RES, V47, P360, DOI 10.1002/(SICI)1097-4636(19991205)47:3<360::AID-JBM10>3.0.CO;2-K
   Zreiqat H, 1996, J BIOMED MATER RES, V33, P217, DOI 10.1002/(SICI)1097-4636(199624)33:4<217::AID-JBM2>3.0.CO;2-S
NR 70
TC 43
Z9 43
U1 1
U2 9
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2002
VL 23
IS 15
BP 3235
EP 3245
AR PII S0142-9612(02)00078-9
DI 10.1016/S0142-9612(02)00078-9
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 563RF
UT WOS:000176268800019
PM 12102195
DA 2018-10-20
ER

PT J
AU Verne, E
   Bosetti, M
   Brovarone, CV
   Moisescu, C
   Lupo, F
   Spriano, S
   Cannas, M
AF Verne, E
   Bosetti, M
   Brovarone, CV
   Moisescu, C
   Lupo, F
   Spriano, S
   Cannas, M
TI Fluoroapatite glass-ceramic coatings on alumina: structural, mechanical
   and biological characterisation
SO BIOMATERIALS
LA English
DT Article
DE glass-ceramic; coatings; osteoblast-like cells; biocompatibility
ID BIOACTIVE GLASS; ZIRCONIA; CARBON; AL2O3
AB The aim of this work was to realise bioactive coatings on full density alpha-alumina substrates. An SiO(2)-CaO-based glass (SC) and an SiO(2)-Al(2)O(3)-P(2)O(5)-K(2)O-CaO-F(-)-based glass-ceramic (SAF) Were used for this purpose. Specifically, SAF is a fluoroapatite containing glass-ceramic and previous studies have shown that it is a highly bioactive biomaterial. Furthermore, these fluoroapatite crystals possess a needle-shaped morphology which mimics that of hydroxylapatite found in human hard tissues. particularly in teeth.
   SAF is a very viscous glass-ceramic and for this reason an intermediate, less viscous, SC layer was interposed in direct contact with alumina aiming, to obtain a good coating adhesion.
   Moreover, this intermediate layer strongly lowers the Al(3+) diffusion and thus minimises both compositional changes in the SAF outer layer and the risk of detrimental modifications of the nature of the crystalline phases.
   A complete characterisation of the coated samples was performed by means of X-ray diffraction, optical and scanning microscopy. Coating adhesion on alumina was tested by comparative shear tests while biocompatibility,vas investigated on alumina. bulk SAF and oil the realised coatings. For this purpose, cytotoxicity, adhesion and proliferation of human osteoblast-like cells were cultured onto the three materials. Results showed that the interposition of the SC layer was Successful ill allowing I good softening and spreading of the SAF outer layer and in avoiding the crystallisation undesired crystalline phases maintaining the good bioactive properties of the bulk one. In vitro results on the coatings showed osteoblast-like cell behaviour similar to bulk fluoroapatite glass-ceramic and better respect to alumina substrates, being a promising index of bone material integration and of its in vivo possible applications. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Politecn Torino, Dept Mat Sci & Chem Engn, I-10129 Turin, Italy.
   Univ Piemonte Orientale, Dept Med Sci, Novara, Italy.
   Univ Jena, Otto Schott Inst, D-6900 Jena, Germany.
RP Verne, E (reprint author), Politecn Torino, Dept Mat Sci & Chem Engn, C So Duca Abruzzi 24, I-10129 Turin, Italy.
EM verne@athena.polito.it
RI Vitale Brovarone, Chiara/G-9630-2012
OI Vitale Brovarone, Chiara/0000-0003-2413-5594; Bosetti,
   Michela/0000-0002-3682-8702; Spriano, Silvia/0000-0002-7367-9777; Verne,
   Enrica/0000-0002-8649-4739
CR Bosetti M, 2001, BIOMATERIALS, V22, P987, DOI 10.1016/S0142-9612(00)00264-7
   Bosetti M, 1998, J BIOMED MATER RES, V40, P307, DOI 10.1002/(SICI)1097-4636(199805)40:2<307::AID-JBM16>3.0.CO;2-I
   Brovarone CV, 2001, J EUR CERAM SOC, V21, P2855
   BUSHBY RS, 1993, MATER SCI TECH SER, V9, P417, DOI 10.1179/mst.1993.9.5.417
   Cao WP, 1996, CERAM INT, V22, P493, DOI 10.1016/0272-8842(95)00126-3
   Ehlers EM, 2001, ANN ANAT, V183, P13, DOI 10.1016/S0940-9602(01)80007-8
   Ferraris M, 2000, BIOMATERIALS, V21, P765, DOI 10.1016/S0142-9612(99)00209-4
   Ferraris M, 1998, J NUCL MATER, V258, P1546, DOI 10.1016/S0022-3115(98)00176-7
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Hulbert SF, 1993, INTRO BIOCERAMICS, P25
   Isola C, 1998, J EUR CERAM SOC, V18, P1017, DOI 10.1016/S0955-2219(97)00203-3
   Jiang GW, 1998, J BIOMED MATER RES, V43, P77, DOI 10.1002/(SICI)1097-4636(199821)43:1<77::AID-JBM9>3.0.CO;2-J
   KEPNER RL, 1994, MICROBIOL REV, V58, P603
   KIMIHIRO Y, 1998, J BIOMED MATER RES, V43, P46
   Lin J, 1995, MATER SCI TECH SER, V11, P1035, DOI 10.1179/mst.1995.11.10.1035
   Moisescu C, 1999, J NON-CRYST SOLIDS, V248, P169, DOI 10.1016/S0022-3093(99)00239-2
   Moisescu C, 1999, J NON-CRYST SOLIDS, V248, P176, DOI 10.1016/S0022-3093(99)00240-9
   NATION JL, 1983, STAIN TECHNOL, V58, P347, DOI 10.3109/10520298309066811
   Payne JM, 1996, J PERIODONTOL, V67, P236, DOI 10.1902/jop.1996.67.3.236
   Verne E, 2000, J EUR CERAM SOC, V20, P473, DOI 10.1016/S0955-2219(99)00181-8
   Verne E, 1997, BIOCERAMICS, VOL 10, P199, DOI 10.1016/B978-008042692-1/50047-9
   Verne E, 2000, ACTA MATER, V48, P4667, DOI 10.1016/S1359-6454(00)00255-X
   VERNE E, 1999, BIOCERAMICS, P491
NR 23
TC 26
Z9 28
U1 0
U2 10
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2002
VL 23
IS 16
BP 3395
EP 3403
AR PII S0142-9612(02)00040-6
DI 10.1016/S0142-9612(02)00040-6
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 563RG
UT WOS:000176268900011
PM 12099282
DA 2018-10-20
ER

PT J
AU Steffens, GCM
   Nothdurft, L
   Buse, G
   Thissen, H
   Hocker, H
   Klee, D
AF Steffens, GCM
   Nothdurft, L
   Buse, G
   Thissen, H
   Hocker, H
   Klee, D
TI High density binding of proteins and peptides to poly(D,L-lactide)
   grafted with polyacrylic acid
SO BIOMATERIALS
LA English
DT Article
DE poly(D,L-lactide); protein immobilisation; polyacrylic acid; graft
   polymerisation
ID COVALENT
AB The use of graft polymers for the functionalisation of biomaterial surfaces is already widespread. We investigated the adsorptive and covalent binding of a variety of proteins and peptides to poly((D),L-lactide) grafted with polyacrylic acid. Covalent attachincrit was achieved through coupling of amino groups of the protein/peptide to the carboxyl groups of the graft polymer by using a water-soluble carbodiimide and N-hydroxysuccinimide. Binding densities were determined by automated amino acid analysis after acid hydrolysis of both the poly((D),L-lactide) and the adsorbed and covalently bound proteins. Experiments in the absence and presence of the coupling reagents allow to discriminate between adsorptive and covalent binding. Although the adsorptive binding is quite substantial in absolute terms, the amount of adsorbed protein is relatively low as compared to the total amount of bound protein.
   Total binding densities of 20-30/mug/cm(2) can easily be achieved. Depending on the concentration and on the properties of the proteins and peptides, between 5% and 80% of the totally bound protein may be physically adsorbed.
   Densities expressed in molecules/10nm(2) vary from 0.5 molecule fibronectin to 2000 laminin-peptide molecules: their binding densities clearly correlate with their respective molecular masses. Obviously, the binding densities are governed by their individual three-dimensional space requirements rather than the density of the available carboxyl groups.
   From the number of carboxyl groups/nm(2) (18,000-30,000 COOH/10 nm(2)) the average length of the acrylic acid graft polymer molecules was estimated. Based on the assumption that about 10 copolymer chains can be accommodated on 10 nm(2), the average length of the polymer chains, which corresponds to the thickness of the graft phase, is estimated to be 0.5-1 mum.
   The organisation of the proteins and peptides within the polyacrylic acid phase was further investigated by experiments in which a protein (BSA) and a peptide (Val-Lys) were allowed to react in either a singular a consecutive or a simultaneous way XPS and IR-ATR surface characterisation experiments a three-dimensional picture of the arrangement of the immobilised proteins and peptides within the graft polymer phase emerges. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Univ Klinikum RWTH, Dept Biochem, Inst Biochem, D-52057 Aachen, Germany.
   Rhein Westfal TH Aachen, Inst Textile Chem & Macromol Chem, D-52062 Aachen, Germany.
RP Steffens, GCM (reprint author), Univ Klinikum RWTH, Dept Biochem, Inst Biochem, Pauwelstr 30, D-52057 Aachen, Germany.
RI Thissen, Helmut/D-3835-2011
CR Atala A, 1997, SYNTHETIC BIODEGRADA
   Hoffman A.S., 1996, BIOMATERIALS SCI INT, P124
   NOBBS CL, 1966, NATURE, V209, P339, DOI 10.1038/209339a0
   Somers W, 1997, EMBO J, V16, P989, DOI 10.1093/emboj/16.5.989
   SUZUKI M, 1986, MACROMOLECULES, V19, P1804, DOI 10.1021/ma00161a005
   THISSEN H, 1999, THESIS AACHEN U TECH
   THISSEN H, 1998, BIODEGRADIERBARE IMP, P59
   THISSEN H, 1996, POLYM MED SURG
   Ulbricht M, 1998, BIOMATERIALS, V19, P1229, DOI 10.1016/S0142-9612(98)00029-5
   Valuev IL, 1998, BIOMATERIALS, V19, P41, DOI 10.1016/S0142-9612(97)00147-6
   Volcker N, 2001, J MATER SCI-MATER M, V12, P111, DOI 10.1023/A:1008938525489
   WELINDER KG, 1976, FEBS LETT, V72, P19, DOI 10.1016/0014-5793(76)80804-6
NR 12
TC 85
Z9 87
U1 0
U2 42
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2002
VL 23
IS 16
BP 3523
EP 3531
AR PII S0142-9612(02)00091-1
DI 10.1016/S0142-9612(02)00091-1
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 563RG
UT WOS:000176268900027
PM 12099298
DA 2018-10-20
ER

PT J
AU Kirkpatrick, CJ
   Krump-Konvalinkova, V
   Unger, RE
   Bittinger, F
   Otto, M
   Peters, K
AF Kirkpatrick, CJ
   Krump-Konvalinkova, V
   Unger, RE
   Bittinger, F
   Otto, M
   Peters, K
TI Tissue response and biomaterial integration: the efficacy of in vitro
   methods
SO BIOMOLECULAR ENGINEERING
LA English
DT Article; Proceedings Paper
CT E-MRS 2001 Spring Meeting
CY JUN 05-08, 2001
CL STRASBOURG, FRANCE
DE biomaterials; in vitro methods; endothelial cells; inflammation;
   angiogenesis; tissue engineering
ID MICROVASCULAR ENDOTHELIAL-CELLS; NECROSIS-FACTOR-ALPHA; HEAVY-METAL
   IONS; VASCULAR ENDOTHELIUM; EXTRACELLULAR-MATRIX; SHEAR-STRESS;
   EXPRESSION; MECHANISMS; APOPTOSIS; DELIVERY
AB Implantation involves tissue trauma, which evokes an inflammatory response, coupled to a wound healing reaction, involving angiogenesis, fibroblast activation and matrix remodelling. Until now the type and extent of such reactions to give optimal integration of various biomaterials are practically unknown. Three principal fields of research can yield useful data to understand these phenomena better: studies on explanted biomaterials, animal models and relevant in vitro techniques. This paper will present examples of the latter field and the application of endothelial cell (EC) culture systems to study the effects of important tissue (e.g. pro-inflammatory cytokines, chemokines) and material (e.g. metal ions, particulate debris) factors on the regulation of the inflammatory and angiogenic response. A central feature is the use of microvascular endothelial cells (MEC), which can be used in both 2-and 3-dimensional (3-D) assays. We have also used genetic manipulation to develop a permanent MEC line from the human lung (HPMEC-ST1), which is being tested for its suitability to study cell-biomaterial interactions. In addition, suitable in vitro techniques are being developed in order to investigate drug delivery systems (DDS). Of particular interest is the targeting of the central nervous system, our approach being to establish a human model of the blood-brain barrier (BBB). A mainstay of our scientific philosophy is that such in vitro methods can make an important contribution to understanding biological reactions at the tissue-biomaterial interface and thus further a causal approach to tissue engineering (TE) and drug delivery applications. (C) 2002 Elsevier Science B.V. All rights reserved.
C1 Univ Mainz, Inst Pathol, D-55101 Mainz, Germany.
RP Kirkpatrick, CJ (reprint author), Univ Mainz, Inst Pathol, Langenbeckstr 1, D-55101 Mainz, Germany.
RI Peters, Kirsten/S-3484-2016
CR BLUMENTHAL NC, 1994, J APPL BIOMATER, V5, P191, DOI 10.1002/jab.770050303
   Chapekar MS, 2000, J BIOMED MATER RES, V53, P617, DOI 10.1002/1097-4636(2000)53:6<617::AID-JBM1>3.3.CO;2-3
   Dard M, 2000, Clin Oral Investig, V4, P126, DOI 10.1007/s007840050128
   DESMOULIERE A, 1995, AM J PATHOL, V146, P56
   Dimmeler S, 2000, CIRC RES, V87, P434
   ELAGLI K, 1995, BIOMATERIALS, V16, P1345, DOI 10.1016/0142-9612(95)91051-Y
   Folkman J, 1996, EUR J CANCER, V32A, P2534, DOI 10.1016/S0959-8049(96)00423-6
   Gariepy J, 2001, TRENDS BIOTECHNOL, V19, P21, DOI 10.1016/S0167-7799(00)01520-1
   GLANT TT, 1993, J BONE MINER RES, V8, P1071
   Guida E, 1998, CELL PHYSIOL BIOCHEM, V8, P75, DOI 10.1159/000016272
   Haynes DR, 2000, J BIOMED MATER RES, V49, P167, DOI 10.1002/(SICI)1097-4636(200002)49:2<167::AID-JBM3>3.0.CO;2-9
   Haynes DR, 1997, J BONE JOINT SURG BR, V79B, P988, DOI 10.1302/0301-620X.79B6.7832
   Jacobs JJ, 1998, J BONE JOINT SURG AM, V80A, P268, DOI 10.2106/00004623-199802000-00015
   Kao WYJ, 2000, BIOMATERIALS, V21, P2295, DOI 10.1016/S0142-9612(00)00156-3
   Kirkpatrick CJ, 1998, P I MECH ENG H, V212, P75, DOI 10.1243/0954411981533845
   Kirkpatrick CJ, 1997, J MATER SCI-MATER M, V8, P131, DOI 10.1023/A:1018567018688
   Kirkpatrick CJ, 1999, J MATER SCI-MATER M, V10, P589, DOI 10.1023/A:1008946615663
   Kirkpatrick CJ, 1997, INT J MICROCIRC, V17, P231, DOI 10.1159/000179235
   Lehmann I, 2000, J VASC RES, V37, P408, DOI 10.1159/000025757
   Lewis JC, 1995, EXP MOL PATHOL, V62, P207, DOI 10.1006/exmp.1995.1023
   Liu JP, 1999, FASEB J, V13, P2091
   MALEK AM, 1993, J CLIN INVEST, V92, P2013, DOI 10.1172/JCI116796
   MALONEY WJ, 1995, J BONE JOINT SURG AM, V77, P1301, DOI 10.2106/00004623-199509000-00002
   MONTESANO R, 1983, J CELL BIOL, V97, P1648, DOI 10.1083/jcb.97.5.1648
   Nakashima Y, 1998, J BONE JOINT SURG BR, V80B, P694, DOI 10.1302/0301-620X.80B4.8374
   NEREM RM, 1993, J BIOMECH ENG-T ASME, V115, P510, DOI 10.1115/1.2895532
   O'Donnell J, 2000, J VASC RES, V37, P540, DOI 10.1159/000054087
   Ono M, 1999, CANCER CHEMOTH PHARM, V43, pS69, DOI 10.1007/s002800051101
   Otto M, 1997, J MATER SCI-MATER M, V8, P119, DOI 10.1023/A:1018515001850
   Peters K, 2001, J MATER SCI-MATER M, V12, P955, DOI 10.1023/A:1012852814570
   RAGHOW R, 1994, FASEB J, V8, P823
   Saunders NR, 1999, CLIN EXP PHARMACOL P, V26, P11, DOI 10.1046/j.1440-1681.1999.02986.x
   SCHNITTLER HJ, 1993, AM J PHYSIOL, V265, P289
   Schwartz JJ, 2000, CURR OPIN MOL THER, V2, P162
   SHAHGALDI BF, 1995, J BONE JOINT SURG BR, V77B, P962
   Sieminski AL, 2000, BIOMATERIALS, V21, P2233, DOI 10.1016/S0142-9612(00)00149-6
   Slavin J, 1996, J PATHOL, V178, P5
   Soppimath KS, 2001, J CONTROL RELEASE, V70, P1, DOI 10.1016/S0168-3659(00)00339-4
   van Kooten TG, 2001, J BIOMED MATER RES, V54, P385
   van Kooten TG, 2000, J BIOMED MATER RES, V52, P199, DOI 10.1002/1097-4636(200010)52:1<199::AID-JBM26>3.0.CO;2-Z
   VERNON RB, 1995, AM J PATHOL, V147, P873
   Wagner M, 1999, AM J PHYSIOL-LUNG C, V277, pL1026, DOI 10.1152/ajplung.1999.277.5.L1026
   Wagner M, 1998, J BIOMED MATER RES, V42, P443, DOI 10.1002/(SICI)1097-4636(19981205)42:3<443::AID-JBM14>3.0.CO;2-H
   Walczak J, 1998, BIOMATERIALS, V19, P229, DOI 10.1016/S0142-9612(97)00208-1
NR 44
TC 62
Z9 65
U1 1
U2 20
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1389-0344
J9 BIOMOL ENG
JI Biomol. Eng.
PD AUG
PY 2002
VL 19
IS 2-6
SI SI
BP 211
EP 217
AR PII S1389-0344(02)00019-9
DI 10.1016/S1389-0344(02)00019-9
PG 7
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Genetics & Heredity
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Genetics & Heredity
GA 598GD
UT WOS:000178266800028
PM 12202185
DA 2018-10-20
ER

PT J
AU Knepper-Nicolai, B
   Reinstorf, A
   Hofinger, I
   Flade, K
   Wenz, R
   Pompe, W
AF Knepper-Nicolai, B
   Reinstorf, A
   Hofinger, I
   Flade, K
   Wenz, R
   Pompe, W
TI Influence of osteocalcin and collagen I on the mechanical and biological
   properties of Biocement D
SO BIOMOLECULAR ENGINEERING
LA English
DT Article; Proceedings Paper
CT E-MRS 2001 Spring Meeting
CY JUN 05-08, 2001
CL STRASBOURG, FRANCE
DE hydroxyapatite-collagen composite; osteocalcin; interface control;
   osteoblast
ID CALCIUM-PHOSPHATE; BONE CEMENTS; PROTEINS; MATRIX; COMPLEX
AB lit order to generate a calcium-phosphate bone cement as a transient replacement for bone defects, we modified Biocement D (Merck Biomaterial GmbH) containing mineralised collagen [1] with osteocalcin, the most abundant non-collageneous protein of bone. Osteocalcin was added to the cement paste during setting in order to control the crystallisation kinetics of hydroxyapatite (HAP) as well as to stimulate the interaction of osteoblasts and osteoclasts with the bone replacement material. Analysts by SEM and AFM shows, that the addition of osteocalcin causes a nanosize microstructure of the calcium cement, which can be explained by inhibited growth of HAP crystals. The fracture strength of the material decreased by incorporation of osteocalcin, pointing onto a higher defect concentration of the crystalline structure. The impact of osteocalcin onto the interaction of bone cells with HAP-Collagen I-cements was studied in a cell culture system using the human osteosarcoma cell line SAOS-2. Results suggest, that osteocalcin might possibly improve the initial adherence of osteoblast-like cells, whereas proliferation of the cells is not effected. (C) 2002 Elsevier Science B.V. All rights reserved.
C1 Tech Univ Dresden, Inst Werkstoffwissensch, D-01069 Dresden, Germany.
   Merck Biomat GMBH, D-64271 Darmstadt, Germany.
RP Pompe, W (reprint author), Tech Univ Dresden, Inst Werkstoffwissensch, Hallwachsstr 3, D-01069 Dresden, Germany.
CR BILEZIKIAN JP, 1996, PRINCIPLES BONE BIOL, P183
   Bradt JH, 1999, CHEM MATER, V11, P2694, DOI 10.1021/cm991002p
   BURTH R, 2000, 1100 WORLD BIOM C KA
   CHENU C, 1994, J CELL BIOL, V127, P1149, DOI 10.1083/jcb.127.4.1149
   DRIESSENS FCM, 1994, J MATER SCI-MATER M, V5, P164, DOI 10.1007/BF00053338
   Driessens FCM, 1998, P I MECH ENG H, V212, P427, DOI 10.1243/0954411981534196
   Flade K, 2001, CHEM MATER, V13, P3596, DOI 10.1021/cm011063z
   GELINSKY M, 2000, CELLS TISSUES ORGANS, V166, P58
   GOLDNER H, 1991, LEHRBUCH HOHERE FEST, V1, P99
   HAUSCHKA PV, 1989, PHYSIOL REV, V69, P990
   HAUSCHKA PV, 1989, ANAT REC, V224, P180, DOI 10.1002/ar.1092240208
   Hunter GK, 1996, BIOCHEM J, V317, P59, DOI 10.1042/bj3170059
   JANSEN JA, 1995, J MATER SCI-MATER M, V6, P653, DOI 10.1007/BF00123447
   Khairoun I, 1999, BIOMATERIALS, V20, P393, DOI 10.1016/S0142-9612(98)00202-6
   Prigodich RV, 1997, ARCH BIOCHEM BIOPHYS, V345, P339, DOI 10.1006/abbi.1997.0254
   RITTER NM, 1992, J BONE MINER RES, V7, P877
NR 16
TC 44
Z9 48
U1 0
U2 10
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1389-0344
J9 BIOMOL ENG
JI Biomol. Eng.
PD AUG
PY 2002
VL 19
IS 2-6
SI SI
BP 227
EP 231
AR PII S1389-0344(02)00036-9
DI 10.1016/S1389-0344(02)00036-9
PG 5
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Genetics & Heredity
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Genetics & Heredity
GA 598GD
UT WOS:000178266800030
PM 12202187
DA 2018-10-20
ER

PT J
AU Eisenbarth, E
   Linez, P
   Biehl, V
   Velten, D
   Breme, J
   Hildebrand, HF
AF Eisenbarth, E
   Linez, P
   Biehl, V
   Velten, D
   Breme, J
   Hildebrand, HF
TI Cell orientation and cytoskeleton organisation on ground titanium
   surfaces
SO BIOMOLECULAR ENGINEERING
LA English
DT Article; Proceedings Paper
CT E-MRS 2001 Spring Meeting
CY JUN 05-08, 2001
CL STRASBOURG, FRANCE
DE cell orientation; surface topography; cell adhesion
ID ADHESION
AB A stable connection between the biomaterial surface and the surrounding tissue is one of the most important prerequisites for the long-term success of implants. Therefore, a strong adhesion of the cells on the biomaterial surface is required. Beside the surface composition the surface topography influences the properties of the adherent cells. The quality of the connection between the cell and the biomaterial is-among other factors-determined by the dimensions of the surface topography. Osteoblasts and fibroblast-like cells in contact with a ground biomaterial surface spread in the direction of the surface structures. These aligned cells provide a more favourable adhesion behaviour than a spherically shaped cell. To determine the influence of the surface structure on the cell alignment and cytoskeleton organisation or arrangement, substrate discs of cp-titanium were ground, producing different roughness of the substrates. The oriented cells had a higher density of focal contacts when they were in contact with the edges of the grooves and showed a better organisation of the cytoskeleton and stronger actin fibres. These changes of the aligned cells depend on the peak to valley height of the surface structures. (C) 2002 Elsevier Science B.V. All rights reserved.
C1 Fac Med H Warembourg, Dept Biophys, Lab Biomat Res, F-59045 Lille, France.
   Univ Saarland, Lehrstuhl Met Werkstoffe, D-66041 Saarbrucken, Germany.
RP Hildebrand, HF (reprint author), Fac Med H Warembourg, Dept Biophys, Lab Biomat Res, 1 Pl Verdun, F-59045 Lille, France.
CR CHESMEL KD, 1995, J BIOMED MATER RES, V29, P1089, DOI 10.1002/jbm.820290909
   Eisenbarth E, 1996, BIOMATERIALS, V17, P1399, DOI 10.1016/0142-9612(96)87281-4
   Goodman SL, 1996, BIOMATERIALS, V17, P2087, DOI 10.1016/0142-9612(96)00016-6
   REES DA, 1977, NATURE, V267, P124, DOI 10.1038/267124a0
   Richards R. G., 1996, Injury, V27, pSC38
   Sinha RK, 1996, BONE, V18, P451, DOI 10.1016/8756-3282(96)00044-0
NR 6
TC 67
Z9 71
U1 0
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1389-0344
J9 BIOMOL ENG
JI Biomol. Eng.
PD AUG
PY 2002
VL 19
IS 2-6
SI SI
BP 233
EP 237
AR PII S1389-0344(02)00028-X
DI 10.1016/S1389-0344(02)00028-X
PG 5
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Genetics & Heredity
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Genetics & Heredity
GA 598GD
UT WOS:000178266800031
PM 12202188
DA 2018-10-20
ER

PT J
AU Manso, M
   Ogueta, S
   Perez-Rigueiro, J
   Garcia, JP
   Martinez-Duart, JM
AF Manso, M
   Ogueta, S
   Perez-Rigueiro, J
   Garcia, JP
   Martinez-Duart, JM
TI Testing biomaterials by the in-situ evaluation of cell response
SO BIOMOLECULAR ENGINEERING
LA English
DT Article; Proceedings Paper
CT E-MRS 2001 Spring Meeting
CY JUN 05-08, 2001
CL STRASBOURG, FRANCE
DE biomaterials; biocompatibility; in-vitro testing; immune reaction; cells
ID MESENCHYMAL STEM-CELLS; ADHESION; TIN
AB In this work, we describe a technique for the in-situ observation of cells adhered on opaque biomaterial surfaces. The visualisation of the morphology of cells adhered onto a surface allows to derive nuclear apoptotic signs or even the existence of organisation between groups of these cells. The technique is based on the use of an auto-immune reaction combined with a fluorescent agent that allows a direct inspection of the cell behaviour. The versatility of the technique is demonstrated by presenting several examples with different cultured cells (human chondrosarcome cells (CSRCs) and pluripotential mesenchymal stem cells (MSCs) from bone marrow) seeded over two different Ti-based surfaces (TiO2 and TiN, respectively). These in-vitro observations are compared with the behaviour of the same cells on bare TiAlV alloy. From our results it is concluded that both TiO2 and TiN surfaces show enhanced biological responses. (C) 2002 Elsevier Science B.V. All rights reserved.
C1 Univ Autonoma Madrid, Dept Fis Aplicada C 12, E-28049 Madrid, Spain.
   Univ Autonoma Madrid, Dept Biol Mol C 10, E-28049 Madrid, Spain.
   Univ Politecn Madrid, ETSI Caminos Canales & Puertos, Dept Ciencia Mat, E-28040 Madrid, Spain.
RP Manso, M (reprint author), Univ Autonoma Madrid, Dept Fis Aplicada C 12, E-28049 Madrid, Spain.
RI Manso Silvan, Miguel/B-4947-2010
OI Manso Silvan, Miguel/0000-0002-5063-1607
CR Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Bruder SP, 1998, J ORTHOPAED RES, V16, P155, DOI 10.1002/jor.1100160202
   CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504
   DION I, 1993, BIOMATERIALS, V14, P712, DOI 10.1016/0142-9612(93)90070-I
   HENCH LL, 1982, BIOMATERIALS INTERFA
   Jones MI, 1999, DIAM RELAT MATER, V8, P457, DOI 10.1016/S0925-9635(98)00426-9
   Lennon DP, 1996, IN VITRO CELL DEV-AN, V32, P602
   LI P, 1993, BIOCERAMICS, V6, P41
   OGUETA S, 2000, J ENDOCRINOL, V165, P329
   Tjia JS, 1999, BIOMATERIALS, V20, P2223, DOI 10.1016/S0142-9612(99)00153-2
NR 10
TC 15
Z9 17
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1389-0344
J9 BIOMOL ENG
JI Biomol. Eng.
PD AUG
PY 2002
VL 19
IS 2-6
SI SI
BP 239
EP 242
AR PII S1389-0344(02)00030-8
DI 10.1016/S1389-0344(02)00030-8
PG 4
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Genetics & Heredity
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Genetics & Heredity
GA 598GD
UT WOS:000178266800032
PM 12202189
DA 2018-10-20
ER

PT J
AU Wefer, J
   Schlote, N
   Sekido, N
   Sievert, KD
   Wefer, AE
   Nunes, L
   Bakircioglu, ME
   Dahiya, R
   Tanagho, EA
AF Wefer, J
   Schlote, N
   Sekido, N
   Sievert, KD
   Wefer, AE
   Nunes, L
   Bakircioglu, ME
   Dahiya, R
   Tanagho, EA
TI Tunica albuginea acellular matrix graft for penile reconstruction in the
   rabbit: a model for treating Peyronie's disease
SO BJU INTERNATIONAL
LA English
DT Article
DE penile induration; surgery; plastic; graft survival
ID VENOUS PATCH GRAFT; FUNCTIONAL-EVALUATION; OUTCOME ANALYSIS;
   REGENERATION; REPLACEMENT; MANAGEMENT; PLICATION; CURVATURE; TISSUE
AB Objective To evaluate the use of an acellular matrix graft of the tunica albuginea for functional penile reconstruction in severe cases of Peyronie's disease.
   Materials and methods In 18 rabbits, an acellular matrix graft of the tunica albuginea was used to cover a 4x8 mm tunical defect, and six animals each were killed 1, 3 and 6 months later; four unoperated animals served as histological controls. Before death an erection was induced by papaverine, with the quality classified on a scale of 0-5, and cavernosography performed. After death the penis was prepared for histological study, and the cell number, collagen and elastic fibre content evaluated in the regenerated matrix, and in control specimens and four unimplanted matrices.
   Results Of 18 experimental animals, 11 had normal erections before death, four had slight penile deviation and three developed no erection. Failure was caused by severe postoperative haematoma, resulting in scar tissue. There was no graft rejection. Histologically there was no difference between natural and regenerated tunica. The collagen content and cell number were not significantly different in regenerated and control samples. There were significantly fewer elastic fibres in the unimplanted grafts and the 1-month group, but in later samples this difference was no longer evident.
   Conclusion The homologous acellular matrix graft of the tunica albuginea warrants further evaluation as an alternative treatment in Peyronie's disease, despite some postoperative failures. The advantage of this orthotopic biomaterial is its rapid integration, with no rejection.
C1 Univ Calif San Francisco, Sch Med, Dept Urol, San Francisco, CA 94143 USA.
   Univ Calif San Francisco, Sch Med, Dept Radiol, San Francisco, CA 94143 USA.
RP Tanagho, EA (reprint author), Univ Calif San Francisco, Sch Med, Dept Urol, Box 0738, San Francisco, CA 94143 USA.
FU NINDS NIH HHS [R01 NS 18029]
CR AMIN M, 1980, J UROLOGY, V124, P815, DOI 10.1016/S0022-5347(17)55681-5
   *ARM FORC I PATH, 1968, MAN HIST STAIN METH, P79
   BAZEED MA, 1983, UROLOGY, V21, P501, DOI 10.1016/0090-4295(83)90050-X
   Brannigan RE, 1998, J UROLOGY, V159, P1064, DOI 10.1016/S0022-5347(01)63836-9
   Burnett AL, 1997, PLAST RECONSTR SURG, V99, P1061, DOI 10.1097/00006534-199704000-00021
   Dahms SE, 1997, UROLOGY, V50, P818, DOI 10.1016/S0090-4295(97)00391-9
   El-Sakka AI, 1998, J UROLOGY, V160, P2050, DOI 10.1016/S0022-5347(01)62240-7
   FAERBER GJ, 1993, J UROLOGY, V149, P1319, DOI 10.1016/S0022-5347(17)36381-4
   HELAL MA, 1995, UROLOGY, V46, P390, DOI 10.1016/S0090-4295(99)80225-8
   Jensen J S, 1992, Ugeskr Laeger, V154, P1104
   JUNQUEIRA LCU, 1979, HISTOCHEM J, V11, P447, DOI 10.1007/BF01002772
   KELAMI A, 1977, EUR UROL, V3, P191
   KISHEV SV, 1983, UROLOGE A, V22, P297
   Kondas J., 1998, International Urology and Nephrology, V30, P321, DOI 10.1007/BF02550318
   Lang TA, 1997, REPORT STAT MED, P65
   Licht MR, 1997, J UROLOGY, V158, P460, DOI 10.1016/S0022-5347(01)64502-6
   LOWE DH, 1982, UROLOGY, V19, P609, DOI 10.1016/0090-4295(82)90010-3
   Lue TF, 1998, J UROLOGY, V160, P2047, DOI 10.1016/S0022-5347(01)62239-0
   Lue TF, 1999, J UROLOGY, V161, P1141, DOI 10.1016/S0022-5347(01)61613-6
   MEEZAN E, 1975, LIFE SCI, V17, P1721, DOI 10.1016/0024-3205(75)90119-8
   MORIEL EZ, 1994, UROLOGY, V43, P697, DOI 10.1016/0090-4295(94)90187-2
   Piechota HJ, 1998, BRIT J UROL, V81, P548
   Probst M, 1997, BRIT J UROL, V79, P505, DOI 10.1046/j.1464-410X.1997.00103.x
   Pryor JP, 1998, INT J IMPOT RES, V10, P129, DOI 10.1038/sj.ijir.3900331
   RALPH DJ, 1995, J UROLOGY, V154, P1362, DOI 10.1016/S0022-5347(01)66862-9
   Sievert KD, 2001, J UROLOGY, V165, P2096, DOI 10.1016/S0022-5347(05)66301-X
   WALDHAUSER M, 1988, J UROLOGY, V140, P525, DOI 10.1016/S0022-5347(17)41709-5
   Wefer J, 2001, J UROLOGY, V165, P1755, DOI 10.1016/S0022-5347(05)66408-7
NR 28
TC 19
Z9 21
U1 0
U2 0
PU BLACKWELL PUBLISHING LTD
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DG, OXON, ENGLAND
SN 1464-4096
J9 BJU INT
JI BJU Int.
PD AUG
PY 2002
VL 90
IS 3
BP 326
EP 331
DI 10.1046/j.1464-410X.2002.02808.x
PG 6
WC Urology & Nephrology
SC Urology & Nephrology
GA 574YM
UT WOS:000176918300022
PM 12133073
OA Bronze
DA 2018-10-20
ER

PT J
AU Khor, E
AF Khor, E
TI Chitin: a biomaterial in waiting
SO CURRENT OPINION IN SOLID STATE & MATERIALS SCIENCE
LA English
DT Review
ID IN-VITRO; CHITOSAN; PROLIFERATION; EXPRESSION; BEHAVIOR; MEMBRANE;
   SPONGE; FILMS; BEADS
C1 Natl Univ Singapore, Dept Chem, Singapore 117543, Singapore.
RP Khor, E (reprint author), Natl Univ Singapore, Dept Chem, 3 Sci Dr, Singapore 117543, Singapore.
CR Chatelet C, 2001, BIOMATERIALS, V22, P261, DOI 10.1016/S0142-9612(00)00183-6
   Chellat F, 2000, J BIOMED MATER RES, V53, P592, DOI 10.1002/1097-4636(200009)53:5<592::AID-JBM20>3.0.CO;2-P
   Chellat F, 2000, J BIOMED MATER RES, V51, P107, DOI 10.1002/(SICI)1097-4636(200007)51:1<107::AID-JBM14>3.0.CO;2-F
   CHEMITE A, 2000, BIOMATERIALS, V21, P2155
   Chupa JM, 2000, BIOMATERIALS, V21, P2315, DOI 10.1016/S0142-9612(00)00158-7
   Dillon GP, 2000, J BIOMED MATER RES, V51, P510, DOI 10.1002/1097-4636(20000905)51:3<510::AID-JBM28>3.0.CO;2-G
   Gupta KC, 2000, BIOMATERIALS, V21, P1115, DOI 10.1016/S0142-9612(99)00263-X
   Haipeng G, 2000, J Biomed Mater Res, V52, P285, DOI 10.1002/1097-4636(200011)52:2<285::AID-JBM7>3.3.CO;2-7
   Hirano S, 2000, BIOMATERIALS, V21, P997, DOI 10.1016/S0142-9612(99)00258-6
   Howling GI, 2001, BIOMATERIALS, V22, P2959, DOI 10.1016/S0142-9612(01)00042-4
   Jarry C, 2001, J BIOMED MATER RES, V58, P127, DOI 10.1002/1097-4636(2001)58:1<127::AID-JBM190>3.0.CO;2-G
   Kato Y, 2000, BIOMATERIALS, V21, P1579, DOI 10.1016/S0142-9612(00)00044-2
   KHOR E, 2001, CHITIN FULFILLING BI, pCH9
   KHOR E, 2001, CHITIN FULFILLING BI, pCH3
   Lahiji A, 2000, J BIOMED MATER RES, V51, P586
   Loke WK, 2000, J BIOMED MATER RES, V53, P8
   Mi FL, 2001, BIOMATERIALS, V22, P165, DOI 10.1016/S0142-9612(00)00167-8
   Ono K, 2000, J BIOMED MATER RES, V49, P289
   Ozmeric N, 2000, J BIOMED MATER RES, V51, P500, DOI 10.1002/1097-4636(20000905)51:3<500::AID-JBM26>3.0.CO;2-P
   Park SB, 2001, BIOMATERIALS, V22, P323, DOI 10.1016/S0142-9612(00)00187-3
   Park YJ, 2000, BIOMATERIALS, V21, P153
   Qu X, 2000, J BIOMED MATER RES, V52, P492, DOI 10.1002/1097-4636(20001205)52:3<492::AID-JBM7>3.0.CO;2-9
   Risbud MV, 2001, J BIOMED MATER RES, V57, P300, DOI 10.1002/1097-4636(200111)57:2<300::AID-JBM1171>3.0.CO;2-Q
   Sechriest VF, 2000, J BIOMED MATER RES, V49, P534, DOI 10.1002/(SICI)1097-4636(20000315)49:4<534::AID-JBM12>3.0.CO;2-#
   Senel S, 2000, BIOMATERIALS, V21, P2067, DOI 10.1016/S0142-9612(00)00134-4
   van der Lubben IM, 2001, BIOMATERIALS, V22, P687, DOI 10.1016/S0142-9612(00)00231-3
   Yamaguchi I, 2001, J BIOMED MATER RES, V55, P20, DOI 10.1002/1097-4636(200104)55:1<20::AID-JBM30>3.0.CO;2-F
   Yan XL, 2001, J BIOMED MATER RES, V58, P358, DOI 10.1002/jbm.1029
   Yusof NLBM, 2001, J BIOMED MATER RES, V54, P59, DOI 10.1002/1097-4636(200101)54:1<59::AID-JBM7>3.0.CO;2-U
   Zhang H, 2001, BIOMATERIALS, V22, P1653, DOI 10.1016/S0142-9612(00)00326-4
   Zhang Y, 2001, J BIOMED MATER RES, V55, P304, DOI 10.1002/1097-4636(20010605)55:3<304::AID-JBM1018>3.0.CO;2-J
NR 31
TC 88
Z9 89
U1 1
U2 29
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1359-0286
J9 CURR OPIN SOLID ST M
JI Curr. Opin. Solid State Mat. Sci.
PD AUG
PY 2002
VL 6
IS 4
BP 313
EP 317
AR PII S1359-0286(02)00002-5
DI 10.1016/S1359-0286(02)00002-5
PG 5
WC Materials Science, Multidisciplinary; Physics, Applied; Physics,
   Condensed Matter
SC Materials Science; Physics
GA 634AN
UT WOS:000180318000005
DA 2018-10-20
ER

PT J
AU Kenefick, NJ
   Vaizey, CJ
   Malouf, AJ
   Norton, CS
   Marshall, M
   Kamm, MA
AF Kenefick, NJ
   Vaizey, CJ
   Malouf, AJ
   Norton, CS
   Marshall, M
   Kamm, MA
TI RETRACTED: Injectable silicone biomaterial for faecal incontinence due
   to internal anal sphincter dysfunction (Retracted Article. See vol 55,
   pg 1824, 2006)
SO GUT
LA English
DT Article; Retracted Publication
ID AUTOLOGOUS FAT; INJECTION; MICROIMPLANTS; PRESSURE
AB Background: A weak or disrupted internal anal sphincter can cause passive faecal incontinence. Conservative measures may help some patients but there is no simple surgical solution for those who fail conservative treatment. A successful technique using trans-sphincteric injection of a bulking agent to augment the internal anal sphincter was developed in a previous pilot study.
   Aim: To determine the clinical results and underlying physiological effects of biomaterial injection.
   Patients: Six patients (four males, median age 53 years (range 36-65)) with faecal incontinence to solid or liquid stool related to poor internal anal sphincter function, of varied aetiology, were recruited.
   Methods: Silicone based biomaterial injections were performed, under local anaesthesia, with antibiotic cover. Three injections were placed circumferentially, trans-sphincterically, entering away from the anal margin and injecting at or just above the dentate line. Anorectal physiological studies, endoanal ultrasound, a bowel symptom diary, a validated incontinence score, and quality of life questionnaires were completed before treatment and on completion of follow up.
   Results: At a median follow up of 18 months (range 15-19), five of six patients had marked symptom. improvement. Faecal incontinence scores improved from a median of 14/24 (range 11-20) before to 8/24 (6-15) after injection. Short form-36 quality of life physical and social function scores improved from a median of 26/100 (5-33) to 79/100 (25-100) and from 10/100 (5-37) to 100/100 (50100), respectively. There was a corresponding physiological increase in maximum anal resting and squeeze pressures. Ultrasound showed the Bioplastique to be retained in the correct position in the improved patients without migration. There were no complications.
   Conclusion: Trans-sphincteric injection of silicone biomaterial can provide a marked improvement in faecal incontinence related to a weak or disrupted internal anal sphincter. This is associated with improved sphincter function and quality of life.
C1 St Marks Hosp, London EC1V 2PS, England.
RP Kamm, MA (reprint author), St Marks Hosp, Watford Rd, Harrow HA1 3UJ, Middx, England.
EM kamm@ic.ac.uk
CR Baeten GMI, 2000, DIS COLON RECTUM, V43, P743, DOI 10.1007/BF02238008
   BEISANG AA, 1992, AESTHET PLAST SURG, V16, P83, DOI 10.1007/BF00455154
   Bernardi C, 1998, PLAST RECONSTR SURG, V102, P1626, DOI 10.1097/00006534-199810000-00046
   BURNETT SJD, 1991, INT J COLORECTAL DIS, V6, P2, DOI 10.1007/BF00703951
   ENGEL AF, 1995, INT J COLORECTAL DIS, V10, P152, DOI 10.1007/BF00298538
   ENGEL AF, 1994, GUT, V35, P857, DOI 10.1136/gut.35.6.857
   ERSEK RA, 1991, PLAST RECONSTR SURG, V87, P693, DOI 10.1097/00006534-199104000-00014
   FRENCKNER B, 1975, GUT, V16, P482, DOI 10.1136/gut.16.6.482
   GARCIAAGUILAR J, 1999, DIS COLON RECTUM, V42, P687
   GIBBONS CP, 1986, INT J COLORECTAL DIS, V1, P231, DOI 10.1007/BF01648344
   Harriss DR, 1996, BRIT J UROL, V78, P722, DOI 10.1046/j.1464-410X.1996.17510.x
   JENKINSON C, 1993, BRIT MED J, V306, P1437, DOI 10.1136/bmj.306.6890.1437
   Kumar D, 1998, BRIT J SURG, V85, P978
   LAW PJ, 1989, GASTROINTEST RADIOL, V14, P349, DOI 10.1007/BF01889235
   Lehur PA, 1998, INT J COLORECTAL DIS, V13, P88, DOI 10.1007/s003840050141
   Leroi AM, 1997, INT J COLORECTAL DIS, V12, P243, DOI 10.1007/s003840050098
   LESTAR B, 1992, INT J COLORECTAL DIS, V7, P159, DOI 10.1007/BF00360358
   LESTAR B, 1989, INT J COLORECTAL DIS, V4, P118, DOI 10.1007/BF01646870
   Malouf AJ, 2001, DIS COLON RECTUM, V44, P595, DOI 10.1007/BF02234337
   Malouf AJ, 2000, ANN SURG, V232, P143, DOI 10.1097/00000658-200007000-00020
   Morgan R, 1997, BRIT J SURG, V84, P226, DOI 10.1002/bjs.1800840225
   SAINIO P, 1985, ACTA CHIR SCAND, V151, P695
   SHAFIK A, 1993, INT SURG, V78, P159
   SHAFIK A, 1995, DIS COLON RECTUM, V38, P583, DOI 10.1007/BF02054115
   Vaizey CJ, 1997, LANCET, V349, P612, DOI 10.1016/S0140-6736(96)09188-X
   Vaizey CJ, 1999, GUT, V44, P77, DOI 10.1136/gut.44.1.77
NR 26
TC 52
Z9 55
U1 3
U2 12
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0017-5749
EI 1468-3288
J9 GUT
JI Gut
PD AUG
PY 2002
VL 51
IS 2
BP 225
EP 228
DI 10.1136/gut.51.2.225
PG 4
WC Gastroenterology & Hepatology
SC Gastroenterology & Hepatology
GA 577XK
UT WOS:000177088100019
PM 12117884
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU Katz, SL
AF Katz, SL
TI Design of heterothermic muscle in fish
SO JOURNAL OF EXPERIMENTAL BIOLOGY
LA English
DT Review
DE fish; swimming; biomechanics; evolution; heterothermy; muscle
ID TUNA SWIMMING PERFORMANCE; LARGE WATER TUNNEL; RED MUSCLE; POWER OUTPUT;
   CONTRACTILE PROPERTIES; SCOMBRID FISHES; MYOXOCEPHALUS-SCORPIUS;
   MECHANICAL-PROPERTIES; STENOTOMUS CHRYSOPS; AEROBIC CAPACITY
AB Among the tremendous diversity of fish, there are a small number that are considered elite in their swimming performance. These include representatives from the tunas, billfish and sharks. In addition to being elite swimmers, these fish share numerous specialized anatomical features including the structure of their swimming muscles and some form of regional endothermy, termed heterothermy. These heterothermies fall into two classes: those that maintain elevated temperatures in swimming muscles and those that have muscle-derived tissues specialized for delivering warm blood to the brain. Because these versions of heterothermy are manifest in fish whose swimming performance is considered elite, it has been parsimonious to hypothesize that heterothermy is part of an integrated high-performance design. Recognizing that the design of skeletal muscle is hierarchical, the design of heterothermic muscle in fish will be examined within a hierarchical framework. This paper will examine, in order, the specific anatomical specializations, the performance of muscle as a biomaterial and then as a dynamic mechanical structure or device - in each case looking at the extent to which heterothermy is part of an integrated high-performance design or is perhaps just a happy accident. This examination will reveal how difficult it is to make a case for the central importance of heterothermy in the design of these swimming muscle systems.
C1 NOAA, Natl Marine Fisheries Serv, NW Fisheries Sci Ctr, Seattle, WA 98112 USA.
RP Katz, SL (reprint author), NOAA, Natl Marine Fisheries Serv, NW Fisheries Sci Ctr, 2725 Montlake Blvd E, Seattle, WA 98112 USA.
CR ALEXANDE.RM, 1969, J MAR BIOL ASSOC UK, V49, P263, DOI 10.1017/S0025315400035906
   ALTRINGHAM JD, 1990, J EXP BIOL, V148, P395
   Altringham JD, 1997, J EXP BIOL, V200, P2617
   ALTRINGHAM JD, 1993, J EXP BIOL, V182, P191
   ALTRINGHAM JD, 2001, FISH PHYSIOL, V19, P314
   BEDDOW TA, 1995, J EXP BIOL, V198, P193
   Bernal D, 2001, COMP BIOCHEM PHYS A, V129, P695, DOI 10.1016/S1095-6433(01)00333-6
   BIEWENER AA, 1988, J EXP BIOL, V137, P191
   Biewener AA, 1999, J EXP BIOL, V202, P3387
   BLOCK BA, 1993, SCIENCE, V260, P210, DOI 10.1126/science.8469974
   BLOCK BA, 1991, AM ZOOL, V31, P726
   BONE Q, 1966, J MAR BIOL ASSOC UK, V46, P321, DOI 10.1017/S0025315400027168
   Bone Q., 1995, BIOL FISHES
   Bone Q., 1978, FISH PHYSIOL, V7, P361
   Breen EC, 1996, J APPL PHYSIOL, V81, P355
   BRETT JR, 1973, J FISH RES BOARD CAN, V30, P379, DOI 10.1139/f73-068
   BRILL RW, 1979, J FISH BIOL, V15, P679, DOI 10.1111/j.1095-8649.1979.tb03677.x
   BRILL RW, 2000, HOT WATER TEMPERATUR
   CAREY FG, 1973, SCI AM, V228, P36, DOI 10.1038/scientificamerican0273-36
   CAREY FG, 1966, P NATL ACAD SCI USA, V56, P1464, DOI 10.1073/pnas.56.5.1464
   CAREY FG, 1982, COPEIA, P254
   CAREY FG, 1969, COMP BIOCHEM PHYSIOL, V28, P199, DOI 10.1016/0010-406X(69)91335-8
   CAREY FG, 1982, SCIENCE, V216, P1327, DOI 10.1126/science.7079766
   Coughlin DJ, 1996, J EXP BIOL, V199, P459
   Coughlin DJ, 1996, AM ZOOL, V36, P666
   Coughlin DJ, 1996, J EXP BIOL, V199, P2703
   D'Aout K, 1999, J EXP BIOL, V202, P1511
   DEWAR H, 1994, J EXP BIOL, V192, P33
   DEWAR H, 1994, J EXP BIOL, V192, P13
   Ellerby DJ, 2000, J EXP BIOL, V203, P2001
   Fierstine H., 1968, MEM STH CALIF ACAD S, V6, P1
   FUDGE DS, 1996, GUELPH ICHTHYOL REV, V4, P1
   Gillis GB, 1998, J EXP BIOL, V201, P3245
   GOODING RM, 1981, FISH B-NOAA, V79, P31
   Graham J.B., 1983, P248
   GRAHAM JB, 1989, EXP BIOL, V48, P89
   GRAHAM JB, 1975, FISH B-NOAA, V73, P219
   Graham JB, 2000, ZOOL J LINN SOC-LOND, V129, P419, DOI 10.1006/zjls.1998.0211
   GRAHAM JB, 1983, CAN J ZOOL, V61, P2087, DOI 10.1139/z83-274
   Hammond L, 1998, J EXP BIOL, V201, P1659
   HAYES JP, 1995, EVOLUTION, V49, P836, DOI 10.1111/j.1558-5646.1995.tb02320.x
   HEBRANK MR, 1986, BIOL BULL, V171, P236, DOI 10.2307/1541920
   HEBRANK MR, 1980, BIOL BULL, V158, P58, DOI 10.2307/1540758
   HESS F, 1984, J EXP BIOL, V109, P229
   JAYNE BC, 1995, J EXP BIOL, V198, P585
   JAYNE BC, 1995, J EXP BIOL, V198, P805
   JOHNSON TP, 1991, J EXP BIOL, V157, P409
   JOHNSON TP, 1991, J COMP PHYSIOL B, V161, P27, DOI 10.1007/BF00258743
   JOHNSON TP, 1994, AM J PHYSIOL, V267, pR481
   JOHNSRUDE CL, 1985, J EXP BIOL, V119, P71
   Johnston I.A., 1983, P36
   JOHNSTON IA, 1993, J EXP BIOL, V185, P251
   JOHNSTON IA, 1974, CAN J ZOOL, V52, P871, DOI 10.1139/z74-118
   JOSEPHSON RK, 1985, J EXP BIOL, V114, P493
   KAFUKU T, 1950, GYORUIGAKI ZASSHI, V1, P89
   Katz B, 1939, J PHYSIOL-LONDON, V96, P45, DOI 10.1113/jphysiol.1939.sp003756
   Katz S. L., 2000, SKELETAL MUSCLE MECH, P475
   Katz SL, 1999, J EXP BIOL, V202, P529
   Katz SL, 2001, NATURE, V410, P770, DOI 10.1038/35071170
   Katz SL, 1998, J THEOR BIOL, V193, P243, DOI 10.1006/jtbi.1998.0696
   KATZ SL, 1997, P 10 INT S UNM UNT S, P135
   Kishinouye K., 1923, Journal of the College of Agriculture Tokyo, V8, P293
   Knower T, 1999, J EXP BIOL, V202, P2127
   Korsmeyer KE, 1996, COMP BIOCHEM PHYS A, V113, P17, DOI 10.1016/0300-9629(95)02061-6
   Korsmeyer KE, 1997, J EXP BIOL, V200, P1975
   Lai NC, 1997, COPEIA, P424, DOI 10.2307/1447765
   LANGFELD KS, 1989, J EXP BIOL, V144, P437
   Long JH, 1996, J EXP BIOL, V199, P2139
   LUCAS MC, 1993, J EXP BIOL, V175, P325
   MOTTA PJ, 1977, COPEIA, P454, DOI 10.2307/1443263
   MULLER UK, 1991, J MAR BIOL ASSOC UK, V71, P738
   NURSALL J. R., 1956, PROC ZOOL SOC LONDON, V126, P127
   OHMENS JH, 1993, J BIOMECH, V26, P665
   RAYNER MD, 1967, NATURE, V214, P392, DOI 10.1038/214392a0
   Richardson RS, 1999, AM J PHYSIOL-HEART C, V277, pH2247, DOI 10.1152/ajpheart.1999.277.6.H2247
   ROME LC, 1993, SCIENCE, V261, P340, DOI 10.1126/science.8332898
   ROME LC, 1992, J EXP BIOL, V163, P281
   ROME LC, 1992, J EXP BIOL, V163, P259
   ROME LC, 1992, J EXP BIOL, V171, P261
   Rome LC, 1984, AM J PHYSIOL, V247, P272
   Rome LC, 1999, J EXP BIOL, V202, P333
   Shadwick RE, 1998, AM ZOOL, V38, P755
   Shadwick RE, 1999, J EXP BIOL, V202, P2139
   STEVENS ED, 1988, J MUSCLE RES CELL M, V9, P329, DOI 10.1007/BF01773876
   STEVENS ED, 1978, FISH PHYSIOL, V7, P316
   TAIGEN TL, 1983, AM NAT, V121, P94, DOI 10.1086/284041
   van Leeuwen J.L., 1992, Advances in Comparative and Environmental Physiology, V11, P191
   Videler J. J., 1993, FISH SWIMMING
   Wagner PD, 2000, ACTA PHYSIOL SCAND, V168, P609, DOI 10.1046/j.1365-201x.2000.00712.x
   Wainwright S.A., 1983, P68
   WARDLE CS, 1993, J FISH BIOL, V42, P347
   WARDLE CS, 1995, J EXP BIOL, V198, P1629
   Webb PW, 1975, B FISH RES BOARD CAN, V190, P1
   WESTNEAT MW, 1993, J MORPHOL, V217, P183, DOI 10.1002/jmor.1052170207
   Willemse J. J., 1966, P K NED AKAD C BIOL, V69, P58
   Young WC, 1989, ROARKS FORMULAS STRE
NR 96
TC 29
Z9 29
U1 2
U2 34
PU COMPANY OF BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL,
   CAMBS, ENGLAND
SN 0022-0949
J9 J EXP BIOL
JI J. Exp. Biol.
PD AUG
PY 2002
VL 205
IS 15
BP 2251
EP 2266
PG 16
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA 586XU
UT WOS:000177612100013
PM 12110659
DA 2018-10-20
ER

PT J
AU Gottenbos, B
   Busscher, HJ
   van der Mei, HC
AF Gottenbos, B
   Busscher, HJ
   van der Mei, HC
TI Pathogenesis and prevention of biomaterial centered infections
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID FOREIGN-BODY INFECTION; BACTERIAL ADHESION; TOTAL HIP; VOICE PROSTHESES;
   IN-VIVO; SURFACES; BIOCOMPATIBILITY; TRANSLOCATION; COLONIZATION;
   POLYMERS
AB One of the major drawbacks in the use of biomedical materials is the occurrence of biomaterials centered infections. After implantation, the host interacts with a biomaterial by forming a conditioning film on its surface and an immune reaction towards the foreign material. When microorganisms can reach the biomaterials surface they can adhere to it. Adhesion of microorganisms to an implant is mediated by their physico-chemical surface properties and the properties of the biomaterials surface itself. Subsequent surface growth of the microorganisms will lead to a mature biofilm and infection, which is difficult to eradicate by antibiotics. The purpose of this review is to give an overview of the mechanisms involved in biomaterials centered infection and the possible methods to prevent these infections. (C) 2002 Kluwer Academic Publishers.
C1 Univ Groningen, Fac Med Sci, Dept Biomed Engn, NL-9713 AV Groningen, Netherlands.
   Univ Groningen, Fac Med Sci, Dept Cell Biol & Histol, NL-9713 AV Groningen, Netherlands.
RP Busscher, HJ (reprint author), Univ Groningen, Fac Med Sci, Dept Biomed Engn, Antonius Deusinglaan 1, NL-9713 AV Groningen, Netherlands.
CR AHLBERG A, 1978, CLIN ORTHOP RELAT R, P69
   AKIYAMA H, 1979, J UROLOGY, V121, P40, DOI 10.1016/S0022-5347(17)56652-5
   An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   ANDERSON JM, 1988, ASAIO T, V34, P1401
   Asaria RHY, 1999, RETINA-J RET VIT DIS, V19, P447, DOI 10.1097/00006982-199909000-00014
   BARTH E, 1989, BIOMATERIALS, V10, P325, DOI 10.1016/0142-9612(89)90073-2
   Barton AJ, 1996, J BIOMED MATER RES, V32, P271, DOI 10.1002/(SICI)1097-4636(199610)32:2<271::AID-JBM17>3.0.CO;2-M
   BENGTSON S, 1987, ACTA ORTHOP SCAND, V58, P529, DOI 10.3109/17453678709146393
   BERG RD, 1975, INFECT IMMUN, V11, P320
   BUSSCHER HJ, 1987, FEMS MICROBIOL LETT, V46, P165, DOI 10.1111/j.1574-6968.1987.tb02457.x
   CARLSSON AS, 1978, J BONE JOINT SURG AM, V60, P1059, DOI 10.2106/00004623-197860080-00007
   CHARNLEY J, 1972, CLIN ORTHOP RELAT R, P167
   CHRISTENSEN GD, 1989, INFECT ASS INDWELLIN, P27
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   COSTERTON JW, 1994, ANTIMICROB AGENTS CH, V38, P2803, DOI 10.1128/AAC.38.12.2803
   DANKERT J, 1986, CRIT REV BIOCOMPAT, V2, P219
   Denstedt JD, 1998, J ENDOUROL, V12, P493, DOI 10.1089/end.1998.12.493
   Dougherty S H, 1982, Curr Probl Surg, V19, P217
   Duchmann R, 1996, EUR J IMMUNOL, V26, P934, DOI 10.1002/eji.1830260432
   ELEK SD, 1957, BRIT J EXP PATHOL, V38, P573
   ELKENAWY R, 1998, J CONTROLED RELEASE, V50, P145
   Everaert EPJM, 1999, ARCH OTOLARYNGOL, V125, P1329, DOI 10.1001/archotol.125.12.1329
   FITZGERALD RH, 1985, AM J MED, V78, P225, DOI 10.1016/0002-9343(85)90389-4
   Flemming RG, 2000, BIOMATERIALS, V21, P273, DOI 10.1016/S0142-9612(99)00176-3
   FOO MC, 1972, INFECT IMMUN, V6, P525
   GEESEY GG, 1990, ANNU REV MICROBIOL, V44, P579
   Gilbert P, 1997, Adv Dent Res, V11, P160
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   GUO W, 1993, SCAND J GASTROENTERO, V28, P393, DOI 10.3109/00365529309098238
   HARKES G, 1992, J BIOMAT SCI-POLYM E, V3, P403, DOI 10.1163/156856292X00213
   HOGT AH, 1986, J BIOMED MATER RES, V20, P533, DOI 10.1002/jbm.820200409
   HUNTER G, 1977, J BONE JOINT SURG BR, V59, P293
   JACKSON JH, 1988, HEMATOL ONCOL CLIN N, V2, P317
   KEOGH JR, 1994, J LAB CLIN MED, V124, P537
   LIDWELL OM, 1982, BRIT MED J, V285, P10, DOI 10.1136/bmj.285.6334.10
   MAHIEU HF, 1986, ARCH OTOLARYNGOL, V112, P321
   MANILOFF G, 1987, CLIN ORTHOP RELAT R, P194
   MAYER KH, 1982, PROG CARDIOVASC DIS, V25, P43, DOI 10.1016/0033-0620(82)90003-2
   Mollnes TE, 1998, VOX SANG, V74, P303, DOI 10.1111/j.1423-0410.1998.tb05435.x
   MORA EM, 1991, ARCH SURG-CHICAGO, V126, P157
   NICKEL JC, 1994, J ANTIMICROB CHEMOTH, V33, P31, DOI 10.1093/jac/33.suppl_A.31
   POELSTRA KA, 2000, J BIOMED MATER RES, V50, P224
   Printzen G, 1996, INJURY, V27, P9
   Rediske AM, 1999, ANTIMICROB AGENTS CH, V43, P1211, DOI 10.1128/AAC.43.5.1211
   REMES A, 1992, BIOMATERIALS, V13, P731, DOI 10.1016/0142-9612(92)90010-L
   Spijker HT, 1999, COLLOID SURFACE B, V15, P89, DOI 10.1016/S0927-7765(99)00056-9
   TANG LP, 1995, AM J CLIN PATHOL, V103, P466
   Tsibouklis J, 1999, BIOMATERIALS, V20, P1229, DOI 10.1016/S0142-9612(99)00023-X
   van de Belt H, 1999, NAT MED, V5, P358, DOI 10.1038/7330
   van de Belt H, 2000, BIOMATERIALS, V21, P1981, DOI 10.1016/S0142-9612(00)00082-X
   Van Oss C. J., 1991, BIOFOULING, V4, P25
   VandenHoogen FJA, 1996, ACTA OTO-LARYNGOL, V116, P119, DOI 10.3109/00016489609137724
   VANLEEUWEN PAM, 1994, GUT, V35, pS28, DOI 10.1136/gut.35.1_Suppl.S28
   VANLOOSDRECHT MCM, 1990, MICROBIOL REV, V54, P75
   vanWachem PB, 1997, J BIOMED MATER RES, V35, P217, DOI 10.1002/(SICI)1097-4636(199705)35:2<217::AID-JBM10>3.0.CO;2-E
   WELLS CL, 1987, ARCH SURG-CHICAGO, V122, P48
   ZIMMERLI W, 1984, J CLIN INVEST, V73, P1191, DOI 10.1172/JCI111305
   ZIMMERLI W, 1982, J INFECT DIS, V146, P487, DOI 10.1093/infdis/146.4.487
NR 58
TC 81
Z9 86
U1 2
U2 22
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD AUG
PY 2002
VL 13
IS 8
BP 717
EP 722
DI 10.1023/A:1016175502756
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 572EN
UT WOS:000176760600001
PM 15348557
DA 2018-10-20
ER

PT J
AU Kumar, TRS
   Krishnan, LK
AF Kumar, TRS
   Krishnan, LK
TI Fibrin-mediated endothelial cell adhesion to vascular biomaterials
   resists shear stress due to flow
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID BIOPROSTHETIC HEART-VALVE; GRAFTS; ATTACHMENT; SUBSTRATE; GLUE
AB In vitro endothelial cell (EC) seeding onto biomaterials for blood-contacting applications can improve the blood compatibility of materials. Adhesive proteins adsorbed from serum that is supplemented with the culture medium intercede the initial cell adhesion and subsequent spreading on material surface during culture. Nevertheless, physical and chemical properties of vascular biomaterial surface fluctuate widely between materials resulting in dissimilarity in protein adsorption characteristics. Thus, a variation is expected in cell adhesion, growth and the ability of cell to resist shear stress when tissue engineering on to vascular biomaterials is attempted. This study was carried out with an objective to determine the significance of a matrix coating on cell adhesion and shear stress resistance when cells are cultured on materials such as polytetrafluoroethylene (PTFE, Teflon) and polyethyleneterephthalate (Dacron), ultra high molecular weight polyethylene (UHMWPE) and titanium (Ti), that are used for prosthetic devices. The study illustrates the distinction of EC attachment and proliferation between uncoated and matrix-coated surfaces. The cell attachment and proliferation on uncoated UHMWPE and titanium surfaces were not significantly different from matrix-coated surfaces. However, shear stress resistance of the cells grown on composite coated surfaces appeared superior compared to the cells grown on uncoated surface. On uncoated vascular graft materials, the cell adhesion was not supported by serum alone and proliferation was scanty as compared to matrix-coated surface. Therefore, coating of implant devices with a composite of adhesive proteins and growth factors can improve EC attachment and resistance of the cells to the forces of flow. (C) 2002 Kluwer Academic Publishers.
C1 Sree Chitra Tirunal Inst Med Sci & Technol, Biomed Technol Wing, Thrombosis Res Unit, Trivandrum 695012, Kerala, India.
RP Krishnan, LK (reprint author), Rajiv Gandhi Ctr Biotechnol, Div Canc Biol, Thycaud PO, Thiruvananthapuram 695014, Kerala, India.
CR ANDRADE JD, 1986, ADV POLYM SCI, V79, P1
   BENGTSSON L, 1993, EUR J CARDIO-THORAC, V7, P393, DOI 10.1016/1010-7940(93)90001-R
   Bengtsson L A, 1993, J Heart Valve Dis, V2, P352
   Bhat VD, 1998, J BIOMED MATER RES, V40, P57, DOI 10.1002/(SICI)1097-4636(199804)40:1<57::AID-JBM7>3.3.CO;2-6
   GRABENWOGER M, 1992, J CARDIAC SURG, V7, P79, DOI 10.1111/j.1540-8191.1992.tb00778.x
   JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470
   KAEHLER J, 1989, J VASC SURG, V9, P535, DOI 10.1067/mva.1989.vs0090535
   Laube HR, 2000, J THORAC CARDIOV SUR, V120, P134, DOI 10.1067/mtc.2000.106327
   MAZZUCOTELLI JP, 1991, INT J ARTIF ORGANS, V14, P482
   MCINTIRE LV, 1992, BLOOD CONTACT NATURA, V516, P513
   Meinhart J, 1997, ASAIO J, V43, P515
   PRATT KJ, 1988, J VASC SURG, V7, P591, DOI 10.1067/mva.1988.avs0070591
   SANTHOSHKUMAR TR, IN PRESS BIOMATERIAL
   SHINOKA T, 1995, ANN THORAC SURG, V60, P513
   SINGHVI R, 1994, SCIENCE, V264, P696, DOI 10.1126/science.8171320
   WILLIAMS SK, 1985, J SURG RES, V38, P618, DOI 10.1016/0022-4804(85)90084-8
   ZILLA P, 1989, SURGERY, V105, P515
   Zund G, 1997, EUR J CARDIO-THORAC, V11, P493, DOI 10.1016/S1010-7940(96)01005-6
NR 18
TC 13
Z9 13
U1 0
U2 5
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD AUG
PY 2002
VL 13
IS 8
BP 751
EP 755
DI 10.1023/A:1016162706391
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 572EN
UT WOS:000176760600005
PM 15348561
DA 2018-10-20
ER

PT J
AU Michanetzis, GPA
   Missirlis, YF
   Rhodes, NP
   Williams, DF
   Eloy, R
   Lemm, W
AF Michanetzis, GPA
   Missirlis, YF
   Rhodes, NP
   Williams, DF
   Eloy, R
   Lemm, W
TI Influence of test protocol response to model in determining the blood
   polymers
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID THROMBOSIS; COMPATIBILITY; FLOW; SUBENDOTHELIUM; SUBCOMMITTEE;
   PARAMETERS; COMMITTEE; RHEOLOGY; SURFACES; INVIVO
AB A multi-parametric, multi-center evaluation of three polymers was performed measuring their response to blood contact. The purpose of this study was to pinpoint differences in tests performed for assessing "basic" hemocompatibility on identical materials at different centers and attempt to rationalize. Assays for platelet adhesion, activation, aggregability and activation of the coagulation system in addition to an ex vivo patency assay were performed at four centers across Europe, using protocols favored by each center for determining the blood-contacting performance of a biomaterial. Three polymers were chosen for their expected blood response spanning the range of undesirable to desirable: ethylenevinylacetate (EVA), polyvinylchloride (PVC) and PVC modified with polyethylene oxide (PEO). The assays were ranked in terms of their efficacy compared to cost and simplicity. A correlation between assays was calculated, indicating the ability of one test to correctly determine the blood response compared to another. Some assays were unable to distinguish between materials, but of the assays which could, the materials were ranked in the following order: EVA; PVC; PVC-PEO, EVA producing the most undesirable response. It is concluded that many commonly used assays for determining hemocompatibility are inappropriate, but there are simple and reliable test methods available which correlate well with the more sophisticated protocols. (C) 2002 Kluwer Academic Publishers.
C1 Univ Patras, Mech & Aer Engn Dept, Biomed Engn Lab, GR-26110 Patras, Greece.
   Univ Liverpool, Dept Clin Engn, Liverpool L69 3BX, Merseyside, England.
   Biomatech, Chasse Sur Rhone, France.
   Rudolf Virchow Clin, Dept Expt Surg, Berlin, Germany.
RP Missirlis, YF (reprint author), Univ Patras, Mech & Aer Engn Dept, Biomed Engn Lab, GR-26110 Patras, Greece.
EM misirlis@mech.upatras.gr
CR ANDERSON JM, 1987, J LAB CLIN MED, V110, P666
   AQUEY C, 1991, BIORHEOLOGY, V28, P463
   BLACK J, 1981, BIOL PERFORMANCE MAT
   BRASH JL, 1991, MODERN ASPECTS OF PROTEIN ADSORPTION ON BIOMATERIALS, P39
   BUCHANAN MJ, 1998, MED DEV DIAGN IN NOV
   CAZENAVE JP, 1993, TESTS PROCEDURES BLO, P359
   COOPER SL, 1987, ANN NY ACAD SCI, V516, P572, DOI 10.1111/j.1749-6632.1987.tb33074.x
   COURTNEY JM, 1994, BIOMATERIALS, V15, P737, DOI 10.1016/0142-9612(94)90026-4
   COURTNEY JM, 1986, BLOOD COMPATIBLE MAT, P135
   DAVIES JA, 1986, BLOOD SURFACE INTERA
   DAWIDS S, 1986, BLOOD COMPATIBLE MAT
   Dawids S. G., 1993, TEST PROCEDURES BLOO
   DEWANJEE MK, 1987, ANN NY ACAD SCI, V516, P541, DOI 10.1111/j.1749-6632.1987.tb33073.x
   DIDISHEIM P, 1984, CONT BIOMATERIALS MA, P132
   DUDLEY B, 1976, T AM SOC ART INT ORG, V22, P538
   GALLOWAY MJ, 1984, THROMB RES, V33, P229, DOI 10.1016/0049-3848(84)90184-1
   GOLDSMITH HL, 1986, THROMB HAEMOSTASIS, V55, P415
   Han DK, 1996, J BIOMED MATER RES, V30, P23, DOI 10.1002/(SICI)1097-4636(199601)30:1<23::AID-JBM4>3.0.CO;2-T
   Hill D, 1995, Med Device Technol, V6, P14
   KAPLAN KL, 1981, BLOOD, V57, P199
   KIRKPATRICK CJ, 1998, MED DEVICE TECHNOL, V1, P38
   KLINKMANN H, 1984, CONTRIB NEPHROL
   LEE JH, 1995, PROG POLYM SCI, V20, P1043, DOI 10.1016/0079-6700(95)00011-4
   LEMM W, 1992, REFERENCE MATERIALS OF THE EUROPEAN COMMUNITIES, P173
   MCEVER RP, 1984, J BIOL CHEM, V259, P9799
   Michanetzis GPA, 1996, J MATER SCI-MATER M, V7, P29, DOI 10.1007/BF00121186
   MISSIRLIS Y, 1992, REFERENCE MATERIALS OF THE EUROPEAN COMMUNITIES, P157
   MISSIRLIS YF, 1993, ROLE PLATELETS BLOOD
   MULVIHILL JN, 1993, TEST PROCEDURES BLOO, P377
   Nelson KD, 1996, ASAIO J, V42, pM884, DOI 10.1097/00002480-199609000-00119
   *NIH, 1985, NIH PUBL
   Northup SJ, 1999, INT J TOXICOL, V18, P275, DOI 10.1080/109158199225431
   NOSE Y, 1991, ARTIF ORGANS, V15, P1
   Rhodes NP, 1996, BIOMATERIALS, V17, P1995, DOI 10.1016/0142-9612(96)00018-X
   RHODES NP, 1994, BIOMATERIALS, V15, P35, DOI 10.1016/0142-9612(94)90194-5
   RISSOAN MC, 1993, TEST PROCEDURES BLOO, P461
   SAKARIASSEN KS, 1980, THROMB RES, V19, P547, DOI 10.1016/0049-3848(80)90027-4
   SALZMAN EW, 1971, BLOOD-J HEMATOL, V38, P509
   Schulze T, 1983, Life Support Syst, V1 Suppl 1, P231
   SHUMAKOV VI, 1984, T AM SOC ART INT ORG, V30, P137
   SLACK SM, 1994, THROMB HAEMOSTASIS, V72, P777
   TURITTO VT, 1979, J RHEOL, V23, P735, DOI 10.1122/1.549542
   TURITTO VT, 1975, T AM SOC ART INT ORG, V21, P593
   WILLIAMS DF, 1986, TECHNIQUES BIOCOMPAT
   Williams DF, 1981, BIOCOMPATIBILITY CLI
NR 45
TC 10
Z9 10
U1 0
U2 3
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD AUG
PY 2002
VL 13
IS 8
BP 757
EP 765
DI 10.1023/A:1016166807299
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 572EN
UT WOS:000176760600006
PM 15348562
DA 2018-10-20
ER

PT J
AU Yoon, SJ
   Yu, MA
   Sim, GS
   Kwon, ST
   Hwang, JK
   Shin, JK
   Yeo, IH
   Pyun, YR
AF Yoon, SJ
   Yu, MA
   Sim, GS
   Kwon, ST
   Hwang, JK
   Shin, JK
   Yeo, IH
   Pyun, YR
TI Screening and characterization of microorganisms with fibrinolytic
   activity from fermented foods
SO JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY
LA English
DT Article
DE fibrinolysis; fermented foods; Tempe; Enterococcus faecalis;
   antiplatelet activity
ID ENTEROCOCCUS-FAECALIS; ENZYME; PURIFICATION; COAGULATION; BLOOD;
   ENDOCARDITIS; NATTOKINASE; COMPLEMENT; KININ; JANG
AB Fibrinolytic microorganisms were screened from 42 samples of Korean fermented food (7 kinds of Chungook-jang, 14 kinds of commercial Doen-jang, 5 kinds of home-made Doen-jang, and 16 kinds of Jeot-gal), 15 samples of Japanese fermented food (5 kinds of home-made soybean paste, and 10 kinds of Natto), and 19 samples of Indonesian fermented food (Tempe) as well as starters of Meju (500 microflora from Korea, and 22 from China). Initially, I I isolates with strong fibrinolytic activity were selected for further characterization. The fibrinolytic activity of the I I isolates ranged from 89 to 199% of standard plasmin. Four strains, M51 from Korean fermented food (Meju), 1 1-1, 1 1-4, and 1 5-1 from Indonesian fermented food (Tempe), were chosen based on the degree of activity and reproducibility, and identified as Staphylococcus sciuri, Citrobacter or Enterobacter, Enterococcus faecalis, and Bacillus subtilis, respectively. The first two isolates are pathogenic strains while the latter two are considered as GRAS (Generally Recognized As Safe). Fibrinolytic activity of E faecalis, characterized and designated as BRCA-5, reached a maximum, when the producer was cultivated in M17 broth supplemented with 1.0% glucose for 5 h at 37degreesC with shaking at 180 rpm. Compared to commercial fibrinolytic enzymes, the cell-free culture supernatant of E. faecalis BRCA-5 showed stronger activity than plasmin and streptokinase, but similar degree of specific activity as nattokinase and urokinase, and it also demonstrated anticoagulant and antiplatelet activity ex vivo. These features of E. faecalis make it an attractive agent as a biomaterial for health-promoting foods.
C1 Yonsei Univ, Dept Biotechnol, Seoul 120749, South Korea.
   Yonsei Univ, Bioprod Res Ctr, Seoul 120749, South Korea.
   Yonsei Univ, Grad Program Biomat Sci & Engn, Seoul 120749, South Korea.
   Pulmuone Co Ltd, R&D Ctr, Seoul 120749, South Korea.
RP Pyun, YR (reprint author), Yonsei Univ, Dept Biotechnol, Seoul 120749, South Korea.
CR ASCH AS, 1985, BLOOD, V66, P926
   ASTRUP T, 1952, ARCH BIOCHEM BIOPHYS, V40, P346, DOI 10.1016/0003-9861(52)90121-5
   CARDINAL DC, 1980, J PHARMACOL METHOD, V3, P135, DOI 10.1016/0160-5402(80)90024-8
   Collen D, 2000, FIBRINOLYSIS PROTEOL, V14, P66, DOI 10.1054/fipr.2000.0070
   DAVIE EW, 1995, THROMB HAEMOSTASIS, V74, P1
   DIMINNO G, 1983, J PHARMACOL EXP THER, V225, P57
   FURLAN M, 1988, FIBRINOGEN FIBRIN ST, P17
   GOGSTAD GO, 1982, BLOOD, V60, P664
   HOLSTROM B, 1968, APPL MICROBIOL, V16, P73
   HOLT JG, 1984, BERGEYS MANUAL SYSTE
   Hricak V, 1998, SCAND J INFECT DIS, V30, P540
   JACOBY GA, 1995, ANN INTERN MED, V122, P238, DOI 10.7326/0003-4819-122-3-199502010-00023
   Kim HK, 1997, J FERMENT BIOENG, V84, P307
   KIM JO, 1998, J KOREAN SOC FOOD SC, V27, P51
   Kim S.H., 1998, KOREAN J MICROBIOL, V34, P87
   Kim SH, 2000, BIOSCI BIOTECH BIOCH, V64, P1722, DOI 10.1271/bbb.64.1722
   Kim SH, 1998, KOREA SOYBEAN DIGEST, V15, P8
   Kim W, 1996, APPL ENVIRON MICROB, V62, P2482
   Kim Y. T., 1995, KOR J APPL MICROBIOL, V23, P1
   Lee SK, 1998, KOR J APPL MICROBIOL, V26, P226
   Lijnen HR, 2001, ANN NY ACAD SCI, V936, P226
   Milbrandt E, 1998, CLIN CARDIOL, V21, P123, DOI 10.1002/clc.4960210211
   MURANO G, 1978, AM J HEMATOL, V4, P409, DOI 10.1002/ajh.2830040412
   NAIDU AS, 1999, CRIT REV FOOD SCI NU, V38, P13
   NIEUWENHUIS HK, 1986, BLOOD, V68, P692
   *NIH, 1985, GUIDL CAR US LAB AN
   Noh K. A., 1999, KOREAN J FOOD SCI TE, V31, P219
   OZAWA A, 1986, TOKAI J EXP CLIN M S, P65
   OZAWA K, 1983, APPL ENVIRON MICROB, V45, P1513
   RALF K, 1995, THROMB RES, V78, P161
   SAMAMA MG, 1985, THROMB HAEMOSTASIS, V154, P726
   SMYTH CJ, 1974, ACTA PATH MICRO IM B, VB 82, P860
   SUMI H, 1990, ACTA HAEMATOL-BASEL, V84, P139, DOI 10.1159/000205051
   SUMI H, 1987, EXPERIENTIA, V43, P1110, DOI 10.1007/BF01956052
   SUMI H, 1995, COMP BIOCHEM PHYS B, V112, P543, DOI 10.1016/0305-0491(95)00100-X
   SUMI H, 1998, BIOINDUSTRY, V7, P725
   SUNDSMO JS, 1983, SPRINGER SEMIN IMMUN, V6, P231
   Yoo CK, 1998, KOREAN J APPL MICROB, V26, P507
   ZWIERZINA WD, 1985, THROMB RES, V38, P91, DOI 10.1016/0049-3848(85)90010-6
NR 39
TC 9
Z9 10
U1 1
U2 5
PU KOREAN SOC MICROBIOLOGY & BIOTECHNOLOGY
PI SEOUL
PA KOREA SCI TECHNOL CENTER #507,  635-4 YEOGSAM-DONG, KANGNAM-GU, SEOUL
   135-703, SOUTH KOREA
SN 1017-7825
J9 J MICROBIOL BIOTECHN
JI J. Microbiol. Biotechnol.
PD AUG
PY 2002
VL 12
IS 4
BP 649
EP 656
PG 8
WC Biotechnology & Applied Microbiology; Microbiology
SC Biotechnology & Applied Microbiology; Microbiology
GA 588UQ
UT WOS:000177720400018
DA 2018-10-20
ER

PT J
AU Casaletto, MP
   Kaciulis, S
   Mattogno, G
   Mezzi, A
   Ambrosio, L
   Branda, F
AF Casaletto, MP
   Kaciulis, S
   Mattogno, G
   Mezzi, A
   Ambrosio, L
   Branda, F
TI XPS characterization of biocompatible hydroxyapatite-polymer coatings
SO SURFACE AND INTERFACE ANALYSIS
LA English
DT Article; Proceedings Paper
CT 9th European Conference on Applications of Surface and Interface
   Analysis
CY SEP 30-OCT 05, 2001
CL AVIGNON, FRANCE
DE XPS; biomaterial; hydroxyapatite; biomimetic method; PMMA; PHEMA
ID BIOMIMETIC PROCESS; SURFACE; APATITE; TITANIUM
AB Hydroxyapatite coatings on polymeric substrates have been prepared by treating samples of poly(methyl methacrylate) (PMMA) and poly(2-hydroxyethyl methacrylate) with a biomimetic method and by producing a mechanical mixture of polymers (PMMA and poly(butylmethyl methacrylate) and hydroxyapatite (1:1). The surface chemical composition of the samples has been studied by using X-ray photoelectron spectroscopy. Both the reference polymers and the hydroxyapatite coatings have been analyzed. The surface modifications induced by interaction of the coatings with osteoblast cells have been studied as a function of the exposure time, after in vitro treatment for 7, 15 and 21 days. Quantitative XPS analysis enabled us to compare the quality of the samples and the different response to the in vitro treatment. Copyright (C) 2002 John Wiley Sons, Ltd.
C1 CNR, Inst Mat Chem, I-00016 Monterotondo, RM, Italy.
   CNR, Inst Technol Composite Mat, I-80125 Naples, Italy.
   Univ Naples Federico II, Dept Mat & Prod Engn, I-80125 Naples, Italy.
RP Casaletto, MP (reprint author), CNR, Inst Mat Chem, POB 10, I-00016 Monterotondo, RM, Italy.
RI Mezzi, Alessio/G-5137-2010; Kaciulis, Saulius/G-5252-2010; Casaletto,
   Maria Pia/P-6715-2017
OI Kaciulis, Saulius/0000-0002-9868-7626; Casaletto, Maria
   Pia/0000-0002-2236-5671; MEZZI, ALESSIO/0000-0002-2887-520X; AMBROSIO,
   LUIGI/0000-0002-8367-2405
CR Battistoni C, 2000, SURF INTERFACE ANAL, V29, P773, DOI 10.1002/1096-9918(200011)29:11<773::AID-SIA928>3.3.CO;2-U
   BRANDA F, 2001, KEY ENGI MAT, V192, P127
   Casaletto MP, 2001, APPL SURF SCI, V172, P167, DOI 10.1016/S0169-4332(00)00844-8
   CASALETTO MP, BIOMATERIALS
   CIRILLI F, 1997, P ECASIA 97, P1063
   Dalby MJ, 2001, BIOMATERIALS, V22, P1739, DOI 10.1016/S0142-9612(00)00334-3
   Ducheyne P, 1988, SURFACE CHARACTERIZA, P175
   HATA K, 1995, J AM CERAM SOC, V78, P1049, DOI 10.1111/j.1151-2916.1995.tb08435.x
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Kaciulis S, 1999, APPL SURF SCI, V151, P1, DOI 10.1016/S0169-4332(99)00267-6
   Kaciulis S, 1998, J ELECTRON SPECTROSC, V95, P61, DOI 10.1016/S0368-2048(98)00202-3
   Kokubo T, 1999, COMPOS PART A-APPL S, V30, P405, DOI 10.1016/S1359-835X(98)00127-4
   Kokubo T, 1996, THERMOCHIM ACTA, V280, P479, DOI 10.1016/0040-6031(95)02784-X
   Kokubo T, 1997, AN QUIM, V93, P549
   LI PJ, 1994, J BIOMED MATER RES, V28, P7, DOI 10.1002/jbm.820280103
   MONTENERO A, 2000, J MATER SCI, V35, P1
   MOULDER JF, 1995, HDB XRAY PHOTOELECTR, P213
   RIMONDINI L, 1999, REPORT CNR MSTA2 FIN
   SEAH MP, 1990, PRACTICAL SURFACE AN, V1, P240
   Tanahashi M., 1992, BIOCERAMICS, P57
   WAGNER CD, 1995, HDB XRAY PHOTOELECTR, P42
   WAGNER CD, 1986, SURF INTERFACE ANAL, V2, P53
   1997, HIGH RESOLUTION XPS, P15
NR 23
TC 29
Z9 30
U1 2
U2 19
PU JOHN WILEY & SONS LTD
PI W SUSSEX
PA BAFFINS LANE CHICHESTER, W SUSSEX PO19 1UD, ENGLAND
SN 0142-2421
J9 SURF INTERFACE ANAL
JI Surf. Interface Anal.
PD AUG
PY 2002
VL 34
IS 1
BP 45
EP 49
DI 10.1002/sia.1249
PG 5
WC Chemistry, Physical
SC Chemistry
GA 591NC
UT WOS:000177885900010
DA 2018-10-20
ER

PT J
AU Bowen, WR
   Fenton, AS
   Lovitt, RW
   Wright, CJ
AF Bowen, WR
   Fenton, AS
   Lovitt, RW
   Wright, CJ
TI The measurement of Bacillus mycoides spore adhesion using atomic force
   microscopy, simple counting methods, and a spinning disk technique
SO BIOTECHNOLOGY AND BIOENGINEERING
LA English
DT Article
DE adhesion; atomic force microscopy; Bacillus mycoides; hydrodynamic shear
ID FLOW DETACHMENT ASSAY; BACTERIAL ADHESION; DIRECT QUANTIFICATION;
   BIOMATERIAL SURFACES; ORAL STREPTOCOCCI; ESCHERICHIA-COLI; CEREUS
   SPORES; CELL; MODEL; CONSTANT
AB An atomic force microscope has been used to study the adhesion of Bacillus mycoides spores to a hydrophilic glass surface and a hydrophobic-coated glass surface. AFM images of spores attached to the hydrophobic-coated mica surface allowed the measurement of spore dimensions in an aqueous environment without desiccation. The spore exosporium was observed to be flexible and to promote the adhesion of the spore by increasing the area of spore contact with the surface. Results from counting procedures using light microscopy matched the density of spores observed on the hydrophobic-coated glass surface with AFM. However, no spores were observed on the hydrophilic glass surface with AFM, a consequence of the weaker adhesion of the spores at this surface. AFM was also used to quantify directly the interactions of B. mycoides spores at the two surfaces in an aqueous environment. The measurements used "spore probes" constructed by immobilizing a single spore at the apex of a tipless AFM cantilever. The data showed that stretching and sequential bond breaking occurred as the spores were retracted from the hydrophilic glass surface. The greatest spore adhesion was measured at the hydrophobic-coated glass surface. An attractive force on the spores was measured as the spores approached the hydrophobic-coated surface. At the hydrophilic glass surface, only repulsive forces were measured during the approach of the spores. The AFM force measurements were in qualitative agreement with the results of a hydrodynamic shear adhesion assay that used a spinning disk technique. Quantitatively, AFM measurements of adhesive force were up to 4 x 10(3) times larger than the estimates made using the spinning disk data. This is a consequence of the different types of forces applied to the spore in the different adhesion assays. AFM has provided some unique insights into the interactions of spores with surfaces. No other instrument can make such direct measurements for single microbiological cells. (C) 2002 Wiley Periodicals, Inc.
C1 Univ Wales Swansea, Dept Chem & Biol Proc Engn, Ctr Complex Fluids Proc, Swansea SA2 8PP, W Glam, Wales.
RP Bowen, WR (reprint author), Univ Wales Swansea, Dept Chem & Biol Proc Engn, Ctr Complex Fluids Proc, Singleton Pk, Swansea SA2 8PP, W Glam, Wales.
OI Wright, Chris/0000-0003-2375-8159; Lovitt, robert/0000-0002-5587-2776
CR ALTMAN J, 1990, ACS SYM SER, V439, P240
   An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   Andersson A, 1998, INT J FOOD MICROBIOL, V39, P93, DOI 10.1016/S0168-1605(97)00121-9
   ANDERSSON A, 1995, INT J FOOD MICROBIOL, V28, P144
   Azeredo J, 1999, COLLOID SURFACE B, V14, P141, DOI 10.1016/S0927-7765(99)00031-4
   BELLONFONTAINE MN, 1990, CELL BIOPHYS, V17, P93, DOI 10.1007/BF02989805
   BENTON ER, 1966, J FLUID MECH, V24, P781, DOI 10.1017/S0022112066001009
   Bowen WR, 2000, COLLOID SURFACE A, V173, P205, DOI 10.1016/S0927-7757(00)00566-5
   Bowen WR, 2000, J COLLOID INTERF SCI, V228, P428, DOI 10.1006/jcis.2000.6969
   Bowen WR, 1998, J COLLOID INTERF SCI, V197, P348, DOI 10.1006/jcis.1997.5247
   Bowen WR, 1999, J MEMBRANE SCI, V154, P205
   Bowen WR, 1998, COLLOID SURFACE A, V136, P231, DOI 10.1016/S0927-7757(97)00243-4
   Bower CK, 1999, INT J FOOD MICROBIOL, V50, P33, DOI 10.1016/S0168-1605(99)00075-6
   Brown KL, 2000, BRIT MED BULL, V56, P158, DOI 10.1258/0007142001902860
   Casey E, 2000, BIOTECHNOL BIOENG, V67, P476, DOI 10.1002/(SICI)1097-0290(20000220)67:4<476::AID-BIT11>3.3.CO;2-U
   Chang KC, 1996, LANGMUIR, V12, P2271, DOI 10.1021/la950690y
   CLEVELAND JP, 1993, REV SCI INSTRUM, V64, P403, DOI 10.1063/1.1144209
   COZENSROBERTS C, 1990, BIOPHYS J, V58, P857, DOI 10.1016/S0006-3495(90)82431-0
   COZENSROBERTS C, 1990, BIOPHYS J, V58, P107, DOI 10.1016/S0006-3495(90)82357-2
   DUCKER WA, 1991, NATURE, V353, P239, DOI 10.1038/353239a0
   Garcia AJ, 1997, BIOMATERIALS, V18, P1091, DOI 10.1016/S0142-9612(97)00042-2
   Grantham MC, 1996, GEOCHIM COSMOCHIM AC, V60, P2473, DOI 10.1016/0016-7037(96)00155-X
   Hermansson M, 1999, COLLOID SURFACE B, V14, P105, DOI 10.1016/S0927-7765(99)00029-6
   HOH JH, 1994, J CELL SCI, V107, P1105
   HUSMARK U, 1990, J APPL BACTERIOL, V69, P557, DOI 10.1111/j.1365-2672.1990.tb01548.x
   Husmark U, 1992, BIOFOULING, V5, P335
   Lele SS, 1996, BIOTECHNOL LETT, V18, P515, DOI 10.1007/BF00140195
   LUCKHAM PF, 1994, ADV COLLOID INTERFAC, V49, P341, DOI 10.1016/0001-8686(94)80019-7
   Ming F, 1998, ENZYME MICROB TECH, V22, P94, DOI 10.1016/S0141-0229(97)00136-1
   ONEILL ME, 1968, CHEM ENG SCI, V23, P1293, DOI 10.1016/0009-2509(68)89039-6
   Ong YL, 1999, LANGMUIR, V15, P2719, DOI 10.1021/la981104e
   Otto K, 1999, J BACTERIOL, V181, P5210
   PARAPURA V, 1993, J VAC SCI TECHNOL A, V11, P773
   PRATTTERPSTRA IH, 1988, CURR MICROBIOL, V16, P311, DOI 10.1007/BF01568537
   Razatos A, 1998, J BIOMAT SCI-POLYM E, V9, P1361, DOI 10.1163/156856298X00442
   ROBERTS CJ, 1993, NANOBIOLOGY, V2, P73
   RONNER U, 1990, J APPL BACTERIOL, V69, P550, DOI 10.1111/j.1365-2672.1990.tb01547.x
   Sagvolden G, 1999, P NATL ACAD SCI USA, V96, P471, DOI 10.1073/pnas.96.2.471
   Shive MS, 1999, J BIOMED MATER RES, V46, P511, DOI 10.1002/(SICI)1097-4636(19990915)46:4<511::AID-JBM9>3.0.CO;2-M
   SJOLLEMA J, 1990, J ADHES SCI TECHNOL, V4, P765, DOI 10.1163/156856190X00658
   Sosa-Gomez DR, 1998, J INVERTEBR PATHOL, V71, P115, DOI 10.1006/jipa.1997.4716
   STAMATAKIS K, 1993, AICHE J, V39, P1292, DOI 10.1002/aic.690390805
   Svensson B, 1999, INT DAIRY J, V9, P903, DOI 10.1016/S0958-6946(00)00014-5
   Thoumine O, 1996, CELL MOTIL CYTOSKEL, V33, P276
   Toikka G, 1996, J COLLOID INTERF SCI, V180, P329, DOI 10.1006/jcis.1996.0311
   TURNBULL PCB, 1994, BACTERIOLOGY, P349
   Vacheethasanee K, 1998, J BIOMED MATER RES, V42, P425, DOI 10.1002/(SICI)1097-4636(19981205)42:3<425::AID-JBM12>3.0.CO;2-F
   Veeramasuneni S, 1996, J COLLOID INTERF SCI, V184, P594, DOI 10.1006/jcis.1996.0656
NR 48
TC 68
Z9 68
U1 1
U2 27
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0006-3592
J9 BIOTECHNOL BIOENG
JI Biotechnol. Bioeng.
PD JUL 20
PY 2002
VL 79
IS 2
BP 170
EP 179
DI 10.1002/bit.10321
PG 10
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 564XX
UT WOS:000176339800006
PM 12115433
DA 2018-10-20
ER

PT J
AU Hodde, J
   Hiles, M
AF Hodde, J
   Hiles, M
TI Virus safety of a porcine-derived medical device: Evaluation of a viral
   inactivation method
SO BIOTECHNOLOGY AND BIOENGINEERING
LA English
DT Article
DE small intestinal submucosa; SIS; peracetic acid; ethanol; sterilization
ID SMALL-INTESTINAL SUBMUCOSA; PERACETIC-ACID; CALCIFICATION; AUGMENTATION;
   EFFICACY; MODEL
AB The goal of this study was to evaluate the efficacy of a virus-inactivating process for use during the preparation of porcine-derived extracellular matrix biomaterials for human clinical implantation. Porcine small intestine, the source material for the tissue-engineered, small intestinal submucosa (SIS) biomaterial, was evaluated. Relevant enveloped, non-enveloped, and model viruses representative of different virus families were included in the investigation: porcine parvovirus (PPV), porcine reovirus, murine leukemia retrovirus (LRV), and porcine pseudorabies (herpes) virus (PRV). Samples of small intestine were deliberately inoculated with approximately 1 x 10(7) plaque-forming units (PFU) of virus which were thereafter exposed to a 0.18% peracetic acid/4.8% aqueous ethanol mixture for time periods ranging from 5 minutes to 2 hours. Enveloped viruses were more easily inactivated than non-enveloped viruses, but material processed for 30 minutes or longer inactivated all of the viruses. D-10 values were calculated and used to extrapolate the extent of inactivation after 2 hours. Viral titers were reduced by more than 14.0 log(10) PPV, 21.0 log(10) reovirus, 40.0 log(10) PRV, and 27.0 log(10) LRV, meeting international standards for viral sterility. These results demonstrate that treatment of porcine small intestine with a peracetic acid/ethanol solution leads to a virus-free, non-crosslinked biomaterial safe for xeno-transplantation into humans. (C) 2002 Wiley Periodicals, Inc.
C1 Cook Biotech Inc, W Lafayette, IN 47906 USA.
RP Hodde, J (reprint author), Cook Biotech Inc, 3055 Kent Ave, W Lafayette, IN 47906 USA.
CR Badylak S, 2001, J SURG RES, V99, P282, DOI 10.1006/jsre.2001.6176
   Badylak S, 1999, CLIN ORTHOP RELAT R, pS333, DOI 10.1097/00003086-199910001-00032
   BADYLAK SF, 1993, TISSUE ENGINEERING, P179
   Calvano CJ, 2000, J ENDOUROL, V14, P213, DOI 10.1089/end.2000.14.213
   Cronmiller JR, 1999, GASTROINTEST ENDOSC, V50, P152, DOI 10.1016/S0016-5107(99)70217-8
   Hodde JP, 2001, WOUNDS, V13, P195
   HODDE JP, 2002, IN PRESS TISSUE ENG, V8
   Hurst RE, 2001, J BIOMAT SCI-POLYM E, V12, P1267, DOI 10.1163/156856201753395798
   KLINE LB, 1960, AM J CLIN PATHOL, V33, P30
   Knoll LD, 2001, UROLOGY, V57, P753, DOI 10.1016/S0090-4295(00)01079-7
   KROPP BP, 1995, ADV EXP MED BIOL, V385, P229
   Li ZL, 1999, J VIROL METHODS, V81, P47, DOI 10.1016/S0166-0934(99)00064-6
   Matheny RG, 2000, J HEART VALVE DIS, V9, P769
   Nimni ME, 1997, J BIOMED MATER RES, V35, P531
   Owen TJ, 1997, J SURG RES, V71, P179, DOI 10.1006/jsre.1997.5148
   Pruss A, 1999, BIOLOGICALS, V27, P195, DOI 10.1006/biol.1999.0177
   Sherr C J, 1979, Methods Enzymol, V58, P412
   WERNER HP, 1973, ZBL BAKT MIK HYG B, V157, P387
   WESLEY RD, 1988, VET MICROBIOL, V18, P197, DOI 10.1016/0378-1135(88)90087-9
   Wieler LH, 2001, J VET MED B, V48, P151, DOI 10.1046/j.1439-0450.2001.00431.x
   Wutzler P, 2000, J HOSP INFECT, V46, P304, DOI 10.1053/jhin.2000.0850
   YASUHARA H, 1989, JPN J VET SCI, V51, P337
NR 22
TC 55
Z9 61
U1 2
U2 14
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0006-3592
J9 BIOTECHNOL BIOENG
JI Biotechnol. Bioeng.
PD JUL 20
PY 2002
VL 79
IS 2
BP 211
EP 216
DI 10.1002/bit.10281
PG 6
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 564XX
UT WOS:000176339800010
PM 12115437
DA 2018-10-20
ER

PT J
AU Yuan, GL
   Kuramoto, N
   Su, SJ
AF Yuan, GL
   Kuramoto, N
   Su, SJ
TI Template synthesis of polyaniline in the presence of phosphomannan
SO SYNTHETIC METALS
LA English
DT Article
DE polyaniline; phosphomannan; aqueous solution; template polymerization
ID CHEMICAL OXIDATIVE POLYMERIZATION; CONDUCTING POLYANILINE; SUBSTITUTED
   POLYANILINE; ANILINE; ACID); SALTS
AB The synthesis of a water-soluble and conducting polyaniline (PANI)-phosphomannan (PMa) complex is presented. Chemical polymerization of aniline was carried out in the presence of PMa, a novel polymeric phosphoric acid and a kind of biomaterial. It was found that the extent of polymerization was affected greatly by initial molar ratio of aniline to PMa in reaction media. A water-soluble and conducting PANI-PMa complex has been obtained under suitable conditions and it exhibited a maximum conductivity by appropriate control of molar ratio of aniline to PMa. The synthesized PANI was characterized by UV-VIS, Fourier transform infrared spectrometer (FT-IR), thermogravimetric analysis (TGA) and inherent viscosity. TGA showed that PANI-PMa complex has highly thermal stability, which was also confirmed by conductivity measurement after exposing the casting films at high temperature. (C) 2002 Elsevier Science B.V. All rights reserved.
C1 Yamagata Univ, Grad Sch Sci & Engn, Grad Program Human Sensing & Funct Sensor ENgn, Jonan 4-3-16, Yonezawa, Yamagata 992, Japan.
RP Kuramoto, N (reprint author), Yamagata Univ, Grad Sch Sci & Engn, Grad Program Human Sensing & Funct Sensor ENgn, Jonan 4-3-16, Yonezawa, Yamagata 992, Japan.
EM kuramoto@dip.yz.yamagata-u.ac.jp
RI Su, Shi-Jian/A-2036-2013
CR Adams PN, 1996, POLYMER, V37, P3411, DOI 10.1016/0032-3861(96)88489-8
   CAO Y, 1993, POLYMER, V34, P3139, DOI 10.1016/0032-3861(93)90381-J
   CAO Y, 1992, SYNTHETIC MET, V48, P91, DOI 10.1016/0379-6779(92)90053-L
   CHAN HSO, 1995, J AM CHEM SOC, V117, P8517, DOI 10.1021/ja00138a004
   CHEN SA, 1995, J AM CHEM SOC, V117, P10055, DOI 10.1021/ja00145a017
   Chen SA, 1996, MACROMOLECULES, V29, P3950, DOI 10.1021/ma951783p
   CHEVALIER JW, 1992, MACROMOLECULES, V25, P3325, DOI 10.1021/ma00039a001
   CHIANG JC, 1986, SYNTHETIC MET, V13, P193, DOI 10.1016/0379-6779(86)90070-6
   Davey JM, 2000, MACROMOLECULES, V33, P7044, DOI 10.1021/ma000206k
   DEARMITT C, 1993, POLYMER, V34, P158, DOI 10.1016/0032-3861(93)90299-P
   DEBERRY DW, 1985, J ELECTROCHEM SOC, V132, P1022, DOI 10.1149/1.2114008
   Geng YH, 1999, POLYMER, V40, P5723, DOI 10.1016/S0032-3861(99)00134-2
   GENIES EM, 1990, SYNTHETIC MET, V36, P139, DOI 10.1016/0379-6779(90)90050-U
   GOSPODINOVA N, 1993, POLYMER, V34, P2438, DOI 10.1016/0032-3861(93)90835-X
   GUSTAFSSON G, 1992, NATURE, V357, P477, DOI 10.1038/357477a0
   JELLE BP, 1993, J ELECTROCHEM SOC, V140, P3560, DOI 10.1149/1.2221126
   KULSZEWICZBAJER I, 1995, MACROMOLECULES, V28, P610, DOI 10.1021/ma00106a028
   Kuramoto N, 1997, POLYMER, V38, P3055, DOI 10.1016/S0032-3861(96)00861-0
   Liu W, 1999, J AM CHEM SOC, V121, P71, DOI 10.1021/ja982270b
   LUI W, 1999, J AM CHEM SOC, V121, P11345
   MACDIARMID AG, 1989, FARADAY DISCUSS, V88, P495
   Nagarajan R, 2000, MACROMOLECULES, V33, P9542, DOI 10.1021/ma000954+
   NAKAJIMA T, 1989, SYNTHETIC MET, V28, pC629
   NALWA HS, 1997, HDB ORGANIC CONDUCTI, V2, P534
   OSTERHOLM JE, 1993, SYNTHETIC MET, V55, P1034, DOI 10.1016/0379-6779(93)90195-3
   Paul RK, 1999, SYNTHETIC MET, V104, P189, DOI 10.1016/S0379-6779(99)00063-6
   SHANNON K, 1994, J CHEM SOC CHEM COMM, P643, DOI 10.1039/c39940000643
   SLODKI ME, 1972, P 4 IFS FERM TECHN T, P597
   Stejskal J, 1996, POLYMER, V37, P367, DOI 10.1016/0032-3861(96)81113-X
   Wei XL, 1996, J AM CHEM SOC, V118, P2545, DOI 10.1021/ja952277i
   Yue J., 1990, J AM CHEM SOC, V112, P2800, DOI DOI 10.1021/JA00163A051
   ZHENG WY, 1994, MACROMOLECULES, V27, P7754, DOI 10.1021/ma00104a034
NR 32
TC 32
Z9 36
U1 1
U2 8
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0379-6779
J9 SYNTHETIC MET
JI Synth. Met.
PD JUL 10
PY 2002
VL 129
IS 2
BP 173
EP 178
AR PII S0379-6779(02)00049-8
DI 10.1016/S0379-6779(02)00049-8
PG 6
WC Materials Science, Multidisciplinary; Physics, Condensed Matter; Polymer
   Science
SC Materials Science; Physics; Polymer Science
GA 580GK
UT WOS:000177226700010
DA 2018-10-20
ER

PT J
AU Jones, DB
   Middelberg, APJ
AF Jones, DB
   Middelberg, APJ
TI Micromechanical testing of interfacial protein networks demonstrates
   ensemble behavior characteristic of a nanostructured biomaterial
SO LANGMUIR
LA English
DT Article
ID OIL-WATER INTERFACE; SELF-ASSEMBLED MONOLAYERS; MONTE-CARLO SIMULATION;
   LIQUID INTERFACES; MILK-PROTEINS; DILATATIONAL PROPERTIES; COMPETITIVE
   ADSORPTION; AIR/WATER INTERFACE; BETA-LACTOGLOBULIN; SHEAR PROPERTIES
AB We develop and use novel instrumentation, the Cambridge Interfacial Tensiometer (CIT), to characterize the micromechanical response of a beta-lactoglobulin network adsorbed at the air-water interface. The technique is an interfacial two-dimensional analogy of conventional materials testing methodology but is conducted with high spatial resolution and requires the measurement of micro-Newton forces. Here we characterize interfacially adsorbed networks using an elasticity modulus (Et) derived from the gradient of the stress-strain plot at low strain. Measured Et values were of order 200 mN/m at the air-water interface, consistent with a calculated ensemble average estimated using atomic force microscopy derived data on the unfolding of individual protein molecules, Hydrophobic intermolecular interactions were identified as a possible dominant mechanism by which networks transmit force laterally in the interfacial plane. Covalent disulfide linkages did not significantly contribute to network rigidity in these tests, as the addition of the reducing agent dithiothreitol did not affect force transmission. Networks demonstrated a clear ability for "repair" that is dependent on bulk protein concentration and hence the rate of transport into the interfacial region during tensile testing. Importantly, this study suggests that network mechanical response is determined by residual protein tertiary structure and that adsorbed networks should therefore be analyzed as nanostructured biomaterials. The CIT technique complements existing surface rheology approaches for the characterization of interfacial protein networks and advantageously does not require a priori assumptions about network properties and behavior.
C1 Univ Cambridge, Dept Chem Engn, Cambridge CB2 3RA, England.
RP Middelberg, APJ (reprint author), Univ Cambridge, Dept Chem Engn, Pembroke St, Cambridge CB2 3RA, England.
RI Middelberg, Anton/B-2434-2013
CR Abel AP, 1996, ANAL CHEM, V68, P2905, DOI 10.1021/ac960071+
   Anderson RE, 2000, J CHEM PHYS, V112, P9167, DOI 10.1063/1.481537
   ANDRADE JD, 1986, ADV POLYM SCI, V79, P1
   BENJAMINS J, 1992, COLLOID SURFACE, V65, P161, DOI 10.1016/0166-6622(92)80271-3
   Best RB, 2001, BIOPHYS J, V81, P2344, DOI 10.1016/S0006-3495(01)75881-X
   BISWAS B, 1963, PROC R SOC LON SER-A, V271, P296, DOI 10.1098/rspa.1963.0019
   BOYD JV, 1973, J COLLOID INTERF SCI, V45, P478, DOI 10.1016/0021-9797(73)90163-X
   Burgess DJ, 1997, J COLLOID INTERF SCI, V189, P74, DOI 10.1006/jcis.1997.4803
   Caessens PWJR, 1999, BBA-PROTEIN STRUCT M, V1430, P73, DOI 10.1016/S0167-4838(98)00274-X
   Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P3694, DOI 10.1073/pnas.96.7.3694
   CLARK DC, 1994, FARADAY DISCUSS, V98, P253, DOI 10.1039/fd9949800253
   Cooper A, 2000, BIOPHYS CHEM, V85, P25, DOI 10.1016/S0301-4622(00)00136-8
   COURTHAUDON JL, 1991, COLLOID SURFACE, V56, P293, DOI 10.1016/0166-6622(91)80128-B
   DICKINSON E, 1985, J COLLOID INTERF SCI, V106, P259, DOI 10.1016/0021-9797(85)90406-0
   DICKINSON E, 1992, ADV COLLOID INTERFAC, V42, P89, DOI 10.1016/0001-8686(92)80021-O
   Dickinson E, 1997, J DAIRY SCI, V80, P2607, DOI 10.3168/jds.S0022-0302(97)76218-0
   DICKINSON E, 1991, INT J BIOL MACROMOL, V13, P26, DOI 10.1016/0141-8130(91)90006-G
   DICKINSON E, 1990, INT J BIOL MACROMOL, V12, P189, DOI 10.1016/0141-8130(90)90031-5
   DICKINSON E, 1992, INTRO FOOD COLLOIDS
   Faergemand M, 1998, J AGR FOOD CHEM, V46, P884, DOI 10.1021/jf970733b
   Faergemand M, 1997, J AGR FOOD CHEM, V45, P2514, DOI 10.1021/jf9609789
   FRAGNETO G, 1995, SCIENCE, V267, P657, DOI 10.1126/science.7839141
   GRAHAM DE, 1980, J COLLOID INTERF SCI, V76, P240, DOI 10.1016/0021-9797(80)90290-8
   GRAHAM DE, 1979, J COLLOID INTERF SCI, V70, P427, DOI 10.1016/0021-9797(79)90050-X
   GRAHAM DE, 1980, J COLLOID INTERF SCI, V76, P227, DOI 10.1016/0021-9797(80)90289-1
   GRAHAM DE, 1979, J COLLOID INTERF SCI, V70, P415, DOI 10.1016/0021-9797(79)90049-3
   Hickel A, 1999, BIOTECHNOL BIOENG, V65, P425, DOI 10.1002/(SICI)1097-0290(19991120)65:4<425::AID-BIT7>3.3.CO;2-P
   Idiris A, 2000, PROTEIN ENG, V13, P763, DOI 10.1093/protein/13.11.763
   Improta S, 1996, STRUCTURE, V4, P323, DOI 10.1016/S0969-2126(96)00036-6
   Jones DB, 2002, CHEM ENG SCI, V57, P1711, DOI 10.1016/S0009-2509(02)00057-X
   LOEB GI, 1968, J COLLOID INTERF SCI, V27, P38, DOI 10.1016/0021-9797(68)90007-6
   Mackie AR, 1999, J COLLOID INTERF SCI, V210, P157, DOI 10.1006/jcis.1998.5941
   Makievski AV, 1997, COLLOID SURFACE A, V122, P269, DOI 10.1016/S0927-7757(96)03857-5
   MAUGUEN Y, 1982, NATURE, V297, P162, DOI 10.1038/297162a0
   MCKENZIE HA, 1972, BIOCHEMISTRY-US, V11, P4539, DOI 10.1021/bi00774a017
   Middelberg APJ, 2000, P NATL ACAD SCI USA, V97, P5054, DOI 10.1073/pnas.080042597
   Moore WJ, 1938, J CHEM PHYS, V6, P391, DOI 10.1063/1.1750274
   Petkov JT, 2000, LANGMUIR, V16, P3703, DOI 10.1021/la991287k
   POLSON A, 1950, J PHYS COLLOID CHEM, V54, P649, DOI 10.1021/j150479a007
   TERRISSE I, 1994, COLLOID SURFACE A, V91, P121, DOI 10.1016/0927-7757(94)02790-0
   Williams A, 1996, COLLOID SURFACE A, V114, P267, DOI 10.1016/0927-7757(96)03534-0
   Xu GF, 2001, P NATL ACAD SCI USA, V98, P3652, DOI 10.1073/pnas.071400098
NR 42
TC 30
Z9 30
U1 0
U2 16
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD JUL 9
PY 2002
VL 18
IS 14
BP 5585
EP 5591
DI 10.1021/la020090g
PG 7
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 569XB
UT WOS:000176627000038
DA 2018-10-20
ER

PT J
AU Guler, M
   Kologlu, M
   Kama, NA
   Renda, N
   Gozalan, U
   Yuksek, YN
   Daglar, G
AF Guler, M
   Kologlu, M
   Kama, NA
   Renda, N
   Gozalan, U
   Yuksek, YN
   Daglar, G
TI Effect of topically applied charged particles on healing of colonic
   anastomoses
SO ARCHIVES OF SURGERY
LA English
DT Article
ID SUBCUTANEOUS AUGMENTATION; INTRAABDOMINAL SEPSIS; ELECTRICAL-CURRENT;
   BEADS; STIMULATION; WOUNDS; FIELDS; ACCELERATION; BIOMATERIAL; FRACTURES
AB Hypothesis: Various forms of electrical stimulation can improve wound healing in different tissues, but their application to gastrointestinal tract healing has not been investigated. We assumed that positively charged diethylaminoethyl cross-linked dextran bead (diethylaminoethyl Sephadex [DEAE-S]) particles would have a beneficial effect on the healing of colonic anastomoses.
   Design: Experimental animal study.
   Setting: Animal research laboratory of a university hospital.
   Animals: Forty female Wistar albino rats.
   Interventions: Right colonic transection and anastomosis was performed in 5 animal groups. The control group received no treatment; the placebo group, methylcellulose gel; and the DEAE-S group, DEAE-S in methyl cellulose gel applied topically around the anastomoses. The fecal peritonitis (FP) group underwent cecal ligation and perforation simultaneously with the anastomosis to cause FP; the FP + DEAE-S group also received DEAE-S applied around the anastomoses.
   Main Outcome Measures: After the completion of postoperative day 4, all rats were killed. Anastomotic bursting pressures and hydroxyproline concentrations in perianastomotic tissue were measured and compared.
   Results: Mean bursting pressures were 115.1 mm Hg in the control group, 113.6 mm Hg in the placebo group, 159.4 mm Hg in the DEAE-S group, 62.8 mm Hg in the FP group, and 121.1 mm Hg in the FP + DEAE-S group (P=.001, 1-way analysis of variance [ANOVA]). The differences between the control vs DEAE-S groups, placebo vs DEAE-S groups, and FP vs FP + DEAE-S groups were significant (P<.05, t test). Mean hydroxyproline concentrations were 5.2 mug/mg in the control group, 4.9 mug/mg in the placebo group, 5.6 mug/mg in the DEAE-S group, 4.5 mug/mg in the FP group, and 5.4 mug/mg in the FP + DEAE-S group (P=.09, 1-way ANOVA). The difference between the FP and FP + DEAE-S groups was significant (P=.04, t test).
   Conclusions: A positively charged particle, DEAE-S, improves healing of colonic anastomoses in healthy rats and in rats with FP. This inexpensive, nontoxic material is easily applied and deserves further evaluation in gastrointestinal tract healing.
C1 Ankara Numune Hosp, Dept Surg 4, Ankara, Turkey.
   Hacettepe Univ, Dept Biochem, TR-06100 Ankara, Turkey.
RP Kama, NA (reprint author), Uzmanlar Tip Grubu,3 Cadde,41 Sokak,No 3-1 Bahcel, TR-06500 Ankara, Turkey.
EM nak4ceranur@superonline.com
CR Ahrendt GM, 1996, AM J SURG, V171, P102, DOI 10.1016/S0002-9610(99)80082-8
   AHRENDT GM, 1994, ARCH SURG-CHICAGO, V129, P1179
   ALVAREZ OM, 1983, J INVEST DERMATOL, V81, P144, DOI 10.1111/1523-1747.ep12543498
   ASSIMACO.D, 1968, AM J SURG, V115, P683, DOI 10.1016/0002-9610(68)90101-3
   Assimacopoulos D, 1968, Am Surg, V34, P423
   BALLANTYNE GH, 1984, DIS COLON RECTUM, V27, P61, DOI 10.1007/BF02554084
   BARKER AT, 1982, AM J PHYSIOL, V242, pR358
   BARRANCO SD, 1974, CLIN ORTHOP RELAT R, P250
   BASSETT CAL, 1982, JAMA-J AM MED ASSOC, V247, P623, DOI 10.1001/jama.247.5.623
   BASSETT CAL, 1968, J CELL BIOL, V39, pA9
   BASSETT CAL, 1981, J BONE JOINT SURG AM, V63, P511, DOI 10.2106/00004623-198163040-00001
   BECKER RO, 1961, J BONE JOINT SURG AM, V43, P643, DOI 10.2106/00004623-196143050-00002
   Beech JA, 1997, BIOELECTROMAGNETICS, V18, P341, DOI 10.1002/(SICI)1521-186X(1997)18:5<341::AID-BEM1>3.0.CO;2-2
   BERGMAN I, 1963, ANAL CHEM, V35, P1961, DOI 10.1021/ac60205a053
   BIGELOW JB, 1978, ELECTRICAL PROPERTIE, P289
   BOURGUIGNON GJ, 1987, FASEB J, V1, P398
   Burgess E, 1998, PLAST RECONSTR SURG, V102, P2395, DOI 10.1097/00006534-199812000-00019
   BURR H. S., 1940, YALE JOUR BIOL AND MED, V12, P483
   CARLEY PJ, 1985, ARCH PHYS MED REHAB, V66, P443
   EPPLEY BL, 1994, ANN PLAS SURG, V32, P463, DOI 10.1097/00000637-199405000-00004
   EPPLEY BL, 1994, AESTHET PLAST SURG, V18, P413, DOI 10.1007/BF00451350
   ERICKSON CA, 1984, J CELL BIOL, V98, P296, DOI 10.1083/jcb.98.1.296
   FALANGA V, 1987, J INVEST DERMATOL, V88, P488
   FUKADA E, 1957, J PHYS SOC JPN, V12, P1158, DOI 10.1143/JPSJ.12.1158
   Galiano RD, 1996, ANN PLAS SURG, V36, P608, DOI 10.1097/00000637-199606000-00008
   Gault W R, 1976, Phys Ther, V56, P265
   HENDRIKS T, 1990, DIS COLON RECTUM, V33, P891, DOI 10.1007/BF02051930
   KLOTH LC, 1988, PHYS THER, V68, P503, DOI 10.1093/ptj/68.4.503
   Kologlu M, 1999, AM J SURG, V178, P293, DOI 10.1016/S0002-9610(99)00175-0
   Kologlu M, 2000, SURGERY, V128, P99, DOI 10.1067/msy.2000.107414
   KONIKOFF JJ, 1976, ANN BIOMED ENG, V4, P1, DOI 10.1007/BF02363553
   KORUDA MJ, 1990, J SURG RES, V48, P504, DOI 10.1016/0022-4804(90)90021-S
   KRUKOWSKI M, 1988, J BONE MINER RES, V3, P165
   Lechner F, 1978, Acta Orthop Belg, V44, P699
   MUSTOE TA, 1992, PLAST RECONSTR SURG, V89, P891, DOI 10.1097/00006534-199205000-00018
   ORIDA N, 1982, CELL MOTIL CYTOSKEL, V2, P243, DOI 10.1002/cm.970020305
   PESSA ME, 1987, J SURG RES, V42, P207, DOI 10.1016/0022-4804(87)90120-X
   ROWLEY BA, 1974, ANN NY ACAD SCI, V238, P543, DOI 10.1111/j.1749-6632.1974.tb26820.x
   SCHROCK TR, 1973, ANN SURG, V177, P513, DOI 10.1097/00000658-197305000-00002
   SMITH SD, 1967, ANAT REC, V158, P89, DOI 10.1002/ar.1091580110
   Taskan I, 1997, PLAST RECONSTR SURG, V100, P966
   Tawil NJ, 1999, WOUND REPAIR REGEN, V7, P389, DOI 10.1046/j.1524-475X.1999.00389.x
   WOLCOTT LE, 1969, SOUTH MED J, V62, P795, DOI 10.1097/00007611-196907000-00008
   Wu LC, 1999, J SURG RES, V85, P43, DOI 10.1006/jsre.1999.5354
NR 44
TC 3
Z9 4
U1 0
U2 0
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 0004-0010
EI 1538-3644
J9 ARCH SURG-CHICAGO
JI Arch. Surg.
PD JUL
PY 2002
VL 137
IS 7
BP 813
EP 817
DI 10.1001/archsurg.137.7.813
PG 5
WC Surgery
SC Surgery
GA 571JU
UT WOS:000176714900013
PM 12093338
OA Bronze
DA 2018-10-20
ER

PT J
AU Schmitt, M
   Weiss, P
   Bourges, X
   del Valle, GA
   Daculsi, G
AF Schmitt, M
   Weiss, P
   Bourges, X
   del Valle, GA
   Daculsi, G
TI Crystallization at the polymer/calclum-phosphate interface in a
   sterilized injectable bone substitute IBS
SO BIOMATERIALS
LA English
DT Article
DE calcium phosphate ceramic; biomaterial; interface; cellulose ether
ID CALCIUM-PHOSPHATE; DENTAL ENAMEL; IMPLANTATION; BIOMATERIALS; COMPOSITE;
   CERAMICS; PROTEINS; POLYMER
AB Calcium phosphate (CaP) ceramics are the main raw, materials used to elaborate blocks or granules for bone substitutes. In this study injectable bone Substitutes (1BS) were developed for application,, it) orthopedic or dental surgery. Sterile, ready-to-use composite containing CaP granules (biphasic calcium phosphate. BCP) and polymer (hydroxypropylmethylcellulose, HPMC) was prepared. Steam sterilization produced ne. phenomena at the CaP polymer interface. resulting in crystal growth. These phenomena may constitute a model for the biomineralization study. Scanning electron microscopy showed that the formed crystallites organize themselves into a three-dimensional structure. Currently, the mechanisms of crystal growth are unknown and have been observed with only one combination of polymer BCP ceramics after steam sterilization. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Fac Dent, UFR Odontol, Res Ctr Mat Biol Interest, INSERM, F-44042 Nantes 01, France.
   Biomatlante ZA, F-44360 Vigneux de Bretagne, France.
RP Weiss, P (reprint author), Fac Dent, UFR Odontol, Res Ctr Mat Biol Interest, INSERM, EMI 99-03,1 Pl Alexis Ricordeau, F-44042 Nantes 01, France.
RI Weiss, Pierre/P-1372-2014; Daculsi, Guy/P-1320-2014
OI Weiss, Pierre/0000-0002-6159-8590; Daculsi, Guy/0000-0003-1030-3446
CR Aoba T, 1997, CRIT REV ORAL BIOL M, V8, P136, DOI 10.1177/10454411970080020301
   Bohic S, 2001, J MATER SCI-MATER M, V12, P201, DOI 10.1023/A:1008902829840
   Bouler JM, 2000, J BIOMED MATER RES, V51, P680, DOI 10.1002/1097-4636(20000915)51:4<680::AID-JBM16>3.0.CO;2-#
   CHRISTIANSEN DL, 1993, CELL MATER, V3, P177
   CONSTANTZ BR, 1995, SCIENCE, V267, P1796, DOI 10.1126/science.7892603
   DACULSI G, 1990, CALCIFIED TISSUE INT, V46, P20, DOI 10.1007/BF02555820
   Daculsi G, 1997, INT REV CYTOL, V172, P129, DOI 10.1016/S0074-7696(08)62360-8
   Daculsi G, 1999, BONE, V25, P59
   DELUCAS L, 1975, CARBOHYD RES, V41, P19, DOI 10.1016/S0008-6215(00)87003-2
   Fincham AG, 1997, CIBA F SYMP, V205, P118
   Gauthier O, 1999, J BIOMED MATER RES, V47, P28, DOI 10.1002/(SICI)1097-4636(199910)47:1<28::AID-JBM4>3.0.CO;2-P
   Gauthier O, 1999, J PERIODONTOL, V70, P375, DOI 10.1902/jop.1999.70.4.375
   Gauthier O, 2001, J MATER SCI-MATER M, V12, P385, DOI 10.1023/A:1011284517429
   GROVER JA, 1986, FOOD HYDROCOLLOIDS, V3, P121
   Hunter GK, 1996, BIOCHEM J, V317, P59, DOI 10.1042/bj3170059
   LeGeros R.Z., 1991, CALCIUM PHOSPHATES O, V15
   Richard M, 1998, CALCIFIED TISSUE INT, V62, P437, DOI 10.1007/s002239900456
   Robinson C, 1996, Adv Dent Res, V10, P173
   Rohanizadeh R, 1999, CALCIFIED TISSUE INT, V64, P430, DOI 10.1007/PL00005825
   SIMMER JP, 1995, CRIT REV ORAL BIOL M, V6, P84, DOI 10.1177/10454411950060020701
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   WALSH D, 1994, SCIENCE, V264, P1576, DOI 10.1126/science.264.5165.1576
   Weiss P, 1997, J MATER SCI-MATER M, V8, P621, DOI 10.1023/A:1018519419539
   Weiss P, 1999, BONE, V25, p67S, DOI 10.1016/S8756-3282(99)00146-5
   Yokogawa Y, 1998, J MATER RES, V13, P922, DOI 10.1557/JMR.1998.0126
   YUBAO L, 1993, BIOCERAMICS, V6, P173
NR 26
TC 28
Z9 29
U1 0
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUL
PY 2002
VL 23
IS 13
BP 2789
EP 2794
AR PII S0142-9612(02)00015-7
DI 10.1016/S0142-9612(02)00015-7
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 554DM
UT WOS:000175718600020
PM 12059030
DA 2018-10-20
ER

PT J
AU Madhan, B
   Muralidharan, C
   Jayakumar, R
AF Madhan, B
   Muralidharan, C
   Jayakumar, R
TI Study on the stabilisation of collagen with vegetable tannins in the
   presence of acrylic polymer
SO BIOMATERIALS
LA English
DT Article
DE vegetable tannins; polyphenols; acrylics; collagen; stabilisation;
   biomaterial
ID GREEN TEA; POLYPHENOLS; ACID
AB Collagen, a unique connective tissue protein finds extensive application as biocompatible biomaterial in wound healing, as drug carriers, cosmetics, etc. A study has been undertaken to stabilise, Type-I collagen of rat-tail tendon using plant polyphenol (Acacia Mollissima) in the presence of an acrylic polymer. It has been found that collagen fibres pre-treated with acrylic polymer followed by the treatment with Acacia Mollissima exhibited an increase in hydrothermal stability by 25degreesC. Infrared spectroscopic studies display the changes in the spectral characteristics of native and treated collagen films. Transmission electron microscopic and circular dichroic studies provide an insight into the understanding of the improved stabilisation of collagen, due to treatment with acrylic polymer and plant polyphenols. The study is expected to enhance the biomaterial applications of collagen tissues. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Cent Leather Res Inst, Council Sci & Ind Res, Madras 600020, Tamil Nadu, India.
RP Muralidharan, C (reprint author), Cent Leather Res Inst, Council Sci & Ind Res, Adyar, Madras 600020, Tamil Nadu, India.
RI Madhan, Balaraman/B-3136-2009
OI Madhan, Balaraman/0000-0002-4198-8452
CR BEAR RS, 1952, ADV PROTEIN CHEM, V7, P69, DOI 10.1016/S0065-3233(08)60018-2
   Borasky R., 1949, J AM LEATHER CHEM AS, V44, P830
   BRADFIELD AE, 1948, J CHEM SOC, P2249, DOI 10.1039/jr9480002249
   CHANDRAKASAN G, 1976, J BIOL CHEM, V251, P6062
   GAUGLHOFER J, 1986, J SOC LEATH TECH CH, V70, P11
   GAYATRI R, 1997, P INDIAN ACAD SCI CH, V109, P145
   Gustavson K. H, 1956, CHEM TANNING PROCESS
   GUSTAVSON KH, 1954, J POLYM SCI, V12, P317, DOI 10.1002/pol.1954.120120126
   HARBORNE JB, 1959, J CHROMATOGR, V2, P581, DOI 10.1016/S0021-9673(01)86351-2
   HART GJ, 1971, BIOCHEM J, V125, P599, DOI 10.1042/bj1250599
   KOMORI A, 1993, JPN J CLIN ONCOL, V23, P186
   LAURENT TC, 1974, EUR J BIOCHEM, V43, P231, DOI 10.1111/j.1432-1033.1974.tb03404.x
   LOLLAR RM, 1977, CHEM TECHNOLOGY LEAT, V2, P1
   Madhan B, 2001, J AM LEATHER CHEM AS, V96, P120
   Madhan B, 2001, CHEM PHYS LETT, V346, P334, DOI 10.1016/S0009-2614(01)00910-1
   Nezu T, 2000, BIOMATERIALS, V21, P415, DOI 10.1016/S0142-9612(99)00204-5
   NIMMI HE, 1988, COLLAGEN, P1
   Okuda T, 1995, Fortschr Chem Org Naturst, V66, P1
   PRESTON BN, 1972, BIOPOLYMERS, V11, P1645, DOI 10.1002/bip.1972.360110811
   PROCKOP DJ, 1995, ANNU REV BIOCHEM, V64, P403, DOI 10.1146/annurev.biochem.64.1.403
   RAMACHANDRAN GN, 1965, BIOCHIM BIOPHYS ACTA, V109, P314, DOI 10.1016/0926-6585(65)90119-6
   RAMACHANDRAN GN, 1954, NATURE, V174, P269, DOI 10.1038/174269c0
   RAMACHANDRAN GN, 1968, BIOPOLYMERS, V6, P1648
   Rao JR, 1999, BBA-GEN SUBJECTS, V1472, P595
   RICH A, 1955, NATURE, V176, P915, DOI 10.1038/176915a0
   ROUX DG, 1960, BIOCHEM J, V74, P44, DOI 10.1042/bj0740044
   ROUX DG, 1961, BIOCHEM J, V78, P834, DOI 10.1042/bj0780834
   ROUX DG, 1960, J CHROMATOGR, V4, P65, DOI 10.1016/S0021-9673(01)98371-2
   SANTAPPA M, 1982, J SCI IND RES INDIA, V41, P616
   SHARPHOUSE JH, 1989, LEATHER TECHNICIANS, P20
   SHUTTLEWORTH SG, 1952, J AM LEATHER CHEM AS, V47, P603
   Sykes R. L., 1956, J AM LEATHER CHEM AS, V51, P235
   TU ST, 1950, J AM LEATHER CHEM AS, V45, P324
   WANG ZY, 1988, DRUG METAB DISPOS, V16, P98
   WEI DQ, 1995, J SOC LEATH TECH CH, V79, P110
   WHITE T, 1952, J SOC LEATHER TRADES, V36, P148
   WHITE T, 1956, CHEM TANNING PROCESS, P1
   WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0
NR 38
TC 54
Z9 54
U1 1
U2 13
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUL
PY 2002
VL 23
IS 14
BP 2841
EP 2847
AR PII S0142-9612(01)00410-0
DI 10.1016/S0142-9612(01)00410-0
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 559FP
UT WOS:000176015400003
PM 12069323
DA 2018-10-20
ER

PT J
AU Noah, EM
   Chen, JS
   Jiao, XY
   Heschel, I
   Pallua, N
AF Noah, EM
   Chen, JS
   Jiao, XY
   Heschel, I
   Pallua, N
TI Impact of sterilization on the porous design and cell behavior in
   collagen sponges prepared for tissue engineering
SO BIOMATERIALS
LA English
DT Article
DE collagen sponges; sterilization; ethylene oxide; gamma irradiation; pore
   structure; cell proliferation
ID GAMMA-IRRADIATION; PORE-SIZE; IN-VITRO; BIOMATERIAL; AERATION; POLYMERS;
   DEVICES; SHAPE
AB This study investigates the impact of different sterilization processes on structural integrity and stability of collagen sponges designed for tissue engineering. Collagen sponges with uniform pore size (20 mum) were sterilized either with ethylene oxide (EO) or gamma irradiation (2.5 Mrad). Gamma-sterilized sponges showed a dramatic decrease of resistance against enzyme degradation and severe shrinkage after cell seeding. Collapsed porosity inhibited fibroblasts and barred completely the human umbilical vein endothelial cell ingrowth into the sponges. On the contrary, the porous structure and stability of EO-sterilized sponges remained almost unaltered. Fibroblasts and endothelial cells exhibited favorable proliferation and migration within sponges with normal morphology. Tubular formation by seeded endothelial cells occurred early in the first week. Therefore, we emphasize that the impact of sterilization of biomaterials is substantial and any new procedure has to be evaluated by correlating the impact of the procedure on the porous structure with cell proliferation behavior. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Technol Univ Aachen, Dept Plast Hand & Burn Surg, D-52074 Aachen, Germany.
   Technol Univ Aachen, Helmholtz Inst Biomed Engn, D-52074 Aachen, Germany.
RP Noah, EM (reprint author), Technol Univ Aachen, Dept Plast Hand & Burn Surg, Pauwelsstr 30, D-52074 Aachen, Germany.
CR BELKOFF SM, 1992, J ORTHOPAED RES, V10, P461, DOI 10.1002/jor.1100100320
   BERTHOD F, 1994, CLIN MATER, V15, P259, DOI 10.1016/0267-6605(94)90055-8
   CHEUNG DT, 1990, J BIOMED MATER RES, V24, P581, DOI 10.1002/jbm.820240505
   DAMINK LHHO, 1995, J BIOMED MATER RES, V29, P149, DOI 10.1002/jbm.820290203
   Doillon CJ, 1997, J BIOMED MATER RES, V37, P212
   DOILLON CJ, 1994, MAT SCI ENG C-BIOMIM, V2, P43, DOI 10.1016/0928-4931(94)90028-0
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   HESCHEL I, 1997, Patent No. 9803403
   HESCHEL I, 1996, ADV CRYOGEN ENG, P13
   Ingber DE, 1995, J BIOMECH, V28, P1471, DOI 10.1016/0021-9290(95)00095-X
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   LIU BC, 1989, J BIOMED MATER RES, V23, P833, DOI 10.1002/jbm.820230803
   MATTHEWS IP, 1989, J BIOMED MATER RES, V23, P143, DOI 10.1002/jbm.820230202
   MIYATA T, 1992, Clinical Materials, V9, P139, DOI 10.1016/0267-6605(92)90093-9
   Moore MA, 1997, ASAIO J, V43, P23, DOI 10.1097/00002480-199701000-00006
   Nehrer S, 1997, BIOMATERIALS, V18, P769, DOI 10.1016/S0142-9612(97)00001-X
   Pachence JM, 1996, J BIOMED MATER RES, V33, P35, DOI 10.1002/(SICI)1097-4636(199621)33:1<35::AID-JBM6>3.0.CO;2-N
   Schoof H., 1998, KI LUFT KAELTETECHNI, V34, P247
   Sheridan RL, 1999, BURNS, V25, P97, DOI 10.1016/S0305-4179(98)00176-4
   SINGHVI R, 1994, SCIENCE, V264, P696, DOI 10.1126/science.8171320
   VINK P, 1986, BIOMATERIALS, V7, P225, DOI 10.1016/0142-9612(86)90108-0
   von Heimburg D, 2001, BIOMATERIALS, V22, P429, DOI 10.1016/S0142-9612(00)00186-1
NR 22
TC 67
Z9 78
U1 2
U2 9
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUL
PY 2002
VL 23
IS 14
BP 2855
EP 2861
AR PII S0142-9612(01)00412-4
DI 10.1016/S0142-9612(01)00412-4
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 559FP
UT WOS:000176015400005
PM 12069325
DA 2018-10-20
ER

PT J
AU Leszczyszyn, J
   Gerber-Leszczyszyn, H
   Helen, M
   Lebski, I
   Skoczylas, M
AF Leszczyszyn, J
   Gerber-Leszczyszyn, H
   Helen, M
   Lebski, I
   Skoczylas, M
TI SIS biomaterial application in treatment of fecal incontinence caused by
   anal sphincter injury - An animal study.
SO GASTROENTEROLOGY
LA English
DT Meeting Abstract
NR 0
TC 0
Z9 0
U1 0
U2 0
PU W B SAUNDERS CO
PI PHILADELPHIA
PA INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA
   19106-3399 USA
SN 0016-5085
J9 GASTROENTEROLOGY
JI Gastroenterology
PD JUL
PY 2002
VL 123
IS 1
SU S
BP 11
EP 11
PG 1
WC Gastroenterology & Hepatology
SC Gastroenterology & Hepatology
GA 570WX
UT WOS:000176684400052
DA 2018-10-20
ER

PT J
AU Vollrath, F
   Barth, P
   Basedow, A
   Engstrom, W
   List, H
AF Vollrath, F
   Barth, P
   Basedow, A
   Engstrom, W
   List, H
TI Local tolerance to spider silks and protein polymers in vivo
SO IN VIVO
LA English
DT Article
DE spider silk; biomaterial; medical use; histology; compatibility
ID WEBS
AB Spider silks were implanted subcutaneously in pigs for a study of the tolerance against this material. Four types of spider silks of high purity and cleanliness were implanted : (i) major ampullate dragline silk reeled from the golden silk spider Nephila clavipes, (ii) native (unsterilised) silk reeled from a Brachypelma spider, (iii) native silk taken from this spider's web and (iv) its web silk thermally treated at 80degreesC. For comparison we used fibrous silk analogue protein polymers and four already marketed wound dressings (polyurethane film, collagen dressings, gauze pads). All materials were applied epicutaneously to split skin wounds. The implants were examined macroscopically as well as by light microscopy. Superficially, all sites healed rapidly. There were marked inflammatory reactions in all sites with lympho-plasmacellular infiltrations, evidence of phagocytosis and granuloma formation as indicated by the appearance of giant cells. However there was a marked absence of epitheloid cells indicating that the observed reaction was a foreign body granuloma. Furthermore, the histopathological images recorded after 14 days revealed no marked differences between the dressings. Polyurethane films, however, seemed to be superior with respect to the duration of the wound healing process.
C1 Univ Oxford, Dept Zool, Oxford OX1 3PS, England.
   LOHMANN GmbH & Co KG, D-56567 Neuwied, Germany.
   Swedish Univ Agr Sci, Fac Vet Med, Dept Pathol, S-75007 Uppsala, Sweden.
RP Vollrath, F (reprint author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.
CR Frische S, 1998, J MICROSC-OXFORD, V189, P64
   Hillyard P., 1994, BOOK SPIDER
   Lazaris A, 2002, SCIENCE, V295, P472, DOI 10.1126/science.1065780
   MAYNES E, 1998, ADV MATER, V10, P801
   MCKINSTRY D, 1994, WILDERNESS ENV MED, V6, P228
   NEWMAN J, 1995, INT J DERMATOL, V34, P290, DOI 10.1111/j.1365-4362.1995.tb01600.x
   OBRIEN JP, 1993, TRENDS POLYM SCI, V1, P228
   RIEKEL C, 2002, UNPUB J BIOL MACROMO
   Santin M, 1999, J BIOMED MATER RES, V46, P382, DOI 10.1002/(SICI)1097-4636(19990905)46:3<382::AID-JBM11>3.0.CO;2-R
   SCHILDKNECHT H, 1972, NATURWISSENSCHAFTEN, V59, P98, DOI 10.1007/BF00591781
   Shao ZZ, 1999, POLYMER, V40, P1799, DOI 10.1016/S0032-3861(98)00266-3
   SOONG HK, 1984, OPHTHALMOLOGY, V91, P479
   VADLAMUDI S, 1995, PHARM RS S9, V12, P235
   VOLLRATH F, 1990, NATURE, V345, P526, DOI 10.1038/345526a0
   VOLLRATH F, 1991, NATURWISSENSCHAFTEN, V78, P557, DOI 10.1007/BF01134447
   VOLLRATH F, 1992, SCI AM, V266, P70, DOI 10.1038/scientificamerican0392-70
   Vollrath F, 1996, P ROY SOC B-BIOL SCI, V263, P147, DOI 10.1098/rspb.1996.0023
   Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000
   Vollrath F, 2001, P ROY SOC B-BIOL SCI, V268, P2339, DOI 10.1098/rspb.2001.1590
   Vollrath F., 2000, REV MOL BIOTECHNOL, V74, P67, DOI DOI 10.1016/S1389-0352(00)00006-4)
NR 20
TC 63
Z9 64
U1 0
U2 8
PU INT INST ANTICANCER RESEARCH
PI ATHENS
PA EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22,
   ATHENS 19014, GREECE
SN 0258-851X
J9 IN VIVO
JI In Vivo
PD JUL-AUG
PY 2002
VL 16
IS 4
BP 229
EP 234
PG 6
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 582ET
UT WOS:000177337300002
PM 12224131
DA 2018-10-20
ER

PT J
AU Salmons, S
AF Salmons, S
TI Electrically stimulated skeletal muscle: An adaptive, functional
   biomaterial
SO INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Article; Proceedings Paper
CT 29th Conference of the European-Society-for-Artificial-Organs
CY AUG 28-31, 2002
CL VIENNA, AUSTRIA
SP European Soc Artificial Organs
ID LATISSIMUS-DORSI MUSCLE
C1 Univ Liverpool, Dept Human Anat & Cell Biol, Liverpool L69 3BX, Merseyside, England.
RP Salmons, S (reprint author), Univ Liverpool, Dept Human Anat & Cell Biol, POB 147, Liverpool L69 3BX, Merseyside, England.
CR Salmons S, 1998, J ANAT, V193, P93, DOI 10.1046/j.1469-7580.1998.19310093.x
   SALMONS S, 1981, MUSCLE NERVE, V4, P94, DOI 10.1002/mus.880040204
   SALMONS S, 1980, TRENDS NEUROSCI, V3, P134, DOI 10.1016/0166-2236(80)90050-8
   Tang ATM, 1999, ANN THORAC SURG, V68, P46, DOI 10.1016/S0003-4975(99)00313-6
   Tansey PA, 1998, SPORTS EXERC INJURY, V4, P131
   WOO EBC, 2002, IN PRESS ANN THORAC, V73
NR 6
TC 0
Z9 0
U1 0
U2 0
PU WICHTIG EDITORE
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 0391-3988
J9 INT J ARTIF ORGANS
JI Int. J. Artif. Organs
PD JUL
PY 2002
VL 25
IS 7
BP 625
EP 626
PG 2
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 575DL
UT WOS:000176931300016
DA 2018-10-20
ER

PT J
AU Bessho, K
   Carnes, DL
   Cavin, R
   Ong, JL
AF Bessho, K
   Carnes, DL
   Cavin, R
   Ong, JL
TI Experimental studies on bone induction using low-molecular-weight poly
   (DL-lactide-co-glycolide) as a carrier for recombinant human bone
   morphogenetic protein-2
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE bone morphogenetic protein; carrier; synthetic biomaterial;
   biodegradable polymer; poly(DL-latide-co-glycolide)
ID ACID); DEGRADATION
AB An appropriate carrier acting as a slow delivery vehicle for the BMPs is required for maximal clinical effectiveness of these bone-inductive proteins, The purpose of this study was to evaluate a low-molecular-weight PLGA copolymer as a synthetic, biodegradable carrier for rhBMP-2 implantation in vivo. Two, 10, or 50 mug of recombinant human BMP-2 were mixed with 10 mg Of a Poly (DL-lactide-co-glycolide) (PLGA) 50:50 copolymer and implanted into the calf muscles of Wistar rats. Soft X-ray analysis and histologic examination indicated that new borne formation occurred at all rhBMP-2-implanted sites within 3 weeks after implantation. Correlation of rhBMP-2 concentration with the amount of bone induction was confirmed by specific alkaline phosphatase activity and calcium content assay. In vitro analysis indicated that 78.5% of the PLGA copolymer was degraded to smaller molecular weight material after 14 days in PBS solution. It is suggested that rhBMP-2 was released in an active form at the implant site during the degradation of the copolymer, resulting in the induction of new bone formation. Thus this low-molecular-weight PLGA copolymer material represents a promising delivery vehicle for E MPs, and possibly other growth factors, around dental and orthopedic implants. (C) 2002 Wiley Periodicals, Inc.
C1 Kyoto Univ, Grad Sch Med, Dept Oral & Maxillofacial Surg, Sakyo Ku, Kyoto 6068507, Japan.
   Univ Texas, Hlth Sci Ctr, San Antonio, TX 78229 USA.
   Dept Periodont, San Antonio, TX 78229 USA.
   Dept Restorat Dent, San Antonio, TX 78229 USA.
RP Ong, JL (reprint author), Kyoto Univ, Grad Sch Med, Dept Oral & Maxillofacial Surg, Sakyo Ku, 54 Knwahara Cho, Kyoto 6068507, Japan.
CR Bessho K, 2000, BRIT J ORAL MAX SURG, V38, P645, DOI 10.1054/bjom.2000.0533
   BESSHO K, 1989, BIOCHEM BIOPH RES CO, V165, P595, DOI 10.1016/S0006-291X(89)80008-7
   Bessho K, 1999, BRIT J ORAL MAX SURG, V37, P2, DOI 10.1054/bjom.1998.0379
   BESSHO K, 1995, ORAL ONCOL, V4, P304
   Celeste AJ, 1994, J BONE MINER RES  S1, V9, pS136
   FUJIMURA K, 1995, BIOCHEM BIOPH RES CO, V208, P316, DOI 10.1006/bbrc.1995.1340
   GILDING DK, 1979, POLYMER, V20, P1459, DOI 10.1016/0032-3861(79)90009-0
   Isobe M, 1996, J BIOMED MATER RES, V32, P433
   Ruppert R, 1996, EUR J BIOCHEM, V237, P295, DOI 10.1111/j.1432-1033.1996.0295n.x
   VERT M, 1994, BIOMATERIALS, V15, P1209, DOI 10.1016/0142-9612(94)90271-2
   VONRECUM HA, 1995, BIOMATERIALS, V16, P441, DOI 10.1016/0142-9612(95)98816-W
   WANG EA, 1990, P NATL ACAD SCI USA, V87, P2220, DOI 10.1073/pnas.87.6.2220
   Witschi C, 1998, J CONTROL RELEASE, V51, P327, DOI 10.1016/S0168-3659(97)00188-0
   Wozney J M, 1989, Prog Growth Factor Res, V1, P267, DOI 10.1016/0955-2235(89)90015-X
NR 14
TC 51
Z9 58
U1 0
U2 3
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JUL
PY 2002
VL 61
IS 1
BP 61
EP 65
DI 10.1002/jbm.10169
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 556GA
UT WOS:000175840000009
PM 12001247
DA 2018-10-20
ER

PT J
AU Muller, BP
   Ensslen, S
   Dott, W
   Hollender, J
AF Muller, BP
   Ensslen, S
   Dott, W
   Hollender, J
TI Improved sample preparation of biomaterials for in vitro genotoxicity
   testing using reference materials
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE in vitro genotoxicity testing; biomaterial; reference material;
   extraction; sample preparation
ID DENTIN BONDING AGENTS; IN-VITRO; COMET ASSAY; CHEMICALS; CYTOTOXICITY;
   POLYETHERURETHANES; IMPLANTATION; MUTAGENICITY; INHIBITION; RESPONSES
AB New biomaterial related reference materials with known genotoxic properties were produced in order to study the sample preparation and in vitro genotoxicity testing of biomaterials. We incorporated genotoxic substances like benzo[a]pyrene into the biomaterial Tecoflex, a polyurethane frequently used for catheters and other applications. We demonstrated that the model compound benzo[a]pyrene is sufficiently extracted by organic solvents, whereas cell culture medium only extracts very limited quantities. By changing the medium several times during extraction the extracted amount was augmented. Using higher amounts of organic solvent in relation to the reference material's surface led to a higher recovery of extracted benzo[a]pyrene. For the in vitro genotoxicity testing using the Mammalian Cell Gene Mutation Test (HPRT test), Mammalian Chromosome Aberration Test, and bacterial umu- and SOS-tests, concentration of extracts is a prerequisite because of the low sensitivity of the test systems. Often cytotoxicity interferes with the evaluation of genotoxic effects. We demonstrated that some recommendations of the ISO 10993-Part 3 and 12,(1,2) dealing with the biological evaluation of medical devices, seem to be insufficient, and new rules for the in vitro genotoxicity testing of biomaterials have to be established. (C) 2002 Wiley Periodicals, Inc.
C1 Rhein Westfal TH Aachen Klinikum, IZKF Biomat, D-52074 Aachen, Germany.
   Univ Klinikum, RWTH Aachen, Inst Hyg & Umweltmed, D-52074 Aachen, Germany.
RP Muller, BP (reprint author), Rhein Westfal TH Aachen Klinikum, IZKF Biomat, Pauwelsstr 30, D-52074 Aachen, Germany.
RI Hollender, Juliane/A-2145-2014
OI Hollender, Juliane/0000-0002-4660-274X
CR [Anonymous], 1996, 1099312 ISO 12
   Baun A, 1999, MUTAT RES-GEN TOX EN, V441, P171, DOI 10.1016/S1383-5718(99)00043-1
   Chauvel-Lebret DJ, 2001, BIOMATERIALS, V22, P1795, DOI 10.1016/S0142-9612(00)00351-3
   Ehrlichmann H, 2000, ECOTOX ENVIRON SAFE, V46, P73, DOI 10.1006/eesa.1999.1875
   Gebel T, 1999, MUTAT RES-GEN TOX EN, V444, P405, DOI 10.1016/S1383-5718(99)00111-4
   Hartmann A, 2001, FOOD CHEM TOXICOL, V39, P843, DOI 10.1016/S0278-6915(01)00031-X
   Heil J, 1996, MUTAT RES-GENET TOX, V368, P181, DOI 10.1016/S0165-1218(96)90060-9
   Henderson L, 2000, MUTAT RES-GEN TOX EN, V464, P123, DOI 10.1016/S1383-5718(99)00173-4
   Hilliard CA, 1998, ENVIRON MOL MUTAGEN, V31, P316, DOI 10.1002/(SICI)1098-2280(1998)31:4<316::AID-EM3>3.3.CO;2-2
   *ISO, 2000, 1099312 ISODIS 12
   *ISO, 1992, 109933 ISO 3
   *ISO, 2000, 100933ISODIS 3
   Kirkland D, 1998, MUTAT RES-FUND MOL M, V404, P173, DOI 10.1016/S0027-5107(98)00111-0
   KIRKLAND DJ, 1992, MUTAGENESIS, V7, P95, DOI 10.1093/mutage/7.2.95
   Kirkpatrick CJ, 2000, AM J PATHOL, V156, P1455, DOI 10.1016/S0002-9440(10)65014-6
   Leyhausen G, 1998, BIOMATERIALS, V19, P559, DOI 10.1016/S0142-9612(97)00137-3
   Lutermann C, 1998, J CHROMATOGR A, V811, P151, DOI 10.1016/S0021-9673(98)00266-0
   Muller L, 1999, MUTAT RES-REV MUTAT, V436, P195, DOI 10.1016/S1383-5742(99)00004-6
   NAKAMURA A, 1992, J BIOMED MATER RES, V26, P631, DOI 10.1002/jbm.820260506
   OBERLY TJ, 1993, CELL BIOL TOXICOL, V9, P243, DOI 10.1007/BF00755603
   Sasaki YF, 2000, CRIT REV TOXICOL, V30, P629, DOI 10.1080/10408440008951123
   Schweikl H, 1997, J BIOMED MATER RES, V36, P284, DOI 10.1002/(SICI)1097-4636(19970905)36:3<284::AID-JBM2>3.0.CO;2-A
   SCHWEIKL H, 1994, J BIOMED MATER RES, V28, P1061, DOI 10.1002/jbm.820280911
   SHELBY MD, 1993, ENVIRON MOL MUTAGEN, V21, P160, DOI 10.1002/em.2850210210
   Stea S, 1998, J BIOMED MATER RES, V40, P545, DOI 10.1002/(SICI)1097-4636(19980615)40:4<545::AID-JBM5>3.0.CO;2-F
   STEA S, 1994, J BIOMED MATER RES, V28, P319, DOI 10.1002/jbm.820280306
   Tsuchiya T, 1996, J BIOMED MATER RES, V31, P299
   TSUCHIYA T, 1993, J APPL BIOMATER, V4, P153, DOI 10.1002/jab.770040206
   TSUCHIYA T, 1995, J BIOMED MATER RES, V29, P113, DOI 10.1002/jbm.820290116
   WENING JV, 1995, BIOMATERIALS, V16, P337, DOI 10.1016/0142-9612(95)93262-C
   Wever DJ, 1997, BIOMATERIALS, V18, P1115, DOI 10.1016/S0142-9612(97)00041-0
NR 31
TC 5
Z9 6
U1 0
U2 1
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JUL
PY 2002
VL 61
IS 1
BP 83
EP 90
DI 10.1002/jbm.10158
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 556GA
UT WOS:000175840000012
PM 12001250
DA 2018-10-20
ER

PT J
AU Gough, JE
   Scotchford, CA
   Downes, S
AF Gough, JE
   Scotchford, CA
   Downes, S
TI Cytotoxicity of glutaraldehyde crosslinked collagen/poly(vinyl alcohol)
   films is by the mechanism of apoptosis
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE human osteoblasts; collagen; crosslinking; apoptosis; IGF-1; glutamic
   acid
ID BIOARTIFICIAL POLYMERIC MATERIALS; FLOW-CYTOMETRIC METHOD; DRUG-DELIVERY
   SYSTEMS; CROSS-LINKING; IN-VITRO; GROWTH-HORMONE; GLUTAMIC-ACID;
   COLLAGEN; CELLS; BONE
AB Collagen has been investigated as a potential natural biomaterial, because of its occurrence in the extracellular matrix. Collagen requires crosslinking in this context, by reagents that are often cytotoxic. Glutaraldehyde is one such agent that is potentially cytotoxic. The aim of this study was to determine the cause of poor cell attachment and growth on collagen/poly(vinyl alcohol) bioartificial composite films, when crosslinked with glutaraldehyde. Dehydrothermal crosslinking was used as a comparison. Human osteoblasts were observed to undergo apoptosis on glutaraldehyde crosslinked films dependent on concentration of collagen present. Higher collagen content resulted in higher levels of apoptosis with poor cell attachment and spreading of remaining cells. Post-treatment of films with 8% L-glutamic acid prevented the apoptotic response of osteoblasts and allowed attachment and spreading. The addition of 100 nM insulin-like growth factor-1 to the Culture medium also prevented apoptosis. Glutaraldehyde toxicity of crosslinked collagen has been demonstrated in this study, the mechanism of which is apoptosis. This study indicates that poor biocompatibility and induction of apoptosis on collagen/poly(vinyl alcohol) films crosslinked by glutaraldehyde are attributed to glutaraldehyde components on the surface of the films (not residual glutaraldehyde), whose effects can be quenched by glutamic acid, and prevented by insulin-like growth factor-1. (C) 2002 Wiley Periodicals, Inc.
C1 Univ Nottingham, Sch Med, Sch Biomed, Queens Med Ctr, Nottingham NG7 2UH, England.
   Smith & Nephew Grp, Res Ctr, York YO10 5DF, N Yorkshire, England.
RP Gough, JE (reprint author), Univ Nottingham, Sch Med, Sch Biomed, Queens Med Ctr, E Floor, Nottingham NG7 2UH, England.
EM j.gough@ic.ac.uk
OI Scotchford, Colin/0000-0003-1937-6692
CR ARNOTT N, 1998, JOINT M BRIT ORTH RE
   BELLOC F, 1994, CYTOMETRY, V17, P59, DOI 10.1002/cyto.990170108
   Burczak K, 1996, BIOMATERIALS, V17, P2351, DOI 10.1016/S0142-9612(96)00076-2
   CASAGRANDA F, 1994, J MATER SCI-MATER M, V5, P332
   CASCONE MG, 1995, BIOMATERIALS, V16, P569, DOI 10.1016/0142-9612(95)91131-H
   CASCONE MG, 1994, J MATER SCI-MATER M, V5, P770, DOI 10.1007/BF00120374
   CHANDA J, 1994, ARTIF ORGANS, V18, P408, DOI 10.1111/j.1525-1594.1994.tb02223.x
   Damink LHHO, 1996, BIOMATERIALS, V17, P679, DOI 10.1016/0142-9612(96)86737-8
   Damink LHHO, 1996, BIOMATERIALS, V17, P765, DOI 10.1016/0142-9612(96)81413-X
   DISILVIO L, 1995, THESIS U COLL LONDON
   EYBL E, 1989, J BIOMED MATER RES, V23, P1355, DOI 10.1002/jbm.820231111
   EYBL E, 1992, J THORAC CARDIOV SUR, V104, P763
   Flautre B, 1996, J MATER SCI-MATER M, V7, P63, DOI 10.1007/BF00058716
   GIUSTI P, 1994, BIOMATERIALS, V15, P1229, DOI 10.1016/0142-9612(94)90274-7
   GIUSTI P, 1993, TRENDS POLYM SCI, V1, P261
   Goissis G, 1998, ARTIF ORGANS, V22, P210, DOI 10.1046/j.1525-1594.1998.06006.x
   Goissis G, 1998, ARTIF ORGANS, V22, P203, DOI 10.1046/j.1525-1594.1998.06109.x
   GORHAM SD, 1987, UROL RES, V15, P53
   GORHAM SD, 1991, BIOMATERIALS NOVEL M, P57
   Gough JE, 2001, J BIOMED MATER RES, V57, P497, DOI 10.1002/1097-4636(20011215)57:4<497::AID-JBM1195>3.0.CO;2-U
   Grabenwoger M, 1996, ANN THORAC SURG, V62, P772
   GRIMM M, 1992, J CARDIAC SURG, V7, P58, DOI 10.1111/j.1540-8191.1992.tb00775.x
   Gudkin LR, 1997, RUSS J APPL CHEM+, V70, P782
   HARRINGTON EA, 1994, EMBO J, V13, P3286, DOI 10.1002/j.1460-2075.1994.tb06630.x
   Hill PA, 1997, ENDOCRINOLOGY, V138, P3849, DOI 10.1210/en.138.9.3849
   Jayakrishnan A, 1996, BIOMATERIALS, V17, P471, DOI 10.1016/0142-9612(96)82721-9
   KLEINMAN HK, 1981, J CELL BIOL, V88, P473, DOI 10.1083/jcb.88.3.473
   KOIDE M, 1993, J BIOMED MATER RES, V27, P79, DOI 10.1002/jbm.820270111
   MCGAHON AJ, 1995, METHOD CELL BIOL, V46, P153
   Nimni ME, 1988, COLLAGEN, VIII, P1
   NIMNI ME, 1992, CARDIOVASCULAR BIOMA
   Norgren L, 1990, Eur J Vasc Surg, V4, P379, DOI 10.1016/S0950-821X(05)80871-0
   NORGREN L, 1985, ANGIO ARCH, V9, P39
   POHUNKOVA H, 1995, BIOMATERIALS, V16, P67, DOI 10.1016/0142-9612(95)91098-J
   Pohunkova H, 1996, BIOMATERIALS, V17, P1567, DOI 10.1016/0142-9612(95)00310-X
   Qian JJ, 1996, J BIOMED MATER RES, V31, P545, DOI 10.1002/(SICI)1097-4636(199608)31:4<545::AID-JBM15>3.0.CO;2-F
   RICHARDS FM, 1968, J MOL BIOL, V37, P231, DOI 10.1016/0022-2836(68)90086-7
   RINDERKNECHT E, 1978, J BIOL CHEM, V253, P2769
   ROVIRA A, 1993, J MATER SCI-MATER M, V4, P372, DOI 10.1007/BF00122195
   RUSSELL JW, J NEUROBIOL, V36, P455
   SALGALLER ML, 1985, J BIOMED MATER RES, V19, P1, DOI 10.1002/jbm.820190103
   SCHOEN FJ, 1986, AM J PATHOL, V123, P134
   Scotchford CA, 1998, BIOMATERIALS, V19, P1, DOI 10.1016/S0142-9612(97)00236-6
   SCOTCHFORD CA, 1996, P 5 WORLD BIOM C TOR
   SERRE CM, 1993, BIOMATERIALS, V14, P97, DOI 10.1016/0142-9612(93)90217-P
   SUN XM, 1992, ANAL BIOCHEM, V204, P351, DOI 10.1016/0003-2697(92)90251-2
   THANOO BC, 1993, J PHARM PHARMACOL, V45, P16, DOI 10.1111/j.2042-7158.1993.tb03671.x
   TOMITA N, 1992, BIOMATERIAL TISSUE I, V10
   Trump Benjamin F., 1998, P57
   VANLUYN MJA, 1992, J BIOMED MATER RES, V26, P1091, DOI 10.1002/jbm.820260810
   Weadock KS, 1996, J BIOMED MATER RES, V32, P221, DOI 10.1002/(SICI)1097-4636(199610)32:2<221::AID-JBM11>3.0.CO;2-M
   WERGEDAL JE, 1984, P SOC EXP BIOL MED, V176, P60
   YAMAMOTO K, 1993, ARTIF ORGANS, V17, P1010, DOI 10.1111/j.1525-1594.1993.tb03183.x
   Young TH, 1996, BIOMATERIALS, V17, P2139, DOI 10.1016/0142-9612(96)00043-9
   ZUMSTEIN P, 1987, J BIOL CHEM, V262, P11252
NR 55
TC 148
Z9 152
U1 6
U2 46
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JUL
PY 2002
VL 61
IS 1
BP 121
EP 130
DI 10.1002/jbm.10145
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 556GA
UT WOS:000175840000016
PM 12001254
DA 2018-10-20
ER

PT J
AU Lobler, M
   Sass, M
   Kunze, C
   Schmitz, KP
   Hopt, UT
AF Lobler, M
   Sass, M
   Kunze, C
   Schmitz, KP
   Hopt, UT
TI Biomaterial implants induce the inflammation marker CRP at the site of
   implantation
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE biomaterial; implant; Vicryl; PHB; soft tissue; response; mRNA
   differential display
ID PROTEIN GC-GLOBULIN; EXPRESSION
C1 Univ Freiburg, Chirurg Univ Klin, D-79106 Freiburg, Germany.
   Univ Rostock, Klin & Poliklin Chirurg, D-18057 Rostock, Germany.
   Kompetenzzentrum Biomat, Inst Biomed Techn, D-18057 Rostock, Germany.
RP Lobler, M (reprint author), Univ Freiburg, Chirurg Univ Klin, Hugstetter Str 55, D-79106 Freiburg, Germany.
CR Binder R, 1999, MOL IMMUNOL, V36, P885, DOI 10.1016/S0161-5890(99)00110-8
   Branton MH, 1999, MICROBES INFECT, V1, P1349, DOI 10.1016/S1286-4579(99)00250-6
   HADDAD JG, 1995, J STEROID BIOCHEM, V53, P579, DOI 10.1016/0960-0760(95)00104-8
   KAPLAN E, 1989, IMMUNOL RES, V8, P118, DOI 10.1007/BF02919074
   Kishida A, 1996, BIOMATERIALS, V17, P1301, DOI 10.1016/0142-9612(96)88675-3
   Lobler M, 2002, BIOMATERIALS, V23, P577, DOI 10.1016/S0142-9612(01)00144-2
   Robitaille R, 1999, J BIOMED MATER RES, V45, P223, DOI 10.1002/(SICI)1097-4636(19990605)45:3<223::AID-JBM10>3.0.CO;2-L
NR 7
TC 13
Z9 14
U1 0
U2 5
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JUL
PY 2002
VL 61
IS 1
BP 165
EP 167
DI 10.1002/jbm.10155
PG 3
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 556GA
UT WOS:000175840000022
PM 12001260
DA 2018-10-20
ER

PT J
AU Vargas, LG
   Peng, Q
   Apple, DJ
   Escobar-Gomez, M
   Pandey, SK
   Arthur, SN
   Hoddinott, DSM
   Schmidbauer, JM
AF Vargas, LG
   Peng, Q
   Apple, DJ
   Escobar-Gomez, M
   Pandey, SK
   Arthur, SN
   Hoddinott, DSM
   Schmidbauer, JM
TI Evaluation of 3 modern single-piece foldable intraocular lenses -
   Clinicopathological study of posterior capsule opacification in a rabbit
   model
SO JOURNAL OF CATARACT AND REFRACTIVE SURGERY
LA English
DT Article; Proceedings Paper
CT 19th Congress of the
   European-Society-of-Cataract-and-Refractive-Surgeons
CY SEP, 2001
CL AMSTERDAM, NETHERLANDS
SP European Soc Cataract & Refract Surgeons
ID HUMAN AUTOPSY EYES; NEODYMIUM-YAG CAPSULOTOMY; COLLAGEN TYPE-IV;
   SURGICAL PREVENTION; RETINAL-DETACHMENT; CATARACT-SURGERY; PART 1;
   FIXATION; SILICONE; ADHESION
AB Purpose: To assess the development of posterior capsule opacification (PCO) with 3 modern single-piece foldable intraocular lenses (IOLs) in a histopathological study and to compare the potential preventive effects of the IOL design and biomaterial in retarding PCO.
   Setting: Center for Research on Ocular Therapeutics and Biodevices, Storm Eye Institute, Medical University of South Carolina, Charleston, South Carolina, USA.
   Methods: Thirty-one rabbit eyes were randomly operated on with phacoemulsification and implantation of 3 single-piece foldable lenses: a hydrophilic acrylic design, the Rayner Centerflex(R) 570H (n = 11); a hydrophobic acrylic design, the Alcon AcrySof(R) SA30AL (n = 10); and a silicone large-hole plate design, the Staar AA-4203VF (n = 10). Central PCO (CPCO), peripheral PCO (PPCO), and Soemmering's ring formation were evaluated 3 weeks after surgery using the Miyake-Apple posterior photographic technique. Histological sections of each globe were prepared to document capsular bag status and performance of IOL geometry.
   Results: The acrylic IOLs (Centerflex and AcrySof) had lower CPCO and PPCO scores than the silicone plate IOL (P < .05). There was no significant difference in Soemmering's ring formation among the 3 models. Pathological evaluations revealed effective blockage of migrating lens epithelial cells (LECs) at the site of the truncated optic edge of the Centerflex and AcrySof IOLs, even in the presence of large amounts of retained/regenerative cortical material.
   Conclusions:, The AcrySof IOL has a hydrophobic surface and the Centerflex a hydrophilic surface, but no correlation to these characteristics could be identified. The single-piece-AcrySof optic geometry created a clear-cut barrier effect equal to that of its 3-piece predecessor. The anatomic profile of the Centerflex IOL shows the same characteristics. The optics of both acrylic lenses have square truncated edges that functionally block ingrowth of migrating LECs toward the central visual axis, leaving clear posterior capsules. The square optic edge was an appropriate geometric configuration to create a barrier effect. There was no effect of the biomaterial on PCO prevention.
C1 Med Univ S Carolina, Dept Ophthalmol, Storm Eye Inst, Ctr Res Ocular Therapeut & Biodevices, Charleston, SC 29425 USA.
RP Apple, DJ (reprint author), Med Univ S Carolina, Dept Ophthalmol, Storm Eye Inst, Ctr Res Ocular Therapeut & Biodevices, 167 Ashley Ave,POB 250676, Charleston, SC 29425 USA.
CR AMON M, 1993, J CATARACT REFR SURG, V19, P258, DOI 10.1016/S0886-3350(13)80953-4
   Apple D J, 2000, Trans Am Ophthalmol Soc, V98, P257
   Apple D. J., 2000, FOLDABLE INTRAOCULAR
   APPLE DJ, 1990, OPHTHALMOLOGY, V97, P810
   APPLE DJ, 1992, SURV OPHTHALMOL, V37, P73, DOI 10.1016/0039-6257(92)90073-3
   Apple DJ, 2001, OPHTHALMOLOGY, V108, P505, DOI 10.1016/S0161-6420(00)00589-3
   Apple DJ, 2000, J CATARACT REFR SURG, V26, P180, DOI 10.1016/S0886-3350(99)00353-3
   APPLE DJ, 2000, SURV OPHTHALMOL S1, V45, P70
   Auffarth GU, 1996, J CATARACT REFR SURG, V22, P1281, DOI 10.1016/S0886-3350(96)80085-X
   BLACHARSKI PA, 1988, AM J OPHTHALMOL, V105, P417, DOI 10.1016/0002-9394(88)90309-1
   Boulton M, 1998, BRIT J OPHTHALMOL, V82, P468, DOI 10.1136/bjo.82.5.468
   CHANNELL MM, 1984, ARCH OPHTHALMOL-CHIC, V102, P1024
   Hollick EJ, 1999, OPHTHALMOLOGY, V106, P49, DOI 10.1016/S0161-6420(99)90047-7
   Holweger RR, 1997, J CATARACT REFR SURG, V23, P115, DOI 10.1016/S0886-3350(97)80161-7
   JAVITT JC, 1992, OPHTHALMOLOGY, V99, P1487
   Kato K, 1997, J CATARACT REFR SURG, V23, P1556, DOI 10.1016/S0886-3350(97)80029-6
   Kent DG, 1997, J CATARACT REFR SURG, V23, P1371, DOI 10.1016/S0886-3350(97)80116-2
   Kent DG, 1998, J CATARACT REFR SURG, V24, P666, DOI 10.1016/S0886-3350(98)80263-0
   Kim MJ, 1999, J CATARACT REFR SURG, V25, P251, DOI 10.1016/S0886-3350(99)80135-7
   Linnola RJ, 1997, J CATARACT REFR SURG, V23, P1539, DOI 10.1016/S0886-3350(97)80026-0
   Linnola RJ, 2000, J CATARACT REFR SURG, V26, P1792, DOI 10.1016/S0886-3350(00)00748-3
   Linnola RJ, 2000, J CATARACT REFR SURG, V26, P1807, DOI 10.1016/S0886-3350(00)00747-1
   Nagata T, 1998, J CATARACT REFR SURG, V24, P367, DOI 10.1016/S0886-3350(98)80325-8
   NEWLAND TJ, 1994, J CATARACT REFR SURG, V20, P527, DOI 10.1016/S0886-3350(13)80233-7
   Nishi O, 2000, J CATARACT REFR SURG, V26, P1543, DOI 10.1016/S0886-3350(00)00426-0
   Nishi O, 2001, J CATARACT REFR SURG, V27, P608, DOI 10.1016/S0886-3350(00)00644-1
   Pandey SK, 2002, J CATARACT REFR SURG, V28, P139, DOI 10.1016/S0886-3350(01)01069-0
   Peng Q, 2000, J CATARACT REFR SURG, V26, P198, DOI 10.1016/S0886-3350(99)00352-1
   Peng Q, 2000, J CATARACT REFR SURG, V26, P188, DOI 10.1016/S0886-3350(99)00354-5
   Ram J, 1999, OPHTHALMOLOGY, V106, P891, DOI 10.1016/S0161-6420(99)00506-0
   Ram J, 2001, J CATARACT REFR SURG, V27, P1039, DOI 10.1016/S0886-3350(00)00841-5
   RICKMANBARGER L, 1989, AM J OPHTHALMOL, V107, P531, DOI 10.1016/0002-9394(89)90500-X
   Schmidbauer JM, 2001, INT OPHTHALMOL CLIN, V41, P109, DOI 10.1097/00004397-200107000-00010
   Schmidbauer JM, 2001, KLIN MONATSBL AUGENH, V218, P649, DOI 10.1055/s-2001-18386
   STEINERT RF, 1991, AM J OPHTHALMOL, V112, P373, DOI 10.1016/S0002-9394(14)76242-7
   Vargas LG, 2001, INT OPHTHALMOL CLIN, V41, P1, DOI 10.1097/00004397-200107000-00003
   Werner L, 2001, OPHTHALMOLOGY, V108, P1675, DOI 10.1016/S0161-6420(01)00674-1
   Werner L, 2000, OPHTHALMOLOGY, V107, P463, DOI 10.1016/S0161-6420(99)00088-3
NR 38
TC 23
Z9 27
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0886-3350
J9 J CATARACT REFR SURG
JI J. Cataract. Refract. Surg.
PD JUL
PY 2002
VL 28
IS 7
BP 1241
EP 1250
AR PII S0886-3350(02)01216-6
DI 10.1016/S0886-3350(02)01216-6
PG 10
WC Ophthalmology; Surgery
SC Ophthalmology; Surgery
GA 573EC
UT WOS:000176815500029
PM 12106735
DA 2018-10-20
ER

PT J
AU Liu, S
   Boutrand, JP
   Bittoun, J
   Tadie, M
AF Liu, S
   Boutrand, JP
   Bittoun, J
   Tadie, M
TI A collagen-based sealant to prevent in vivo reformation of epidural scar
   adhesions in an adult rat laminectomy model
SO JOURNAL OF NEUROSURGERY
LA English
DT Article
DE dura mater; laminectomy; membrane; nerve root; epidural scar adhesion
ID LUMBAR DISKECTOMY; FOLLOW-UP; SURGERY; GRAFTS
AB Object. The authors investigated the effect of a collagen-based sealant, Gel Amidon Oxyde (GAO), in preventing the reformation of epidural scar adhesions in an adult rat model of laminectomy.
   Methods. Thirty-two adult Sprague-Dawley rats underwent a complete L5-6 laminectomy, after which the dura mater was exposed and the left adjacent L-4 and L-5 nerve roots were exposed. The surgical wound was then closed; 1 month later it was reopened. The epidural scar adhesions that developed were observed and carefully removed, leaving clean dura and nerve roots reexposed. In 16 experimental rats, GAO was placed onto the reexposed dura and around the nerve roots before it polymerized. No treatment was performed in 16 control rats. Postoperatively, all rats were healthy and without neurological deficit. The incisions healed within 1 week regardless of the treatment with the GAO. Three months after reoperation, magnetic resonance imaging revealed that important epidural adhesions were present in the control rats but not in the experimental rats. These findings were then confirmed by gross anatomical examination in which a white tissue layer was found over the dura without adhesions in the experimental animals, whereas significant epidural scar adhesions were demonstrated in the controls. Histological evaluation of the laminectomy site also showed that the peridural space in the experimental rats was larger than that in the controls.
   Conclusions. The authors found that GAO may be a safe and effective antiscarring adhesion biomaterial in vivo. When placed into the laminectomy site, GAO may prove beneficial in preventing the formation and reformation of epidural scar adhesions in humans.
C1 Hop Bicetre, Dept Neurosurg, Lab Expt Neurosurg, Assistance Publ Hop Paris, F-94275 Le Kremlin Bicetre, France.
   Univ Paris 11, CNRS, Res Unit Magnet Resonance Med, Le Kremlin Bicetre, France.
   Biomatech, Biomatech Testing Lab, Chasse Sur Rhone, France.
RP Liu, S (reprint author), Hop Bicetre, Dept Neurosurg, Lab Expt Neurosurg, Assistance Publ Hop Paris, F-94275 Le Kremlin Bicetre, France.
EM liusong986@hotmail.com
CR BARBERA J, 1978, J NEUROSURG, V49, P419, DOI 10.3171/jns.1978.49.3.0419
   BENOIST M, 1980, SPINE, V5, P432, DOI 10.1097/00007632-198009000-00007
   BODEN SC, 1992, SPINE, P1899
   BURTON CV, 1981, CLIN ORTHOP RELAT R, P191
   CAUCHOIX J, 1978, Spine, V3, P256
   Dullerud R, 1998, SPINE, V23, P1464, DOI 10.1097/00007632-199807010-00007
   JACOBS RR, 1980, SPINE, V5, P223, DOI 10.1097/00007632-198005000-00004
   KELLER JT, 1978, J NEUROSURG, V49, P412, DOI 10.3171/jns.1978.49.3.0412
   Kiviluoto O, 1976, Acta Orthop Scand Suppl, P3
   LANGENSKIOLD A, 1976, CLIN ORTHOP RELAT R, V115, P92
   LAROCCA H, 1974, J BONE JOINT SURG BR, VB 56, P545
   LAWSON KJ, 1991, SPINE, V16, pS222, DOI 10.1097/00007632-199106001-00009
   LEE CK, 1984, SPINE, V9, P305, DOI 10.1097/00007632-198404000-00016
   Liu S, 2001, J NEUROSURG, V94, P61, DOI 10.3171/spi.2001.94.1.0061
   LONG DM, 1992, ATLAS SPINAL SURG, P23
   MARTINFERRER S, 1989, NEUROSURGERY, V24, P718, DOI 10.1227/00006123-198905000-00010
   MERRILD U, 1986, J BONE JOINT SURG BR, V68, P706
   NORTH RB, 1991, NEUROSURGERY, V28, P685, DOI 10.1227/00006123-199105000-00008
   Pospiech J, 1995, Eur Spine J, V4, P213, DOI 10.1007/BF00303413
   Ross JS, 1996, NEUROSURGERY, V38, P855, DOI 10.1227/00006123-199604000-00053
   SPANGFORT EV, 1972, ACTA ORTHOP SCAND S, V142, P5
NR 21
TC 15
Z9 16
U1 0
U2 1
PU AMER ASSOC NEUROLOGICAL SURGEONS
PI ROLLING MEADOWS
PA 5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA
SN 0022-3085
EI 1933-0693
J9 J NEUROSURG
JI J. Neurosurg.
PD JUL
PY 2002
VL 97
IS 1
SU S
BP 69
EP 74
DI 10.3171/spi.2002.97.1.0069
PG 6
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA 571RE
UT WOS:000176730200011
PM 12120654
DA 2018-10-20
ER

PT J
AU Kumar, RR
   Wang, M
AF Kumar, RR
   Wang, M
TI Functionally graded bioactive coatings of hydroxyapatite/titanium oxide
   composite system
SO MATERIALS LETTERS
LA English
DT Article
DE hydroxyapatite (HA); biomaterial; composite; functionally graded
   material; Ti6Al4V; nano-indentation
ID PLASMA
AB Hydroxyapatite powder (P81B, HA, Plasma Biotal, UK) was mixed with titanium oxide (TiO2) in different weight percentages for producing functionally graded bioactive coatings. Composite coatings were made on Ti6Al4V metal substrate. A functionally graded coating was obtained by coating titanium oxide (TiO2) powders of known particle size as the first layer, which was sintered at 900degreesC for a few minutes. Coating of subsequent layers of HA-TiO2 composites of different weight ratios (75% TiO2 and 25% HA, 50% TiO2 and 50% HA, 25% TiO2 and 75% HA, and 100% HA) were performed in sequence and these layers were sintered again at 900degreesC for a few minutes so as to ensure a good adhesion between layers. The coatings were subsequently subjected to various characterization such as X-ray diffraction (XRD), scanning electron microscopy (SEM), energy dispersive X-ray (EDX), Fourier infra-red spectroscopy (FTIR) and hardness studies. The XRD results confirmed the presence of the corresponding components in HA composites. SEM micrographs showed the surface morphology of the functionally graded layers, and the presence of elements was also identified by EDX analysis which confirms the versatility of the coating technique performed at low temperature. Nano-indentation studies revealed that RA-TiO2-Ti functionally graded coating yielded 15.1 and 0.405 GPa as the hardness and modulus values, respectively. (C) 2002 Elsevier Science B.V All rights reserved.
C1 Nanyang Technol Univ, Sch Mat Engn, Singapore 639798, Singapore.
   Nanyang Technol Univ, Sch Mech & Prod Engn, Singapore 639798, Singapore.
RP Kumar, RR (reprint author), Nanyang Technol Univ, Sch Mat Engn, Singapore 639798, Singapore.
RI Wang, Min/C-1584-2009
OI Wang, Min/0000-0002-6495-5637
CR BAN S, 1994, BIOCERAMICS, V7, P261
   Cheang P, 1996, BIOMATERIALS, V17, P537, DOI 10.1016/0142-9612(96)82729-3
   FILIAGGI MJ, 1991, J BIOMED MATER RES, V25, P1211, DOI 10.1002/jbm.820251004
   Gledhill HC, 1999, BIOMATERIALS, V20, P315, DOI 10.1016/S0142-9612(98)00166-5
   KUMAR RR, 1997, P IMMM, P618
   LEMONS JE, 1988, CLIN ORTHOP RELAT R, P220
   MARUNO S, 1992, NIPPON SERAM KYO GAK, V100, P362
   Zhitomirsky I, 2000, MATER LETT, V42, P262, DOI 10.1016/S0167-577X(99)00197-4
NR 8
TC 73
Z9 81
U1 2
U2 15
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
J9 MATER LETT
JI Mater. Lett.
PD JUL
PY 2002
VL 55
IS 3
BP 133
EP 137
AR PII S0167-577X(01)00635-8
PG 5
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 573VH
UT WOS:000176852000001
DA 2018-10-20
ER

PT J
AU Sanders, JE
   Malcolm, SG
   Bale, SD
   Wang, YN
   Lamont, S
AF Sanders, JE
   Malcolm, SG
   Bale, SD
   Wang, YN
   Lamont, S
TI Prevascularization of a biomaterial using a chorioallontoic membrane
SO MICROVASCULAR RESEARCH
LA English
DT Article
DE vascular remnants; angiogenesis; polyurethane; vessel ingrowth
ID ANGIOGENESIS
C1 Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.
RP Sanders, JE (reprint author), Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.
RI Wang, Yak-Nam/D-4924-2011
FU NICHD NIH HHS [R01 HD038554, R01 HD038554-01, HD-38554]
CR AUERBACH R, 1974, DEV BIOL, V41, P391, DOI 10.1016/0012-1606(74)90316-9
   Buschard K, 1996, APMIS, V104, P609, DOI 10.1111/j.1699-0463.1996.tb04920.x
   CLOWES AW, 1987, AM J SURG, V153, P501, DOI 10.1016/0002-9610(87)90802-6
   Dermarchez M., 1992, TRANSPLANTATION, V54, P317
   FOLKMAN J, 1992, J BIOL CHEM, V267, P10931
   KUBOTA Y, 1988, J CELL BIOL, V107, P1589, DOI 10.1083/jcb.107.4.1589
   Medalie DA, 1996, ASAIO J, V42, pM455, DOI 10.1097/00002480-199609000-00030
   MENGER MD, 1990, EUR J CARDIO-THORAC, V4, P191, DOI 10.1016/1010-7940(90)90003-I
   POLVERINI PJ, 1989, CYTOKINES, V1, P54
   Sanders JE, 2000, J BIOMED MATER RES, V52, P231, DOI 10.1002/1097-4636(200010)52:1<231::AID-JBM29>3.0.CO;2-E
   SUNDERKOTTER C, 1994, J LEUKOCYTE BIOL, V55, P410
NR 11
TC 7
Z9 8
U1 1
U2 1
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0026-2862
J9 MICROVASC RES
JI Microvasc. Res.
PD JUL
PY 2002
VL 64
IS 1
BP 174
EP 178
DI 10.1006/mvre.2002.2410
PG 5
WC Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA 569YN
UT WOS:000176631000020
PM 12074644
DA 2018-10-20
ER

PT J
AU Bilek, MMM
   McKenzie, DR
   Tarrant, RN
   Lim, SHM
   McCulloch, DG
AF Bilek, MMM
   McKenzie, DR
   Tarrant, RN
   Lim, SHM
   McCulloch, DG
TI Plasma-based ion implantation utilising a cathodic arc plasma
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT 6th International Workshop on Plasma-Based Ion Implantation (PBII-2001)
CY JUN 25-28, 2001
CL GRENOBLE, FRANCE
SP CNRS, Univ Joseph Fourier, Inst Natl Polytechn Grenoble, European Commiss, Minist Affaires Etrangeres, Minist Educ Natl, Minist Defense/DGA, City Grenoble, Reg Rhone Alpes, Grenoble Alps METROPOLE
DE cathodic arc; ion implantation; stress relaxatiom; adhesion; preferred
   orientation; biomaterials
ID PREFERRED ORIENTATION; VACUUM-ARC; DEPOSITION
AB Plasma-based ion implantation (PBII) is usually carried out with isotropic gaseous plasmas, such as a discharge in nitrogen. More recently. it has been applied using drifting plasmas, such as those produced by cathodic arcs, in order to allow efficient implantation of metallic species. The condensable nature of a cathodic are plasma allows for the deposition of ion-stitched thin film coatings, as well as surface modification by ion implantation. In this paper the promising results for biomaterial fabrication are discussed in light of current limitations of the technique. The use of PBII to control preferred orientation ill titanium nitride films is also discussed, together with implications for the physical mechanisms involved in the development of preferred orientations in thin films. (C) 2002 Elsevier Science B.V. All rights reserved.
C1 Univ Sydney, Sch Phys, Appl & Plasma Phys Dept, Sydney, NSW 2006, Australia.
   RMIT Univ, Dept Appl Phys, Melbourne, Vic 3001, Australia.
RP Bilek, MMM (reprint author), Univ Sydney, Sch Phys, Appl & Plasma Phys Dept, A28, Sydney, NSW 2006, Australia.
RI McCulloch, Dougal/G-7039-2012; Lim, Sunnie/A-2827-2012
OI McKenzie, David/0000-0002-2476-1301; Bilek, Marcela/0000-0003-3363-2664
CR ANDERS A, 1994, J VAC SCI TECHNOL B, V12, P815, DOI 10.1116/1.587351
   Anders A, 2001, SURF COAT TECH, V136, P85, DOI 10.1016/S0257-8972(00)01017-3
   Bilek MMM, 2000, J APPL PHYS, V87, P4198, DOI 10.1063/1.373052
   BILEK MMM, 2000, J APPL PHYS, V89, P923
   CONRAD JR, 1987, J APPL PHYS, V62, P4591, DOI 10.1063/1.339055
   Howlett CR, 1999, J BIOMED MATER RES, V45, P345, DOI 10.1002/(SICI)1097-4636(19990615)45:4<345::AID-JBM9>3.0.CO;2-J
   LIEBERMAN MA, 1989, J APPL PHYS, V66, P2926, DOI 10.1063/1.344172
   Lim SH, UNPUB
   Mantese JV, 1996, MRS BULL, V21, P52
   Marks NA, 1997, PHYS REV B, V56, P2441, DOI 10.1103/PhysRevB.56.2441
   Marlo M, 2000, PHYS REV B, V62, P2899, DOI 10.1103/PhysRevB.62.2899
   McKenzie DR, 2001, THIN SOLID FILMS, V382, P280, DOI 10.1016/S0040-6090(00)01702-8
   McKenzie DR, 1999, J APPL PHYS, V86, P230, DOI 10.1063/1.370721
   MULLER KH, 1988, J VAC SCI TECHNOL A, V6, P1690
   PELLEG J, 1991, THIN SOLID FILMS, V197, P117, DOI 10.1016/0040-6090(91)90225-M
   Tarrant RN, 2001, SURF COAT TECH, V136, P188, DOI 10.1016/S0257-8972(00)01052-5
   TARRANT RN, IN PRESS SURF COAT T
   Yap E, 1998, J APPL PHYS, V83, P3404, DOI 10.1063/1.367108
NR 18
TC 75
Z9 75
U1 0
U2 6
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD JUL 1
PY 2002
VL 156
IS 1-3
BP 136
EP 142
AR PII S0257-8972(02)00078-6
DI 10.1016/S0257-8972(02)00078-6
PG 7
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 567JB
UT WOS:000176480700024
DA 2018-10-20
ER

PT J
AU Yang, P
   Huang, N
   Leng, YX
   Chen, JY
   Sun, H
   Wang, J
   Chen, F
   Chu, PK
AF Yang, P
   Huang, N
   Leng, YX
   Chen, JY
   Sun, H
   Wang, J
   Chen, F
   Chu, PK
TI In vivo study of Ti-O thin film fabricated by PIII
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT 6th International Workshop on Plasma-Based Ion Implantation (PBII-2001)
CY JUN 25-28, 2001
CL GRENOBLE, FRANCE
SP CNRS, Univ Joseph Fourier, Inst Natl Polytechn Grenoble, European Commiss, Minist Affaires Etrangeres, Minist Educ Natl, Minist Defense/DGA, City Grenoble, Reg Rhone Alpes, Grenoble Alps METROPOLE
DE in vivo study; blood compatibility; biomaterial; plasma immersion ion
   implantation (PIII)
ID BLOOD COMPATIBILITY; BIOMATERIALS; MORPHOLOGY
AB Over the past decade, much attention has been paid to anti-thrombotic materials applied in artificial organs, Surface modification has shown potential to improve the anti-coagulation of blood-contacting biomedical devices and materials [1-3]. Our in vitro study of Ti-O thin films has recently shown that Ti-O thin films Possess Superior blood compatibility to low temperature isotropic pyrolytic carbon (LTI-carbon) [1]. In this work, we have focussed our attention onto the in vivo evaluation of Ti-O thin films fabricated by plasma immersion ion implantation (PIII). The samples of titanium coated by Ti-O thin films were implanted in dogs' hearts for I month. The results of the implantation showed that no thrombus was found on the surfaces of the Ti-O thin film, although the coagulation occurred on the surfaces of LTI-carbon. (C) 2002 Elsevier Science B.V. All rights reserved.
C1 SW Jiatong Univ, Dept Mat Engn, Inst Surface Engn Biomat, Chengdu 610031, Sichuan, Peoples R China.
   Southeast Univ, Inst Med, Dept Chest Surg, Nanjing 210000, Jiangsu, Peoples R China.
   City Univ Hong Kong, Dept Phys & Mat Sci, Kowloon, Hong Kong, Peoples R China.
RP Huang, N (reprint author), SW Jiatong Univ, Dept Mat Engn, Inst Surface Engn Biomat, Chengdu 610031, Sichuan, Peoples R China.
RI Chu, Paul/B-5923-2013; Leng, Yongxiang/G-5488-2010
OI Chu, Paul/0000-0002-5581-4883; Leng, Y.X./0000-0001-6823-1233
CR BOLZ A, 1990, ARTIF ORGANS, V14, P260, DOI 10.1111/j.1525-1594.1990.tb02967.x
   BRASH JL, 1979, J POLYM SCI POL SYM, P377
   CACCIAFESTA P, 6 WORLD BIOM C T SOC, P287
   COURTNEY JM, 1994, BIOMATERIALS, V15, P737, DOI 10.1016/0142-9612(94)90026-4
   GOODMAN SL, 1995, CELL MATER, V5, P15
   Heublein B, 1998, J ENDOVASC SURG, V5, P32, DOI 10.1583/1074-6218(1998)005<0032:SCCSCE>2.0.CO;2
   Holland NB, 2000, J BIOMED MATER RES, V51, P307, DOI 10.1002/1097-4636(20000905)51:3<307::AID-JBM3>3.0.CO;2-H
   Huang N, 1998, BIOMATERIALS, V19, P771, DOI 10.1016/S0142-9612(98)00212-9
   Nojiri C, 1990, ASAIO Trans, V36, pM168
   Nygren H, 1997, J BIOMED MATER RES, V34, P487, DOI 10.1002/(SICI)1097-4636(19970315)34:4<487::AID-JBM9>3.3.CO;2-6
   SHEPPARD JI, 1994, J BIOMED MATER RES, V28, P1175, DOI 10.1002/jbm.820281008
   SIT PS, 6 WORLD BIOM C T SOC, P63
   Sunny M C, 1991, J Biomater Appl, V6, P89, DOI 10.1177/088532829100600107
   YANGS P, 6 WORLD BIOM C SOC B, P1025
NR 14
TC 35
Z9 42
U1 1
U2 4
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD JUL 1
PY 2002
VL 156
IS 1-3
BP 284
EP 288
AR PII S0257-8972(02)00087-7
DI 10.1016/S0257-8972(02)00087-7
PG 5
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 567JB
UT WOS:000176480700051
DA 2018-10-20
ER

PT J
AU Stoll, MR
   Cook, JL
   Pope, ER
   Carson, WL
   Kreeger, JM
AF Stoll, MR
   Cook, JL
   Pope, ER
   Carson, WL
   Kreeger, JM
TI The use of porcine small intestinal submucosa as a biomaterial for
   perineal herniorrhaphy in the dog
SO VETERINARY SURGERY
LA English
DT Article; Proceedings Paper
CT Meeting of the American-College-of-Veterinary-Surgeons
CY OCT, 2001
CL CHICAGO, ILLINOIS
SP American Coll Veterinary Surg
ID PELVIC DIAPHRAGM; VASCULAR GRAFT; HERNIA; REPAIR; TRANSPOSITION; MUSCLE;
   GROWTH; MODEL
AB Objectives-To develop an in vivo perineal hernia model, to develop a technique for using small intestinal submucosa (SIS) in perineal hernia repair, to further elucidate the biological behavior of SIS, and to compare SIS herniorrhaphy with the internal obturator muscle transposition (IOT) technique.
   Study Design-Prospective evaluation comparing SIS herniorrhaphy with IOT.
   Animals-Twelve adult castrated male, large-breed dogs.
   Methods-All dogs had bilateral pelvic diaphragm defects created by complete excision of the levator am muscle. Each dog had one side repaired using SIS and the other by IOT. Pain and inflammation were subjectively scored. Dogs were killed 2 weeks (n = 4), 12 weeks (n = 4), or 16 weeks (n = 4) after surgery. Each pelvic diaphragm was biomechanically tested to failure. The pelvic diaphragms from 2 normal dogs (n = 4 sides) were also biomechanically tested. Failure site, maximum pressure, displacement at failure, and initial linear stiffness values were determined. Histologic assessment was performed. Statistical analysis was performed with significance set at P < .05
   Results-No significant postoperative complications were noted. There were no significant differences in maximum pressure to failure, displacement, or stiffness when comparing normal, SIS, and IOT at any time point. The SIS group had significantly less displacement (P = .004) at 2 weeks than at weeks 12 or 16. For all herniorrhaphy techniques, the failure site was central (n = 22) or at the suture line (n = 2). At 2 weeks, histologic evaluation of tissues from the IOT group showed inflammation, mineralization, and necrosis, which were not present in tissues from the SIS group. Histologic examination at 12 and 16 weeks showed no microscopic differences in cell population or tissue characteristics between the IOT and SIS groups.
   Conclusions-SIS herniorrhaphy was successfully performed in this in vivo model of perineal hernia in the dog.
   Clinical Relevance-This study suggests that SIS can be used as a primary means of repair, as augmentation when the internal obturator muscle is thin and friable, or as a salvage procedure in cases of recurrence in dogs with perineal hernia. (C) Copyright 2002 by The American College of Veterinary Surgeons.
C1 Univ Missouri, Dept Vet Med & Surg, Columbia, MO 65211 USA.
   Univ Missouri, Comparat Orthopaed Lab, Columbia, MO 65211 USA.
   Univ Missouri, Coll Engn, Columbia, MO 65211 USA.
RP Stoll, MR (reprint author), 379 E Campus Dr,Clydesdale Hall, Columbia, MO 65211 USA.
OI Cook, James/0000-0002-0862-995X
CR BADYLAK SF, 1995, J BIOMED MATER RES, V29, P977, DOI 10.1002/jbm.820290809
   BADYLAK SF, 1993, TISSUE ENGINEERING, P179
   BADYLAK SF, 1989, J SURG RES, V47, P74, DOI 10.1016/0022-4804(89)90050-4
   BADYLAK SF, 1994, J VASC SURG, V19, P465, DOI 10.1016/S0741-5214(94)70073-7
   BELLENGER CR, 1980, AUST VET J, V56, P434, DOI 10.1111/j.1751-0813.1980.tb02637.x
   BLAKELY CL, 1957, CANINE SURG, P458
   BOJRAB MJ, 1981, COMPEND CONTIN ED PR, V3, P8
   BURROWS CF, 1973, J SMALL ANIM PRACT, V14, P315, DOI 10.1111/j.1748-5827.1973.tb06466.x
   CALI RL, 1992, DIS COLON RECTUM, V35, P604, DOI 10.1007/BF02050544
   CHAMBERS JN, 1991, J AM VET MED ASSOC, V199, P84
   Clarke KM, 1996, J SURG RES, V60, P107, DOI 10.1006/jsre.1996.0018
   Cobb MA, 1996, SURG NEUROL, V46, P389, DOI 10.1016/S0090-3019(96)00202-9
   DESAI R, 1982, J AM ANIM HOSP ASSOC, V18, P195
   Francioni G, 1999, Chir Ital, V51, P21
   FRANKLAND AL, 1986, VET REC, V119, P13, DOI 10.1136/vr.119.1.13
   HARVEY CE, 1977, J SMALL ANIM PRACT, V18, P505, DOI 10.1111/j.1748-5827.1977.tb05921.x
   HAYES HM, 1978, J AM ANIM HOSP ASSOC, V14, P703
   HILES MC, 1993, J BIOMED MATER RES, V27, P139, DOI 10.1002/jbm.820270202
   Holmes JR, 1964, VET REC, V76, P1250
   Houlton J. E. F., 1983, Veterinary Annual, V23, P209
   KRAHWINKEL DJ, 1983, VET SURG, V12, P160, DOI 10.1111/j.1532-950X.1983.tb00732.x
   Kropp BP, 1996, J UROLOGY, V155, P2098, DOI 10.1016/S0022-5347(01)66117-2
   LANTZ GC, 1992, J SURG RES, V53, P175, DOI 10.1016/0022-4804(92)90031-T
   LARSEN JS, 1966, J AM VET MED ASSOC, V149, P277
   MANN FA, 1995, AM J VET RES, V56, P134
   MATTHIESEN DT, 1989, COMP CONT EDUC PRACT, V11, P797
   ORSHER RJ, 1985, COMP CONT EDUC PRACT, V7, P233
   ORSHER RJ, 1986, VET SURG, V15, P253, DOI 10.1111/j.1532-950X.1986.tb00218.x
   PETTIT GD, 1962, CORNELL VET, V52, P261
   PREVEL CD, 1995, ANN PLAS SURG, V35, P374, DOI 10.1097/00000637-199510000-00008
   SJOLLEMA BE, 1993, AM J VET RES, V54, P185
   SPRUELL JSA, 1980, J SMALL ANIM PRACT, V21, P265
   Voytik-Harbin SL, 1998, TISSUE ENG, V4, P157, DOI 10.1089/ten.1998.4.157
   VoytikHarbin SL, 1997, J CELL BIOCHEM, V67, P478, DOI 10.1002/(SICI)1097-4644(19971215)67:4<478::AID-JCB6>3.0.CO;2-P
   WALKER RG, 1965, VET REC, V77, P93
   Wallace DG, 1988, COLLAGEN BIOTECHNOLO, P118
   WEAVER AD, 1981, J SMALL ANIM PRACT, V22, P749, DOI 10.1111/j.1748-5827.1981.tb00582.x
NR 37
TC 39
Z9 41
U1 5
U2 11
PU W B SAUNDERS CO
PI PHILADELPHIA
PA INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA
   19106-3399 USA
SN 0161-3499
J9 VET SURG
JI Vet. Surg.
PD JUL-AUG
PY 2002
VL 31
IS 4
BP 379
EP 390
DI 10.1053/jvet.2002.33596
PG 12
WC Veterinary Sciences
SC Veterinary Sciences
GA 568YT
UT WOS:000176573100012
PM 12094353
DA 2018-10-20
ER

PT J
AU Brodbeck, WG
   Nakayama, Y
   Matsuda, T
   Colton, E
   Ziats, NP
   Anderson, JM
AF Brodbeck, WG
   Nakayama, Y
   Matsuda, T
   Colton, E
   Ziats, NP
   Anderson, JM
TI Biomaterial surface chemistry dictates adherent monocyte/macrophage
   cytokine expression in vitro
SO CYTOKINE
LA English
DT Article
DE biocompatibility; foreign body giant cell; inflammation; macrophage;
   wound healing
ID MESSENGER-RNA EXPRESSION; GIANT-CELL FORMATION; BLOOD MONONUCLEAR-CELLS;
   MONOCYTES MACROPHAGES; ADHESION; INTERLEUKIN-4; INVITRO; FUSION; FORM
AB An in vitro human monocyte culture system was used to determine whether adherent monocyte/macrophage cytokine production was influenced by material surface chemistry. A polyethylene terephthalate (PET) base surface was modified by photograft copolymerization to yield hydrophobic, hydrophilic, anionic and cationic surfaces. Freshly isolated human monocytes were cultured onto the surfaces for periods up to 10 days in the presence or absence of interleukin-4 (IL-4). Semi-quantitative RT-PCR analysis on days 3, 7 and 10 of cell culture revealed that interleukin-10 (IL-10) expression significantly increased in cells adherent to the hydrophilic and anionic surfaces but significantly decreased in the cationic surface adherent monocytes/macrophages. Conversely, interleukin-8 (IL-8) expression was significantly decreased in cells adherent to the hydrophilic and anionic surfaces. Further analysis revealed that the hydrophilic and anionic surfaces inhibited monocyte adhesion and IL-4-mediated macrophage fusion into foreign body giant cells (FBGCs). Therefore, hydrophilic and anionic surfaces promote an anti-inflammatory type of response by dictating selective cytokine production by biomaterial adherent monocytes and macrophages. These studies contribute information necessary to enhance our understanding of biocompatibility to be used to improve the in vivo lifetime of implanted medical devices and prostheses. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Case Western Reserve Univ, Dept Pathol, Cleveland, Qld, Australia.
   Case Western Reserve Univ, Dept Biomed Engn, Cleveland, Qld, Australia.
   Natl Cardiovasc Ctr, Dept Bioengn, Osaka, Japan.
   Kyushu Univ, Dept Biomed Engn, Fukuoka 812, Japan.
RP Anderson, JM (reprint author), Case Western Reserve Univ, Sch Med, Inst Pathol, Rm 306, Cleveland, OH 44106 USA.
EM wgb2@po.cwru.cdu
CR Anderson JM, 1999, J MATER SCI-MATER M, V10, P579, DOI 10.1023/A:1008976531592
   ANDERSON JM, 1996, BIOMATERIALS SCI, P451
   Barth S, 2000, INFLAMM RES, V49, P266, DOI 10.1007/PL00000206
   Brodbeck WG, 2002, J LAB CLIN MED, V139, P90, DOI 10.1067/mlc.2002.121260
   Brodbeck WG, 2001, J BIOMED MATER RES, V55, P661, DOI 10.1002/1097-4636(20010615)55:4<661::AID-JBM1061>3.0.CO;2-F
   Csiszar A, 2000, CLIN EXP IMMUNOL, V122, P464, DOI 10.1046/j.1365-2249.2000.01369.x
   De Rossi M, 2000, INT IMMUNOL, V12, P1329, DOI 10.1093/intimm/12.9.1329
   DEFIFE KM, 1995, J BIOMED MATER RES, V29, P431, DOI 10.1002/jbm.820290403
   DeFife KM, 1999, J BIOMED MATER RES, V45, P148, DOI 10.1002/(SICI)1097-4636(199905)45:2<148::AID-JBM10>3.0.CO;2-U
   Defife KM, 1999, J BIOMAT SCI-POLYM E, V10, P1063, DOI 10.1163/156856299X00685
   GROTH T, 1994, J BIOMAT SCI-POLYM E, V6, P729
   Harris PR, 2000, J INFECT DIS, V181, P783, DOI 10.1086/315257
   HASSAN NF, 1989, J IMMUNOL, V143, P2179
   HORBETT TA, 1993, CARDIOVASC PATHOL, V2, pS137
   Jenney CR, 2000, J BIOMED MATER RES, V49, P435
   KAO WYJ, 1995, J BIOMED MATER RES, V29, P1267, DOI 10.1002/jbm.820291014
   KREIPE H, 1988, AM J PATHOL, V130, P232
   MAEDA M, 1986, J BIOMED MATER RES, V20, P25, DOI 10.1002/jbm.820200104
   MATSUSHIMA K, 1992, CHEM IMMUNOL, V51, P236
   MCINNES A, 1988, J EXP MED, V167, P598, DOI 10.1084/jem.167.2.598
   MCNALLY AK, 1995, AM J PATHOL, V147, P1487
   MCNALLY AK, 1994, P NATL ACAD SCI USA, V91, P10119, DOI 10.1073/pnas.91.21.10119
   MURCH AR, 1982, J PATHOL, V137, P177, DOI 10.1002/path.1711370302
   Nakaoka R, 2000, J BIOMED MATER RES, V49, P99, DOI 10.1002/(SICI)1097-4636(200001)49:1<99::AID-JBM12>3.3.CO;2-2
   Nakayama Y, 1996, MACROMOLECULES, V29, P8622, DOI 10.1021/ma9606014
   Shimozato O, 1996, CYTOKINE, V8, P99, DOI 10.1006/cyto.1996.0013
   SUTTON JS, 1966, J CELL BIOL, V28, P303, DOI 10.1083/jcb.28.2.303
   Tanaka T, 2000, J CATARACT REFR SURG, V26, P1409, DOI 10.1016/S0886-3350(99)00469-1
   VanCoillie E, 1997, BIOCHEM BIOPH RES CO, V231, P726, DOI 10.1006/bbrc.1997.6177
   WEINBERG JB, 1984, P NATL ACAD SCI-BIOL, V81, P4554, DOI 10.1073/pnas.81.14.4554
   ZHAO Q, 1991, J BIOMED MATER RES, V25, P177, DOI 10.1002/jbm.820250205
   ZIATS NP, 1988, BIOMATERIALS, V9, P5, DOI 10.1016/0142-9612(88)90063-4
NR 32
TC 146
Z9 150
U1 1
U2 40
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 1043-4666
EI 1096-0023
J9 CYTOKINE
JI Cytokine
PD JUN 21
PY 2002
VL 18
IS 6
BP 311
EP 319
DI 10.1006/cyto.2002.1048
PG 9
WC Biochemistry & Molecular Biology; Cell Biology; Immunology
SC Biochemistry & Molecular Biology; Cell Biology; Immunology
GA 588TH
UT WOS:000177716400003
PM 12160519
DA 2018-10-20
ER

PT J
AU Shinzato, S
   Nakamura, T
   Kokubo, T
   Kitamura, Y
AF Shinzato, S
   Nakamura, T
   Kokubo, T
   Kitamura, Y
TI Composites consisting of poly(methyl methacrylate) and alumina powder:
   An evaluation of their mechanical and biological properties
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE alumina; composite; crystal phase; osteoconductivity; poly(methyl
   methacrylate) (PMMA)
ID BIOACTIVE BONE-CEMENT; BEAD COMPOSITE; FILLER CONTENT; GLASS POWDER;
   IN-VITRO; OSTEOCONDUCTIVITY; INTERFACE; RESIN
AB We developed new composites consisting of comparatively high molecular weight poly(methyl methacrylate) (hPMMA) and delta-alumina powder or alpha-alumina powder (designated delta-APC and alpha-APC, respectively) that allowed direct bone formation on their surfaces in vivo. delta-Alumina powder was manufactured by the fusing and quenching of pulverized alumina powder. It was composed mainly of delta-crystal phases of alumina. The purpose of this study was to evaluate the static mechanical properties and biological properties of these composites. The hPMMA itself was used as a reference material. The bending strength and Young's modulus of both delta-APC and alpha-APC were significantly higher than those of hPMMA, and the alumina composites are believed to be strong enough for use under weight-bearing conditions. The three types of composites were packed into the intramedullary canals of rat tibiae to evaluate osteoconductivity, as determined by an affinity index. Rats were sacrificed 4 and 8 weeks after surgery. The affinity index, equal to the length of bone in direct contact with the composite surface and expressed as a percentage of the total length of the composite surface, was calculated for each composite at each interval. Histologic ally, new bone had formed along the surfaces of both delta-APC and alpha-APC within 4 weeks. The affinity indices for both delta-APC and alpha-APC increased significantly with time up to 8 weeks. At 8 weeks, the affinity index for delta-APC was significantly higher than the indices for alpha-APC and hPMMA. This study revealed that the excellent osteoconductivity of delta-APC was due to the delta-crystal phases of alumina and the high molecular weight of hPMMA. delta-APC shows promise as a base for developing a highly osteoconductive and mechanically strong biomaterial. (C) 2002 Wiley Periodicals, Inc.
C1 Kyoto Univ, Grad Sch Med, Dept Orthopaed Surg, Sakyo Ku, Kyoto 6068507, Japan.
   Kyoto Univ, Grad Sch Engn, Dept Chem Mat, Sakyo Ku, Kyoto 6068501, Japan.
   Nippon Elect Glass Co Ltd, Otsu, Shiga 5208639, Japan.
RP Shinzato, S (reprint author), Kyoto Univ, Grad Sch Med, Dept Orthopaed Surg, Sakyo Ku, Kawahara Cho 54, Kyoto 6068507, Japan.
CR EVANS EJ, 1994, BIOMATERIALS, V15, P713, DOI 10.1016/0142-9612(94)90170-8
   FREEMAN MAR, 1982, J BONE JOINT SURG BR, V64, P489
   Fujita H, 2000, J BIOMED MATER RES, V49, P273, DOI 10.1002/(SICI)1097-4636(200002)49:2<273::AID-JBM17>3.0.CO;2-Y
   HAPER EJ, 1997, P INSTRUM MECH ENG H, V212, P113
   Hulbert SF, 1993, INTRO BIOCERAMICS, P25
   KAWANABE K, 1993, J APPL BIOMATER, V4, P135, DOI 10.1002/jab.770040204
   Kobayashi M, 2000, J BIOMED MATER RES, V49, P319, DOI 10.1002/(SICI)1097-4636(20000305)49:3<319::AID-JBM4>3.3.CO;2-I
   Kobayashi M, 1999, J BIOMED MATER RES, V46, P447, DOI 10.1002/(SICI)1097-4636(19990915)46:4<447::AID-JBM2>3.3.CO;2-G
   Kobayashi M, 1997, J BIOMED MATER RES, V37, P68, DOI 10.1002/(SICI)1097-4636(199710)37:1<68::AID-JBM9>3.0.CO;2-H
   Kobayashi M, 1997, J BIOMED MATER RES, V37, P554
   KOKUBO T, 1985, J MATER SCI, V20, P2001, DOI 10.1007/BF01112282
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   MALONEY WJ, 1990, J BONE JOINT SURG BR, V72, P966
   Miyaji F, 1998, J BIOMED MATER RES, V42, P604, DOI 10.1002/(SICI)1097-4636(19981215)42:4<604::AID-JBM17>3.0.CO;2-G
   Mousa WF, 2000, BIOMATERIALS, V21, P2137, DOI 10.1016/S0142-9612(00)00097-1
   NAKAMURA T, 1985, J BIOMED MATER RES, V19, P685, DOI 10.1002/jbm.820190608
   NAKAMURA T, 2000, T 6 WORLD BIOM C KAM, V3, P1098
   NAKAMURA T, 2000, BIOCERAMICS, V13, P661
   Okada Y, 2000, J BIOMED MATER RES, V49, P106, DOI 10.1002/(SICI)1097-4636(200001)49:1<106::AID-JBM13>3.3.CO;2-N
   SAHA S, 1984, J BIOMED MATER RES, V18, P435, DOI 10.1002/jbm.820180411
   Shinzato S, 2001, J BIOMED MATER RES, V54, P491, DOI 10.1002/1097-4636(20010315)54:4<491::AID-JBM40>3.3.CO;2-F
   Shinzato S, 2001, J BIOMED MATER RES, V55, P277, DOI 10.1002/1097-4636(20010605)55:3<277::AID-JBM1015>3.0.CO;2-5
   Shinzato S, 1999, J BIOMED MATER RES, V46, P287, DOI 10.1002/(SICI)1097-4636(199908)46:2<287::AID-JBM19>3.0.CO;2-I
   Shinzato S, 2000, J BIOMED MATER RES, V53, P51
   Shinzato S, 2000, J BIOMED MATER RES, V51, P258, DOI 10.1002/(SICI)1097-4636(200008)51:2<258::AID-JBM15>3.0.CO;2-S
   SHINZATO S, 2000, BIOCERAMICS, V13, P665
   SHINZATO S, 2000, T 6 WORLD BIOM C KAM, V3, P1109
   Sun JS, 1998, J BIOMED MATER RES, V39, P390, DOI 10.1002/(SICI)1097-4636(19980305)39:3<390::AID-JBM7>3.0.CO;2-E
   Tamura J, 1996, J BIOMED MATER RES, V30, P85, DOI 10.1002/(SICI)1097-4636(199601)30:1<85::AID-JBM11>3.0.CO;2-P
NR 29
TC 10
Z9 10
U1 0
U2 5
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JUN 15
PY 2002
VL 60
IS 4
BP 585
EP 591
DI 10.1002/jbm.10104
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 548BE
UT WOS:000175367500009
PM 11948517
DA 2018-10-20
ER

PT J
AU Cornelius, RM
   Archambault, JG
   Berry, L
   Chan, AKC
   Brash, JL
AF Cornelius, RM
   Archambault, JG
   Berry, L
   Chan, AKC
   Brash, JL
TI Adsorption of proteins from infant and adult plasma to biomaterial
   surfaces
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE infant; plasma; protein adsorption; SDS-PAGE; immunoblots;
   thromboembolism
ID MOLECULAR-WEIGHT KININOGEN; SULFONATED POLYURETHANE SURFACES; DEEP
   VENOUS THROMBOSIS; CORD-BLOOD; THROMBOEMBOLIC COMPLICATIONS;
   RADIOIODINATION METHODS; HEMOSTATIC SYSTEM; BINARY-MIXTURES;
   SINGLE-CHAIN; FIBRINOGEN
AB The hemostatic mechanism of the newborn is immature. In general, the clotting times in screening tests are prolonged, the coagulation factors are low, and the coagulation inhibitors (with the exception of alpha-2-macroglobulin) are low. Recognizing that many of the proteins present in infant plasma are at low levels, it is of interest to determine if, following exposure to artificial surfaces, the profile of adsorbed proteins is different for infant versus adult plasma. The question of whether differences in protein profiles could lead to differences in thromboembolic episodes associated with the use of central venous catheters (or other blood-contacting devices) in infant versus adult subjects also is relevant. To address these issues, the adsorption of proteins from pooled infant plasma and pooled normal adult plasma to three different polymer surfaces (polyvinyl chloride, PVC; polymethyl methacrylate, PMMA; and polyethylene oxide-modified polyurethane, PEO-PU) was studied using SDS-PAGE and immunoblotting techniques. The total amount of protein adsorbed to each surface also was determined. It was found that the PMMA and PVC surfaces adsorbed considerably more protein than the PEO-PU surface, Furthermore, the amount of protein adsorbed to the PMMA and PVC surfaces from infant plasma was significantly less than that adsorbed from adult plasma. No such difference was seen for the protein-repellent PEO-PU surface. The immunoblot responses of proteins bound to the PMMA and PVC surfaces from infant plasma were, in general, weaker than those bound from adult plasma. It is likely that these differences were due to decreased protein levels in infant plasma. (C) 2002 Wiley Periodicals, Inc.
C1 McMaster Univ, Dept Chem Engn, Hamilton, ON L8S 4L7, Canada.
   McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON L8S 4L7, Canada.
   Hamilton Civ Hosp, Res Ctr, Hamilton, ON L8V 1C3, Canada.
RP Brash, JL (reprint author), McMaster Univ, Dept Chem Engn, Hamilton, ON L8S 4L7, Canada.
OI Chan, Anthony K. C./0000-0003-1551-3995
CR Andrade J.D., 1985, PROTEIN ADSORPTION
   ANDREW M, 1994, BLOOD, V83, P1251
   ANDREW M, 1987, BLOOD, V70, P165
   ANDREW M, 1990, AM J PEDIAT HEMATOL, V12, P95
   ANDREW M, 1992, BLOOD, V80, P1998
   ANDREW M, 1995, THROMB HAEMOSTASIS, V74, P415
   Archambault J. G., 1998, T SOC BIOMATER, V21, P251
   BAHAKIM H, 1990, ANN SAUDI MED, V10, P149, DOI 10.5144/0256-4947.1990.149
   BRASH JL, 1996, INTERFACIAL PHENOMEN
   CHINN JA, 1992, J BIOMED MATER RES, V26, P757, DOI 10.1002/jbm.820260606
   COON WW, 1973, CIRCULATION, V48, P839, DOI 10.1161/01.CIR.48.4.839
   Cornelius RM, 1997, J BIOMED MATER RES, V37, P314
   CORNELIUS RM, 1993, J BIOMAT SCI-POLYM E, V4, P291, DOI 10.1163/156856293X00573
   Cornelius RM, 1997, BIOMATERIALS, V18, P429, DOI 10.1016/S0142-9612(96)00148-2
   Cornelius RM, 1999, BIOMATERIALS, V20, P341, DOI 10.1016/S0142-9612(98)00174-4
   DEJARDIN P, 1995, LANGMUIR, V11, P4001, DOI 10.1021/la00010a061
   Du YJ, 2000, COLLOID SURFACE B, V17, P59, DOI 10.1016/S0927-7765(99)00053-3
   Ehrenforth S, 1999, EUR J PEDIATR, V158, pS97, DOI 10.1007/PL00014359
   GALANAKIS DK, 1976, BLOOD, V48, P109
   GIBSON BES, 1991, FETAL NEONATAL HAEMO, P123
   HAMULYAK K, 1983, THROMB RES, V32, P301, DOI 10.1016/0049-3848(83)90165-2
   HATHAWAY W, 1991, THROMB HAEMOSTASIS, V65, P323
   Hentschel R, 1999, EUR J PEDIATR, V158, pS126, DOI 10.1007/PL00014337
   Horbett TA, 1992, STABILITY PROTEIN A, P195
   JACKSON JC, 1987, J PEDIATR-US, V110, P102
   Luck M, 1998, J BIOMED MATER RES, V39, P478
   McClung WG, 2000, J BIOMED MATER RES, V49, P409, DOI 10.1002/(SICI)1097-4636(20000305)49:3<409::AID-JBM14>3.0.CO;2-0
   MEHTA S, 1992, J PEDIATR SURG, V27, P18, DOI 10.1016/0022-3468(92)90095-O
   Monreal M, 1996, THROMB HAEMOSTASIS, V75, P251
   MULZER SR, 1989, J BIOMED MATER RES, V23, P1483, DOI 10.1002/jbm.820231210
   Prandoni P, 1997, ARCH INTERN MED, V157, P57, DOI 10.1001/archinte.157.1.57
   RAPOZA RJ, 1990, J COLLOID INTERF SCI, V136, P480, DOI 10.1016/0021-9797(90)90395-5
   Salonvaara M, 1999, ACTA PAEDIATR, V88, P642, DOI 10.1080/08035259950169305
   Schneider DM, 1997, J PERINAT MED, V25, P55, DOI 10.1515/jpme.1997.25.1.55
   Sheardown H, 1997, COLLOID SURFACE B, V10, P29, DOI 10.1016/S0927-7765(97)00045-3
   WITT I, 1969, THROMB DIATH HAEMOST, V22, P101
   Yamazaki A, 1999, BBA-BIOMEMBRANES, V1421, P103, DOI 10.1016/S0005-2736(99)00117-0
NR 37
TC 37
Z9 37
U1 1
U2 13
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JUN 15
PY 2002
VL 60
IS 4
BP 622
EP 632
DI 10.1002/jbm.10117
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 548BE
UT WOS:000175367500013
PM 11948521
DA 2018-10-20
ER

PT J
AU Xing, SM
   Waddell, JE
   Boynton, EL
AF Xing, SM
   Waddell, JE
   Boynton, EL
TI Changes in macrophage morphology and prolonged cell viability following
   exposure to polyethylene particulate in vitro
SO MICROSCOPY RESEARCH AND TECHNIQUE
LA English
DT Article
DE cell culture; wear particulate; biomaterials; implant failure
ID IN-VITRO; WEAR DEBRIS; PARTICLES; ARTHROPLASTY; INFLAMMATION;
   PHAGOCYTOSIS; SIZE
AB The interaction of macrophages and ultra-high molecular weight polyethylene (PE) wear plays an important role in perpetuating chronic inflammation at the bone implant interface, leading to peri-implant osteolysis and mechanical failure of the implant. A model to study the interaction of human mature macrophages with orthopaedic biomaterial wear has been previously developed. With the use of the model, in this study, the mature human monocyte-derived macrophages (MDMs) were observed with light, fluorescent, and scanning electron microscopy (SEM), as well as transmission electron microscopy (TEM). The cell viability was investigated using calcein and ethidium staining. Following exposure to PE particulate, the morphology of the human MDMs was heterogeneous: rounded, flattened, and elongated. There was no morphological evidence of cytotoxicity or apoptosis. The MDM viability was not influenced by phagocytosis of PE particulate in a negative fashion. In fact, more prolonged cell viability was observed in the human MDMs exposed to PE particulate when compared to controls. (C) 2002 Wiley-Liss, Inc.
C1 Univ Toronto, Dept Surg, Inst Biomat & Biomed Engn, Toronto, ON M5S 1A8, Canada.
   Univ Toronto, Mt Sinai Hosp, Dept Surg, Toronto, ON M5G 1X5, Canada.
RP Boynton, EL (reprint author), Univ Toronto, Dept Surg, Inst Biomat & Biomed Engn, Toronto, ON M5S 1A8, Canada.
CR BOYNTON E, 1991, CAN J SURG, V34, P599
   Boynton EL, 2000, J BIOMED MATER RES, V52, P239, DOI 10.1002/1097-4636(200011)52:2<239::AID-JBM1>3.0.CO;2-R
   Boynton EL, 1995, CAN J SURG, V38, P507
   CAMPBELL P, 1995, J BIOMED MATER RES, V29, P127, DOI 10.1002/jbm.820290118
   FRIEDMAN RJ, 1994, AAOS INSTR COURS LEC, V43, P233
   Green TR, 1998, BIOMATERIALS, V19, P2297, DOI 10.1016/S0142-9612(98)00140-9
   Heidenreich S, 1997, J IMMUNOL, V159, P3178
   Howie DW, 1996, CLIN ORTHOP RELAT R, pS217
   Labow RS, 2001, J BIOMED MATER RES, V54, P189, DOI 10.1002/1097-4636(200102)54:2<189::AID-JBM5>3.0.CO;2-8
   Lee AW, 2000, BIOMATERIALS, V21, P851, DOI 10.1016/S0142-9612(99)00257-4
   MISIEK DJ, 1984, J ORAL MAXIL SURG, V42, P150, DOI 10.1016/S0278-2391(84)80025-7
   Morrissette Naomi, 1999, Trends in Cell Biology, V9, P199, DOI 10.1016/S0962-8924(99)01540-8
   Neale SD, 1999, ACTA ORTHOP SCAND, V70, P452, DOI 10.3109/17453679909000980
   PAPADIMITRIOU JM, 1989, ULTRASTRUCT PATHOL, V13, P343, DOI 10.3109/01913128909048488
   PETTY HR, 1981, J CELL BIOL, V89, P223, DOI 10.1083/jcb.89.2.223
   RABINOVITCH M, 1995, TRENDS CELL BIOL, V5, P85, DOI 10.1016/S0962-8924(00)88955-2
   Roodman GD, 1996, ENDOCR REV, V17, P308, DOI 10.1210/er.17.4.308
   Sandhu J, 1998, J RHEUMATOL, V25, P1794
   Santerre JP, 2000, CAN J SURG, V43, P173
   SHANBHAG AS, 1994, J BIOMED MATER RES, V28, P81, DOI 10.1002/jbm.820280111
   Voronov I, 1998, J BIOMED MATER RES, V39, P40, DOI 10.1002/(SICI)1097-4636(199801)39:1<40::AID-JBM6>3.3.CO;2-Y
   XING S, 2002, IN PRESS J BIOMED MA
   XING S, 2002, IN RPESS BIOMATERIAL
NR 23
TC 12
Z9 12
U1 3
U2 9
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 1059-910X
J9 MICROSC RES TECHNIQ
JI Microsc. Res. Tech.
PD JUN 15
PY 2002
VL 57
IS 6
BP 523
EP 529
DI 10.1002/jemt.10106
PG 7
WC Anatomy & Morphology; Biology; Microscopy
SC Anatomy & Morphology; Life Sciences & Biomedicine - Other Topics;
   Microscopy
GA 568GW
UT WOS:000176534900012
PM 12112435
DA 2018-10-20
ER

PT J
AU Abendan, RS
   Swift, JA
AF Abendan, RS
   Swift, JA
TI Surface characterization of cholesterol monohydrate single crystals by
   chemical force microscopy
SO LANGMUIR
LA English
DT Article
ID SELF-ASSEMBLED MONOLAYERS; TAPPING MODE; ATHEROSCLEROTIC LESIONS;
   MOLECULAR ASSEMBLIES; CONTACT ANGLES; MODIFIED TIPS; PHASE IMAGES;
   FRICTION; ADHESION; GOLD
AB Atomic force microscopy (AFM) and chemical force microscopy (CFM) techniques have been used to characterize the chemical functionality of cholesterol monohydrate single-crystal surfaces in different solution environments. Both synthetic and natural crystals adopt a platelike habit in which the largest face is (001). Under aqueous and organic solution conditions, in situ contact mode topographical images reveal that the plate face is primarily terminated by bilayer molecular structures and therefore largely homogeneous. Adhesion force measurements obtained with chemically modified tips demonstrate that the functionality of the crystal surface can be altered by changes in the solution composition. The 3-hydroxyl end of cholesterol molecules is presented on the plate face in aqueous media, while alkyl tail groups terminate the surface in organic solutions. Contact angle measurements on (001) surfaces exposed to solvents of different hydrophilicity also show similar trends, providing additional support to these AFM assignments. These studies link molecular-level and macroscopic adhesion properties and demonstrate that solution environment can exert a strong influence on the surface properties of this important biomaterial.
C1 Georgetown Univ, Dept Chem, Washington, DC 20057 USA.
RP Swift, JA (reprint author), Georgetown Univ, Dept Chem, 37th & O St NW, Washington, DC 20057 USA.
EM jas2@georgetown.edu
CR ADMIRAND WH, 1968, J CLIN INVEST, V47, P1043, DOI 10.1172/JCI105794
   BABCOCK KL, DIGITAL INSTRUMENTS
   BAIN CD, 1989, J AM CHEM SOC, V111, P321, DOI 10.1021/ja00183a049
   Bar G, 1997, LANGMUIR, V13, P3807, DOI 10.1021/la970091m
   Beake BD, 1999, PHYS CHEM CHEM PHYS, V1, P3345, DOI 10.1039/a809994d
   BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930
   BOGREN H, 1963, BIOCHIM BIOPHYS ACTA, V75, P65, DOI 10.1016/0006-3002(63)90580-8
   Brandsch R, 1997, LANGMUIR, V13, P6349, DOI 10.1021/la970822i
   Brewer NJ, 2001, LANGMUIR, V17, P1970, DOI 10.1021/la001568o
   Burnham N. A., 1993, Nanotechnology, V4, P64, DOI 10.1088/0957-4484/4/2/002
   Chen X, 2000, SURF SCI, V460, P292, DOI 10.1016/S0039-6028(00)00574-4
   CRAVEN BM, 1976, NATURE, V260, P727, DOI 10.1038/260727a0
   Danesh A, 2000, ANAL CHEM, V72, P3419, DOI 10.1021/ac991498u
   Drelich J, 1996, LANGMUIR, V12, P1913, DOI 10.1021/la9509763
   Duwez AS, 2001, LANGMUIR, V17, P6351, DOI 10.1021/la010440j
   Eaton PJ, 2000, LANGMUIR, V16, P7887, DOI 10.1021/la000159p
   FLYNN GL, 1979, J PHARM SCI, V68, P1090, DOI 10.1002/jps.2600680908
   FRISBIE CD, 1994, SCIENCE, V265, P2071, DOI 10.1126/science.265.5181.2071
   Good RJ, 1996, J ADHESION, V59, P25, DOI 10.1080/00218469608011074
   GREEN JBD, 1995, J PHYS CHEM-US, V99, P10960, DOI 10.1021/j100027a041
   JOHNSON KL, 1971, PROC R SOC LON SER-A, V324, P301, DOI 10.1098/rspa.1971.0141
   KATZ S S, 1976, Journal of Clinical Investigation, V58, P200
   Lioubashevski O, 2001, LANGMUIR, V17, P5134, DOI 10.1021/la0105174
   LOOMIS CR, 1979, J LIPID RES, V20, P525
   Magonov SN, 1997, SURF SCI, V375, pL385, DOI 10.1016/S0039-6028(96)01591-9
   McKendry R, 1998, LANGMUIR, V14, P2846, DOI 10.1021/la970374e
   *MERCK CO, 1996, MERCK IND
   Noy A, 1998, LANGMUIR, V14, P1508, DOI 10.1021/la970948f
   NOY A, 1995, J AM CHEM SOC, V117, P7943, DOI 10.1021/ja00135a012
   Noy A, 1997, ANNU REV MATER SCI, V27, P381, DOI 10.1146/annurev.matsci.27.1.381
   NUZZO RG, 1983, J AM CHEM SOC, V105, P4481, DOI 10.1021/ja00351a063
   OBERDOERFER Y, WWWU MUENSTER
   OVERNEY RM, 1994, LANGMUIR, V10, P1281, DOI 10.1021/la00016a049
   PerlTreves D, 1996, CHEM BIOL, V3, P567, DOI 10.1016/S1074-5521(96)90148-9
   PORTER MD, 1987, J AM CHEM SOC, V109, P3559, DOI 10.1021/ja00246a011
   SAAD HY, 1965, J PHARM SCI, V54, P1205, DOI 10.1002/jps.2600540826
   Schonherr H, 2000, CHEM MATER, V12, P3689, DOI 10.1021/cm0010351
   SEDAGHAT A, 1980, NEW ENGL J MED, V302, P1274, DOI 10.1056/NEJM198006053022302
   SHIEH HS, 1977, NATURE, V267, P287, DOI 10.1038/267287a0
   Sinniah SK, 1996, J AM CHEM SOC, V118, P8925, DOI 10.1021/ja961295c
   SMALL DM, 1974, SCIENCE, V185, P222, DOI 10.1126/science.185.4147.222
   STARY HC, 1990, EUR HEART J, V11, P3, DOI 10.1093/eurheartj/11.suppl_E.3
   Tejada F, 2001, CRYST GROWTH DES, V1, P199, DOI 10.1021/cg0102857
   Ton-That C, 2000, CHEM MATER, V12, P2106, DOI 10.1021/cm000124a
   Viswanathan R, 1997, LANGMUIR, V13, P1840, DOI 10.1021/la9607823
   WANG JL, 1992, J PHYS CHEM-US, V96, P15, DOI 10.1021/j100180a006
   WEISENHORN AL, 1992, PHYS REV B, V45, P11226, DOI 10.1103/PhysRevB.45.11226
   Woodward JT, 2000, LANGMUIR, V16, P2957, DOI 10.1021/1a991068z
   Yang ZP, 1996, LANGMUIR, V12, P1704, DOI 10.1021/la951524t
NR 49
TC 45
Z9 45
U1 0
U2 29
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD JUN 11
PY 2002
VL 18
IS 12
BP 4847
EP 4853
DI 10.1021/la025649r
PG 7
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 560QC
UT WOS:000176091900046
DA 2018-10-20
ER

PT J
AU Anastase-Ravion, S
   Carreno, MP
   Blondin, C
   Ravion, O
   Champion, J
   Chaubet, F
   Haeffner-Cavaillon, N
   Letourneur, D
AF Anastase-Ravion, S
   Carreno, MP
   Blondin, C
   Ravion, O
   Champion, J
   Chaubet, F
   Haeffner-Cavaillon, N
   Letourneur, D
TI Heparin-like polymers modulate proinflammatory cytokine production by
   lipopolysaccharide-stimulated human monocytes
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE cytokine; heparin-like; interleukin; lipopolysaccharide; monocytes
ID NECROSIS-FACTOR-ALPHA; IN-VITRO; COMPLEMENT ACTIVATION;
   ENDOTHELIAL-CELLS; DEXTRAN SULFATE; SEPSIS SYNDROME; WHOLE-BLOOD;
   ANTICOAGULANT; FUCOIDAN; PROLIFERATION
AB The search for heparin-like materials remains an intensive field of research. In this context, we studied the immunomodulatory properties of semisynthetic dextran derivatives and naturally occurring sulfated polysaccharides present in brown seaweed (fucans). In this study, we investigated the functional potencies of fucan and dextran derivatives by analyzing their effects on the release of proinflammatory cytokines by resting or lipopolysaccharide (LPS)stimulated human monocytes and their interactions on monocyte surfaces. The results showed that fucan, dextran derivatives, and heparin differentially (1) triggered interleukin-let, tumor necrosis factor alpha, interleukin-6, and interleukin-8 production by monocytes in a dose-dependent manner, (2) modulated cytokine production by LPS-stimulated monocytes, and (3) specifically inhibited the binding of biotinylated LPS to monocyte membranes. Taken together, these data indicated that fucan and dextran derivatives displayed interesting immunomodulatory effects on human blood cells that could be relevant as new drugs or biomaterial coatings. Indeed, such polysaccharides, by regulating monocyte activation, could contribute to the improved biocompatibility of implants. (C) 2002 Wiley Periodicals, Inc.
C1 X Bichat Med Sch, INSERM, ERIT M, F-75018 Paris, France.
   Univ Paris 13, Inst Galilee, LRM, F-93430 Villetaneuse, France.
   Hop Broussais, INSERM, U430, F-75014 Paris, France.
RP Letourneur, D (reprint author), X Bichat Med Sch, INSERM, ERIT M, F-75018 Paris, France.
RI Didier, letourneur/H-5268-2012; Chaubet, Frederic/L-4570-2017;
   Haeffner-Cavaillon, Nicole/A-1921-2013
OI Didier, letourneur/0000-0003-2197-9468; Chaubet,
   Frederic/0000-0001-7375-0425; Haeffner-Cavaillon,
   Nicole/0000-0002-1703-8561
CR ABRAHAM E, 1995, JAMA-J AM MED ASSOC, V273, P934, DOI 10.1001/jama.273.12.934
   ANASTASERAVION S, 1999, THESIS U PARIS 13 PA
   ANDERSON JM, 1988, ASAIO, V11, P101
   Attanasio M, 1998, THROMB HAEMOSTASIS, V79, P959
   Benahmed M, 1997, J BIOMED MATER RES, V34, P115, DOI 10.1002/(SICI)1097-4636(199701)34:1<115::AID-JBM15>3.0.CO;2-J
   Blondin C, 1996, BIOMATERIALS, V17, P597, DOI 10.1016/0142-9612(96)88710-2
   Carr S, 1999, Biomed Sci Instrum, V35, P211
   Cavaillon JM, 1996, J ENDOTOXIN RES, V3, P471, DOI 10.1177/096805199600300605
   CAVAILLON JM, 1992, BACTERIAL ENDOTOXIC
   Chaubet F, 1995, CARBOHYD POLYM, V28, P145, DOI 10.1016/0144-8617(95)00084-4
   Chaubet F, 1999, POLYM INT, V48, P313, DOI 10.1002/(SICI)1097-0126(199904)48:4<313::AID-PI151>3.0.CO;2-H
   Chevolot L, 2001, CARBOHYD RES, V330, P529, DOI 10.1016/S0008-6215(00)00314-1
   Daniels AU, 2000, J BIOMED MATER RES, V49, P469, DOI 10.1002/(SICI)1097-4636(20000315)49:4<469::AID-JBM5>3.3.CO;2-1
   ELSASSERBEILE U, 1991, J IMMUNOL METHODS, V139, P191, DOI 10.1016/0022-1759(91)90188-L
   FISHER CJ, 1994, CRIT CARE MED, V22, P12, DOI 10.1097/00003246-199401000-00008
   GALLAY P, 1993, J IMMUNOL, V150, P5086
   Giraux JL, 1998, EUR J CELL BIOL, V77, P352, DOI 10.1016/S0171-9335(98)80094-0
   Guth HJ, 2000, INT J ARTIF ORGANS, V23, P675
   Heinzelmann M, 1998, INFECT IMMUN, V66, P5842
   Ingalls RR, 1999, INFECT DIS CLIN N AM, V13, P341, DOI 10.1016/S0891-5520(05)70078-7
   ITOH K, 1995, EUR SURG RES, V27, P184, DOI 10.1159/000129398
   JOHANN S, 1995, THROMB HAEMOSTASIS, V74, P998
   Khouw IMSL, 2000, J BIOMED MATER RES, V52, P439, DOI 10.1002/1097-4636(20001205)52:3<439::AID-JBM1>3.0.CO;2-C
   Kremer JP, 1996, ACTA HAEMATOL-BASEL, V95, P268
   KUENDER DY, 1996, PEDIATR INFECT DIS J, V15, P355
   LETOURNEUR D, 1993, J BIOMAT SCI-POLYM E, V4, P431, DOI 10.1163/156856293X00681
   LEY K, 1993, BLOOD, V81, P177
   Logeart D, 1997, EUR J CELL BIOL, V74, P376
   Lohmann CH, 2000, BIOMATERIALS, V21, P551, DOI 10.1016/S0142-9612(99)00211-2
   Manaster J, 1996, BRIT J HAEMATOL, V94, P48, DOI 10.1046/j.1365-2141.1996.6202063.x
   MAUZAC M, 1984, BIOMATERIALS, V5, P301, DOI 10.1016/0142-9612(84)90078-4
   McFadden G, 1997, BIOCHEM PHARMACOL, V54, P1271, DOI 10.1016/S0006-2952(97)00182-2
   Millet J, 1999, THROMB HAEMOSTASIS, V81, P391
   MYRVANG AK, 1995, THROMB RES, V80, P179
   Nardella A, 1996, CARBOHYD RES, V289, P201, DOI 10.1016/0008-6215(96)00110-3
   NELSON RM, 1993, BLOOD, V82, P3253
   Panichi V, 2000, KIDNEY INT, V58, pS96, DOI 10.1046/j.1523-1755.2000.07612.x
   Pertosa G, 2000, KIDNEY INT, V58, pS104, DOI 10.1046/j.1523-1755.2000.07613.x
   Rosenberg RD, 1997, J CLIN INVEST, V99, P2062, DOI 10.1172/JCI119377
   Schumann RR, 1996, BLOOD, V87, P2805
   Senni K, 1998, J BIOMED MATER RES, V40, P164, DOI 10.1002/(SICI)1097-4636(199804)40:1<164::AID-JBM19>3.3.CO;2-4
   SOEDA S, 1995, BBA-MOL CELL RES, V1269, P85
   Solberg R, 1998, TRANSPLANT INT, V11, P252, DOI 10.1007/s001470050137
   SORIMACHI K, 1993, CELL BIOL INT, V17, P881, DOI 10.1006/cbir.1993.1151
   THOMAS H, 1995, BIOMATERIALS, V16, P1163, DOI 10.1016/0142-9612(95)93581-W
   Trindade MCD, 2001, BIOMATERIALS, V22, P253, DOI 10.1016/S0142-9612(00)00181-2
   TYRRELL DJ, 1995, TRENDS PHARMACOL SCI, V16, P198, DOI 10.1016/S0165-6147(00)89022-7
   VanOsselaer N, 1996, MEDIAT INFLAMM, V5, P346, DOI 10.1155/S0962935196000506
   Wuillemin WA, 1997, J IMMUNOL, V159, P1953
   YUE TL, 1994, CIRC RES, V75, P1, DOI 10.1161/01.RES.75.1.1
NR 50
TC 18
Z9 19
U1 0
U2 4
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JUN 5
PY 2002
VL 60
IS 3
BP 375
EP 383
DI 10.1002/jbm.10112
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 536TD
UT WOS:000174717200005
PM 11920660
DA 2018-10-20
ER

PT J
AU Ohan, MP
   Weadock, KS
   Dunn, MG
AF Ohan, MP
   Weadock, KS
   Dunn, MG
TI Synergistic effects of glucose and ultraviolet irradiation on the
   physical properties of collagen
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE collagen; ultraviolet irradiation; glucose; crosslinking; enzyme
   resistance
ID CROSS-LINKING; FREE-RADICALS; IN-VITRO; GLYCATION; SUSCEPTIBILITY;
   GLYCOSYLATION; DEGRADATION; BIOMATERIAL; PROTEINS; FIBERS
AB Our objective was to strengthen and stabilize collagen films without the introduction of cytotoxic chemical crosslinkers. We hypothesized that collagen could be rapidly crosslinked with glucose with ultraviolet (UV) irradiation as a catalyst. In theory, UV-generated free radicals can expedite collagen crosslinking with glucose via the formation of reactive, linear glucose molecules. The mechanical properties of glucose-incorporated, UV-exposed collagen films and appropriate controls were determined under various conditions: (1) hydration in phosphate-buffered saline, (2) heat-denaturation, (3) incubation in a collagenase solution, and (4) incubation in a trypsin solution. Without exposure to UV, the incorporation of glucose into the films had no effect. Without glucose, exposure to UV increased the strength but caused significant denaturation. The combination of glucose and UV, however, synergistically improved the mechanical properties and enzyme resistance of collagen films, indicative of increased crosslinking without significant denaturation effects. The addition of thiourea, a potent free-radical scavenger, or aminoguanidine, an inhibitor of glucose-derived crosslinking, to the collagen films markedly hindered these synergistic effects. These data strongly suggest that free-radical-dependent, glucose-derived crosslinks provide the enhanced strength and enzyme resistance observed in glucose-incorporated, UV-exposed collagen films. Further studies are required to explore biomaterial applications of this novel collagen crosslinking method. (C) 2002 Wiley Periodicals, Inc.
C1 Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Div Orthopaed Surg, Orthopaed Res Labs, New Brunswick, NJ 08903 USA.
RP Dunn, MG (reprint author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Div Orthopaed Surg, Orthopaed Res Labs, New Brunswick, NJ 08903 USA.
EM dunnmg@umdnj.edu
OI Letourneur, Didier/0000-0003-2197-9468; Chaubet,
   Frederic/0000-0001-7375-0425
FU NIAMS NIH HHS [AR-42230]
CR ANGYAL SJ, 1984, ADV CARBOHYD CHEM BI, V42, P15, DOI 10.1016/S0065-2318(08)60122-5
   BAILEY AJ, 1964, RADIAT RES, V22, P606, DOI 10.2307/3571543
   BAYNES JW, 1991, DIABETES, V40, P405, DOI 10.2337/diabetes.40.4.405
   BROWNLEE M, 1986, SCIENCE, V232, P1629, DOI 10.1126/science.3487117
   BUNN HF, 1981, SCIENCE, V213, P222, DOI 10.1126/science.12192669
   CARBONARE MD, 1992, J PHOTOCH PHOTOBIO B, V14, P105, DOI 10.1016/1011-1344(92)85086-A
   CHACE KV, 1991, ARCH BIOCHEM BIOPHYS, V288, P473, DOI 10.1016/0003-9861(91)90223-6
   CHEUNG DT, 1990, J BIOMED MATER RES, V24, P581, DOI 10.1002/jbm.820240505
   CHVAPIL M, 1973, INT REV CONNECTIVE T, P1
   Elgawish A, 1996, J BIOL CHEM, V271, P12964, DOI 10.1074/jbc.271.22.12964
   FU MX, 1994, DIABETES, V43, P676, DOI 10.2337/diabetes.43.5.676
   FUJIMORI E, 1989, BIOCHIM BIOPHYS ACTA, V998, P105, DOI 10.1016/0167-4838(89)90260-4
   Girton TS, 1999, J BIOMED MATER RES, V46, P87, DOI 10.1002/(SICI)1097-4636(199907)46:1<87::AID-JBM10>3.0.CO;2-K
   GORHAM SD, 1992, INT J BIOL MACROMOL, V14, P129, DOI 10.1016/S0141-8130(05)80002-9
   HANS S, 1992, ANAL BIOCHEM, V201, P336
   HUANGLEE LLH, 1990, J BIOMED MATER RES, V24, P1185, DOI 10.1002/jbm.820240905
   Khor E, 1997, BIOMATERIALS, V18, P95, DOI 10.1016/S0142-9612(96)00106-8
   Koide T, 1997, Dent Mater J, V16, P1
   KRISTAL BS, 1992, J GERONTOL, V47, pB107, DOI 10.1093/geronj/47.4.B107
   KUNTZ E, 1962, RADIAT RES, V16, P568
   Miles CA, 2000, J BIOL CHEM, V275, P33014, DOI 10.1074/jbc.M002346200
   MIYATA T, 1992, Clinical Materials, V9, P139, DOI 10.1016/0267-6605(92)90093-9
   Nimni ME, 1988, COLLAGEN, VIII, P1
   Rault I, 1996, J MATER SCI-MATER M, V7, P215, DOI 10.1007/BF00119733
   RUBIN AL, 1968, T AM SOC ART INT ORG, V14, P169
   Sajithlal GB, 1998, BBA-MOL BASIS DIS, V1407, P215, DOI 10.1016/S0925-4439(98)00043-X
   SIMMONS DM, 1993, BIOTECHNOL APPL BIOC, V17, P23
   STENZEL KH, 1974, ANNU REV BIOPHYS BIO, V3, P231, DOI 10.1146/annurev.bb.03.060174.001311
   STRYER L, 1988, BIOCHEMISTRY
   VLASSARA H, 1994, LAB INVEST, V70, P138
   WEADOCK K, 1984, BIOMAT MED DEV ARTIF, V29, P1373
   WEADOCK KS, 1995, J BIOMED MATER RES, V29, P1373, DOI 10.1002/jbm.820291108
   Weadock KS, 1996, J BIOMED MATER RES, V32, P221, DOI 10.1002/(SICI)1097-4636(199610)32:2<221::AID-JBM11>3.0.CO;2-M
   WOLFF SP, 1986, BIOCHEM J, V234, P399, DOI 10.1042/bj2340399
   YANNAS AV, 1967, NATURE, V215, P509
   Yannas I. V., 1996, BIOMATERIALS SCI INT, V1, P84
NR 36
TC 51
Z9 52
U1 0
U2 19
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JUN 5
PY 2002
VL 60
IS 3
BP 384
EP 391
DI 10.1002/jbm.10111
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 536TD
UT WOS:000174717200006
PM 11920661
DA 2018-10-20
ER

PT J
AU Walboomers, XF
   Dalton, BA
   Evans, MD
   Steele, JG
   Jansen, JA
AF Walboomers, XF
   Dalton, BA
   Evans, MD
   Steele, JG
   Jansen, JA
TI Transforming growth factor-beta 1, 2, and 3 can inhibit epithelial
   tissue outgrowth on smooth and microgrooved substrates
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE growth factor-beta; epithelial tissue outgrowth; microgrooved substrates
ID UNMODIFIED POLYSTYRENE; NEUTRALIZING ANTIBODY; CULTURE POLYSTYRENE;
   SURFACE-TOPOGRAPHY; GROOVED SUBSTRATA; CELL ATTACHMENT; FIBROBLASTS;
   MIGRATION; CHEMISTRY; POLYMER
AB In this study, we describe the influence of parallel surface microgrooves, and of TGF-beta, on the outgrowth of corneal epithelial tissue. Microgrooves (depth 1 mum, width 1-10 mum) were made in polystyrene culturing surfaces. These surfaces were left untreated, or loaded with TGF-beta 1, 2, or 3 (6.0 ng /cm(2)). Subsequently, epithelial explants from bovine corneas were placed on the experimental surfaces. After 9 days of culturing, tissue outgrowth was evaluated. Furthermore, the tissue cultures were analyzed histologically. It was shown that epithelial tissue grew from the explants over all experimental surfaces. On microgrooved surfaces outgrowth proceeded in the direction of the grooves, rather than perpendicular to the grooves. The addition of each type of TGF-beta resulted in a reduction of outgrowth. However, outgrowth remained directed by the grooves. Further, the explants had shrunk after TGF treatment. Histology showed that this shrinkage was not related to alpha-smooth muscle actin expression in the explants. We conclude that microgrooves can direct, and TGF-betas can inhibit the outgrowth of epithelial tissue. This finding could be useful in biomaterial applications where the growth of epithelial tissue needs to be discouraged. (C) 2002 Wiley Periodicals, Inc.
C1 Univ Nijmegen, Med Ctr, Coll Dent Sci, Dept Biomat, NL-6500 HB Nijmegen, Netherlands.
   CSIRO Mol Sci, N Ryde, NSW 1670, Australia.
RP Jansen, JA (reprint author), Univ Nijmegen, Med Ctr, Coll Dent Sci, Dept Biomat, POB 9101, NL-6500 HB Nijmegen, Netherlands.
RI Walboomers, X.Frank/B-3692-2013; Evans, Margaret/B-3261-2011; Jansen,
   John/H-8055-2014
OI Evans, Margaret/0000-0003-3078-1576; 
CR ALBERTS B, 1995, MOL BIOL CELL
   BRUNET CL, 1995, INT J DEV BIOL, V39, P345
   BRUNETTE DM, 1986, EXP CELL RES, V167, P203, DOI 10.1016/0014-4827(86)90217-X
   BRUNETTE DM, 1983, J DENT RES, V62, P1045, DOI 10.1177/00220345830620100701
   CHESMEL KD, 1995, J BIOMED MATER RES, V29, P1089, DOI 10.1002/jbm.820290909
   CLARK P, 1991, J CELL SCI, V99, P73
   Cordeiro MF, 1999, INVEST OPHTH VIS SCI, V40, P2225
   Dalton BA, 1999, J BIOMED MATER RES, V45, P384, DOI 10.1002/(SICI)1097-4636(19990615)45:4<384::AID-JBM14>3.0.CO;2-O
   Dalton BA, 1998, J BIOMAT SCI-POLYM E, V9, P781, DOI 10.1163/156856298X00154
   DALTON BA, 2000, J BIOMED MATER RES, V56, P195
   Damji A, 1996, EXP CELL RES, V228, P114, DOI 10.1006/excr.1996.0306
   Evans MDM, 2000, INVEST OPHTH VIS SCI, V41, P1674
   Fitton JH, 1998, J BIOMED MATER RES, V42, P245
   GABBIANI G, 1992, KIDNEY INT, V41, P530, DOI 10.1038/ki.1992.75
   Hartsough MT, 1997, PHARMACOL THERAPEUT, V75, P21, DOI 10.1016/S0163-7258(97)00020-X
   Imanishi J, 2000, PROG RETIN EYE RES, V19, P113, DOI 10.1016/S1350-9462(99)00007-5
   OKane S, 1997, INT J BIOCHEM CELL B, V29, P63, DOI 10.1016/S1357-2725(96)00120-3
   Paquay YCGJ, 1996, BIOMATERIALS, V17, P1251, DOI 10.1016/0142-9612(96)84946-5
   SHAH M, 1995, J CELL SCI, V108, P985
   SHAH M, 1994, J CELL SCI, V107, P1137
   SHAH M, 1992, LANCET, V339, P213, DOI 10.1016/0140-6736(92)90009-R
   STEELE JG, 1993, J BIOMAT SCI-POLYM E, V5, P245
   STEELE JG, 1993, J BIOMED MATER RES, V27, P927, DOI 10.1002/jbm.820270712
   TALIANA LT, 2000, IN PRESS INVEST OPHT
   Taya Y, 1999, DEVELOPMENT, V126, P3869
   Tseng SCG, 1999, J CELL PHYSIOL, V179, P325, DOI 10.1002/(SICI)1097-4652(199906)179:3<325::AID-JCP10>3.3.CO;2-O
   von Recum A.F., 1998, HDB BIOMATERIALS EVA
   Walboomers XF, 1999, J BIOMED MATER RES, V47, P204, DOI 10.1002/(SICI)1097-4636(199911)47:2<204::AID-JBM10>3.0.CO;2-H
   Walboomers XF, 1999, J BIOMED MATER RES, V46, P212, DOI 10.1002/(SICI)1097-4636(199908)46:2<212::AID-JBM10>3.0.CO;2-Y
   WANATABE K, 1987, INVEST OPHTH VIS SCI, V28, P205
   Yang LJ, 1999, AM J PATHOL, V154, P105, DOI 10.1016/S0002-9440(10)65256-X
   Zicha D, 1999, J CELL SCI, V112, P447
NR 32
TC 3
Z9 4
U1 0
U2 1
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JUN 5
PY 2002
VL 60
IS 3
BP 445
EP 451
DI 10.1002/jbm.1290
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 536TD
UT WOS:000174717200013
PM 11920668
DA 2018-10-20
ER

PT J
AU Collier, TO
   Anderson, JM
AF Collier, TO
   Anderson, JM
TI Protein and surface effects on monocyte and macrophage adhesion,
   maturation, and survival
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE apoptosis; fibronectin; foreign-body giant cell; immunoglobulin G; human
   macrophage; RGD; vitronectin
ID GIANT-CELL FORMATION; IN-VITRO; BIOMATERIALS; FIBRONECTIN; FUSION;
   BINDING; IGG; RGD; VITRONECTIN; ATTACHMENT
AB Cell adhesion and maturation can be affected by the protein adsorption profile on the surface of an implanted biomaterial. In this study we have investigated how surface chemistry and adsorbed proteins can modulate monocyte and macrophage adhesion, IL-13-induced foreign-body giant cell formation, and apoptosis in vitro. Compared to a dimethylsilane-modified surface (DM), a surface modified with RGD peptides had no effect on adhesion density, foreign-body giant cell (FBGC) formation, or apoptosis in non-depleted serum conditions. The depletion of specific adhesive proteins affected adhesion, FBGC formation, and apoptosis. While the depletion of fibronectin and vitronectin had no overall effect compared to nondepleted serum conditions, the depletion of IgG from serum caused a significant decrease in initial adherent cell density [1000 +/- 200 compared to 2460 +/- 590 (p = 0.02)], a significant decrease in FBGC formation [2% compared to 17% (p = 0.02)], and a significant increase in the level of apoptosis [57% compared to 32% (p = 0.01)] on DM. The lowered initial adherent cell density on DM was not observed on the RGD surface, indicating that the RGD surface promotes increased initial adhesion. However, the RGD surface does not affect FBGC formation (i.e., macrophage fusion) or levels of apoptosis, which remained comparable to those on the DM surfaces at days 7 and 10. (C) 2002 Wiley Periodicals, Inc.
C1 Case Western Reserve Univ, Inst Pathol, Cleveland, OH 44106 USA.
   Case Western Reserve Univ, Dept Macromol Sci, Cleveland, OH 44106 USA.
RP Anderson, JM (reprint author), Case Western Reserve Univ, Inst Pathol, 2085 Adelbert Rd, Cleveland, OH 44106 USA.
FU NHLBI NIH HHS [HL-55714, HL-33894]
CR Anderson JM, 1999, J MATER SCI-MATER M, V10, P579, DOI 10.1023/A:1008976531592
   ANDERSON JM, 1984, BIOMATERIALS, V5, P5, DOI 10.1016/0142-9612(84)90060-7
   ANDERSON JM, 1993, CARDIOVASC PATHOL S, V2, P33
   Berton G, 1999, CELL SIGNAL, V11, P621, DOI 10.1016/S0898-6568(99)00003-0
   BLYSTONE SD, 1991, BLOOD, V78, P2900
   Brodbeck WG, 1996, J IMMUNOL, V156, P2528
   Brodbeck WG, 2001, J BIOMED MATER RES, V55, P661, DOI 10.1002/1097-4636(20010615)55:4<661::AID-JBM1061>3.0.CO;2-F
   CAVAILLON JM, 1994, BIOMED PHARMACOTHER, V48, P445, DOI 10.1016/0753-3322(94)90005-1
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Collier T O, 1997, Biomed Sci Instrum, V33, P178
   Collier TO, 2000, J BIOMED MATER RES, V49, P141, DOI 10.1002/(SICI)1097-4636(200001)49:1<141::AID-JBM18>3.0.CO;2-A
   COLLIER TO, 2001, IN PRESS J BIOMED MA
   CRAMER AD, 1973, AM J CLIN PATHOL, V60, P148
   DeFife KM, 1999, J HISTOCHEM CYTOCHEM, V47, P65, DOI 10.1177/002215549904700107
   DeFife KM, 1997, J IMMUNOL, V158, P3385
   DeFife KM, 1999, FASEB J, V13, P823
   Defilippi P, 1999, MICROSC RES TECHNIQ, V47, P67, DOI 10.1002/(SICI)1097-0029(19991001)47:1<67::AID-JEMT7>3.3.CO;2-G
   DETOMA FJ, 1987, EXPT IMMUNOLOGY GUID
   ENGVALL E, 1977, INT J CANCER, V20, P1, DOI 10.1002/ijc.2910200102
   ERTEL SI, 1994, J BIOMED MATER RES, V28, P667, DOI 10.1002/jbm.820280603
   Gahmberg CG, 1998, CELL MOL LIFE SCI, V54, P549, DOI 10.1007/s000180050183
   Giacomelli CE, 1999, J COLLOID INTERF SCI, V220, P13, DOI 10.1006/jcis.1999.6479
   GRINNELL F, 1982, J BIOL CHEM, V257, P4888
   HAYMAN EG, 1985, EXP CELL RES, V160, P245, DOI 10.1016/0014-4827(85)90173-9
   Horbett TA, 1993, CARDIOVASC PATHOL, V2, P137, DOI DOI 10.1016/1054-8807(93)90054-6)
   Howe A, 1998, CURR OPIN CELL BIOL, V10, P220, DOI 10.1016/S0955-0674(98)80144-0
   Jenney CR, 1999, J BIOMED MATER RES, V46, P11, DOI 10.1002/(SICI)1097-4636(199907)46:1<11::AID-JBM2>3.3.CO;2-P
   Jenney CR, 2000, J BIOMED MATER RES, V49, P435
   Jenney CR, 1998, J BIOMED MATER RES, V41, P171, DOI 10.1002/(SICI)1097-4636(199808)41:2<171::AID-JBM1>3.0.CO;2-F
   Jenney CR, 2000, J BIOMED MATER RES, V50, P281, DOI 10.1002/(SICI)1097-4636(20000605)50:3<281::AID-JBM1>3.0.CO;2-5
   Kao WJ, 1996, J BIOMED MATER RES, V32, P99, DOI 10.1002/(SICI)1097-4636(199609)32:1<99::AID-JBM12>3.3.CO;2-E
   Kao WJ, 2001, J BIOMED MATER RES, V55, P79, DOI 10.1002/1097-4636(200104)55:1<79::AID-JBM110>3.3.CO;2-Q
   Kao WYJ, 1999, BIOMATERIALS, V20, P2213, DOI 10.1016/S0142-9612(99)00152-0
   Kaufmann SH, 2000, EXP CELL RES, V256, P42, DOI 10.1006/excr.2000.4838
   Leahy DJ, 1996, CELL, V84, P155, DOI 10.1016/S0092-8674(00)81002-8
   MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089
   MCNALLY AK, 1994, P NATL ACAD SCI USA, V91, P10119, DOI 10.1073/pnas.91.21.10119
   PANKOWSKY DA, 1990, J VASC SURG, V11, P599, DOI 10.1067/mva.1990.18272
   Rezania A, 1999, J ORTHOPAED RES, V17, P615, DOI 10.1002/jor.1100170423
   Richard CAH, 2000, BIOCHEM BIOPH RES CO, V271, P70, DOI 10.1006/bbrc.2000.2594
   ROSALES C, 1995, J LEUKOCYTE BIOL, V57, P189
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0
   TANG LP, 1993, J LAB CLIN MED, V122, P292
   Thomas CH, 1997, J BIOMED MATER RES, V37, P81, DOI 10.1002/(SICI)1097-4636(199710)37:1<81::AID-JBM10>3.0.CO;2-T
   UNDERWOOD PA, 1989, J CELL SCI, V93, P641
   VISSERS MCM, 1988, J IMMUNOL METHODS, V110, P203, DOI 10.1016/0022-1759(88)90104-4
   Werthen M, 2001, BIOMATERIALS, V22, P827, DOI 10.1016/S0142-9612(00)00246-5
   ZHAO Q, 1991, J BIOMED MATER RES, V25, P177, DOI 10.1002/jbm.820250205
   ZIATS NP, 1988, BIOMATERIALS, V9, P5, DOI 10.1016/0142-9612(88)90063-4
NR 50
TC 51
Z9 53
U1 1
U2 8
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JUN 5
PY 2002
VL 60
IS 3
BP 487
EP 496
DI 10.1002/jbm.10043
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 536TD
UT WOS:000174717200019
PM 11920674
DA 2018-10-20
ER

PT J
AU Raitman, OA
   Katz, E
   Buckmann, AF
   Willner, I
AF Raitman, OA
   Katz, E
   Buckmann, AF
   Willner, I
TI Integration of polyaniline/poly(acrylic acid) films and redox enzymes on
   electrode supports: An in situ electrochemical/surface plasmon resonance
   study of the bioelectrocatalyzed oxidation of glucose or lactate in the
   integrated bioelectrocatalytic systems
SO JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Article
ID SELF-ASSEMBLED MONOLAYERS; DIRECT ELECTRICAL COMMUNICATION;
   QUARTZ-CRYSTAL MICROBALANCE; CHEMICALLY-MODIFIED ENZYMES;
   SURFACE-PLASMON; POLYANILINE FILMS; THIN-FILMS; AMPEROMETRIC BIOSENSORS;
   BIOFUEL CELL; METAL-ELECTRODES
AB Electropolymerization of aniline in the presence of poly(acrylic acid) on Au electrodes yields a polyaniline/poly(acrylic acid) composite film, exhibiting reversible redox functions in aqueous solutions at pH = 7.0. In situ electrochemical-SPR measurements are used to identify the dynamics of swelling and shrinking of the polymer film upon the oxidation of the polyaniline (PAn) to its oxidized state (PAn(2+)) and the reduction of the oxidized polymer (PAn(2+)) back to its reduced state (PAn), respectively. Covalent attachment of N-6-(2-aminoethyl)-flavin adenin dinucleotide (amino-FAD, 1) to the carboxylic groups of the composite polyaniline/poly(acrylic acid) film followed by the reconstitution of apoglucose oxidase on the functional polymer yields an electrically contacted glucose oxidase of unprecedented electrical communication efficiency with the electrode: electron-transfer turnover rate similar to1000 s(-1) at 30 degreesC. In situ electrochemical-SPR analyses are used to characterize the bioelectrocatalytic functions of the biomaterial-polymer interface. The current responses of the bioelectrocatalytic system increase as the glucose concentrations are elevated. Similarly, the SPR spectra of the system are controlled by the concentration of glucose. The glucose concentration controls the steady-state concentration ratio of PAn/PAn(2+) in the film composition. Therefore, the SPR spectrum of the film measured upon its electrochemical oxidation is shifted from the spectrum typical for the oxidized PAn(2+) at low glucose concentration to the spectrum characteristic of the reduced PAn at high glucose concentration. Similarly, the polyaniline/poly(acrylic acid) film acts as an electrocatalyst for the oxidation of NADH. Accordingly, an integrated bioelectrocatalytic assembly was constructed on the electrode by the covalent attachment of N-6-(2-aminoethyl)-beta-nicotinamide adenine dinucleotide (amino-NAD(+), 2) to the polymer film, and the two-dimensional cross-linking of an affinity complex formed between lactate dehydrogenase and the NAD(+)-cofactor units associated with the polymer using glutaric dialdehyde as a cross-linker. In situ electrochemical-SPR measurements are used to characterize the bioelectrocatalytic functions of the system. The amperometric responses of the system increase as the concentrations of lactate are elevated, and an electron-transfer turnover rate of 350 s(-1) between the biocatalyst and the electrode is estimated. As the PAn(2+) oxidizes the NADH units generated by the biocatalyzed oxidation of lactate, the PAn/PAn(2+) steady-state ratio in the film is controlled by the concentration of lactate, Accordingly, the SPR spectrum measured upon electrochemical oxidation of the film is similar to the spectrum of PAn(2+). at low lactate concentration, whereas the SPR spectrum resembles that of PAn at high concentrations of lactate.
C1 Hebrew Univ Jerusalem, Inst Chem, IL-91904 Jerusalem, Israel.
   Gesell Biotechnol Forsch mbH, Dept Mol Struct Res, D-38124 Braunschweig, Germany.
RP Willner, I (reprint author), Hebrew Univ Jerusalem, Inst Chem, IL-91904 Jerusalem, Israel.
EM willnea@vms.huji.ac.il
RI Raitman, Oleg/S-3960-2016
CR ANDRIEUX CP, 1978, J ELECTROANAL CHEM, V93, P163, DOI 10.1016/0368-1874(78)85010-2
   BADIA A, 1993, J AM CHEM SOC, V115, P7053, DOI 10.1021/ja00069a001
   Badia A, 1999, SENSOR ACTUAT B-CHEM, V54, P145, DOI 10.1016/S0925-4005(98)00333-5
   Bardea A, 1997, J AM CHEM SOC, V119, P9114, DOI 10.1021/ja971192+
   BARTLETT P N, 1991, Progress in Reaction Kinetics, V16, P55
   Bartlett PN, 2001, PHYS CHEM CHEM PHYS, V3, P1491, DOI 10.1039/b009377g
   Bartlett PN, 1996, J CHEM SOC FARADAY T, V92, P3123, DOI 10.1039/ft9969203123
   BARTLETT PN, 1993, ANAL CHEM, V65, P1118, DOI 10.1021/ac00056a029
   Bartlett PN, 2000, PHYS CHEM CHEM PHYS, V2, P2599, DOI 10.1039/b001107j
   Bartlett PN, 1997, J CHEM SOC FARADAY T, V93, P1951, DOI 10.1039/a700468k
   BARTLETT PN, 1994, ANAL CHEM, V66, P1552, DOI 10.1021/ac00081a031
   Bartlett PN, 1996, J CHEM SOC FARADAY T, V92, P4137, DOI 10.1039/ft9969204137
   Bechinger C, 1996, NATURE, V383, P608, DOI 10.1038/383608a0
   Beketov GV, 1998, SENSOR ACTUAT B-CHEM, V48, P432, DOI 10.1016/S0925-4005(98)00081-1
   Berger CEH, 2000, SENSOR ACTUAT B-CHEM, V63, P103, DOI 10.1016/S0925-4005(00)00307-5
   Blonder R, 1997, J AM CHEM SOC, V119, P11747, DOI 10.1021/ja972663v
   Brennan CB, 2001, SENSOR ACTUAT B-CHEM, V72, P1, DOI 10.1016/S0925-4005(00)00622-5
   Buckmann AF, 1997, METHOD ENZYMOL, V280, P360
   BUCKMANN AF, 1992, BIOTECHNOL APPL BIOC, V15, P303
   BUTTRY DA, 1992, CHEM REV, V92, P1355, DOI 10.1021/cr00014a006
   Cao TB, 2001, LANGMUIR, V17, P6034, DOI 10.1021/1a0102830
   Chegel V, 2001, CHEM COMMUN, P883, DOI 10.1039/b101243f
   COSNIER S, 1994, ANAL CHEM, V66, P3198, DOI 10.1021/ac00091a032
   Cosnier S, 1998, ELECTROANAL, V10, P521, DOI 10.1002/(SICI)1521-4109(199807)10:8<521::AID-ELAN521>3.3.CO;2-I
   Cui SY, 1999, SYNTHETIC MET, V105, P91, DOI 10.1016/S0379-6779(99)00079-X
   DEGANI Y, 1988, J AM CHEM SOC, V110, P2615, DOI 10.1021/ja00216a040
   DEGANI Y, 1987, J PHYS CHEM-US, V91, P1285, DOI 10.1021/j100290a001
   DIAZ AF, 1980, J ELECTROANAL CHEM, V111, P111, DOI 10.1016/S0022-0728(80)80081-7
   Disley DM, 1998, BIOSENS BIOELECTRON, V13, P1213, DOI 10.1016/S0956-5663(98)00059-1
   Ehler TT, 2000, J ELECTROANAL CHEM, V480, P94, DOI 10.1016/S0022-0728(99)00449-0
   EICHNER RD, 1982, METHOD ENZYMOL, V89, P359
   EMR SA, 1995, ELECTROANAL, V7, P913, DOI 10.1002/elan.1140071002
   Flatmark T, 2001, ANAL BIOCHEM, V294, P95, DOI 10.1006/abio.2001.5163
   Georgiadis R, 2000, LANGMUIR, V16, P6759, DOI 10.1021/la9917076
   GREGG BA, 1991, J PHYS CHEM-US, V95, P5970, DOI 10.1021/j100168a046
   Habermuller L, 2000, FRESEN J ANAL CHEM, V366, P560
   HECHT HJ, 1993, J MOL BIOL, V229, P153, DOI 10.1006/jmbi.1993.1015
   HELLER A, 1990, ACCOUNTS CHEM RES, V23, P128, DOI 10.1021/ar00173a002
   Homola J, 1999, SENSOR ACTUAT B-CHEM, V54, P3, DOI 10.1016/S0925-4005(98)00321-9
   Iwasaki Y, 2001, ANAL CHEM, V73, P1595, DOI 10.1021/ac0012851
   JANNAKOUDAKIS PD, 1994, SYNTHETIC MET, V68, P17, DOI 10.1016/0379-6779(94)90142-2
   JIN W, 1995, BIOSENS BIOELECTRON, V10, P823, DOI 10.1016/0956-5663(95)99221-6
   JOHNSTON KS, 1995, MATER CHEM PHYS, V42, P242, DOI 10.1016/0254-0584(95)01659-I
   Kalinowski J, 1999, J PHYS D APPL PHYS, V32, pR179, DOI 10.1088/0022-3727/32/24/201
   Kambhampati DK, 1999, CURR OPIN COLLOID IN, V4, P273, DOI 10.1016/S1359-0294(99)90008-0
   Kang XF, 2001, ELECTROCHEM COMMUN, V3, P489, DOI 10.1016/S1388-2481(01)00170-9
   Katakis I, 1997, MIKROCHIM ACTA, V126, P11, DOI 10.1007/BF01242656
   Katz E, 1999, NEW J CHEM, V23, P481, DOI 10.1039/a808561g
   Katz E, 1999, J ELECTROANAL CHEM, V479, P64, DOI 10.1016/S0022-0728(99)00425-8
   KATZ E, 1994, J ELECTROANAL CHEM, V367, P59, DOI 10.1016/0022-0728(93)03010-M
   Katz E, 1999, ANAL CHIM ACTA, V385, P45, DOI 10.1016/S0003-2670(98)00688-6
   KATZ E, IN PRESS HDB FUEL CE
   Kharitonov AB, 2000, J ELECTROANAL CHEM, V487, P133, DOI 10.1016/S0022-0728(00)00178-9
   Kienle S, 1997, BIOSENS BIOELECTRON, V12, P779, DOI 10.1016/S0956-5663(97)00044-4
   Knoll W, 1998, ANNU REV PHYS CHEM, V49, P569, DOI 10.1146/annurev.physchem.49.1.569
   Koide S, 1999, J ELECTROANAL CHEM, V468, P193, DOI 10.1016/S0022-0728(99)00174-6
   Kruchinin AA, 1996, SENSOR ACTUAT B-CHEM, V30, P77, DOI 10.1016/0925-4005(95)01752-H
   KUMABATA S, 1995, ANAL CHEM, V67, P1684
   Lahav M, 2001, ANGEW CHEM INT EDIT, V40, P4095, DOI 10.1002/1521-3773(20011105)40:21<4095::AID-ANIE4095>3.0.CO;2-9
   MACDIARMID AG, 1985, MOL CRYST LIQ CRYST, V121, P187, DOI 10.1080/00268948508074859
   McDonnell JM, 2001, CURR OPIN CHEM BIOL, V5, P572, DOI 10.1016/S1367-5931(00)00251-9
   Meyer WH, 1998, ADV MATER, V10, P439, DOI 10.1002/(SICI)1521-4095(199804)10:6<439::AID-ADMA439>3.0.CO;2-I
   Mitschke U, 2000, J MATER CHEM, V10, P1471, DOI 10.1039/a908713c
   MO D, 1993, THIN SOLID FILMS, V234, P468, DOI 10.1016/0040-6090(93)90309-D
   MORRIS DL, 1983, METHOD ENZYMOL, V92, P413
   Mullett WM, 2000, METHODS, V22, P77, DOI 10.1006/meth.2000.1039
   Oekermann T, 2001, PHYS CHEM CHEM PHYS, V3, P3387, DOI 10.1039/b101024g
   OHSAKA T, 1984, J ELECTROANAL CHEM, V161, P399, DOI 10.1016/0368-1874(84)83662-X
   Palaniappan S, 2001, EUR POLYM J, V37, P975, DOI 10.1016/S0014-3057(00)00207-X
   Raiteri R, 2001, SENSOR ACTUAT B-CHEM, V79, P115, DOI 10.1016/S0925-4005(01)00856-5
   Rao JH, 1999, J AM CHEM SOC, V121, P2629, DOI 10.1021/ja9838763
   SADOWSKI JW, 1995, OPT ENG, V34, P2581, DOI 10.1117/12.208083
   Salamon Z, 1997, BBA-REV BIOMEMBRANES, V1331, P117, DOI 10.1016/S0304-4157(97)00004-X
   Sasaki S, 1998, ANAL CHIM ACTA, V368, P71, DOI 10.1016/S0003-2670(98)00200-1
   Schlereth DD, 1998, J ELECTROANAL CHEM, V444, P231, DOI 10.1016/S0022-0728(97)00578-0
   Schlereth DD, 1999, J ELECTROANAL CHEM, V464, P198, DOI 10.1016/S0022-0728(99)00019-4
   Schmidt HL, 1996, BIOSENS BIOELECTRON, V11, P127, DOI 10.1016/0956-5663(96)83720-1
   SCHUHMANN W, 1991, J AM CHEM SOC, V113, P1394, DOI 10.1021/ja00004a048
   Shipway AN, 2001, ACCOUNTS CHEM RES, V34, P421, DOI 10.1021/ar000180h
   Sota H, 1998, ANAL CHEM, V70, P2019, DOI 10.1021/ac9713666
   Tsoi PY, 2000, LANGMUIR, V16, P6590, DOI 10.1021/la9912951
   Willner I, 1996, J AM CHEM SOC, V118, P10321, DOI 10.1021/ja9608611
   WILLNER I, 1993, ADV MATER, V5, P912, DOI 10.1002/adma.19930051206
   Willner I, 1998, J CHEM SOC PERK T 2, P1817, DOI 10.1039/a801487f
   Willner I, 1997, BIOSENS BIOELECTRON, V12, P337, DOI 10.1016/S0956-5663(96)00065-6
   Willner I, 2000, ANGEW CHEM INT EDIT, V39, P1180, DOI 10.1002/(SICI)1521-3773(20000403)39:7<1180::AID-ANIE1180>3.0.CO;2-E
   WILLNER I, 1992, J AM CHEM SOC, V114, P10965, DOI 10.1021/ja00053a045
   Willner I, 2001, PURE APPL CHEM, V73, P535, DOI 10.1351/pac200173030535
   Willner I, 1996, ANGEW CHEM INT EDIT, V35, P367, DOI 10.1002/anie.199603671
   Willner I, 1998, J PHYS ORG CHEM, V11, P546, DOI 10.1002/(SICI)1099-1395(199808/09)11:8/9<546::AID-POC49>3.0.CO;2-Q
   Willner I, 1997, ELECTROANAL, V9, P965, DOI 10.1002/elan.1140091302
   WILLNER I, 1994, J AM CHEM SOC, V116, P1428, DOI 10.1021/ja00083a031
   Yan JC, 2001, J PHYS CHEM B, V105, P8905, DOI 10.1021/jp011233v
   YANG CY, 1994, POLYMER, V35, P1142, DOI 10.1016/0032-3861(94)90004-3
NR 94
TC 222
Z9 225
U1 3
U2 92
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0002-7863
J9 J AM CHEM SOC
JI J. Am. Chem. Soc.
PD JUN 5
PY 2002
VL 124
IS 22
BP 6487
EP 6496
DI 10.1021/ja012680r
PG 10
WC Chemistry, Multidisciplinary
SC Chemistry
GA 558FC
UT WOS:000175954800042
PM 12033880
DA 2018-10-20
ER

PT J
AU Chang, Y
   Tsai, CC
   Liang, HC
   Sung, HW
AF Chang, Y
   Tsai, CC
   Liang, HC
   Sung, HW
TI In vivo evaluation of cellular and acellular bovine pericardia fixed
   with a naturally occurring crosslinking agent (genipin)
SO BIOMATERIALS
LA English
DT Article
DE acellular tissue; genipin; glutaraldehyde; biocompatibility; tissue
   regeneration
ID IN-VITRO EVALUATION; CROSS-LINKING AGENT; TISSUE FIXATION; FOLLOW-UP;
   BIOMATERIAL; COLLAGEN; CALCIFICATION; CYTOTOXICITY
AB A cell extraction process was employed in the study to remove the cellular components from bovine pericardium leaving a framework of largely insoluble collagen and elastin. It was hypothesized in the literature that this process may decrease the antigenic load (or increase the biocompatibility) within the material. Additionally, acellular tissues may provide a natural microenvironment for host-cell migration to regenerate the tissue. The study was to evaluate the biocompatibility of cellular and acellular bovine pericardia fixed with a naturally occurring crosslinking agent (genipin) implanted subcutaneously in a growing rat model. Additionally, the tissue regeneration rate ill the genipin-fixed acellular tissue was investigated. The glutaraldehyde-fixed counterparts were used as controls. The results indicated that the degrees in inflammatory reaction for the genipin-fixed cellular and acellular tissues were significantly less than their glutaraldehyde-fixed counterparts. Additionally. it was noted that the inflammatory reactions for the glutaraldehyde-fixed cellular and acellular tissues lasted much longer than their genipin-fixed counterparts. The tissue regeneration rate for the genipin-fixed acellular tissue was significantly faster than its glutaraldehyde-fixed counterpart. The calcium content of each Studied group, analyzed by atomic absorption, did not change significantly until at the 52nd week, postoperatively. The differences in calcium content between the cellular and acellular tissues were insignificant for both the glutaraldehyde- and genipin-fixed groups throughout the entire course of the study. In summary, the biocompatibility of the genipin-fixed cellular and acellular tissues was superior to their glutaraldehyde-fixed counterparts. The genipin-fixed acellular tissue provided a better microenvironment for tissue regeneration than its glutaraldehyde-fixed counterpart, due to its low cytotoxicity. These results suggested that the genipin-fixed acellular tissue might be used as a tissue-engineering matrix in the clinical applications. (C) 2002 Published by Elsevier Science Ltd.
C1 Natl Tsing Hua Univ, Dept Chem Engn, Hsinchu 30013, Taiwan.
   Natl Yang Ming Univ, Coll Med, Taipei 112, Taiwan.
   Vet Gen Hosp, Div Cardiovasc Surg, Taichung, Taiwan.
RP Sung, HW (reprint author), Natl Tsing Hua Univ, Dept Chem Engn, Hsinchu 30013, Taiwan.
CR ARAUJO JD, 1987, J CARDIOVASC SURG, V28, P434
   CIPRIANO PR, 1982, CIRCULATION, V66, P1100, DOI 10.1161/01.CIR.66.5.1100
   COURTMAN DW, 1994, J BIOMED MATER RES, V28, P655, DOI 10.1002/jbm.820280602
   Courtman DW, 2001, J BIOMED MATER RES, V55, P576, DOI 10.1002/1097-4636(20010615)55:4<576::AID-JBM1051>3.0.CO;2-9
   GABBAY S, 1984, J THORAC CARDIOV SUR, V88, P758
   GORHAM SD, 1990, BIOMATERIALS, V11, P113, DOI 10.1016/0142-9612(90)90125-A
   MALONE JM, 1984, J VASC SURG, V1, P181, DOI 10.1067/mva.1984.avs0010181
   MCCLAIN PE, 1972, J BIOL CHEM, V247, P692
   Nimni ME, 1988, COLLAGEN, VIII, P1
   NISHI C, 1995, J BIOMED MATER RES, V29, P829, DOI 10.1002/jbm.820290707
   Noishiki Y., 1989, U. S. Patent, Patent No. [4,806,599, 4806599]
   Rosenberg D., 1978, VASCULAR GRAFTS, P261
   SCHOEN FJ, 1988, J BIOMED MATER RES-A, V22, P11
   SEGESSER L V, 1987, Journal of Thoracic and Cardiovascular Surgery, V93, P616
   SILVER IA, 1988, EXP CELL RES, V175, P266, DOI 10.1016/0014-4827(88)90191-7
   SPEER DP, 1980, J BIOMED MATER RES, V14, P753, DOI 10.1002/jbm.820140607
   Sung HW, 1999, J BIOMAT SCI-POLYM E, V10, P63, DOI 10.1163/156856299X00289
   Sung HW, 1996, J BIOMED MATER RES, V31, P511, DOI 10.1002/(SICI)1097-4636(199608)31:4<511::AID-JBM11>3.0.CO;2-J
   Sung HW, 1999, BIOMATERIALS, V20, P1759, DOI 10.1016/S0142-9612(99)00069-1
   Tsai CC, 2000, J BIOMED MATER RES, V52, P58, DOI 10.1002/1097-4636(200010)52:1<58::AID-JBM8>3.0.CO;2-0
   VALENTE M, 1985, AM J PATHOL, V119, P12
   WILSON GJ, 1990, T AM SOC ART INT ORG, V36, P340
NR 22
TC 110
Z9 119
U1 1
U2 16
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2002
VL 23
IS 12
BP 2447
EP 2457
AR PII S0142-9612(01)00379-9
DI 10.1016/S0142-9612(01)00379-9
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 551EU
UT WOS:000175547200002
PM 12033592
DA 2018-10-20
ER

PT J
AU Krasteva, N
   Harms, U
   Albrecht, W
   Seifert, B
   Hopp, M
   Altankov, G
   Groth, T
AF Krasteva, N
   Harms, U
   Albrecht, W
   Seifert, B
   Hopp, M
   Altankov, G
   Groth, T
TI Membranes for biohybrid liver support systems - investigations on
   hepatocyte attachment, morphology and growth
SO BIOMATERIALS
LA English
DT Article
DE polymer membranes; surface properties; hepatoblastoma cells;
   cell-biomaterial interaction; biohybrid liver
ID SURFACE WETTABILITY; CYTOSKELETAL ORGANIZATION; CELL ATTACHMENT;
   ADHESION; BIOMATERIALS; FIBRONECTIN; BIOCOMPATIBILITY; MODULATION;
   TISSUE; TOPOGRAPHY
AB The biological properties of four different membranes were studied regarding their possible application in biohybrid liver support systems. Two of them, one made of polyetherimide (PEI), and a second based on polyacrylonitrile-N-vinylpyrollidone co-polymer (P(AN-NVP)), were recently developed in our lab and studied for the first time. Together with pure polyacrylonitrile (PAN) membranes, the three preparations were characterised as ultra-filtration membranes. Their ability to support cell attachment, morphology, proliferation and function of human hepatoblastoma C3A cells was studied. The role of surface morphology for the interaction with hepatocytes was highlighted using a commercial, moderately wettable polyvinylidendifluoride (PVDF) membrane with micro-filtration properties. Comparative investigations showed strongest interaction of C3A cells with PAN membranes, as the focal adhesion contacts were more expressed and cell growth was also high. However, the functional activity in terms of albumin synthesis was reduced. Very similar results were obtained with the most hydrophobic PEI membrane. In contrast, the most hydrophilic membrane P(AN-NVP) was found to provoke stronger homotypic adhesion (E-cadherin expression) of C3A cells and less substratum attachment (focal adhesions). but enhanced albumin secretion. However, proliferation of C3A cells was lowered. Micro-porous PVDF membrane showed very good initial attachment, but the resulting cell material and cell-cell interaction were relatively poor developed. Among four membranes tested, PEI seems to be the most attractive membrane for biohybrid liver devices, as it provides good surface properties for hepatocytes interaction, but in addition it is highly thermostable, which would permit steam sterilisation. No simple relationship, however, between the wettability of the membranes and their ability to support hepatocyte adhesion and function was found in this study. (C) 2002 Published by Elsevier Science Ltd.
C1 GKSS Forschungszentrum Geesthacht GmbH, Dept Membrane Res, Inst Chem, Dept Biomat, D-14513 Teltow, Germany.
   Bulgarian Acad Sci, Inst Biophys, BG-1113 Sofia, Bulgaria.
   Humboldt Univ, Fac Med Charite, Clin Dent Prosthet, D-10177 Berlin, Germany.
RP Groth, T (reprint author), GKSS Forschungszentrum Geesthacht GmbH, Dept Membrane Res, Inst Chem, Dept Biomat, Kantstr 55, D-14513 Teltow, Germany.
RI Seifert, Barbara/K-7569-2012
OI Groth, Thomas/0000-0001-6647-9657
CR Altankov G, 1996, J BIOMED MATER RES, V30, P385, DOI 10.1002/(SICI)1097-4636(199603)30:3<385::AID-JBM13>3.0.CO;2-J
   Altankov G, 1996, J BIOMAT SCI-POLYM E, V8, P299
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   BADER A, 1995, ARTIF ORGANS, V19, P368, DOI 10.1111/j.1525-1594.1995.tb02343.x
   Biran R, 1999, J BIOMED MATER RES, V46, P150, DOI 10.1002/(SICI)1097-4636(199908)46:2<150::AID-JBM3>3.3.CO;2-K
   Catapano G, 1996, J BIOMAT SCI-POLYM E, V7, P1017, DOI 10.1163/156856296X00417
   Culp LA, 1998, J BIOMAT SCI-POLYM E, V9, P1161, DOI 10.1163/156856298X00703
   Dalton BA, 1999, J BIOMED MATER RES, V45, P384, DOI 10.1002/(SICI)1097-4636(19990615)45:4<384::AID-JBM14>3.0.CO;2-O
   Deligianni DD, 2001, BIOMATERIALS, V22, P87, DOI 10.1016/S0142-9612(00)00174-5
   Evans MDM, 1999, J BIOMED MATER RES, V46, P485, DOI 10.1002/(SICI)1097-4636(19990915)46:4<485::AID-JBM6>3.0.CO;2-F
   GERLACH J, 1989, INT J ARTIF ORGANS, V12, P788
   Gerlach JC, 1996, INT J ARTIF ORGANS, V19, P645
   Griffith LG, 2000, ACTA MATER, V48, P263, DOI 10.1016/S1359-6454(99)00299-2
   GRINNELL F, 1981, J BIOMED MATER RES, V15, P363, DOI 10.1002/jbm.820150308
   GRINNELL F, 1973, BIOCHEM MED METAB B, V7, P87, DOI 10.1016/0006-2944(73)90102-6
   Groth T, 1998, BIOM HLTH R, V16, P12
   GROTH T, IN PRESS DEPENDENCE
   Gumbiner BM, 2000, J CELL BIOL, V148, P399, DOI 10.1083/jcb.148.3.399
   Hughes RD, 1996, INT J ARTIF ORGANS, V19, P3
   IMAI Y, 1983, J BIOMED MATER RES, V17, P905, DOI 10.1002/jbm.820170602
   INGBER DE, 1997, PRINCIPLES TISSUE EN, P89
   JULIANO DJ, 1993, J BIOMED MATER RES, V27, P1103
   KLINKMANN H, 1995, NEPHROL DIAL TRANSPL, V10, P39, DOI 10.1093/ndt/10.supp3.39
   KNEIFEL K, 1992, J MEMBRANE SCI, V65, P295, DOI 10.1016/0376-7388(92)87030-2
   Krasteva N, 2001, J BIOMAT SCI-POLYM E, V12, P613, DOI 10.1163/156856201316883449
   LEDU C, 1999, MED DEV TECHN C LOND
   Park D, 1996, J FOOD LIPIDS, V3, P1, DOI 10.1111/j.1745-4522.1996.tb00050.x
   Paul D, 1998, CHEM UNSERER ZEIT, V32, P197, DOI 10.1002/ciuz.19980320405
   Peinemann KV, 1998, POLYMER, V39, P3411, DOI 10.1016/S0032-3861(97)10067-2
   PELUSO G, 1994, J MATER SCI-MATER M, V4, P738
   Qiang S, 1997, INT J ARTIF ORGANS, V20, P119
   RICHARDSON RR, 1993, BIOMATERIALS, V14, P627, DOI 10.1016/0142-9612(93)90183-3
   Ruardy T. G., 1997, Cells and Materials, V7, P123
   Sawamoto K, 1997, IN VITRO CELL DEV-AN, V33, P569
   SEIFERT B, IN PRESS ARTIF ORGAN
   STEELE JG, 1993, J BIOMAT SCI-POLYM E, V5, P245
   TAGAKI M, 1997, CYTOTECHNOLOGY, V24, P39
   TAMADA Y, 1995, BIOMATERIALS, V16, P259, DOI 10.1016/0142-9612(95)92126-Q
   TAMADA Y, 1994, J BIOMED MATER RES, V28, P667
   Te Velde Anje, 1995, Journal of Hepatology, V23, P184, DOI 10.1016/0168-8278(95)80333-5
   TSONEVA R, 2001, 15 AACH C BIOM, P84
   ULUDAG H, 1993, J BIOMED MATER RES, V27, P1213, DOI 10.1002/jbm.820271002
   VANWACHEM PB, 1985, BIOMATERIALS, V6, P403, DOI 10.1016/0142-9612(85)90101-2
   VONSENGBUSCH G, 1993, ARTIF ORGANS, V17, P244
   Webb K, 1998, J BIOMED MATER RES, V41, P422, DOI 10.1002/(SICI)1097-4636(19980905)41:3<422::AID-JBM12>3.0.CO;2-K
   Webb K, 2000, J BIOMED MATER RES, V49, P362, DOI 10.1002/(SICI)1097-4636(20000305)49:3<362::AID-JBM9>3.0.CO;2-S
   10030307244
NR 47
TC 56
Z9 58
U1 0
U2 18
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2002
VL 23
IS 12
BP 2467
EP 2478
AR PII S0142-9612(01)00381-7
DI 10.1016/S0142-9612(01)00381-7
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 551EU
UT WOS:000175547200004
PM 12033594
DA 2018-10-20
ER

PT J
AU Stephansson, SN
   Byers, BA
   Garcia, AJ
AF Stephansson, SN
   Byers, BA
   Garcia, AJ
TI Enhanced expression of the osteoblastic phenotype on substrates that
   modulate fibronectin conformation and integrin receptor binding
SO BIOMATERIALS
LA English
DT Article
DE osteoblast; fibronectin; integrin; biomaterial surface; mineralization
ID BONE CELL-CULTURES; IN-VITRO; BIOACTIVE GLASS; GENE-EXPRESSION; MC3T3-E1
   CELLS; SURFACE-CHEMISTRY; DIFFERENTIATION; ADHESION; MINERALIZATION;
   PROLIFERATION
AB Integrins represent the primary mechanism of cell-extracellular matrix interactions and control cell morphology, proliferation, and differentiation. We have previously shown that substrate-dependent modulation of adsorbed fibronectin (Fn) conformation alters alpha(5)beta(1) integrin binding to Fn and directs C2Cl2 myoblast proliferation and differentiation (Mol. Biol. Cell 10 ( 1999) 785). The model substrates used in these experiments were bacteriological (untreated) polystyrene (B), tissue culture polystyrene (T), and type-I collagen-coated T (C). In the present study, we examined MC3T3-E1 osteoblast-like cell differentiation on Fn-coated B, T, and C substrates. Immunofluorescence staining revealed substrate-dependent differences in integrin alpha(5)beta(1) binding and clustering into focal adhesions (C > T > B), consistent with our previous integrin binding analysis. Alkaline phosphatase activity and matrix mineralization showed substrate-dependent differences (C > T > B, p < 0.05). Similar trends were observed for alkaline phosphatase, osteocalcin, and bone sialoprotein gene expression. Blocking experiments with antibodies directed against Fn completely inhibited matrix mineralization on Fn-coated C, indicating that Fn is critical to expression of the osteoblastic phenotype oil this extracellular matrix component. These substrate-dependent differences in osteoblast differentiation correlated with differences in &alpha;(5)&beta;(1) binding, suggesting that these differences arise from substrate modulation of integrin-matrix interactions. Substrate-dependent modulation of cell function may provide a versatile mechanism to control cell responses in numerous biomedical applications. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Georgia Inst Technol, Sch Mech Engn, Atlanta, GA 30332 USA.
   Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA.
   Georgia Inst Technol, Undergrad Res Scholars Program, Atlanta, GA 30332 USA.
   Georgia Inst Technol, Sch Chem Engn, Atlanta, GA 30332 USA.
RP Garcia, AJ (reprint author), Georgia Inst Technol, Sch Mech Engn, 315 Ferst Drive,Room 2314, Atlanta, GA 30332 USA.
CR ADAMS JC, 1990, CELL, V63, P425, DOI 10.1016/0092-8674(90)90175-E
   Aubin Jane E., 1996, P51
   BISCHOFF R, 1968, J CELL BIOL, V36, P111, DOI 10.1083/jcb.36.1.111
   Choi JY, 1996, J CELL BIOCHEM, V61, P609, DOI 10.1002/(SICI)1097-4644(19960616)61:4<609::AID-JCB15>3.0.CO;2-A
   DAVIES JE, 1988, SCANNING MICROSCOPY, V2, P1445
   Dee KC, 1996, BIOMATERIALS, V17, P209, DOI 10.1016/0142-9612(96)85765-6
   Dickson G, 1984, METHODS CALCIFIED TI
   ELGENDY HM, 1993, BIOMATERIALS, V14, P263, DOI 10.1016/0142-9612(93)90116-J
   ElGhannam A, 1997, J BIOMED MATER RES, V36, P167, DOI 10.1002/(SICI)1097-4636(199708)36:2<167::AID-JBM5>3.0.CO;2-I
   ELGHANNAM A, 1995, J BIOMED MATER RES, V29, P359, DOI 10.1002/jbm.820290311
   FRANCESCHI RT, 1992, J BONE MINER RES, V7, P235
   FRANCESCHI RT, 1994, J BONE MINER RES, V9, P843
   Garcia AJ, 1999, BIOMATERIALS, V20, P2427, DOI 10.1016/S0142-9612(99)00170-2
   Garcia AJ, 1999, MOL BIOL CELL, V10, P785, DOI 10.1091/mbc.10.3.785
   Healy KE, 1996, BIOMATERIALS, V17, P195, DOI 10.1016/0142-9612(96)85764-4
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   ISHAUG SL, 1994, J BIOMED MATER RES, V28, P1445, DOI 10.1002/jbm.820281210
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   MENKO AS, 1987, CELL, V51, P51, DOI 10.1016/0092-8674(87)90009-2
   Moursi AM, 1997, J CELL SCI, V110, P2187
   PARK PK, 1990, J VASC SURG, V11, P468, DOI 10.1067/mva.1990.17242
   PULCO DA, 1991, J BIOMED MATER RES, V25, P711
   Rezania A, 1997, J BIOMED MATER RES, V37, P9, DOI 10.1002/(SICI)1097-4636(199710)37:1<9::AID-JBM2>3.0.CO;2-W
   SAUTIER JM, 1994, CALCIFIED TISSUE INT, V55, P458, DOI 10.1007/BF00298560
   SCHOEN RC, 1982, HYBRIDOMA, V1, P99, DOI 10.1089/hyb.1.1982.1.99
   Scotchford CA, 1998, J BIOMED MATER RES, V41, P431, DOI 10.1002/(SICI)1097-4636(19980905)41:3<431::AID-JBM13>3.0.CO;2-L
   SHARMA SK, 1980, J CHROMATOGR, V184, P471, DOI 10.1016/S0021-9673(00)93875-5
   Simpson D, 2000, MOL VIS, V6, P178
   SODEK J, 1987, METHOD ENZYMOL, V145, P303
   SOROKIN L, 1990, J CELL BIOL, V111, P1265, DOI 10.1083/jcb.111.3.1265
   Stein Gary S., 1996, P69
   STREULI CH, 1991, J CELL BIOL, V115, P1383, DOI 10.1083/jcb.115.5.1383
   SUDO H, 1983, J CELL BIOL, V96, P191, DOI 10.1083/jcb.96.1.191
   VROUWENVELDER WCA, 1992, BIOMATERIALS, V13, P382, DOI 10.1016/0142-9612(92)90044-O
   WERB Z, 1989, J CELL BIOL, V109, P877, DOI 10.1083/jcb.109.2.877
   Xiao GZ, 1998, J BIOL CHEM, V273, P32988, DOI 10.1074/jbc.273.49.32988
   Zhu XY, 1996, J CELL BIOL, V133, P391, DOI 10.1083/jcb.133.2.391
NR 37
TC 97
Z9 102
U1 0
U2 16
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2002
VL 23
IS 12
BP 2527
EP 2534
AR PII S0142-9612(01)00387-8
DI 10.1016/S0142-9612(01)00387-8
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 551EU
UT WOS:000175547200010
PM 12033600
DA 2018-10-20
ER

PT J
AU Hu, WJ
   Eaton, JW
   Ugarova, TP
   Tang, LP
AF Hu, WJ
   Eaton, JW
   Ugarova, TP
   Tang, LP
TI Molecular basis of biomaterial-mediated foreign body reactions (vol 98,
   pg 1231, 2001)
SO BLOOD
LA English
DT Correction
CR Hu WJ, 2001, BLOOD, V98, P1231, DOI 10.1182/blood.V98.4.1231
NR 1
TC 2
Z9 2
U1 0
U2 5
PU AMER SOC HEMATOLOGY
PI WASHINGTON
PA 1900 M STREET. NW SUITE 200, WASHINGTON, DC 20036 USA
SN 0006-4971
J9 BLOOD
JI Blood
PD JUN 1
PY 2002
VL 99
IS 11
BP 3908
EP 3908
PG 1
WC Hematology
SC Hematology
GA 555QL
UT WOS:000175804700005
DA 2018-10-20
ER

PT J
AU Comuzzi, L
   Ooms, E
   Jansen, JA
AF Comuzzi, L
   Ooms, E
   Jansen, JA
TI Injectable calcium phosphate cement as a filler for bone defects around
   oral implants: an experimental study in goats
SO CLINICAL ORAL IMPLANTS RESEARCH
LA English
DT Article
DE oral implants; calcium phosphate cement; gap bone filler; animal study
ID HYDROXYAPATITE CEMENT; EXTRACTION SOCKETS; COATED IMPLANTS; TRABECULAR
   BONE; MEMBRANES; INTERFACE; COMBINATION; BIOMATERIAL; COATINGS; SITES
AB The aim of this study was to evaluate the clinical applicability and biological behavior of a newly developed injectable calcium phosphate (Ca-P) cement as bone filler for gaps around oral implants. Twenty-four step-like implants, creating gaps of 1 and 2 mm, were inserted into the trabecular bone of the medial femoral condyles of six goats. Four different situations were tested: (1) implant + gaps; (2) implant + gaps, but covered with a polylactic acid membrane; (3) implant + gaps that were filled with Ca-P cement; and (4) implant + gaps that were filled with Ca-P cement and covered with a membrane. All implants were left in place for 12 weeks. Histological and quantitative histomorphometrical measurements demonstrated that implants + gaps had generally poor bone contact at the implant base. Furthermore, fibrous encapsulation was observed in the gap part. In contrast, the presence of a membrane promoted bone ingrowth into the gap and also the bone contact at the implant base. Injection of Ca-P cement resulted in an almost complete filling of the gaps around the implant. The cement surface was completely covered by bone. Active resorption and remodeling of cement particles was observed, suggesting a pattern of slow resorption associated with full replacement with newly formed bone. Additional use of a membrane did not result in adjunctive benefits. Bone-to-implant contact at the implant base was comparable with the implants provided only with a membrane. In conclusion, the Ca-P cement used here showed excellent clinical handling proper-ties combined with a superior bone behavior. On the other hand, the degradation rate of the material was still very slow. This current characteristic can hamper the final clinical applicability of the material as gap filler for periimplant or periodontal defects.
C1 Univ Nijmegen, Med Ctr, Coll Dent Sci, Dept Biomat, NL-6500 HB Nijmegen, Netherlands.
   Univ Nijmegen, Med Ctr, Coll Dent Sci, Dept Periodontol, NL-6500 HB Nijmegen, Netherlands.
RP Jansen, JA (reprint author), Univ Nijmegen, Med Ctr, Coll Dent Sci, Dept Biomat, POB 9101, NL-6500 HB Nijmegen, Netherlands.
RI Jansen, John/H-8055-2014
CR Akimoto K, 1999, INT J ORAL MAX IMPL, V14, P351
   BECKER W, 1992, J PERIODONTOL, V63, P929, DOI 10.1902/jop.1992.63.11.929
   BECKER W, 1990, INT J PERIODONT REST, V10, P377
   Brunski JB, 2000, INT J ORAL MAX IMPL, V15, P15
   CARLSSON L, 1988, ACTA ORTHOP SCAND, V59, P272, DOI 10.3109/17453678809149361
   Clemens JAM, 1998, J BIOMED MATER RES, V40, P341, DOI 10.1002/(SICI)1097-4636(19980605)40:3<341::AID-JBM1>3.3.CO;2-V
   Clemens JAM, 1997, J BIOMED MATER RES, V36, P55, DOI 10.1002/(SICI)1097-4636(199707)36:1<55::AID-JBM7>3.0.CO;2-K
   DENISSEN HW, 1989, J PROSTHET DENT, V61, P706, DOI 10.1016/S0022-3913(89)80047-2
   Dies F, 1996, CLIN ORAL IMPLAN RES, V7, P277, DOI 10.1034/j.1600-0501.1996.070310.x
   Friedman CD, 1998, J BIOMED MATER RES, V43, P428, DOI 10.1002/(SICI)1097-4636(199824)43:4<428::AID-JBM10>3.0.CO;2-0
   Ginebra MP, 1997, J DENT RES, V76, P905, DOI 10.1177/00220345970760041201
   HJORTING-HANSEN E, 1990, International Journal of Oral and Maxillofacial Implants, V5, P255
   JANSEN JA, 1995, J MATER SCI-MATER M, V6, P653, DOI 10.1007/BF00123447
   Jansen JA, 1996, J INVEST SURG, V9, P463, DOI 10.3109/08941939609025864
   KLEIN CPAT, 1994, J APPL BIOMATER, V5, P369, DOI 10.1002/jab.770050413
   KLEIN CPAT, 1994, J MATER SCI-MATER M, V5, P569, DOI 10.1007/BF00120332
   KNOX R, 1991, INT J PERIODONT REST, V11, P365
   LeGeros R Z, 1988, Adv Dent Res, V2, P164
   LEKHOLM U, 1993, CLIN ORAL IMPLAN RES, V4, P121, DOI 10.1034/j.1600-0501.1993.040302.x
   Lekovic V, 1997, J PERIODONTOL, V68, P563, DOI 10.1902/jop.1997.68.6.563
   MAXIAN SH, 1994, J BIOMED MATER RES, V28, P1311, DOI 10.1002/jbm.820281109
   MELLONIG JT, 1993, INT J PERIODONT REST, V13, P109
   Meraw SJ, 2000, J PERIODONTOL, V71, P8, DOI 10.1902/jop.2000.71.1.8
   Simion M, 1997, INT J ORAL MAX IMPL, V12, P159
   Soballe K, 1993, Acta Orthop Scand Suppl, V255, P1
   Szmukler-Moncler S, 1998, J BIOMED MATER RES, V43, P192, DOI 10.1002/(SICI)1097-4636(199822)43:2<192::AID-JBM14>3.0.CO;2-K
   Vercaigne S, 2000, CLIN ORAL IMPLAN RES, V11, P314, DOI 10.1034/j.1600-0501.2000.011004314.x
   Wennerberg A, 1998, CLIN ORAL IMPLAN RES, V9, P11, DOI 10.1034/j.1600-0501.1998.090102.x
   Wilson TG, 1998, INT J ORAL MAX IMPL, V13, P333
   Wiskott HWA, 1999, CLIN ORAL IMPLAN RES, V10, P429, DOI 10.1034/j.1600-0501.1999.100601.x
NR 30
TC 66
Z9 69
U1 0
U2 6
PU BLACKWELL MUNKSGAARD
PI COPENHAGEN
PA 35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK
SN 0905-7161
J9 CLIN ORAL IMPLAN RES
JI Clin. Oral Implant. Res.
PD JUN
PY 2002
VL 13
IS 3
BP 304
EP 311
DI 10.1034/j.1600-0501.2002.130311.x
PG 8
WC Dentistry, Oral Surgery & Medicine; Engineering, Biomedical
SC Dentistry, Oral Surgery & Medicine; Engineering
GA 554NM
UT WOS:000175742100011
PM 12010162
DA 2018-10-20
ER

PT J
AU Andersson, J
   Ekdahl, KN
   Larsson, R
   Nilsson, UR
   Nilsson, B
AF Andersson, J
   Ekdahl, KN
   Larsson, R
   Nilsson, UR
   Nilsson, B
TI C3 adsorbed to a polymer surface can form an initiating alternative
   pathway convertase
SO JOURNAL OF IMMUNOLOGY
LA English
DT Article
ID HUMAN-COMPLEMENT; MONOCLONAL-ANTIBODIES; PUTATIVE THIOESTER;
   SOLID-SURFACES; C-3 CONVERTASE; HUMAN-PLASMA; BOUND C-3; FACTOR-B;
   ACTIVATION; BINDING
AB Contact between blood and a biomaterial surface induces an immediate complement-mediated inflammatory response. Under these conditions, the alternative pathway of complement is often initiated and amplified on the biomaterial surface. Adsorption of a protein such as C3 to a polymer surface induces conformational changes in the protein. Based on the expression on adsorbed C3 of conformational neoepitopes specific for bound C3 fragments, we have hypothesized that adsorbed C3 is able to bind factor B and form a functional C3,Bb convertase. Using a quartz crystal microbalance to monitor binding of proteins to a polymer surface, we have demonstrated that a functional C3-containing alternative pathway convertase can be formed, in particular, in the presence of properdin. These data indicate that adsorption of C3 induces conformational changes that turn C3 into a Cab-like molecule that is able to participate in the functioning of the alternative convertase, and they suggest a new mechanism for complement activation on a biomaterial surface.
C1 Univ Uppsala Hosp, Dept Oncol Radiol & Clin Immunol, S-75185 Uppsala, Sweden.
   Univ Kalmar, Dept Chem & Biomed Sci, Kalmar, Sweden.
RP Nilsson, B (reprint author), Univ Uppsala Hosp, Dept Oncol Radiol & Clin Immunol, S-75185 Uppsala, Sweden.
EM Bo.Nilsson@klinimm.uu.se
RI Nilsson, Bo/B-3102-2012; Nilsson Ekdahl, Kristina/B-5301-2012
OI Nilsson, Bo/0000-0003-0057-2730; 
CR ALSENZ J, 1990, CURR TOP MICROBIOL, V153, P235
   CARRENO MP, 1988, MOL IMMUNOL, V25, P165, DOI 10.1016/0161-5890(88)90064-8
   Caruso F, 1997, J COLLOID INTERF SCI, V186, P129, DOI 10.1006/jcis.1996.4625
   CATANA E, 1991, J IMMUNOL METHODS, V138, P265, DOI 10.1016/0022-1759(91)90175-F
   DISCIPIO RG, 1981, BIOCHEM J, V199, P485, DOI 10.1042/bj1990485
   EKDAHL KN, 1992, SCAND J IMMUNOL, V35, P85, DOI 10.1111/j.1365-3083.1992.tb02837.x
   ELWING H, 1988, J COLLOID INTERF SCI, V125, P139, DOI 10.1016/0021-9797(88)90062-8
   FEARON DT, 1977, J IMMUNOL, V119, P1248
   FEARON DT, 1977, J EXP MED, V146, P22, DOI 10.1084/jem.146.1.22
   FISHELSON Z, 1982, J IMMUNOL, V129, P2603
   GOBEL RJ, 1987, BIOMATERIALS, V8, P285, DOI 10.1016/0142-9612(87)90116-5
   Gupta-Bansal R, 2000, MOL IMMUNOL, V37, P191, DOI 10.1016/S0161-5890(00)00047-X
   HACK CE, 1990, J IMMUNOL, V144, P4249
   HAMMER CH, 1981, J BIOL CHEM, V256, P3995
   Hook F, 2001, ANAL CHEM, V73, P5796, DOI 10.1021/ac0106501
   Hook F, 1998, P NATL ACAD SCI USA, V95, P12271, DOI 10.1073/pnas.95.21.12271
   Hook F, 1998, J COLLOID INTERF SCI, V208, P63, DOI 10.1006/jcis.1998.5774
   Jokiranta TS, 2001, INT IMMUNOPHARMACOL, V1, P495, DOI 10.1016/S1567-5769(00)00042-4
   LACHMANN PJ, 1973, LANCET, V1, P465
   LACHMANN PJ, 1975, CLIN EXP IMMUNOL, V21, P109
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LAMBRIS JD, 1984, J BIOL CHEM, V259, P2685
   MARTIN A, 1976, IMMUNOCHEMISTRY, V13, P317, DOI 10.1016/0019-2791(76)90341-4
   MEDICUS RG, 1980, J IMMUNOL, V124, P602
   MINTA JO, 1978, J IMMUNOL METHODS, V19, P153, DOI 10.1016/0022-1759(78)90175-8
   NILSSON B, 1990, BIOCHEM J, V268, P55, DOI 10.1042/bj2680055
   Nilsson B, 1998, BLOOD, V92, P1661
   NILSSON B, 1986, IMMUNOL LETT, V13, P11, DOI 10.1016/0165-2478(86)90118-5
   NILSSON B, 1986, SCAND J IMMUNOL, V23, P357, DOI 10.1111/j.1365-3083.1986.tb01976.x
   NILSSON B, 1987, MOL IMMUNOL, V24, P487, DOI 10.1016/0161-5890(87)90023-X
   NILSSON B, 1989, MOL IMMUNOL, V26, P383, DOI 10.1016/0161-5890(89)90127-2
   NILSSON B, 1985, SCAND J IMMUNOL, V22, P703, DOI 10.1111/j.1365-3083.1985.tb01933.x
   NILSSON B, 1992, BIOCHEM J, V282, P715, DOI 10.1042/bj2820715
   NILSSON B, 1988, J IMMUNOL METHODS, V107, P281, DOI 10.1016/0022-1759(88)90229-3
   NILSSON UR, 1984, J IMMUNOL METHODS, V72, P49, DOI 10.1016/0022-1759(84)90432-0
   NILSSON UR, 1965, J EXP MED, V122, P277, DOI 10.1084/jem.122.2.277
   NILSSON UR, 1982, J IMMUNOL, V129, P2594
   NILSSON UR, 1993, MOL IMMUNOL, V30, P211, DOI 10.1016/0161-5890(93)90050-L
   PANGBURN MK, 1980, J EXP MED, V152, P1102, DOI 10.1084/jem.152.4.1102
   PANGBURN MK, 1978, P NATL ACAD SCI USA, V75, P2416, DOI 10.1073/pnas.75.5.2416
   PANGBURN MK, 1983, J IMMUNOL, V131, P1930
   PANGBURN MK, 1981, J EXP MED, V154, P856, DOI 10.1084/jem.154.3.856
   PEKNA M, 1993, CLIN EXP IMMUNOL, V91, P404
   PLATTSMI.TA, 1974, J IMMUNOL, V113, P348
   RODAHL M, 1995, REV SCI INSTRUM, V66, P3924, DOI 10.1063/1.1145396
   SAUERBREY G, 1959, Z PHYS, V155, P206, DOI 10.1007/BF01337937
NR 46
TC 83
Z9 86
U1 0
U2 5
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0022-1767
EI 1550-6606
J9 J IMMUNOL
JI J. Immunol.
PD JUN 1
PY 2002
VL 168
IS 11
BP 5786
EP 5791
DI 10.4049/jimmunol.168.11.5786
PG 6
WC Immunology
SC Immunology
GA 555WA
UT WOS:000175815200052
PM 12023380
OA Bronze
DA 2018-10-20
ER

PT J
AU Mendes, SC
   Sleijster, M
   van den Muysenberg, A
   de Bruijn, JD
   van Blitterswijk, CA
AF Mendes, SC
   Sleijster, M
   van den Muysenberg, A
   de Bruijn, JD
   van Blitterswijk, CA
TI A cultured living bone equivalent enhances bone formation when compared
   to a cell seeding approach
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID MARROW STROMAL FIBROBLASTS; IN-VIVO; POROUS CERAMICS; TRANSPLANTATION;
   OSTEOGENESIS; HYDROXYAPATITE; INVITRO; GROWTH; GRAFT; RAT
AB The development of cell therapy methods to confer osteogenic potential to synthetic bone replacement materials has become common during the last years. At present, in the bone tissue engineering field, two different approaches use patient own cultured osteogenic cells in combination with a scaffold material to engineer autologous osteogenic grafts. One of the approaches consists of seeding cells on a suitable biomaterial, after which the construct is ready for implantation. In the other approach, the seeded cells are further cultured on the scaffold to obtain in vitro formed bone (extracellular matrix and cells), prior to implantation. In the present study, we investigated the in vivo osteogenic potential of both methods through the implantation of porous hydroxyapatite (HA) scaffolds coated with a layer of in vitro formed bone and porous HA scaffolds seeded with osteogenic cells. Results showed that as early as 2 days after implantation, de novo bone tissue was formed on scaffolds in which an in vitro bone-like tissue was cultured, while it was only detected on the cell seeded implants from 4 days onwards. In addition, after 4 days of implantation statistical analysis revealed a significantly higher amount of bone in the bone-like tissue containing scaffolds as compared to cell seeded ones. (C) 2002 Kluwer Academic Publishers.
C1 IsoTis NV, NL-3723 MB Bilthoven, Netherlands.
   Univ Twente, IBME, NL-7500 AE Enschede, Netherlands.
RP Mendes, SC (reprint author), IsoTis NV, Prof Bronkhorstlaan 10, NL-3723 MB Bilthoven, Netherlands.
OI van Blitterswijk, Clemens/0000-0003-2371-4615
CR AUBIN JE, 1996, PRINCIPLES BONE BIOL, P39
   Bianco P, 2001, STEM CELLS, V19, P180, DOI 10.1634/stemcells.19-3-180
   Bruder SP, 1998, J ORTHOPAED RES, V16, P155, DOI 10.1002/jor.1100160202
   DAMIEN CJ, 1991, J APPL BIOMATER, V2, P187, DOI 10.1002/jab.770020307
   DAVIES JE, 1991, CELL MATER, V1, P3
   de Bruijn J D, 1999, Adv Dent Res, V13, P74
   DEBOER HH, 1988, CLIN ORTH OP, P226
   DEBRUIJN JD, 1992, MATER RES SOC SYMP P, V252, P63
   Dennis JE, 1998, BIOMATERIALS, V19, P1323, DOI 10.1016/S0142-9612(97)00170-1
   HAYNESWORTH SE, 1992, BONE, V13, P81, DOI 10.1016/8756-3282(92)90364-3
   Ishaug Riley S L, 1997, J BIOMED MATER RES, V36, P1
   Ishaug Riley SL, 1998, BIOMATERIALS, V19, P1405
   Ishaug SL, 1997, J BIOMED MATER RES, V36, P17
   Krebsbach PH, 1997, TRANSPLANTATION, V63, P1059, DOI 10.1097/00007890-199704270-00003
   Kuznetsov SA, 1997, J BONE MINER RES, V12, P1335, DOI 10.1359/jbmr.1997.12.9.1335
   Lee YM, 2001, J BIOMED MATER RES, V54, P216, DOI 10.1002/1097-4636(200102)54:2<216::AID-JBM8>3.0.CO;2-C
   Lennon DP, 1996, IN VITRO CELL DEV-AN, V32, P602
   Lind M, 1996, ACTA ORTHOP SCAND, V67, P407, DOI 10.3109/17453679609002342
   MANIATOPOULOS C, 1988, CELL TISSUE RES, V254, P317
   Mendes SC, 1998, J MATER SCI-MATER M, V9, P855, DOI 10.1023/A:1008904413859
   MENDES SC, 2002, IN PRESS TISSUE ENG
   MENDES SC, 2000, BONE ENG, P505
   OHGUSHI H, 1990, J BIOMED MATER RES, V24, P1563, DOI 10.1002/jbm.820241202
   OHGUSHI H, 1990, ACTA ORTHOP SCAND, V61, P431, DOI 10.3109/17453679008993556
   SCUTT A, 1992, BIOFACTORS, V4, P1
   TRIFFITT JT, 1998, ADV ORGAN BIOL SERIE, P429
   Yaszemski MJ, 1996, BIOMATERIALS, V17, P175, DOI 10.1016/0142-9612(96)85762-0
   Yoshikawa T, 2000, TRANSPLANTATION, V69, P128, DOI 10.1097/00007890-200001150-00022
   Yoshikawa T, 1998, BIO-MED MATER ENG, V8, P311
   Yoshikawa T, 1997, BIO-MED MATER ENG, V7, P49
NR 30
TC 20
Z9 21
U1 0
U2 2
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JUN
PY 2002
VL 13
IS 6
BP 575
EP 581
DI 10.1023/A:1015178827323
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 542WM
UT WOS:000175068600006
PM 15348587
DA 2018-10-20
ER

PT J
AU Wang, M
   Chandrasekaran, M
   Bonfield, W
AF Wang, M
   Chandrasekaran, M
   Bonfield, W
TI Friction and wear of hydroxyapatite reinforced high density polyethylene
   against the stainless steel counterface
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID COMPOSITES
AB Hydroxyapatite (HA) reinforced high density polyethylene (HDPE) was invented as a biomaterial for skeletal applications. In this investigation, tribological properties (e.g. wear rate and coefficient of friction) of unfilled HDPE and HA/HDPE composites were evaluated against the duplex stainless steel in dry and lubricated conditions, with distilled water or aqueous solutions of proteins (egg albumen or glucose) being lubricants. Wear tests were conducted in a custom-built test rig for HDPE and HA/HDPE containing up to 40 vol % of HA. It was found that HA/HDPE composites had lower coefficients of friction than unfilled HDPE under certain conditions. HA/HDPE also exhibited less severe fatigue failure marks than HDPE. The degradation and fatigue failure of HDPE due to the presence of proteins were severe for low speed wear testing (100 rpm) as compared to high speed wear testing (200 rpm). This was due possibly to the high shear rate at the contact which could remove any degraded film instantaneously at high sliding speed, while with a low sliding speed the build-up of a degraded layer of protein could occur. The degraded protein layer would stay at the contact for a longer time and mechanical activation would induce adverse reactions, weakening the surface layer of HDPE. Both egg albumen and glucose were found to be corrosive to steel and adversely reactive for HDPE and HA/HDPE composites. The wear modes observed were similar to that of ultra-high molecular weight polyethylene. Specimens tested with egg albumen also displayed higher wear rates, which was again attributed to corrosion accelerated wear. (C) 2002 Kluwer Academic Publishers.
C1 Nanyang Technol Univ, Sch Mech & Prod Engn, Singapore 639798, Singapore.
   Univ Cambridge, Dept Mat Sci & Met, Cambridge CB2 3QZ, England.
RP Wang, M (reprint author), Nanyang Technol Univ, Sch Mech & Prod Engn, Nanyang Ave, Singapore 639798, Singapore.
RI Wang, Min/C-1584-2009
OI Wang, Min/0000-0002-6495-5637
CR Bonfield W, 1998, ACTA MATER, V46, P2509, DOI 10.1016/S1359-6454(98)80035-9
   BONFIELD W, 1981, BIOMATERIALS, V2, P185, DOI 10.1016/0142-9612(81)90050-8
   BONFIELD W, 1991, BONE-BIOMATERIAL INTERFACE, P89
   Bonfield W., 1998, BIOCERAMICS, V11, P37
   Charnley J.P., 1979, LOW FRICTION ANTHROP
   Di Silvio L, 1998, J MATER SCI-MATER M, V9, P845, DOI 10.1023/A:1008900312950
   Downes RN, 1991, BIOCERAMICS, V4, P239
   GUILD FJ, 1993, BIOMATERIALS, V14, P985, DOI 10.1016/0142-9612(93)90190-D
   Huang J, 1997, J MATER SCI-MATER M, V8, P775, DOI 10.1023/A:1018516813604
   HUANG J, 1998, BIOCERAMICS, V11, P165
   Lu Z, 1997, P I MECH ENG H, V211, P101, DOI 10.1243/0954411971534728
   McKee G K, 1966, J Bone Joint Surg Br, V48, P245
   Suwanprateeb J, 1997, J MATER SCI-MATER M, V8, P469, DOI 10.1023/A:1018522025474
   Wang M, 1998, BIOMATERIALS, V19, P2357, DOI 10.1016/S0142-9612(98)00154-9
   WANG M, 1994, BRIT CERAM T, V93, P91
   Wang M, 1998, J MATER SCI-MATER M, V9, P621, DOI 10.1023/A:1008975323486
   WANG M, 1997, P 11 INT C COMP MAT, V1, P488
   WANG M, 1996, P 7 EUR C COMP MAT L, V2, P455
   Wroblewski BM, 1997, P I MECH ENG H, V211, P109, DOI 10.1243/0954411971534737
NR 19
TC 12
Z9 15
U1 0
U2 5
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JUN
PY 2002
VL 13
IS 6
BP 607
EP 611
DI 10.1023/A:1015139213211
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 542WM
UT WOS:000175068600011
PM 15348592
DA 2018-10-20
ER

PT J
AU Brodke, DS
   Willie, BM
   Maaranen, TA
   Bloebaum, RD
AF Brodke, DS
   Willie, BM
   Maaranen, TA
   Bloebaum, RD
TI Spinal cage retrieval and assessment of biologic response
SO JOURNAL OF SPINAL DISORDERS & TECHNIQUES
LA English
DT Article; Proceedings Paper
CT 13th Annual Meeting of the North-American-Spine-Society
CY OCT 28-31, 1998
CL SAN FRANCISCO, CALIFORNIA
SP N Amer Spine Soc
DE spine; interbody fusion device; allograft; cage; pseudoarthrosis;
   corpectomy
ID HUMAN CANCELLOUS BONE; BACKSCATTERED ELECTRON IMAGES; LUMBAR INTERBODY
   FUSION; POROUS-COATED IMPLANTS; TRABECULAR BONE; MINERAL-CONTENT;
   INTERFACE; COMPONENTS; GRAYLEVELS; TITANIUM
AB Implant retrieval programs have been effective in understanding implant failure and biomaterial compatibility in joint arthroplasty; however, its application has not been extended extensively to the assessment of spinal constructs and implants. The objective of this study is to determine the efficacy of implant retrieval analysis as a standard for the assessment of explanted spinal implants. The limitations of clinical radiographic assessment of fusion through metal interbody devices are also identified. The implant analysis protocol is shown through a case report of a titanium mesh spinal fusion cage retrieved from a 54-year-old woman who had a pseudoarthrosis at the T12 cage interface. The implant analysis techniques include backscattered electron imaging, high-resolution contact radiography, histology, and fluorochrome analysis. Ail implant retrieval analysis program similar to the one discussed in the presented case study will enable an accurate assessment of outcomes of these commonly used implants and will guide future development.
C1 Univ Utah, Sch Med, Dept Orthoped, Salt Lake City, UT 84132 USA.
   Salt Lake City Vet Affairs Hlth Care Syst, Bone & Joint Res Lab, Salt Lake City, UT USA.
RP Brodke, DS (reprint author), Univ Utah, Sch Med, Dept Orthoped, 3B165,50 N Med Dr, Salt Lake City, UT 84132 USA.
RI Willie, Bettina/G-2397-2014
OI Willie, Bettina/0000-0003-2907-3580
CR Bloebaum R D, 1990, J Biomater Appl, V5, P56
   Bloebaum RD, 1997, J ARTHROPLASTY, V12, P920, DOI 10.1016/S0883-5403(97)90162-5
   Bloebaum RD, 1997, J BONE JOINT SURG AM, V79A, P1013, DOI 10.2106/00004623-199707000-00007
   Bloebaum RD, 1998, J BONE JOINT SURG AM, V80A, P518, DOI 10.2106/00004623-199804000-00008
   Bloebaum RD, 1997, BONE, V20, P485, DOI 10.1016/S8756-3282(97)00015-X
   BLOEBAUM RD, 1989, J HISTOTECHNOL, V12, P307
   BLOEBAUM RD, 1994, J BIOMED MATER RES, V28, P537, DOI 10.1002/jbm.820280503
   BLOEBAUM RD, 1991, CLIN ORTHOP RELAT R, P179
   BLOEBAUM RD, 1991, CLIN ORTHOP RELAT R, P97
   BLOEBAUM RD, 1995, T ORTHOP RES SOC, V20, P776
   BRANTIGAN JW, 1994, SPINE, V19, P1436, DOI 10.1097/00007632-199407000-00002
   BRANTIGAN JW, 1991, SPINE S, V16, P277
   Brodke DS, 1997, SPINE, V22, P26, DOI 10.1097/00007632-199701010-00005
   BRODKE DS, 1998, N AM SPIN SOC 13 ANN
   Brodsky AE, 1991, SPINE S, V16, P261
   CHOW SP, 1980, SPINE, V5, P452, DOI 10.1097/00007632-198009000-00010
   CLEVELAND M, 1948, J BONE JOINT SURG AM, V30-A, P302, DOI 10.2106/00004623-194830020-00005
   CUNNINGHAM BW, 1998, T ORTHOP RES SOC, V23, P250
   DEBOWES RM, 1984, AM J VET RES, V45, P191
   EMMANUAL J, 1987, STAIN TECHNOL, V62, P401, DOI 10.3109/10520298709108030
   FROST HM, 1983, BONE HISTOMORPHOMETR, P109
   HIBBS RA, 1929, SURG GYNECOL OBSTET, V48, P604
   Hofmann AA, 1997, ACTA ORTHOP SCAND, V68, P161, DOI 10.3109/17453679709004000
   HOFMANN AA, 1993, J ARTHROPLASTY, V8, P157, DOI 10.1016/S0883-5403(06)80056-2
   HOFMANN AA, 1992, INT ORTHOP, V16, P349
   KIMMEL DB, 1982, ANAT REC, V203, P31, DOI 10.1002/ar.1092030104
   Kuslich SD, 1998, SPINE, V23, P1267, DOI 10.1097/00007632-199806010-00019
   McAfee PC, 1999, J BONE JOINT SURG AM, V81A, P859, DOI 10.2106/00004623-199906000-00014
   MELSEN F, 1978, CALC TISS RES, V26, P99, DOI 10.1007/BF02013242
   MELSEN F, 1978, METAB BONE DIS RELAT, V1, P45, DOI 10.1016/0221-8747(78)90036-X
   Meunier P, 1977, BONE HISTOMORPHOMETR, P249
   Ray CD, 1997, SPINE, V22, P667, DOI 10.1097/00007632-199703150-00019
   RHODES DM, 1989, J HISTOTECHNOL, V13, P63
   SANDERSON C, 1994, J HISTOTECHNOL, V17, P343, DOI 10.1179/his.1994.17.4.343
   Shea JE, 2001, J ANAT, V198, P153, DOI 10.1046/j.1469-7580.2001.19820153.x
   SKEDROS JG, 1993, J BIOMED MATER RES, V27, P47, DOI 10.1002/jbm.820270107
   SKEDROS JG, 1993, J BIOMED MATER RES, V27, P57, DOI 10.1002/jbm.820270108
   THOMPSON WA, 1974, J BONE JOINT SURG AM, VA 56, P1643, DOI 10.2106/00004623-197456080-00014
   TREHARNE RW, 1979, CLIN ORTHOP RELAT R, P240
   Willie BM, 2000, J BIOMED MATER RES, V53, P137, DOI 10.1002/(SICI)1097-4636(2000)53:2<137::AID-JBM2>3.0.CO;2-Y
   WILLIE BM, 1999, TRANSCR SOC BIOM 25
   WRONSKI TJ, 1981, CALCIFIED TISSUE INT, V33, P583, DOI 10.1007/BF02409495
NR 42
TC 7
Z9 7
U1 0
U2 2
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1536-0652
J9 J SPINAL DISORD TECH
JI J. Spinal Disord. Tech.
PD JUN
PY 2002
VL 15
IS 3
BP 206
EP 212
DI 10.1097/00024720-200206000-00007
PG 7
WC Clinical Neurology; Orthopedics
SC Neurosciences & Neurology; Orthopedics
GA 577LQ
UT WOS:000177062700006
PM 12131421
DA 2018-10-20
ER

PT J
AU Xu, JY
   Liu, ZS
   Erhan, SZ
   Carriere, CJ
AF Xu, JY
   Liu, ZS
   Erhan, SZ
   Carriere, CJ
TI A potential biodegradable rubber-viscoelastic properties of a soybean
   oil-based composite
SO JOURNAL OF THE AMERICAN OIL CHEMISTS SOCIETY
LA English
DT Article
DE biodegradable material; rheology; soybean oil; viscoelastic properties
AB Scientists are more and more interested in biodegradable materials owing to their environmental advantage. We investigated viscoelastic properties of a newly developed biomaterial made from epoxidized soybean oil (ESO). ESO crosslinked by triethylene glycol d amine exhibited viscoelastic solid properties. The storage modulus (G') was 2 x 10(4) Pa over four frequency decades. The phase angles were 14-18degrees. Stress relaxation measurements showed that there was no relaxation up to 500 s. From the plateau modulus we estimated that the MAN. of this cross-linked soybean oil was on the order of 10(5). The composites of cross-linked ESO with three different fibers had 50 times higher elasticity (G') than those without fiber. Phase shifts were the same as those of cross-linked oil without fibers, but the linear range of rheological properties was much narrower than that of the material without filers. All these results indicated that this new biopolymer made from soybean oil exhibited strong viscoelastic solid properties similar to synthetic rubbers. These rheological properties implied that this biomaterial has high potential to replace some of the synthetic rubber and/or plastics.
C1 ARS, USDA, NCAUR, Peoria, IL 60604 USA.
RP Xu, JY (reprint author), ARS, USDA, NCAUR, 1815 N Univ St, Peoria, IL 60604 USA.
EM xuj@mail.ncaur.usda.gov
CR BAGLEY EB, 1992, IFT BAS SYM, V7, P573
   Fomin V.A., 2001, PLAST MASSY, V2, P42
   LIU Z, IN PRESS J APPL POLY
   Macosko C. W., 1994, RHEOLOGY PRINCIPLES, P109
   MISHRA DP, 2000, POP PLAST PACKAG, V45, P68
   Ngai K. L., 1996, PHYSICAL PROPERTIES, P341
   Rabek J., 1980, EXPT METHODS POLYM C
   SCHROETER J, 2000, KUNSTSTOFFE, V90, P64
   SCHROETER J, 2000, KUNSTSTOFFE, V90, P68
   WEN J, 1996, PHYSICAL PROPERTIES, P371
   Wool R. P., 1998, POLYM PREP AM CHEM S, V39, P90
   Wool RP, 1999, CHEMTECH, V29, P44
   WOOL RP, 1998, 216 AM CHEM SOC NAT
   Xu JY, 2001, CEREAL CHEM, V78, P181, DOI 10.1094/CCHEM.2001.78.2.181
NR 14
TC 20
Z9 20
U1 0
U2 7
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0003-021X
J9 J AM OIL CHEM SOC
JI J. Am. Oil Chem. Soc.
PD JUN
PY 2002
VL 79
IS 6
BP 593
EP 596
AR UNSP J10177
DI 10.1007/s11746-002-0528-0
PG 4
WC Chemistry, Applied; Food Science & Technology
SC Chemistry; Food Science & Technology
GA 565WX
UT WOS:000176393400014
DA 2018-10-20
ER

PT J
AU Hutson, MS
   Hauger, SA
   Edwards, G
AF Hutson, MS
   Hauger, SA
   Edwards, G
TI Thermal diffusion and chemical kinetics in laminar biomaterial due to
   heating by a free-electron laser
SO PHYSICAL REVIEW E
LA English
DT Article
ID IRRADIATION; CONDUCTION; ABLATION; CORNEA
AB We have theoretically investigated the role of thermal diffusion and chemical kinetics as a possible dynamic explanation for the preferential ablative properties of infrared radiation from a free-electron laser (FEL). The model is based on a laminar system composed of alternating layers of protein and saline. We have compared exposure to 3 mum where water is the main absorber and 6.45 mum where both water and protein absorb. The picosecond pulses of the superpulse are treated as a train of impulses. We find that the heating rates are sufficient to superheat the outer saline layers on the nanosecond time scale, leading to explosive vaporization. We also find that competition between the layer-specific heating rates and thermal diffusion results in a wavelength-dependent separation in layer temperatures. We consider the onset of both chemical bond breaking and the helix-coil transition of protein prior to vaporization in terms of the thermal, chemical, and structural properties of the system as well as laser wavelength and pulse structure. There is no evidence for thermal bond breaking on these time scales. At 6.45 mum, but not 3 mum, there is evidence for a significant helix-coil transition. While the native protein is ductile, the denatured protein exhibits brittle fracture. This model provides a dynamic mechanism to account for the preferential ablative properties observed with FEL radiation tuned near 6.45 mum.
C1 Duke Univ, Free Electron Laser Lab, Durham, NC 27708 USA.
   Duke Univ, Dept Phys, Durham, NC 27708 USA.
RP Edwards, G (reprint author), Duke Univ, Free Electron Laser Lab, Box 90319, Durham, NC 27708 USA.
EM edwards@fel.duke.edu
CR COLE KD, 1993, J HEAT TRANS-T ASME, V115, P767, DOI 10.1115/1.2910750
   COPELAND M, 2000, INT BIOM S SPIE SAN
   CROOK AW, 1948, J OPT SOC AM, V38, P954, DOI 10.1364/JOSA.38.000954
   DAVSON H, 1972, PHYSL EYE
   EDWARDS G, 1994, NATURE, V371, P416, DOI 10.1038/371416a0
   FRANKKAMENETSKI.D, 1969, DIFFUSION HEAT TRANS, pCH6
   HECTOR LG, 1992, INT J ENG SCI, V30, P1731, DOI 10.1016/0020-7225(92)90091-T
   Joos KM, 2000, LASER SURG MED, V27, P191, DOI 10.1002/1096-9101(2000)27:3<191::AID-LSM1>3.0.CO;2-D
   Kampmeier J, 2000, CORNEA, V19, P355, DOI 10.1097/00003226-200005000-00020
   LANDAU LD, 1987, FLUID MECH, pCH5
   LIEBMAN JF, 2000, AMIDE LINKAGE, pCH5
   LIM JJ, 1974, BIOPOLYMERS, V13, P1791, DOI 10.1002/bip.1974.360130912
   MADEY JMJ, 1971, J APPL PHYS, V42, P1906, DOI 10.1063/1.1660466
   PRIVALOV PL, 1970, BIOPOLYMERS, V9, P127, DOI 10.1002/bip.1970.360090202
   SHIH OW, 1994, J APPL PHYS, V75, P4382, DOI 10.1063/1.355982
   Skripov V. P., 1988, THERMOPHYSICAL PROPE
   Sporl E, 1997, GER J OPHTHALMOL, V5, P322
   STRYER L, 1995, BIOCHEMISTRY-US, P32
   Tribble J, 1997, PHYS REV E, V55, P7385, DOI 10.1103/PhysRevE.55.7385
   VANGEMERT MJC, 1995, OPTICAL THERMAL RESP, pCH13
   Venugopalan V, 1996, BIOPHYS J, V70, P2981, DOI 10.1016/S0006-3495(96)79868-5
NR 21
TC 26
Z9 26
U1 0
U2 2
PU AMER PHYSICAL SOC
PI COLLEGE PK
PA ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA
SN 1539-3755
J9 PHYS REV E
JI Phys. Rev. E
PD JUN
PY 2002
VL 65
IS 6
AR 061906
DI 10.1103/PhysRevE.65.061906
PN 1
PG 6
WC Physics, Fluids & Plasmas; Physics, Mathematical
SC Physics
GA 572FH
UT WOS:000176762500069
PM 12188758
DA 2018-10-20
ER

PT J
AU Schroder, K
   Meyer-Plath, A
   Keller, D
   Ohl, A
AF Schroder, K
   Meyer-Plath, A
   Keller, D
   Ohl, A
TI On the applicability of plasma assisted chemical micropatterning to
   different polymeric biomaterials
SO PLASMAS AND POLYMERS
LA English
DT Article
DE microwave plasma; ammonia; hydrogen; polymer surface; cell culture; XPS;
   fluorescence
ID NEURONAL CELL ATTACHMENT; ETHYLENE-PROPYLENE FILMS; BIOMEDICAL
   APPLICATIONS; AMMONIA PLASMA; ADHESION; SURFACES; DEPOSITION
AB A plasma process sequence has been developed to prepare chemical micropatterns on polymeric biomaterial surfaces. These patterns induce a guided localized cell layover at microscopic dimension. Two subsequent plasma steps are applied. In the first functionalization step a microwave ammonia plasma introduces amino groups to obtain areas for very good cell adhesion; the second passivation step combines pattern generation and creation of cell repelling areas. This downstream microwave hydrogen plasma process removes functional groups and changes the linkages of polymer chains' at the outermost surfaces. Similar results have been. obtained on, different polymers including polystyrene (PS), polyhydroxyethylmethacrylate (PHEMA), polyetheretherketone (PEEK), polyethleneterephthalate (PET) and polyethylenenaphthalate (PEN). Such a rather universal chemical structuring process could widen the availability of biomaterials with specific surface preparations.
C1 Inst Niedertemp Plasmaphys EV, D-17489 Greifswald, Germany.
RP Schroder, K (reprint author), Inst Niedertemp Plasmaphys EV, Friedrich Ludwig Jahn Str 19, D-17489 Greifswald, Germany.
RI Meyer-Plath, Asmus/E-4573-2011
OI Meyer-Plath, Asmus/0000-0001-9037-7706
CR BABUCKE G, 2001, P 10 BUND FACHT PLAS, P67
   Favia P, 1997, SURFACE MODIFICATION OF POLYMERIC BIOMATERIALS, P69
   Favia P, 1998, SURF COAT TECH, V98, P1102, DOI 10.1016/S0257-8972(97)00285-5
   HOLLANDER A, 1993, J APPL POLYM SCI, V49, P1857, DOI 10.1002/app.1993.070491016
   KELLER D, 1997, POLYM PREPR AM CHEM, V38, P1043
   KELLER D, 1999, P 14 INT S PLASM CHE, V4, P1767
   KOONTZ SL, 1998, Patent No. 9832789
   LaRocca P, 1996, CELL LINE, V6, P1
   LEE JH, 1994, BIOMATERIALS, V15, P705, DOI 10.1016/0142-9612(94)90169-4
   Lhoest JB, 1996, J BIOMAT SCI-POLYM E, V7, P1039, DOI 10.1163/156856296X00534
   MATSON RS, 1994, ANAL BIOCHEM, V217, P306, DOI 10.1006/abio.1994.1123
   MEYERPLATH A, 2002, THESIS EMAU GREIFSWA
   NUZZO RG, 1984, MACROMOLECULES, V17, P1013, DOI 10.1021/ma00135a007
   Ohl A, 1999, SURF COAT TECH, V116, P1006, DOI 10.1016/S0257-8972(99)00139-5
   Ohl A, 1999, J MATER SCI-MATER M, V10, P747, DOI 10.1023/A:1008943625715
   Ohl A, 1999, SURF COAT TECH, V116, P820, DOI 10.1016/S0257-8972(99)00150-4
   OHL A, 1997, INT J ART ORG, V20, P517
   OHL A, 2000, P 6 WORLD BIOM C KAM
   RANIERI JP, 1994, INT J DEV NEUROSCI, V12, P725, DOI 10.1016/0736-5748(94)90052-3
   RANIERI JP, 1993, J BIOMED MATER RES, V27, P917, DOI 10.1002/jbm.820270711
   RANIERI JP, 1995, J BIOMED MATER RES, V29, P779, DOI 10.1002/jbm.820290614
   Ratner B. D., 1997, SURFACE MODIFICATION
   RATNER BD, 1992, J BIOMAT SCI-POLYM E, V4, P3
   Schroder K, 2001, CONTRIB PLASM PHYS, V41, P562, DOI 10.1002/1521-3986(200111)41:6<562::AID-CTPP562>3.0.CO;2-Y
   Schroder K., 2000, MAT MED ENG, P161
   Shahidzadeh N, 1996, PLASMAS POLYM, V1, P27
   SIPEHIA R, 1990, BIOMATER ARTIF CELL, V18, P643, DOI 10.3109/10731199009117333
   TAMADA Y, 1993, POLYMER, V34, P2208, DOI 10.1016/0032-3861(93)90752-V
   VANWACHEM PB, 1987, BIOMATERIALS, V8, P323, DOI 10.1016/0142-9612(87)90001-9
   VARGO TG, 1992, LANGMUIR, V8, P130, DOI 10.1021/la00037a025
   VARGO TG, 1995, J BIOMED MATER RES, V29, P767, DOI 10.1002/jbm.820290613
NR 31
TC 41
Z9 42
U1 0
U2 19
PU KLUWER ACADEMIC/PLENUM PUBL
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1084-0184
J9 PLASMAS POLYM
JI Plasmas Polym.
PD JUN
PY 2002
VL 7
IS 2
BP 103
EP 125
DI 10.1023/A:1016239302194
PG 23
WC Polymer Science
SC Polymer Science
GA 627RN
UT WOS:000179948700002
DA 2018-10-20
ER

PT J
AU Gao, TJ
   Kousinioris, NA
   Wozney, JM
   Winn, S
   Uludag, H
AF Gao, TJ
   Kousinioris, NA
   Wozney, JM
   Winn, S
   Uludag, H
TI Synthetic thermoreversible polymers are compatible with osteoinductive
   activity of recombinant human bone morphogenetic protein 2
SO TISSUE ENGINEERING
LA English
DT Article
ID COLLAGEN; CARRIERS; RATS
AB Recombinant human bone morphogenetic protein 2 (rhBMP-2) is currently in clinical studies as part of an implantable device that contains a biomaterial carrier. Implant retention of rhBMP-2 by the biomaterial carrier is important for the osteoinductive activity. To control in situ retention of rhBMP-2, thermoreversible polymers were synthesized and characterized, and their compatibility with rhBMP-2-induced osteoinduction was investigated. The results indicated that polymers with a controlled "solubility <-> insolubility" transition temperature could be prepared from N-isopropylacrylamide, ethylmethacrylate, and N-acryloxysuccinimide (NASI). NASI-containing polymers were able to conjugate to rhBMP-2 without additional cross-linkers. Implantation in the rat ectopic model, where alkaline phosphatase and calcium deposition were utilized as markers of osteoinductive activity, indicated that rhBMP-2 mixed with the polymers were effective for osteoinduction. Moreover, rhBMP-2 conjugated to the chosen polymers was as effective as native rhBMP-2 in inducing ALP activity and calcium deposition. We conclude that thermoreversible polymers are compatible with rhBMP-2-induced osteogenesis and can serve as novel biomaterials for rhBMP-2 delivery.
C1 Univ Alberta, Fac Engn, Dept Chem & Mat Engn, Edmonton, AB T6G 2G6, Canada.
   Genet Inst Inc, Andover, MA USA.
   Oregon Hlth Sci Univ, Dept Surg, Portland, OR 97201 USA.
RP Uludag, H (reprint author), Univ Alberta, Fac Engn, Dept Chem & Mat Engn, 526 Chem & Mat Engn Bldg, Edmonton, AB T6G 2G6, Canada.
CR Bentz H, 1998, J BIOMED MATER RES, V39, P539, DOI 10.1002/(SICI)1097-4636(19980315)39:4<539::AID-JBM6>3.0.CO;2-K
   BESSEY OA, 1946, J BIOL CHEM, V164, P321
   Bromberg LE, 1998, ADV DRUG DELIVER REV, V31, P197, DOI 10.1016/S0169-409X(97)00121-X
   CARRINGTON JL, 1988, J CELL BIOL, V107, P1969, DOI 10.1083/jcb.107.5.1969
   CHEN JP, 1990, BIOMATERIALS, V11, P631, DOI 10.1016/0142-9612(90)90020-Q
   FEIL H, 1993, MACROMOLECULES, V26, P2496, DOI 10.1021/ma00062a016
   Friess W, 1999, INT J PHARM, V185, P51, DOI 10.1016/S0378-5173(99)00128-3
   Gao T, 2001, MATERIALWISS WERKST, V32, P953
   GAO TJ, 1996, BONE MORPHOGENETIC P, P121
   GUTOWSKA A, 1995, J BIOMED MATER RES, V29, P811, DOI 10.1002/jbm.820290705
   KESSLER G, 1964, CLIN CHEM, V10, P686
   KINLEY RA, 1993, PHARMACEUT RES, V10, P1393
   POLLAK A, 1980, J AM CHEM SOC, V102, P6324, DOI 10.1021/ja00540a026
   Riley EH, 1996, CLIN ORTHOP RELAT R, P39, DOI 10.1097/00003086-199603000-00006
   SAKANO S, 1993, CLIN ORTHOP RELAT R, P337
   Sasano Y, 1997, ANAT RECORD, V247, P472, DOI 10.1002/(SICI)1097-0185(199704)247:4<472::AID-AR5>3.0.CO;2-T
   Shimizu S, 1996, ARTIF ORGANS, V20, P1232
   Takita H, 1997, EUR J ORAL SCI, V105, P588, DOI 10.1111/j.1600-0722.1997.tb00222.x
   Uludag H, 2000, J BIOMED MATER RES, V50, P227, DOI 10.1002/(SICI)1097-4636(200005)50:2<227::AID-JBM18>3.0.CO;2-2
   ULUDAG H, 2000, CONTROLLED DRUG DELI, P253
   Vunjak-Novakovic G, 1998, BIOTECHNOL PROGR, V14, P193, DOI 10.1021/bp970120j
   WOZNEY J, 1988, SCIENCE, V241, P1528
NR 22
TC 21
Z9 21
U1 0
U2 2
PU MARY ANN LIEBERT INC PUBL
PI LARCHMONT
PA 2 MADISON AVENUE, LARCHMONT, NY 10538 USA
SN 1076-3279
J9 TISSUE ENG
JI Tissue Eng.
PD JUN
PY 2002
VL 8
IS 3
BP 429
EP 440
DI 10.1089/107632702760184691
PG 12
WC Cell & Tissue Engineering
SC Cell Biology
GA 570UW
UT WOS:000176677800008
PM 12167229
DA 2018-10-20
ER

PT J
AU Dalby, MJ
   Di Silvio, L
   Gurav, N
   Annaz, B
   Kayser, MV
   Bonfield, W
AF Dalby, MJ
   Di Silvio, L
   Gurav, N
   Annaz, B
   Kayser, MV
   Bonfield, W
TI Optimizing HAPEX (TM) topography influences osteoblast response
SO TISSUE ENGINEERING
LA English
DT Article
ID HYDROXYAPATITE-REINFORCED POLYETHYLENE; IN-VITRO; LAMELLIPODIA
   FORMATION; EXTRACELLULAR-MATRIX; SIGNAL-TRANSDUCTION; BONE-FORMATION;
   CELLS; EXPRESSION; GUIDANCE; ACTIN
AB HAPEX(TM) (hydroxyapatite-reinforeed polyethylene composite) is a second-generation orthopedic biomaterial designed as a bone analog material, which has found clinical success. The use of topography in cell engineering has been shown to affect cell attachment and subsequent response. Thus, by combining bioactivity and enhancing osteoblast response to the implant surface, improved tissue repair and implant life span may be achieved. In this study a primary human osteoblast-like cell model has been used to study the influence of surface topography and chemistry produced by three different production methods. Scanning electron microscopy, fluorescence microscopy, and confocal scanning laser microscopy have been used to study cell adhesion; tritiated thymidine uptake has been used to observe cell proliferation; and the reverse transcriptase-polymerase chain reaction and biochemical methods have been used to study phenotypic expression. Transmission electron microscopy has also been used to look at more long-term morphology. The results show that topography significantly influences cell response, and may be a means of enhancing bone apposition on HAPEX(TM).
C1 Royal Natl Orthopaed Hosp Trust, Inst Orthopaed, IRC Biomed Mat, Stanmore, Middx, England.
RP Dalby, MJ (reprint author), Univ Glasgow, Ctr Cell Engn, Inst Biomed & Life Sci, Glasgow G12 800, Lanark, Scotland.
EM m.dalby@bio.gla.ac.uk
RI Dalby, Matthew/G-2426-2012
OI Di Silvio, Lucy/0000-0003-2554-2052; Dalby, Matthew/0000-0002-0528-3359
CR ABRAM J, 1984, PLAST RUB PROC APPL, V4, P261
   ALBERTS B, 1994, MOL BIOL CELL
   ALI SY, 1992, BONE BIOL SKELETAL D, P19
   ANDERSON HC, 1989, LAB INVEST, V60, P320
   ANDERSON HC, 1976, BIOCH PHYSL BONE, P135
   Berridge MJ, 1998, NATURE, V395, P645, DOI 10.1038/27094
   BIRK DE, 1984, J CELL BIOL, V99, P2024, DOI 10.1083/jcb.99.6.2024
   BONFIELD W, 1981, BIOMATERIALS, V2, P185, DOI 10.1016/0142-9612(81)90050-8
   BONFIELD W, 1986, BIOL BIOMECHANICAL P, P153
   Britland S, 1996, EXP CELL RES, V228, P313, DOI 10.1006/excr.1996.0331
   Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463
   Christenson RH, 1997, CLIN BIOCHEM, V30, P573, DOI 10.1016/S0009-9120(97)00113-6
   COOPER GM, 1997, CELL MOL APPROACH
   Cowles EA, 1998, CALCIFIED TISSUE INT, V62, P74, DOI 10.1007/s002239900397
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   Curtis A, 2001, TRENDS BIOTECHNOL, V19, P97, DOI 10.1016/S0167-7799(00)01536-5
   Dalby MJ, 2000, J MATER SCI-MATER M, V11, P805, DOI 10.1023/A:1008957630020
   Dalby MJ, 1999, J MATER SCI-MATER M, V10, P793, DOI 10.1023/A:1008907218330
   Dalton BA, 1999, J BIOMED MATER RES, V45, P384, DOI 10.1002/(SICI)1097-4636(19990615)45:4<384::AID-JBM14>3.0.CO;2-O
   Degasne I, 1999, CALCIFIED TISSUE INT, V64, P499, DOI 10.1007/s002239900640
   Di Silvio L, 1998, J MATER SCI-MATER M, V9, P845, DOI 10.1023/A:1008900312950
   Di Silvio L, 2001, HUMAN CELL CULTURE, P221
   Dornhoffer JL, 1998, LARYNGOSCOPE, V108, P531, DOI 10.1097/00005537-199804000-00013
   Downes RN, 1991, BIOCERAMICS, V4, P239
   FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619
   Gray C, 1996, BONE, V18, P115, DOI 10.1016/8756-3282(95)00456-4
   Gronowicz G, 1996, J ORTHOPAED RES, V14, P878, DOI 10.1002/jor.1100140606
   Gronthos S, 1997, J BONE MINER RES, V12, P1189, DOI 10.1359/jbmr.1997.12.8.1189
   GRUEN TA, 1979, CLIN ORTHOP RELAT R, V141, P17
   HEMACHANDRA K, 1992, THESIS U LONDON LOND
   Huang J., 1997, J MATER SCI-MATER M, V8, P1
   JULIANO RL, 1993, J CELL BIOL, V120, P577, DOI 10.1083/jcb.120.3.577
   KASEMO B, 1994, ENV HLTH PROSPECTS, V102, P878
   KOLODNEY MS, 1995, P NATL ACAD SCI USA, V92, P10252, DOI 10.1073/pnas.92.22.10252
   MARIE PJ, 1995, CALCIF TISSUE INT S, V56
   MEREDITH JE, 1993, MOL BIOL CELL, V4, P953
   OCONNOR TP, 1993, J CELL BIOL, V123, P935, DOI 10.1083/jcb.123.4.935
   Ohgushi H, 1996, J BIOMED MATER RES, V32, P333, DOI 10.1002/(SICI)1097-4636(199611)32:3<333::AID-JBM5>3.0.CO;2-T
   POSNER AS, 1975, ACCOUNTS CHEM RES, V8, P273, DOI 10.1021/ar50092a003
   PULEO DA, 1992, BONE MINER, V18, P215, DOI 10.1016/0169-6009(92)90808-Q
   Rajnicek AM, 1997, J CELL SCI, V110, P2915
   REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208
   Robison R, 1923, BIOCHEM J, V17, P286, DOI 10.1042/bj0170286
   SABOKBAR A, 1994, BONE MINER, V27, P57, DOI 10.1016/S0169-6009(08)80187-0
   Scaife RM, 2000, J CELL SCI, V113, P215
   Schneider GB, 1999, BONE, V24, P321, DOI 10.1016/S8756-3282(99)00007-1
   SINHA RK, 1994, CLIN ORTHOP RELAT R, P258
   Spaargaren M, 1999, MOL BIOL CELL, V10, P3239, DOI 10.1091/mbc.10.10.3239
   SPURR AR, 1969, J ULTRA MOL STRUCT R, V26, P31, DOI 10.1016/S0022-5320(69)90033-1
   Stein Gary S., 1993, P47
   Stephenson P K, 1991, J Arthroplasty, V6, P51, DOI 10.1016/S0883-5403(06)80157-9
   Sumi T, 1999, J CELL BIOL, V147, P1519, DOI 10.1083/jcb.147.7.1519
   VROUWENVELDER WCA, 1993, J BIOMED MATER RES, V27, P465, DOI 10.1002/jbm.820270407
   Wang M, 2000, J MATER SCI, V35, P1023, DOI 10.1023/A:1004731315328
NR 54
TC 52
Z9 55
U1 0
U2 12
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 2152-4947
J9 TISSUE ENG
JI Tissue Eng.
PD JUN
PY 2002
VL 8
IS 3
BP 453
EP 467
DI 10.1089/107632702760184718
PG 15
WC Cell & Tissue Engineering
SC Cell Biology
GA 570UW
UT WOS:000176677800010
PM 12167231
DA 2018-10-20
ER

PT J
AU Raeder, RH
   Badylak, SF
   Sheehan, C
   Kallakury, B
   Metzger, DW
AF Raeder, RH
   Badylak, SF
   Sheehan, C
   Kallakury, B
   Metzger, DW
TI Natural anti-galactose alpha 1,3 galactose antibodies delay, but do not
   prevent the acceptance of extracellular matrix xenografts
SO TRANSPLANT IMMUNOLOGY
LA English
DT Article
DE alpha 1,3-galactose; small intestinal submucosa; xenotransplantation;
   immune recognition
ID SMALL-INTESTINAL SUBMUCOSA; GAL O/O MICE; ANTI-GAL-ALPHA-1-3GAL
   ANTIBODIES; GAL-ALPHA-1,3GAL EPITOPES; COMPLEMENT; IGG; PIG;
   XENOTRANSPLANTATION; MODEL; CELLS
AB Naturally occurring antibodies to the galactose alpha1,3 galactose (alphagal) epitope expressed on xenogeneic grafts are a major barrier to organ transplantation in humans. Porcine small intestinal submucosa (SIS) expresses the agal epitope and is currently being used as a bioscaffold for tissue remodeling. To examine in detail the potential role of the alphagal epitope in immune recognition of this acellular, avascular biomaterial, we have used mice which have a genetic disruption in the alpha1,3 galactosyltransferase gene (alpha gal(-/-) mice) and thus express natural anti-alpha gal antibodies in a manner similar to humans. It was found that alpha gal(-/-) mice produced IgM anti-alpha gal antibodies in addition to IgG1 SIS-specific antibodies, which did not bind to the U gal epitope. Histological examination of implant sites demonstrated an early inflammatory response that consisted predominantly of neutrophils in both alphagal(+/+) and alphagal(-/-) mice. However, while alphagal(+/+) mice completely remodeled SIS implants by day 25, alphagal(-/-) mice still exhibited some visible SIS together with inflammatory cellular infiltrates at this time point. Nevertheless, by day 35, the implant site in alpha gal(-/-) mice appeared to be entirely remodeled although a few acute inflammatory cells were still present. Immunization of alpha gal(-/-) mice with sheep erythrocytes to enhance anti-a gal antibody levels led to a more robust early inflammatory response following implantation but did not change the ultimate fate of the graft. We conclude that, in contrast to xenotransplantation of whole organs, naturally-occurring anti-alpha gal antibodies do not influence the ability of xenogeneic extracellular matrices to serve as bioscaffolds for tissue remodeling. (C) 2002 Elsevier Science B.V. All rights reserved.
C1 Albany Med Coll, Ctr Immunol & Microbial Dis, Albany, NY 12208 USA.
   Med Coll Ohio, Dept Microbiol & Immunol, Toledo, OH 43699 USA.
   Purdue Univ, Dept Biomed Engn, W Lafayette, IN 47907 USA.
   Albany Med Ctr, Dept Pathol, Albany, NY USA.
RP Metzger, DW (reprint author), Albany Med Coll, Ctr Immunol & Microbial Dis, MC 151,47 New Scotland Ave, Albany, NY 12208 USA.
EM metzged@mail.ame.edu
OI Metzger, Dennis/0000-0002-8000-9907; Badylak,
   Stephen/0000-0003-3555-0689
FU NHLBI NIH HHS [HL60359]
CR Allman AJ, 2001, TRANSPLANTATION, V71, P1631, DOI 10.1097/00007890-200106150-00024
   Badylak S, 1999, CLIN ORTHOP RELAT R, pS333, DOI 10.1097/00003086-199910001-00032
   Badylak S, 2000, J PEDIATR SURG, V35, P1097, DOI 10.1053/jpsu.2000.7834
   BADYLAK SF, 1993, TISSUE ENGINEERING, P179
   GALILI U, 1984, J EXP MED, V160, P1519, DOI 10.1084/jem.160.5.1519
   GALILI U, 1993, IMMUNOL TODAY, V14, P480, DOI 10.1016/0167-5699(93)90261-I
   Goldberg LC, 1996, TRANSPLANT P, V28, P549
   GOOD AH, 1992, TRANSPL P, V24, P559
   HAMADEH RM, 1992, J CLIN INVEST, V89, P1223, DOI 10.1172/JCI115706
   KOREN E, 1994, TRANSPLANT P, V26, P1336
   Lewin GA, 1999, J SMALL ANIM PRACT, V40, P340, DOI 10.1111/j.1748-5827.1999.tb03094.x
   McKenzie IFC, 1998, TRANSPLANTATION, V66, P754, DOI 10.1097/00007890-199809270-00010
   McKenzie IFC, 1998, J IMMUNOL, V161, P5116
   McPherson TB, 2000, TISSUE ENG, V6, P233, DOI 10.1089/10763270050044416
   Ohdan H, 2000, J IMMUNOL, V165, P5518, DOI 10.4049/jimmunol.165.10.5518
   Parker W, 1999, GLYCOBIOLOGY, V9, P865, DOI 10.1093/glycob/9.9.865
   Pearse M J, 1999, Subcell Biochem, V32, P281
   Pearse MJ, 1998, TRANSPLANTATION, V66, P748, DOI 10.1097/00007890-199809270-00009
   ROSS JR, 1993, TRANSPLANTATION, V55, P1144, DOI 10.1097/00007890-199305000-00040
   SANDRIN MS, 1993, P NATL ACAD SCI USA, V90, P11391, DOI 10.1073/pnas.90.23.11391
   Tanemura M, 2000, J CLIN INVEST, V105, P301, DOI 10.1172/JCI7358
   Tearle RG, 1996, TRANSPLANTATION, V61, P13, DOI 10.1097/00007890-199601150-00004
   THALL AD, 1995, J BIOL CHEM, V270, P21437, DOI 10.1074/jbc.270.37.21437
   Yang YG, 1998, J EXP MED, V187, P1335, DOI 10.1084/jem.187.8.1335
   YING-ZI C, 1991, International Immunology, V3, P467, DOI 10.1093/intimm/3.5.467
   Yu PB, 1999, J CLIN IMMUNOL, V19, P116, DOI 10.1023/A:1020506617105
   Yu PB, 1996, J IMMUNOL, V157, P5163
NR 27
TC 54
Z9 59
U1 1
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0966-3274
EI 2210-3384
J9 TRANSPL IMMUNOL
JI Transpl. Immunol.
PD JUN
PY 2002
VL 10
IS 1
BP 15
EP 24
AR PII S0966-3274(01)00044-2
DI 10.1016/S0966-3274(01)00044-2
PG 10
WC Immunology; Transplantation
SC Immunology; Transplantation
GA 582VZ
UT WOS:000177373000002
PM 12182460
DA 2018-10-20
ER

PT J
AU Pei, M
   Seidel, J
   Vunjak-Novakovic, G
   Freed, LE
AF Pei, M
   Seidel, J
   Vunjak-Novakovic, G
   Freed, LE
TI Growth factors for sequential cellular de- and re-differentiation in
   tissue engineering
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE tissue engineering; chondrocyte; biomaterial; bioreactor; TGF-beta 1;
   FGF-2; IGF-I
ID HUMAN ARTICULAR CHONDROCYTES; FACTOR-I; CARTILAGE EXPLANTS; IGF-I;
   DYNAMIC COMPRESSION; FACTOR-BETA; COLLAGEN; CULTIVATION; PROTEIN; MATRIX
AB A model system for the in vitro generation of cartilaginous constructs was used to study a tissue engineering paradigm whereby sequentially applied growth factors promoted chondrocytes to first de-differentiate into a proliferative state and then re-differentiate and undergo chondrogenesis. Early cultivation in medium with supplemental TGF-beta1/FGF-2 doubled cell fractions in 2-week constructs compared to unsupplemented controls. Subsequent culture with supplemental IGF-I yielded large 4-week constructs with high fractions of cartilaginous extracellular matrix (ECM) and high compressive moduli, whereas prolonged culture with supplemental FGF-2 yielded small 4-week constructs with low ECM fractions and moduli. Sequential supplementation with TGF-beta1/ FGF-2 and then lGF-I yielded 4-week constructs with type-specific mRNA expression and protein levels that were high for type II and negligible for type I collagen, in contrast to other growth factor regimens studied. The data demonstrate that structural, functional, and molecular properties of engineered cartilage can be modulated by sequential application of growth factors. (C) 2002 Elsevier Science (USA). All rights reserved.
C1 MIT, Div Hlth Sci & Technol, Cambridge, MA 02139 USA.
RP Freed, LE (reprint author), MIT, Div Hlth Sci & Technol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
OI Vunjak-Novakovic, Gordana/0000-0002-9382-1574; Freed,
   Lisa/0000-0002-0720-8432
CR Ausubel F.M., 1999, SHORT PROTOCOLS MOL
   Blunk T, 2002, TISSUE ENG, V8, P73, DOI 10.1089/107632702753503072
   Bonassar LJ, 2001, J ORTHOPAED RES, V19, P11, DOI 10.1016/S0736-0266(00)00004-8
   Bradham DM, 1998, CLIN ORTHOP RELAT R, P239
   BRADHAM DM, 1994, J CELL PHYSIOL, V158, P61, DOI 10.1002/jcp.1041580109
   Chen AC, 2001, J BIOMECH, V34, P1, DOI 10.1016/S0021-9290(00)00170-6
   CUEVAS P, 1988, BIOCHEM BIOPH RES CO, V156, P611, DOI 10.1016/S0006-291X(88)80887-8
   CURTIS AJ, 1992, BIOCHEM J, V288, P721, DOI 10.1042/bj2880721
   EVANS CH, 1999, CLIN ORTHOP S, V367, pS410
   FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5
   Fortier LA, 2002, J BONE JOINT SURG BR, V84B, P276, DOI 10.1302/0301-620X.84B2.11167
   Fortier LA, 1999, J ORTHOPAED RES, V17, P467, DOI 10.1002/jor.1100170403
   FRANK EH, 1987, J BIOMECH, V20, P615, DOI 10.1016/0021-9290(87)90282-X
   FREED LE, 1993, J BIOMED MATER RES, V27, P11, DOI 10.1002/jbm.820270104
   FREED LE, 1994, BIO-TECHNOL, V12, P689, DOI 10.1038/nbt0794-689
   Freed LE, 1998, EXP CELL RES, V240, P58, DOI 10.1006/excr.1998.4010
   FREED LE, 1995, BIOTECHNOL BIOENG, V46, P306, DOI 10.1002/bit.260460403
   FREED LE, 1999, CLIN ORTHOP S, V367, pS46
   Gooch KJ, 2001, BIOCHEM BIOPH RES CO, V286, P909, DOI 10.1006/bbrc.2001.5486
   HOLLANDER AP, 1994, J CLIN INVEST, V93, P1722, DOI 10.1172/JCI117156
   HORTON WE, 1989, J CELL PHYSIOL, V141, P8, DOI 10.1002/jcp.1041410103
   Hunziker EB, 2000, BIORHEOLOGY, V37, P163
   Jakob M, 2001, J CELL BIOCHEM, V81, P368, DOI 10.1002/1097-4644(20010501)81:2<368::AID-JCB1051>3.0.CO;2-J
   KIM YJ, 1988, ANAL BIOCHEM, V174, P168, DOI 10.1016/0003-2697(88)90532-5
   MADRY H, 2001, T ORTHOP RES SOC, V26, P289
   Mahoney MJ, 2001, NAT BIOTECHNOL, V19, P934, DOI 10.1038/nbt1001-934
   Martin I, 1999, EXP CELL RES, V253, P681, DOI 10.1006/excr.1999.4708
   Martin I, 2001, J CELL BIOCHEM, V83, P121, DOI 10.1002/jcb.1203
   MCQUILLAN DJ, 1986, BIOCHEM J, V240, P423, DOI 10.1042/bj2400423
   Nixon AJ, 2001, J ORTHOPAED RES, V19, P26, DOI 10.1016/S0736-0266(00)00013-9
   OSBORN KD, 1989, J ORTHOP RES, V7, P35, DOI 10.1002/jor.1100070106
   Riesle J, 1998, J CELL BIOCHEM, V71, P313, DOI 10.1002/(SICI)1097-4644(19981201)71:3<313::AID-JCB1>3.0.CO;2-C
   SAH RL, 1994, ARCH BIOCHEM BIOPHYS, V308, P137, DOI 10.1006/abbi.1994.1020
   Sah RL, 1996, J ORTHOPAED RES, V14, P44, DOI 10.1002/jor.1100140109
   SAH RLY, 1989, J ORTHOPAED RES, V7, P619, DOI 10.1002/jor.1100070502
   Sasano Y, 1996, ANAT EMBRYOL, V194, P247
   Shea LD, 1999, NAT BIOTECHNOL, V17, P551
   Vunjak-Novakovic G, 1999, J ORTHOPAED RES, V17, P130, DOI 10.1002/jor.1100170119
   WARDALE RJ, 1993, J CELL SCI, V105, P975
   WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0
   WROBLEWSKI J, 1995, J BONE MINER RES, V10, P735
   WU JJ, 1984, BIOCHEM BIOPH RES CO, V123, P1033, DOI 10.1016/S0006-291X(84)80237-5
   Xu C, 1996, ENDOCRINOLOGY, V137, P3557, DOI 10.1210/en.137.8.3557
   Yaeger PC, 1997, EXP CELL RES, V237, P318, DOI 10.1006/excr.1997.3781
NR 44
TC 112
Z9 118
U1 0
U2 6
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD MAY 31
PY 2002
VL 294
IS 1
BP 149
EP 154
AR PII S0006-291X(02)00439-4
DI 10.1016/S0006-291X(02)00439-4
PG 6
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 563BU
UT WOS:000176234500025
PM 12054755
DA 2018-10-20
ER

PT J
AU Scott-Burden, T
   Bosley, JP
   Rosenstrauch, D
   Henderson, KD
   Clubb, FJ
   Eichstaedt, HC
   Eya, K
   Gregoric, I
   Myers, TJ
   Radovancevic, B
   Frazier, OH
AF Scott-Burden, T
   Bosley, JP
   Rosenstrauch, D
   Henderson, KD
   Clubb, FJ
   Eichstaedt, HC
   Eya, K
   Gregoric, I
   Myers, TJ
   Radovancevic, B
   Frazier, OH
TI Use of autologous auricular chondrocytes for lining artificial surfaces:
   A feasibility study
SO ANNALS OF THORACIC SURGERY
LA English
DT Article
ID IMPERVIOUS DACRON GRAFTS; ENDOTHELIAL-CELLS; SHEAR-STRESS; TISSUE; DOG
AB Background. Auricular elastic cartilage is a potential source of autologous cells for lining the luminal surfaces of cardiovascular prostheses. We tested this potential in vitro and in vivo using a left ventricular assist device (LVAD) and a calf model.
   Methods. In vitro, auricular cartilage was harvested from the anesthetized ear of a calf, isolated, and cultured on tissue culture dishes. Primary chondrocytes were typed by immunocytochemistry, transferred into culture media, passaged twice, and seeded onto the blood-contacting luminal surfaces of four LVADs (HeartMate; Thoratec Corporation, Woburn, MA). Seeded cell linings were preconditioned under simulated flow conditions to promote cell adhesion to luminal surfaces. Seeding efficiency and cumulative cell loss under flow conditions were quantitated. In vivo, one of the four autologous chondrocyte-lined and preconditioned LVADs was implanted into the tissue-donor calf, run for 7 days; explanted; and evaluated grossly, by scanning electron microscopy, and by transmission electron microscopy.
   Results. The efficiency of seeding chondrocytes onto the luminal surfaces of the four LVADs was 95.11% +/- 4.23% (n = 4). Cumulative cell loss during preconditioning under flow conditions in vitro did not exceed 12% (n = 4). After 7 days of in vivo implantation, the luminal surfaces of the implanted LVAD demonstrated an intact, strongly adherent cellular lining.
   Conclusions. Auricular elastic cartilage is a ready and easily accessible source of chondrocytes whose ability to produce collagen 11 and other important extracellular matrix constituents allows them to adhere strongly to the luminal surfaces of LVADs. The simple method of isolating and expanding auricular chondrocytes presented here could be used to provide strongly adherent autologous cell linings for LVADs and other cardiovascular devices. If and when chondrocytes can be genetically engineered to produce antithrombogenic factors and then used to line the luminal surfaces of LVADs or other cardiovascular prostheses, they may be able to improve the hemocompatibility of the blood-biomaterial interface in such devices. Our successful feasibility study in a calf model warrants further studies of this concept in vivo.
C1 St Lukes Episcopal Hosp, Texas Heart Inst, Vasc Cell Biol Lab, Cardiovasc Surg Res Labs, Houston, TX USA.
   St Lukes Episcopal Hosp, Texas Heart Inst, Dept Cardiovasc Pathol, Houston, TX USA.
   Univ Texas, Hlth Sci Ctr Houston, Houston, TX USA.
RP Frazier, OH (reprint author), 1101 Bates Ave,Suite P357, Houston, TX 77030 USA.
FU NHLBI NIH HHS [HL 53233]
CR BERNHARD WF, 1975, J THORAC CARDIOV SUR, V70, P880
   Bordenave L, 1999, ENDOTHELIUM-J ENDOTH, V6, P267, DOI 10.3109/10623329909078494
   Fedewa MM, 1998, J ORTHOPAED RES, V16, P227, DOI 10.1002/jor.1100160210
   Fernandez P, 2001, BIOMATERIALS, V22, P649, DOI 10.1016/S0142-9612(00)00227-1
   FRAZIER OH, 1993, TEX HEART I J, V20, P78
   LISS RH, 1975, MED INSTRUM, V9, P81
   LUSCHER TF, 1990, ENDOTHELIUM MODULATO
   Megerian CA, 2000, TISSUE ENG, V6, P69, DOI 10.1089/107632700320900
   ROBINSON WJ, 1975, ANN THORAC SURG, V19, P540, DOI 10.1016/S0003-4975(10)64430-X
   SCOTTBURDEN T, 1998, CIRCULATION, V98, P339
   SHI Q, 1994, J VASC SURG, V20, P546, DOI 10.1016/0741-5214(94)90279-8
   Shi Q, 1998, ANN VASC SURG, V12, P341, DOI 10.1007/s100169900165
   Sodian R, 2000, ANN THORAC SURG, V70, P140, DOI 10.1016/S0003-4975(00)01255-8
   Tock CL, 1999, ASAIO J, V45, P172, DOI 10.1097/00002480-199905000-00013
NR 14
TC 7
Z9 7
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-4975
J9 ANN THORAC SURG
JI Ann. Thorac. Surg.
PD MAY
PY 2002
VL 73
IS 5
BP 1528
EP 1533
AR PII S0003-4975(01)03600-1
DI 10.1016/S0003-4975(01)03600-1
PG 6
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA 550QE
UT WOS:000175513100035
PM 12022544
DA 2018-10-20
ER

PT J
AU Busuttil, SJ
   Ploplis, VA
   Plow, EF
AF Busuttil, SJ
   Ploplis, VA
   Plow, EF
TI Role of the plasminogen system in the inflammatory response to
   biomaterial implants
SO ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
LA English
DT Meeting Abstract
C1 Case Western Reserve Univ, VAMC, Cleveland, OH 44106 USA.
   Univ Notre Dame, W M Keck Ctr Transgene Res, Notre Dame, IN 46556 USA.
   Cleveland Clin Fdn, Cleveland, OH 44195 USA.
   Joseph J Jacobs Ctr Thrombosis & Vasc Biol, Cleveland, OH USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1079-5642
J9 ARTERIOSCL THROM VAS
JI Arterioscler. Thromb. Vasc. Biol.
PD MAY
PY 2002
VL 22
IS 5
MA P259
BP A45
EP A45
PG 1
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA 550PP
UT WOS:000175511700276
DA 2018-10-20
ER

PT J
AU Kim, JH
   Kim, SC
AF Kim, JH
   Kim, SC
TI PEO-grafting on PU/PS IPNs for enhanced blood compatibility - effect of
   pendant length and grafting density
SO BIOMATERIALS
LA English
DT Article
DE blood compatibility; hydrophilic hydrophobic IPN; PEO-grafting;
   fibrinogen; platelet; protein-biomaterial interaction
ID HYDROPHOBIC POLYSTYRENE IPNS; PLASMA POLYMER SURFACES; PROTEIN
   ADSORPTION; POLYETHYLENE OXIDE; PLATELET-ADHESION; IN-VITRO; FIBRINOGEN;
   ANTITHROMBOGENICITY; RESISTANCE; INTERFACE
AB Polyurethane (PU) homopolymers and PU/polystyrene (PS) interpenetrating polymer networks (IPNs) were successfully synthesized changing the length of the pendant poly(ethylene oxide) (PEO) chains and the grafting density of PEO chains. All the PU/PS IPNs had the microphase-separated structures in which the PS-rich phase domains were dispersed in the matrix of the PU-rich phase. The domain size decreased a little, as the degree of grafting with PEO chains was increased. The water swelling ratio increased, and the interfacial energy decreased, as the length of the pendant PEO chains, and the grafting density of PEO chains of the PEO-grafted PU/PS IPNs were increased, since the mobile hydrophilic pendant PEO chains effectively induced and absorbed the water, when they were contacted with water. The hydrophilic and highly concentrated pendant PEO chains could easily prohibit the adhesion of the fibrinogens and the platelets on the surface, and the blood compatibility of IPNs was enhanced by increasing of grafting with PEO chains. The adsorption of the fibrinogens and the platelets was suppressed, as the length of pendant PEO chains, and the grafting density were increased. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Korea Adv Inst Sci & Technol, Ctr Adv Funct Polymers, Yusong Gu, Taejon 305701, South Korea.
RP Kim, SC (reprint author), Korea Adv Inst Sci & Technol, Ctr Adv Funct Polymers, Yusong Gu, 373-1 Kusong Dong, Taejon 305701, South Korea.
CR ANDRADE JD, 1979, J COLLOID INTERF SCI, V72, P488, DOI 10.1016/0021-9797(79)90350-3
   BASZKIN A, 1980, J BIOMED MATER RES, V14, P393, DOI 10.1002/jbm.820140406
   Chen X, 1997, LANGMUIR, V13, P4106, DOI 10.1021/la970172i
   DEFLFE KM, 1999, J BIOMED MATER RES, V44, P298
   DEGENNES JH, 1979, J BIOMATER SCI POLYM
   DEGENNES PG, 1980, MACROMOLECULES, V13, P1069, DOI 10.1021/ma60077a009
   deGennes PG, 1979, SCALING CONCEPTS POL
   Everse SJ, 1998, THROMB HAEMOSTASIS, V80, P1
   Feng L., 1995, PROTEINS INTERFACES
   HAN DK, 1989, J BIOMED MATER RES-A, V23, P211
   Holmberg K, 1997, COLLOID SURFACE A, V123, P297, DOI 10.1016/S0927-7757(96)03810-1
   Ishihara K, 1998, J BIOMED MATER RES, V39, P323, DOI 10.1002/(SICI)1097-4636(199802)39:2<323::AID-JBM21>3.0.CO;2-C
   Ishihara K, 1996, J POLYM SCI POL CHEM, V34, P199, DOI 10.1002/(SICI)1099-0518(19960130)34:2<199::AID-POLA6>3.0.CO;2-P
   JEON SI, 1992, B KOR CHEM SOC, V13, P245
   JEON SI, 1993, B KOR CHEM SOC, V14, P352
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P159, DOI 10.1016/0021-9797(91)90044-9
   Joen S. I., 1991, J COLLOID INTERF SCI, V142, P149
   Kim JH, 2000, J BIOMAT SCI-POLYM E, V11, P197, DOI 10.1163/156856200743652
   Lassen B, 1997, J COLLOID INTERF SCI, V186, P9, DOI 10.1006/jcis.1996.4529
   LEE SST, 1989, PESTIC BIOCHEM PHYS, V35, P1, DOI 10.1016/0048-3575(89)90096-5
   MALMSTEN M, 1995, J COLLOID INTERF SCI, V172, P106, DOI 10.1006/jcis.1995.1231
   Malmsten M, 1997, J COLLOID INTERF SCI, V193, P88, DOI 10.1006/jcis.1997.5039
   Marchant RE, 1997, THROMB HAEMOSTASIS, V77, P1048
   McPherson T, 1998, LANGMUIR, V14, P176, DOI 10.1021/la9706781
   MORI Y, 1982, T AM SOC ART INT ORG, V28, P459
   PERRIN DD, 1980, PURIFICATION LAB CHE
   Roh HW, 1999, J BIOMAT SCI-POLYM E, V10, P123, DOI 10.1163/156856299X00324
   SHIN YC, 1994, J BIOMAT SCI-POLYM E, V6, P281
   SHIN YC, 1994, J BIOMAT SCI-POLYM E, V6, P195
   Sugiyama K, 1999, MACROMOL CHEM PHYSIC, V200, P1439, DOI 10.1002/(SICI)1521-3935(19990601)200:6<1439::AID-MACP1439>3.0.CO;2-B
   Tanaka M, 2000, BIOMATERIALS, V21, P1471, DOI 10.1016/S0142-9612(00)00031-4
   Tsai WB, 1999, J BIOMED MATER RES, V44, P130, DOI 10.1002/(SICI)1097-4636(199902)44:2<130::AID-JBM2>3.0.CO;2-9
NR 32
TC 64
Z9 70
U1 1
U2 16
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2002
VL 23
IS 9
BP 2015
EP 2025
AR PII S0142-9612(01)00330-1
DI 10.1016/S0142-9612(01)00330-1
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 536FJ
UT WOS:000174689800013
PM 11996043
DA 2018-10-20
ER

PT J
AU dos Santos, LA
   Carrodeguas, RG
   Rogero, SO
   Higa, OZ
   Boschi, AO
   de Arruda, ACF
AF dos Santos, LA
   Carrodeguas, RG
   Rogero, SO
   Higa, OZ
   Boschi, AO
   de Arruda, ACF
TI alpha-tricalcium phosphate cement: "in vitro" cytotoxicity
SO BIOMATERIALS
LA English
DT Article
DE citotoxicity; calcium phosphate cement; bioceramic; biomaterial
ID SIMULATED BODY-FLUID; BONE CEMENTS; SETTING REACTION; SYSTEM; TCP
AB Calcium phosphate-based bioceramics have revolutionized orthopedic and dental repair of damaged parts of the bone system. Among these materials, calcium phosphate-based cements, with hydraulic setting, stand out due to their biocompatibility and in situ hardening, which allow easy manipulation and adaptation to the shape and dimensions of bone defects. An investigation was made of the in vitro cytotoxic effect of calcium phosphate cement based on a-tricalcium phosphate, immersed for different lengths of time in simulated body fluid (SBF), based on the ISO-10993 "Biological Evaluation of Medical Devices" standard. The culture medium was Chinese hamster ovary (CHO) cells in contact with diluted cement extracts. The results revealed that the calcium phosphate cement used was cytotoxic and that the material's cytotoxicity decreased the longer the cement was immersed in SBF. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Univ Estadual Campinas, UNICAMP, FEM, CEP, BR-13081970 Campinas, SP, Brazil.
   Univ La Habana, Ctr Biomat, Havana 10600, Cuba.
   CNEN, IPEN, BR-05422970 Sao Paulo, Brazil.
   Univ Fed Sao Carlos, Dept Mat Engn, BR-13565905 Sao Carlos, SP, Brazil.
RP dos Santos, LA (reprint author), Univ Estadual Campinas, UNICAMP, FEM, CEP, Caixa Postal 6122, BR-13081970 Campinas, SP, Brazil.
RI Garcia Carrodeguas, Raul/E-5087-2012; BOSCHI, Anselmo/K-7091-2013
OI Garcia Carrodeguas, Raul/0000-0002-4379-4598; 
CR BERMUDEZ O, 1994, J MATER SCI-MATER M, V5, P144, DOI 10.1007/BF00053334
   BERMUDEZ O, 1994, J MATER SCI-MATER M, V5, P160, DOI 10.1007/BF00053337
   CARRODEGUAS RG, UNPUB J MAT SCI MAT
   CARRODEGUAS RG, BIOMAT 97 C INT BIOM
   CHOW LC, 1991, NIPPON SERAM KYO GAK, V99, P954
   DRIESSENS FCM, 1994, J MATER SCI-MATER M, V5, P164, DOI 10.1007/BF00053338
   Driessens FCM, 1997, AN QUIM-INT, V93, pS38
   FAMERY R, 1994, CERAM INT, V20, P327, DOI 10.1016/0272-8842(94)90050-7
   Fernandez E, 1996, J BIOMED MATER RES, V32, P367, DOI 10.1002/(SICI)1097-4636(199611)32:3<367::AID-JBM9>3.0.CO;2-Q
   Fernandez E, 1999, J MATER SCI-MATER M, V10, P223, DOI 10.1023/A:1008958112257
   FERNANDEZ E, 1995, J MATER SCI LETT, V14, P4, DOI 10.1007/BF02565267
   FRESA R, 1995, BIOMATERIALS, V16, P849
   Ginebra MP, 1997, J DENT RES, V76, P905, DOI 10.1177/00220345970760041201
   GINEBRA MP, 1998, BIOCERAMICS, V11, P243
   GRUNINGER SE, 1984, J DENT RES, V63, P200
   International Standardization Organization, 1992, 109935 ISO
   ISHIKAWA K, 1998, J DENT RES, V1446, P812
   JENKINS R, 1971, INTRO XRAY POWDER DI
   LI PJ, 1992, J AM CERAM SOC, V75, P2094, DOI 10.1111/j.1151-2916.1992.tb04470.x
   Miyamoto Y, 1999, J BIOMED MATER RES, V48, P36, DOI 10.1002/(SICI)1097-4636(1999)48:1<36::AID-JBM8>3.0.CO;2-I
   Monma H, 1984, GYPSUM LIME, V188, P11
   NAKAMURA A, 1989, P JAP AT RES I JAERI, P79
   OLIVEIRA JM, 1995, BIOMATERIALS, V16, P849, DOI 10.1016/0142-9612(95)94146-C
   Santos L.A., 1999, BONE, V25, p99S
   SANTOS L.A., 2000, ARTIF ORGANS, V24, P212
   Tampieri A, 1997, J MATER SCI-MATER M, V8, P29, DOI 10.1023/A:1018538212328
   YU D, 1992, J PHARM SCI, V81, P529, DOI 10.1002/jps.2600810611
NR 27
TC 44
Z9 45
U1 0
U2 11
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2002
VL 23
IS 9
BP 2035
EP 2042
AR PII S0142-9612(01)00333-7
DI 10.1016/S0142-9612(01)00333-7
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 536FJ
UT WOS:000174689800015
PM 11996045
DA 2018-10-20
ER

PT J
AU Puleo, DA
   Kissling, RA
   Sheu, MS
AF Puleo, DA
   Kissling, RA
   Sheu, MS
TI A technique to immobilize bioactive proteins, including bone
   morphogenetic protein-4 (BMP-4), on titanium alloy
SO BIOMATERIALS
LA English
DT Article
DE protein immobilization; plasma polymerization; carbodiimide; BMP;
   biomolecular modification
ID CO-CR-MO; IN-VITRO; GROWTH-FACTOR; CHEMICAL MODIFICATION; CELL-ADHESION;
   SURFACES; BIOMATERIALS; TI-6AL-4V; MINERALIZATION; DEPOSITION
AB Immobilization of biomolecules on surfaces enables both localization and retention of molecules at the cell-biomaterial interface. Since metallic biomaterials used for orthopedic and dental implants possess a paucity of reactive functional groups, biomolecular modification of these materials is challenging. In the present work, we investigated the use of a plasma surface modification strategy to enable immobilization of bioactive molecules on a "bioinert" metal. Conditions during plasma polymerization of allyl amine on Ti-6Al-4V were varied to yield 5 ("low")- and 12 ("high")-NH2/nm(2). One- and two-step carbodiimide schemes were used to immobilize lysozyme, a model biomolecule, and bone morphogenetic protein-4 (BMP-4) on the aminated surfaces. Both schemes could be varied to control the amount of protein bound, but the one-step method destroyed the activity of immobilized lysozyme because of crosslinking. BMP-4 was then immobilized using the two-step scheme. Although BMP bound to both low- and high-NH2 surfaces was initially able to induce alkaline phosphatase activity in pluripotent C3H10T1/2 cells, only high amino group surfaces were effective following removal of weakly bound protein by incubation in cell culture medium. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Univ Kentucky, Ctr Biomed Engn, Wenner Gren Lab 205, Lexington, KY 40505 USA.
   AST Prod, Billerica, MA 01821 USA.
RP Puleo, DA (reprint author), Univ Kentucky, Ctr Biomed Engn, Wenner Gren Lab 205, Lexington, KY 40505 USA.
CR ALBELDA SM, 1990, FASEB J, V4, P2868
   Aronsson BO, 1997, J BIOMED MATER RES, V35, P49
   BAIER RE, 1982, BIOMATERIALS, V3, P241, DOI 10.1016/0142-9612(82)90027-8
   Dee KC, 1996, BIOMATERIALS, V17, P209, DOI 10.1016/0142-9612(96)85765-6
   Dee KC, 1998, J BIOMED MATER RES, V40, P371, DOI 10.1002/(SICI)1097-4636(19980605)40:3<371::AID-JBM5>3.3.CO;2-G
   Endo K, 1995, Dent Mater J, V14, P185
   GOMBOTZ WR, 1988, J APPL POLYM SCI APP, V42, P285
   HOFFMAN AS, 1988, J APPL POLYM SCI APP, V42, P251
   HUBBELL JA, 1991, BIO-TECHNOL, V9, P568, DOI 10.1038/nbt0691-568
   Ito Y, 1998, BIOCONJUGATE CHEM, V9, P277, DOI 10.1021/bc970190b
   KENLEY RA, 1993, PHARMACEUT RES, V10, P1393, DOI 10.1023/A:1018902720816
   KUHL PR, 1996, NAT MED, V2, P1202
   Lee WH, 2000, J MATER SCI, V35, P593, DOI 10.1023/A:1004768125476
   Leong LM, 1996, INT J BIOCHEM CELL B, V28, P1293, DOI 10.1016/S1357-2725(96)00075-1
   LIU SQ, 1992, BIOMATERIALS, V13, P50, DOI 10.1016/0142-9612(92)90095-6
   Maheshwari G, 2000, J CELL SCI, V113, P1677
   MASSIA SP, 1990, ANAL BIOCHEM, V187, P292, DOI 10.1016/0003-2697(90)90459-M
   Mikulec LJ, 1996, J BIOMED MATER RES, V32, P203, DOI 10.1002/(SICI)1097-4636(199610)32:2<203::AID-JBM8>3.0.CO;2-X
   Morra M, 1997, J BIOMED MATER RES, V37, P198, DOI 10.1002/(SICI)1097-4636(199711)37:2<198::AID-JBM8>3.0.CO;2-M
   Nanci A, 1998, J BIOMED MATER RES, V40, P324
   OKUYAMA T, 1960, J BIOCHEM-TOKYO, V47, P454, DOI 10.1093/oxfordjournals.jbchem.a127083
   Ollis D F, 1976, Methods Enzymol, V44, P444
   PHILLIPS DC, 1966, SCI AM, V215, P78, DOI 10.1038/scientificamerican1166-78
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   Pimentel E, 1994, HDB GROWTH FACTORS
   POGGI A, 1984, EXP CELL RES, V150, P436, DOI 10.1016/0014-4827(84)90587-1
   Puleo DA, 1997, J CELL PHYSIOL, V173, P93, DOI 10.1002/(SICI)1097-4652(199710)173:1<93::AID-JCP11>3.0.CO;2-O
   Puleo DA, 1998, J BIOMED MATER RES, V41, P104, DOI 10.1002/(SICI)1097-4636(199807)41:1<104::AID-JBM13>3.0.CO;2-N
   PULEO DA, 1995, J BIOMED MATER RES, V29, P951, DOI 10.1002/jbm.820290806
   Puleo DA, 1997, J BIOMED MATER RES, V37, P222, DOI 10.1002/(SICI)1097-4636(199711)37:2<222::AID-JBM11>3.0.CO;2-G
   RATNER BD, 1992, J BIOMAT SCI-POLYM E, V4, P3
   Rezania A, 1999, BIOTECHNOL PROGR, V15, P19, DOI 10.1021/bp980083b
   TAKAOKA K, 1993, CLIN ORTHOP RELAT R, P329
   TERLINGEN JGA, 1993, J BIOMAT SCI-POLYM E, V4, P165, DOI 10.1163/156856293X00500
   Thompson GJ, 1996, BIOMATERIALS, V17, P1949, DOI 10.1016/0142-9612(96)00009-9
   THOMPSON GJ, 1995, J APPL BIOMATER, V6, P249, DOI 10.1002/jab.770060406
   YUAN SM, 1994, APPL POLYM SYMP SER, V54, P77
NR 37
TC 208
Z9 216
U1 1
U2 60
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2002
VL 23
IS 9
BP 2079
EP 2087
AR PII S0142-9612(01)00339-8
DI 10.1016/S0142-9612(01)00339-8
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 536FJ
UT WOS:000174689800020
PM 11996050
DA 2018-10-20
ER

PT J
AU Coombes, AGA
   Verderio, E
   Shaw, B
   Li, X
   Griffin, M
   Downes, S
AF Coombes, AGA
   Verderio, E
   Shaw, B
   Li, X
   Griffin, M
   Downes, S
TI Biocomposites of non-crosslinked natural and synthetic polymers
SO BIOMATERIALS
LA English
DT Article
DE collagen; polycaprolactone; bone cells; biocomposite
ID EXTRACELLULAR-MATRIX; BIOMATERIALS; SKIN
AB Biocomposite films comprising a non-crosslinked, natural polymer (collagen) and a synthetic polymer, poly(epsilon-caprolactone) (PCL). have been produced by impregnation of lyophilised collagen mats with a solution of PCL in dichloromethane followed by solvent evaporation. This approach avoids the toxicity problem, associated with chemical crosslinking. Distinct changes in film morphology, from continuous surface coating to open porous format, were achieved by variation of processing parameters such Lis collagen:PCL ratio and the weight of the starting lyophilised collagen mat. Collagenase digestion indicated that the collagen content of 1:4 and 1:8 collagen:PCL biocomposites was almost totally accessible for enzymatic digestion indicating a high degree of collagen exposure for interaction with other ECM proteins or cells contacting the biomaterial Surface. Much reduced collagen exposure (around 50%) was measured for the 1:20 collagen:PCL materials. These findings were consistent with the SEM examination of collagen:PCL biocomposites which revealed a highly porous morphology for the 1:4 and 1:8 blends but virtually complete Coverage of the collagen component by PCL in the 1:20 samples. Investigations of the attachment and spreading characteristics of human osteoblast (HOB) cells on PCL films and collagen:PCL materials respectively. indicated that HOB cells poorly recognised PCL but attachment and spreading were much improved on the biocomposites. The non-chemically crosslinked, collagen:PCL biocomposites described are expected to provide a useful addition to the range of biomaterials and matrix systems for tissue engineering. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Univ Nottingham, Queens Med Ctr, Sch Biomed Sci, Nottingham NG7 2UH, England.
   Nottingham Trent Univ, Dept Life Sci, Nottingham NG11 8NS, England.
RP Coombes, AGA (reprint author), Aston Univ, Aston Pharm Sch, Birmingham B4 7ET, W Midlands, England.
RI Verderio, Elisabetta/H-2789-2016
OI Verderio, Elisabetta/0000-0001-9153-8997
CR BENSLIMANE S, 1988, EUR SURG RES, V20, P18
   GIUSTI P, 1993, TRENDS POLYM SCI, V1, P261
   Grzesiak JJ, 1997, BIOMATERIALS, V18, P1625, DOI 10.1016/S0142-9612(97)00103-8
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   HYNES RO, 1986, SCI AM, V254, P42, DOI 10.1038/scientificamerican0686-42
   Lebaron RG, 2000, TISSUE ENG, V6, P85, DOI 10.1089/107632700320720
   MATSUDA K, 1993, BIOMATERIALS, V14, P1030, DOI 10.1016/0142-9612(93)90197-A
   Santin M, 1996, BIOMATERIALS, V17, P1459, DOI 10.1016/0142-9612(96)89769-9
   Scotchford CA, 1998, BIOMATERIALS, V19, P1, DOI 10.1016/S0142-9612(97)00236-6
   Verderio E, 2001, J BIOMED MATER RES, V54, P294, DOI 10.1002/1097-4636(200102)54:2<294::AID-JBM17>3.0.CO;2-Q
   YANNAS IV, 1989, P NATL ACAD SCI USA, V86, P933, DOI 10.1073/pnas.86.3.933
NR 11
TC 74
Z9 75
U1 3
U2 17
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2002
VL 23
IS 10
BP 2113
EP 2118
AR PII S0142-9612(01)00341-6
DI 10.1016/S0142-9612(01)00341-6
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 571HZ
UT WOS:000176713100003
PM 11962651
DA 2018-10-20
ER

PT J
AU Ronold, HJ
   Ellingsen, JE
AF Ronold, HJ
   Ellingsen, JE
TI The use of a coin shaped implant for direct in situ measurement of
   attachment strength for osseointegrating biomaterial surfaces
SO BIOMATERIALS
LA English
DT Article
DE biomaterials; attachment strength; surface roughness; tensile testing;
   bone bonding; perpendicular forces; titanium implants; animal model
ID PLASMA-SPRAYED COATINGS; EXPERIMENTAL IN-VIVO; PUSH-OUT TEST; TITANIUM
   IMPLANTS; BIOMECHANICAL CHARACTERIZATION; TENSILE-STRENGTH; COATED
   IMPLANTS; BONE; INTERFACE; HYDROXYLAPATITE
AB Most animal models currently used to study the retention of implants in bone are influenced by shear forces introduced during the retention test. This is mainly due to the implant design, which most often are cylindrical, conical or threaded. In these models interlocking between bone and implant surface will increase the effect of genuine bone bonding and thus give a false positive outcome. The purpose of the present study was to establish a model for testing functional attachment of implants in situ, with minimal influence of interlocking and shear forces, The model involves the use of flat coin shaped implant placed onto the cortical bone of rabbit tibia without mechanical fixation to the bone. The implant is passively retained on the cortical bone by a titanium band retainer. During the healing period, the contact between the coin shaped implants and the bone is restricted to the flat test surfaces. To prevent interlocking effects from lateral bone attachments a polytetrafluoroethylene (PTFE) cap covering the vertical and the upper faces of the implants were used. The tensile test was performed with a gradual, calibrated pull, perpendicular to the bone-implant interface. This pullout model makes it possible to study the kinetics and strength of bone bonding with negligible influence of shear forces or mechanical interlocking. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Univ Oslo, Oral Res Lab, Fac Dent, Dept Prosthet & Oral Funct, N-0317 Oslo, Norway.
RP Ellingsen, JE (reprint author), Univ Oslo, Oral Res Lab, Fac Dent, Dept Prosthet & Oral Funct, POB 1109, N-0317 Oslo, Norway.
CR ALBREKTSSON T, 1981, ACTA ORTHOP SCAND, V52, P155, DOI 10.3109/17453678108991776
   Berzins A, 1997, J BIOMED MATER RES, V34, P337
   BERZINS A, 1999, MECH TESTING BONE BO, P463
   Branemark R, 1998, J ORTHOPAED RES, V16, P61, DOI 10.1002/jor.1100160111
   Branemark R, 1997, BIOMATERIALS, V18, P969, DOI 10.1016/S0142-9612(97)00018-5
   BUSER D, 1991, J BIOMED MATER RES, V25, P889, DOI 10.1002/jbm.820250708
   de Groot K, 1989, J Biomed Mater Res, V23, P1367, DOI 10.1002/jbm.820231112
   DEGROOT K, 1987, J BIOMED MATER RES, V21, P1375, DOI 10.1002/jbm.820211203
   DHERT WJA, 1992, J BIOMED MATER RES, V26, P119, DOI 10.1002/jbm.820260111
   DHERT WJA, 1999, MECH TESTING BONE BO, P477
   Edwards JT, 1997, J BIOMED MATER RES, V36, P454
   ELLINGSEN JE, 1995, J MATER SCI-MATER M, V6, P125, DOI 10.1007/BF00120287
   Ellingsen JE, 1995, J MATER SCI-MATER M, V6, P749, DOI 10.1007/BF00134312
   Ellingsen JE, 1998, PERIODONTOL 2000, V17, P36, DOI 10.1111/j.1600-0757.1998.tb00121.x
   GEESINK RGT, 1987, CLIN ORTHOP RELAT R, P147
   GROSS U, 1981, J BIOMED MATER RES, V15, P291, DOI 10.1002/jbm.820150302
   Jinno T, 1998, J BIOMED MATER RES, V42, P20, DOI 10.1002/(SICI)1097-4636(199810)42:1<20::AID-JBM4>3.0.CO;2-Q
   KANGASNIEMI IMO, 1994, J BIOMED MATER RES, V28, P563, DOI 10.1002/jbm.820280506
   Lewis CG, 1997, J ARTHROPLASTY, V12, P451, DOI 10.1016/S0883-5403(97)90202-3
   Lin H, 1998, J BIOMED MATER RES, V43, P113, DOI 10.1002/(SICI)1097-4636(199822)43:2<113::AID-JBM5>3.0.CO;2-R
   LIN H, 1992, J BIOMED MATER RES, V26, P7
   NAKAMURA T, 1985, J BIOMED MATER RES, V19, P685, DOI 10.1002/jbm.820190608
   Nakashima Y, 1997, J BIOMED MATER RES, V35, P287
   Ogiso M, 1998, J BIOMED MATER RES, V39, P364
   OSBORN JF, 1989, BIOCERAMICS, V1, P388
   Pebe P, 1997, Implant Dent, V6, P259
   Skripitz R, 1998, ACTA ORTHOP SCAND, V69, P315, DOI 10.3109/17453679809000938
   STEINEMANN SG, 1986, ADV BIOMATER, V6, P409
   Taborelli M, 1997, CLIN ORAL IMPLAN RES, V8, P208, DOI 10.1034/j.1600-0501.1997.080307.x
   TAKATSUKA K, 1995, J BIOMED MATER RES, V29, P157, DOI 10.1002/jbm.820290204
   THOMAS KA, 1987, J BIOMED MATER RES, V21, P1395, DOI 10.1002/jbm.820211205
   Vercaigne S, 1998, J BIOMED MATER RES, V41, P41, DOI 10.1002/(SICI)1097-4636(199807)41:1<41::AID-JBM5>3.0.CO;2-Q
   Wennerberg A, 1996, J BIOMED MATER RES, V30, P251, DOI 10.1002/(SICI)1097-4636(199602)30:2<251::AID-JBM16>3.0.CO;2-P
   WENNERBERG A, 1995, CLIN ORAL IMPLAN RES, V6, P24, DOI 10.1034/j.1600-0501.1995.060103.x
   WILKE HJ, 1990, ADV BIOMAT, V9, P309
   YOSHII S, 1988, J BIOMED MATER RES-A, V22, P327, DOI 10.1002/jbm.820221410
NR 36
TC 39
Z9 39
U1 0
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2002
VL 23
IS 10
BP 2201
EP 2209
AR PII S0142-9612(01)00353-2
DI 10.1016/S0142-9612(01)00353-2
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 571HZ
UT WOS:000176713100013
PM 11962661
DA 2018-10-20
ER

PT J
AU Duncan, AC
   Weisbuch, F
   Rouais, F
   Lazare, S
   Baquey, C
AF Duncan, AC
   Weisbuch, F
   Rouais, F
   Lazare, S
   Baquey, C
TI Laser microfabricated model surfaces for controlled cell growth
SO BIOSENSORS & BIOELECTRONICS
LA English
DT Article
DE microfabricated; surfaces; controlled cell growth; osteoblast
ID OXYGEN-CONTAINING FILMS; EXCIMER-LASER; MICROTEXTURED SILICONE;
   IN-VITRO; MICROARCHITECTURAL DESIGN; BIOMEDICAL APPLICATIONS;
   SUBCUTANEOUS IMPLANTS; PERCUTANEOUS IMPLANTS; TITANIUM SUBSTRATA;
   BEHAVIOR INVITRO
AB The relatively recent applications of microelectronics technology into the biological sciences arena has drastically revolutionized the field. New foreseeable applications include miniaturized, multiparametric biosensors for high performance multianalyte assays or DNA sequencing, biocomputers, and substrates for controlled cell growth (i.e. tissue engineering). The objectives of this work were to investigate a new method combining microphotolithographical techniques with laser excimer beam technology to create surfaces with well defined 3-D microdomains in order to delineate critical microscopic surface features governing material-cell interaction. Another obvious application of this study pertains to the fabrication of cell-based biosensors. Microfabricated surfaces were obtained with micron resolution, by 'microsculpturing' polymer model surfaces using a laser excimer KrF beam coupled with a microlithographic projection technique. The laser beam after exiting a mask was focused onto the polymer target surface via an optical setup allowing for a 10-fold reduction of the mask pattern. Various 3-D micropatterned features were obtained at the micron level. Reproducible submicron features could also be obtained using this method. Subsequently, model osteoblast-like cells were plated onto the laser microfabricated surfaces in order to study the effects of particular surface microtopography on preferential cell deposition and orientation. Preferential cell deposition was observed on surfaces presenting 'smooth' microtopographical transitions. This system may provide an interesting model for further insights into correlations between 3-D surface microtopography and cell response with new applications in the field biosensor, biomaterial and pharmaceutical engineering sciences (e.g. new cell based biosensors, controlled synthesis of immobilized cell derived active ingredients). (C) 2002 Elsevier Science B.V. All rights reserved.
C1 Univ Bordeaux 2, Natl Inst Hlth & Med Res, Biomat & Tissue Repair Unit, INSERM U443, F-33076 Bordeaux, France.
   Univ Bordeaux 1, CNRS, UMR 5803, Lab Physicochim Mol, F-33405 Talence, France.
RP Duncan, AC (reprint author), CNRS, 115 Ave Docteur Albert Schweitzer, F-3360 Pessac, France.
EM aduncan65@hotmail.com
CR Amirpour ML, 2001, ANAL CHEM, V73, P1560, DOI 10.1021/ac000907f
   BORDENAVE L, 1993, J BIOMED MATER RES, V27, P1367, DOI 10.1002/jbm.820271104
   Brunette DM, 1999, J BIOMECH ENG-T ASME, V121, P49, DOI 10.1115/1.2798042
   Campbell C E, 1989, J Invest Surg, V2, P51, DOI 10.3109/08941938909016503
   Chehroudi B, 1997, J BIOMED MATER RES, V34, P279
   CHEHROUDI B, 1989, J BIOMED MATER RES, V23, P1067, DOI 10.1002/jbm.820230907
   CHEHROUDI B, 1991, J BIOMED MATER RES, V25, P387, DOI 10.1002/jbm.820250310
   CHEHROUDI B, 1990, J BIOMED MATER RES, V24, P1203, DOI 10.1002/jbm.820240906
   CHEHROUDI B, 1988, J BIOMED MATER RES, V22, P459, DOI 10.1002/jbm.820220603
   CHEHROUDI B, 1995, J BIOMED MATER RES, V29, P371, DOI 10.1002/jbm.820290312
   CHESMEL KD, 1995, J BIOMED MATER RES, V29, P1101, DOI 10.1002/jbm.820290910
   CLARK P, 1990, DEVELOPMENT, V108, P635
   CLARK P, 1992, J CELL SCI, V103, P287
   COREY JM, 1991, J NEUROSCI RES, V30, P300, DOI 10.1002/jnr.490300204
   Dalton BA, 2001, J BIOMED MATER RES, V56, P195, DOI 10.1002/1097-4636(200108)56:2<195::AID-JBM1084>3.0.CO;2-7
   den Braber ET, 1998, J BIOMED MATER RES, V40, P425, DOI 10.1002/(SICI)1097-4636(19980605)40:3<425::AID-JBM13>3.0.CO;2-I
   denBraber ET, 1997, J BIOMED MATER RES, V37, P539, DOI 10.1002/(SICI)1097-4636(19971215)37:4<539::AID-JBM13>3.0.CO;2-3
   denBraber ET, 1996, BIOMATERIALS, V17, P1093, DOI 10.1016/0142-9612(96)85910-2
   ERTEL SI, 1990, J BIOMED MATER RES, V24, P1637, DOI 10.1002/jbm.820241207
   ERTEL SI, 1991, J COLLOID INTERF SCI, V147, P433, DOI 10.1016/0021-9797(91)90176-9
   ERTEL SI, 1991, J BIOMAT SCI-POLYM E, V3, P163, DOI 10.1163/156856291X00269
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   GREEN AM, 1994, J BIOMED MATER RES, V28, P647, DOI 10.1002/jbm.820280515
   HIRONO T, 1988, BRAIN RES, V446, P189, DOI 10.1016/0006-8993(88)91314-5
   Hunt JA, 1995, J MATER SCI-MATER M, V6, P813, DOI 10.1007/BF00134323
   Ito Y, 1999, BIOMATERIALS, V20, P2333, DOI 10.1016/S0142-9612(99)00162-3
   Kapur R, 1999, J BIOMECH ENG-T ASME, V121, P65, DOI 10.1115/1.2798044
   Kasemo B, 1999, Adv Dent Res, V13, P8
   LAZARE S, 1986, J PHYS CHEM-US, V90, P2124, DOI 10.1021/j100401a028
   LAZARE S, 1989, LASER CHEM, V10, P25, DOI 10.1155/1989/18750
   LAZARE S, 1990, COMMUNICATION
   LEE JS, 1994, APPL PHYS LETT, V65, P400, DOI 10.1063/1.112314
   Matsuda T, 1996, J BIOMED MATER RES, V31, P235, DOI 10.1002/(SICI)1097-4636(199606)31:2<235::AID-JBM10>3.0.CO;2-K
   Matsuzaka K, 1999, BIOMATERIALS, V20, P1293, DOI 10.1016/S0142-9612(99)00029-0
   Matsuzaka K, 2000, CLIN ORAL IMPLAN RES, V11, P325, DOI 10.1034/j.1600-0501.2000.011004325.x
   MEYLE J, 1995, J BIOMED MATER RES, V29, P81, DOI 10.1002/jbm.820290112
   NAKAYAMA Y, 1995, J BIOMED MATER RES, V29, P1295, DOI 10.1002/jbm.820291017
   NIINO H, 1989, APPL PHYS LETT, V54, P2159, DOI 10.1063/1.101154
   NIINO H, 1992, APPL PHYS LETT, V2697
   Pins GD, 2000, FASEB J, V14, P593
   Qu J, 1996, Oral Dis, V2, P102
   Ranucci CS, 2001, J BIOMED MATER RES, V54, P149, DOI 10.1002/1097-4636(200102)54:2<149::AID-JBM1>3.0.CO;2-O
   SCHAMBERGER PC, 1994, COLLOID SURFACE B, V2, P209, DOI 10.1016/0927-7765(94)80036-7
   SCHMIDT J, 1990, BIOMATERIALS, V12, P385
   SCHMIDT JA, 1992, BIOMATERIALS, V13, P1059, DOI 10.1016/0142-9612(92)90138-E
   SCHMIDT JA, 1992, BIOMATERIALS, V13, P675
   SHIMO N, 1994, N-HOLLAND D, P109
   SHIMO N, 1990, MATER RES SOC SYMP P, V191, P91, DOI 10.1557/PROC-191-91
   Thess A, 1996, SCIENCE, V273, P483, DOI 10.1126/science.273.5274.483
   VILAMITJANAAMEDEE J, 1993, IN VITRO CELL DEV-AN, V29, P699
   Walboomers XF, 2000, BIOMATERIALS, V21, P629, DOI 10.1016/S0142-9612(99)00230-6
   Walboomers XF, 1999, J BIOMED MATER RES, V46, P212, DOI 10.1002/(SICI)1097-4636(199908)46:2<212::AID-JBM10>3.0.CO;2-Y
   WALTER J, 1987, DEVELOPMENT, V101, P685
NR 53
TC 68
Z9 72
U1 0
U2 11
PU ELSEVIER ADVANCED TECHNOLOGY
PI OXFORD
PA OXFORD FULFILLMENT CENTRE THE BOULEVARD, LANGFORD LANE, KIDLINGTON,
   OXFORD OX5 1GB, OXON, ENGLAND
SN 0956-5663
J9 BIOSENS BIOELECTRON
JI Biosens. Bioelectron.
PD MAY
PY 2002
VL 17
IS 5
BP 413
EP 426
AR PII S0956-5663(01)00281-0
DI 10.1016/S0956-5663(01)00281-0
PG 14
WC Biophysics; Biotechnology & Applied Microbiology; Chemistry, Analytical;
   Electrochemistry; Nanoscience & Nanotechnology
SC Biophysics; Biotechnology & Applied Microbiology; Chemistry;
   Electrochemistry; Science & Technology - Other Topics
GA 539JX
UT WOS:000174867700009
PM 11888732
DA 2018-10-20
ER

PT J
AU Einmahl, S
   Savoldelli, M
   D'Hermies, F
   Tabatabay, C
   Gurny, R
   Behar-Cohen, F
AF Einmahl, S
   Savoldelli, M
   D'Hermies, F
   Tabatabay, C
   Gurny, R
   Behar-Cohen, F
TI Evaluation of a novel biomaterial in the suprachoroidal space of the
   rabbit eye
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Article
ID BIOERODIBLE POLY(ORTHO ESTER); DRUG-DELIVERY SYSTEMS; CHOROIDAL
   NEOVASCULARIZATION; MACULAR DEGENERATION; RELEASE; BIOCOMPATIBILITY;
   5-FLUOROURACIL; STERILIZATION; DEXAMETHASONE; ANGIOGENESIS
AB PURPOSE. Drug delivery to treat diseases of the posterior segment of the eye, such as choroidal neovascularization and its complications, is hampered by poor intraocular penetration and rapid elimination of the drug from the eye. The purpose of this study was to investigate the feasibility and tolerance of suprachoroidal injections of poly(ortho ester) (POE), a bio-erodible and biocompatible polymer, as a biomaterial potentially useful for development of sustained drug delivery systems.
   METHODS. After tunnelization of the sclera, different formulations based on POE were injected (100 muL) into the suprachoroidal space of pigmented rabbits and compared with 1% sodium hyaluronate. Follow-up consisted of fundus observations, echography, fluorescein angiography, and histologic analysis over 3 weeks.
   RESULTS. After injection, POE spread in the suprachoroidal space at the posterior pole. It was well tolerated and progressively disappeared from the site of injection without sequelae. No bleeding or retinal detachment occurred. Echographic pictures showed that the material was present in the suprachoroidal space for 3 weeks. Angiography revealed minor pigment irregularities at the site of injection, but no retinal edema or necrosis. Histology showed that POE was well tolerated in the choroid.
   CONCLUSIONS. POE suprachoroidal injections, an easy, controllable, and reproducible procedure, were well tolerated in the rabbit eye. POE appears to be a promising biomaterial to deliver drugs focally to the choroid and the retina.
C1 Univ Geneva, Dept Pharmaceut Technol & Biopharmaceut, Sch Pharm, CH-1211 Geneva 4, Switzerland.
   INSERM, Lab U450, Paris, France.
   Hop Hotel Dieu, Dept Ophthalmol, Paris, France.
RP Gurny, R (reprint author), Univ Geneva, Dept Pharmaceut Technol & Biopharmaceut, Sch Pharm, 30 Quai Ernest Ansermet, CH-1211 Geneva 4, Switzerland.
EM robert.gurny@pharm.unige.ch
CR Ambati J, 2000, INVEST OPHTH VIS SCI, V41, P1186
   Castellarin AA, 1998, BRIT J OPHTHALMOL, V82, P480, DOI 10.1136/bjo.82.5.480
   DAMATO RJ, 1995, OPHTHALMOLOGY, V102, P1261
   DAMORE PA, 1994, INVEST OPHTH VIS SCI, V35, P3974
   Einmahl S, 2001, INVEST OPHTH VIS SCI, V42, P695
   Einmahl S, 2000, J BIOMED MATER RES, V50, P566, DOI 10.1002/(SICI)1097-4636(20000615)50:4<566::AID-JBM12>3.0.CO;2-M
   Einmahl S, 1999, INT J PHARM, V185, P189, DOI 10.1016/S0378-5173(99)00149-0
   Ferrara N, 1999, NAT MED, V5, P1359, DOI 10.1038/70928
   FERRIS FL, 1984, ARCH OPHTHALMOL-CHIC, V102, P1640
   FOULDS WS, 1988, BRIT J OPHTHALMOL, V72, P278, DOI 10.1136/bjo.72.4.278
   GHADIALLY FN, 1982, J SUBMICR CYTOL PATH, V14, P63
   GUYER DR, 1989, RETINA, P17
   Ishida K, 1999, INVEST OPHTH VIS SCI, V40, P1512
   Keshet E, 1999, J CLIN INVEST, V104, P1497, DOI 10.1172/JCI8849
   Martidis A, 1999, J OCUL PHARMACOL TH, V15, P425, DOI 10.1089/jop.1999.15.425
   MERKLI A, 1993, J BIOMAT SCI-POLYM E, V4, P505, DOI 10.1163/156856293X00168
   Merkli A, 1996, BIOMATERIALS, V17, P897, DOI 10.1016/0142-9612(96)83285-6
   MERKLI A, 1995, J CONTROL RELEASE, V33, P415, DOI 10.1016/0168-3659(94)00117-D
   MITTL RN, 1987, OPHTHALMIC RES, V19, P255, DOI 10.1159/000265503
   POOLE TA, 1986, OPHTHALMOLOGY, V93, P1408
   PROIA AD, 1993, EXP EYE RES, V57, P693, DOI 10.1006/exer.1993.1177
   Rothen-Weinhold A, 2001, J CONTROL RELEASE, V71, P31, DOI 10.1016/S0168-3659(00)00348-5
   Sintzel MB, 1998, INT J PHARM, V175, P165, DOI 10.1016/S0378-5173(98)00274-9
   Yasukawa T, 1999, INVEST OPHTH VIS SCI, V40, P2690
   Zignani M, 1997, J CONTROL RELEASE, V48, P115, DOI 10.1016/S0168-3659(97)00050-3
   Zignani M, 2000, BIOMATERIALS, V21, P1773, DOI 10.1016/S0142-9612(00)00065-X
   Zignani M, 1998, J BIOMED MATER RES, V39, P277
   Zignani M, 2000, EUR J PHARM BIOPHARM, V50, P251, DOI 10.1016/S0939-6411(00)00107-7
NR 28
TC 65
Z9 67
U1 0
U2 7
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
EI 1552-5783
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD MAY
PY 2002
VL 43
IS 5
BP 1533
EP 1539
PG 7
WC Ophthalmology
SC Ophthalmology
GA 548FN
UT WOS:000175378100037
PM 11980871
DA 2018-10-20
ER

PT J
AU Muller, LT
   Gombos, DS
   Mishra, CK
   Gunderson, CA
   Calvano, CJ
AF Muller, LT
   Gombos, DS
   Mishra, CK
   Gunderson, CA
   Calvano, CJ
TI Biocompatability studies of a novel biomaterial for ocular surface
   reconstruction
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Meeting Abstract
CT Annual Meeting of the
   Association-for-Research-in-Vision-and-Ophthalmology
CY MAY 05-10, 2002
CL FT LAUDERDALE, FLORIDA
SP Assoc Res Vis & Ophthalmol
C1 Univ Texas, Med Branch, Galveston, TX 77550 USA.
   MD Anderson, Dept Plast Surg, Div Ophthalmol, Houston, TX USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD MAY
PY 2002
VL 43
SU 1
MA 1110
BP U242
EP U242
PG 1
WC Ophthalmology
SC Ophthalmology
GA 709CF
UT WOS:000184606601067
DA 2018-10-20
ER

PT J
AU Hardouin, P
   Fayada, P
   Leclet, H
   Chopin, D
AF Hardouin, P
   Fayada, P
   Leclet, H
   Chopin, D
TI Kyphoplasty
SO JOINT BONE SPINE
LA English
DT Review
DE biomaterial; kyphoplasty; osteoporosis; vertebroplasty; vertebral
   collapse
ID PERCUTANEOUS VERTEBROPLASTY; FRACTURES; BONE; VIVO
AB A variant of vertebroplasty known as "kyphoplasty" has been suggested for correcting vertebral compression fractures. A balloon placed inside the vertebral body is inflated to create a cavity, thereby restoring vertebral body height and allowing low-pressure cement injection. This procedure is gaining popularity in the United States. Over 1000 patients had been treated by the end of 2000. However, kyphoplasty is costly (chiefly because the balloon is disposable) and has not been evaluated in carefully designed studies. Although retrospective findings have been reported as highly promising, they are not sufficient to validate this procedure. The principle is innovative and the procedure deserves further investigation as a potentially effective means of correcting loss of vertebral height. Furthermore, use of a bone substitute instead of cement deserves investigation. (C) 2002 Editions scientificlues et medicales Elsevier SAS.
C1 Inst Calot, Serv Rhumatol, Grp Hopale, F-62608 Berck Sur Mer, France.
   Univ Littoral Cote Opale, Inst Rech Biomat & Biotechnol IR2B, F-62608 Berck Sur Mer, France.
   Inst Calot, Serv Chirurg Rachis, Grp Hopale, F-62608 Berck Sur Mer, France.
   Inst Calot, Serv Radiol, Grp Hopale, F-62608 Berck Sur Mer, France.
RP Hardouin, P (reprint author), Inst Calot, Serv Rhumatol, Grp Hopale, F-62608 Berck Sur Mer, France.
CR Belkoff SM, 2001, SPINE, V26, P151, DOI 10.1097/00007632-200101150-00008
   CONSTANTZ BR, 1995, SCIENCE, V267, P1796, DOI 10.1126/science.7892603
   Cortet B, 1999, J RHEUMATOL, V26, P2222
   DUDENEY S, 2000, 1 WORLD C OST CHIC 2, V11
   GALIBERT P, 1987, NEUROCHIRURGIE, V33, P166
   Garfin S, 1998, CHALLENGES SPINE FIX
   GARFIN SR, 2000, EARLY OUTCOMES FIRST
   GARFIN SR, IN PRESS SPINE
   HARDOUIN P, 1997, SEMIN MUSCULOSKELETA, V1, P319
   HARDOUIN P, 2001, REV RHUM, V68, P392
   Lane JM, 2000, J BONE MINER RES, V15, pS198
   Lieberman IH, 2000, J BONE MINER RES, V15, pS560
   LIEBERMAN IH, IN PRESS SPINE
   Maus T, 2000, J BONE MINER RES, V15, pS580
   Ohura K, 1996, J BIOMED MATER RES, V30, P193, DOI 10.1002/(SICI)1097-4636(199602)30:2<193::AID-JBM9>3.0.CO;2-M
   Schlaich C, 1998, OSTEOPOROSIS INT, V8, P261, DOI 10.1007/s001980050063
   SILVERSTEIN H, 1992, AM J OTOL, V13, P23
   Wilson DR, 2000, SPINE, V25, P158, DOI 10.1097/00007632-200001150-00004
   Wong X, 2000, J WOMENS IMAGING, P117
   YUAN HA, 2000, AANS CNS SECT DIS SP, P23
NR 20
TC 31
Z9 38
U1 0
U2 1
PU EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI PARIS CEDEX 15
PA 23 RUE LINOIS, 75724 PARIS CEDEX 15, FRANCE
SN 1297-319X
J9 JOINT BONE SPINE
JI Joint Bone Spine
PD MAY
PY 2002
VL 69
IS 3
BP 256
EP 261
AR UNSP S1297319X02003901/REV
DI 10.1016/S1297-319X(02)00390-1
PG 6
WC Rheumatology
SC Rheumatology
GA 582KP
UT WOS:000177349900005
PM 12102271
DA 2018-10-20
ER

PT J
AU Rowley, JA
   Mooney, DJ
AF Rowley, JA
   Mooney, DJ
TI Alginate type and RGD density control myoblast phenotype
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE tissue engineering; RGD; alginates; skeletal muscle; biomaterial design
ID EXTRACELLULAR-MATRIX; GROWTH-FACTOR; GEL BEADS; CELL; DIFFERENTIATION;
   HEPATOCYTES; INDUCTION
AB Alginates are being increasingly used for cell encapsulation and tissue engineering applications; however, these materials cannot specifically interact with mammalian cells. We have covalently modified alginates of varying monomeric ratio with RGD-containing cell adhesion ligands using carbodiimide chemistry to initiate cell adhesion to these polymers. We hypothesized that we could control the function of cells adherent to RGD-modified alginate hydrogels by varying alginate polymer type and cell adhesion ligand density, and we have addressed this possibility by studying the proliferation and differentiation of C2C12 skeletal myoblasts adherent to these materials. RGD density on alginates of varying monomeric ratio could be controlled over several orders of magnitude, creating a range of surface densities from 1-100 fmol/cm(2). Myoblast adhesion to these materials was specific to the RGD ligand, because adhesion could be competed away with soluble RGD in a dose-dependent manner. Myoblast proliferation and differentiation could be regulated by varying the alginate monomeric ratio and the density of RGD ligands at the substrate surface, and specific combinations of alginate type and RGD density were required to obtain efficient myoblast differentiation on these materials. (C) 2002 John Wiley Sons, Inc.
C1 Univ Michigan, Coll Engn, Dept Biomed Engn, Ann Arbor, MI 48109 USA.
   Univ Michigan, Coll Dent, Dept Biomed Engn, Ann Arbor, MI USA.
   Univ Michigan, Coll Engn, Dept Chem Engn, Ann Arbor, MI USA.
   Univ Michigan, Coll Dent, Dept Chem Engn, Ann Arbor, MI USA.
   Univ Michigan, Coll Dent, Dept Biol & Mat Sci, Ann Arbor, MI USA.
   Univ Michigan, Coll Engn, Dept Biol & Mat Sci, Ann Arbor, MI USA.
RP Mooney, DJ (reprint author), Univ Michigan, Coll Engn, Dept Biomed Engn, Ann Arbor, MI 48109 USA.
FU NIDCR NIH HHS [R01-DE13349]
CR Alsberg E, 2001, J DENT RES, V80, P2025, DOI 10.1177/00220345010800111501
   Andres V, 1996, J CELL BIOL, V132, P657, DOI 10.1083/jcb.132.4.657
   ATALA A, 1994, J UROLOGY, V152, P641, DOI 10.1016/S0022-5347(17)32671-X
   CHAMBERLAIN JS, 1985, MOL CELL BIOL, V5, P484, DOI 10.1128/MCB.5.3.484
   Chang SCN, 2001, J BIOMED MATER RES, V55, P503, DOI 10.1002/1097-4636(20010615)55:4<503::AID-JBM1043>3.0.CO;2-S
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   ESPEVIK T, 1993, EUR J IMMUNOL, V23, P255, DOI 10.1002/eji.1830230140
   FREMOND B, 1993, CELL TRANSPLANT, V2, P453, DOI 10.1177/096368979300200603
   Galbraith CG, 1997, P NATL ACAD SCI USA, V94, P9114, DOI 10.1073/pnas.94.17.9114
   Hauselmann H. J., 1996, AM J PHYSIOL, V271, P742
   Huang S, 1999, NAT CELL BIOL, V1, pE131
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   INGBER DE, 1989, J CELL BIOL, V109, P317, DOI 10.1083/jcb.109.1.317
   Ingber D, 1991, CURR OPIN CELL BIOL, V3, P841, DOI 10.1016/0955-0674(91)90058-7
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   LIN CQ, 1993, FASEB J, V7, P737
   Loebsack A, 2001, J BIOMED MATER RES, V57, P575, DOI 10.1002/1097-4636(20011215)57:4<575::AID-JBM1204>3.0.CO;2-9
   Marler JJ, 2000, PLAST RECONSTR SURG, V105, P2049, DOI 10.1097/00006534-200005000-00020
   MARTINSEN A, 1989, BIOTECHNOL BIOENG, V33, P79, DOI 10.1002/bit.260330111
   MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089
   MOONEY DJ, 1994, MOL BIOL CELL, V5, P1281
   OTTERLEI M, 1991, J IMMUNOTHER, V10, P286, DOI 10.1097/00002371-199108000-00007
   Palecek SP, 1997, NATURE, V385, P537, DOI 10.1038/385537a0
   Peters MC, 1998, J BIOMAT SCI-POLYM E, V9, P1267, DOI 10.1163/156856298X00389
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   Putnam AJ, 1996, NAT MED, V2, P824, DOI 10.1038/nm0796-824
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   SMIDSROD O, 1990, TRENDS BIOTECHNOL, V8, P71, DOI 10.1016/0167-7799(90)90139-O
   Thomas A, 2000, BIOMATERIALS, V21, P1797, DOI 10.1016/S0142-9612(00)00072-7
   Yao CC, 1996, J CELL SCI, V109, P3139
NR 30
TC 255
Z9 260
U1 2
U2 63
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD MAY
PY 2002
VL 60
IS 2
BP 217
EP 223
DI 10.1002/jbm.1287
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 527YM
UT WOS:000174215600001
PM 11857427
DA 2018-10-20
ER

PT J
AU Vehof, JWM
   Fisher, JP
   Dean, D
   van der Waerden, JPCM
   Spauwen, PHM
   Mikos, AG
   Jansen, JA
AF Vehof, JWM
   Fisher, JP
   Dean, D
   van der Waerden, JPCM
   Spauwen, PHM
   Mikos, AG
   Jansen, JA
TI Bone formation in transforming growth factor beta-1-coated porous
   poly(propylene fumarate) scaffolds
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE bone regeneration; transforming growth factor-beta; recombinant
   proteins; osteoinduction; porous poly(propylene fumarate); scaffolds
ID RAT ECTOPIC MODEL; IN-VIVO; BIOMATERIAL CARRIERS; TRANSGENIC MICE;
   IMPLANTS; GROWTH-FACTOR-BETA-1; CEMENT; PHARMACOKINETICS;
   HYDROXYAPATITE; REGENERATION
AB This study determined the bone growth into pretreated poly(propylene fumarate) (PPF) scaffolds implanted into a subcritical size, ribbit cranial defect. PPF scaffolds were constructed by using a photocrosslinking-porogen leaching technique. These scaffolds were then either prewetted (PPF-Pw), treated with RF glow-discharge (PPF-Gd), coated with fibronectin (PPF-Fn), or coated with rhTGF-beta(1) (PPF-TGF-beta(1)). One of each scaffold type was then placed into the cranium of nine rabbits. The rabbits were sacrificed after 8 weeks, and the scaffolds were retrieved for histological analysis. The most bone formation was present in the PPF-TGF-beta(1) implants; the newly formed bone had a trabecular appearance together with bone marrow-like tissue. Little or no bone formation was observed in implants without rhTGF-beta(1). These histological findings were confirmed by image analysis. Bone surface area, bone area percentage, pore fill percentage, and pore area percentage were significantly higher in the rhTGF-beta(1)-coated implants than in the noncoated implants. No statistical difference was seen between the PPF-Fn, PPF-Pw, or PPF-Gd scaffolds for these parameters. Quadruple fluorochrome labeling showed that in PPF-TGF-beta(1) implants bone formation mainly started in the interior of a pore and proceeded toward the scaffold. We conclude that (a) PPF-TGF-beta(1) scaffolds can indeed adequately induce bone formation in porous PPF, and (b) PPF scaffolds prepared by the photocrosslinking-porogen leaching technique are good candidates for the creation of bone graft substitutes. (C) 2002 John Wiley Sons, Inc.
C1 Univ Nijmegen, Ctr Med, Coll Dent Sci, Dept Biomat, NL-6500 HB Nijmegen, Netherlands.
   Rice Univ, Dept Bioengn, Houston, TX 77251 USA.
   Case Western Reserve Univ, Univ Hosp Cleveland, Dept Neurol Surg, Cleveland, OH USA.
   Univ Nijmegen, Ctr Med, Dept Plast & Reconstruct Surg, Nijmegen, Netherlands.
RP Jansen, JA (reprint author), Univ Nijmegen, Ctr Med, Coll Dent Sci, Dept Biomat, POB 9101, NL-6500 HB Nijmegen, Netherlands.
RI Jansen, John/H-8055-2014; Fisher, John/F-8078-2012; Dean,
   David/F-9605-2017
OI Dean, David/0000-0002-1217-3764
FU NIAMS NIH HHS [R01-AR44381]; NIDCR NIH HHS [R01-DE13031, R01-DE13740]
CR ARNAUD E, 1994, CALCIFIED TISSUE INT, V54, P493, DOI 10.1007/BF00334331
   BECK LS, 1993, J BONE MINER RES, V8, P753
   BLOM EJ, 2000, P 6 WORLD C BIOM KAM
   Calabresi PA, 1998, NEUROLOGY, V51, P289, DOI 10.1212/WNL.51.1.289
   Clouthier DE, 1997, J CLIN INVEST, V100, P2697, DOI 10.1172/JCI119815
   Dennis J E, 1993, J Oral Implantol, V19, P106
   Fisher JP, 2001, ANN REV MATER RES, V31, P171, DOI 10.1146/annurev.matsci.31.1.171
   Fisher JP, 2001, J BIOMAT SCI-POLYM E, V12, P673
   Goldstein AS, 1999, TISSUE ENG, V5, P421, DOI 10.1089/ten.1999.5.421
   GOMBOTZ WR, 1994, J APPL BIOMATER, V5, P141, DOI 10.1002/jab.770050207
   GRESSER JD, 1995, J BIOMED MATER RES, V29, P1241, DOI 10.1002/jbm.820291011
   He S, 2001, POLYMER, V42, P1251, DOI 10.1016/S0032-3861(00)00479-1
   Healy KE, 1999, ANN NY ACAD SCI, V875, P24, DOI 10.1111/j.1749-6632.1999.tb08491.x
   Heckman JD, 1999, J BONE JOINT SURG AM, V81A, P1717, DOI 10.2106/00004623-199912000-00009
   Kopp JB, 1996, LAB INVEST, V74, P991
   Kornu R, 1996, J ORTHOPAED RES, V14, P871, DOI 10.1002/jor.1100140605
   Kuboki Y, 1998, J BIOMED MATER RES, V39, P190, DOI 10.1002/(SICI)1097-4636(199802)39:2<190::AID-JBM4>3.0.CO;2-K
   Ledbetter S, 2000, KIDNEY INT, V58, P2367, DOI 10.1046/j.1523-1755.2000.00420.x
   Lewandrowski KU, 2000, BIOMATERIALS, V21, P757, DOI 10.1016/S0142-9612(99)00179-9
   Lind M, 1996, ACTA ORTHOP SCAND, V67, P611, DOI 10.3109/17453679608997766
   McKinney L, 1996, J CRANIOFAC SURG, V7, P36, DOI 10.1097/00001665-199601000-00010
   MIKOS AG, 1994, BIOMATERIALS, V15, P55, DOI 10.1016/0142-9612(94)90197-X
   Moxham JP, 1996, J OTOLARYNGOL, V25, P82
   Peter SJ, 1998, J BIOMED MATER RES, V41, P1
   Peter SJ, 1999, J BIOMED MATER RES, V44, P314
   Peter SJ, 1999, J BIOMAT SCI-POLYM E, V10, P363, DOI 10.1163/156856299X00423
   Peter SJ, 1997, J BIOMAT SCI-POLYM E, V8, P893, DOI 10.1163/156856297X00074
   Schaffner P, 1999, J MATER SCI-MATER M, V10, P837, DOI 10.1023/A:1008904513304
   SUMNER DR, 1995, J BONE JOINT SURG AM, V77A, P1135, DOI 10.2106/00004623-199508000-00001
   Uludag H, 2000, J BIOMED MATER RES, V50, P227, DOI 10.1002/(SICI)1097-4636(200005)50:2<227::AID-JBM18>3.0.CO;2-2
   Uludag H, 1999, J BIOMED MATER RES, V46, P193, DOI 10.1002/(SICI)1097-4636(199908)46:2<193::AID-JBM8>3.0.CO;2-1
   VANDERLUBBE HBM, 1988, STAIN TECHNOL, V63, P171, DOI 10.3109/10520298809107179
   Vehof JWM, 2001, PLAST RECONSTR SURG, V108, P434, DOI 10.1097/00006534-200108000-00024
   Vehof JWM, 2000, BIOMATERIALS, V21, P2003, DOI 10.1016/S0142-9612(00)00094-6
   VEHOF JWM, 2001, IN PRESS CLIN ORAL I
   Winn SR, 1998, ADV DRUG DELIVER REV, V31, P303, DOI 10.1016/S0169-409X(97)00126-9
   Yaszemski M J, 1995, Tissue Eng, V1, P41, DOI 10.1089/ten.1995.1.41
   Zellin G, 1998, BONE, V22, P613, DOI 10.1016/S8756-3282(98)00059-3
NR 38
TC 81
Z9 83
U1 0
U2 12
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD MAY
PY 2002
VL 60
IS 2
BP 241
EP 251
DI 10.1002/jbm.10073
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 527YM
UT WOS:000174215600004
PM 11857430
DA 2018-10-20
ER

PT J
AU Kang, SB
   Yoon, KS
   Nam, TH
   Kim, JS
   Gjunter, VE
AF Kang, SB
   Yoon, KS
   Nam, TH
   Kim, JS
   Gjunter, VE
TI Fracture treatment using TiNi shape memory alloy bone fixater (BRM-SH
   system)
SO MATERIALS TRANSACTIONS
LA English
DT Article; Proceedings Paper
CT 4th Pacific Rim International Conference on Advanced Materials and
   Processing (PRICM4)
CY DEC 11-15, 2001
CL HONOLULU, HI
SP Japan Inst Met, Chinese Soc Met, Korean Inst Met & Mat, Minerals, Met & Mat Soc, Iketani Sci & Technol Fdn, USN, Off Naval Res Int Field Off, Asian Off Aerosp Res & Dev, USA Res Off Far E
DE shape memory alloy; fracture; bone fixater
ID IN-VITRO BIOCOMPATIBILITY; NICKEL-TITANIUM; METAL
AB Titanium-Nickel shape memory alloy (TiNi SMA) has great potential as a biomaterial in orthopaedic applications due to its unique thermal shape memory effects, superelasticity and high damping properties. We designed and manufactured bone fixaters using newly developed TiNi SMA wire (Af, 35 +/- 2degreesC). Two bone fixater designs (single and double ring) were prepared for the treatment of bone fracture in twenty patients (6 distal femur, 5 distal fibular, 4 distal tibia, 2 metacarpal bone, 2 periprosthetic fracture and 1 subtrochanter of femur). Serial radiographs, complete blood count (CBC) and urine analysis were performed postoperatively. Radiological union was achieved without complications in approximate eight weeks after operation. There were no abnormal findings on follow-up CBC or urine analysis. On a subjective level, use and application of the TiNi SMA fixater was not as demanding as conventional fixation methods, such as cerclage or the Dall-Miles technique. The efficacy of SMA bone fixater in this study is very excellent as demonstrated in this clinical study. It gives the new armament to orthopedic surgeon.
C1 Seoul Natl Univ, Coll Med, Dept Orthopaed Surg, Dongjakgu, Seoul 156012, South Korea.
   Seoul Municipal Boramae Hosp, Seoul 156012, South Korea.
   Gyeongsang Natl Univ, Dept Mat Sci & Engn, Gyeongnam 660701, South Korea.
   Univ Ulsan, Sch mat & Met Engn, Ulsan 680749, South Korea.
   Inst Med Mat & Shape Memory Implants, Tomsk, Russia.
RP Kang, SB (reprint author), Seoul Natl Univ, Coll Med, Dept Orthopaed Surg, Dongjakgu, 395 Shindaebangdong, Seoul 156012, South Korea.
RI Kang, Seung Baik/J-5362-2012; Gunther, Viktor/O-6678-2014
CR Assad M, 1998, J BIOMED MATER RES, V41, P154, DOI 10.1002/(SICI)1097-4636(199807)41:1<154::AID-JBM18>3.3.CO;2-0
   Assad M, 1999, BIO-MED MATER ENG, V9, P1
   Banim RH, 2000, J ARTHROPLASTY, V15, P131, DOI 10.1016/S0883-5403(00)91493-1
   BergerGorbet M, 1996, J BIOMED MATER RES, V32, P243, DOI 10.1002/(SICI)1097-4636(199610)32:2<243::AID-JBM14>3.0.CO;2-K
   CASTLEMAN LS, 1976, J BIOMED MATER RES, V10, P695, DOI 10.1002/jbm.820100505
   Gil FJ, 1998, P I MECH ENG H, V212, P473, DOI 10.1243/0954411981534231
   Nam TH, 2002, MATER LETT, V52, P234, DOI 10.1016/S0167-577X(01)00424-4
   PUTTERS JLM, 1992, EUR SURG RES, V24, P378, DOI 10.1159/000129231
   Ryhanen J, 1997, J BIOMED MATER RES, V35, P451
   Ryhanen J, 1999, BIOMATERIALS, V20, P1309, DOI 10.1016/S0142-9612(99)00032-0
   Zehntner M K, 1992, J Orthop Trauma, V6, P318, DOI 10.1097/00005131-199209000-00009
NR 11
TC 5
Z9 5
U1 0
U2 1
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD MAY
PY 2002
VL 43
IS 5
SI SI
BP 1049
EP 1051
DI 10.2320/matertrans.43.1049
PG 3
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 562RE
UT WOS:000176212100046
OA Bronze
DA 2018-10-20
ER

PT J
AU Stolt, UG
   Liss, PE
   Svensson, T
   Ludvigsson, J
AF Stolt, UG
   Liss, PE
   Svensson, T
   Ludvigsson, J
TI Attitudes to bioethical issues: a case study of a screening project
SO SOCIAL SCIENCE & MEDICINE
LA English
DT Article
DE ethics; screening; neonatal; informed consent; diabetes; ABIS; Sweden
ID DUCHENNE MUSCULAR-DYSTROPHY
AB Commonly expressed in theoretical discussions about ethical problems in the context of epidemiology and screening is the need for more data. A study was carried out involving 21 explorative interviews with participant and nonparticipant mothers in a neonatal research screening project in progress in Sweden, ABIS (All Babies in Southeast Sweden). The respondents were asked, by way of open-ended questions, to give their opinions about certain ethical issues: informed consent; reasons for joining/declining: surrogate decisions the collection, analysis and storage of written and "live" material (biobanks); intervention etc.
   The ethical implications mentioned in the literature mostly concern the risk of creating distress and anxiety (anxiety and possible stigmatisation in respect of positive or false-positive results, worry about material collected and stored, distress caused by blood sampling procedures. etc.). Our results do not support the idea that the risks are substantial. The respondents rather indicate an attitude of benevolence-they are positive both to the current research on children, to the material they contribute (both written material and "biomaterial"), to possible results and intervention plans. On the other hand the participants expressed concern about the storage of material and the right to be informed of any screening/project results. Further studies in this field are needed and would be of help in theoretical discussion, the work of ethical committees and the designing of, for example, screening and research projects, (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Linkoping Univ, Fac Hlth Sci, Div Paediat, Dept Hlth & Environm, S-58185 Linkoping, Sweden.
   Linkoping Univ, Dept Hlth & Soc, S-58183 Linkoping, Sweden.
   Linkoping Univ, Dept Behav Sci, S-58183 Linkoping, Sweden.
RP Ludvigsson, J (reprint author), Linkoping Univ, Fac Hlth Sci, Div Paediat, Dept Hlth & Environm, S-58185 Linkoping, Sweden.
CR [Anonymous], 1989, Paediatr Perinat Epidemiol, V3, P460
   Beauchamp T, 1994, PRINCIPLES BIOMEDICA
   Beauchamp TL, 1997, MED ETHICS
   BRADLEY DM, 1993, BRIT MED J, V306, P357, DOI 10.1136/bmj.306.6874.357
   BRODY H, 1997, MED ETHICS
   Childress J. F., 1997, PRACTICAL REASONING
   FADEN RR, 1982, AM J PUBLIC HEALTH, V72, P1396, DOI 10.2105/AJPH.72.12.1396
   FADEN RR, 1985, AM J PUBLIC HEALTH, V75, P1381, DOI 10.2105/AJPH.75.12.1381
   FENTONMAY J, 1994, ARCH DIS CHILD, V70, P551, DOI 10.1136/adc.70.6.551
   FOST N, 1999, NEW ETHICS PUBLICS H
   GOLDING J, 1996, CONT REV OBSTET GYNA, V8, P89
   HARTH SC, 1992, J MED ETHICS, V18, P86, DOI 10.1136/jme.18.2.86
   HERMEREN G, 1999, ACTA PAEDIATR, V432, P99
   HOLM S, 1996, THESIS U COPENHAGEN
   HOLTZMAN NA, 1983, PEDIATRICS, V72, P807
   HOLTZMAN NA, 1988, AM J HUM GENET, V42, P642
   Kvale S., 1997, KVALITATIVA FORSKNIN
   MUMFORD SE, 1999, ARCH DIS CHILDHOOD N, V81, P228
   MUMFORD SE, 1999, ARCH DIS CHILDHOOD N, V81, P146
   Parsons E, 1996, ARCH DIS CHILD, V74, P550, DOI 10.1136/adc.74.6.550
   PATTON MQ, 1980, QUALITATIVE EVALUATI
   RIIS P, 1999, ACTA PAEDIATR, V432, P96
   Schulte P. A., 1996, ETHICS EPIDEMIOLOGY, P178
   SCHULTE PA, 1985, AM J EPIDEMIOL, V121, P351, DOI 10.1093/oxfordjournals.aje.a114006
   SHICKLE D, 1994, J MED ETHICS, V20, P12, DOI 10.1136/jme.20.1.12
   SMITH RA, 1990, BRIT MED J, V300, P1112, DOI 10.1136/bmj.300.6732.1112
   STOLT UG, 2001, IN PRESS PERSPECTIVE
   Trost J., 1997, KVALITATIVA INTERVJU
   VEATCH RM, 1989, MED ETHICS
   WALTERS L, 1997, MED ETHICS
NR 30
TC 16
Z9 16
U1 0
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0277-9536
J9 SOC SCI MED
JI Soc. Sci. Med.
PD MAY
PY 2002
VL 54
IS 9
BP 1333
EP 1344
AR PII S0277-9536(01)00099-5
PG 12
WC Public, Environmental & Occupational Health; Social Sciences, Biomedical
SC Public, Environmental & Occupational Health; Biomedical Social Sciences
GA 548GG
UT WOS:000175379800003
PM 12058850
DA 2018-10-20
ER

PT J
AU Brown-Etris, M
   Cutshall, WD
   Hiles, MC
AF Brown-Etris, M
   Cutshall, WD
   Hiles, MC
TI A new biomaterial derived from small intestine submucosa and developed
   into a wound matrix device
SO WOUNDS-A COMPENDIUM OF CLINICAL RESEARCH AND PRACTICE
LA English
DT Review
ID FIBROBLAST GROWTH-FACTOR; ACHILLES-TENDON REPAIR; EXTRACELLULAR-MATRIX;
   VASCULAR GRAFT; DOG-MODEL; IN-VITRO; GENE-EXPRESSION; CAROTID-ARTERY;
   CELL-GROWTH; REGENERATION
AB A biomaterial derived from porcine intestinal submucosa has been used in the development of a new biologic wound matrix. This review describes the origin of the wound matrix device, including the discovery of the biomaterial and its properties, to the development of the commercial product currently in clinical use. The composition and structure of this biomaterial are described and considered as mechanisms that contribute to its effectiveness in wound management. The wound matrix developed from this unique biomaterial was evaluated in a pilot study of human partial-thickness dermal wounds and was found to be beneficial, especially in its dehydrated form. Other applications of this biomaterial, as well as its limitations, are also discussed.
C1 Etris Associates Inc, Philadelphia, PA 19116 USA.
   Cook Biotech Inc, W Lafayette, IN USA.
RP Brown-Etris, M (reprint author), Etris Associates Inc, 14450 Bustleton Ave, Philadelphia, PA 19116 USA.
EM mbeetris@aol.com
CR AIKEN SW, 1994, VET COMP ORTHOPAED, V7, P124
   ALLMAN AJ, UNPUB IMMUNOLOGY
   Badylak S, 1999, CLIN ORTHOP RELAT R, pS333, DOI 10.1097/00003086-199910001-00032
   Badylak S, 1999, BIOMATERIALS, V20, P2257, DOI 10.1016/S0142-9612(99)00156-8
   BADYLAK SF, 1995, J BIOMED MATER RES, V29, P977, DOI 10.1002/jbm.820290809
   BADYLAK SF, 1993, TISSUE ENGINEERING, P179
   Badylak SF, 1998, TISSUE ENG, V4, P379, DOI 10.1089/ten.1998.4.379
   BADYLAK SF, 1989, J SURG RES, V47, P74, DOI 10.1016/0022-4804(89)90050-4
   BADYLAK SF, 1994, J VASC SURG, V19, P465, DOI 10.1016/S0741-5214(94)70073-7
   Badylak SF, 1998, J BIOMAT SCI-POLYM E, V9, P863, DOI 10.1163/156856298X00208
   BADYLAK SF, 2001, IN PRESS TISSUE ENG
   BISSELL MJ, 1982, J THEOR BIOL, V99, P31, DOI 10.1016/0022-5193(82)90388-5
   BROMBERG B E, 1965, Plast Reconstr Surg, V36, P80, DOI 10.1097/00006534-196507000-00011
   Brown-Etris M, 1995, Adv Wound Care, V8, P53
   BROWNETRIS M, 1994, WOUNDS, V6, P54
   BROWNETRIS M, 2001, S ADV WOUND CAR LAS
   Calvin M, 1998, WOUNDS, V10, P12
   Clarke KM, 1996, J SURG RES, V60, P107, DOI 10.1006/jsre.1996.0018
   Cobb MA, 1996, SURG NEUROL, V46, P389, DOI 10.1016/S0090-3019(96)00202-9
   Cobb MA, 1999, SURG NEUROL, V51, P99, DOI 10.1016/S0090-3019(97)00475-8
   COLTRINI D, 1993, EUR J BIOCHEM, V214, P51, DOI 10.1111/j.1432-1033.1993.tb17895.x
   Dalla Vecchia LD, 1999, J PEDIATR SURG, V34, P167, DOI 10.1016/S0022-3468(99)90250-6
   Eaglstein W H, 1998, Adv Wound Care, V11, P1
   ELLIOTT RA, 1973, PLAST RECONSTR SURG, V52, P401, DOI 10.1097/00006534-197352040-00013
   FERRAND BK, 1993, J BIOMED MATER RES, V27, P1235, DOI 10.1002/jbm.820271004
   Greenfield E, 1996, Crit Care Nurs Clin North Am, V8, P203
   HILES MC, 1995, J BIOMED MATER RES, V29, P883, DOI 10.1002/jbm.820290714
   HILES MC, 1993, J BIOMED MATER RES, V27, P139, DOI 10.1002/jbm.820270202
   HINMAN CD, 1963, NATURE, V200, P377, DOI 10.1038/200377a0
   Hodde J P, 1996, Tissue Eng, V2, P209, DOI 10.1089/ten.1996.2.209
   Hodde JP, 1997, TISSUE ENG, V3, P27, DOI 10.1089/ten.1997.3.27
   HODDE JP, 1998, 2 SIS S ORL FL, P92
   HODDE JP, 2001, S ADV WOUND CAR LAS
   KAJIO T, 1992, FEBS LETT, V306, P243, DOI 10.1016/0014-5793(92)81009-B
   KNAPP PM, 1994, J ENDOUROL, V8, P125, DOI 10.1089/end.1994.8.125
   Knoll LD, 2001, UROLOGY, V57, P753, DOI 10.1016/S0090-4295(00)01079-7
   Kosir MA, 2000, J SURG RES, V92, P45, DOI 10.1006/jsre.2000.5840
   Kropp B P, 1995, Urology, V46, P396, DOI 10.1016/S0090-4295(99)80227-1
   Kropp BP, 1998, UROLOGY, V52, P138, DOI 10.1016/S0090-4295(98)00114-9
   Kropp BP, 1996, J UROLOGY, V155, P2098, DOI 10.1016/S0022-5347(01)66117-2
   Lantz G C, 1990, J Invest Surg, V3, P217, DOI 10.3109/08941939009140351
   Lantz G C, 1993, J Invest Surg, V6, P297, DOI 10.3109/08941939309141619
   LANTZ GC, 1992, J SURG RES, V53, P175, DOI 10.1016/0022-4804(92)90031-T
   LEIPZIGER LS, 1985, J AM ACAD DERMATOL, V12, P409, DOI 10.1016/S0190-9622(85)80004-9
   McGrath JA, 1997, J PATHOL, V183, P251
   MCPHERSON JM, 1988, COLLAGEN REL RES, V8, P65
   McPherson TB, 1998, TISSUE ENG, V4, P75, DOI 10.1089/ten.1998.4.75
   MURPHY GF, 1990, LAB INVEST, V62, P305
   NAKAGAWA S, 1989, EXP CELL RES, V182, P572, DOI 10.1016/0014-4827(89)90260-7
   NIEZGODA JA, 2001, S ADV WOUND CAR LAS
   PARMENTER MA, 2001, ACFAS PRS JOINT ANN
   Peel SAF, 1998, TISSUE ENG, V4, P143, DOI 10.1089/ten.1998.4.143
   PREVEL CD, 1995, ANN PLAS SURG, V35, P374, DOI 10.1097/00000637-199510000-00008
   PREVEL CD, 1995, ANN PLAS SURG, V35, P381, DOI 10.1097/00000637-199510000-00009
   PREVEL CD, 1994, MICROSURG, V15, P586, DOI 10.1002/micr.1920150812
   Robotin-Johnson MC, 1998, J THORAC CARDIOV SUR, V116, P805, DOI 10.1016/S0022-5223(98)00436-X
   Roeder R, 1999, J BIOMED MATER RES, V47, P65, DOI 10.1002/(SICI)1097-4636(199910)47:1<65::AID-JBM9>3.0.CO;2-F
   ROSKELLEY CD, 1995, CURR OPIN CELL BIOL, V7, P736, DOI 10.1016/0955-0674(95)80117-0
   SANDUSKY GE, 1995, J SURG RES, V58, P415, DOI 10.1006/jsre.1995.1064
   SANDUSKY GE, 1992, AM J PATHOL, V140, P317
   SHETTIGAR UR, 1982, ARTIF ORGANS, V6, P256
   Suckow MA, 1999, J INVEST SURG, V12, P277, DOI 10.1080/089419399272395
   Vaught JD, 1996, J UROLOGY, V155, P374, DOI 10.1016/S0022-5347(01)66663-1
   Voytik-Harbin SL, 1998, IN VITRO CELL DEV-AN, V34, P239
   Voytik-Harbin SL, 1998, TISSUE ENG, V4, P157, DOI 10.1089/ten.1998.4.157
   VoytikHarbin SL, 1997, J CELL BIOCHEM, V67, P478, DOI 10.1002/(SICI)1097-4644(19971215)67:4<478::AID-JCB6>3.0.CO;2-P
   VOYTIKHARBIN SL, COMMUNICATION
   Whitson BA, 1998, J BIOMED MATER RES, V43, P277, DOI 10.1002/(SICI)1097-4636(199823)43:3<277::AID-JBM8>3.3.CO;2-M
NR 68
TC 37
Z9 43
U1 0
U2 6
PU H M P COMMUNICATIONS
PI MALVERN
PA 83 GENERAL WARREN BLVD, STE 100, MALVERN, PA 19355 USA
SN 1044-7946
EI 1943-2704
J9 WOUNDS
JI Wounds-Compend. Clin. Res. Pract.
PD MAY
PY 2002
VL 14
IS 4
BP 150
EP 166
PG 17
WC Dermatology; Surgery
SC Dermatology; Surgery
GA 607QJ
UT WOS:000178802000005
DA 2018-10-20
ER

PT J
AU Liu, GY
   Amro, NA
AF Liu, GY
   Amro, NA
TI Positioning protein molecules on surfaces: A nanoengineering approach to
   supramolecular chemistry
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
ID SELF-ASSEMBLED MONOLAYERS; ATOMIC-FORCE MICROSCOPY;
   SCANNING-TUNNELING-MICROSCOPY; DIP-PEN NANOLITHOGRAPHY; NANOMETER-SCALE;
   PROBE LITHOGRAPHY; ALKANETHIOLATE MONOLAYERS; CHEMICAL SYNTHESIS;
   FABRICATION; IMMOBILIZATION
AB We discuss a nanoengineering approach for supramolecular chemistry and self assembly. The collective properties and biofunctionalities of molecular ensembles depend not only on individual molecular building blocks but also on organization at the molecular or nanoscopic level. Complementary to "bottom-up" approaches, which construct supramolecular ensembles by the design and synthesis of functionalized small molecular units or large molecular motifs, nanofabrication explores whether individual units, such as small molecular ligands, or large molecules, such as proteins, can be positioned with nanometer precision. The separation and local environment can be engineered to control subsequent intermolecular interactions. Feature sizes as small as 2 x 4 nm(2) (32 alkanethiol molecules) are produced. Proteins may be aligned along a 10-nm-wide line or within two-dimensional islands of desired geometry. These high-resolution engineering and imaging studies provide new and molecular-level insight into supramolecular chemistry and self-assembly processes in bioscience that are otherwise unobtainable, e.g., the influence of size, separation, orientation, and local environment of reaction sites. This nanofabrication methodology also offers a new strategy in construction of two- and three-dimensional supramolecular structures for cell, virus, and bacterial adhesion, as well as biomaterial and biodevice engineering.
C1 Univ Calif Davis, Dept Chem, Davis, CA 95616 USA.
RP Liu, GY (reprint author), Univ Calif Davis, Dept Chem, Davis, CA 95616 USA.
EM liu@chem.ucdavis.edu
CR Amro NA, 2000, LANGMUIR, V16, P3006, DOI 10.1021/la000079l
   Atwood J. L., 1996, COMPREHENSIVE SUPRAM
   AVOURIS P, 1995, ACCOUNTS CHEM RES, V28, P95, DOI 10.1021/ar00051a002
   Baker A, 1998, CHEM RES TOXICOL, V11, P730, DOI 10.1021/tx970167e
   Baur C, 1997, J VAC SCI TECHNOL B, V15, P1577, DOI 10.1116/1.589404
   Binnig G, 2000, IBM J RES DEV, V44, P279, DOI 10.1147/rd.441.0279
   BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930
   BINNING G, 1982, PHYS REV LETT, V49, P57, DOI 10.1103/PhysRevLett.49.57
   BLAKE CCF, 1965, NATURE, V206, P757, DOI 10.1038/206757a0
   BrowningKelley ME, 1997, LANGMUIR, V13, P343, DOI 10.1021/la960918x
   Buijs J, 1998, LANGMUIR, V14, P335, DOI 10.1021/la970669s
   Chen C. J., 1993, INTRO SCANNING TUNNE
   CROMMIE MF, 1993, SCIENCE, V262, P218, DOI 10.1126/science.262.5131.218
   Cruchon-Dupeyrat S, 2001, APPL SURF SCI, V175, P636, DOI 10.1016/S0169-4332(01)00076-9
   Dagata JA, 1998, J APPL PHYS, V84, P6891, DOI 10.1063/1.368986
   Delamarche E, 1996, ADV MATER, V8, P719, DOI 10.1002/adma.19960080903
   Despont M, 2000, SENSOR ACTUAT A-PHYS, V80, P100, DOI 10.1016/S0924-4247(99)00254-X
   Dinolfo PH, 2001, CHEM MATER, V13, P3113, DOI 10.1021/cm010176f
   EIGLER DM, 1970, NATURE, V244, P524
   FODOR SPA, 1991, SCIENCE, V251, P767, DOI 10.1126/science.1990438
   FROMMER J, 1992, ANGEW CHEM INT EDIT, V31, P1298, DOI 10.1002/anie.199212981
   Greig LM, 2001, CHEM SOC REV, V30, P287, DOI 10.1039/b104962n
   Hamers RJ, 1996, J PHYS CHEM-US, V100, P13103, DOI 10.1021/jp960054o
   HEGNER M, 1993, SURF SCI, V291, P39, DOI 10.1016/0039-6028(93)91474-4
   Hong SH, 2000, SCIENCE, V288, P1808, DOI 10.1126/science.288.5472.1808
   Hong SH, 1999, SCIENCE, V286, P523, DOI 10.1126/science.286.5439.523
   Hu K, 1997, LANGMUIR, V13, P5114, DOI 10.1021/la9700782
   HUANG JY, 1994, LANGMUIR, V10, P626, DOI 10.1021/la00015a005
   IMOTO T, 1972, VERTEBRATE LYSOZYMES
   Kang J, 1996, LANGMUIR, V12, P2813, DOI 10.1021/la951015r
   KOLBE WF, 1992, ULTRAMICROSCOPY, V42, P1113, DOI 10.1016/0304-3991(92)90411-C
   LEE GU, 1994, LANGMUIR, V10, P354, DOI 10.1021/la00014a003
   LEHN JM, 1995, SUBRAMOLECULAR CHEM
   Leininger S, 2000, CHEM REV, V100, P853, DOI 10.1021/cr9601324
   Liu GY, 2000, ACCOUNTS CHEM RES, V33, P457, DOI 10.1021/ar980081s
   LOPEZ GP, 1993, J AM CHEM SOC, V115, P10774, DOI 10.1021/ja00076a038
   LYO IW, 1991, SCIENCE, V253, P173, DOI 10.1126/science.253.5016.173
   Mammen M, 1998, ANGEW CHEM INT EDIT, V37, P2755
   Miller SA, 1999, CURR OPIN COLLOID IN, V4, P338, DOI 10.1016/S1359-0294(99)90018-3
   MULLER WT, 1995, SCIENCE, V268, P272, DOI 10.1126/science.268.5208.272
   Nguyen SBT, 2001, P NATL ACAD SCI USA, V98, P11849, DOI 10.1073/pnas.201373898
   Niemeyer CM, 2001, ANGEW CHEM INT EDIT, V40, P4128, DOI 10.1002/1521-3773(20011119)40:22<4128::AID-ANIE4128>3.0.CO;2-S
   Norde W, 1995, COLLOID SURFACE B, V5, P255, DOI 10.1016/0927-7765(95)01223-9
   Patel N, 1997, LANGMUIR, V13, P6485, DOI 10.1021/la970933h
   Piner RD, 1999, SCIENCE, V283, P661, DOI 10.1126/science.283.5402.661
   Poirier GE, 1996, J CHEM PHYS, V105, P2089, DOI 10.1063/1.472078
   POIRIER GE, 1994, LANGMUIR, V10, P2853, DOI 10.1021/la00021a001
   Ramachandran TR, 1998, NANOTECHNOLOGY, V9, P237, DOI 10.1088/0957-4484/9/3/015
   ROSS CB, 1993, LANGMUIR, V9, P632, DOI 10.1021/la00027a002
   Sarid D., 1991, SCANNING FORCE MICRO
   Schoer JK, 1996, J PHYS CHEM-US, V100, P11086, DOI 10.1021/jp960271p
   Schwartz PV, 2001, LANGMUIR, V17, P5971, DOI 10.1021/la001625d
   SILVERTON EW, 1977, P NATL ACAD SCI USA, V74, P5140, DOI 10.1073/pnas.74.11.5140
   SNOW ES, 1995, SCIENCE, V270, P1639, DOI 10.1126/science.270.5242.1639
   Stipe BC, 1997, PHYS REV LETT, V78, P4410, DOI 10.1103/PhysRevLett.78.4410
   TARLOV MJ, 1993, J AM CHEM SOC, V115, P5305, DOI 10.1021/ja00065a056
   Wadu-Mesthrige K, 2000, SCANNING, V22, P380
   Wadu-Mesthrige K, 1999, LANGMUIR, V15, P8580, DOI 10.1021/la991196n
   Wadu-Mesthrige K, 2001, BIOPHYS J, V80, P1891, DOI 10.1016/S0006-3495(01)76158-9
   Wagner P, 1996, BIOPHYS J, V70, P2052, DOI 10.1016/S0006-3495(96)79810-7
   WAGNER P, 1995, LANGMUIR, V11, P3867, DOI 10.1021/la00010a043
   WEISS PS, 1995, ANAL CHIM ACTA, V307, P355, DOI 10.1016/0003-2670(94)00555-Z
   Wilson DL, 2001, P NATL ACAD SCI USA, V98, P13660, DOI 10.1073/pnas.241323198
   Xu S, 1999, LANGMUIR, V15, P7244, DOI 10.1021/la9906727
   Xu S, 1997, LANGMUIR, V13, P127, DOI 10.1021/la962029f
   ZEPPENFELD P, 1992, ULTRAMICROSCOPY, V42, P128, DOI 10.1016/0304-3991(92)90256-J
   Zhang X, 1999, ADV MATER, V11, P1139, DOI 10.1002/(SICI)1521-4095(199909)11:13<1139::AID-ADMA1139>3.0.CO;2-7
NR 67
TC 151
Z9 152
U1 1
U2 31
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD APR 16
PY 2002
VL 99
IS 8
BP 5165
EP 5170
DI 10.1073/pnas.072695699
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 543DX
UT WOS:000175087000081
PM 11959965
OA Bronze, Green Published
DA 2018-10-20
ER

PT J
AU Miyamoto, K
   Kanemoto, A
   Hashimoto, K
   Tokita, M
   Komai, T
AF Miyamoto, K
   Kanemoto, A
   Hashimoto, K
   Tokita, M
   Komai, T
TI Immobilized gellan sulfate surface for cell adhesion and multiplication:
   development of cell-hybrid biomaterials using self-produced fibronectin
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article
DE gellan sulfated; extra domain A containing fibronectin; human unbilical
   vein endothelial cells
ID MOLECULES
AB A new concept for cell-hybrid biomaterial is proposed in which human unbilical vein endothelial cells (HUVEC) are adhered to an immobilized gellan sulfate (GS) surface. Extra domain A containing fibronectin (EDA(+)FN) released from HUVEC is necessary for cell adhesion and multiplication, The material design in this study is based on these self-released cell adhesion proteins. The interaction between GS and EDA(+)FN was evaluated using the affinity constant (KA); the value obtained was 1.03 x 10(8) (M-1). These results suggest that the adhesion of HUVEC to GS may be supported by the adhesion of EDA(+)FN to GS. We also found that this new material adheres to HUVEC, allowing the reintroduction of EDA(+)FN, which is self-produced by the cell. This material is relatively easy to produce, not requiring the usual coating of adhesion proteins in pretreatment. (C) 2002 Elsevier Science B.V. All rights reserved.
C1 Mie Univ, Fac Engn, Dept Chem Mat, Tsu, Mie 5148507, Japan.
RP Miyamoto, K (reprint author), Mie Univ, Fac Engn, Dept Chem Mat, 1515 Kamihama Cho, Tsu, Mie 5148507, Japan.
CR CUNANAN CM, 1991, J CATARACT REFR SURG, V17, P767
   DAVIS LS, 1990, J IMMUNOL, V145, P785
   Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4
   Guidoin R, 1996, ASAIO J, V42, P974, DOI 10.1097/00002480-199642060-00010
   HIRANO H, 1992, J CLIN LAB INSTRUM R, V15, P179
   Hynes RO, 1990, FIBRONECTINS
   KOBAYASHI K, 1988, J MACROMOL SCI CHEM, VA25, P655, DOI 10.1080/00222338808053391
   MATRISIAN LM, 1992, BIOESSAYS, V14, P455, DOI 10.1002/bies.950140705
   Miyamoto K, 2001, INT J BIOL MACROMOL, V28, P381, DOI 10.1016/S0141-8130(01)00135-0
   MIYAMOTO K, UNPUB GELLAN SULFATE
   MIYAMOTO K, UNPUB ADHESION ACTIV
   MIYAMOTO K, 1999, JPN J ARTIF ORGANS, V28, P191
   Miyashita K, 1998, INT J BIOL MACROMOL, V22, P91, DOI 10.1016/S0141-8130(97)00093-7
   NOSE K, 1971, T AM SOC ART INT ORG, V17, P482
   OCONNOR CM, 1994, THORAX, V49, P602, DOI 10.1136/thx.49.6.602
   PETERS JH, 1990, BLOOD, V75, P1801
   RICHARD AJ, 1986, ANN THORAC SURG, V41, P657
   SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x
   Shibuya M, 1999, CURR TOP MICROBIOL, V237, P59
   TRELSTAD RL, 1990, ANN NY ACAD SCI, V580, P391, DOI 10.1111/j.1749-6632.1990.tb17947.x
   Vladkova T, 1999, J BIOMAT SCI-POLYM E, V10, P609, DOI 10.1163/156856299X00838
NR 21
TC 3
Z9 3
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0141-8130
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD APR 8
PY 2002
VL 30
IS 2
BP 75
EP 80
AR PII S0141-8130(02)00013-2
DI 10.1016/S0141-8130(02)00013-2
PG 6
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 543NJ
UT WOS:000175107800002
PM 11911896
DA 2018-10-20
ER

PT J
AU Pierre, S
   Jean-Claude, V
   Frederic, C
   Gero, D
   Bernard, T
AF Pierre, S
   Jean-Claude, V
   Frederic, C
   Gero, D
   Bernard, T
TI Fundamental aspects of polyelectrolytes multilayers used as biomaterial
   coatings.
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
C1 CNRS, Inst Charles Sadron, F-67083 Strasbourg, France.
   INSERM, Strasbourg, France.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD APR 7
PY 2002
VL 223
MA 396-COLL
BP U445
EP U446
PN 1
PG 2
WC Chemistry, Multidisciplinary
SC Chemistry
GA 564CD
UT WOS:000176296702473
DA 2018-10-20
ER

PT J
AU Gretzer, C
   Werthen, M
   Thomsen, P
AF Gretzer, C
   Werthen, M
   Thomsen, P
TI Apoptosis and cytokine release in human monocytes cultured on
   polystyrene and fibrinogen-coated polystyrene surfaces
SO BIOMATERIALS
LA English
DT Article
DE mononuclear cells; adhesion; apoptosis; cytokines; biomaterial;
   particles; fibrinogen
ID IN-VITRO; POLYETHYLENE PARTICLES; PHOSPHATIDYLSERINE RECEPTOR;
   INFLAMMATORY RESPONSES; VITRONECTIN RECEPTOR; HUMAN MACROPHAGES;
   BONE-RESORPTION; WEAR DEBRIS; CELLS; CD14
AB The effects of polystyrene (PS) material surface preadsorption with fibrinogen (3mg/ml) and a low concentration of lipopolysaccharide (LPS: 10 ng/ml) and polystyrene particles (PS: 10(5)/ml) on human monocyte adhesion, viability and cytokine release were Studied during 24h culture in vitro. LPS caused an upregulation of CD14 in adherent cells. In comparison with unstimulated cells on uncoated polystyrene surfaces, LPS did not alter the number of adherent cells but caused a markedly increased release of the proinflammatory cytokines (IL-1alpha and TNF-alpha)) and the down-regulating IL-10. The expression of indicators of various stages of cell death, TdT, annexin-V, propidium iodide (M) and lactate dehydrogenase (LDH), were unaltered, decreased, decreased and increased, respectively, after LPS stimulation. PS particles (3mum phi) caused an increased DNA fragmentation but had a reduced proportion of annexin-V and PI positive cells in comparison with unstimulated cells on uncoated PS. In contrast, 1 mum phi particles had a similar proportion of TdT, annexin-V and PI expressing cells as unstimulated controls. Cultures stimulated with particles (irrespective of size), had a similar concentration of proinflammatory cytokines as unstimulated controls, whereas a higher level of IL-10 was detected. Precoating of PS with fibrinogen revealed an enhanced cell adhesion and a concomitant reduction of CD 14 expression, irrespective of stimulation with various agonists. The proportions of TdT, annexin-V and PI positive cells were unaltered or reduced on fibrinogen-coated PS in both unstimulated and agonist-challenged Cultures. However, depending on the presence and type of agonist, fibrinogen mediated either a markedly increased (LPS) or equivalent (particles and unstimulated) IL-1alpha and TNFalpha release. Further, in comparison with uncoated substrates, fibrinogen was associated with a reduction of IL-10 release, irrespective of the type of stimuli. These observations, using low concentrations of bacterial and material products, indicate that fibrinogen modulates cell material interactions and up- and down-regulates specific events depending on the nature/type of immediate stimuli. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Univ Gothenburg, Inst Anat & Cell Biol, S-40530 Gothenburg, Sweden.
   Univ Gothenburg, Dept Cell & Mol Biol Microbiol, S-40530 Gothenburg, Sweden.
RP Gretzer, C (reprint author), Univ Gothenburg, Inst Anat & Cell Biol, Box 420 Med Gatan 3, S-40530 Gothenburg, Sweden.
OI Thomsen, Peter/0000-0003-3910-6665
CR Al-Saffar N, 1999, J LONG-TERM EFF MED, V9, P319
   ANDERSON JM, 1995, J BIOMAT SCI-POLYM E, V7, P159, DOI 10.1163/156856295X00670
   ANDERSON JM, 1988, ASAIO, V11, P101
   ANDREE HAM, 1990, J BIOL CHEM, V265, P4923
   Baran J, 1996, INFECT IMMUN, V64, P4242
   BAZIL V, 1991, J IMMUNOL, V147, P1567
   BONFIELD TL, 1992, J BIOMED MATER RES, V26, P837, DOI 10.1002/jbm.820260702
   BRANDSLUND I, 1982, J IMMUNOL METHODS, V48, P199, DOI 10.1016/0022-1759(82)90194-6
   Catelas I, 1999, BIOMATERIALS, V20, P625, DOI 10.1016/S0142-9612(98)00214-2
   Catelas I, 1998, J BIOMED MATER RES, V41, P600, DOI 10.1002/(SICI)1097-4636(19980915)41:4<600::AID-JBM12>3.3.CO;2-7
   DE WMR, 1991, J EXP MED, V174, P1209
   DEFIFE KM, 1995, J BIOMED MATER RES, V29, P431, DOI 10.1002/jbm.820290403
   DeFife KM, 1999, FASEB J, V13, P823
   Devitt A, 1998, NATURE, V392, P505
   Dinarello CA, 1996, BLOOD, V87, P2095
   FADOK VA, 1992, J IMMUNOL, V149, P4029
   Fadok VA, 1998, J IMMUNOL, V161, P6250
   Flad HD, 1998, RES IMMUNOL, V149, P733, DOI 10.1016/S0923-2494(99)80048-0
   GLANT TT, 1993, J BONE MINER RES, V8, P1071
   Gonzalez O, 1996, J BIOMED MATER RES, V30, P463, DOI 10.1002/(SICI)1097-4636(199604)30:4<463::AID-JBM4>3.3.CO;2-I
   Goodier MR, 2000, J IMMUNOL, V165, P139, DOI 10.4049/jimmunol.165.1.139
   Goodman SB, 1996, J BIOMED MATER RES, V31, P421, DOI 10.1002/(SICI)1097-4636(199607)31:3<421::AID-JBM17>3.0.CO;2-L
   Gretzer C, 1996, BIOMATERIALS, V17, P851, DOI 10.1016/0142-9612(96)83279-0
   Gretzer C, 2000, CYTOKINE, V12, P32, DOI 10.1006/cyto.1999.0523
   Gretzer C, 2000, BIOMATERIALS, V21, P1047, DOI 10.1016/S0142-9612(99)00279-3
   GRETZER C, UNPUB H2O2 PRODUCTIO
   Grunwald U, 1996, J IMMUNOL, V157, P4119
   Hahn DW, 1996, J BIOMED MATER RES, V31, P355
   HASKILL S, 1988, J IMMUNOL, V140, P1690
   Haynes DR, 1998, CLIN ORTHOP RELAT R, P223
   Heidenreich S, 1999, J LEUKOCYTE BIOL, V65, P737
   Horowitz SM, 1996, CALCIFIED TISSUE INT, V59, P392, DOI 10.1007/s002239900145
   Horowitz SM, 1998, J BIOMED MATER RES, V41, P468, DOI 10.1002/(SICI)1097-4636(19980905)41:3<468::AID-JBM17>3.3.CO;2-7
   HOROWITZ SM, 1995, J BIOMED MATER RES, V29, P477, DOI 10.1002/jbm.820290407
   Ingham E, 2000, P I MECH ENG H, V214, P21, DOI 10.1243/0954411001535219
   Kalltorp M, 1999, BIOMATERIALS, V20, P2123, DOI 10.1016/S0142-9612(99)00115-5
   Kitchens RL, 2000, CHEM IMMUNOL, V74, P61
   Kreuzer J, 1996, J MOL MED-JMM, V74, P161
   MANGAN DF, 1991, J IMMUNOL, V146, P1541
   MARCHANT A, 1992, EUR J IMMUNOL, V22, P1663, DOI 10.1002/eji.1830220650
   Matthews JB, 2000, BIOMATERIALS, V21, P2033, DOI 10.1016/S0142-9612(00)00089-2
   MCKELLOP HA, 1990, J BIOMED MATER RES, V24, P1413, DOI 10.1002/jbm.820241102
   Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7
   Paysant J, 1998, BRIT J HAEMATOL, V100, P45, DOI 10.1046/j.1365-2141.1998.00528.x
   PERTOFT H, 1980, J IMMUNOL METHODS, V33, P221, DOI 10.1016/0022-1759(80)90209-4
   Pollice PF, 1998, J ORTHOP RES, V16, P697, DOI 10.1002/jor.1100160611
   Prabhu A, 1998, J BIOMED MATER RES, V42, P655, DOI 10.1002/(SICI)1097-4636(19981215)42:4<655::AID-JBM23>3.3.CO;2-2
   SAVILL J, 1993, IMMUNOL TODAY, V14, P131, DOI 10.1016/0167-5699(93)90215-7
   Schmidt M, 2000, EUR J IMMUNOL, V30, P1769, DOI 10.1002/1521-4141(200006)30:6<1769::AID-IMMU1769>3.0.CO;2-9
   SHANBHAG AS, 1995, J ORTHOPAED RES, V13, P792, DOI 10.1002/jor.1100130520
   SHANBHAG AS, 1994, J BIOMED MATER RES, V28, P81, DOI 10.1002/jbm.820280111
   SIMON DI, 1993, BLOOD, V82, P2414
   Stea S, 2000, BIOMATERIALS, V21, P1393, DOI 10.1016/S0142-9612(00)00041-7
   TANG LP, 1993, J LAB CLIN MED, V122, P292
   TANG LP, 1993, J EXP MED, V178, P2147, DOI 10.1084/jem.178.6.2147
   Tang LP, 1996, J CLIN INVEST, V97, P1329, DOI 10.1172/JCI118549
   TANG LP, 1994, CELL MATER, V4, P429
   Volk HD, 2000, CHEM IMMUNOL, V74, P162
   WERTHEN M, 2001, BIOMATERIALS, V8, P827
   WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311
   YAM LT, 1971, AM J CLIN PATHOL, V55, P283
   YUN JK, 1995, J BIOMED MATER RES, V29, P257, DOI 10.1002/jbm.820290217
   Zhang XS, 1999, J MATER SCI-MATER M, V10, P879, DOI 10.1023/A:1008937419664
   ZIEGLERHEITBROCK HWL, 1993, IMMUNOL TODAY, V14, P121, DOI 10.1016/0167-5699(93)90212-4
NR 64
TC 12
Z9 16
U1 0
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD APR
PY 2002
VL 23
IS 7
BP 1639
EP 1648
AR PII S0142-9612(01)00290-3
DI 10.1016/S0142-9612(01)00290-3
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 527PX
UT WOS:000174196100010
PM 11922467
DA 2018-10-20
ER

PT J
AU Handschel, J
   Wiesmann, HP
   Stratmann, U
   Kleinheinz, J
   Meyer, U
   Joos, U
AF Handschel, J
   Wiesmann, HP
   Stratmann, U
   Kleinheinz, J
   Meyer, U
   Joos, U
TI TCP is hardly resorbed and not osteoconductive in a non-loading
   calvarial model
SO BIOMATERIALS
LA English
DT Article
DE tricalciumphosphate; non-loaded bone; biodegredation; biomaterial;
   tissue engineering
ID CALCIUM-PHOSPHATE CEMENT; TISSUE-RESPONSE; MONOXIDE CEMENT; BONE
   INTERFACE; IN-VIVO; IMPLANTATION; OSTEOBLASTS; DEFECTS; STRAIN;
   BIOMATERIALS
AB Tricalciumphosphate (TCP) has been used as a ceramic bone substitute material in the orthopedic field as well as in craniofacial surgery. Sonic controversies exist concerning the osteoconductive potential of this material in different implantation sites. This study was designed to evaluate the biological response of calvarial bone towards TCP granules under non-loading conditions to assess the potential of TCP as a biodegredable and osteoconductive bone substitue material for the cranial vault.
   Full-thickness non-critical size defects were made bilaterally in the calvaria of 21 adult Wistar rats. One side was filled by TCP granules, the contralateral side was left empty and used as a control. Animals were sacrificed in defined time intervals up to 6 months. Bone regeneration was analyzed with special respect toward the micromorphological and microanalytical features of the material-bone interaction by electron microscopy and electron diffraction analysis.
   Histologic examination revealed no TCP degradation even after 6 months of implantation. In contrast, a nearly complete bone regeneration of control defects was found after 6 months. At all times TCP was surrounded by a thin fibrous layer without presence of osteoblasts and features of regular mineralization. As far as degradation and substitution are concerned, TCP is a less favourable material under conditions of non-loading. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Univ Munster, Dept Cranio & Maxillofacial Surg, D-48129 Munster, Germany.
   Univ Munster, Biomineralizat Res Unit, D-48129 Munster, Germany.
   Univ Munster, Dept Anat, D-48129 Munster, Germany.
RP Handschel, J (reprint author), Univ Munster, Dept Cranio & Maxillofacial Surg, Waldeyerstr 30, D-48129 Munster, Germany.
CR BHASKAR SN, 1971, ORAL SURG ORAL MED O, V32, P336, DOI 10.1016/0030-4220(71)90238-6
   Bidwell JP, 1998, J BONE MINER RES, V13, P155, DOI 10.1359/jbmr.1998.13.2.155
   Buser D, 1998, CLIN ORAL IMPLAN RES, V9, P137, DOI 10.1034/j.1600-0501.1998.090301.x
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   DAVIES JE, 1988, SCANNING MICROSCOPY, V2, P1445
   DELANGE GL, 1990, J BIOMED MATER RES, V24, P829, DOI 10.1002/jbm.820240704
   DENISSEN HW, 1980, J BIOMED MATER RES, V14, P713, DOI 10.1002/jbm.820140603
   FOITZIK C, 1997, QUINTESSENZ, V48, P1365
   Frayssinet P, 1998, BIOMATERIALS, V19, P971, DOI 10.1016/S0142-9612(97)00163-4
   HENCH LL, 1984, SCIENCE, V226, P630, DOI 10.1126/science.6093253
   Kurashina K, 1997, BIOMATERIALS, V18, P539, DOI 10.1016/S0142-9612(96)00162-7
   Kurashina K, 1998, BIOMATERIALS, V19, P701, DOI 10.1016/S0142-9612(97)00178-6
   LANYON LE, 1996, BONE S1, V18, P37
   Marie PJ, 2000, CALCIFIED TISSUE INT, V67, P2, DOI 10.1007/s00223001088
   MEYER U, 1993, CELL MATER, V3, P129
   Meyer U, 1997, BIOCHEM CELL BIOL, V75, P81, DOI 10.1139/bcb-75-1-81
   Meyer U, 1999, J ORAL MAXIL SURG, V57, P1331, DOI 10.1016/S0278-2391(99)90872-8
   MOLLER K, 1994, CELL MATER, V4, P263
   MUNTING E, 1993, J MATER SCI-MATER M, V4, P337, DOI 10.1007/BF00122290
   NEO M, 1992, J BIOMED MATER RES, V26, P255, DOI 10.1002/jbm.820260210
   Neo M, 1996, J BIOMED MATER RES, V30, P485, DOI 10.1002/(SICI)1097-4636(199604)30:4<485::AID-JBM6>3.0.CO;2-L
   Neo M, 1998, J BIOMED MATER RES, V39, P71, DOI 10.1002/(SICI)1097-4636(199801)39:1<71::AID-JBM9>3.0.CO;2-F
   Pioletti DP, 2000, BIOMATERIALS, V21, P1103, DOI 10.1016/S0142-9612(99)00250-1
   RAMSELAAR MMA, 1991, J MATER SCI-MATER M, V2, P63, DOI 10.1007/BF00703460
   REJDA BV, 1977, J BIOENG, V1, P93
   Schliephake H, 1997, Mund Kiefer Gesichtschir, V1, P115
   Schmitt JM, 1997, J PERIODONTOL, V68, P1043, DOI 10.1902/jop.1997.68.11.1043
   Yao JL, 1997, J BONE JOINT SURG AM, V79A, P107, DOI 10.2106/00004623-199701000-00011
   Yuan HP, 2000, BIOMATERIALS, V21, P1283, DOI 10.1016/S0142-9612(00)00016-8
NR 29
TC 71
Z9 75
U1 1
U2 12
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD APR
PY 2002
VL 23
IS 7
BP 1689
EP 1695
AR PII S0142-9612(01)00296-4
DI 10.1016/S0142-9612(01)00296-4
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 527PX
UT WOS:000174196100016
PM 11922472
DA 2018-10-20
ER

PT J
AU Nimeri, G
   Ohman, L
   Elwing, H
   Wettero, J
   Bengtsson, T
AF Nimeri, G
   Ohman, L
   Elwing, H
   Wettero, J
   Bengtsson, T
TI The influence of plasma proteins and platelets on oxygen radical
   production and F-actin distribution in neutrophils adhering to polymer
   surfaces
SO BIOMATERIALS
LA English
DT Article
DE neutrophil; platelet; polymer; plasma protein; oxygen radicals; actin
ID ENHANCED ALBUMIN AFFINITY; P-SELECTIN; ADHERENT PLATELETS; RESPIRATORY
   BURST; INFLAMMATORY RESPONSES; IMMUNOGLOBULIN-G; ACTIVATION; ADHESION;
   FIBRINOGEN; BIOMATERIALS
AB It is well known that blood cell interactions with artificial surfaces might have deleterious effects on host tissue, however. the mechanisms involved are far from understood. In this study, neutrophil platelet interaction on uncoated or protein-coated polymer surfaces was investigated. Cell spreading, reorganization of actin filaments and release of oxygen metabolites (measured as luminol-amplified chemiluminescence) were used as criteria for cell activation on positively charged, hydrophilic 1,2-diaminocyclohexane, and negatively charged, hydrophobic hexamethylene-disiloxane. The model surfaces were made by radio frequency plasma discharge polymerization. Neutrophil contact with the uncoated polymers induced a prolonged generation of oxygen radicals. Precoating of the polymer surfaces with human serum albumin (HSA) or fibrinogen, markedly reduced neutrophil activation, whereas coating with human immunoglobulin G (IgG), a well-known opsonin. resulted in significantly higher levels of cell activation. Consequently, protein coating overruled the activating effects of the polymer surfaces. The presence of unstimulated or thrombin-stimulated platelets markedly increased the reactivity of neutrophils against fibrinogen- and I-G-coated surfaces. However, neutrophils remained relatively unreactive in the presence of platelets on HSA-treated surfaces. Comparison of the different types of surfaces used, reveals a correlation between the degree of cell spreading, reorganization of the actin cytoskeleton and the amount of oxygen radicals produced. Our results suggest that the acute inflammatory reaction on a biomaterial surface is highly dependent on the nature and composition of the first adsorbed protein layer and the extent of platelet activation. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Linkoping Univ, Fac Hlth Sci, Dept Hlth & Environm, Div Med Microbiol, SE-58185 Linkoping, Sweden.
   Univ Gothenburg, Dept Cell & Mol Biol, SE-40530 Gothenburg, Sweden.
RP Bengtsson, T (reprint author), Linkoping Univ, Fac Hlth Sci, Dept Hlth & Environm, Div Med Microbiol, SE-58185 Linkoping, Sweden.
RI Wettero, Jonas/C-9578-2009
OI Wettero, Jonas/0000-0002-6916-5490
CR Bengtsson T, 1996, BLOOD, V87, P4411
   BENGTSSON T, 1993, EUR J CELL BIOL, V62, P49
   Bengtsson T, 1999, SCAND J CLIN LAB INV, V59, P439, DOI 10.1080/00365519950185463
   BENGTSSON T, 1994, EUR J CELL BIOL, V63, P345
   Berton G, 1996, INT J CLIN LAB RES, V26, P160, DOI 10.1007/BF02592978
   BERTON G, 1994, J CELL BIOL, V126, P1111, DOI 10.1083/jcb.126.4.1111
   BORREGAARD N, 1991, Journal of Cell Biology, V115, p257A
   BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77
   Brown KK, 1998, AM J RESP CELL MOL, V18, P100, DOI 10.1165/ajrcmb.18.1.2314
   Cerletti C, 1999, THROMB HAEMOSTASIS, V82, P787
   CHUANG HYK, 1980, THROMB RES, V19, P1, DOI 10.1016/0049-3848(80)90398-9
   DAHLGREN C, 1983, IMMUNOLOGY, V49, P329
   DELAHARPE J, 1989, J IMMUNOL, V143, P596
   DEUEL TF, 1981, P NATL ACAD SCI-BIOL, V78, P4584, DOI 10.1073/pnas.78.7.4584
   DEUEL TF, 1982, J CLIN INVEST, V69, P1046, DOI 10.1172/JCI110509
   Diacovo TG, 1996, BLOOD, V88, P146
   DRI P, 1991, INT J TISSUE REACT, V13, P193
   FALCK P, 1995, BIOMATERIALS, V16, P61, DOI 10.1016/0142-9612(95)91097-I
   FRAUTSCHI JR, 1983, T AM SOC ART INT ORG, V29, P242
   GOETZL EJ, 1977, J CLIN INVEST, V59, P179, DOI 10.1172/JCI108617
   GOLANDER CG, 1993, J APPL POLYM SCI, V49, P39, DOI 10.1002/app.1993.070490106
   Hartwig JH, 1999, THROMB HAEMOSTASIS, V82, P392
   HIGAZI AA, 1994, INFLAMMATION, V18, P525, DOI 10.1007/BF01560699
   HORBETT TA, 1994, COLLOID SURFACE B, V2, P225, DOI 10.1016/0927-7765(94)80037-5
   Jirouskova M, 1997, THROMB HAEMOSTASIS, V78, P1125
   KAPLAN SS, 1994, J BIOMED MATER RES, V28, P377, DOI 10.1002/jbm.820280313
   KATZ DA, 1995, SURGERY, V118, P154, DOI 10.1016/S0039-6060(05)80318-6
   Klinger MHF, 1997, ANAT EMBRYOL, V196, P1, DOI 10.1007/s004290050075
   KOTTKEMARCHANT K, 1989, BIOMATERIALS, V10, P147, DOI 10.1016/0142-9612(89)90017-3
   LASSEN B, 1992, Clinical Materials, V11, P99, DOI 10.1016/0267-6605(92)90034-Q
   Lassen B, 1997, J COLLOID INTERF SCI, V186, P9, DOI 10.1006/jcis.1996.4529
   Liu L, 1997, CLIN EXP IMMUNOL, V109, P204, DOI 10.1046/j.1365-2249.1997.4311329.x
   MORLEY DJ, 1989, THROMB HAEMOSTASIS, V62, P1023
   MUNRO MS, 1981, T AM SOC ART INT ORG, V27, P499
   NATHAN CF, 1987, J CLIN INVEST, V80, P1550, DOI 10.1172/JCI113241
   NIMERI G, 1994, J BIOMAT SCI-POLYM E, V6, P741
   NIMERI G, 1994, J BIOMAT SCI-POLYM E, V6, P573, DOI 10.1163/156856294X00527
   NYGREN H, 1995, J VAC SCI TECHNOL A, V13, P2613, DOI 10.1116/1.579459
   PALABRICA T, 1992, NATURE, V359, P848, DOI 10.1038/359848a0
   SEVASTIANOV VI, 1988, CRIT REV BIOCOMPAT, V4, P109
   Simon DI, 2000, J EXP MED, V192, P193, DOI 10.1084/jem.192.2.193
   TANG LP, 1993, J LAB CLIN MED, V122, P292
   TANG LP, 1993, J EXP MED, V178, P2147, DOI 10.1084/jem.178.6.2147
   TANG LP, 1994, CELL MATER, V4, P429
   TSUJI T, 1994, J LEUKOCYTE BIOL, V56, P583
   Weber C, 1997, J CLIN INVEST, V100, P2085, DOI 10.1172/JCI119742
   WEKSLER B. B., 1992, INFLAMMATION BASIC P, P727
   Wettero J, 2000, J BIOMED MATER RES, V51, P742, DOI 10.1002/1097-4636(20000915)51:4<742::AID-JBM24>3.0.CO;2-D
   Zalavary S, 1996, J LEUKOCYTE BIOL, V60, P58
NR 49
TC 40
Z9 42
U1 0
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD APR
PY 2002
VL 23
IS 8
BP 1785
EP 1795
AR PII S0142-9612(01)00305-2
DI 10.1016/S0142-9612(01)00305-2
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 536FD
UT WOS:000174689300008
PM 11950049
DA 2018-10-20
ER

PT J
AU Park, JH
   Bae, YH
AF Park, JH
   Bae, YH
TI Hydrogels based on poly(ethylene oxide) and poly(tetramethylene oxide)
   or poly(dimethyl siloxane): synthesis, characterization, in vitro
   protein adsorption and platelet adhesion
SO BIOMATERIALS
LA English
DT Article
DE poly(ethylene oxide); poly(tetramethylene oxide); poly(dimethyl
   siloxane); hydrogel; protein adsorption; platelet adhesion
ID POLYDIMETHYLSILOXANE POLYUREA-URETHANES; POLYMERIC BIOMATERIALS;
   SILICONE-RUBBER; SURFACES; FIBRINOGEN; COPOLYMERS; BIOCOMPATIBILITY;
   COEFFICIENT; WETTABILITY; ACTIVATION
AB In vitro protein adsorption, platelet adhesion and activation on now hydrogel surfaces, composed of poly(ethylene oxide) (PEO) and poly(tetramethylene oxide) (PTMO) or poly(dimethyl siloxane) (PDMS), were investigated. By varying PEO length (MW = 2000 or 3400), hydrophobic components (PTMO or PDMS) or polymer topology (block or graft copolymers), various physical hydrogels were produced. Their structures were verified by, H-1 NMR and ATR-IR and the molecular weights were determined by gel permeation chromatography. The hydrogels were soluble in a variety of organic solvents, while absorbed a significant amount of water with preserved three-dimensional structure by physical crosslinking. The dynamic contact angle measurement revealed that the surface hydrophilicity increased by incorporating longer PEO, PEO grafting, and adopting PDMS as a hydrophobic segment instead of PTMO. It was observed from in vitro protein adsorption Study that the hydrogels exhibited significantly lower adsorption Of human scrum albumin (HSA), human fibrinogen (HFg), and IgG, when compared with Pellethane (H), a commercial polyurethane taken as a control. The hydrogels were attractive for HSA but not sensitive to HFg and I-G. And more than 65% of the proteins detected on the surfaces of the hydrogels were reversibly detached by being treated with an SDS solution. It was evident that the hydrogels synthesized in this Study were much more resistant to platelet adhesion than the control, which might depend on the composition of proteins adsorbed on the surfaces and their degree of denaturation, Among the hydrogels tested, PE03.4kPDMS exhibited albumin-rich and platelet-resistant surfaces, implying a potential candidate for biomaterial. (C) 2002 Published by Elsevier Science Ltd.
C1 Kwangju Inst Sci & Technol, Dept Mat Sci & Engn, Ctr Biomat & Biotechnol, Puk Gu, Kwangju 500712, South Korea.
RP Bae, YH (reprint author), Kwangju Inst Sci & Technol, Dept Mat Sci & Engn, Ctr Biomat & Biotechnol, Puk Gu, 1 Oryong Dong, Kwangju 500712, South Korea.
RI byun, jaehyun/G-5584-2014; Park, Jae Hyung/B-5967-2018
CR Balasubramanian V, 1999, J BIOMED MATER RES, V44, P253, DOI 10.1002/(SICI)1097-4636(19990305)44:3<253::AID-JBM3>3.0.CO;2-K
   Bell CL, 1996, BIOMATERIALS, V17, P1203, DOI 10.1016/0142-9612(96)84941-6
   BERGSTROM K, 1992, J BIOMED MATER RES, V26, P779, DOI 10.1002/jbm.820260607
   Bernacca GM, 1998, BIOMATERIALS, V19, P1151, DOI 10.1016/S0142-9612(98)00016-7
   Chinn JA, 1996, J COLLOID INTERF SCI, V184, P11, DOI 10.1006/jcis.1996.0592
   DETTRE RH, 1965, J PHYS CHEM-US, V69, P1507, DOI 10.1021/j100889a012
   DUST JM, 1990, MACROMOLECULES, V23, P3742, DOI 10.1021/ma00218a005
   FABRIZIUSHOMAN DJ, 1991, J BIOMAT SCI-POLYM E, V3, P27, DOI 10.1163/156856292X00060
   Francois P, 1996, BIOMATERIALS, V17, P667, DOI 10.1016/0142-9612(96)86736-6
   GOMBOTZ WR, 1991, J BIOMED MATER RES, V25, P1547, DOI 10.1002/jbm.820251211
   GRAIVER D, 1993, BIOMATERIALS, V14, P465, DOI 10.1016/0142-9612(93)90150-Z
   Griffith LG, 2000, ACTA MATER, V48, P263, DOI 10.1016/S1359-6454(99)00299-2
   GUTOWSKA A, 1994, MACROMOLECULES, V27, P4167, DOI 10.1021/ma00093a018
   Han DK, 1996, J BIOMED MATER RES, V30, P23, DOI 10.1002/(SICI)1097-4636(199601)30:1<23::AID-JBM4>3.0.CO;2-T
   Hanson S. R., 1996, BIOMATERIALS SCI INT, P193
   HERGENROTHER RW, 1994, BIOMATERIALS, V15, P635, DOI 10.1016/0142-9612(94)90215-1
   Hoffman AS, 1982, ADV CHEM SER, V199, P3
   HOGT AH, 1985, J COLLOID INTERF SCI, V106, P289, DOI 10.1016/S0021-9797(85)80002-3
   Horak D, 1997, J BIOMED MATER RES, V34, P183, DOI 10.1002/(SICI)1097-4636(199702)34:2<183::AID-JBM7>3.0.CO;2-M
   Hsiue GH, 1998, J BIOMED MATER RES, V42, P134, DOI 10.1002/(SICI)1097-4636(199810)42:1<134::AID-JBM17>3.0.CO;2-L
   Irvine DJ, 1996, MACROMOLECULES, V29, P6037, DOI 10.1021/ma951903t
   Iza M, 1998, J CONTROL RELEASE, V52, P41, DOI 10.1016/S0168-3659(97)00191-0
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P149, DOI 10.1016/0021-9797(91)90043-8
   Karadag E, 1996, BIOMATERIALS, V17, P67, DOI 10.1016/0142-9612(96)80757-5
   Kidane A, 2000, COLLOID SURFACE B, V18, P347, DOI 10.1016/S0927-7765(99)00160-5
   Lamba N. M. K., 1998, POLYURETHANES BIOMED
   Lee JH, 1998, J COLLOID INTERF SCI, V205, P323, DOI 10.1006/jcis.1998.5688
   Lee JH, 1998, J BIOMED MATER RES, V40, P314, DOI 10.1002/(SICI)1097-4636(199805)40:2<314::AID-JBM17>3.0.CO;2-L
   LI C, 1988, J POLYM SCI POL PHYS, V26, P315, DOI 10.1002/polb.1988.090260209
   LIM F, 1994, BIOMATERIALS, V15, P408, DOI 10.1016/0142-9612(94)90218-6
   LINDON JN, 1986, BLOOD, V68, P355
   Mackay TG, 1996, ARTIF ORGANS, V20, P1017, DOI 10.1111/j.1525-1594.1996.tb04589.x
   MAJERUS PW, 1980, REGULATION COAGULATI, P215
   Naim JO, 1998, COLLOID SURFACE B, V11, P79, DOI 10.1016/S0927-7765(98)00023-X
   NICKEL JC, 1987, UROLOGY, V29, P501, DOI 10.1016/0090-4295(87)90037-9
   Park JH, 1999, BIOMATERIALS, V20, P943, DOI 10.1016/S0142-9612(98)00250-6
   PARK K, 1990, BIOMATERIALS, V11, P24, DOI 10.1016/0142-9612(90)90047-T
   PEPPAS NA, 1987, HYDROGELS MED PHARM, V3
   PEZRON E, 1988, MACROMOLECULES, V21, P1121, DOI 10.1021/ma00182a045
   PITT WG, 1986, J COLLOID INTERF SCI, V111, P343, DOI 10.1016/0021-9797(86)90039-1
   PRIME KL, 1993, J AM CHEM SOC, V115, P10714, DOI 10.1021/ja00076a032
   Renken J, 1996, ANAL CHEM, V68, P176, DOI 10.1021/ac9504777
   RISBUD MV, DRUG DELIV, V200, P69
   SEIFERT LM, 1985, J BIOMED MATER RES, V19, P1043, DOI 10.1002/jbm.820190916
   TALJA M, 1990, BRIT J UROL, V66, P652, DOI 10.1111/j.1464-410X.1990.tb07203.x
   TANAKA F, 1992, MACROMOLECULES, V25, P1516, DOI 10.1021/ma00031a024
   van der Heiden AP, 1998, J BIOMED MATER RES, V40, P195, DOI 10.1002/(SICI)1097-4636(199805)40:2<195::AID-JBM4>3.0.CO;2-G
   Welle A, 1998, J COLLOID INTERF SCI, V197, P263, DOI 10.1006/jcis.1997.5238
   WILLARD JE, 1994, CIRCULATION, V89, P2190, DOI 10.1161/01.CIR.89.5.2190
   YU XH, 1985, J POLYM SCI POL PHYS, V23, P2319, DOI 10.1002/pol.1985.180231106
   Zhang MQ, 1998, BIOMATERIALS, V19, P953, DOI 10.1016/S0142-9612(98)00026-X
NR 51
TC 105
Z9 110
U1 10
U2 93
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD APR
PY 2002
VL 23
IS 8
BP 1797
EP 1808
AR PII S0142-9612(01)00306-4
DI 10.1016/S0142-9612(01)00306-4
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 536FD
UT WOS:000174689300009
PM 11950050
DA 2018-10-20
ER

PT J
AU Murata, M
   Arisue, M
   Sato, D
   Sasaki, T
   Shibata, T
   Kuboki, Y
AF Murata, M
   Arisue, M
   Sato, D
   Sasaki, T
   Shibata, T
   Kuboki, Y
TI Bone induction in subcutaneous tissue in rats by a newly developed
   DNA-coated atelocollagen and bone morphogenetic protein
SO BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY
LA English
DT Article
ID RECOMBINANT HUMAN BMP-2; ARTIFICIAL SKIN; ECTOPIC SITES; I COLLAGEN;
   DIFFERENTIATION; AUGMENTATION; FIBRILLAR; RHBMP-2; IMPLANT; CARRIER
AB A unique biomaterial, a mixture of DNA and collagen (DNA/collagen), was developed and its efficacy as a carrier matrix for bone morphogenetic protein (BMP) was evaluated histologically. The material was prepared as a composite of DNA from salmon milt and pepsin-digested type I collagen (atelocollagen) from bovine dermis. Phase-contrast and fluorescence microscopy showed atelocollagen fibres with DNA coating. The dose-response and time-course of bone induction by BMP in DNA/collagen (5 x 10 x 1 mm) in the subcutaneous tissue was investigated in 20 male Wistar rats. The BMP/DNA/collagen induced new bone in a dose-dependent manner (0, 25, 50 or 100 mug of BMP). Histological examination in the time-course study showed that the BMP (100 mug)/DNA/collagen induced bone formation, while the DNA/collagen alone resulted in the accumulation of fibroblasts. These results indicate that the DNA/collagen is effective as a carrier matrix for BMP. It provides a cell anchorage for differentiation of osteoblasts and is absorbed as bone matures. (C) 2002 The British Association of Oral and Maxillofacial Surgeons.
C1 Hokkaido Univ, Sch Dent, Dept Oral & Maxillofacial Surg 2, Tobetsu, Hokkaido 060, Japan.
   Hokkaido Univ, Grad Sch Dent Med, Dept Oral Hlth Sci, Sapporo, Hokkaido, Japan.
RP Murata, M (reprint author), Hokkaido Univ, Sch Dent, Dept Oral & Maxillofacial Surg 2, Tobetsu, Hokkaido 060, Japan.
CR AONO A, 1995, BIOCHEM BIOPH RES CO, V210, P670, DOI 10.1006/bbrc.1995.1712
   BASSETT CA, 1961, NATURE, V190, P460, DOI 10.1038/190460a0
   BERNSTEIN KA, 1995, J IMMUNOL, V154, P2424
   Boyne PJ, 1999, BRIT J ORAL MAX SURG, V37, P344, DOI 10.1054/bjom.1999.0205
   HEY KB, 1990, BIOTECHNOL APPL BIOC, V12, P85
   Hollinger JO, 1998, J BIOMED MATER RES, V43, P356, DOI 10.1002/(SICI)1097-4636(199824)43:4<356::AID-JBM3>3.0.CO;2-7
   IZUI S, 1976, J EXP MED, V144, P28
   KAWAI T, 1993, CLIN ORTHOP RELAT R, P296
   Kitamura H, 1997, INT J BIOL MACROMOL, V20, P241, DOI 10.1016/S0141-8130(97)00021-4
   KOIDE M, 1993, J BIOMED MATER RES, V27, P79, DOI 10.1002/jbm.820270111
   KUBOKI Y, 1995, CONNECT TISSUE RES, V31, P1
   Kusumoto K, 1997, BRIT J ORAL MAX SURG, V35, P433, DOI 10.1016/S0266-4356(97)90722-1
   Ma Q, 2000, BRIT J ORAL MAX SURG, V38, P561, DOI 10.1054/bjom.2000.0458
   Mirkin CA, 1996, NATURE, V382, P607, DOI 10.1038/382607a0
   Murata M, 1998, INT J ORAL MAX SURG, V27, P391, DOI 10.1016/S0901-5027(98)80071-4
   Murata M, 1999, INT J ORAL MAX SURG, V28, P232, DOI 10.1034/j.1399-0020.1999.283280316.x
   Murata M, 2000, CLIN ORAL IMPLAN RES, V11, P289, DOI 10.1034/j.1600-0501.2000.011004289.x
   Nagai N, 1999, INT J ORAL MAX SURG, V28, P143
   Omura S, 1998, INT J ORAL MAX SURG, V27, P129, DOI 10.1016/S0901-5027(98)80312-3
   REDDI AH, 1985, BONE MINERAL RES, V3, P27
   RHODES RK, 1978, BIOCHEMISTRY-US, V17, P3442, DOI 10.1021/bi00610a003
   RIPAMONTI U, 1992, MATRIX, V12, P202, DOI 10.1016/S0934-8832(11)80063-6
   SAMPATH TK, 1983, P NATL ACAD SCI-BIOL, V80, P6591, DOI 10.1073/pnas.80.21.6591
   SASANO Y, 1993, ANAT REC, V236, P373, DOI 10.1002/ar.1092360211
   URIST MR, 1983, SCIENCE, V220, P680, DOI 10.1126/science.6403986
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   WANG EA, 1990, P NATL ACAD SCI USA, V87, P2220, DOI 10.1073/pnas.87.6.2220
   Wozney J M, 1989, Prog Growth Factor Res, V1, P267, DOI 10.1016/0955-2235(89)90015-X
   WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241
   YANNAS IV, 1980, J BIOMED MATER RES, V14, P65, DOI 10.1002/jbm.820140108
   YANNAS IV, 1980, J BIOMED MATER RES, V14, P107, DOI 10.1002/jbm.820140203
NR 31
TC 8
Z9 8
U1 0
U2 0
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 0266-4356
J9 BRIT J ORAL MAX SURG
JI Br. J. Oral Maxillofac. Surg.
PD APR
PY 2002
VL 40
IS 2
BP 131
EP 135
DI 10.1054/bjom.2001.0743
PG 5
WC Dentistry, Oral Surgery & Medicine; Surgery
SC Dentistry, Oral Surgery & Medicine; Surgery
GA 557ZR
UT WOS:000175940000008
PM 12180204
DA 2018-10-20
ER

PT J
AU Tegoulia, VA
   Cooper, SL
AF Tegoulia, VA
   Cooper, SL
TI Staphylococcus aureus adhesion to self-assembled monolayers: effect of
   surface chemistry and fibrinogen presence
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE bacterial adhesion; self-assembled monolayers; Staphylococcus aureus;
   well-defined flow field; automated videomicroscopy
ID BACTERIAL ADHESION; PROTEIN ADSORPTION; POLYETHYLENE OXIDE; FREE-ENERGY;
   OLIGO(ETHYLENE GLYCOL); POLYURETHANE SURFACES; BIOMATERIAL SURFACES;
   SILICONE-RUBBER; SOLID-SURFACES; PARALLEL-PLATE
AB Staphylococcus aureus adhesion on self-assembled monolayers (SAMs) formed by the adsorption of alkanethiols on transparent gold films has been studied in real time under well-defined flow conditions using a radial flow chamber and an automated videornicroscopy system. SAMs terminated with methyl, hydroxyl, carboxylic acid and tri(ethylene oxide) groups were investigated. SAMs were characterized using contact angle measurements, ellipsometry and X-ray photoelectron spectroscopy. Adhesion experiments using the Newman strain of S. aureits were performed on bare monolayers and monolayers pre-incubated with fibrinogen. Adhesion was round to be lowest on the ethylene oxide-bearing surfaces, followed by the hydroxyl surfaces. Adhesion on the carboxylic- and methyl-terminated SAMs was much higher. Bacterial adhesion was higher on the hydrophobic surfaces. Pre-incubation of surfaces with fibrinogen minimized the effect of the surface properties of the substrate. Adhesion was increased on all surfaces when fibrinogen was present and no significant differences were observed between adhesion to the different SAMs. This study showed that surfaces rich in ethylene oxide groups can be effectively used to prevent bacterial adhesion. However, under physiological conditions, most of the substrate properties are masked by the presence of the adsorbed protein layer and the effect of substrate properties on bacteria adhesion under flow is minimal. (C) 2002 Elsevier Science B.V. All rights reserved.
C1 Univ Delaware, Dept Chem Engn, Newark, DE 19716 USA.
   N Carolina State Univ, Raleigh, NC 27695 USA.
CR ABSOLOM DR, 1983, APPL ENVIRON MICROB, V46, P90
   Alberte RS, 1992, BIOFOULING, V6, P91, DOI 10.1080/08927019209386214
   An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   BAIN CD, 1989, J AM CHEM SOC, V111, P7155, DOI 10.1021/ja00200a039
   BAIN CD, 1989, LANGMUIR, V5, P1370, DOI 10.1021/la00090a019
   BAIN CD, 1989, J AM CHEM SOC, V111, P321, DOI 10.1021/ja00183a049
   Barton AJ, 1996, J BIOMED MATER RES, V30, P403, DOI 10.1002/(SICI)1097-4636(199603)30:3<403::AID-JBM15>3.0.CO;2-K
   Baumgartner JN, 1998, J BIOMED MATER RES, V40, P660, DOI 10.1002/(SICI)1097-4636(19980615)40:4<660::AID-JBM18>3.0.CO;2-J
   Bos R, 1996, MICROBIOL-UK, V142, P2355, DOI 10.1099/00221287-142-9-2355
   BUSSCHER HJ, 1984, APPL ENVIRON MICROB, V48, P980
   BUSSCHER HJ, 1999, PHYSICAL CHEM BIOL I
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   DESAI NP, 1992, BIOMATERIALS, V13, P417, DOI 10.1016/0142-9612(92)90160-P
   Dickinson RB, 1997, J BIOMED MATER RES, V36, P152, DOI 10.1002/(SICI)1097-4636(199708)36:2<152::AID-JBM3>3.0.CO;2-J
   DICKINSON RB, 1995, INFECT IMMUN, V63, P3143
   DICKINSON RB, 1995, AICHE J, V41, P2160, DOI 10.1002/aic.690410915
   EGINTON PJ, 1995, COLLOID SURFACE B, V5, P153, DOI 10.1016/0927-7765(95)01219-9
   Everaert EPJM, 1998, COLLOID SURFACE B, V10, P179, DOI 10.1016/S0927-7765(98)00003-4
   FERREIROS CM, 1989, FEMS MICROBIOL LETT, V60, P89, DOI 10.1016/0378-1097(89)90083-9
   FLETCHER M, 1985, J COLLOID INTERF SCI, V104, P5, DOI 10.1016/0021-9797(85)90004-9
   Fletcher M, 1996, BACTERIAL ADHESION M, P1
   Hashimoto N, 1998, J FERMENT BIOENG, V86, P424, DOI 10.1016/S0922-338X(99)89019-9
   HERRMANN M, 1993, J INFECT DIS, V167, P312, DOI 10.1093/infdis/167.2.312
   HERRMANN M, 1988, J INFECT DIS, V158, P693, DOI 10.1093/infdis/158.4.693
   Higashi JM, 1998, J BIOMED MATER RES, V39, P341, DOI 10.1002/(SICI)1097-4636(19980305)39:3<341::AID-JBM1>3.0.CO;2-J
   Ista LK, 1996, FEMS MICROBIOL LETT, V142, P59
   LAIBINIS PE, 1995, J PHYS CHEM-US, V99, P7663, DOI 10.1021/j100019a054
   Lappin-Scott H. M., 1989, Biofouling, V1, P323
   LEE JH, 1990, BIOMATERIALS, V11, P455, DOI 10.1016/0142-9612(90)90058-X
   LEE JH, 1993, J BIOMAT SCI-POLYM E, V4, P468
   LEE TR, 1994, LANGMUIR, V10, P741, DOI 10.1021/la00015a024
   Lestelius M, 1997, LANGMUIR, V13, P5900, DOI 10.1021/la970187g
   LLANOS GR, 1993, J BIOMAT SCI-POLYM E, V4, P381
   MCCRACKIN FL, 1963, J RES NBS A PHYS CH, VA 67, P363, DOI 10.6028/jres.067A.040
   MCDEVITT D, 1994, MOL MICROBIOL, V11, P237, DOI 10.1111/j.1365-2958.1994.tb00304.x
   MEINDERS JM, 1994, J COLLOID INTERF SCI, V164, P355, DOI 10.1006/jcis.1994.1177
   Merrill EW, 1983, AM SOC ARTIF INTERN, V6, P60
   Mittelman M. W., 1996, BACTERIAL ADHESION M, P89
   MOHAMMAD SF, 1988, T AM SOC ART INT ORG, V34, P573
   MOLLER PS, 1963, AERONAUT QUART, V14, P163, DOI 10.1017/S0001925900002742
   Mrksich M, 1997, CURR OPIN COLLOID IN, V2, P83, DOI 10.1016/S1359-0294(97)80012-X
   Ostuni E, 1999, COLLOID SURFACE B, V15, P3, DOI 10.1016/S0927-7765(99)00004-1
   PALEGROSDEMANGE C, 1991, J AM CHEM SOC, V113, P12, DOI 10.1021/ja00001a002
   Park KD, 1998, BIOMATERIALS, V19, P851, DOI 10.1016/S0142-9612(97)00245-7
   PAULSSON M, 1993, BIOMATERIALS, V14, P845, DOI 10.1016/0142-9612(93)90006-N
   Petas A, 1998, BIOMATERIALS, V19, P677, DOI 10.1016/S0142-9612(97)00171-3
   PRIME KL, 1991, SCIENCE, V252, P1164, DOI 10.1126/science.252.5009.1164
   RIJNAARTS HHM, 1995, COLLOID SURFACE B, V4, P5, DOI DOI 10.1016/0927-7765(94)01146-V
   RUTTER P R, 1984, P21
   Silver JH, 1999, BIOMATERIALS, V20, P1533, DOI 10.1016/S0142-9612(98)00173-2
   SLACK SM, 1993, CARDIOVASC PATHOL, V2, pS11
   Tegoulia VA, 2000, J BIOMED MATER RES, V50, P291, DOI 10.1002/(SICI)1097-4636(20000605)50:3<291::AID-JBM2>3.0.CO;2-1
   Tidwell CD, 1997, LANGMUIR, V13, P3404, DOI 10.1021/la9604341
   TYLER BJ, 1992, J BIOMED MATER RES, V26, P273, DOI 10.1002/jbm.820260302
   Wadstrom T., 1990, MICROBIAL CELL SURFA, P315
   Wang RLC, 1997, J PHYS CHEM B, V101, P9767, DOI 10.1021/jp9716952
   Wassall MA, 1997, J BIOMED MATER RES, V36, P325, DOI 10.1002/(SICI)1097-4636(19970905)36:3<325::AID-JBM7>3.3.CO;2-L
   WHICHER SJ, 1978, J BIOMED MATER RES, V12, P181, DOI 10.1002/jbm.820120205
   WIENCEK KM, 1995, J BACTERIOL, V177, P1959, DOI 10.1128/jb.177.8.1959-1966.1995
   Yang JL, 1999, J COLLOID INTERF SCI, V220, P410, DOI 10.1006/jcis.1999.6539
NR 60
TC 63
Z9 64
U1 3
U2 22
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD APR
PY 2002
VL 24
IS 3-4
BP 217
EP 228
AR PII S0927-7765(01)00240-5
DI 10.1016/S0927-7765(01)00240-5
PG 12
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA 533XN
UT WOS:000174555700006
DA 2018-10-20
ER

PT J
AU Ma, DHK
   Wang, SF
   Su, WY
   Tsai, RJF
AF Ma, DHK
   Wang, SF
   Su, WY
   Tsai, RJF
TI Amniotic membrane graft for the management of scleral melting and
   corneal perforation in recalcitrant infectious scleral and corneoscleral
   ulcers
SO CORNEA
LA English
DT Article
DE amniotic membrane graft; scleral ulcer; corneoscleral ulcer
ID OCULAR SURFACE RECONSTRUCTION; STEVENS-JOHNSON-SYNDROME; TOPICAL
   MITOMYCIN-C; PTERYGIUM EXCISION; THERMAL BURNS; TRANSPLANTATION;
   SCLERITIS; COMPLICATIONS; ULCERATION; PROTEINS
AB Purpose. To study the efficacy and safety of using cryopreserved human amniotic membrane (AM) graft as a patch graft to reduce stromal melting and promote reepithelialization in extensive infectious scleral and corneoscleral ulcers. Methods. Four cases of infectious scleral ulcers with persistent scleral melting and no sign of reepithelialization and three cases of corneoscleral ulcers with corneal perforation were studied. All patients had previously undergone pterygium excision, and infections were caused by Pseudomonas (n = 4), fungi (n = 2), and atypical Mycobacterium (n = 1). The area of limbus involved ranged from 3 to 9 (mean, 4.7) o'clock positions. Repeated debridements were performed, the causative microorganisms were identified, and the appropriate topical and systemic antibiotics were given to all patients before AM grafting. Postoperatively, the speed of reepithelialization, changes in the severity of scleral melting and inflammation recurrence of infection, and visual acuity were documented. Results. Melting and inflammation at the lesion site decreased after AM grafting. Reepithelialization of the scleral lesions was complete at an average 15.7 +/- 8.7 days (range, 5-31) postoperatively. Focal melting of the AM graft occurred in two cases, and in one case, it was necessary to perform further corneoscleral graft. No recurrent infection was encountered, but sterile abscess occurred in three cases that were located away from the original lesion. Useful vision above 201400 was maintained in all patients at the end of follow-up. Conclusion. The AM graft is effective in promoting conjunctival reepithelialization and reducing scleral melting and inflammation and can be considered as an alternative biomaterial to improve wound healing in scleral and comeoscleral ulcerations.
C1 Chang Gung Mem Hosp, Dept Ophthalmol, Taoyuan, Taiwan.
   Taipei Vet Gen Hosp, Dept Radiol, Taipei, Taiwan.
   Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan.
RP Tsai, RJF (reprint author), 2F 350 Sect 4,Cheng Kung Rd, Taipei 114, Taiwan.
CR ALTMAN AJ, 1991, CORNEA, V10, P341, DOI 10.1097/00003226-199107000-00010
   Azuara-Blanco A, 1999, BRIT J OPHTHALMOL, V83, P399, DOI 10.1136/bjo.83.4.399
   BUTLMANN S, 1999, INVEST OPHTHALMOL  S, V40, pS578
   Casey ML, 1997, J CLIN ENDOCR METAB, V82, P3319, DOI 10.1210/jc.82.10.3319
   Chen HJ, 2000, BRIT J OPHTHALMOL, V84, P826, DOI 10.1136/bjo.84.8.826
   Dua HS, 1999, BRIT J OPHTHALMOL, V83, P748, DOI 10.1136/bjo.83.6.748
   EIFERMAN RA, 1979, ARCH OPHTHALMOL-CHIC, V97, P1637
   FARRELL PLR, 1989, AM J OPHTHALMOL, V107, P515, DOI 10.1016/0002-9394(89)90496-0
   Foster CS, 1994, SCLERA, P242
   Fukuda K, 1999, CORNEA, V18, P73, DOI 10.1097/00003226-199901000-00013
   Hanada K, 2001, AM J OPHTHALMOL, V131, P324, DOI 10.1016/S0002-9394(00)00825-4
   Hao YX, 2000, CORNEA, V19, P348, DOI 10.1097/00003226-200005000-00018
   Heiligenhaus A, 2001, INVEST OPHTH VIS SCI, V42, P1969
   Helm CJ, 1997, OPHTHALMOLOGY, V104, P838, DOI 10.1016/S0161-6420(97)30225-5
   Honavar SG, 2000, OPHTHALMOLOGY, V107, P975, DOI 10.1016/S0161-6420(00)00026-9
   Hsiao CH, 1998, BRIT J OPHTHALMOL, V82, P29, DOI 10.1136/bjo.82.1.29
   Huang FC, 2000, CORNEA, V19, P34, DOI 10.1097/00003226-200001000-00008
   Huang SCM, 1999, CORNEA, V18, P608, DOI 10.1097/00003226-199909000-00016
   KERNACKI KA, 1995, INVEST OPHTH VIS SCI, V36, P1371
   Kim HS, 2001, CORNEA, V20, P628, DOI 10.1097/00003226-200108000-00014
   KIM JC, 1995, CORNEA, V14, P473
   KIM JC, 2000, INVEST OPHTHALMOL  S, V4, pS265
   Kim JS, 2000, EXP EYE RES, V70, P329, DOI 10.1006/exer.1999.0794
   Kim JS, 2001, CORNEA, V20, P720, DOI 10.1097/00003226-200110000-00010
   Koizumi N, 2000, CURR EYE RES, V20, P173, DOI 10.1076/0271-3683(200003)20:3;1-9;FT173
   KRUSE FE, 1999, OPHTHALMOLOGY, V106, P1505
   Lee SH, 1997, AM J OPHTHALMOL, V123, P303, DOI 10.1016/S0002-9394(14)70125-4
   Lin CP, 1997, BRIT J OPHTHALMOL, V81, P980, DOI 10.1136/bjo.81.11.980
   Ma DHK, 2000, BRIT J OPHTHALMOL, V84, P973, DOI 10.1136/bjo.84.9.973
   Meller D, 1999, INVEST OPHTH VIS SCI, V40, P878
   Meller D, 2000, OPHTHALMOLOGY, V107, P980, DOI 10.1016/S0161-6420(00)00024-5
   MORIARTY AP, 1993, EYE, V7, P525, DOI 10.1038/eye.1993.114
   MORIARTY AP, 1993, ARCH OPHTHALMOL-CHIC, V111, P947, DOI 10.1001/archopht.1993.01090070065021
   Na BK, 1999, TROPHOBLAST RES, P453
   OBRIEN TP, 1997, CORNEA, P1144
   Prabhasawat P, 1997, OPHTHALMOLOGY, V104, P974, DOI 10.1016/S0161-6420(97)30197-3
   RABER IM, 1981, AM J OPHTHALMOL, V92, P353, DOI 10.1016/0002-9394(81)90524-9
   RAO TV, 1981, ARCH SURG-CHICAGO, V116, P891
   REYNOLDSMG, 1991, AM J OPHTHALMOL, V112, P353
   ROBSON MC, 1973, ANN SURG, V177, P144, DOI 10.1097/00000658-197302000-00003
   Rodriguez-Ares MT, 1999, OPHTHALMIC SURG LAS, V30, P485
   RUBINFELD RS, 1992, OPHTHALMOLOGY, V99, P1647
   SCHWAM BL, 1997, CORNEA, P1485
   Shimazaki J, 1997, OPHTHALMOLOGY, V104, P2068, DOI 10.1016/S0161-6420(97)30057-8
   Shimmura S, 2001, CORNEA, V20, P408, DOI 10.1097/00003226-200105000-00015
   Solomon A, 2001, BRIT J OPHTHALMOL, V85, P444, DOI 10.1136/bjo.85.4.444
   Solomon A, 2001, OPHTHALMOLOGY, V108, P449, DOI 10.1016/S0161-6420(00)00567-4
   Solomon A, 2001, INVEST OPHTH VIS SCI, V42, pS270
   Stark WJ, 1999, INVEST OPHTH VIS SCI, V40, pS690
   Svinarich DM, 1997, AM J REPROD IMMUNOL, V38, P252
   TALMI YP, 1991, PLACENTA, V12, P285, DOI 10.1016/0143-4004(91)90010-D
   TARR KH, 1980, BRIT J OPHTHALMOL, V64, P496, DOI 10.1136/bjo.64.7.496
   THADEPALLI H, 1977, AM J OBSTET GYNECOL, V127, P250, DOI 10.1016/0002-9378(77)90463-X
   THADEPALLI H, 1978, OBSTET GYNECOL, V52, P198
   TRELFORD JD, 1979, AM J OBSTET GYNECOL, V134, P833, DOI 10.1016/0002-9378(79)90957-8
   Tsai RJ, 2000, NEW ENGL J MED, V343, P86, DOI 10.1056/NEJM200007133430202
   Tseng SCG, 1997, AM J OPHTHALMOL, V124, P765, DOI 10.1016/S0002-9394(14)71693-9
   Tseng SCG, 1998, ARCH OPHTHALMOL-CHIC, V116, P431, DOI 10.1001/archopht.116.4.431
   Tseng SCG, 1999, J CELL PHYSIOL, V179, P325, DOI 10.1002/(SICI)1097-4652(199906)179:3<325::AID-JCP10>3.3.CO;2-O
   Tsubota K, 1996, AM J OPHTHALMOL, V122, P38, DOI 10.1016/S0002-9394(14)71962-2
   TWINING SS, 1993, INVEST OPHTH VIS SCI, V34, P2699
NR 61
TC 42
Z9 51
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0277-3740
J9 CORNEA
JI Cornea
PD APR
PY 2002
VL 21
IS 3
BP 275
EP 283
DI 10.1097/00003226-200204000-00008
PG 9
WC Ophthalmology
SC Ophthalmology
GA 536BR
UT WOS:000174681300007
PM 11917176
DA 2018-10-20
ER

PT J
AU Xu, DH
   Mei, XT
   Zhang, CH
   Xu, SB
AF Xu, DH
   Mei, XT
   Zhang, CH
   Xu, SB
TI Anti-myocardial ischemia effects of marine biomaterial C01
SO DRUG DEVELOPMENT RESEARCH
LA English
DT Meeting Abstract
DE anti-ischemia; starfish; sterol; C01
C1 Zhongshan Univ, Dept Pharm, Guangzhou 510275, Peoples R China.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0272-4391
J9 DRUG DEVELOP RES
JI Drug Dev. Res.
PD APR
PY 2002
VL 55
IS 4
MA P19
BP 265
EP 265
PG 1
WC Chemistry, Medicinal; Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 569RL
UT WOS:000176615900073
DA 2018-10-20
ER

PT J
AU Chotard-Ghodsnia, R
   Drochon, A
   Grebe, R
AF Chotard-Ghodsnia, R
   Drochon, A
   Grebe, R
TI New flow chamber for the study of shear stress and transmural pressure
   upon cells adhering to a porous biomaterial
SO JOURNAL OF BIOMECHANICAL ENGINEERING-TRANSACTIONS OF THE ASME
LA English
DT Article
ID CULTURED ENDOTHELIAL-CELLS; HYDROSTATIC-PRESSURE; HEMODIALYSIS;
   ADHESION; SURFACES
AB Biomaterials used in some biomedical devices are porous and exposed to normal and tangential flow of biofluids. To examine the influence of flow induced forces on the morphology and the biochemical responses of cells adhering to such biomaterials, a Hele-Shaw cell with a porous bottom wall was designed and characterized experimentally. Theoretical predictions for the flow in the chamber are provided and allow to quantify the shear stress and/or transmural pressure exerted on cells. It is thus possible to follow up continuously the shape changes of cells that are adherent on a permeable membrane used in bioreactors.
C1 Univ Technol Compiegne, CNRS, UMR Biomecan & Genie Biomed 6600, F-60205 Compiegne, France.
RP Chotard-Ghodsnia, R (reprint author), Univ Technol Compiegne, CNRS, UMR Biomecan & Genie Biomed 6600, BP 20529, F-60205 Compiegne, France.
EM roxana.ghodsnia@utc.fr; agnes.drochon@utc.fr; reinhard.grebe@utc.fr
CR ACEVEDO AD, 1993, J CELL PHYSIOL, V157, P603, DOI 10.1002/jcp.1041570321
   ARTMANN GM, 1995, BIORHEOLOGY, V32, P553, DOI 10.1016/0006-355X(95)00032-5
   DEEN WM, 1998, ANAL TRANSPORT PHENO, P274
   DEWEY CF, 1981, J BIOMECH ENG-T ASME, V103, P177, DOI 10.1115/1.3138276
   HONIGER J, 1994, INT J ARTIF ORGANS, V17, P46
   JAFFRIN MY, 1988, J BIOMECH ENG-T ASME, V110, P1, DOI 10.1115/1.3108400
   LEVESQUE MJ, 1985, J BIOMECH ENG-T ASME, V107, P341, DOI 10.1115/1.3138567
   LEW HS, 1969, J APPL MATH PHYS, V20, P750
   LUNDBERG L, 1994, INT J ARTIF ORGANS, V17, P131
   MULVIHILL J, 1992, BIOMATERIALS, V13, P527, DOI 10.1016/0142-9612(92)90104-V
   OFSTHUN NJ, 1995, ARTIF ORGANS, V19, P1143, DOI 10.1111/j.1525-1594.1995.tb02276.x
   STILL HW, 1995, AM J PHYSIOL-HEART C, V268, pH535
   Tarbell JM, 1999, J APPL PHYSIOL, V87, P261
   THOUMINE O, 1995, IN VITRO CELL DEV-AN, V31, P45
   TRUSKEY GA, 1990, J BIOMED MATER RES, V24, P1333, DOI 10.1002/jbm.820241006
   TRUSKEY GA, 1993, BIOMATERIALS, V14, P243, DOI 10.1016/0142-9612(93)90114-H
NR 16
TC 12
Z9 12
U1 0
U2 0
PU ASME
PI NEW YORK
PA TWO PARK AVE, NEW YORK, NY 10016-5990 USA
SN 0148-0731
EI 1528-8951
J9 J BIOMECH ENG-T ASME
JI J. Biomech. Eng.-Trans. ASME
PD APR
PY 2002
VL 124
IS 2
BP 258
EP 261
DI 10.1115/1.1448520
PG 4
WC Biophysics; Engineering, Biomedical
SC Biophysics; Engineering
GA 547QT
UT WOS:000175343800015
PM 12002137
DA 2018-10-20
ER

PT J
AU Price, C
   Waters, MGJ
   Williams, DW
   Lewis, MAO
   Stickler, D
AF Price, C
   Waters, MGJ
   Williams, DW
   Lewis, MAO
   Stickler, D
TI Surface modification of an experimental silicone rubber aimed at
   reducing initial candidal adhesion
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE Candida albicans; silicone rubber; water wettability; surface chemistry
ID DENTURE-LINING MATERIALS; ACRYLIC SURFACES; ADHERENCE; ALBICANS;
   INVITRO; HYDROPHOBICITY; YEASTS
AB Silicone rubber, which is a widely used biomaterial, is often used to make soft liners for permanent denture. Colonization of denture soft lining materials by Candida albicans can result in clinical problems. The aim of this study was to chemically modify the surface of an experimental silicone rubber in order to produce a silicone that was less susceptible to candidal colonization. Surface modification was carried out with the use of argon-plasma bombardment followed by silane treatment, which caused the incorporation of either hydrophilic or hydrophobic functional groups onto the surface. Changes in water contact angles and chemical analysis of the materials with scanning ion mass spectroscopy confirmed surface changes. In vitro assays were carried out using C. albicans to measure levels of adherence to the surface-modified silicone after I h. C. albicans exhibited very low adherence to all silane-treated surfaces, whether hydrophobic or hydrophilic. This led to the conclusion that incorporated long-chain functional groups were inhibiting the adherence of the yeast, possibly by the formation of a barrier between the surface of the material and the yeast. In conclusion, silane surface treatment of an experimental silicone rubber has been successful in reducing candidal adherence. (C) 2002 John Wiley Sons, Inc.
C1 Univ Wales Coll Cardiff, Coll Med, Sch Dent, Dept Dent Hlth & Biol Sci, Cardiff CF14 4XY, S Glam, Wales.
   Univ Wales Coll Cardiff, Coll Med, Dept Oral Surg Med & Pathol, Cardiff CF14 4XY, S Glam, Wales.
   Cardiff Univ, Sch Biosci, Cardiff, S Glam, Wales.
RP Waters, MGJ (reprint author), Univ Wales Coll Cardiff, Coll Med, Sch Dent, Dept Dent Hlth & Biol Sci, Heath Pk, Cardiff CF14 4XY, S Glam, Wales.
RI Williams, David/E-5506-2012
OI Williams, David/0000-0002-7351-5131
CR Allison R T, 1973, J Dent, V1, P198, DOI 10.1016/0300-5712(73)90059-6
   Baillie GS, 1999, J MED MICROBIOL, V48, P671, DOI 10.1099/00222615-48-7-671
   BURNS DR, 1987, J PROSTHET DENT, V57, P507, DOI 10.1016/0022-3913(87)90026-6
   EVERAERT EP, 1995, J ADHES SCI TECHNOL, V9, P1263, DOI 10.1163/156856195X01030
   Everaert EPJM, 1998, COLLOID SURFACE B, V10, P179, DOI 10.1016/S0927-7765(98)00003-4
   GIBBONS P, 1965, J MICHIGAN DENT ASS, V47, P64
   GRUBER RG, 1966, J AM DENT ASSOC, V73, P641, DOI 10.14219/jada.archive.1966.0276
   Lee SD, 1996, BIOMATERIALS, V17, P1599, DOI 10.1016/0142-9612(95)00316-9
   MAKILA E, 1977, ACTA ODONTOL SCAND, V35, P197, DOI 10.3109/00016357709004655
   MCCOURTIE J, 1985, J MED MICROBIOL, V20, P97, DOI 10.1099/00222615-20-1-97
   MCCOURTIE J, 1984, INFECT IMMUN, V45, P6
   MINAGI S, 1985, INFECT IMMUN, V47, P11
   MIYAKE Y, 1986, MICROBIOS, V46, P7
   NIKAWA H, 1992, J PROSTHET DENT, V68, P804, DOI 10.1016/0022-3913(92)90206-P
   OKITA N, 1991, DENT MATER, V7, P155, DOI 10.1016/0109-5641(91)90035-W
   OLSEN I, 1974, ACTA ODONTOL SCAND, V32, P329, DOI 10.3109/00016357409002556
   OLSSON J, 1990, J DENT RES, V69, P1586, DOI 10.1177/00220345900690091001
   RATNER BD, 1992, J BIOMAT SCI-POLYM E, V4, P3
   Samaranayake YH, 1995, APMIS, V103, P707, DOI 10.1111/j.1699-0463.1995.tb01427.x
   SILVER JH, 1995, J BIOMED MATER RES, V29, P535, DOI 10.1002/jbm.820290414
   VASILAS A, 1992, ARCH ORAL BIOL, V37, P613, DOI 10.1016/0003-9969(92)90123-P
   WATERS MGJ, 2000, J BIOMED MAT RES APP, V48, P765
   Williams DW, 1998, J CLIN PATHOL, V51, P390, DOI 10.1136/jcp.51.5.390
   WRIGHT PS, 1985, J DENT RES, V64, P122, DOI 10.1177/00220345850640020501
NR 24
TC 28
Z9 33
U1 2
U2 10
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD APR
PY 2002
VL 63
IS 2
BP 122
EP 128
DI 10.1002/jbm.10094
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 535JK
UT WOS:000174641300006
PM 11870644
DA 2018-10-20
ER

PT J
AU Lindfors, NC
   Tallroth, K
   Aho, AJ
AF Lindfors, NC
   Tallroth, K
   Aho, AJ
TI Bioactive glass as bone-graft substitute for posterior spinal fusion in
   rabbit
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE bioactive glass; spinal fusion; biomaterial; autograft bone; bone
   substitute
ID OSTEOINDUCTIVE GROWTH-FACTOR; IN-VIVO EVALUATION; MODEL
AB Bioactive glass S53P4 and autogenous bone were studied as bone graft materials for spinal fusion in a rabbit model. Sixteen rabbits underwent surgery by a dorsal approach. A bioactive glass, a combination of bioactive glass and autogenous bone (70/30 vol%), and autogenous bone were implanted at two thoracolumbar vertebraes for 4 and 12 weeks. The volume, consolidation to vertebrae, and fusion of the graft material were evaluated with plain-film radiology, computed tomography (CT) and bone-mineral density measurements, and compared with histomorphometrical measurements. Radiological consolidation by CT of bone graft to underlying vertebrae at 12 weeks was observable in all groups. This was histologically confirmed as bone was growing from the vertebrae into the graft material. Radiologic fusion of vertebraes was, at 12 weeks, observable in all groups in 50-75% of the cases. The radiologic fusion seen at the CT scans could, however, not be confirmed by histology in any of the three groups. Significant differences for graft material and observation period with the use of bone-mineral density measurements (Hounsfield units) were also observable, with the highest measured values for the bioactive glass group and the lowest for the autogenous bone group. The results indicate that bioactive glass have potential as bone-graft material in spinal fusion. The reliability of radiologic evaluation methods in spinal surgery using bone substitutes is also questioned and discussed. (C) 2002 John Wiley Sons, Inc.
C1 Turku Univ, Biomat Project Turku, Turku 20520, Finland.
   Orton Res Inst, Invalid Fdn, Helsinki 00280, Finland.
   Univ Turku, Cent Hosp, Dept Surg, FIN-20520 Turku, Finland.
RP Lindfors, NC (reprint author), Missnebacken 9D2, Espoo 02180, Finland.
CR ANDERSSON OH, 1991, J BIOMED MATER RES, V25, P1019, DOI 10.1002/jbm.820250808
   BODEN SD, 1995, SPINE, V20, P412, DOI 10.1097/00007632-199502001-00003
   Boden SD, 1995, SPINE, V20, P2626, DOI 10.1097/00007632-199512150-00003
   Boden SD, 1995, SPINE, V20, P2633, DOI 10.1097/00007632-199512150-00004
   Brodsky AE, 1991, SPINE S, V16, P261
   COOK SD, 1995, SPINE, V20, P877, DOI 10.1097/00007632-199504150-00002
   COOK SD, 1994, SPINE, V19, P1655, DOI 10.1097/00007632-199408000-00002
   FLATLEY TJ, 1983, CLIN ORTHOP RELAT R, P246
   FRYMOYER JW, 1978, CLIN ORTHOP RELAT R, P196
   GATTI AM, 1993, CELL MATER, V3, P283
   GUIGUI P, 1994, SPINE, V19, P2798, DOI 10.1097/00007632-199412150-00012
   Hench L.L., 1973, J BIOMED MATER RES S, V4, P25
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Lindfors NC, 2000, EUR SPINE J, V9, P30, DOI 10.1007/s005860050005
   LINDHOLM TS, 1988, CLIN ORTHOP RELAT R, P296
   MONTGOMERY DM, 1990, J SPINAL DISORD, V3, P370
   MUSCHLER GF, 1993, J ORTHOPAED RES, V11, P514, DOI 10.1002/jor.1100110406
   STEINMANN JC, 1992, CLIN ORTHOP RELAT R, P80
   YAMAMURO T, 1990, J BONE JOINT SURG BR, V72, P814
NR 19
TC 9
Z9 9
U1 0
U2 2
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD APR
PY 2002
VL 63
IS 2
BP 237
EP 244
DI 10.1002/jbm.10177
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 535JK
UT WOS:000174641300021
PM 11870659
DA 2018-10-20
ER

PT J
AU Rosenson-Schloss, RS
   Chang, CC
   Constantinides, A
   Moghe, PV
AF Rosenson-Schloss, RS
   Chang, CC
   Constantinides, A
   Moghe, PV
TI Alteration of leukocyte motility on plasma-conditioned prosthetic
   biomaterial, ePTFE, via a flow-responsive cell adhesion molecule, CD43
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE leukocytes; physiologic shear; CD43; cell migration; prosthetic
   biomaterial; ePTFE
ID CROSS-LINKING; EXPANDED POLYTETRAFLUOROETHYLENE; SURFACE
   SIALOGLYCOPROTEIN; CHEMOSENSORY MIGRATION; NEUTROPHIL ACTIVATION;
   SIALOPHORIN CD43; IN-VITRO; LEUKOSIALIN; INDUCTION; PHOSPHORYLATION
AB The physiologic determinants of leukocyte migration on vascular prosthetic biomaterials remain poorly understood, despite their relevance to the control of periprosthetic infection. Using hemodynamic exposure of human polymorphonuclear leukocytes adherent to expanded polytetrafluoroethylene (ePTFE) in vitro, we investigated the role of fluid shear in regulating leukocyte migratory behavior on plasma-adsorbed, prosthetic vascular biomaterial. The presence of flow at a wall shear stress of 25 dyn/cm(2) increased the degree of leukocyte displacement along the flow direction without altering the degree of overall cell attachment. Moreover, plasma-ePTFE elicited a lower overall degree of displacement under flow in comparison with untreated ePTFE. We further probed the molecular level regulation of leukocyte migratory responses under flow through the immunocytochemical quantification of specific leukocyte adhesion molecules and determined that CD43, a cell adhesion molecule, was upregulated via flow exposure for leukocytes adherent to plasma-ePTFE, whereas basal levels of CD43 expression were not significantly altered on untreated ePTFE. When flow-exposed, adherent leukocytes were incubated in the presence of substrate immobilized anti-CD43 immunoglobulin, the degree of cell displacement along flow was found to be significantly enhanced on plasma-cPTFE. Quantification of the cell population redistribution under flow using a modified random motility model, indicated that the incorporation of anti-CD43 on plasma-ePTFE led to a significant increase (243 +/- 60%) in the cell dispersion coefficient, mu(D), whereas only a minimal increase (61 +/- 30%) was detected on non-adsorbed ePTFE. Overall, our results suggest that flow exposure can induce the migration of leukocytes adherent to prosthetic materials in a substrate-dependent manner, An important implication of our study is that, although biomaterials exposed to plasma intrinsically passivate leukocyte migration even under hemodynamic conditions, it may be possible to promote cell motility by targeting a specific, flow-responsive, adhesion molecule. (C) 2002 John Wiley & Sons, Inc. J Biomed Mater Res 60: 8-19, 2002.
C1 Rutgers State Univ, Dept Chem & Biochem Engn, Piscataway, NJ 08854 USA.
RP Moghe, PV (reprint author), Rutgers State Univ, Dept Chem & Biochem Engn, C230,98 Brett Rd, Piscataway, NJ 08854 USA.
EM moghe@rci.rutgers.edu
CR Anderson J M, 1988, ASAIO Trans, V34, P101, DOI 10.1097/00002480-198804000-00005
   ANDRADE JD, 1987, ANN NY ACAD SCI, V516, P158, DOI 10.1111/j.1749-6632.1987.tb33038.x
   Benton LD, 1996, J SURG RES, V64, P116, DOI 10.1006/jsre.1996.0316
   BOYCE B, 1982, BIOL SYNTHETIC VASCU, P553
   CAMPOCCIA D, 1993, BIOMATERIALS, V14, P1135, DOI 10.1016/0142-9612(93)90156-V
   Cenni E, 1997, BIOMATERIALS, V18, P489, DOI 10.1016/S0142-9612(96)00160-3
   Chang CC, 1999, BIOMATERIALS, V20, P273, DOI 10.1016/S0142-9612(98)00171-9
   Chang CC, 2000, J MATER SCI-MATER M, V11, P337, DOI 10.1023/A:1008925722623
   Chang CC, 2000, BIOMATERIALS, V21, P2305, DOI 10.1016/S0142-9612(00)00157-5
   CHANG JK, 1996, TISS ENG SOC C P ORL, P59
   COURTNEY JM, 1994, BIOMATERIALS, V15, P737, DOI 10.1016/0142-9612(94)90026-4
   CYSTER JG, 1991, EMBO J, V10, P893, DOI 10.1002/j.1460-2075.1991.tb08022.x
   CYSTER JG, 1992, EUR J IMMUNOL, V22, P2565, DOI 10.1002/eji.1830221015
   DICKINSON RB, 1994, ANN BIOMED ENG, V22, P342, DOI 10.1007/BF02368241
   FRANGOS JA, 1988, BIOTECHNOL BIOENG, V32, P1053, DOI 10.1002/bit.260320812
   GOLDSTONE J, 1974, AM J SURG, V128, P225
   Gopalan PK, 1997, J IMMUNOL, V158, P367
   Gorbet MB, 1999, J BIOMED MATER RES, V44, P289, DOI 10.1002/(SICI)1097-4636(19990305)44:3<289::AID-JBM7>3.0.CO;2-O
   Granchi D, 1998, J BIOMED MATER RES, V39, P549, DOI 10.1002/(SICI)1097-4636(19980315)39:4<549::AID-JBM7>3.0.CO;2-J
   Hammer DA, 1996, ANNU REV MATER SCI, V26, P651
   HAMMER DA, 1994, KINETICS MECH CELL A, P121
   KATZ DA, 1994, SURGERY, V116, P446
   KAWAGUCHI H, 1986, BIOMATERIALS, V7, P61, DOI 10.1016/0142-9612(86)90091-8
   KUIJPERS TW, 1992, J IMMUNOL, V149, P998
   Lopez S, 1998, CELL ADHES COMMUN, V5, P151, DOI 10.3109/15419069809040288
   MCINTIRE LV, 1994, ANN BIOMED ENG, V22, P2, DOI 10.1007/BF02368217
   NATHAN C, 1993, J CELL BIOL, V122, P243, DOI 10.1083/jcb.122.1.243
   PILLER V, 1989, J BIOL CHEM, V264, P18824
   Rainger GE, 1999, AM J PHYSIOL-HEART C, V276, pH858, DOI 10.1152/ajpheart.1999.276.3.H858
   ROSENKRANZ AR, 1993, IMMUNOLOGY, V80, P431
   Rosenson-Schloss RS, 1999, MED BIOL ENG COMPUT, V37, P257, DOI 10.1007/BF02513296
   Seveau S, 1997, J CELL SCI, V110, P1465
   Sundaram S, 1996, BIOMATERIALS, V17, P1041, DOI 10.1016/0142-9612(96)84681-3
   Swartbol P, 1996, J BIOMED MATER RES, V32, P669, DOI 10.1002/(SICI)1097-4636(199612)32:4<669::AID-JBM21>3.0.CO;2-7
   Tomczok J, 1996, BIOMATERIALS, V17, P1359, DOI 10.1016/0142-9612(96)87275-9
   TRANQUILLO RT, 1988, CELL MOTIL CYTOSKEL, V11, P1, DOI 10.1002/cm.970110102
   YOUNG EJ, 1988, SURG CLIN N AM, V68, P167
   Zigmond S H, 1980, Ciba Found Symp, V71, P299, DOI 10.1002/9780470720547.ch16
NR 38
TC 1
Z9 1
U1 1
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD APR
PY 2002
VL 60
IS 1
BP 8
EP 19
DI 10.1002/jbm.1278
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 518VC
UT WOS:000173687700002
PM 11835154
DA 2018-10-20
ER

PT J
AU Sanders, JE
   Baker, AB
   Golledge, SL
AF Sanders, JE
   Baker, AB
   Golledge, SL
TI Control of in vivo microvessel ingrowth by modulation of biomaterial
   local architecture and chemistry
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE laser machining; surface grafting; secreted protein acidic and rich in
   cysteine (SPARC); thrombospondin; angiogenesis
ID FIBROBLAST GROWTH-FACTOR; POLYTETRAFLUOROETHYLENE ARTERIAL GRAFTS;
   ENHANCES VASCULARIZATION; ANGIOGENESIS; POROSITY; SURFACE; TISSUE;
   NEOVASCULARIZATION; THROMBOSPONDIN-2; POLYPROPYLENE
AB We developed a method for controlling local architecture and chemistry simultaneously in biomaterial implants to control microvessel ingrowth in vivo. Porous polypropylene disks (5 mm in diameter and 40 mum thick) were plasma-coated with a fluoropolymer and then laser-drilled with 50-mum-diameter holes through their thickness. We then oxidized the disks to create hydroxyl functionality on the exposed polypropylene (inside the holes). Acrylamide was grafted to the hydroxyl groups through polymerization in the presence of activating ceric ions. Staining with toluidine blue O demonstrated that grafting occurred only inside the holes. We used the Hoffman degradation reaction to convert the amide groups of acrylamide to amine groups, and then we used ethylene glycol diglycidyl ether to attach biomolecules of interest inside the holes: secreted protein acidic and rich in cysteine (SPARC) peptide Lys-Gly-His-Lys (KGHK; angiogenic), thrombospondin-2 (TSP; antiangiogenic), or albumin (rat; neutral). In vivo testing in a rat subcutaneous dorsum model for a 3-week interval demonstrated a greater vessel surface area (p = 0.032) and a greater number of vessels (p = 0.043) in tissue local to the holes with KGHK-immobilized disks than with TSP-immobilized disks. However, differences between KGHK-immobilized and albumin-immobilized disks were less significant (p = 0.120 and p = 0.289 for the vessel surface area and number of vessels, respectively). The developed methods have potential applications in biomaterial design applications for which selective neovascularization is desired. (C) 2002 John Wiley & Sons, Inc. J Biomed Mater Res 00: 36-43, 2002.
C1 Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.
RP Sanders, JE (reprint author), Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.
FU NCRR NIH HHS [RR-01296]
CR Atici OG, 1999, J APPL POLYM SCI, V71, P1385, DOI 10.1002/(SICI)1097-4628(19990228)71:9<1385::AID-APP4>3.0.CO;2-F
   BAMFORD CH, 1994, POLYMER, V35, P2844, DOI 10.1016/0032-3861(94)90316-6
   BOLENDER RP, 1993, AM J PHYSIOL, V265, pL521
   BRAUKER JH, 1995, J BIOMED MATER RES, V29, P1517, DOI 10.1002/jbm.820291208
   Doi K, 1997, J BIOMED MATER RES, V34, P361, DOI 10.1002/(SICI)1097-4636(19970305)34:3<361::AID-JBM11>3.0.CO;2-J
   Doi K, 1996, ASAIO J, V42, pM394, DOI 10.1097/00002480-199609000-00018
   Favia P., 1996, PLASMAS POLYM, V1, P299
   Fournier N, 1996, BIOMATERIALS, V17, P1659, DOI 10.1016/0142-9612(96)87645-9
   GOLDEN MA, 1990, J VASC SURG, V11, P838, DOI 10.1067/mva.1990.18047
   Hazama K, 1999, J SURG RES, V81, P174, DOI 10.1006/jsre.1998.5497
   HIRABAYASHI K, 1992, J BIOMED MATER RES, V26, P1433, DOI 10.1002/jbm.820261104
   Hunter SK, 1999, ASAIO J, V45, P37, DOI 10.1097/00002480-199901000-00009
   JONES MEB, 1973, BRIT J SURG, V60, P305
   Klein S, 1997, EXS, V79, P159
   Kyriakides TR, 1999, P NATL ACAD SCI USA, V96, P4449, DOI 10.1073/pnas.96.8.4449
   LANE TF, 1994, J CELL BIOL, V125, P929, DOI 10.1083/jcb.125.4.929
   LEE KW, 1988, MACROMOLECULES, V21, P309, DOI 10.1021/ma00180a005
   Maheshwari G, 2000, J CELL SCI, V113, P1677
   Masuda S, 1997, ASAIO J, V43, pM530
   Nagae T, 1995, Cardiovasc Surg, V3, P479, DOI 10.1016/0967-2109(95)94445-3
   Nishibe T, 1997, SURG TODAY, V27, P149, DOI 10.1007/BF02385905
   Ohkashiwa H, 1997, SURG TODAY, V27, P846, DOI 10.1007/BF02385276
   Rubin PAD, 1997, OPHTHALMIC PLAST REC, V13, P8, DOI 10.1097/00002341-199703000-00002
   Sanders JE, 2000, J BIOMED MATER RES, V52, P231, DOI 10.1002/1097-4636(200010)52:1<231::AID-JBM29>3.0.CO;2-E
   SANO S, 1993, BIOMATERIALS, V14, P817, DOI 10.1016/0142-9612(93)90003-K
   SCHLAUDRAFF K, 1993, EUR J CARDIO-THORAC, V7, P637, DOI 10.1016/1010-7940(93)90258-D
   SINGH RP, 1992, PROG POLYM SCI, V17, P251, DOI 10.1016/0079-6700(92)90024-S
   STERPETTI AV, 1992, SURGERY, V111, P677
   Streit M, 1999, P NATL ACAD SCI USA, V96, P14888, DOI 10.1073/pnas.96.26.14888
   Tomizawa Y, 1996, ASAIO J, V42, pM698, DOI 10.1097/00002480-199609000-00077
   Veikkola T, 1999, SEMIN CANCER BIOL, V9, P211, DOI 10.1006/scbi.1998.0091
NR 31
TC 9
Z9 9
U1 0
U2 6
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD APR
PY 2002
VL 60
IS 1
BP 36
EP 43
DI 10.1002/jbm.1279
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 518VC
UT WOS:000173687700005
PM 11835157
DA 2018-10-20
ER

PT J
AU Kanno, M
   Kawakami, H
   Nagaoka, S
   Kubota, S
AF Kanno, M
   Kawakami, H
   Nagaoka, S
   Kubota, S
TI Biocompatibility of fluorinated polyimide
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE fluorinated polyimide; protein adsorption; neutrophil adhesion;
   complement activation; curing
ID SULFONE DIAMINE MOIETIES; GAS-TRANSPORT PROPERTIES; COMPLEMENT
   ACTIVATION; AROMATIC POLYIMIDES; MEMBRANE-OXYGENATOR; CELL-ADHESION;
   HOLLOW-FIBER; PLATELET; BLOOD; HEMODIALYSIS
AB Contact between blood and biomaterial triggers a complex series of events including protein adsorption, leukocyte adhesion and activation, and complement activation. In this article, a series of fluorinated polyimides cured at a different temperatures was prepared, and the biocompatibility of the membranes was evaluated using in vitro protein adsorption, neutrophil adhesion, and complement activation experiments under static conditions. We found that protein adsorption, neutrophil adhesion, and complement activation for the polyimides significantly depends on the curing temperature and decreases with an increase in the temperature and that the polyimide has a good biocompatibility compared with poly(styrene) and polydimethylsiloxane. We concluded that the rearrangement of molecules such as CF3, sulfone, and ketone at the outermost surface occurs because of curing, which induces an increase in the hydrophobicity and that the cured polyimide suppresses protein adsorption, neutrophil adhesion, and complement activation because of its high hydrophobicity and low surface free energy. (C) 2002 John Wiley & Sons, Inc. J Biomed Mater Res 60: 53-60, 2002.
C1 Tokyo Metropolitan Univ, Dept Ind Chem, Hachioji, Tokyo 1920397, Japan.
   St Marianna Univ, Sch Med, Dept Surg 1, Kawasaki, Kanagawa 2168511, Japan.
RP Kawakami, H (reprint author), Tokyo Metropolitan Univ, Dept Ind Chem, Hachioji, Tokyo 1920397, Japan.
CR Bahulekar R, 1999, BIOMATERIALS, V20, P357, DOI 10.1016/S0142-9612(98)00176-8
   CRISTOL JP, 1994, NEPHROL DIAL TRANSPL, V9, P389
   FINN A, 1993, AGENTS ACTIONS, V38, P44
   Frautschi JR, 1996, J BIOMAT SCI-POLYM E, V7, P707, DOI 10.1163/156856296X00471
   GEMMELL CH, 1995, J LAB CLIN MED, V125, P276
   Goodman S L, 1991, J Biomater Sci Polym Ed, V2, P147, DOI 10.1163/156856291X00133
   GOODMAN SL, 1989, J BIOMED MATER RES, V23, P105, DOI 10.1002/jbm.820230109
   HAKIM RM, 1993, CARDIOVASC PATHOL, V2, pS187
   HAMMER DA, 1993, BLOOD CELLS, V19, P261
   INAGAKI N, 1994, J ADHES SCI TECHNOL, V8, P395, DOI 10.1163/156856194X00302
   INNES A, 1994, J CLIN PATHOL, V47, P155, DOI 10.1136/jcp.47.2.155
   Jahns Gerlinde, 1993, Clinical Materials, V14, P303, DOI 10.1016/0267-6605(93)90017-2
   JOHNSON RJ, 1994, NEPHROL DIAL TRANSPL, V9, P36
   Kawakami H, 1996, J MEMBRANE SCI, V118, P223, DOI 10.1016/0376-7388(96)00115-9
   Kawakami H, 1996, J APPL POLYM SCI, V62, P965, DOI 10.1002/(SICI)1097-4628(19961114)62:7<965::AID-APP2>3.0.CO;2-Q
   KAWAKAMI H, 1995, J APPL POLYM SCI, V57, P789, DOI 10.1002/app.1995.070570703
   Kawakami H, 1997, ASAIO J, V43, pM490
   KAWAKAMI H, 1995, ASAIO J, V41, pM379, DOI 10.1097/00002480-199507000-00035
   Kawakami H, 1996, ASAIO J, V42, pM871, DOI 10.1097/00002480-199609000-00116
   Kawakami H., 1995, Japanese Journal of Artificial Organs, V24, P65
   KAWAKAMI H, 2001, J ADV TECH, V12, P244
   KIAEI D, 1995, J BIOMED MATER RES, V29, P729, DOI 10.1002/jbm.820290609
   KIMURA H, 1988, FEBS LETT, V239, P347, DOI 10.1016/0014-5793(88)80949-9
   Krajewski A, 1996, BIOMATERIALS, V17, P53, DOI 10.1016/0142-9612(96)80755-1
   LAWRENCE MB, 1987, BLOOD, V70, P1284
   LOFTUS JC, 1984, J CELL BIOL, V99, P822, DOI 10.1083/jcb.99.3.822
   NAGAOKA S, 1981, JPN J ARTIF ORGANS, V10, P1058
   NAKANO M, 1990, ANAL BIOCHEM, V187, P277, DOI 10.1016/0003-2697(90)90457-K
   Sueda T, 1997, ARTIF ORGANS, V21, P75
   WILLEMS GM, 1993, BLOOD, V82, P497
   WOFFINDIN C, 1992, NEPHROL DIAL TRANSPL, V7, P340, DOI 10.1093/oxfordjournals.ndt.a092139
   Yamane S, 1998, ASAIO J, V44, pM384, DOI 10.1097/00002480-199809000-00011
NR 32
TC 48
Z9 55
U1 1
U2 11
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD APR
PY 2002
VL 60
IS 1
BP 53
EP 60
DI 10.1002/jbm.1280
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 518VC
UT WOS:000173687700007
PM 11835159
DA 2018-10-20
ER

PT J
AU Poelstra, KA
   Barekzi, NA
   Rediske, AM
   Felts, AG
   Slunt, JB
   Grainger, DW
AF Poelstra, KA
   Barekzi, NA
   Rediske, AM
   Felts, AG
   Slunt, JB
   Grainger, DW
TI Prophylactic treatment of gram-positive and gram-negative abdominal
   implant infections using locally delivered polyclonal antibodies
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE antibody; infection; biomaterials; implant; abdominal surgery; local
   delivery; gram-positive
ID PSEUDOMONAS-AERUGINOSA; BACTERIAL ADHESION; IMMUNE GLOBULIN;
   STAPHYLOCOCCUS-EPIDERMIDIS; ANTIBIOTIC-RESISTANCE; IMMUNOGLOBULIN-G;
   MODEL; PREVENTION; THERAPY; HYDROPHOBICITY
AB The increasing clinical incidence and host risk of biomaterial-centered infections, as well as the reduced effectiveness of clinically relevant antibiotics to treat such infections, provide compelling reasons to develop new approaches for treating implanted biomaterials in a surgical context. We describe the direct local delivery of polyclonal human antibodies to abdominal surgical implant sites to reduce infection severity and mortality in a lethal murine model of surgical implant-centered peritoneal infection. Surgical implant-centered peritonitis was produced in 180 female CF-1 mice by the direct inoculation of surgical-grade polypropylene mesh disks placed in the peritoneal cavity with lethal doses of either methicillin-resistant Staphylococcus aureus (MRSA) or Pseudomonas aeruginosa. Mice randomly received a resorbable antibody delivery vehicle at the implant site: either a blank carboxymethylcellulose (CMC) aqueous get or the same CMC gel containing 10 mg of pooled polyclonal human immunoglobulin G locally on the implant after infection, either alone or in combination with systemic doses of cefazolin or vancomycin antibiotics. Human antibodies were rapidly released (first-order kinetics) from the gel carrier to both peritoneal fluids and serum in both infection senarios. Inocula required for lethal infection were substantially reduced by surgery and the presence of the implant versus a closed lethal peritonitis model. Survival to 10 days with two different gram-negative P. aeruginosa strains was significantly enhanced (p < 0.01) by the direct application of CMC gel containing antibodies alone to the surgical implant site. Human-equivalent doses of systemic vancomycin provided a significantly improved benefit (p < 0.01) against lethal, implant-centered, gram-positive MRSA infection. However, locally delivered polyclonal human antibodies in combination with a range of systemic vancomycin doses against MRSA failed to improve host survival. Successful antibody therapy against gram-negative, implant-centered infections complements the clinically routine use of systemic antibiotics, providing a mechanism of protection independent of antibiotic resistance. (C) 2002 John Wiley Sons, Inc.
C1 Anthony G Gristina Inst Biomed Res, Herndon, VA 20170 USA.
   Gamma A Technol Incorp, Herndon, VA 20170 USA.
RP Grainger, DW (reprint author), Colorado State Univ, Dept Chem, Ft Collins, CO 80523 USA.
FU NIAMS NIH HHS [R01 AR26957-11A1]
CR ABSOLOM DR, 1988, CAN J MICROBIOL, V34, P287, DOI 10.1139/m88-054
   ABSOLOM DR, 1982, J RETICULOENDOTH SOC, V31, P59
   Anderson RM, 1999, NAT MED, V5, P147, DOI 10.1038/5507
   Anglen J, 1996, J ORTHOPAED RES, V14, P251, DOI 10.1002/jor.1100140213
   BAREKZI N, 2001, UNPUB LOCALLY DELIVE
   Barekzi NA, 1999, ANTIMICROB AGENTS CH, V43, P1609, DOI 10.1128/AAC.43.7.1609
   BARTLETT JG, 1998, POCKET BOOK INFECT D, P125
   Bax RP, 1998, NAT MED, V4, P545, DOI 10.1038/nm0598-545
   CALANDRA T, 1991, AM J MED, V91, P23, DOI 10.1016/0002-9343(91)90069-A
   CASADEVALL A, 1995, CLIN INFECT DIS, V21, P150, DOI 10.1093/clinids/21.1.150
   Casadevall A, 1996, EMERG INFECT DIS, V2, P200, DOI 10.3201/eid0203.960306
   CASADEVALL A, 1994, ANTIMICROB AGENTS CH, V38, P1695, DOI 10.1128/AAC.38.8.1695
   CLAPP DW, 1989, J PEDIATR-US, V115, P973, DOI 10.1016/S0022-3476(89)80753-X
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   DALHOFF A, 1984, AM J MED, V76, P91, DOI 10.1016/0002-9343(84)90326-7
   DANKERT J, 1986, CRIT REV BIOCOMPAT, V2, P219
   DIAMOND MP, 1988, INT J FERTIL, V33, P372
   Donta ST, 1996, J INFECT DIS, V174, P537, DOI 10.1093/infdis/174.3.537
   DOUGHERTY SH, 1988, REV INFECT DIS, V10, P1102
   EMMERSON MA, 1998, NEW HORIZONS S, V3, P6
   Falagas ME, 1996, EUR J CLIN MICROBIOL, V15, P913, DOI 10.1007/BF01690508
   Felts AG, 1999, BURNS, V25, P415, DOI 10.1016/S0305-4179(99)00017-0
   FISCHER GW, 1994, J INFECT DIS, V169, P324, DOI 10.1093/infdis/169.2.324
   GAGNON RF, 1993, INT J ARTIF ORGANS, V16, P789
   Gemmell CG, 1996, DRUG EXP CLIN RES, V22, P51
   Gould IM, 1998, NAT MED, V4, P985, DOI 10.1038/1955
   GRIFFITHS HJ, 1995, RADIOL CLIN N AM, V33, P401
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Gristina Anthony G., 1994, Clinical Microbiology Newsletter, V16, P171, DOI 10.1016/0196-4399(94)90037-X
   HAMMARSTROM L, 1990, INFECTION, V18, P70
   Holmdahl Lena E., 1994, Wound Repair and Regeneration, V2, P171, DOI 10.1046/j.1524-475X.1994.20306.x
   Holmes C J, 1994, Kidney Int Suppl, V48, pS58
   HOLMES CJ, 1994, KIDNEY INT, V46, pS59
   John SF, 1996, FEMS MICROBIOL LETT, V144, P241, DOI 10.1016/0378-1097(96)00352-7
   LAMPERI S, 1986, PERITON DIALYSIS INT, V6, P87
   LAMPERI S, 1986, PERITON DIALYSIS B, V6, P110
   Leber GE, 1998, ARCH SURG-CHICAGO, V133, P378, DOI 10.1001/archsurg.133.4.378
   LOWRY FD, 1998, NEW ENGL J MED, V339, P520
   MAGNY JF, 1991, PEDIATRICS, V88, P437
   Moussa FW, 1996, CLIN ORTHOP RELAT R, P255, DOI 10.1097/00003086-199608000-00032
   PECK LS, 1995, J INVEST SURG, V8, P337, DOI 10.3109/08941939509015380
   Poelstra KA, 2000, TISSUE ENG, V6, P401, DOI 10.1089/107632700418100
   Poelstra KA, 2000, J BIOMED MATER RES, V51, P224, DOI 10.1002/(SICI)1097-4636(200008)51:2<224::AID-JBM11>3.0.CO;2-G
   Reijnen MMPJ, 1999, ARCH SURG-CHICAGO, V134, P997, DOI 10.1001/archsurg.134.9.997
   Rojas IA, 2000, J CONTROL RELEASE, V63, P175, DOI 10.1016/S0168-3659(99)00195-9
   Sheridan R L, 1994, Adv Surg, V27, P43
   SIBER GR, 1992, NEW ENGL J MED, V327, P269, DOI 10.1056/NEJM199207233270409
   SIBER GR, 1992, CURRENT CLIN TOPICS, P208
   Smith ME, 1999, LAT AM ANTIQ, V10, P330, DOI 10.2307/972049
   Twardowski ZJ, 1996, AM J KIDNEY DIS, V27, P99, DOI 10.1016/S0272-6386(96)90036-0
   WARD KH, 1992, J MED MICROBIOL, V36, P406, DOI 10.1099/00222615-36-6-406
   ZIMMERLI W, 1982, J INFECT DIS, V146, P487, DOI 10.1093/infdis/146.4.487
   1985, RENAL INSUFFICIENCY, P518
NR 53
TC 98
Z9 101
U1 0
U2 13
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD APR
PY 2002
VL 60
IS 1
BP 206
EP 215
DI 10.1002/jbm.10069
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 518VC
UT WOS:000173687700025
PM 11835177
DA 2018-10-20
ER

PT J
AU Wen, CE
   Yamada, Y
   Shimojima, K
   Chino, Y
   Asahina, T
   Mabuchi, M
AF Wen, CE
   Yamada, Y
   Shimojima, K
   Chino, Y
   Asahina, T
   Mabuchi, M
TI Processing and mechanical properties of autogenous titanium implant
   materials
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID ALLOYS
AB Pure titanium and some of its alloys are currently considered as the most attractive metallic materials for biomedical applications due to their excellent mechanical properties, corrosion resistance, and biocompatibility. It has been demonstrated that titanium and titanium alloys are well accepted by human tissues as compared to other metals such as SUS316L stainless steel and Co-Cr-Mo type alloy. In the present study, highly porous titanium foams with porosities less than or equal to80% are produced by using a novel powder metallurgical process, which includes the adding of the selected spacers into the starting powders. The optimal process parameters are investigated. The porous titanium foams are characterized by using optical microscopy and scanning electron microscopy. The distribution of the pore size is measured by quantitative image analyses. The mechanical properties are investigated by compressive tests. This open-cellular titanium foams, with the pore size of 200-500 mum are expected to be a very promising biomaterial candidates for bone implants because its porous structure permits the ingrowths of new-bone tissues and the transport of body fluids. (C) 2002 Kluwer Academic Publisher.
C1 Natl Inst Adv Ind Sci & Techol, Inst Struct & Engn Mat, Kita Ku, Nagoya, Aichi 4628510, Japan.
RP Wen, CE (reprint author), Natl Inst Adv Ind Sci & Techol, Inst Struct & Engn Mat, Kita Ku, Hirate Cho, Nagoya, Aichi 4628510, Japan.
RI Chino, Yasumasa/L-9782-2018
OI Chino, Yasumasa/0000-0002-0725-8237; Wen, Cuie/0000-0001-8008-3536
CR *ASTM, 1994, F6789 ASTM
   *ASTM, 1994, F13682 ASTM
   Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Chang YS, 1996, BIOMATERIALS, V17, P1141, DOI 10.1016/0142-9612(96)85917-5
   CLEMOW AJT, 1981, J BIOMED MATER RES, V15, P73, DOI 10.1002/jbm.820150111
   Cornell CN, 1999, ORTHOP CLIN N AM, V30, P591, DOI 10.1016/S0030-5898(05)70112-7
   Freyman TM, 2001, PROG MATER SCI, V46, P273, DOI 10.1016/S0079-6425(00)00018-9
   Gibson L. J., 1997, CELLULAR SOLIDS STRU, P1
   Hench LL, 1998, BIOMATERIALS, V19, P1419, DOI 10.1016/S0142-9612(98)00133-1
   Hiromoto S, 2000, CORROS SCI, V42, P1651, DOI 10.1016/S0010-938X(00)00022-6
   LEMONS JE, 1987, ASTM STP, V953, P185
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Nie X, 2000, SURF COAT TECH, V125, P407, DOI 10.1016/S0257-8972(99)00612-X
   Niinomi M, 1998, MAT SCI ENG A-STRUCT, V243, P231, DOI 10.1016/S0921-5093(97)00806-X
   Okazaki Y, 1998, MAT SCI ENG A-STRUCT, V243, P250, DOI 10.1016/S0921-5093(97)00809-5
   Okazaki Y, 2001, BIOMATERIALS, V22, P599, DOI 10.1016/S0142-9612(00)00221-0
   Pineda LM, 1996, J BIOMED MATER RES, V31, P385
   Song Y, 1999, MAT SCI ENG A-STRUCT, V260, P269, DOI 10.1016/S0921-5093(98)00886-7
   TAKADAMA H, 2001, KEY ENG MATER, V192, P51
   Wen C, 2000, MATER T JIM, V41, P1192, DOI 10.2320/matertrans1989.41.1192
   Yamada Y, 2000, PHIL MAG LETT, V80, P215, DOI 10.1080/095008300176182
   Zardiackas LD, 2001, J BIOMED MATER RES, V58, P180, DOI 10.1002/1097-4636(2001)58:2<180::AID-JBM1005>3.0.CO;2-5
NR 22
TC 166
Z9 172
U1 1
U2 30
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD APR
PY 2002
VL 13
IS 4
BP 397
EP 401
DI 10.1023/A:1014344819558
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 542PX
UT WOS:000175054400008
PM 15348615
DA 2018-10-20
ER

PT J
AU Korovessis, PG
   Deligianni, DD
   Lenke, LG
AF Korovessis, PG
   Deligianni, DD
   Lenke, LG
TI Role of surface roughness of titanium versus hydroxyapatite on human
   bone marrow cells response
SO JOURNAL OF SPINAL DISORDERS & TECHNIQUES
LA English
DT Article
DE bone marrow cell culture; osteoblasts; titanium; hydroxyapatite; surface
   roughness
ID OSTEOBLAST-LIKE CELLS; IN-VITRO; PROLIFERATION; BIOMATERIALS;
   FIBROBLASTS; INVITRO; DIFFERENTIATION; ATTACHMENT; CULTURE; MATRIX
AB This study was designed to assess human bone marrow cell response and particularly cell adhesion. proliferation, and differentiation, when cultured in vitro on titanium alloy and hydroxyapatite With different values of surface roughness. A further aim was to compare the cell response on the two materials, currently used in spinal surgery. Cell adhesion was determined after 0.5, 2, 4, and 18 hours of incubation; proliferation after 8, 11, 14, and 16 days of culture; and differentiation was evaluated with the expression of alkaline phosphatase activity after 8 and 16 days of culture. This study showed that bone marrow cells grew faster on titanium alloy than on hydroxyapatite, although fewer cells attached to titanium, compared to those attached to hydroxyapatite. No statistically significant difference was observed as the expression of alkaline phosphatase activity on hydroxyapatite and titanium alloy of the same roughness. Cell adhesion, proliferation, and differentiation are dependent on surface roughness of the biomaterial, and all three increased as the roughness of titanium alloy increased. Conclusively, surface roughness of titanium and hydroxyapatite significantly influences bone marrow cell response, and therefore these biomaterials should be used with rough outer surface, if a significant cell response on them is desired. These advantages of titanium and hydroxyapatite theoretically seem to be of particular importance in the following situations: long fusions, lumbosacral fusion, revision surgery with poor bone bank, neuropathic scoliosis associated with few bone graft reserves, and adult patients with severe osteoporosis.
C1 Gen Hosp Agios Andreas, Dept Orthopaed, Spine Unit, Patras, Greece.
   Univ Patras, Dept Mech & Aeronaut Engn, Biomed Engn Lab, GR-26110 Patras, Greece.
   Washington Univ, Sch Med, Dept Orthopaed Surg, St Louis, MO USA.
RP Korovessis, PG (reprint author), Gen Hosp Agios Andreas, Dept Orthopaed, Spine Unit, 65-67 Haralabi Str, Patras, Greece.
CR Bordji K, 1996, BIOMATERIALS, V17, P929, DOI 10.1016/0142-9612(96)83289-3
   Bowers K T, 1992, Int J Oral Maxillofac Implants, V7, P302
   Brunette D M, 1988, Int J Oral Maxillofac Implants, V3, P231
   BUSHER D, 1991, J BIOMED MATER RES, V25, P889
   CHEHROUDI B, 1990, J BIOMED MATER RES, V24, P1203, DOI 10.1002/jbm.820240906
   CHEHROUDI B, 1989, J BIOMED MATER RES, V23, P1289
   DAVIES JE, 1990, J BIOMED MATER RES, V24, P1067
   DONLEY TG, 1991, J PERIODONTOL, V62, P153, DOI 10.1902/jop.1991.62.2.153
   GROESSNERSCHREIBER B, 1992, J CELL SCI, V101, P209
   Hott M, 1997, J BIOMED MATER RES, V37, P508, DOI 10.1002/(SICI)1097-4636(19971215)37:4<508::AID-JBM9>3.0.CO;2-P
   HUNTER A, 1995, BIOMATERIALS, V16, P287, DOI 10.1016/0142-9612(95)93256-D
   INOUE T, 1987, J BIOMED MATER RES, V21, P107, DOI 10.1002/jbm.820210114
   KAPLOW LS, 1968, ANN NY ACAD SCI, V155, P911, DOI 10.1111/j.1749-6632.1968.tb55077.x
   Keller JC, 1997, DENT MATER, V13, P62, DOI 10.1016/S0109-5641(97)80010-3
   Klokkevold PR, 1997, CLIN ORAL IMPLAN RES, V8, P442, DOI 10.1034/j.1600-0501.1997.080601.x
   MARTIN JY, 1995, J BIOMED MATER RES, V29, P389, DOI 10.1002/jbm.820290314
   MCAUSLAN BR, 1998, J BIOMED MATER RES, V22, P905
   Michaels C. M., 1989, J DENT RES, V68, P278
   NANCOLLAS GH, 1970, ARCH ORAL BIOL, V15, P731, DOI 10.1016/0003-9969(70)90037-3
   OKUMURA M, 1997, J BIOMED MATER RES, V39, P176
   Ong J L, 1996, Implant Dent, V5, P83, DOI 10.1097/00008505-199600520-00002
   Ong J.L., 1998, J BIOMED MATER RES, V29, P389
   ONG JL, 1995, J BIOMED MATER RES, V29, P165, DOI 10.1002/jbm.820290205
   Ozawa S, 1996, BIOMATERIALS, V17, P23, DOI 10.1016/0142-9612(96)80751-4
   PULEO DA, 1991, J BIOMED MATER RES, V25, P711, DOI 10.1002/jbm.820250603
   VILAMITJANAAMEDEE J, 1993, IN VITRO CELL DEV-AN, V29, P699
   Wilke A, 1998, J BIOMED MATER RES, V40, P301, DOI 10.1002/(SICI)1097-4636(199805)40:2<301::AID-JBM15>3.0.CO;2-O
   Williams D.F, 1981, BIOCOMPATIBILITY CLI, V1, P9
   Yliheikkila P K, 1995, Int J Oral Maxillofac Implants, V10, P655
   Yliheikkila P K, 1996, Int J Oral Maxillofac Implants, V11, P456
   ZAMBONIN G, 1995, BIOMATERIALS, V16, P397, DOI 10.1016/0142-9612(95)98857-A
NR 31
TC 26
Z9 26
U1 0
U2 8
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1536-0652
J9 J SPINAL DISORD TECH
JI J. Spinal Disord. Tech.
PD APR
PY 2002
VL 15
IS 2
BP 175
EP 183
DI 10.1097/00024720-200204000-00015
PG 9
WC Clinical Neurology; Orthopedics
SC Neurosciences & Neurology; Orthopedics
GA 539AT
UT WOS:000174847800014
PM 11927830
DA 2018-10-20
ER

PT J
AU Badylak, S
   Kokini, K
   Tullius, B
   Simmons-Byrd, A
   Morff, R
AF Badylak, S
   Kokini, K
   Tullius, B
   Simmons-Byrd, A
   Morff, R
TI Morphologic study of small intestinal submucosa as a body wall repair
   device
SO JOURNAL OF SURGICAL RESEARCH
LA English
DT Article
DE small intestinal submucosa (SIS); extracellular matrix (ECM);
   biomaterial; scaffold; remodeling; tissue engineering
ID ANIMAL-MODEL; DOGS; BIOMATERIAL; REPLACEMENT; DEFECTS; GRAFTS
AB Background. The extracellular matrix (ECM) derived from porcine small intestinal submucosa (SIS) has been used as a constructive scaffold for tissue repair in both preclinical animal studies and human clinical trials. Quantitative characterization of the host tissue response to this xenogeneic scaffold material has been lacking.
   Materials and methods. The morphologic response to a multilaminate form of the SIS-ECM was evaluated in a chronic, 2-year study of body wall repair in two separate species: the dog and the rat. Morphologic response to the SIS-ECM was compared to that for three other commonly used bioscaffold materials including Marlex mesh, Dexon, and Perigard. Quantitative measurements were made of tissue consistency, polymorphonuclear cell response, mononuclear cell response, tissue organization, and vascularity at five time points after surgical implantation: 1 week, 1, 3, and 6 dmonths, and 2 years.
   Results. All bioscaffold materials functioned well as a repair device for large ventral abdominal wall defects created in these two animal models. The SIS-ECM bioscaffold showed a greater number of polymorphonuclear leukocytes at the 1-week time point and a greater degree of graft site tissue organization after 3 months compared to the other three scaffold materials. There was no evidence for local infection or other detrimental local pathology to any of the graft materials at any time point.
   Conclusions. Like Marlex, Dexon, and Perigard, the SIS-ECM is an effective bioscaffold for long-term repair of body wall defects. Unlike the other scaffold materials, the resorbable SIS-ECM scaffold was replaced by well-organized host tissues including differentiated skeletal muscle. (C) 2002 Elsevier Science (USA).
C1 Purdue Univ, Dept Biomed Engn, W Lafayette, IN 47907 USA.
   Purdue Univ, Dept Mech Engn, W Lafayette, IN 47907 USA.
   Sentron Med Ventures, Cincinnati, OH 45242 USA.
RP Badylak, S (reprint author), Purdue Univ, Dept Biomed Engn, W Lafayette, IN 47907 USA.
OI Badylak, Stephen/0000-0003-3555-0689
CR Abraham GA, 2000, J BIOMED MATER RES, V51, P442, DOI 10.1002/1097-4636(20000905)51:3<442::AID-JBM19>3.3.CO;2-W
   AIKEN SW, 1994, VET COMP ORTHOPAED, V7, P124
   Badylak S, 2001, J SURG RES, V99, P282, DOI 10.1006/jsre.2001.6176
   Badylak S, 1999, CLIN ORTHOP RELAT R, pS333, DOI 10.1097/00003086-199910001-00032
   Badylak SF, 2001, EXP HEMATOL, V29, P1310, DOI 10.1016/S0301-472X(01)00729-9
   BADYLAK SF, 1989, J SURG RES, V47, P74, DOI 10.1016/0022-4804(89)90050-4
   Clarke KM, 1996, J SURG RES, V60, P107, DOI 10.1006/jsre.1996.0018
   Cobb MA, 1996, SURG NEUROL, V46, P389, DOI 10.1016/S0090-3019(96)00202-9
   Cobb MA, 1999, SURG NEUROL, V51, P99, DOI 10.1016/S0090-3019(97)00475-8
   DEBORD J, 1994, PROTHESES ABDOMINAL, P1
   Dejardin LM, 2001, AM J SPORT MED, V29, P175, DOI 10.1177/03635465010290021001
   Dejardin LM, 1999, J BIOMED MATER RES, V46, P203, DOI 10.1002/(SICI)1097-4636(199908)46:2<203::AID-JBM9>3.0.CO;2-4
   DELANY HM, 1982, ANN SURG, V196, P187, DOI 10.1097/00000658-198208000-00011
   Gloeckner DC, 2000, J BIOMED MATER RES, V52, P365, DOI 10.1002/1097-4636(200011)52:2<365::AID-JBM17>3.0.CO;2-3
   GREISLER HP, 1994, PROTHESES ABDOMINAL, P180
   JAMES NL, 1991, BIOMATERIALS, V12, P801, DOI 10.1016/0142-9612(91)90065-I
   Kropp BP, 1999, ADV EXP MED BIOL, V462, P129
   LAMB JP, 1983, SURGERY, V93, P643
   Lantz G C, 1993, J Invest Surg, V6, P297, DOI 10.3109/08941939309141619
   Portis AJ, 2000, J UROLOGY, V164, P1405, DOI 10.1016/S0022-5347(05)67207-2
   PREVEL CD, 1995, ANN PLAS SURG, V35, P374, DOI 10.1097/00000637-199510000-00008
   PREVEL CD, 1995, ANN PLAS SURG, V35, P381, DOI 10.1097/00000637-199510000-00009
   READ RC, 1994, PROTHESES ABDOMINAL, P1
   SANDUSKY GE, 1995, J SURG RES, V58, P415, DOI 10.1006/jsre.1995.1064
   Shalhav AL, 1999, J ENDOUROL, V13, P241, DOI 10.1089/end.1999.13.241
   USHER F, 1962, ARCH SURG-CHICAGO, V84, P73
   WALKER PM, 1976, CAN J SURG, V19, P211
NR 27
TC 214
Z9 222
U1 2
U2 15
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0022-4804
EI 1095-8673
J9 J SURG RES
JI J. Surg. Res.
PD APR
PY 2002
VL 103
IS 2
BP 190
EP 202
DI 10.1006/jsre.2001.6349
PG 13
WC Surgery
SC Surgery
GA 539BD
UT WOS:000174848900010
PM 11922734
DA 2018-10-20
ER

PT J
AU Wefer, J
   Schlote, N
   Sekido, N
   Sievert, KD
   Bakircioglu, ME
   Nunes, L
   Dahiya, R
   Jonas, U
   Tanagho, EA
AF Wefer, J
   Schlote, N
   Sekido, N
   Sievert, KD
   Bakircioglu, ME
   Nunes, L
   Dahiya, R
   Jonas, U
   Tanagho, EA
TI Acellular tissue matrix as a new biomaterial for vaginal reconstruction:
   A pilotstudy in rats
SO JOURNAL OF UROLOGY
LA English
DT Meeting Abstract
CT 97th Annual Meeting of the American-Urological-Association
CY MAY 25-30, 2002
CL ORLANDO, FLORIDA
SP Amer Urol Assoc
NR 0
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0022-5347
J9 J UROLOGY
JI J. Urol.
PD APR
PY 2002
VL 167
IS 4
SU S
BP 76
EP 76
PG 1
WC Urology & Nephrology
SC Urology & Nephrology
GA 708KU
UT WOS:000184566700303
DA 2018-10-20
ER

PT J
AU Pariente, JL
   Kim, BS
   Atala, A
AF Pariente, JL
   Kim, BS
   Atala, A
TI In vitro biocompatibility evaluation of naturally derived and synthetic
   biomaterials using normal human bladder smooth muscle cells
SO JOURNAL OF UROLOGY
LA English
DT Article
DE bladder; muscle, smooth; biocompatible materials; cell culture
ID SMALL-INTESTINAL SUBMUCOSA; HUMAN UROTHELIAL CELLS; VESICOURETERAL
   REFLUX; COLORIMETRIC ASSAY; COLLAGEN MATRIX; URINARY-BLADDER;
   CYTO-TOXICITY; CULTURE; CHONDROCYTES; POLYMERS
AB Purpose: Tissue engineering of the urinary tract often requires the use of various biomaterials. Adequate biomaterial biocompatibility is necessary for successful urinary reconstruction. In this study using a primary normal human bladder smooth muscle cell culture system we evaluated the in vitro biocompatibility of a number of naturally derived biomaterials, including bladder submucosa, small intestinal submucosa, collagen and alginate, and polymeric biomaterials, including polyglycolic acid, poly(L-lactic acid) and poly(lactic-co-glycolic acid, which have been used for urinary reconstruction experimentally or clinically.
   Materials and Methods: To determine the cytotoxic and bioactive effects of bladder submucosa, small intestinal submucosa, collagen, alginate, polyglycolic acid, poly(L-lactic acid) and poly(lactic-co-glycolic acid) we measured cell viability, metabolic activity, apoptotic properties and DNA synthesis activity with 4 types of assays, namely Neutral Red (Sigma Chemical Co., St. Louis, Missouri), 3-(4,5-dimethyltliiazol-2-yl)-2,5-diphenyl tetrazolium bromide (Sigma Chemical Co.), apoptotic activity and tritiated thymidine incorporation (Dupont NEN, Boston, Massachusetts) assays. Normal human bladder smooth muscle cells were cultured with the extracts of the biomaterials or cultured in direct contact with the biomaterials.
   Results: All naturally derived and synthetic biomaterials tested in this study except alginate exhibited nontoxic and bioactive effects on human bladder smooth muscle cells (HBSMCs) in vitro, as indicated by the 4 types of biocompatibility assays using the extract and direct contact methods. Cell viability, apoptotic properties, metabolic activity and DNA synthesis activity of HBSMCs cultured with the extracts of the biomaterials or cultured in direct contact with the biomaterials were not significantly different from those of negative controls (fresh medium with no extracts or tissue culture plates without biomaterials).
   Conclusions: All naturally derived and synthetic biomaterials tested in this study except alginate exhibited nontoxic and bioactive effects on HBSMCs in vitro. This normal primary human bladder smooth muscle cell culture model is suitable for in vitro biocompatibility assessment. It provides information on cell-biomaterial interactions and on the ability of biomaterials to support bioactive cell functions.
C1 Childrens Hosp, Lab Tissue Engn & Cellular Therapeut, Boston, MA 02115 USA.
   Harvard Univ, Sch Med, Boston, MA USA.
RP Atala, A (reprint author), 300 Longwood Ave, Boston, MA 02115 USA.
RI Kim, Byung-Soo/O-2352-2013
OI Atala, Anthony/0000-0001-8186-2160
CR *ANN SOC TEST MAT, 1991, ANN BOOK AM SOC TEST
   [Anonymous], 1992, ISO109935
   Atala A, 1999, J UROLOGY, V162, P1148, DOI 10.1016/S0022-5347(01)68105-9
   ATALA A, 1993, J UROLOGY, V150, P745, DOI 10.1016/S0022-5347(17)35603-3
   ATALA A, 1994, J UROLOGY, V152, P641, DOI 10.1016/S0022-5347(17)32671-X
   Atala A, 2000, J ENDOUROL, V14, P49, DOI 10.1089/end.2000.14.49
   Badylak SF, 1998, TISSUE ENG, V4, P379, DOI 10.1089/ten.1998.4.379
   Brauers A, 1998, Tech Urol, V4, P214
   Chen F, 1999, UROLOGY, V54, P407, DOI 10.1016/S0090-4295(99)00179-X
   CIAPETTI G, 1993, BIOMATERIALS, V14, P359, DOI 10.1016/0142-9612(93)90055-7
   Diamond DA, 1999, J UROLOGY, V162, P1185, DOI 10.1016/S0022-5347(01)68124-2
   Ignatius AA, 1996, BIOMATERIALS, V17, P831, DOI 10.1016/0142-9612(96)81421-9
   Kassaby El A., 2000, Journal of Urology, V163, P70
   Kershen RT, 1999, UROL CLIN N AM, V26, P81, DOI 10.1016/S0094-0143(99)80008-1
   Kim BS, 1999, EXP CELL RES, V251, P318, DOI 10.1006/excr.1999.4595
   KIM BS, WORLD J UROL, V18, P2000
   Kirkpatrick CJ, 1998, P I MECH ENG H, V212, P75, DOI 10.1243/0954411981533845
   Kropp BP, 1996, J UROLOGY, V155, P2098, DOI 10.1016/S0022-5347(01)66117-2
   Lattari Vincent, 1997, Journal of Burn Care and Rehabilitation, V18, P147, DOI 10.1097/00004630-199703000-00010
   MOHAMMED R, 1987, UROL RES, V15, P239
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Oberpenning F, 1999, NAT BIOTECHNOL, V17, P149
   OZTURK SS, 1990, BIOTECHNOL PROGR, V6, P121, DOI 10.1021/bp00002a005
   Pariente JL, 1998, J BIOMED MATER RES, V40, P31, DOI 10.1002/(SICI)1097-4636(199804)40:1<31::AID-JBM4>3.0.CO;2-S
   Pariente JL, 1998, UROLOGY, V52, P524, DOI 10.1016/S0090-4295(98)00198-8
   Pariente JL, 2000, BIOMATERIALS, V21, P835, DOI 10.1016/S0142-9612(99)00253-7
   PARISH CR, 1983, J IMMUNOL METHODS, V58, P225, DOI 10.1016/0022-1759(83)90277-6
   Pizzoferrato Arturo, 1994, Clinical Materials, V15, P173, DOI 10.1016/0267-6605(94)90081-7
   SGOURAS D, 1990, J MATER SCI-MATER M, V1, P61, DOI 10.1007/BF00839070
   Shapiro L, 1997, BIOMATERIALS, V18, P583, DOI 10.1016/S0142-9612(96)00181-0
   Shive M. S., 1997, ADV DRUG DELIV REV, V28, P5
   TACHIBANA M, 1985, J UROLOGY, V133, P866, DOI 10.1016/S0022-5347(17)49268-8
   UPHILL PF, 1990, MED DEVICE TECHN NOV, P24
   Vaught JD, 1996, J UROLOGY, V155, P374, DOI 10.1016/S0022-5347(01)66663-1
   Winfrey M E, 1999, Dimens Crit Care Nurs, V18, P14, DOI 10.1097/00003465-199901000-00003
   Yoo JJ, 1998, UROLOGY, V51, P221, DOI 10.1016/S0090-4295(97)00644-4
NR 36
TC 98
Z9 108
U1 1
U2 15
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0022-5347
J9 J UROLOGY
JI J. Urol.
PD APR
PY 2002
VL 167
IS 4
BP 1867
EP 1871
DI 10.1016/S0022-5347(05)65251-2
PG 5
WC Urology & Nephrology
SC Urology & Nephrology
GA 531VB
UT WOS:000174437000107
PM 11912450
DA 2018-10-20
ER

PT J
AU Ektessabi, AM
   Hamdi, M
AF Ektessabi, AM
   Hamdi, M
TI Characterization of calcium phosphate bioceramic films using ion beam
   analysis techniques
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article
DE hydroxyapatite; ion beam analysis; PIXE; RBS; ERDA; RE-RBS
ID ASSISTED SPUTTER-DEPOSITION; RESONANCE SCATTERING; CERAMIC COATINGS;
   THIN-FILMS; TITANIUM; OXYGEN; SURFACE; HYDROXYAPATITE; BIOMATERIALS;
   IMPLANTS
AB The analytical techniques using ion beams are powerful tools for surface analysis of solid materials. Constituent elements are important in determining the biocompatibility and corrosion resistance of a biomaterial implant. The focus of this article is on the application of ion beam analysis towards quantifying the composition of calcium phosphate based biomaterials. Thin films of calcium phosphate bioceramics were prepared on Si and Ti substrates using ion beam sputter deposition (IBSD) and ion beam assisted sputter deposition (IBASD) methods. Precise amounts of calcium, phosphorus, oxygen and hydrogen in these thin films are determined by combining four ion beam analysis techniques. The simultaneous application of proton induced X-ray emission (PIXE) and Rutherford backscattering spectrometry (RBS) were utilized to quantify composition and amounts of elements heavier than helium. Elastic recoil detection analysis (ERDA) was used to determine hydrogen content while resonance-enhanced RBS (RE-RBS) was utilized to measure oxygen concentration. The amount of assisting ion beam current density during deposition affected the concentration ratios of Ca, O and H to P. Combination of different ion beam analysis methods is useful in characterizing the elemental composition and distribution of composite biomaterials. (C) 2002 Elsevier Science B.V. All rights reserved.
C1 Kyoto Univ, Int Innovat Ctr, Sakyo Ku, Kyoto 6068501, Japan.
   Kyoto Univ, Grad Sch Engn, Dept Precis Engn, Sakyo Ku, Kyoto 6068501, Japan.
RP Ektessabi, AM (reprint author), Kyoto Univ, Int Innovat Ctr, Sakyo Ku, Kyoto 6068501, Japan.
RI shukor, hamdi/B-9093-2010
CR ALMEIDA FJD, 1993, NUCL INSTRUM METH B, V82, P393, DOI 10.1016/0168-583X(93)95986-F
   Barradas NP, 2000, NUCL INSTRUM METH B, V161, P308, DOI 10.1016/S0168-583X(99)00976-3
   Bender SA, 2000, BIOMATERIALS, V21, P299, DOI 10.1016/S0142-9612(99)00183-0
   CAMERON JR, 1953, PHYS REV, V90, P839, DOI 10.1103/PhysRev.90.839
   CHEN CM, 2000, MAT SCI ENG B-FLUID, V27, P113
   COOK SD, 1988, CLIN ORTHOP RELAT R, P225
   Cui FZ, 1999, SURF COAT TECH, V112, P278, DOI 10.1016/S0257-8972(98)00763-4
   DENBRABER ET, 1995, J BIOMED MATER RES, V29, P511, DOI 10.1002/jbm.820290411
   DUCHEYNE P, 1988, J BIOMED MATER RES, V22, P1137, DOI 10.1002/jbm.820221207
   Ektessabi AM, 1997, NUCL INSTRUM METH B, V127, P1008, DOI 10.1016/S0168-583X(97)00049-9
   EKTESSABI AM, 1994, SURF COAT TECH, V68, P208, DOI 10.1016/0257-8972(94)90162-7
   Ektessabi AM, 1995, THIN SOLID FILMS, V270, P335, DOI 10.1016/0040-6090(95)06714-0
   Ektessabi AM, 1996, NUCL INSTRUM METH B, V109, P278, DOI 10.1016/0168-583X(95)00922-1
   EKTESSABI AM, 1995, NUCL INSTRUM METH B, V99, P610, DOI 10.1016/0168-583X(94)00568-0
   EKTESSABI AM, 1994, INT J PIXE, V4, P81
   FUJINO Y, 1982, J APPL PHYS, V51, P1047
   Jansen J A, 1993, Clin Oral Implants Res, V4, P28, DOI 10.1034/j.1600-0501.1993.040104.x
   KLEIN CPAT, 1994, BIOMATERIALS, V15, P146, DOI 10.1016/0142-9612(94)90264-X
   LEAVITT JA, 1990, NUCL INSTRUM METH B, V44, P260, DOI 10.1016/0168-583X(90)90637-A
   OHTSUKA Y, 1994, SURF COAT TECH, V65, P224, DOI 10.1016/S0257-8972(94)80037-5
   Russell SW, 1996, J BIOMED MATER RES, V30, P165
   SINGHVI R, 1994, BIOTECHNOL BIOENG, V43, P764, DOI 10.1002/bit.260430811
   SOROKA VI, 1993, NUCL INSTRUM METH B, V83, P311, DOI 10.1016/0168-583X(93)95848-Y
   van Dijk K, 1998, J BIOMED MATER RES, V42, P266, DOI 10.1002/(SICI)1097-4636(199811)42:2<266::AID-JBM11>3.3.CO;2-U
   VAUGHN B K, 1992, Dental Clinics of North America, V36, P263
   WANG ZL, 1983, NUCL INSTRUM METHODS, V211, P193, DOI 10.1016/0167-5087(83)90569-0
   Yang Guohua, 1991, Nuclear Science and Techniques, V2, P29
   Zeng H, 1999, BIOMATERIALS, V20, P443, DOI 10.1016/S0142-9612(98)00190-2
NR 28
TC 12
Z9 13
U1 0
U2 2
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD APR 1
PY 2002
VL 153
IS 1
BP 10
EP 15
AR PII S0257-8972(01)01519-5
DI 10.1016/S0257-8972(01)01519-5
PG 6
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 538BY
UT WOS:000174795200002
DA 2018-10-20
ER

PT J
AU Xiang, Z
   Spector, M
AF Xiang, Z
   Spector, M
TI A glimpse of tissue engineering in China
SO TISSUE ENGINEERING
LA English
DT Review
AB Tissue engineering activities in China have expanded and advanced to the extent that it is not possible to acknowledge all of the work in one review. Substantial progress has been made in the development of novel biomaterial scaffolds and in the genetic manipulation of cells in vitro. Moreover, certain aspects of tissue engineering strategies have begun to undergo clinical trial. A glimpse of tissue engineering in China was afforded at the First International Conference on Biomaterials (China) held in Beijing, July 24-26, 2001. Several papers presented at the meeting, which was conducted in English only, reflected many of the tissue engineering activities in the country. A brief summary of some of the papers may begin to suggest possibilities for collaboration between tissue engineers inside and outside of China, as well as to facilitate dissemination of important findings.
C1 Harvard Univ, Brigham & Womens Hosp, Dept Orthopaed Surg, Sch Med, Boston, MA 02115 USA.
   W China Univ Med Sci, Dept Orthopaed Surg, Univ Hosp 1, Chengdu 610041, Sichuan, Peoples R China.
RP Spector, M (reprint author), Harvard Univ, Brigham & Womens Hosp, Dept Orthopaed Surg, Sch Med, MRB 106,75 Francis St, Boston, MA 02115 USA.
OI Spector, Myron/0000-0003-3328-4858
CR CAI Q, 2001, P 1 INT C BIOM CHIN, P20
   Fu X, 1995, Wound Repair Regen, V3, P237, DOI 10.1046/j.1524-475X.1995.30216.x
   FU XB, 1999, MODERN WOUND HEALING, P1
   GE XM, 2001, P 1 INT C BIOM CHIN, P28
   MAO JS, 2001, P 1 INT C BIOM CHIN, P51
   REN X, 1988, CHIN J MED HIST, V18, P81
   SANG GW, 2001, P 1 INT C BIOM CHIN, P1
   WANG CY, 2001, P 1 INT C BIOM CHIN, P55
   WANG XJ, 2001, P 1 INT C BIOM CHIN, P199
   XIANG Z, 2001, P 1 INT C BIOM CHIN, pS1
   XIONG Z, 2001, P 1 INT C BIOM CHIN, P77
   YANG J, 2001, P 1 INT C BIOM CHIN, P45
   YANG ZH, 2001, P 1 INT C BIOM CHIN, pS2
   YANG ZM, 2000, CHINESE J SCI, V6, P914
   YANG ZM, 2000, CHINESE J REPARAT RE, V14, P365
   YUAN XY, 2001, P 1 INT C BIOM CHIN, P150
   ZHAO FY, 2001, P 1 INT C BIOM CHIN, P23
   ZHOU CR, 2001, P 1 INT C BIOM CHIN, P329
NR 18
TC 0
Z9 0
U1 0
U2 1
PU MARY ANN LIEBERT INC PUBL
PI LARCHMONT
PA 2 MADISON AVENUE, LARCHMONT, NY 10538 USA
SN 1076-3279
J9 TISSUE ENG
JI Tissue Eng.
PD APR
PY 2002
VL 8
IS 2
BP 169
EP 174
DI 10.1089/107632702753724941
PG 6
WC Cell & Tissue Engineering
SC Cell Biology
GA 549KN
UT WOS:000175443200001
PM 12031107
DA 2018-10-20
ER

PT J
AU Halberstadt, C
   Austin, C
   Rowley, J
   Culberson, C
   Loebsack, A
   Wyatt, S
   Coleman, S
   Blacksten, L
   Burg, K
   Mooney, D
   Holder, W
AF Halberstadt, C
   Austin, C
   Rowley, J
   Culberson, C
   Loebsack, A
   Wyatt, S
   Coleman, S
   Blacksten, L
   Burg, K
   Mooney, D
   Holder, W
TI A hydrogel material for plastic and reconstructive applications injected
   into the subcutaneous space of a sheep
SO TISSUE ENGINEERING
LA English
DT Article
ID TISSUE-ENGINEERED GROWTH; ALGINATE HYDROGELS; LIVER-TISSUE; CARTILAGE;
   TRANSPLANTATION; MATRIX; PEPTIDES; POLYMERS; GRAFTS; FLAPS
AB Soft tissue reconstruction using tissue-engineered constructs requires the development of materials that are biocompatible and support cell adhesion and growth. The objective of this study was to evaluate the use of macroporous hydrogel fragments that were formed using either unmodified alginate or alginate covalently linked with the fibronectin cell adhesion peptide RGD (alginate-RGD). These materials were injected into the subcutaneous space of adult, domesticated female sheep and harvested for histological comparisons at 1 and 3 months. In addition, the alginate-RGD porous fragments were seeded with autologous sheep preadipocytes isolated from the omentum, and these cell-based constructs were also implanted. The results from this study indicate that both the alginate and alginate-RGD subcutaneous implants supported tissue and vascular ingrowth. Furthermore, at all time points of the experiment, a minimal inflammatory response and capsule formation surrounding the implant were observed. The implanted materials also maintained their sizes over the 3-month study period. In addition, the alginate-RGD fragments supported the adhesion and proliferation of sheep preadipocytes, and adipose tissue was present within the transplant site of these cellular constructs, which was not present within the biomaterial control sites.
C1 Carolinas Med Ctr, Charlotte, NC 28232 USA.
   Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA.
   Univ Michigan, Sch Med, Ann Arbor, MI 48109 USA.
   Clemson Univ, Dept Bioengn, Clemson, SC USA.
RP Halberstadt, C (reprint author), Carolinas Med Ctr, Cannon Res Bldg,POB 32861, Charlotte, NC 28232 USA.
EM chalberstadt@carolinas.org
CR Arnez ZM, 1999, BRIT J PLAST SURG, V52, P351, DOI 10.1054/bjps.1999.3099
   Austin C., 2000, Tissue Engineering, V6, P662
   BURG KJL, 2000, 6 WORLD BIOM C
   Clugston PA, 2000, PLAST RECONSTR SURG, V105, P77, DOI 10.1097/00006534-200001000-00013
   Eiselt P, 2000, BIOMATERIALS, V21, P1921, DOI 10.1016/S0142-9612(00)00033-8
   FONTAINE M, 1995, J PEDIATR SURG, V30, P56, DOI 10.1016/0022-3468(95)90610-X
   Grande DA, 1997, J BIOMED MATER RES, V34, P211, DOI 10.1002/(SICI)1097-4636(199702)34:2<211::AID-JBM10>3.0.CO;2-L
   GREENE KG, 2000, 6 WORLD BIOM C
   Griffith LG, 1997, ANN NY ACAD SCI, V831, P382
   HALBERSTADT CR, 2000, 6 WORLD BIOM C
   HANSBROUGH JF, 1992, SURGERY, V111, P438
   Hern DL, 1998, J BIOMED MATER RES, V39, P266, DOI 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B
   Hofmann C, 1999, J AM ACAD DERMATOL, V40, P100, DOI 10.1016/S0190-9622(99)70536-0
   Kao WYJ, 1998, BIOTECHNOL BIOENG, V59, P2, DOI 10.1002/(SICI)1097-0290(19980705)59:1<2::AID-BIT2>3.0.CO;2-G
   KIM WS, 1994, PLAST RECONSTR SURG, V94, P233, DOI 10.1097/00006534-199408000-00001
   LUM H, 1985, AM REV RESPIR DIS, V132, P1078
   MASSIA SP, 1990, ANAL BIOCHEM, V187, P292, DOI 10.1016/0003-2697(90)90459-M
   MOONEY DJ, 1994, TRANSPLANT P, V26, P3425
   NAUGHTON BA, 1995, APPL BIOCHEM BIOTECH, V54, P65, DOI 10.1007/BF02787912
   OZGENTAS HE, 1994, ANN PLAS SURG, V33, P171
   Parenteau N, 1999, SCI AM, V280, P83
   Peter SJ, 1998, J BIOMED MATER RES, V43, P422, DOI 10.1002/(SICI)1097-4636(199824)43:4<422::AID-JBM9>3.3.CO;2-T
   PUELACHER WC, 1994, INT J ORAL MAX SURG, V23, P49, DOI 10.1016/S0901-5027(05)80328-5
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Shanklin DR, 1999, EXP MOL PATHOL, V67, P26, DOI 10.1006/exmp.1999.2269
   STICKLAND NC, 1975, STAIN TECHNOL, V50, P255, DOI 10.3109/10520297509117068
   Urry DW, 1998, J BIOMAT SCI-POLYM E, V9, P1015, DOI 10.1163/156856298X00316
   VACANTI CA, 1993, TRANSPLANT P, V25, P1019
   Wakitani S, 1998, TISSUE ENG, V4, P429, DOI 10.1089/ten.1998.4.429
   Wyatt LE, 1998, PLAST RECONSTR SURG, V102, P1922, DOI 10.1097/00006534-199811000-00017
NR 30
TC 103
Z9 104
U1 1
U2 12
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 2152-4947
J9 TISSUE ENG
JI Tissue Eng.
PD APR
PY 2002
VL 8
IS 2
BP 309
EP 319
DI 10.1089/107632702753725067
PG 11
WC Cell & Tissue Engineering
SC Cell Biology
GA 549KN
UT WOS:000175443200013
PM 12031119
DA 2018-10-20
ER

PT J
AU Suh, H
   Lee, JE
AF Suh, H
   Lee, JE
TI Behavior of fibroblasts on a porous hyaluronic acid incorporated
   collagen matrix
SO YONSEI MEDICAL JOURNAL
LA English
DT Article
DE hyaluronic acid; atelocollagen; biodegradation; mechanical properties;
   ultraviolet irradiation; fibroblast growing behavior
ID CONTAINING ARTIFICIAL SKIN; CROSS-LINKING; EXTRACELLULAR-MATRIX; PORE
   STRUCTURE; SPONGE; BURN; ATELOCOLLAGEN; REGENERATION; BIOMATERIAL;
   THICKNESS
AB A hyaluronic acid (HA) incorporated porous collagen matrix was fabricated at -70degreesC by lyophilization. The HA incorporated collagen matrix showed increased pore size in comparison with collagen matrix. Biodegradability and mechanical properties of matrices were controllable by varying the ultraviolet (UV) irradiation time for cross-linking collagen molecules. Addition of HA to collagen matrix did not effect ultimate tensile stress after UV irradiation. HA incorporated collagen matrices demonstrated a higher resistance against the collagenase degradation than collagen matrix. In an in vitro investigation of cellular behavior using dermal fibroblasts on the porous matrix, HA incorporated collagen matrix induced increased dermal fibroblast migration and proliferation in comparison with collagen matrix. These results suggest that the HA incorporated collagen porous matrix assumes to enhance dermal fibroblast adaptation and regenerative potential.
C1 Yonsei Univ, Coll Med, Dept Med Engn, Seoul 120752, South Korea.
   Yonsei Ctr Nano Technol, Nano Biomat Grp, Seoul, South Korea.
RP Suh, H (reprint author), Yonsei Univ, Coll Med, Dept Med Engn, CPO Box 8044, Seoul 120752, South Korea.
EM hwal@yunic.yonsei.ac.kr
CR ABRAMO AC, 1992, BRIT J PLAST SURG, V45, P117, DOI 10.1016/0007-1226(92)90170-3
   AHN S, 1996, J KOSOMBE, V17, P479
   AKIYAMA SK, 1990, BIOCHIM BIOPHYS ACTA, V1031, P91, DOI 10.1016/0304-4157(90)90004-V
   Balazs Endre A., 1995, P1693
   BENEDETTI L, 1993, BIOMATERIALS, V14, P1154, DOI 10.1016/0142-9612(93)90160-4
   BERTHOD F, 1994, CLIN MATER, V15, P259, DOI 10.1016/0267-6605(94)90055-8
   Chen WYJ, 1999, WOUND REPAIR REGEN, V7, P79, DOI 10.1046/j.1524-475X.1999.00079.x
   Choi YS, 1999, BIOMATERIALS, V20, P409, DOI 10.1016/S0142-9612(98)00180-X
   Choi YS, 1999, J BIOMED MATER RES, V48, P631, DOI 10.1002/(SICI)1097-4636(1999)48:5<631::AID-JBM6>3.0.CO;2-Y
   DAGALAKIS N, 1980, J BIOMED MATER RES, V14, P511, DOI 10.1002/jbm.820140417
   DOILLON CJ, 1986, J BIOMED MATER RES, V20, P1219, DOI 10.1002/jbm.820200811
   FRESHNEY RI, 1994, CULTURE ANIMAL CELLS
   GORHAM SD, 1992, INT J BIOL MACROMOL, V14, P129, DOI 10.1016/S0141-8130(05)80002-9
   HIROSHI K, 1992, JPN J ORAL BIOL, V34, P331
   Horch RE, 1998, SCAND J PLAST RECONS, V32, P407, DOI 10.1080/02844319850158499
   Kang HW, 1999, BIOMATERIALS, V20, P1339, DOI 10.1016/S0142-9612(99)00036-8
   Koide T, 1997, Dent Mater J, V16, P1
   KUROYANAGI Y, 1993, ANN PLAS SURG, V31, P340, DOI 10.1097/00000637-199310000-00011
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Langholz O, 1995, J CELL BIOL, V131, P1903, DOI 10.1083/jcb.131.6.1903
   LARSEN NE, 1993, J BIOMED MATER RES, V27, P1129, DOI 10.1002/jbm.820270903
   LINGE C, 1989, EXP CELL RES, V185, P519, DOI 10.1016/0014-4827(89)90320-0
   Liu LS, 1999, BIOMATERIALS, V20, P1097, DOI 10.1016/S0142-9612(99)00006-X
   Lorenz C, 1997, BURNS, V23, P505, DOI 10.1016/S0305-4179(97)00022-3
   Malette W.G., 1986, CHITIN NATURE TECHNO, P435
   MENTER JM, 1995, PHOTOCHEM PHOTOBIOL, V62, P402, DOI 10.1111/j.1751-1097.1995.tb02360.x
   Mooney DJ, 1996, BIOMATERIALS, V17, P1417, DOI 10.1016/0142-9612(96)87284-X
   Mooney DT, 1996, BIOMATERIALS, V17, P115, DOI 10.1016/0142-9612(96)85756-5
   OLIVE RF, 1987, BURNS, V12, P49
   OLIVER RF, 1980, BRIT J EXP PATHOL, V61, P544
   Park JC, 2000, J BIOMED MATER RES, V52, P669, DOI 10.1002/1097-4636(20001215)52:4<669::AID-JBM11>3.3.CO;2-L
   PETITE H, 1990, J BIOMED MATER RES, V24, P179, DOI 10.1002/jbm.820240205
   Rao KP, 1995, J BIOMAT SCI-POLYM E, V7, P623
   SEAGER H, 1985, Journal of Parenteral Science and Technology, V39, P161
   STMENKOVIC I, 1994, METHODS ENZYMOLOGY E, V245, P195
   SUH H, 1995, ASAIO J, V41, pM652, DOI 10.1097/00002480-199507000-00091
   SUH H, 1998, BIOMATER RES, V2, P95
   SUH H, 1999, BIOMED ENG APPL BASI, V11, P167
   SUZUKI S, 1990, BIOMATERIALS, V11, P356, DOI 10.1016/0142-9612(90)90114-6
   SUZUKI S, 1990, BRIT J PLAST SURG, V43, P47, DOI 10.1016/0007-1226(90)90044-Z
   VIZAROVA K, 1995, BIOMATERIALS, V16, P1217, DOI 10.1016/0142-9612(95)98127-Z
   WEADOCK K, 1983, BIOMATER ARTIF CELL, V11, P293, DOI 10.3109/10731198309118815
   WEADOCK KS, 1995, J BIOMED MATER RES, V29, P1373, DOI 10.1002/jbm.820291108
   YANNAS IV, 1980, J BIOMED MATER RES, V14, P107, DOI 10.1002/jbm.820140203
   YANNAS IV, 1989, P NATL ACAD SCI USA, V86, P933, DOI 10.1073/pnas.86.3.933
NR 45
TC 0
Z9 0
U1 0
U2 0
PU YONSEI UNIV COLL MEDICINE
PI SEOUL
PA 50-1 YONSEI-RO, SEODAEMUN-GU, SEOUL 120-752, SOUTH KOREA
SN 0513-5796
EI 1976-2437
J9 YONSEI MED J
JI Yonsei Med. J.
PD APR
PY 2002
VL 43
IS 2
BP 193
EP 202
DI 10.3349/ymj.2002.43.2.193
PG 10
WC Medicine, General & Internal
SC General & Internal Medicine
GA 549QJ
UT WOS:000175455500008
PM 11971213
OA Bronze
DA 2018-10-20
ER

PT J
AU Rose, FRAJ
   Oreffo, ROC
AF Rose, FRAJ
   Oreffo, ROC
TI Bone tissue engineering: Hope vs hype
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE osteoprogenitor; bone marrow; bio-degradable polymer; tissue
   engineering; scaffold; artificial bone; bone regeneration; stem cell
ID MESENCHYMAL STEM-CELLS; IN-VITRO; MORPHOGENETIC PROTEIN-2; POLYMER
   SCAFFOLDS; MARROW; VIVO; OSTEOGENESIS; REGENERATION; BIOMATERIAL;
   CARTILAGE
AB The requirement for new bone to replace or restore the function of traumatised, damaged, or lost bone is a major clinical and socioeconomic need. Bone formation strategies, although attractive, have yet to yield functional and mechanically competent bone. Bone tissue engineering has been heralded as the alternative strategy to regenerate bone. In essence, the discipline aims to combine progenitor or mature cells with biocompatible materials or scaffolds, with or without appropriate growth factors, to initiate repair and regeneration. This brief review outlines the concepts, challenges, and limitations in bone tissue engineering and the potential that could improve the quality of life for many as a result of interdisciplinary collaboration. (C) 2002 Elsevier Science (USA).
C1 Univ Southampton, Gen Hosp, Southampton SO16 6YD, Hants, England.
   Univ Nottingham, Sch Pharmaceut Sci, Nottingham NG7 2RD, England.
RP Oreffo, ROC (reprint author), Univ Southampton, Gen Hosp, MP817 CF86, Southampton SO16 6YD, Hants, England.
EM roco@soton.ac.uk
RI Xu, Qingguo/C-1962-2014; Oreffo, Richard/A-4615-2011
OI Xu, Qingguo/0000-0003-3191-0771; Oreffo, Richard/0000-0001-5995-6726;
   Rose, Felicity/0000-0001-6640-8840
CR Agrawal CM, 2001, J BIOMED MATER RES, V55, P141, DOI 10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.3.CO;2-A
   Almqvist N, 1999, MAT SCI ENG C-BIO S, V7, P37, DOI 10.1016/S0928-4931(98)00072-1
   Andriano KP, 1999, J BIOMED MATER RES, V48, P602, DOI 10.1002/(SICI)1097-4636(1999)48:5<602::AID-JBM3>3.0.CO;2-6
   ASHTON BA, 1980, CLIN ORTHOP RELAT R, P294
   Bianco P, 2001, STEM CELLS, V19, P180, DOI 10.1634/stemcells.19-3-180
   BODEN SD, 1999, CLIN ORTHOP S, V367, pS84
   Breitbart AS, 1999, ANN PLAS SURG, V42, P488, DOI 10.1097/00000637-199905000-00005
   Brekke JH, 1998, J BIOMED MATER RES, V43, P380, DOI 10.1002/(SICI)1097-4636(199824)43:4<380::AID-JBM6>3.0.CO;2-D
   Bruder SP, 1997, J CELL BIOCHEM, V64, P278, DOI 10.1002/(SICI)1097-4644(199702)64:2<278::AID-JCB11>3.0.CO;2-F
   Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   Chapekar MS, 2000, J BIOMED MATER RES, V53, P617, DOI 10.1002/1097-4636(2000)53:6<617::AID-JBM1>3.3.CO;2-3
   CHRISCHILLES E, 1994, BONE, V15, P377, DOI 10.1016/8756-3282(94)90813-3
   COHEN S, 1993, CLIN MATER, V13, P3, DOI 10.1016/0267-6605(93)90082-I
   CONNOLLY JF, 1995, CLIN ORTHOP RELAT R, V313, P8
   Cooper AI, 2000, J MATER CHEM, V10, P207, DOI 10.1039/a906486i
   DOLL BA, 1990, J PERIODONTOL, V61, P745, DOI 10.1902/jop.1990.61.12.745
   Einhorn TA, 1999, CLIN ORTHOP RELAT R, pS59, DOI 10.1097/00003086-199910001-00007
   FIALKOV KA, 2000, BONE ENG, P548
   FREED LE, 1994, BIO-TECHNOL, V12, P689, DOI 10.1038/nbt0794-689
   FRIEDENSTEIN AJ, 1976, INT REV CYTOL, V47, P327, DOI 10.1016/S0074-7696(08)60092-3
   GUNDLE R, 1995, BONE, V16, P597, DOI 10.1016/8756-3282(95)00112-Q
   Hollinger JO, 1998, J BIOMED MATER RES, V43, P356, DOI 10.1002/(SICI)1097-4636(199824)43:4<356::AID-JBM3>3.0.CO;2-7
   HORISAKA Y, 1991, CLIN ORTHOP RELAT R, V268, P303
   Horwitz EM, 1999, NAT MED, V5, P309, DOI 10.1038/6529
   Howdle SM, 2001, CHEM COMMUN, P109, DOI 10.1039/b008188o
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Itoh S, 2001, J BIOMED MATER RES, V54, P445, DOI 10.1002/1097-4636(20010305)54:3<445::AID-JBM190>3.0.CO;2-9
   Jackson D W, 1999, Clin Orthop Relat Res, pS31, DOI 10.1097/00003086-199910001-00005
   Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I
   Joyner CJ, 1997, BONE, V21, P1, DOI 10.1016/S8756-3282(97)00074-4
   Kadiyala S, 1997, CELL TRANSPLANT, V6, P125, DOI 10.1016/S0963-6897(96)00279-5
   Kawabata M, 1998, CYTOKINE GROWTH F R, V9, P49, DOI 10.1016/S1359-6101(97)00036-1
   Kawakami Y, 1996, DEVELOPMENT, V122, P3557
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee KY, 2000, NATURE, V408, P998
   Lieberman JR, 1999, J BONE JOINT SURG AM, V81A, P905, DOI 10.2106/00004623-199907000-00002
   Louisia S, 1999, J BONE JOINT SURG BR, V81B, P719, DOI 10.1302/0301-620X.81B4.9358
   Ma PX, 2001, J BIOMED MATER RES, V54, P284, DOI 10.1002/1097-4636(200102)54:2<284::AID-JBM16>3.0.CO;2-W
   Mann S, 1996, NATURE, V382, P313, DOI 10.1038/382313a0
   Middleton JC, 2000, BIOMATERIALS, V21, P2335, DOI 10.1016/S0142-9612(00)00101-0
   Mori M, 2000, J BIOMED MATER RES, V50, P191, DOI 10.1002/(SICI)1097-4636(200005)50:2<191::AID-JBM14>3.0.CO;2-0
   Musgrave DS, 1999, BONE, V24, P541, DOI 10.1016/S8756-3282(99)00086-1
   NAKAHARA H, 1990, BONE, V11, P181, DOI 10.1016/8756-3282(90)90212-H
   Nuttall ME, 1998, J BONE MINER RES, V13, P371, DOI 10.1359/jbmr.1998.13.3.371
   OHGUSHI H, 1989, J ORTHOPAED RES, V7, P568, DOI 10.1002/jor.1100070415
   Okubo Y, 2001, J BONE JOINT SURG AM, V83A, pS99
   Olmsted EA, 2001, J CELL BIOCHEM, V82, P11, DOI 10.1002/jcb.1106
   Oreffo ROC, 1999, BONE, V25, p5S, DOI 10.1016/S8756-3282(99)00124-6
   Park SR, 1999, BONE, V24, P549, DOI 10.1016/S8756-3282(99)00084-8
   Patel N, 1998, FASEB J, V12, P1447
   Perry CR, 1999, CLIN ORTHOP RELAT R, P71
   Peter SJ, 1998, J BIOMED MATER RES, V43, P422, DOI 10.1002/(SICI)1097-4636(199824)43:4<422::AID-JBM9>3.3.CO;2-T
   Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449
   Quarto R, 2001, NEW ENGL J MED, V344, P385, DOI 10.1056/NEJM200102013440516
   Quirk RA, 2001, BIOMATERIALS, V22, P865, DOI 10.1016/S0142-9612(00)00250-7
   Reddi A. Hari, 1992, Current Opinion in Cell Biology, V4, P850
   Reeve J., 1998, AGENET REPORT, P1
   Saad B, 1998, J BIOMED MATER RES, V39, P594, DOI 10.1002/(SICI)1097-4636(19980315)39:4<594::AID-JBM14>3.0.CO;2-7
   Sakkers RJB, 2000, J BIOMED MATER RES, V49, P312, DOI 10.1002/(SICI)1097-4636(20000305)49:3<312::AID-JBM3>3.3.CO;2-5
   Schmitt JM, 1999, J ORTHOPAED RES, V17, P269, DOI 10.1002/jor.1100170217
   Seal BL, 2001, MAT SCI ENG R, V34, P147, DOI 10.1016/S0927-796X(01)00035-3
   SIMMONS PJ, 1991, BLOOD, V78, P55
   Sittinger M, 1996, BIOMATERIALS, V17, P237, DOI 10.1016/0142-9612(96)85561-X
   SPECTOR M, 1992, ORTHOP CLIN N AM, V23, P211
   Stewart K, 1999, J BONE MINER RES, V14, P1345, DOI 10.1359/jbmr.1999.14.8.1345
   Tabata Yasuhiko, 2000, Pharmaceutical Science and Technology Today, V3, P80, DOI 10.1016/S1461-5347(00)00242-X
   Temenoff JS, 2000, BIOMATERIALS, V21, P431, DOI 10.1016/S0142-9612(99)00213-6
   TRIFFITT JT, 1998, ADV ORGAN BIOL SERIE, P429
   Turgeman G, 2001, J GENE MED, V3, P240
   VACANTI CA, 2000, PRINCIPLES TISSUE EN
   Whitaker MJ, 2001, J PHARM PHARMACOL, V53, P1427, DOI 10.1211/0022357011777963
   Wilson JM, 1996, NEW ENGL J MED, V334, P1185, DOI 10.1056/NEJM199605023341809
   Winn SR, 1999, CLIN ORTHOP RELAT R, pS95
   WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241
   Yang XB, 2001, BONE, V29, P523, DOI 10.1016/S8756-3282(01)00617-2
   2001, TIMES M, V4, P15
NR 76
TC 333
Z9 360
U1 1
U2 60
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD MAR 22
PY 2002
VL 292
IS 1
BP 1
EP 7
DI 10.1006/bbrc.2002.6519
PG 7
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 534NF
UT WOS:000174591900001
PM 11890663
DA 2018-10-20
ER

PT J
AU Lay, AN
   Gentleman, ED
   Dee, KC
   Livesay, GA
AF Lay, AN
   Gentleman, ED
   Dee, KC
   Livesay, GA
TI Evaluation of a collageneous biomaterial for soft tissue engineering
SO FASEB JOURNAL
LA English
DT Meeting Abstract
C1 Tulane Univ, Dept Biomed Engn, New Orleans, LA 70118 USA.
NR 0
TC 0
Z9 0
U1 0
U2 2
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
J9 FASEB J
JI Faseb J.
PD MAR 20
PY 2002
VL 16
IS 4
BP A37
EP A37
PN 1
PG 1
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA 533MG
UT WOS:000174533600204
DA 2018-10-20
ER

PT J
AU Yamada, M
   Kato, K
   Nomizu, M
   Sakairi, N
   Ohkawa, K
   Yamamoto, H
   Nishi, N
AF Yamada, M
   Kato, K
   Nomizu, M
   Sakairi, N
   Ohkawa, K
   Yamamoto, H
   Nishi, N
TI Preparation and characterization of DNA films induced by UV irradiation
SO CHEMISTRY-A EUROPEAN JOURNAL
LA English
DT Article
DE DNA structures; environmental chemistry; functional materials;
   intercalations; water-insolubilized DNA
ID SCANNING FORCE MICROSCOPY; DOUBLE-STRANDED DNA; NUCLEIC-ACIDS; LIPID
   COMPLEX; CAST FILM; BINDING; AFFINITY; SEPARATION; MOLECULES; MODE
AB Large amounts of DNA-enriched materials, such as salmon milts and shellfish gonads, are discarded as industrial waste. We have been able to convert the discarded DNA to a useful material by preparing novel DNA films by UV irradiation. When DNA films were irradiated with UV light, the molecular weight of DNA was greatly increased. The reaction was inhibited by addition of the radical scavenger galvinoxyl suggesting that the DNA polymerization with UV irradiation proceeded by a radical reaction. Although this UV-irradiated DNA film was water-insoluble and resistant to hydrolysis by nuclease, the structure of the DNA film in water was similar to non-irradiated DNA and maintained B-form structure. In addition, the UV-irradiated DNA film could effectively accumulate and condense harmful DNA-intercalating compounds, such as ethidium bromide and acridine orange, from diluted aqueous solutions. The binding constant and exclusion number of ethidium bromide for UV-irradiated DNA were determined to be 6.8+/-0.3 x 10(4) M-1 and 1.6+/-0.2, respectively; these values are consisted with reported results for non-irradiated DNA. The UV-irradiated DNA films have potential uses as a biomaterial filter for the removal of harmful DNA intercalating compounds.
C1 Hokkaido Univ, Grad Sch Environm Earth Sci, Div Biosci, Lab Biomat Chem,Kita Ku, Sapporo, Hokkaido 0600810, Japan.
   Shinshu Univ, Fac Text Sci & Technol, Ueda, Nagano 3868567, Japan.
RP Nishi, N (reprint author), Hokkaido Univ, Grad Sch Environm Earth Sci, Div Biosci, Lab Biomat Chem,Kita Ku, Kita 10,Nishi 5, Sapporo, Hokkaido 0600810, Japan.
RI Ohkawa, Kousaku/E-1497-2014
OI Ohkawa, Kousaku/0000-0001-5199-092X
CR Alberts B., 1971, METHOD ENZYMOL, V21, P198
   Alivisatos AP, 1996, NATURE, V382, P609, DOI 10.1038/382609a0
   ALLEN FS, 1972, BIOPOLYMERS, V11, P853, DOI 10.1002/bip.1972.360110410
   ARMSTRONG RW, 1970, J AM CHEM SOC, V92, P3174, DOI 10.1021/ja00713a041
   BARTLETT PD, 1962, J AM CHEM SOC, V84, P2596, DOI 10.1021/ja00872a026
   BERMAN HM, 1981, ANNU REV BIOPHYS BIO, V10, P87, DOI 10.1146/annurev.bb.10.060181.000511
   BEUKERS R, 1960, BIOCHIM BIOPHYS ACTA, V41, P550, DOI 10.1016/0006-3002(60)90063-9
   BEUKERS R, 1958, RECL TRAV CHIM PAY B, V77, P729
   Coury JE, 1996, P NATL ACAD SCI USA, V93, P12283, DOI 10.1073/pnas.93.22.12283
   FULLER W, 1964, BERICH BUNSEN GESELL, V68, P805, DOI 10.1002/bbpc.19640680830
   GOPALAKRISHNAN S, 1989, BIOCHEMISTRY-US, V28, P726, DOI 10.1021/bi00428a047
   Iwata K, 1996, INT J BIOL MACROMOL, V18, P149, DOI 10.1016/0141-8130(95)01073-4
   Joseph A, 2000, J AM CHEM SOC, V122, P11219, DOI 10.1021/ja002541u
   Kawabe Y, 2000, ADV MATER, V12, P1281, DOI 10.1002/1521-4095(200009)12:17<1281::AID-ADMA1281>3.0.CO;2-0
   Kitamura H, 1997, INT J BIOL MACROMOL, V20, P75, DOI 10.1016/S0141-8130(97)01146-X
   Kitamura H, 1997, INT J BIOL MACROMOL, V20, P241, DOI 10.1016/S0141-8130(97)00021-4
   KITAMURA H, 1997, NUCL ACIDS S SER, V37, P273
   LEPECQ JB, 1967, J MOL BIOL, V27, P87, DOI 10.1016/0022-2836(67)90353-1
   LITMAN RM, 1968, J BIOL CHEM, V243, P6222
   Machida S, 1999, POLYM J, V31, P1179, DOI 10.1295/polymj.31.1179
   Mirkin CA, 1996, NATURE, V382, P607, DOI 10.1038/382607a0
   Mucic RC, 1998, J AM CHEM SOC, V120, P12674, DOI 10.1021/ja982721s
   MULLER W, 1975, EUR J BIOCHEM, V54, P267, DOI 10.1111/j.1432-1033.1975.tb04137.x
   NISHI N, 1989, PEPT CHEM, P325
   Okahata Y, 1998, J AM CHEM SOC, V120, P6165, DOI 10.1021/ja980165w
   Qu XG, 1999, J AM CHEM SOC, V121, P2649, DOI 10.1021/ja984366b
   Rippe K, 1997, NUCLEIC ACIDS RES, V25, P1736, DOI 10.1093/nar/25.9.1736
   SAENGER W, 1987, PRINCIPLES NUCL ACID
   Samori B, 1996, ANGEW CHEM INT EDIT, V35, P529, DOI 10.1002/anie.199605291
   SAMORI B, 1996, ANGEW CHEM, V108, P569
   Sugiki T, 1996, B CHEM SOC JPN, V69, P1777, DOI 10.1246/bcsj.69.1777
   Tanaka K, 1996, J AM CHEM SOC, V118, P10679, DOI 10.1021/ja9617855
   Tanigawa M, 1998, ANAL CHIM ACTA, V365, P19, DOI 10.1016/S0003-2670(97)00709-5
   Tohnai N, 1999, B CHEM SOC JPN, V72, P1143, DOI 10.1246/bcsj.72.1143
   Umeno D, 1998, ANAL CHIM ACTA, V365, P101, DOI 10.1016/S0003-2670(98)00094-4
   Umeno D, 1998, BIOCONJUGATE CHEM, V9, P719, DOI 10.1021/bc980019f
   WARING MJ, 1965, J MOL BIOL, V13, P269, DOI 10.1016/S0022-2836(65)80096-1
   WARING MJ, 1981, ANNU REV BIOCHEM, V50, P159, DOI 10.1146/annurev.bi.50.070181.001111
   Yamada M, 2001, BIOMATERIALS, V22, P3121, DOI 10.1016/S0142-9612(01)00061-8
   YAMADA M, IN PRESS ENV SCI TEC
   YOUNG T, 1990, PHOTOCHEM PHOTOBIOL, V52, P661, DOI 10.1111/j.1751-1097.1990.tb08664.x
   ZHONG Q, 1993, SURF SCI, V290, pL688, DOI 10.1016/0167-2584(93)90906-Y
NR 42
TC 78
Z9 81
U1 3
U2 10
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 0947-6539
J9 CHEM-EUR J
JI Chem.-Eur. J.
PD MAR 15
PY 2002
VL 8
IS 6
BP 1407
EP 1412
DI 10.1002/1521-3765(20020315)8:6<1407::AID-CHEM1407>3.0.CO;2-L
PG 6
WC Chemistry, Multidisciplinary
SC Chemistry
GA 533XK
UT WOS:000174555400016
PM 11921224
DA 2018-10-20
ER

PT J
AU Goldstein, AS
   DiMilla, PA
AF Goldstein, AS
   DiMilla, PA
TI Effect of adsorbed fibronectin concentration on cell adhesion and
   deformation under shear on hydrophobic surfaces
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE radial-flow chamber; fibronectin; detachment; deformation
ID SELF-ASSEMBLED MONOLAYERS; PLATE FLOW CHAMBER; BONE-DERIVED CELLS;
   EXTRACELLULAR-MATRIX; RADIAL-FLOW; CHEMICAL MODIFICATION;
   ENDOTHELIAL-CELLS; SOLID-SURFACES; STRENGTH; INTEGRIN
AB To facilitate tissue integration with biomaterials proteins and peptides frequently are immobilized on the biomaterial surface. In particular, extracellular matrix proteins-which interact specifically with integrin adhesion receptors on the cell surface-can stimulate initial cell attachment by serving both as a ligand for receptor-mediated attachment and as a stimulant of focal adhesion formation and cytoskeletal reorganization. Consequently, the strength of cell adhesion should depend both on the strength of cell/surface contacts and cytoskeleton-dependent properties of the cell (i.e., morphology, compliance). To examine this dual role of extracellular matrix proteins, murine fibroblasts were seeded onto self-assembled monolayers (SAMs) of dodecanethiolate coated with 0 to 0.45 mug/cm(2) of fibronectin (Fn) and then detached by hydrodynamic shear using a radial-flow chamber (RFC). Cell adhesion was characterized in terms of the critical wall shear stress for detachment (tau (wc)), and the compliance was evaluated from measurements of cell displacement and elongation as a function of the fibronectin concentration. Critical wall shear stress and cell displacement were found to be insensitive to Fn at concentrations below 0.23 mug/cm(2) while above this threshold tau (wc) increased and displacement decreased with increasing Fn concentration. Elongation of the cells in the direction of flow was independent of Fn concentration, but correlated linearly with tau (wc) for Fn densities below 0.23 mug/cm(2). These studies show that Fn concentration affects both tau (wc) and cell displacement under shear, and that tau (wc) is sensitive to cell compliance. In addition, they suggest that the dominant mechanism of cell detachment from hydrophobic substrates involves cell displacement. (C) 2001 John Wiley Sons, Inc.
C1 Carnegie Mellon Univ, Dept Chem Engn, Ctr Light Microscope Imaging & Biotechnol, Colloids Polymers & Surfaces Program, Pittsburgh, PA 15213 USA.
RP Goldstein, AS (reprint author), Virginia Polytech Inst & State Univ, Dept Chem Engn, 0211, Blacksburg, VA 24061 USA.
CR ABBOTT NL, 1992, SCIENCE, V257, P1380, DOI 10.1126/science.257.5075.1380
   ADAMS JC, 1993, DEVELOPMENT, V117, P1183
   BAIN CD, 1989, J AM CHEM SOC, V111, P7155, DOI 10.1021/ja00200a039
   BAIN CD, 1989, J AM CHEM SOC, V111, P321, DOI 10.1021/ja00183a049
   BAIN CD, 1989, J AM CHEM SOC, V111, P7164, DOI 10.1021/ja00200a040
   Burmeister JS, 1996, J BIOMED MATER RES, V30, P13, DOI 10.1002/(SICI)1097-4636(199601)30:1<13::AID-JBM3>3.0.CO;2-U
   Chen CS, 1998, BIOTECHNOL PROGR, V14, P356, DOI 10.1021/bp980031m
   Chen KD, 1999, J BIOL CHEM, V274, P18393, DOI 10.1074/jbc.274.26.18393
   CHENG SS, 1994, J COLLOID INTERF SCI, V162, P135, DOI 10.1006/jcis.1994.1018
   COZENSROBERTS C, 1990, BIOPHYS J, V58, P107, DOI 10.1016/S0006-3495(90)82357-2
   Dean D, 1999, PLAST RECONSTR SURG, V104, P705, DOI 10.1097/00006534-199909030-00014
   Dee KC, 1998, J BIOMED MATER RES, V40, P371, DOI 10.1002/(SICI)1097-4636(19980605)40:3<371::AID-JBM5>3.3.CO;2-G
   DIMILLA PA, 1992, J COLLOID INTERF SCI, V153, P212, DOI 10.1016/0021-9797(92)90313-B
   DIMILLA PA, 1993, J CELL BIOL, V122, P729, DOI 10.1083/jcb.122.3.729
   Dong C, 1999, ANN BIOMED ENG, V27, P298, DOI 10.1114/1.143
   Garcia AJ, 1999, BIOMATERIALS, V20, P2427, DOI 10.1016/S0142-9612(99)00170-2
   Garcia AJ, 1997, TISSUE ENG, V3, P197, DOI 10.1089/ten.1997.3.197
   Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028
   GIROUX TA, 1990, J COLLOID INTERF SCI, V139, P351, DOI 10.1016/0021-9797(90)90109-2
   Goldstein AS, 1998, AICHE J, V44, P465, DOI 10.1002/aic.690440222
   Goldstein AS, 1997, BIOTECHNOL BIOENG, V55, P616, DOI 10.1002/(SICI)1097-0290(19970820)55:4<616::AID-BIT4>3.0.CO;2-K
   HAMMER DA, 1987, BIOPHYS J, V52, P475, DOI 10.1016/S0006-3495(87)83236-8
   HERTZ CM, 1985, BIOTECHNOL BIOENG, V27, P603, DOI 10.1002/bit.260270509
   Hulshoff JEG, 1998, J BIOMED MATER RES, V40, P464, DOI 10.1002/(SICI)1097-4636(19980605)40:3<464::AID-JBM18>3.0.CO;2-J
   Irvine DJ, 1998, J BIOMED MATER RES, V40, P498, DOI 10.1002/(SICI)1097-4636(19980605)40:3<498::AID-JBM21>3.0.CO;2-E
   IULIANO DJ, 1993, J BIOMED MAT RES, V27
   Jalali S, 2001, P NATL ACAD SCI USA, V98, P1042, DOI 10.1073/pnas.031562998
   KUO SC, 1993, BIOPHYS J, V65, P2191, DOI 10.1016/S0006-3495(93)81277-3
   Lhoest JB, 1998, J BIOMED MATER RES, V41, P95, DOI 10.1002/(SICI)1097-4636(199807)41:1<95::AID-JBM12>3.0.CO;2-G
   LOK BK, 1983, J COLLOID INTERF SCI, V91, P87, DOI 10.1016/0021-9797(83)90316-8
   LOPEZ GP, 1993, J AM CHEM SOC, V115, P5877, DOI 10.1021/ja00066a087
   LOPEZ GP, 1993, J AM CHEM SOC, V115, P10774, DOI 10.1021/ja00076a038
   MASSIA SP, 1990, ANAL BIOCHEM, V187, P292, DOI 10.1016/0003-2697(90)90459-M
   MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089
   MOONEY DJ, 1995, J CELL SCI, V108, P2311
   NARASIMHAN C, 1989, BIOCHEMISTRY-US, V28, P5041, DOI 10.1021/bi00438a021
   Neff JA, 1999, BIOMATERIALS, V20, P2377, DOI 10.1016/S0142-9612(99)00166-0
   OLIVIER LA, 1993, BIOTECHNOL BIOENG, V42, P963, DOI 10.1002/bit.260420807
   Palecek SP, 1997, NATURE, V385, P537, DOI 10.1038/385537a0
   Peel MM, 1999, ANN BIOMED ENG, V27, P236, DOI 10.1114/1.178
   PLOPPER GE, 1995, MOL BIOL CELL, V6, P1349
   REUTELINGSPERGER CPM, 1994, J MATER SCI-MATER M, V5, P361, DOI 10.1007/BF00058964
   Rezania A, 1997, J BIOMED MATER RES, V37, P9, DOI 10.1002/(SICI)1097-4636(199710)37:1<9::AID-JBM2>3.0.CO;2-W
   Rezania A, 1997, ANN BIOMED ENG, V25, P190, DOI 10.1007/BF02738550
   Scotchford CA, 1998, J BIOMED MATER RES, V41, P431, DOI 10.1002/(SICI)1097-4636(19980905)41:3<431::AID-JBM13>3.0.CO;2-L
   Short SM, 1998, MOL BIOL CELL, V9, P1969, DOI 10.1091/mbc.9.8.1969
   SINGHVI R, 1994, SCIENCE, P264
   Tegoulia VA, 2000, J BIOMED MATER RES, V50, P291, DOI 10.1002/(SICI)1097-4636(20000605)50:3<291::AID-JBM2>3.0.CO;2-1
   Thomas CH, 1997, J BIOMED MATER RES, V37, P81, DOI 10.1002/(SICI)1097-4636(199710)37:1<81::AID-JBM10>3.0.CO;2-T
   Thoumine O, 1996, CELL MOTIL CYTOSKEL, V33, P276
   TRUSKEY GA, 1990, J BIOMED MATER RES, V24, P1333, DOI 10.1002/jbm.820241006
   TRUSKEY GA, 1993, BIOMATERIALS, V14, P243, DOI 10.1016/0142-9612(93)90114-H
   USAMI S, 1993, ANN BIOMED ENG, V21, P77, DOI 10.1007/BF02368167
   VANKOOTEN TG, 1992, J BIOMED MATER RES, V26, P725, DOI 10.1002/jbm.820260604
   VANKOOTEN TG, 1994, COLLOID SURFACE B, V3, P147
   Xu JH, 1996, J CELL BIOL, V132, P239, DOI 10.1083/jcb.132.1.239
   Zreiqat H, 1999, J BIOMED MATER RES, V44, P389, DOI 10.1002/(SICI)1097-4636(19990315)44:4<389::AID-JBM4>3.0.CO;2-O
NR 57
TC 42
Z9 42
U1 1
U2 8
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD MAR 15
PY 2002
VL 59
IS 4
BP 665
EP 675
DI 10.1002/jbm.1276
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 507LQ
UT WOS:000173030300009
PM 11774328
DA 2018-10-20
ER

PT J
AU Lahann, J
   Pluster, W
   Rodon, T
   Fabry, M
   Klee, D
   Gattner, HG
   Hocker, H
AF Lahann, J
   Pluster, W
   Rodon, T
   Fabry, M
   Klee, D
   Gattner, HG
   Hocker, H
TI Universal approach towards r-Hirudin derivatives with high anti-thrombin
   activity based on chemical differentiation of primary amino groups
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Article
DE biomaterials; biotinylation; MALDI; protein derivatization; r-Hirudin
ID HUMAN ALPHA-THROMBIN; RECOMBINANT HIRUDIN; SANDWICH ELISAS;
   IMMUNOCHEMISTRY; INHIBITOR; COMPLEX; SYSTEM
AB Chemical modification of recombinant hirudin (r-hirudin) is necessary whenever surface-confinement to a biomaterial or biotinylation for subsequent conjugation with carriers is intended. Here, we report a modification strategy that permits chemical discrimination between r-hirudin's amino groups and preserves its thrombin inhibitor activity. By reaction with Msc-ONSu, protective groups were successively introduced in r-hirudin yielding four derivatives (Msc)(x)-hirudin (1 less than or equal to x less than or equal to 4) and pure fractions were isolated by ion exchange chromatography. Structure-function relationships were studied for all derivatives and revealed a decrease in activity of more than 90% as compared to unprotected r-hirudin. MALDI-TOF MS was used to determine the locations of the Msc groups. Furthermore, evidence was provided that r-hirudin's N-terminal amino group is highly important for its anti-thrombin activity. Selective modification of the lysine residues which maintained the free N-terminal amino group preserved the anti-thrombin activity of r-hirudin even after biotinylation and subsequent linkage to streptavidin or confinement to a polymer surface.
C1 Rhein Westfal TH Aachen, Dept Macromol & Text Chem, D-52062 Aachen, Germany.
RP Hocker, H (reprint author), Rhein Westfal TH Aachen, Dept Macromol & Text Chem, Veltmanpl 8, D-52062 Aachen, Germany.
RI Lahann, Joerg/J-7663-2013
CR Agnelli G, 1996, CARDIOVASC RES, V31, P232, DOI 10.1016/S0008-6363(96)00004-1
   BAYKAL D, 1995, AM J CARDIOL, V75, pB82, DOI 10.1016/0002-9149(95)80019-O
   Black FE, 1999, LANGMUIR, V15, P3157, DOI 10.1021/la9803575
   CHANG JY, 1989, J BIOL CHEM, V264, P7141
   CHANG JY, 1983, FEBS LETT, V164, P307, DOI 10.1016/0014-5793(83)80307-X
   DODT J, 1984, FEBS LETT, V165, P180, DOI 10.1016/0014-5793(84)80165-9
   DODT J, 1995, ANGEW CHEM, V107, P867
   FENTON JW, 1992, SEMIN THROMBOSIS HAE, V18, P193
   FOLKERS PJM, 1989, BIOCHEMISTRY-US, V28, P2601, DOI 10.1021/bi00432a038
   Huang RP, 2001, ANAL BIOCHEM, V294, P55, DOI 10.1006/abio.2001.5156
   Lahann J, 2001, ANGEW CHEM INT EDIT, V40, P3166, DOI 10.1002/1521-3773(20010903)40:17<3166::AID-ANIE3166>3.0.CO;2-#
   MARCKWARDT F, 1970, METHOD ENZYMOL, V19, P924
   McNamara CA, 1996, SEMIN THROMB HEMOST, V22, P139, DOI 10.1055/s-2007-999001
   RYDEL TJ, 1990, SCIENCE, V249, P277, DOI 10.1126/science.2374926
   SCHMITZ T, 1991, EUR J BIOCHEM, V195, P251, DOI 10.1111/j.1432-1033.1991.tb15701.x
   Seiler SM, 1996, SEMIN THROMB HEMOST, V22, P223, DOI 10.1055/s-2007-999012
   SUTER M, 1986, IMMUNOL LETT, V13, P313, DOI 10.1016/0165-2478(86)90064-7
   SUTER M, 1989, MOL IMMUNOL, V26, P221, DOI 10.1016/0161-5890(89)90075-8
   WALKER JU, 1988, METHODS MOL BIOL, V5
   Warkentin TE, 1997, DRUG SAFETY, V17, P325, DOI 10.2165/00002018-199717050-00005
NR 20
TC 7
Z9 7
U1 0
U2 4
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1616-5187
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD MAR 15
PY 2002
VL 2
IS 2
BP 82
EP 87
PG 6
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA 533MD
UT WOS:000174533200004
DA 2018-10-20
ER

PT J
AU Demers, CN
   Tabrizian, M
   Petit, A
   Hamdy, RC
   Yahia, L
AF Demers, CN
   Tabrizian, M
   Petit, A
   Hamdy, RC
   Yahia, L
TI Effect of experimental parameters on the in vitro release kinetics of
   transforming growth factor beta 1 from coral particles
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE coral particles; transforming growth factor beta 1; protein adsorption;
   growth factor delivery system; coral degradation
ID BONE MORPHOGENETIC PROTEINS; RAT ECTOPIC MODEL; BIOMATERIAL CARRIERS;
   DELIVERY SYSTEM; TGF-BETA; ADSORPTION; IMPLANT; PHARMACOKINETICS;
   REGENERATION; TISSUE
AB Coral bone graft substitutes have been supplemented in the past with growth factors to further enhance bone regeneration in defects. Little is known, however, on the dynamics of protein release from coral. Coral particles were studied for their ability to release transforming growth factor beta 1 (TGF-beta1) in vitro, under different adsorption conditions. Adsorption of TGF-beta1 (0.05 mug/mL) on coral particles (<80 <mu>m or 300-450 mum) after 24 h of incubation was high, regardless of conditions. TGF-beta1 release kinetics in an artificial bone fluid followed a specific profile: an initial 1-h protein burst, followed by a decreasing release during the next 24 h at which time the release increased again to reach a constant rate until the end of the 2-week study. The protein release rate appeared mainly to depend upon the diffusion of TGF-beta1. TGF-beta1 release from coral particles was enhanced in the presence of bovine serum albumin (BSA) compared to the release in the presence of gelatin, and was dependent on the pH of adsorption. The highest total TGF-beta1 release was obtained when adsorption occurred with BSA at pH 7.4 (82 +/-3%), while the lowest release was observed when adsorption was done in the presence of gelatin at pH 11 (38 +/-1%). TGF-beta1 release was also found to vary with particle size, higher release being obtained with the smaller particles. These results suggest that coral particles could be used as a delivery system for growth factors, and that the release rate may be modulated through modification of the adsorption conditions and coral particle size. (C) 2001 John Wiley & Sons, Inc. J Biomed Mater Res 59: 403-410,2002.
C1 Ecole Polytech, Dept Mech Engn, BBRG, Montreal, PQ H3C 3A7, Canada.
   McGill Univ, Dept Biomed Engn, Montreal, PQ H3A 2B4, Canada.
   McGill Univ, Lady Davis Inst Med Res, Div Orthopaed Surg, Montreal, PQ H3T 1E2, Canada.
   McGill Univ, Shriners Hosp Children, Montreal, PQ H3G 1A6, Canada.
   McGill Univ, Montreal Childrens Hosp, Res Inst, Montreal, PQ H3G 1A6, Canada.
   McGill Univ, Dept Orthopaed, Montreal, PQ H3G 1A6, Canada.
RP Demers, CN (reprint author), Ecole Polytech, Dept Mech Engn, BBRG, POB 6079,Stn Ctr-ville, Montreal, PQ H3C 3A7, Canada.
CR Arnaud E, 1999, BIOMATERIALS, V20, P1909, DOI 10.1016/S0142-9612(99)00090-3
   Arnaud E, 1998, Ann Chir Plast Esthet, V43, P40
   BEGLEY CT, 1995, BIOMATERIALS, V16, P1181, DOI 10.1016/0142-9612(95)93584-Z
   Boden SD, 1995, SPINE, V20, P2633, DOI 10.1097/00007632-199512150-00004
   BONEWALD LF, 1994, J CELL BIOCHEM, V55, P350, DOI 10.1002/jcb.240550312
   Bostrom M P, 1998, Clin Orthop Relat Res, pS124, DOI 10.1097/00003086-199810001-00014
   CHAMBERLAIN JA, 1978, PALEOBIOLOGY, V4, P419
   Chinn J. A., 1995, BIOMEDICAL ENG HDB, P1597
   DANIELPOUR D, 1989, J CELL PHYSIOL, V138, P79, DOI 10.1002/jcp.1041380112
   de Visser KE, 1999, LEUKEMIA, V13, P1188, DOI 10.1038/sj.leu.2401477
   DEMERS C, 2001, IN PRESS BIOMED MAT
   Eliaz RE, 2000, J BIOMED MATER RES, V50, P388, DOI 10.1002/(SICI)1097-4636(20000605)50:3<388::AID-JBM13>3.0.CO;2-F
   Fricain JC, 1998, J BIOMED MATER RES, V42, P96, DOI 10.1002/(SICI)1097-4636(199810)42:1<96::AID-JBM12>3.0.CO;2-M
   GAUTAM J, 1994, J PHARM SCI, V83, P316, DOI 10.1002/jps.2600830310
   GOMBOTZ WR, 1994, J APPL BIOMATER, V5, P141, DOI 10.1002/jab.770050207
   GUILLEMIN G, 1987, J BIOMED MATER RES, V21, P557, DOI 10.1002/jbm.820210503
   HIGUCHI T, 1963, J PHARM SCI, V52, P1145, DOI 10.1002/jps.2600521210
   Jameela SR, 1998, J CONTROL RELEASE, V52, P17, DOI 10.1016/S0168-3659(97)00187-9
   Kirker-Head CA, 2000, ADV DRUG DELIVER REV, V43, P65, DOI 10.1016/S0169-409X(00)00078-8
   KomsaPenkova R, 1996, J BIOCHEM BIOPH METH, V32, P33, DOI 10.1016/0165-022X(95)00046-T
   Krewson CE, 1996, J BIOMAT SCI-POLYM E, V8, P103
   Laffargue P, 2000, J BIOMED MATER RES, V49, P415, DOI 10.1002/(SICI)1097-4636(20000305)49:3<415::AID-JBM15>3.3.CO;2-Q
   Lu L, 2000, J BIOMED MATER RES, V50, P440, DOI 10.1002/(SICI)1097-4636(20000605)50:3<440::AID-JBM19>3.0.CO;2-G
   MASSON M, 1988, NORME FRANCAISE, P9
   Ongpipattanakul B, 1997, J BIOMED MATER RES, V36, P295, DOI 10.1002/(SICI)1097-4636(19970905)36:3<295::AID-JBM4>3.0.CO;2-9
   OREFFO ROC, 1989, BIOCHEM BIOPH RES CO, V158, P817, DOI 10.1016/0006-291X(89)92795-2
   Patat J L, 1992, Acta Orthop Belg, V58 Suppl 1, P115
   PATAT JL, 1989, ANN CHIR PLAST ESTH, V34, P221
   Perry CR, 1999, CLIN ORTHOP RELAT R, P71
   SOUYRIS F, 1985, J MAXILLOFAC SURG, V13, P64, DOI 10.1016/S0301-0503(85)80018-7
   Temenoff JS, 2000, BIOMATERIALS, V21, P2405, DOI 10.1016/S0142-9612(00)00108-3
   Uludag H, 2000, J BIOMED MATER RES, V50, P227, DOI 10.1002/(SICI)1097-4636(200005)50:2<227::AID-JBM18>3.0.CO;2-2
   Uludag H, 1999, J BIOMED MATER RES, V46, P193, DOI 10.1002/(SICI)1097-4636(199908)46:2<193::AID-JBM8>3.0.CO;2-1
   Volpi N, 1999, BIOMATERIALS, V20, P1359, DOI 10.1016/S0142-9612(99)00031-9
   WASSELL DTH, 1995, BIOMATERIALS, V16, P697, DOI 10.1016/0142-9612(95)99697-K
   Wassell DTH, 1997, BIOMATERIALS, V18, P1001, DOI 10.1016/S0142-9612(97)00028-8
   Yamamoto M, 2000, J CONTROL RELEASE, V64, P133, DOI 10.1016/S0168-3659(99)00129-7
   Yaylaoglu MB, 1999, BIOMATERIALS, V20, P711, DOI 10.1016/S0142-9612(98)00199-9
NR 38
TC 14
Z9 15
U1 0
U2 3
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD MAR 5
PY 2002
VL 59
IS 3
BP 403
EP 410
DI 10.1002/jbm.1256
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 507GX
UT WOS:000173019600001
PM 11774297
DA 2018-10-20
ER

PT J
AU Welch, JA
   Montgomery, RD
   Lenz, SD
   Plouhar, P
   Shelton, WR
AF Welch, JA
   Montgomery, RD
   Lenz, SD
   Plouhar, P
   Shelton, WR
TI Evaluation of small-intestinal submucosa implants for repair of meniscal
   defects in dogs
SO AMERICAN JOURNAL OF VETERINARY RESEARCH
LA English
DT Article
ID AUGMENTATION CYSTOPLASTY; MECHANICAL-PROPERTIES; VASCULAR GRAFT;
   GROWTH-FACTOR; MODEL; REGENERATION; BIOMATERIAL; TRANSPLANTATION;
   BIOSCAFFOLD; REPLACEMENT
AB Objective-To assess the effects of porcine small intestinal submucosa (SIS) implants on the healing of meniscal lesions in dogs.
   Animals-16 adult Greyhounds of both sexes.
   Procedure-Unilateral osteotomy was performed at time 0 to disrupt the medial collateral ligament attachment, and two (1 cranial and 1 caudal) 4-mm circular defects were created in the avascular portion of the medial meniscus. One defect was filled with an SIS graft, and the other defect remained empty (control). Three months later, the identical procedure was performed on the contralateral limb. Three months after the second surgery, dogs were euthanatized, and meniscal tissue specimens from both stifle joints were collected for gross, histologic, biomechanical, and biochemical evaluations.
   Results-Regenerative tissue was evident in 4 (2 SIS-implanted and 2 control) of 16 defects examined histologically. In 3 defects, this thin bridge of tissue was composed of immature haphazardly arranged fibrous connective tissue with a relatively uniform distribution of fibroblasts. Aggregate modulus, Poisson ratio, permeability, and shear modulus were not significantly different between control and SIS-implanted defects either 3 or 6 months after surgery. Hydroxyproline content also did not differ between SIS-implanted and control defects at 3 or 6 months.
   Conclusions and Clinical Relevance-implantation of porcine SIS into experimentally induced meniscal lesions in dogs did not promote tissue regeneration.
C1 Auburn Univ, Coll Vet Med, Dept Clin Sci, Auburn, AL 36832 USA.
   Auburn Univ, Coll Vet Med, Dept Pathobiol, Auburn, AL 36832 USA.
   DePuy Inc, Warsaw, IN 46581 USA.
   Mississippi Sports Med, Jackson, MS 39202 USA.
RP Welch, JA (reprint author), Auburn Univ, Coll Vet Med, Dept Clin Sci, Auburn, AL 36832 USA.
CR AIKEN SW, 1994, VET COMP ORTHOPAED, V7, P124
   Arnoczky S. P, 1993, DIS MECH SMALL ANIMA, P764
   ARNOCZKY SP, 1983, AM J SPORT MED, V11, P131, DOI 10.1177/036354658301100305
   ARNOCZKY SP, 1988, J BONE JOINT SURG AM, V70A, P1209, DOI 10.2106/00004623-198870080-00012
   ATHANASIOU KA, 1994, J ORTHOPAED RES, V12, P340, DOI 10.1002/jor.1100120306
   ATHANASIOU KA, 1995, CLIN ORTHOP RELAT R, P254
   Badylak S, 1999, BIOMATERIALS, V20, P2257, DOI 10.1016/S0142-9612(99)00156-8
   BADYLAK SF, 1995, J BIOMED MATER RES, V29, P977, DOI 10.1002/jbm.820290809
   Badylak SF, 1998, TISSUE ENG, V4, P379, DOI 10.1089/ten.1998.4.379
   BADYLAK SF, 1989, J SURG RES, V47, P74, DOI 10.1016/0022-4804(89)90050-4
   BADYLAK SF, 1994, J VASC SURG, V19, P465, DOI 10.1016/S0741-5214(94)70073-7
   Calvano CJ, 2000, J ENDOUROL, V14, P213, DOI 10.1089/end.2000.14.213
   Cobb MA, 1999, SURG NEUROL, V51, P99, DOI 10.1016/S0090-3019(97)00475-8
   Collier S, 1996, VET COMP ORTHOPAED, V9, P60
   Cook JL, 1999, AM J SPORT MED, V27, P658, DOI 10.1177/03635465990270051901
   COX JS, 1975, CLIN ORTHOP RELAT R, P178
   Dejardin LM, 1999, J BIOMED MATER RES, V46, P203, DOI 10.1002/(SICI)1097-4636(199908)46:2<203::AID-JBM9>3.0.CO;2-4
   DOWDY PA, 1995, AM J SPORT MED, V23, P721, DOI 10.1177/036354659502300615
   HILES MC, 1995, J BIOMED MATER RES, V29, P883, DOI 10.1002/jbm.820290714
   HOSGOOD G, 1993, VET SURG, V22, P490, DOI 10.1111/j.1532-950X.1993.tb00426.x
   Kim SS, 1999, J PEDIATR SURG, V34, P124, DOI 10.1016/S0022-3468(99)90241-5
   King D, 1936, J BONE JOINT SURG, V18, P333
   Koski JA, 2000, ORTHOP CLIN N AM, V31, P419, DOI 10.1016/S0030-5898(05)70161-9
   Kropp BP, 1996, J UROLOGY, V156, P599, DOI 10.1016/S0022-5347(01)65761-6
   Kropp BP, 1996, J UROLOGY, V155, P2098, DOI 10.1016/S0022-5347(01)66117-2
   Lantz G C, 1990, J Invest Surg, V3, P217, DOI 10.3109/08941939009140351
   Lewin GA, 1999, J SMALL ANIM PRACT, V40, P340, DOI 10.1111/j.1748-5827.1999.tb03094.x
   MILACHOWSKI KA, 1989, INT ORTHOP, V13, P1
   Pearson P T, 1971, Vet Clin North Am, V1, P489
   Portis AJ, 2000, J ENDOUROL, V14, P203, DOI 10.1089/end.2000.14.203
   PREVEL CD, 1995, ANN PLAS SURG, V35, P374, DOI 10.1097/00000637-199510000-00008
   PREVEL CD, 1995, ANN PLAS SURG, V35, P381, DOI 10.1097/00000637-199510000-00009
   Robotin-Johnson MC, 1998, J THORAC CARDIOV SUR, V116, P805, DOI 10.1016/S0022-5223(98)00436-X
   Shalhav AL, 1999, J ENDOUROL, V13, P241, DOI 10.1089/end.1999.13.241
   SPINDLER KP, 1995, J ORTHOP RES, V13, P201, DOI 10.1002/jor.1100130208
   STEGEMAN.H, 1967, CLIN CHIM ACTA, V18, P267, DOI 10.1016/0009-8981(67)90167-2
   Suckow MA, 1999, J INVEST SURG, V12, P277, DOI 10.1080/089419399272395
   VoytikHarbin SL, 1997, J CELL BIOCHEM, V67, P478, DOI 10.1002/(SICI)1097-4644(19971215)67:4<478::AID-JCB6>3.0.CO;2-P
NR 38
TC 29
Z9 40
U1 2
U2 10
PU AMER VETERINARY MEDICAL ASSOC
PI SCHAUMBURG
PA 1931 N MEACHAM RD SUITE 100, SCHAUMBURG, IL 60173-4360 USA
SN 0002-9645
J9 AM J VET RES
JI Am. J. Vet. Res.
PD MAR
PY 2002
VL 63
IS 3
BP 427
EP 431
DI 10.2460/ajvr.2002.63.427
PG 5
WC Veterinary Sciences
SC Veterinary Sciences
GA 526ML
UT WOS:000174134200020
PM 11911579
DA 2018-10-20
ER

PT J
AU Gottenbos, B
   van der Mei, HC
   Klatter, F
   Nieuwenhuis, P
   Busscher, HJ
AF Gottenbos, B
   van der Mei, HC
   Klatter, F
   Nieuwenhuis, P
   Busscher, HJ
TI In vitro and in vivo antimicrobial activity of covalently coupled
   quaternary ammonium silane coatings on silicone rubber
SO BIOMATERIALS
LA English
DT Article
DE 3-(trimethoxysilyl)-propyldimethyloctadecylammonium chloride;
   poly(dimethylsiloxane); antimicrobial agents; biomaterial-centered
   infection; parallel plate flow chamber; rat model
ID BIOFILM FORMATION; BETAINE ESTERS; CHAIN-LENGTH; INFECTIONS; ADHESION;
   SURFACES; GROWTH
AB Biomaterial-centered infection is a dreaded complication associated with the use of biomedical implants. In this paper, the antimicrobial activity of silicone rubber with a covalently coupled 3-(trimethoxysilyl)-propyldimethyloctadecylammonium chloride (QAS) coating was studied in vitro and in vivo. Gram-positive Staphylococcus aureus ATCC 12600, Staphylococcus epidermidis HBH2 102, and Gram-negative Escherichia coli O2K2 and Pseudomonas aeruginosa AK1 were seeded on silicone rubber with and without QAS-coating, in the absence or presence of adsorbed human plasma proteins. The viability of the adherent bacteria was determined using a live/dead fluorescent stain and a confocal laser scanning microscope. The coating reduced the viability of adherent staphylococci from 90% to 0%, and of Gram-negative bacteria from 90% to 25%, while the presence of adsorbed plasma proteins had little influence. The biomaterials were also subcutaneously implanted in rats for 3 or 7 days, while pre- or postoperatively seeded with S. aureus ATCC 12600. Preoperative seeding resulted in infection of 7 out of 8 silicone rubber implants against 1 out of 8 QAS-coated silicone rubber implants. Postoperative seeding resulted in similar infection incidences on both implant types, but the numbers of adhering bacteria were 70% lower on QAS-coated silicone rubber. In conclusion, QAS-coated silicone rubber shows antimicrobial properties against adhering bacteria, both in vitro and in vivo. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Univ Groningen, Dept Biomed Engn, NL-9713 AV Groningen, Netherlands.
   Univ Groningen, Fac Med Sci, Dept Cell Biol, Immunol Sect, NL-9713 AV Groningen, Netherlands.
RP Busscher, HJ (reprint author), Univ Groningen, Dept Biomed Engn, Antonius Deusinglaan 1, NL-9713 AV Groningen, Netherlands.
CR Ahlstrom B, 1999, APMIS, V107, P318, DOI 10.1111/j.1699-0463.1999.tb01560.x
   AHLSTROM B, 1995, ANTIMICROB AGENTS CH, V39, P50, DOI 10.1128/AAC.39.1.50
   Calas M, 1997, J MED CHEM, V40, P3557, DOI 10.1021/jm9701886
   Chen CZ, 1999, CHEM COMMUN, P1585
   CHRISTENSEN GD, 1989, INFECT ASS INDWELLIN, P27
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Everaert EPJM, 1999, ARCH OTOLARYNGOL, V125, P1329, DOI 10.1001/archotol.125.12.1329
   Flemming RG, 2000, BIOMATERIALS, V21, P273, DOI 10.1016/S0142-9612(99)00176-3
   Gottenbos B, 2001, J ANTIMICROB CHEMOTH, V48, P7, DOI 10.1093/jac/48.1.7
   Gottenbos B, 1999, METHODS ENZYMOL, V310, P523
   Gould IM, 1999, J ANTIMICROB CHEMOTH, V43, P459, DOI 10.1093/jac/43.4.459
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   HARKES G, 1992, J BIOMAT SCI-POLYM E, V3, P403, DOI 10.1163/156856292X00213
   Hugo WB, 1992, PRINCIPLES PRACTICE, P7
   ISQUITH AJ, 1972, APPL MICROBIOL, V24, P859
   Kenawy ER, 1998, J CONTROL RELEASE, V50, P145, DOI 10.1016/S0168-3659(97)00126-0
   LINDSTEDT M, 1990, ANTIMICROB AGENTS CH, V34, P1949, DOI 10.1128/AAC.34.10.1949
   MERRIANOS JJ, 1991, DISINFECTION STERILI, P225
   MURRAY PR, 1988, J CLIN MICROBIOL, V26, P1884
   Printzen G, 1996, INJURY, V27, P9
   Silver JH, 1999, BIOMATERIALS, V20, P1533, DOI 10.1016/S0142-9612(98)00173-2
   VANWAGENEN RA, 1980, J COLLOID INTERF SCI, V76, P305, DOI 10.1016/0021-9797(80)90374-4
   Verkerke GJ, 1997, ARTIF ORGANS, V21, P413
NR 23
TC 293
Z9 304
U1 6
U2 112
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 2002
VL 23
IS 6
BP 1417
EP 1423
DI 10.1016/S0142-9612(01)00263-0
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 515EC
UT WOS:000173481600003
PM 11829437
DA 2018-10-20
ER

PT J
AU Ziegelaar, BW
   Aigner, J
   Staudenmaier, R
   Lempart, K
   Mack, B
   Happ, T
   Sittinger, M
   Endres, M
   Naumann, A
   Kastenbauer, E
   Rotter, N
AF Ziegelaar, BW
   Aigner, J
   Staudenmaier, R
   Lempart, K
   Mack, B
   Happ, T
   Sittinger, M
   Endres, M
   Naumann, A
   Kastenbauer, E
   Rotter, N
TI The characterisation of human respiratory epithelial cells cultured on
   resorbable scaffolds: first steps towards a tissue engineered tracheal
   replacement
SO BIOMATERIALS
LA English
DT Article
DE tissue engineering; respiratory epithelium; lectins; biodegradable
   scaffolds
ID CILIOGENESIS; EXPRESSION; TOPOGRAPHY; CARTILAGE; MATRIX
AB In this study we have used lectin histochemistry and scanning electron microscopy (SEM) to assess the growth and characterise the differentiation of human respiratory epithelial cells (REC) cultured on two biomaterial scaffolds. The first scaffold, based on a hyaluronic acid derivative, was observed to be non-adhesive for REC. This lack of adhesion was found to be unrelated to the presence of the hyaluronic acid binding domain on the surface of isolated REC. The other scaffold, consisting of equine collagen, was observed to encourage REC spreading and adhesion. Positive Ulex Europaeus agglutinin (UEA) lectin staining of this preparation indicated the presence of ciliated REC on the scaffold surface. However, the marked decrease in peanut agglutinin (PNA) positive staining, relative to that of control cultures and native tissue, indicates a dedifferentiation of the secretory cells of the REC monolayer. SEM analysis of REC cultured on the collagen scaffold confirmed the presence of ciliated cells thereby validating the UEA positive staining. The presence of both established and developing cilia was also verified. This study indicates that collagen biomaterials are appropriate for the tissue engineering of REC. Furthermore, that UEA and PNA staining is a useful tool in the characterisation of cells cultured on biomaterials, therefore helpful in identifying biomaterials that are suitable for specific tissue engineering purposes. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Univ Munich, Dept Otorhinolaryngol Head & Neck Surg, D-81377 Munich, Germany.
   Tech Univ Munich, Cent Inst Med Engn, D-85748 Munich, Germany.
   German Rheumatism Res Ctr, Lab Tissue Engn, D-10117 Berlin, Germany.
RP Ziegelaar, BW (reprint author), Univ Munich, Dept Otorhinolaryngol Head & Neck Surg, Marchioninistr 15, D-81377 Munich, Germany.
OI Rotter, Nicole/0000-0003-1537-8340
CR Aigner J, 1998, J BIOMED MATER RES, V42, P172, DOI 10.1002/(SICI)1097-4636(199811)42:2<172::AID-JBM2>3.0.CO;2-M
   BELITSOS PC, 1990, J IMMUNOL, V144, P1661
   BOTTEMA JR, 1986, J SURG RES, V41, P16, DOI 10.1016/0022-4804(86)90003-X
   Bucheler M, 2000, LARYNGO RHINO OTOL, V79, P160
   Carbognani P, 1999, EUR SURG RES, V31, P210, DOI 10.1159/000008641
   COLOMBATTI A, 1982, P NATL ACAD SCI-BIOL, V79, P1926, DOI 10.1073/pnas.79.6.1926
   CULL DL, 1990, ANN THORAC SURG, V50, P889
   DEJONG PM, 1994, AM J RESP CELL MOL, V10, P271, DOI 10.1165/ajrcmb.10.3.8117445
   Evans MDM, 1999, J BIOMED MATER RES, V46, P485, DOI 10.1002/(SICI)1097-4636(19990915)46:4<485::AID-JBM6>3.0.CO;2-F
   Fitton JH, 1998, J BIOMED MATER RES, V42, P245
   Galassi G, 2000, BIOMATERIALS, V21, P2183, DOI 10.1016/S0142-9612(00)00147-2
   HANAMURE Y, 1994, ANN OTO RHINOL LARYN, V103, P889, DOI 10.1177/000348949410301111
   Hassid S, 1997, EUR J MORPHOL, V35, P79, DOI 10.1076/ejom.35.2.79.13066
   HE YG, 1991, CURR EYE RES, V10, P851, DOI 10.3109/02713689109013881
   Horch RE, 2000, TISSUE ENG, V6, P53, DOI 10.1089/107632700320892
   JORISSEN M, 1990, ORL J OTO-RHINO-LARY, V52, P368, DOI 10.1159/000276166
   KEENAN KP, 1983, VIRCHOWS ARCH B, V43, P213, DOI 10.1007/BF02932958
   Messineo A, 1992, J PEDIATR SURG, V27, P1134
   MORISSEN M, 1991, EUR RESPIR J, V2, P210
   OKAMURA N, 1991, ASAIO T, V37, P317
   Orwin EJ, 2000, TISSUE ENG, V6, P307, DOI 10.1089/107632700418038
   Otori N, 1998, ORL J OTO-RHINO-LARY, V60, P339, DOI 10.1159/000027621
   Radice M, 2000, J BIOMED MATER RES, V50, P101, DOI 10.1002/(SICI)1097-4636(200005)50:2<101::AID-JBM2>3.0.CO;2-M
   SUEMASU K, 1975, GANN, V66, P109
   TOURNIER JM, 1992, ARCH INT PHYSIOL BIO, V100, pA47, DOI 10.3109/13813459209000713
   VACANTI CA, 1994, J PEDIATR SURG, V29, P201, DOI 10.1016/0022-3468(94)90318-2
   WATT FM, 1986, TRENDS BIOCHEM SCI, V11, P482, DOI 10.1016/0968-0004(86)90252-5
NR 27
TC 22
Z9 30
U1 1
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 2002
VL 23
IS 6
BP 1425
EP 1438
DI 10.1016/S0142-9612(01)00264-2
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 515EC
UT WOS:000173481600004
PM 11829438
DA 2018-10-20
ER

PT J
AU Hillmann, G
   Steinkamp-Zucht, A
   Geurtsen, W
   Gross, G
   Hoffmann, A
AF Hillmann, G
   Steinkamp-Zucht, A
   Geurtsen, W
   Gross, G
   Hoffmann, A
TI Culture of primary human gingival fibroblasts on biodegradable membranes
SO BIOMATERIALS
LA English
DT Article
DE gingiva; fibroblasts; biodegradable membranes; tissue engineering; bone
   morphogenetic proteins
ID ARTIFICIAL TISSUES; POLYMER SCAFFOLDS; BONE-FORMATION; BIO-OSS;
   CARTILAGE; CHONDROCYTES; REGENERATION; EXPRESSION; TRANSPLANTATION;
   MATRICES
AB Repair and regeneration of periodontal tissues by tissue engineering is dependent on the use of biodegradable polymer scaffolds which serve as a carrier for cells or bioactive substances. There is a need to understand how a specific biomaterial may influence gene expression. The aim of this investigation was to develop and to optimize an in vitro technique for the adhearance and proliferation of primary human gingiva cells on implantable and biodegradable matrices. Square pieces of Bio-GIDE(R) matrix (BG) and slices of ETHISORB(R) tamponade (ET) were coated with poly-L-lactide. The stability of coated and uncoated scaffolds was investigated by incubation in standard culture medium. Various concentrations of the cells were seeded onto coated and uncoated polymer matrices in tissue culture dishes without shaking ("static seeding") or continuous shaking ("agitated seeding"). Cultures were grown for 4 week and were then evaluated by light and scanning electron microscopy. After a culture period of 10 d, BG-carriers showed a delicate consistency which made histological processing difficult. Cells were grown only sparsely in coated and non-coated BG-scaffolds. Contrary, ET-specimens were stable during a 4 week culture period. After "static seeding" a significantly higher number of cells resulted in comparison to those in "agitated" cultures. The cells were evenly distributed throughout the ET-carriers and produced extracellular matrix compounds as well. Furthermore, the examination with RT-PCR (reverse transcription-polymerase chain reaction) revealed that the cells synthesized and secreted type I collagen, and expressed genes implicated in transducing bone morphogenetic protein (BMP) signals. Messenger RNAs for BMP-2, -4, -7, the BMP type I receptors Act R-I (alk 2, activin-like kinase receptor), BMPR-IA (alk 3), -IB (alk 6), and the type II receptor BMPR-II were detected. These data reveal that static seeding favors the adherence and proliferation of primary gingival cells on polyglactin matrices. This system may serve as a valuable tool for periodontal tissue engineering. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Hannover Med Sch, Sch Dent, Dept Conservat Dent & Periodontol, D-30623 Hannover, Germany.
   GBF, D-38124 Braunschweig, Germany.
RP Hillmann, G (reprint author), Hannover Med Sch, Sch Dent, Dept Conservat Dent & Periodontol, Carl Neuberg Str 1, D-30623 Hannover, Germany.
CR Alpaslan C, 1996, BRIT J ORAL MAX SURG, V34, P414, DOI 10.1016/S0266-4356(96)90098-4
   Buurma B, 1999, EUR J ORAL SCI, V107, P282, DOI 10.1046/j.0909-8836.1999.eos107408.x
   Camelo M, 1998, INT J PERIODONT REST, V18, P321
   GLOWACKI J, 1983, P SOC EXP BIOL MED, V172, P93
   Han DK, 1998, J BIOMAT SCI-POLYM E, V9, P667
   HAYASHI T, 1994, PROG POLYM SCI, V19, P663, DOI 10.1016/0079-6700(94)90030-2
   Hillmann G, 1999, J CELL SCI, V112, P2823
   Hoerstrup S P, 1998, Swiss Surg, VSuppl 2, P23
   KARNOVSKY MJ, 1965, J CELL BIOL, V27, P137
   Kim BS, 1998, TRENDS BIOTECHNOL, V16, P224, DOI 10.1016/S0167-7799(98)01191-3
   KIM WS, 1994, PLAST RECONSTR SURG, V94, P233, DOI 10.1097/00006534-199408000-00001
   Krebsbach PH, 1997, TRANSPLANTATION, V63, P1059, DOI 10.1097/00007890-199704270-00003
   Kuboki Y, 1998, EUR J ORAL SCI, V106, P197, DOI 10.1111/j.1600-0722.1998.tb02176.x
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Minuth WW, 1998, CELL TISSUE RES, V291, P1
   PUELACHER WC, 1994, INT J ORAL MAX SURG, V23, P49, DOI 10.1016/S0901-5027(05)80328-5
   Rotter N, 1998, J BIOMED MATER RES, V42, P347, DOI 10.1002/(SICI)1097-4636(19981205)42:3<347::AID-JBM2>3.0.CO;2-J
   Saldanha V, 2000, BIOMATERIALS, V21, P2427, DOI 10.1016/S0142-9612(00)00110-1
   SASANO Y, 1993, ANAT REC, V236, P373, DOI 10.1002/ar.1092360211
   Sittinger M, 1997, INT J ARTIF ORGANS, V20, P57
   Tatakis DN, 1999, PERIODONTOL 2000, V19, P59, DOI 10.1111/j.1600-0757.1999.tb00147.x
   Unsal B, 1999, J Oral Sci, V41, P57
   Vunjak-Novakovic G, 1998, BIOTECHNOL PROGR, V14, P193, DOI 10.1021/bp970120j
   Zitzmann NU, 1997, INT J ORAL MAX IMPL, V12, P844
   Zund G, 1998, EUR J CARDIO-THORAC, V13, P160, DOI 10.1016/S1010-7940(97)00309-6
NR 25
TC 43
Z9 53
U1 0
U2 14
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 2002
VL 23
IS 6
BP 1461
EP 1469
DI 10.1016/S0142-9612(01)00270-8
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 515EC
UT WOS:000173481600008
PM 11829442
DA 2018-10-20
ER

PT J
AU Arciola, CR
   Campoccia, D
   Montanaro, L
AF Arciola, CR
   Campoccia, D
   Montanaro, L
TI Effects on antibiotic resistance of Staphylococcus epidermidis following
   adhesion to polymethylmethacrylate and to silicone surfaces
SO BIOMATERIALS
LA English
DT Article
DE bacterial adhesion; antibiotic resistance; Staphylococcus epidermidis;
   biomaterials; polymethylmethacrylate (PMMA); silicone
ID COAGULASE-NEGATIVE STAPHYLOCOCCI; IN-VITRO; METHICILLIN RESISTANCE;
   PROSTHESIS INFECTIONS; SLIME PRODUCTION; AUREUS; ADHERENCE; BACTERIA;
   INVITRO; STRAINS
AB A number of studies appears to give emphasis to the role of prosthetic materials in determining microbial adherence and resistance to host defence and drug therapy. Aim of this study was to explore whether the direct contact with biomaterial substrata of different chemical nature could influence bacterial behaviour, determining possible changes in the bacteria population as far as antibiotic resistance is concerned. To this end, susceptibility to penicillin, erythromycin, clindamycin, cefamandole, imipenem, vancomycin, ciprofloxacin, ampicillin, cefazolin, trimethoprim-sulfamethoxazole, chloramphenicol, amikacin and netilmicin was evaluated in a methicillin-, gentamicin- and tobramycin-resistant Staphylococcus epidermidis strain, after in vitro adhesion to polymethylmethacrylate (PMMA) and to silicone elastomer. The susceptibility to antibiotics of both adherent bacteria and bacteria which, although exposed to the materials, had not undergone adhesion was measured as bacterial growth inhibition area onto a plate antibiogram, according to Kirby-Bauer and using an image analyser system. The results obtained suggest that the two test materials considered in this study were capable to condition bacterial behaviour. In particular, the adhesion onto PMMA surfaces induced a marked and significant decrease in susceptibility to the following beta-lactam antibiotics: cefamandole (32%), cefazolin (23%), imipenem (27%), ampicillin (31%). Moreover, PMMA caused a lower but significant reduction in resistance to vancomycin (15%), chloramphenicol (16%), amikacin (13%), netilmicin (13%), erythromycin (11%), trimethoprim-sulfamethoxazole (13%). In contrast, the adhesion onto silicone elastomer appeared to influence bacterial changes to a lesser extent and elicited a significant decrease in susceptibility only to cefazolin (10%) and amikacin (11%). Further studies are required to thoroughly investigate the mechanisms of these variations, even though, also according to other authors, one of the best conceivable conclusions is that some material substrata can lead to selection of variant adhesive bacteria with increased antibiotic resistance. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Rizzoli Orthopaed Inst, Res Lab Biocompatibil Implant Mat, I-40136 Bologna, Italy.
   Univ Bologna, Dept Expt Pathol, Bologna, Italy.
RP Arciola, CR (reprint author), Rizzoli Orthopaed Inst, Res Lab Biocompatibil Implant Mat, Via Barbiano 1-10, I-40136 Bologna, Italy.
EM carlarenata.arciola@ior.it
RI Campoccia, Davide/K-5348-2018
OI Campoccia, Davide/0000-0002-3336-0219
CR An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   An YH, 2000, HDB BACTERIAL ADHESI, P609
   ARCIOLA CR, 1995, BIOMATERIALS, V16, P681, DOI 10.1016/0142-9612(95)99694-H
   Arciola CR, 1998, J BIOMED MATER RES, V42, P1
   ARCIOLA CR, 1993, BIOMATERIALS, V14, P1161, DOI 10.1016/0142-9612(93)90161-T
   ARCIOLA CR, 1994, J CATARACT REFR SURG, V20, P158, DOI 10.1016/S0886-3350(13)80157-5
   ARIZONO T, 1992, ACTA ORTHOP SCAND, V63, P661
   BAUER AW, 1966, AM J CLIN PATHOL, V45, P493
   Chambers HF, 1997, CLIN MICROBIOL REV, V10, P781
   CRISTHENSEN GD, 1982, INFECT IMMUN S, V2, P2870
   Foster T. J., 1994, P31
   Francois P, 1996, INFECT CONT HOSP EP, V17, P514
   FREEMAN DJ, 1989, J CLIN PATHOL, V42, P872, DOI 10.1136/jcp.42.8.872
   Frere JM, 1999, NAT BIOTECHNOL, V17, pBV17, DOI 10.1038/7158
   GRISTINA AG, 1989, ANTIMICROB AGENTS CH, V33, P813, DOI 10.1128/AAC.33.6.813
   GRISTINA AG, 1987, BIOMATERIALS, V8, P423, DOI 10.1016/0142-9612(87)90077-9
   Huebner J, 1999, ANNU REV MED, V50, P223
   Kelly CG, 1999, NAT BIOTECHNOL, V17, P42, DOI 10.1038/5213
   MEMPEL M, 1994, ANTIMICROB AGENTS CH, V38, P1251, DOI 10.1128/AAC.38.6.1251
   MEMPEL M, 1995, MED MICROBIOL IMMUN, V184, P109
   Montanaro L, 1999, BIOMATERIALS, V20, P1945, DOI 10.1016/S0142-9612(99)00099-X
   Montanaro L, 1999, MICROBIOLOGICA, V22, P331
   Montanaro L, 2001, MICROBIOLOGICA, V24, P57
   Montanaro L., 2000, HDB BACTERIAL ADHESI, P331
   *NAT COMM CLIN LAB, 1998, M2T4 NAT COMM CLIN L
   Oga M, 1992, J Long Term Eff Med Implants, V1, P321
   PATTI JM, 1994, ANNU REV MICROBIOL, V48, P585, DOI 10.1146/annurev.mi.48.100194.003101
   PRATT W B, 1990, P565
   Vaudaux PE, 1998, ANTIMICROB AGENTS CH, V42, P564, DOI 10.1128/AAC.42.3.564
   WEBB LX, 1994, J ORTHOP TRAUMA, V8, P28, DOI 10.1097/00005131-199402000-00007
   Williams I, 1997, MICROBIOL-UK, V143, P2407, DOI 10.1099/00221287-143-7-2407
NR 31
TC 50
Z9 51
U1 0
U2 12
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 2002
VL 23
IS 6
BP 1495
EP 1502
DI 10.1016/S0142-9612(01)00275-7
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 515EC
UT WOS:000173481600012
PM 11829446
DA 2018-10-20
ER

PT J
AU Heath, DJ
   Christian, P
   Griffin, M
AF Heath, DJ
   Christian, P
   Griffin, M
TI Involvement of tissue trans glutaminase in the stabilisation of
   biomaterial/tissue interfaces important in medical devices
SO BIOMATERIALS
LA English
DT Article
DE human osteoblasts; tissue transglutaminase; ECM stabilisation;
   poly(epsilon-caprolactone); bioactive biomaterial
ID CROSS-LINKING ENZYMES; CELL-ADHESION; 3T3 FIBROBLASTS; BINDING SITE;
   TRANSGLUTAMINASE; FIBRONECTIN; EXPRESSION; POLYMERS; SURFACE;
   IDENTIFICATION
AB Tissue transglutaminase (tTG) has recently been established as a novel cell surface adhesion protein that binds with high affinity to fibronectin in the pericellular matrix. In this study, we have made use of this property to enhance the biocompatibility of poly(epsilon-caprolactone) (PCL), a biomaterial currently used in bone repair. Poly(epsilon-caprolactone) discs were first coated with fibronectin and then tTG. The surface localisation of the two proteins was confirmed using ELISA and the tTG shown to be active on the surface by incorporation of biotin cadaverine into the fibronectin coating. When human osteoblasts (HOBs) were seeded onto the coated polymer surfaces in serum free medium, the surface coated with fibronectin and then tTG showed an increase in the spreading of the cells as compared to the surface coated with fibronectin alone, when analysed using environmental scanning electron microscopy. The presence of tTG had no effect on HOB cell differentiation when analysed by determining alkaline phosphatase activity. The use of tTG as a novel adhesion protein in this way may therefore have considerable potential in forming a stable tissue/bio material interface for application in medical devices. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Nottingham Trent Univ, Dept Life Sci, Nottingham NG11 8NS, England.
   Univ Nottingham, Sch Med, Queens Med Ctr, Sch Biomed Sci, Nottingham NG7 2UH, England.
   Univ Nottingham, Sch Mech Mat Mfg Engn & Management, Nottingham NG7 2RD, England.
RP Griffin, M (reprint author), Nottingham Trent Univ, Dept Life Sci, Clifton Lane, Nottingham NG11 8NS, England.
CR ACHYUTHAN KE, 1995, J IMMUNOL METHODS, V180, P69, DOI 10.1016/0022-1759(94)00300-L
   ACHYUTHAN KE, 1987, J BIOL CHEM, V262, P1901
   AESCHLIMANN D, 1995, J CELL BIOL, V129, P881, DOI 10.1083/jcb.129.3.881
   AESCHLIMANN D, 1994, THROMB HAEMOSTASIS, V71, P402
   AESCHLIMANN D, 1993, J CELL BOIL, V120, P1462
   Akimov SS, 2000, J CELL BIOL, V148, P825, DOI 10.1083/jcb.148.4.825
   ALI SAM, 1992, BIOMATER TISSUE INTE, V10, P399
   Blitterswijk CAv, 1991, BIOMATERIALS, V12, P187
   Borge L, 1996, BBA-MOL CELL RES, V1312, P117, DOI 10.1016/0167-4889(96)00028-6
   Coombes A. G. A., 1994, Clinical Materials, V17, P35, DOI 10.1016/0267-6605(94)90046-9
   DANIELS AU, 1990, J APPL BIOMATER, V1, P57, DOI 10.1002/jab.770010109
   DISILVIO L, 1995, THESIS U LONDON UK
   FENG XD, 1983, J POLYM SCI POL LETT, V21, P593, DOI 10.1002/pol.1983.130210802
   FESUS L, 1986, EUR J BIOCHEM, V154, P371, DOI 10.1111/j.1432-1033.1986.tb09407.x
   FRAZZA E J, 1971, Journal of Biomedical Materials Research Biomedical Materials Symposium, V1, P43
   Gaudry CA, 1999, J BIOL CHEM, V274, P30707, DOI 10.1074/jbc.274.43.30707
   Gaudry CA, 1999, EXP CELL RES, V252, P104, DOI 10.1006/excr.1999.4633
   GAUDRY CA, 1998, THESIS NOTTINGHAM TR
   GENTILE V, 1992, J CELL BIOL, V119, P463, DOI 10.1083/jcb.119.2.463
   GREENBERG CS, 1991, FASEB J, V5, P3071
   Heath DJ, 2001, J BONE MINER RES, V16, P1477, DOI 10.1359/jbmr.2001.16.8.1477
   HOHENADL C, 1995, J BIOL CHEM, V270, P23415, DOI 10.1074/jbc.270.40.23415
   Isobe T, 1999, EUR J CELL BIOL, V78, P876, DOI 10.1016/S0171-9335(99)80089-2
   JEONG JM, 1995, J BIOL CHEM, V270, P5654, DOI 10.1074/jbc.270.10.5654
   Jones RA, 1997, J CELL SCI, V110, P2461
   Kaartinen MT, 1997, J BIOL CHEM, V272, P22736, DOI 10.1074/jbc.272.36.22736
   Lemmouchi Y, 1998, BIOMATERIALS, V19, P1827, DOI 10.1016/S0142-9612(98)00074-X
   LEMOSY EK, 1992, J BIOL CHEM, V267, P7880
   Lowry KJ, 1997, J BIOMED MATER RES, V36, P536
   PELUSO G, 1996, J MATER SCI-MATER M, V7, P701
   PITT CG, 1981, J APPL POLYM SCI, V26, P3779, DOI 10.1002/app.1981.070261124
   PITT CG, 1979, J BIOMED MATER RES, V13, P479
   POTTS JR, 1994, CURR OPIN CELL BIOL, V6, P648, DOI 10.1016/0955-0674(94)90090-6
   RAGO R, 1990, ANAL BIOCHEM, V191, P31
   RUOSLAHTI E, 1988, ANNU REV BIOCHEM, V57, P375, DOI 10.1146/annurev.bi.57.070188.002111
   Scotchford CA, 1998, J BIOMED MATER RES, V41, P431, DOI 10.1002/(SICI)1097-4636(19980905)41:3<431::AID-JBM13>3.0.CO;2-L
   Smethurst PA, 1996, BIOCHEM J, V313, P803, DOI 10.1042/bj3130803
   SMITH K L, 1990, Advanced Drug Delivery Reviews, V4, P343, DOI 10.1016/0169-409X(90)90026-O
   Ueki S, 1996, J CELL SCI, V109, P2727
   UPCHURCH HF, 1991, J CELL PHYSIOL, V149, P375, DOI 10.1002/jcp.1041490304
   Verderio E, 1999, J HISTOCHEM CYTOCHEM, V47, P1417, DOI 10.1177/002215549904701108
   Verderio E, 1998, EXP CELL RES, V239, P119, DOI 10.1006/excr.1997.3874
NR 42
TC 33
Z9 33
U1 0
U2 9
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 2002
VL 23
IS 6
BP 1519
EP 1526
DI 10.1016/S0142-9612(01)00282-4
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 515EC
UT WOS:000173481600015
PM 11829448
DA 2018-10-20
ER

PT J
AU Levy, I
   Nussinovitch, A
   Shpigel, E
   Shoseyov, O
AF Levy, I
   Nussinovitch, A
   Shpigel, E
   Shoseyov, O
TI Recombinant cellulose crosslinking protein: a novel paper-modification
   biomaterial
SO CELLULOSE
LA English
DT Article
DE cellulose crosslinking protein; cellulose fibers; cellulose-binding
   domain; mechanical properties; paper
ID BINDING DOMAIN; CRYSTALLINE CELLULOSE; FIMI; PURIFICATION; COMPOSITES;
   ADSORPTION; RESIDUES; DRY
AB Cellulose-binding domains have been isolated from various cellulases, and proteins, which lack hydrolytic activity. The hypothesis that a cellulose-binding domain can be used to alter surface and mechanical properties of paper was tested. Two cellulose-binding domains from Clostriium cellulovorans were fused to form a cellulose crosslinking protein (CCP). The recombinant bifunctional cellulose-binding protein was expressed in E. coli, applied by immersion onto Whatman cellulose filter paper, and its mechanical properties were tested. The purified protein improved the treated paper's mechanical properties (tensile strength, brittleness, Young's modulus and energy to break). In addition, cellulose crosslinking protein treatment was shown to transform filter paper into a more water-repellent paper. The binding of cellulose-binding domains to cellulose under a wide range of envi-ronmental conditions, without the need for chemical reactions, and its biodegradability make them attractive moieties for the design of a new class of paper-modification materials.
C1 Hebrew Univ Jerusalem, Kennedy Leigh Ctr Hort Res, IL-76100 Rehovot, Israel.
   Hebrew Univ Jerusalem, Otto Warburg Ctr Agr Biotechnol, IL-76100 Rehovot, Israel.
   Hebrew Univ Jerusalem, Inst Biochem Food Sci & Human Nutr, Fac Agr Food & Environm Qual Sci, IL-76100 Rehovot, Israel.
   CBD Technol Ltd, IL-76100 Rehovot, Israel.
CR Askling C, 1998, J MATER SCI, V33, P1997, DOI 10.1023/A:1004390313084
   Bayer EA, 1998, J STRUCT BIOL, V124, P221, DOI 10.1006/jsbi.1998.4065
   Bledzki AK, 1996, J APPL POLYM SCI, V59, P1329, DOI 10.1002/(SICI)1097-4628(19960222)59:8<1329::AID-APP17>3.3.CO;2-5
   DIN N, 1994, MOL MICROBIOL, V11, P747, DOI 10.1111/j.1365-2958.1994.tb00352.x
   DOI RH, 1994, CRIT REV MICROBIOL, V20, P87, DOI 10.3109/10408419409113548
   Dourado F, 1999, CELLULOSE, V6, P265, DOI 10.1023/A:1009251722598
   Dufresne A, 1997, J APPL POLYM SCI, V64, P1185
   Gassan J, 1999, J APPL POLYM SCI, V71, P623, DOI 10.1002/(SICI)1097-4628(19990124)71:4<623::AID-APP14>3.3.CO;2-B
   GILKES NR, 1992, J BIOL CHEM, V267, P6743
   GILKES NR, 1991, MICROBIOL REV, V55, P303
   Glasser WG, 1999, J APPL POLYM SCI, V73, P1329, DOI 10.1002/(SICI)1097-4628(19990815)73:7<1329::AID-APP26>3.0.CO;2-Q
   GOLDSTEIN MA, 1993, J BACTERIOL, V175, P5762
   HARSH DC, 1991, J CONTROL RELEASE, V17, P175, DOI 10.1016/0168-3659(91)90057-K
   HAYDEN W, 1956, MECH BEHAV, P1
   HENRISSAT B, 1994, CELLULOSE, V1, P169, DOI 10.1007/BF00813506
   Kauffmann C, 2000, ENVIRON SCI TECHNOL, V34, P1292, DOI 10.1021/es990754h
   Linder M, 1996, P NATL ACAD SCI USA, V93, P12251, DOI 10.1073/pnas.93.22.12251
   Linder M, 1996, J BIOL CHEM, V271, P21268, DOI 10.1074/jbc.271.35.21268
   McLean BW, 2000, PROTEIN ENG, V13, P801, DOI 10.1093/protein/13.11.801
   Rechter M, 1999, BIOCHEM BIOPH RES CO, V255, P657, DOI 10.1006/bbrc.1999.0181
   Roberts JC, 1996, CHEM PAPER ROYAL SOC
   Sambrook J, 1989, MOL CLONING LAB MANU
   Sellen D. B., 1980, The mechanical properties of biological materials., P315
   SHOSEYOV O, 1990, BIOCHEM BIOPH RES CO, V169, P667, DOI 10.1016/0006-291X(90)90382-W
   SHOSEYOV O, 1990, P NATL ACAD SCI USA, V87, P2192, DOI 10.1073/pnas.87.6.2192
   SHOSEYOV O, 1992, P NATL ACAD SCI USA, V89, P3483, DOI 10.1073/pnas.89.8.3483
   Shpigel E, 1998, PROTEIN EXPRES PURIF, V14, P185, DOI 10.1006/prep.1998.0929
   Shpigel E, 2000, BIOTECHNOL APPL BIOC, V31, P197, DOI 10.1042/BA20000002
   Shpigel E, 1999, BIOTECHNOL BIOENG, V65, P17, DOI 10.1002/(SICI)1097-0290(19991005)65:1<17::AID-BIT3>3.0.CO;2-Y
   SPENCE EE, 1987, ENCY POLYM SCI TECHN, V10, P761
   Teeri T T, 1992, Biotechnology, V21, P417
   TESORO GC, 1961, CELLULOSE CELLULOS 5, P835
   Tomme P, 1998, J CHROMATOGR B, V715, P283, DOI 10.1016/S0378-4347(98)00053-X
   Tomme P, 1995, Adv Microb Physiol, V37, P1, DOI 10.1016/S0065-2911(08)60143-5
   Tormo J, 1996, EMBO J, V15, P5739, DOI 10.1002/j.1460-2075.1996.tb00960.x
   VILLALOBOS JA, 1981, J TAPPI, V64, P129
   WHITE A, 1994, BIOCHEMISTRY-US, V33, P12546, DOI 10.1021/bi00208a003
   Xu GG, 1999, J APPL POLYM SCI, V74, P907, DOI 10.1002/(SICI)1097-4628(19991024)74:4<907::AID-APP17>3.0.CO;2-9
   XU GY, 1995, BIOCHEMISTRY-US, V34, P6993, DOI 10.1021/bi00021a011
NR 39
TC 38
Z9 39
U1 0
U2 15
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0969-0239
J9 CELLULOSE
JI Cellulose
PD MAR
PY 2002
VL 9
IS 1
BP 91
EP 98
DI 10.1023/A:1015848701029
PG 8
WC Materials Science, Paper & Wood; Materials Science, Textiles; Polymer
   Science
SC Materials Science; Polymer Science
GA 562YU
UT WOS:000176227200010
DA 2018-10-20
ER

PT J
AU Hubbard, SC
   Burns, JW
AF Hubbard, SC
   Burns, JW
TI Effects of a hyaluronan-based membrane (Seprafilm (R)) on
   intraperitoneally disseminated human colon cancer cell growth in a nude
   mouse model
SO DISEASES OF THE COLON & RECTUM
LA English
DT Article
DE Seprafilm (R) adhesion prevention; human xenograft model; nude mouse;
   colon cancer
ID REGENERATED CELLULOSE INTERCEED; TEX SURGICAL MEMBRANE; ADHESIONS;
   REDUCTION; MULTICENTER; LOCOMOTION; RECEPTORS; SELECTION; VARIANTS;
   BARRIER
AB PURPOSE: The purpose of this study was to examine whether a hyaluronan-based membrane (Seprafilm(R) Adhesion Barrier) could affect growth and metastasis of colon cancer in a human xenograft/nude mouse model. METHODS: Male athymic (nude) mice underwent a midline abdominal incision followed by an intraperitoneal inoculation of KM12-L4 human colon cancer cells. Seprafilm(R) membrane was placed under the incision or on the right lateral abdominal wall control groups received no Seprafilm(R) membrane. In another group, Vicryl(TM) mesh was placed on the right lateral abdominal wall and removed after I minute to control for surgical trauma associated with biomaterial placement. RESULTS: Intraperitoneal Seprafilm did not affect human colon cancer tumor metastasis, including the liver, spleen, and mesenteric lymph nodes. The application of a biomaterial such as Seprafilm(R) or Vicryl(TM) mesh to the peritoneal sidewall away from the midline wound was associated with in increased rate of local tumor growth. This was Likely because of the local trauma of biomaterial placement in the nude mouse model and not because of the presence of a foreign material. CONCLUSIONS: Our study suggests that Seprafilm(R) does not affect tumor metastasis. Additionally, placement of biomaterials may cause local trauma that stimulates the formation of localized sidewall tumors in the nude mouse model. Further studies in other animal models and ultimately, in humans are required to unambiguously understand the safety of Seprafilm(R) and other biomaterials in cancer patients.
C1 Genzyme Corp, Biomat & Surg Prod Res Lab, Cambridge, MA 02139 USA.
RP Burns, JW (reprint author), Genzyme Corp, Biomat & Surg Prod Res Lab, 1 Kendall Sq, Cambridge, MA 02139 USA.
CR ANTILTILA MA, 2000, CANCER RES, V60, P15
   Becker JM, 1996, J AM COLL SURGEONS, V183, P297
   Burns JW, 1997, EUR J SURG, V163, P40
   Diamond MP, 1996, FERTIL STERIL, V66, P904, DOI 10.1016/S0015-0282(16)58716-0
   Entwistle J, 1996, J CELL BIOCHEM, V61, P569, DOI 10.1002/(SICI)1097-4644(19960616)61:4<569::AID-JCB10>3.0.CO;2-B
   GROW DR, 1994, FERTIL STERIL, V61, P1141
   HANEY AF, 1992, AM J OBSTET GYNECOL, V166, P1137, DOI 10.1016/S0002-9378(11)90600-0
   HANEY AF, 1992, FERTIL STERIL, V57, P202
   KIMATA K, 1983, CANCER RES, V43, P1347
   KNUDSON W, 1989, CIBA F SYMP, V143, P150
   LINSKY CB, 1987, J REPROD MED, V32, P17
   LINSKY CB, 1989, FERTIL STERIL, V51, P933
   MCBRIDE WH, 1979, J EXP MED, V149, P507, DOI 10.1084/jem.149.2.507
   MORIKAWA K, 1988, CANCER RES, V48, P1943
   MORIKAWA K, 1988, CANCER RES, V48, P6863
   Tan B, 2001, BRIT J SURG, V88, P246, DOI 10.1046/j.1365-2168.2001.01664.x
   Toole B, 1982, CELL BIOL EXTRACELLU, P259
   TURLEY EA, 1993, EXP CELL RES, V207, P277, DOI 10.1006/excr.1993.1194
   TURLEY EA, 1985, CANCER RES, V45, P5098
   TURLEY EA, 1992, CANCER METAST REV, V11, P21, DOI 10.1007/BF00047600
   Underwood RA, 1999, DIS COLON RECTUM, V42, P614, DOI 10.1007/BF02234137
   YANG BH, 1993, J BIOL CHEM, V268, P8617
   ZENG C, 1998, INT J CANCER, V77, P936
   ZHANG LR, 1995, CANCER RES, V55, P428
NR 24
TC 18
Z9 20
U1 0
U2 2
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0012-3706
EI 1530-0358
J9 DIS COLON RECTUM
JI Dis. Colon Rectum
PD MAR
PY 2002
VL 45
IS 3
BP 334
EP 341
PG 8
WC Gastroenterology & Hepatology; Surgery
SC Gastroenterology & Hepatology; Surgery
GA 539VA
UT WOS:000174891300008
PM 12068190
DA 2018-10-20
ER

PT J
AU Schuster, M
   Kocher, A
   John, R
   Hoffman, M
   Ankersmit, J
   Lietz, K
   Edwards, O
   Oz, M
   Itescu, S
AF Schuster, M
   Kocher, A
   John, R
   Hoffman, M
   Ankersmit, J
   Lietz, K
   Edwards, O
   Oz, M
   Itescu, S
TI B-cell activation and allosensitization after left ventricular assist
   device implantation is due to T-cell activation and CD40 ligand
   expression
SO HUMAN IMMUNOLOGY
LA English
DT Article
DE LVAD; CD40L; allosensitization
ID SYSTEMIC-LUPUS-ERYTHEMATOSUS; DECREASED PRODUCTION; APOPTOTIC CELLS;
   LVAD RECIPIENTS; NUCLEAR FACTOR; ANTIBODIES; DEATH; INTERLEUKIN-2;
   TRANSFUSIONS; DYSFUNCTION
AB Left ventricular assist device (LVAD) implantation is frequently complicated by B-cell activation and allosensitization, posing a significant risk to successful transplant outcome. This study investigated whether B-cell hyperreactivity and alloantibody production in LVAD recipients involves T-cell dependent pathways. T-cell calcium flux and nuclear translocation of NFATc were used to determine states of T-cell activation. Flow cytometry was used to assess human T- and B-cell activation after culture with LVAD-derived biomattrial particles. Sera from LVAD recipients and controls were tested for the presence of anti-HLA antibodies, and for soluble CD40 ligand. LVAD-derived biomaterial induced rapid and sustained calcium flux into normal T cells, resulting in calcineurin-dependent nuclear translocation of NFATc. This resulted in increased T-cell expression of CD40 ligand and subsequent B-cell activation, which was reduced by inhibitors of T-cell activation (CsA or anti-CD25 mAb) or by anti-CD40 ligand mAb. LVAD recipients demonstrated higher frequencies of anti-FILA antibodies and serum levels of soluble CD40 ligand compared with heart failure controls. The results indicate that exposure of human mononuclear cells to LVAD-derived biomaterial leads to T-cell dependent B-cell activation via CD40-CD40 ligand interaction, and suggest that treatment with calcineurin inhibitors or monoclonal antibodies against either CD25 or CD-40 ligand could be effective at preventing B-cell hyperreactivity and allosensitization after LVAD implantation. (C) American Society for Histocompatibility and Immunogenetics, 2002. Published by Elsevier Science Inc.
C1 Columbia Univ, Coll Phys & Surg, Dept Surg, New York, NY 10032 USA.
RP Itescu, S (reprint author), Columbia Univ, Coll Phys & Surg, Dept Surg, 630 W 168th St,P&S 14-402, New York, NY 10032 USA.
CR Al-Maini MH, 2000, LUPUS, V9, P132, DOI 10.1191/096120300678828145
   ALCOCERVARELA J, 1982, J CLIN INVEST, V69, P1388, DOI 10.1172/JCI110579
   AMEISEN JC, 1991, IMMUNOL TODAY, V12, P102
   Ankersmit HJ, 1999, LANCET, V354, P550, DOI 10.1016/S0140-6736(98)10359-8
   Ankersmit HJ, 1999, CIRCULATION, V100, P211
   BACH FH, 1997, NAT MED, V3, P1
   BERNARD C, 1990, J ACQ IMMUN DEF SYND, V3, P536
   Bijl M, 2001, CLIN EXP IMMUNOL, V123, P127, DOI 10.1046/j.1365-2249.2001.01418.x
   CasciolaRosen L, 1996, P NATL ACAD SCI USA, V93, P1624, DOI 10.1073/pnas.93.4.1624
   Casiano CA, 1996, J EXP MED, V184, P765, DOI 10.1084/jem.184.2.765
   DASSE KA, 1987, T AM SOC ART INT ORG, V33, P418
   Datta SK, 1998, LUPUS, V7, P591, DOI 10.1191/096120398678920703
   Funauchi M, 1998, SCAND J RHEUMATOL, V27, P219
   Goldstein D J, 1995, ASAIO J, V41, P873, DOI 10.1097/00002480-199510000-00010
   GROUX H, 1992, J EXP MED, V175, P331, DOI 10.1084/jem.175.2.331
   Hermann M, 1997, CIRCULATION, V95, P814
   HOGNES JR, 1991, ARTIFICIAL HEART PRO
   Horwitz DA, 1998, ARTHRITIS RHEUM, V41, P838, DOI 10.1002/1529-0131(199805)41:5<838::AID-ART10>3.0.CO;2-S
   HUANG YP, 1986, J IMMUNOL, V137, P3515
   Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657
   Itescu S, 1998, CIRCULATION, V98, P786, DOI 10.1161/01.CIR.98.8.786
   ITESCU S, 1998, J HEART LUNG TRANSPL, V17, P105
   Jayaraman T, 1997, MOL CELL BIOL, V17, P3005, DOI 10.1128/MCB.17.6.3005
   Kanakaraj P, 2001, CYTOKINE, V13, P25, DOI 10.1006/cyto.2000.0793
   Kato K, 1999, J CLIN INVEST, V104, P947, DOI 10.1172/JCI7014
   Khan WN, 1997, INT IMMUNOL, V9, P395, DOI 10.1093/intimm/9.3.395
   KLINMAN DM, 1991, ARTHRITIS RHEUM, V34, P11
   Ma J, 1996, J IMMUNOL, V157, P417
   MACCHIA D, 1993, NATURE, V363, P464, DOI 10.1038/363464a0
   Massad MG, 1997, ANN THORAC SURG, V64, P1120, DOI 10.1016/S0003-4975(97)00807-2
   MATSUDA T, 1994, BIOMATERIALS, V15, P417, DOI 10.1016/0142-9612(94)90219-4
   Mevorach D, 1998, J EXP MED, V188, P387, DOI 10.1084/jem.188.2.387
   Moazami N, 1998, J HEART LUNG TRANSPL, V17, P876
   Niimi M, 1998, J IMMUNOL, V161, P5331
   Refaeli Y, 1998, IMMUNITY, V8, P615, DOI 10.1016/S1074-7613(00)80566-X
   ROBINS JP, 1997, CURRENT PROTOCOLS CY, V1
   ROSE EA, 1994, CIRCULATION, V50, P1187
   SCHOCKEN DD, 1992, J AM COLL CARDIOL, V20, P301, DOI 10.1016/0735-1097(92)90094-4
   Shapiro VS, 1998, J IMMUNOL, V161, P6455
   SOLLINGER AM, 1991, RHEUM DIS CLIN N AM, V17, P157
   Stringham JC, 1999, J HEART LUNG TRANSPL, V18, P160, DOI 10.1016/S1053-2498(98)00006-0
   Tsytsykova AV, 1996, J BIOL CHEM, V271, P3763
   *US DEP HHS, 1990, ANN REP US SCI REG O
   Vakkalanka RK, 1999, ARTHRITIS RHEUM, V42, P871, DOI 10.1002/1529-0131(199905)42:5<871::AID-ANR5>3.0.CO;2-J
   Waples LM, 1996, J BIOMED MATER RES, V32, P65, DOI 10.1002/(SICI)1097-4636(199609)32:1<65::AID-JBM8>3.0.CO;2-N
NR 45
TC 44
Z9 46
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0198-8859
J9 HUM IMMUNOL
JI Hum. Immunol.
PD MAR
PY 2002
VL 63
IS 3
BP 211
EP 220
AR PII S0198-8859(01)00380-9
DI 10.1016/S0198-8859(01)00380-9
PG 10
WC Immunology
SC Immunology
GA 532VJ
UT WOS:000174495500007
PM 11872239
DA 2018-10-20
ER

PT J
AU Whang, K
   Satsangi, N
   Norling, BK
   Kadapakkam, S
   Furman, BR
   Glover, R
   Cardenas, HL
   Liska, B
   Emmons, J
   Vo, J
AF Whang, K
   Satsangi, N
   Norling, BK
   Kadapakkam, S
   Furman, BR
   Glover, R
   Cardenas, HL
   Liska, B
   Emmons, J
   Vo, J
TI The development of a novel osteotropic biomaterial: OG-PLG.
SO JOURNAL OF DENTAL RESEARCH
LA English
DT Meeting Abstract
C1 Univ Texas, Hlth Sci Ctr, San Antonio, TX USA.
RI Norling, Barry/I-4119-2013
OI Norling, Barry/0000-0001-6655-8750
NR 0
TC 0
Z9 0
U1 0
U2 1
PU INT AMER ASSOC DENTAL RESEARCHI A D R/A A D R
PI ALEXANDRIA
PA 1619 DUKE ST, ALEXANDRIA, VA 22314-3406 USA
SN 0022-0345
J9 J DENT RES
JI J. Dent. Res.
PD MAR
PY 2002
VL 81
SI SI
MA 2138
BP A274
EP A274
PG 1
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 559KE
UT WOS:000176024702118
DA 2018-10-20
ER

PT J
AU Dayi, E
   Aslan, M
   Simsek, G
   Yilmaz, AB
AF Dayi, E
   Aslan, M
   Simsek, G
   Yilmaz, AB
TI The effects of bone chips dehydrated with solvent on healing bone
   defects
SO JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
LA English
DT Article
DE biomaterial; bone chips dehydrated with solvent; graft; bone healing
ID POROUS HYDROXYLAPATITE; DEMINERALIZED BONE; TISSUE-RESPONSE;
   RHESUS-MONKEYS; AUGMENTATION; ALLOGRAFT; PARTICLES
AB The effect of bone chips dehydrated with solvent on the healing of bone defects was evaluated. Solvent-dehydrated spongiose bone chips were placed in experimentally formed cavities in the right back tibia of rabbits. After 10, 20 and 30 days, histopathological cross-sections from the bone grafts were examined microscopically for bone healing and formation of spongiose bone, cortex and bone marrow. Spongiose bone chips had a positive and accelerating influence on the healing of bone defects in the 10-day period after transplantation, but no significant differences were observed between the treated and control groups 20 and 30 days after transplantation.
C1 Ataturk Univ, Dishekimligi Fak, Erzurum, Turkey.
   Ataturk Univ, Dept Oral & Maxillofacial Surg, Erzurum, Turkey.
   Ataturk Univ, Dept Oral Diagnosis & Maxillofacial Radiol, Erzurum, Turkey.
RP Dayi, E (reprint author), Ataturk Univ, Dishekimligi Fak, Erzurum, Turkey.
CR AKAL U, 1995, J DENT ANKARA U, V22, P103
   BELL R, 1988, J ORAL MAXIL SURG, V46, P589, DOI 10.1016/0278-2391(88)90150-4
   BLOCK MS, 1986, J ORAL MAXIL SURG, V44, P89, DOI 10.1016/0278-2391(86)90187-4
   Boyce T, 1999, ORTHOP CLIN N AM, V30, P571, DOI 10.1016/S0030-5898(05)70110-3
   CHAO SY, 1987, J ORAL MAXIL SURG, V45, P359, DOI 10.1016/0278-2391(87)90361-2
   Davy DT, 1999, ORTHOP CLIN N AM, V30, P553, DOI 10.1016/S0030-5898(05)70108-5
   Dayi E, 1997, AUST DENT J, V42, P315, DOI 10.1111/j.1834-7819.1997.tb00136.x
   ELDEEB M, 1989, J ORAL MAXIL SURG, V47, P1282, DOI 10.1016/0278-2391(89)90725-8
   FRAME JW, 1987, J ORAL MAXIL SURG, V45, P771, DOI 10.1016/0278-2391(87)90200-X
   HOSNY M, 1985, J ORAL MAXIL SURG, V43, P837, DOI 10.1016/0278-2391(85)90219-8
   KUTLU H, 2001, TUTOPLAST
   LEHTINEN R, 1990, J ORAL MAXIL SURG, V48, P1075, DOI 10.1016/0278-2391(90)90292-A
   MARX RE, 1981, J ORAL SURG, V39, P264
   OZCAN A, 2000, TURKIYE KLIN J DENT, V6, P138
   PETRI WH, 1991, J ORAL MAXIL SURG, V49, P392, DOI 10.1016/0278-2391(91)90377-X
   PINHOLT EM, 1992, J ORAL MAXIL SURG, V50, P1300, DOI 10.1016/0278-2391(92)90231-N
   Shors EC, 1999, ORTHOP CLIN N AM, V30, P599, DOI 10.1016/S0030-5898(05)70113-9
   Stevenson S, 1999, ORTHOP CLIN N AM, V30, P543, DOI 10.1016/S0030-5898(05)70107-3
NR 18
TC 3
Z9 3
U1 0
U2 0
PU CAMBRIDGE MED PUBL
PI WORTHING
PA WICKER HOUSE, HIGH ST, WORTHING BN11 1DJ, W SUSSEX, ENGLAND
SN 0300-0605
J9 J INT MED RES
JI J. Int. Med. Res.
PD MAR-APR
PY 2002
VL 30
IS 2
BP 168
EP 173
DI 10.1177/147323000203000209
PG 6
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA 548RU
UT WOS:000175403900009
PM 12025524
OA Bronze
DA 2018-10-20
ER

PT J
AU Broberg, M
   Eriksson, C
   Nygren, H
AF Broberg, M
   Eriksson, C
   Nygren, H
TI GPIIb/IIIa is the main receptor for initial platelet adhesion to glass
   and titanium surfaces in contact with whole blood
SO JOURNAL OF LABORATORY AND CLINICAL MEDICINE
LA English
DT Article
ID GLYCOPROTEIN-IIB-IIIA; VON-WILLEBRAND-FACTOR; DIFFERENT OXIDE
   THICKNESSES; ADSORBED PLASMA-PROTEINS; HUMAN-MELANOMA CELLS;
   MONOCLONAL-ANTIBODY; FC-RECEPTOR; ELECTROPOLISHED IMPLANTS; FIBRINOGEN
   ADSORPTION; VITRONECTIN RECEPTOR
AB Platelets are the first cells to adhere to a surface in contact with blood and are capable of mediating several different responses after contact with different protein-coated surfaces. They are the main source of growth factors such as platelet-derived growth factor and are therefore important in the healing process. In this study, initial platelet adhesion to and spread on hydrophilic and hydrophobic (methylized) glass and titanium with similar wettability were investigated. Whole coagulating blood was used to simulate the in vivo situation shortly after implantation, in which bleeding precedes inflammation and wound healing. Several different antibodies directed against platelet integrins and receptors (CD9, FcgammaRII, GPIIb/IIIa, vitronectin receptor, GPIb/V/IX) were used in an attempt to block platelet adhesion to the surfaces. Immunofluorescence results show that initial platelet adhesion to all the surfaces we investigated can be almost completely inhibited (approximately 95%) by clone M148, an antibody against the GPIIb/IIIa complex (integrin alpha(IIbbeta)3; CD41/CD61), but not with other antibodies to the separate parts of the integrin. Antibodies known to inhibit fibrinogen binding to GPIIb/IIIa after adenosine diphosphate- and collagen-induced aggregation had very little effect on initial platelet adhesion. None of the other integrins were found to have such an effect on initial platelet adhesion. Antibody clone M148 was furthermore found to inhibit platelet spreading. This study shows that regardless of wettability and the biomaterial used, initial adhesion of platelets appears to be mediated by GPIIb/IIIa binding to surface adsorbed fibrinogen.
C1 Gothenburg Univ, Dept Anat & Cell Biol, SE-40530 Gothenburg, Sweden.
RP Broberg, M (reprint author), Gothenburg Univ, Dept Anat & Cell Biol, Box 420, SE-40530 Gothenburg, Sweden.
CR ALBREKTSSON T, 1985, Critical Reviews in Biocompatibility, V1, P53
   ANDERSON GP, 1991, BRIT J HAEMATOL, V79, P75, DOI 10.1111/j.1365-2141.1991.tb08010.x
   ANDREWS RK, 1991, J BIOL CHEM, V266, P7144
   BERNDT MC, 1993, PLATELETS, V4, P190, DOI 10.3109/09537109309013216
   BEUMER S, 1994, BLOOD, V84, P3724
   Brisson C, 1997, HISTOCHEM J, V29, P153, DOI 10.1023/A:1026437522882
   Broberg M, 1998, COLLOID SURFACE B, V11, P67, DOI 10.1016/S0927-7765(98)00026-5
   CHINN JA, 1991, THROMB HAEMOSTASIS, V65, P608
   Clemetson KJ, 1997, THROMB HAEMOSTASIS, V78, P266
   CRAMER EM, 1990, BLOOD, V75, P1220
   DAHLGREN C, 1981, J IMMUNOL METHODS, V40, P171, DOI 10.1016/0022-1759(81)90064-8
   DEVRIES JE, 1986, INT J CANCER, V38, P465, DOI 10.1002/ijc.2910380403
   DiazRicart M, 1996, ARTERIOSCL THROM VAS, V16, P883, DOI 10.1161/01.ATV.16.7.883
   DSOUZA SE, 1990, J BIOL CHEM, V265, P3440
   Eriksson C, 2001, J LAB CLIN MED, V137, P296, DOI 10.1067/mlc.2001.114066
   Eriksson C, 1997, J BIOMED MATER RES, V37, P130, DOI 10.1002/(SICI)1097-4636(199710)37:1<130::AID-JBM16>3.0.CO;2-K
   Falati S, 1999, BLOOD, V94, P1648
   FITZGERALD LA, 1985, ANAL BIOCHEM, V151, P169, DOI 10.1016/0003-2697(85)90067-3
   FUJIMURA K, 1983, J BIOL CHEM, V258, P247
   GINSBERG MH, 1993, THROMB HAEMOSTASIS, V70, P87
   GOODMAN SL, 1993, J BIOMED MATER RES, V27, P683, DOI 10.1002/jbm.820270516
   Grunkemeier JM, 2000, BIOMATERIALS, V21, P2243, DOI 10.1016/S0142-9612(00)00150-2
   Grunkemeier JM, 2000, J BIOMED MATER RES, V51, P669, DOI 10.1002/1097-4636(20000915)51:4<669::AID-JBM15>3.0.CO;2-#
   HECKER M, 1989, BIOCHEM BIOPH RES CO, V159, P961, DOI 10.1016/0006-291X(89)92202-X
   HORNBY EJ, 1991, BRIT J HAEMATOL, V79, P277, DOI 10.1111/j.1365-2141.1991.tb04533.x
   IKEDA Y, 1991, J CLIN INVEST, V87, P1234, DOI 10.1172/JCI115124
   Inngjerdingen M, 1999, THROMB RES, V95, P215, DOI 10.1016/S0049-3848(99)00035-3
   Jamieson GA, 1997, THROMB HAEMOSTASIS, V78, P242
   Ji P, 1999, BBA-MOL CELL RES, V1448, P543, DOI 10.1016/S0167-4889(98)00160-8
   JONES D, 1984, BRIT J HAEMATOL, V57, P621, DOI 10.1111/j.1365-2141.1984.tb02939.x
   KARAS SP, 1982, BLOOD, V60, P1277
   KIEFFER N, 1991, J CELL BIOL, V113, P451, DOI 10.1083/jcb.113.2.451
   KUNICKI TJ, 1981, BLOOD, V58, P268
   KURODA K, 1995, J IMMUNOL, V155, P4427
   LAM SCT, 1989, J BIOL CHEM, V264, P3742
   Larsson C, 1996, BIOMATERIALS, V17, P605, DOI 10.1016/0142-9612(96)88711-4
   LARSSON C, 1994, BIOMATERIALS, V15, P1062, DOI 10.1016/0142-9612(94)90092-2
   LINDON JN, 1986, BLOOD, V68, P355
   MASON RG, 1971, P SOC EXP BIOL MED, V137, P680
   MCEVER RP, 1983, J BIOL CHEM, V258, P5269
   McNicol A, 1999, THROMB RES, V95, P1, DOI 10.1016/S0049-3848(99)00015-8
   MILLER JL, 1986, BLOOD, V68, P743
   MODDERMAN PW, 1988, THROMB HAEMOSTASIS, V60, P68
   Nygren H, 1998, J BIOMAT SCI-POLYM E, V9, P817, DOI 10.1163/156856298X00172
   Nygren H, 1996, COLLOID SURFACE B, V6, P329, DOI 10.1016/0927-7765(96)01270-2
   NYGREN H, 1988, ACTA PHYSIOL SCAND, V133, P573, DOI 10.1111/j.1748-1716.1988.tb08443.x
   PACKHAM MA, 1969, J LAB CLIN MED, V73, P686
   RUAN C, 1987, THROMB HAEMOSTASIS, V58, P243
   RUBINSTEIN E, 1991, BRIT J HAEMATOL, V78, P80, DOI 10.1111/j.1365-2141.1991.tb04386.x
   SAVAGE B, 1991, J BIOL CHEM, V266, P11227
   Slupsky JR, 1997, EUR J BIOCHEM, V244, P168, DOI 10.1111/j.1432-1033.1997.00168.x
   STEL HV, 1985, BLOOD, V65, P85
   STIBBE J, 1977, THROMB HAEMOSTASIS, V38, P1042
   TETTEROO PAT, 1983, BRIT J HAEMATOL, V55, P509, DOI 10.1111/j.1365-2141.1983.tb02166.x
   Tsai WB, 1999, J BIOMED MATER RES, V44, P130, DOI 10.1002/(SICI)1097-4636(199902)44:2<130::AID-JBM2>3.0.CO;2-9
   VROMAN L, 1980, BLOOD, V55, P156
   VRZHESHCH PV, 1992, THROMB RES, V67, P505, DOI 10.1016/0049-3848(92)90012-Y
   ZUCKER MB, 1969, P SOC EXP BIOL MED, V131, P318
NR 58
TC 39
Z9 40
U1 1
U2 9
PU MOSBY, INC
PI ST LOUIS
PA 11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA
SN 0022-2143
J9 J LAB CLIN MED
JI J. Lab. Clin. Med.
PD MAR
PY 2002
VL 139
IS 3
BP 163
EP 172
DI 10.1067/mlc.2002.121604
PG 10
WC Medical Laboratory Technology; Medicine, General & Internal; Medicine,
   Research & Experimental
SC Medical Laboratory Technology; General & Internal Medicine; Research &
   Experimental Medicine
GA 544NK
UT WOS:000175166500006
PM 11944027
DA 2018-10-20
ER

PT J
AU Manso-Silvan, M
   Martinez-Duart, JM
   Ogueta, S
   Garcia-Ruiz, P
   Perez-Rigueiro, J
AF Manso-Silvan, M
   Martinez-Duart, JM
   Ogueta, S
   Garcia-Ruiz, P
   Perez-Rigueiro, J
TI Development of human mesenchymal stem cells on DC sputtered titanium
   nitride thin films
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID DIFFUSION BARRIER; TIN; NANOINDENTATION; ADHESION; BEHAVIOR; MODULUS; CU
AB The biocompatible properties of titanium nitride (TiN) have opened a new field of applications for this material. In the present work, TiN coatings with thicknesses around 1 mum have been prepared by DC magnetron sputtering. The aim has been to evaluate the adherence, growth and proliferation of human pluripotent mesenchymal stem cells (hMSCs) on the surface of TiN films with contrasted structural, electrical, and mechanical properties. For this purpose, the films were characterized by X-ray diffraction, scanning electron microscopy, sheet resistance measurements, and nanoindentation. Biological tests show that hMSCs adhere and proliferate onto TiN surfaces. The combination of the mechanical, electrical, and biological responses suggest that TiN coatings present appropriate properties to induce the in vitro stimulated differentiation of hMSCs. This possibility gives an added value to TiN based biomaterial coatings. (C) 2002 Academic Publishers.
C1 Univ Autonoma Madrid, Dept Fis Aplicada, E-28049 Madrid, Spain.
   Univ Autonoma Madrid, Ctr Biol Mol, E-28049 Madrid, Spain.
   Univ Politecn Madrid, ETSI Caminos Canales & Puertos, Dept Ciencia Mat, E-28040 Madrid, Spain.
RP Manso-Silvan, M (reprint author), Univ Autonoma Madrid, Dept Fis Aplicada, E-28049 Madrid, Spain.
RI Manso Silvan, Miguel/B-4947-2010
OI Manso Silvan, Miguel/0000-0002-5063-1607
CR ALJAROUDI MY, 1991, THIN SOLID FILMS, V195, P63, DOI 10.1016/0040-6090(91)90259-Z
   AMIGLIATO A, 1985, THIN SOLID FILMS, V129, P55
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Bruder SP, 1998, J ORTHOPAED RES, V16, P155, DOI 10.1002/jor.1100160202
   CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504
   Chun JS, 1999, J APPL PHYS, V86, P3633, DOI 10.1063/1.371271
   DION I, 1993, BIOMATERIALS, V14, P712, DOI 10.1016/0142-9612(93)90070-I
   HARAKI Y, 1987, BIOCHIM BIOPHYS ACTA, V931, P94
   Hayashi T, 1999, THIN SOLID FILMS, V349, P199, DOI 10.1016/S0040-6090(99)00241-2
   HUBLER R, 1993, J VAC SCI TECHNOL A, V11, P451
   Jones MI, 1999, DIAM RELAT MATER, V8, P457, DOI 10.1016/S0925-9635(98)00426-9
   Lennon DP, 1996, IN VITRO CELL DEV-AN, V32, P602
   Ljungcrantz H, 1996, J APPL PHYS, V80, P6725, DOI 10.1063/1.363799
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Ogueta S, 2000, J ENDOCRINOL, V165, P321, DOI 10.1677/joe.0.1650321
   OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564
   PARK KC, 1995, J ELECTROCHEM SOC, V142, P3109, DOI 10.1149/1.2048697
   Rho JY, 1997, BIOMATERIALS, V18, P1325, DOI 10.1016/S0142-9612(97)00073-2
   Rie KT, 1995, SURF COAT TECH, V74-75, P973, DOI 10.1016/0257-8972(95)08316-2
   Samuels L. E., 1986, MICROINDENTATION TEC, P5
   SCHLALDACH M, 1995, MED PROG TECHNOL, V21, P1
   Schmidt H, 1998, MATER SCI TECH-LOND, V14, P592, DOI 10.1179/mst.1998.14.6.592
   TOROK E, 1987, THIN SOLID FILMS, V153, P37, DOI 10.1016/0040-6090(87)90167-2
   TORREGROSA F, 1995, THIN SOLID FILMS, V266, P245, DOI 10.1016/0040-6090(96)80028-9
   WANG SQ, 1990, J APPL PHYS, V68, P5176, DOI 10.1063/1.347059
NR 25
TC 12
Z9 12
U1 0
U2 4
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD MAR
PY 2002
VL 13
IS 3
BP 289
EP 293
DI 10.1023/A:1014062918261
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 519BR
UT WOS:000173705200007
PM 15348626
DA 2018-10-20
ER

PT J
AU Boeck-Neto, R
   Gabrielli, MFR
   Lia, RCC
   Marcantonio, E
   Shibli, JA
   Marcantonio, E
AF Boeck-Neto, R
   Gabrielli, MFR
   Lia, RCC
   Marcantonio, E
   Shibli, JA
   Marcantonio, E
TI Histomorphometrical analysis of bone formed after maxillary sinus floor
   augmentation by grafting with a combination of autogenous bone and
   demineralized freeze-dried bone allograft or hydroxyapatite
SO JOURNAL OF PERIODONTOLOGY
LA English
DT Article
DE dental implants; hydroxyapatite/therapeutic use; regeneration grafts,
   bone; maxillary sinus augmentation; comparison studies
ID ANIONIC COLLAGEN MEMBRANES; DENTAL IMPLANTS; CLINICAL REPORT; ENDOSSEOUS
   IMPLANTS; ELEVATION; PLACEMENT; DEVICE; SITES
AB Background: Maxillary sinus floor augmentation procedures are currently the treatment of choice when the alveolar crest of the posterior maxilla is insufficient for dental implant anchorage. This procedure aims to obtain enough bone with biomaterial association with the autogenous bone graft to create volume and allow osteo conduction. The objective of this study was to histologically and histometrically evaluate the bone formed after maxillary sinus floor augmentation by grafting with a combination of autogenous bone, from the symphyseal area mixed with DFDBA or hydroxyapatite.
   Methods: Ten biopsies were taken from 10 patients 10 months after sinus floor augmentation using a combination of 50% autogenous bone plus 50% dernineralized freeze-dried bone allograft (DFDBA group) or 50% autogenous bone plus 50% hydroxyapatite (HA group). Routine histological processing and staining with hernatoxylin and eosin and Masson's trichrome were performed.
   Results: The histomorphometrical analysis indicated good regenerative results in both groups for the bone tissue mean in the grafted area (50.46 +/- 16.29% for the DFDBA group and 46.79 +/- 8.56% for the HA group). Histological evaluation revealed the presence of mature bone with compact and cancellous areas in both groups. The inflammatory infiltrate was on average nonsignificant and of mononuclear prevalence. Some biopsies showed blocks of the biomaterial in the medullary spaces close to the bone wall, with absence of osteogenic activity.
   Conclusions: The results indicated that both DFDBA and HA associated with an autogenous bone graft were biocompatible and promoted osteoconduction, acting as a matrix for bone formation. However, both materials were still present after 10 months.
C1 State Univ Sao Paulo, Araraquara Dent Sch, Dept Periodontol, Araraquara, SP, Brazil.
   State Univ Sao Paulo, Araraquara Dent Sch, Dept Oral & Maxillofacial Surg, Araraquara, SP, Brazil.
   State Univ Sao Paulo, Araraquara Dent Sch, Dept Pathol & Physiol, Araraquara, SP, Brazil.
RP Marcantonio, E (reprint author), UNESP, Fac Odontol Araraquara, Rua Humaita 1680, BR-14801903 Araraquara, SP, Brazil.
RI Marcantonio, Elcio/A-4784-2008; Shibli, Jamil/A-1361-2014
OI Marcantonio, Elcio/0000-0003-1294-2305; Shibli,
   Jamil/0000-0003-1971-0195
CR ADELL R, 1990, International Journal of Oral and Maxillofacial Implants, V5, P233
   Anitua E, 1999, INT J ORAL MAX IMPL, V14, P529
   Block MS, 1997, J ORAL MAXIL SURG, V55, P1281, DOI 10.1016/S0278-2391(97)90185-3
   BLOCK MS, 1993, J AM DENT ASSOC, V124, P139, DOI 10.14219/jada.archive.1993.0127
   Blomqvist JE, 1998, INT J ORAL MAX IMPL, V13, P758
   BLOMQVIST JE, 1998, ORAL SURG ORAL MED O, V85, P268
   BOYNE PJ, 1980, J ORAL SURG, V38, P613
   Cancian DCJ, 1999, INT J ORAL MAX IMPL, V14, P859
   Chavanaz M, 1990, J ORAL IMPLANTOL, V16, P199
   Cirelli JA, 1997, BIOMATERIALS, V18, P1227, DOI 10.1016/S0142-9612(97)00053-7
   Cordioli G, 2001, CLIN ORAL IMPLAN RES, V12, P270, DOI 10.1034/j.1600-0501.2001.012003270.x
   De Leonardis D, 1999, INT J ORAL MAX IMPL, V14, P869
   DENISSEN HW, 1980, J BIOMED MATER RES, V14, P713, DOI 10.1002/jbm.820140603
   Furusawa T, 1997, Implant Dent, V6, P93, DOI 10.1097/00008505-199700620-00003
   Goissis G, 1999, BIOMATERIALS, V20, P27, DOI 10.1016/S0142-9612(97)00198-1
   Groeneveld EHJ, 1999, CLIN ORAL IMPLAN RES, V10, P499, DOI 10.1034/j.1600-0501.1999.100608.x
   Groenveld HHJ, 1999, J CLIN PERIODONTOL, V26, P841, DOI 10.1034/j.1600-051X.1997.00841.x
   Hanisch O, 1999, INT J ORAL MAX IMPL, V14, P329
   Hanisch O, 1997, INT J ORAL MAX IMPL, V12, P785
   Lundgren S, 1997, INT J ORAL MAX SURG, V26, P428, DOI 10.1016/S0901-5027(97)80007-0
   Mazor Z, 1999, INT J ORAL MAX IMPL, V14, P55
   MOY PK, 1993, J ORAL MAXIL SURG, V51, P857, DOI 10.1016/S0278-2391(10)80103-X
   Peleg M, 1998, J PERIODONTOL, V69, P1397, DOI 10.1902/jop.1998.69.12.1397
   Quinones CR, 1997, CLIN ORAL IMPLAN RES, V8, P497, DOI 10.1034/j.1600-0501.1997.080608.x
   Rosetti EP, 2000, J PERIODONTOL, V71, P1441, DOI 10.1902/jop.2000.71.9.1441
   ten Bruggenkate CM, 1998, PERIODONTOL 2000, V17, P176
   WAGNER J R, 1991, Journal of Oral Implantology, V17, P152
   Wallace SS, 1996, INT J PERIODONT REST, V16, P47
   WATZEK G, 1998, INT J ORAL MAXILLOF, V26, P841
   Wheeler S L, 1996, Int J Oral Maxillofac Implants, V11, P26
   Wheeler SL, 1997, J ORAL MAXIL SURG, V55, P1287, DOI 10.1016/S0278-2391(97)90186-5
NR 31
TC 28
Z9 28
U1 0
U2 3
PU AMER ACAD PERIODONTOLOGY
PI CHICAGO
PA 737 NORTH MICHIGAN AVENUE, SUITE 800, CHICAGO, IL 60611-2690 USA
SN 0022-3492
J9 J PERIODONTOL
JI J. Periodont.
PD MAR
PY 2002
VL 73
IS 3
BP 266
EP 270
DI 10.1902/jop.2002.73.3.266
PG 5
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 532CK
UT WOS:000174453900003
PM 11922255
DA 2018-10-20
ER

PT J
AU Yang, MC
   Lin, WC
AF Yang, MC
   Lin, WC
TI Ultrafiltration of myoglobin using surface-sulfonated polysulfone hollow
   fiber
SO JOURNAL OF POLYMER RESEARCH-TAIWAN
LA English
DT Article
DE blanc reaction; hollow fiber; membrane; polysulfone; sulfonation;
   ultrafiltration
ID POLYDIMETHYLSILOXANE GRAFT COPOLYMER; CHEMICAL MODIFICATION; MEMBRANES;
   POLYETHERSULFONE; PROTEINS
AB The usage of ionic polysulfone (PSF) hollow fiber for the ultrafiltration of protein was investigated. The surface of polysulfone hollow fiber was sulfonated through the Blanc chloromethylation reaction to become anionic. Characterization of the modified hollow fiber was performed including ion exchange titration, pure water permeation, and molecular sieving measurement. The performance of ultrafiltration of protein was evaluated using myoglobin at various pH values. The results show that the water contact angles and hydraulic resistance are markedly decreased, indicating that the surface-modified PSF hollow fibers are more hydrophilic. In addition, the retention of myoglobin depends on the pH of the solution. At a pH higher than the isoelectric point of myoglobin, both hollow fiber and the protein have the same charge sign, and both the flux of the solution and the retention are the highest. The sulfonated PSF hollow fiber may be used as a biomaterial for protein separation and purification.
C1 Natl Taiwan Univ Sci & Technol, Dept Fiber & Polymer Engn, Taipei 106, Taiwan.
RP Yang, MC (reprint author), Natl Taiwan Univ Sci & Technol, Dept Fiber & Polymer Engn, Taipei 106, Taiwan.
CR *AM PERF PROD INC, UDEL POL DES ENG DAT
   CABASSO I, 1977, J APPL POLYM SCI, V21, P165, DOI 10.1002/app.1977.070210115
   CABASSO I, 1976, J APPL POLYM SCI, V20, P2377, DOI 10.1002/app.1976.070200908
   CABASSO I, 1977, J APPL POLYM SCI, V21, P1883, DOI 10.1002/app.1977.070210715
   DALY WH, 1985, J MACROMOL SCI CHEM, V A22, P713, DOI 10.1080/00222338508056632
   HAMEL JFP, 1990, ACS S SERIES, V419
   HIGUCHI A, 1991, J MEMBRANE SCI, V57, P175, DOI 10.1016/S0376-7388(00)80677-8
   HIGUCHI A, 1988, J APPL POLYM SCI, V36, P1753, DOI 10.1002/app.1988.070360804
   HIGUCHI A, 1990, J APPL POLYM SCI, V40, P709, DOI 10.1002/app.1990.070400508
   HIGUCHI A, 1988, J APPL POLYM SCI, V36, P1973
   HINKE E, 1991, J APPL POLYM SCI, V42, P2951, DOI 10.1002/app.1991.070421112
   HOWELL JA, 1993, MEMBRANES BIOPROCESS, pCH6
   KIM KJ, 1994, J MEMBRANE SCI, V87, P35, DOI 10.1016/0376-7388(93)E0044-E
   LEROUX JD, 1992, J MEMBRANE SCI, V74, P233, DOI 10.1016/0376-7388(92)80064-Q
   LIU TH, 1992, SEPAR SCI TECHNOL, V27, P161, DOI 10.1080/01496399208018871
   LUCA C, 1980, J POLYM SCI POL CHEM, V18, P449, DOI 10.1002/pol.1980.170180205
   MIYAMA H, 1988, J APPL POLYM SCI, V36, P925, DOI 10.1002/app.1988.070360415
   MIYAMA H, 1977, J BIOMED MATER RES, V11, P251, DOI 10.1002/jbm.820110210
   NAGASE Y, 1989, POLYMER, V30, P1931, DOI 10.1016/0032-3861(89)90368-6
   NAGASE Y, 1990, POLYMER, V31, P121, DOI 10.1016/0032-3861(90)90361-2
   NAKAO S, 1988, DESALINATION, V70, P191, DOI 10.1016/0011-9164(88)85054-9
   SHELDON JM, 1991, J MEMBRANE SCI, V62, P87, DOI 10.1016/0376-7388(91)85006-Q
   SHELDON JM, 1991, J MEMBRANE SCI, V62, P75, DOI 10.1016/0376-7388(91)85005-P
   SUKI A, 1984, J MEMBRANE SCI, V21, P269, DOI 10.1016/S0376-7388(00)80218-5
   VOGEL AI, 1978, VOGELS TXB PRACTICAL, P636
   ZSCHOCKE P, 1985, J MEMBRANE SCI, V22, P325, DOI 10.1016/S0376-7388(00)81290-9
NR 26
TC 11
Z9 12
U1 0
U2 8
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1022-9760
J9 J POLYM RES-TAIWAN
JI J. Polym. Res.-Taiwan
PD MAR
PY 2002
VL 9
IS 1
BP 61
EP 67
DI 10.1023/A:1020610919593
PG 7
WC Polymer Science
SC Polymer Science
GA 619DH
UT WOS:000179458400009
DA 2018-10-20
ER

PT J
AU Chertin, B
   Colhoun, E
   Velayudham, M
   Puri, P
AF Chertin, B
   Colhoun, E
   Velayudham, M
   Puri, P
TI Endoscopic treatment of vesicoureteral reflux: 11 to 17 years of
   followup
SO JOURNAL OF UROLOGY
LA English
DT Article
DE polytetrafluoroethylene; vesico-ureteral reflux; endoscopy
ID POLYTETRAFLUOROETHYLENE INJECTION; INTRAVESICAL INJECTION; SUBURETERIC
   INJECTION; TEFLON INJECTION; MIGRATION; BRAIN; PASTE; INCONTINENCE;
   EXPERIENCE; URETERS
AB Purpose: We review our 17-experience with endoscopic subureteral polytetrafluoroethylene, injection for the treatment of primary vesicoureteral reflux in children.
   Materials and Methods: We retrospectively reviewed the charts of 258 patients with primary vesicoureteral reflux who were treated with subureteral polytetrafluoroethylene injection from 1984 to 1990.
   Results: The study included 205 girls and 53 boys between 3 months and 14 years old (median age 6 years). Of the patients 92 had unilateral vesicoureteral reflux, 129 had bilateral reflux and 37 had a refluxing duplex system including 6 with bilateral duplex systems. Endoscopic treatment by subureteral polytetrafluoroethylene injection was performed in 393 ureters. Reflux was corrected in 302 ureters (76.8%) after a single injection. Injection failed to stop reflux in 7 ureters (7 patients) and reimplantation was required. Patients were followed from 11 to 17 years with a mean followup plus or minus standard deviation of 13.5 +/- 3.4 years. Four patients were either lost to followup or parents refused to let them undergo voiding cystourethrography. Voiding cystourethrography in 247 patients with 379 ureters revealed that 360 ureters (95%) remain free of reflux whereas reflux recurred in 19 ureters (5%). Of these 19 ureters reflux was grade I or II in 13 for which no treatment was given and reflux was grade III or IV in 6, which required repeat injection. No untoward effects were seen in any of these patients with use of polytetrafluoroethylene as an injectable biomaterial.
   Conclusions: Endoscopic subureteral polytetrafluoroethylene injection is a simple and effective outpatient procedure for in the treatment of vesicoureteral reflux. No long-term morbidity was observed in our patients with small amounts of injectable polytetrafluoroethylene.
C1 Natl Childrens Hosp, Dublin, Ireland.
   Our Ladys Hosp Sick Children, Childrens Res Ctr, Dublin 12, Ireland.
RP Chertin, B (reprint author), Natl Childrens Hosp, Dublin, Ireland.
CR AARONSON IA, 1993, EUR UROL, V23, P394, DOI 10.1159/000474637
   Aragona F, 1997, J UROLOGY, V158, P1539, DOI 10.1016/S0022-5347(01)64275-7
   ARNOLD GE, 1963, ANN OTO RHINOL LARYN, V72, P384, DOI 10.1177/000348946307200209
   BAILEY RR, 1993, DIS KIDNEY, P68
   BECMEUR F, 1990, EUR UROL, V17, P299
   BISCHOFF F, 1972, CLIN CHEM, V18, P869
   Caldamone AA, 2001, J UROLOGY, V165, P2224, DOI 10.1016/S0022-5347(05)66170-8
   DEMOURIGUAND P, 1995, ROB SMITHS OPERATIVE, P638
   FARKAS A, 1990, J UROLOGY, V144, P534, DOI 10.1016/S0022-5347(17)39515-0
   Joyner BD, 1997, UROLOGY, V50, P489, DOI 10.1016/S0090-4295(97)00261-6
   Kershen RT, 1999, UROL CLIN N AM, V26, P81, DOI 10.1016/S0094-0143(99)80008-1
   LEVITT SB, 1981, PEDIATRICS, V67, P392
   MALIZIA AA, 1984, JAMA-J AM MED ASSOC, V251, P3277, DOI 10.1001/jama.251.24.3277
   Misra D, 1996, J PEDIATR SURG, V31, P1262, DOI 10.1016/S0022-3468(96)90246-8
   Miyakita H, 1998, EUR UROL, V34, P233, DOI 10.1159/000019720
   MIYAKITA H, 1994, J UROLOGY, V152, P636, DOI 10.1016/S0022-5347(17)32670-8
   MONTGOMERY R, 1982, PATTYS IND HYGIENE C, V2, P4308
   ODONNELL B, 1988, J UROLOGY, V140, P1101, DOI 10.1016/S0022-5347(17)41971-9
   ODONNELL B, 1984, BRIT MED J, V289, P7, DOI 10.1136/bmj.289.6436.7
   PETERS CA, 1991, DIAL PED UROL, V14, P4
   POLITANO VA, 1974, J UROLOGY, V111, P180, DOI 10.1016/S0022-5347(17)59921-8
   Puri P, 1998, J UROLOGY, V160, P1007, DOI 10.1016/S0022-5347(01)62683-1
   PURI P, 1984, BRIT MED J, V289, P5, DOI 10.1136/bmj.289.6436.5
   Puri P, 2000, Curr Opin Urol, V10, P593, DOI 10.1097/00042307-200011000-00010
   PURI P, 1987, J PEDIATR SURG, V22, P1087, DOI 10.1016/S0022-3468(87)80714-5
   PURI P, 1995, EUR UROL, V27, P67
   PURI P, 1990, LANCET, V335, P1320, DOI 10.1016/0140-6736(90)91197-I
   PURI P, 1995, BRIT J UROL, V75, P126, DOI 10.1111/j.1464-410X.1995.tb07296.x
   PURI P, 1986, BRIT J UROL, V58, P504, DOI 10.1111/j.1464-410X.1986.tb05455.x
   PURI P, 1995, EUR UROL, V27, P71
   Puri Prem, 1995, P638
   RAMES RA, 1991, PEDIATR SURG INT, V6, P239
   SCHULMAN CC, 1987, J UROLOGY, V138, P953
   SILVER F, 1989, BIOCOMPTIBILITY, V1, P129
   1991, PEDIATRICS, V88, P410
NR 35
TC 53
Z9 60
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0022-5347
J9 J UROLOGY
JI J. Urol.
PD MAR
PY 2002
VL 167
IS 3
BP 1443
EP 1445
DI 10.1016/S0022-5347(05)65340-2
PG 3
WC Urology & Nephrology
SC Urology & Nephrology
GA 519YK
UT WOS:000173752900083
PM 11832767
DA 2018-10-20
ER

PT J
AU Keeley, FW
   Bellingham, CM
   Woodhouse, KA
AF Keeley, FW
   Bellingham, CM
   Woodhouse, KA
TI Elastin as a self-organizing biomaterial: use of recombinantly expressed
   human elastin polypeptides as a model for investigations of structure
   and self-assembly of elastin
SO PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
LA English
DT Article
DE elastin; self-assembly; recombinant elastin polypeptide; coacervation;
   cross-linking
ID BINDING PROTEIN; TROPOELASTIN; COACERVATION; PENTAPEPTIDE; OXIDATION;
   DESMOSINE; AORTA
AB Elastin is the major extracellular matrix protein of large arteries such as the aorta, imparting characteristics of extensibility and elastic recoil. Once laid down in tissues, polymeric elastin is not subject to turnover, but is able to sustain its mechanical resilience through thousands of millions of cycles of extension and recoil. Elastin consists of ca. 36 domains with alternating hydrophobic and cross-linking characteristics. It has been suggested that these hydrophobic domains, predominantly containing glycine, proline, leucine and valine, often occurring in tandemly repeated sequences, are responsible for the ability of elastin to align monomeric chains for covalent cross-linking. We have shown that small, recombinantly expressed polypeptides based on sequences of human elastin contain sufficient information to self-organize into fibrillar structures and promote the formation of lysine-derived cross-links. These cross-linked polypeptides can also be fabricated into membrane structures that have solubility and mechanical properties reminiscent of native insoluble elastin. Understanding the basis of the self-organizational ability of elastin-based polypeptides may provide important clues for the general design of self-assembling biomaterials.
C1 Hosp Sick Children, Res Inst, Cardiovasc Res Program, Toronto, ON M5G 1X8, Canada.
   Univ Toronto, Dept Biochem, Toronto, ON M5S 1A1, Canada.
   Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A1, Canada.
   Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON M5S 1A1, Canada.
RP Keeley, FW (reprint author), Hosp Sick Children, Res Inst, Cardiovasc Res Program, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.
EM fwk@sickkids.ca
CR Baldock C, 2001, J CELL BIOL, V152, P1045, DOI 10.1083/jcb.152.5.1045
   BEDELLHOGAN D, 1993, J BIOL CHEM, V268, P10345
   Bellingham CM, 2001, BBA-PROTEIN STRUCT M, V1550, P6, DOI 10.1016/S0167-4838(01)00262-X
   BRESSAN GM, 1986, J ULTRA MOL STRUCT R, V94, P209, DOI 10.1016/0889-1605(86)90068-6
   COX BA, 1973, BIOCHIM BIOPHYS ACTA, V317, P209, DOI 10.1016/0005-2795(73)90215-8
   DAVIS EC, 1993, HISTOCHEMISTRY, V100, P17, DOI 10.1007/BF00268874
   Debelle L, 1998, EUR J BIOCHEM, V258, P533, DOI 10.1046/j.1432-1327.1998.2580533.x
   GRAY WR, 1973, NATURE, V246, P461, DOI 10.1038/246461a0
   HINEK A, 1994, J CELL BIOL, V126, P563, DOI 10.1083/jcb.126.2.563
   HINEK A, 1988, SCIENCE, V239, P1539, DOI 10.1126/science.2832941
   JAMIESON AM, 1972, BIOCHIM BIOPHYS ACTA, V271, P34, DOI 10.1016/0005-2795(72)90130-4
   KING GS, 1980, CONNECT TISSUE RES, V7, P263, DOI 10.3109/03008208009152362
   McConnell CJ, 1996, EXPERIENTIA, V52, P918, DOI 10.1007/BF01938880
   Mecham R. P., 1994, EXTRACELLULAR MATRIX, P281
   Mecham R. P, 1991, CELL BIOL EXTRACELLU, P79
   MORELLI MAC, 1993, J BIOMOL STRUCT DYN, V11, P181
   PARTRIDGE SM, 1955, BIOCHEM J, V61, P11, DOI 10.1042/bj0610011
   PARTRIDGE SM, 1966, FED PROC, V25, P1023
   PASQUALIRONCHET.I, 1979, MICRON, V10, P89
   Reiersen H, 1998, J MOL BIOL, V283, P255, DOI 10.1006/jmbi.1998.2067
   ROSS R, 1969, J CELL BIOL, V40, P366, DOI 10.1083/jcb.40.2.366
   Ross R, 1977, Adv Exp Med Biol, V79, P7
   SHAH MA, 1992, BIOCHIM BIOPHYS ACTA, V1159, P311, DOI 10.1016/0167-4838(92)90061-H
   STAHMANN MA, 1977, BIOPOLYMERS, V16, P1307, DOI 10.1002/bip.1977.360160611
   STARCHER B, 1995, RESPIRATION, V62, P252
   STARCHER B, 1985, CONNECT TISSUE RES, V13, P207, DOI 10.3109/03008208509152400
   TAMBURRO AM, 1992, J BIOMOL STRUCT DYN, V10, P441, DOI 10.1080/07391102.1992.10508661
   URRY DW, 1969, NATURE, V222, P795, DOI 10.1038/222795a0
   URRY DW, 1974, BIOCHIM BIOPHYS ACTA, V371, P597, DOI 10.1016/0005-2795(74)90057-9
   URRY DW, 1988, J PROTEIN CHEM, V7, P1, DOI 10.1007/BF01025411
   Vrhovski B, 1998, EUR J BIOCHEM, V258, P1, DOI 10.1046/j.1432-1327.1998.2580001.x
   Vrhovski B, 1997, EUR J BIOCHEM, V250, P92, DOI 10.1111/j.1432-1033.1997.00092.x
NR 32
TC 94
Z9 96
U1 0
U2 21
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 0962-8436
EI 1471-2970
J9 PHILOS T R SOC B
JI Philos. Trans. R. Soc. B-Biol. Sci.
PD FEB 28
PY 2002
VL 357
IS 1418
BP 185
EP 189
DI 10.1098/rstb.2001.1027
PG 5
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA 535NJ
UT WOS:000174650300008
PM 11911775
OA Green Published
DA 2018-10-20
ER

PT J
AU Valluzzi, R
   Winkler, S
   Wilson, D
   Kaplan, DL
AF Valluzzi, R
   Winkler, S
   Wilson, D
   Kaplan, DL
TI Silk: molecular organization and control of assembly
SO PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY OF LONDON SERIES
   B-BIOLOGICAL SCIENCES
LA English
DT Article
DE silk; redox; copolymers
ID CRYSTALLIZATION
AB The interface between the science and engineering of biology and materials is an area of growing interest. One of the goals of this field is to utilize biological synthesis and processing of polymers as a route to gain insight into topics such as molecular recognition, self-assembly and the formation of materials with well-defined architectures. The biological processes involved in polymer synthesis and assembly can offer important information on fundamental interactions involved in the formation of complex material architectures, as well as practical knowledge into new and important materials related to biomaterial uses and tissue engineering needs. Classic approaches in biology, including genetic engineering, controlled microbial physiology and enzymatic synthesis, are prototypical methods used to control polymer structure and chemistry, including stereoselectivity and regioselectivity, to degrees unattainable using traditional synthetic chemistry. This type of control can lead to detailed and systematic studies of the formation of the structural hierarchy in materials and the subsequent biological responses to these materials.
C1 Tufts Univ, Dept Chem & Biol Engn, Biotechnol & Bioengn Ctr, Medford, MA 02155 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Chem & Biol Engn, Biotechnol & Bioengn Ctr, Medford, MA 02155 USA.
CR McGrath K. P., 1997, PROTEIN BASED MAT
   Szela S, 2000, BIOMACROMOLECULES, V1, P534, DOI 10.1021/bm0055697
   Valluzzi R, 1999, INT J BIOL MACROMOL, V24, P227, DOI 10.1016/S0141-8130(99)00005-7
   Valluzzi R, 1999, J PHYS CHEM B, V103, P11382, DOI 10.1021/jp991363s
   Wilson D, 2000, BIOPHYS J, V78, P2690, DOI 10.1016/S0006-3495(00)76813-5
   Winkler S, 2000, BIOCHEMISTRY-US, V39, P12739, DOI 10.1021/bi001335w
   WINKLER S, 2000, MOL BIOTECHNOL, V74, P85
NR 7
TC 42
Z9 46
U1 3
U2 13
PU ROYAL SOC LONDON
PI LONDON
PA 6 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 0962-8436
J9 PHILOS T ROY SOC B
JI Philos. Trans. R. Soc. Lond. Ser. B-Biol. Sci.
PD FEB 28
PY 2002
VL 357
IS 1418
BP 165
EP 167
DI 10.1098/rstb.2001.1032
PG 3
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA 535NJ
UT WOS:000174650300006
PM 11911773
OA Green Published
DA 2018-10-20
ER

PT J
AU Hiromoto, S
   Hanawa, T
AF Hiromoto, S
   Hanawa, T
TI Re-passivation current of amorphous Zr65Al7.5Ni10Cu17.5 alloy in a
   Hanks' balanced solution
SO ELECTROCHIMICA ACTA
LA English
DT Article
DE amorphous Zr-Al-Ni-Cu alloy; biomaterial; chronoamperometry
   re-passivation
ID PHOSPHATE-BUFFERED SOLUTION; CR-P ALLOYS; POLARIZATION BEHAVIOR;
   REPASSIVATION; ELECTRODE; APPLICABILITY; RESISTANCE; PASSIVITY;
   SURFACES; FRACTURE
AB To evaluate the repassivation behavior of amorphous phase with chemical and structural homogeneity, time transient of re-passivation current density was measured on amorphous Zr65Al7.5Ni10Cu17.5 alloy and crystalline pure Zr with a momentary fracture of a ribbon shaped specimen in an artificial body fluid. Current density abruptly increased to a peak, J(peak), and exponentially decreased to the constant value, J(infinity), J(peak) and J(infinity) on the amorphous specimen were smaller than those on the crystalline specimen, indicating that the amorphous phase would show the smaller dissolution rate from bare metal surface and from a re-passive film than the crystalline specimen, respectively. On the other hand, decrease rate of the current density on the amorphous specimen was smaller than that on the crystalline specimen, indicating the regeneration of passive film on the amorphous specimen was delayed probably because the amount of metal ions dissolved at the initial stage, i.e. the source of re-passive film, was smaller on the amorphous specimen. Consequently, the total charge for the re-passivation of the amorphous specimen was smaller than that of the crystalline specimen, supposing that the amount of dissolved metal ions during re-passivation was smaller on the amorphous specimen than the crystalline specimen. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Natl Inst Mat Sci, Ctr Biomat, Reconstruct Mat Res Grp, Tsukuba, Ibaraki 3050047, Japan.
RP Hiromoto, S (reprint author), Natl Inst Mat Sci, Ctr Biomat, Reconstruct Mat Res Grp, 1-2-1 Sengen, Tsukuba, Ibaraki 3050047, Japan.
RI HIROMOTO, Sachiko/H-2686-2011; BAI, JIE/D-7448-2016
CR BASTEK PD, 1993, J ELECTROCHEM SOC, V140, P1884, DOI 10.1149/1.2220733
   BURSTEIN GT, 1983, CORROS SCI, V23, P125, DOI 10.1016/0010-938X(83)90111-7
   BURSTEIN GT, 1991, CORROS SCI, V32, P1195, DOI 10.1016/0010-938X(91)90132-9
   Goldberg JR, 1997, J BIOMED MATER RES, V37, P421, DOI 10.1002/(SICI)1097-4636(19971205)37:3<421::AID-JBM13>3.0.CO;2-E
   HANAWA T, 2000, ZAIRYO TO KANKYO, V49, P463
   HASHIMOTO K, 1976, CORROS SCI, V16, P71, DOI 10.1016/0010-938X(76)90031-7
   HASHIMOTO K, 1978, BOSHOKU GIJUTSU, V27, P279
   Hiromoto S, 2000, CORROS SCI, V42, P1651, DOI 10.1016/S0010-938X(00)00022-6
   Hiromoto S, 2000, CORROS SCI, V42, P2193, DOI 10.1016/S0010-938X(00)00056-1
   Hiromoto S, 2000, CORROS SCI, V42, P2167, DOI 10.1016/S0010-938X(00)00043-3
   HIROMOTO S, UNPUB J ELECTROCHEM
   HIROMOTO S, UNPUB MAT T
   Itagaki M, 1997, J ELECTROCHEM SOC, V144, P64, DOI 10.1149/1.1837366
   Kolman DG, 1996, J ELECTROCHEM SOC, V143, P1847, DOI 10.1149/1.1836914
   KOLMAN DG, 1995, J ELECTROCHEM SOC, V142, P2179, DOI 10.1149/1.2044272
   LEAMY HJ, 1972, METALL TRANS, V3, P699, DOI 10.1007/BF02642754
   PEARSON HJ, 1981, J ELECTROCHEM SOC, V128, P2297, DOI 10.1149/1.2127238
   POURBAIX M, 1974, ATLAS ELECTROCHEMICA, P226
   VIRTANEN S, 1990, CORROS SCI, V31, P333, DOI 10.1016/0010-938X(90)90128-R
   VIRTANEN S, 1991, ISIJ INT, V31, P229, DOI 10.2355/isijinternational.31.229
   WATSON SW, 1992, CORROSION, V48, P727, DOI 10.5006/1.3315993
NR 21
TC 29
Z9 31
U1 0
U2 7
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0013-4686
J9 ELECTROCHIM ACTA
JI Electrochim. Acta
PD FEB 15
PY 2002
VL 47
IS 9
BP 1343
EP 1349
AR PII S0013-4686(01)00876-3
DI 10.1016/S0013-4686(01)00876-3
PG 7
WC Electrochemistry
SC Electrochemistry
GA 536WD
UT WOS:000174724100001
DA 2018-10-20
ER

PT J
AU Lopez, MF
   Gutierrez, A
   Jimenez, JA
AF Lopez, MF
   Gutierrez, A
   Jimenez, JA
TI In vitro corrosion behaviour of titanium alloys without vanadium
SO ELECTROCHIMICA ACTA
LA English
DT Article
DE electrochemical techniques; corrosion Biomaterials; Ti alloys; surfaces
ID PHYSIOLOGICAL SOLUTION; COATINGS
AB The corrosion behaviour of three new non-toxic titanium alloys for use as biomaterials has been investigated. The corrosion current densities of these Ti alloys have low values, indicating a passive state that is stable with time. These values were calculated by using both direct and alternate current methods. The comparison with Ti-6Al-4V, widely used as biomaterial, shows slightly lower corrosion rates for the non V-containing alloys. To determine the pitting corrosion resistance, anodic polarisation curves were performed. Those alloys containing Zr, with very low passivation current densities, show the best behaviour. This indicates a low susceptibility to localised corrosion in these alloys. The chemical surface analysis performed on the samples suggests an influence of the passive layer composition on the passivation current density. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 CSIC, Inst Ciencia Mat, E-28049 Madrid, Spain.
   Univ Miguel Hernandez, Dept Fis & Ciencia Mat, E-03202 Elche, Spain.
   CSIC, Ctr Nacl Invest Met, E-28040 Madrid, Spain.
RP Lopez, MF (reprint author), CSIC, Inst Ciencia Mat, E-28049 Madrid, Spain.
RI Lopez, Maria/C-4571-2011; Gutierrez, Alejandro/A-9092-2011; Jimenez,
   Jose/H-2644-2015
OI Lopez, Maria/0000-0001-7894-566X; Gutierrez,
   Alejandro/0000-0002-1150-0719; Jimenez, Jose/0000-0003-4272-6873
CR Bathias C, 1997, ENG FRACT MECH, V56, P255, DOI 10.1016/0013-7944(95)00256-1
   BOYER R, 1994, MAT PROPERTIES HDB T
   BREME HJ, 1998, METALS BIOMATERIALS, pCH2
   Cabrini M, 1997, BIOMATERIALS, V18, P783, DOI 10.1016/S0142-9612(96)00205-0
   CORDERO J, 1994, J BONE JOINT SURG BR, V76B, P717
   Escudero ML, 1996, J BIOMED MATER RES, V31, P313
   FRAKER AC, 1977, J MET, V5, P22
   Jones D., 1996, PRINCIPLES PREVENTIO
   KOHN DH, 1992, SERIE MAT SCI TECHNO, V14, pCH2
   Lopez MF, 2001, SURF SCI, V482, P300, DOI 10.1016/S0039-6028(00)01005-0
   LYTH C, 1970, AUST CORR ENG, V25, P34
   Milosev I, 2000, BIOMATERIALS, V21, P2103, DOI 10.1016/S0142-9612(00)00145-9
   Okazaki Y, 1998, BIOMATERIALS, V19, P1197, DOI 10.1016/S0142-9612(97)00235-4
   PARK JB, 1995, BIOMEDICAL ENG HDB, pCH40
   SHIRKHANZADEH M, 1995, J MATER SCI-MATER M, V6, P206, DOI 10.1007/BF00146857
   SIBUM H, 1998, ALLOYS PREPARATION P, pCH11
   Steinemann S., 1980, EVALUATION BIOMATERI
   STERN M, 1957, J ELECTROCHEM SOC, V104, P56, DOI 10.1149/1.2428496
   Talbot D. E. J, 1998, CORROSION SCI TECHNO
NR 19
TC 105
Z9 106
U1 0
U2 10
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0013-4686
J9 ELECTROCHIM ACTA
JI Electrochim. Acta
PD FEB 15
PY 2002
VL 47
IS 9
BP 1359
EP 1364
AR PII S0013-4686(01)00860-X
DI 10.1016/S0013-4686(01)00860-X
PG 6
WC Electrochemistry
SC Electrochemistry
GA 536WD
UT WOS:000174724100003
DA 2018-10-20
ER

PT J
AU Fricain, JC
   Alouf, J
   Bareille, R
   Rouais, F
   Rouvillain, JL
AF Fricain, JC
   Alouf, J
   Bareille, R
   Rouais, F
   Rouvillain, JL
TI Cytocompatibility study of organic matrix extracted from Caribbean coral
   porites astroides
SO BIOMATERIALS
LA English
DT Article
DE coral; bone substitute; organic matrix; biomaterial cells
ID BONE-GRAFT SUBSTITUTE; RAT BONE; PROLIFERATION; STERILIZATION;
   RESORPTION; INVITRO
AB Since 1980, natural coral exoskeleton has been widely used as bone graft substitute. Despite numerous in vitro and in vivo studies, there is still a lack of knowledge concerning the organic matrix associated with coral exoskeleton (COM). In fact, some surgical interventions have failed and this has sometimes been attributed to the exoskeleton organic matrix. For others, only amino acids are present in the matrix after coral preparation for clinical use. The objective of this study was to extract the exoskeleton organic matrix to carry out biochemical analysis and study its specific cytocompatibility. Demineralized bone powder (DBP) was used as control. A decalcification process was used to extract CONI and DBP. Protein, carbohydrate and glycosaminoglycan analysis was carried out in DBP and CONI using classical staining methods. Human bone marrow cells were cultured in the presence of 20, 40, 80, 160 mug Of COM or DBP for 24, 48 and 72 h. The methods used to analyze COM and DBP effects were scanning electron microscopy, immunocytochemistry. manual cell count, and cyto-compatibility assay (Neutral red and MTT tests). Results showed that in spite of treating coral before clinical use, a COM was present in which GAG, protein and carbohydrate were found. The in vitro cytocompatibility of COM was confirmed for 20 and 40 mug values but was less pronounced for 80 and 160 mug levels. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Univ Bordeaux 2, INSERM, U443, F-33076 Bordeaux, France.
   CHR Ft de France, Serv Chirurg Orthoped & Traumatol, F-97261 Ft de, France.
RP Fricain, JC (reprint author), Univ Bordeaux 2, INSERM, U443, Bat 4A,146 Rue Leo Saignat, F-33076 Bordeaux, France.
OI ROUVILLAIN, JEAN LOUIS/0000-0002-9076-9096
CR *AFNOR NF, 1994, 309935 AFNORNF EN
   ALLEMAND D, 1994, B I OCEANOGR MONACO, V14, P1
   [Anonymous], 1992, ISO109935
   *ASTM, 1991, F748 ASTM
   BORENFREUND E, 1985, TOXICOL LETT, V24, P119, DOI 10.1016/0378-4274(85)90046-3
   CHIROFF RT, 1975, J BIOMED MATER RES S, V6, P29
   DEPERETTI F, 1995, COMMUNICATION GR NOV
   Fricain JC, 1998, J BIOMED MATER RES, V42, P96, DOI 10.1002/(SICI)1097-4636(199810)42:1<96::AID-JBM12>3.0.CO;2-M
   FRICAIN JC, 1997, BIOCERAMICS, V10, P383
   GOLD EW, 1979, ANAL BIOCHEM, V99, P183, DOI 10.1016/0003-2697(79)90061-7
   GRASSE P, 1987, TRAITE ZOOLOGIE, V3
   GUILLEMIN G, 1989, J BIOMED MATER RES, V23, P765, DOI 10.1002/jbm.820230708
   GUILLEMIN G, 1987, J BIOMED MATER RES, V21, P557, DOI 10.1002/jbm.820210503
   HEINEGARD D, 1989, FASEB J, V3, P2042
   HUANG DST, 1988, J ORAL MAXIL SURG, V46, P460, DOI 10.1016/0278-2391(88)90411-9
   LOPEZ E, 1992, TISSUE CELL, V24, P667, DOI 10.1016/0040-8166(92)90037-8
   Lopez E., 1995, B I OCEANOGR MONACO, V143, P49
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Marchac D, 1994, J Craniofac Surg, V5, P213, DOI 10.1097/00001665-199409000-00003
   MORA F, 1995, J CLIN PERIODONTOL, V22, P877, DOI 10.1111/j.1600-051X.1995.tb01787.x
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   MUNTING E, 1988, ACTA ORTHOP SCAND, V59, P34, DOI 10.3109/17453678809149340
   PARACHARALAMBOU.SK, 1993, ORAL MAXILLOFAC SURG, V22, P260
   ROUDIER M, 1995, J BIOMED MATER RES, V29, P909, DOI 10.1002/jbm.820290802
   ROUVILLAIN J., 1995, J BONE JOINT SURG BR, V77B, P226
   ROUX FX, 1988, J NEUROSURG, V69, P510, DOI 10.3171/jns.1988.69.4.0510
   SCHWARZ N, 1988, ACTA ORTHOP SCAND, V59, P165
   SWIFT DM, 1986, J EXP ZOOL, V240, P65, DOI 10.1002/jez.1402400109
   Weiner S, 1983, BIOMINERALIZATION BI, P205
NR 29
TC 9
Z9 10
U1 0
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2002
VL 23
IS 3
BP 673
EP 679
DI 10.1016/S0142-9612(01)00155-7
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 500RF
UT WOS:000172640000006
PM 11771687
DA 2018-10-20
ER

PT J
AU Dalby, MJ
   Kayser, MV
   Bonfield, W
   Di Silvio, L
AF Dalby, MJ
   Kayser, MV
   Bonfield, W
   Di Silvio, L
TI Initial attachment of osteoblasts to an optimised HAPEX (TM) topography
SO BIOMATERIALS
LA English
DT Article
DE osteoblasts; HAPEX; topography
ID IN-VITRO; MECHANICAL-PROPERTIES; SIGNAL-TRANSDUCTION; FOCAL ADHESIONS;
   BIOACTIVE GLASS; BONE-FORMATION; CELL BEHAVIOR; SURFACE; HYDROXYAPATITE;
   POLYETHYLENE
AB The interactions between an implant material and the Surrounding tissue are of a complicated nature, and the initial attachment of Cells to the surface is important in determining the implant success. HAPEX(TM) has been developed as a second-generation orthopaedic biomaterial. with both mechanical and biological characteristics that make it suitable for bone augmentation. Further optimisation of the material is being continued to increase the attachment of osteoblasts coupled with improving mechanical characteristics. so it may be used in load bearing applications, It has been previously observed that polishing followed by roughening the Surface of HAPEX(TM) enhances osteoblast proliferation and phenotype. This article discusses the recruitment of primary human osteoblast cells onto the optimised Surface, by examining morphology and cytoskeletal changes using scanning electron microscopy and confocal laser scanning microscopy. The results show that the cells attach in greater numbers to the optimised surface. and develop notably faster. than cells on machined HAPEX(TM). (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 IRC Biomed Mat, Inst Orthopaed, Stanmore HA7 4LP, Middx, England.
RP Dalby, MJ (reprint author), Univ Glasgow, Inst Biomed & Life Sci, Ctr Cell Engn, Glasgow G12 8QQ, Lanark, Scotland.
RI Dalby, Matthew/G-2426-2012
OI Di Silvio, Lucy/0000-0003-2554-2052
CR ABRAM J, 1984, PLAST RUB PROC APPL, V4, P261
   ALI SY, 1992, BONE BIOL SKELETAL D, P19
   BONFIELD W, 1981, BIOMATERIALS, V2, P185, DOI 10.1016/0142-9612(81)90050-8
   Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463
   CARY LA, 1999, FRONT BIOSCI, V4, P102
   CLARK P, 1990, DEVELOPMENT, V108, P635
   CLOVER J, 1992, J CELL SCI, V103, P267
   COOPER GM, 1997, CELL MOL APPROACH
   Cowles EA, 1998, CALCIFIED TISSUE INT, V62, P74, DOI 10.1007/s002239900397
   CURTIS A, 1999, BIOCH SOC S, V65, P15
   Curtis ASG, 1998, J BIOMAT SCI-POLYM E, V9, P1313, DOI 10.1163/156856298X00415
   CURTIS ASG, 1990, CRIT REV BIOCOMPAT, V5, P343
   Dalby MJ, 1999, J MATER SCI-MATER M, V10, P793, DOI 10.1023/A:1008907218330
   Dalby MJ, 2001, BIOMATERIALS, V22, P1739, DOI 10.1016/S0142-9612(00)00334-3
   DALBY MJ, OPTIMISING HAPEX TOP
   Dalton BA, 1999, J BIOMED MATER RES, V45, P384, DOI 10.1002/(SICI)1097-4636(19990615)45:4<384::AID-JBM14>3.0.CO;2-O
   DALTON BA, 2000, S26 TISS ENG
   Degasne I, 1999, CALCIFIED TISSUE INT, V64, P499, DOI 10.1007/s002239900640
   DISILVIO L, 1995, THESIS U LONDON
   DOWNES S, 1991, CELL MATER, V1, P171
   Gray C, 1996, BONE, V18, P115, DOI 10.1016/8756-3282(95)00456-4
   HARRIS SA, 1995, J BONE MINER RES, V10, P178
   HEMACHANDRA K, 1992, THESIS U LONDON
   JULIANO RL, 1993, J CELL BIOL, V120, P577, DOI 10.1083/jcb.120.3.577
   KASEMO B, 1994, ENVIRON HEALTH PERSP, V102, P41, DOI 10.2307/3432057
   KASEMO B, 1986, CRIT REV BIOCOMPAT, V2, P335
   LARSSON C, 1994, BIOMATERIALS, V15, P1061
   MARIE PJ, 1995, CALCIF TISSUE INT S, V56
   OCONNOR TP, 1993, J CELL BIOL, V123, P935, DOI 10.1083/jcb.123.4.935
   Ohgushi H, 1996, J BIOMED MATER RES, V32, P341, DOI 10.1002/(SICI)1097-4636(199611)32:3<341::AID-JBM6>3.0.CO;2-S
   Ohgushi H, 1996, J BIOMED MATER RES, V32, P333, DOI 10.1002/(SICI)1097-4636(199611)32:3<333::AID-JBM5>3.0.CO;2-T
   POSNER AS, 1975, ACCOUNTS CHEM RES, V8, P273, DOI 10.1021/ar50092a003
   PULEO DA, 1992, BONE MINER, V18, P215, DOI 10.1016/0169-6009(92)90808-Q
   Rajnicek AM, 1997, J CELL SCI, V110, P2915
   RIEHLE M, 2000, S28 TISS ENG
   SINHA RK, 1994, CLIN ORTHOP RELAT R, P258
   Stein Gary S., 1993, P47
   Stephenson P K, 1991, J Arthroplasty, V6, P51, DOI 10.1016/S0883-5403(06)80157-9
   VROUWENVELDER WCA, 1993, J BIOMED MATER RES, V27, P465, DOI 10.1002/jbm.820270407
   Vuori K, 1998, J MEMBRANE BIOL, V165, P191, DOI 10.1007/s002329900433
   Walboomers XF, 1999, J BIOMED MATER RES, V46, P212, DOI 10.1002/(SICI)1097-4636(199908)46:2<212::AID-JBM10>3.0.CO;2-Y
   Wang M, 2000, J MATER SCI, V35, P1023, DOI 10.1023/A:1004731315328
   WEISS MJ, 1986, P NATL ACAD SCI USA, V83, P7182, DOI 10.1073/pnas.83.19.7182
NR 43
TC 46
Z9 47
U1 1
U2 10
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2002
VL 23
IS 3
BP 681
EP 690
DI 10.1016/S0142-9612(01)00156-9
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 500RF
UT WOS:000172640000007
PM 11771688
DA 2018-10-20
ER

PT J
AU Schumacher, K
   Strehl, R
   de Vries, U
   Minuth, WW
AF Schumacher, K
   Strehl, R
   de Vries, U
   Minuth, WW
TI Advanced technique for long term culture of epithelia in a continuous
   luminal-basal medium gradient
SO BIOMATERIALS
LA English
DT Article
DE epithelia; biomaterial testing; tissue engineering; gradient perfusion
   culture
ID NEONATAL RABBIT KIDNEY; COLLECTING DUCT; IN-VITRO; CELL-DIFFERENTIATION;
   INTERCALATED CELLS; PERFUSION CULTURE; RAT-KIDNEY; REPLACEMENT;
   CYCLOOXYGENASE-2; CONTAINER
AB The majority of epithelia in Our organism perform barrier functions on being exposed to different fluids at the luminal and basal sides. To simulate this natural situation under in vitro conditions for biomaterial testing and tissue engineering the epithelia have to withstand mechanical and fluid stress over a prolonged period of time. Leakage. edge damage and pressure differences in the Culture system have to be avoided so that the epithelial barrier function is maintained. Besides, the environmental influences on important cell biological features Such as, sealing or transport functions, have to remain upregulated and a loss of characteristics by dedifferentiation is prevented.
   Our aim is to expose embryonic renal collecting duct (CD) epithelia as model tissue for 14 days to fluid gradients and to monitor the development of tissue-specific features, For these experiments, Cultured embryonic epithelia are placed in tissue carriers and in gradient containers, where different media are superfused at the luminal and as basal sides. Epithelia growing on the tissue carriers act as a physiological barrier during the whole Culture period. To avoid mechanical damage of the tissue and to suppress fluid pressure differences between the luminal and basal compartments improved transport of the medium and an elimination of unilaterally accumulated gas bubbles in the gradient container compartments by newly developed gas expander modules is introduced. By the application of these tools the yield of embryonic renal collecting duct epithelia with intact barrier function on a fragile natural support material Could be increased significantly as compared to earlier experiments. Epithelia treated with a luminal NaCl load ranging from 3 to 24 mmol/l were analyzed by immunohistochemical methods to determine the degree of differentiation. The tissue showed an upregulation of individual CD cell features as compared to embryonic epithelia in the neonatal kidney. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Univ Regensburg, Dept Anat, D-93053 Regensburg, Germany.
RP Minuth, WW (reprint author), Univ Regensburg, Dept Anat, Univ Str 31, D-93053 Regensburg, Germany.
CR Bader A, 1999, EXP CELL RES, V246, P221, DOI 10.1006/excr.1998.4295
   Coppelli A, 1996, ACTA DIABETOL, V33, P166, DOI 10.1007/BF00569429
   EMMONS C, 1994, J CLIN INVEST, V93, P417, DOI 10.1172/JCI116976
   Fey-Lamprecht F, 1998, J MATER SCI-MATER M, V9, P711, DOI 10.1023/A:1008994601138
   Goto Y, 1999, AM J RESP CELL MOL, V20, P312, DOI 10.1165/ajrcmb.20.2.3062
   GROSS P, 1988, PFLUG ARCH EUR J PHY, V412, P434, DOI 10.1007/BF01907564
   Gstraunthaler G, 2000, AM J PHYSIOL-RENAL, V278, pF227
   Gustafson CJ, 1999, BURNS, V25, P331, DOI 10.1016/S0305-4179(99)00004-2
   HARRIS RC, 1994, J CLIN INVEST, V94, P2504, DOI 10.1172/JCI117620
   Humes HD, 1999, NAT BIOTECHNOL, V17, P451, DOI 10.1038/8626
   ISCOVE NN, 1978, J EXP MED, V147, P923, DOI 10.1084/jem.147.3.923
   KIM J, 1994, AM J PHYSIOL, V266, pF977
   Ludwikowski B, 1999, BJU INT, V84, P507
   Miki H, 1999, ASAIO J, V45, P502, DOI 10.1097/00002480-199909000-00025
   MINUTH WW, 1987, DIFFERENTIATION, V36, P12, DOI 10.1111/j.1432-0436.1987.tb00177.x
   Minuth WW, 1997, PEDIATR NEPHROL, V11, P140, DOI 10.1007/s004670050245
   MINUTH WW, 1994, IN VITRO CELL DEV-AN, V30A, P12
   Minuth WW, 1999, EXP NEPHROL, V7, P394
   MINUTH WW, 1993, KIDNEY INT, V44, P337
   Negrete HO, 1996, AM J PHYSIOL-RENAL, V271, pF886
   Niklason LE, 1999, SCIENCE, V284, P489, DOI 10.1126/science.284.5413.489
   Ohshima N, 1997, J CHIN INST CHEM ENG, V28, P441
   Papas KK, 1999, BIOTECHNOL BIOENG, V66, P231, DOI 10.1002/(SICI)1097-0290(1999)66:4<231::AID-BIT4>3.3.CO;2-L
   Schumacher K, 1999, IN VITRO CELL DEV-AN, V35, P465
   Steiner P, 1997, DIFFERENTIATION, V62, P193
   Stockmann M, 1999, PFLUG ARCH EUR J PHY, V438, P107, DOI 10.1007/s004240050886
   Strehl R, 1999, CELL TISSUE RES, V298, P539, DOI 10.1007/s004410050076
   Strehl R, 1997, KIDNEY INT, V52, P1469, DOI 10.1038/ki.1997.477
   Surowiec SM, 2000, J SURG RES, V88, P34, DOI 10.1006/jsre.1999.5759
   Takimoto Y, 1998, J THORAC CARDIOV SUR, V116, P98, DOI 10.1016/S0022-5223(98)70247-8
   TAUC M, 1992, BIOL CELL, V76, P55, DOI 10.1016/0248-4900(92)90195-7
   Van Dorp AGM, 1999, WOUND REPAIR REGEN, V7, P214
   Waybill PN, 1999, J VASC INTERV RADIOL, V10, P1051, DOI 10.1016/S1051-0443(99)70191-0
   Williams CS, 1999, ONCOGENE, V18, P7908
   WILLIAMS CS, 1996, AM J PHYSIOL, V270, P873
   Yang TX, 1998, AM J PHYSIOL-RENAL, V274, pF481, DOI 10.1152/ajprenal.1998.274.3.F481
   Zhang MZ, 1999, P NATL ACAD SCI USA, V96, P15280, DOI 10.1073/pnas.96.26.15280
NR 37
TC 23
Z9 23
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2002
VL 23
IS 3
BP 805
EP 815
DI 10.1016/S0142-9612(01)00186-7
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 500RF
UT WOS:000172640000021
PM 11771700
DA 2018-10-20
ER

PT J
AU Ishihara, M
   Nakanishi, K
   Ono, K
   Sato, M
   Kikuchi, M
   Saito, Y
   Yura, H
   Matsui, T
   Hattori, H
   Uenoyama, M
   Kurita, A
AF Ishihara, M
   Nakanishi, K
   Ono, K
   Sato, M
   Kikuchi, M
   Saito, Y
   Yura, H
   Matsui, T
   Hattori, H
   Uenoyama, M
   Kurita, A
TI Photocrosslinkable chitosan as a dressing for wound occlusion and
   accelerator in healing process
SO BIOMATERIALS
LA English
DT Article
DE chitosan; chitin; photocrosslinking; wound occlusion; wound healing
ID FIBROBLAST-GROWTH-FACTOR; DEACETYLATED CHITIN; CYTOKINE PRODUCTION;
   BIOMATERIAL; STIMULATION; MIGRATION; MICE; DOGS
AB Application of ultraviolet light (UV-) irradiation to a photocrosslinkable chitosan (Az-CH-LA) aqueous solution resulted in an insoluble. flexible hydrogel like soft rubber within 60 s. The chitosan hydrogel could completely stop bleeding from a cut Mouse tail within 30 s of UV-irradiation and could firmly adhere two pieces of sliced skins of mouse to each other. In order to evaluate its accelerating effect on wound healing, full thickness-skin incisions were made on the back of mice and subsequently an Az-CH-LA aqueous solution was added into the wound and irradiated with UV light for 90 s. Application of the chitosan hydrogel significantly induced wound contraction and accelerated wound closure and healing. Histological examinations also have demonstrated an advanced granulation tissue formation and epithelialization in the chitosan hydrogel treated wounds. The chitosan hydrogel due to its accelerating healing ability is considered to become an excellent dressing for wound occlusion and tissue adhesive in urgent hemostasis Situations, (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Natl Def Med Coll, Res Inst, Dept Surg 2, Saitama 3598513, Japan.
   Natl Def Med Coll, Res Inst, Dept Orthopaed Surg, Saitama 3598513, Japan.
   Natl Def Med Coll, Dept Med Engn, Saitama 3598513, Japan.
   NeTech Inc, Kanagawa 2130012, Japan.
RP Ishihara, M (reprint author), Natl Def Med Coll, Res Inst, Dept Surg 2, 3-2 Namiki Tokorozawa, Saitama 3598513, Japan.
OI Sato, Masato/0000-0003-4049-7325
CR ALLAN GG, 1995, CARBOHYD RES, V277, P257, DOI 10.1016/0008-6215(95)00207-A
   CHANDY T, 1990, BIOMATER ARTIF CELL, V18, P1, DOI 10.3109/10731199009117286
   Cho YW, 1999, BIOMATERIALS, V20, P2139, DOI 10.1016/S0142-9612(99)00116-7
   FUKASAWA M, 1992, SURG TODAY, V22, P333, DOI 10.1007/BF00308742
   GUO Y, 1989, ANAL BIOCHEM, V176, P96, DOI 10.1016/0003-2697(89)90278-9
   KOCH AE, 1992, SCIENCE, V258, P1798, DOI 10.1126/science.1281554
   Mori T, 1997, BIOMATERIALS, V18, P947, DOI 10.1016/S0142-9612(97)00017-3
   MUZZARELLI RAA, 1993, CARBOHYD POLYM, V20, P7, DOI 10.1016/0144-8617(93)90027-2
   NISHIMURA K, 1986, VACCINE, V4, P151, DOI 10.1016/0264-410X(86)90002-2
   OKAMOTO Y, 1995, J VET MED SCI, V57, P851, DOI 10.1292/jvms.57.851
   Ono I, 1999, J BIOMED MATER RES, V48, P621, DOI 10.1002/(SICI)1097-4636(1999)48:5<621::AID-JBM5>3.0.CO;2-1
   Ono K, 2000, J BIOMED MATER RES, V49, P289
   PELUSO G, 1994, BIOMATERIALS, V15, P1215, DOI 10.1016/0142-9612(94)90272-0
   PRUDDEN JF, 1970, AM J SURG, V119, P560, DOI 10.1016/0002-9610(70)90175-3
   Purna S K, 2000, Burns, V26, P54
   Radhakrishnan VV, 1991, BIOMEDICINE, V2, P3
   Rao SB, 1997, J BIOMED MATER RES, V34, P21, DOI 10.1002/(SICI)1097-4636(199701)34:1<21::AID-JBM4>3.0.CO;2-P
   SHIGEMASA Y, 1995, BIOTECHNOL GENET ENG, V13, P383
   TSUBOI R, 1990, J EXP MED, V172, P245, DOI 10.1084/jem.172.1.245
   Ueno H, 1999, BIOMATERIALS, V20, P1407, DOI 10.1016/S0142-9612(99)00046-0
   USAMI Y, 1994, J VET MED SCI, V56, P761, DOI 10.1292/jvms.56.761
   USAMI Y, 1994, J VET MED SCI, V56, P1215, DOI 10.1292/jvms.56.1215
   WINTER GD, 1962, NATURE, V193, P293, DOI 10.1038/193293a0
NR 23
TC 289
Z9 325
U1 20
U2 175
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2002
VL 23
IS 3
BP 833
EP 840
DI 10.1016/S0142-9612(01)00189-2
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 500RF
UT WOS:000172640000024
PM 11771703
DA 2018-10-20
ER

PT J
AU Amaral, M
   Lopes, MA
   Silva, RF
   Santos, JD
AF Amaral, M
   Lopes, MA
   Silva, RF
   Santos, JD
TI Densification route and mechanical properties of Si3N4-bioglass
   biocomposites
SO BIOMATERIALS
LA English
DT Article
DE Si3N4-bioglass composites; hot-pressing; densification behaviour;
   mechanical properties
ID SILICON-NITRIDE; BRITTLE SOLIDS
AB The processing route and the final microstructural and mechanical characteristics of a Nobel biomaterial composite are described, This new material is composed of 70 wt% Si3N4 ceramic phase and 30 wt% bioglass, the later performing as a liquid sintering aid system and simultaneously providing bioactivity characteristics to the composite. The conditions for fabrication of an almost fully dense material (similar to 98% of relative density) were pursued. Optimised parameters were 1350 degreesC-40 min-30 MPa by hot-pressing technique, The very fast densification rate of the process avoided the crystallisation of the bioglass intergranular phase and therefore its intrinsic properties were maintained. Also, the large amount of glassy phase assured the densification by liquid phase assisted grain rearrangement Without Si3N4 Phase transformation. The final mechanical properties of the Si3N4-bioglass were as follows: fracture toughness. K-IC = 4.4 MPa m(1/2). Vickers hardness. H-V = 10.3 GPa, Young's modulus, E = 197 GPa; bending strength, sigma (R) = 383 MPa, Weibull modulus, m = 8.3. These values provide an attractive set of properties among other bioactive materials, namely by upgrading the main drawback of bioceramics and bioglasses for high-load medical applications, which is the lack of satisfactory fracture toughness. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Univ Porto, Seccao Mat, Fac Engn, DEMM, P-4200465 Oporto, Portugal.
   Inst Biomed Engn, Lab Biomat, P-4150 Oporto, Portugal.
   Univ Aveiro, Dept Ceram & Glass Engn, UIMC, P-3810193 Aveiro, Portugal.
RP Santos, JD (reprint author), Univ Porto, Seccao Mat, Fac Engn, DEMM, Rua Roberto Frias, P-4200465 Oporto, Portugal.
RI Amaral, Margarida/B-7393-2008; Lopes, Maria A./P-4442-2014; Silva,
   Rui/B-8208-2008; Lopes, Cristina/A-4241-2010
OI Amaral, Margarida/0000-0003-4966-2614; Lopes, Maria
   A./0000-0003-4105-8148; Silva, Rui/0000-0002-2584-1792; Santos, Jose
   Domingos/0000-0002-6871-9850
CR *ASTM, C125995 ASTM
   DUCHEYNE P, 1993, ADV SERIES CERAMICS, V1, P281
   EVANS AG, 1976, ACTA METALL MATER, V24, P939, DOI 10.1016/0001-6160(76)90042-0
   Filho OP, 1996, J BIOMED MATER RES, V30, P509
   GAZZARA CP, 1977, AM CERAM SOC BULL, V56, P777
   Hench LL, 1998, BIOMATERIALS, V19, P1419, DOI 10.1016/S0142-9612(98)00133-1
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Howlett C., 1989, CLIN ORTHOP RELAT R, V244, P296
   KINGERY WD, 1959, J APPL PHYS, V30, P301, DOI 10.1063/1.1735155
   KONG YM, 1999, J AM CERAM SOC, V82, P963
   Kue R, 1999, BIOMATERIALS, V20, P1195, DOI 10.1016/S0142-9612(99)00007-1
   NIIHARA K, 1982, J MATER SCI LETT, V1, P13, DOI 10.1007/BF00724706
   Radin S, 2000, J BIOMED MATER RES, V49, P264, DOI 10.1002/(SICI)1097-4636(200002)49:2<264::AID-JBM16>3.0.CO;2-2
   Ravaglioli A., 1992, BIOCERAMICS MAT PROP
   Santos J. D., 2001, KEY ENG MATER, V192-195, P589
   YAMAMURO T, 1990, HDB BIOACTIVE CERAMI, V1, P335
   ZIEGLER G, 1987, J MATER SCI, V22, P3041, DOI 10.1007/BF01161167
NR 17
TC 48
Z9 48
U1 1
U2 20
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2002
VL 23
IS 3
BP 857
EP 862
DI 10.1016/S0142-9612(01)00194-6
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 500RF
UT WOS:000172640000027
PM 11771704
DA 2018-10-20
ER

PT J
AU Wettero, J
   Askendal, A
   Bengtsson, T
   Tengvall, P
AF Wettero, J
   Askendal, A
   Bengtsson, T
   Tengvall, P
TI On the binding of complement to solid artificial surfaces in vitro
SO BIOMATERIALS
LA English
DT Article
DE biomaterial; complement activation; protein adsorption; IgG;
   hemodialysis
ID NEUTROPHIL RESPIRATORY BURST; ALTERNATIVE PATHWAY; HEMODIALYSIS
   MEMBRANES; METHYLATED SILICON; ESTER LINKAGE; GOLD SURFACES;
   HUMAN-SERUM; BOUND C-3; ACTIVATION; IGG
AB Since the realization of a complement activation capacity by artificial surfaces upon contact with blood. a common belief has evolved that charged nucleophilic surface groups such as amine (-NH2) and hydroxyl (-OH) react with and eventually bind to the internal thioester in complement factor 3 (C3). A covalent amide or ester linkage is thereby supposed to form between Ob and the surface itself. In this report, we present complement surface binding data by null-ellipsometry for two nucleophilic Surfaces (-NH2 and -OH), for surfaces with immunoglobulin G (IgG) covalently bound, and for IgG spontaneously pre-adsorbed to hydrophobic silicon. The results reveal that the plasma proteins that were deposited during complement activation became eluted by sodium dodecyl sulfate. Hence the direct covalent binding between C3 and solid nucleophilic surfaces seems to be only of moderate importance. at least during shorter serum incubations. This strongly suggests that the prevalent covalent linkage model between solid artificial Surfaces and C3b is not accurate. Instead we suggest a more pronounced role for C3 associations to other adsorbed proteins and/or electrostatic and hydrophobic protein-surface interactions. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Linkoping Univ, Div Appl Phys, Dept Phys & Measurement Technol, SE-58183 Linkoping, Sweden.
   Linkoping Univ, Fac Hlth Sci, Dept Hlth & Environm, Div Med Microbiol, SE-58185 Linkoping, Sweden.
RP Wettero, J (reprint author), Linkoping Univ, Div Appl Phys, Dept Phys & Measurement Technol, SE-58183 Linkoping, Sweden.
EM jonwe@ifm.liu.se
RI Wettero, Jonas/C-9578-2009
OI Wettero, Jonas/0000-0002-6916-5490
CR BENESCH J, 2001, IN PRESS J BIOMATER
   CHENOWETH DE, 1984, ARTIF ORGANS, V8, P281, DOI 10.1111/j.1525-1594.1984.tb04291.x
   CHENOWETH DE, 1987, ANN NY ACAD SCI, V516, P306, DOI 10.1111/j.1749-6632.1987.tb33051.x
   CHEUNG AK, 1989, KIDNEY INT, V35, P576, DOI 10.1038/ki.1989.26
   CHEUNG AK, 1989, KIDNEY INT, V36, P257, DOI 10.1038/ki.1989.188
   COOPER NR, 1999, INFLAMMATION BASIC P, P281
   CORNELIUS RM, 1993, J BIOMAT SCI-POLYM E, V4, P291, DOI 10.1163/156856293X00573
   DEFEIJTER JA, 1978, BIOPOLYMERS, V17, P1759, DOI 10.1002/bip.1978.360170711
   ELWING H, 1987, J COLLOID INTERF SCI, V119, P203, DOI 10.1016/0021-9797(87)90260-8
   GACHON A M F, 1991, Journal of Biomaterials Science Polymer Edition, V2, P263, DOI 10.1163/156856291X00160
   GADD KJ, 1981, BIOCHEM J, V195, P471, DOI 10.1042/bj1950471
   Gemmell CH, 1997, J BIOMED MATER RES, V37, P474
   GOODMAN EB, 1995, J LEUKOCYTE BIOL, V58, P168
   HERMANSON GT, 1992, IMMOBILIZED AFFINITY, P51
   Hirata I, 2000, COLLOID SURFACE B, V18, P285, DOI 10.1016/S0927-7765(99)00154-X
   IKEDA K, 1987, J BIOL CHEM, V262, P7451
   JANATOVA J, 1991, COMPLEMENT INFLAMMAT, V8, P61, DOI 10.1159/000463181
   JOHNSON U, 1982, ACTA PATH MICRO IM C, V90, P321
   KAZATCHKINE MD, 1988, BIOMATERIALS, V9, P30, DOI 10.1016/0142-9612(88)90066-X
   KERN W, 1970, RCA REV, V31, P187
   LAW SK, 1977, P NATL ACAD SCI USA, V74, P2701, DOI 10.1073/pnas.74.7.2701
   LAW SK, 1979, J IMMUNOL, V123, P1388
   Law SKA, 1997, PROTEIN SCI, V6, P263
   Lhotta K, 1998, KIDNEY INT, V53, P1044
   Liu L, 1997, CLIN EXP IMMUNOL, V109, P204, DOI 10.1046/j.1365-2249.1997.4311329.x
   LIU L, 1994, J BIOMED MATER RES, V28, P767, DOI 10.1002/jbm.820280703
   Liu L, 1996, J BIOMED MATER RES, V30, P535, DOI 10.1002/(SICI)1097-4636(199604)30:4<535::AID-JBM12>3.0.CO;2-G
   Loos M., 1998, COMPLEMENT SYSTEM, P1
   McCrackin F. L., 1969, 479 NBS
   NILSSON B, 1986, IMMUNOL LETT, V13, P11, DOI 10.1016/0165-2478(86)90118-5
   NILSSON B, 1989, MOL IMMUNOL, V26, P383, DOI 10.1016/0161-5890(89)90127-2
   NILSSON B, 1985, SCAND J IMMUNOL, V22, P703, DOI 10.1111/j.1365-3083.1985.tb01933.x
   NILSSON B, 1998, COMPLEMENT SYSTEM, P23
   Pangburn M. K., 1998, COMPLEMENT SYSTEM, P93
   PANGBURN MK, 1989, J IMMUNOL, V142, P2766
   PANGBURN MK, 1989, J IMMUNOL, V142, P2759
   PETERS DA, 1979, J ELECTROCHEM SOC, V126, P883, DOI 10.1149/1.2129162
   REID KBM, 1998, COMPLEMENT SYSTEM, P86
   SAHU A, 1994, J BIOL CHEM, V269, P28997
   SIM RB, 1981, BIOCHEM J, V193, P115, DOI 10.1042/bj1930115
   STOSSEL TP, 1975, J EXP MED, V141, P1329, DOI 10.1084/jem.141.6.1329
   Tang LP, 1998, J BIOMED MATER RES, V41, P333, DOI 10.1002/(SICI)1097-4636(199808)41:2<333::AID-JBM19>3.0.CO;2-L
   Tengvall P, 1997, J BIOMED MATER RES, V35, P81, DOI 10.1002/(SICI)1097-4636(199704)35:1<81::AID-JBM8>3.0.CO;2-I
   Tengvall P, 1996, BIOMATERIALS, V17, P1001, DOI 10.1016/0142-9612(96)84675-8
   Tengvall P, 1996, J BIOMED MATER RES, V31, P305, DOI 10.1002/(SICI)1097-4636(199607)31:3<305::AID-JBM3>3.0.CO;2-Q
   VENKATESH YP, 1983, ANN NY ACAD SCI, V421, P313, DOI 10.1111/j.1749-6632.1983.tb18119.x
   VENKATESH YP, 1988, MOL IMMUNOL, V25, P821, DOI 10.1016/0161-5890(88)90118-6
   VENKATESH YP, 1984, J IMMUNOL, V132, P1435
   Walivaara B, 1996, J BIOMAT SCI-POLYM E, V8, P41, DOI 10.1163/156856297X00560
   WEETALL HH, 1993, APPL BIOCHEM BIOTECH, V41, P157, DOI 10.1007/BF02916421
   Wettero J, 2001, J BIOMED MATER RES, V57, P550, DOI 10.1002/1097-4636(20011215)57:4<550::AID-JBM1201>3.0.CO;2-T
   Wettero J, 2000, J BIOMED MATER RES, V51, P742, DOI 10.1002/1097-4636(20000915)51:4<742::AID-JBM24>3.0.CO;2-D
   ZHANG W, 1994, IMMUNOLOGY, V81, P137
   ZHOU MJ, 1994, J CELL BIOL, V125, P1407, DOI 10.1083/jcb.125.6.1407
NR 54
TC 40
Z9 40
U1 0
U2 17
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2002
VL 23
IS 4
BP 981
EP 991
DI 10.1016/S0142-9612(01)00203-4
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 502HR
UT WOS:000172738500002
PM 11791932
DA 2018-10-20
ER

PT J
AU Grigolo, B
   Lisignoli, G
   Piacentini, A
   Fiorini, M
   Gobbi, P
   Mazzotti, G
   Duca, M
   Pavesio, A
   Facchini, A
AF Grigolo, B
   Lisignoli, G
   Piacentini, A
   Fiorini, M
   Gobbi, P
   Mazzotti, G
   Duca, M
   Pavesio, A
   Facchini, A
TI Evidence for redifferentiation of human chondrocytes grown on a
   hyaluronan-based biomaterial (HYAFF (R) 11): molecular,
   immunohistochemical and ultrastructural analysis
SO BIOMATERIALS
LA English
DT Article
DE hyaluronan; tissue engineering; chondrocytes; collagen; proteoglycans
ID ARTICULAR-CARTILAGE; CELL-SHAPE; DEFECTS; REPAIR; TRANSPLANTATION;
   EXPRESSION; PHENOTYPE; ALGINATE; CULTURES; INVITRO
AB Association of biomaterials with autologous cells can provide a new generation of implantable devices for cartilage repair. Such scaffolds should provide a preformed three-dimensional shape and prevent cells from escaping into the articular cavity. Furthermore, these constructs should have sufficient mechanical strength to facilitate handling in a clinical setting and stimulate the uniform spreading of cells and their phenotype redifferentiation. The aim of this study was to verify the ability of HYAFF (R) 11, a recently developed hyaluronic-acid-based biodegradable polymer, to support the growth of human chondrocytes and to maintain their original phenotype. This capability was assessed by the evaluation of collagen types I, II and aggrecan mRNA expression. Immunohistochemical analyses were also performed to evaluate collagen types I, II and proteoglycans synthesis. A field emission in lens scanning microscopy was utilized to verify the interactions between the cells and the biomaterial.
   Our data indicate that human chondrocytes seeded on HYAFF (R) 11 express and produce collagen type II and aggrecan and downregulate the production of collagen type I. These results provide an in vitro demonstration for the therapeutic potential of HYAFF (R) 11 as a delivery vehicle in a tissue-engineered approach towards the repair of articular cartilage defects. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Ist Ortoped Rizzoli, Ist Ric Codivilla Putti, Lab Immunol & Genet, I-40136 Bologna, Italy.
   Univ Bologna, Unita Complessa Sci Anat Umane & Fisiopatol Appar, I-40126 Bologna, Italy.
   Fidia Adv Biopolymers, I-35031 Abano Terme, Padova, Italy.
   Univ Bologna, Dipartimento Med Interna & Gastroenterol, I-40138 Bologna, Italy.
RP Facchini, A (reprint author), Ist Ortoped Rizzoli, Ist Ric Codivilla Putti, Lab Immunol & Genet, Via di Barbiano 1-10, I-40136 Bologna, Italy.
EM labimge@alma.unibo.it
RI Grigolo, Brunella/J-5417-2016; Gobbi, Pietro/J-2566-2012
OI Grigolo, Brunella/0000-0002-3990-6745; Gobbi, Pietro/0000-0003-4705-0833
CR Aigner J, 1998, J BIOMED MATER RES, V42, P172, DOI 10.1002/(SICI)1097-4636(199811)42:2<172::AID-JBM2>3.0.CO;2-M
   ARCHER CW, 1990, J CELL SCI, V97, P361
   AULTHOUSE AL, 1989, IN VITRO CELL DEV B, V25, P659
   BASSLEER C, 1986, IN VITRO CELL DEV B, V22, P113
   BONAVENTURE J, 1994, EXP CELL RES, V212, P97, DOI 10.1006/excr.1994.1123
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   Brun P, 1999, J BIOMED MATER RES, V46, P337, DOI 10.1002/(SICI)1097-4636(19990905)46:3<337::AID-JBM5>3.3.CO;2-H
   BUCKWALTER JA, 1990, BRIS MYER Z, P19
   BUCKWALTER JA, 1994, J BONE JOINT SURG AM, V76A, P1405, DOI 10.2106/00004623-199409000-00019
   COLETTI JM, 1972, J BONE JOINT SURG AM, VA 54, P147, DOI 10.2106/00004623-197254010-00014
   CORTIVO R, 1990, CELL BIOL INT REP, V14, P111
   DELBRUCK A, 1986, CONNECT TISSUE RES, V15, P115
   DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6
   GRANDE DA, 1989, J ORTHOP RES, V7, P208, DOI 10.1002/jor.1100070208
   HENDRICKSON DA, 1994, J ORTHOP RES, V12, P484
   HOMMINGA GN, 1989, ACTA ORTHOP SCAND, V60, P326, DOI 10.3109/17453678909149287
   HORTON W, 1986, DEV BIOL, V115, P392, DOI 10.1016/0012-1606(86)90258-7
   KIMURA T, 1984, CLIN ORTHOP RELAT R, P231
   KUETTNER KE, 1992, CLIN BIOCHEM, V25, P155, DOI 10.1016/0009-9120(92)90224-G
   KUETTNER KE, 1998, RHEUMATOLOGY, V2
   LEFREED, 1993, J BIOMED MATER RES, V27, P11
   MALLEINGERIN F, 1990, DIFFERENTIATION, V43, P204, DOI 10.1111/j.1432-0436.1990.tb00447.x
   MANKIN HJ, 1982, J BONE JOINT SURG AM, V64, P460, DOI 10.2106/00004623-198264030-00022
   O'Driscoll SW, 1998, J BONE JOINT SURG AM, V80A, P1795, DOI 10.2106/00004623-199812000-00011
   RASTRELLI A, 1990, CLIN IMPLANT MAT, V9, P199
   SHAPIRO F, 1993, J BONE JOINT SURG AM, V75A, P532, DOI 10.2106/00004623-199304000-00009
   Solchaga LA, 1999, J ORTHOPAED RES, V17, P205, DOI 10.1002/jor.1100170209
   Stanton JS, 1995, J MATER SCI-MATER M, V6, P739
   TRIPPEL SB, 1995, NEW ENGL J MED, V332, P539
   VACHON AM, 1991, AM J VET RES, V52, P317
   vanSusante JLC, 1995, ACTA ORTHOP SCAND, V66, P549, DOI 10.3109/17453679509002314
   WRIGHT JG, 1995, NEW ENGL J MED, V332, P540
NR 32
TC 189
Z9 195
U1 1
U2 17
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2002
VL 23
IS 4
BP 1187
EP 1195
DI 10.1016/S0142-9612(01)00236-8
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 502HR
UT WOS:000172738500024
PM 11791922
DA 2018-10-20
ER

PT J
AU Bruining, MJ
   Pijpers, AP
   Kingshott, P
   Koole, LH
AF Bruining, MJ
   Pijpers, AP
   Kingshott, P
   Koole, LH
TI Studies on new polymeric biomaterials with tunable hydrophilicity, and
   their possible utility in corneal repair surgery
SO BIOMATERIALS
LA English
DT Article
DE polymeric biomaterials; tunable hydrophilicity; corneal repair surgery
ID PERFORATION; KERATOPROSTHESIS
AB A well-known complication in corneal repair surgery is (recurrent) rejection of donor corneal tissue, particularly in patients suffering from an auto-immune disease such as rheumatoid arthritis. Down-regulation of their immune system, by means of drugs, is necessary in order to perform an allograft implantation afterwards. The patient may need a temporary prosthetic cornea while the immune system is inactivated. Recently, NeuroPatch (R), a mesh-type polyurethane, was used for this purpose. The material exhibits excellent biocompatibility and allows ingrowth of stromal fibroblasts which deposit matrix material into the pores. A serious drawback of NeuroPatch (R) is its non-transparency, which impairs vision. In this work we attempted to develop an improved biomaterial that combines the advantages of NeuroPatch (R) with optical transparency. Based on previous findings that copolymers of hexaethyleneglycolmethacrylate (HEGMA) and butylmethacrylate (BMA), are transparent and well accepted by human corneal epithelial cells, we studied these materials further in detail. (Bruining et al., Bio-Macromolecules 1 (2000) 418) Copolymerizations were studied by means of H-1 NMR. The influence of the HEGMA content on hydrophilicity, flexibility and resistance to protein adsorption was studied. The results indicate that materials with a HEGMA content of approximately 20 mol% are potentially useful in corneal repair surgery. These biomaterials meet most of the stringent physical and biological requirements. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Univ Maastricht, Ctr Biomat Res, NL-6200 MD Maastricht, Netherlands.
   DSM Res & Patents, Geleen, Netherlands.
   Aachen Ctr Competence, Dept Text Chem & Macromol Chem, Aachen, Germany.
RP Koole, LH (reprint author), Univ Maastricht, Ctr Biomat Res, POB 616, NL-6200 MD Maastricht, Netherlands.
OI Kingshott, Peter/0000-0001-5882-5804
CR Adachi W, 1998, BRIT J OPHTHALMOL, V82, P1445
   Beamson G., 1992, HIGH RESOLUTION XPS
   Bruining MJ, 2000, BIOMATERIALS, V21, P595, DOI 10.1016/S0142-9612(99)00223-9
   Bruining MJ, 2000, BIOMACROMOLECULES, V1, P418, DOI 10.1021/bm000009t
   Cheng CL, 1999, AUST NZ J OPHTHALMOL, V27, P437
   Hicks C, 2000, PROG RETIN EYE RES, V19, P149, DOI 10.1016/S1350-9462(99)00013-0
   Kingshott P, 1999, ANAL BIOCHEM, V273, P156, DOI 10.1006/abio.1999.4201
   Kingshott P, 1999, CURR OPIN SOLID ST M, V4, P403, DOI 10.1016/S1359-0286(99)00018-2
   Kompa S, 2000, INT J ARTIF ORGANS, V23, P345
   Kruft MAB, 1996, MACROMOLECULES, V29, P5513, DOI 10.1021/ma951399s
   Lekskul M, 2000, CORNEA, V19, P313, DOI 10.1097/00003226-200005000-00011
   NOLLER HG, 1974, J ELECTRON SPECTROSC, V5, P705, DOI 10.1016/0368-2048(74)85047-4
   Nuyts RMMA, 1999, ARCH OPHTHALMOL-CHIC, V117, P1427
   Sandeman SR, 2000, BRIT J OPHTHALMOL, V84, P640, DOI 10.1136/bjo.84.6.640
   SCOFIELD JH, 1976, J ELECTRON SPECTROSC, V8, P129, DOI 10.1016/0368-2048(76)80015-1
NR 15
TC 17
Z9 17
U1 0
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2002
VL 23
IS 4
BP 1213
EP 1219
DI 10.1016/S0142-9612(01)00237-X
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 502HR
UT WOS:000172738500027
PM 11791925
DA 2018-10-20
ER

PT J
AU Rosengren, A
   Pavlovic, E
   Oscarsson, S
   Krajewski, A
   Ravaglioli, A
   Piancastelli, A
AF Rosengren, A
   Pavlovic, E
   Oscarsson, S
   Krajewski, A
   Ravaglioli, A
   Piancastelli, A
TI Plasma protein adsorption pattern on characterized ceramic biomaterials
SO BIOMATERIALS
LA English
DT Article
DE biomaterials; ceramics; protein adsorption; plasma proteins
ID HUMAN CORTICAL BONE; OSTEOBLAST ADHESION; CALCIUM-PHOSPHATE;
   HYDROXYAPATITE; SURFACES; SERUM; ELECTROPHORESIS; REACTIVITY; ALBUMIN
AB The protein/biomaterial interactions of three biomaterials used in hard tissue surgery were studied in vitro. A dynamic flow system and two-dimensional polyacrylamide gel electrophoresis (2D-PAGE) were used to investigate the adsorption of proteins from diluted human plasma on hydroxyapatite, alumina and zirconia, with regard to total protein binding capacity, relative binding capacity for specific proteins and flow-through and desorption patterns. The ceramics were characterized regarding physicochemical properties, namely, chemical composition by elementary analyses and specific surface, pore volume and pore size distribution using the BET-method and Hg-porosimetry.
   The materials were found to adsorb a surprisingly low amount of plasma proteins, leaving more than 70% of the surface free. The cellular response will therefore be highly affected by the physico-chemical properties of the material, in contrast to a surface fully covered with proteins. Regarding the adsorption of proteins, most proteins exhibited similar flow-through patterns on the three adsorbents. The exceptions with different flow-through patterns were apolipoprotein D (Apo D), apolipoprotein J (Apo J), complement factor C1s (C1s). complement factor C3 (C3), ceruloplasmin, fibrinogen, alpha (1) B glycoprotein and alpha (2) HS glycoprotein a nd serum retinal-binding protein (SRBP). The role of these proteins on acceptance or rejection of implants has to be investigated. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Univ Uppsala, Ctr Surface Biotechnol, S-75123 Uppsala, Sweden.
   Malardalen Univ, Dept Biol & Chem Engn, S-63105 Eskilstuna, Sweden.
   Italian Natl Res Council, Inst Technol Res Ceram, I-48018 Faenza, Italy.
RP Rosengren, A (reprint author), Univ Uppsala, Ctr Surface Biotechnol, Box 577, S-75123 Uppsala, Sweden.
CR Allen T., 1997, PARTICLE SIZE MEASUR, V2
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   ASHTON BA, 1976, CALC TISS RES, V22, P27
   Bergkvist M, 1998, J COLLOID INTERF SCI, V206, P475, DOI 10.1006/jcis.1998.5630
   Brash J. L., 1995, ACS SYM SER, V602, P1
   BROADLEY C, 1989, AM J PATHOL, V135, P647
   CHRISTEL PS, 1992, CLIN ORTHOP RELAT R, P10
   CLARKE IC, 1992, CLIN ORTHOP RELAT R, P19
   Ducheyne P, 1999, BIOMATERIALS, V20, P2287, DOI 10.1016/S0142-9612(99)00181-7
   El-Ghannam A, 1999, J ORTHOPAED RES, V17, P340, DOI 10.1002/jor.1100170307
   FAIR BD, 1980, J COLLOID INTERF SCI, V77, P525, DOI 10.1016/0021-9797(80)90325-2
   FENG L, 1995, COLLOID SURFACE B, V4, P313, DOI 10.1016/0927-7765(95)01190-T
   FLOWER DR, 1994, FEBS LETT, V354, P7, DOI 10.1016/0014-5793(94)01078-1
   GARNETT J, 1990, BIOCHEM J, V266, P863
   GOLAZ O, 1993, ELECTROPHORESIS, V14, P1223, DOI 10.1002/elps.11501401183
   Green RJ, 1999, BIOMATERIALS, V20, P385, DOI 10.1016/S0142-9612(98)00201-4
   GRINNELL F, 1981, J BIOMED MATER RES, V15, P363, DOI 10.1002/jbm.820150308
   Hanson S. R., 1996, BIOMATERIALS SCI INT, P193
   HELENIUS A, 1975, BIOCHIM BIOPHYS ACTA, V415, P29, DOI 10.1016/0304-4157(75)90016-7
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   HO CH, 1991, J BIOMED MATER RES, V25, P423, DOI 10.1002/jbm.820250402
   Hoffman A. S., 1982, BIOMATERIALS INTERFA, P3
   HORBETT TA, 1994, COLLOID SURFACE B, V2, P225, DOI 10.1016/0927-7765(94)80037-5
   HORBETT TA, 1989, BIOMATERIALS INTERFA, P233
   Hulbert SF, 1993, INTRO BIOCERAMICS, P25
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   Johnson R. J., 1996, BIOMATERIALS SCI, P173
   KARLSSON E, 1997, PROTEIN PURIFICATION, P145
   KLEIN CPAT, 1983, BIOMATERIALS, V4, P181, DOI 10.1016/0142-9612(83)90007-8
   Krajewski A, 1996, BIOMATERIALS, V17, P53, DOI 10.1016/0142-9612(96)80755-1
   Lemons JE, 1996, BONE, V19, pS121, DOI 10.1016/S8756-3282(96)00128-7
   NORDE W, 1986, J COLLOID INTERF SCI, V112, P447, DOI 10.1016/0021-9797(86)90113-X
   Okazaki J, 1999, BIOMATERIALS, V20, P309, DOI 10.1016/S0142-9612(98)00162-8
   Pankhurst GJ, 1998, BIOCHEMISTRY-US, V37, P4823, DOI 10.1021/bi972367v
   Peracchia MT, 1999, BIOMATERIALS, V20, P1269, DOI 10.1016/S0142-9612(99)00021-6
   Ratner B. D., 1996, BIOMATERIALS SCI INT
   Ravaglioli A., 1992, BIOCERAMICS MAT PROP
   RAVAGLIOLI A, 1992, MAT SURG USE BIOCERA, P101
   ROSENBERG ME, 1995, INT J BIOCHEM CELL B, V7, P669
   SCHADEL A, 1993, ORL J OTO-RHINO-LARY, V55, P216, DOI 10.1159/000276426
   Schinke T, 1996, J BIOL CHEM, V271, P20789, DOI 10.1074/jbc.271.34.20789
   SILVER F, 1989, BIOCOMPATIBILITY INT, V1, P97
   Slack SM, 1995, ACS SYM SER, V602, P112
   SMITH AJ, 1985, CALCIFIED TISSUE INT, V37, P208, DOI 10.1007/BF02554843
   SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   Takami Y, 1998, J BIOMED MATER RES, V40, P24, DOI 10.1002/(SICI)1097-4636(199804)40:1<24::AID-JBM3>3.3.CO;2-U
   TUNG PS, 1992, J CELL PHYSIOL, V152, P410, DOI 10.1002/jcp.1041520224
   UNIYAL S, 1982, THROMB HAEMOSTASIS, V47, P285
   VEERMAN ECI, 1988, IMPLANT MATERIALS BI, V8, P331
   VROMAN L, 1969, SURF SCI, V16, P438, DOI 10.1016/0039-6028(69)90037-5
   WESTERMEIER R, 1997, PROTEIN PURIFICATION, P557
   YOUNG BR, 1982, BIOMATERIALS INTERFA, P317
   Zeng HT, 1999, BIOMATERIALS, V20, P377, DOI 10.1016/S0142-9612(98)00184-7
   Zreiqat H., 1996, Cells and Materials, V6, P45
NR 55
TC 90
Z9 91
U1 2
U2 29
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2002
VL 23
IS 4
BP 1237
EP 1247
DI 10.1016/S0142-9612(01)00244-7
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 502HR
UT WOS:000172738500030
PM 11791928
DA 2018-10-20
ER

PT J
AU LeGeros, RZ
AF LeGeros, RZ
TI Properties of osteoconductive biomaterials: Calcium phosphates
SO CLINICAL ORTHOPAEDICS AND RELATED RESEARCH
LA English
DT Article
ID IN-VITRO; BONE-FORMATION; OSTEOCLASTIC RESORPTION; ELECTRON-MICROSCOPY;
   HA/BETA-TCP; HYDROXYAPATITE; INTERFACE; IMPLANTS; CERAMICS; CELLS
AB Bone is formed by a series of complex events involving the mineralization of extracellular matrix proteins rigidly orchestrated by cells with specific functions of maintaining the integrity of the bone. Bone, similar to other calcified tissues, is an intimate composite of the organic (collagen and non-collagenous proteins) and inorganic or mineral phases. The bone mineral idealized as calcium hydroxyapatite, Ca-10(PO4)(6)(OH)(2), is a carbonate-hydroxyapatite, approximated by the formula: (Ca,X)(10)(PO4,HPO4,CO3)(6)(OH,Y)(2), where X are cations (magnesium, sodium, strontium ions) that can substitute for the calcium ions, and Y are anions (chloride or fluoride ions) that can substitute for the hydroxyl group. The current author presents a brief review of CaP biomaterials that now are used as grafts for bone repair, augmentation, or substitution. Commercially-available CaP biomaterials differ in origin (natural or synthetic), composition (hydroxyapatite, beta-tricalcium phosphate, and biphasic CaP), or physical forms (particulates, blocks, cements, coatings on metal implants, composites with polymers), and in physicochemical properties. CaP biomaterials have outstanding properties: similarity in composition to bone mineral; bioactivity (ability to form bone apatitelike material or carbonate hydroxyapatite on their surfaces), ability to promote cellular function and expression leading to formation of a uniquely strong bone-CaP biomaterial interface; and osteoconductivity (ability to provide the appropriate scaffold or template for bone formation). In addition, CaP biomaterials with appropriate three-dimensional geometry are able to bind and concentrate endogenous bone morphogenetic proteins in circulation, and may become osteoinductive (capable of osteogenesis), and can be effective carriers of bone cell seeds. Therefore, CaP biomaterials potentially are useful in tissue engineering for regeneration of hard tissues.
C1 NYU, Coll Dent, Dept Biomat & Biomimet, New York, NY 10010 USA.
RP LeGeros, RZ (reprint author), NYU, Coll Dent, Dept Biomat, 345 E 24th St, New York, NY 10010 USA.
RI Xu, Qingguo/C-1962-2014
OI Xu, Qingguo/0000-0003-3191-0771
FU NIDCR NIH HHS [DE 04123, DE 12388, DE07223]; NCRR NIH HHS [S07RR076226]
CR Acil Y, 2000, J BIOMED MATER RES, V51, P703, DOI 10.1002/1097-4636(20000915)51:4<703::AID-JBM19>3.0.CO;2-A
   Albee FH, 1920, ANN SURG, V71, P32
   AlliotLicht B, 1997, J PERIODONTOL, V68, P158, DOI 10.1902/jop.1997.68.2.158
   AOKI H, 1991, SCI MED APPL HYDROXY
   Aoki H., 1977, J DENT ENG, V18, P86
   BAGAMBISA F B, 1990, International Journal of Oral and Maxillofacial Implants, V5, P217
   BARON R, 1985, J CELL BIOL, V101, P2210, DOI 10.1083/jcb.101.6.2210
   BAUER TW, 1995, ORTHOPEDICS, V18, P885
   BECKHAM CA, 1971, CALC TISS RES, V8, P165, DOI 10.1007/BF02010133
   BEEVERS CA, 1946, MINERAL MAG, V27, P254, DOI DOI 10.1180/MINMAG.1946.027.194.05
   BLOEBAUM RD, 1994, CLIN ORTHOP RELAT R, P19
   Bouler JM, 2000, J BIOMED MATER RES, V51, P680, DOI 10.1002/1097-4636(20000915)51:4<680::AID-JBM16>3.0.CO;2-#
   Boyde A, 1999, BONE, V24, P579, DOI 10.1016/S8756-3282(99)00083-6
   BROWN WE, 1976, ANNU REV MATER SCI, V6, P213, DOI 10.1146/annurev.ms.06.080176.001241
   BROWN WE, 1962, NATURE, V196, P1048, DOI 10.1038/1961048b0
   Chang YL, 2000, J BIOMED MATER RES, V52, P270, DOI 10.1002/1097-4636(200011)52:2<270::AID-JBM5>3.0.CO;2-1
   CHOW LC, 1991, MATER RES SOC SYMP P, V179, P3
   CHOW LC, 1998, BIOCERAMICS, V11, P45
   CONSTANTZ BR, 1995, SCIENCE, V267, P1796, DOI 10.1126/science.7892603
   COOK SD, 1992, J BIOMED MATER RES, V26, P989, DOI 10.1002/jbm.820260803
   Craig RG, 1999, J BIOMED MATER RES, V47, P585, DOI 10.1002/(SICI)1097-4636(19991215)47:4<585::AID-JBM16>3.0.CO;2-O
   Cranin A N, 1987, Compendium, V8, P334
   DACULSI G, 1989, J BIOMED MATER RES, V23, P883, DOI 10.1002/jbm.820230806
   DACULSI G, 1990, SCANNING MICROSCOPY, V4, P309
   DACULSI G, 1990, J BIOMED MATER RES, V24, P379, DOI 10.1002/jbm.820240309
   DAMIEN CJ, 1991, J APPL BIOMATER, V2, P187, DOI 10.1002/jab.770020307
   DAVIES HML, 1995, ADV NITROG HETERCYC, V1, P1
   Davies JE, 1996, ANAT REC, V245, P426
   de Jong WF, 1926, RECL TRAV CHIM PAY-B, V45, P445
   DEBRUIJN JD, 1994, J BIOMED MATER RES, V28, P105, DOI 10.1002/jbm.820280114
   DEGROOT K, 1983, BIOCERAMICS CAP
   DENISSEN HW, 1989, J PROSTHET DENT, V61, P706, DOI 10.1016/S0022-3913(89)80047-2
   DENISSEN HW, 1979, THESIS VRIJE U
   Doyle C, 1990, HDB BIOACTIVE CERAMI, V2, P195
   Driessens F. C. M., 1995, P855
   DRIESSENS FCM, 1985, CALCIFIED TISSUE INT, V37, P376, DOI 10.1007/BF02553705
   ELLIOTT JC, 1974, CLIN ORTHOP RELAT R, V93, P313
   FRONDOZA CG, 1998, BIOCERAMICS, V11, P289
   GANELES J, 1986, J PERIODONTOL, V57, P133, DOI 10.1902/jop.1986.57.3.133
   Gatti AM, 1998, BIOCERAMICS, V11, P399
   Gauthier O, 1999, J PERIODONTOL, V70, P375, DOI 10.1902/jop.1999.70.4.375
   GEESINK RGT, 1995, J BONE JOINT SURG BR, V77B, P534
   GREGOIRE M, 1990, J BIOMED MATER RES, V24, P165, DOI 10.1002/jbm.820240204
   HAYEK E, 1963, INORG SYN, V7, P63, DOI 10.1002/9780470132388.ch17
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   HENCH LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   HEUGHEBAERT M, 1988, J BIOMED MATER RES-A, V22, P257, DOI 10.1002/jbm.820221406
   HOLMES RE, 1979, PLAST RECONSTR SURG, V63, P626, DOI 10.1097/00006534-197905000-00004
   Hubbard W, 1974, THESIS MARQUETTE U M
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   JARCHO M, 1976, J MATER SCI, V11, P2027, DOI 10.1007/BF02403350
   Kamakura S, 1999, J DENT RES, V78, P1682, DOI 10.1177/00220345990780110401
   Kawai N, 1997, J BIOMED MATER RES, V37, P1
   Kawamura H, 2000, J BIOMED MATER RES, V50, P184, DOI 10.1002/(SICI)1097-4636(200005)50:2<184::AID-JBM13>3.0.CO;2-3
   KAZIMIROFF J, 1996, BIOCERAMICS, V9, P169
   Khairoun I, 2002, J BIOMED MATER RES, V60, P633, DOI 10.1002/jbm.10132
   KLAWITTER JJ, 1979, THESIS CLEMSON U CLE
   Koerten HK, 1999, J BIOMED MATER RES, V44, P78, DOI 10.1002/(SICI)1097-4636(199901)44:1<78::AID-JBM9>3.0.CO;2-6
   Kokubo T, 1996, THERMOCHIM ACTA, V280, P479, DOI 10.1016/0040-6031(95)02784-X
   Kuboki Y, 1998, J BIOMED MATER RES, V39, P190, DOI 10.1002/(SICI)1097-4636(199802)39:2<190::AID-JBM4>3.0.CO;2-K
   LANDIS WJ, 1993, J STRUCT BIOL, V110, P39, DOI 10.1006/jsbi.1993.1003
   LAURIE SWS, 1984, PLAST RECONSTR SURG, V73, P933, DOI 10.1097/00006534-198406000-00014
   Lee D D, 1999, Clin Orthop Relat Res, pS396, DOI 10.1097/00003086-199910001-00038
   LEGEROS JP, 1994, AM SOC TEST MATER, V1196, P33, DOI 10.1520/STP25181S
   LeGeros JP, 2000, J DENT RES, V79, P560
   LEGEROS R Z, 1982, Journal of Dental Research, V61, P343
   LeGeros R Z, 1996, Adv Dent Res, V10, P225
   LeGeros R Z, 1995, Connect Tissue Res, V33, P203, DOI 10.3109/03008209509017003
   LeGeros R Z, 1988, Adv Dent Res, V2, P164
   LeGeros R. Z., 1970, DEV APPL SPEC      B, V7B, P3
   LeGeros R.Z, 1983, HDB EXPT ASPECTS ORA, P159
   LeGeros R. Z., 1993, INTRO BIOCERAMICS, P139
   LeGeros R. Z., 1995, ENCY HDB BIOMATERI A, V2, P1429
   Legeros Racquel Z., 1993, Clinical Materials, V14, P65, DOI 10.1016/0267-6605(93)90049-D
   LEGEROS RZ, 1981, PROG CRYST GROWTH CH, V4, P1
   LEGEROS RZ, 1973, CALC TISS RES, V13, P173, DOI 10.1007/BF02015408
   LEGEROS RZ, 1991, BONE-BIOMATERIAL INTERFACE, P76
   LeGeros RZ, 1999, AM J DENT, V12, P65
   LEGEROS RZ, 1983, CARIES RES, V17, P419, DOI 10.1159/000260696
   LEGEROS RZ, 1986, J DENT RES, V65, P292
   LEGEROS RZ, 1967, SCIENCE, V155, P1409, DOI 10.1126/science.155.3768.1409
   LEGEROS RZ, BIOCERAMICS, V9, P796
   Legeros RZ, 1988, J DENT RES, V67, P177
   LEGEROS RZ, 1989, MAGNESIUM HLTH DIS, P11
   LEGEROS RZ, 1992, P INT SEM ORTH RES N, P147
   LEGEROS RZ, 1993, BONE BONDING BIOMATE, P201
   LEGEROS RZ, 1995, CERAMIC T, V48, P173
   LeGeros RZ, 1971, ADV XRAY ANALYSIS, V14, P57
   LEGEROS RZ, 1998, BIOCERAMIC, V11, P181
   LEGEROS RZ, 1995, BIOCERAMICS, V8, P81
   LeGeros RZ, 1967, THESIS NEW YORK U NE
   LEGEROS RZ, 1990, HDB BIOACTIVE CERAMI, V2, P17
   LEGEROS RZ, 1988, 3 WORLD BIOM C JAP, P35
   Levitt S R, 1969, J Biomed Mater Res, V3, P683, DOI 10.1002/jbm.820030413
   LINKOW L, 1984, J ORAL IMPLANTOL, V11, P211
   Liu DM, 1997, MATER SCI FORUM, V250, P183, DOI 10.4028/www.scientific.net/MSF.250.183
   MCCONNELL D, 1952, J DENT RES, V31, P53, DOI 10.1177/00220345520310012301
   METSGER DS, 1982, J AM DENT ASSOC, V105, P1035, DOI 10.14219/jada.archive.1982.0408
   MONROE EA, 1971, J DENT RES, V50, P860, DOI 10.1177/00220345710500041201
   MORENO EC, 1977, CARIES RES, V11, P142, DOI 10.1159/000260299
   NERY EB, 1992, J PERIODONTOL, V63, P729, DOI 10.1902/jop.1992.63.9.729
   Nery EB, 1978, PROSTHET DENT, V43, P338
   NIKI M, 1991, BONE-BIOMATERIAL INTERFACE, P350
   Ohgushi H, 1999, J BIOMED MATER RES, V48, P913, DOI 10.1002/(SICI)1097-4636(1999)48:6<913::AID-JBM22>3.0.CO;2-0
   Ohgushi H, 1997, MATER SCI FORUM, V250, P209, DOI 10.4028/www.scientific.net/MSF.250.209
   Okazaki M, 1992, Magnes Res, V5, P103
   Okazaki M., 1998, BIOCERAMICS, V11, P85
   Oonishi H, 1999, J BIOMED MATER RES, V44, P31, DOI 10.1002/(SICI)1097-4636(199901)44:1<31::AID-JBM4>3.0.CO;2-9
   OSBORN JF, 1980, BIOMATERIALS, V1, P108, DOI 10.1016/0142-9612(80)90009-5
   POSNER AS, 1954, EXPERIENTIA, V10, P424, DOI 10.1007/BF02318507
   RAY RD, 1951, SURG FORUM, V2, P429
   Reddi AH, 2000, TISSUE ENG, V6, P351, DOI 10.1089/107632700418074
   REY C, 1991, CALCIFIED TISSUE INT, V49, P251, DOI 10.1007/BF02556214
   RING ME, 1985, DENT ILLUSTRATED HIS, P15
   RIPAMONTI U, 1992, MATRIX, V12, P202, DOI 10.1016/S0934-8832(11)80063-6
   ROBEY PG, 1992, DISORDERS BONE MINER, P241
   ROUFOSSE AH, 1979, J ULTRA MOL STRUCT R, V68, P235, DOI 10.1016/S0022-5320(79)90157-6
   ROY DM, 1974, NATURE, V247, P220, DOI 10.1038/247220a0
   Ryan LM, 1999, CALCIFIED TISSUE INT, V65, P374, DOI 10.1007/s002239900716
   SAKAE T, 2000, BIOCERAMICS, V13, P347
   SCHEVILL WE, 1965, NATURE, V205, P373, DOI 10.1038/205373a0
   Schroeder H. E., 1969, FORMATION INHIBITION
   SHIRKAHANZADEH M, 1994, J MATER SCI LETT, V10, P1415
   Shors C, 1993, INTRO BIOCERAMICS, P181
   TAKATA T, 1995, J PERIODONTOL, V66, P125, DOI 10.1902/jop.1995.66.2.125
   TERMINE JD, 1966, SCIENCE, V153, P1523, DOI 10.1126/science.153.3743.1523
   Toquet J, 1999, J BIOMED MATER RES, V44, P98, DOI 10.1002/(SICI)1097-4636(199901)44:1<98::AID-JBM11>3.0.CO;2-P
   TOTH JM, 1993, BIOCERAMICS, V6, P9
   TRACY BM, 1984, J BIOMED MATER RES, V18, P719, DOI 10.1002/jbm.820180702
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   URIST MR, 1984, CLIN ORTHOP RELAT R, V187, P277
   Valentini P, 2000, INT J PERIODONT REST, V20, P245
   VIJAYARAGHAVAN TV, 1994, J MATER SCI LETT, V13, P1782, DOI 10.1007/BF00776358
   WAGNER J R, 1989, Journal of Oral Implantology, V15, P186
   WEINER S, 1989, CONNECT TISSUE RES, V21, P589, DOI 10.3109/03008208909050015
   WINTER J, 1989, Journal of Dental Research, V68, P353
   Wykrota L. L., 1998, BIOCERAMICS, V11, P641
   Yamada S, 1997, J BIOMED MATER RES, V37, P346, DOI 10.1002/(SICI)1097-4636(19971205)37:3<346::AID-JBM5>3.0.CO;2-L
   Zambonin G, 2000, J BIOMED MATER RES, V49, P120, DOI 10.1002/(SICI)1097-4636(200001)49:1<120::AID-JBM15>3.0.CO;2-Q
NR 139
TC 920
Z9 950
U1 20
U2 415
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0009-921X
EI 1528-1132
J9 CLIN ORTHOP RELAT R
JI Clin. Orthop. Rel. Res.
PD FEB
PY 2002
IS 395
BP 81
EP 98
PG 18
WC Orthopedics; Surgery
SC Orthopedics; Surgery
GA 522XE
UT WOS:000173921600010
PM 11937868
DA 2018-10-20
ER

PT J
AU Chotard-Ghodsnia, R
   Drochon, A
   Faucheux, N
   Nagel, MD
   Grebe, R
AF Chotard-Ghodsnia, R
   Drochon, A
   Faucheux, N
   Nagel, MD
   Grebe, R
TI Effect of shear stress and of transmural pressure on cAMP-dependent
   responses of cells adhering to a biomaterial
SO EUROPEAN PHYSICAL JOURNAL-APPLIED PHYSICS
LA English
DT Article
ID CULTURED ENDOTHELIAL-CELLS; HYDROSTATIC-PRESSURE; CYCLIC-AMP;
   VISCOELASTIC PROPERTIES; HYDRAULIC CONDUCTIVITY; ADHESION; ACTIVATION;
   MEMBRANE; SURFACES; PROTEIN
AB Biomaterials used in some bioreactors are porous and exposed to normal and tangential flow of physiological fluid. Flow-induced forces may influence the morphological and biochemical responses of cells adhering to these materials. The objective of this work is to examine the capacity of mechanical stress to cause changes in cell morphology via the cAMP pathway (cyclic adenosine monophosphate). This second messenger is known to modulate cell morphology in static conditions. In classical flow devices, cells are submitted to only tangential stresses. We designed a new flow system, a Hele-Shaw cell with a porous bottom wall, in order to take into account the influence of a transmural pressure. This flow chamber allows to follow up continuously the shape changes of cells that are adherent to a porous biomaterial (polyacrylonitrile) and are exposed to controlled levels of shear stress or transmural pressure. Mouse Swiss 3T3 fibroblasts exposed to a 1.1-Pa shear stress, as well as those exposed to a 84-mm Hg transmural pressure, round up (up to 50%) in a few minutes. If the cAMP pathway is inhibited when a mechanical stress is applied, cell rounding is significantly prevented. These observations suggest that flow-induced cell shape changes are cAMP-dependent. This conclusion is supported by an increased cAMP accumulation measured in cells under mechanical stress when compared to static experiments. Our in vitro flow system is thus useful to study the influence of transmural pressure or shear stress on the early morphological and biochemical responses of cells in contact with a biomaterial.
C1 Univ Technol Compiegne, CNRS, UMR 6600, F-60205 Compiegne, France.
RP Chotard-Ghodsnia, R (reprint author), Univ Technol Compiegne, CNRS, UMR 6600, BP 20529, F-60205 Compiegne, France.
CR ACEVEDO AD, 1993, J CELL PHYSIOL, V157, P603, DOI 10.1002/jcp.1041570321
   BIAGINI G, 1994, INT J ARTIF ORGANS, V17, P620
   BOURNS B, 1988, CELL MOTIL CYTOSKEL, V10, P380, DOI 10.1002/cm.970100305
   CAILLA HL, 1973, ANAL BIOCHEM, V56, P394, DOI 10.1016/0003-2697(73)90205-4
   CHOTARDGHODSNIA R, IN PRESS ASME
   CHOTARDGHODSNIA R, 2000, THESIS U TECHNOLOGY
   CHOTARDGHODSNIA R, IN PRESS BIORHEOLOGY
   Cohen CR, 1997, EXP CELL RES, V231, P184, DOI 10.1006/excr.1996.3450
   DEWEY CF, 1981, J BIOMECH ENG-T ASME, V103, P177, DOI 10.1115/1.3138276
   Faucheux N, 1999, BIOMATERIALS, V20, P159, DOI 10.1016/S0142-9612(98)00156-2
   Faucheux N, 2000, BIOMATERIALS, V21, P1031, DOI 10.1016/S0142-9612(99)00277-X
   Faucheux N, 2001, BIOMATERIALS, V22, P2993, DOI 10.1016/S0142-9612(01)00045-X
   FRANGOS JA, 1988, BIOTECHNOL BIOENG, V32, P1053, DOI 10.1002/bit.260320812
   GLASS WF, 1993, J CELL PHYSIOL, V157, P296
   Groth T, 1995, ATLA-ALTERN LAB ANIM, V23, P790
   HALL AC, 1991, J ORTHOPAED RES, V9, P1, DOI 10.1002/jor.1100090102
   HASKIN C, 1993, BIOCHEM CELL BIOL, V71, P27, DOI 10.1139/o93-005
   HONIGER J, 1994, INT J ARTIF ORGANS, V17, P46
   HSIUNG CC, 1984, BIORHEOLOGY, V21, P207
   JAFFRIN MY, 1988, J BIOMECH ENG-T ASME, V110, P1, DOI 10.1115/1.3108400
   Kessler L, 1997, J BIOMED MATER RES, V34, P235, DOI 10.1002/(SICI)1097-4636(199702)34:2<235::AID-JBM13>3.0.CO;2-H
   LEVESQUE MJ, 1985, J BIOMECH ENG-T ASME, V107, P341, DOI 10.1115/1.3138567
   LEW HS, 1969, J APPL MATH PHYS, V20, P750
   LUNDBERG L, 1994, INT J ARTIF ORGANS, V17, P131
   MALEK AM, 1993, P NATL ACAD SCI USA, V90, P5999, DOI 10.1073/pnas.90.13.5999
   MANOLOPOULOS VG, 1993, BIOCHEM BIOPH RES CO, V191, P1379, DOI 10.1006/bbrc.1993.1370
   MARTINY L, 1991, FEBS LETT, V286, P105, DOI 10.1016/0014-5793(91)80951-X
   MCNAMEE CJ, 1995, CELL BIOL INT, V19, P769, DOI 10.1006/cbir.1995.1128
   MULVIHILL J, 1992, BIOMATERIALS, V13, P527, DOI 10.1016/0142-9612(92)90104-V
   Nerem R.E., 1992, ASME, V114, P274, DOI DOI 10.1115/1.2891384
   RAMIREZ OT, 1990, BIOTECHNOL BIOENG, V36, P911, DOI 10.1002/bit.260360906
   RATNER BD, 1993, J BIOMED MATER RES, V27, P837, DOI 10.1002/jbm.820270702
   REICH KM, 1990, J CELL PHYSIOL, V143, P100, DOI 10.1002/jcp.1041430113
   Sato M, 1996, J BIOMECH, V29, P461, DOI 10.1016/0021-9290(95)00069-0
   SATO M, 1990, J BIOMECH ENG-T ASME, V112, P263, DOI 10.1115/1.2891183
   SILL HW, 1995, AM J PHYSIOL-HEART C, V268, pH535
   SMAJE LH, 1984, BIORHEOLOGY, V21, P171
   SMIRNOV VN, 1989, J MOL CELL CARDIOL, V21, P3, DOI 10.1016/0022-2828(89)90832-8
   Tarbell JM, 1999, J APPL PHYSIOL, V87, P261
   THOUMINE O, 1995, IN VITRO CELL DEV-AN, V31, P45
   Thoumine O, 1997, BIORHEOLOGY, V34, P309, DOI 10.1016/S0006-355X(98)00007-9
   TRUSKEY GA, 1990, J BIOMED MATER RES, V24, P1333, DOI 10.1002/jbm.820241006
   TRUSKEY GA, 1993, BIOMATERIALS, V14, P243, DOI 10.1016/0142-9612(93)90114-H
   VANKOOTEN TG, 1992, J BIOMED MATER RES, V26, P725, DOI 10.1002/jbm.820260604
   VANKOOTEN TG, 1992, BIOMATERIALS, V13, P897, DOI 10.1016/0142-9612(92)90112-2
   VIGGERS RF, 1986, J BIOMECH ENG-T ASME, V108, P332, DOI 10.1115/1.3138624
   WATSON PA, 1991, FASEB J, V5, P2013
NR 47
TC 2
Z9 2
U1 0
U2 2
PU E D P SCIENCES
PI LES ULIS CEDEXA
PA 7, AVE DU HOGGAR, PARC D ACTIVITES COURTABOEUF, BP 112, F-91944 LES ULIS
   CEDEXA, FRANCE
SN 1286-0042
J9 EUR PHYS J-APPL PHYS
JI Eur. Phys. J.-Appl. Phys
PD FEB
PY 2002
VL 17
IS 2
BP 155
EP 162
DI 10.1051/epjap:2002007
PG 8
WC Physics, Applied
SC Physics
GA 522CX
UT WOS:000173879100007
DA 2018-10-20
ER

PT J
AU Mantero, S
   Piuri, D
   Montevecchi, FM
   Vesentini, S
   Ganazzoli, F
   Raffaini, G
AF Mantero, S
   Piuri, D
   Montevecchi, FM
   Vesentini, S
   Ganazzoli, F
   Raffaini, G
TI Albumin adsorption onto pyrolytic carbon: A molecular mechanics approach
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE molecular modeling; protein adsorption; albumin; pyrolytic carbon;
   molecular mechanics
ID TEMPERATURE ISOTROPIC CARBON; PROTEIN ADSORPTION; FIBRINOGEN
AB A number of implants of cardiac valve prosthesis, vascular prosthesis, and coronary stents present a pyrolytic carbon interface to blood. Plasma protein adsorption is essential for the hemocompatibility of the implanted devices. This work quantitatively evaluates the molecular interaction force between a biomaterial surface (pyrolytic carbon) and plasma protein (albumin) binding sites through a simplified molecular model of the interface consisting of (i) multioriented graphite micro crystallites; (ii) selected fragments of albumin; and (iii) a water environment. A number of simplifying assumptions were made in the calculation: the albumin molecule was divided into hydrophobic and hydrophilic subunits (helices); an idealized clean, nonoxidized polycrystalline graphite surface was assumed to approximate the surface of pyrolytic carbon. The interaction forces between albumin helices and pyrolytic carbon surfaces are evaluated from potential energy data. These forces are decomposed into a normal and a tangential component. The first one is calculated using a docking procedure (F-perpendicular to tot MAX = 4.16 x 10(-20) N). The second one (F-parallel to), calculated by mean of geometric models estimating the energy variation associated with the protein sliding on the material surface, varies within the range +/-9.62 x 10(-21) N. The molecular simulations were performed using the commercial soft-ware package Hyperchem 5.0 (Hyperchem, Hypercube, Canada). (C) 2001 John Wiley & Sons, Inc.
C1 Politecn Milan, Dipartimento Bioingn, I-20133 Milan, Italy.
   Politecn Milan, Dipartimento Chim, I-20131 Milan, Italy.
RP Mantero, S (reprint author), Politecn Milan, Dipartimento Bioingn, Piazza Leonardo da Vinci 32, I-20133 Milan, Italy.
RI Ganazzoli, Fabio/F-9543-2013; Raffaini, Giuseppina/N-1578-2014; Mantero,
   Sara/F-6587-2013
OI Ganazzoli, Fabio/0000-0002-9762-4535; Raffaini,
   Giuseppina/0000-0003-3462-6514; MANTERO, SARA/0000-0002-1264-0465
CR BALE MD, 1988, J COLLOID INTERF SCI, V125, P516, DOI 10.1016/0021-9797(88)90017-3
   Blawas AS, 1998, BIOMATERIALS, V19, P595, DOI 10.1016/S0142-9612(97)00218-4
   CHUN FL, 1994, J COLLOID INTERF SCI, V168, P152
   FENG L, 1994, J BIOMED MATER RES, V28, P735, DOI 10.1002/jbm.820280611
   FENG L, 1995, J BIOMAT SCI-POLYM E, V7, P439, DOI 10.1163/156856295X00445
   FENG L, 1993, J BIOMED MATER RES, V27, P177, DOI 10.1002/jbm.820270206
   FENG L, 1994, BIOMATERIALS, V15, P323
   Frenkel D., 1996, UNDERSTANDING MOL SI
   Hentschke R, 1997, MACROMOL THEOR SIMUL, V6, P287, DOI 10.1002/mats.1997.040060201
   Israelachvili J. N., 1991, INTERMOLECULAR SURFA
   Jo S, 2000, BIOMATERIALS, V21, P605, DOI 10.1016/S0142-9612(99)00224-0
   KIRAKI N, 1989, J MICROSS, V156, P267
   Lu D R, 1990, J Biomater Sci Polym Ed, V1, P243
   LU DR, 1991, J BIOMAT SCI-POLYM E, V3, P127, DOI 10.1163/156856291X00232
   MIN X, 1992, NATURE, V358, P209
   PARK K, 1986, J BIOMED MATER RES, V20, P589, DOI 10.1002/jbm.820200506
   Pitt W G, 1991, J Biomater Sci Polym Ed, V2, P317, DOI 10.1163/156856291X00205
   PUSINERI C, 1986, BLOOD SURFACE INTERA, P45
   Sheth SR, 1997, P NATL ACAD SCI USA, V94, P8399, DOI 10.1073/pnas.94.16.8399
NR 19
TC 12
Z9 13
U1 0
U2 7
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD FEB
PY 2002
VL 59
IS 2
BP 329
EP 339
DI 10.1002/jbm.1249
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 497JT
UT WOS:000172452300017
PM 11745570
DA 2018-10-20
ER

PT J
AU Sigurdson, L
   Carney, DE
   Hou, YX
   Hall, L
   Hard, R
   Hicks, W
   Bright, FV
   Gardella, JA
AF Sigurdson, L
   Carney, DE
   Hou, YX
   Hall, L
   Hard, R
   Hicks, W
   Bright, FV
   Gardella, JA
TI A comparative study of primary and immortalized cell adhesion
   characteristics to modified polymer surfaces: Toward the goal of
   effective re-epithelialization
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE tissue engineering; cell adhesion; primary cells; fluoropolymer; PVA
ID ETHYLENE-PROPYLENE FILMS; RESPIRATORY EPITHELIUM; TRACHEAL REPLACEMENT;
   IN-VITRO; COLLAGEN; POPULATION; ATTACHMENT; SEQUENCES; CANCER; GROWTH
AB Facilitating tissue regeneration or replacement requires development of synthetic surfaces that promote cell adhesion, migration, and proliferation. Two successful approaches have been to incorporate minimal cell adhesion recognition sequences at the biomaterial surface and to integrate the entire adhesion molecule into a compatible synthetic matrix. While adhesion assays using immortalized cell lines are important in evaluating synthetic materials, cell type and source play a significant role in the ability of such models to mimic real tissues. Models that utilize multiple cell types or primary cells are more representative of native tissues than models that use single cell types or primary cells. In this study we investigated primary respiratory epithelial cell (REC) adhesion to modified fluoropolymers incorporating simple functional groups and minimal peptide recognition sequences, and we evaluated the potential of hybrid biopolymer materials to support adhesion and proliferation. X-ray photoelectron spectroscopy (XPS) was used to verify substrate surface composition. Significant differences were found in the adhesion characteristics of primary REC and in the A549 lung carcinoma cell line. Model Systems composed of multiple cell types and/or primary cells necessarily represent increased levels of complexity for an investigation of cellular responses to synthetic surfaces. When evaluating biomaterials, adhesion studies using immortalized cell lines cannot necessarily be extrapolated to normal cell behavior. (C) 2001 John Wiley & Sons, Inc.
C1 SUNY Buffalo, Dept Chem, Buffalo, NY 14214 USA.
   Roswell Pk Canc Inst, Dept Head & Neck Surg, Buffalo, NY 14263 USA.
   SUNY Buffalo, Dept Anat Sci, Buffalo, NY 14214 USA.
RP Gardella, JA (reprint author), SUNY Buffalo, Dept Chem, Buffalo, NY 14214 USA.
CR AKIYAMA SK, 1993, SEMIN CANCER BIOL, V4, P215
   BEKOS EJ, 1996, THESIS STATE U NEW Y
   BREEZE RG, 1977, AM REV RESPIR DIS, V116, P705, DOI 10.1164/arrd.1977.116.4.705
   Cascone MG, 1996, J MATER SCI-MATER M, V7, P297, DOI 10.1007/BF00058570
   Cascone MG, 1998, POLYMER, V39, P6357, DOI 10.1016/S0032-3861(98)00148-7
   Chen CS, 1998, BIOTECHNOL PROGR, V14, P356, DOI 10.1021/bp980031m
   CHOPRA DP, 1992, LARYNGOSCOPE, V102, P528, DOI 10.1288/00005537-199205000-00011
   GRILLO HC, 1990, ANN THORAC SURG, V49, P864, DOI 10.1016/0003-4975(90)90857-3
   Hicks W, 1997, EXP CELL RES, V237, P357, DOI 10.1006/excr.1997.3796
   Hicks W. L. Jr., 1994, Molecular Biology of the Cell, V5, p118A
   HORBETT TA, 1994, COLLOID SURFACE B, V2, P225, DOI 10.1016/0927-7765(94)80037-5
   Howe A, 1998, CURR OPIN CELL BIOL, V10, P220, DOI 10.1016/S0955-0674(98)80144-0
   Hynes RO, 1999, TRENDS CELL BIOL, V9, pM33, DOI 10.1016/S0962-8924(99)01667-0
   ITOH S, 1999, BIOMATERIALS, V15, P1229
   JOLINO VG, 1982, BIOTECHNOL BIOENG, V24, P1069
   Juliano Rudy, 1996, Bioessays, V18, P911, DOI 10.1002/bies.950181110
   Kim HA, 1998, CLIN EXP RHEUMATOL, V16, P9
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lelievre S, 1996, RECENT PROG HORM RES, V51, P417
   Lukashev ME, 1998, TRENDS CELL BIOL, V8, P437, DOI 10.1016/S0962-8924(98)01362-2
   MASSIA SP, 1991, J BIOMED MATER RES, V25, P223, DOI 10.1002/jbm.820250209
   METTE SA, 1993, AM J RESP CELL MOL, V8, P562, DOI 10.1165/ajrcmb/8.5.562
   Okumura N, 1991, ASAIO Trans, V37, pM317
   PLOPPER CG, 1983, EXP LUNG RES, V5, P281, DOI 10.3109/01902148309061521
   RANDELL SH, 1992, CHEST, V101, pS11
   RANIERI JP, 1993, J BIOMED MATER RES, V27, P917, DOI 10.1002/jbm.820270711
   RANIERI JP, 1995, J BIOMED MATER RES, V29, P779, DOI 10.1002/jbm.820290614
   SCHWARTZ MA, 1994, MOL BIOL CELL, V5, P389
   Scotchford CA, 1998, BIOMATERIALS, V19, P1, DOI 10.1016/S0142-9612(97)00236-6
   SEPNICK D, 1997, OTOLARYNGOL J CLUB J, V4, P258
   Sigurdson SL, 1998, EXP LUNG RES, V24, P307, DOI 10.3109/01902149809041537
   STAATZ WD, 1991, J BIOL CHEM, V266, P7363
   VACANTI CA, 1994, J PEDIATR SURG, V29, P201, DOI 10.1016/0022-3468(94)90318-2
   VARGO TG, 1992, LANGMUIR, V8, P130, DOI 10.1021/la00037a025
   VARGO TG, 1995, J BIOMED MATER RES, V29, P767, DOI 10.1002/jbm.820290613
   VARGO TG, 1991, J POLYM SCI POL CHEM, V29, P555, DOI 10.1002/pola.1991.080290412
   YAMADA KM, 1991, J BIOL CHEM, V266, P12809
NR 37
TC 12
Z9 12
U1 0
U2 3
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD FEB
PY 2002
VL 59
IS 2
BP 357
EP 365
DI 10.1002/jbm.1252
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 497JT
UT WOS:000172452300020
PM 11745573
DA 2018-10-20
ER

PT J
AU Kidd, KR
   Nagle, RB
   Williams, SK
AF Kidd, KR
   Nagle, RB
   Williams, SK
TI Angiogenesis and neovascularization associated with extracellular
   matrix-modified porous implants
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE angiogenesis; ePTFE; endothelium; extracellular matrix
ID TISSUE-RESPONSE; ENDOTHELIUM; MACROPHAGES; PROSTHESES; POROSITY; GRAFTS
AB Therapies directed toward stimulation of angiogenesis seek to accelerate the development of new blood vessels in tissues rendered dysfunctional because of an insufficient microvascular supply. The goal of the current study was the stimulation of an angiogenic response around and within porous biomedical implants, such as vascular grafts, constructed from a base polymer composed of expanded polytetrafluoroethylene (ePTFE). Similar to many biomaterial, ePTFE does not elicit a significant angiogenic response and the porous interstices of this material remain avascular after implantation. Studies were performed to evaluate the ability of a tumorigenic cell line, the 804-G rat kidney cell to secrete an angiogenic extracellular matrix on and within the porous structures of ePTFE. A rat model was used to evaluate and compare implant-associated healing responses between nonmodified materials and extracellular matrix-modified ePTFE. Results demonstrated that, in contrast to untreated ePTFE, the matrix-modified ePTFE stimulated both angiogenesis in implant-associated tissue and neovascularization of the pores within the ePTFE interstices. Deposition of an insoluble matrix stimulates an angiogenic response and has a potential application for the improvement of medical device function. (C) 2001 John Wiley & Sons, Inc.
C1 Univ Arizona, Biomed Engn Program, Tucson, AZ 85724 USA.
   Univ Arizona, Physiol Sci Grad Program, Tucson, AZ 85724 USA.
   Univ Arizona, Dept Pathol, Tucson, AZ 85724 USA.
RP Williams, SK (reprint author), Univ Arizona, Biomed Engn Program, 1501 N Campbell Ave, Tucson, AZ 85724 USA.
CR Anderson J M, 1988, ASAIO Trans, V34, P101, DOI 10.1097/00002480-198804000-00005
   Bellon JM, 1996, J BIOMED MATER RES, V31, P1, DOI 10.1002/(SICI)1097-4636(199605)31:1<1::AID-JBM1>3.0.CO;2-S
   BRAUKER JH, 1995, J BIOMED MATER RES, V29, P1517, DOI 10.1002/jbm.820291208
   CLOWES AW, 1986, AM J PATHOL, V123, P220
   DIDISHEIM P, 1993, CARDIOVASC PATHOL, V2, pS1
   Didisheim P, 1994, ASAIO J, V40, P230, DOI 10.1097/00002480-199404000-00020
   Gerritsen M, 2000, DIABETES CARE, V23, P143, DOI 10.2337/diacare.23.2.143
   GOLDEN MA, 1990, J VASC SURG, V11, P838, DOI 10.1067/mva.1990.18047
   MATLAGA BF, 1976, J BIOMED MATER RES, V10, P391, DOI 10.1002/jbm.820100308
   POLVERINI PJ, 1984, LAB INVEST, V51, P635
   Polverini PJ, 1996, EUR J CANCER, V32A, P2430, DOI 10.1016/S0959-8049(96)00386-3
   Salzmann DL, 1999, CARDIOVASC PATHOL, V8, P63, DOI 10.1016/S1054-8807(98)00003-9
   Salzmann DL, 1997, J BIOMED MATER RES, V34, P463, DOI 10.1002/(SICI)1097-4636(19970315)34:4<463::AID-JBM7>3.0.CO;2-I
   Sanders JE, 2000, J BIOMED MATER RES, V52, P231, DOI 10.1002/1097-4636(200010)52:1<231::AID-JBM29>3.0.CO;2-E
   SCHREUDERS PD, 1988, J BIOMED MATER RES, V22, P121, DOI 10.1002/jbm.820220205
   Sharkawy AA, 1997, J BIOMED MATER RES, V37, P401
   SUNDERKOTTER C, 1994, J LEUKOCYTE BIOL, V55, P410
   Updike SJ, 2000, DIABETES CARE, V23, P208, DOI 10.2337/diacare.23.2.208
   WILLIAMS SK, 1991, J ELECTRON MICR TECH, V19, P439, DOI 10.1002/jemt.1060190406
NR 19
TC 36
Z9 40
U1 0
U2 1
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD FEB
PY 2002
VL 59
IS 2
BP 366
EP 377
DI 10.1002/jbm.1253
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 497JT
UT WOS:000172452300021
PM 11745574
DA 2018-10-20
ER

PT J
AU Brodbeck, WG
   Shive, MS
   Colton, E
   Ziats, NP
   Anderson, JM
AF Brodbeck, WG
   Shive, MS
   Colton, E
   Ziats, NP
   Anderson, JM
TI Interleukin-4 inhibits tumor necrosis factor-alpha-induced and
   spontaneous apoptosis of biomaterial-adherent macrophages
SO JOURNAL OF LABORATORY AND CLINICAL MEDICINE
LA English
DT Article
ID MULTINUCLEATED GIANT-CELLS; HUMAN-MONOCYTES; FACTOR CACHECTIN;
   EXPRESSION; TNF; DEATH; ADHESION; CRACKING; INVITRO; FUSION
AB Biocompatibility of implanted materials is determined by the host foreign-body response, which is comprised of cellular (adherent monocytes and macrophages) and soluble (secreted cytokines) components. Modulating the presence, activity or both of adherent macrophages may increase or decrease the biocompatibility of implants because these cells remain adherent to the implant surface and fuse to form foreign-body giant cells (FBGCs), leading to failure of the implant. An attractive mechanism of eliminating these cells is through the induction of apoptosis; therefore ways of Inducing or inhibiting apoptosis of biomaterial-adherent inflammatory cells are being investigated. We hypothesized that interleukin-4 (IL-4) promotes macrophage survival by inhibiting tumor necrosis factor-alpha (TNF-alpha)-induced apoptosis. We found that TNF-alpha induces apoptosis in a time- and dose-dependent manner, whereas IL-4 inhibits TNF-alpha-induced and spontaneous apoptosis of biomaterial-adherent macrophages. Blocking experiments and evaluation of shedding of soluble TNF receptor type I (TNF-RI) demonstrated that endogenous TNF-alpha production Is responsible for spontaneous apoptosis of biomaterial-adherent cells and that IL-4 inhibits this opoptosis by increasing levels of shedding of soluble TNF-RI. These findings suggest that TNF-alpha and IL-4 play key roles in determining the fate of biomaterial-adherent cells and that fusion of macrophages Into FBGCs is a mechanism for promoting inflammatory-cell survival on implanted materials.
C1 Case Western Reserve Univ, Sch Med, Inst Pathol, Dept Pathol, Cleveland, OH 44106 USA.
   Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
RP Anderson, JM (reprint author), Case Western Reserve Univ, Sch Med, Inst Pathol, Dept Pathol, Room 306, Cleveland, OH 44106 USA.
FU NIGMS NIH HHS [GM-20380]; NHLBI NIH HHS [HL-55714]
CR AGGARWAL BB, 1985, J BIOL CHEM, V260, P2345
   Anderson JM, 2000, CURR OPIN HEMATOL, V7, P40, DOI 10.1097/00062752-200001000-00008
   ANDERSON JM, 1993, CARDIOVASC PATHOL S, V2, P33
   ANDERSON JM, 1996, BIOMATERIALS SCI, P451
   BELLOMO G, 1992, CANCER RES, V52, P1342
   BEUTLER B, 1989, ANNU REV IMMUNOL, V7, P625, DOI 10.1146/annurev.immunol.7.1.625
   Brodbeck WG, 2001, J BIOMED MATER RES, V55, P661, DOI 10.1002/1097-4636(20010615)55:4<661::AID-JBM1061>3.0.CO;2-F
   CARDONA MA, 1992, J BIOMED MATER RES, V26, P851, DOI 10.1002/jbm.820260703
   COLLIER TO, 1999, J BIOMED MATER RES, P141
   COTTER TG, 1990, ANTICANCER RES, V10, P1153
   DeFife KM, 1997, J IMMUNOL, V158, P3385
   DINARELLO CA, 1986, J EXP MED, V163, P1433, DOI 10.1084/jem.163.6.1433
   EIRMAN DF, 1989, J IMMUNOL, V142, P1970
   ESSNER R, 1989, J IMMUNOL, V142, P3857
   Estaquier J, 1997, BLOOD, V90, P1618
   FADY C, 1995, J INTERF CYTOK RES, V15, P71, DOI 10.1089/jir.1995.15.71
   FESUS L, 1993, FEBS LETT, V328, P1, DOI 10.1016/0014-5793(93)80952-Q
   Fraser A, 1996, CELL, V85, P781, DOI 10.1016/S0092-8674(00)81005-3
   GORCZEYOA W, 1993, LEUKEMIA, V14, P659
   HASKILL S, 1988, J IMMUNOL, V140, P1690
   HASSAN NF, 1989, J IMMUNOL, V143, P2179
   HERNANDEZCASELLES T, 1993, J IMMUNOL, V151, P3999
   Huppertz B, 1999, ANAT EMBRYOL, V200, P1, DOI 10.1007/s004290050254
   Igleslas J, 1999, AM J PHYSIOL-RENAL, V277, pF711, DOI 10.1152/ajprenal.1999.277.5.F711
   Jenney CR, 2000, J BIOMED MATER RES, V49, P435
   Jenney CR, 1998, J BIOMED MATER RES, V41, P171, DOI 10.1002/(SICI)1097-4636(199808)41:2<171::AID-JBM1>3.0.CO;2-F
   Joyce DA, 1996, CYTOKINE, V8, P49, DOI 10.1006/cyto.1996.0007
   KAO WYJ, 1995, J BIOMED MATER RES, V29, P1267, DOI 10.1002/jbm.820291014
   KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33
   Kidd VJ, 1998, ANNU REV PHYSIOL, V60, P533, DOI 10.1146/annurev.physiol.60.1.533
   KLEBANOFF SJ, 1986, J IMMUNOL, V136, P4220
   KREIPE H, 1988, AM J PATHOL, V130, P232
   LARRICK JW, 1990, FASEB J, V4, P3215
   Lieberthal W, 1998, AM J PHYSIOL-RENAL, V275, pF691, DOI 10.1152/ajprenal.1998.275.5.F691
   MAJNO G, 1995, AM J PATHOL, V146, P3
   MANAGAN DF, 1991, J IMMUNOL, V147, P3408
   MANAGAN DF, 1991, J IMMUNOL, V146, P1541
   MARTIN SJ, 1995, J EXP MED, V182, P1545, DOI 10.1084/jem.182.5.1545
   MARTINET Y, 1988, AM REV RESPIR DIS, V138, P659, DOI 10.1164/ajrccm/138.3.659
   MCINNES A, 1988, J EXP MED, V167, P598, DOI 10.1084/jem.167.2.598
   MCNALLY AK, 1995, AM J PATHOL, V147, P1487
   MCNALLY AK, 1994, P NATL ACAD SCI USA, V91, P10119, DOI 10.1073/pnas.91.21.10119
   MOHLER KM, 1993, J IMMUNOL, V151, P1548
   MUNKER R, 1992, ANN HEMATOL, V65, P50, DOI 10.1007/BF01715127
   MURCH AR, 1982, J PATHOL, V137, P177, DOI 10.1002/path.1711370302
   OGASAWARA J, 1993, NATURE, V364, P806, DOI 10.1038/364806a0
   Perera LP, 1998, P NATL ACAD SCI USA, V95, P14308, DOI 10.1073/pnas.95.24.14308
   SUTTON JS, 1966, J CELL BIOL, V28, P303, DOI 10.1083/jcb.28.2.303
   TAKEDA Y, 1993, INT IMMUNOL, V5, P691, DOI 10.1093/intimm/5.6.691
   WEINRAUCH LA, 1984, UREMIA INVEST, V8, P1
   WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0
   ZHAO Q, 1990, J BIOMED MATER RES, V24, P621, DOI 10.1002/jbm.820240508
   ZHAO Q, 1991, J BIOMED MATER RES, V25, P177, DOI 10.1002/jbm.820250205
   ZHAO QH, 1993, J BIOMED MATER RES, V27, P379, DOI 10.1002/jbm.820270311
NR 54
TC 37
Z9 37
U1 1
U2 6
PU MOSBY, INC
PI ST LOUIS
PA 11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA
SN 0022-2143
J9 J LAB CLIN MED
JI J. Lab. Clin. Med.
PD FEB
PY 2002
VL 139
IS 2
BP 90
EP 100
DI 10.1067/mlc.2002.121260
PG 11
WC Medical Laboratory Technology; Medicine, General & Internal; Medicine,
   Research & Experimental
SC Medical Laboratory Technology; General & Internal Medicine; Research &
   Experimental Medicine
GA 535XE
UT WOS:000174671000004
PM 11919547
DA 2018-10-20
ER

PT J
AU Hiromoto, S
   Asami, K
   Tsai, AP
   Hanawa, T
AF Hiromoto, S
   Asami, K
   Tsai, AP
   Hanawa, T
TI Surface characterization of amorphous Zr-Al-(Ni, Cu) alloys immersed in
   cell-culture medium
SO MATERIALS TRANSACTIONS
LA English
DT Article
DE zirconium-base amorphous alloy; surface composition; cell-culture
   medium; biomaterial
ID PHOSPHATE-BUFFERED SOLUTION; POLARIZATION BEHAVIOR; CORROSION; XPS;
   ADSORPTION; CHROMIUM; PROTEINS; OXIDES; OXYGEN; IRON
AB For the evaluation of zirconium-base amorphous alloys as biomaterials, the surface compositions of amorphous Zr-Al-Ni-Cu and Zr-Al-Cu alloys were characterized using X-ray photoelectron spectroscopy. The alloys were polished, autoclaved, and immersed in Hanks' solution or Eagle's minimum essential medium containing fetal bovine serum, MEM + FBS, Aluminum was enriched in the surface oxide film and the substrate just under the film of the alloys polished in water, After autoclaving, aluminum and copper were enriched in the substrate while zirconium was preferentially oxidized and incorporated into the surface oxide film. In Hanks' solution, copper and nickel decreased in the substrate and surface oxide film, resulting in the enrichment of aluminum in the substrate. In MEM + FBS, zirconium preferentially decreased by the effects of amino acids and proteins while copper was enriched in the substrate, The surface composition of zirconium-base amorphous alloys was much influenced by amino acids and proteins in MEM + FBS.
C1 Natl Inst Mat Sci, Tsukuba, Ibaraki 3050047, Japan.
   Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan.
RP Hiromoto, S (reprint author), Natl Inst Mat Sci, Tsukuba, Ibaraki 3050047, Japan.
RI HIROMOTO, Sachiko/H-2686-2011; BAI, JIE/D-7448-2016
CR ASAMI K, 1984, CORROS SCI, V24, P83, DOI 10.1016/0010-938X(84)90039-8
   ASAMI K, 1976, J ELECTRON SPECTROSC, V9, P469, DOI 10.1016/0368-2048(76)80065-5
   ASAMI K, 1977, CORROS SCI, V17, P559, DOI 10.1016/S0010-938X(77)80002-4
   ASAMI K, 1977, CORROS SCI, V17, P713, DOI 10.1016/0010-938X(77)90067-1
   CLARK GCF, 1982, J BIOMED MATER RES, V16, P125, DOI 10.1002/jbm.820160205
   do Serro APVA, 1999, J BIOMED MATER RES, V46, P376, DOI 10.1002/(SICI)1097-4636(19990905)46:3<376::AID-JBM10>3.0.CO;2-T
   EAGLE H, 1959, SCIENCE, V130, P432, DOI 10.1126/science.130.3373.432
   Gebert A, 1999, MAT SCI ENG A-STRUCT, V267, P294, DOI 10.1016/S0921-5093(99)00105-7
   HANAWA T, 1992, J JPN I MET, V56, P1168, DOI 10.2320/jinstmet1952.56.10_1168
   HANKS JH, 1949, P SOC EXP BIOL MED, V71, P196
   HASHIMOTO K, 1979, CORROS SCI, V19, P3, DOI 10.1016/0010-938X(79)90003-9
   HASHIMOTO K, 1977, BOSHOKU GIJUTSU, V26, P445
   HILL D, 1998, DESIGN ENG BIOMATERI, P157
   Hiromoto S, 2000, CORROS SCI, V42, P1651, DOI 10.1016/S0010-938X(00)00022-6
   Hiromoto S, 2000, CORROS SCI, V42, P2193, DOI 10.1016/S0010-938X(00)00056-1
   Hiromoto S, 2000, CORROS SCI, V42, P2167, DOI 10.1016/S0010-938X(00)00043-3
   HIROMOTO S, IN PRESS J ELECTROCH
   HIROMOTO S, IN PRESS ELECTROCHIM
   Inoue A, 2000, ACTA MATER, V48, P279, DOI 10.1016/S1359-6454(99)00300-6
   IVARSSON BA, 1985, COLLOID SURFACE, V13, P169
   Mu Y, 2000, J BIOMED MATER RES, V49, P238, DOI 10.1002/(SICI)1097-4636(200002)49:2<238::AID-JBM12>3.0.CO;2-J
   SCOFIELD JH, 1976, J ELECTRON SPECTROSC, V8, P129, DOI 10.1016/0368-2048(76)80015-1
   TERAMOTO K, 1978, BOSHOKU GIJUTSU, V27, P57
   UENO K, 1964, CHELETMETRIC TITRATI, P31
   Wagner C., 1979, HDB XRAY PHOTOELECTR, P54
   WAGNER CD, 1990, APP, V5, P595
   YOSHIOKA H, 1991, CORROS SCI, V32, P313, DOI 10.1016/0010-938X(91)90076-2
NR 27
TC 23
Z9 24
U1 0
U2 8
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD FEB
PY 2002
VL 43
IS 2
BP 261
EP 266
DI 10.2320/matertrans.43.261
PG 6
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 540MA
UT WOS:000174931700030
OA Bronze
DA 2018-10-20
ER

PT J
AU Hitchcock, AP
   Morin, C
   Tyliszczak, T
   Koprinarov, IN
   Ikeura-Sekiguchi, H
   Lawrence, JR
   Leppard, GG
AF Hitchcock, AP
   Morin, C
   Tyliszczak, T
   Koprinarov, IN
   Ikeura-Sekiguchi, H
   Lawrence, JR
   Leppard, GG
TI Soft X-ray microscopy of soft matter - Hard information from two softs
SO SURFACE REVIEW AND LETTERS
LA English
DT Article; Proceedings Paper
CT 13th International Conference on Vacuum Ultraviolet Radiation Physics
   (VUV-13)
CY JUL 23-27, 2001
CL TRIESTE, ITALY
ID POLYURETHANE POLYMERS; SPECTROMICROSCOPY; SPECTROSCOPY; ABSORPTION;
   FOAMS
AB Scanning transmission X-ray microscopy (STXM) and X-ray photoelectron emission microscopy (X-PEEM) provide quantitative chemical analysis at a spatial resolution well below 100 nm. Soft X-ray absorption or near edge X-ray absorption (NEXAFS) contrast provides sensitive differentiation of species which have similar elemental composition but are chemically distinct. Due to the ability of soft X-rays at wavelengths below the O K-edge to penetrate water, and on account of lower radiation damage, soft X-ray microscopy is an ideal tool for providing quantitative information about soft matter in the context of biological, polymer and environmental studies. Examples are given from recent studies of: phase segregation in polyurethanes and polymer blends, protein adsorption on polymers relating to biomaterial optimization, and metal mapping in biofilms. These examples show that it is indeed possible to get quantitative (hard) information by combining soft X-rays and soft materials.
C1 McMaster Univ, Brockhouse Inst Mat Res, Hamilton, ON L8S 4M1, Canada.
   Natl Water Res Inst Branch, Saskatoon, SK S7N 3H5, Canada.
   NWRI, Burlington, ON L7R 4A6, Canada.
   AIST, Tsukuba, Ibaraki 3058568, Japan.
RP Hitchcock, AP (reprint author), McMaster Univ, Brockhouse Inst Mat Res, Hamilton, ON L8S 4M1, Canada.
RI Ikeura-Sekiguchi, Hiromi/M-4150-2018; Lawrence, John/D-5758-2011
OI Ikeura-Sekiguchi, Hiromi/0000-0002-8593-0332; Lawrence,
   John/0000-0001-5872-1212
CR ADE H, 1998, EXPT METHODS PHYSICA, V32, P255
   ADE H, 2001, CHEM APPL SYNCHROTRO
   ADE H, 1992, SCIENCE, V258, P971
   ARMISTEAD JP, 1988, J APPL POLYM SCI, V35, P601, DOI 10.1002/app.1988.070350305
   Bauer E, 2001, J ELECTRON SPECTROSC, V114, P975, DOI 10.1016/S0368-2048(00)00261-9
   BAUER E, 1991, ULTRAMICROSCOPY, V36, P52, DOI 10.1016/0304-3991(91)90137-U
   Chapman HN, 1996, ULTRAMICROSCOPY, V62, P191, DOI 10.1016/0304-3991(96)00003-4
   Cornelius RM, 1999, BIOMATERIALS, V20, P341, DOI 10.1016/S0142-9612(98)00174-4
   Dawes K., 1996, EFFECTS ELECT BEAM G
   De Stasio G, 2001, J ELECTRON SPECTROSC, V114, P997, DOI 10.1016/S0368-2048(00)00369-8
   do Rego AMB, 2000, LANGMUIR, V16, P2385, DOI 10.1021/1a981657p
   Herrington R. M., 1997, FLEXIBLE POLYURETHAN
   Hitchcock AP, 2001, J SYNCHROTRON RADIAT, V8, P66, DOI 10.1107/S0909049500016447
   Hitchcock AP, 2001, ULTRAMICROSCOPY, V88, P33, DOI 10.1016/S0304-3991(00)00113-3
   HITCHCOCK AP, UNPUB
   KILCOYNE ALD, 2001, SYNCHROTRON RAD INST
   KIRZ J, 1995, Q REV BIOPHYS, V28, P33, DOI 10.1017/S0033583500003139
   Koprinarov I, 2001, MACROMOLECULES, V34, P4424, DOI 10.1021/ma001626c
   KOPRINAROV IN, UNPUB J PHYS CHEM B
   Maser J, 2000, J MICROSC-OXFORD, V197, P68
   MORELAND JC, 1994, J APPL POLYM SCI, V52, P1459, DOI 10.1002/app.1994.070521011
   MORIN C, 2001, IN PRESS J ELECT SPE
   Neuhausler U, 1999, COLLOID POLYM SCI, V277, P719, DOI 10.1007/s003960050445
   Rightor EG, 1997, J PHYS CHEM B, V101, P1950, DOI 10.1021/jp9622748
   RIGHTOR EG, UNPUB
   Rothe J, 1999, J SYNCHROTRON RADIAT, V6, P359, DOI 10.1107/S0909049599001715
   Smith AP, 1996, APPL PHYS LETT, V69, P3833, DOI 10.1063/1.117120
   TONNER BP, 1988, REV SCI INSTRUM, V59, P853, DOI 10.1063/1.1139792
   Tonner BP, 1999, SURF INTERFACE ANAL, V27, P247, DOI 10.1002/(SICI)1096-9918(199904)27:4<247::AID-SIA553>3.0.CO;2-M
   Urquhart SG, 1999, J PHYS CHEM B, V103, P4603, DOI 10.1021/jp990059w
   URQUHART SG, 1995, J POLYM SCI POL PHYS, V33, P1593, DOI 10.1002/polb.1995.090331104
   Urquhart SG, 1999, J ELECTRON SPECTROSC, V100, P119, DOI 10.1016/S0368-2048(99)00043-2
   Vermette P., 2001, BIOMEDICAL APPL POLY
   YOUNG AT, UNPUB PHYS REV B
NR 34
TC 16
Z9 16
U1 0
U2 6
PU WORLD SCIENTIFIC PUBL CO PTE LTD
PI SINGAPORE
PA JOURNAL DEPT PO BOX 128 FARRER ROAD, SINGAPORE 912805, SINGAPORE
SN 0218-625X
J9 SURF REV LETT
JI Surf. Rev. Lett.
PD FEB
PY 2002
VL 9
IS 1
BP 193
EP 201
DI 10.1142/S0218625X02001781
PG 9
WC Chemistry, Physical; Physics, Condensed Matter
SC Chemistry; Physics
GA 589JE
UT WOS:000177754500031
DA 2018-10-20
ER

PT J
AU Zimehl, R
   Drews, J
   Fischer-Brandies, H
AF Zimehl, R
   Drews, J
   Fischer-Brandies, H
TI Thermometric monitoring of setting biomaterials
SO THERMOCHIMICA ACTA
LA English
DT Article; Proceedings Paper
CT 14th Ulm-Freiberg Calorimetry Conference
CY MAR 21-23, 2001
CL TECHN UNIV BERGAKAD FREIBERG, FREIBERG, GERMANY
SP Inst Phys Chem, German Soc Thermal Anal
HO TECHN UNIV BERGAKAD FREIBERG
DE micro-calorimetry; biomaterials; glassionomer cements; water adsorption;
   dental enamel
ID GLASS-IONOMER CEMENTS; PELLICLE FORMATION; RESTORATIVE MATERIALS;
   HYDROXYAPATITE
AB The setting reaction of different dental glues, i.e. conventional glassionomer cement (GIC), resin modified glassionomer cement (RMGIC) and composite adhesive were investigated with the thermal activity monitor (TAM). The water content of the materials and the water activity in the specimens were determined with isopiestic measurements after different setting periods. The information extracted from the thermochemical analysis for the setting reaction at different time intervals were further correlated with the material balance of the setting biomaterial. In respect to the practical application of the materials in dentistry we discussed the formation and the mechanical strength of the interfacial layer formed between enamel and orthodontic attachments. The study clearly revealed that the use of the aforementioned techniques, namely calorimetric, adsorption measurements, and the combination with microscopy and spectroscopic techniques is a suitable tool in examining the setting process of dental material. The study further elucidate information on several aspects of bonding orthodontic attachments with GIC to enamel surfaces, evaluation of material properties, future developments of biomaterials and related dental materials for orthodontic, conservative and restoring strategies. (C) 2002 Elsevier Science B.V. All rights reserved.
C1 Univ Kiel, Inst Inorgan Chem, D-24098 Kiel, Germany.
   Univ Kiel, Clin Orthodont, D-24105 Kiel, Germany.
RP Zimehl, R (reprint author), Univ Kiel, Inst Inorgan Chem, Olshausenstr 40, D-24098 Kiel, Germany.
EM r.zimehl@email.uni-kiel.de
CR Buonocore MG., 1955, J DENT RES, V34, P849, DOI DOI 10.1177/00220345550340060801
   Craig RG, 1997, RESTORATIVE DENT MAT
   DIEDRICH P, 1992, PRAXIS ZAHNHEILKUNDE, V12, P291
   EMBERY G, 1986, ARCH ORAL BIOL, V31, P623, DOI 10.1016/0003-9969(86)90087-7
   Es-Souni M, 1999, COLLOID POLYM SCI, V277, P382, DOI 10.1007/s003960050396
   FISCHER-BRANDIES H, 1991, Deutsche Zahn- Mund- und Kieferheilkunde, V79, P349
   Fischer-Brandies H, 1992, Fortschr Kieferorthop, V53, P131, DOI 10.1007/BF02341447
   Hannig M, 2001, COLLOID POLYM SCI, V279, P479, DOI 10.1007/s003960000478
   Hannig M, 1997, EUR J ORAL SCI, V105, P422, DOI 10.1111/j.1600-0722.1997.tb02139.x
   LIE T, 1975, ARCH ORAL BIOL, V20, P739, DOI 10.1016/0003-9969(75)90045-X
   NEWMAN GV, 1965, AMER J ORTHODONTICS, V51, P901, DOI 10.1016/0002-9416(65)90203-4
   Smith AMV, 2000, ARCH ORAL BIOL, V45, P277, DOI 10.1016/S0003-9969(99)00141-7
   SMITH DC, 1990, J AM DENT ASSOC, V120, P20, DOI 10.14219/jada.archive.1990.0002
   *THERM AB, THERM DIGITAM 2 SOFT
   *THERM AB, INSTR MAN 2277 THERM
   Thylstrup A, 1994, TXB CLIN CARIOLOGY
   TSANIDIS V, 1992, J DENT RES, V71, P7, DOI 10.1177/00220345920710011201
   WILSON AD, 1971, J APPL CHEM BIOTECHN, V21, P313
   WILSON AD, 1983, J DENT RES, V62, P590, DOI 10.1177/00220345830620051801
   WILSON AD, 1970, J DENT RES, V49, P21, DOI 10.1177/00220345700490012501
   WILSON AD, 1970, J DENT RES, V49, P7, DOI 10.1177/00220345700490013301
   WILSON AD, 1988, GLASS IONOMER CEMENT
   Yoshida Y, 2000, J DENT RES, V79, P709, DOI 10.1177/00220345000790020301
   Zimehl R, 2000, COLLOID SURFACE A, V163, P55, DOI 10.1016/S0927-7757(99)00430-6
   ZIMEHL R, 2001, PROGR COLL POLYM SCI, V117
   1974, CRC HDB CHEM PHYSICS
NR 26
TC 2
Z9 2
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0040-6031
EI 1872-762X
J9 THERMOCHIM ACTA
JI Thermochim. Acta
PD JAN 31
PY 2002
VL 382
IS 1-2
BP 161
EP 168
DI 10.1016/S0040-6031(01)00726-2
PG 8
WC Thermodynamics; Chemistry, Analytical; Chemistry, Physical
SC Thermodynamics; Chemistry
GA 521CB
UT WOS:000173820200017
DA 2018-10-20
ER

PT J
AU Klok, HA
   Hwang, JJ
   Iyer, SN
   Stupp, SI
AF Klok, HA
   Hwang, JJ
   Iyer, SN
   Stupp, SI
TI Cholesteryl-(L-lactic acid)((n)over-bar) building blocks for
   self-assembling biomaterials
SO MACROMOLECULES
LA English
DT Article
ID LIQUID-CRYSTALS; POLYMER; POLYLACTONES; CHOLESTEROL; SURFACES; LACTIDE;
   FUNCTIONALIZATION; TRANSPLANTATION; INITIATORS; MEMBRANE
AB The synthesis and properties of a novel set of building blocks for the preparation of self-assembling biomaterials are described. These molecules consist of a relatively short oligo(L-lactic acid)((n) over bar) segment ((n) over bar = 10-40) that is substituted with a cholesterol moiety as an end group and in some cases has a second biofunctional substituent at its other terminus. The cholesterol moiety not only serves to induce liquid crystalline properties and drive the self-assembly of these oligomers, but also is expected to have an effect on the interaction of cells with these materials. The cholesteryl-(L-lactic acid)((n) over bar) (CLA((n) over bar)) oligomers form thermotropic liquid crystals and self-assemble into lamellar structures consisting of interdigitated bilayers. In addition, the CLA((n) over bar) oligomers can be homogeneously blended with poly(L-lactic acid), thereby offering the possibility to improve the cell interaction properties of this common surgical biomaterial. Furthermore, the secondary alcohol terminus of the CLA((n) over bar) oligomers allows the opportunity to introduce additional bioactive substituents such as cholesterol, indomethacin (an antiinflammatory drug), and pyrene and rhodamine B (which can act as fluorescent labels for bioimaging purposes) and various alpha-amino acids. These biofunctional CLA((n) over bar) oligomers can also be homogeneously mixed with the unsubstituted CLA((n) over bar) oligomers and thus could enable a further noncovalent functionalization of self-assembling biomaterials.
C1 Northwestern Univ, Sch Med, Dept Chem, Dept Mat Sci & Engn, Evanston, IL 60208 USA.
RP Stupp, SI (reprint author), Northwestern Univ, Sch Med, Dept Chem, Dept Mat Sci & Engn, 2225 N Campus Dr, Evanston, IL 60208 USA.
RI Stupp, Samuel/B-6737-2009
CR AKASHI M, 1990, ADV POLYM SCI, V97, P107
   Alberts B, 1989, MOL BIOL CELL
   BARAKAT I, 1993, J POLYM SCI POL CHEM, V31, P505, DOI 10.1002/pola.1993.080310222
   BEDNAREK MA, 1983, INT J PEPT PROT RES, V21, P196
   BERO M, 1990, MAKROMOL CHEM, V191, P2287
   BOLIN DR, 1989, ORG PREP PROCED INT, V21, P67, DOI 10.1080/00304948909356348
   Cao YL, 1997, PLAST RECONSTR SURG, V100, P297, DOI 10.1097/00006534-199708000-00001
   Chen CS, 1998, BIOTECHNOL PROGR, V14, P356, DOI 10.1021/bp980031m
   CIFERRI A, 2000, SUPRAMOLECULAR POLYM
   Cook AD, 1997, J BIOMED MATER RES, V35, P513
   de Jong SJ, 1998, MACROMOLECULES, V31, P6397, DOI 10.1021/ma980553i
   DESANTIS P, 1968, BIOPOLYMERS, V6, P299, DOI 10.1002/bip.1968.360060305
   DUBOIS P, 1991, MAKROMOL CHEM-M SYMP, V42-3, P103, DOI 10.1002/masy.19910420108
   Emrick T, 1999, CURR OPIN COLLOID IN, V4, P15, DOI 10.1016/S1359-0294(99)00008-4
   Goodby JW, 1998, LIQ CRYST, V24, P25, DOI 10.1080/026782998207550
   Heino S, 2000, P NATL ACAD SCI USA, V97, P8375, DOI 10.1073/pnas.140218797
   Hench LL, 1999, MATER SCI FORUM, V293, P37, DOI 10.4028/www.scientific.net/MSF.293.37
   Hubbell JA, 1998, CURR OPIN SOLID ST M, V3, P246, DOI 10.1016/S1359-0286(98)80098-3
   JAMSHIDI K, 1988, POLYMER, V29, P2229, DOI 10.1016/0032-3861(88)90116-4
   KESSLER H, 1983, TETRAHEDRON LETT, V24, P281, DOI 10.1016/S0040-4039(00)81385-4
   KLOK HA, 1998, POLYM PREPR DIV POLY, V39, P166
   KLOK HA, UNPUB
   Knoll W, 1996, ISRAEL J CHEM, V36, P357
   KRICHELDORF HR, 1995, POLYMER, V36, P1253, DOI 10.1016/0032-3861(95)93928-F
   KRICHELDORF HR, 1994, POLYMER, V35, P4175, DOI 10.1016/0032-3861(94)90593-2
   KULKARNI RK, 1966, ARCH SURG-CHICAGO, V93, P839
   Li LS, 1996, LIQ CRYST, V21, P469, DOI 10.1080/02678299608032856
   Lowe CR, 2000, CURR OPIN STRUC BIOL, V10, P428, DOI 10.1016/S0959-440X(00)00110-X
   Maquet V, 1997, MATER SCI FORUM, V250, P15, DOI 10.4028/www.scientific.net/MSF.250.15
   Montaudo G, 1996, MACROMOLECULES, V29, P6461, DOI 10.1021/ma960538i
   MOORE JS, 1990, MACROMOLECULES, V23, P65, DOI 10.1021/ma00203a013
   Olabisi O., 1979, POLYM POLYM MISCIBIL
   Radler J, 1997, CURR OPIN SOLID ST M, V2, P330, DOI 10.1016/S1359-0286(97)80124-6
   Reinitzer F., 1888, MONATSH CHEM, V9, P421, DOI DOI 10.1007/BF01516710
   Ringsdorf H., 1975, J POLYM SCI POLYM S, V51, P135
   Sasaki S., 1985, HDB PROTON NMR SPECT, V5
   SCRIVEN EFV, 1983, CHEM SOC REV, V12, P129, DOI 10.1039/cs9831200129
   SHEEHAN JC, 1961, J ORG CHEM, V26, P2525, DOI 10.1021/jo01351a600
   Sijbesma RP, 1999, CURR OPIN COLLOID IN, V4, P24, DOI 10.1016/S1359-0294(99)00011-4
   Stupp SI, 2000, MRS BULL, V25, P42, DOI 10.1557/mrs2000.28
   TARBELL DS, 1972, P NATL ACAD SCI USA, V69, P730, DOI 10.1073/pnas.69.3.730
   vanDijkWolthuis WNE, 1997, POLYMER, V38, P6235, DOI 10.1016/S0032-3861(97)00189-4
   WEISS RG, 1988, TETRAHEDRON, V44, P3413, DOI 10.1016/S0040-4020(01)85977-9
   YEAGLE PL, 1991, BIOCHIMIE, V73, P1303, DOI 10.1016/0300-9084(91)90093-G
   YEAGLE PL, 1985, BIOCHIM BIOPHYS ACTA, V822, P267, DOI 10.1016/0304-4157(85)90011-5
NR 45
TC 84
Z9 94
U1 1
U2 12
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0024-9297
J9 MACROMOLECULES
JI Macromolecules
PD JAN 29
PY 2002
VL 35
IS 3
BP 746
EP 759
DI 10.1021/ma010907x
PG 14
WC Polymer Science
SC Polymer Science
GA 515CQ
UT WOS:000173478200026
DA 2018-10-20
ER

PT J
AU Vago, R
   Plotquin, D
   Bunin, A
   Sinelnikov, I
   Atar, D
   Itzhak, D
AF Vago, R
   Plotquin, D
   Bunin, A
   Sinelnikov, I
   Atar, D
   Itzhak, D
TI Hard tissue remodeling using biofabricated coralline biomaterials
SO JOURNAL OF BIOCHEMICAL AND BIOPHYSICAL METHODS
LA English
DT Article; Proceedings Paper
CT Era of Biotechnology Internatiuonal Conference
CY OCT, 2000
CL BEN-GURION UNIV NEGEV, BEER SHEVA, ISRAEL
HO BEN-GURION UNIV NEGEV
DE bone; cartilage; biomaterial; remodeling; calcium carbonate; hydrocoral
AB Biotechnical and biomedical approaches were combined in an attempt to identify potential uses of biofabricated marine carbonate materials in biomedical applications. particularly as biomatrices for remodeling bone and cartilage tissue. After grafting, it is desirable for bone ingrowth to proceed as quickly as possible because the strength of the implanted region depends on a good mechanical bond forming between the implant and surrounding regions in the body. Ingrowth can take place as a result of growth of tissue and cells into the implanted porous material. or it may be promoted by transplanting cells seeded onto such a material. The rate at which ingrowth occurs is dependent on many factors, including pore size and the interconnectivity of the implanted structure. In vivo graftings into osteochondral defects demonstrated that our biofabricated porous material is highly biocompatible with cartilage and bone tissue. The biofabricated matrix was well incorporated into the biphasic osteochondral area. Resorption was followed by bone and cartilage formation, and after 4 months, the biomaterial had been replaced by new tissue. Ossification was induced and enhanced without introduction of additional factors. We believe that this is the first time that such biofabricated materials have been used for biomedical purposes. In face of the obvious environmental disadvantages of harvesting from limited natural resources, we propose the use of bioengineered coralline and other materials such as those cultured by our group under field and laboratory conditions as a possible biomatrix for hard tissue remodeling. (C) 2002 Elsevier Science B.V, All rights reserved.
C1 Ben Gurion Univ Negev, Inst Appl Biosci, IL-84105 Beer Sheva, Israel.
   Ben Gurion Univ Negev, Dept Biotechnol Engn, IL-84105 Beer Sheva, Israel.
   Ben Gurion Univ Negev, Dept Orthoped Surg, IL-84105 Beer Sheva, Israel.
   Soroka Med Ctr, Dept Pathol, IL-84105 Beer Sheva, Israel.
   Ben Gurion Univ Negev, Dept Mat Engn, IL-84105 Beer Sheva, Israel.
RP Vago, R (reprint author), Ben Gurion Univ Negev, Inst Appl Biosci, IL-84105 Beer Sheva, Israel.
CR ABRAMOVITCHGOTT.L, 2001, J BIOCH BIOPHYS METH
   BENNISSAN B, 2000, BIOCERAMICS KEY ENG, V191, P959
   BRIAN K, 1993, BONE, V14, P225
   BRONZINO J, 1995, BIOMEDICAL ENG HDB
   Dee KC, 1996, BIOTECHNOL BIOENG, V50, P438, DOI 10.1002/(SICI)1097-0290(19960520)50:4<438::AID-BIT11>3.0.CO;2-F
   DUNN MG, 1994, IMPLANTATION BIOL HO, P230
   Hench L. L., 1993, INTRO BIOCERAMICS, P1
   Hu J, 2000, J MATER SCI TECHNOL, V16, P591
   LACEFIELD R, 1993, INTRO BIOCERAMICS, P223
   Shahgaldi BF, 1998, BIOMATERIALS, V19, P205, DOI 10.1016/S0142-9612(98)80002-1
   Vago R, 1997, NATURE, V386, P30, DOI 10.1038/386030a0
   Weiner S, 1997, J MATER CHEM, V7, P689, DOI 10.1039/a604512j
NR 12
TC 40
Z9 40
U1 0
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0165-022X
J9 J BIOCHEM BIOPH METH
JI J. Biochem. Biophys. Methods
PD JAN 4
PY 2002
VL 50
IS 2-3
BP 253
EP 259
DI 10.1016/S0165-022X(01)00235-4
PG 7
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 510CE
UT WOS:000173190500014
PM 11741712
DA 2018-10-20
ER

PT B
AU Ringeisen, BR
   Chrisey, DB
   Krizman, DB
   Kim, H
   Young, HD
   Wu, PK
   Spargo, B
AF Ringeisen, BR
   Chrisey, DB
   Krizman, DB
   Kim, H
   Young, HD
   Wu, PK
   Spargo, B
BE Dittmar, A
   Beebe, D
TI Cell-by-cefl construction of living tissue by ambient laser transfer
SO 2ND ANNUAL INTERNATIONAL IEEE-EMBS SPECIAL TOPIC CONFERENCE ON
   MICROTECHNOLOGIES IN MEDICINE & BIOLOGY, PROCEEDINGS
SE IEEE Engineering in Medicine and Biology Society Annual Conference
   (EMBS)
LA English
DT Proceedings Paper
CT 2nd Annual International IEEE/EMBS Conference on Microtechnologies in
   Medicine and Biology
CY MAY 02-04, 2002
CL MADISON, WI
SP IEEE/Engn Med & Biol Soc, Natl Inst Hlth, Defense Adv Res Project Agcy, Motorola, NimbleGen Syst Inc, PanVera Corp, Dow Chem Co, GWC Instruments, Venture Invest LLC, Univ Wisconsin-Madison, Dept Biomed Engn, IEEE/Robot & Automat Soc, Promega
DE MAPLE DW; tissue engineering; laser processing; biomaterial patteming;
   biosensing; protein microarray; rapid prototyping
ID OXIDE STRUCTURES; SURFACE; KERATINOCYTES; RECONSTITUTE; MONOLAYERS;
   EPIDERMIS; CARTILAGE; POLYMERS; MODEL; LIVER
AB In order to fabricate and interface biological systems for next generation applications such as biosensors, protein recognition microarrays, and engineered tissues, it is imperative to have a method of accurately and rapidly depositing different active biomaterials in patterns or layered structures. Ideally, the biomaterial structures would also be compatible with many different substrates including technologically relevant platforms such as electronic circuits, microfluidic devices, or even living tissue. We have developed a technique termed matrix assisted pulsed laser evaporation direct write (MAPLE DW), that is able to form patterns and three-dimensional structures of numerous biologically active species ranging from protein solutions to living cells. Specifically, we have shown that MAPLE DW is capable of forming inesoscopic pattems of many components needed to construct complex 3D tissue such as living mammalian cells (mouse pluripotent, human ostcoblast, rat cardiac), nurnerous active proteins, extracellular matrix materials, and semi-rigid scaffold materials. This manuscript presents experimental results on our stepwise efforts to fabricate living tissue constructs. We first demonstrate the ability to form 2D microarrays from active proteins and living cells. We then discuss our efforts to begin 3D printing of both living cells and scaffold materials.
C1 USN, Res Lab, Washington, DC 20375 USA.
RP Ringeisen, BR (reprint author), USN, Res Lab, 4555 Overlook Ave SW,Codes 6372 & 6115, Washington, DC 20375 USA.
CR ASONUMA K, 1992, J PEDIATR SURG, V27, P298, DOI 10.1016/0022-3468(92)90850-7
   Athanasiou K, 1997, TISSUE ENG, V3, P363, DOI 10.1089/ten.1997.3.363
   CAPLAN AI, 1996, PRINCIPLES TISSUE EN, P599
   Caplan AI, 1998, FRONTIERS TISSUE ENG, P471
   Chrisey D, 2000, LASER FOCUS WORLD, V36, P113
   Chrisey DB, 2000, SCIENCE, V289, P879, DOI 10.1126/science.289.5481.879
   CHRISEY DB, 2000, APPL SURF SCI, V6683, P1
   DeBoer C, 1998, J IMAGING SCI TECHN, V42, P63
   FEINBERG SE, 2000, SHANGHAI J STOMATOL, V9, P36
   Fishman HA, 1996, ANAL CHEM, V68, P1181, DOI 10.1021/ac950904g
   Fitz-Gerald JM, 2000, APPL PHYS LETT, V76, P1386, DOI 10.1063/1.126040
   Folch A, 2000, J BIOMED MATER RES, V52, P346, DOI 10.1002/1097-4636(200011)52:2<346::AID-JBM14>3.0.CO;2-H
   Folch A, 2000, ANNU REV BIOMED ENG, V2, P227, DOI 10.1146/annurev.bioeng.2.1.227
   GIAEVER I, 1993, NATURE, V366, P591, DOI 10.1038/366591a0
   Hollister SJ, 2000, INT J ORAL MAX SURG, V29, P67, DOI 10.1034/j.1399-0020.2000.290115.x
   Horch RE, 2000, TISSUE ENG, V6, P53, DOI 10.1089/107632700320892
   Ito Y, 1999, BIOMATERIALS, V20, P2333, DOI 10.1016/S0142-9612(99)00162-3
   Jung DR, 2001, CRIT REV BIOTECHNOL, V21, P111, DOI 10.1080/20013891081700
   Kane RS, 1999, BIOMATERIALS, V20, P2363, DOI 10.1016/S0142-9612(99)00165-9
   KANTOR Z, 1992, APPL PHYS A-MATER, V54, P170, DOI 10.1007/BF00323905
   Kapur R, 1996, J BIOMED MATER RES, V33, P205, DOI 10.1002/(SICI)1097-4636(199624)33:4<205::AID-JBM1>3.0.CO;2-T
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Lysaght MJ, 2001, TISSUE ENG, V7, P485, DOI 10.1089/107632701753213110
   Odde DJ, 2000, BIOTECHNOL BIOENG, V67, P312, DOI 10.1002/(SICI)1097-0290(20000205)67:3<312::AID-BIT7>3.3.CO;2-6
   Pique A, 1999, APPL PHYS A-MATER, V69, pS279, DOI 10.1007/s003390051400
   RENN MJ, 1999, TIBTECH, V17, P383
   Rennekampff HO, 1996, J SURG RES, V62, P288, DOI 10.1006/jsre.1996.0210
   RINGEISEN, UNPUB BIOTECHNOLOGY
   Ringeisen BR, 2002, BIOMATERIALS, V23, P161, DOI 10.1016/S0142-9612(01)00091-6
   RINGEISEN BR, 2001, P 4 INT C MOD SIM MI
   RINGEISEN BR, 2001, AM BIOTECHNOLOGY LAB
   Solchaga LA, 1999, J ORTHOPAED RES, V17, P205, DOI 10.1002/jor.1100170209
   SPARGO BJ, 1994, P NATL ACAD SCI USA, V91, P11070, DOI 10.1073/pnas.91.23.11070
   Takayama S, 1999, P NATL ACAD SCI USA, V96, P5545, DOI 10.1073/pnas.96.10.5545
   Takezawa T, 2000, TISSUE ENG, V6, P641, DOI 10.1089/10763270050199587
   Temenoff JS, 2000, BIOMATERIALS, V21, P431, DOI 10.1016/S0142-9612(99)00213-6
   VACANTI JP, 1993, CELL TRANSPLANT, V2, P409, DOI 10.1177/096368979300200508
   Voigt M, 1999, TISSUE ENG, V5, P563, DOI 10.1089/ten.1999.5.563
   Wilbur JL, 1996, NANOTECHNOLOGY, V7, P452, DOI 10.1088/0957-4484/7/4/028
   Young D, 2001, J MATER RES, V16, P1720, DOI 10.1557/JMR.2001.0237
   Zeltinger J, 2001, TISSUE ENG, V7, P9, DOI 10.1089/107632701300003250
   Zergioti I, 1998, APPL PHYS A-MATER, V66, P579, DOI 10.1007/s003390050717
NR 43
TC 3
Z9 3
U1 0
U2 6
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 0-7803-7480-0
J9 ENG MED BIOL SOC ANN
PY 2002
BP 120
EP 125
DI 10.1109/MMB.2002.1002277
PG 6
WC Biochemical Research Methods; Engineering, Biomedical; Engineering,
   Electrical & Electronic; Instruments & Instrumentation
SC Biochemistry & Molecular Biology; Engineering; Instruments &
   Instrumentation
GA BU48A
UT WOS:000176123400024
DA 2018-10-20
ER

PT J
AU Dost, P
   ten Cate, WJF
   Wiemann, M
AF Dost, P
   ten Cate, WJF
   Wiemann, M
TI Osteoblast-like cell cultures from human stapes
SO ACTA OTO-LARYNGOLOGICA
LA English
DT Article
DE alkaline phosphatase; biomaterials; osteoblast-like cells; osteocalcine;
   stapes
ID HUMAN-BONE; BIOCOMPATIBILITY; EXPRESSION; MARROW; GROWTH
AB Objective-In order to develop new middle ear prostheses for ossicular reconstruction it is important to study how the recipient middle ear tissues, especially the stapes footplate and superstructure, react to the implanted biomaterial. In this respect, animal studies and cell cultures using non-specific cells are of limited value.
   Material and methods-The morphology and growth pattern of cells cultured from human stapes were studied. Cultured cells were examined for the presence of alkaline phosphatase and were processed for immunocytochemistry in order to detect the presence of osteocalcine. Fibroblast cultures served as controls.
   Results-Cultured stapes cells proliferated in a polygonal-cubic shape and without any regular pattern in the culture. These cells were shown to contain alkaline phosphatase and osteocalcine. Cultured fascia fibroblasts proliferated in a spindle-shaped form and in a pattern resembling a shoal of fish. Cultured fibroblasts did not contain alkaline phosphatase or osteocalcine.
   Conclusions-It is possible to culture osteoblasts from human stapes. These cells can be characterized as osteoblast-like cells by means of their external shape and the presence of alkaline phosphatase and osteocalcine. Using these cultures, specific in vitro investigations concerning the interaction of biomaterials and middle ear ossicles could be performed.
C1 Univ Essen Gesamthsch, Dept Otorhinolaryngol, Essen, Germany.
   Univ Essen Gesamthsch, Inst Physiol, Essen, Germany.
RP Dost, P (reprint author), Univ HNO Klin, DE-45122 Essen, Germany.
CR ASHTON BA, 1985, BONE, V6, P313, DOI 10.1016/8756-3282(85)90321-7
   ATTAWIA MA, 1995, J BIOMED MATER RES, V29, P843, DOI 10.1002/jbm.820290709
   BELEITES E, 1985, LARYNG RHINOL OTOL V, V64, P217, DOI 10.1055/s-2007-1008123
   BODO M, 1991, CELL MOL BIOL, V37, P597
   BUDDECKE E, 1980, GRUNDRISS BIOCH
   CHEUNG HS, 1989, BIOMATERIALS, V10, P63, DOI 10.1016/0142-9612(89)90012-4
   DOST P, 2002, IN PRESS ORL J OTORH
   EAGLE H, 1959, SCIENCE, V130, P432, DOI 10.1126/science.130.3373.432
   ERIKSEN EF, 1988, SCIENCE, V241, P84, DOI 10.1126/science.3388021
   HARRIS SA, 1995, J BONE MINER RES, V10, P178
   HENDRICH C, 1996, BIOMED TECH, V41, P276
   JAHNKE K, 1987, HNO, V35, P1
   LANGEFELD S, 1997, 10 C BIOM 13 14 FEBR
   LIND M, 1995, CYTOKINE, V7, P78, DOI 10.1006/cyto.1995.1010
   Liu F, 1997, EXP CELL RES, V232, P97, DOI 10.1006/excr.1997.3501
   LIU F, 1994, DEV BIOL, V166, P220, DOI 10.1006/dbio.1994.1309
   LUBBEN B, 1996, CHIRURGIE, V1, P155
   MAURIZI M, 1988, AM J OTOLARYNG, V9, P68, DOI 10.1016/S0196-0709(88)80010-3
   MAURIZI M, 1983, CELL TISSUE RES, V229, P505
   Moschinsky E, 1991, Dtsch Zahn Mund Kieferheilkd Zentralbl, V79, P269
   Park Yong-Koo, 1995, Journal of Korean Medical Science, V10, P263
   WILKE A, 1993, BIOMED TECH, V38, P126, DOI 10.1515/bmte.1993.38.6.126
   1994, BIOL BEURTEILUNG MED, V5
NR 23
TC 3
Z9 8
U1 0
U2 2
PU TAYLOR & FRANCIS AS
PI OSLO
PA CORT ADELERSGT 17, PO BOX 2562, SOLLI, 0202 OSLO, NORWAY
SN 0001-6489
J9 ACTA OTO-LARYNGOL
JI Acta Oto-Laryngol.
PY 2002
VL 122
IS 8
BP 836
EP 840
DI 10.1080/000164802321040964
PG 5
WC Otorhinolaryngology
SC Otorhinolaryngology
GA 635GG
UT WOS:000180390400007
PM 12542202
DA 2018-10-20
ER

PT S
AU Gibson, AL
   Wilson, LH
   Wilkerson, WR
   Feinberg, AW
   Seegert, CA
   Baney, RH
   Brennan, AB
AF Gibson, AL
   Wilson, LH
   Wilkerson, WR
   Feinberg, AW
   Seegert, CA
   Baney, RH
   Brennan, AB
BE Moss, SC
TI Characterization of chemically and topographically modified siloxane
   elastomer for controlled cell growth
SO ADVANCED BIOMATERIALS-CHARACTERIZATION, TISSUE ENGINEERING AND
   COMPLEXITY
SE MATERIALS RESEARCH SOCIETY SYMPOSIUM PROCEEDINGS
LA English
DT Proceedings Paper
CT Symposia on Physical Characterization of Biological Materials and
   Systems/Polymeric Biomaterials for Tissue Engineering/BioInspired
   Materials-Moving Toward Complexity
CY NOV 26-29, 2001
CL BOSTON, MA
SP Mat Res Soc
ID SILICONE; COATINGS; SURFACES; BEHAVIOR; RELEASE
AB A main limitation of biomedical devices is the inability to start, stop, and control cell growth making it crucial to develop biomaterial surfaces that induce a desired cellular response. Micropatterns of ridges and pillars were created in a siloxane elastomer (Dow Corning) by casting against epoxy replicates of a micromachined silicon wafer. Silicone oils were incorporated to determine the change in modulus and surface energy caused by these additives. SEM and white light interference profilometry verified that the micropatterning process produced high fidelity, low defect micropatterns. Mechanical analysis indicated that varying the viscosity, weight percent and functionality of the added silicone oil could change the elastic modulus by over an order of magnitude (0.1-2.3 MPa). As a self-wetting resin, silicone oils migrate to the surface, hence changing the surface properties from the bulk. Both topographical and chemical features define the surface energy, which in combination with elastic modulus, dictate biological activity. The results imply that the morphology, mechanical properties and surface energy of the siloxane elastomer can be modified to elicit a specific cell response as a function of engineered topographical and chemical functionalization.
C1 Univ Florida, Dept Mat Sci & Engn, Biomed Engn Program, Gainesville, FL 32611 USA.
RP Gibson, AL (reprint author), Univ Florida, Dept Mat Sci & Engn, Biomed Engn Program, Gainesville, FL 32611 USA.
CR Berglin M, 1999, J ADHES SCI TECHNOL, V13, P713, DOI 10.1163/156856199X00956
   Brady RF, 2000, BIOFOULING, V15, P73, DOI 10.1080/08927010009386299
   DENBRABER ET, 1995, J BIOMED MATER RES, V29, P511, DOI 10.1002/jbm.820290411
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   GOOD RJ, 1992, J ADHES SCI TECHNOL, V6, P1269, DOI 10.1163/156856192X00629
   Kohl JG, 1999, PROG ORG COAT, V36, P15, DOI 10.1016/S0300-9440(98)00074-5
   Oner D, 2000, LANGMUIR, V16, P7777, DOI 10.1021/la000598o
   SAFRIN EG, LANGMUIR, V64, P519
   SCHMIDT JA, 1992, BIOMATERIALS, V13, P675
   Tan J, 2000, J BIOMED MATER RES, V51, P694, DOI 10.1002/1097-4636(20000915)51:4<694::AID-JBM18>3.3.CO;2-E
NR 10
TC 1
Z9 1
U1 0
U2 0
PU MATERIALS RESEARCH SOCIETY
PI WARRENDALE
PA 506 KEYSTONE DRIVE, WARRENDALE, PA 15088-7563 USA
SN 0272-9172
BN 1-55899-647-8
J9 MATER RES SOC SYMP P
PY 2002
VL 711
BP 169
EP 174
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA BU92B
UT WOS:000177402200023
DA 2018-10-20
ER

PT S
AU Miller, DC
   Thapa, A
   Haberstroh, KM
   Webster, TJ
AF Miller, DC
   Thapa, A
   Haberstroh, KM
   Webster, TJ
BE Moss, SC
TI An in vitro study of nano-fiber polymers for guided vascular
   regeneration
SO ADVANCED BIOMATERIALS-CHARACTERIZATION, TISSUE ENGINEERING AND
   COMPLEXITY
SE MATERIALS RESEARCH SOCIETY SYMPOSIUM PROCEEDINGS
LA English
DT Proceedings Paper
CT Symposia on Physical Characterization of Biological Materials and
   Systems/Polymeric Biomaterials for Tissue Engineering/BioInspired
   Materials-Moving Toward Complexity
CY NOV 26-29, 2001
CL BOSTON, MA
SP Mat Res Soc
AB Biomaterials that successfully integrate into surrounding tissue should match not only the tissue's mechanical properties, but also the dimensions of the associated nano-structured extracellular matrix (ECM) components. The goal of this research was to use these ideals to develop a synthetic, nano-structured, polymeric biomaterial that has cytocompatible and mechanical behaviors similar to that of natural vascular tissue. In a novel manner, poly-lactic acid/polyglycolic acid (PLGA) (50/50 wt.% mix) and polyurethane were separately synthesized to possess a range of fiber dimensions in the micron and nanometer regime. Preliminary results indicated that decreasing fiber diameter on both PLGA and PU enhanced arterial smooth muscle cell adhesion; specifically, arterial smooth muscle cell adhesion increased 23% when PLGA fiber dimensions decreased from 500 to 50 nm and increased 76% on nano-structured, compared to conventional structured, polyurethane. However, nano-structured PLGA decreased endothelial cell adhesion by 52%, whereas adhesion of these same cells was increased by 50% on polyurethane. For these reasons, the present in vitro study provides the first evidence that polymer fiber dimensions can be used to selectively control cell functions for vascular prosthesis.
C1 Purdue Univ, Dept Biomed Engn, W Lafayette, IN 47907 USA.
RP Miller, DC (reprint author), Purdue Univ, Dept Biomed Engn, W Lafayette, IN 47907 USA.
CR Gao JM, 1998, J BIOMED MATER RES, V42, P417, DOI 10.1002/(SICI)1097-4636(19981205)42:3<417::AID-JBM11>3.3.CO;2-N
   Salacinski HJ, 2001, J BIOMATER APPL, V15, P241, DOI 10.1106/NA5T-J57A-JTDD-FD04
   Webster TJ, 2002, J BIOMED MATER RES, V59, P312, DOI 10.1002/jbm.1247
NR 3
TC 1
Z9 1
U1 0
U2 2
PU MATERIALS RESEARCH SOCIETY
PI WARRENDALE
PA 506 KEYSTONE DRIVE, WARRENDALE, PA 15088-7563 USA
SN 0272-9172
BN 1-55899-647-8
J9 MATER RES SOC SYMP P
PY 2002
VL 711
BP 201
EP 204
PG 4
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA BU92B
UT WOS:000177402200028
DA 2018-10-20
ER

PT J
AU Rivers, TJ
   Hudson, TW
   Schmidt, CE
AF Rivers, TJ
   Hudson, TW
   Schmidt, CE
TI Synthesis of a novel, biodegradable electrically conducting polymer for
   biomedical applications
SO ADVANCED FUNCTIONAL MATERIALS
LA English
DT Article
ID NERVE REGENERATION; ELECTROMAGNETIC-FIELDS; GUIDANCE CHANNELS;
   BONE-FORMATION; STIMULATION; POLYPYRROLE; ROUTE
AB We report the synthesis and characterization of a novel biomaterial that possesses the unique properties of being both electrically conducting and biodegradable; and thus capable of electronic interfacing with tissue. This polymer was synthesized from conducting oligomers of pyrrole and thiophene that are connected together via degradable ester linkages. We demonstrate that this polymer is conductive, degradable, and biocompatible.
C1 Univ Texas, Texas Mat Inst & Biomed Engn, Dept Chem Engn, Austin, TX 78712 USA.
RP Rivers, TJ (reprint author), Univ Texas, Texas Mat Inst & Biomed Engn, Dept Chem Engn, 26th & Speedway,MC C0400, Austin, TX 78712 USA.
RI Schmidt, Christine/P-1613-2016
CR AARON RK, 1993, J CELL BIOCHEM, V52, P42, DOI 10.1002/jcb.240520107
   BISWAS M, 1994, J APPL POLYM SCI, V51, P1574
   CIOMBOR DM, 1993, J CELL BIOCHEM, V52, P37, DOI 10.1002/jcb.240520106
   Collier JH, 2000, J BIOMED MATER RES, V50, P574, DOI 10.1002/(SICI)1097-4636(20000615)50:4<574::AID-JBM13>3.0.CO;2-I
   Cui XY, 2001, J BIOMED MATER RES, V56, P261, DOI 10.1002/1097-4636(200108)56:2<261::AID-JBM1094>3.0.CO;2-I
   Donat-Bouillud A, 1997, CHEM MATER, V9, P2815, DOI 10.1021/cm9701926
   FINE EG, 1991, BIOMATERIALS, V12, P775, DOI 10.1016/0142-9612(91)90029-A
   Goldman R, 1996, BIOELECTROMAGNETICS, V17, P450, DOI 10.1002/(SICI)1521-186X(1996)17:6<450::AID-BEM4>3.0.CO;2-2
   Green TR, 2000, J BIOMED MATER RES, V53, P490, DOI 10.1002/1097-4636(200009)53:5<490::AID-JBM7>3.0.CO;2-7
   GROENENDAAL L, 1995, MACROMOLECULES, V28, P116, DOI 10.1021/ma00105a015
   HONG YL, 1995, CHEM MATER, V7, P1999, DOI 10.1021/cm00059a003
   IKADA Y, 1994, BIOMATERIALS, V15, P725, DOI 10.1016/0142-9612(94)90025-6
   Ikada Y, 1996, J BIOMED MATER RES, V30, P553
   KANAZAWA KK, 1980, SYNTHETIC MET, V1, P329, DOI 10.1016/0379-6779(80)90022-3
   Kotwal A, 2001, BIOMATERIALS, V22, P1055, DOI 10.1016/S0142-9612(00)00344-6
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   MERRILL BA, 1990, J ORG CHEM, V55, P2904, DOI 10.1021/jo00296a062
   PFLUGER P, 1984, J CHEM PHYS, V80, P544, DOI 10.1063/1.446428
   POLITIS MJ, 1989, NEUROSURGERY, V25, P71, DOI 10.1227/00006123-198907000-00012
   POMERANZ B, 1993, BRAIN RES, V603, P271, DOI 10.1016/0006-8993(93)91247-P
   Schmidt CE, 1997, P NATL ACAD SCI USA, V94, P8948, DOI 10.1073/pnas.94.17.8948
   SISKEN BF, 1993, J CELL BIOCHEM, V51, P404, DOI 10.1002/jcb.2400510404
   TAMADA Y, 1994, J BIOMED MATER RES, V28, P783, DOI 10.1002/jbm.820280705
   VALENTINI RF, 1992, BIOMATERIALS, V13, P183, DOI 10.1016/0142-9612(92)90069-Z
   VALENTINI RF, 1989, BRAIN RES, V480, P300, DOI 10.1016/0006-8993(89)90196-0
   WALLACE DM, 1993, J ORG CHEM, V58, P7245, DOI 10.1021/jo00077a056
   ZANAKIS MF, 1990, ACUPUNCTURE ELECTRO, V15, P185, DOI 10.3727/036012990816358199
NR 27
TC 216
Z9 219
U1 3
U2 114
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1616-301X
J9 ADV FUNCT MATER
JI Adv. Funct. Mater.
PD JAN
PY 2002
VL 12
IS 1
BP 33
EP 37
DI 10.1002/1616-3028(20020101)12:1<33::AID-ADFM33>3.0.CO;2-E
PG 5
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 515YQ
UT WOS:000173524600005
DA 2018-10-20
ER

PT S
AU Mazzobre, MF
   Longinotti, MP
   Corti, HR
   Buera, MP
AF Mazzobre, MF
   Longinotti, MP
   Corti, HR
   Buera, MP
BE Levine, H
TI Thermophysical properties of amorphous dehydrated and frozen sugar
   systems, as affected by salts
SO AMORPHOUS FOOD AND PHARMACEUTICAL SYSTEMS
SE Royal Society of Chemistry Special Publications
LA English
DT Proceedings Paper
CT Conference on the Amorphous State - A Critical Review
CY MAY 15-17, 2001
CL CHURCHILL COLL, CAMBRIDGE, ENGLAND
SP BioUpdate Fdn, Royal Soc Chem, Biotechnol Grp
HO CHURCHILL COLL
ID DIFFERENTIAL SCANNING CALORIMETRY; AQUEOUS-SOLUTIONS; BIOMATERIAL
   STABILIZATION; ELECTRICAL-CONDUCTIVITY; SUPERCOOLED LIQUIDS;
   GLASS-TRANSITION; WATER ACTIVITY; ICE FORMATION; TREHALOSE; STATE
C1 Univ Buenos Aires, Fac Ciencias Exactas & Nat, INQUIMAE, Dpto Ind, RA-1428 Buenos Aires, DF, Argentina.
RP Mazzobre, MF (reprint author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, INQUIMAE, Dpto Ind, RA-1428 Buenos Aires, DF, Argentina.
EM florm@di.fcem.uba.ar; pilar@di.fcen.uba.ar
CR ANGELL CA, 1994, J FOOD ENG, V22, P115, DOI 10.1016/0260-8774(94)90028-0
   Angyal SJ, 1973, PURE APPL CHEM, V35, P131, DOI DOI 10.1351/PAC197335020131
   Avrami M, 1939, J CHEM PHYS, V7, P1103, DOI 10.1063/1.1750380
   BARTHEL J, 1983, J SOLUTION CHEM, V12, P449, DOI 10.1007/BF00651698
   BARTHEL J, 1980, J SOLUTION CHEM, V9, P209, DOI 10.1007/BF00648327
   Cardona S, 1997, J FOOD SCI, V62, P105, DOI 10.1111/j.1365-2621.1997.tb04378.x
   CARPENTER JF, 1988, CRYOBIOLOGY, V25, P459, DOI 10.1016/0011-2240(88)90054-5
   CHVOJ Z, 1991, KINETIC PHASE DIAGRA, P169
   COOK WJ, 1973, CARBOHYD RES, V31, P265, DOI 10.1016/S0008-6215(00)86191-1
   DOREMUS RH, 1985, RATES PHASE TRANSFOR, V24
   Ediger MD, 2000, ANNU REV PHYS CHEM, V51, P99, DOI 10.1146/annurev.physchem.51.1.99
   FLINK J M, 1983, P473
   GOETZE W, 1991, LIQUIDS FREEZING GLA
   GOLDBERG RN, 1978, J PHYS CHEM REF DATA, V7, P263, DOI 10.1063/1.555569
   GRAYDON JW, 1994, J NON-CRYST SOLIDS, V175, P31, DOI 10.1016/0022-3093(94)90312-3
   HEMMINGA MA, 1993, GLASSY STATE IN FOODS, P157
   HER LM, 1995, PHARMACEUT RES, V12, P768, DOI 10.1023/A:1016280113800
   Iglesias HA, 1997, J SCI FOOD AGR, V75, P183, DOI 10.1002/(SICI)1097-0010(199710)75:2<183::AID-JSFA860>3.0.CO;2-T
   Johnson WA, 1939, T AM I MIN MET ENG, V135, P416
   KAREL M, 1981, WATER RELATIONS FOOD, P639
   Kedward CJ, 2000, J FOOD SCI, V65, P324, DOI 10.1111/j.1365-2621.2000.tb16001.x
   KOLMOGOROV AN, 1937, VESTN USSR ACAD SCI, V3, P3551
   Longinotti MP, 2002, PHYS CHEM CHEM PHYS, V4, P533, DOI 10.1039/b107746e
   Mazzobre MF, 2001, CRYOBIOLOGY, V43, P199, DOI 10.1006/cryo.2001.2345
   Mazzobre MF, 1999, BBA-GEN SUBJECTS, V1473, P337, DOI 10.1016/S0304-4165(99)00207-X
   Miller DP, 2000, J PHYS CHEM B, V104, P10419, DOI 10.1021/jp000730t
   Miller DP, 1997, PHARMACEUT RES, V14, P578, DOI 10.1023/A:1012192725996
   MORELDESROSIERS N, 1991, J CHEM SOC FARADAY T, V87, P2173, DOI 10.1039/ft9918702173
   Noel TR, 1996, J CHEM SOC FARADAY T, V92, P1921, DOI 10.1039/ft9969201921
   PETRIELLA C, 1985, J FOOD SCI, V50, P622, DOI 10.1111/j.1365-2621.1985.tb13759.x
   ROBINSON RA, 1955, ELECTROLYTE SOLUTION
   RONGERE P, 1995, J CHEM SOC FARADAY T, V91, P2771, DOI 10.1039/ft9959102771
   ROOS YH, 1991, CRYO-LETT, V12, P367
   ROOS YH, 1991, INT J FOOD SCI TECH, V26, P553
   ROOS YH, 1991, FOOD TECHNOL-CHICAGO, V45, P66
   ROSSLER E, 1990, PHYS REV LETT, V65, P1595, DOI 10.1103/PhysRevLett.65.1595
   SIMATOS D, 1991, ADV EXP MED BIOL, P139
   SLADE L, 1991, CRIT REV FOOD SCI, V30, P115, DOI 10.1080/10408399109527543
   SPIRO M, 1973, ORGANIC SOLVENT SYST, pCH6
   Stokes R. H., 1959, STRUCTURE ELECTROLYT, P298
   SUN WQ, 1993, PHYSIOL PLANTARUM, V89, P767
   Suzuki T, 1997, J CHEM ENG JPN, V30, P609, DOI 10.1252/jcej.30.609
NR 42
TC 1
Z9 1
U1 0
U2 1
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, CAMBRIDGE CB4 4WF, CAMBS, ENGLAND
SN 0260-6291
BN 0-85404-866-9
J9 ROY SOC CH
PY 2002
IS 281
BP 231
EP 243
DI 10.1039/9781847550118-00231
PG 13
WC Chemistry, Applied; Food Science & Technology; Pharmacology & Pharmacy
SC Chemistry; Food Science & Technology; Pharmacology & Pharmacy
GA BW12L
UT WOS:000180940400020
DA 2018-10-20
ER

PT J
AU Zhang, LH
   Ma, DR
   Wang, FJ
   Zhang, QQ
AF Zhang, LH
   Ma, DR
   Wang, FJ
   Zhang, QQ
TI The modification of scaffold material in building artificial dermis
SO ARTIFICIAL CELLS BLOOD SUBSTITUTES AND IMMOBILIZATION BIOTECHNOLOGY
LA English
DT Article
DE dermis; collagen; chondroitin sulfate; tissue engineering
ID HUMAN-FIBROBLASTS; CROSS-LINKING; SKIN; REGENERATION; DESIGN
AB Type X collagen is principal extracellular matrix (ECM) in natural dermis. To prepare artificial dermis, collagen is traditional, and most superior biomaterial. But beside collagen, the dermis also contains many other ECM. Among them, glycosaminoglycan (GAG) is another important substance. To imitate the natural dermis, and modificate the scaffold, materials, two types of scaffolds were prepared: one is traditional type X collagen spongy scaffold, the other is collagen-chondroitin sulfate (CS) spongy scaffold. Collagen was blended with CS, one kind of GAG, and cross-linked by 1-ethyl-3-(3-dimethyl aminopropyl) carbodiimide (EDC). Dermis fibroblast was isolated from neonate prepuce, and dermis fibroblasts were cultured on the scaffolds. The physical and chemical properties of the scaffolds were tested, including SEM, DSC, H&E staining, immunohistochemical staining and cs content analysis and so on. The results indicated that EDC is an effective and non-cytotoxic cross-link reagent, and attaching CS into collagen scaffold could improve the stability and histocompatibility of scaffold.
C1 Chinese Acad Med Sci, Inst Biomed Engn, Tianjin 300192, Peoples R China.
   Chinese Acad Med Sci, Peking Union Med Coll, Tianjin 300192, Peoples R China.
RP Zhang, LH (reprint author), Chinese Acad Med Sci, Inst Biomed Engn, POB 25-204, Tianjin 300192, Peoples R China.
RI Zhang, QQ/G-3361-2010
CR BELL E, 1979, P NATL ACAD SCI USA, V76, P1274, DOI 10.1073/pnas.76.3.1274
   Black AF, 1998, FASEB J, V12, P1331
   BOYCE ST, 1988, J BIOMED MATER RES, V22, P935
   Dermarchez M., 1992, TRANSPLANTATION, V54, P317
   DEVIRE HJC, 1993, WOUND REPAIR REGEN, V1, P244
   Gratzer PF, 1996, J BIOMED MATER RES, V31, P533, DOI 10.1002/(SICI)1097-4636(199608)31:4<533::AID-JBM14>3.0.CO;2-H
   HANSBROUGH JF, 1994, SURGERY, V115, P633
   MIDDELKOOP E, 1995, CELL TISSUE RES, V280, P447, DOI 10.1007/BF00307818
   Osborne CS, 1998, MED BIOL ENG COMPUT, V36, P129, DOI 10.1007/BF02522870
   RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8
   SHUUICHI I, 1991, J JAN PRS, V11, P515
   Valle CAL, 1996, TRANSPLANTATION, V62, P317, DOI 10.1097/00007890-199608150-00003
   Yang HY, 2001, J MATER SCI TECHNOL, V17, P495
   YANNAS IV, 1980, J BIOMED MATER RES, V14, P65, DOI 10.1002/jbm.820140108
   YANNAS IV, 1980, J BIOMED MATER RES, V14, P107, DOI 10.1002/jbm.820140203
   YANNAS IV, 1989, P NATL ACAD SCI USA, V86, P933, DOI 10.1073/pnas.86.3.933
   Zhang QQ, 1997, J APPL POLYM SCI, V64, P2127
   Zhang QQ, 1999, ARTIF CELL BLOOD SUB, V27, P245, DOI 10.3109/10731199909117697
NR 18
TC 13
Z9 15
U1 2
U2 4
PU MARCEL DEKKER INC
PI NEW YORK
PA 270 MADISON AVE, NEW YORK, NY 10016 USA
SN 1073-1199
J9 ARTIF CELL BLOOD SUB
JI Artif. Cells Blood Substit. Immobil. Biotechnol.
PY 2002
VL 30
IS 4
BP 319
EP 332
DI 10.1081/BIO-120006122
PG 14
WC Biotechnology & Applied Microbiology; Engineering, Biomedical; Materials
   Science, Biomaterials
SC Biotechnology & Applied Microbiology; Engineering; Materials Science
GA 594TL
UT WOS:000178067000006
PM 12227650
DA 2018-10-20
ER

PT J
AU Gourlay, T
   Stefanou, D
   Taylor, KM
AF Gourlay, T
   Stefanou, D
   Taylor, KM
TI The effect of methanol washing of plasticized polyvinyl chloride on
   biomaterial-contact-mediated CD11b (mac-1) expression in a rat
   recirculation model
SO ARTIFICIAL ORGANS
LA English
DT Article
DE CD11b expression; inflammatory response; methanol-washing technique;
   neutrophils
ID CARDIOPULMONARY BYPASS; INFLAMMATORY RESPONSE; IN-VITRO; LEUKOCYTE;
   BLOOD; COMPLEMENT; ACTIVATION; ADHESION; HEPARIN; PVC
AB Our objective was to assess whether using a methanol wash to reduce the level of plasticizer present on the surface of medical-grade polyvinyl chloride (PVC) has a moderating effect on the expression of CD11b (mac-1) on neutrophils in rats undergoing recirculation. The study was carried out on 3 groups of 10 adult male Sprague-Dawley rats weighing between 350 and 450 g. In the 2 test groups, the animals were exposed to 48 cm(2) of di-(2-ethyl-hexyl)-phthalate (DEHP)-plasticized PVC in a parallel plate recirculating test cell through which blood was recirculated at 1.5 ml/min. In the first test group, the PVC was untreated; in the second test group, the PVC was washed in methanol to reduce the level of plasticizer on the surface. The test cell was connected to the right femoral circulation, and recirculation was established for a period of 60 min. Blood samples were taken at 0, 30, and 60 min for assessment of CD11b expression on neutrophils using flow cytometric analysis. In a third group of 10 control experiments, rats underwent the entire surgical procedure, but without recirculation through the test cell. There was statistically significant (p < 0.001) lower Cd11b expression on neutrophils in the blood of rats perfused through the cell containing methanol-washed PVC after 30 min and at 60 min. CD11b expression was significantly (p < 0.001) lower in the control group than in both test groups at both the 30 and 60 min time points and at the 60 min time point on comparison with the group where blood was perfused through methanol-washed PVC. These results demonstrate that the biomaterial-contact-mediated upregulation of CD11b may be significantly reduced by employing a methanol-washing technique on the plasticized PVC. Although this technique does not entirely eliminate the expression of CD11b on neutrophils, the difference is significant and suggests the role of the plasticizer in the development of this inappropriate inflammatory response.
C1 Hammersmith Hosp, Imperial Coll Sch Med, Natl Heart & Lung Inst, Dept Cardiac Surg, London W12 0NN, England.
RP Gourlay, T (reprint author), Hammersmith Hosp, Imperial Coll Sch Med, Natl Heart & Lung Inst, Dept Cardiac Surg, 2nd Floor B Block,DuCane Rd, London W12 0NN, England.
CR Asimakopoulos G, 1998, ANN THORAC SURG, V66, P2135, DOI 10.1016/S0003-4975(98)00727-9
   Asimakopoulos G, 2000, ANN THORAC SURG, V69, P1192, DOI 10.1016/S0003-4975(99)01553-2
   Asimakopoulos G, 1999, PERFUSION-UK, V14, P269, DOI 10.1177/026765919901400406
   BONE RC, 1992, CRIT CARE MED, V20, P864
   BUTLER J, 1993, ANN THORAC SURG, V55, P552, DOI 10.1016/0003-4975(93)91048-R
   GAKINANES M, 1996, CIRCULATION, V94, P364
   Gourlay T, 2001, ARTIF ORGANS, V25, P475, DOI 10.1046/j.1525-1594.2001.025006475.x
   HILL GE, 1994, ANAESTH ANALG, V79, P1201
   Lamba NMK, 2000, BIOMATERIALS, V21, P89, DOI 10.1016/S0142-9612(99)00145-3
   Landis NT, 1999, AM J HEALTH-SYST PH, V56, P937
   Latini G, 1999, ACTA PAEDIATR, V88, P1174, DOI 10.1080/08035259950168333
   LEDEIST F, 1995, CIRCULATION, V92, P354, DOI 10.1161/01.CIR.92.9.354
   MATHEW JP, 1995, J THORAC CARDIOV SUR, V109, P448, DOI 10.1016/S0022-5223(95)70275-X
   Mettang T, 2000, PERITON DIALYSIS INT, V20, P80
   Moen O, 1997, ANN THORAC SURG, V63, P105
   TAGGART DP, 1994, ANN THORAC SURG, V57, P376, DOI 10.1016/0003-4975(94)91000-6
   Zhao XB, 1999, ARTIF ORGANS, V23, P104, DOI 10.1046/j.1525-1594.1999.06267.x
NR 17
TC 7
Z9 7
U1 0
U2 1
PU BLACKWELL PUBLISHING INC
PI MALDEN
PA 350 MAIN ST, MALDEN, MA 02148 USA
SN 0160-564X
J9 ARTIF ORGANS
JI Artif. Organs
PD JAN
PY 2002
VL 26
IS 1
BP 5
EP 9
DI 10.1046/j.1525-1594.2002.06730.x
PG 5
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 520AG
UT WOS:000173757200003
PM 11872005
DA 2018-10-20
ER

PT J
AU Demers, C
   Hamdy, CR
   Corsi, K
   Chellat, F
   Tabrizian, M
   Yahia, L
AF Demers, C
   Hamdy, CR
   Corsi, K
   Chellat, F
   Tabrizian, M
   Yahia, L
TI Natural coral exoskeleton as a bone graft substitute: A review
SO BIO-MEDICAL MATERIALS AND ENGINEERING
LA English
DT Article; Proceedings Paper
CT 2nd International Symposium on Advanced Biomaterials
CY JUN   28, 2000
CL MONTREAL, CANADA
SP Biomech Biomat Res Grp, Lab Innovat & Bioperformance Anal Med Devices, Minis Res, Sci & Technol, Digital Instruments, CAMECA, Syst Res Corp, Inotevb, CERAVER, Memoflex
DE coral; biomaterial; bone graft substitute; bioresorbable;
   osteoconductive
ID MARROW-INDUCED OSTEOGENESIS; LUMBAR SPINAL-FUSION; CALCIUM-CARBONATE;
   IN-VIVO; MORPHOGENETIC PROTEIN-2; MADREPORIC CORAL; GROWTH-FACTOR;
   COMPRESSIVE STRENGTH; DIFFERENT POROSITIES; RESORPTION KINETICS
AB Natural coral graft substitutes are derived from the exoskeleton of marine madreporic corals. Researchers first started evaluating corals as potential bone graft substitutes in the early 1970s in animals and in 1979 in humans. The structure of the commonly used coral, Porites, is similar to that of cancellous bone and its initial mechanical properties resemble those of bone. The exoskeleton of these high content calcium carbonate scaffolds has since been shown to be biocompatible, osteoconductive, and biodegradable at variable rates depending on the exoskeleton porosity, the implantation site and the species. Although not osteoinductive or osteogenic, coral grafts act as an adequate carrier for growth factors and allow cell attachment, growth, spreading and differentiation. When applied appropriately and when selected to match the resorption rate with the bone formation rate of the implantation site, natural coral exoskeletons have been found to be impressive bone graft substitutes. The purpose of this article is to review and summarize all the pertinent work that has been published on natural coral as a bone graft including in vitro, animal and clinical human studies. Preliminary report of our own experiments as well as our recommendations on the use of coral are also included.
C1 Ecole Polytech, Dept Mech Engn, Biomech & Biomat Res Grp, Montreal, PQ H3C 3A7, Canada.
   McGill Univ, Montreal Childrens Hosp, Res Inst, Shriners Hosp Children, Montreal, PQ H3H 1P3, Canada.
   McGill Univ, Dept Orthopaed, Montreal, PQ H3H 1P3, Canada.
   Ecole Polytech, Notre Dame Hosp CHUM, Montreal, PQ H3C 3A7, Canada.
   McGill Univ, Dept Biomed Engn, Montreal, PQ, Canada.
RP Yahia, L (reprint author), Ecole Polytech, Dept Mech Engn, Biomech & Biomat Res Grp, POB 6079,Stn Ctr Ville, Montreal, PQ H3C 3A7, Canada.
CR ALPASLAN C, 1994, ORAL SURG ORAL MED O, V77, P335, DOI 10.1016/0030-4220(94)90193-7
   ARNAUD E, 1994, CALCIFIED TISSUE INT, V54, P493, DOI 10.1007/BF00334331
   Arnaud E, 1999, BIOMATERIALS, V20, P1909, DOI 10.1016/S0142-9612(99)00090-3
   Arnaud E, 1998, Ann Chir Plast Esthet, V43, P40
   ATLAN G, 1991, Revue de Stomatologie et de Chirurgie Maxillo-Faciale, V92, P199
   BEGLEY CT, 1995, BIOMATERIALS, V16, P1181, DOI 10.1016/0142-9612(95)93584-Z
   BEGLEY CT, 1993, BONE, V14, P661, DOI 10.1016/8756-3282(93)90089-S
   Bizette C, 1999, NEUROCHIRURGIE, V45, P4
   Boden SD, 1997, J SPINAL DISORD, V10, P1
   Boden SD, 1995, SPINE, V20, P2633, DOI 10.1097/00007632-199512150-00004
   Boiteux J P, 1988, Rev Odontostomatol (Paris), V17, P291
   BOUABBOUD NN, 1994, BIOMATERIALS, V15, P201, DOI 10.1016/0142-9612(94)90068-X
   BOUABBOUD NN, 1998, INT J ORAL MAXILLOF, V13, P115
   Boutault F, 1997, Ann Chir Plast Esthet, V42, P216
   Bravetti P, 1998, J ORAL MAXIL SURG, V56, P1170, DOI 10.1016/S0278-2391(98)90765-0
   Braye F, 1996, BIOMATERIALS, V17, P1345, DOI 10.1016/0142-9612(96)88682-0
   BUCKWALTER JA, 1995, J BONE JOINT SURG AM, V77A, P1256, DOI 10.2106/00004623-199508000-00019
   CHAMBERLAIN JA, 1978, PALEOBIOLOGY, V4, P419
   CHEN L, 1996, CHIN MED J, V76, P527
   CHIROFF RT, 1975, J BIOMED MATER RES S, V6, P29
   Collangettes-Peyrat D, 1989, INNOV TECH BIOL MED, V10, P679
   Cunin G, 2000, SPINE, V25, P1070, DOI 10.1097/00007632-200005010-00006
   DAMIEN CJ, 1993, ANN CHIR GYNAECOL FE, V82, P117
   DAMIEN CJ, 1994, CALCIFIED TISSUE INT, V55, P151, DOI 10.1007/BF00297191
   DAMIEN CJ, 1998, ACTUALITES BIOMATERI, V4, P181
   Davy DT, 1999, ORTHOP CLIN N AM, V30, P553, DOI 10.1016/S0030-5898(05)70108-5
   de la Caffiniere JY, 1998, REV CHIR ORTHOP, V84, P501
   DEMERS C, 2000, SIROT CSOS 2000 MAY
   DEMERS C, 2000, IN VITRO KINETICS RE
   dePeretti F, 1996, REV CHIR ORTHOP, V82, P234
   DOHERTY MJ, 1994, BIOMATERIALS, V15, P601, DOI 10.1016/0142-9612(94)90210-0
   Fricain JC, 1995, J MATER SCI-MATER M, V6, P680, DOI 10.1007/BF00134300
   Fricain JC, 1998, J DENT RES, V77, P406, DOI 10.1177/00220345980770020901
   Fricain JC, 1998, J BIOMED MATER RES, V42, P96, DOI 10.1002/(SICI)1097-4636(199810)42:1<96::AID-JBM12>3.0.CO;2-M
   Fricain JC, 1996, J PERIODONTAL RES, V31, P463, DOI 10.1111/j.1600-0765.1996.tb01410.x
   Fuller DA, 1996, SPINE, V21, P2131, DOI 10.1097/00007632-199609150-00015
   Furla P, 2000, M S-MED SCI, V16, P1139, DOI 10.4267/10608/1543
   Gao T, 1996, INT ORTHOP, V20, P321, DOI 10.1007/s002640050086
   Gao TJ, 1997, INT ORTHOP, V21, P194, DOI 10.1007/s002640050149
   Gao TJ, 1997, BIOMATERIALS, V18, P219, DOI 10.1016/S0142-9612(96)00133-0
   Ghiamphy K, 1999, EUROPEAN J ORTHOP SU, V9, P209
   GUIGUI P, 1994, SPINE, V19, P2798, DOI 10.1097/00007632-199412150-00012
   GUILLEMIN G, 1989, J BIOMED MATER RES, V23, P765, DOI 10.1002/jbm.820230708
   GUILLEMIN G, 1981, CR ACAD SCI III-VIE, V293, P371
   GUILLEMIN G, 1987, J BIOMED MATER RES, V21, P557, DOI 10.1002/jbm.820210503
   GUILLEMIN G, 1993, J MATER SCI-MATER M, V4, P575, DOI 10.1007/BF00125596
   Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505
   Hippolyte M P, 1991, J Parodontol, V10, P279
   HOTT M, 1989, C INSERM, V177, P311
   HULBERT S F, 1970, Journal of Biomedical Materials Research, V4, P433, DOI 10.1002/jbm.820040309
   IRIGARAY JL, 1993, J RADIOAN NUCL CH AR, V174, P93, DOI 10.1007/BF02040337
   IRIGARAY JL, 1993, J RADIOAN NUCL CH AR, V169, P339, DOI 10.1007/BF02042992
   IRIGARAY JL, 1990, BIOMATERIALS, V11, P73
   IRIGARAY JL, 1993, J THERM ANAL CALORIM, V39, P3, DOI 10.1007/BF02235441
   Issahakian S, 1989, J Parodontol, V8, P251
   ISSAHAKIAN S, 1987, INFORMATION DENTAIRE, V24, P2123
   Jammet P, 1993, Chirurgie, V119, P273
   JAMMET P, 1994, J CRANIO MAXILL SURG, V22, P103, DOI 10.1016/S1010-5182(05)80019-8
   Kajiwara S, 1990, Fukuoka Shika Daigaku Gakkai Zasshi, V17, P358
   KANATANI M, 1995, J BONE MINER RES, V10, P1681, DOI 10.1002/jbmr.5650101110
   Kaneko H, 2000, BONE, V27, P479, DOI 10.1016/S8756-3282(00)00358-6
   Kania RE, 1998, J BIOMED MATER RES, V43, P38, DOI 10.1002/(SICI)1097-4636(199821)43:1<38::AID-JBM4>3.0.CO;2-N
   KEHR P, 1998, ACTUALITES BIOMATERI, V4, P147
   Kenesi C, 1997, Chirurgie, V122, P379
   Koide M, 1999, BIOCHEM BIOPH RES CO, V259, P97, DOI 10.1006/bbrc.1999.0715
   Kreklau B, 1999, BIOMATERIALS, V20, P1743, DOI 10.1016/S0142-9612(99)00061-7
   LEVET Y, 1983, ANN CHIR PLAST ESTH, V28, P180
   LOTY B, 1990, INT ORTHOP, V14, P255
   Louisia S, 1999, J BONE JOINT SURG BR, V81B, P719, DOI 10.1302/0301-620X.81B4.9358
   Ma Q, 2000, BRIT J ORAL MAX SURG, V38, P561, DOI 10.1054/bjom.2000.0458
   Marchac D, 1994, J Craniofac Surg, V5, P213, DOI 10.1097/00001665-199409000-00003
   Mercier J., 1996, Revue de Stomatologie et de Chirurgie Maxillo-Faciale, V97, P324
   MIAO L, 1997, CHUNG KUO HSIU FU CH, V11, P132
   MIAO L, 1997, CHUNG HUA KOU CHIANG, V32, P221
   OHGUSHI H, 1989, J ORTHOPAED RES, V7, P568, DOI 10.1002/jor.1100070415
   OHGUSHI H, 1992, J BIOMED MATER RES, V26, P885, DOI 10.1002/jbm.820260705
   Ongpipattanakul Boonsri, 1994, Pharmaceutical Research (New York), V11, pS82
   Ouhayoun J P, 1991, J Parodontol, V10, P61
   OUHAYOUN JP, 1992, J MATER SCI-MATER M, V3, P222, DOI 10.1007/BF00713454
   PAPACHARALAMBOUS SK, 1993, INT J ORAL MAX SURG, V22, P260, DOI 10.1016/S0901-5027(05)80511-9
   Patat J L, 1992, Acta Orthop Belg, V58 Suppl 1, P115
   PATAT JL, 1989, ANN CHIR PLAST ESTH, V34, P221
   PATEL A, 1980, CHIRURGIE, V106, P199
   Petite H, 1996, J MATER SCI-MATER M, V7, P665, DOI 10.1007/BF00123405
   Piattelli A, 1997, BIOMATERIALS, V18, P623, DOI 10.1016/S0142-9612(96)00158-5
   POULIQUEN JC, 1989, REV CHIR ORTHOP, V75, P360
   POULIQUEN JC, 1990, ANN PEDIATR-PARIS, V37, P59
   RAE T, 1986, CRIT REV BIOCOMPAT, V2, P97
   Reis SA, 1996, CLIN ORAL IMPLAN RES, V7, P253, DOI 10.1034/j.1600-0501.1996.070307.x
   Richard M, 1998, CALCIFIED TISSUE INT, V62, P437, DOI 10.1007/s002239900456
   Robier A, 1987, Ann Otolaryngol Chir Cervicofac, V104, P303
   ROUDIER M, 1995, J BIOMED MATER RES, V29, P909, DOI 10.1002/jbm.820290802
   Roux F X, 1996, Ann Otolaryngol Chir Cervicofac, V113, P29
   ROUX FX, 1995, ACTA NEUROCHIR, V133, P201, DOI 10.1007/BF01420075
   ROUX FX, 1988, J NEUROSURG, V69, P510, DOI 10.3171/jns.1988.69.4.0510
   ROY DM, 1974, NATURE, V247, P220, DOI 10.1038/247220a0
   Santanche P, 1997, PLAST RECONSTR SURG, V99, P266, DOI 10.1097/00006534-199701000-00058
   SAUTIER JM, 1990, IN VITRO CELL DEV B, V26, P1079
   SAUTIER JM, 1992, BIOMATERIALS, V13, P400, DOI 10.1016/0142-9612(92)90046-Q
   Sciadini MF, 1997, J ORTHOPAED RES, V15, P844, DOI 10.1002/jor.1100150609
   SERVERA C, 1987, REV STOMATOL CHIR, V88, P326
   Shahgaldi BF, 1998, BIOMATERIALS, V19, P205, DOI 10.1016/S0142-9612(98)80002-1
   SHANBHAG A, 1992, J BIOMED MATER RES, V26, P185, DOI 10.1002/jbm.820260205
   SHANBHAG AS, 1995, J ORTHOPAED RES, V13, P792, DOI 10.1002/jor.1100130520
   Shors EC, 1999, ORTHOP CLIN N AM, V30, P599, DOI 10.1016/S0030-5898(05)70113-9
   SOUYRIS F, 1985, J MAXILLOFAC SURG, V13, P64, DOI 10.1016/S0301-0503(85)80018-7
   Tho K. S., 1996, Annals Academy of Medicine Singapore, V25, P824
   Turunen T, 1997, CLIN ORAL IMPLAN RES, V8, P96, DOI 10.1034/j.1600-0501.1997.080204.x
   Volpi N, 1999, BIOMATERIALS, V20, P1359, DOI 10.1016/S0142-9612(99)00031-9
   Vuola J, 1996, BIOMATERIALS, V17, P1761, DOI 10.1016/0142-9612(95)00351-7
   Vuola J, 1998, BIOMATERIALS, V19, P223, DOI 10.1016/S0142-9612(97)00211-1
   Vuola J, 2000, J BIOMED MATER RES, V51, P117, DOI 10.1002/(SICI)1097-4636(200007)51:1<117::AID-JBM15>3.0.CO;2-9
   WEBER JN, 1973, MINER SCI ENGNG, V5, P151
   WHITE RA, 1972, SCIENCE, V176, P922, DOI 10.1126/science.176.4037.922
   Wikesjo UME, 1998, J CLIN PERIODONTOL, V25, P475, DOI 10.1111/j.1600-051X.1998.tb02476.x
   Yamashiro H, 2000, DIS AQUAT ORGAN, V41, P211, DOI 10.3354/dao041211
   Yukna RA, 1998, J CLIN PERIODONTOL, V25, P1036, DOI 10.1111/j.1600-051X.1998.tb02410.x
   ZAFFE D, 1995, MAT CLIN APPL, P431
   ZANER DJ, 1984, J PERIODONTOL, V55, P406, DOI 10.1902/jop.1984.55.7.406
   Zellin G, 1998, BONE, V22, P613, DOI 10.1016/S8756-3282(98)00059-3
   ZENG R, 1997, CHUNG HUA KOU CHIANG, V32, P16
   ZENG RS, 1991, CHUNG HUA KOU CHIANG, V26, P389
NR 122
TC 81
Z9 90
U1 1
U2 17
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0959-2989
J9 BIO-MED MATER ENG
JI Bio-Med. Mater. Eng.
PY 2002
VL 12
IS 1
BP 15
EP 35
PG 21
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 521XL
UT WOS:000173866600003
PM 11847406
DA 2018-10-20
ER

PT J
AU Assad, M
   Chernyshov, A
   Leroux, MA
   Rivard, CH
AF Assad, M
   Chernyshov, A
   Leroux, MA
   Rivard, CH
TI A new porous titanium-nickel alloy: Part 2. Sensitization, irritation
   and acute systemic toxicity evaluation
SO BIO-MEDICAL MATERIALS AND ENGINEERING
LA English
DT Article
DE porous; titanium-nickel; biocompatibility; sensitization testing;
   irritation testing
ID SHAPE-MEMORY ALLOY; IN-VITRO; ORTHODONTIC APPLIANCES;
   CORROSION-RESISTANCE; METAL-IONS; TI-NI; BEHAVIOR; BIOCOMPATIBILITY;
   BIODEGRADATION; MONOCYTES
AB Porous titanium-nickel (PTN) represents a new biomaterial with orthopedic applications as a long-term implant. Because of its nickel content, PTN was tested for its potential to stimulate sensitization, irritation, and systemic toxicity reactions after semi-physiological extraction. In order to do so, an in vivo biocompatibility evaluation was performed following three ISO-standardized methods using accepted animal models for immunity testing: the classical skin sensitization assay (Buehler patch test) in guinea pigs, the rabbit intracutaneous test, and the systemic injection test in mice. The Buehler patch test in guinea pigs revealed no significant change in skin-reactions such as erythema or swelling between the induction and the challenge period. In the rabbit intracutaneous irritation test, no irritation or sensitization reactions were observed in saline-extracted PTN samples. Negligible to slight irritation was observed at some of the sites involving PTN samples extracted in cottonseed oil, however the resulting primary irritation index was similar to the one elicited by the blank solution itself. Finally, no toxic symptoms were observed-with any of the mice injected with porous titanium-nickel extracts during the acute systemic toxicity test. Based on the above results, porous titanium-nickel is considered to be a non-sensitizing, non-irritant, and non-toxic biomaterial for medical applications.
C1 Biorthex Inc, R&D, Biomat Dept, Montreal, PQ H4N 3H5, Canada.
   Natl Res Council Canada, IMI, Boucherville, PQ J4B 6Y4, Canada.
   Hop St Justine, Ctr Rech Pediat, Montreal, PQ H3T 1C5, Canada.
RP Assad, M (reprint author), Biorthex Inc, R&D, Biomat Dept, 9001 Blvd Lacadie,Suite 802, Montreal, PQ H4N 3H5, Canada.
EM massad@biorthex.com
OI Assad, Michel/0000-0001-8734-0267
CR Al-Waheidi E M, 1995, Quintessence Int, V26, P385
   Assad M, 1999, BIO-MED MATER ENG, V9, P1
   ASSAD M, 2002, IN PRESS BIOMED MAT, V12
   Barber FA, 1996, ARTHROSCOPY, V12, P32, DOI 10.1016/S0749-8063(96)90216-9
   Barras CDJ, 2000, EUR J VASC ENDOVASC, V19, P564, DOI 10.1053/ejvs.2000.1111
   BARRETT RD, 1993, AM J ORTHOD DENTOFAC, V103, P8, DOI 10.1016/0889-5406(93)70098-9
   BASS JK, 1993, AM J ORTHOD DENTOFAC, V103, P280, DOI 10.1016/0889-5406(93)70009-D
   BISHARA SE, 1993, AM J ORTHOD DENTOFAC, V103, P115, DOI 10.1016/S0889-5406(05)81760-3
   BOUR H, 1994, CLIN IMMUNOL IMMUNOP, V73, P142, DOI 10.1006/clin.1994.1180
   de Silva BD, 2000, CONTACT DERMATITIS, V42, P102
   DUNLAP CL, 1989, J AM DENT ASSOC, V118, P449, DOI 10.14219/jada.archive.1989.0174
   Gil FJ, 1998, BIO-MED MATER ENG, V8, P335
   GUNTHER VE, 1999, Patent No. 5986169
   Gunther VE, 2000, DELAY LAW NEW CLASS
   *INT LAB OFF, 1993, 1993 WORLD LAB REP, P1
   ITIN VI, 1994, MATER CHARACT, V32, P179, DOI 10.1016/1044-5803(94)90087-6
   Jia WY, 1999, J BIOMED MATER RES, V48, P488, DOI 10.1002/(SICI)1097-4636(1999)48:4<488::AID-JBM14>3.3.CO;2-4
   MAYOR MB, 1980, AM J SURG, V139, P477, DOI 10.1016/0002-9610(80)90323-2
   MERRITT K, 1981, SYSTEMIC ASPECTS BIO, V2, P33
   PAPANASTASOULIS GS, 2000, P 2 INT S ADV BIOM M, P78
   Rhalmi S, 1999, BIO-MED MATER ENG, V9, P151
   Rondelli G, 1996, BIOMATERIALS, V17, P2003, DOI 10.1016/0142-9612(95)00352-5
   Ryhanen J, 1997, J BIOMED MATER RES, V35, P451
   RYHANEN J, 1999, THESIS U OULU FINLAN, P39
   Savarino L, 1999, J BIOMED MATER RES, V47, P543, DOI 10.1002/(SICI)1097-4636(19991215)47:4<543::AID-JBM11>3.0.CO;2-G
   SIMON M, 1977, RADIOLOGY, V125, P89, DOI 10.1148/125.1.89
   SPECK KM, 1980, J DENT RES, V59, P1590, DOI 10.1177/00220345800590100601
   Thierry B, 2000, J BIOMED MATER RES, V51, P685, DOI 10.1002/1097-4636(20000915)51:4<685::AID-JBM17>3.0.CO;2-S
   Trepanier C, 1998, J BIOMED MATER RES, V43, P433, DOI 10.1002/(SICI)1097-4636(199824)43:4<433::AID-JBM11>3.0.CO;2-#
   Trepanier C, 1999, J BIOMED MATER RES, V48, P165, DOI 10.1002/(SICI)1097-4636(1999)48:2<165::AID-JBM11>3.0.CO;2-#
   *US PHARM, 2000, BIOL REACT TEST LESS, P1832
   Wataha JC, 1996, DENT MATER, V12, P322, DOI 10.1016/S0109-5641(96)80041-8
   Wataha JC, 1999, J BIOMED MATER RES, V45, P251, DOI 10.1002/(SICI)1097-4636(19990605)45:3<251::AID-JBM13>3.0.CO;2-5
   Watarai M, 1999, BIO-MED MATER ENG, V9, P73
   Wever DJ, 1998, BIOMATERIALS, V19, P761, DOI 10.1016/S0142-9612(97)00210-X
   Wever DJ, 1997, BIOMATERIALS, V18, P1115, DOI 10.1016/S0142-9612(97)00041-0
   WEVER DJ, 2000, SHAPE MEMORY IMPLANT, P129
NR 37
TC 19
Z9 19
U1 0
U2 7
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0959-2989
EI 1878-3619
J9 BIO-MED MATER ENG
JI Bio-Med. Mater. Eng.
PY 2002
VL 12
IS 4
BP 339
EP 346
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 642PC
UT WOS:000180811900002
PM 12652028
DA 2018-10-20
ER

PT S
AU Kim, SR
   Riu, DH
   Lee, YJ
   Kim, YH
AF Kim, SR
   Riu, DH
   Lee, YJ
   Kim, YH
BE Brown, S
   Clarke, I
   Williams, P
TI Synthesis and characterization of silicon substituted hydroxyapatite
SO BIOCERAMICS 14
SE Key Engineering Materials
LA English
DT Article; Proceedings Paper
CT 14th International Symposium on Ceramics in Medicine (BIOCERAMICS-14)
CY NOV 14-17, 2001
CL PALM SPRINGS, CA
SP Int Soc Ceram Med
AB A silicon-substituted hydroxyapatite has been prepared using tetraethylorthosilicate as a silicon source to obtain a biomaterial having an improved biocompatibility. From the XRD analysis, it was confirmed that the single-phase hydroxyapatite containing silicon has formed without revealing the presence of extra phases related to silicon oxide or other calcium phosphate species. Silicon content was up to 3.32% by weight. (29)Si MAS NMR investigation elucidated the presence of tetrahedral silicate in the framework of hydroxyapatite structure. Substitution of silicon into the hydroxyapatite framework (Ca(10)(PO(4))(6-x)(SiO(4))(x)(OH)(2-x)) reduced the amount of hydroxyl group to compensate for the extra negative charge of the silicate group, which is confirmed by FT-IR.
C1 Korea Inst Ceram Engn & Technol, Seoul, South Korea.
RP Kim, SR (reprint author), Korea Inst Ceram Engn & Technol, Seoul, South Korea.
EM yhkokim@kicet.re.kr
CR CARLISLE EM, 1970, SCIENCE, V167, P179
   Gibson IR, 1999, J BIOMED MATER RES, V44, P422, DOI 10.1002/(SICI)1097-4636(19990315)44:4<422::AID-JBM8>3.0.CO;2-#
   Layrolle P, 1998, J AM CERAM SOC, V81, P1421
   Marques PAAP, 2000, KEY ENG MAT, V192-1, P247
   Wakamura M, 2000, COLLOID SURFACE A, V164, P297, DOI 10.1016/S0927-7757(99)00384-2
NR 5
TC 22
Z9 23
U1 0
U2 7
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1013-9826
BN 0-87849-889-3
J9 KEY ENG MATER
PY 2002
VL 218-2
BP 85
EP 88
DI 10.4028/www.scientific.net/KEM.218-220.85
PG 4
WC Materials Science, Ceramics; Materials Science, Composites
SC Materials Science
GA BU17P
UT WOS:000175229300018
DA 2018-10-20
ER

PT S
AU de Campos, M
   Bressiani, AH
AF de Campos, M
   Bressiani, AH
BE Brown, S
   Clarke, I
   Williams, P
TI Comparative study of the synthesis and processing of hydroxyapatite
SO BIOCERAMICS 14
SE Key Engineering Materials
LA English
DT Article; Proceedings Paper
CT 14th International Symposium on Ceramics in Medicine (BIOCERAMICS-14)
CY NOV 14-17, 2001
CL PALM SPRINGS, CA
SP Int Soc Ceram Med
DE hydroxyapatite; synthesis; processing; and plasma spraying
AB The HAp is a biomaterial applied as dense, porous or coating bioceramics, in the medical and odontological areas. The aim of this work was obtain hydroxyapatite with characteristics that allow its application as dense or porous bodies, and coating studying three methods of syntheses: precipitation, neutralization and sol-gel in alcoholic media. Precipitation and neutralization showed the best results for thermal spraying stability, being thereafter reproduced in a pilot scale, in an open and closed system. Nitrogen atmosphere was used to avoid the formation of hydroxyapatite carbonate. The powders obtained by neutralization were used for coating titanium alloy substrate. Plasma spraying technique was used for deposition. On coating layer HAp was the main phase detected, showing a good adherence to the substrate. Porous ceramic bodies were obtained by gel casting foam with the HAp from the neutralization method in an inert atmosphere. The main techniques used on the characterization of powder, metallic substrates, coatings, porous and dense ceramic bodies were: particle size distribution (D), scanning electron microscopy (SEM) and X-ray diffractometry (XRD). The HAp phase was detected as the majority in all conditions and results are no cytotoxicity.
C1 Univ Mogi Das Cruzes, Technol Res Ctr, BR-08780911 Mogi Das Cruzes, SP, Brazil.
   IPEN CNEN SP, DMC, Dept Mat Engn, BR-05508900 Sao Paulo, Brazil.
RP de Campos, M (reprint author), Univ Mogi Das Cruzes, Technol Res Ctr, Av Dr Candido Xavier De Almeida Souza 200, BR-08780911 Mogi Das Cruzes, SP, Brazil.
EM magali@umc.br
RI Bressiani, Ana/I-1402-2012
CR Ravaglioli A., 1992, BIOCERAMICS MAT PROP
   Sepulveda P, 2000, J AM CERAM SOC, V83, P3021, DOI 10.1111/j.1151-2916.2000.tb01677.x
   Valente MDC, 2001, KEY ENG MAT, V189-1, P623
NR 3
TC 3
Z9 3
U1 0
U2 0
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1013-9826
BN 0-87849-889-3
J9 KEY ENG MATER
PY 2002
VL 218-2
BP 171
EP 174
DI 10.4028/www.scientific.net/KEM.218-220.171
PG 4
WC Materials Science, Ceramics; Materials Science, Composites
SC Materials Science
GA BU17P
UT WOS:000175229300037
DA 2018-10-20
ER

PT S
AU Mendes, SC
   Sleijster, M
   van den Muysenberg, A
   van Blitterswijk, CA
   de Bruijn, JD
AF Mendes, SC
   Sleijster, M
   van den Muysenberg, A
   van Blitterswijk, CA
   de Bruijn, JD
BE Brown, S
   Clarke, I
   Williams, P
TI Cultured living bone equivalents enhance bone formation when compared to
   a cell seeding approach
SO BIOCERAMICS 14
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 14th International Symposium on Ceramics in Medicine (BIOCERAMICS-14)
CY NOV 14-17, 2001
CL PALM SPRINGS, CALIFORNIA
SP Int Soc Ceram Med
DE tissue engineering; bone; calcium phosphates; bone marrow stromal cells;
   osteogenesis
ID HUMAN MARROW-CELLS; POROUS CERAMICS; IN-VIVO
AB At present, two different approaches use patient own cultured osteogenic cells in combination with a scaffold material to engineer autologous osteoinductive grafts. One of the approaches consists of seeding cells on a suitable biomaterial, after which the construct is ready for implantation. In another approach, the seeded cells are further cultured on the scaffold to obtain in vitro formed bone, prior to implantation. We investigated the in vivo osteogenic potential of both methods through the implantation of porous HA scaffolds coated with a layer of in vitro formed bone and porous HA scaffolds seeded with osteogenic cells. As early as 2 days after implantation, bone was formed on scaffolds in which a bone-like tissue was cultured, while it was only detected on the cell seeded implants from 4 days onwards. After 4 days of implantation there was a significantly higher amount of bone in the bone-like tissue containing scaffolds as compared to cell-seeded ones.
C1 IsoTis BV, NL-3723 MB Bilthoven, Netherlands.
   Univ Twente, IBME, Enschede, Netherlands.
RP Mendes, SC (reprint author), IsoTis BV, Prof Bronkhorstlaan 10, NL-3723 MB Bilthoven, Netherlands.
OI van Blitterswijk, Clemens/0000-0003-2371-4615
CR Bruder SP, 1998, J ORTHOPAED RES, V16, P155, DOI 10.1002/jor.1100160202
   de Bruijn J D, 1999, Adv Dent Res, V13, P74
   Kuznetsov SA, 1997, J BONE MINER RES, V12, P1335, DOI 10.1359/jbmr.1997.12.9.1335
   MENDES SC, UNPUB TISSIE ENG
   OHGUSHI H, 1990, J BIOMED MATER RES, V24, P1563, DOI 10.1002/jbm.820241202
   OHGUSHI H, 1990, ACTA ORTHOP SCAND, V61, P431, DOI 10.3109/17453679008993556
   Yoshikawa T, 2000, TRANSPLANTATION, V69, P128, DOI 10.1097/00007890-200001150-00022
   Yoshikawa T, 1998, BIO-MED MATER ENG, V8, P311
NR 8
TC 0
Z9 0
U1 0
U2 1
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-889-3
J9 KEY ENG MAT
PY 2002
VL 218-2
BP 227
EP 231
DI 10.4028/www.scientific.net/KEM.218-220.227
PG 5
WC Materials Science, Ceramics; Materials Science, Composites
SC Materials Science
GA BU17P
UT WOS:000175229300051
DA 2018-10-20
ER

PT S
AU Vandenbulcke, L
   De Barros, MI
   Met, C
   Farges, G
AF Vandenbulcke, L
   De Barros, MI
   Met, C
   Farges, G
BE Brown, S
   Clarke, I
   Williams, P
TI Nano-smooth diamond surfaces of duplex coatings on titanium alloy for
   low friction and low wear of biomaterial counterfaces
SO BIOCERAMICS 14
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 14th International Symposium on Ceramics in Medicine (BIOCERAMICS-14)
CY NOV 14-17, 2001
CL PALM SPRINGS, CALIFORNIA
SP Int Soc Ceram Med
ID COATED TI-6AL-4V ALLOY; DEPOSITION
C1 CNRS, Lab Combust & Syst Reactifs, F-45071 Orleans 2, France.
   DGA, CTA, F-94114 Arcueil, France.
RP Vandenbulcke, L (reprint author), CNRS, Lab Combust & Syst Reactifs, F-45071 Orleans 2, France.
CR De Barros MI, 2000, DIAM RELAT MATER, V9, P1862, DOI 10.1016/S0925-9635(00)00335-6
   De Barros MI, 2000, SURF COAT TECH, V127, P193, DOI 10.1016/S0257-8972(00)00668-X
   De Barros MI, 1999, DIAM RELAT MATER, V8, P1022, DOI 10.1016/S0925-9635(98)00439-7
   De Barros MI, 2001, DIAM RELAT MATER, V10, P337, DOI 10.1016/S0925-9635(00)00433-7
   De Barros MI, 2001, WEAR, V249, P68
   DEBARROS MI, 2001, SURF COATINGS TECHNO
   DJEMIA P, 2001, J APPL PHYS, V90, pR30
   DJEMIA P, 2001, SURF COATING TECHNOL
NR 8
TC 1
Z9 1
U1 1
U2 3
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-889-3
J9 KEY ENG MAT
PY 2002
VL 218-2
BP 595
EP 600
DI 10.4028/www.scientific.net/KEM.218-220.595
PG 6
WC Materials Science, Ceramics; Materials Science, Composites
SC Materials Science
GA BU17P
UT WOS:000175229300139
DA 2018-10-20
ER

PT S
AU Matsunaga, T
   Okamura, Y
AF Matsunaga, T
   Okamura, Y
BE Aizenberg, J
   McKittrick, JM
   Orme, CA
TI Molecular mechanism of bacterial magnetite formation and its application
SO BIOLOGICAL BIOMIMETIC MATERIALS-PROPERTIES TO FUNCTION
SE Materials Research Society Symposium Proceedings
LA English
DT Proceedings Paper
CT Symposium on Biological and Biomimetic Materials - Properties to
   Function held at the 2002 MRS Spring Meeting
CY APR 01-05, 2002
CL SAN FRANCISCO, CA
SP Mat Res Soc
ID SP STRAIN AMB-1; MAGNETOTACTIC BACTERIA; PARTICLES; IMMUNOASSAY;
   PROTEIN; MAGNETOSOME; GENE; BIOMINERALIZATION; MICROBIOLOGY; SEDIMENTS
AB Nano-technology has been identified as an area which will bring about new evolutions in materials, devices and processes. ne challenges of nano-biotechnology entail manufacturing more sophisticated and highly efficient biosensors and biomaterials at the nano-scale level for use in interdisciplinary fields. Here, we introduce a biomaterial produced by magnetic bacteria, bacterial magnetic particles (BMPs), and the molecular architecture technique we have used for its application.
   Magnetic bacteria synthesize intracellular magnets which are encapsulated by lipid bilayer membranes. Sizes of BMPs vary from 50 - 100 nm in diameter, and number over 10 per cell. BMPs are composed of magnetite (Fe3O4) with a single magnetic domain. Easy aqueous dispersion of BMPs enable development of highly sensitive chemiluminescence enzyme immunoassays by the chemical coupling of antibodies on BMP surfaces. BMPs can likewise be used as drug delivery systems employing magnetoliposomes with high capture volumes. We previously reported a technique for preparing recombinant BMPs on which proteins were displayed by gene-fusion. We furthermore applied such recombinant BMPs to biotechnologically-important issues, including novel bioassay platforms for medicine and environmental management. We envisage the production of more refined chemicals and agents through expression on BMPs by gene-fusion followed by simple purification using magnet.
C1 Tokyo Univ Agr & Technol, Dept Biotechnol, Tokyo 1848588, Japan.
RP Matsunaga, T (reprint author), Tokyo Univ Agr & Technol, Dept Biotechnol, Naka Cho, Tokyo 1848588, Japan.
CR BALKWILL DL, 1980, J BACTERIOL, V141, P1399
   BAZYLINSKI DA, 1995, ASM NEWS, V61, P337
   BLAKEMORE R, 1975, SCIENCE, V190, P377, DOI 10.1126/science.170679
   BLAKEMORE RP, 1982, ANNU REV MICROBIOL, V36, P217, DOI 10.1146/annurev.mi.36.100182.001245
   BLAKEMORE RP, 1991, IRON BIOMINERALS, P51
   BLAKEMORE RP, 1989, BERGEYS MANUAL SYSTE, V3, P1882
   ESOUIVEL DMS, 1986, J EXP BIOL, V121, P153
   FASSBINDER JWE, 1990, NATURE, V343, P161, DOI 10.1038/343161a0
   GORBY YA, 1988, J BACTERIOL, V170, P834, DOI 10.1128/jb.170.2.834-841.1988
   MANN S, 1990, ADV MICROB PHYSIOL, V31, P125
   MATSUNAGA T, 1987, APPL MICROBIOL BIOT, V26, P328
   Matsunaga T, 1999, J MAGN MAGN MATER, V194, P126, DOI 10.1016/S0304-8853(98)00575-7
   MATSUNAGA T, 1990, IEEE T MAGN, V26, P1557, DOI 10.1109/20.104444
   MATSUNAGA T, 1992, J BACTERIOL, V174, P2748
   MATSUNAGA T, 1991, APPL MICROBIOL BIOT, V35, P651
   Matsunaga T, 2000, BIOCHEM BIOPH RES CO, V268, P932, DOI 10.1006/bbrc.2000.2236
   MATSUNAGA T, 1993, P 3 IUMRS INT C ADV, P449
   NAKAMURA C, 1995, J BIOCHEM-TOKYO, V118, P23, DOI 10.1093/oxfordjournals.jbchem.a124884
   NAKAMURA C, 1995, J BIOL CHEM, V270, P28392
   NAKAMURA N, 1993, ANAL CHEM, V65, P2036, DOI 10.1021/ac00063a018
   NAKAMURA N, 1993, ANAL CHIM ACTA, V281, P585, DOI 10.1016/0003-2670(93)85018-F
   NAKAMURA N, 1991, ANAL CHEM, V63, P268, DOI 10.1021/ac00003a015
   OBERHACK M, 1987, Z NATURFORSCH C, V42, P300
   Okamura Y, 2001, J BIOL CHEM, V276, P48183, DOI 10.1074/jbc.M106408200
   Okamura Y, 2000, APPL BIOCHEM BIOTECH, V84-6, P441, DOI 10.1385/ABAB:84-86:1-9:441
   SAKAGUCHI T, 1993, NATURE, V365, P47, DOI 10.1038/365047a0
   Schuler D, 1999, APPL MICROBIOL BIOT, V52, P464, DOI 10.1007/s002530051547
   SCHULER D, 1997, TRANSITION METALS MI
   SODE K, 1993, BIOTECHNOL TECH, V7, P688, DOI 10.1007/BF00151871
   SPARKS NHC, 1986, FEMS MICROBIOL LETT, V37, P305, DOI 10.1016/0378-1097(86)90424-6
   STOLZ JF, 1993, J GEN MICROBIOL, V139, P1663, DOI 10.1099/00221287-139-8-1663
   STOLZ JF, 1986, NATURE, V321, P849, DOI 10.1038/321849a0
   TAKEYAMA H, 1995, BIOTECHNOL TECH, V9, P355, DOI 10.1007/BF00638870
   Tanaka T, 2000, ANAL CHEM, V72, P3518, DOI 10.1021/ac9912505
   Tanaka T, 2001, BIOSENS BIOELECTRON, V16, P1089, DOI 10.1016/S0956-5663(01)00187-7
   THORNHILL RH, 1994, FEMS MICROBIOL LETT, V115, P169
   Yang CD, 2001, ENZYME MICROB TECH, V29, P13, DOI 10.1016/S0141-0229(01)00343-X
NR 37
TC 1
Z9 1
U1 0
U2 6
PU MATERIALS RESEARCH SOC
PI WARRENDALE
PA 506 KEYSTONE DRIVE, WARRENDALE, PA 15088-7563 USA
SN 0272-9172
BN 1-55899-660-5
J9 MATER RES SOC SYMP P
PY 2002
VL 724
BP 11
EP 24
DI 10.1017/CBO9780511606397.003
PG 14
WC Materials Science, Biomaterials; Materials Science, Characterization &
   Testing; Materials Science, Composites; Polymer Science
SC Materials Science; Polymer Science
GA BV76S
UT WOS:000179970700002
DA 2018-10-20
ER

PT J
AU Tanaka, M
   Mochizuki, A
   Ishii, N
   Motomura, T
   Hatakeyama, T
AF Tanaka, M
   Mochizuki, A
   Ishii, N
   Motomura, T
   Hatakeyama, T
TI Study of blood compatibility with poly(2-methoxyethyl acrylate).
   Relationship between water structure and platelet compatibility in
   poly(2-methoxyethylacrylate-co-2-hydroxyethylmethacrylate)
SO BIOMACROMOLECULES
LA English
DT Article
ID SELF-ASSEMBLED MONOLAYERS; DIFFERENTIAL SCANNING CALORIMETRY; PROTEIN
   ADSORPTION; MOLECULAR-CONFORMATION; METHACRYLATE HYDROGELS; SURFACES;
   ADHESION; POLYMER; RESISTANCE; BIOMATERIAL
AB Previously, we reported that poly(2-methoxyethylacrylate) (PMEA) showed excellent blood compatibility and implied that the water structure in PMEA contributed to the blood compatibility. In this study, the relationship between the water structure and the blood compatibility is clarified by studying the influence of the monomer composition of poly(MEA-co-HEMA) on the water structure and the blood compatibility of the copolymers. The water in the polymer was classified into three types: free water, freezing bound water, and nonfreezing water. The polymers with 0-30 mol % of HEMA content had a significant amount of freezing bound water, and the amount decreases greatly when the composition of HEMA exceeded 30 mol %. On the other hand. the amount of other water increased simply with an increase of HEMA content. The evaluation of the platelet compatibility of poly(MEA-co-HEMA) revealed that the adhesion number and the morphological change of platelet on the copolymer surface were least when the HEMA content was 0-20 mol %. These two results strongly suggest that the freezing bound water relates to the platelet compatibility of the polymers.
C1 Terumo Co Ltd, Ctr Res & Dev, Nakai, Kanagawa 2590151, Japan.
   Otsuma Womens Univ, Chiyoda Ku, Tokyo 1028357, Japan.
RP Tanaka, M (reprint author), Hokkaido Univ, Res Inst Elect Sci, Mol Device Lab, Kita Ku, N12W6, Sapporo, Hokkaido 0600812, Japan.
OI Tanaka, Masaru/0000-0002-1115-2080; Mochizuki, Akira/0000-0001-8104-7764
CR AIZAWA M, 1971, B CHEM SOC JPN, V44, P2967, DOI 10.1246/bcsj.44.2967
   ANDRADE JD, 1973, T AM SOC ART INT ORG, V19, P1
   Anzai T., 2000, JPN J ARTIF ORGANS, V29, P73
   CORKHILL PH, 1987, POLYMER, V28, P1758, DOI 10.1016/0032-3861(87)90021-8
   DEQUEIROZ AAA, 1997, THEOCHEM-J MOL STRUC, V394, P271
   Feldman K, 1999, J AM CHEM SOC, V121, P10134, DOI 10.1021/ja991049b
   GRAHAM NB, 1989, POLYMER, V30, P528, DOI 10.1016/0032-3861(89)90026-8
   Harder P, 1998, J PHYS CHEM B, V102, P426, DOI 10.1021/jp972635z
   Harris J.M., 1992, POLYETHYLENE GLYCOL
   HATAKEYAMA H, 1995, THERMOCHIM ACTA, V308, P3
   HAZLEWOO.CF, 1969, NATURE, V222, P747, DOI 10.1038/222747a0
   Horbett Thomas A., 1996, P133
   Ishihara K, 1998, J BIOMED MATER RES, V39, P323, DOI 10.1002/(SICI)1097-4636(199802)39:2<323::AID-JBM21>3.0.CO;2-C
   Israelachvili J, 1996, NATURE, V379, P219, DOI 10.1038/379219a0
   Iwasaki Y, 1996, J BIOMAT SCI-POLYM E, V8, P91, DOI 10.1163/156856296X00174
   Iwasaki Y, 2000, J BIOMED MATER RES, V52, P701, DOI 10.1002/1097-4636(20001215)52:4<701::AID-JBM15>3.3.CO;2-Y
   JHON MS, 1973, J BIOMED MATER RES, V7, P509, DOI 10.1002/jbm.820070604
   Kataoka K, 1998, J BIOMAT SCI-POLYM E, V9, P111, DOI 10.1163/156856298X00460
   KIKUCHI A, 1993, J COLLOID INTERF SCI, V158, P10, DOI 10.1006/jcis.1993.1222
   Kulik E, 1996, J BIOMED MATER RES, V30, P295, DOI 10.1002/(SICI)1097-4636(199603)30:3<295::AID-JBM4>3.0.CO;2-L
   LING GN, 1983, PHYSIOL CHEM PHYS M, V15, P407
   Morra M, 2000, J BIOMAT SCI-POLYM E, V11, P547, DOI 10.1163/156856200743869
   NAGAOKA S, 1987, ASAIO, V10, P76
   Nishinari K, 1997, COLLOID POLYM SCI, V275, P1078, DOI 10.1007/s003960050186
   OKANO T, 1981, J BIOMED MATER RES, V15, P393, DOI 10.1002/jbm.820150310
   PEPPAS NA, 1987, HYDROGEL MED PHARM, V2
   Ratner B. D., 1976, ACS SYM SER, V31, P1, DOI [DOI 10.1021/SYMPOSIUM, 10.1021/bk-1976-0031.ch001]
   RATNER BD, 1975, J BIOMED MATER RES, V9, P407, DOI 10.1002/jbm.820090505
   RATTO J, 1995, POLYMER, V36, P2915, DOI 10.1016/0032-3861(95)94340-Y
   ROWLAND SP, 1980, ACS S SERIES, V127
   Saito N, 2000, ARTIF ORGANS, V24, P547, DOI 10.1046/j.1525-1594.2000.06520.x
   Suhara H, 2001, ANN THORAC SURG, V71, P1603, DOI 10.1016/S0003-4975(01)02466-3
   Tanaka M, 2000, POLYM INT, V49, P1709, DOI 10.1002/1097-0126(200012)49:12<1709::AID-PI601>3.0.CO;2-L
   Tanaka M, 2000, BIOMATERIALS, V21, P1471, DOI 10.1016/S0142-9612(00)00031-4
   Tanaka M, 2001, COLLOID SURFACE A, V193, P145, DOI 10.1016/S0927-7757(01)00682-3
   TANAKA M, IN PRESS COLLOIDS A
   TANAKA M, 2000, JPN J ARTIF ORGANS, V9, P209
   TANAKA M, IN PRESS RECENT ADV
   TANZAWA H, 1986, JPN J ARTIF ORGANS, V15, P16
   Tsuruta T, 1996, ADV POLYM SCI, V126, P1
   UEDA T, 1992, POLYM J, V24, P1259, DOI 10.1295/polymj.24.1259
   UEDAIRA H, 1980, WATER METAL CATIONS, P47
   Vogler EA, 1998, ADV COLLOID INTERFAC, V74, P69, DOI 10.1016/S0001-8686(97)00040-7
   Vogler EA, 1999, J BIOMAT SCI-POLYM E, V10, P1015, DOI 10.1163/156856299X00667
   Wang RLC, 1997, J PHYS CHEM B, V101, P9767, DOI 10.1021/jp9716952
   Wolfgang G. G., 1992, ACS S SERIES, V489
   YAMADANOSAKA A, 1990, J APPL POLYM SCI, V39, P2443, DOI 10.1002/app.1990.070391117
   YAMADANOSAKA A, 1991, J APPL POLYM SCI, V43, P1165, DOI 10.1002/app.1991.070430617
   YUI N, 1986, J BIOMED MATER RES, V20, P929, DOI 10.1002/jbm.820200708
NR 49
TC 165
Z9 170
U1 5
U2 60
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD JAN-FEB
PY 2002
VL 3
IS 1
BP 36
EP 41
DI 10.1021/bm010072y
PG 6
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 528RJ
UT WOS:000174256500006
PM 11866553
DA 2018-10-20
ER

PT J
AU Rapoport, HS
   Shadwick, RE
AF Rapoport, HS
   Shadwick, RE
TI Mechanical characterization of an unusual elastic biomaterial from the
   egg capsules of marine snails (Busycon spp.)
SO BIOMACROMOLECULES
LA English
DT Article
ID ENCAPSULATION; MURICIDAE; GASTROPOD; MOLLUSKS; ENERGY
AB Egg capsule material serves as a putative protection mechanism for developing snail embryos facing the perils of the marine environment. We conducted the first quantitative study of this acellular structural protein with the goals of characterizing its chemical and mechanical properties and the relationship of these properties to its biological protective function. We have found that this protein polymer exhibits long-range elasticity with an interesting recoverable yield evidenced by an order of magnitude decrease in elastic modulus (apparent failure) that begins at 3%-5% strain. This material differs significantly from other common structural proteins such as collagen and elastin in mechanical response to strain. Qualitative similarities in stress/strain behavior to keratin, another common structural protein, are more than coincidental when composition and detailed mechanical quantification are considered. This suggests the possibility of a-helical structure and matrix organization that might be similar in these two proteins. Indeed, the egg capsule protein may be closely related to vertebrate keratins such as intermediate filaments. We conclude that while this material's bimodal tensile properties may serve as useful protection against the impact loading egg capsules encounter in the intertidal zone, the full biological importance of these capsules is not known.
C1 Univ Calif San Diego, Scripps Inst Oceanog, Div Marine Biol Res, La Jolla, CA 92093 USA.
RP Rapoport, HS (reprint author), Univ Calif San Diego, Scripps Inst Oceanog, Div Marine Biol Res, La Jolla, CA 92093 USA.
CR CASTILLA JC, 1976, MAR BIOL, V37, P255, DOI 10.1007/BF00387611
   COWAN PM, 1955, S SOC EXP BIOL, V9
   CUNNINGHAM JT, 1899, NATURE, V59, P557
   DASARO CN, 1993, OPHELIA, V38, P149, DOI 10.1080/00785326.1993.10429896
   DASARO CN, 1991, OPHELIA, V35, P1
   DASARO CN, 1993, OPHELIA, V46, P83
   Denny M. W., 1988, BIOL MECH WAVE SWEPT
   Dougherty DA, 1996, SCIENCE, V271, P163, DOI 10.1126/science.271.5246.163
   FLOWER NE, 1973, J ULTRA MOL STRUCT R, V44, P134, DOI 10.1016/S0022-5320(73)90046-4
   FLOWER NE, 1969, J ULTRA MOL STRUCT R, V26, P262, DOI 10.1016/S0022-5320(69)80006-7
   FRETTER VERA, 1941, JOUR MARINE BIOL ASSOC UNITED KINGDOM, V25, P173
   Fung Y.C., 1993, BIOMECHANICS MECH PR
   Garrido Orlando, 1993, Revista de Biologia Marina, V28, P191
   GATHERCOLE L, 1969, THESIS U LEEDS
   GOLDSMITH LA, 1978, COMP BIOCHEM PHYS B, V59, P133, DOI 10.1016/0305-0491(78)90193-1
   GRUBER GL, 1982, THESIS U DELAWARE
   Hearle JWS, 2000, INT J BIOL MACROMOL, V27, P123, DOI 10.1016/S0141-8130(00)00116-1
   HEPWORTH DG, 1994, J STRUCT BIOL, V112, P231, DOI 10.1006/jsbi.1994.1023
   HOLLAND ND, 1990, ACTA ZOOL-STOCKHOLM, V71, P225, DOI 10.1111/j.1463-6395.1990.tb01081.x
   Holmgren SK, 1999, CHEM BIOL, V6, P63, DOI 10.1016/S1074-5521(99)80003-9
   HUNT S, 1971, COMP BIOCHEM PHYSIOL, V40, P37, DOI 10.1016/0305-0491(71)90059-9
   HUNT S, 1978, PHILOS T R SOC B, V283, P417, DOI 10.1098/rstb.1978.0048
   HUNT S, 1990, TISSUE CELL, V22, P191, DOI 10.1016/0040-8166(90)90021-Z
   KALYANI R, 1985, INT J INVER REP DEV, V8, P73, DOI 10.1080/01688170.1985.10510129
   Kasapi MA, 1996, J EXP BIOL, V199, P1133
   Knight D.P., 1992, Biomimetics, V1, P151
   MAGALHAES H, 1948, ECOL MONOGR, V18, P377, DOI 10.2307/1948577
   Martin KLM, 1999, AM ZOOL, V39, P215
   MATOLTSY A, 1965, BIOL SKIN HAIR GROWT
   Parry DAD, 1999, Q REV BIOPHYS, V32, P99, DOI 10.1017/S0033583500003516
   PECHENIK JA, 1986, AM MALACOL BULL, V4, P165
   PECHENIK JA, 1979, AM NAT, V114, P859, DOI 10.1086/283533
   PERRON FE, 1981, AM NAT, V118, P110, DOI 10.1086/283805
   PETROVIC ZS, 1991, J APPL POLYM SCI, V42, P391, DOI 10.1002/app.1991.070420211
   PIEZ KA, 1984, EXTRACELLULAR MATRIX, P1
   PRICE N R, 1973, Biochemical Society Transactions, V1, P158
   PRICE NR, 1976, TISSUE CELL, V8, P217, DOI 10.1016/0040-8166(76)90048-3
   RAWLINGS TA, 1990, BIOL BULL, V179, P312, DOI 10.2307/1542323
   Rawlings TA, 1999, AM ZOOL, V39, P230
   RUDALL KM, 1968, COMPREHENSIVE BIOC B, V26, P559
   SHADWICK RE, 1992, PHILOS T ROY SOC B, V337, P419, DOI 10.1098/rstb.1992.0118
   SHADWICK RE, 1990, J APPL PHYSIOL, V68, P1033
   SHADWICK RE, 1983, MOLLUSCA, V1, P399
   SKERTCHLY ARB, 1964, NATURE, V202, P161, DOI 10.1038/202161a0
   SULLIVAN CH, 1984, BIOL BULL-US, V167, P378, DOI 10.2307/1541284
   TAMARIN A, 1967, J ULTRA MOL STRUCT R, V21, P26, DOI 10.1016/S0022-5320(67)80004-2
   Vincent J. F. V., 1990, STRUCTURAL BIOMATERI
NR 47
TC 25
Z9 25
U1 2
U2 10
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD JAN-FEB
PY 2002
VL 3
IS 1
BP 42
EP 50
DI 10.1021/bm0155470
PG 9
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 528RJ
UT WOS:000174256500007
PM 11866554
DA 2018-10-20
ER

PT J
AU Gorbunov, V
   Fuchigami, N
   Stone, M
   Grace, M
   Tsukruk, VV
AF Gorbunov, V
   Fuchigami, N
   Stone, M
   Grace, M
   Tsukruk, VV
TI Biological thermal detection: Micromechanical and microthermal
   properties of biological infrared receptors
SO BIOMACROMOLECULES
LA English
DT Article
ID POLYMERIC MATERIALS; SCANNING PROBE; MICROSCOPY; FILMS; ULTRASTRUCTURE
AB Bioinspired design of biomimetic sensors relies upon the complete understanding of properties and functioning of biological analogues in conjunction with an understanding of their microstructural organization at various length scales, In the spirit of this approach, the microscopic properties of infrared (IR) receptors of snakes with "infrared vision" were studied with scanning thermal microscopy and micromechanical analysis. Low surface thermal conductivity of 0.11 W/(m K) was measured for the IR receptor surfaces as compared to the nonspecific skin areas. This difference in surface thermal conductivity should result in a significant local temperature gradient around the receptor areas. Micromechanical analysis showed that pit organs were more compliant than surrounding skin areas with an elastic modulus close to 40 MPa. In addition, the maximum elastic modulus was detected for the outermost layer with gradually reduced elastic resistance for the interior. The porous microstructure of the underlying tissue combined with the highly branched microfibrillar network (Biomacromolecules 2001, 2, 757) is thought to be responsible for such a combination of biomaterial properties. Considering these biomaterials features, we postulated a possible design of an artificial photothermal detector inspired by the microstructure of natural receptors. This bioinspired design would include a microfabricated cavity filled with an ordered lattice of microspheres with a gradient periodicity from the surface to the interior. Such a "photonic cavity" could provide an opportunity for multiple scattering at wavelength tuned to 8-12 mum as a range of highest sensitivity.
C1 Iowa State Univ, Dept Mat Sci & Engn, Ames, IA 50011 USA.
   TM Microscopes, Sunnyvale, CA 94089 USA.
   USAF, Res Lab, MLPJ, Mat & Mfg Directorate, Wright Patterson AFB, OH 45433 USA.
   Florida Inst Technol, Dept Biol Sci, Melbourne, FL 32901 USA.
RP Tsukruk, VV (reprint author), Iowa State Univ, Dept Mat Sci & Engn, Ames, IA 50011 USA.
CR Amemiya F, 1996, ANAT RECORD, V246, P135
   Amemiya F, 1995, BIOMED RES-TOKYO, V16, P411, DOI 10.2220/biomedres.16.411
   AMEMIYA F., 1996, ANIMAL EYE RES, V15, P13
   Bliznyuk VN, 1998, ACS SYM SER, V695, P220
   Campbell AL, 1999, J STRUCT BIOL, V126, P105, DOI 10.1006/jsbi.1999.4121
   Chizhik SA, 1998, LANGMUIR, V14, P2606, DOI 10.1021/la980042p
   Gorbunov VV, 1999, LANGMUIR, V15, P8340, DOI 10.1021/la990913a
   GORBUNOV VV, 2000, PROBE MICROSC, V2, P65
   GORBUNOV VV, 2000, PROBE MICROSC, V2, P53
   Grace MS, 2001, BEHAV BRAIN RES, V119, P23, DOI 10.1016/S0166-4328(00)00336-3
   Hammiche A, 1996, REV SCI INSTRUM, V67, P4268, DOI 10.1063/1.1147525
   Hazel J, 1999, J BIOMECH, V32, P477, DOI 10.1016/S0021-9290(99)00013-5
   Hazel J, 2001, BIOMACROMOLECULES, V2, P304, DOI 10.1021/bm005648i
   HUES SM, 1993, MRS BULL, V18, P41
   Jiang H, 2000, THIN SOLID FILMS, V372, P85, DOI 10.1016/S0040-6090(00)01033-6
   Jones BS, 2001, J THEOR BIOL, V209, P201, DOI 10.1006/jtbi.2000.2256
   LIDE D, 27 HDB CHEM PHYSICS
   Lvov Y. M., 1994, Crystallography Reports, V39, P628
   POLLOCK H, 2001, J PHYS D, V34, P23
   Pollock HM, 1998, J ADHESION, V67, P217, DOI 10.1080/00218469808011109
   Ratner B. D., 1998, ACS S SERIES, V694
   Sarid D., 1991, SCANNING FORCE MICRO
   Terashima S, 1997, CELL MOL NEUROBIOL, V17, P195, DOI 10.1023/A:1026313828426
   TERASHIMA S, 1998, INFRARED RECEPTORS T
   Tsukruk VV, 1997, PROG POLYM SCI, V22, P247, DOI 10.1016/S0079-6700(96)00005-6
   Tsukruk VV, 2000, POLYMER, V41, P5541, DOI 10.1016/S0032-3861(00)00004-5
   Tsukruk VV, 1998, J MATER SCI, V33, P4905, DOI 10.1023/A:1004457532183
   Tsukruk VV, 1997, RUBBER CHEM TECHNOL, V70, P430, DOI 10.5254/1.3538437
   TSUKRUK VV, UNPUB PROBE MICROSC
   TSUKRUK VV, 2001, MICROSC TODAY, V1, P8
NR 30
TC 26
Z9 26
U1 0
U2 18
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD JAN-FEB
PY 2002
VL 3
IS 1
BP 106
EP 115
DI 10.1021/bm015591f
PG 10
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 528RJ
UT WOS:000174256500015
PM 11866562
DA 2018-10-20
ER

PT J
AU Flynn, JM
   Shelton, RM
   Landini, G
AF Flynn, JM
   Shelton, RM
   Landini, G
TI Investigation of primary cell-biomaterial interactions using silver
   nitrate staining of nucleolar organising regions
SO BIOMATERIALS
LA English
DT Article
DE osteoblast; biomaterial; nucleolar organiser; surface; BrdU
ID ORGANIZER REGION; POLYMER SURFACES; IN-VITRO; ADHESION; PROTEINS;
   SUBSTRATUM; RESPONSES; LYMPHOMAS; CULTURE; INVITRO
AB The quantification of silver nitrate staining of nucleolar organising regions (AgNORs) within the nucleus of the cell has been shown to give a relative measure of the metabolic activity of the cell. In the present study, silver nitrate staining was utilised to identify metabolic variations in cells cultured on different surfaces and compared with proliferative activity assessed using bromodeoxyuridine (BrdU) uptake. Primary osteoblast and periosteal cells, isolated from the calvaria of neonate rats, were cultured on tissue culture-grade (TCPS) and bacteriological-grade (BACPS) polystyrene petri dishes for 3, 5, 7 and 9 days (silver nitrate) or 14 days (BrdU). The phenotype of the cells was examined using RT-PCR of the mRNA for osteocalcin, collagen la, alkaline phosphatase and osteopontin. The number and area of AgNORs and the proportion of BrdU positive cells were statistically different in cells cultured on TCPS compared with BACPS at each culture period tested. The results suggest that the metabolic activity and proliferation of cells were affected by the substrate which they colonise. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Univ Birmingham, Biomat Unit, Sch Dent, Birmingham B4 6NN, W Midlands, England.
   Univ Birmingham, Oral Pathol Unit, Sch Dent, Birmingham B4 6NN, W Midlands, England.
RP Shelton, RM (reprint author), Univ Birmingham, Biomat Unit, Sch Dent, Birmingham B4 6NN, W Midlands, England.
CR ALBERTS B, 1994, MOL BIOL CELL
   AMSTEIN CF, 1975, J CLIN MICROBIOL, V2, P46
   CHESMEL KD, 1995, J BIOMED MATER RES, V29, P1101, DOI 10.1002/jbm.820290910
   CROCKER J, 1988, J PATHOL, V154, P151, DOI 10.1002/path.1711540207
   CROCKER J, 1987, J PATHOL, V151, P111, DOI 10.1002/path.1711510203
   CURTIS ASG, 1983, J CELL BIOL, V97, P1500, DOI 10.1083/jcb.97.5.1500
   DERENZINI M, 1990, LAB INVEST, V63, P137
   Dewez JL, 1996, J BIOMED MATER RES, V30, P373
   FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0
   HALL PA, 1988, HISTOPATHOLOGY, V12, P373, DOI 10.1111/j.1365-2559.1988.tb01952.x
   HUGHES FJ, 1995, ENDOCRINOLOGY, V136, P2671, DOI 10.1210/en.136.6.2671
   ISHAUG SL, 1994, J BIOMED MATER RES, V28, P1445, DOI 10.1002/jbm.820281210
   Josset Y, 1998, BIOMATERIALS, V19, P1791, DOI 10.1016/S0142-9612(98)00090-8
   Klemperer H.G., 1977, LAB PRACT, V26, P179
   KNAPP PE, 1992, J HISTOCHEM CYTOCHEM, V40, P1405, DOI 10.1177/40.9.1506676
   LANDINI G, 1990, J ORAL PATHOL MED, V19, P257, DOI 10.1111/j.1600-0714.1990.tb00837.x
   LISCHWE MA, 1979, LIFE SCI, V25, P701, DOI 10.1016/0024-3205(79)90512-5
   MAROUDAS NG, 1975, J THEOR BIOL, V49, P417, DOI 10.1016/0022-5193(75)90182-4
   PLOTON D, 1986, HISTOCHEM J, V18, P5, DOI 10.1007/BF01676192
   PULEO DA, 1991, J BIOMED MATER RES, V25, P711, DOI 10.1002/jbm.820250603
   REVEL JP, 1974, EXP CELL RES, V84, P207, DOI 10.1016/0014-4827(74)90398-X
   Shelton R. M., 1997, Cells and Materials, V7, P147
   TAMADA Y, 1994, J BIOMED MATER RES, V28, P783, DOI 10.1002/jbm.820280705
   TANAKA T, 1989, JPN J CANCER RES, V80, P1047, DOI 10.1111/j.1349-7006.1989.tb02257.x
   VANDERVALK P, 1983, J BIOMED MATER RES, V17, P807, DOI 10.1002/jbm.820170508
   WILLIAMS MA, 1982, EXP CELL RES, V137, P341, DOI 10.1016/0014-4827(82)90035-0
   Yonemori K, 1996, BONE, V19, P173, DOI 10.1016/8756-3282(96)00169-X
NR 27
TC 1
Z9 2
U1 0
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2002
VL 23
IS 1
BP 19
EP 26
DI 10.1016/S0142-9612(01)00074-6
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 496YF
UT WOS:000172425400003
PM 11762838
DA 2018-10-20
ER

PT J
AU Mottu, F
   Rufenacht, DA
   Laurent, A
   Doelker, E
AF Mottu, F
   Rufenacht, DA
   Laurent, A
   Doelker, E
TI Iodine-containing cellulose mixed esters as radiopaque polymers for
   direct embolization of cerebral aneurysms and arteriovenous
   malformations
SO BIOMATERIALS
LA English
DT Article
DE embolization; embolic liquids; aneurysms; arteriovenous malformations;
   cellulose esters; iodine-containing cellulose mixed esters; cellulose
   acetate iodobenzoates; radiopacity
ID VINYL ALCOHOL COPOLYMER; ACETATE POLYMER; DIRECT THROMBOSIS;
   LITHIUM-CHLORIDE; BIOMEDICAL APPLICATIONS; CLINICAL-EXPERIENCE;
   IN-VITRO; N,N-DIMETHYLACETAMIDE; BIOMATERIAL; COMBINATION
AB The present study deals with the synthesis and characterization of radiopaque polymers which could, when solubilized in an appropriate water-miscible solvent, be useful embolic materials for the treatment of cerebral aneurysms and arteriovenous malformations. For this purpose cellulose (both microcrystalline and powdered) and partially substituted cellulose acetate (two different viscosity grades) were selected as starting materials to prepare iodine-containing polymers through various synthetic routes. The materials obtained were characterized by IR and NMR spectroscopy, molecular weight, iodine content, radiopacity and solubility in selected injectable organic solvents. The embolic liquids were evaluated for their precipitation behavior in a phosphate buffer solution (pH 7.4) mimicking physiological conditions using an in vitro aneurysm model. A sheep model was also used to assess in vivo the radiopacity and precipitation properties of a highly concentrated solution of a cellulose acetate 2,3,4-triiodobenzoate mixed ester. AH materials with 4-iodo- and 2,3,5-triiodobenzoyl groups gave sufficient radiopacity to be regarded as possible embolization materials, whereas iododeoxycellulose and iododeoxycellulose acetate were not radiopaque because of their low iodine content. Esters synthesized using cellulose as starting material were not soluble in the selected organic solvents due to the presence of many residual hydroxyl groups, but could be used for other biomedical applications where insoluble radiopaque materials are used. In contrast, solubility of the materials as well as satisfactory precipitation properties were ensured using cellulose acetate as the starting material. In conclusion, cellulose acetate iodobenzoate mixed esters dissolved in diglyme or dimethyl isosorbide (dimethyl sulfoxide is probably less appropriate because of its toxicity and hemolytic properties) could be useful embolic liquids for the treatment of cerebral aneurysms or arteriovenous malformations. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Univ Geneva, Sch Pharm, CH-1211 Geneva 4, Switzerland.
   Univ Hosp Geneva, Div Diagnost & Intervent Radiol, Geneva, Switzerland.
   INRA, APHP, Ctr Res Intenvent Radiol, Jouy En Josas, France.
RP Doelker, E (reprint author), Univ Geneva, Sch Pharm, 30 Quai E Ansermet, CH-1211 Geneva 4, Switzerland.
CR BENZINA A, 1994, BIOMATERIALS, V15, P1122, DOI 10.1016/0142-9612(94)90232-1
   CHALOUPKA JC, 1993, J NEUROSURG, V78, P1006
   CHALOUPKA JC, 1994, AM J NEURORADIOL, V15, P1107
   Davy KWM, 1997, POLYM INT, V43, P143, DOI 10.1002/(SICI)1097-0126(199706)43:2<143::AID-PI717>3.0.CO;2-M
   DOELKER E, 1987, POWDER TECHNOL, V52, P207, DOI 10.1016/0032-5910(87)80106-7
   DOTTER CT, 1975, RADIOLOGY, V114, P227, DOI 10.1148/114.1.227
   Gailloud P, 1997, SURG RADIOL ANAT, V19, P119
   Gardner TS, 1942, J AM CHEM SOC, V64, P1539, DOI 10.1021/ja01259a014
   Hassner A., 1978, TETRAHEDRON LETT, V19, P4475
   Heinze T, 1998, MACROMOL CHEM PHYSIC, V199, P2341, DOI 10.1002/macp.1998.021991101
   HEUSER E, 1950, J AM CHEM SOC, V72, P670, DOI 10.1021/ja01158a007
   HIROTSUNE N, 1996, ADV INTERVENTIONAL N, P149
   JAYAKRISHNAN A, 1992, J APPL POLYM SCI, V44, P743, DOI 10.1002/app.1992.070440421
   KINUGASA K, 1993, J NEUROSURG, V78, P1007
   KINUGASA K, 1994, NEUROSURGERY, V34, P694, DOI 10.1227/00006123-199404000-00019
   KINUGASA K, 1994, NEUROSURGERY, V35, P755, DOI 10.1227/00006123-199410000-00027
   KINUGASA K, 1992, J NEUROSURG, V77, P501, DOI 10.3171/jns.1992.77.4.0501
   KINUGASA K, 1995, J NEUROSURG, V83, P34, DOI 10.3171/jns.1995.83.1.0034
   LAURENT A, 1997, J NEURORADIOLOGY, V24, P314
   LAURENT A, 2001, UNPUB PDA J PHARM SC
   MALM CJ, 1954, ANAL CHEM, V26, P188, DOI 10.1021/ac60085a029
   MALM CJ, 1948, J AM CHEM SOC, V70, P2740, DOI 10.1021/ja01188a031
   Mandai S, 1998, INTERV NEURORADIOL, V4, P173, DOI 10.1177/15910199980040S135
   MANDAI S, 1992, J NEUROSURG, V77, P497, DOI 10.3171/jns.1992.77.4.0497
   MCCORMICK CL, 1990, CARBOHYD RES, V208, P183, DOI 10.1016/0008-6215(90)80098-N
   MCCORMICK CL, 1987, POLYMER, V28, P2317, DOI 10.1016/0032-3861(87)90393-4
   MCCORMICK CL, 1985, MACROMOLECULES, V18, P2394, DOI 10.1021/ma00154a010
   MOSZNER N, 1995, ANGEW MAKROMOL CHEM, V224, P115, DOI 10.1002/apmc.1995.052240112
   Mottu F, 2000, PDA J PHARM SCI TECH, V54, P456
   Mottu F, 1999, INVEST RADIOL, V34, P323, DOI 10.1097/00004424-199905000-00001
   Mottu F, 2001, PDA J PHARM SCI TECH, V55, P16
   MOTTU F, 1999, BIOMATERIALS, V21, P803
   MOTTU F, 2000, Patent No. 0003814
   SAMARANAYAKE G, 1993, CARBOHYD POLYM, V22, P1, DOI 10.1016/0144-8617(93)90159-2
   SAMPEI K, 1996, ADV INTERVENTIONAL N, P293
   Schoniger W., 1955, MIKROCHIM ACTA, V1, P123
   SUGIU K, 1995, J NEUROSURG, V83, P531, DOI 10.3171/jns.1995.83.3.0531
   TAKI W, 1992, J NEUROSURG, V77, P37, DOI 10.3171/jns.1992.77.1.0037
   TAKI W, 1990, AM J NEURORADIOL, V11, P163
   TERADA T, 1991, J NEUROSURG, V75, P655, DOI 10.3171/jns.1991.75.4.0655
   Tipson RS, 1944, J ORG CHEM, V9, P235, DOI 10.1021/jo01185a005
   TIPSON RS, 1947, J ORG CHEM, V12, P133, DOI 10.1021/jo01165a017
   TIPSON RS, 1953, ADV CARBOHYD CHEM, P107
   Tokunaga K, 1998, NEUROSURGERY, V42, P1135, DOI 10.1097/00006123-199805000-00108
   TOKUNAGA K, 1996, ADV INTERVENTIONAL N, P15
   Williamson SL, 1998, J MACROMOL SCI PURE, VA35, P1915, DOI 10.1080/10601329808000987
   WOLFROM ML, 1941, J AM CHEM SOC, V63, P1688
   YAMASHITA K, 1994, AM J NEURORADIOL, V15, P1103
NR 48
TC 62
Z9 64
U1 3
U2 28
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2002
VL 23
IS 1
BP 121
EP 131
DI 10.1016/S0142-9612(01)00087-4
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 496YF
UT WOS:000172425400015
PM 11762830
DA 2018-10-20
ER

PT J
AU Koob, TJ
   Hernandez, DJ
AF Koob, TJ
   Hernandez, DJ
TI Material properties of polymerized NDGA-collagen composite fibers:
   development of biologically based tendon constructs
SO BIOMATERIALS
LA English
DT Article
DE collagen; tendon; ligament; biomaterial; NDGA; polymerization; fibrous
   tissues
ID CONTROLLED PASSIVE MOBILIZATION; NORDIHYDROGUAIARETIC ACID; FLEXOR
   TENDONS; FL5.12 CELLS; REPAIR; DOGS; RECONSTRUCTION; EXPRESSION;
   APOPTOSIS; LIGAMENT
AB Methods for stabilizing collagen-based materials with catechol containing monomers were developed in order to produce fibers with mechanical properties in tension comparable to those of normal tendon. Fibers produced from pepsin solubilized, bovine tendon type I collagen were polymerized with the di-catechol nordihydroguaiaretic acid (NDGA). Polymerization was based on the chemical oxidation of the constituent o-catechols to reactive o-quinone functionalities. NDGA caused a dose dependent increase in the tensile strength and stiffness of the type I collagen fibers. A second treatment with NDGA improved the tensile properties significantly. Comparison of the effects of NDGA with those of biologically relevant mono-catechols indicated that the bi-catechol functionality of NDGA was responsible for generation of the superior tensile properties. Elimination of unreacted intermediates from the treated fibers with ethanol increased the effectiveness of the cross-linking process while simultaneously sterilizing the material. Catalyzing oxidation by saturating the reaction buffer with oxygen increased the effectiveness of polymerization and the resulting tensile properties of the treated fibers. The ultimate tensile strength of the optimized NDGA-treated fibers averaged 90 MPa the elastic modulus of these fibers averaged 580 Wa. Both values are comparable to native tendon. The material properties of the NDGA cross-linked fibers exceed the properties of collagen fibers treated with other cross-linking strategies such as glutaraldehyde and carbodiimide, These results indicate that NDGA cross-linking may provide a viable approach to stabilizing collagenous materials for use in repair of ruptured, lacerated or surgically transected tendons, as well as other biomaterial constructs for surgical repair of musculoskeletal injuries and disease. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Shriners Hosp Children, Skeletal Biol Sect, Ctr Res Skeletal Dev & Pediat Orthopaed, Tampa, FL 33612 USA.
RP Koob, TJ (reprint author), Shriners Hosp Children, Skeletal Biol Sect, Ctr Res Skeletal Dev & Pediat Orthopaed, 12502 N Pine Dr, Tampa, FL 33612 USA.
CR ABRAHAMSSON SO, 1995, J ORTHOPAED RES, V13, P58, DOI 10.1002/jor.1100130110
   ABRAHAMSSON SO, 1994, J HAND SURG-AM, V19A, P259, DOI 10.1016/0363-5023(94)90016-7
   AMIEL D, 1995, J ORTHOPAED RES, V13, P459, DOI 10.1002/jor.1100130321
   AOKI M, 1994, J HAND SURG-AM, V19A, P984, DOI 10.1016/0363-5023(94)90102-3
   ARK JW, 1994, J HAND SURG-AM, V19A, P249, DOI 10.1016/0363-5023(94)90015-9
   Awad HA, 1999, TISSUE ENG, V5, P267, DOI 10.1089/ten.1999.5.267
   BAINBRIDGE LC, 1994, J HAND SURG-BRIT EUR, V19B, P517, DOI 10.1016/0266-7681(94)90219-4
   Becker H, 1979, J Hand Surg Am, V4, P454
   BENEDICT CV, 1989, ACS SYM SER, V385, P465, DOI 10.1021/bk-1989-0385.ch033
   Biswal SS, 2000, TOXICOL SCI, V53, P77, DOI 10.1093/toxsci/53.1.77
   BRUNELLI G, 1983, HAND, V15, P352
   Datta K, 1998, J BIOL CHEM, V273, P28163, DOI 10.1074/jbc.273.43.28163
   DOCKERY G L, 1986, Journal of Foot Surgery, V25, P469
   DUNN MG, 1993, J BIOMED MATER RES, V27, P1545, DOI 10.1002/jbm.820271211
   ELLIOT D, 1994, J HAND SURG-BRIT EUR, V19B, P607, DOI 10.1016/0266-7681(94)90126-0
   Esa AH, 1996, SCAND J IMMUNOL, V43, P127, DOI 10.1046/j.1365-3083.1996.d01-20.x
   GELBERMAN RH, 1992, J BONE JOINT SURG AM, V74A, P1207, DOI 10.2106/00004623-199274080-00011
   GELBERMAN RH, 1981, HAND, V13, P120, DOI 10.1016/S0072-968X(81)80051-4
   GELBERMAN RH, 1990, J HAND SURG-AM, V15A, P69, DOI 10.1016/S0363-5023(09)91108-X
   GELBERMAN RH, 1986, J HAND SURG-AM, V11A, P106, DOI 10.1016/S0363-5023(86)80115-0
   GELBERMAN RH, 1982, J HAND SURG-AM, V7, P170, DOI 10.1016/S0363-5023(82)80083-X
   GELBERMAN RH, 1991, CLIN ORTHOP RELAT R, P189
   GELBERMAN RH, 1983, J BONE JOINT SURG AM, V65, P70, DOI 10.2106/00004623-198365010-00010
   GOLDSTEIN JD, 1989, J BONE JOINT SURG AM, V71A, P1183, DOI 10.2106/00004623-198971080-00010
   GREEN K, 1997, SURG ADHESIVES SEALA
   HUNTER JM, 1988, J HAND SURG-AM, V13A, P849, DOI 10.1016/0363-5023(88)90259-6
   IANNACE S, 1995, BIOMATERIALS, V16, P675, DOI 10.1016/0142-9612(95)99693-G
   KAIN CC, 1988, J ORTHOPAED RES, V6, P871, DOI 10.1002/jor.1100060611
   KATO YP, 1989, BIOMATERIALS, V10, P38, DOI 10.1016/0142-9612(89)90007-0
   KATO YP, 1991, J BONE JOINT SURG AM, V73A, P561, DOI 10.2106/00004623-199173040-00013
   Koob TJ, 2001, J BIOMED MATER RES, V56, P31, DOI 10.1002/1097-4636(200107)56:1<31::AID-JBM1065>3.0.CO;2-N
   Koob TJ, 2001, J BIOMED MATER RES, V56, P40, DOI 10.1002/1097-4636(200107)56:1<40::AID-JBM1066>3.3.CO;2-9
   LEE H, 1990, J HAND SURG-AM, V15A, P953, DOI 10.1016/0363-5023(90)90022-J
   LEE H, 1990, J HAND SURG-AM, V15A, P945, DOI 10.1016/0363-5023(90)90021-I
   MAY EJ, 1992, J HAND SURG-AM, V17A, P1133, DOI 10.1016/S0363-5023(09)91080-2
   MAY EJ, 1992, J HAND SURG-AM, V17A, P942, DOI 10.1016/0363-5023(92)90475-5
   MCMASTER WC, 1986, B HOSP JOINT DIS ORT, V46, P174
   MENDES DG, 1986, J BIOMED MATER RES, V20, P699, DOI 10.1002/jbm.820200604
   MESSINA A, 1992, J HAND SURG-AM, V17A, P137, DOI 10.1016/0363-5023(92)90129-D
   Messinger PR, 1997, MARKET SCI, V16, P1, DOI 10.1287/mksc.16.1.1
   MILTHORPE BK, 1994, BIOMATERIALS, V15, P745, DOI 10.1016/0142-9612(94)90027-2
   Noguchi M, 1997, J HAND SURG-AM, V22A, P457, DOI 10.1016/S0363-5023(97)80013-5
   ROBISON TW, 1990, TOXICOL APPL PHARM, V105, P113, DOI 10.1016/0041-008X(90)90363-Y
   ROE S C, 1992, Clinical Materials, V9, P149, DOI 10.1016/0267-6605(92)90094-A
   ROGERS GT, 1995, BIOMATERIALS, V16, P803, DOI 10.1016/0142-9612(95)99643-Z
   SALERNO AJ, 1993, APPL MICROBIOL BIOT, V39, P221
   SAVAGE R, 1989, J HAND SURG-BRIT EUR, V14B, P396, DOI 10.1016/0266-7681(89)90154-X
   SEILER JG, 1995, J HAND SURG-AM, V20A, P492, DOI 10.1016/S0363-5023(05)80115-7
   SEILER JG, 1993, J BONE JOINT SURG AM, V75A, P1004, DOI 10.2106/00004623-199307000-00006
   SILFVERSKIOLD KL, 1993, J HAND SURG-AM, V18A, P654, DOI 10.1016/0363-5023(93)90312-Q
   SILFVERSKIOLD KL, 1994, J HAND SURG-AM, V19A, P53, DOI 10.1016/0363-5023(94)90224-0
   SMITH DJ, 1986, J HAND SURG-AM, V11A, P97, DOI 10.1016/S0363-5023(86)80114-9
   STRICKLAND JW, 1980, J HAND SURG-AM, V5, P537, DOI 10.1016/S0363-5023(80)80101-8
   Strickland JW, 2000, J HAND SURG-AM, V25A, P214
   STROM H, 1990, J VET PHARMACOL THER, V13, P186, DOI 10.1111/j.1365-2885.1990.tb00767.x
   Sung HW, 1999, J BIOMAT SCI-POLYM E, V10, P63, DOI 10.1163/156856299X00289
   TAKAI S, 1991, J ORTHOP RES, V9, P705, DOI 10.1002/jor.1100090510
   Tang DG, 1997, J CELL PHYSIOL, V172, P155, DOI 10.1002/(SICI)1097-4652(199708)172:2<155::AID-JCP3>3.0.CO;2-N
   WAITE JH, 1990, COMP BIOCHEM PHYS B, V97, P19, DOI 10.1016/0305-0491(90)90172-P
   WAITE JH, 1995, METHOD ENZYMOL, V258, P1
   WOO SLY, 1981, ACTA ORTHOP SCAND, V52, P615, DOI 10.3109/17453678108992156
   Young RG, 1998, J ORTHOPAED RES, V16, P406, DOI 10.1002/jor.1100160403
   Yu ME, 1999, J AM CHEM SOC, V121, P5825, DOI 10.1021/ja990469y
NR 63
TC 51
Z9 57
U1 1
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2002
VL 23
IS 1
BP 203
EP 212
DI 10.1016/S0142-9612(01)00096-5
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 496YF
UT WOS:000172425400024
PM 11762839
DA 2018-10-20
ER

PT J
AU Caplan, MR
   Schwartzfarb, EM
   Zhang, SG
   Kamm, RD
   Lauffenburger, DA
AF Caplan, MR
   Schwartzfarb, EM
   Zhang, SG
   Kamm, RD
   Lauffenburger, DA
TI Control of self-assembling oligopeptide matrix formation through
   systematic variation of amino acid sequence
SO BIOMATERIALS
LA English
DT Article
DE oligopeptide; biomaterial; self-assembly; amino acid sequence
ID HYDROPHOBICITY SCALE; COMPLEMENTARY OLIGOPEPTIDE; PROTEINS
AB In order to elucidate design principles for biocompatible materials that can be created by in situ transformation from self assembling oligopeptides, we investigate a class of oligopeptides that can self-assemble in salt solutions to form three-dimensional matrices. This class of peptides. possesses a repeated sequence of amino acid residues with the type: hydrophobic/negatively-charged/hydrophobic/positively-charged. We systematically vary three chief aspects of this sequence type: (1) the hydrophobic side chains: (2) the charged side-chains, and (3) the number of repeats. Employing a rheometric assay to judge matrix formation, we determine the critical concentration of NaCl salt solution required to drive transformation from viscous state to gel state. We find that increasing side-chain hydrophobicity decreases the critical salt concentration in accord with our previous validation of DLVO theory for explaining this self-assembly phenomenon Caplan et al. (Biomacromolecules 1 (2000) 627). Further, we find that increasing the number of repeats yields a biphasic dependence-first decreasing, then increasing, the critical salt concentration. We believe that this result is likely due to an unequal competition between a greater hydrophobic (favorable) effect and a greater entropic (unfavorable) effect as the peptide length is increased. Finally, we find that we can use this understanding to rationally alter the charged side-chains to create a self-assembling oligopeptide sequence that at pH 7 remains viscous in the absence of salt but gels in the presence of physiological salt concentrations, a highly useful property for technological applications. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 MIT, Dept Chem Engn, Cambridge, MA 02139 USA.
   MIT, Ctr Biomed Engn, Cambridge, MA 02139 USA.
   MIT, Dept Mech Engn, Cambridge, MA 02139 USA.
   MIT, Div Bioengn & Environm Hlth, Cambridge, MA 02139 USA.
RP Lauffenburger, DA (reprint author), MIT, Dept Chem Engn, Bldg 56,Room 341 B, Cambridge, MA 02139 USA.
FU NIGMS NIH HHS [GM55781]
CR Anderson J. P., 1997, PROTEIN BASED MAT, P371
   BRANDEN C, 1991, INTRO PROTEIN FOLDIN
   BULL HB, 1974, ARCH BIOCHEM BIOPHYS, V161, P665, DOI 10.1016/0003-9861(74)90352-X
   Caplan MR, 2000, BIOMACROMOLECULES, V1, P627, DOI 10.1021/bm005586w
   CLARK AH, 1987, ADV POLYM SCI, V83, P58
   CREIGHTON T. E., 1993, PROTEINS STRUCTURE M
   Hiemenz P.C., 1997, PRINCIPLES COLLOID S
   Hubbell JA, 1996, MRS BULL, V21, P33
   Leon EJ, 1998, J BIOMAT SCI-POLYM E, V9, P297, DOI 10.1163/156856298X00668
   NOZAKI Y, 1971, J BIOL CHEM, V246, P2211
   Overbeek J. T. G, 1952, COLLOID SCI, VI, P302
   Petka WA, 1998, SCIENCE, V281, P389, DOI 10.1126/science.281.5375.389
   Tanford C, 1973, HYDROPHOBIC EFFECT F
   Urry DW, 1997, J PHYS CHEM B, V101, P11007, DOI 10.1021/jp972167t
   VERWEY EJW, 1948, THEORY STABILITY LYO
   Vorobev MM, 1997, Z NATURFORSCH C, V52, P227
   WELLINGS DA, 1997, METHOD ENZYMOL, P61
   ZHANG SG, 1994, BIOPOLYMERS, V34, P663, DOI 10.1002/bip.360340508
   ZHANG SG, 1993, P NATL ACAD SCI USA, V90, P3334, DOI 10.1073/pnas.90.8.3334
   ZHANG SG, 1995, BIOMATERIALS, V16, P1385, DOI 10.1016/0142-9612(95)96874-Y
NR 20
TC 170
Z9 178
U1 1
U2 43
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2002
VL 23
IS 1
BP 219
EP 227
DI 10.1016/S0142-9612(01)00099-0
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 496YF
UT WOS:000172425400026
PM 11762841
DA 2018-10-20
ER

PT J
AU Rocha, LB
   Goissis, G
   Rossi, MA
AF Rocha, LB
   Goissis, G
   Rossi, MA
TI Biocompatibility of anionic collagen matrix as scaffold for bone healing
SO BIOMATERIALS
LA English
DT Article
DE collagen/therapeutic use; bone substitutes; bone regeneration;
   osteogenesis; biocompatible materials
ID CALCIFIC DEGENERATION; INJECTABLE COLLAGEN; CLINICAL USE; REPLACEMENT;
   BIOMATERIAL; GRAFTS; REPAIR
AB The basic approach to the treatment of bone defects involves the use of scaffolds to favor tissue growth. Although several bioscaffolds have been proposed for this purpose, the search for new and enhanced materials continues in an attempt to address the drawbacks of the present ones. Modifying current materials can be a fast and cheap way to develop new ones. Among them, type I collagen allows its structure to be modified using relatively simple techniques. By means of an alkaline treatment, anionic collagen with enhanced piezoelectric properties can be obtained through hydrolysis of carboxyamides groups of asparagine and glutamine residues from collagen in carboxylic. The process applied to a raw source of collagen, bovine pericardium, provided a sponge-like structure, with heterogeneous pore size, and, moreover, the complete removal of interstitial cells. For the evaluation of the biocompatibility of such matrices, they were implanted in surgically created bone defects in rat tibias. Empty defects served as controls. This experimental model allowed a preliminary evaluation of the osteoconductiveness of the matrices. The histological results presented a low inflammatory response and bone formation within a short period of Lime, similar to that of controls. The low cost of production associated to the biocompatibility and osteoconductivity performance make the anionic collagen matrices promising alternatives for bone defects treatment. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Pathol, BR-14049900 Ribeirao Preto, SP, Brazil.
   Univ Sao Paulo, Dept Mol Chem & Phys, Inst Chem Sao Carlos, BR-13560250 Sao Carlos, SP, Brazil.
RP Rocha, LB (reprint author), Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Pathol, Av Bandeirantes 3900, BR-14049900 Ribeirao Preto, SP, Brazil.
RI Rocha, Lenaldo/D-2382-2011
OI Rocha, Lenaldo/0000-0002-4345-6994
CR Chang BS, 2000, BIOMATERIALS, V21, P1291, DOI 10.1016/S0142-9612(00)00030-2
   Chiang TM, 1999, HISTOL HISTOPATHOL, V14, P579, DOI 10.14670/HH-14.579
   CITARDI MJ, 1994, OTOLARYNG CLIN N AM, V27, P891
   Constantino PD, 1994, OTOLARYNGOL CLIN N A, V27, P1037
   DAVIES JE, 1986, BIOMATERIALS, V7, P231
   DELACURE MD, 1994, OTOLARYNG CLIN N AM, V27, P859
   DELBALSO AM, 1976, ORAL SURG ORAL MED O, V42, P562, DOI 10.1016/0030-4220(76)90205-X
   DELUSTRO F, 1987, PLAST RECONSTR SURG, V79, P581, DOI 10.1097/00006534-198704000-00012
   Gauthier O, 1998, BIOMATERIALS, V19, P133, DOI 10.1016/S0142-9612(97)00180-4
   Goissis G, 1998, ARTIF ORGANS, V22, P203, DOI 10.1046/j.1525-1594.1998.06109.x
   Horton M. A., 1996, P217
   JACKSON RL, 1991, PHYSIOL REV, V71, P481
   KAMER FM, 1984, ARCH OTOLARYNGOL, V110, P93
   Lacerda C, 1998, QUIM NOVA, V21, P267, DOI 10.1590/S0100-40421998000300006
   Lee JH, 1997, BIOMATERIALS, V18, P351, DOI 10.1016/S0142-9612(96)00128-7
   Luster AD, 1998, NEW ENGL J MED, V338, P436, DOI 10.1056/NEJM199802123380706
   MITCHELL R, 1992, BRIT J ORAL MAX SURG, V30, P180, DOI 10.1016/0266-4356(92)90153-A
   NIMNI ME, 1987, J BIOMED MATER RES, V21, P741, DOI 10.1002/jbm.820210606
   Pachence JM, 1996, J BIOMED MATER RES, V33, P35, DOI 10.1002/(SICI)1097-4636(199621)33:1<35::AID-JBM6>3.0.CO;2-N
   Pieper JS, 1999, BIOMATERIALS, V20, P847, DOI 10.1016/S0142-9612(98)00240-3
   Plepis AMD, 1996, POLYM ENG SCI, V36, P2932
   Pohunkova H, 1996, BIOMATERIALS, V17, P1567, DOI 10.1016/0142-9612(95)00310-X
   Radhika M, 1999, COMP BIOCHEM PHYS C, V124, P131, DOI 10.1016/S0742-8413(99)00042-0
   Radhika M, 1997, J BIOMED MATER RES, V35, P497
   RAPPAPORT C, 1960, EXP CELL RES, V20, P465, DOI 10.1016/0014-4827(60)90117-8
   ROSSI MA, 1986, INT J CARDIOL, V12, P331, DOI 10.1016/0167-5273(86)90269-X
   ROSSI MA, 1990, J EXP PATHOL, V71, P187
   Toung JS, 1999, LARYNGOSCOPE, V109, P1580, DOI 10.1097/00005537-199910000-00006
   Van Heest Ann, 1999, Lancet (North American Edition), V353, P28
   Watson SP, 1999, THROMB HAEMOSTASIS, V82, P365
   Wight Thomas N., 1992, Current Opinion in Cell Biology, V4, P793, DOI 10.1016/0955-0674(92)90102-I
NR 31
TC 93
Z9 105
U1 1
U2 23
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2002
VL 23
IS 2
BP 449
EP 456
DI 10.1016/S0142-9612(01)00126-0
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 498FC
UT WOS:000172498300015
PM 11761165
DA 2018-10-20
ER

PT J
AU Wooley, PH
   Morren, R
   Andary, J
   Sud, SA
   Yang, SY
   Mayton, L
   Markel, D
   Sieving, A
   Nasser, S
AF Wooley, PH
   Morren, R
   Andary, J
   Sud, SA
   Yang, SY
   Mayton, L
   Markel, D
   Sieving, A
   Nasser, S
TI Inflammatory responses to orthopaedic biomaterials in the murine air
   pouch
SO BIOMATERIALS
LA English
DT Article
DE orthopaedic biomaterials; particulates; inflammation; polymers; alloys
ID TOTAL HIP-ARTHROPLASTY; TISSUE; MODEL; IMPLANTATION; PARTICLES;
   SYNOVITIS; CYTOKINE; DEBRIS; WEAR
AB An in vivo model of the inflammatory response to orthopaedic biomaterials was used to examine cellular and cytokine responses to polymer particles of ultra high molecular weight polyethylene (UHMWPE) and polymethylmethacrylate (PMMA), and metal particles of cobalt-chrome (Co Cr) and titanium alloy (Ti-6Al-4V). Responses were determined separately and in combinations, to examine interactions between different forms of biomaterials. Murine air pouches were injected with particle suspensions, and reactions evaluated using histological, immunological, and molecular techniques. All particulate biomaterials caused significant increases in membrane thickness compared with control (saline) air pouches, with the highest reaction seen in response to Ti-6Al-4V particles. A synergistic increase in membrane thickness was observed when PMMA was combined with UHMWPE, suggesting that multiple biomaterial stimuli markedly increase the inflammatory reaction. Cellular analysis indicated that all particles increased the absolute number and the percentage of macrophages in the membrane over the control level, with the most pronounced increase due to individual biomaterial occurring with UHMWPE particles. Cytokine analysis revealed that biomaterials provoked a strong IL-I response. Ti-6Al-4V stimulated the highest IL-6 gene transcription and the lowest IL-I gene transcription. The data suggest that synergism in the inflammatory response to biomaterials may be important in adverse responses to orthopaedic wear debris. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Wayne State Univ, Hutzel Hosp, Sch Med, Dept Orthopaed Surg, Detroit, MI 48201 USA.
   Vet Adm Med Ctr, Detroit, MI 48201 USA.
RP Wooley, PH (reprint author), Wayne State Univ, Hutzel Hosp, Sch Med, Dept Orthopaed Surg, 1 South,4707 St Antoine Blvd, Detroit, MI 48201 USA.
OI Yang, Shang-You/0000-0002-8835-5302
CR AGINS HJ, 1988, J BONE JOINT SURG AM, V70A, P347, DOI 10.2106/00004623-198870030-00005
   AKAGAWA Y, 1985, J PROSTHET DENT, V53, P681, DOI 10.1016/0022-3913(85)90023-X
   ALSAFFAR N, 1994, BRIT J RHEUMATOL, V33, P309
   Bi Y, 1999, T ORTHOP RES SOC, V45, P5
   BOS I, 1995, ACTA ORTHOP SCAND, V66, P1, DOI 10.3109/17453679508994628
   BOSS JH, 1990, INT ORTHOP, V14, P399
   Buly R L, 1992, J Arthroplasty, V7, P315, DOI 10.1016/0883-5403(92)90056-V
   CHADHA HS, 1995, INFLAMM RES, V44, P145, DOI 10.1007/BF01782811
   DAWSON J, 1989, AGENTS ACTIONS, V27, P461, DOI 10.1007/BF01972853
   EFTEKHAR NS, 1985, PROSTHETIC SYNOVITIS, P169
   GELB H, 1994, J ORTHOP RES, V12, P83, DOI 10.1002/jor.1100120111
   Gonzales JB, 1996, CLIN ORTHOP RELAT R, P244
   GOODMAN SB, 1990, J BIOMED MATER RES, V24, P517, DOI 10.1002/jbm.820240408
   Haynes DR, 1998, CLIN ORTHOP RELAT R, P223
   Haynes DR, 1996, CLIN ORTHOP RELAT R, P316
   ISAJI M, 1989, BRIT J EXP PATHOL, V70, P705
   JIRANEK WA, 1993, J BONE JOINT SURG AM, V75A, P863, DOI 10.2106/00004623-199306000-00007
   KAUFMAN RL, 1985, J RHEUMATOL, V12, P1066
   KOROVESSIS P, 1994, CLIN ORTHOP RELAT R, P155
   Liu HC, 1999, ARTIF ORGANS, V23, P1099, DOI 10.1111/j.1525-1594.1999.06343.x
   LOMBARDI AV, 1989, J BONE JOINT SURG AM, V71A, P1337, DOI 10.2106/00004623-198971090-00009
   MORRIS CJ, 1987, ANN RHEUM DIS, V46, P334, DOI 10.1136/ard.46.4.334
   NAGASE M, 1988, J RHEUMATOL, V15, P1334
   Nagase M, 1990, Nihon Seikeigeka Gakkai Zasshi, V64, P602
   Perry MJ, 1995, BRIT J RHEUMATOL, V34, P1127
   SANTAVIRTA S, 1990, J BONE JOINT SURG AM, V72A, P252, DOI 10.2106/00004623-199072020-00014
   Schaefer CJ, 1997, ARTHRITIS RHEUM-US, V40, P1064, DOI 10.1002/art.1780400611
   SEDGWICK AD, 1983, J PATHOL, V141, P483, DOI 10.1002/path.1711410406
   SHANBHAG AS, 1995, J ARTHROPLASTY, V10, P498, DOI 10.1016/S0883-5403(05)80152-4
   WITT JD, 1991, J BONE JOINT SURG BR, V73, P559
   Wooley PH, 1998, AUTOIMMUNITY, V27, P91, DOI 10.3109/08916939809008039
   Wooley PH, 1996, CLIN ORTHOP RELAT R, P63
   WOOLEY PH, 1996, ORTHOP T, V21, P500
   WOOLEY PH, 1996, ARTHRITIS RHEUM, V39, P175
NR 34
TC 139
Z9 154
U1 1
U2 28
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2002
VL 23
IS 2
BP 517
EP 526
DI 10.1016/S0142-9612(01)00134-X
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 498FC
UT WOS:000172498300023
PM 11761173
DA 2018-10-20
ER

PT J
AU Lobler, M
   Sass, M
   Kunze, C
   Schmitz, KP
   Hopt, UT
AF Lobler, M
   Sass, M
   Kunze, C
   Schmitz, KP
   Hopt, UT
TI Biomaterial patches sutured onto the rat stomach induce a set of genes
   encoding pancreatic enzymes
SO BIOMATERIALS
LA English
DT Article
DE biomaterial; gastrointestine; differential display; polyhydroxybutyric
   acid; mRNA; hydrolases
ID MESSENGER-RNA EXPRESSION; DIFFERENTIAL DISPLAY; BIODEGRADABLE PATCH; PCR
   ANALYSIS; POLY(3-HYDROXYBUTYRATE); ANASTOMOSES; SURGERY; TISSUE
AB Asymmetric patches of polyhydroxybutyric acid with one smooth and one rough surface were produced by a dipping procedure. These patches were implanted into the rat gastrointestine and tissue samples were generated at distinct time intervals after surgery. The host's response towards the foreign material was analyzed by Differential Display and RNA profiles were compared to each other. One to two weeks after surgery a group of mRNAs encoding pancreatic enzymes was transiently present after biomaterial implantation. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Univ Rostock, Chirurg Klin & Poliklin, Forschungslab, D-18057 Rostock, Germany.
   Univ Rostock, Inst Biomed Tech, Kompetenzzentrum Biomat, D-18057 Rostock, Germany.
RP Lobler, M (reprint author), Univ Freiburg, Chirurg Klin, Abt Allg & Visceralchirurg, Hugstetter Str 55, D-79106 Freiburg, Germany.
CR Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   AMID PK, 1994, J BIOMED MATER RES, V28, P373, DOI 10.1002/jbm.820280312
   Anderson J M, 1988, ASAIO Trans, V34, P101, DOI 10.1097/00002480-198804000-00005
   DINARELLO CA, 1990, BLOOD PURIFICAT, V8, P208, DOI 10.1159/000169968
   DUVERNOY O, 1995, THORAC CARDIOV SURG, V43, P271, DOI 10.1055/s-2007-1013226
   FREIER T, IN VITRO IN VIVO DEG
   GOLDBERG RB, 1981, DEV BIOL, V83, P201, DOI 10.1016/0012-1606(81)90467-X
   Hazari A, 1999, J HAND SURG-BRIT EUR, V24B, P291, DOI 10.1054/jhsb.1998.0001
   HUBANK M, 1994, NUCLEIC ACIDS RES, V22, P5640, DOI 10.1093/nar/22.25.5640
   Kishida A, 1996, BIOMATERIALS, V17, P1301, DOI 10.1016/0142-9612(96)88675-3
   LIANG P, 1992, SCIENCE, V257, P967, DOI 10.1126/science.1354393
   LIANG P, 1993, NUCLEIC ACIDS RES, V21, P3269, DOI 10.1093/nar/21.14.3269
   Ljungberg C, 1999, MICROSURG, V19, P259, DOI 10.1002/(SICI)1098-2752(1999)19:6<259::AID-MICR1>3.3.CO;2-H
   MALM T, 1992, SCAND J THORAC CARD, V26, P15, DOI 10.3109/14017439209099048
   MALM T, 1992, SCAND J THORAC CARD, V26, P9, DOI 10.3109/14017439209099047
   Miguel O, 1999, J APPL POLYM SCI, V73, P455, DOI 10.1002/(SICI)1097-4628(19990725)73:4<455::AID-APP1>3.0.CO;2-Y
   MOREHEAD JM, 1994, OTOLARYNG CLIN N AM, V27, P195
   Mutter D, 1997, EUR J SURG, V163, P287
   Nkere UU, 1998, THORAC CARDIOV SURG, V46, P77, DOI 10.1055/s-2007-1010194
   Park YK, 1998, NEUROSURGERY, V42, P813, DOI 10.1097/00006123-199804000-00076
   Shinohe T, 1996, FEMS MICROBIOL LETT, V141, P103
   SIEGLING A, 1994, J IMMUNOL METHODS, V177, P23, DOI 10.1016/0022-1759(94)90139-2
   WINKELTAU GJ, 1993, DIS COLON RECTUM, V36, P154, DOI 10.1007/BF02051171
NR 23
TC 16
Z9 17
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2002
VL 23
IS 2
BP 577
EP 583
DI 10.1016/S0142-9612(01)00144-2
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 498FC
UT WOS:000172498300029
PM 11761178
DA 2018-10-20
ER

PT S
AU Te, CC
   Ferguson, B
   Abbott, D
AF Te, CC
   Ferguson, B
   Abbott, D
BE Nicolau, DV
   Lee, AP
TI Investigation of biomaterial classification using T-rays
SO BIOMEDICAL APPLICATIONS OF MICRO- AND NANOENGINEERING
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT International Symposium on Smart Materials, Nano-, and Micro-Smart
   Systems
CY DEC 16-18, 2002
CL RMIT UNIV, MELBOURNE, AUSTRALIA
SP SPIE, Univ Arkansas, Natl Inst Adv Ind Sci & Technol, Cooperat Res Ctr Microtechnol, Dept Def, Australia, Swinburne Univ Technol, Adelaide Univ, Japanese Soc Electr Packaging, New Energy & Ind Technol Dev Org
HO RMIT UNIV
DE terahertz detection; T-rays; statistical pattern classification
AB The use of terahertz pulses (T-rays) for imaging has created a wide range of new applications. This paper investigates a number of techniques for optimally classifying terahertz data. Specifically we consider statistical pattern classification methods.
   A goal of this research is to implement a classifier as for classifying biomaterials. The objective is to train a classifier using THz images of known materials and then to use the classifier to identify the materials present in unknown images. Potential applications in security systems for airports, customs, and post offices are significant, because we can actually identify the material inside the package without opening it, based on a material's broadband frequency signature.
C1 Univ Adelaide, Ctr Biomed Engn, Adelaide, SA 5005, Australia.
RP Te, CC (reprint author), Univ Adelaide, Ctr Biomed Engn, Adelaide, SA 5005, Australia.
RI Abbott, Derek/E-8352-2011
OI Abbott, Derek/0000-0002-0945-2674
CR BACHMAN G, 1999, FOURIER WAVELET ANAL
   Balakrishnama S., 1998, LINEAR DISCRIMINANT
   Chen C, 1988, SIGNAL PROCESSING HD
   CHERKASSKY V, 1998, LEARNING DATA
   Duda R. O., 1973, PATTERN CLASSIFICATI
   Duda RO, 2001, PATTERN CLASSIFICATI
   Ferguson B, 2001, FLUCT NOISE LETT, V1, pL65, DOI 10.1142/S0219477501000226
   FERGUSON B, IN PRESS MICROELECTR
   HAIR JF, 1995, MULTIVARIATE DATA AN
   JAIN AK, 2000, IEEE PATTERN ANAL MA, V22
   Ljung L, 2000, SYSTEM IDENTIFICATIO
   *MATHWORKS INC, 2000, STAT TOOLB US GUID V
   Misiti M, 2000, WAVELET TOOLBOX USER
   Mittleman DM, 1996, IEEE J SEL TOP QUANT, V2, P679, DOI 10.1109/2944.571768
   Prasad L., 1997, WAVELET ANAL APPL IM
   SUTER BW, 1998, MULTIRATE WAVELET SI
NR 16
TC 5
Z9 5
U1 1
U2 1
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-4732-3
J9 P SOC PHOTO-OPT INS
PY 2002
VL 4937
BP 294
EP 306
DI 10.1117/12.476426
PG 13
WC Engineering, Biomedical; Engineering, Electrical & Electronic;
   Instruments & Instrumentation
SC Engineering; Instruments & Instrumentation
GA BW27F
UT WOS:000181394800033
OA Green Published
DA 2018-10-20
ER

PT S
AU Maitland, DJ
   Wilson, T
   Metzger, M
   Schumann, DL
AF Maitland, DJ
   Wilson, T
   Metzger, M
   Schumann, DL
BE Bornhop, DJ
   Dunn, DA
   Mariella, RP
   Murphy, CJ
   Nicolau, DV
   Nie, S
   Palmer, M
   Raghavachari, R
TI Laser-activated shape memory polymer microactuators for treating stroke
SO BIOMEDICAL NANOTECHNOLOGY ARCHITECTURES AND APPLICATIONS
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Biomedical Nanotechnology Architectures and Applications
CY JAN 20-24, 2002
CL SAN JOSE, CA
SP SPIE
DE diode laser; hemorrhagic stroke; ischemic stroke; biomaterial
ID RHEOLYTIC CATHETER; THROMBECTOMY
AB In this paper the photothermal engineering issues of novel shape memory polymer (SMP) microactuators for treating stroke are presented. The engineering issues for using lasers to heat and subsequently actuate these SMP devices are presented in order to provide design criteria and guidelines for intravascular, laser activated SMP devices. The optical properties of SMP, methods for coupling laser light into SMP, heating distributions in the SMP devices and the impact of operating the thermally activated material in a blood vessel (with and without flow) are presented. A total of three devices will be presented: two interventional ischemic stroke devices and one device for releasing embolic coils. The optical properties of SMP, methods for coupling laser light into SMP, heating distributions in the SNP devices and the impact of operating the thermally activated material in a blood vessel are presented. Actuating the devices requires device temperatures in the range of 65 degreesC - 85 degreesC. Attaining these temperatures under flow conditions requires critical engineering of the SMP optical properties, optical coupling into the SMP, and device geometries. Laser-activated SMP devices are a unique combination of laser-tissue and biomaterial technologies. Successful deployment of the microactuator requires well-engineered coupling of the light from the diffusing fiber through the blood into the SMP.
C1 Lawrence Livermore Natl Lab, Livermore, CA 94551 USA.
RP Maitland, DJ (reprint author), Lawrence Livermore Natl Lab, Livermore, CA 94551 USA.
CR BENDERSON JB, 2000, STROKE, V31, P2742
   BENETT WJ, 1998, Patent No. 5783130
   Broderick J, 1998, STROKE, V29, P415, DOI 10.1161/01.STR.29.2.415
   CONNORS JJ, 1999, INTERV NEURORADIOL, P650
   CONNORS JJ, 1999, INTERV NEURORADIOL, P276
   FITCH JP, 1998, Patent No. 5722989
   Gorelick PB, 1999, JAMA-J AM MED ASSOC, V281, P1112, DOI 10.1001/jama.281.12.1112
   Hayashi S., 1991, U. S. Patent, Patent No. [5,049,591, 5049591]
   HAYASHI S, 1988, MITSUBHISHI TECHNICA, V184
   Katzan IL, 2000, JAMA-J AM MED ASSOC, V283, P1151, DOI 10.1001/jama.283.9.1151
   KUSY RP, 1994, THERMOCHIM ACTA, V243, P253, DOI 10.1016/0040-6031(94)85060-7
   LAFONTAINE D, 1996, Patent No. 5662621
   Maitland DJ, 2002, LASER SURG MED, V30, P1
   MAITLAND DJ, 1998, Patent No. 6102917
   METZGER MF, 2002, IN PRESS J BIOMEDICA
   National Institute of Neurological Disorders and Stroke rt-PA Study Group, 1995, NEW ENGL J MED, V333, P1581, DOI DOI 10.1056/NEJM199512143332401
   Opatowsky MJ, 1999, AM J NEURORADIOL, V20, P414
   OTA S, 1981, RADIAT PHYS CHEM, V18, P81, DOI 10.1016/0146-5724(81)90066-2
   Otsuka K., 1998, SHAPE MEMORY MAT
   Ratner BD, 1996, INTRO MAT MED
   Takahashi T, 1996, J APPL POLYM SCI, V60, P1061
   Vesely TM, 1999, J VASC INTERV RADIOL, V10, P1195, DOI 10.1016/S1051-0443(99)70220-4
   Wang MT, 1999, J POLYM SCI POL PHYS, V37, P101, DOI 10.1002/(SICI)1099-0488(19990115)37:2<101::AID-POLB1>3.0.CO;2-X
   Wiebers D, 1998, NEW ENGL J MED, V339, P1725
NR 24
TC 9
Z9 9
U1 3
U2 12
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-4365-4
J9 P SOC PHOTO-OPT INS
PY 2002
VL 4626
BP 394
EP 402
DI 10.1117/12.472105
PG 9
WC Biotechnology & Applied Microbiology; Optics; Imaging Science &
   Photographic Technology
SC Biotechnology & Applied Microbiology; Optics; Imaging Science &
   Photographic Technology
GA BU92U
UT WOS:000177419500047
DA 2018-10-20
ER

PT J
AU Scholler, M
   Hauck, A
   Thull, R
   Steinmeyer, R
   Hedrich, R
   Schneider, FW
   Kiefer, W
   Popp, J
AF Scholler, M
   Hauck, A
   Thull, R
   Steinmeyer, R
   Hedrich, R
   Schneider, FW
   Kiefer, W
   Popp, J
TI Laser scanning microscopy study on adsorption of biologically relevant
   proteins on implant materials
SO BIOPOLYMERS
LA English
DT Article; Proceedings Paper
CT 9th European Conference on the Spectroscopy of Biological Molecules
CY SEP 08-13, 2001
CL PRAGUE, CZECH REPUBLIC
DE laser scanning microscopy; protein; adsorption; implant
ID FLUORESCENCE CORRELATION SPECTROSCOPY; TITANIUM
AB The adsorption of proteins at implant surfaces plays a key role in osscointegration and is therefore of great importance in biomaterial science. Laser scanning microscopy (LSM) is described, a method that is used here for the first study of the adsorption of proteins on implant surfaces. These LSM measurements provide information on the surface morphology, and the spatial distribution of adsorbed proteins can be deduced. (C) 2002 Wiley Periodicals, Inc.
C1 Univ Wurzburg, Inst Phys Chem, D-97074 Wurzburg, Germany.
   Abt Funkt Werkostoffe Med & Zahnheilkunde, D-97072 Wurzburg, Germany.
   Julius Von Sachs Inst Biowissensch, D-97082 Wurzburg, Germany.
RP Popp, J (reprint author), Univ Wurzburg, Inst Phys Chem, Hubland, D-97074 Wurzburg, Germany.
RI Popp, Juergen/E-6471-2012; Hedrich, Rainer/G-8771-2011
OI Hedrich, Rainer/0000-0003-3224-1362
CR Benes M, 2001, COLLECT CZECH CHEM C, V66, P855, DOI 10.1135/cccc20010855
   Branemark P I, 1977, Scand J Plast Reconstr Surg Suppl, V16, P1
   BRANEMARK P I, 1969, Scandinavian Journal of Plastic and Reconstructive Surgery, V3, P81
   ELLINGSEN JE, 1991, BIOMATERIALS, V12, P593, DOI 10.1016/0142-9612(91)90057-H
   ELSON EL, 1974, BIOPOLYMERS, V13, P1, DOI 10.1002/bip.1974.360130102
   Francois P, 1997, CLIN ORAL IMPLAN RES, V8, P217, DOI 10.1034/j.1600-0501.1997.080308.x
   KONONEN M, 1992, J BIOMED MATER RES, V26, P1325
   MADGE D, 1974, BIOPOLYMERS, V13, P29
   Olbrich KC, 1996, BIOMATERIALS, V17, P759, DOI 10.1016/0142-9612(96)81412-8
   Ramsden J. J., 1993, Q REV BIOPHYS, V27, P41
   RAMSDEN JJ, 1993, J STAT PHYS, V73, P853, DOI 10.1007/BF01052813
   STRYER L, 1999, BIOCHIMIE, P266
   TENGVALL P, 1992, Clinical Materials, V9, P115, DOI 10.1016/0267-6605(92)90056-Y
   WILLIAMS RL, 1995, J BIOMED MATER RES, V29, P1545, DOI 10.1002/jbm.820291211
NR 14
TC 0
Z9 0
U1 0
U2 2
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0006-3525
J9 BIOPOLYMERS
JI Biopolymers
PY 2002
VL 67
IS 4-5
BP 344
EP 348
DI 10.1002/bip.10100
PG 5
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 548PH
UT WOS:000175397200033
PM 12012463
DA 2018-10-20
ER

PT J
AU Filmon, R
   Basle, MF
   Atmani, H
   Chappard, D
AF Filmon, R
   Basle, MF
   Atmani, H
   Chappard, D
TI Adherence of osteoblast-like cells on calcospherites developed on a
   biomaterial combining poly(2-hydroxyethyl) methacrylate and alkaline
   phosphatase
SO BONE
LA English
DT Article
DE mineralization; osteoblast; polymer; 2-hydroxyethylmethacrylate; hybrid
   material; confocal microscopy; immunogold technique; cytomorphometry;
   cellular adhesion; bone sialoprotein; fibronectin
ID BIOMIMETIC PEPTIDE SURFACES; BONE SIALOPROTEIN; FIBRONECTIN; ATTACHMENT;
   ADHESION; MINERALIZATION; ORGANIZATION; ADSORPTION; MORPHOLOGY;
   SUBSTRATE
AB The polymer poly (2-hydroxyethyl) methacrylate (pHEMA) can copolymerize with alkaline phosphatase (AlkP) to form a hybrid material. The enzyme retains its biological activity and forms hydroxyapatite nodules (calcospherites) when polymer pellets are incubated with a synthetic body fluid. Osteoblast-like cells (ROS 17/2.8) were seeded on pellets of pHEMA and pHEMA-AlkP on which calcospherites were grown. They were examined by scanning electron microscopy, (SEM) with backscattered electron imaging. Cell surface and shape were measured by image analysis combining the SEM images. Cells grown on pHEMA-AlkP had an increased surface area (449 +/- 216 mum(2) vs. 204 +/- 80 mum(2)). The number of filopodia anchoring the cells on the free polymer surface was reduced on pHEMA-AlkP, but numerous thick pseudopodia permitted a direct anchorage on the calcospherites. Pseudopodia were-wider and longer than the filopodia. The backscattered images revealed that each cell was seated on 7.1 +/- 1.5 calcospherites and partially covered 10.3 +/- 1.9 others. Antifibronectin and anti-bone sialoprotein antibodies were used to investigate cell attachment. With confocal microscopy, both molecules were located at the interface between the cells and the mineral, inside the cells, and as free molecules on the calcospherites. Immunogold labeling was done with the same antibodies and examined with transmission electron microscopy (TEM). Adsorption of fibronectin and bone sialoprotein was noticeable at the cell/calcospherite interface and on the surface of the hydroxyapatite crystals. Immunogold studies revealed adhesion proteins (bone sialoprotein, fibronectin) to be present at the surface of crystals and at focal points of cell contact. (C) 2002 by Elsevier Science Inc. All rights reserved.
C1 Fac Med, Lab Histol Embryol, LHEA, GEROM, F-49045 Angers, France.
   Fac Med, Serv Commun Imagerie & Anal Microscop, Angers, France.
RP Chappard, D (reprint author), Fac Med, Lab Histol Embryol, LHEA, GEROM, F-49045 Angers, France.
CR ANDRADE JD, 1986, ADV POLYM SCI, V79, P1
   CHEN JK, 1992, J BONE MINER RES, V7, P987
   Degasne I, 1999, CALCIFIED TISSUE INT, V64, P499, DOI 10.1007/s002239900640
   Deligianni DD, 2001, BIOMATERIALS, V22, P1241, DOI 10.1016/S0142-9612(00)00274-X
   DENIZLI A, 1995, INT J ARTIF ORGANS, V18, P90
   Filmon R, 1997, J HISTOTECHNOL, V20, P343
   Filmon R., 1996, Cells and Materials, V6, P11
   Filmon R, 2000, J BIOMAT SCI-POLYM E, V11, P849, DOI 10.1163/156856200744057
   Ganss B, 1999, CRIT REV ORAL BIOL M, V10, P79, DOI 10.1177/10454411990100010401
   Garrett Q, 1998, BIOMATERIALS, V19, P2175, DOI 10.1016/S0142-9612(98)00125-2
   Gehron-Robey P, 1996, OSTEOPOROSIS, P95
   Gronowicz G, 1996, J ORTHOPAED RES, V14, P878, DOI 10.1002/jor.1100140606
   Harris J G, 1995, J Int Neuropsychol Soc, V1, P10
   Healy KE, 1996, BIOMATERIALS, V17, P195, DOI 10.1016/0142-9612(96)85764-4
   HUBBELL JA, 1992, ANN NY ACAD SCI, V665, P253, DOI 10.1111/j.1749-6632.1992.tb42589.x
   LAI CS, 1993, J MOL BIOL, V230, P625, DOI 10.1006/jmbi.1993.1174
   Lombello CB, 2000, CYTOBIOS, V101, P115
   MASSIA SP, 1990, ANAL BIOCHEM, V187, P292, DOI 10.1016/0003-2697(90)90459-M
   MONTHEARD JP, 1997, REFERENCE FUNCTIONAL, P699
   Moursi AM, 1997, J CELL SCI, V110, P2187
   Neff JA, 1998, J BIOMED MATER RES, V40, P511, DOI 10.1002/(SICI)1097-4636(19980615)40:4<511::AID-JBM1>3.3.CO;2-M
   OKANO T, 1993, J BIOMED MATER RES, V27, P1519, DOI 10.1002/jbm.820271208
   REGINATO AM, 1994, ARTHRITIS RHEUM, V37, P1338, DOI 10.1002/art.1780370912
   Rezania A, 1999, J ORTHOPAED RES, V17, P615, DOI 10.1002/jor.1100170423
   Rezania A, 1997, J BIOMED MATER RES, V37, P9, DOI 10.1002/(SICI)1097-4636(199710)37:1<9::AID-JBM2>3.0.CO;2-W
   Rezania A, 1999, BIOTECHNOL PROGR, V15, P19, DOI 10.1021/bp980083b
   WATTS KC, 1984, ANAL QUANT CYTOL, V6, P272
   WENNERBERG A, 1992, J BIOMED ENG, V14, P412, DOI 10.1016/0141-5425(92)90087-2
   WHYTE MP, 1995, J CLIN INVEST, V95, P1440, DOI 10.1172/JCI117814
   WUTHIER RE, 1982, CLIN ORTHOP RELAT R, P219
NR 30
TC 40
Z9 40
U1 2
U2 16
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 8756-3282
J9 BONE
JI Bone
PD JAN
PY 2002
VL 30
IS 1
BP 152
EP 158
DI 10.1016/S8756-3282(01)00634-2
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 516DP
UT WOS:000173536900023
PM 11792578
DA 2018-10-20
ER

PT J
AU del Real, RP
   Arcos, D
   Vallet-Regi, M
AF del Real, RP
   Arcos, D
   Vallet-Regi, M
TI Implantable magnetic glass-ceramic based on (Fe,Ca)SiO3 solid solutions
SO CHEMISTRY OF MATERIALS
LA English
DT Article
ID INTRACELLULAR HYPERTHERMIA; SYSTEM FEO-FE2O3-CAO-SIO2; FERROMAGNETIC
   IMPLANTS; IN-VITRO; SURFACE; CELLS; CANCER; CRYSTALLIZATION;
   DISTRIBUTIONS; INDUCTION
AB A magnetic glass-ceramic suitable to be used as biomaterial has been synthesized. After the NaO-Fe2O3-CaO-SiO2 starting glass is annealed, a glass-ceramic based on ferroan wollastonite-like and is an element of-(Fe,Ca)SiO3-like phases is obtained. Both phases contain Fe 21 ions, leading to two magnetic phases with different coercive forces. Because of the magnetic properties, this material could be used as a thermoseed for cancer treatment by hyperthermia. This glass-ceramic is coated by an amorphous layer when it is soaked in simulated body fluid (SBF). This new layer, formed with the incorporation of phosphorus over the surface, would lead to a good integration with the bone tissue after being implanted.
C1 Univ Complutense, Fac Farm, Dept Quim Inorgan & Bioinorgan, E-28040 Madrid, Spain.
RP Vallet-Regi, M (reprint author), Univ Complutense, Fac Farm, Dept Quim Inorgan & Bioinorgan, E-28040 Madrid, Spain.
RI Arcos, Daniel/L-6167-2014; Vallet-Regi, Maria/M-3378-2014; perez del
   real, rafael/C-2178-2013
OI Arcos, Daniel/0000-0002-5367-7272; Vallet-Regi,
   Maria/0000-0002-6104-4889; PEREZ DEL REAL, RAFAEL/0000-0003-1374-8037
CR Andra W, 1999, J MAGN MAGN MATER, V194, P197, DOI 10.1016/S0304-8853(98)00552-6
   BREZOVICH IA, 1989, RADIOL CLIN N AM, V27, P589
   BREZOVICH IA, 1984, MED PHYS, V11, P145, DOI 10.1118/1.595490
   Burgman P., 1995, THERMORADIOTHERAPY T, V1
   Case JA, 2000, J BIOMED MATER RES, V53, P791, DOI 10.1002/1097-4636(2000)53:6<791::AID-JBM21>3.0.CO;2-A
   CHAN DCF, 1993, J MAGN MAGN MATER, V122, P374
   EBISAWA Y, 1991, NIPPON SERAM KYO GAK, V99, P7
   Ebisawa Y, 1997, BIOMATERIALS, V18, P1277, DOI 10.1016/S0142-9612(97)00067-7
   Ebisawa Y, 1997, J CERAM SOC JPN, V105, P947, DOI 10.2109/jcersj.105.947
   FAIRBAIRN JJ, 1995, CANCER LETT, V89, P183, DOI 10.1016/0304-3835(94)03668-9
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Hiergeist R, 1999, J MAGN MAGN MATER, V201, P420, DOI 10.1016/S0304-8853(99)00145-6
   Hulbert S. F., 1982, CERAM INT, V8, P121
   IKENAGA I, 1991, BIOCERAMICS, V4, P255
   IKENAGA M, 1993, J ORTHOP RES, V11, P849, DOI 10.1002/jor.1100110611
   Jordan A, 1999, J MAGN MAGN MATER, V194, P185, DOI 10.1016/S0304-8853(98)00558-7
   KIMURA I, 1986, IEEE T MAGN, V22, P1897, DOI 10.1109/TMAG.1986.1064667
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Konaka H, 1997, J CERAM SOC JPN, V105, P833, DOI 10.2109/jcersj.105.833
   Kurkjian C. R., 1970, Journal of Non-Crystalline Solids, V3, P157, DOI 10.1016/0022-3093(70)90174-2
   Lee YK, 2000, J MATER SCI-MATER M, V11, P511, DOI 10.1023/A:1008913909247
   LURDERER AA, 1983, RADIAT RES, V94, P190
   MATSUKI H, 1990, IEEE T MAGN, V26, P1551, DOI 10.1109/20.104442
   MULTHOFF G, 1995, INT J CANCER, V61, P272, DOI 10.1002/ijc.2910610222
   OHASHI Y, 1978, AM MINERAL, V63, P274
   OHURA K, 1991, J APPL BIOMATER, V2, P153, DOI 10.1002/jab.770020303
   OVERGAARD J, 1977, CANCER-AM CANCER SOC, V39, P2637, DOI 10.1002/1097-0142(197706)39:6<2637::AID-CNCR2820390650>3.0.CO;2-S
   Shinkai M, 1999, J MAGN MAGN MATER, V194, P176, DOI 10.1016/S0304-8853(98)00586-1
   Singh K, 1999, J MATER SCI-MATER M, V10, P481, DOI 10.1023/A:1008949025635
   SONG CW, 1995, THERMORADIOTHERAPY T, V1
   STAUFFER PR, 1984, IEEE T BIO-MED ENG, V31, P76, DOI 10.1109/TBME.1984.325373
   Takahashi H, 2000, EXP ONCOL, V22, P186
   Tucker RD, 2000, J ENDOUROL, V14, P511, DOI 10.1089/end.2000.14.511
   Uzuka T, 2001, INT J HYPERTHER, V17, P114
   Vallet-Regi M, 1999, J BIOMED MATER RES, V46, P560
   Vallet-Regi M, 2001, J CHEM SOC DALTON, P97, DOI 10.1039/b007852m
   Wiersma J, 2001, INT J HYPERTHER, V17, P63, DOI 10.1080/02656730150201606
NR 37
TC 16
Z9 16
U1 2
U2 11
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0897-4756
EI 1520-5002
J9 CHEM MATER
JI Chem. Mat.
PD JAN
PY 2002
VL 14
IS 1
BP 64
EP 70
DI 10.1021/cm011020i
PG 7
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA 514UK
UT WOS:000173459300016
DA 2018-10-20
ER

PT B
AU Li, MQ
   Shang, DS
   Chen, HT
   Ma, C
AF Li, MQ
   Shang, DS
   Chen, HT
   Ma, C
BE Zhang, S
   Zhou, ZR
   Liu, JJ
   Zhu, MH
TI Study on the subsonically thermal sprayed coating of hydroxyapatite
SO CONTRIBUTIONS OF SURFACE ENGINEERING TO MODERN MANUFACTURING AND
   REMANUFACTURING
LA English
DT Proceedings Paper
CT 3rd International Conference on Surface Engineering
CY OCT 10-13, 2002
CL CHENGDU, PEOPLES R CHINA
SP Chinese Mech Engn Soc, SW Jiaotong Univ
DE subsonic thermal spraying; hydroxyapatite; coating; biomaterial; tensile
   strength
AB A new method of preparation of biomaterial composite coating by the technique of subsonic thermal spraying was discussed in this paper. Ti6Al4V and pure Ti were chosen as substrate and sublayer material respectively and the working layer was sprayed with biomaterial hydroxyapatite(HAP), forming the composite coating. The experiments of heat shock and tensile strength show that the bonding strength between coating and substrate is almost the same as that of specimen in which Ni/Al powder was adopted as sublayer. The phases of TiN, TiO2, Ti2O3 were formed in the sublayer, which are free of toxic and have no side effects. The powder of working layer HAP was decomposed partly during spraying, but it can be solved by the later treatment.
C1 Jiamusi Univ, Key Lab Biomat, Jiamusi, Heilongjiang Pr, Peoples R China.
RP Li, MQ (reprint author), Jiamusi Univ, Key Lab Biomat, Jiamusi, Heilongjiang Pr, Peoples R China.
CR GAO JC, 1998, CHINESE J MAT RES, V12, P95
   Gledhill HC, 2001, BIOMATERIALS, V22, P695, DOI 10.1016/S0142-9612(00)00232-5
   Huang L Y, 1999, J CHINESE CERAMIC SO, V27, P351
   Kim HM, 2000, BIOMATERIALS, V21, P353, DOI 10.1016/S0142-9612(99)00190-8
   XI YX, 1999, DEV APPL MAT, V14, P41
   YUAN RZ, 1994, RES DEV TECHNIQUE SE
   Zheng XB, 2000, BIOMATERIALS, V21, P841, DOI 10.1016/S0142-9612(99)00255-0
NR 7
TC 0
Z9 0
U1 0
U2 0
PU SOUTHWEST JIAOTONG UNIV PRESS
PI CHENGDU
PA ERHUAN RD, CHENGDU 610031, SICHUAN, PEOPLES R CHINA
BN 7-81057-661-5
PY 2002
BP 478
EP 480
PG 3
WC Engineering, Mechanical; Materials Science, Coatings & Films
SC Engineering; Materials Science
GA BV99R
UT WOS:000180624600099
DA 2018-10-20
ER

PT J
AU Garcia, AJ
   Keselowsky, BG
AF Garcia, AJ
   Keselowsky, BG
TI Biomimetic surfaces for control of cell adhesion to facilitate bone
   formation
SO CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION
LA English
DT Article
DE biomaterial; integrin; fibronectin; collagen; RGD
ID OSTEOBLAST-LIKE CELLS; COLLAGEN-ALPHA-2-BETA-1 INTEGRIN INTERACTION;
   MURINE MC3T3-E1 CELLS; AMINO-ACID-SEQUENCE; BIOACTIVE GLASS; IN-VITRO;
   EXTRACELLULAR-MATRIX; GENE-EXPRESSION; CHEMICAL MODIFICATION;
   BIOLOGICAL-ACTIVITY
AB Cell adhesion to extracellular matrix ligands through integrin receptors plays a central role in bone formation and maintenance by anchoring cells and triggering signals that direct osteoblast proliferation and differentiation. Moreover, osteoblast adhesion to adsorbed, synthesized, or engineered extracellular ligands on synthetic surfaces is critical to numerous biomedical and biotechnological applications. Considerable research efforts have concentrated on the development of surfaces that promote osteoblast differentiation and bone formation. Emerging surface engineering approaches have focused on creating biomimetic substrates that target integrins to activate signaling pathways directing the osteoblast differentiation program. These initiatives generally rely on controlling the adsorption of extracellular matrix ligands or engineering synthetic supports presenting bioadhesive motifs from extracellular matrix proteins. These biomolecular approaches provide promising strategies for the engineering of robust biofunctional matrices that control cell adhesion and signaling and promote osteoblast proliferation, differentiation, and matrix mineralization.
C1 Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.
   Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA.
   Georgia Inst Technol, Coulter Sch Biomed Engn, Atlanta, GA 30332 USA.
RP Garcia, AJ (reprint author), Georgia Inst Technol, George W Woodruff Sch Mech Engn, 315 Ferst Dr,Room 2314 IBB, Atlanta, GA 30332 USA.
EM andres.garcia@me.gatech.edu
RI Keselowsky, Benjamin/A-8000-2009
CR ADAMS JC, 1990, CELL, V63, P425, DOI 10.1016/0092-8674(90)90175-E
   AKIYAMA SK, 1995, CELL ADHES COMMUN, V3, P13, DOI 10.3109/15419069509081275
   Alsberg E, 2001, J DENT RES, V80, P2025, DOI 10.1177/00220345010800111501
   AOTA S, 1994, J BIOL CHEM, V269, P24756
   Aubin JE, 1996, PRINCIPLES BONE BIOL
   Bearinger JP, 1998, J BIOMAT SCI-POLYM E, V9, P629, DOI 10.1163/156856298X00064
   Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463
   Cheng SL, 2001, J BONE MINER RES, V16, P277, DOI 10.1359/jbmr.2001.16.2.277
   COOK SD, 1988, CLIN ORTHOP RELAT R, V230, P303
   CRANE GM, 1995, NAT MED, V1, P1322, DOI 10.1038/nm1295-1322
   CUTLER SM, 2002, IN PRESS BIOMATERIAL
   Damsky CH, 1999, BONE, V25, P95, DOI 10.1016/S8756-3282(99)00106-4
   De Arcangelis A, 2000, TRENDS GENET, V16, P389, DOI 10.1016/S0168-9525(00)02074-6
   Dee KC, 1996, BIOMATERIALS, V17, P209, DOI 10.1016/0142-9612(96)85765-6
   Dee KC, 1998, J BIOMED MATER RES, V40, P371, DOI 10.1002/(SICI)1097-4636(19980605)40:3<371::AID-JBM5>3.3.CO;2-G
   DUCHEYNE P, 1981, J BIOMED MATER RES, V15, P441, DOI 10.1002/jbm.820150315
   DUCHEYNE P, 1980, J BIOMED MATER RES, V14, P225, DOI 10.1002/jbm.820140305
   Ducheyne P, 1992, Clin Orthop Relat Res, P102
   DUCHEYNE P, 1993, BONE BIOACTIVE BIOMA
   Einhorn TA, 1999, CLIN ORTHOP RELAT R, pS59, DOI 10.1097/00003086-199910001-00007
   El-Ghannam A, 1999, J ORTHOPAED RES, V17, P340, DOI 10.1002/jor.1100170307
   ElGhannam A, 1997, J BIOMED MATER RES, V36, P167, DOI 10.1002/(SICI)1097-4636(199708)36:2<167::AID-JBM5>3.0.CO;2-I
   ElGhannam A, 1997, BIOMATERIALS, V18, P295, DOI 10.1016/S0142-9612(96)00059-2
   ELGHANNAM A, 1995, J BIOMED MATER RES, V29, P359, DOI 10.1002/jbm.820290311
   Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4
   FAULL RJ, 1993, J CELL BIOL, V121, P155, DOI 10.1083/jcb.121.1.155
   FRANCESCHI RT, 1994, J BONE MINER RES, V9, P843
   Garcia AJ, 2002, BIOCHEMISTRY-US, V41, P9063, DOI 10.1021/bi025752f
   Garcia AJ, 1999, MOL BIOL CELL, V10, P785, DOI 10.1091/mbc.10.3.785
   Garcia AJ, 1998, J BIOMED MATER RES, V40, P48, DOI 10.1002/(SICI)1097-4636(199804)40:1<48::AID-JBM6>3.0.CO;2-R
   Garcia AJ, 1998, J BIOL CHEM, V273, P10988, DOI 10.1074/jbc.273.18.10988
   Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028
   Globus RK, 1998, J CELL SCI, V111, P1385
   Grant RP, 1997, J BIOL CHEM, V272, P6159, DOI 10.1074/jbc.272.10.6159
   GRINNELL F, 1982, J BIOL CHEM, V257, P4888
   GRINNELL F, 1981, J BIOMED MATER RES, V15, P363, DOI 10.1002/jbm.820150308
   GRONOWICZ GA, 1994, J BONE MINER RES, V9, P193, DOI 10.1002/jbmr.5650090208
   HENCH L L, 1972, Journal of Biomedical Materials Research Biomedical Materials Symposium, V2, P117
   HOWLETT CR, 1994, BIOMATERIALS, V15, P213, DOI 10.1016/0142-9612(94)90070-1
   Hubbell JA, 1999, CURR OPIN BIOTECH, V10, P123, DOI 10.1016/S0958-1669(99)80021-4
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   ISHAUG SL, 1994, J BIOMED MATER RES, V28, P1445, DOI 10.1002/jbm.820281210
   Jaiswal RK, 2000, J BIOL CHEM, V275, P9645, DOI 10.1074/jbc.275.13.9645
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   Jikko A, 1999, J BONE MINER RES, V14, P1075, DOI 10.1359/jbmr.1999.14.7.1075
   Jockusch BM, 1995, ANNU REV CELL DEV BI, V11, P379, DOI 10.1146/annurev.cellbio.11.1.379
   Kao WJ, 2001, J BIOMED MATER RES, V55, P79, DOI 10.1002/1097-4636(200104)55:1<79::AID-JBM110>3.3.CO;2-Q
   Kao WYJ, 2001, BIOMATERIALS, V22, P2901, DOI 10.1016/S0142-9612(01)00037-0
   KESELOWSKY BG, 2002, IN PRESS J BIOMED MA
   Kilpadi KL, 2001, J BIOMED MATER RES, V57, P258, DOI 10.1002/1097-4636(200111)57:2<258::AID-JBM1166>3.0.CO;2-R
   Knight CG, 2000, J BIOL CHEM, V275, P35, DOI 10.1074/jbc.275.1.35
   Lai CF, 2001, J BIOL CHEM, V276, P14443, DOI 10.1074/jbc.M010021200
   Martin P, 1995, CELEST MECH DYN ASTR, V63, P29, DOI 10.1007/BF00691913
   MASSIA SP, 1990, ANAL BIOCHEM, V187, P292, DOI 10.1016/0003-2697(90)90459-M
   Matsuzaka K, 1999, BIOMATERIALS, V20, P1293, DOI 10.1016/S0142-9612(99)00029-0
   MENKO AS, 1987, CELL, V51, P51, DOI 10.1016/0092-8674(87)90009-2
   Mizuno M, 2000, J CELL PHYSIOL, V184, P207, DOI 10.1002/1097-4652(200008)184:2<207::AID-JCP8>3.3.CO;2-L
   Moursi AM, 1997, J CELL SCI, V110, P2187
   Moursi AM, 1996, J CELL SCI, V109, P1369
   Moursi AM, 2002, BIOMATERIALS, V23, P133, DOI 10.1016/S0142-9612(01)00088-6
   NAKAMURA T, 1985, J BIOMED MATER RES, V19, P685, DOI 10.1002/jbm.820190608
   Ohgushi H, 1996, J BIOMED MATER RES, V32, P341, DOI 10.1002/(SICI)1097-4636(199611)32:3<341::AID-JBM6>3.0.CO;2-S
   OHGUSHI H, 1989, ACTA ORTHOP SCAND, V60, P334, DOI 10.3109/17453678909149289
   PETTIT DK, 1992, J BIOMED MATER RES, V26, P1259, DOI 10.1002/jbm.820261002
   PIERSCHBACHER M, 1983, P NATL ACAD SCI-BIOL, V80, P1224, DOI 10.1073/pnas.80.5.1224
   Plenk H, 1998, J BIOMED MATER RES, V43, P350
   PRAEMER A, 1992, MUSCULOSKELETAL COND
   PULEO DA, 1991, J BIOMED MATER RES, V25, P711, DOI 10.1002/jbm.820250603
   Redick SD, 2000, J CELL BIOL, V149, P521, DOI 10.1083/jcb.149.2.521
   REYES CD, 2002, IN PRESS J BIOMED MA
   Rezania A, 1999, BIOTECHNOL PROGR, V15, P19, DOI 10.1021/bp980083b
   Rezania A, 2000, J BIOMED MATER RES, V52, P595, DOI 10.1002/1097-4636(20001215)52:4<595::AID-JBM3>3.0.CO;2-3
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   SAUTIER JM, 1994, CALCIFIED TISSUE INT, V55, P458, DOI 10.1007/BF00298560
   SCHEPERS E, 1991, J ORAL REHABIL, V18, P439, DOI 10.1111/j.1365-2842.1991.tb01689.x
   Scotchford CA, 1998, J BIOMED MATER RES, V41, P431, DOI 10.1002/(SICI)1097-4636(19980905)41:3<431::AID-JBM13>3.0.CO;2-L
   Shakesheff KM, 1998, J BIOMAT SCI-POLYM E, V9, P507, DOI 10.1163/156856298X00596
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Stephansson SN, 2002, BIOMATERIALS, V23, P2527, DOI 10.1016/S0142-9612(01)00387-8
   STREULI CH, 1991, J CELL BIOL, V115, P1383, DOI 10.1083/jcb.115.5.1383
   Takeuchi Y, 1997, J BIOL CHEM, V272, P29309, DOI 10.1074/jbc.272.46.29309
   Tamura Y, 2001, J BONE MINER RES, V16, P1772, DOI 10.1359/jbmr.2001.16.10.1772
   ULMAN A, 1989, LANGMUIR, V5, P1147, DOI 10.1021/la00089a003
   VROUWENVELDER WCA, 1993, J BIOMED MATER RES, V27, P465, DOI 10.1002/jbm.820270407
   WEISS RE, 1981, EXP CELL RES, V133, P247, DOI 10.1016/0014-4827(81)90316-5
   WERB Z, 1989, J CELL BIOL, V109, P877, DOI 10.1083/jcb.109.2.877
   Xiao GZ, 1998, J BIOL CHEM, V273, P32988, DOI 10.1074/jbc.273.49.32988
   Xiao GZ, 2000, J BIOL CHEM, V275, P4453, DOI 10.1074/jbc.275.6.4453
   Xynos ID, 2000, CALCIFIED TISSUE INT, V67, P321, DOI 10.1007/s002230001134
   Yang XB, 2001, BONE, V29, P523, DOI 10.1016/S8756-3282(01)00617-2
   Zhu XY, 1996, J CELL BIOL, V133, P391, DOI 10.1083/jcb.133.2.391
   Zimmerman D, 2000, DEV BIOL, V220, P2, DOI 10.1006/dbio.2000.9633
   Zreiqat H, 1999, J BIOMED MATER RES, V44, P389, DOI 10.1002/(SICI)1097-4636(19990315)44:4<389::AID-JBM4>3.0.CO;2-O
NR 93
TC 43
Z9 46
U1 1
U2 16
PU BEGELL HOUSE INC
PI DANBURY
PA 50 NORTH ST, DANBURY, CT 06810 USA
SN 1045-4403
EI 2162-6502
J9 CRIT REV EUKAR GENE
JI Crit. Rev. Eukaryot. Gene Expr.
PY 2002
VL 12
IS 2
BP 151
EP 162
DI 10.1615/CritRevEukaryotGeneExpr.v12.i2.50
PG 12
WC Biotechnology & Applied Microbiology; Genetics & Heredity
SC Biotechnology & Applied Microbiology; Genetics & Heredity
GA 610WH
UT WOS:000178984300005
PM 12434928
DA 2018-10-20
ER

PT J
AU Pelled, G
   Turgeman, G
   Aslan, H
   Gazit, Z
   Gazit, D
AF Pelled, G
   Turgeman, G
   Aslan, H
   Gazit, Z
   Gazit, D
TI Mesenchymal Stem Cells for bone gene therapy and tissue engineering
SO CURRENT PHARMACEUTICAL DESIGN
LA English
DT Review
DE Mesenchymal Stem Cells; bone marrow; osteoprogenitors; bone;
   osteoporosis; gene therapy; tissue engineering
ID MARROW STROMAL CELLS; IN-VIVO; POSTMENOPAUSAL OSTEOPOROSIS;
   APLASTIC-ANEMIA; MICE; DIFFERENTIATION; CYTOKINES; ESTROGEN; CULTURE;
   PROGENITORS
AB Mesenchymal Stem Cells (MSCs) are adult stem cells that constitute a variety of adult tissues. MSCs maintain self-renewal ability with the ability to give rise to different mesenchymal cells, and are therefore responsible in part, for the regenerative capacity of mesenchymal tissues. MSCs throughout a variety of species were found to be able to differentiate to several mesenchymal tissues including: bone, cartilage, stroma, adipose, connective tissue, muscle and tendon. MSCs are relatively easily isolated from the bone marrow and expanded in vitro. It was found that MSCs play an important role in bone physiology and hematopiesis, and in part participate in the pathophysiology related to bone diseases, mainly osteoporosis. MSCs were widely used in experimental studies in vivo, and were shown to form mesenchymal tissues. These discovered features have made MSCs good candidate's for the development of various therapeutic modalities aimed to regenerate mesenchymal tissues, mainly bone. The more important approaches currently utilizing MSCs are gene therapy and tissue engineering. Both exploit the current knowledge in molecular biology and biomaterial science in order to direct MSCs to differentiate in vivo to desired lineages and tissues. Better understanding of the molecular mechanism directing the differentiation of MSCs, will eventually allow us to properly manipulate MSCs both in vivo and ex vivo to allow the regeneration of complex tissues and organs.
C1 Hebrew Univ Jerusalem, Hadassah Med & Gene Therapy Ctr, Skeletal Biotech Lab, Jerusalem, Israel.
RP Gazit, D (reprint author), Hebrew Univ Jerusalem, Hadassah Med & Gene Therapy Ctr, Skeletal Biotech Lab, POB 12272, Jerusalem, Israel.
CR Allay JA, 1997, HUM GENE THER, V8, P1417, DOI 10.1089/hum.1997.8.12-1417
   Anderson WF, 1998, NATURE, V392, P25
   AZIZI SA, 1998, P NATL ACAD SCI USA, V95, P7
   Bardies M, 2000, CURR PHARM DESIGN, V6, P1469, DOI 10.2174/1381612003399176
   Bartholomew A, 2001, HUM GENE THER, V12, P1527, DOI 10.1089/10430340152480258
   Bergman RJ, 1996, J BONE MINER RES, V11, P568
   Bruder SP, 1998, J ORTHOPAED RES, V16, P155, DOI 10.1002/jor.1100160202
   Bruder SP, 1998, J BONE JOINT SURG AM, V80A, P985, DOI 10.2106/00004623-199807000-00007
   Byers RJ, 2001, J ENDOCRINOL, V168, P353, DOI 10.1677/joe.0.1680353
   CAMPAGNOLI C, 2001, BLOOD, V98, P8
   D'Ippolito G, 1999, J BONE MINER RES, V14, P1115, DOI 10.1359/jbmr.1999.14.7.1115
   Deans RJ, 2000, EXP HEMATOL, V28, P875, DOI 10.1016/S0301-472X(00)00482-3
   Dennis JE, 1999, J BONE MINER RES, V14, P700, DOI 10.1359/jbmr.1999.14.5.700
   Devine SM, 2001, EXP HEMATOL, V29, P244, DOI 10.1016/S0301-472X(00)00635-4
   Engstrand T, 2000, HUM GENE THER, V11, P205, DOI 10.1089/10430340050016274
   ERICES A, 2000, BRIT J HAEMATOL, V109, P1
   FERNANDEZ M, 1997, J BONE MARROW TRANSP, V20, P4
   FRIEDENSTEIN AIA, 1982, ARKH PATOL, V44, P10
   Gao JZ, 2001, CELLS TISSUES ORGANS, V169, P12, DOI 10.1159/000047856
   Gao JZ, 2001, TISSUE ENG, V7, P363, DOI 10.1089/10763270152436427
   Gazit D, 1999, J GENE MED, V1, P121, DOI 10.1002/(SICI)1521-2254(199903/04)1:2<121::AID-JGM26>3.0.CO;2-J
   Gazit D, 1998, J CELL BIOCHEM, V70, P478, DOI 10.1002/(SICI)1097-4644(19980915)70:4<478::AID-JCB5>3.0.CO;2-G
   Gerson SL, 1999, NAT MED, V5, P262, DOI 10.1038/6470
   Gharaee-Kermani M, 2001, CURR PHARM DESIGN, V7, P1083, DOI 10.2174/1381612013397573
   GRONTHOS S, 1995, BLOOD, V85, P4
   HAYNESWORTH SE, 1992, BONE, V13, P1
   Horwitz EM, 1999, NAT MED, V5, P309, DOI 10.1038/6529
   Hou Z, 1999, P NATL ACAD SCI USA, V96, P7294, DOI 10.1073/pnas.96.13.7294
   Ishaug SL, 1997, J BIOMED MATER RES, V36, P17
   Jilka RL, 1998, BONE, V23, P75, DOI 10.1016/S8756-3282(98)00077-5
   Kadiyala S, 1997, CELL TRANSPLANT, V6, P125, DOI 10.1016/S0963-6897(96)00279-5
   KAHN A, 1995, CLIN ORTHOP RELAT R, P69
   Kassem Moustapha, 1996, P691
   KELEMENT BJ, 1993, J CELL BIOCHEM, V51, P252
   Kostenuik PJ, 2001, CURR PHARM DESIGN, V7, P613, DOI 10.2174/1381612013397807
   Krebsbach PH, 1998, TRANSPLANTATION, V66, P1272, DOI 10.1097/00007890-199811270-00002
   KUZNETSOV SA, 2001, J CELL BIOL, V153, P5
   Labat ML, 2001, BIOMED PHARMACOTHER, V55, P179, DOI 10.1016/S0753-3322(01)00057-9
   Lieberman JR, 1998, J ORTHOP RES, V16, P330, DOI 10.1002/jor.1100160309
   Liechty KW, 2000, NAT MED, V6, P1282
   LOU J, 1999, ORTHOP RES, V17, P43
   MACKAY AM, 1998, TISSUE ENG, V4, P4
   MACKENZIE TC, 2001, BLOOD CELL MOL DIS, V27, P3
   MAJUMDAR MK, 2000, J CELL PHYSL, V185, P1
   MAJUMDAR MK, 2000, J HEMATOTH STEM CELL, V9, P6
   MANKANI MH, 2001, BIOTECHNOL BIOENG, V72, P1
   MARESCHI K, 2001, HAEMATOLOGICA, V86, P10
   MARSH JCW, 1991, BRIT J HAEMATOL, V78, P258, DOI 10.1111/j.1365-2141.1991.tb04426.x
   MARSH JCW, 1990, BLOOD, V76, P1748
   Martin I, 1998, J ORTHOPAED RES, V16, P181, DOI 10.1002/jor.1100160205
   MARTIN I, 2001, J BIOMED MATER RES, V21, P231
   MOSCA DJ, 2000, CLIN ORTHOP S, V379, P71
   Moutsatsos IK, 2001, MOL THER, V3, P449, DOI 10.1006/mthe.2001.0291
   MURRAY JF, 1999, PRIMER METABOLIC BON, V4
   Nishida S, 1999, J BONE MINER METAB, V17, P171, DOI 10.1007/s007740050081
   NOLTA JA, 1994, BLOOD, V83, P3041
   Notelovitz M, 1997, AM J MED SCI, V313, P2, DOI 10.1097/00000441-199701000-00002
   Odorico JS, 2001, STEM CELLS, V19, P193, DOI 10.1634/stemcells.19-3-193
   Pacifici R, 1998, ENDOCRINOLOGY, V139, P2659, DOI 10.1210/en.139.6.2659
   Pacifici R, 1996, J BONE MINER RES, V11, P1043
   PEREIRA RF, 1995, P NATL ACAD SCI USA, V92, P4857, DOI 10.1073/pnas.92.11.4857
   Pittenger M. F., 1996, Molecular Biology of the Cell, V7, p305A
   Pittenger Mark F., 1999, SCIENCE, V284, P5411
   QUARTO R, 1995, CALCIFIED TISSUE INT, V56, P123, DOI 10.1007/BF00296343
   Radice M, 2000, J BIOMED MATER RES, V50, P101, DOI 10.1002/(SICI)1097-4636(200005)50:2<101::AID-JBM2>3.0.CO;2-M
   REYES M, 2001, BLOOD, V98, P9
   Scopes J, 2001, BRIT J HAEMATOL, V115, P642, DOI 10.1046/j.1365-2141.2001.03134.x
   Stenderup K, 2001, J BONE MINER RES, V16, P1120, DOI 10.1359/jbmr.2001.16.6.1120
   Thalmeier K, 2001, ACTA HAEMATOL-BASEL, V105, P159, DOI 10.1159/000046559
   TREMAIN N, 2001, STEM CELLS, V19, P5
   Turgeman G, 2001, J GENE MED, V3, P240
   YOO JU, 1998, J BONE JOINT SURG AM, V80, P12
   YOUNG RG, 1998, J ORTHOPAED RES, V16, P4
   ZHOU S, 2001, J CELL BIOCHEM, V8, P144
   ZILBERMAN Y, 2002, IN PRESS PAT
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
   ZVAIFLER NJ, 2000, ARTHRITIS RES, V2, P6
NR 77
TC 48
Z9 58
U1 0
U2 11
PU BENTHAM SCIENCE PUBL LTD
PI HILVERSUM
PA PO BOX 1673, 1200 BR HILVERSUM, NETHERLANDS
SN 1381-6128
J9 CURR PHARM DESIGN
JI Curr. Pharm. Design
PY 2002
VL 8
IS 21
BP 1917
EP 1928
DI 10.2174/1381612023393666
PG 12
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 582PB
UT WOS:000177359400005
PM 12171527
DA 2018-10-20
ER

PT J
AU Ichikawa, A
   Tsuchiya, T
AF Ichikawa, A
   Tsuchiya, T
TI A strategy for the suppression of tumorigenesis induced by biomaterials:
   Restoration of transformed phenotype of polyetherurethane-induced tumor
   cells by Cx43 transfection
SO CYTOTECHNOLOGY
LA English
DT Article
DE biomaterial; connexin 43; gap junctional intercellular communication;
   malignant fibrous histiocytoma; polyetherurethane; subcutaneous
   implantation
ID GAP-JUNCTIONAL COMMUNICATION; C6 GLIOMA-CELLS; INTERCELLULAR
   COMMUNICATION; METABOLIC COOPERATION; PROMOTING ACTIVITY; SUBCUTANEOUS
   IMPLANTATION; CARCINOMA-CELLS; GROWTH-CONTROL; CANCER-CELLS; EXPRESSION
AB Biomaterials such as polyetherurethans (PEUs) are the scaffolding, which is indispensable for the development of the bio-artificial organs. However, PEUs can induce tumors in subcutaneous implantation sites in rat. We have shown that the different inhibitory potential of gap junctional intercellular communication (GJIC) on the surface of the biomaterials, including PEUs, is a key step in determining the tumorigenic potential. Here we show that suppression of a gap junctional protein connexin 43 (Cx43) plays an important role in in vivo tumorigenesis induced by PEUs for the first time and that Cx43 transfection may be an effective strategy for preventing tumorigenesis induced by biomaterials. Rat tumor cell line U41 is derived from tumors in the subcutaneous implantation of PEU films. The GJIC and the expression of Cx43 were suppressed in U41. The restoration of normal phenotype, such as reduction of growth rate, recovery of contact inhibition and loss of colony formation ability in soft agar, was achieved by Cx43 transfection. These results strongly suggest that suppression of Cx43 expression plays an important role in the development of rat malignant fibrous histiocytoma (MFHC) caused by PEUs and that Cx43 transfection is effective for prevention of tumorigenesis induced by PEUs.
C1 Natl Inst Hlth Sci, Div Med Devices, Setagaya Ku, Tokyo 1588501, Japan.
   Japan Sci & Technol Corp, Kawaguchi 3320012, Japan.
RP Tsuchiya, T (reprint author), Natl Inst Hlth Sci, Div Med Devices, Setagaya Ku, 1-18-1 Kamiyoga, Tokyo 1588501, Japan.
CR Asamoto M, 1998, JPN J CANCER RES, V89, P481, DOI 10.1111/j.1349-7006.1998.tb03287.x
   BENNETT MVL, 1991, NEURON, V6, P305, DOI 10.1016/0896-6273(91)90241-Q
   EGHBALI B, 1991, P NATL ACAD SCI USA, V88, P10701, DOI 10.1073/pnas.88.23.10701
   ELFOULY MH, 1987, EXP CELL RES, V168, P422, DOI 10.1016/0014-4827(87)90014-0
   GROSSMAN HB, 1994, CANCER RES, V54, P3062
   GUTHRIE SC, 1989, TRENDS NEUROSCI, V12, P12, DOI 10.1016/0166-2236(89)90150-1
   Huang RP, 1998, CANCER RES, V58, P5089
   KARASUYAMA H, 1988, EUR J IMMUNOL, V18, P97, DOI 10.1002/eji.1830180115
   KLAUNIG JE, 1990, LAB INVEST, V62, P135
   Klugherz BD, 2000, NAT BIOTECHNOL, V18, P1181
   LEE SW, 1992, J CELL BIOL, V118, P1213, DOI 10.1083/jcb.118.5.1213
   LO CW, 1979, CELL, V18, P411, DOI 10.1016/0092-8674(79)90060-6
   LOEWENSTEIN WR, 1979, BIOCHIM BIOPHYS ACTA, V560, P1, DOI 10.1016/0304-419X(79)90002-7
   MESNIL M, 1993, MOL CARCINOGEN, V7, P14, DOI 10.1002/mc.2940070103
   MESNIL M, 1995, CANCER RES, V55, P629
   NAKAMURA A, 1992, J BIOMED MATER RES, V26, P631, DOI 10.1002/jbm.820260506
   Nakaoka R, 1997, J BIOMED MATER RES, V35, P391, DOI 10.1002/(SICI)1097-4636(19970605)35:3<391::AID-JBM13>3.0.CO;2-I
   NAUS CCG, 1992, CANCER RES, V52, P4208
   Schoen F.J., 1987, T AM SOC ART INT ORG, V33, P8
   STEWART WW, 1978, CELL, V14, P741, DOI 10.1016/0092-8674(78)90256-8
   STEWART WW, 1981, NATURE, V292, P17, DOI 10.1038/292017a0
   TOMASETTO C, 1993, J CELL BIOL, V122, P157, DOI 10.1083/jcb.122.1.157
   Tsai H, 1996, BIOCHEM BIOPH RES CO, V227, P64, DOI 10.1006/bbrc.1996.1468
   TSUCHIYA T, 1995, J BIOMED MATER RES, V29, P835, DOI 10.1002/jbm.820290708
   Tsuchiya T., 1998, Proceedings of the American Association for Cancer Research Annual Meeting, V39, P200
   Tsuchiya T, 1995, J LONG-TERM EFF MED, V5, P233
   Tsuchiya T, 1996, J BIOMED MATER RES, V31, P299
   TSUCHIYA T, 1995, J BIOMED MATER RES, V29, P113, DOI 10.1002/jbm.820290116
   Tsuchiya T, 2000, J BIOMAT SCI-POLYM E, V11, P947, DOI 10.1163/156856200744129
   TSUCHIYA T, 1999, SURG IMPLANTS OTHER, V74, P290
   TSUCHIYA T, 1999, SURG IMPLANTS OTHER, V74, P293
   TSUDA H, 1995, CARCINOGENESIS, V16, P101, DOI 10.1093/carcin/16.1.101
   UPHAM BL, 1995, ENVIRON SCI TECHNOL, V29, P2923, DOI 10.1021/es00012a006
   WILGENBUS KK, 1992, INT J CANCER, V51, P522, DOI 10.1002/ijc.2910510404
   WU Y, 1992, J APPL POLYM SCI, V46, P201, DOI 10.1002/app.1992.070460202
   XI TF, 1994, J BIOMED MATER RES, V28, P483, DOI 10.1002/jbm.820280411
   Zhang ZQ, 1998, CARCINOGENESIS, V19, P1889, DOI 10.1093/carcin/19.11.1889
   ZHU D, 1991, P NATL ACAD SCI USA, V88, P1883, DOI 10.1073/pnas.88.5.1883
NR 38
TC 2
Z9 2
U1 0
U2 2
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0920-9069
J9 CYTOTECHNOLOGY
JI Cytotechnology
PY 2002
VL 39
IS 1
BP 1
EP 8
DI 10.1023/A:1022430021868
PG 8
WC Biotechnology & Applied Microbiology; Cell Biology
SC Biotechnology & Applied Microbiology; Cell Biology
GA 646MN
UT WOS:000181039000001
PM 19003298
DA 2018-10-20
ER

PT J
AU Burillon, C
   Kodjikian, L
   Pellon, G
   Martra, A
   Freney, J
   Renaud, FNR
AF Burillon, C
   Kodjikian, L
   Pellon, G
   Martra, A
   Freney, J
   Renaud, FNR
TI In-vitro study of bacterial adherence to different types of intraocular
   lenses
SO DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
LA English
DT Article
ID COAGULASE-NEGATIVE STAPHYLOCOCCI; ADHESION; EPIDERMIDIS; HYDROPHOBICITY;
   HEPARIN; METHACRYLATE; PREVENTION; CATHETERS; SURFACES; ORIGIN
AB The aim of this study was to determine the adherence of Staphylococcus epidermidis to intraocular lenses made of five different biomaterials: polymethylmethacrylate (PMMA), heparinized PMMA, silicone, hydrophilic acrylic, and hydrogel. The extent of bacterial binding was measured by counting. The results were compared using a one-factor variance analysis. Adherence was weakest on hydrogel and strongest on the silicone polymer. Bacterial adherence to the implant surface must therefore depend on the hydrophobicity or hydrophilicity of the biomaterial.
C1 Inst Sci Pharmaceut & Biol, Microbiol Lab, F-69379 Lyon 08, France.
RP Renaud, FNR (reprint author), Inst Sci Pharmaceut & Biol, Microbiol Lab, Pavillon Netien,8 Av Rockefeller, F-69379 Lyon 08, France.
RI burillon, carole/C-5989-2014
OI burillon, carole/0000-0002-1850-9038
CR AbuElAsrar AM, 1997, INT OPHTHALMOL, V21, P71, DOI 10.1023/A:1005835013581
   ALFONSO EC, 1995, ARCH OPHTHALMOL-CHIC, V113, P1369, DOI 10.1001/archopht.1995.01100110029018
   ARCIOLA CR, 1994, J CATARACT REFR SURG, V20, P158, DOI 10.1016/S0886-3350(13)80157-5
   Bos R, 1999, FEMS MICROBIOL REV, V23, P179, DOI 10.1016/S0168-6445(99)00004-2
   CARRUTHERS MM, 1983, INFECT IMMUN, V40, P444
   CUSUMANO A, 1991, OPHTHALMOLOGY, V98, P1703
   DANKERT J, 1986, CRITICAL REV BIOCOMP, V2, P263
   DILLY PN, 1989, J CATARACT REFR SURG, V15, P317, DOI 10.1016/S0886-3350(89)80092-6
   HOGT AH, 1986, J BIOMED MATER RES, V20, P533, DOI 10.1002/jbm.820200409
   JANSEN B, 1991, J HOSP INFECT, V19, P83, DOI 10.1016/0195-6701(91)90100-M
   Kenne L, 1983, POLYSACCHARIDES, P287
   KRISTINSSON KG, 1989, J MED MICROBIOL, V28, P249, DOI 10.1099/00222615-28-4-249
   LUDWICKA A, 1985, J MICROBIOL METH, V4, P169, DOI 10.1016/0167-7012(85)90033-8
   MAGNUSSON KE, 1982, SCAND J INFECT DIS, P32
   MULLER E, 1993, INFECT IMMUN, V61, P551
   MULLER E, 1993, J INFECT DIS, V168, P1211, DOI 10.1093/infdis/168.5.1211
   Ng EWM, 1996, J CATARACT REFR SURG, V22, P1331, DOI 10.1016/S0886-3350(96)80093-9
   NODA Y, 1986, J BACTERIOL, V167, P1016, DOI 10.1128/jb.167.3.1016-1019.1986
   PASCUAL A, 1986, EUR J CLIN MICROBIOL, V5, P518, DOI 10.1007/BF02017694
   Pinna A, 2000, OPHTHALMOLOGY, V107, P1042, DOI 10.1016/S0161-6420(00)00080-4
   PORTOLES M, 1993, J CATARACT REFR SURG, V19, P755, DOI 10.1016/S0886-3350(13)80345-8
   RASKIN EM, 1993, ARCH OPHTHALMOL-CHIC, V111, P250, DOI 10.1001/archopht.1993.01090020104032
   REES D. A., 1982, POLYSACCHARIDES, V1, P195
   Rutter PR, 1980, MICROBIAL ADHESION S
   Schloricke E, 1997, OPHTHALMOLOGE, V94, P785, DOI 10.1007/s003470050204
   Schmidt H, 1998, ZBL BAKT-INT J MED M, V287, P135, DOI 10.1016/S0934-8840(98)80159-X
   TETZ MR, 1996, ASCRS S CAT IOL REFR
   VANDERMEI HC, 1992, J DISPER SCI TECHNOL, V13, P447, DOI 10.1080/01932699208943327
   VANOSS CJ, 1995, COLLOID SURFACE B, V5, P91, DOI 10.1016/0927-7765(95)01217-7
NR 29
TC 23
Z9 28
U1 1
U2 4
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0363-9045
EI 1520-5762
J9 DRUG DEV IND PHARM
JI Drug Dev. Ind. Pharm.
PY 2002
VL 28
IS 1
BP 95
EP 99
DI 10.1081/DDC-120001490
PG 5
WC Chemistry, Medicinal; Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 521WX
UT WOS:000173865300011
PM 11859867
DA 2018-10-20
ER

PT S
AU Yamada, K
   Nakamura, S
   Tsuchiya, T
   Yamashita, K
AF Yamada, K
   Nakamura, S
   Tsuchiya, T
   Yamashita, K
BE Murata, M
   Kimura, T
   Fujitsu, S
   Shinozaki, K
TI Electrical properties of polarized partially stabilized zirconia for
   biomaterials
SO ELECTROCERAMICS IN JAPAN IV
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 20th Electronics Division Meeting of the Ceramic-Society-of-Japan
CY OCT, 2000
CL KAWASAKI, JAPAN
SP Ceram Soc Japan
DE biomaterial; grain and grain boundary; Partially Stabilized Zirconia;
   polarization; thermally stimulated depolarization current
AB Partially Stabilized Zirconia. (PSZ) ceramics for biomaterials were electrically polarized. The depolarization process of PSZ was investigated by thermally stabilized depolarized current (TSDC) measurement. The biocompatibility of polarized PSZ was examined using osteoblastic cell cultivation. The PSZ (containing 3 mol% Y2O3) pellets sintered at 1400 degreesC for Ih were polarized at 800 degreesC for 1h in a d.c. field of 50Vcm(-1). The proliferation of adhesive cells were accelerated on the negative charge surface and decelerated on the positive charge surface.
C1 Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Chiyoda Ku, Tokyo 1010062, Japan.
   Sci Univ Tokyo, Fac Ind Sci & Technol, Chiba 2788510, Japan.
RP Yamada, K (reprint author), Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Chiyoda Ku, 2-3-10 Kanda Surugadai, Tokyo 1010062, Japan.
CR KOKUBO T, 1990, J BIOMED MATER RES, V24, P331, DOI 10.1002/jbm.820240306
   NAKAMURA S, IN PRESS J APP PHYS
   OHGAKI M, 1999, P 12 INT S CERM MED, P187
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Yamashita K, 1996, CHEM MATER, V8, P2697, DOI 10.1021/cm9602858
NR 5
TC 3
Z9 3
U1 0
U2 1
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-883-4
J9 KEY ENG MAT
PY 2002
VL 216
BP 149
EP 152
DI 10.4028/www.scientific.net/KEM.216.149
PG 4
WC Materials Science, Ceramics; Materials Science, Composites
SC Materials Science
GA BT31S
UT WOS:000172619400035
DA 2018-10-20
ER

PT J
AU Schweiger, M
   Rheinberger, V
   Holand, W
AF Schweiger, M
   Rheinberger, V
   Holand, W
TI Sintered apatite glass-ceramic and nanophase formation in glass-ceramics
SO GLASS SCIENCE AND TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT 7th International Otto Schott Colloquium
CY JUL 07-11, 2002
CL FRIEDRICH SCHILLER UNIV, JENA, GERMANY
HO FRIEDRICH SCHILLER UNIV
AB The formation of fluorapatite in translucent glass-ceramics was studied in the SiO2-Li2O-K2O-ZnO-CaO-P2O5-F system by SEM and thermal analysis. Needle-like apatite represented the main crystal phase of the glass-ceramic. By means of the precipitation of fluorapatite crystals, optical properties similar to those of natural teeth were achieved. Therefore, the glass-ceramic was proposed as a biomaterial for restorative dental treatment. The apatite glass-ceramic is characterized by a flexural strength of 106 +/- 17 MPa (requirement according to dental ISO standards: 50 MPa), good chemical durability in 4% acetic acid, and a thermal expansion coefficient (100-400 degreesC) of 9.75 +/- 0.25 . 10(-6) K-1. Additionally, the material can be homogeneously sintered at 750 degreesC with low residual porosity. Nanophase formation was studied in apatite-containing glass-ceramics. The main goal of the investigation was to control the nucleation processes. Glassy nanophases and crystalline nanophases were developed in glass-ceramics for dental applications.
C1 Ivoclar Vivadent AG, FL-9494 Schaan, Liechtenstein.
RP Schweiger, M (reprint author), Ivoclar Vivadent AG, Bendererstr 2, FL-9494 Schaan, Liechtenstein.
CR BEALL GH, 1971, SPECIAL PUBLICATION, V5, P251
   *BRIT STAND I, 1978, 56121978 BSI
   Chan JCC, 2001, CHEM MATER, V13, P4198, DOI 10.1021/cm0101834
   Clifford A, 1996, J NON-CRYST SOLIDS, V196, P346, DOI 10.1016/0022-3093(95)00611-7
   Frank M., 1994, GLASTECH BER GLASS C, V67, P117
   Holand W, 2002, GLASS CERAMIC TECHNO
   International Organization for Standardization, 1995, 68721995E ISO
   Moisescu C, 1999, PHOSPHORUS RES B, V10, P515
   Muller R, 1999, J MATER SCI, V34, P65, DOI 10.1023/A:1004457305970
   PANNHORST W, 1993, CERAM TRANS, V30, P267
   SCHWEIGER M, 2002, IN PRESS P 104 AM CE
NR 11
TC 0
Z9 0
U1 0
U2 0
PU VERLAG DEUTSCHEN GLASTECHNISCHEN
PI FRANKFURT
PA MENDELSSOHNSTR 75-77, D-60325 FRANKFURT, GERMANY
SN 0946-7475
J9 GLASS SCI TECHNOL
JI Glass Sci. Technol.
PY 2002
VL 75
SU S
BP 103
EP 108
PG 6
WC Materials Science, Ceramics
SC Materials Science
GA 667UP
UT WOS:000182252600019
DA 2018-10-20
ER

PT J
AU Fini, M
   Giavaresi, G
   Rimondini, L
   Giardino, R
AF Fini, M
   Giavaresi, G
   Rimondini, L
   Giardino, R
TI Titanium alloy osseointegration in cancellous and cortical bone of
   ovariectomized animals: Histomorphometric and bone hardness measurements
SO INTERNATIONAL JOURNAL OF ORAL & MAXILLOFACIAL IMPLANTS
LA English
DT Article
DE bone-biomaterial interface; implant; microhardness; osseointegration;
   osteoporosis; titanium alloy
ID RAT MODEL; POSTMENOPAUSAL WOMEN; IMPLANTS; OSTEOPOROSIS; INTERFACE;
   HYDROXYAPATITE; MICROHARDNESS; BIOMATERIALS; FRACTURES; TIBIA
AB Purpose: Histomorphometry and microhardness measurements were performed after Ti6Al4V implantation in cancellous and cortical bone of healthy and ovariectomized animals to determine characterization of the bone-biomaterial interface in osteopenic bone. Materials and Methods: Nine ovariectomized and 9 sham-aged rats were used. Four months later, nails were implanted in the distal femurs, and the animals were sacrificed after 8 weeks. Moreover, 3 ovariectomized and 3 sham-aged sheep were used. Twenty-four months later, screws were implanted in the tibial diaphyses and the animals were sacrificed after 12 weeks. Results: Histomorphometry showed the development of osteopenia in both trabecular and cortical bone, and revealed a significant decrease in the osseointegration rate in osteopenic versus sham-aged animals for both trabecular (Affinity Index: -18.6%, P < .001) and cortical bone (Affinity Index: -23.5%, P < .005; Bone Ingrowth: -9%, P < .05). At the interfaces of the sham-aged animals in both trabecular and cortical bone, a decrease of bone microhardness was observed in comparison with preexisting bone (trabecular: -9.8%, P < .0005; cortical: -19.3%, P < .0005). In case of osteopenia, this decrease was even more extensive (trabecular: -15.5%, P < .0005; cortical: -24.7%, P < .0005). Discussion: The present data suggest that bone formation around Ti6Al4V was not associated with complete bone maturation, even in healthy animals. In case of osteopenia, both bone formation and maturation were delayed. Conclusion: These results apparently demonstrate the utility of investigating biomaterials in osteopenic bone and the importance of careful evaluation of the healing rate and bone maturation degree around implanted biomaterials.
C1 Rizzoli Orthopaed Inst, Res Inst Codivilla Putti, Dept Expt Surg, I-40136 Bologna, Italy.
   Univ Milan, Dept Oral Med & Pathol, Milan, Italy.
   Univ Bologna, Fac Med, Bologna, Italy.
RP Fini, M (reprint author), Rizzoli Orthopaed Inst, Res Inst Codivilla Putti, Dept Expt Surg, Via Barbiano 1-10, I-40136 Bologna, Italy.
RI Fini, Milena/J-4808-2016
OI Fini, Milena/0000-0002-3732-3570; Giavaresi,
   Gianluca/0000-0001-7843-5969
CR BARRIOS C, 1993, J ORTHOP TRAUMA, V7, P438, DOI 10.1097/00005131-199310000-00006
   Becker W, 2000, J PERIODONTOL, V71, P625, DOI 10.1902/jop.2000.71.4.625
   Bellino FL, 2000, MENOPAUSE, V7, P14, DOI 10.1097/00042192-200007010-00004
   Blomqvist JE, 1996, INT J ORAL MAX SURG, V25, P63, DOI 10.1016/S0901-5027(96)80015-4
   Bollen AM, 2000, ORAL SURG ORAL MED O, V90, P518, DOI 10.1067/moe.2000.107802
   Buser D, 1999, PROCEEDINGS OF THE 3RD EUROPEAN WORKSHOP ON PERIODONTOLOGY: IMPLANT DENTISTRY, P88
   Celiker R, 2000, RHEUMATOL INT, V19, P205, DOI 10.1007/s002960000058
   Chappard D, 1999, INT J ORAL MAX IMPL, V14, P189
   CHENG SL, 1995, J BONE MINER RES, V10, P139
   Dao T T, 1993, Int J Oral Maxillofac Implants, V8, P137
   Fini M, 2000, INT J ARTIF ORGANS, V23, P275
   Fini M, 1997, INT J ARTIF ORGANS, V20, P291
   Fini M, 2001, J BONE JOINT SURG BR, V83B, P139, DOI 10.1302/0301-620X.83B1.10162
   Fini M, 2000, J MATER SCI-MATER M, V11, P579, DOI 10.1023/A:1008932303913
   FROST HM, 1992, BONE MINER, V18, P227, DOI 10.1016/0169-6009(92)90809-R
   Fujimoto T, 1998, INT J ORAL MAX IMPL, V13, P183
   Fujimoto T, 1996, Int J Oral Maxillofac Implants, V11, P539
   Giavaresi G, 2000, BONE, V26, P297, DOI 10.1016/S8756-3282(99)00267-7
   GLOWACKI J, 1991, BONE-BIOMATERIAL INTERFACE, P265
   HAMMERLE CHF, 1994, PROCEEDINGS OF THE 1ST EUROPEAN WORKSHOP ON PERIODONTOLOGY, P297
   Hara T, 1999, J BONE JOINT SURG BR, V81B, P705, DOI 10.1302/0301-620X.81B4.9138
   HAYASHI K, 1994, BIOMATERIALS, V15, P11, DOI 10.1016/0142-9612(94)90189-9
   Huja SS, 1998, J ORTHOPAED RES, V16, P54, DOI 10.1002/jor.1100160110
   HUJA SS, 1999, MECH TESTING BONE BO, P247
   *ISO, 1994, 10993 ISO
   Jilka RL, 1998, BONE, V23, P75, DOI 10.1016/S8756-3282(98)00077-5
   Kannus P, 2000, ARCH INTERN MED, V160, P2145, DOI 10.1001/archinte.160.14.2145
   KLEEREKOPER M, 1998, METABOLIC BONE DIS, P387
   Krall EA, 1996, CALCIFIED TISSUE INT, V59, P433, DOI 10.1007/BF00369206
   KRIBBS PJ, 1990, J PROSTHET DENT, V63, P218, DOI 10.1016/0022-3913(90)90108-O
   Kubo T, 1999, J STEROID BIOCHEM, V68, P197, DOI 10.1016/S0960-0760(99)00032-1
   Linkhart TA, 1996, BONE, V19, pS1, DOI 10.1016/S8756-3282(96)00138-X
   Marie PJ, 1999, HISTOL HISTOPATHOL, V14, P525, DOI 10.14670/HH-14.525
   MARTIN RB, 1988, J BONE JOINT SURG AM, V70A, P540, DOI 10.2106/00004623-198870040-00010
   Miller SC, 1997, J DENT RES, V76, P1471, DOI 10.1177/00220345970760080901
   MILLER SC, 1991, BONE, V12, P439, DOI 10.1016/8756-3282(91)90033-F
   Mori H, 1997, J ORAL MAXIL SURG, V55, P351, DOI 10.1016/S0278-2391(97)90124-5
   Moroni A, 1997, J ORTHOP TRAUMA, V11, P154, DOI 10.1097/00005131-199704000-00003
   Muschler G.F., 1992, BONE GRAFTS BONE SUB, P375
   Namkung-Matthai H, 2001, BONE, V28, P80, DOI 10.1016/S8756-3282(00)00414-2
   NEWMAN E, 1995, BONE, V16, pS277, DOI 10.1016/8756-3282(95)00026-A
   NISHIMURA I, 1992, J PROSTHET DENT, V67, P820, DOI 10.1016/0022-3913(92)90592-X
   Oleksik A, 2000, J BONE MINER RES, V15, P1384, DOI 10.1359/jbmr.2000.15.7.1384
   Pan JL, 2000, J ORAL MAXIL SURG, V58, P877, DOI 10.1053/joms.2000.8212
   PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617
   RALTSON SH, 1992, CYTOKINE BONE METABO, P362
   Roberts W E, 1992, Implant Dent, V1, P11, DOI 10.1097/00008505-199200110-00002
   RUFF CB, 1988, J ORTHOP RES, V6, P886, DOI 10.1002/jor.1100060613
   SAVARINO L, 1995, J BIOMED MATER RES, V29, P701, DOI 10.1002/jbm.820290605
   Soballe K, 1993, Acta Orthop Scand Suppl, V255, P1
   STEA S, 1995, J BIOMED MATER RES, V29, P695, DOI 10.1002/jbm.820290604
   Takeshita F, 1997, J PERIODONTOL, V68, P180, DOI 10.1902/jop.1997.68.2.180
   Thomas John G., 1995, Clinical Microbiology Newsletter, V17, P125, DOI 10.1016/S0196-4399(00)80022-7
   Thorndike E. A., 1998, FRONT BIOSCI, V3, P17
   VONWOWERN N, 1994, J PERIODONTOL, V65, P1134, DOI 10.1902/jop.1994.65.12.1134
   Walsh WR, 1997, CLIN ORTHOP RELAT R, P218
   Weber R L, 1997, Periodontal Clin Investig, V19, P5
   WHEELER DL, 2000, J ORTHOP TRAUMA, V2, P86
   Wiktorowicz ME, 2001, OSTEOPOROSIS INT, V12, P271, DOI 10.1007/s001980170116
   YAMAZAKI I, 1989, J BONE MINER RES, V4, P13
   Yamazaki M, 1999, ORAL SURG ORAL MED O, V87, P411, DOI 10.1016/S1079-2104(99)70239-8
NR 61
TC 33
Z9 36
U1 0
U2 5
PU QUINTESSENCE PUBL CO INC
PI CAROL STREAM
PA 551 NORTH KIMBERLY DR, CAROL STREAM, IL 60188-1881 USA
SN 0882-2786
J9 INT J ORAL MAX IMPL
JI Int. J. Oral Maxillofac. Implants
PD JAN-FEB
PY 2002
VL 17
IS 1
BP 28
EP 37
PG 10
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 521DY
UT WOS:000173824700004
PM 11858572
DA 2018-10-20
ER

PT J
AU Saikumar, C
AF Saikumar, C
TI Adhesives in the leather industry - perspectives for changing needs
SO JOURNAL OF ADHESION SCIENCE AND TECHNOLOGY
LA English
DT Article
DE leather surface; adhesive formulations; joint design; footwear adhesives
ID SURFACE; STRENGTH; FAILURE; ENERGY
AB Adhesion is a surface physico-chemical phenomenon. The nature of the adhesive joint and its mechanical proper-ties depend strongly on the nature of the substrate and the interaction of adhesive with the substrate. The adhesives are used in a wide array of applications ranging from packaging to aircraft and spacecraft. Leather is a unique biomaterial. It has a three-dimensional fibrillar textured surface. The use of adhesives in the leather industry has been mostly confined to the production of footwear and, to some extent, in leather goods and garments. Leather articles and footwear are made using synthetic dissimilar materials. where the adhesion between the leather and other materials such as cotton fiber, nylon, polyester, and other synthetics is important. The use of adhesives in such instances requires a careful selection and application of adhesives depending on the end-use of the leather product. The present overview discusses, at length, the various aspects of usage of adhesives in the leather industry, keeping in view the perspectives for the changing needs that are emerging in the third millennium. The description of adhesives widely in use and the improvements required to meet the environmental aspects and on-line production are discussed in terms of their formulations, physical properties. cure, and substrate preparations.
C1 Cent Leather Res Inst, Ind Chem Div, Chennai 600020, Tamil Nadu, India.
RP Saikumar, C (reprint author), Cent Leather Res Inst, Ind Chem Div, Chennai 600020, Tamil Nadu, India.
CR AHMED SU, 1999, ADHESIVES AGE, V34
   Almela M, 1999, J SOC LEATH TECH CH, V83, P32
   Arrowsmith D. J., 1970, T I MET FINISH, V48, P88, DOI 10.1080/00202967.1970.11870136
   *ASTM, 1955, TERMS REL ADH D907
   ATTENBURROW GE, 1994, J AM LEATHER CHEM AS, V89, P391
   Bikerman J. J., 1961, SCI ADHESIVE JOINTS
   BOLGER JC, 1973, TREATISE ADHESION AD, V6, pCH3
   BOLLARD I, 1995, WORLD LEATHER    JUN, P31
   Bosch T, 1999, J SOC LEATH TECH CH, V83, P243
   BRENNAN WJ, 1991, POLYMER, V32, P527
   CAGLE CV, 1968, ADHESIVE BONDING, pCH2
   DEMPSEY M, 1948, PROGR LEATHER SCI
   DERJAGUIN BV, 1960, P 3 INT C SURF ACT B, V2, P349
   DICKINSON JT, 1994, J ADHES SCI TECHNOL, V8, P1285, DOI 10.1163/156856194X00618
   FAFARD M, 1994, J ADHES SCI TECHNOL, V8, P1383, DOI 10.1163/156856194X00681
   FERRANDIZGOMEZ TP, 1994, J ADHES SCI TECHNOL, V8, P1043, DOI 10.1163/156856194X00915
   FOX HW, 1952, J COLL SCI IMP U TOK, V7, P428, DOI 10.1016/0095-8522(52)90008-1
   GLEDHILL RA, 1974, J ADHESION, V6, P315, DOI 10.1080/00218467408075035
   HOMES CM, 1971, J SOC LEATHER TECHNO, V55, P242
   HUNSTON DL, 1989, J ADHESION, V28, P103, DOI 10.1080/00218468908030877
   IYENGAR Y, 1967, J APPL POLYM SCI, V11, P2311, DOI 10.1002/app.1967.070111118
   KAELBLE DH, 1962, ADHESION COHESION, P75
   KAZUTAMI W, 1998, HIKAKU KAGAKU SCI, V44, P159
   Kinloch A. J., 1975, AM CHEM SOC DIV ORG, V35, P546
   KRONICK PL, 1995, JALCA, V91, P39
   Landrock AK, 1985, ADHESIVE TECHNOLOGY
   Lange S, 1999, J SOC LEATH TECH CH, V83, P1
   LEVINE M, 1964, POLYM LETT, V2, P915
   Liu CK, 1997, J AM LEATHER CHEM AS, V92, P157
   Long AJ, 1999, J SOC LEATH TECH CH, V83, P167
   Maeser M., 1960, JALCA, V55, P501
   MANGIPUDI V, 1994, J ADHES SCI TECHNOL, V8, P1251, DOI 10.1163/156856194X00591
   MANSFIELD KF, 1991, MACROMOLECULES, V24, P6283, DOI 10.1021/ma00023a034
   McBain JW, 1927, IND ENG CHEM, V19, P1005, DOI 10.1021/ie50213a016
   MCBAIN JW, 1925, J PHYS CHEM-US, V29, P88
   MCLAUGHLIN GD, 1945, CHEM LEATHER MANUFAC
   Mittal K. L., 2000, ACID BASE INTERACTIO, V2
   Mittal K. L., 1991, ACID BASE INTERACTIO
   MITTAL KL, 1977, POLYM ENG SCI, V17, P467, DOI 10.1002/pen.760170709
   MITTAL KL, 1975, ADHESION SCI TECHNOL, P129
   MITTAL KL, 1992, METALLIZED PLASTICS, V3
   MOORE JS, 1998, Patent No. 5807409
   NEEDLES HL, 1980, J APPL POLYM SCI, V25, P1745, DOI 10.1002/app.1980.070250821
   NEGRU D, 1998, PIEL BLANURI INLOCUI, V7, P29
   OFLAHERTY F, 1958, CHEM TECHNOL LEATHER, V1, P5
   QIAN AU, 1997, HENAN HUAGONG, V4, P18
   RAHMAN MA, 1993, BANGLADESH J SCI RES, V28, P142
   SAMMS JB, 1998, ADHESIVES AGE, V18
   *SATRA, 1990, SATRA B          MAR, P5
   SKLYAR TA, 1993, Patent No. 1792845
   STIRTZ T, 1975, DAS LEDER, V26, P156
   Strobel M., 1994, PLASMA SURFACE MODIF
   TAME R, 1996, WORLD LEATHER    JAN, P69
   THIAGARAJAN M, 1992, ADHESIVES AGE, V34
   VACULIC J, 1992, DAS LEDER, V43, P104
   VACULIK J, 1995, LEDER, V46, P28
   VOSS PA, 1998, ADHESIVES AGE, V26
   Wake W C, 1973, J COATED FABRICS, V3, P84
   WHITTAKER RE, 1975, J SOC LEATHER TECHNO, V59, P172
   WILSON JA, 1944, MODERN PRACTICE LEAT
   WU SH, 1987, POLYM ENG SCI, V27, P335, DOI 10.1002/pen.760270506
   ZISMAN WA, 1963, IND ENG CHEM, V55, P19
   ZISMAN WA, 1962, ADHESION COHESION, P176
NR 63
TC 3
Z9 3
U1 0
U2 4
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0169-4243
J9 J ADHES SCI TECHNOL
JI J. Adhes. Sci. Technol.
PY 2002
VL 16
IS 5
BP 543
EP 563
DI 10.1163/156856102760070367
PG 21
WC Engineering, Chemical; Materials Science, Multidisciplinary; Mechanics
SC Engineering; Materials Science; Mechanics
GA 560TE
UT WOS:000176096800004
DA 2018-10-20
ER

PT J
AU Spijker, HT
   Bos, R
   Busscher, HJ
   Graaff, R
   van Oeveren, W
AF Spijker, HT
   Bos, R
   Busscher, HJ
   Graaff, R
   van Oeveren, W
TI Adhesion of blood platelets under flow to wettability gradient
   polyethylene surfaces made in a shielded gas plasma
SO JOURNAL OF ADHESION SCIENCE AND TECHNOLOGY
LA English
DT Article
DE platelets; wettability gradients; adhesion; flow; detachment
ID PROTEIN ADSORPTION; FIBROBLASTS; FIBRINOGEN; ABSORPTION; ACTIVATION
AB Adhesion and activation of platelets are important steps in the thrombosis of blood after contact with a biomaterial surface and are governed, in part, by the wettability of the surface. Since most implanted devices are in contact with blood under flow conditions, it is important to study the effect of wettability of device surfaces on the behavior of platelets also under flow. To this end, wettability gradient polyethylene surfaces were prepared through glow discharge with partial shielding over a length of 5 cm, with advancing water contact angles varying from 95 to 45 degrees and a contact angle hysteresis of 30 degrees. The role of blood flow on the adhesion of platelets was examined by incubating these gradient surfaces in anticoagulated, whole human blood under static conditions or in blood under a flow of 10 or 40 ml/min through a 3 mm diameter circuit or for 5 or 15 min with either the hydrophobic or hydrophilic end upstream. Generally, more platelets adhered on the hydrophilic end of the wettability gradient than on the hydrophobic end, although the increment along the wettability gradient was dependent on both the flow conditions and direction. More platelets adhered under a flow of 10 ml/min than under static conditions, due to higher mass transport. Especially when the hydrophilic end was upstream, there was a more pronounced adhesion. This can be explained in terms of immediate platelet activation by shear stress imposed at the upstream end. During flow of 40 ml/min, platelet adhesion on an upstream hydrophilic end was less than on a downstream hydrophilic end. We conclude that platelets detach from the hydrophilic end at high shear stress due to the spherical form of adhered platelets. Platelets on the hydrophobic end could withstand detachment by strong, flat shaped platelet-material contact.
C1 Univ Groningen, Dept Biomed Engn, NL-9713 AV Groningen, Netherlands.
RP Busscher, HJ (reprint author), Univ Groningen, Dept Biomed Engn, Antonius Deusinglaan 1, NL-9713 AV Groningen, Netherlands.
RI Graaff, Reindert/G-8941-2011
CR Andrade JD, 1985, SURFACE INTERFACIAL, VI, P15
   Dintenfass L., 1976, RHEOLOGY BLOOD DIAGN
   ELWING H, 1987, J COLLOID INTERF SCI, V119, P203, DOI 10.1016/0021-9797(87)90260-8
   ELWING H, 1990, ADV COLLOID INTERFAC, V32, P317, DOI 10.1016/0001-8686(90)80022-R
   Elwing H, 1998, BIOMATERIALS, V19, P397, DOI 10.1016/S0142-9612(97)00112-9
   FREDRICKSON BJ, 1987, HEMOSTASIS THOMBOSIS, P625
   Jen CJ, 1996, AM J PHYSIOL-HEART C, V270, pH160
   LEE JH, 1992, J COLLOID INTERF SCI, V151, P563, DOI 10.1016/0021-9797(92)90504-F
   Lee JH, 1999, J BIOMAT SCI-POLYM E, V10, P283
   OBRIEN JR, 1990, LANCET, V335, P711, DOI 10.1016/0140-6736(90)90815-M
   Otto K, 1999, COLLOID SURFACE B, V15, P99, DOI 10.1016/S0927-7765(99)00050-8
   OWEN MJ, 1988, POLYM SURFACE DYNAMI, P101
   Petibois C, 2001, CLIN CHEM, V47, P730
   POLANOWSKAGRABOWSKA R, 1992, P NATL ACAD SCI USA, V89, P5754, DOI 10.1073/pnas.89.13.5754
   Ruardy TG, 1997, J COLLOID INTERF SCI, V188, P209, DOI 10.1006/jcis.1997.4769
   RUARDY TG, 1995, J BIOMED MATER RES, V29, P1415, DOI 10.1002/jbm.820291113
   RUARDY TG, 1997, SURF SCI REP, V27, P1
   Spijker H. T., 1997, Cells and Materials, V7, P201
   Spijker HT, 1999, COLLOID SURFACE B, V15, P89, DOI 10.1016/S0927-7765(99)00056-9
   Spijker HT, 2002, BIOMATERIALS, V23, P757, DOI 10.1016/S0142-9612(01)00181-8
   Suzuki H, 1996, PROG HISTOCHEM CYTOC, V30, P1
   VANDERMEI HC, 1991, J ADHES SCI TECHNOL, V5, P757, DOI 10.1163/156856191X00684
   VENNART JK, 1982, ELEMENTARY FLUID MEC
   Vroman L, 1969, J Biomed Mater Res, V3, P43, DOI 10.1002/jbm.820030106
   VROMAN L, 1980, BLOOD, V55, P156
   WAHLGREN M, 1995, COLLOID SURFACE B, V4, P23
   WARKENTIN P, 1994, BIOMATERIALS, V15, P786, DOI 10.1016/0142-9612(94)90033-7
   Welle A, 1998, J COLLOID INTERF SCI, V197, P263, DOI 10.1006/jcis.1997.5238
   Yayapour N, 1999, COLLOID SURFACE B, V15, P127, DOI 10.1016/S0927-7765(99)00049-1
NR 29
TC 10
Z9 10
U1 2
U2 9
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0169-4243
J9 J ADHES SCI TECHNOL
JI J. Adhes. Sci. Technol.
PY 2002
VL 16
IS 13
BP 1703
EP 1713
DI 10.1163/156856102320396094
PG 11
WC Engineering, Chemical; Materials Science, Multidisciplinary; Mechanics
SC Engineering; Materials Science; Mechanics
GA 607WW
UT WOS:000178814600001
DA 2018-10-20
ER

PT J
AU Motta, A
   Migliaresi, C
   Lloyd, AW
   Denyer, SP
   Santin, M
AF Motta, A
   Migliaresi, C
   Lloyd, AW
   Denyer, SP
   Santin, M
TI Serum protein absorption on silk fibroin fibers and films: Surface
   opsonization and binding strength
SO JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS
LA English
DT Article
ID COMPLEMENT ACTIVATION; POLYMER SURFACES; SOLID-SURFACES; ADSORPTION;
   ALPHA-1-MICROGLOBULIN
AB Fibroin, the core of the silk filament protein, has been proposed as a biomaterial for different biomedical applications since it can be engineered as a thread, fabric or film. Infrared spectroscopy suggests that the dissolution of the fibroin filaments and subsequent casting of the fibroin solution into films followed by treatment with methanol alters the protein structure leading to an increase in amorphous domains. The adsorption of serum proteins on fabrics and films showed different hydrophobic binding strengths for the two materials with the protein binding being greatest for the more hydrophobic fibroin fibers. Differences between the materials were also observed in the adsorption of key immunoproteins. Although the C3 fragment of the complement system was adsorbed on both the surfaces, it appeared to be activated preferentially on the fibroin films and not on the fibroin fibers, whereas the Bb and C1q factors were only significantly present on the fibroin fabric. IgG appeared to be adsorbed, although to different extents, on both types of fibroin substrates. These results suggest that the biocompatibility of the silk fibroin may be affected by changes in protein structure induced by processing the material.
C1 Univ Trent, Dipartimento Ingn Mat, I-38050 Trent, Italy.
   Univ Brighton, Sch Pharm & Biomol Sci, Brighton BN2 4GJ, E Sussex, England.
RP Motta, A (reprint author), Univ Trent, Dipartimento Ingn Mat, Via Mesiano 77, I-38050 Trent, Italy.
RI Lloyd, Andrew/D-1369-2011
OI Lloyd, Andrew/0000-0003-2778-8195
CR AMBROSE EJ, 1951, NATURE, V167, P264, DOI 10.1038/167264a0
   ANDERSON JM, 1988, AM SOC ARTIF INTERN, V28, P767
   BARBUCCI R, 1994, BIOMATERIALS, V15, P955, DOI 10.1016/0142-9612(94)90075-2
   BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5
   ELWING H, 1988, J COLLOID INTERF SCI, V125, P139, DOI 10.1016/0021-9797(88)90062-8
   Gemmell CH, 1997, J BIOMED MATER RES, V37, P474
   Gotoh Y, 1997, BIOMATERIALS, V18, P267, DOI 10.1016/S0142-9612(96)00137-8
   HIRABAYASHI K, 1968, SEN-I GAKKAISHI, V24, P392
   IIZUKA E, 1968, BIOCHEMISTRY-US, V7, P2218, DOI 10.1021/bi00846a026
   KATAOKA K, 1976, KOBUNSHI RONBUNSHU, V33, P453, DOI 10.1295/koron.33.453
   KREJCHI MT, 1994, SCIENCE, V265, P1427, DOI 10.1126/science.8073284
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LOTZ B, 1979, BIOCHIMIE, V61, P205, DOI 10.1016/S0300-9084(79)80067-X
   MAGOSHI J, 1975, J APPL POLYM SCI, V19, P1013, DOI 10.1002/app.1975.070190410
   MAGOSHI J, 1985, J APPL POLYM SCI APP, V41, P187
   MINOURA N, 1990, BIOMATERIALS, V11, P430, DOI 10.1016/0142-9612(90)90100-5
   MONTI P, IN PRESS J RAMAN SPE
   PAYNE MS, 1987, J BIOMED MATER RES, V21, P843, DOI 10.1002/jbm.820210703
   Sakabe H., 1989, SEN-I GAKKAISHI, V45, P487
   Santin M, 1998, J MATER SCI-MATER M, V9, P135, DOI 10.1023/A:1008863518572
   Santin M, 1997, BIOMATERIALS, V18, P823, DOI 10.1016/S0142-9612(97)00004-5
   Santin M, 1999, J BIOMED MATER RES, V46, P382, DOI 10.1002/(SICI)1097-4636(19990905)46:3<382::AID-JBM11>3.0.CO;2-R
   SOONG HK, 1984, OPHTHALMOLOGY, V91, P479
   Um IC, 2001, INT J BIOL MACROMOL, V29, P91, DOI 10.1016/S0141-8130(01)00159-3
   WAHLGREN M, 1991, TRENDS BIOTECHNOL, V9, P201, DOI 10.1016/0167-7799(91)90064-O
   Wilson D, 2000, BIOPHYS J, V78, P2690, DOI 10.1016/S0006-3495(00)76813-5
NR 26
TC 29
Z9 29
U1 1
U2 16
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 6 BONHILL STREET, LONDON EC2A 4PU, ENGLAND
SN 0883-9115
J9 J BIOACT COMPAT POL
JI J. Bioact. Compat. Polym.
PD JAN
PY 2002
VL 17
IS 1
BP 23
EP 35
DI 10.1106/088391102023195
PG 13
WC Biotechnology & Applied Microbiology; Materials Science, Biomaterials;
   Polymer Science
SC Biotechnology & Applied Microbiology; Materials Science; Polymer Science
GA 551KF
UT WOS:000175559600002
DA 2018-10-20
ER

PT J
AU Karakecili, AG
   Gumusderelioglu, M
AF Karakecili, AG
   Gumusderelioglu, M
TI Comparison of bacterial and tissue cell initial adhesion on
   hydrophilic/hydrophobic biomaterials
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE bacterial adhesion; tissue integration; biomaterials;
   biomaterial-centered infection
ID STAPHYLOCOCCUS-EPIDERMIDIS; PSEUDOMONAS-AERUGINOSA; MICROBIAL ADHESION;
   SURFACES; POLYMERS; INVITRO; GROWTH; ENERGY; PHEMA; PU
AB In this study, interactions of widely-used polymeric biomaterials, i.e. poly(hydroxyethyl methacrylate) (PHEMA) and its copolymer with dimethylaminoethyl methacrylate (PHEMA-20% DMAEMA), polyurethane (PU), polypropylene (PP), poly(vinyl chloride) (PVC), and poly(lactide-glycolide) (PLGA), with three pathogenic bacteria and one nonpathogen were investigated comparatively with the adhesion of two tissue cells in different morphologies, i.e. fibroblast-like baby hamster kidney (BHK 21) cells and epithelia] Madine Darby kidney (MDBK) cells. Biomaterials were prepared in the membrane form by bulk polymerization or solvent casting. Surface characterization studies showed that these polymers have different surface free energies in the range of 26.9-63.1 erg cm(-2) and they have smooth surfaces. The bacteria used were; Escherichia coli ATCC 25922, Staphylococcus epidermidis ATCC 12228, Staphylococcus aureus, and Lactobacillus acidophilus B-13. Initial adhesion of bacteria to the polymeric surfaces was examined under static conditions and in a laminar flow cell. The adhesion behaviour of S. aureus and S. epidermidis was found independent of the polymeric surface hydrophobicity. However, the percentage of attached E. coli decreased when increasing the surface free energy of the polymer, while L. acidophilus showed just the opposite behaviour. The comparative results indicated that the adhesion of BHK and MDBK cell was lowest on the most hydrophilic PHEMA surface and highest oil the most hydrophobic PP surface. In contrast to the case of bacterial adhesion, no relationship was found between polymer hydrophobicity and mammalian cell adherence.
C1 Hacettepe Univ, Dept Chem Engn, TR-06532 Ankara, Turkey.
RP Gumusderelioglu, M (reprint author), Hacettepe Univ, Dept Chem Engn, TR-06532 Ankara, Turkey.
CR ANDRADE JD, 1979, J COLLOID INTERF SCI, V72, P488, DOI 10.1016/0021-9797(79)90350-3
   Anwar H., 1992, ASM NEWS, V58, P665
   Bos R, 1999, FEMS MICROBIOL REV, V23, P179, DOI 10.1016/S0168-6445(99)00004-2
   BROKKE P, 1992, J MATER SCI-MATER M, V3, P101, DOI 10.1007/BF00705276
   Busscher H J, 1997, Adv Dent Res, V11, P24
   BUTRUS SI, 1990, CURR EYE RES, V9, P717, DOI 10.3109/02713689008999566
   COOK AD, 1993, J BIOMED MATER RES, V27, P119, DOI 10.1002/jbm.820270115
   Gottenbos B, 2000, J BIOMED MATER RES, V50, P208, DOI 10.1002/(SICI)1097-4636(200005)50:2<208::AID-JBM16>3.0.CO;2-D
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   GRISTINA AG, 1991, INTERFACIAL PHENOMEN, P106
   GRISTINA AG, 1996, BIOMATERIALS SCI INT, P205
   Gumusderelioglu M, 2000, J BIOMAT SCI-POLYM E, V11, P1039, DOI 10.1163/156856200743562
   HOEDEMAKER HOT, 1997, BIOMEDICAL MAT RES G, P109
   KIREMITCI M, 1991, Clinical Materials, V8, P9, DOI 10.1016/0267-6605(91)90004-Y
   KIREMITCI M, 1994, J BIOMAT SCI-POLYM E, V6, P425
   Kiremitci M, 1993, J Biomater Appl, V7, P250, DOI 10.1177/088532829300700304
   KiremitciGumusderelioglu M, 1996, BIOMATERIALS, V17, P443, DOI 10.1016/0142-9612(96)89662-1
   KUNIN CM, 1985, J CLIN MICROBIOL, V21, P902
   REID G, 1988, MICROBIAL ECOL, V16, P241, DOI 10.1007/BF02011698
   REID G, 1991, BIOFOULING, V4, P171, DOI DOI 10.1080/08927019109378207
   Schakenraad J.M., 1996, BIOMATERIALS SCI INT, P141
   SCHAKENRAAD JM, 1986, J BIOMED MATER RES, V20, P773, DOI 10.1002/jbm.820200609
   TANG LP, 1995, AM J CLIN PATHOL, V103, P466
   Tsibouklis J, 1999, BIOMATERIALS, V20, P1229, DOI 10.1016/S0142-9612(99)00023-X
   Vacheethasanee K, 2000, J BIOMED MATER RES, V50, P302, DOI 10.1002/(SICI)1097-4636(20000605)50:3<302::AID-JBM3>3.0.CO;2-1
   VANLOOSDRECHT MCM, 1989, MICROBIAL ECOL, V17, P1, DOI 10.1007/BF02025589
   VANWACHEM PB, 1985, BIOMATERIALS, V6, P403, DOI 10.1016/0142-9612(85)90101-2
   VERHEYEN CCPM, 1993, J BIOMED MATER RES, V27, P775, DOI 10.1002/jbm.820270610
   VERHEYEN CCPM, 1993, BIOMATERIALS, V14, P383, DOI 10.1016/0142-9612(93)90059-B
   VISSER SA, 1996, BIOMATERIALS SCI INT, P50
NR 30
TC 34
Z9 35
U1 3
U2 30
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2002
VL 13
IS 2
BP 185
EP 196
DI 10.1163/156856202317414366
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 553WA
UT WOS:000175698300006
PM 12022749
DA 2018-10-20
ER

PT J
AU Caplan, MR
   Schwartzfarb, EM
   Zhang, SG
   Kamm, RD
   Lauffenburger, DA
AF Caplan, MR
   Schwartzfarb, EM
   Zhang, SG
   Kamm, RD
   Lauffenburger, DA
TI Effects of systematic variation of amino acid sequence on the mechanical
   properties of a self-assembling, oligopeptide biomaterial
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE shear modulus; protein engineering; rational design
ID COMPLEMENTARY OLIGOPEPTIDE; HYDROPHOBICITY SCALE; RESIDUES; POLYMERS;
   MATRIX
AB In order to elucidate design principles for biocompatible materials that can be created by in situ transformation from self-assembling oligopeptides, we investigate a class of oligopeptides that can self-assemble in salt solutions to form three-dimensional matrices. This class of peptides possesses a repeated sequence of amino acid residues with the type: hydrophobic/negativelycharged/hydrophobic/positively-charged. We systematically vary three chief aspects of this sequence type: (1) the hydrophobic side chains; (2) the charged side chains; and (3) the number of repeats. Each of these has been previously shown to influence the self-assembly properties of these materials. Employing a rheometric assay we measure the shear modulus of gels created from variants of each of these aspects. First, we observe order-of-magnitude changes in shear moduli when we vary oligopeptide length, with biphasic dependence on length. This result may be due to competition between, in short oligopeptides, additional repeats either increasing the diameter of the filaments or increasing the area of interaction between individual molecules and, in large oligopeptides, additional repeats allowing the oligopeptides to fold back upon themselves and decrease their effective length. Second, no statistically significant difference is observed among the hydrophobic variants, suggesting that hydrophobicity and steric overlap are unlikely to play a significant role in filament mechanical properties. Finally, in variation of the charged side chains we observe a small difference in the shear moduli that, if significant, may mean that decreasing the energetic penalty for dehydrating the charged side chains can lead to a stiffer matrix. Overall, we demonstrate that it is possible to achieve order-of-magnitude changes in shear modulus by simple variations of oligopeptide length, while the residue substitutions affect only self-assembly properties. Thus. diverse aspects of these molecules can be designed rationally to yield desirable materials properties of different type.
C1 MIT, Dept Chem Engn, Cambridge, MA 02139 USA.
   MIT, Ctr Biomed Engn, Cambridge, MA 02139 USA.
   MIT, Dept Mech Engn, Cambridge, MA 02139 USA.
   MIT, Biol Engn Div, Cambridge, MA 02139 USA.
RP Lauffenburger, DA (reprint author), MIT, Dept Chem Engn, Cambridge, MA 02139 USA.
OI /0000-0002-7232-304X
FU NIGMS NIH HHS [GM55781]
CR Bostman OM, 2000, CLIN ORTHOP RELAT R, P216
   BULL HB, 1974, ARCH BIOCHEM BIOPHYS, V161, P665, DOI 10.1016/0003-9861(74)90352-X
   Caplan MR, 2000, BIOMACROMOLECULES, V1, P627, DOI 10.1021/bm005586w
   Caplan MR, 2002, BIOMATERIALS, V23, P219, DOI 10.1016/S0142-9612(01)00099-0
   CLARK AH, 1987, ADV POLYM SCI, V83, P58
   CREIGHTON TE, 1993, PROTEINS STRUCTURE M, P142
   Gibson L. J., 1988, CELLULAR SOLIDS
   Ignatius AA, 1996, BIOMATERIALS, V17, P831, DOI 10.1016/0142-9612(96)81421-9
   Leon EJ, 1998, J BIOMAT SCI-POLYM E, V9, P297, DOI 10.1163/156856298X00668
   Prockop D. J., 1994, EXTRACELLULAR MATRIX, P47
   ROSE GD, 1985, SCIENCE, V229, P834, DOI 10.1126/science.4023714
   Urry DW, 1998, BIOPOLYMERS, V47, P167, DOI 10.1002/(SICI)1097-0282(1998)47:2<167::AID-BIP6>3.0.CO;2-S
   Vorobev MM, 1997, Z NATURFORSCH C, V52, P227
   WELLINGS DA, 1997, METHOD ENZYMOL, V289, P61
   ZHANG SG, 1994, BIOPOLYMERS, V34, P663, DOI 10.1002/bip.360340508
   ZHANG SG, 1993, P NATL ACAD SCI USA, V90, P3334, DOI 10.1073/pnas.90.8.3334
   ZHANG SG, 1995, BIOMATERIALS, V16, P1385, DOI 10.1016/0142-9612(95)96874-Y
NR 17
TC 63
Z9 64
U1 0
U2 17
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2002
VL 13
IS 3
BP 225
EP 236
DI 10.1163/156856202320176493
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 576ET
UT WOS:000176990400001
PM 12102591
DA 2018-10-20
ER

PT J
AU Ma, N
   Petit, A
   Yahia, L
   Huk, OL
   Tabrizian, M
AF Ma, N
   Petit, A
   Yahia, L
   Huk, OL
   Tabrizian, M
TI Cytotoxic reaction and TNF-alpha response of macrophages to polyurethane
   particles
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE polyurethane particles; inflammatory response; macrophage; cytotoxicity
ID TUMOR NECROSIS FACTOR; POLYETHYLENE PARTICLES; INFLAMMATORY RESPONSE;
   IN-VITRO; DEGRADATION; INVIVO; BIOCOMPATIBILITY; BIODEGRADATION;
   BIOMATERIALS; SIZE
AB Their unique mechanical and biological properties make polyurethanes (PUs) ideal materials for many implantable devices. However, uncertain long-term biostability in the human physiological environment limits their extensive clinical applications. Chronic inflammatory response associated with macrophage activation has been suggested as a prime factor; although the mechanism of macrophage activation in response to biomaterial surfaces and debris is still unknown. The overall objective of this work was to study the response of macrophages to PU materials in vitro by measuring cell viability and activity. The studies were carried out using phagocytozable-size PU particles from three types of commercially-available PUs: Pellethane(R) 2363 80ABA (PL); Tecothane(R) TT2065 (TC65); and Tecothane(R) TT2085 (TC85). These polymers posess the same generic composition but differ in the length of hard and soft segments, as revealed by the FTIR and NMR studies. The results showed that PU particles affected both viability and activity of J774 macrophages. The percentage of mortality ranged front 1 to 15% with 10-100 mugml(-1) of particles after 24 and 48 h incubation. These three types of particles induced different mortality on the macrophages. Specifically, the mortality with PL particles was 1-4% (p > 0.05), while the mortality with TC85 particles was 2-10% (p < 0.05) and 4-15% with TC65 (p < 0.05). Conversely, these particles also affected cell proliferation. Cell numbers increased by 132 and 167% after 24 and 48 h incubation, respectively, without particles, whereas the cell numbers increased only 46 and 78% with TC65, 66 and 105% with TC85, and 67 and 110% with PL in the presence of 100 mug ml(-1) of particles for the respective incubation times. PU particles also increased TNF-alpha release from macrophage. After having been incubated for 24 h with 100 mug ml(-1) particles of TC65, TC85, and PL, macrophages release TNF-alpha 7.4, 5.2, and 4.1 times more than the control. In conclusion, PU particles had cytotoxic effects on J774 macrophage at high concentrations. The order of macrophage response for three types of particles was TC65 > TC85 > PL. PU particles' effect on macrophage viability and activity depends on the concentration of particles and their chemical composition, especially on the ratio of hard to soft segments.
C1 McGill Univ, Dept Biomed Engn, Montreal, PQ H3A 2B4, Canada.
   Ecole Polytech, GRBB, Inst Biomed Engn, Montreal, PQ H3C 3A7, Canada.
   McGill Univ, Lady Davis Inst Med Res, Div Orthoped Surg, Montreal, PQ H3T 1E2, Canada.
RP Tabrizian, M (reprint author), McGill Univ, Dept Biomed Engn, 3775 Univ St, Montreal, PQ H3A 2B4, Canada.
CR Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593
   ANDERSON JM, 1984, BIOMATERIALS, V5, P5, DOI 10.1016/0142-9612(84)90060-7
   AZIZSOLTANI E, 1995, J BIOMED MATER RES, V29, P101, DOI 10.1002/jbm.820290114
   Bellingan GJ, 1996, J IMMUNOL, V157, P2577
   BENOIT FM, 1993, J BIOMED MATER RES, V27, P1341, DOI 10.1002/jbm.820271014
   BOUVIER M, 1991, J BIOMED MATER RES, V25, P773, DOI 10.1002/jbm.820250607
   BRUNSTEDT MR, 1990, BIOMATERIALS, V11, P370, DOI 10.1016/0142-9612(90)90089-9
   CASAS J, 1999, J BIOMED MATER RES, V15, P475
   Catelas I, 1998, J BIOMED MATER RES, V41, P600, DOI 10.1002/(SICI)1097-4636(19980915)41:4<600::AID-JBM12>3.3.CO;2-7
   Chen JH, 1998, J BIOMED MATER RES, V41, P633, DOI 10.1002/(SICI)1097-4636(19980915)41:4<633::AID-JBM16>3.0.CO;2-F
   Clark RAF, 1988, MOL CELLULAR BIOL WO
   Collier T, 1998, J BIOMED MATER RES, V41, P192, DOI 10.1002/(SICI)1097-4636(199808)41:2<192::AID-JBM3>3.0.CO;2-D
   DARBY TD, 1978, TOXICOL APPL PHARM, V46, P449, DOI 10.1016/0041-008X(78)90090-X
   DEVOR DE, 1993, TOXICOL PATHOL, V21, P261, DOI 10.1177/019262339302100301
   FERRANTE A, 1988, INT ARCH ALLER A IMM, V86, P82, DOI 10.1159/000234610
   GRASEL TG, 1986, BIOMATERIALS, V7, P315, DOI 10.1016/0142-9612(86)90002-5
   Green TR, 2000, J BIOMED MATER RES, V53, P490, DOI 10.1002/1097-4636(200009)53:5<490::AID-JBM7>3.0.CO;2-7
   GUIDOIN R, 1992, ANN PLAS SURG, V28, P342, DOI 10.1097/00000637-199204000-00009
   Holevinsky KO, 1998, BIOPHYS J, V75, P2577, DOI 10.1016/S0006-3495(98)77703-3
   Hunt JA, 1996, J BIOMED MATER RES, V31, P139, DOI 10.1002/(SICI)1097-4636(199605)31:1<139::AID-JBM15>3.0.CO;2-I
   Jayabalan M, 1993, J Biomater Appl, V8, P64, DOI 10.1177/088532829300800104
   Johnston CJ, 1996, TOXICOL APPL PHARM, V140, P154, DOI 10.1006/taap.1996.0208
   LABOW RS, 1995, BIOMATERIALS, V16, P51, DOI 10.1016/0142-9612(95)91096-H
   Labow RS, 1999, J BIOMATER APPL, V13, P187, DOI 10.1177/088532829901300302
   Lamba N. M. K., 1998, POLYURETHANES BIOMED
   LUU HMD, 1994, J APPL BIOMATER, V5, P1, DOI 10.1002/jab.770050102
   MCGRATH MH, 1990, CLIN PLAST SURG, V17, P421
   MEIJS GF, 1993, J BIOMED MATER RES, V27, P345, DOI 10.1002/jbm.820270308
   MILLER KM, 1988, J BIOMED MATER RES, V22, P713, DOI 10.1002/jbm.820220805
   MOONEY DP, 1990, ANN SURG, V211, P124, DOI 10.1097/00000658-199002000-00002
   Pauluhn J, 2000, ARCH TOXICOL, V74, P257, DOI 10.1007/s002040000114
   PHILLIPS R, 1988, PACING CLIN ELECTROP, V9, P1166
   Rice JM, 1998, J BIOMAT SCI-POLYM E, V9, P833, DOI 10.1163/156856298X00181
   Saad B, 1997, J BIOMED MATER RES, V36, P65, DOI 10.1002/(SICI)1097-4636(199707)36:1<65::AID-JBM8>3.3.CO;2-#
   SATO M, 1995, J BIOMED MATER RES, V29, P1201, DOI 10.1002/jbm.820291007
   SINCLAIR TM, 1995, PLAST RECONSTR SURG, V96, P1326, DOI 10.1097/00006534-199511000-00014
   STOKES K, 1995, J BIOMATER APPL, V9, P321, DOI 10.1177/088532829500900402
   Szycher M, 1991, J Biomater Appl, V6, P110, DOI 10.1177/088532829100600202
   Szycher M., 1985, CORROSION DEGRADATIO, P308
   SZYCHER M, 1991, HIGH PERFORMANCE BIO, P223
   TANG LP, 1995, AM J CLIN PATHOL, V103, P466
   Tsuchiya T, 1996, J BIOMED MATER RES, V31, P299
   Vermette P, 1999, J BIOMAT SCI-POLYM E, V10, P729, DOI 10.1163/156856299X00612
   Wang GB, 1997, J CHROMATOGR B, V698, P69, DOI 10.1016/S0378-4347(97)00282-X
   WILLIAMS DF, 1991, CONCISE ENCY MED DEN
   WU Y, 1991, J BIOMED MATER RES, V25, P1415, DOI 10.1002/jbm.820251109
   Zdrahala RJ, 1996, J BIOMATER APPL, V11, P37, DOI 10.1177/088532829601100102
   Zhang Z, 1997, BIOMATERIALS, V18, P113, DOI 10.1016/S0142-9612(96)00054-3
   ZHAO Q, 1990, J BIOMED MATER RES, V24, P621, DOI 10.1002/jbm.820240508
   ZHAO QH, 1992, J BIOMED MATER RES, V26, P1019, DOI 10.1002/jbm.820260805
NR 50
TC 13
Z9 13
U1 1
U2 4
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2002
VL 13
IS 3
BP 257
EP 272
PG 16
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 576ET
UT WOS:000176990400003
PM 12102593
DA 2018-10-20
ER

PT J
AU Wagner, MS
   McArthur, SL
   Shen, MC
   Horbett, TA
   Castner, DG
AF Wagner, MS
   McArthur, SL
   Shen, MC
   Horbett, TA
   Castner, DG
TI Limits of detection for time of flight secondary ion mass spectrometry
   (ToF-SIMS) and X-ray photoelectron spectroscopy (XPS): detection of low
   amounts of adsorbed protein
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE ToF-SIMS; XPS; protein adsorption; quantitation; limit of detection
ID PRINCIPAL COMPONENT ANALYSIS; SURFACE-PLASMON RESONANCE; BIOMATERIAL
   SURFACES; S-SIMS; ADSORPTION; FILMS; POLYMERS; ALBUMIN
AB Characterization of biomaterial surfaces requires analytical techniques that are capable of detecting a wide concentration range of adsorbed protein. This range includes detection of low amounts of adsorbed protein (<10 ng/cm(2)) that may be present on non-fouling biomaterials. X-ray Photoelectron Spectroscopy (XPS) and Time of Flight Secondary Ion Mass Spectrometry (ToF-SIMS) are surface sensitive techniques capable of detecting adsorbed proteins. We have investigated the lower limits of detection of both XPS and ToF-SIMS on four model substrates each presenting unique challenges for analysis by XPS and ToF-SIMS: mica, poly(tetrafluoroethylene), allyl amine plasma polymer and heptyl amine plasma polymer. The detection limit for XPS ranged from 10 ng/cm(2) of fibrinogen (on mica) to 200 ng/cm(2) (on allyl amine plasma polymers). The detection limit for ToF-SIMS ranged from 0.1 ng/cm(2) of fibrinogen to 100 ng/cm(2), depending on the substrate and data analysis. Optimal conditions provided detection limits between 0.1 ng/cm(2) and 15 ng/cm(2) on all of the substrates used in this study. While both techniques were shown to be effective in detecting protein, the sensitivity of both XPS and ToF-SIMS was, shown to be dependent on substrate surface chemistry and the organization of the adsorbed protein film. This study specifically highlights the applicability of ToF-SIMS in the characterization of low level protein adsorption.
C1 Univ Washington, Dept Chem Engn, Natl ESCA & Surface Anal Ctr Biomed Problems, Seattle, WA 98195 USA.
   Univ Washington, Dept Bioengn, Natl ESCA & Surface Anal Ctr Biomed Problems, Seattle, WA 98195 USA.
RP Castner, DG (reprint author), Univ Washington, Dept Chem Engn, Natl ESCA & Surface Anal Ctr Biomed Problems, Box 351750, Seattle, WA 98195 USA.
RI McArthur, Sally/B-6848-2008
OI McArthur, Sally/0000-0002-4914-6989
FU NCRR NIH HHS [RR-01296]; NHLBI NIH HHS [HL19419]
CR Adriaens A, 1999, MASS SPECTROM REV, V18, P48, DOI 10.1002/(SICI)1098-2787(1999)18:1<48::AID-MAS2>3.3.CO;2-9
   Balcells M, 1999, J COLLOID INTERF SCI, V220, P198, DOI 10.1006/jcis.1999.6527
   BARBUCCI R, 1992, Clinical Materials, V11, P37, DOI 10.1016/0267-6605(92)90028-R
   Briggs D, 1996, SURF INTERFACE ANAL, V24, P419, DOI 10.1002/(SICI)1096-9918(199606)24:6<419::AID-SIA132>3.3.CO;2-P
   Burlingame AL, 1998, ANAL CHEM, V70, p647R
   Chittur KK, 1998, BIOMATERIALS, V19, P357, DOI 10.1016/S0142-9612(97)00223-8
   Douglas MA, 1998, SURF INTERFACE ANAL, V26, P984, DOI 10.1002/(SICI)1096-9918(199812)26:13<984::AID-SIA446>3.0.CO;2-K
   Elwing H, 1998, BIOMATERIALS, V19, P397, DOI 10.1016/S0142-9612(97)00112-9
   FADLEY CS, 1984, PROG SURF SCI, V16, P275, DOI 10.1016/0079-6816(84)90001-7
   Ferrari S, 2000, SURF INTERFACE ANAL, V29, P837, DOI 10.1002/1096-9918(200012)29:12<837::AID-SIA937>3.0.CO;2-O
   FITZPATRICK H, 1992, J COLLOID INTERF SCI, V149, P1, DOI 10.1016/0021-9797(92)90384-X
   Green RJ, 1999, BIOMATERIALS, V20, P385, DOI 10.1016/S0142-9612(98)00201-4
   Green RJ, 2000, BIOMATERIALS, V21, P1823, DOI 10.1016/S0142-9612(00)00077-6
   HAGENHOFF B, 1995, BIOSENS BIOELECTRON, V10, P885, DOI 10.1016/0956-5663(95)99226-B
   HORBETT TA, 1981, J BIOMED MATER RES, V15, P673, DOI 10.1002/jbm.820150506
   HORBETT TA, 1986, TECHNIQUES BIOCOMPAT, P183
   Jackson J.E., 1991, USERS GUIDE PRINCIPA
   John CM, 1997, INT J MASS SPECTROM, V161, P47, DOI 10.1016/S0168-1176(96)04505-3
   Kingshott P, 2000, J BIOMED MATER RES, V49, P36, DOI 10.1002/(SICI)1097-4636(200001)49:1<36::AID-JBM5>3.0.CO;2-B
   Leonard D, 1999, FRESEN J ANAL CHEM, V365, P3, DOI 10.1007/s002160051437
   Leonard D., 1999, Plasmas and Polymers, V4, P97, DOI 10.1023/A:1021892707963
   Lhoest JB, 1998, J BIOMED MATER RES, V41, P95, DOI 10.1002/(SICI)1097-4636(199807)41:1<95::AID-JBM12>3.0.CO;2-G
   Lhoest JB, 2001, J BIOMED MATER RES, V57, P432, DOI 10.1002/1097-4636(20011205)57:3<432::AID-JBM1186>3.0.CO;2-G
   LHOEST JB, 1999, 12 INT C SEC ION MAS, P935
   LOPEZ GP, 1991, LANGMUIR, V7, P766, DOI 10.1021/la00052a027
   MANTUS DS, 1993, ANAL CHEM, V65, P1431, DOI 10.1021/ac00058a021
   MARLETTA G, 1990, SURF INTERFACE ANAL, V16, P407, DOI 10.1002/sia.740160185
   MULZER S R, 1990, Journal of Biomaterials Science Polymer Edition, V1, P173
   PAYNTER RW, 1984, J COLLOID INTERF SCI, V101, P233, DOI 10.1016/0021-9797(84)90023-7
   PAYNTER RW, 1985, SURFACE INTERFACIAL, V2, P189
   Ratner BD, 1997, SURFACE ANALYSIS - THE PRINCIPAL TECHNIQUES, P43
   RATNER BD, 1981, J COLLOID INTERF SCI, V83, P630, DOI 10.1016/0021-9797(81)90358-1
   Siedlecki CA, 1998, BIOMATERIALS, V19, P441, DOI 10.1016/S0142-9612(97)00222-6
   SUNDGREN JE, 1986, J COLLOID INTERF SCI, V113, P530, DOI 10.1016/S0021-9797(86)90446-7
   Tidwell CD, 2001, SURF INTERFACE ANAL, V31, P724, DOI 10.1002/sia.1101
   Turner NH, 1998, ANAL CHEM, V70, p229R
   Van Vaeck L, 1999, MASS SPECTROM REV, V18, P1
   Wagner MS, 2001, LANGMUIR, V17, P4649, DOI 10.1021/la001209t
   WELLE A, 1998, J COLLOID INTERF SCI, V197, P262
   WOLD S, 1987, CHEMOMETR INTELL LAB, V2, P37, DOI 10.1016/0169-7439(87)80084-9
NR 40
TC 95
Z9 97
U1 2
U2 57
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2002
VL 13
IS 4
BP 407
EP 428
DI 10.1163/156856202320253938
PG 22
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 586HE
UT WOS:000177577900006
PM 12160301
DA 2018-10-20
ER

PT J
AU Tang, YW
   Labow, RS
   Revenko, I
   Santerre, JP
AF Tang, YW
   Labow, RS
   Revenko, I
   Santerre, JP
TI Influence of surface morphology and chemistry on the enzyme catalyzed
   biodegradation of polycarbonate-urethanes
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE AFM; XPS; polyurethanes; enzymes; hard segment; biodegradation; esterase
ID ATOMIC-FORCE MICROSCOPY; SEGMENTED POLYURETHANES; PHASE-DETECTION;
   POLYMER BLENDS; DEGRADATION; BIOMATERIAL; POLYETHER; CHOLESTEROL;
   HYDROLYSIS; POLY(ETHER
AB Polycarbonate based polyurethanes were synthesized with varying hard segment content as well as hard segment chemistry based on three different diisocyanates,1,6-hexane diisocyanate (HDI), 4,4'-methylene bisphenyl diisocyanate (MDI) and 4,4-methylene biscyclohexyl diisocyanate (HMDI). The surface chemistry and morphology were characterized using X-ray photoelectron spectroscopy (XPS) and atomic force microscopy (AFM). The polymers were incubated with cholesterol esterase (CE) in a phosphate buffer solution at 37degreesC over 10 weeks. XPS results showed that the surface chemistry changed as the size and chemistry of the hard segment varied within the materials. AFM images exhibited distinctive surface morphologies for all polymers, and this was particularly apparent with changes in the hard segment chemistry. The results showed that the surface of HDI polymers consisted of relatively stiff rod-like structures, which corresponded to the soft segment domains. Polymers with a higher HDI content exhibited a dense top layer containing a relatively higher hard segment component, covering the sub-surface matrix of rod like structures. The MDI based polyurethane had large aggregates on its top surface, which corresponded to the aggregation of harder components. The HMDI based polycarbonate-urethane presented a relatively homogeneous surface where no phase separation could be detected. The relative differences in hard and soft segment content in their surface structure was supported by XPS findings. The analysis of the biodegradation results, concluded that enzyme catalyzed biodegradation within these materials was initiated in amorphous soft segment regions located in the region of the interface between hard and soft segments. A higher hard segment content at the surface contributed significantly to an increase in biostability. The findings provided an enhanced understanding for the role of surface molecular structure in the enzyme catalyzed biodegradation of polyurethanes.
C1 Univ Toronto, Fac Dent, Dept Biol & Diagnost Sci, Toronto, ON M5G 1G6, Canada.
   Univ Ottawa, Inst Heart, Ottawa, ON K1Y 4W7, Canada.
   Digital Instruments, Goleta, CA 93117 USA.
RP Santerre, JP (reprint author), Univ Toronto, Fac Dent, Dept Biol & Diagnost Sci, 124 Edward St, Toronto, ON M5G 1G6, Canada.
CR ABE H, 1995, MACROMOLECULES, V28, P844, DOI 10.1021/ma00108a007
   Bar G, 1997, LANGMUIR, V13, P3807, DOI 10.1021/la970091m
   Bourauel C, 1998, EUR J ORTHODONT, V20, P79, DOI 10.1093/ejo/20.1.79
   CHAPMAN TM, 1989, J POLYM SCI POL CHEM, V27, P1993, DOI 10.1002/pola.1989.080270620
   Chen X, 1998, MACROMOLECULES, V31, P2278, DOI 10.1021/ma9704525
   Focarete ML, 1998, MACROMOLECULES, V31, P8485, DOI 10.1021/ma981115e
   Gorman SP, 1998, J BIOMED MATER RES, V39, P642, DOI 10.1002/(SICI)1097-4636(19980315)39:4<642::AID-JBM20>3.0.CO;2-7
   Grobe GL, 1996, J BIOMED MATER RES, V32, P45, DOI 10.1002/(SICI)1097-4636(199609)32:1<45::AID-JBM6>3.0.CO;2-P
   Han DK, 1998, J BIOMAT SCI-POLYM E, V9, P667
   HEARN MJ, 1988, MACROMOLECULES, V21, P2950, DOI 10.1021/ma00188a011
   Iwata T, 1998, MACROMOLECULES, V31, P2461, DOI 10.1021/ma980008h
   LABOW RS, 1994, J BIOMAT SCI-POLYM E, V6, P169, DOI 10.1163/156856294X00293
   LABOW RS, 1995, BIOMATERIALS, V16, P51, DOI 10.1016/0142-9612(95)91096-H
   Labow RS, 1998, J BIOMED MATER RES, V39, P469, DOI 10.1002/(SICI)1097-4636(19980305)39:3<469::AID-JBM18>3.0.CO;2-5
   Lamba N. M. K., 1998, POLYURETHANES BIOMED
   Larsson C, 1996, BIOMATERIALS, V17, P605, DOI 10.1016/0142-9612(96)88711-4
   Magonov SN, 1997, ANNU REV MATER SCI, V27, P175, DOI 10.1146/annurev.matsci.27.1.175
   Magonov SN, 1997, SURF SCI, V375, P385
   McLean RS, 1997, MACROMOLECULES, V30, P8314, DOI 10.1021/ma970350e
   PINCHUK L, 1994, J BIOMAT SCI-POLYM E, V6, P225, DOI 10.1163/156856294X00347
   RATNER BD, 1988, J BIOMED MATER RES, V22, P509, DOI 10.1002/jbm.820220607
   RATNER BD, 1993, CARDIOVASC PATHOL, V2, pS87, DOI 10.1016/1054-8807(93)90049-8
   RATNER BD, 1987, POLYM SURFACES INTER, P231
   Revenko I, 2001, SURF SCI, V491, P346, DOI 10.1016/S0039-6028(01)01298-5
   SANTERRE JP, 1994, J BIOMED MATER RES, V28, P1187, DOI 10.1002/jbm.820281009
   SANTERRE JP, 1993, J BIOMED MATER RES, V27, P97, DOI 10.1002/jbm.820270113
   SERRY FM, 1998, BIOMATERIALS FORUM, V20, P11
   STOKES K, 1982, BIOMATERIALS, V3, P225, DOI 10.1016/0142-9612(82)90024-2
   Stokes K B, 1988, J Biomater Appl, V3, P228, DOI 10.1177/088532828800300205
   Suyama T, 1997, ENZYME MICROB TECH, V20, P122, DOI 10.1016/S0141-0229(96)00084-1
   Szycher M, 1988, J Biomater Appl, V3, P297, DOI 10.1177/088532828800300207
   TABAK A, 1994, J PHARM PHARMACOL, V46, P789, DOI 10.1111/j.2042-7158.1994.tb03731.x
   Tang YW, 2001, J BIOMED MATER RES, V57, P597, DOI 10.1002/1097-4636(20011215)57:4<597::AID-JBM1207>3.0.CO;2-T
   Tang YW, 2001, J BIOMED MATER RES, V56, P516, DOI 10.1002/1097-4636(20010915)56:4<516::AID-JBM1123>3.0.CO;2-B
   Tanzi MC, 1997, J BIOMED MATER RES, V36, P550, DOI 10.1002/(SICI)1097-4636(19970915)36:4<550::AID-JBM14>3.0.CO;2-E
   TINGEY KG, 1991, LANGMUIR, V7, P2471, DOI 10.1021/la00059a013
   TINGEY KG, 1995, SER ACS S, V602, P66
   VANBOGART JWC, 1980, J MACROMOL SCI PHYS, VB17, P267, DOI 10.1080/00222348008213125
NR 38
TC 48
Z9 49
U1 2
U2 14
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2002
VL 13
IS 4
BP 463
EP 483
DI 10.1163/156856202320253965
PG 21
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 586HE
UT WOS:000177577900009
PM 12160304
DA 2018-10-20
ER

PT J
AU Rubens, FD
AF Rubens, FD
TI Cardiopulmonary bypass technology transfer: musings of a cardiac surgeon
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE biocompatibility; heparin-coated circuits; SMA; PMEA; biomembrane
   mimicry; thrombosis; inflammation; cardiopulmonary bypass; review
ID REDUCED COMPLEMENT ACTIVATION; MOLECULAR-WEIGHT KININOGEN;
   HEPARIN-COATED CIRCUITS; HUMAN-PLATELETS; PROCOAGULANT ACTIVITY; PLASMA
   KALLIKREIN; EXTRACORPOREAL-CIRCULATION; PLASMINOGEN-ACTIVATOR;
   IMMOBILIZED HEPARIN; ARTIFICIAL SURFACES
AB The development of cardiopulmonary bypass (CPB) has been one of the greatest technical advancements in cardiovascular medicine. With heparin anticoagulation, this device can safely replace the circulatory and gas-exchanging functions of the heart and lung, facilitating complex cardiac operations. Limitations still exist however, related to blood reactions at the biomaterial surface, such as cell activation, inflammation and low-grade thrombosis. In this brief review, the thought processes which paralleled the development of CPB biocompatible surfaces such as heparin-coating, will be explored, as well as current theories on the suspected mechanisms by which heparin-coated surfaces act as an anti-inflammatory device during CPB. Results with new surfaces for CPB designed to capitalize on superior protein adsorption properties, such as surface modifying additive (SMA) and poly (2-methoxyethylacrylate) (PMEA), will also be described. Finally, the significance of biomaterial-independent blood activation will be discussed, emphasizing the current need to develop strategies utilizing optimal biomaterials, modified surgical technique and pharmacologic therapy to minimize the systemic complications of CPB.
C1 Ottawa Heart Inst, Ottawa, ON K1Y 4W7, Canada.
RP Rubens, FD (reprint author), Ottawa Heart Inst, Room H211,40 Ruskin St, Ottawa, ON K1Y 4W7, Canada.
CR Aldea GS, 1996, ANN THORAC SURG, V62, P410, DOI 10.1016/0003-4975(96)00249-4
   BAIER RE, 1972, B NEW YORK ACAD MED, V48, P257
   BAKHLE YS, 1977, BRIT J PHARMACOL, V59, P123, DOI 10.1111/j.1476-5381.1977.tb06985.x
   Bannan S, 1998, BRIT J HAEMATOL, V101, P455, DOI 10.1046/j.1365-2141.1998.00723.x
   Barstad RM, 1996, BRIT J HAEMATOL, V94, P517, DOI 10.1111/j.1365-2141.1996.tb08989.x
   Baufreton C, 1997, ANN THORAC SURG, V63, P50
   BOISCLAIR MD, 1993, BLOOD, V82, P3350
   BORDET J, 1901, ANN I PASTEUR PARIS, V15, P129
   BRACE LD, 1985, SEMIN THROMB HEMOST, V11, P190, DOI 10.1055/s-2007-1004374
   BRAMSON ML, 1965, J THORAC CARDIOV SUR, V50, P391
   CAMPBELL EJ, 1994, ASAIO J, V40, P853
   CAVAROCCHI NC, 1986, J THORAC CARDIOV SUR, V91, P252
   Chung JH, 1996, CIRCULATION, V93, P2014, DOI 10.1161/01.CIR.93.11.2014
   COLMAN RW, 1990, HEMATOL ONCOL CLIN N, V4, P27
   COLMAN RW, 1984, J CLIN INVEST, V73, P1249, DOI 10.1172/JCI111326
   Davies MG, 1996, J VASC SURG, V23, P410, DOI 10.1016/S0741-5214(96)80005-X
   De Somer F, 2000, EUR J CARDIO-THORAC, V18, P602, DOI 10.1016/S1010-7940(00)00508-X
   Defraigne JO, 2000, ANN THORAC SURG, V70, P2075, DOI 10.1016/S0003-4975(00)01838-5
   DEHAAN J, 1995, ANN THORAC SURG, V59, P901, DOI 10.1016/0003-4975(95)00012-A
   DEHAAN J, 1993, J THORAC CARDIOV SUR, V106, P1017
   deHaan J, 1996, J THORAC CARDIOV SUR, V111, P272, DOI 10.1016/S0022-5223(96)70427-0
   DEWALL RA, 1961, SURGERY, V50, P931
   DEWALL RA, 1962, SURGERY, V51, P251
   DEWALL RA, 1956, SURG CLIN N AM, V36, P1025
   EDMUNDS LH, 1978, ANN THORAC SURG, V25, P306, DOI 10.1016/S0003-4975(10)63546-1
   EDMUNDS LH, 1994, ANN THORAC SURG, V58, P285, DOI 10.1016/0003-4975(94)92193-8
   ELGUE G, 1993, THROMB HAEMOSTASIS, V70, P289
   ELLISON N, 1978, ANESTHESIOLOGY, V48, P65, DOI 10.1097/00000542-197801000-00008
   Ernofsson M, 1997, J THORAC CARDIOV SUR, V113, P576, DOI 10.1016/S0022-5223(97)70373-8
   FEARON DT, 1980, J EXP MED, V152, P20, DOI 10.1084/jem.152.1.20
   Ferraris VA, 1998, ANN THORAC SURG, V65, P352, DOI 10.1016/S0003-4975(97)01348-9
   FUHRER G, 1992, BLOOD COAGUL FIBRIN, V3, P99, DOI 10.1097/00001721-199202000-00014
   GIBBON J H Jr, 1954, Minn Med, V37, P171
   Gorman RC, 1996, J THORAC CARDIOV SUR, V111, P1, DOI 10.1016/S0022-5223(96)70395-1
   Gott VL, 1999, ANN THORAC SURG, V68, pS19, DOI 10.1016/S0003-4975(99)00817-6
   GOTT VL, 1963, SCIENCE, V142, P1297, DOI 10.1126/science.142.3597.1297
   Heller W, 1989, Adv Exp Med Biol, V247B, P43
   Hufnagel C A, 1968, Ann N Y Acad Sci, V146, P262, DOI 10.1111/j.1749-6632.1968.tb20287.x
   Jansen PGM, 1996, ANN THORAC SURG, V61, P1363, DOI 10.1016/0003-4975(96)00056-2
   JUNOD AF, 1977, AM REV RESPIR DIS, V115, P51
   KAZATCHKINE MD, 1979, J EXP MED, V150, P1202, DOI 10.1084/jem.150.5.1202
   KHURI SF, 1995, ANN THORAC SURG, V60, P1008, DOI 10.1016/0003-4975(95)00668-B
   KINLOUGHRATHBONE RL, 1995, THROMB HAEMOSTASIS, V74, P958
   KITAGUCHI H, 1979, THROMB RES, V16, P407, DOI 10.1016/0049-3848(79)90088-4
   LANDE AJ, 1970, T AM SOC ART INT ORG, V16, P352
   LARM O, 1983, BIOMATER ARTIF CELL, V11, P161, DOI 10.3109/10731198309118804
   Lee JH, 1998, J BIOMED MATER RES, V41, P304, DOI 10.1002/(SICI)1097-4636(199808)41:2<304::AID-JBM16>3.0.CO;2-K
   LISTER J, 1863, P ROY SOC, V12, P580
   LOVINGER AJ, 1993, J POLYM SCI POL PHYS, V31, P115, DOI 10.1002/polb.1993.090310201
   Mahoney CB, 1998, PERFUSION-UK, V13, P192, DOI 10.1177/026765919801300307
   Moen O, 1997, ANN THORAC SURG, V63, P105
   MOLLNES TE, 1995, ARTIF ORGANS, V19, P909, DOI 10.1111/j.1525-1594.1995.tb02450.x
   Mombouli JV, 1999, J MOL CELL CARDIOL, V31, P61, DOI 10.1006/jmcc.1998.0844
   Muriithi EW, 2000, ANN THORAC SURG, V69, P1827, DOI 10.1016/S0003-4975(00)01299-6
   NILSSON T, 1983, THROMB HAEMOSTASIS, V49, P193
   OKANO T, 1986, J BIOMED MATER RES, V20, P919, DOI 10.1002/jbm.820200707
   OKANO T, 1981, J BIOMED MATER RES, V15, P393, DOI 10.1002/jbm.820150310
   OLSON ST, 1993, BIOCHEMISTRY-US, V32, P12136, DOI 10.1021/bi00096a026
   Ovrum E, 1995, ANN THORAC SURG, V60, P1755, DOI 10.1016/0003-4975(95)00763-6
   OVRUM E, 1995, ANN THORAC SURG, V60, P365, DOI 10.1016/0003-4975(95)00366-S
   Ovrum E, 1996, ANN THORAC SURG, V62, P1128, DOI 10.1016/0003-4975(96)00490-0
   PACKHAM MA, 1969, J LAB CLIN MED, V73, P686
   Parratt R, 1998, BRIT J HAEMATOL, V101, P40, DOI 10.1046/j.1365-2141.1998.00674.x
   PEKNA M, 1994, ANN THORAC SURG, V58, P421, DOI 10.1016/0003-4975(94)92219-5
   RABHISABILE S, 1995, THROMB HAEMOSTASIS, V73, P693
   Ranucci M, 1999, ANN THORAC SURG, V67, P994, DOI 10.1016/S0003-4975(99)00062-4
   RATNOFF OD, 1955, J CLIN INVEST, V34, P602, DOI 10.1172/JCI103109
   RINDER CS, 1992, BLOOD, V79, P1201
   RINDER CS, 1995, J CLIN INVEST, V96, P1564, DOI 10.1172/JCI118195
   Rubens FD, 1999, ANN THORAC SURG, V67, P689, DOI 10.1016/S0003-4975(99)00068-5
   RUBENS FD, 1995, THROMB HAEMOSTASIS, V73, P850
   RUCINSKI B, 1979, BLOOD, V53, P47
   RYGG IH, 1956, ACTA CHIR SCAND, V112, P443
   Saito N, 2000, ARTIF ORGANS, V24, P547, DOI 10.1046/j.1525-1594.2000.06520.x
   SALZMAN EW, 1971, BLOOD-J HEMATOL, V38, P509
   Shapira OM, 1996, J CARDIAC SURG, V11, P307, DOI 10.1111/j.1540-8191.1996.tb00055.x
   SHUMACKER HB, 2000, CARDIOPULMONARY BYPA, P22
   SIMS PJ, 1995, SEMIN CELL BIOL, V6, P275, DOI 10.1006/scel.1995.0037
   STEINBERG BM, 1995, ANN THORAC SURG, V60, P525, DOI 10.1016/0003-4975(95)00482-Z
   STEINBERG JB, 1993, J THORAC CARDIOV SUR, V106, P1008
   Suhara H, 2001, ANN THORAC SURG, V71, P1603, DOI 10.1016/S0003-4975(01)02466-3
   TABUCHI N, 1993, J THORAC CARDIOV SUR, V106, P828
   Te Velthuis Henk, 1997, Journal of Thoracic and Cardiovascular Surgery, V114, P117, DOI 10.1016/S0022-5223(97)70124-7
   Tengvall P, 1997, J BIOMED MATER RES, V35, P81, DOI 10.1002/(SICI)1097-4636(199704)35:1<81::AID-JBM8>3.0.CO;2-I
   TRACY PB, 1988, SEMIN THROMB HEMOST, V14, P227, DOI 10.1055/s-2007-1002782
   *TRILL, 2000, PROD MON TRILL
   Tsai C C, 1994, ASAIO J, V40, pM619, DOI 10.1097/00002480-199407000-00073
   Videm V, 1999, J THORAC CARDIOV SUR, V117, P803, DOI 10.1016/S0022-5223(99)70302-8
   Videm V, 1999, J THORAC CARDIOV SUR, V117, P794, DOI 10.1016/S0022-5223(99)70301-6
   VONSEGESSER LK, 1994, ANN THORAC SURG, V58, P391
   Voorhees ME, 1996, INT ANESTHESIOL CLIN, V34, P29, DOI 10.1097/00004311-199603420-00005
   WARD PA, 1967, J EXP MED, V126, P189, DOI 10.1084/jem.126.2.189
   WARD RS, 1987, Patent No. 4663413
   WEITZ JI, 1990, J CLIN INVEST, V86, P385, DOI 10.1172/JCI114723
   Wendel HP, 1999, IMMUNOPHARMACOLOGY, V43, P149, DOI 10.1016/S0162-3109(99)00073-9
   WIEDMER T, 1993, BLOOD, V82, P1192
   WIGGINS RC, 1981, J EXP MED, V153, P1391, DOI 10.1084/jem.153.6.1391
   Wildevuur CRH, 1997, EUR J CARDIO-THORAC, V11, P616, DOI 10.1016/S1010-7940(96)01122-0
   Williams D., 1990, CONCISE ENCY MED DEN
NR 99
TC 16
Z9 17
U1 2
U2 5
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2002
VL 13
IS 4
BP 485
EP 499
DI 10.1163/156856202320253974
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 586HE
UT WOS:000177577900010
PM 12160305
DA 2018-10-20
ER

PT J
AU Merrett, K
   Cornelius, RM
   McClung, WG
   Unsworth, LD
   Sheardown, H
AF Merrett, K
   Cornelius, RM
   McClung, WG
   Unsworth, LD
   Sheardown, H
TI Surface analysis methods for characterizing polymeric biomaterials
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Review
DE surface characterization; SEM; AFM; XPS; SIMS; contact angle;
   ellipsometry
ID ATOMIC-FORCE MICROSCOPY; SELF-ASSEMBLED MONOLAYERS; AIR-WATER-INTERFACE;
   ION MASS-SPECTROMETRY; ORGANIZED MOLECULAR ASSEMBLIES; SOLID-LIQUID
   INTERFACE; NEUTRON REFLECTION; X-RAY; PROTEIN ADSORPTION; IN-VITRO
AB Surface properties have an enormous effect on the success or failure of a biomaterial device, thus signifying the considerable importance of and the need for adequate characterization of the biomaterial surface. Microscopy techniques used in the analysis of biomaterial surfaces include scanning electron microscopy, transmission electron microscopy, atomic force microscopy, and confocal microscopy. Spectroscopic techniques include X-ray photoelectron spectroscopy, Fourier Transform infrared attenuated total reflection and secondary ion mass spectrometry. The measurement of contact angles, although one of the earlier techniques developed remains a very useful tool in the evaluation of surface hydrophobicity/ hydrophilicity. This paper provides a brief, easy to understand synopsis of these and other techniques including emerging techniques, which are proving useful in the analysis of the surface properties of polymeric biomaterials. Cautionary statements have been made, numerous authors referenced and examples used to show the specific type of information that can be acquired from the different techniques used in the characterization of polymeric biomaterials surfaces.
C1 McMaster Univ, Dept Chem Engn, Hamilton, ON L8S 4L7, Canada.
   McMaster Univ, Dept Pathol, Hamilton, ON L8S 4L7, Canada.
   McMaster Univ, Dept Mol Med, Hamilton, ON L8S 4L7, Canada.
   Univ Ottawa, Dept Chem Engn, Ottawa, ON K1N 6N5, Canada.
RP Sheardown, H (reprint author), McMaster Univ, Dept Chem Engn, Hamilton, ON L8S 4L7, Canada.
RI Unsworth, Larry/A-7231-2011
CR AKINYEMI O, 1992, SCANNING, V14, P136, DOI 10.1002/sca.4950140303
   ALLARA DL, 1985, LANGMUIR, V1, P45, DOI 10.1021/la00061a007
   Amato I, 1997, SCIENCE, V276, P1982, DOI 10.1126/science.276.5321.1982
   Andrade J.D., 1985, SURFACE INTERFACIAL, V1, P1985
   Appenzeller T, 1997, SCIENCE, V276, P1981, DOI 10.1126/science.276.5321.1981
   Azzam R. M. A., 1977, ELLIPSOMETRY POLARIZ
   BARBUCCI R, 1992, Clinical Materials, V11, P37, DOI 10.1016/0267-6605(92)90028-R
   BATICH CD, 1988, APPL SURF SCI, V32, P57, DOI 10.1016/0169-4332(88)90073-6
   Battistoni C, 2000, SURF INTERFACE ANAL, V29, P773, DOI 10.1002/1096-9918(200011)29:11<773::AID-SIA928>3.3.CO;2-U
   Benesch J, 2001, J BIOMAT SCI-POLYM E, V12, P581, DOI 10.1163/156856201316883421
   BENNINGHOVEN A, 1984, ORG MASS SPECTROM, V19, P346, DOI 10.1002/oms.1210190713
   Bianco-Peled H, 2001, LANGMUIR, V17, P6931, DOI 10.1021/la990383i
   Born R, 1998, FRESEN J ANAL CHEM, V361, P697, DOI 10.1007/s002160050997
   BRANDRUP J, 1975, POLYM HDB
   BROWNE MA, 1992, SCANNING, V14, P145, DOI 10.1002/sca.4950140304
   Brunner H, 1999, J COLLOID INTERF SCI, V212, P545, DOI 10.1006/jcis.1998.6062
   Burns NL, 1998, BIOMATERIALS, V19, P423, DOI 10.1016/S0142-9612(97)00225-1
   CHEN J, 2000, MACROMOLECULES, V33, P4276
   Chen JX, 1999, MACROMOLECULES, V32, P7380, DOI 10.1021/ma990205w
   CHILKOTI A, 1991, CHEM MATER, V3, P51, DOI 10.1021/cm00013a016
   Chittur KK, 1998, BIOMATERIALS, V19, P301, DOI 10.1016/S0142-9612(97)00107-5
   Clifton BJ, 1998, PHYSICA B, V248, P289, DOI 10.1016/S0921-4526(98)00252-X
   Conrad KA, 1996, REV SCI INSTRUM, V67, P3954, DOI 10.1063/1.1147273
   Cook AD, 1997, J BIOMED MATER RES, V35, P513
   Cullander C, 1998, J Investig Dermatol Symp Proc, V3, P166
   CUMPSON PJ, 1995, J ELECTRON SPECTROSC, V73, P25, DOI 10.1016/0368-2048(94)02270-4
   Cunningham T, 2000, SURF ENG, V16, P295, DOI 10.1179/026708400101517260
   Dai LM, 2000, SURF INTERFACE ANAL, V29, P46, DOI 10.1002/(SICI)1096-9918(200001)29:1<46::AID-SIA692>3.0.CO;2-6
   Daw R, 1998, BIOMATERIALS, V19, P1717, DOI 10.1016/S0142-9612(98)00080-5
   DEFEIJTER JA, 1978, BIOPOLYMERS, V17, P1759, DOI 10.1002/bip.1978.360170711
   DELANEY PM, 1994, J ANAT, V184, P157
   DEQUEIROZ AAA, 1997, THEOCHEM-J MOL STRUC, V394, P271
   DILKS A, 1981, ELECT SPECTROSCOPY T, V4
   Drude P, 1889, ANN PHYS CHEM, V272, P865
   EGBERS G, 1981, SECONDARY ION MASS S
   Fergg F, 2001, COLLOID POLYM SCI, V279, P61, DOI 10.1007/s003960000398
   FERNANDEZ ML, 1988, POLYMER, V29, P1923, DOI 10.1016/0032-3861(88)90162-0
   Gad M, 1997, CELL BIOL INT, V21, P697, DOI 10.1006/cbir.1997.0214
   GENTLE IR, 1993, LANGMUIR, V9, P646, DOI 10.1021/la00027a005
   Gilchrist VA, 1999, LANGMUIR, V15, P250, DOI 10.1021/la9810758
   Goedel WA, 1999, MACROMOLECULES, V32, P7599, DOI 10.1021/ma981900r
   GROBE GL, 1982, RES SOC S P, V55, P401
   GROSS ML, 1992, MASS SPECTROMETRY C, V353
   HAGENHOFF B, 1992, J PHYS D APPL PHYS, V25, P818, DOI 10.1088/0022-3727/25/5/012
   HAGENHOFF B, 1995, BIOSENS BIOELECTRON, V10, P885, DOI 10.1016/0956-5663(95)99226-B
   Harzallah B, 1998, INT J BIOL MACROMOL, V23, P73, DOI 10.1016/S0141-8130(98)00035-X
   Heavens O. S., 1965, OPTICAL PROPERTIES T
   HOEVE CAJ, 1970, J POLYM SCI POL SYM, P361
   Hoeve CAJ, 1971, J POLYMER SCI      C, V34, P1
   Holland NB, 2000, J BIOMED MATER RES, V51, P307, DOI 10.1002/1097-4636(20000905)51:3<307::AID-JBM3>3.0.CO;2-H
   HOPKINSON I, 1995, MACROMOLECULES, V28, P627, DOI 10.1021/ma00106a031
   Howse JR, 1999, PHYS REV E, V59, P5577, DOI 10.1103/PhysRevE.59.5577
   HWANG J, 1995, SCIENCE, V270, P610, DOI 10.1126/science.270.5236.610
   Ignjatovic N, 2001, BIOMATERIALS, V22, P571, DOI 10.1016/S0142-9612(00)00215-5
   Irvine DJ, 1998, J BIOMED MATER RES, V40, P498, DOI 10.1002/(SICI)1097-4636(19980605)40:3<498::AID-JBM21>3.0.CO;2-E
   Iucci G, 2000, SURF INTERFACE ANAL, V30, P40, DOI 10.1002/1096-9918(200008)30:1<40::AID-SIA812>3.0.CO;2-B
   Jablonski A, 2000, POL J CHEM, V74, P1533
   Jeppesen C, 2001, SCIENCE, V293, P465, DOI 10.1126/science.293.5529.465
   JESPERSEN S, 1994, RAPID COMMUN MASS SP, V8, P581, DOI 10.1002/rcm.1290080802
   JESTER JV, 1991, J ELECTRON MICR TECH, V18, P50, DOI 10.1002/jemt.1060180108
   JOANNY JF, 1984, J CHEM PHYS, V81, P552, DOI 10.1063/1.447337
   Johnston EE, 1996, J ELECTRON SPECTROSC, V81, P303, DOI 10.1016/0368-2048(95)02666-5
   Karlsson CAC, 2001, COLLOID SURFACE B, V20, P9, DOI 10.1016/S0927-7765(99)00134-4
   KASEMO B, 1997, SURFACE CHARACTERIZA
   Kingshott P, 2000, J BIOMED MATER RES, V49, P36, DOI 10.1002/(SICI)1097-4636(200001)49:1<36::AID-JBM5>3.0.CO;2-B
   KINGSHOTT P, 1997, POLYM MAT SCI ENG, V76, P81
   Kinumi T, 2000, J MASS SPECTROM, V35, P417, DOI 10.1002/(SICI)1096-9888(200003)35:3<417::AID-JMS952>3.0.CO;2-#
   KLEE D, 2000, ADV POLYM SCI, V149, P1
   LEE EM, 1990, EUROPHYS LETT, V13, P135, DOI 10.1209/0295-5075/13/2/007
   Lee JW, 2001, MACROMOLECULES, V34, P3928, DOI 10.1021/ma0022351
   Lee LT, 1999, J PHYS CHEM B, V103, P7489, DOI 10.1021/jp991032f
   Leonard D, 1999, FRESEN J ANAL CHEM, V365, P3, DOI 10.1007/s002160051437
   Leonard D, 1998, SURF INTERFACE ANAL, V26, P783, DOI 10.1002/(SICI)1096-9918(199810)26:11<783::AID-SIA420>3.0.CO;2-O
   LI D, 1992, J COLLOID INTERF SCI, V148, P190, DOI 10.1016/0021-9797(92)90127-8
   Lin JC, 1999, BIOMATERIALS, V20, P1613, DOI 10.1016/S0142-9612(99)00068-X
   Liu JS, 1999, MACROMOLECULES, V32, P5777, DOI 10.1021/ma9905324
   Lu JR, 1998, J CHEM SOC FARADAY T, V94, P3279, DOI 10.1039/a805731a
   Lu JR, 1999, LANGMUIR, V15, P6975, DOI 10.1021/la990131h
   LU JR, 1995, J PHYS CHEM-US, V99, P8233, DOI 10.1021/j100020a055
   Maierhofer AP, 1999, BIOPHYS J, V76, pA211
   Malmsten M, 1998, J COLLOID INTERF SCI, V202, P507, DOI 10.1006/jcis.1998.5513
   Marchant RE, 1997, THROMB HAEMOSTASIS, V77, P1048
   MATSUNAGA T, 1981, J COLLOID INTERF SCI, V84, P8, DOI 10.1016/0021-9797(81)90253-8
   McLean KM, 2000, COLLOID SURFACE B, V17, P23, DOI 10.1016/S0927-7765(99)00055-7
   MEYER E, 1992, ULTRAMICROSCOPY, V274, P42
   MILLER DR, 1986, J MACROMOL SCI R M C, VC26, P33
   MISSIRLIS Y, 1991, MODERN ASPECTS PROTE
   OLESCHUK RD, 2001, BIOMATERIALS, V21, P1701
   Olivieri MP, 1999, J BIOMED MATER RES, V46, P355, DOI 10.1002/(SICI)1097-4636(19990905)46:3<355::AID-JBM7>3.0.CO;2-O
   Paynter RW, 2000, SURF INTERFACE ANAL, V29, P56, DOI 10.1002/(SICI)1096-9918(200001)29:1<56::AID-SIA693>3.0.CO;2-2
   PENFOLD J, 1991, PHYSICA B, V173, P1, DOI 10.1016/0921-4526(91)90028-D
   PENFOLD J, 1990, J PHYS-CONDENS MAT, V2, P1369, DOI 10.1088/0953-8984/2/6/001
   PerezLuna VH, 1997, J APPL POLYM SCI, V63, P1467, DOI 10.1002/(SICI)1097-4628(19970314)63:11<1467::AID-APP9>3.0.CO;2-K
   Petroll WM, 1996, INT REV EXP PATHOL, V36, P93
   PORTER MD, 1987, J AM CHEM SOC, V109, P3559, DOI 10.1021/ja00246a011
   Poste G, 1972, PROGR SURFACE SCI
   RABE JP, 1988, THIN SOLID FILMS, V159, P359, DOI 10.1016/0040-6090(88)90649-9
   RATNER B D, 1992, Clinical Materials, V11, P25, DOI 10.1016/0267-6605(92)90027-Q
   Ratner B. D., 1996, BIOMATERIALS SCI INT
   RATNER BD, 1995, SURF INTERFACE ANAL, V23, P521, DOI 10.1002/sia.740230712
   RATNER BD, 1993, CLIN MATER, V13, P71, DOI 10.1016/0267-6605(93)90093-M
   RATNER BD, 1986, SPECTROSCOPY BIOMEDI
   REVENKO I, 2000, INT LAB          JUL, P32
   Russell T. P., 1990, Material Science Reports, V5, P171, DOI 10.1016/S0920-2307(05)80002-7
   Sabbatini L, 1996, J ELECTRON SPECTROSC, V81, P285, DOI 10.1016/0368-2048(95)02528-6
   Schneider SW, 1999, P NATL ACAD SCI USA, V96, P12180, DOI 10.1073/pnas.96.21.12180
   SHOTTON DM, 1995, HISTOCHEM CELL BIOL, V104, P97, DOI 10.1007/BF01451571
   SILBERBERG A, 1962, J PHYS CHEM-US, V66, P1884, DOI 10.1021/j100816a024
   SILBERBERG A, 1971, PURE APPL CHEM, V26, P583
   Sodhi RNS, 1996, J ELECTRON SPECTROSC, V81, P269, DOI 10.1016/0368-2048(95)02665-7
   SPENGLER B, 1991, RAPID COMMUN MASS SP, V5, P198, DOI 10.1002/rcm.1290050412
   STJOHN HAW, 1997, POLYM MAT SCI ENG, V76, P83
   STOCKER W, 1993, MACROMOLECULES, V26, P5915, DOI 10.1021/ma00074a013
   Strutwolf J, 2000, J ELECTROANAL CHEM, V483, P163, DOI 10.1016/S0022-0728(00)00027-9
   Su TJ, 1998, LANGMUIR, V14, P438, DOI 10.1021/la970623z
   Tadrous PJ, 2000, J PATHOL, V191, P345, DOI 10.1002/1096-9896(200008)191:4<345::AID-PATH696>3.0.CO;2-R
   Tegoulia VA, 2000, J BIOMED MATER RES, V50, P291, DOI 10.1002/(SICI)1097-4636(20000605)50:3<291::AID-JBM2>3.0.CO;2-1
   Tengvall P, 2001, COLLOID SURFACE B, V20, P51, DOI 10.1016/S0927-7765(00)00174-0
   TILLMAN N, 1988, J AM CHEM SOC, V110, P6136, DOI 10.1021/ja00226a031
   ULMAN A, 1991, INTRO ULTRATHIN ORGA
   Uyama Y, 1998, ADV POLYM SCI, V137, P1
   Vansteenkiste SO, 1998, PROG SURF SCI, V57, P95, DOI 10.1016/S0079-6816(98)00014-8
   Vickerman J. C., 1989, SECONDARY ION MASS S
   VROMAN L, 1964, NBS MISCELLANEOUS PU, V256, P335
   Vroman L, 1969, P S REC DEV ELL
   WASSERMAN SR, 1989, J AM CHEM SOC, V111, P5852, DOI 10.1021/ja00197a054
   Werner C, 1999, INT J ARTIF ORGANS, V22, P160
   WERNER C, 1995, J BIOMAT SCI-POLYM E, V7, P61, DOI 10.1163/156856295X00832
   WEST RH, 1995, J MATER SCI-MATER M, V6, P63, DOI 10.1007/BF00120408
   WHITESIDES GM, 1990, LANGMUIR, V6, P87, DOI 10.1021/la00091a013
   Wold DJ, 2001, J AM CHEM SOC, V123, P5549, DOI 10.1021/ja0101532
   Wong JY, 1997, SCIENCE, V275, P820, DOI 10.1126/science.275.5301.820
   ZHOU XL, 1995, PHYS REP, V257, P223, DOI 10.1016/0370-1573(94)00110-O
NR 133
TC 64
Z9 65
U1 1
U2 49
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2002
VL 13
IS 6
BP 593
EP 621
DI 10.1163/156856202320269111
PG 29
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 587NT
UT WOS:000177648500001
PM 12182547
DA 2018-10-20
ER

PT J
AU Poshusta, AK
   Bowman, CN
   Anseth, KS
AF Poshusta, AK
   Bowman, CN
   Anseth, KS
TI Application of a kinetic gelation simulation to the characterization of
   in situ cross-linking biomaterials
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE cross-linking simulation; kinetic gelation model; in situ forming
   polymers
ID FREE-RADICAL POLYMERIZATION; DENTAL COMPOSITES; REACTION BEHAVIOR;
   NETWORK FORMATION; PREDICTIONS; CARTILAGE
AB Multifunctional monomers that are polymerized in situ to form highly cross-linked biomaterials have been an area of recent interest for medical applications. From a biomaterial application standpoint, the relationship between the reaction conditions, polymer structure. and final physical properties is important, particularly for in situ formed materials, as they must have optimum network properties immediately after formation. However, multifunctional monomer reaction mechanisms are complicated by mobility restrictions on the reacting species, cyclization of pendant groups, unequal reactivity of functional groups, and structural heterogeneities. Also. experimental characterization of these complexities is difficult and limited by the insolubility of the resulting cross-linked structure. Thus, in this contribution, a kinetic gelation simulation was used to understand and characterize the evolution of in situ forming, three-dimensional polymer structures. Specifically. the reaction of tetrafunctional monomers (i,e. divinyl monomers) to form high strength networks with degradable cross-links was modeled. This work focuses on using a lattice-based model to characterize network properties important for biomaterial applications and compare them with an experimental system (i.e. cross-linked polvanhydrides) where appropriate. Simulated results for pendant group reactivity. kinetic chain lengths. and radical concentrations (trapped and free) are presented herein.
C1 Univ Colorado, Dept Chem Engn, Boulder, CO 80309 USA.
   Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA.
RP Anseth, KS (reprint author), Univ Colorado, Dept Chem Engn, Boulder, CO 80309 USA.
RI Bowman, Christopher/B-1490-2008
OI Bowman, Christopher/0000-0001-8458-7723
FU NIAMS NIH HHS [AR44375]
CR ANSETH KS, 1995, J POLYM SCI POL PHYS, V33, P1769, DOI 10.1002/polb.1995.090331207
   ANSETH KS, 1994, CHEM ENG SCI, V49, P2207, DOI 10.1016/0009-2509(94)E0055-U
   ANSETH KS, 1994, POLYMER, V35, P3243, DOI 10.1016/0032-3861(94)90129-5
   Anseth KS, 1995, ADV POLYM SCI, V122, P177
   Anseth KS, 1996, J DENT RES, V75, P1607, DOI 10.1177/00220345960750081301
   Ashiku SK, 1997, MATER SCI FORUM, V250, P129, DOI 10.4028/www.scientific.net/MSF.250.129
   BANSIL R, 1984, MACROMOLECULES, V17, P998, DOI 10.1021/ma00135a004
   BOWMAN CN, 1992, CHEM ENG SCI, V47, P1411, DOI 10.1016/0009-2509(92)80286-L
   Burkoth AK, 1999, MACROMOLECULES, V32, P1438, DOI 10.1021/ma9814651
   Burkoth AK, 2000, BIOMATERIALS, V21, P2395, DOI 10.1016/S0142-9612(00)00107-1
   Cao YL, 1998, J BIOMAT SCI-POLYM E, V9, P475
   Elliott JE, 1999, MACROMOLECULES, V32, P8621, DOI 10.1021/ma990797i
   ENGELBRECHT J, 1989, Patent No. 4872936
   GARRETT RW, 1989, POLYM BULL, V22, P611
   HERRMANN HJ, 1982, PHYS REV LETT, V49, P412, DOI 10.1103/PhysRevLett.49.412
   KINNEY AB, 1994, ACS SYM SER, V273, P2
   KLOOSTERBOER JG, 1988, ADV POLYM SCI, V84, P1
   KUHN KD, 2000, BONE CEMENTS DATE CO, P272
   MANNEVILLE P, 1981, PERCOLATION GELATION, P116
   MIYAZAKI K, 1988, J BIOMED MATER RES, V22, P1011, DOI 10.1002/jbm.820221105
   ODIAN G, 1991, PRINCIPLES POLYM, P768
   Svaldi-Muggli D., 1999, J BIOMED MATER RES, V46, P271
   SVALDIMUGGLI D, 1998, MACROMOLECULES, V31, P4120
   ZHU S, 1990, MACROMOLECULES, V23, P1144, DOI 10.1021/ma00206a037
   Zilling TL, 1999, EUR J SURG, V165, P61, DOI 10.1080/110241599750007522
NR 25
TC 7
Z9 7
U1 0
U2 7
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2002
VL 13
IS 7
BP 797
EP 815
DI 10.1163/156856202760197429
PG 19
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 611KP
UT WOS:000179016500005
PM 12296445
DA 2018-10-20
ER

PT J
AU Yuan, YL
   Al, F
   Zhang, J
   Zang, XB
   Shen, J
   Lin, SC
AF Yuan, YL
   Al, F
   Zhang, J
   Zang, XB
   Shen, J
   Lin, SC
TI Grafting sulfobetaine monomer onto the segmented poly(ether-urethane)
   surface to improve hemocompatibility
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE ozonization; SPEU-g-DNIAPS; platelet adhesion
ID PLATELET-ADHESION; POLYMERIZATION; ACRYLAMIDE
AB Polyurethanes are widely used as blood-contacting biomaterials, due to their good biocompatibility and mechanical properties. Nevertheless, their blood compatibility is still not adequate for more demanding applications. Surface modification is an effective way to improve the hemocompatibility for biomaterials. The purpose of the present study was to synthesize a novel nonthrombogenic biomaterial by modifying the surface of polyurethane. Ozonization was used to introduce active peroxide groups onto the segmented poly (ether-urethane) (SPEU) film surface and graft polymerization of N,N'-dimethyl (methacryloyloxyethyl) ammonium propanesulfonate (DMAPS), a sulfobetaine structure. onto the ozone-activated SPEU surface was conducted. The SPEU-g-PDMAPS film was characterized by ATR-FTIR. XPS, and contact angle measurements. ATR-FTIR and XPS confirmed the graft polymerization, The grafted film possessed a relatively hydrophilic surface. as revealed by contact angle measurement. The blood compatibility of the grafted films was evaluated by a platelet-rich plasma (PRP) adhesion study and scanning electron microscopy, using SPEU film as the reference. No platelet adhesion was observed for the grafted films incubated with PRP at 37degreesC for 60 and 180 min. This new sulfobetaine structure grafted biomaterial might have potential for biomedical applications.
C1 Nanjing Univ, Ctr Res Surface & Interface Chem Engn & Technol, Nanjing 210093, Peoples R China.
RP Shen, J (reprint author), Nanjing Univ, Ctr Res Surface & Interface Chem Engn & Technol, Nanjing 210093, Peoples R China.
CR Andrade J. D., 1987, ASAIO J, V33, P75
   BRASH JL, 1985, MAKROMOL CHEM S, V9, P69
   Dickinson RB, 1997, J BIOMED MATER RES, V36, P152, DOI 10.1002/(SICI)1097-4636(199708)36:2<152::AID-JBM3>3.0.CO;2-J
   FOUGNOT C, 1984, MACROMOLECULAR BIOMA
   FUJIMOTO K, 1993, BIOMATERIALS, V14, P442, DOI 10.1016/0142-9612(93)90147-T
   FUJIMOTO K, 1993, J POLYM SCI POL CHEM, V31, P1035, DOI 10.1002/pola.1993.080310426
   HOESCHELE GK, 1977, ANGEW MAKROMOL CHEM, V58, P299, DOI 10.1002/apmc.1977.050580113
   HORNING EC, 1955, ORGANIC SYNTHESIS CO, V3, P415
   IKADA Y, 1983, POLYM PREPR JPN, V32, P314
   Ishihara K, 1997, TRENDS POLYM SCI, V5, P401
   Kokatnur V. R., 1941, J AM CHEM SOC, V63, P1432
   Lee JH, 2000, BIOMATERIALS, V21, P683, DOI 10.1016/S0142-9612(99)00197-0
   Lee JH, 1998, J BIOMED MATER RES, V40, P314, DOI 10.1002/(SICI)1097-4636(199805)40:2<314::AID-JBM17>3.0.CO;2-L
   Lelah M. D., 1986, POLYURETHANES MED
   LELAH MD, 1985, J COLLOID INTERF SCI, V104, P422, DOI 10.1016/0021-9797(85)90051-7
   Li YJ, 1997, J BIOMATER APPL, V12, P167, DOI 10.1177/088532829701200205
   Lin JC, 2000, J BIOMAT SCI-POLYM E, V11, P701, DOI 10.1163/156856200743968
   LIN SC, 1991, J BIOMED MATER RES, V25, P791, DOI 10.1002/jbm.820250608
   Lin SC, 1998, POLYM B, V1, P1
   Nakaya T, 1999, PROG POLYM SCI, V24, P143, DOI 10.1016/S0079-6700(98)00015-X
   NEILL TO, 1972, J POLYM SCI POL CHEM, V10, P569
   NVSTROM M, 1991, J MEMBRANE SCI, V60, P275
   SUZUKI M, 1986, MACROMOLECULES, V19, P1804, DOI 10.1021/ma00161a005
   TANIGUCHI M, 1982, ACS SYM SER, V187, P217
   THOMPSON AR, 1983, MANUAL HEMOSTASIS TH
   TYLER BJ, 1992, J BIOMED MATER RES, V26, P273, DOI 10.1002/jbm.820260302
   WANG CH, 1997, ACTA POLYM SIN, V1, P114
NR 27
TC 56
Z9 59
U1 3
U2 33
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2002
VL 13
IS 10
BP 1081
EP 1092
DI 10.1163/156856202320813800
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 630MV
UT WOS:000180112600002
PM 12484485
DA 2018-10-20
ER

PT J
AU Sen Gupta, A
   Lopina, ST
AF Sen Gupta, A
   Lopina, ST
TI L-Tyrosine-based backbone-modified poly(amino acids)
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE pseudo-peptide; L-tyrosine; cyanogen bromide; polyiminocarbonate;
   triphosgene polycarbonate
ID HYDROLYTIC DEGRADATION; BIOMATERIALS; POLYCARBONATES; POLYMERIZATION
AB Tyrosine-based pseudo-peptide polymers, first introduced in 1987 by Kohn and Langer, have been identified for potential biomaterial applications. These materials combine the desired polypeptide proper-ties of biocompatibility. biodegradability, non-toxicity, and non-immunogenicity with good processing properties including solubility, thermal stability. and moldability which a-rise from alternating non-amide bonds along the polymer backbone. This paper focuses on the analysis of two such polymers based on the natural amino acid L-tyrosine. Starting from L-tyrosine and its deaminated analogue, 3-(4-para-hydroxy)-phenylpropionic acid. a diphenolic structure containing an amide linkage, was synthesized following standard procedures of peptide synthesis. This diphenolic structure was then used as a monomer to synthesize a polyiminocarbonate using a cyanogen bromide-initiated reaction and a polycarbonate using a triphosgene-initiated reaction. The polyiminocarbonate has iminocarbonate linkages and the polycarbonate has carbonate linkages alternating with amide linkages in the respective polymer backbone. Analytical studies were performed regarding the feasibility of the reaction procedures. the physical proper-ties of the polymers. and their degradation processes, to gain insight into the potential biomaterial applications of these polymers. These results independently reaffirm the studies published by Kohn et tit. working on similar polymeric systems.
C1 Univ Akron, Dept Chem Engn, Akron, OH 44325 USA.
   Univ Akron, Dept Biomed Engn, Akron, OH 44325 USA.
RP Lopina, ST (reprint author), Univ Akron, Dept Chem Engn, Olson,Rm 301K, Akron, OH 44325 USA.
CR BODZANSKY M, 1984, PRACTICE PEPTIDE SYN
   Borda J, 2000, J POLYM SCI POL CHEM, V38, P2925, DOI 10.1002/1099-0518(20000815)38:16<2925::AID-POLA100>3.0.CO;2-E
   Drumright RE, 2000, ADV MATER, V12, P1841, DOI 10.1002/1521-4095(200012)12:23<1841::AID-ADMA1841>3.3.CO;2-5
   ECKERT H, 1987, ANGEW CHEM INT EDIT, V26, P894, DOI 10.1002/anie.198708941
   ERTEL SI, 1995, J BIOMED MATER RES, V29, P1337, DOI 10.1002/jbm.820291105
   GELBIN ME, 1992, J AM CHEM SOC, V114, P3962, DOI 10.1021/ja00036a051
   James K, 1996, TRENDS POLYM SCI, V4, P394
   KOHN J, 1986, BIOMATERIALS, V7, P176, DOI 10.1016/0142-9612(86)90098-0
   KOHN J, 1987, J AM CHEM SOC, V109, P817, DOI 10.1021/ja00237a030
   KOHN J, 1993, Patent No. 5198507
   KOHN J, 1992, Patent No. 5099060
   KOHN J, 1991, Patent No. 4980449
   KOHN J, 1996, Patent No. 5587507
   Lunt J, 1998, POLYM DEGRAD STABIL, V59, P145, DOI 10.1016/S0141-3910(97)00148-1
   PULAPURA S, 1990, BIOMATERIALS, V11, P666, DOI 10.1016/0142-9612(90)90025-L
   PULAPURA S, 1992, BIOPOLYMERS, V32, P411, DOI 10.1002/bip.360320418
   Tangpasuthadol V, 2000, BIOMATERIALS, V21, P2371, DOI 10.1016/S0142-9612(00)00104-6
   Tangpasuthadol V, 2000, BIOMATERIALS, V21, P2379, DOI 10.1016/S0142-9612(00)00105-8
NR 18
TC 8
Z9 8
U1 1
U2 9
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2002
VL 13
IS 10
BP 1093
EP 1104
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 630MV
UT WOS:000180112600003
DA 2018-10-20
ER

PT J
AU Woo, GLY
   Yang, ML
   Yin, HQ
   Jaffer, F
   Mittleman, MW
   Santerre, JP
AF Woo, GLY
   Yang, ML
   Yin, HQ
   Jaffer, F
   Mittleman, MW
   Santerre, JP
TI Biological characterization of a novel biodegradable antimicrobial
   polymer synthesized with fluoroquinolones
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE ciprofloxacin; antimicrobial; polyurethane; biodegradation; enzyme;
   bacteria; cytotoxicity; drug polymer
ID RAPID COLORIMETRIC ASSAY; BACTERIAL-COLONIZATION; CHOLESTEROL ESTERASE;
   DELIVERY SYSTEM; INFECTION; CATHETERS; POLYURETHANE; HYDROLYSIS;
   RELEASE; RESISTANCE
AB Biomaterial-related infections continue to represent a significant challenge to the medical community. Several approaches have been utilized to incorporate antimicrobial agents at the surface of implant devices in attempts to delay or eliminate the formation of biofilms. To date, most of these strategies have focused on drug conjugation or diffusion-limited systems for the delivery of such pharmaceutical agents. More recently, work has been presented on the feasibility of incorporating drugs into the backbone of polymers as a main-chain monomer. When sequenced into the backbone of the polymer with other monomers that are hydrolytically sensitive to enzyme-catalyzed breakdown, it is thought that drugs may be able to be selectively released. Specifically, degradable polyurethanes have been synthesized with fluoroquinolone antibiotics and have shown an ability to kill bacteria when released following degradation of the polymer chains by the macrophage-derived enzyme cholesterol esterase. However, specificity of the cleavage sites in the polymer was difficult to control. Since cholesterol esterase has specificity for hydrophobic moieties, it is desirable to alter the formulation of the polyurethanes to incorporate long hydrophobic monomers immediately adjacent to the ciprofloxacin molecule. Hence, the current study focuses on evaluating the enzyme-catalyzed degradation of a degradable polyurethane synthesized with 1,12 diisocyanatododecane as a substitute for 1,6 diisocyanatohexane, which was used in previous work. Validation of specific ciprofloxacin release and the generation of antimicrobial are shown. A preliminary cell study to assess the cytotoxicity of this biodegradable antibiotic polymer shows that the material has no observable effects on cell proliferation or cell membrane structure. (C) 2001 John Wiley & Sons, Inc.
C1 Univ Toronto, Fac Engn, Dept Chem Engn & Appl Chem, Toronto, ON, Canada.
   Univ Toronto, Fac Dent, Dept Biomat, Toronto, ON M5G 1G6, Canada.
   Westaim Corp, Ft Saskatchewan, AB, Canada.
   Altran Corp, Boston, MA USA.
RP Santerre, JP (reprint author), Univ Toronto, Fac Engn, Dept Chem Engn & Appl Chem, 100 Coll St, Toronto, ON, Canada.
CR ACAR JF, 1985, REV INFECT DIS S4, V7, P545
   ANDERSON JM, 1993, CARDIOVASC PATHOL S, V2, P33
   ANWAR H, 1989, ANTIMICROB AGENTS CH, V33, P1824, DOI 10.1128/AAC.33.10.1824
   Anwar H, 1990, ANTIMICROB AGENTS CH, V71, P101
   ARIZONO T, 1992, ACTA ORTHOP SCAND, V63, P661
   *ASTM, ASTM PUB E, V442
   Bach A, 1996, J ANTIMICROB CHEMOTH, V37, P315, DOI 10.1093/jac/37.2.315
   BACH A, 1994, J ANTIMICROB CHEMOTH, V33, P969
   BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77
   Brockerhoff H., 1974, LIPOLYTIC ENZYMES, P176
   CHRISTENSEN GD, 1989, INFECT ASS INDWELLIN, P27
   Ciresi DL, 1996, AM SURGEON, V62, P641
   Costerton J. W., 1985, BACTERIAL ADHESION M, P3
   COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431
   DANKERT J, 1986, CRIT REV BIOCOMPAT, V2, P219
   Dasgupta MK, 1997, PERITON DIALYSIS INT, V17, pS142
   DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6
   Erfle DJ, 1997, CARDIOVASC PATHOL, V6, P333, DOI 10.1016/S1054-8807(97)00031-8
   ERLANSON CH, 1970, SCAND J GASTROENTERO, V5, P333
   Gold HS, 1996, NEW ENGL J MED, V335, P1445, DOI 10.1056/NEJM199611073351907
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   GRISTINA AG, 1985, SCIENCE, V228, P990, DOI 10.1126/science.4001933
   Hasaniya NWMA, 1996, CHEST, V109, P1030, DOI 10.1378/chest.109.4.1030
   HSIEH DST, 1981, P NATL ACAD SCI-BIOL, V78, P1863, DOI 10.1073/pnas.78.3.1863
   Isaacson D. M., 1986, MANUAL IND MICROBIOL, P410
   JANSEN B, 1990, CLIN IMPLANT MAT ADV, V9, P117
   LABOW RS, 1994, J BIOMAT SCI-POLYM E, V6, P169, DOI 10.1163/156856294X00293
   LABOW RS, 1983, BIOCHIM BIOPHYS ACTA, V749, P32, DOI 10.1016/0167-4838(83)90147-4
   LABOW RS, 1995, BIOMATERIALS, V16, P51, DOI 10.1016/0142-9612(95)91096-H
   LY Y, 1993, J MEMBRANE SCI, V77, P99, DOI 10.1016/0376-7388(93)85238-R
   LYNN KR, 1982, BIOORG CHEM, V11, P19, DOI 10.1016/0045-2068(82)90044-X
   MITTELMAN MW, 1997, MOL ECOLOGICAL DIVER, P89
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   *NCCLS, 1990, M7A2 NCCLS, V10
   RATNER BD, 1993, J BIOMED MATER RES, V27, P837, DOI 10.1002/jbm.820270702
   ROSKOS KV, 1993, CLIN MATER, V13, P109, DOI 10.1016/0267-6605(93)90097-Q
   SANTERRE JP, 1994, J BIOMED MATER RES, V28, P1187, DOI 10.1002/jbm.820281009
   SHERERTZ RJ, 1989, ANTIMICROB AGENTS CH, V33, P1174, DOI 10.1128/AAC.33.8.1174
   SUTTON LD, 1986, BIOCHEM BIOPH RES CO, V134, P386, DOI 10.1016/0006-291X(86)90575-9
   SUTTON LD, 1990, BIOCHIM BIOPHYS ACTA, V1041, P79, DOI 10.1016/0167-4838(90)90125-Y
   Suzuki Y, 1998, J BIOMED MATER RES, V42, P112, DOI 10.1002/(SICI)1097-4636(199810)42:1<112::AID-JBM14>3.0.CO;2-N
   TROOSKIN SZ, 1985, SURGERY, V97, P547
   Wang GB, 1997, J CHROMATOGR B, V698, P69, DOI 10.1016/S0378-4347(97)00282-X
   Woo GLY, 2000, BIOMATERIALS, V21, P1235, DOI 10.1016/S0142-9612(00)00003-X
   ZAHALKA HA, 1987, BIOCHIM BIOPHYS ACTA, V921, P481, DOI 10.1016/0005-2760(87)90075-0
NR 45
TC 55
Z9 61
U1 1
U2 23
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JAN
PY 2002
VL 59
IS 1
BP 35
EP 45
DI 10.1002/jbm.1214
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 493DP
UT WOS:000172207000005
PM 11745535
DA 2018-10-20
ER

PT J
AU Basoli, A
   Bordi, F
   Cametti, C
   Gili, T
AF Basoli, A
   Bordi, F
   Cametti, C
   Gili, T
TI Structural alteration of erythrocyte cell membrane in presence of
   artificial prostheses: a radiowave dielectric spectroscopy study
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE cardiovascular biomaterials; erythrocyte membrane; electrical impedance;
   erythrocyte surface charge
ID ELECTRICAL-PROPERTIES; ADHESION; BLOOD; SUSPENSIONS
AB The exposure of a biomaterial to blood gives rise to complex reactions playing an important role in many biological phenomena, such as the problem of biocompatibility and the mechanism of cardiovascular and thromboembolic diseases. In the present work, we use a frequency-domain dielectric spectroscopy approach to evaluate possible changes in the passive electrical parameters of the erythrocyte membrane, i.e., the membrane conductivity sigma (s) and the membrane permittivity epsilon (s), after the insertion of a prosthesis (mean implantation time 8 days) in the circulatory system of patients treated for aortic aneurysm and the consequent interactions of erythrocyte cells with the biomaterial surface. We observe an increase of both the membrane conductivity and membrane permittivity, indicating changes at molecular level in the structural organization of the membrane. These membrane alterations can be viewed as precursory events for the initiation of the complex sequence of enzymatic reactions that take place on the material surface. Our results, although preliminary imply that a direct interaction between erythrocyte cell membrane and vascular prostheses may occur, causing a marked alteration in the electrical properties of the cell membrane. These findings might have relevant clinical implications and might offer possibilities to predict biocompatibility of biomaterials and give some further suggestions to resolve the problem of biomaterial-associated thrombogenicity. (C) 2001 John Wiley & Sons, Inc.
C1 Univ Roma La Sapienza, Dipartimento Fis, I-00185 Rome, Italy.
   Univ Roma La Sapienza, Clin Chirurg 2, I-00185 Rome, Italy.
   Ist Nazl Fis Mat, Unita Roma, Rome, Italy.
RP Cametti, C (reprint author), Univ Roma La Sapienza, Dipartimento Fis, Piazzale A Morro 2, I-00185 Rome, Italy.
RI Bordi, Federico/H-1862-2011
OI Bordi, Federico/0000-0001-6373-5176; Gili, Tommaso/0000-0001-9154-1758;
   Cametti, Cesare/0000-0003-2077-3660
CR ASAMI K, 1989, BIOCHIM BIOPHYS ACTA, V1010, P49, DOI 10.1016/0167-4889(89)90183-3
   ASAMI K, 1980, JPN J APPL PHYS, V19, P359, DOI 10.1143/JJAP.19.359
   Asami K, 1995, BBA-GEN SUBJECTS, V1245, P317, DOI 10.1016/0304-4165(95)00116-6
   ASAMI K, 1980, BIOPHYS J, V31, P215, DOI 10.1016/S0006-3495(80)85052-1
   BALLARIO C, 1984, Z NATURFORSCH C, V39, P1163
   BELL GI, 1984, BIOPHYS J, V45, P1051, DOI 10.1016/S0006-3495(84)84252-6
   BONGRAND P, 1988, PHYSICAL BASIS CELL
   Bordi F, 1996, BIOPOLYMERS, V40, P485, DOI 10.1002/(SICI)1097-0282(1996)40:5<485::AID-BIP6>3.0.CO;2-S
   Bordi F, 1997, EUR BIOPHYS J BIOPHY, V26, P215, DOI 10.1007/s002490050074
   CORRY WD, 1981, J BIOCHEM BIOPH METH, V4, P29, DOI 10.1016/0165-022X(81)90003-8
   DIOCIAIUTI M, 1991, BIOELECTROCH BIOENER, V26, P177, DOI 10.1016/0302-4598(91)80022-U
   EYLAR EH, 1962, J BIOL CHEM, V237, P1992
   Godin C, 1997, EUR BIOPHYS J BIOPHY, V26, P175, DOI 10.1007/s002490050069
   GODIN C, 1996, EUR BIOPHYS J, V25, P35
   Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9
   HANAI T, 1960, KOLLOID Z, V171, P23, DOI DOI 10.1007/BF01520320
   HASTED JB, 1973, AQUEOUS DIELECTRICS
   Havriliak S.J, 1997, DIELECTRIC MECH RELA
   HYNES RO, 1992, CELL, V68, P303, DOI 10.1016/0092-8674(92)90472-O
   Karlsson C, 2000, COLLOID SURFACE B, V17, P95, DOI 10.1016/S0927-7765(99)00018-1
   LOOYENGA H, 1965, PHYSICA, V31, P401, DOI 10.1016/0031-8914(65)90045-5
   Santini MT, 1997, J BIOMED MATER RES, V35, P165
   SEAMAN GVF, 1963, ARCH BIOCHEM BIOPHYS, V100, P463
   SINGER JS, 1976, SURFACE MEMBRANE REC, P1
   STORYGIN A, 1971, IEEE T MICR THEORY T, V19, P733
   Stratton J. A., 1941, ELECTROMAGNETIC THEO
   Swartbol P, 1996, J BIOMED MATER RES, V32, P669, DOI 10.1002/(SICI)1097-4636(199612)32:4<669::AID-JBM21>3.0.CO;2-7
   Takashima S., 1989, ELECT PROPERTIES BIO
NR 28
TC 5
Z9 12
U1 2
U2 4
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JAN
PY 2002
VL 59
IS 1
BP 100
EP 109
DI 10.1002/jbm.1221
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 493DP
UT WOS:000172207000012
PM 11745542
DA 2018-10-20
ER

PT J
AU Musgrave, DS
   Pruchnic, R
   Bosch, P
   Ziran, BH
   Whalen, J
   Huard, J
AF Musgrave, DS
   Pruchnic, R
   Bosch, P
   Ziran, BH
   Whalen, J
   Huard, J
TI Human skeletal muscle cells in ex vivo gene therapy to deliver bone
   morphogenetic protein-2
SO JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME
LA English
DT Article
ID RAT ECTOPIC MODEL; BIOMATERIAL CARRIERS; DIFFERENTIATION;
   PHARMACOKINETICS; IMPLANTATION; LINEAGE; REPAIR
AB We have examined whether primary human muscle-derived cells can he used in ex vivo gene therapy to deliver BMP-2 and to produce bone in vivo. Two in vitro experiments and one in vivo experiment were used to determine the osteocompetence and BMP-2 secretion capacity of cells isolated from human skeletal muscle.
   We isolated five different populations of primary muscle cells from human skeletal muscle in three patients. In the first in vitro experiment, production of alkaline phosphatase by the cells in response to stimulation by rhBMP-2 was measured and used as an indicator of cellular osteocompetence. In the second, secretion of BMP-2 was measured after the cell populations had been transduced by an adenovirus encoding for BMP-2. In the in vivo experiment, the cells were cotransduced with a retrovirus encoding for a nuclear, localised beta-galactosidase gene and an adenovirus encoding for BMP-2. The cotransduced cells,were then injected into the hind limbs of severe combined immune-deficient (SCID) mice and analysed radiographically and histologically. The nuclear localised beta-galactosidase gene allowed identification of the injected cells in histological specimens. In the first in vitro experiment, the five different cell populations all responded to in vitro stimulation of rhBMP-2 by producing higher levels of alkaline phosphatase when compared with non-stimulated cells. In the second, the five different cell populations were all successfully transduced by an adenovirus to express and secrete BMP-2. The cells secreted between 444 and 2551 ng of BMP-2 over three days. In the in vivo experiment, injection of the transduced cells into the hind-limb musculature of SCID mice resulted in the formation of ectopic bone at 1, 2, 3 and 4 weeks after injection. Retroviral labelling of the cell nuclei showed labelled human muscle-derived cells occupying locations of osteoblasts in the ectopic bone, further supporting their osteocompetence.
   Cells from human skeletal muscle, because of their availability to orthopaedic surgeons, their osteocompetence, and their ability to express BMP-2 after genetic engineering, are an attractive cell population for use in BMP-2 gene therapy approaches.
C1 Univ Pittsburgh, Pittsburgh, PA 15260 USA.
RP Huard, J (reprint author), Childrens Hosp Pittsburgh, Dept Orthopaed Surg, 4151 Rangos Res Ctr,3705 5th Ave, Pittsburgh, PA 15213 USA.
FU NIAMS NIH HHS [1P60 AR44811-01]; NIDCR NIH HHS [IR01 DE13420-01A2]
CR Alden TD, 1999, J NEUROSURG, V90, P109, DOI 10.3171/spi.1999.90.1.0109
   Bosch P, 2000, CELL TRANSPLANT, V9, P463, DOI 10.1177/096368970000900403
   Bosch P, 2000, J ORTHOP RES, V18, P933, DOI 10.1002/jor.1100180613
   CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504
   Fang JM, 1996, P NATL ACAD SCI USA, V93, P5753, DOI 10.1073/pnas.93.12.5753
   Hardy S, 1997, J VIROL, V71, P1842
   KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755
   Kawasaki K, 1998, BONE, V23, P223, DOI 10.1016/S8756-3282(98)00105-7
   Khouri RK, 1996, PLAST RECONSTR SURG, V98, P103, DOI 10.1097/00006534-199607000-00017
   Lee JY, 2000, J CELL BIOL, V150, P1085, DOI 10.1083/jcb.150.5.1085
   Lieberman JR, 1998, J ORTHOP RES, V16, P330, DOI 10.1002/jor.1100160309
   Lieberman JR, 1999, J BONE JOINT SURG AM, V81A, P905, DOI 10.2106/00004623-199907000-00002
   Lou JR, 1999, J ORTHOPAED RES, V17, P43, DOI 10.1002/jor.1100170108
   Mason JM, 1998, GENE THER, V5, P1098, DOI 10.1038/sj.gt.3300703
   Musgrave DS, 1999, BONE, V24, P541, DOI 10.1016/S8756-3282(99)00086-1
   Musgrave DS, 2000, CLIN ORTHOP RELAT R, P290
   Qu ZQ, 1998, J CELL BIOL, V142, P1257, DOI 10.1083/jcb.142.5.1257
   RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275
   SANES JR, 1986, EMBO J, V5, P3133, DOI 10.1002/j.1460-2075.1986.tb04620.x
   Uludag H, 2000, J BIOMED MATER RES, V50, P227, DOI 10.1002/(SICI)1097-4636(200005)50:2<227::AID-JBM18>3.0.CO;2-2
   Uludag H, 1999, J BIOMED MATER RES, V46, P193, DOI 10.1002/(SICI)1097-4636(199908)46:2<193::AID-JBM8>3.0.CO;2-1
   URIST MR, 1969, CLIN ORTHOP RELAT R, P194
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   WANG EA, 1990, P NATL ACAD SCI USA, V87, P2220, DOI 10.1073/pnas.87.6.2220
   YAMAGUCHI A, 1991, J CELL BIOL, V113, P681, DOI 10.1083/jcb.113.3.681
NR 25
TC 75
Z9 92
U1 0
U2 0
PU BRITISH EDITORIAL SOC BONE JOINT SURGERY
PI LONDON
PA 22 BUCKINGHAM STREET, LONDON WC2N 6ET, ENGLAND
SN 0301-620X
J9 J BONE JOINT SURG BR
JI J. Bone Joint Surg.-Br. Vol.
PY 2002
VL 84B
BP 120
EP 127
DI 10.1302/0301-620X.84B1.11708
PG 8
WC Orthopedics; Surgery
SC Orthopedics; Surgery
GA 520YN
UT WOS:000173811500027
PM 11837817
OA Bronze
DA 2018-10-20
ER

PT J
AU Trombelli, L
   Heitz-Mayfield, LJA
   Needleman, I
   Moles, D
   Scabbia, A
AF Trombelli, L
   Heitz-Mayfield, LJA
   Needleman, I
   Moles, D
   Scabbia, A
TI A systematic review of graft materials and biological agents for
   periodontal intraosseous defects
SO JOURNAL OF CLINICAL PERIODONTOLOGY
LA English
DT Article; Proceedings Paper
CT 4th European Workshop on Periodontology
CY FEB 02-06, 2002
CL ITTINGEN, SWITZERLAND
DE periodontal diseases/therapy; periodontal regeneration; intrabony
   defects; grafts/bone substitutes; systematic review; meta-analysis
ID GUIDED TISSUE REGENERATION; MATRIX DERIVATIVE EMDOGAIN(R); CANCELLOUS
   BONE ALLOGRAFT; OPEN FLAP DEBRIDEMENT; OSSEOUS DEFECTS; INTRABONY
   DEFECTS; CLINICAL-EVALUATION; ALLOPLASTIC IMPLANT; HYDROXYLAPATITE
   IMPLANT; HISTOLOGIC EVALUATION
AB Objectives: To determine the adjunctive effect of grafting biomaterials/biological agents with open flap debridement (OFD) in the treatment of deep intraosseous defects.
   Background: No systematic review of treatment outcomes in patients who received graft biomaterials or biological agents have been published.
   Methods: A rigorous systematic review of randomized controlled trials of at least 6-month duration was conducted comparing grafting biomaterials/biological agents (alone or in combination) + OFD (test group) to OFD alone or in combination with a placebo (control group).
   Results: The difference in CAL change between test and control groups varied from -1.45 mm to 1.40 mm with respect to different biomaterials/biological agents. Meta-analysis showed that CAL change significantly improved after treatment for coralline calcium carbonate (weighted mean difference 0.90 mm; 95% CI: 0.53-1.27), bioactive glass (weighted mean difference 1.04 mm; 95% CI: 0.31-1.76), hydroxyapatite (weighted mean difference 1.40 mm, 95% Cl 0.64-2.16), and enamel matrix proteins (weighted mean difference 1.33 mm, 95% CI 0.78-1.88). However, heterogeneity in results between studies was highly statistically significant for most of biomaterials/biologicals and could not be fully explained.
   Conclusions: Overall, the use of specific biomaterials/biologicals was more effective than OFD in improving attachment levels in intraosseous defects. Difference in CAL gain varied greatly with respect to different biomaterial/biological agent. Due to a significant heterogeneity in results between studies in most treatment groups, general conclusions about the expected clinical benefit of graft biomaterials/biologicals need to be interpreted with caution. Further research should focus on understanding this variability.
C1 Univ Ferrara, Res Ctr Study Periodontal Dis, I-44100 Ferrara, Italy.
   Univ Bern, Dept Periodontol & Fixed Prosthodont, CH-3012 Bern, Switzerland.
   UCL, Eastman Dent Inst, Dept Periodontol, London WC1E 6BT, England.
   UCL, Eastman Dent Inst, Dept Oral Pathol, London WC1E 6BT, England.
RP Trombelli, L (reprint author), Univ Ferrara, Res Ctr Study Periodontal Dis, Corso Giovecca 203, I-44100 Ferrara, Italy.
EM l.trombelli@unife.it
RI Trombelli, Leonardo/I-4671-2015
OI Trombelli, Leonardo/0000-0002-1147-2199; Moles,
   David/0000-0001-9797-6226
CR ALTIERE ET, 1979, J PERIODONTOL, V50, P510, DOI 10.1902/jop.1979.50.10.510
   BLUMENTHAL N, 1990, J PERIODONTOL, V61, P319, DOI 10.1902/jop.1990.61.6.319
   BORGHETTI A, 1993, J PERIODONTOL, V64, P128, DOI 10.1902/jop.1993.64.2.128
   BOWERS GM, 1989, J PERIODONTOL, V60, P675, DOI 10.1902/jop.1989.60.12.675
   Brown GD, 1998, J PERIODONTOL, V69, P146, DOI 10.1902/jop.1998.69.2.146
   CARRARO J J, 1976, Journal of Clinical Periodontology, V3, P104, DOI 10.1111/j.1600-051X.1976.tb01856.x
   DRAGOO MR, 1973, J PERIODONTOL, V44, P599, DOI 10.1902/jop.1973.44.10.599
   ELLEGAARD B, 1971, J PERIODONTOL, V42, P648, DOI 10.1902/jop.1971.42.10.648
   Flemmig TF, 1998, J PERIODONTOL, V69, P47, DOI 10.1902/jop.1998.69.1.47
   FOLLMANN D, 1992, J CLIN EPIDEMIOL, V45, P769, DOI 10.1016/0895-4356(92)90054-Q
   Froum SJ, 2001, J PERIODONTOL, V72, P25, DOI 10.1902/jop.2001.72.1.25
   FROUM SJ, 1976, J PERIODONTOL, V47, P287, DOI 10.1902/jop.1976.47.5.287
   Froum SJ, 1998, J PERIODONTOL, V69, P698, DOI 10.1902/jop.1998.69.6.698
   GALGUT P N, 1990, Journal of Oral Implantology, V16, P173
   GALGUT PN, 1991, J PERIODONTOL, V62, P44, DOI 10.1902/jop.1991.62.1.44
   GALGUT PN, 1992, J CLIN PERIODONTOL, V19, P570, DOI 10.1111/j.1600-051X.1992.tb00685.x
   Garrett S, 1996, Ann Periodontol, V1, P621, DOI 10.1902/annals.1996.1.1.621
   Hancock EB, 1989, P WORLD WORKSH CLIN, pVI1
   Heijl L, 1997, J CLIN PERIODONTOL, V24, P705, DOI 10.1111/j.1600-051X.1997.tb00253.x
   Hiatt W H, 1986, Int J Periodontics Restorative Dent, V6, P8
   HIATT WH, 1973, J PERIODONTOL, V44, P194, DOI 10.1902/jop.1973.44.4.194
   Howell TH, 1997, J PERIODONTOL, V68, P1186, DOI 10.1902/jop.1997.68.12.1186
   KENNEY EB, 1985, J PERIODONTOL, V56, P82, DOI 10.1902/jop.1985.56.2.82
   Kilic AR, 1997, J CLIN PERIODONTOL, V24, P372, DOI 10.1111/j.1600-051X.1997.tb00200.x
   Kim CK, 1996, J PERIODONTOL, V67, P1301, DOI 10.1902/jop.1996.67.12.1301
   Kornman KS, 2000, PERIODONTOL 2000, V22, P22, DOI 10.1034/j.1600-0757.2000.2220103.x
   KREJCI CB, 1987, J PERIODONTOL, V58, P521, DOI 10.1902/jop.1987.58.8.521
   Levin M P, 1974, J Clin Periodontol, V1, P197
   LEVIN MP, 1974, ORAL SURG ORAL MED O, V38, P344, DOI 10.1016/0030-4220(74)90359-4
   Louise F, 1987, J Parodontol, V6, P203
   MABRY TW, 1985, J PERIODONTOL, V56, P74, DOI 10.1902/jop.1985.56.2.74
   Masters LB, 1996, J PERIODONTOL, V67, P770, DOI 10.1902/jop.1996.67.8.770
   MEADOWS CL, 1993, J PERIODONTOL, V64, P103, DOI 10.1902/jop.1993.64.2.103
   MEFFERT RM, 1985, J PERIODONTOL, V56, P63, DOI 10.1902/jop.1985.56.2.63
   MELLONIG JT, 1984, INT J PERIODONT REST, V4, P41
   Moher D, 1998, LANCET, V352, P609, DOI 10.1016/S0140-6736(98)01085-X
   MORA F, 1995, J CLIN PERIODONTOL, V22, P877, DOI 10.1111/j.1600-051X.1995.tb01787.x
   MOVIN S, 1982, J CLIN PERIODONTOL, V9, P141, DOI 10.1111/j.1600-051X.1982.tb01230.x
   NEEDLEMAN IG, 2001, COCHRANE LIB
   NERY EB, 1990, J PERIODONTOL, V61, P737, DOI 10.1902/jop.1990.61.12.737
   Okuda K, 2000, J PERIODONTOL, V71, P1821, DOI 10.1902/jop.2000.71.12.1821
   Ong MMA, 1998, J PERIODONTOL, V69, P1346, DOI 10.1902/jop.1998.69.12.1346
   PAPAPANOU PN, 1991, J CLIN PERIODONTOL, V18, P317, DOI 10.1111/j.1600-051X.1991.tb00435.x
   Park JS, 2001, J PERIODONTOL, V72, P730, DOI 10.1902/jop.2001.72.6.730
   PEARSON GE, 1981, J PERIODONTOL, V52, P55, DOI 10.1902/jop.1981.52.2.55
   Pontoriero R, 1999, J CLIN PERIODONTOL, V26, P833
   RABALAIS ML, 1981, J PERIODONTOL, V52, P680, DOI 10.1902/jop.1981.52.11.680
   Rosen PS, 2000, PERIODONTOL 2000, V22, P88, DOI 10.1034/j.1600-0757.2000.2220107.x
   SCHALLHORN RG, 1972, J PERIODONTOL, V43, P67, DOI 10.1902/jop.1972.43.2.67
   SCHALLHORN RG, 1980, INT DENT J, V30, P101
   SCHRAD SC, 1986, J PERIODONTOL, V57, P205, DOI 10.1902/jop.1986.57.4.205
   Schulz A, 2000, Clin Oral Investig, V4, P98, DOI 10.1007/s007840050123
   SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408
   SHAFFER CD, 1971, J PERIODONTOL, V42, P685, DOI 10.1902/jop.1971.42.11.685
   SHAHMIRI S, 1992, INT J PERIODONT REST, V12, P295
   Silvestri M, 2000, J CLIN PERIODONTOL, V27, P603, DOI 10.1034/j.1600-051x.2000.027008603.x
   STAHL SS, 1983, J PERIODONTOL, V54, P325, DOI 10.1902/jop.1983.54.6.325
   Tonetti MS, 2002, J CLIN PERIODONTOL, V29, P317, DOI 10.1034/j.1600-051X.2002.290407.x
   TROMBELLI L, 2002, IN PRESS J CLIN PERI
   YUKNA RA, 1994, J PERIODONTOL, V65, P177, DOI 10.1902/jop.1994.65.2.177
   Yukna RA, 1998, J PERIODONTOL, V69, P655, DOI 10.1902/jop.1998.69.6.655
   Yukna RA, 2000, J PERIODONTOL, V71, P752, DOI 10.1902/jop.2000.71.5.752
   YUKNA RA, 1989, J CLIN PERIODONTOL, V16, P398, DOI 10.1111/j.1600-051X.1989.tb01667.x
   YUKNA RA, 1985, J PERIODONTOL, V56, P540, DOI 10.1902/jop.1985.56.9.540
   YUKNA RA, 1984, J PERIODONTOL, V55, P633, DOI 10.1902/jop.1984.55.11.633
   YUKNA RA, 1989, J PERIODONTOL, V60, P544, DOI 10.1902/jop.1989.60.10.544
   YUKNA RA, 1990, J PERIODONTOL, V61, P633, DOI 10.1902/jop.1990.61.10.633
   YUKNA RA, 1986, INT J PERIODONT REST, V6, P35
   Zamet JS, 1997, J CLIN PERIODONTOL, V24, P410, DOI 10.1111/j.1600-051X.1997.tb00205.x
   Zetterstrom O, 1997, J CLIN PERIODONTOL, V24, P697, DOI 10.1111/j.1600-051X.1997.tb00252.x
NR 70
TC 138
Z9 140
U1 1
U2 15
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0303-6979
J9 J CLIN PERIODONTOL
JI J. Clin. Periodontol.
PY 2002
VL 29
SU 3
BP 117
EP 135
DI 10.1034/j.1600-051X.29.s3.7.x
PG 19
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 662UU
UT WOS:000181967900013
PM 12787213
DA 2018-10-20
ER

PT J
AU Sabino, MA
   Feijoo, JL
   Nunez, O
   Ajami, D
AF Sabino, MA
   Feijoo, JL
   Nunez, O
   Ajami, D
TI Interaction of fibroblast with poly(p-dioxanone) and its degradation
   products
SO JOURNAL OF MATERIALS SCIENCE
LA English
DT Article
ID IN-VITRO; POLYMERS; ADHESION
AB In vitro techniques were used to evaluate the interactions between Fibroblastic cells and Poly(p-Dioxanone) PPDX and compared its performance with that of other polymeric substrates. In vitro biocompatibility was assessed by studying cell adhesion and cell growth of cells on the polymer films themselves as well as in media enriched with the degradation products of PPDX and Poly(glycolic)/Poly(L-lactide 90:10 copolymer (PGLA-910). Our results show that althought all polymers tested were suitable for initial attachment, PPDX proved to be the most favorable surface for cell growth; as cell density after 48 h of culture was similar to that obtained on tissue culture Polystyrene TCPS (control). No signs of cell damage were detected using scanning electron microscopy (SEM) where after 48 h. of cell seeding on PPDX, fibroblast exhibited a confluent cell multilayer similar to TCPS. In addition, the products of the hydrolytic degradation of PPDX had no citotoxic effect on the adherence and proliferation of fibroblastic cell on TCPS. The hydrolytic degradation starts in the amorphous regions, as the tie-chain segments in these regions degrade into fragments causing the pH decrease in buffer solution and weight loss of degradable polymers. The in vitro evaluation suggests that PPDX may be candidate biomaterial for the construction a cell-polymer matrix. (C) 2002 Kluwer Academic Publishers.
C1 Univ Simon Bolivar, Dept Biol Celular, Caracas 1080A, Venezuela.
   Univ Simon Bolivar, Dept Proc & Sistemas, Caracas 1080A, Venezuela.
   Univ Simon Bolivar, Dept Ciencias Mat, Grp Polimeros USB, Caracas 1080A, Venezuela.
RP Ajami, D (reprint author), Univ Simon Bolivar, Dept Biol Celular, Apartado 89000, Caracas 1080A, Venezuela.
RI Ajami, Dariush/A-1312-2014
CR ATTAWIA MA, 1995, J BIOMED MATER RES, V29, P1233, DOI 10.1002/jbm.820291010
   Behravesh E, 1999, CLIN ORTHOP RELAT R, pS118
   Burmeister JS, 1999, J BIOMED MATER RES, V47, P577, DOI 10.1002/(SICI)1097-4636(19991215)47:4<577::AID-JBM15>3.0.CO;2-S
   Elvira C, 1999, REV PLAST MOD, V77, P49
   Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9
   HORBETT TA, 1999, J BIOMAT SCI-POLYM E, V10, P2
   ISHAUG SL, 1994, J BIOMED MATER RES, V28, P1445, DOI 10.1002/jbm.820281210
   KARLSSON S, 1995, J MACROMOL SCI PURE, VA32, P599, DOI 10.1080/10601329508010273
   Lu L, 1999, J BIOMED MATER RES, V46, P236, DOI 10.1002/(SICI)1097-4636(199908)46:2<236::AID-JBM13>3.0.CO;2-F
   MACFARLAND CD, 1999, J BIOMED MATER RES, V44, P1
   Minuth WW, 1998, CELL TISSUE RES, V291, P1
   MORRISON C, 1995, BIOMATERIALS, V16, P987, DOI 10.1016/0142-9612(95)94906-2
   PEPPAS NA, 1994, SCIENCE, V263, P1715, DOI 10.1126/science.8134835
   Saad B, 1997, J BIOMED MATER RES, V36, P65, DOI 10.1002/(SICI)1097-4636(199707)36:1<65::AID-JBM8>3.3.CO;2-#
   SABINO MA, IN PRESS POLYM DEG S
   Sung HW, 1996, J BIOMED MATER RES, V31, P511, DOI 10.1002/(SICI)1097-4636(199608)31:4<511::AID-JBM11>3.0.CO;2-J
   TAMADA Y, 1994, J BIOMED MATER RES, V28, P783, DOI 10.1002/jbm.820280705
   TORMALA P, 1991, J BIOMED MATER RES, V21, P1
   VERT M, 1992, BIOMATERIALS HARD TI, P223
   Walboomers XF, 1999, J BIOMED MATER RES, V47, P204, DOI 10.1002/(SICI)1097-4636(199911)47:2<204::AID-JBM10>3.0.CO;2-H
   Walboomers XF, 1999, J BIOMED MATER RES, V46, P212, DOI 10.1002/(SICI)1097-4636(199908)46:2<212::AID-JBM10>3.0.CO;2-Y
   WILLIAMS DF, 1982, J MATER SCI, V17, P1233, DOI 10.1007/BF00752233
NR 22
TC 13
Z9 14
U1 0
U2 12
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0022-2461
J9 J MATER SCI
JI J. Mater. Sci.
PD JAN
PY 2002
VL 37
IS 1
BP 35
EP 40
DI 10.1023/A:1013129421038
PG 6
WC Materials Science, Multidisciplinary
SC Materials Science
GA 500XT
UT WOS:000172654500003
DA 2018-10-20
ER

PT J
AU Zhao, XB
   Fraser, JE
   Alexander, C
   Lockett, C
   White, BJ
AF Zhao, XB
   Fraser, JE
   Alexander, C
   Lockett, C
   White, BJ
TI Synthesis and characterization of a novel double crosslinked hyaluronan
   hydrogel
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID CROSS-LINKING; ACID; DERIVATIVES
AB Hyaluronan has great potential in medicine as a biomaterial. However, in its native form, hyaluronan is rapidly metabolized in vivo by free radicals and enzymes such as hyaluronidase, and it is highly soluble. Various methods have been adopted therefore, to modify the physicochemical properties of hyaluronan, while maintaining biocompatibility, and thereby widen its spectrum of therapeutic applications.
   Hyaluronan has four reactive groups (acetamido, carboxyl, hydroxyl and the reducing end) available for crosslinking to itself or other polymers. Using a variety of crosslinking agents, researchers have developed a host of crosslinked hyaluronan derivatives with an increased in vivo residence time. This chemical modification has enabled the production of gels and films, which can be used in applications such as the prevention of post-surgical adhesions, wound healing and dermal augmentation.
   We have found that if hyaluronan is crosslinked to itself, or to other polymers (either synthetic or biopolymer), in two stages, then a high degree of crosslinking is achieved, conferring improved biostability. In each of the two stages, the same crosslinking agent is used, but different functional groups are bound by altering the reaction conditions. The novel process can be tailored to yield water insoluble gels and films with a broad range of physical and chemical characteristics, and greater resistance to degradation by hyaluronidase and free radicals. These derivatives are currently undergoing biocompatibility testing, and should ultimately lead to a series of innovative second-generation medical products. (C) 2002 Kluwer Academic Publishers.
C1 Vitrolife UK Ltd, Edinburgh EH14 4AP, Midlothian, Scotland.
RP Zhao, XB (reprint author), Vitrolife UK Ltd, Heriot Watt Res Pk, Edinburgh EH14 4AP, Midlothian, Scotland.
CR Balazs E A, 1986, US patent, Patent No. [4582865, 4,582,865]
   Bell E, 1995, Tissue Eng, V1, P163, DOI 10.1089/ten.1995.1.163
   BITTER T, 1962, ANAL BIOCHEM, V4, P330, DOI 10.1016/0003-2697(62)90095-7
   Bulpitt P, 1999, J BIOMED MATER RES, V47, P152
   Campoccia D, 1998, BIOMATERIALS, V19, P2101, DOI 10.1016/S0142-9612(98)00042-8
   De Belder A. N., 1989, U.S. patent, Patent No. [4886787, 4,886,787]
   Dickerson K.T., 1997, US Patent, Patent No. [5,677,276, 5677276]
   DURANTI F, 1998, DERMATOL SURG, V24, P1314
   JOHNS DB, 1997, FERTIL STERIL, V68, P137
   LAURENT TC, 1964, ACTA CHEM SCAND, V18, P274, DOI 10.3891/acta.chem.scand.18-0274
   LONGAKER M T, 1991, Clinical Materials, V8, P223, DOI 10.1016/0267-6605(91)90035-E
   Meyer K, 1934, J BIOL CHEM, V107, P629
   RASTRELLI A, 1990, CLIN IMPLANT MAT, V9, P199
   RHEE W, 1996, Patent No. 5510121
   Tomihata K, 1997, BIOMATERIALS, V18, P189, DOI 10.1016/S0142-9612(96)00116-0
   Tomihata K, 1997, J BIOMED MATER RES, V37, P243
   Tomihata K, 1997, J POLYM SCI POL CHEM, V35, P3553, DOI 10.1002/(SICI)1099-0518(19971130)35:16<3553::AID-POLA22>3.0.CO;2-D
   Vercruysse KP, 1998, CRIT REV THER DRUG, V15, P513
   YUI N, 1992, J CONTROL RELEASE, V22, P105
   ZHAO X, 2000, Patent No. 0046253
   ZHAO X, 2000, Patent No. 0046254
NR 21
TC 35
Z9 35
U1 4
U2 21
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JAN
PY 2002
VL 13
IS 1
BP 11
EP 16
DI 10.1023/A:1013618115163
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 509JH
UT WOS:000173144300004
PM 15348198
DA 2018-10-20
ER

PT J
AU Giannoulis, CS
   Desai, TA
AF Giannoulis, CS
   Desai, TA
TI Characterization of proteins and fibroblasts on thin inorganic films
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID SILICON SURFACES; ELLIPSOMETRY; CELLS
AB The ability of biomaterial surfaces to regulate cell behavior requires control over surface chemistry and material microstructure. One of the goals in the development of silicon-based biomedical devices such as biosensors or drug delivery systems is improved biocompatibility which may be achieved through the deposition or adsorption of thin films. In this study, films of single crystal silicon, stoichiometric and low stress silicon nitride, doped and undoped polysilicon, as well as Arg-Gly-Asp (RGD) peptide adsorbed surfaces characterized in terms of protein adsorption or cellular adhesion for a period of four days. Protein adsorption studies using fibrinogen and albumin, two proteins implicated in cellular adhesion and surface activity, reveal that low stress silicon nitride surfaces have a 223%+/-2.50% greater protein adsorption compared to undoped polysilicon surfaces, followed by silicon nitride, unmodified silicon, and doped polysilicon surfaces, respectively. The thickness of the adsorbed albumin and fibrinogen layer on various thin films was measured by ellipsometry and compared to contact angle measurements. The greatest cellular adhesion was observed on undoped polysilicon, followed by unmodified (control) silicon, low stress silicon nitride, silicon nitride, and doped polysilicon surfaces. Cellular binding supports the differential protein adsorption found on modified and unmodified silicon surfaces. Understanding the biological response to thin films will allow us to design more appropriate interfaces for implantable diagnostic and therapeutic silicon-based microdevices. (C) 2002 Kluwer Academic Publishers.
C1 Univ Illinois, Dept Bioengn MC 063, Chicago, IL 60607 USA.
RP Desai, TA (reprint author), Univ Illinois, Dept Bioengn MC 063, 851 S Morgan St, Chicago, IL 60607 USA.
CR ANDRADE JD, 1986, ADV POLYM SCI, V79, P1
   Bhat VD, 1998, J BIOMAT SCI-POLYM E, V9, P1117, DOI 10.1163/156856298X00686
   Canham LT, 1995, ADV MATER, V7, P1033, DOI 10.1002/adma.19950071215
   Desai TA, 1998, BIOTECHNOL BIOENG, V57, P118, DOI 10.1002/(SICI)1097-0290(19980105)57:1<118::AID-BIT14>3.0.CO;2-G
   Elwing H, 1998, BIOMATERIALS, V19, P397, DOI 10.1016/S0142-9612(97)00112-9
   HANSFORD DJ, 1999, THESIS U CALIFORNIA
   Henry S, 1999, J PHARM SCI, V88, P948
   HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9
   JAEGER RC, 1998, INTRO MICROELECTRONI, V5
   MALMSTEN M, 1995, PROTEINS INTERFACES, V2, P228
   MANDENIUS CF, 1984, ANAL BIOCHEM, V137, P106, DOI 10.1016/0003-2697(84)90354-3
   MARGEL S, 1993, J BIOMED MATER RES, V27, P1463, DOI 10.1002/jbm.820271202
   MASSIA SP, 1990, ANAL BIOCHEM, V187, P292, DOI 10.1016/0003-2697(90)90459-M
   Ratner B. D., 1996, BIOMATERIALS SCI INT
   Ratner B. D., 1997, SURFACE MODIFICATION
   STENSAAS SS, 1978, ACTA NEUROPATHOL, V41, P145, DOI 10.1007/BF00689766
   TUNER JN, 1999, EXP NEUROL, V156, P33
   ULMAN A, 1991, INTRO ULTRATHIN ORGA
   Zhang MQ, 1998, BIOMATERIALS, V19, P953, DOI 10.1016/S0142-9612(98)00026-X
NR 19
TC 16
Z9 16
U1 0
U2 1
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JAN
PY 2002
VL 13
IS 1
BP 75
EP 80
DI 10.1023/A:1013646805593
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 509JH
UT WOS:000173144300015
PM 15348209
DA 2018-10-20
ER

PT J
AU White, JF
   Werkmeister, JA
   Darby, IA
   Bisucci, T
   Birk, DE
   Ramshaw, JAM
AF White, JF
   Werkmeister, JA
   Darby, IA
   Bisucci, T
   Birk, DE
   Ramshaw, JAM
TI Collagen fibril formation in a wound healing model
SO JOURNAL OF STRUCTURAL BIOLOGY
LA English
DT Article; Proceedings Paper
CT Workshop on Coiled-Coils, Collagen, and Co-Proteins
CY SEP 16-21, 2001
CL ALPBACH, AUSTRIA
DE collagen; fibril formation; gentamicin; heterotypic fibrils; histology;
   in situ hybridization; immunoelectron microscopy; immunofluorescence;
   wound healing
ID FIBRILLOGENESIS IN-SITU; EXTRACELLULAR COMPARTMENTS; III COLLAGEN;
   POINTED TIPS; TENDON; SEGMENTS; MATRIX; GROWTH; MORPHOGENESIS; LIGAMENT
AB Control of tissue composition and organization will be a key feature in the development of successful products through tissue engineering. However, the mechanism of collagen fibril formation, growth, and organization is not yet fully understood. In this study we have examined collagen fibril formation in a wound healing model in which the newly formed fibrils were kept distinct from preexisting tissue through use of a porous tubular biomaterial implant. Samples were examined after 4, 6, 14, and 28 days by light microscopy, in situ hybridization, and immunofluorescence microscopy. These showed a normal wound healing response, with significant collagen formation at 14 and 28 days. Individual collagen fibrils were isolated from these samples by gentle extraction in a gentamicin-containing buffer which allowed extraction of a large proportion of intact fibrils. Examination by transmission electron microscopy showed that similar to80% of the intact fibrils showed a single polarity reversal, with both ends of each fibril comprising collagen amino-terminal domains; the remaining fibrils had no polarity reversal. All fibrils had similar diameters at both time points. Immunoelectron microscopy showed that all labeled fibrils contained both type I and III collagens. These data indicate that this wound healing model provides a system in which collagen fibril formation can be readily followed. (C) 2002 Elsevier Science (USA).
C1 CSIRO Mol Sci, Parkville, Vic, Australia.
   RMIT Univ, Dept Human Biol & Movement Sci, Bundoora, Vic, Australia.
   Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA.
RP Ramshaw, JAM (reprint author), CSIRO Mol Sci, 343 Royal Parade, Parkville, Vic, Australia.
RI Birk, David/I-4072-2012; Ramshaw, John/A-9411-2011
OI Birk, David/0000-0002-4865-9088; Darby, Ian/0000-0002-0990-1986
CR BAILEY AJ, 1975, BIOCHIM BIOPHYS ACTA, V405, P412, DOI 10.1016/0005-2795(75)90106-3
   BARNES MJ, 1976, BIOCHEM J, V157, P263, DOI 10.1042/bj1570263
   BIRK DE, 1995, DEV DYNAM, V202, P229, DOI 10.1002/aja.1002020303
   BIRK DE, 1994, J ANAT, V184, P457
   Birk DE, 1997, DEV DYNAM, V208, P291
   Birk DE, 1996, MATRIX BIOL, V15, P111, DOI 10.1016/S0945-053X(96)90152-3
   BIRK DE, 1984, J CELL BIOL, V99, P2024, DOI 10.1083/jcb.99.6.2024
   BIRK DE, 1989, P NATL ACAD SCI USA, V86, P4549, DOI 10.1073/pnas.86.12.4549
   BIRK DE, 1990, ANN NY ACAD SCI, V580, P176, DOI 10.1111/j.1749-6632.1990.tb17928.x
   Bisucci T, 2000, METH MOL B, V123, P291
   BRUNS RR, 1979, P NATL ACAD SCI USA, V76, P313, DOI 10.1073/pnas.76.1.313
   Clark RAF, 1988, MOL CELLULAR BIOL WO
   CRAIG AS, 1989, CONNECT TISSUE RES, V19, P51, DOI 10.3109/03008208909016814
   DeVente JE, 1997, J ELECTRON MICROSC, V46, P353, DOI 10.1093/oxfordjournals.jmicro.a023530
   FLEISCHMAJER R, 1983, P NATL ACAD SCI-BIOL, V80, P3354, DOI 10.1073/pnas.80.11.3354
   FLEISCHMAJER R, 1990, J STRUCT BIOL, V105, P162, DOI 10.1016/1047-8477(90)90110-X
   Graham HK, 2000, J MOL BIOL, V295, P891, DOI 10.1006/jmbi.1999.3384
   HOLMES DF, 1994, J MOL BIOL, V235, P80, DOI 10.1016/S0022-2836(05)80016-6
   Kadler KE, 1996, BIOCHEM J, V316, P1
   KADLER KE, 1990, BIOCHEM J, V268, P339, DOI 10.1042/bj2680339
   Langer RS, 1999, SCI AM, V280, P86, DOI 10.1038/scientificamerican0499-86
   MIYAHARA M, 1984, J BIOL CHEM, V259, P9891
   MULLERMAI CM, 1991, J APPL BIOMATER, V2, P29, DOI 10.1002/jab.770020105
   NAKATSUKASA H, 1990, J CLIN INVEST, V85, P1833, DOI 10.1172/JCI114643
   Neame PJ, 2000, CELL MOL LIFE SCI, V57, P859, DOI 10.1007/s000180050048
   PARKINSON J, 1994, PHYS REV E, V50, P2963, DOI 10.1103/PhysRevE.50.2963
   Parry D A D, 1988, COLLAGEN, V2, P1
   SCOTT JE, 1992, INT J BIOL MACROMOL, V14, P292, DOI 10.1016/S0141-8130(05)80043-1
   SILVER D, 1992, P NATL ACAD SCI USA, V89, P9860, DOI 10.1073/pnas.89.20.9860
   THURMOND FA, 1994, J MOL BIOL, V235, P73, DOI 10.1016/S0022-2836(05)80015-4
   Trotter JA, 1998, J MOL BIOL, V284, P1417, DOI 10.1006/jmbi.1998.2230
   VEIS A, 1988, COLLAGEN, V1, P113
   WERKMEISTER JA, 1990, EUR J BIOCHEM, V187, P439, DOI 10.1111/j.1432-1033.1990.tb15323.x
   WERKMEISTER JA, 1991, BIOCHEM J, V274, P895, DOI 10.1042/bj2740895
NR 34
TC 23
Z9 23
U1 0
U2 2
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1047-8477
J9 J STRUCT BIOL
JI J. Struct. Biol.
PD JAN-FEB
PY 2002
VL 137
IS 1-2
BP 23
EP 30
DI 10.1006/jsbi.2002.4460
PG 8
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 566XL
UT WOS:000176453500005
PM 12064930
DA 2018-10-20
ER

PT S
AU De Ford, D
   Higgins, A
   Gregory, KW
AF De Ford, D
   Higgins, A
   Gregory, KW
BE Bartels, KE
   Bass, LS
   DeRiese, WTW
   Gregory, KW
   Katzir, A
   Kollias, N
   Lucroy, MD
   Malek, RS
   Peavy, GM
   Reidenbach, HD
   Robinson, DS
   Shah, UK
   Tate, LP
   Trowers, EA
   Wong, BJF
   Woodward, TA
TI Vascular anastomosis using a pulsed diode laser
SO LASERS IN SURGERY: ADVANCED CHARACTERIZATION, THERAPEUTICS, AND SYSTEMS
   XII
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Lasers in Surgery - Advanced Characterization,
   Therapeutics, and Systems XII
CY JAN 19-22, 2002
CL SAN JOSE, CA
SP SPIE
DE laser welding; vascular anastomosis; elastin patch; albumin films; organ
   repair; tissue repair
ID INDOCYANINE GREEN
AB The objective of this research is to provide a novel approach to the problem of vascular anastomosis. The work subscribes to the idea that if we use a human protein that has adhesive properties, denatures by heat in an irreversible way and forms a semi-hard but flexible matter. Also belongs to the circulatory system, is liquid in its native state, and after denaturing it is not soluble in water, blood plasma or any other related fluids anymore. Therefore, a pulsed diode laser beam can be used on this protein in order to have a strong welding for vascular anastomosis.
   It was established in the Oregon Medical Laser Center that the best proteins to be used, as a welding biomaterial, is human albumin. Indocyanine Green was added to provide a compound that absorbs light and transforms it in heat to the denaturing and welding process.
   Tests with liquid albumin were performed, the results obtained were unreliable due to the following facts: the variation in the liquid film thickness produced pockets of native (non-denatured albumin) underneath the denatured welded crust and bubbles produced by water evaporation. This phenomenon led to a weak welding.
   After testing different options, it was decided that the manufacturing of a solid thin film of albumin/ICG with a content of water between 37-40% was the best option. It reduces the number of bubbles, and provides a constant thickness between 200-250 mum. This thin film can be used alone on the vascular surface to be welded, or in combination with an elastin strip to increase strength.
   To avoid collapsing of the blood vessel while welding, and also keep both edges of the vessel together, an albumin/ICG stent was designed so the configuration of the stent does not allow the vessel to slip away or collapse. The stent is made out of native human albumin with water content between 37-40%. When the weld is completed and the forceps are released, it is expected that the natural flow of blood will dissolve the stent in less than 12 minutes (according with experiments already performed with lukewarm water).
C1 Oregon State Univ, Oregon Med Laser Ctr, Corvallis, OR 97331 USA.
RP De Ford, D (reprint author), Oregon State Univ, Oregon Med Laser Ctr, Corvallis, OR 97331 USA.
CR GOLNIK G, 1993, IR EO SYSTEMS HDB, V8, P403
   LaJoie EN, 1997, LASER MED SCI, V12, P49, DOI 10.1007/BF02763921
   PETERS TJ, 1996, ALL ABOUT ALBUMIN
   POSEY J A JR, 1973, Cardiovascular Research Center Bulletin (Houston), V11, P83
   ROSENBLOOM J, 1987, METHOD ENZYMOL, V144, P172
   SAWYER P, 1987, MODERN VASCULAR GRAF, P326
   ZHOU JF, 1994, P SOC PHOTO-OPT INS, V2128, P495, DOI 10.1117/12.184936
NR 7
TC 0
Z9 0
U1 0
U2 2
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-4348-4
J9 P SOC PHOTO-OPT INS
PY 2002
VL 4609
BP 449
EP 455
DI 10.1117/12.444382
PG 7
WC Engineering, Biomedical; Optics; Surgery
SC Engineering; Optics; Surgery
GA BU92L
UT WOS:000177417100061
DA 2018-10-20
ER

PT J
AU Simpson, KH
   Bowden, MG
   Hook, M
   Anvari, B
AF Simpson, KH
   Bowden, MG
   Hook, M
   Anvari, B
TI Measurement of adhesive forces between S-epidermidis and
   fibronectin-coated surfaces using optical tweezers
SO LASERS IN SURGERY AND MEDICINE
LA English
DT Article
DE bacterial adhesion; biofilm; extracellular matrix; infection
ID FIBRINOGEN; PROTEIN
AB Background and Objectives: Biomaterial-mediated infection, a common cause of medical device failure, is initiated by bacterial adhesion to an adsorbed protein layer on the implant surface. This adhesion is thought to be mediated by specific molecules present on the bacterial cell surface. Optical tweezers can be used to measure the adhesive force between a single bacterium and a protein-coated surface.
   Study Design/Materials and Methods: Using optical tweezers, a bacterium was trapped and brought in contact with a 10-mum diameter polystyrene microsphere coated with fibronectin. The minimum force required to detach the cell from the bead was determined over a range of fibronectin concentrations and contact times.
   Results: The detachment forces were integer multiples of an 18-pN base value that was independent of contact time and coating concentration; we propose that the variation in force is related to the number of bonds formed.
   Conclusions: These experiments demonstrate that optical tweezers can be used to investigate the adhesion of individual bacteria to surfaces. The results suggest that S. epidermidis has surface proteins capable of binding fibronectin. (C) 2002 Wiley-Liss, Inc.
C1 Rice Univ, Dept Bioengn, Houston, TX 77251 USA.
   Texas A&M Univ, Syst Hlth Sci Ctr, Albert B Alkek Inst Biosci & Technol, Ctr Extracellular Matrix Biol, Houston, TX 77030 USA.
RP Anvari, B (reprint author), Rice Univ, Dept Bioengn, POB 1892,MS 142, Houston, TX 77251 USA.
CR Boland T, 2000, CRIT REV BIOMED ENG, V28, P195, DOI 10.1615/CritRevBiomedEng.v28.i12.330
   DICKINSON RB, 2000, HDB BACTERIAL ADHESI, P297
   Evans E, 1997, BIOPHYS J, V72, P1541, DOI 10.1016/S0006-3495(97)78802-7
   FELGNER H, 1995, APPL OPTICS, V34, P977, DOI 10.1364/AO.34.000977
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   HERRMANN M, 1988, J INFECT DIS, V158, P693, DOI 10.1093/infdis/158.4.693
   Hook M, 2000, GRAM-POSITIVE PATHOGENS, P386
   KUUSELA P, 1985, INFECT IMMUN, V50, P77
   Liang H, 1996, BIOPHYS J, V70, P1529, DOI 10.1016/S0006-3495(96)79716-3
   Mohamed N, 2000, BIOTECHNOL BIOENG, V68, P628, DOI 10.1002/(SICI)1097-0290(20000620)68:6<628::AID-BIT5>3.3.CO;2-4
   Neuman KC, 1999, BIOPHYS J, V77, P2856, DOI 10.1016/S0006-3495(99)77117-1
   Nilsson M, 1998, INFECT IMMUN, V66, P2666
   Razatos A, 1998, J BIOMAT SCI-POLYM E, V9, P1361, DOI 10.1163/156856298X00442
   Schwesinger F, 2000, P NATL ACAD SCI USA, V97, P9972, DOI 10.1073/pnas.97.18.9972
   Stout AL, 2001, BIOPHYS J, V80, P2976, DOI 10.1016/S0006-3495(01)76263-7
   SVOBODA K, 1994, ANNU REV BIOPH BIOM, V23, P247, DOI 10.1146/annurev.bb.23.060194.001335
   Wann ER, 2000, J BIOL CHEM, V275, P13863, DOI 10.1074/jbc.275.18.13863
   WRIGHT WH, 1994, APPL OPTICS, V33, P1735, DOI 10.1364/AO.33.001735
NR 18
TC 24
Z9 24
U1 1
U2 8
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0196-8092
J9 LASER SURG MED
JI Lasers Surg. Med.
PY 2002
VL 31
IS 1
BP 45
EP 52
DI 10.1002/lsm.10070
PG 8
WC Dermatology; Surgery
SC Dermatology; Surgery
GA 581UL
UT WOS:000177311900008
PM 12124715
DA 2018-10-20
ER

PT J
AU Maitland, DJ
   Metzger, MF
   Schumann, D
   Lee, A
   Wilson, TS
AF Maitland, DJ
   Metzger, MF
   Schumann, D
   Lee, A
   Wilson, TS
TI Photothermal properties of shape memory polymer micro-actuators for
   treating stroke
SO LASERS IN SURGERY AND MEDICINE
LA English
DT Article
DE diode laser; hemorrhagic stroke; ischemic stroke; biomaterial
ID RHEOLYTIC CATHETER; THROMBECTOMY
AB Background and Objectives: In this paper the photothermal engineering issues of novel shape memory polymer (SMP) microactuators for treating stroke are presented. The engineering issues for using lasers to heat and subsequently actuate these SMP devices are presented in order to provide design criteria and guidelines for intravascular, laser activated SMP devices.
   Materials and Methods: A total of three devices will be presented: two interventional ischemic stroke devices (coil and umbrella) and one device for releasing embolic coils (microgripper). The optical properties of SMP, methods for coupling laser light into SMP, heating distributions in the SMP devices, and the impact of operating the thermally activated material in a blood vessel are presented.
   Results: Actuating the devices requires device temperatures in the range of 65-85degreesC. Attaining these temperatures under flow conditions requires critical engineering of the SMP optical properties, optical coupling into the SMP, and device geometries.
   Conclusion: Laser-activated SMP devices are a unique combination of laser-tissue and biomaterial technologies. Successful deployment of the microactuator requires well-engineered coupling of the light from the diffusing fiber through the blood into the SMP. (C) 2002 Wiley-Liss, Inc.
C1 Lawrence Livermore Natl Lab, Med Technol Program, Livermore, CA 94550 USA.
RP Maitland, DJ (reprint author), Lawrence Livermore Natl Lab, Med Technol Program, 7000 E Ave,Mail Stop L-174, Livermore, CA 94550 USA.
CR BENDERSON JB, 2000, STROKE, V31, P2742
   BENETT WJ, 1998, Patent No. 5788130
   Broderick J, 1998, STROKE, V29, P415, DOI 10.1161/01.STR.29.2.415
   CONNORS JJ, 1999, INTERV NEURORADIOL, P650
   CONNORS JJ, 1999, INTERV NEURORADIOL, P276
   FITCH JP, 1998, Patent No. 5722989
   Gorelick PB, 1999, JAMA-J AM MED ASSOC, V281, P1112, DOI 10.1001/jama.281.12.1112
   Hayashi S., 1988, MITSUBISHI TECHNICAL, V184
   Hayashi S., 1991, U. S. Patent, Patent No. [5,049,591, 5049591]
   Katzan IL, 2000, JAMA-J AM MED ASSOC, V283, P1151, DOI 10.1001/jama.283.9.1151
   KUSY RP, 1994, THERMOCHIM ACTA, V243, P253, DOI 10.1016/0040-6031(94)85060-7
   LAFONTAINE D, 1996, Patent No. 5662621
   Maitland DJ, 1997, LASER SURG MED, V20, P310, DOI 10.1002/(SICI)1096-9101(1997)20:3<310::AID-LSM10>3.0.CO;2-H
   MAITLAND DJ, 1998, Patent No. 6102917
   MARLER JR, 1995, NEW ENGL J MED, V333, P1581
   Opatowsky MJ, 1999, AM J NEURORADIOL, V20, P414
   OTA S, 1981, RADIAT PHYS CHEM, V18, P81, DOI 10.1016/0146-5724(81)90066-2
   Otsuka K., 1998, SHAPE MEMORY MAT
   Pearce JA, 1995, OPTICAL THERMAL RESP, P561
   Ratner BD, 1996, INTRO MAT MED
   Takahashi T, 1996, J APPL POLYM SCI, V60, P1061
   Vesely TM, 1999, J VASC INTERV RADIOL, V10, P1195, DOI 10.1016/S1051-0443(99)70220-4
   Wang MT, 1999, J POLYM SCI POL PHYS, V37, P101, DOI 10.1002/(SICI)1099-0488(19990115)37:2<101::AID-POLB1>3.0.CO;2-X
   Wiebers D, 1998, NEW ENGL J MED, V339, P1725
NR 24
TC 201
Z9 203
U1 4
U2 79
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0196-8092
J9 LASER SURG MED
JI Lasers Surg. Med.
PY 2002
VL 30
IS 1
BP 1
EP 11
PG 11
WC Dermatology; Surgery
SC Dermatology; Surgery
GA 514DT
UT WOS:000173423500001
PM 11857597
DA 2018-10-20
ER

PT J
AU Vena, P
   Contro, R
AF Vena, P
   Contro, R
TI Micromechanical analysis of the trabecular bone stress state at the
   interface with metallic biomedical devices
SO MECCANICA
LA English
DT Article; Proceedings Paper
CT 15th Congress of AIMETA
CY SEP 26-29, 2001
CL SICILY, ITALY
DE microstructures; interface behaviour; finite elements; multi-scale
   computing; iterative techniques
ID FINITE-ELEMENT MODELS; ACCURACY
AB An iterative procedure for the stress analysis at interfaces between dissimilar materials is presented. The problem is specialised to the case of biomaterial interfaces with particular reference to materials which are characterised by tiny microstructures. The procedure is based on a recursive analysis of small size problems defined upon subdomains obtained by partitioning the whole structural domain. The kinematic boundary conditions are iteratively adjusted by using appropriate preconditioners. The numerical example reported in this paper shows that the procedure is effective regardless of the degree of material heterogeneity, in contrast with the results obtained by using a coarse mesh for the whole domain. The procedure seems to be a promising one for determining the structural strength of interfaces between trabecular bone and metal implants requiring accurate evaluation of stress at the scale level of the single microstructure exhibited by the bone.
C1 Politecn Milan, Dept Struct Engn, Lab Biol Struct Mech, I-20133 Milan, Italy.
RP Vena, P (reprint author), Politecn Milan, Dept Struct Engn, Lab Biol Struct Mech, Piazza Leonardo da Vinci 32, I-20133 Milan, Italy.
RI Vena, Pasquale/F-6684-2013
OI Vena, Pasquale/0000-0003-2229-5156
CR Charras GT, 2000, J BIOMECH, V33, P255, DOI 10.1016/S0021-9290(99)00141-4
   Guldberg RE, 1998, J BIOMECH ENG-T ASME, V120, P289, DOI 10.1115/1.2798314
   Jacobs CR, 1999, J BIOMECH, V32, P1159, DOI 10.1016/S0021-9290(99)00115-3
   Le Tallec P, 1994, COMPUT MECH ADV, V1, P121
   Niebur GL, 2000, J BIOMECH, V33, P1575, DOI 10.1016/S0021-9290(00)00149-4
   Pistoia W, 2001, J BIOMECH ENG-T ASME, V123, P176, DOI 10.1115/1.1352734
   Terada K, 2000, INT J SOLIDS STRUCT, V37, P2285, DOI 10.1016/S0020-7683(98)00341-2
   Wentorf R, 1999, COMPUT METHOD APPL M, V172, P273, DOI 10.1016/S0045-7825(98)00232-1
   ZOHDI TI, 1999, COMPUT METHODS APPL, V172, P3
NR 9
TC 2
Z9 2
U1 0
U2 0
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0025-6455
J9 MECCANICA
JI Meccanica
PY 2002
VL 37
IS 4-5
BP 431
EP 439
DI 10.1023/A:1020852108109
PG 9
WC Mechanics
SC Mechanics
GA 606DG
UT WOS:000178717800012
DA 2018-10-20
ER

PT S
AU Gonsalves, KE
   He, W
   Poker, DB
   Batina, N
   Merhari, L
AF Gonsalves, KE
   He, W
   Poker, DB
   Batina, N
   Merhari, L
BE Merhari, L
   Gonsalves, KE
   Dobisz, EA
   Angelopoulos, M
   Herr, D
TI A versatile approach for biomaterial patterning: Masked ion beam
   lithography
SO NANOPATTERNING-FROM ULTRALARGE-SCALE INTERGRATION TO BIOTECHNOLOGY
SE MATERIALS RESEARCH SOCIETY SYMPOSIUM PROCEEDINGS
LA English
DT Proceedings Paper
CT Symposium on Nanopatterning - From Ultralarge-Scale Integration to
   Biotechnology held at the 2001 MRS Fall Meeting
CY NOV 25-29, 2001
CL BOSTON, MA
SP CERAMEC France, Motorola France, Res Ctr, Nanoresist Technologies Inc, Natl Sci Fdn, Whitaker Fdn, Mat Res Soc
ID IMPLANTATION
AB We describe a new approach for biomaterial patterning, viz, masked ion beam lithography. Poly (methyl methacrylate) (PMMA) film was used as a model system and subjected to Ca+ and P+ ion implantations through masks. Ca+ ion implantation was performed at an energy of 85 keV with a fluence of 1x10(14) ions/cm(2). P+ ion implantation was done at an energy of 85 keV with fluences of 1x10(15) and 1x10(16) ions/cm(2). Arrays of holes were generated during these processes. AFM showed that the depth of the holes is in the nanoscale region. The surface hydrophobicity of the exposed PMMA films was investigated by contact angle measurement. The results indicated that ion implantation changed the surface hydrophobicity.
C1 Univ N Carolina, Dept Chem, Charlotte, NC 28223 USA.
RP Gonsalves, KE (reprint author), Univ N Carolina, Dept Chem, Charlotte, NC 28223 USA.
RI Batina, Nikola/J-6871-2017; He, Wei/K-7218-2013
OI Batina, Nikola/0000-0001-8217-8563; He, Wei/0000-0002-6638-9691
CR Folch A, 2000, ANNU REV BIOMED ENG, V2, P227, DOI 10.1146/annurev.bioeng.2.1.227
   Hyun J, 2001, J AM CHEM SOC, V123, P6943, DOI 10.1021/ja015798g
   IWAKI M, 1989, CRIT REV SOLID STATE, V15, P473, DOI 10.1080/10408438908243743
   Li DJ, 1999, NUCL INSTRUM METH B, V152, P80, DOI 10.1016/S0168-583X(98)00915-X
   MAGANOV SN, 1994, SURFACE ANAL STM AFM, P31
   TANDON US, 1993, PATTERNING MAT LAYER, P39
NR 6
TC 0
Z9 0
U1 0
U2 2
PU MATERIALS RESEARCH SOCIETY
PI WARRENDALE
PA 506 KEYSTONE DRIVE, WARRENDALE, PA 15088-7563 USA
SN 0272-9172
BN 1-55899-641-9
J9 MATER RES SOC SYMP P
PY 2002
VL 705
BP 247
EP 251
PG 5
WC Biotechnology & Applied Microbiology; Engineering, Multidisciplinary;
   Materials Science, Multidisciplinary; Physics, Applied
SC Biotechnology & Applied Microbiology; Engineering; Materials Science;
   Physics
GA BU87A
UT WOS:000177252400031
DA 2018-10-20
ER

PT S
AU Orth, RN
   Hafez, I
   Wu, M
   Ilic, B
   Baird, B
   Clark, TG
   Craighead, HG
AF Orth, RN
   Hafez, I
   Wu, M
   Ilic, B
   Baird, B
   Clark, TG
   Craighead, HG
BE Merhari, L
   Gonsalves, KE
   Dobisz, EA
   Angelopoulos, M
   Herr, D
TI Micro- and nanofabricating lipid patterns using a polymer-based wet
   lift-off
SO NANOPATTERNING-FROM ULTRALARGE-SCALE INTERGRATION TO BIOTECHNOLOGY
SE MATERIALS RESEARCH SOCIETY SYMPOSIUM PROCEEDINGS
LA English
DT Proceedings Paper
CT Symposium on Nanopatterning - From Ultralarge-Scale Integration to
   Biotechnology held at the 2001 MRS Fall Meeting
CY NOV 25-29, 2001
CL BOSTON, MA
SP CERAMEC France, Motorola France, Res Ctr, Nanoresist Technologies Inc, Natl Sci Fdn, Whitaker Fdn, Mat Res Soc
ID RESONANCE; BILAYERS; BIOTIN
AB Accurate placement of biomaterials at nanoscale resolution opens new capabilities for biological sensing, cell manipulation, and control of cellular transduction cascades. We demonstrate that lipid molecules can be patterned on silicon using a polymer lift-off technique. Patterned lipid bilayers serve as biomaterial patterning platforms useful for studies of cellular function. Submicron feature sizes were achieved using this templating technique which is suitable for delicate biomaterials(1). Projection lithography and reactive ion etching were used to pattern a Parylene-coated surface. The patterned surface was subsequently exposed to 100 nm unilamellar lipid vesicles that bound to the native oxide surfaces of silicon and spread to form supported lipid bilayers. The nanoscale pattern is realized as the polymer is peeled away in deionized water. The versatility of this method is demonstrated by the successful preparation of functionalized lipid bilayer surfaces. Specific intermolecular interactions were demonstrated between supported membranes: DPPE-PE (2000) biotin/avidin, dinitrophenol (DNP)-conjugated lipids/anti-DNP IgE, and cationic lipid and M13 dsDNA:YOYO-1.
C1 Cornell Univ, Sch Appl & Engn Phys, Ithaca, NY 14853 USA.
RP Orth, RN (reprint author), Cornell Univ, Sch Appl & Engn Phys, Ithaca, NY 14853 USA.
RI Wu, Min/H-8048-2012; Ilic, Rob/N-1359-2014
OI Wu, Min/0000-0002-9161-7940; 
CR *AV POL LIP INC, 2001, AV POL LIP CAT
   BAYER EA, 1990, METHOD ENZYMOL, V184, P174
   BAYERL TM, 1990, BIOPHYS J, V58, P357, DOI 10.1016/S0006-3495(90)82382-1
   Biebuyck HA, 1997, IBM J RES DEV, V41, P159, DOI 10.1147/rd.411.0159
   FUCCILLO D A, 1985, Biotechniques, V3, P494
   GORHAM WF, 1966, J POLYM SCI A1, V4, P3027, DOI 10.1002/pol.1966.150041209
   Green N M, 1975, Adv Protein Chem, V29, P85, DOI 10.1016/S0065-3233(08)60411-8
   Hengsakul M, 1996, BIOCONJUGATE CHEM, V7, P249, DOI 10.1021/bc960007z
   Ilic B, 2000, BIOMED MICRODEVICES, V2, P317, DOI 10.1023/A:1009911407093
   JOHNSON SJ, 1991, BIOPHYS J, V59, P289, DOI 10.1016/S0006-3495(91)82222-6
   Keller CA, 1998, BIOPHYS J, V75, P1397, DOI 10.1016/S0006-3495(98)74057-3
   MAYER LD, 1986, BIOCHIM BIOPHYS ACTA, V858, P161, DOI 10.1016/0005-2736(86)90302-0
   Nikolelis DP, 1996, ANAL CHEM, V68, P1735, DOI 10.1021/ac950403v
   ORTH R, 2001, UNPUB LANMUIR
   ORTH R, 2001, IN PRESS BIOMEDICAL
   Roda A, 2000, BIOTECHNIQUES, V28, P492, DOI 10.2144/00283st07
   SALAMON Z, 1994, BBA-BIOMEMBRANES, V1195, P267, DOI 10.1016/0005-2736(94)90266-6
   SAVAGE D, 1994, AVIDINBIOTIN CHEM HD
   WILCHEK M, 1988, ANAL BIOCHEM, V171, P1, DOI 10.1016/0003-2697(88)90120-0
   Xia YN, 1998, ANGEW CHEM INT EDIT, V37, P550, DOI 10.1002/(SICI)1521-3773(19980316)37:5<550::AID-ANIE550>3.0.CO;2-G
   Yang PD, 1998, SCIENCE, V282, P2244, DOI 10.1126/science.282.5397.2244
NR 21
TC 0
Z9 0
U1 0
U2 1
PU MATERIALS RESEARCH SOCIETY
PI WARRENDALE
PA 506 KEYSTONE DRIVE, WARRENDALE, PA 15088-7563 USA
SN 0272-9172
BN 1-55899-641-9
J9 MATER RES SOC SYMP P
PY 2002
VL 705
BP 259
EP 264
PG 6
WC Biotechnology & Applied Microbiology; Engineering, Multidisciplinary;
   Materials Science, Multidisciplinary; Physics, Applied
SC Biotechnology & Applied Microbiology; Engineering; Materials Science;
   Physics
GA BU87A
UT WOS:000177252400033
DA 2018-10-20
ER

PT S
AU Perry, CC
   Eglin, D
   Ali, SAM
   Downes, S
AF Perry, CC
   Eglin, D
   Ali, SAM
   Downes, S
BE Sanchez, C
   Laine, RM
   Yang, S
   Brinker, CJ
TI A statistical approach to the effect of sol-gel process variables on the
   physical properties of polymer [PLLA]-Silica hybrid materials for use as
   Biomaterials
SO ORGANIC/INORGANIC HYBRID MATERIALS-2002
SE MATERIALS RESEARCH SOCIETY SYMPOSIUM PROCEEDINGS
LA English
DT Proceedings Paper
CT Symposium on Hybrid Organic-Inorganic Materials held at the 2002 MRS
   Spring Meeting
CY APR 01-05, 2002
CL SAN FRANCISCO, CA
SP Mat Res Soc
ID BIODEGRADABLE POLYMERS; MECHANICAL-PROPERTIES; MORPHOLOGY; BEHAVIOR;
   SCREWS; SILICA
AB Hybrid poly(L-lactic acid)-silica materials for potential use in orthopaedic applications have been prepared by a sol-gel method using an experimental design approach to investigate the effect of synthesis variables separately and together on the physical form of the organic polymer. The five factors investigated were the molar ratios of tetraethyl orthosilicate (TEOS)/Poly(L-lactic acid) (PLLA), Toluene/PLLA, EtOH/TEOS, Water/TEOS and HCl (catalyst)/TEOS. All other synthesis conditions were kept constant. X-Ray powder diffraction (Statton's graphical method) and differential scanning calorimetry were used to assess the extent of polymer crystallinity in the hybrid materials. In accordance with other studies, increasing the molar ratio of TEOS/PLLA lead to increasing incorporation of the organic polymer into the silica network. Increase of the toluene/PLLA molar ratio lead to an increase in the crystallinity of the polymer phase. As our studies investigated the effect of synthesis variables simultaneously it was possible to identify, for the first time, that interactions between specific reactants are important in the development of the two structural components of this hybrid system. The most important of these was the TEOS/PLLA*H2O/TEOS interaction that may indicate that silica species from hydrolysed TEOS interact with the PLLA phase possibly via hydrogen bonding and leads to the lowering of the crystalline order of the polymer The results from this study give useful information on the ability of the organic polymer and the silica phase to form interpenetrating networks, an important requirement for the generation of a potential hybrid polyester-silica biomaterial for orthopaedic applications.
C1 Nottingham Trent Univ, Dept Phys & Chem, Nottingham NG11 8FU, England.
RP Perry, CC (reprint author), Nottingham Trent Univ, Dept Phys & Chem, Nottingham NG11 8FU, England.
OI Perry, Professor Carole/0000-0003-1517-468X; Eglin,
   David/0000-0002-8500-6887
CR Ahola M., 1999, International Journal of Pharmaceutics (Amsterdam), V181, P181, DOI 10.1016/S0378-5173(99)00022-8
   ANDRIANO KP, 1994, J APPL BIOMATER, V5, P133, DOI 10.1002/jab.770050206
   AUBONNET S, 1999, THESIS NOTTINGHAM TR
   Brizzolara D, 1996, MACROMOLECULES, V29, P191, DOI 10.1021/ma951144e
   Chirila TV, 2002, BIOMATERIALS, V23, P321, DOI 10.1016/S0142-9612(01)00125-9
   CHRISTENSEN RR, 1996, ANAL VARIANCE DESIGN
   Cox D. R., 2000, THEORY DESIGN EXPT
   Dell'Erba R, 2001, POLYMER, V42, P7831, DOI 10.1016/S0032-3861(01)00269-5
   DOMB AJ, 1997, HDB BIODEGRADABLE PO
   EGLIN D, UNPUB POLYMER
   GILDING DK, 1979, POLYMER, V20, P1459, DOI 10.1016/0032-3861(79)90009-0
   Hatakeyama T, 1999, THERMAL ANAL FUNDAME
   HUANG HH, 1987, POLYM BULL, V18, P455
   Ignjatovic N, 1999, BIOMATERIALS, V20, P809, DOI 10.1016/S0142-9612(98)00234-8
   Jiang SC, 2001, POLYMER, V42, P3901, DOI 10.1016/S0032-3861(00)00565-6
   Kasuga T, 1999, J MATER SCI LETT, V18, P2021, DOI 10.1023/A:1006602404232
   KLUG HP, 1952, XRAY DIFFRACTION PRO
   LEENSLAG JW, 1987, BIOMATERIALS, V8, P70, DOI 10.1016/0142-9612(87)90034-2
   Middleton JC, 2000, BIOMATERIALS, V21, P2335, DOI 10.1016/S0142-9612(00)00101-0
   Moukwa M, 1997, JOM-J MIN MET MAT S, V49, P46, DOI 10.1007/BF02915480
   Oye G, 2000, MICROPOR MESOPOR MAT, V34, P291, DOI 10.1016/S1387-1811(99)00181-X
   Pereira MM, 1996, J SOL-GEL SCI TECHN, V7, P59, DOI 10.1007/BF00401884
   Ramakrishna S, 2001, COMPOS SCI TECHNOL, V61, P1189, DOI 10.1016/S0266-3538(00)00241-4
   Rueda N, 2001, APPL CATAL A-GEN, V215, P81, DOI 10.1016/S0926-860X(01)00509-9
   Schliephake H, 2001, J BIOMED MATER RES, V56, P128, DOI 10.1002/1097-4636(200107)56:1<128::AID-JBM1077>3.0.CO;2-L
   Schwach G, 1999, INT J BIOL MACROMOL, V25, P283, DOI 10.1016/S0141-8130(99)00043-4
   Statton W.O., 1963, J APPL POLYM SCI, V7, P803, DOI 10.1002/app.1963.070070302
   Statton WO, 1967, J POLYM SCI C, V18, P33
   Tian D, 1997, CHEM MATER, V9, P871, DOI 10.1021/cm960514q
   Tian D, 1998, POLYMER, V39, P855, DOI 10.1016/S0032-3861(97)00343-1
   Tian D, 1997, J POLYM SCI POL CHEM, V35, P2295, DOI 10.1002/(SICI)1099-0518(199708)35:11<2295::AID-POLA21>3.0.CO;2-8
   Tian D, 1999, POLYMER, V40, P951, DOI 10.1016/S0032-3861(98)00353-X
   Vert M, 1998, J CONTROL RELEASE, V53, P85, DOI 10.1016/S0168-3659(97)00240-X
NR 33
TC 5
Z9 6
U1 0
U2 0
PU MATERIALS RESEARCH SOCIETY
PI WARRENDALE
PA 506 KEYSTONE DRIVE, WARRENDALE, PA 15088-7563 USA
SN 0272-9172
BN 1-55899-662-1
J9 MATER RES SOC SYMP P
PY 2002
VL 726
BP 67
EP 78
PG 12
WC Materials Science, Composites; Polymer Science
SC Materials Science; Polymer Science
GA BV44F
UT WOS:000178977700009
DA 2018-10-20
ER

PT J
AU Longinotti, MP
   Mazzobre, MF
   Buera, MP
   Corti, HR
AF Longinotti, MP
   Mazzobre, MF
   Buera, MP
   Corti, HR
TI Effect of salts on the properties of aqueous sugar systems in relation
   to biomaterial stabilization - Part 2. Sugar crystallization rate and
   electrical conductivity behavior
SO PHYSICAL CHEMISTRY CHEMICAL PHYSICS
LA English
DT Article
ID GLASS-TRANSITION; SUPERCOOLED LIQUIDS; TREHALOSE; STABILITY; PROTEIN;
   MIXTURES; SUCROSE; CONDUCTANCE; TEMPERATURE; DESICCATION
AB Two of the sugars involved in the protection of living organisms, trehalose and sucrose, were employed to analyze the effect of different salts (MgCl2, CaCl2, KCl, NaCl) on sugar crystallization kinetics. The conductivity behavior in supercooled aqueous sugar salt systems was also studied to evaluate the extent of water salt interactions. Trehalose and sucrose crystallization, evaluated by differential scanning calorimetry (DSC), was delayed by the presence of salt without affecting the glass transition temperature, T-g, of the system. Sugar crystallization rates increased as the temperature increased above T-g. The crystallization kinetics was analyzed using the Johnson-Mehl-Avrami-Kolmogorov equation (JMAK), and it was found that the index n varied from 4 for pure sugars to less than 2 for sugar MgCl2 mixtures, suggesting that the presence of salts constrained the number of configurations for crystal growth.
   The electrical conductivity of NaCl and MgCl2 was measured in liquid and supercooled trehalose and sucrose aqueous solutions over a wide range of viscosity to find evidence of preferential solvation in the sugar water solutions. The results indicated that large positive deviations from the Walden rule occur in these systems, due to the higher tendency of the ions to move in water-rich regions. The observed delayed crystallization of sugar in aqueous solutions containing salt could be attributed to effects on the nucleation mechanism of ion-induced microheterogeneities in the supercooled solutions.
C1 Comis Nacl Energia Atom, Unidad Activdad Quim, RA-1650 San Martin, Buenos Aires, Argentina.
   Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Ind, RA-1428 Buenos Aires, DF, Argentina.
   Univ Buenos Aires, Fac Ciencias Exactas & Nat, INQUIMAE, RA-1428 Buenos Aires, DF, Argentina.
RP Longinotti, MP (reprint author), Comis Nacl Energia Atom, Unidad Activdad Quim, Avda Gen Paz 1499, RA-1650 San Martin, Buenos Aires, Argentina.
OI Buera, Pilar/0000-0001-9290-7299
CR ARAKAWA T, 1982, BIOCHEMISTRY-US, V21, P6536, DOI 10.1021/bi00268a033
   ARVANITOYANNIS I, 1994, J FOOD SCI, V59, P197, DOI 10.1111/j.1365-2621.1994.tb06931.x
   Avrami M., 1940, Journal of Chemical Physics, V8, P212, DOI 10.1063/1.1750631
   Avrami M, 1939, J CHEM PHYS, V7, P1103, DOI 10.1063/1.1750380
   BARTHEL J, 1983, J SOLUTION CHEM, V12, P449, DOI 10.1007/BF00651698
   BARTHEL J, 1980, J SOLUTION CHEM, V9, P209, DOI 10.1007/BF00648327
   Buitink J, 2000, BIOPHYS J, V79, P1119, DOI 10.1016/S0006-3495(00)76365-X
   Cardona S, 1997, J FOOD SCI, V62, P105, DOI 10.1111/j.1365-2621.1997.tb04378.x
   CARPENTER JF, 1988, CRYOBIOLOGY, V25, P459, DOI 10.1016/0011-2240(88)90054-5
   Chang BS, 1996, ARCH BIOCHEM BIOPHYS, V331, P249, DOI 10.1006/abbi.1996.0305
   CHVOJ Z, 1991, KINETIC PHASE DIAGRA, P169
   COLACO C, 1992, BIO-TECHNOL, V10, P1007, DOI 10.1038/nbt0992-1007
   Crowe JH, 1998, ANNU REV PHYSIOL, V60, P73, DOI 10.1146/annurev.physiol.60.1.73
   Crowe LM, 1996, BIOPHYS J, V71, P2087, DOI 10.1016/S0006-3495(96)79407-9
   DOREMUS RH, 1985, RATES PHASE TRANSFOR, P24
   Duddu SP, 1997, PHARMACEUT RES, V14, P591, DOI 10.1023/A:1012144810067
   Ediger MD, 2000, ANNU REV PHYS CHEM, V51, P99, DOI 10.1146/annurev.physchem.51.1.99
   EHLICH D, 1990, MACROMOLECULES, V23, P1600, DOI 10.1021/ma00208a008
   GRAYDON JW, 1994, J NON-CRYST SOLIDS, V175, P31, DOI 10.1016/0022-3093(94)90312-3
   Johnson WA, 1939, T AM I MIN MET ENG, V135, P416
   KEDWARD CJ, 2000, J FOOD SCI, V2, P324
   KOLMOGOROV AN, 1937, VESTN USSR ACAD SCI, V3, P3551
   KOSTER KL, 1988, PLANT PHYSIOL, V88, P829, DOI 10.1104/pp.88.3.829
   Kreilgaard L, 1999, J PHARM SCI, V88, P281, DOI 10.1021/js980399d
   LESLIE SB, 1995, APPL ENVIRON MICROB, V61, P3592
   Mazzobre MF, 1999, BBA-GEN SUBJECTS, V1473, P337, DOI 10.1016/S0304-4165(99)00207-X
   MAZZOBRE MF, 2001, IN PRESS CRYOBIOLOGY
   Miller DP, 2000, J PHYS CHEM B, V104, P10419, DOI 10.1021/jp000730t
   Miller DP, 1997, PHARMACEUT RES, V14, P578, DOI 10.1023/A:1012192725996
   Miller DP, 1998, PHARM RES-DORDR, V15, P1215, DOI 10.1023/A:1011987707515
   Noel TR, 1996, J CHEM SOC FARADAY T, V92, P1921, DOI 10.1039/ft9969201921
   PANCOAST HM, 1980, HDB SUGARS, P46
   PETRIELLA C, 1985, J FOOD SCI, V50, P622, DOI 10.1111/j.1365-2621.1985.tb13759.x
   Ross Y., 1991, J FOOD SCI, V56, P1676
   ROSSLER E, 1990, PHYS REV LETT, V65, P1595, DOI 10.1103/PhysRevLett.65.1595
   Shneidman VA, 1998, J CHEM PHYS, V109, P186, DOI 10.1063/1.476548
   SPIRO M, 1973, ORGANIC SOLVENT SYST, pCH6
   Stokes R. H., 1959, STRUCTURE ELECTROLYT, P298
   Storey BT, 1998, CRYOBIOLOGY, V37, P46, DOI 10.1006/cryo.1998.2097
   SUN WQ, 1993, PHYSIOL PLANTARUM, V89, P767
   Suzuki T, 1997, J CHEM ENG JPN, V30, P609, DOI 10.1252/jcej.30.609
   TREINER C, 1965, J PHYS CHEM-US, V69, P2576, DOI 10.1021/j100892a016
   Tzannis ST, 1999, J PHARM SCI-US, V88, P360, DOI 10.1021/js9800127
   URITANI M, 1995, J BIOCHEM-TOKYO, V117, P774, DOI 10.1093/oxfordjournals.jbchem.a124775
NR 44
TC 36
Z9 36
U1 1
U2 12
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD,, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1463-9076
J9 PHYS CHEM CHEM PHYS
JI Phys. Chem. Chem. Phys.
PY 2002
VL 4
IS 3
BP 533
EP 540
DI 10.1039/b107746e
PG 8
WC Chemistry, Physical; Physics, Atomic, Molecular & Chemical
SC Chemistry; Physics
GA 514MY
UT WOS:000173445200020
DA 2018-10-20
ER

PT B
AU Mendes, SC
   De Bruijn, JD
   Van Blitterswijk, CA
AF Mendes, SC
   De Bruijn, JD
   Van Blitterswijk, CA
BE Reis, RL
   Cohn, D
TI Cultured bone on biomaterial substrates - A tissue engineering approach
   to treat bone defects
SO POLYMER BASED SYSTEMS ON TISSUE ENGINEERING, REPLACEMENT AND
   REGENERATION
SE NATO SCIENCE SERIES, SERIES II: MATHEMATICS, PHYSICS AND CHEMISTRY
LA English
DT Proceedings Paper
CT Conference of the NATO-Advanced-Study-Institute on Polymer Based Systems
   on Tissue Engineering, Replacement and Regeneration
CY OCT 15-25, 2001
CL ALVOR, PORTUGAL
SP NATO, Adv Study Inst
ID MARROW STROMAL CELLS; MESENCHYMAL STEM-CELLS; CALCIUM-PHOSPHATE
   CERAMICS; FIBROBLAST-GROWTH-FACTOR; ADULT HUMAN BONE; HUMAN
   OSTEOPROGENITOR CELLS; IN-VITRO; MORPHOGENETIC PROTEIN-2; POROUS
   HYDROXYAPATITE; OSTEOGENIC DIFFERENTIATION
AB In the present work, a tissue engineering approach to treat bone defects was investigated. Such strategy was based on the use of patient own cultured bone marrow stromal cells (BMSCs) in association with biomaterials to produce autologous living bone equivalents. When engineering such implants, three main factors had to be taken into account: (i) the cells, (ii) the culture technology and (iii) the biomaterial scaffolds. The capacity of BMSCs to proliferate, differentiate along the osteogenic lineage and form a bone like tissue was demonstrated in various in vitro assays making use of biochemical, immunological, microscopic and gene expression techniques. The ability of the cells to produce bone in vivo was established using an ectopic (extra osseous) implantation model. Results indicated that BMSC cultures were composed of a heterogeneous population containing a subpopulation of cells with high proliferative capacity and with potential to differentiate into bone forming cells. Both the growth and the differentiation pattern of these cells could be manipulated, to a certain degree, through the use of bioactive factors during culture. After implantation, the bone forming capacity of the cultures proved to be related to the amount of early osteoprogenitors and precursors cells that could be induced into starting the osteogenic differentiation process. In bone marrow aspirates, this subpopulation appeared to decrease with donor age and to be strongly dependent on the donor, indicating that the aspiration procedure plays an important role in the obtained bone marrow cell population. In order to evaluate the in vivo bone formation capacity of BMSC cultures prior to implantation, an experimental method was developed in which the amount of early osteoprogenitors and precursors cells could be quantified. With regard to the technology design, data indicated that the culture of cells on the biomaterial scaffolds prior to implantation resulted in implants with faster in vivo bone forming ability as compared to scaffolds implanted shortly after cell seeding. In addition, two biodegradable polymeric systems were proposed as scaffolds to be used in the described bone engineering approach after evaluating their ability to support bone marrow cell growth, differentiation and in vivo bone, formation. In summary, although the complete knowledge of the, factors controlling BMSC growth and osteogenic differentiation still needs to be further expanded, the obtained results suggest that the bone tissue engineering approach described in this work presents a great potential for the repair of bone defects and will become an advantageous alternative to the traditional autologous bone grafting.
C1 IsoTis NV, NL-3723 MB Bilthoven, Netherlands.
RP Mendes, SC (reprint author), IsoTis NV, Prof Bronkhorstlaan 10, NL-3723 MB Bilthoven, Netherlands.
RI Group, 3Bs/E-4374-2012
OI Group, 3Bs/0000-0002-5195-3456
CR Anderson MLC, 1999, CLIN ORTHOP RELAT R, P231
   Anselme K, 1999, BONE, V25, p51S, DOI 10.1016/S8756-3282(99)00133-7
   Arrington ED, 1996, CLIN ORTHOP RELAT R, P300
   Aspenberg P, 1996, BONE, V19, P499, DOI 10.1016/S8756-3282(96)90257-4
   Athanasiou KA, 2000, TISSUE ENG, V6, P361, DOI 10.1089/107632700418083
   Aubin Jane E., 1996, P51
   Aubin JE, 2000, BONE ENG, P19
   BAB I, 1988, BONE MINER, V4, P373
   Balk ML, 1997, BONE, V21, P7, DOI 10.1016/S8756-3282(97)00075-6
   BENNETT JH, 1991, J CELL SCI, V99, P131
   BERESFORD JN, 1989, CLIN ORTHOP RELAT R, P270
   Bianco P, 2001, STEM CELLS, V19, P180, DOI 10.1634/stemcells.19-3-180
   Boden SD, 1999, SPINE, V24, P320, DOI 10.1097/00007632-199902150-00003
   Boyne P J, 1997, Int J Periodontics Restorative Dent, V17, P11
   Breitbart AS, 1998, PLAST RECONSTR SURG, V101, P567, DOI 10.1097/00006534-199803000-00001
   Brekke JH, 1998, J BIOMED MATER RES, V43, P380, DOI 10.1002/(SICI)1097-4636(199824)43:4<380::AID-JBM6>3.0.CO;2-D
   BROWN KLB, 1982, J BONE JOINT SURG AM, V64, P270, DOI 10.2106/00004623-198264020-00020
   Bruder SP, 1997, J CELL BIOCHEM, V64, P278, DOI 10.1002/(SICI)1097-4644(199702)64:2<278::AID-JCB11>3.0.CO;2-F
   Bruder SP, 1998, J ORTHOPAED RES, V16, P155, DOI 10.1002/jor.1100160202
   Bruder SP, 1997, BONE, V21, P225, DOI 10.1016/S8756-3282(97)00127-0
   Bruder SP, 1998, J BONE JOINT SURG AM, V80A, P985, DOI 10.2106/00004623-199807000-00007
   BUCKWATER JA, 1987, INSTR COURSE LECT, V16, P27
   Bulstra SK, 1996, J BONE JOINT SURG BR, V78B, P892, DOI 10.1302/0301-620X78B6.6806
   Calvert JW, 2000, J BIOMED MATER RES, V52, P279, DOI 10.1002/1097-4636(200011)52:2<279::AID-JBM6>3.0.CO;2-8
   CHENG SL, 1994, ENDOCRINOLOGY, V134, P277, DOI 10.1210/en.134.1.277
   Cook S D, 1987, Int J Oral Maxillofac Implants, V2, P15
   COOK SD, 1992, J BIOMED MATER RES, V26, P989, DOI 10.1002/jbm.820260803
   Coombes A. G. A., 1994, Clinical Materials, V17, P35, DOI 10.1016/0267-6605(94)90046-9
   Cooper LF, 2001, J DENT RES, V80, P314, DOI 10.1177/00220345010800010401
   CORNELL CN, 1998, CLIN ORTHOP RELAT R, V355, pS67
   Cortes F, 1999, BLOOD, V93, P826
   COVENTRY MB, 1972, J BONE JOINT SURG AM, VA 54, P83, DOI 10.2106/00004623-197254010-00008
   COWLEY SP, 1983, J BONE JOINT SURG AM, V65, P1023, DOI 10.2106/00004623-198365070-00022
   D'Ippolito G, 1999, J BONE MINER RES, V14, P1115, DOI 10.1359/jbmr.1999.14.7.1115
   Daculsi G, 1998, BIOMATERIALS, V19, P1473, DOI 10.1016/S0142-9612(98)00061-1
   DAMIEN CJ, 1991, J APPL BIOMATER, V2, P187, DOI 10.1002/jab.770020307
   DAVIES JE, 1991, CELL MATER, V1, P3
   De Bruijin J. D., 2000, BONE ENG, P421
   de Bruijn J D, 1999, Adv Dent Res, V13, P74
   DEBOER HH, 1988, CLIN ORTH OP, P226
   DEBRUIJN JD, 1992, RES SOC SP P, V251, P63
   Dennis JE, 1998, BIOMATERIALS, V19, P1323, DOI 10.1016/S0142-9612(97)00170-1
   Dennis JE, 1999, J BONE MINER RES, V14, P700, DOI 10.1359/jbmr.1999.14.5.700
   Derkx P, 1998, BONE, V22, P367, DOI 10.1016/S8756-3282(97)00299-8
   DESCHAMPS AA, UNPUB J CONTROLLED R
   Dieudonne Suzanne C., 1999, Journal of Cellular Biochemistry, V76, P231
   Doherty MJ, 1998, J BONE MINER RES, V13, P828, DOI 10.1359/jbmr.1998.13.5.828
   DRUDER SP, 1999, CLIN ORTHOP RELAT R, V167, pS68
   EVANS CE, 1990, J ORTHOPAED RES, V8, P234, DOI 10.1002/jor.1100080212
   Filshie RJA, 1998, LEUKEMIA, V12, P414, DOI 10.1038/sj.leu.2400922
   FRIEDENSTEIN AJ, 1987, CELL TISSUE KINET, V20, P263, DOI 10.1111/j.1365-2184.1987.tb01309.x
   Fromigue O, 1997, CYTOKINE, V9, P613, DOI 10.1006/cyto.1997.0209
   Fromigue O, 1998, J CELL BIOCHEM, V68, P411, DOI 10.1002/(SICI)1097-4644(19980315)68:4<411::AID-JCB2>3.0.CO;2-T
   FURLONG RJ, 1991, J BONE JOINT SURG BR, V73, P741
   GALOTTO M, 1994, J BONE MINER RES, V9, P1239
   Geesink RGT, 1999, J BONE JOINT SURG BR, V81B, P710, DOI 10.1302/0301-620X.81B4.9311
   Goldstein AS, 1999, TISSUE ENG, V5, P421, DOI 10.1089/ten.1999.5.421
   GRONTHOS S, 1994, BLOOD, V84, P4164
   GRONTHOS S, 1995, BLOOD, V85, P929
   Gronthos S, 1998, MARROW STROMAL CELL, P26
   Gundle R, 1997, J MATER SCI-MATER M, V8, P519, DOI 10.1023/A:1018538529108
   Hanada K, 1997, J BONE MINER RES, V12, P1606, DOI 10.1359/jbmr.1997.12.10.1606
   HAYNESWORTH SE, 1992, BONE, V13, P81, DOI 10.1016/8756-3282(92)90364-3
   HAYNESWORTH SE, 1992, BONE, V13, P69, DOI 10.1016/8756-3282(92)90363-2
   HERBERTSON A, 1995, J BONE MINER RES, V10, P285
   Hing KA, 1998, P I MECH ENG H, V212, P437, DOI 10.1243/0954411981534204
   Inui K, 1997, CELL BIOL INT, V21, P419, DOI 10.1006/cbir.1997.0165
   IshaugRiley SL, 1997, J BIOMED MATER RES, V36, P1, DOI 10.1002/(SICI)1097-4636(199707)36:1<1::AID-JBM1>3.0.CO;2-P
   Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I
   Joyner CJ, 1997, BONE, V21, P1, DOI 10.1016/S8756-3282(97)00074-4
   Kadiyala S, 1997, TISSUE ENG, V3, P173, DOI 10.1089/ten.1997.3.173
   Kim CH, 1999, J ENDOCRINOL, V162, P371, DOI 10.1677/joe.0.1620371
   Kim KJ, 1997, J BIOMED MATER RES, V35, P279, DOI 10.1002/(SICI)1097-4636(19970605)35:3<279::AID-JBM2>3.3.CO;2-S
   King GN, 1997, J DENT RES, V76, P1460, DOI 10.1177/00220345970760080801
   KLEIN CPAT, 1989, BIOMATERIALS, V10, P59
   KNIGHT S M, 1992, Calcified Tissue International, V50, pA12
   Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5
   Kon E, 2000, J BIOMED MATER RES, V49, P328
   Krebsbach PH, 1997, TRANSPLANTATION, V63, P1059, DOI 10.1097/00007890-199704270-00003
   Krebsbach PH, 1999, CRIT REV ORAL BIOL M, V10, P165, DOI 10.1177/10454411990100020401
   Kuznetsov SA, 1997, J BONE MINER RES, V12, P1335, DOI 10.1359/jbmr.1997.12.9.1335
   Lane JM, 1999, CLIN ORTHOP RELAT R, pS107
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Laurencin C. T., 1999, CURR OPIN ORTHOP, V10, P445, DOI DOI 10.1097/00001433-199912000-00005
   LEBOY PS, 1991, J CELL PHYSIOL, V146, P370, DOI 10.1002/jcp.1041460306
   Lecoeur L, 1997, BIOMATERIALS, V18, P989, DOI 10.1016/S0142-9612(97)00025-2
   Lemons JE, 1996, BONE, V19, pS121, DOI 10.1016/S8756-3282(96)00128-7
   Lennon DP, 1996, IN VITRO CELL DEV-AN, V32, P602
   Lennon DP, 2000, DEV DYNAM, V219, P50, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1037>3.0.CO;2-7
   LI Y, 1998, T SOC BIOMATERIALS 1, P428
   Lind M, 1996, ACTA ORTHOP SCAND, V67, P407, DOI 10.3109/17453679609002342
   Liu P, 1999, CALCIFIED TISSUE INT, V65, P173, DOI 10.1007/s002239900678
   Louisia S, 1999, J BONE JOINT SURG BR, V81B, P719, DOI 10.1302/0301-620X.81B4.9358
   MALAVAL L, 1994, J CELL PHYSIOL, V158, P555, DOI 10.1002/jcp.1041580322
   MANIATOPOULOS C, 1988, CELL TISSUE RES, V254, P317
   Marcacci M, 1999, CALCIFIED TISSUE INT, V64, P83, DOI 10.1007/s002239900583
   Marra KG, 1999, J BIOMED MATER RES, V47, P324, DOI 10.1002/(SICI)1097-4636(19991205)47:3<324::AID-JBM6>3.0.CO;2-Y
   Martin I, 1997, ENDOCRINOLOGY, V138, P4456, DOI 10.1210/en.138.10.4456
   Martin I, 2001, J BIOMED MATER RES, V55, P229, DOI 10.1002/1097-4636(200105)55:2<229::AID-JBM1009>3.3.CO;2-H
   Mehler MF, 1997, TRENDS NEUROSCI, V20, P309, DOI 10.1016/S0166-2236(96)01046-6
   Mendes SC, 2001, BIOMATERIALS, V22, P2057, DOI 10.1016/S0142-9612(00)00395-1
   Miura Y, 1998, CELL TRANSPLANT, V7, P453, DOI 10.1016/S0963-6897(98)00033-5
   Muraglia A, 2000, J CELL SCI, V113, P1161
   Muschler GF, 1997, J BONE JOINT SURG AM, V79A, P1699, DOI 10.2106/00004623-199711000-00012
   Muschler GF, 2001, J ORTHOPAED RES, V19, P117, DOI 10.1016/S0736-0266(00)00010-3
   Nefussi JR, 1997, J HISTOCHEM CYTOCHEM, V45, P493, DOI 10.1177/002215549704500402
   Nichter L S, 1992, J Craniofac Surg, V3, P63, DOI 10.1097/00001665-199209000-00003
   OHGUSHI H, 1990, J BIOMED MATER RES, V24, P1563, DOI 10.1002/jbm.820241202
   OHGUSHI H, 1990, ACTA ORTHOP SCAND, V61, P431, DOI 10.3109/17453679008993556
   OIKARINEN J, 1979, CLIN ORTHOP RELAT R, P208
   OKLUND SA, 1986, CLIN ORTHOP RELAT R, P269
   Oreffo ROC, 1999, BONE, V25, p5S, DOI 10.1016/S8756-3282(99)00124-6
   Oreffo ROC, 1999, J CELL BIOCHEM, V75, P382, DOI 10.1002/(SICI)1097-4644(19991201)75:3<382::AID-JCB4>3.0.CO;2-N
   Owen M, 1985, J CELL SCI S, V10, P63
   Owen ME, 1998, MARROW STROMAL CELL, P1
   Oyajobi BO, 1999, J BONE MINER RES, V14, P351, DOI 10.1359/jbmr.1999.14.3.351
   Perka C, 2000, BIOMATERIALS, V21, P1145, DOI 10.1016/S0142-9612(99)00280-X
   Peter SJ, 2000, BIOMATERIALS, V21, P1207, DOI 10.1016/S0142-9612(99)00254-9
   Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449
   Phinney DG, 1999, J CELL BIOCHEM, V75, P424, DOI 10.1002/(SICI)1097-4644(19991201)75:3<424::AID-JCB8>3.3.CO;2-#
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Pri-Chen S, 1998, BONE, V23, P111, DOI 10.1016/S8756-3282(98)00087-8
   PROLO DJ, 1985, CLIN ORTHOP RELAT R, P322
   Puleo DA, 1997, J CELL PHYSIOL, V173, P93, DOI 10.1002/(SICI)1097-4652(199710)173:1<93::AID-JCP11>3.0.CO;2-O
   RADDER AM, 1994, J BIOMED MATER RES, V28, P141, DOI 10.1002/jbm.820280202
   Reid IR, 1997, EUR J ENDOCRINOL, V137, P209, DOI 10.1530/eje.0.1370209
   Rickard DJ, 1996, J BONE MINER RES, V11, P312
   Ripamonti U, 1996, BIOMATERIALS, V17, P31, DOI 10.1016/0142-9612(96)80752-6
   Ripamonti U, 2001, J BONE JOINT SURG AM, V83A, pS116
   RIPAMONTI U, 1991, J BONE JOINT SURG AM, V73A, P692, DOI 10.2106/00004623-199173050-00007
   ROBEY PG, 1985, CALCIFIED TISSUE INT, V37, P453, DOI 10.1007/BF02557826
   RODAN GA, 1992, BONE, V13, pS3, DOI 10.1016/S8756-3282(09)80003-3
   Saad B, 1998, J BIOMED MATER RES, V39, P594, DOI 10.1002/(SICI)1097-4636(19980315)39:4<594::AID-JBM14>3.0.CO;2-7
   SALYER KE, 1989, PLAST RECONSTR SURG, V84, P236, DOI 10.1097/00006534-198908000-00008
   SIMMONS PJ, 1991, BLOOD, V78, P55
   Solchaga LA, 1999, J ORTHOPAED RES, V17, P205, DOI 10.1002/jor.1100170209
   SPECTOR M, 1992, ORTHOP CLIN N AM, V23, P211
   Stewart K, 1999, J BONE MINER RES, V14, P1345, DOI 10.1359/jbmr.1999.14.8.1345
   Strong DM, 1996, CLIN ORTHOP RELAT R, P107
   SUMNER DR, 1995, J BONE JOINT SURG AM, V77A, P1135, DOI 10.2106/00004623-199508000-00001
   Takiguchi T, 1998, J PERIODONTAL RES, V33, P476
   Takushima A, 1998, J SURG RES, V78, P68, DOI 10.1006/jsre.1998.5378
   THOMSON RC, 1995, J BIOMAT SCI-POLYM E, V7, P23, DOI 10.1163/156856295X00805
   URIST MR, 1983, SCIENCE, V220, P680, DOI 10.1126/science.6403986
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   VANBLITTERSWIJK CA, 1990, J BIOMED MATER RES, V24, P433, DOI 10.1002/jbm.820240403
   VILAMITJANAAMEDEE J, 1993, IN VITRO CELL DEV-AN, V29, P699
   Wada Y, 1998, BONE, V22, P479, DOI 10.1016/S8756-3282(98)00039-8
   Walsh S, 2000, BONE, V27, P185, DOI 10.1016/S8756-3282(00)00319-7
   Weng YL, 2001, J ORAL MAXIL SURG, V59, P185, DOI 10.1053/joms.2001.20491
   Whang K, 1999, TISSUE ENG, V5, P35, DOI 10.1089/ten.1999.5.35
   Whang K, 1998, J BIOMED MATER RES, V42, P491, DOI 10.1002/(SICI)1097-4636(19981215)42:4<491::AID-JBM3>3.0.CO;2-F
   Wikesjo UME, 2001, J BONE JOINT SURG AM, V83A, pS136
   WINTER GD, 1969, NATURE, V223, P88, DOI 10.1038/223088a0
   WYKROTA L. L., 2000, BONE ENG, P516
   Yang ZJ, 1997, J MATER SCI-MATER M, V8, P697, DOI 10.1023/A:1018540024082
   Yang ZJ, 1996, BIOMATERIALS, V17, P2131, DOI 10.1016/0142-9612(96)00044-0
   YAO KL, 1994, J BONE MINER RES, V9, P231
   Yaszemski MJ, 1996, BIOMATERIALS, V17, P175, DOI 10.1016/0142-9612(96)85762-0
   Yoshikawa T, 2000, TRANSPLANTATION, V69, P128, DOI 10.1097/00007890-200001150-00022
   Yoshikawa T, 1998, BIO-MED MATER ENG, V8, P311
   Yoshikawa T, 1997, BIO-MED MATER ENG, V7, P49
   Yoshikawa T, 1996, J BIOMED MATER RES, V32, P481
   Yuan HP, 2001, J BIOMED MATER RES, V58, P270, DOI 10.1002/1097-4636(2001)58:3<270::AID-JBM1016>3.0.CO;2-2
   Yuan HP, 2001, J MATER SCI-MATER M, V12, P7, DOI 10.1023/A:1026792615665
   Yuan HP, 1998, J MATER SCI-MATER M, V9, P723, DOI 10.1023/A:1008950902047
   Yuan HP, 1999, BIOMATERIALS, V20, P1799, DOI 10.1016/S0142-9612(99)00075-7
   Zellin G, 2000, BONE, V26, P161, DOI 10.1016/S8756-3282(99)00252-5
NR 168
TC 0
Z9 0
U1 0
U2 4
PU SPRINGER
PI DORDRECHT
PA PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
BN 1-4020-1000-1
J9 NATO SCI SER II MATH
PY 2002
VL 86
BP 265
EP 298
PG 34
WC Engineering, Biomedical; Engineering, Chemical
SC Engineering
GA BV99N
UT WOS:000180622900015
DA 2018-10-20
ER

PT B
AU Hunkeler, D
   Wandrey, C
   Ceausoglu, I
   Vidal, DS
   Espinosa, D
AF Hunkeler, D
   Wandrey, C
   Ceausoglu, I
   Vidal, DS
   Espinosa, D
BE Prusse, U
   Vorlop, KD
TI Downstream processing of microcapsules: Quality control of capsule
   morphology, permeability and mechanical properties as a function of raw
   material endotoxin levels
SO PRACTICAL ASPECTS OF ENCAPSULATION TECHNOLOGIES
LA English
DT Proceedings Paper
CT Workshop on Practical Aspects of Encapsulation Technologies
CY OCT 12-14, 2001
CL BRAUNSCHWEIG, GERMANY
SP FAL, Inst Technol & Biosyst Engn
DE alginate; bioartificial pancreas; cellulose sulfate; endotoxin;
   microencapsulation
ID ISLETS
AB The large-scale production of microcapsules with defined membrane thickness and permeabilities, both decoupled from the mechanical resistance, is demonstrated. Specifically, a novel apparatus, which controls the downstream part of the microencapsulation process has been developed. The oscillating reactor system permits the formation of capsules with controlled membranes based on pre-cast microbeads. The precise manipulation of the reaction time, and its distribution, between polyanion beads and the cationic receiving bath has been found to be critical. Given this, microcapsule diameters can be produced within 10%, both within and between batches. The membrane thickness can also be controlled to a tolerance of 5 micrometers. The Automatic Reaction Control has been tested on polysaccharide blends of alginate and cellulose sulfate, and found to produce identical capsules, independent of the endotoxin level of the biomaterial. When this is combined with the demonstration that alginate and cellulose sulfate can be depyrogenated to fractions of the limit imposed by the FDA, the novel technology enables, for the first time, the production of clinical quantities of sterile microcapsules suitable for transplantation. The downstream control of microcapsule reaction parameters can be coupled with any front-end system for bead generation, based on air-stripping, electrostatics or jet cutting. It is demonstrated on the former, using calcium and poly(methylene-co-guanidine) hydrochloride as the cations.
C1 AQUA TECH Specialties, CH-117 Geneva, Switzerland.
RP Hunkeler, D (reprint author), AQUA TECH Specialties, 4 Chemin Chalet Bac, CH-117 Geneva, Switzerland.
CR CEAUSOGLU I, IN PRESS MICROENCAPU
   *FDA, 1987, GUID USP BACT END TE
   *FDA, 1991, GUID USP BACT END TE
   Hunkeler D, 1997, TRENDS POLYM SCI, V5, P286
   KLOCK G, 1994, APPL MICROBIOL BIOT, V40, P638
   LIM F, 1980, SCIENCE, V210, P908, DOI 10.1126/science.6776628
   Rehor A, 2001, J BIOMAT SCI-POLYM E, V12, P157, DOI 10.1163/156856201750180898
   Schuldt U, 2000, MINERVA BIOTECNOL, V12, P249
   STEGEMANN JP, 1996, CAN J CHEM ENG, V4, P518
   Wang T, 1997, NAT BIOTECHNOL, V15, P358, DOI 10.1038/nbt0497-358
NR 10
TC 0
Z9 0
U1 1
U2 6
PU BUNDESFORSCHUNGSANSTALT LANDWIRTSCHAFT (FAL)
PI BRAUNSCHWEIG
PA BUNDESALLEE 50, 38116 BRAUNSCHWEIG, GERMANY
BN 3-933140-63-3
PY 2002
BP 59
EP 62
PG 4
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA BW59K
UT WOS:000182532400010
DA 2018-10-20
ER

PT B
AU Agnihotri, A
   Siedlecki, CA
AF Agnihotri, A
   Siedlecki, CA
BE Moxon, K
   ElSherif, D
   Kanakasabai, S
TI AFM investigation of molecular level events at biomaterial-biological
   interface
SO PROCEEDINGS OF THE IEEE 28TH ANNUAL NORTHEAST BIOENGINEERING CONFERENCE
LA English
DT Proceedings Paper
CT IEEE 28th Annual Northeast Bioengineering Conference
CY APR 20-21, 2002
CL DREXEL UNIV, PHILADELPHIA, PA
SP IEEE EMBS, Exponent, GE Global Res Ctr, Johnson & Johnson, Merck Res Labs, Orthovita, Pfizer
HO DREXEL UNIV
ID FIBRINOGEN
AB Interaction of water and proteins with biomateriaIs constitutes the first events occurring at the biomaterial/biological interface, and these events are believed to guide further responses. In this study we report two aspects of these initial events as studied by atomic force microscopy (AFM). First the time dependent conformational changes in fibrinogen adsorbed on a model hydrophobic biomaterial (graphite) and second, the morphological changes in poly(urethane urea) associated with hydration.
C1 Penn State Univ, Dept Bioengn, Hershey, PA 17033 USA.
RP Agnihotri, A (reprint author), Penn State Univ, Dept Bioengn, Hershey, PA 17033 USA.
CR Balasubramanian V, 1999, J BIOMED MATER RES, V44, P253, DOI 10.1002/(SICI)1097-4636(19990305)44:3<253::AID-JBM3>3.0.CO;2-K
   Garrett JT, 2000, MACROMOLECULES, V33, P6353, DOI 10.1021/ma000600i
   HORBETT TA, 1993, CARDIOVASC PATHOL, V2, pS137
   Sit PS, 1999, THROMB HAEMOSTASIS, V82, P1053
   TINGEY KG, 2000, LANGMUIR, V16, P2744
NR 5
TC 0
Z9 0
U1 2
U2 3
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 0-7803-7419-3
PY 2002
BP 125
EP 126
DI 10.1109/NEBC.2002.999497
PG 2
WC Engineering, Biomedical
SC Engineering
GA BU42Z
UT WOS:000175970000063
DA 2018-10-20
ER

PT B
AU Bussard, KM
   Vogler, EA
   Siedlecki, CA
AF Bussard, KM
   Vogler, EA
   Siedlecki, CA
BE Moxon, K
   ElSherif, D
   Kanakasabai, S
TI Effective production of FXIIa and thrombin by model biomaterials
SO PROCEEDINGS OF THE IEEE 28TH ANNUAL NORTHEAST BIOENGINEERING CONFERENCE
LA English
DT Proceedings Paper
CT IEEE 28th Annual Northeast Bioengineering Conference
CY APR 20-21, 2002
CL DREXEL UNIV, PHILADELPHIA, PA
SP IEEE EMBS, Exponent, GE Global Res Ctr, Johnson & Johnson, Merck Res Labs, Orthovita, Pfizer
HO DREXEL UNIV
AB The initiation of contact activation of the coagulation cascade takes place when Factor XII interacts with a procoagulant surface. Subsequent events include FXII autoactivation to the enzyme FXIIa and formation of a contact activation complex. Additional conversions result in the generation of thrombin and formation of an insoluble fibrin clot. This study examines the ability of a biomaterial to generate FXIIa and thrombin by comparing the procoagulant efficiency of glass beads to soluble aliquots of enzymes. FXIIa induced activation of coagulation saturates at surprisingly dilute concentrations (similar to0.5 mug/ml), and this effect is also seen in surface and thrombin induced contact activation. Preliminary analysis of data suggests that 50 turn 2 glass surface area generates the equivalent of 5 ng of FXIIa, or only similar to0.0125% conversion of physiologic concentration, as well as producing the equivalent of similar to2.65 units/ml of thrombin. Addition of procoagulant (glass) surface was also found to modulate a local minimum observed in FXIIa titration curves. The results observed with FXIIa and biomaterials suggest that an investigation of the mechanisms behind FXIIa and thrombin production by biomaterials, as well as a clearer understanding of how signals propagate down the pathway, are necessary for assembling a detailed mechanism for surface activation.
C1 Penn State Univ, Dept Bioengn, Hershey, PA 17033 USA.
RP Bussard, KM (reprint author), Penn State Univ, Dept Bioengn, Hershey, PA 17033 USA.
OI Bussard, Karen/0000-0002-6519-9300
CR FUHRER G, 1990, BLUT, V61, P258, DOI 10.1007/BF01732874
   Marder V., 1994, HEMOSTASIS THROMBOSI, P3
   WACHTFOGEL YT, 1993, THROMB RES, V72, P1, DOI 10.1016/0049-3848(93)90168-N
NR 3
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 0-7803-7419-3
PY 2002
BP 129
EP 130
DI 10.1109/NEBC.2002.999499
PG 2
WC Engineering, Biomedical
SC Engineering
GA BU42Z
UT WOS:000175970000065
DA 2018-10-20
ER

PT B
AU Longsworth, J
   Eppell, S
AF Longsworth, J
   Eppell, S
BE Moxon, K
   ElSherif, D
   Kanakasabai, S
TI Design and assembly of a sterile nanoscale orthopedic biomaterial
SO PROCEEDINGS OF THE IEEE 28TH ANNUAL NORTHEAST BIOENGINEERING CONFERENCE
LA English
DT Proceedings Paper
CT IEEE 28th Annual Northeast Bioengineering Conference
CY APR 20-21, 2002
CL DREXEL UNIV, PHILADELPHIA, PA
SP IEEE EMBS, Exponent, GE Global Res Ctr, Johnson & Johnson, Merck Res Labs, Orthovita, Pfizer
HO DREXEL UNIV
AB This paper details the design and manufacture of a synthetic biomemtic bone biomaterial. The material is a composite of collagen fibrils and nanometer sized mineral apatites to enhance its resorbability over previous hydroxyapatite ceramics and bone cements. An aseptic protocol for producing a sterile composite has been developed and tested It is no;v possible to use this biomaterial in cell experiments.
C1 Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
RP Longsworth, J (reprint author), Case Western Reserve Univ, Dept Biomed Engn, 10900 Euclid Ave, Cleveland, OH 44106 USA.
OI Eppell, Steven/0000-0002-0302-1910
CR BRUCKNER P, 1981, ANAL BIOCHEM, V110, P360, DOI 10.1016/0003-2697(81)90204-9
   Hodge A J, 1989, Connect Tissue Res, V21, P137, DOI 10.3109/03008208909050004
   HOLMES DF, 1986, INT J BIOL MACROMOL, V8, P161, DOI 10.1016/0141-8130(86)90020-6
   Webster TJ, 2001, BIOMATERIALS, V22, P1327, DOI 10.1016/S0142-9612(00)00285-4
   Yuasa T, 2001, J BIOMED MATER RES, V54, P344
NR 5
TC 0
Z9 0
U1 0
U2 2
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 0-7803-7419-3
PY 2002
BP 173
EP 174
DI 10.1109/NEBC.2002.999521
PG 2
WC Engineering, Biomedical
SC Engineering
GA BU42Z
UT WOS:000175970000087
DA 2018-10-20
ER

PT S
AU Li, YH
   Rong, LJ
   Li, YY
AF Li, YH
   Rong, LJ
   Li, YY
BE Ge, CC
   Rogachev, AS
TI Porous NiTi alloy prepared from combustion synthesis
SO PROGRESS IN SELF-PROPAGATING HIGH-TEMPERATURE SYNTHESIS
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 1st Sino-Russian Workshop on Self-Propagating High-Temperature Synthesis
CY SEP 21-24, 2000
CL BEIJING, PEOPLES R CHINA
SP Univ Sci & Technol Bijing, Russian Acad Sci, Inst Struct Macrokinet & Mat Sci
DE combustion synthesis; compressive properties; porous NiTi alloy
ID SHAPE-MEMORY; APPOSITION; INGROWTH; IMPLANT
AB Porous NiTi shape memory alloy (SMA) is a promising biomaterial which can be used as replacement of hard tissue implant It was prepared from elemental titanium and nickel powders by method of combustion synthesis. The phase composition, pore and fracture morphology were investigated by X-ray diffraction (XRD) and scanning electron microscopy (SEM) respectively. Meanwhile the compressive mechanical property was also studied. The preliminary data indicated that porous NiTi SMA prepared from combustion synthesis had homogeneous pore distribution and proper mean pore size. The mechanical property of pure product depended strongly on preheating temperature during synthesis process. It has also good superelasticity.
C1 Chinese Acad Sci, Inst Met Res, Shenyang 110016, Peoples R China.
RP Li, YH (reprint author), Chinese Acad Sci, Inst Met Res, Shenyang 110016, Peoples R China.
OI Li, Yong-Hua/0000-0003-0005-3789
CR Ayers RA, 1999, J BIOMED MATER RES, V45, P42
   Duerig T, 1999, MAT SCI ENG A-STRUCT, V273, P149, DOI 10.1016/S0921-5093(99)00294-4
   GIBSON LJ, 1997, CELLULAR SOLID STRUC, P431
   ITIN VI, 1994, MATER CHARACT, V32, P179, DOI 10.1016/1044-5803(94)90087-6
   Munir Z. A., 1989, Material Science Reports, V3, P277, DOI 10.1016/0920-2307(89)90001-7
   Otsuka K, 1999, INTERMETALLICS, V7, P511, DOI 10.1016/S0966-9795(98)00070-3
   SIMSKE SJ, 1995, J BIOMED MATER RES, V29, P527, DOI 10.1002/jbm.820290413
NR 7
TC 6
Z9 6
U1 0
U2 0
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-885-0
J9 KEY ENG MAT
PY 2002
VL 217
BP 137
EP 141
DI 10.4028/www.scientific.net/KEM.217.137
PG 5
WC Materials Science, Ceramics; Materials Science, Composites
SC Materials Science
GA BU11H
UT WOS:000175042000023
DA 2018-10-20
ER

PT B
AU Tsiridis, V
   Persoone, G
AF Tsiridis, V
   Persoone, G
BE Kungolos, AG
   Liakopoulos, AB
   Korfiatis, GP
   Koutsospyros, AD
   Katsifarakis, KL
   Demetracopoulos, AD
TI Toxkit microbiotests: New low cost tools for hazard detection/monitoring
   in environmental toxicology
SO PROTECTION AND RESTORATION OF THE ENVIRONMENT VI, VOLS I - III,
   PROCEEDINGS
LA English
DT Proceedings Paper
CT 6th International Conference on Protection and Restoration of the
   Environment
CY JUL 01-05, 2002
CL SKIATHOS ISL, GREECE
SP Minist Environm, Phys Planning & Public Works, Municipal Skiathos, USA Res, Dev & Standardizat Grp, Magnesia Prefecture, Volos & Nea Ionia Municipal Assoc Solid Waste Disposal, Univ Thessaly, Res Comm, Univ Thessaly, Civil Engn, Univ Thessaly, Dept Planning & Reg Dev, Stevens Inst Technol, HERACLES G C Co S A, SOVEL S A BIOCHALCO Grp, Coca-Cola 3E Hellen Bottling Co, Themeliodomi S A, SCIETACT S A, AIAS RESEARCH Ltd, AIR METAL Ltd, AQUACHEM Ltd, ARVIS Environm Enterprise Greece, Bio Eco Sol S A, Eurotrans Consulting Ltd, ENVITEC S A, INTERGEO EnvironmTechnol Ltd, BAKAKOS S A, APOSTOLAKIS S A ARGO WINE, EPSA S A, Karkanias Environm Technol SA
ID TOXICITY
AB In recent years, attention has gradually focussed on the use of toxicity tests as a useful tool to estimate chemical contamination and its potential impact on terrestrial and aquatic environments. New microbiotests, called Toxkits, have been developed in the Laboratory for Environmental Toxicology and Aquatic Ecology at the Ghent University in Belgium. The new approach is based on the use of "dormant, inactive or immobilized" stages of selected aquatic biota as the biomaterial from which life test organism can easily be obtained on demand to perform the toxicity tests. Several highly standardized "culture/maintenance free" toxicity tests are now commercially available, with selected species of micro-algae, protozoans, rotifers and crustaceans. A brief review of Toxkit microbiotests and their applications is given in this study.
C1 Air Met Ltd, Thessaloniki 55133, Greece.
RP Tsiridis, V (reprint author), Air Met Ltd, Aegeou 75, Thessaloniki 55133, Greece.
EM airmetal@the.forthnet.gr
CR Artoxkit M, 1990, ARTEMIA TOXICITY SCR
   *ASTM, 1991, E1440 ASTM, P1210
   Clement B, 1996, CHEMOSPHERE, V33, P2303
   *EPA, 1993, EPA600490027F
   Hadjispyrou S, 2001, ECOTOX ENVIRON SAFE, V49, P179, DOI 10.1006/eesa.2001.2059
   Kungolos A, 1999, WATER SCI TECHNOL, V40, P357, DOI 10.1016/S0273-1223(99)00384-4
   MARSALEK B, 2000, MICROBIOTESTS ROUTIN, P519
   OECD, 1984, GUID TEST CHEM DAPHN, P1
   *OECD, 1985, GUID TEST CHEM DAPHN, P1
   PERSOONE G, 1991, Zeitschrift fuer Angewandte Zoologie, V78, P235
   Persoone G, 1998, MICROSCALE TESTING IN AQUATIC TOXICOLOGY, P311
   PERSOONE G, 1989, AQUAT TOXICOL, V14, P149, DOI 10.1016/0166-445X(89)90025-8
   Persoone G, 1998, MICROSCALE TESTING IN AQUATIC TOXICOLOGY, P437
   Persoone G, 2000, NEW MICROBIOTESTS RO
   PERSOONE G, 1993, COST EFFECTIVE ACUTE
   Samaras P, 1998, FRESEN ENVIRON BULL, V7, P623
   Thamnotoxkit FTM, 1995, CRUSTACEAN TOXICITY
   VANHAECKE P, 1981, ECOTOX ENVIRON SAFE, V5, P382, DOI 10.1016/0147-6513(81)90012-9
   VANSTEERTEGEM M, 1993, SETAC SP P, P81
NR 19
TC 0
Z9 0
U1 0
U2 3
PU GRAFIMA LOANNIS TSAROUCHIDIS
PI THESSALONIKI
PA 62-68, D GOUNARI, THESSALONIKI 54635, GREECE
BN 960-86574-5-8
PY 2002
BP 809
EP 816
PG 8
WC Engineering, Environmental; Environmental Sciences; Water Resources
SC Engineering; Environmental Sciences & Ecology; Water Resources
GA BV61E
UT WOS:000179504900098
DA 2018-10-20
ER

PT S
AU Nikolovski, J
   Simmons, CA
   Mooney, DJ
AF Nikolovski, J
   Simmons, CA
   Mooney, DJ
GP IEEE
   IEEE
   IEEE
TI Regulation of bone-associated genes in smooth muscle with mechanical
   strain
SO SECOND JOINT EMBS-BMES CONFERENCE 2002, VOLS 1-3, CONFERENCE
   PROCEEDINGS: BIOENGINEERING - INTEGRATIVE METHODOLOGIES, NEW
   TECHNOLOGIES
SE PROCEEDINGS OF ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING
   IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT 24th Annual International Conference of the
   Engineering-in-Medicine-and-Biology-Society/Annual Fall Meeting of the
   Biomedical-Engineering-Society (EMBS 2002 BMES)
CY OCT 23-26, 2002
CL HOUSTON, TX
SP Engn Med & Biol Soc, Biomed Engn Soc, Natl Sci Fdn, Natl Inst Hlth, Natl Inst Biomed Imaging & Bioengn, Whitaker Fdn
DE smooth muscle; mechanical strain; calcification
ID CELL
AB Calcification is a common problem associated with cardiovascular disease, injury, aging, and as a result of biomaterial implantation. Osteopontin (OPN) and matrix gla protein (MGP) are key bone-associated molecules in the calcification process, and we hypothesize that mechanical strain is an important signal mediating their expression in the cardiovasculature. To address this, we studied the effects of cyclic mechanical strain (7% strain, 1 Hz) on bone-associated gene expression in rat aortic smooth muscle cells grown in a three-dimensional tissue model. Mechanical strain was found to modulate the expression of OPN, MGP, and CBFA-1, a transcription factor normally found in osteoblasts. Significant increases in their expression were noted without chronic cyclic strain exposure. Long-term strain of these tissues appeared to play a protective role in regards to calcification, as strained tissues exhibited decreased amounts of total calcium with respect to controls. These studies suggest that mechanical strain is an important signal in maintaining the smooth muscle phenotype, and its' absence leads cells to switch to a phenotype that is more bone-like.
C1 Univ Michigan, Ann Arbor, MI 48109 USA.
RP Nikolovski, J (reprint author), Univ Michigan, Ann Arbor, MI 48109 USA.
CR Giachelli C M, 2001, Z Kardiol, V90 Suppl 3, P31
   Hungerford JE, 1999, J VASC RES, V36, P2, DOI 10.1159/000025622
   Kim BS, 2000, J BIOMECH ENG-T ASME, V122, P210, DOI 10.1115/1.429651
   Kim BS, 1999, NAT BIOTECHNOL, V17, P979, DOI 10.1038/13671
   Wada T, 1999, CIRC RES, V84, P166, DOI 10.1161/01.RES.84.2.166
   Wozniak M, 2000, J BONE MINER RES, V15, P1731, DOI 10.1359/jbmr.2000.15.9.1731
NR 6
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1094-687X
BN 0-7803-7612-9
J9 P ANN INT IEEE EMBS
PY 2002
BP 314
EP 315
PG 2
WC Computer Science, Artificial Intelligence; Engineering, Biomedical;
   Instruments & Instrumentation; Radiology, Nuclear Medicine & Medical
   Imaging
SC Computer Science; Engineering; Instruments & Instrumentation; Radiology,
   Nuclear Medicine & Medical Imaging
GA BV84T
UT WOS:000180194800148
DA 2018-10-20
ER

PT S
AU Sorensen, EN
   Burgreen, GW
   Wagner, WR
   Antaki, JF
AF Sorensen, EN
   Burgreen, GW
   Wagner, WR
   Antaki, JF
GP IEEE
   IEEE
   IEEE
TI Simulation of platelet deposition in disturbed flow
SO SECOND JOINT EMBS-BMES CONFERENCE 2002, VOLS 1-3, CONFERENCE
   PROCEEDINGS: BIOENGINEERING - INTEGRATIVE METHODOLOGIES, NEW
   TECHNOLOGIES
SE PROCEEDINGS OF ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING
   IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT 24th Annual International Conference of the
   Engineering-in-Medicine-and-Biology-Society/Annual Fall Meeting of the
   Biomedical-Engineering-Society (EMBS 2002 BMES)
CY OCT 23-26, 2002
CL HOUSTON, TX
SP Engn Med & Biol Soc, Biomed Engn Soc, Natl Sci Fdn, Natl Inst Hlth, Natl Inst Biomed Imaging & Bioengn, Whitaker Fdn
DE platelets; thrombosis; computational fluid dynamics; mathematical
   modeling
ID COMPUTATIONAL SIMULATION; ACTIVATION; COLLAGEN
AB We have developed a two-dimensional computational model of platelet-mediated biomaterial thrombosis. When applied to plane Poiseuille flow over collagen, it showed very good agreement with experimental results. Here, we attempt to simulate platelet deposition onto collagen in the presence of disturbed flow in a tubular expansion. At 0% hematocrit, good agreement with experiments is obtained for the recirculation zone, but not for the fully-developed downstream zone. At 20% hematocrit, poor agreement is observed unless the platelet-surface reaction coefficients are altered. In both cases, it appears the deficiencies are due to incomplete modeling of platelet transport mechanisms.
C1 Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15261 USA.
RP Sorensen, EN (reprint author), Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15261 USA.
CR AARTS PAMM, 1988, ARTERIOSCLEROSIS, V8, P819, DOI 10.1161/01.ATV.8.6.819
   KARINO T, 1979, MICROVASC RES, V17, P238, DOI 10.1016/S0026-2862(79)80002-3
   Sorensen EN, 1999, ANN BIOMED ENG, V27, P436, DOI 10.1114/1.200
   Sorensen EN, 1999, ANN BIOMED ENG, V27, P449, DOI 10.1114/1.201
   ZYDNEY A, 1988, PHYSICO CHEM HYDRODY, V10, P79
NR 5
TC 2
Z9 2
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1094-687X
BN 0-7803-7612-9
J9 P ANN INT IEEE EMBS
PY 2002
BP 390
EP 391
PG 2
WC Computer Science, Artificial Intelligence; Engineering, Biomedical;
   Instruments & Instrumentation; Radiology, Nuclear Medicine & Medical
   Imaging
SC Computer Science; Engineering; Instruments & Instrumentation; Radiology,
   Nuclear Medicine & Medical Imaging
GA BV84T
UT WOS:000180194800186
DA 2018-10-20
ER

PT S
AU Janis, AD
   Lagerquist, KA
   Hinds, MT
AF Janis, AD
   Lagerquist, KA
   Hinds, MT
GP IEEE
   IEEE
   IEEE
TI Directional permeability in a porcine carotid elastin biomaterial
   vascular conduit - 2(nd) Joint Conference of the IEEE Engineering in
   Medicine and Biology Society and the Biomedical Engineering Society
SO SECOND JOINT EMBS-BMES CONFERENCE 2002, VOLS 1-3, CONFERENCE
   PROCEEDINGS: BIOENGINEERING - INTEGRATIVE METHODOLOGIES, NEW
   TECHNOLOGIES
SE PROCEEDINGS OF ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING
   IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT 24th Annual International Conference of the
   Engineering-in-Medicine-and-Biology-Society/Annual Fall Meeting of the
   Biomedical-Engineering-Society (EMBS 2002 BMES)
CY OCT 23-26, 2002
CL HOUSTON, TX
SP Engn Med & Biol Soc, Biomed Engn Soc, Natl Sci Fdn, Natl Inst Hlth, Natl Inst Biomed Imaging & Bioengn, Whitaker Fdn
DE elastin; vascular; permeability
AB Purified porcine carotid elastin is under development as a substrate for a vascular conduit. The permeability of the graft may have implications in recellularlization. Light and scanning electron microscopy indicate that the lumen and adventitial surfaces have unique extracellular matrix morphology. This study investigates the permeability of the material, with consideration of the direction of the flow. The permeability of the adventitial surface was found to be approximately twice that of the lumenal surface. The mean permeability was 0.0123 +/- 0.005 mL/min*cm(2) for flow through from lumen surface to the adventitial surface and 0.0310 +/- 0.007 mL/min*cm(2) for flow through the adventitial surface to the lumen surface. The difference in elastin architecture can be taken advantage of to optimize recellularization in vitro and in vivo This is only the second biomaterial to have this described behavior.
C1 Providence St Vincent Hosp, Oregon Med Laser Ctr, Portland, OR USA.
RP Janis, AD (reprint author), Providence St Vincent Hosp, Oregon Med Laser Ctr, Portland, OR USA.
CR FERRAND BK, 1993, J BIOMED MATER RES, V27, P1235, DOI 10.1002/jbm.820271004
   WESOLOWSKI SA, 1962, EVALUATION TISSUE PR
NR 2
TC 0
Z9 0
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1094-687X
BN 0-7803-7612-9
J9 P ANN INT IEEE EMBS
PY 2002
BP 413
EP 414
PG 2
WC Computer Science, Artificial Intelligence; Engineering, Biomedical;
   Instruments & Instrumentation; Radiology, Nuclear Medicine & Medical
   Imaging
SC Computer Science; Engineering; Instruments & Instrumentation; Radiology,
   Nuclear Medicine & Medical Imaging
GA BV84T
UT WOS:000180194800197
DA 2018-10-20
ER

PT S
AU Shea, LD
   Whittlesey, KJ
   Segura, T
   Jang, J
   Yang, Y
AF Shea, LD
   Whittlesey, KJ
   Segura, T
   Jang, J
   Yang, Y
GP IEEE
   IEEE
   IEEE
TI Tissue engineering scaffolds for controlled protein and plasmid delivery
SO SECOND JOINT EMBS-BMES CONFERENCE 2002, VOLS 1-3, CONFERENCE
   PROCEEDINGS: BIOENGINEERING - INTEGRATIVE METHODOLOGIES, NEW
   TECHNOLOGIES
SE PROCEEDINGS OF ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING
   IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT 24th Annual International Conference of the
   Engineering-in-Medicine-and-Biology-Society/Annual Fall Meeting of the
   Biomedical-Engineering-Society (EMBS 2002 BMES)
CY OCT 23-26, 2002
CL HOUSTON, TX
SP Engn Med & Biol Soc, Biomed Engn Soc, Natl Sci Fdn, Natl Inst Hlth, Natl Inst Biomed Imaging & Bioengn, Whitaker Fdn
DE tissue engineering; gene therapy; drug delivery
ID MATRICES
AB Tissue engineering approaches employ polymer scaffolds to supports, promote, and direct tissue formation by progenitor cells, which are either present in the surrounding tissue or transplanted with the polymer. We hypothesize that scaffolds capable of delivering tissue-inductive factors, or genes encoding for these factors, at the correct time and location, and in the appropriate concentration could enhance the effectiveness of current regenerative approaches. Scaffolds have been developed that provide a controlled, sustained delivery of protein and non-viral DNA. Polymeric scaffolds capable of sustained drug release can be fabricated by the assembly of drug-loaded microspheres and subsequent fusion of the microspheres using a gas foaming process. This process has been developed to regulate the amount released and the release rates for protein, naked DNA, and DNA complexed with cationic lipid and polymers. Alternatively, we have developed a controlled DNA delivery system based on the tethering of DNA complexes to a biomaterial surfaces. Complexes can be immobilized at high densities and cells cultured on the substrates can internalize and express the DNA. These systems for the controlled delivery of proteins, or DNA-encoding for these proteins, are versatile and can be readily applied to the regeneration of various tissues.
C1 Northwestern Univ, Dept Chem Engn, Evanston, IL 60208 USA.
RP Shea, LD (reprint author), Northwestern Univ, Dept Chem Engn, Evanston, IL 60208 USA.
RI Shea, Lonnie/B-7615-2009
CR Murphy WL, 1999, J PERIODONTAL RES, V34, P413, DOI 10.1111/j.1600-0765.1999.tb02275.x
   Putnam AJ, 1996, NAT MED, V2, P824, DOI 10.1038/nm0796-824
NR 2
TC 1
Z9 1
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1094-687X
BN 0-7803-7612-9
J9 P ANN INT IEEE EMBS
PY 2002
BP 474
EP 474
PG 1
WC Computer Science, Artificial Intelligence; Engineering, Biomedical;
   Instruments & Instrumentation; Radiology, Nuclear Medicine & Medical
   Imaging
SC Computer Science; Engineering; Instruments & Instrumentation; Radiology,
   Nuclear Medicine & Medical Imaging
GA BV84T
UT WOS:000180194800227
DA 2018-10-20
ER

PT S
AU Ghosh, K
   Chen, WL
   Rafailovich, M
   Ge, SR
AF Ghosh, K
   Chen, WL
   Rafailovich, M
   Ge, SR
GP IEEE
   IEEE
   IEEE
TI Formulation and characterization of biodegrdable hyaluronan (HA) gene
   delivery films
SO SECOND JOINT EMBS-BMES CONFERENCE 2002, VOLS 1-3, CONFERENCE
   PROCEEDINGS: BIOENGINEERING - INTEGRATIVE METHODOLOGIES, NEW
   TECHNOLOGIES
SE PROCEEDINGS OF ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING
   IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT 24th Annual International Conference of the
   Engineering-in-Medicine-and-Biology-Society/Annual Fall Meeting of the
   Biomedical-Engineering-Society (EMBS 2002 BMES)
CY OCT 23-26, 2002
CL HOUSTON, TX
SP Engn Med & Biol Soc, Biomed Engn Soc, Natl Sci Fdn, Natl Inst Hlth, Natl Inst Biomed Imaging & Bioengn, Whitaker Fdn
DE crosslinking; hydrophobicity; HA films
AB Hyaluronan is a naturally occurring polysaccharide found in the human body. Its unique physical/chemical properties make HA a prospective biomaterial for clinical applications. Gene Delivery coronary stent coating can be formulated using HA. 1 % HA (a gel) was used to make the HA and HA-DNA-Protamine films. The films were cross-linked with Adipic dihydrazide. Atomic Force Microscopy (AFM) on the dried films was done to determine a) surface topography at nm- and mum- resolution and b) relative Young's Modulus. Results indicated the overnight crosslinked films to have a relatively higher Young's modulus as compared to the 4-hour crosslinked ones. Comparison of the surface topography of the HA-DNA films (with 2.5% and 5% DNA loading) revealed the DNA-Protamine on the film sample. Results of Contact angle measurements indicate that the films with 4-hour crosslinking have smaller contact angles, indicating lesser hydophobicity than the overnight crosslinked samples. The results obtained from the AFM and contact angle assays thereby suggest that crosslinking of HA and HA-DNA Protamine films renders them more hydrophobic, and thereby more suitable for gene delivery applications.
C1 SUNY Stony Brook, Dept Biomed Engn, Stony Brook, NY 11794 USA.
RP Ghosh, K (reprint author), SUNY Stony Brook, Dept Biomed Engn, Stony Brook, NY 11794 USA.
CR Adam N, 2001, INFLAMM RES, V50, P294, DOI 10.1007/PL00000247
   Engstrom PE, 2001, J PERIODONTOL, V72, P1192, DOI 10.1902/jop.2000.72.9.1192
   Ge S, 2000, PHYS REV LETT, V85, P2340, DOI 10.1103/PhysRevLett.85.2340
   LARSEN NE, 1993, J BIOMED MATER RES, V27, P1129, DOI 10.1002/jbm.820270903
   POUYANI T, 1994, BIOCONJUGATE CHEM, V5, P339, DOI 10.1021/bc00028a010
   POUYANI T, 1997, Patent No. 5616568
   PRESTWICH GD, CONTROLLED CHEM MODI, P93
NR 7
TC 0
Z9 0
U1 0
U2 3
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1094-687X
BN 0-7803-7612-9
J9 P ANN INT IEEE EMBS
PY 2002
BP 541
EP 542
PG 2
WC Computer Science, Artificial Intelligence; Engineering, Biomedical;
   Instruments & Instrumentation; Radiology, Nuclear Medicine & Medical
   Imaging
SC Computer Science; Engineering; Instruments & Instrumentation; Radiology,
   Nuclear Medicine & Medical Imaging
GA BV84T
UT WOS:000180194800261
DA 2018-10-20
ER

PT S
AU Ai, H
   Lvov, YM
   Mills, DK
   Meng, HD
   Qiao, XX
   Alexander, JS
   Jones, SA
AF Ai, H
   Lvov, YM
   Mills, DK
   Meng, HD
   Qiao, XX
   Alexander, JS
   Jones, SA
GP IEEE
   IEEE
   IEEE
TI Coating bio-nanofilm on PDMS through layer-by-layer self-assembly
SO SECOND JOINT EMBS-BMES CONFERENCE 2002, VOLS 1-3, CONFERENCE
   PROCEEDINGS: BIOENGINEERING - INTEGRATIVE METHODOLOGIES, NEW
   TECHNOLOGIES
SE PROCEEDINGS OF ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING
   IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT 24th Annual International Conference of the
   Engineering-in-Medicine-and-Biology-Society/Annual Fall Meeting of the
   Biomedical-Engineering-Society (EMBS 2002 BMES)
CY OCT 23-26, 2002
CL HOUSTON, TX
SP Engn Med & Biol Soc, Biomed Engn Soc, Natl Sci Fdn, Natl Inst Hlth, Natl Inst Biomed Imaging & Bioengn, Whitaker Fdn
DE PDMS; bio-nanofilm; layer-by-layer; cell adhesion; self-assembly
ID FILMS
AB PDMS is a popular biomaterial, and its surface modification with biocompatible ultrathin films may have potential applications in many biomedical areas. The technique of electrostatic Layer-by-Layer (LbL) assembly of polyions has been widely used in recent years to form ultrathin films. In this study, cationic Poly(ethyleneimine) (PEI) and anionic poly(styrene sulfonate) (PSS) were alternately adsorbed onto PDMS through LbL self-assembly. Then poly-D-lysine, gelatin, collagen, fibronectin, laminin, hyaluronic acid, and heparin were coated on PDMS through LbL assembly by alternate adsorption with oppositely charged polyelectrolytes. The film coated on PDMS was hydrophilic compared to the PDMS substrate, as verified through contact angle measurement. The film thickness could be controlled precisely with an accuracy of nanometers by varying the number of layers. The protein nanofilm was biocompatible, enabling endothelial cells, nerve cells, hepatocytes, or smooth muscle cells to adhere and grow. No cell growth was found on the unmodified PDMS substrate.
C1 Louisiana Tech Univ, Dept Biomed Engn, Ruston, LA 71272 USA.
RP Ai, H (reprint author), Louisiana Tech Univ, Dept Biomed Engn, Ruston, LA 71272 USA.
CR Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   KELLER SW, 1994, J AM CHEM SOC, V116, P8817, DOI 10.1021/ja00098a055
   LVOV Y, 1993, LANGMUIR, V9, P481, DOI 10.1021/la00026a020
   LVOV Y, 1995, J AM CHEM SOC, V117, P6117, DOI 10.1021/ja00127a026
   SAUERBREY G, 1959, Z PHYS, V155, P206, DOI 10.1007/BF01337937
NR 5
TC 5
Z9 5
U1 0
U2 10
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1094-687X
BN 0-7803-7612-9
J9 P ANN INT IEEE EMBS
PY 2002
BP 608
EP 609
PG 2
WC Computer Science, Artificial Intelligence; Engineering, Biomedical;
   Instruments & Instrumentation; Radiology, Nuclear Medicine & Medical
   Imaging
SC Computer Science; Engineering; Instruments & Instrumentation; Radiology,
   Nuclear Medicine & Medical Imaging
GA BV84T
UT WOS:000180194800294
DA 2018-10-20
ER

PT S
AU Brown, CT
   Weng, ZP
   Zhang, H
   Wong, JY
AF Brown, CT
   Weng, ZP
   Zhang, H
   Wong, JY
GP IEEE
   IEEE
   IEEE
TI Mutational analysis verifies that "kneed" sequence of fibronectin
   participates in cell-substrate interactions
SO SECOND JOINT EMBS-BMES CONFERENCE 2002, VOLS 1-3, CONFERENCE
   PROCEEDINGS: BIOENGINEERING - INTEGRATIVE METHODOLOGIES, NEW
   TECHNOLOGIES
SE PROCEEDINGS OF ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING
   IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT 24th Annual International Conference of the
   Engineering-in-Medicine-and-Biology-Society/Annual Fall Meeting of the
   Biomedical-Engineering-Society (EMBS 2002 BMES)
CY OCT 23-26, 2002
CL HOUSTON, TX
SP Engn Med & Biol Soc, Biomed Engn Soc, Natl Sci Fdn, Natl Inst Hlth, Natl Inst Biomed Imaging & Bioengn, Whitaker Fdn
DE adhesion; bioadhesion; tissue engineering
ID RECOGNITION; DOMAINS; RGD
AB Interactions between cell-surface integrins and extracellular matrix (ECM) proteins underlie a versatile recognition system providing cells with anchorage and traction for migration or matrix remodeling. Short peptide sequences of fibronectin (FN), most notably RGD found on a loop in the tenth type III domain, are effective in promoting cell adhesion when immobilized to a biomaterial scaffold. Using bioinformatics, we identified a candidate cell-binding peptide sequence, KNEED, located on the loop region of the 8(th) domain of fibronectin that from in vitro studies appears to participate in cell attachment and spreading. To demonstrate its importance, the KNEED sequence of Fibronectin type III domains 7-10 (FN7-10) was mutated to AAAAA or SNSSS (FN7-10 AAAAA and FN7-10 SNSSS respectively). Wildtype and mutant proteins were expressed in E. omegali, purified by conventional chromatography and tested in cell adhesion assays. Results indicate that the extent of cell spreading on surfaces coated with either FN7-10 AAAAA or FN7-10 SNSSS was measurably less than on surfaces coated with wildtype FN7-10. Mutational analysis may aid in the characterization of new targets for applications where biorecognition plays a key role.
C1 Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA.
RP Brown, CT (reprint author), Boston Univ, Dept Biomed Engn, 44 Cummington St, Boston, MA 02215 USA.
RI Wong, Joyce/F-3732-2011
OI Wong, Joyce/0000-0002-3526-6381
CR AUKHIL I, 1993, J BIOL CHEM, V268, P2542
   KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211
   KIMIZUKA F, 1991, J BIOCHEM-TOKYO, V110, P284, DOI 10.1093/oxfordjournals.jbchem.a123572
   Leahy DJ, 1996, CELL, V84, P155, DOI 10.1016/S0092-8674(00)81002-8
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   WONG JY, IN PRESS BIOMATERIAL
NR 6
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1094-687X
BN 0-7803-7612-9
J9 P ANN INT IEEE EMBS
PY 2002
BP 614
EP 615
PG 2
WC Computer Science, Artificial Intelligence; Engineering, Biomedical;
   Instruments & Instrumentation; Radiology, Nuclear Medicine & Medical
   Imaging
SC Computer Science; Engineering; Instruments & Instrumentation; Radiology,
   Nuclear Medicine & Medical Imaging
GA BV84T
UT WOS:000180194800297
DA 2018-10-20
ER

PT S
AU Yoshida, M
   Babensee, JE
AF Yoshida, M
   Babensee, JE
GP IEEE
   IEEE
   IEEE
TI Assessment of monocyte derived dendritic cell phenotype upon biomaterial
   contact in vitro
SO SECOND JOINT EMBS-BMES CONFERENCE 2002, VOLS 1-3, CONFERENCE
   PROCEEDINGS: BIOENGINEERING - INTEGRATIVE METHODOLOGIES, NEW
   TECHNOLOGIES
SE PROCEEDINGS OF ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING
   IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT 24th Annual International Conference of the
   Engineering-in-Medicine-and-Biology-Society/Annual Fall Meeting of the
   Biomedical-Engineering-Society (EMBS 2002 BMES)
CY OCT 23-26, 2002
CL HOUSTON, TX
SP Engn Med & Biol Soc, Biomed Engn Soc, Natl Sci Fdn, Natl Inst Hlth, Natl Inst Biomed Imaging & Bioengn, Whitaker Fdn
DE biomaterial; dendritic cells
AB Immune response remains a concern associated with the successful integration of tissue engineered device into living systems. Upon implantation, both living and non-living device components elicit a specific immune and a nonspecific inflammatory response, respectively. We hypothesize that biomaterial contact is a maturation stimulus for dendritic cells (DC), the antigen presenting cells that activate T cells and initiate adaptive immunity. Maturation of DC was reconstituted by culturing human blood monocytes with GM-CSF and IL-4 to induce differentiation into immature DC (iDC). iDC were then treated with 4 mum poly(lactic-co-glycolic) acid microparticles (PLGA MP), or with LPS to yield mature DC (mDC) as positive control. Cell morphology and surface phenotype were monitored as a function of time. On day 10, biomaterial- treated cells morphologically most closely resembled mDC with dendritic processes. In contrast and as expected, monocytes/ macrophages did not exhibit processes and expressed high levels of CD14. mDC expressed high levels of costimulatory and MHC molecules compared to iDC. Our preliminary, results show that biomaterial microparticles were phagocytosed, and the level of costimulatory and MHC molecules expression by biomaterial- treated cells was between that expressed by iDC and mDC.
C1 Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.
RP Yoshida, M (reprint author), Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.
CR Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588
NR 1
TC 0
Z9 0
U1 0
U2 3
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1094-687X
BN 0-7803-7612-9
J9 P ANN INT IEEE EMBS
PY 2002
BP 619
EP 620
PG 2
WC Computer Science, Artificial Intelligence; Engineering, Biomedical;
   Instruments & Instrumentation; Radiology, Nuclear Medicine & Medical
   Imaging
SC Computer Science; Engineering; Instruments & Instrumentation; Radiology,
   Nuclear Medicine & Medical Imaging
GA BV84T
UT WOS:000180194800299
DA 2018-10-20
ER

PT S
AU Leach, JB
   Patrick, CW
   Schmidt, CE
AF Leach, JB
   Patrick, CW
   Schmidt, CE
GP IEEE
   IEEE
   IEEE
TI Directing tissue regeneration via hyaluronic acid hydrogel scaffolds
SO SECOND JOINT EMBS-BMES CONFERENCE 2002, VOLS 1-3, CONFERENCE
   PROCEEDINGS: BIOENGINEERING - INTEGRATIVE METHODOLOGIES, NEW
   TECHNOLOGIES
SE PROCEEDINGS OF ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING
   IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT 24th Annual International Conference of the
   Engineering-in-Medicine-and-Biology-Society/Annual Fall Meeting of the
   Biomedical-Engineering-Society (EMBS 2002 BMES)
CY OCT 23-26, 2002
CL HOUSTON, TX
SP Engn Med & Biol Soc, Biomed Engn Soc, Natl Sci Fdn, Natl Inst Hlth, Natl Inst Biomed Imaging & Bioengn, Whitaker Fdn
DE biomaterial; hyaluronic acid; biodegradable; polymer;
   photopolymerization; tissue engineering
AB Comprehensive regeneration therapies should provide a bioactive, degradable support structure as well as promote the ingrowth of new blood vessels and nerves. The ultimate goal of our research is to synthesize a biomimetic tissue engineering hydrogel that will promote rapid incorporation of the scaffold with the host's vascular and nervous systems. Hyaluronic acid (HA), a naturally occurring non-immunogenic polymer, is inherently angiogenic and involved with neural development and regeneration. HA presents unique advantages due to its ease of production and modification, hydrophilic and non-adhesive character, natural biodegradation and prominent role in scar-free wound healing. Therefore, the aim of the research presented here is to utilize HA's distinctive advantages to create a novel scaffold suitable for supporting angiogenesis and neurite outgrowth. We have chemically modified HA with methacrylate groups and used photo-initiated polymerization to synthesize cross-linked HA hydrogels, resulting in a selection of materials that span a range of physiochemical and biochemical properties. In vitro and in vivo studies have been used to assess the hydrogels' potential to support angiogenesis and nerve repair. Finally, we seek to modify HA's non-adhesiveness through the addition of bioactive sequences to tune the specific cellular responses to the material.
C1 Univ Texas, Dept Chem Engn, Austin, TX 78712 USA.
RP Leach, JB (reprint author), Univ Texas, Dept Chem Engn, Austin, TX 78712 USA.
CR Anseth KS, 2002, MRS BULL, V27, P130, DOI 10.1557/mrs2002.49
   FLORY PJ, 1953, PRINCIPLES POLYM CHE
   KING TW, IN PRESS INTERNET J
   LEACH JB, UNPUB HYALURONIC ACI
   Ratner BD, 2002, J CONTROL RELEASE, V78, P211, DOI 10.1016/S0168-3659(01)00502-8
   Stocum David L., 1998, Wound Repair and Regeneration, V6, P276, DOI 10.1046/j.1524-475X.1998.60404.x
NR 6
TC 1
Z9 1
U1 1
U2 6
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1094-687X
BN 0-7803-7612-9
J9 P ANN INT IEEE EMBS
PY 2002
BP 753
EP 754
PG 2
WC Computer Science, Artificial Intelligence; Engineering, Biomedical;
   Instruments & Instrumentation; Radiology, Nuclear Medicine & Medical
   Imaging
SC Computer Science; Engineering; Instruments & Instrumentation; Radiology,
   Nuclear Medicine & Medical Imaging
GA BV84T
UT WOS:000180194800361
DA 2018-10-20
ER

PT S
AU Brieva, TA
   Moghe, PV
AF Brieva, TA
   Moghe, PV
GP IEEE
   IEEE
   IEEE
TI Hepatocellular engineering via acellular cadherin-derived
   microinterfaces
SO SECOND JOINT EMBS-BMES CONFERENCE 2002, VOLS 1-3, CONFERENCE
   PROCEEDINGS: BIOENGINEERING - INTEGRATIVE METHODOLOGIES, NEW
   TECHNOLOGIES
SE PROCEEDINGS OF ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING
   IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT 24th Annual International Conference of the
   Engineering-in-Medicine-and-Biology-Society/Annual Fall Meeting of the
   Biomedical-Engineering-Society (EMBS 2002 BMES)
CY OCT 23-26, 2002
CL HOUSTON, TX
SP Engn Med & Biol Soc, Biomed Engn Soc, Natl Sci Fdn, Natl Inst Hlth, Natl Inst Biomed Imaging & Bioengn, Whitaker Fdn
DE cadherin; biomaterial; hepatocyte; differentiation
ID DIFFERENTIATION; HEPATOCYTES
AB The development of cell-based therapies for liver failure relies on the availability of scaffolds that support high levels of cellular function. In this work, we functionalize biomaterial surfaces using a novel cell-based ligand as an alternative to traditional extracellular matrix-derived ligands. Initial studies in a model coculture system indicate that E-cadherin, a key cell-cell adhesion molecule present on hepatocytes, enhances liver-specific function when presented by chaperone cells. We then investigate the behavior of hepatocytes on acellular cadherin-presenting immobilized microparticle-based biomaterials. Biologically activity of acellular cadherins is ensured by appending to the extracellular domain of E-cadherin to an immunoglobulin Fc region, which induces dimerization and specifically adheres to a Protein A coating on the microbeads. Hepatocellular function was elevated on these surfaces as compared to control, Fc presenting surfaces. Both surfaces exhibited similar cell adhesion and morphogenesis, suggesting that induction of hepatocyte function by cadherins was due to signaling activities rather than adhesive activities. Overall, we have demonstrated that functionalization of biomaterials with acellular cadherins is a powerful way to induce hepatocyte function.
C1 Rutgers State Univ, Dept Chem & Biochem Engn, Piscataway, NJ 08855 USA.
RP Brieva, TA (reprint author), Rutgers State Univ, Dept Chem & Biochem Engn, Piscataway, NJ 08855 USA.
CR Brieva TA, 2001, BIOTECHNOL BIOENG, V76, P295, DOI 10.1002/bit.10041
   Goichberg P, 1998, MOL BIOL CELL, V9, P3119, DOI 10.1091/mbc.9.11.3119
   Jayaraman A, 2000, METAB ENG, V2, P239, DOI 10.1006/mben.2000.0153
   Knudsen K A, 1998, J Cell Biochem Suppl, V30-31, P168
   Maheshwari G, 2000, J CELL SCI, V113, P1677
   Mariadason JM, 2001, CANCER RES, V61, P3465
   MOONEY D, 1992, J CELL PHYSIOL, V151, P497, DOI 10.1002/jcp.1041510308
   Pertz O, 1999, EMBO J, V18, P1738, DOI 10.1093/emboj/18.7.1738
NR 8
TC 0
Z9 0
U1 0
U2 3
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1094-687X
BN 0-7803-7612-9
J9 P ANN INT IEEE EMBS
PY 2002
BP 778
EP 779
PG 2
WC Computer Science, Artificial Intelligence; Engineering, Biomedical;
   Instruments & Instrumentation; Radiology, Nuclear Medicine & Medical
   Imaging
SC Computer Science; Engineering; Instruments & Instrumentation; Radiology,
   Nuclear Medicine & Medical Imaging
GA BV84T
UT WOS:000180194800373
DA 2018-10-20
ER

PT S
AU Fisher, JP
   Lalani, Z
   Demian, N
   Wong, MEK
   Mikos, AG
AF Fisher, JP
   Lalani, Z
   Demian, N
   Wong, MEK
   Mikos, AG
GP IEEE
   IEEE
   IEEE
TI Immunohistochemical characterization of guided bone formation by a
   biodegradable-tissue engineering scaffold in a healing tooth socket of a
   rabbit model
SO SECOND JOINT EMBS-BMES CONFERENCE 2002, VOLS 1-3, CONFERENCE
   PROCEEDINGS: BIOENGINEERING - INTEGRATIVE METHODOLOGIES, NEW
   TECHNOLOGIES
SE PROCEEDINGS OF ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING
   IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT 24th Annual International Conference of the
   Engineering-in-Medicine-and-Biology-Society/Annual Fall Meeting of the
   Biomedical-Engineering-Society (EMBS 2002 BMES)
CY OCT 23-26, 2002
CL HOUSTON, TX
SP Engn Med & Biol Soc, Biomed Engn Soc, Natl Sci Fdn, Natl Inst Hlth, Natl Inst Biomed Imaging & Bioengn, Whitaker Fdn
DE tissue engineering; scaffold; bone formation; immunohistochemistry
ID FUMARATE)
AB We have developed a novel, biocompatible, biodegradable tissue engineering scaffold that has been shown to facilitate bone formation in vivo. The process of bone formation within this scaffold, however, is unknown at a molecular level. To study this process, a rabbit's four healing incisor sockets (two mandibular and two maxillar) that remain after tooth extraction were used as a bone defect model. One socket was left empty, while the remaining three were filled with crosslinked polymer networks formed from either the hydrophobic polymer poly(propylene fumarate) (PPF), the hydrophilic oligomer oligo(poly(ethylene glycol) fumarate) (OPF), or PPF with adsorbed transforming growth factor - beta1 (PPF+TGF-beta1). At 4 days, 1 week, 2 weeks, 4 weeks, 8 weeks, and 16 weeks both the mandible and maxilla were removed and prepared for histological analysis. Using immunohistochemical techniques, frozen sections were stained for the presence of TGF-beta1, platelet derived growth factor (PDGF), fibroblast growth factor - 2 (FGF-2), vascular endothelial growth factor (VEGF), and bone morphogenetic protein - 2 (BMP-2). Results indicate the effect of differing biomaterial properties upon bone formation as described by the spatial and temporal development of those growth factors. thought to be intimately involved in the process.
C1 Rice Univ, Dept Bioengn, Houston, TX 77251 USA.
RP Fisher, JP (reprint author), Rice Univ, Dept Bioengn, Houston, TX 77251 USA.
CR BUCKWALTER JA, 1995, J BONE JOINT SURG AM, V77A, P1276, DOI 10.2106/00004623-199508000-00020
   Fisher JP, 2001, J BIOMAT SCI-POLYM E, V12, P673
   Jo S, 2001, MACROMOLECULES, V34, P2839, DOI 10.1021/ma001563y
   SHUNG AK, IN PRESS J BIOMATER
NR 4
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1094-687X
BN 0-7803-7612-9
J9 P ANN INT IEEE EMBS
PY 2002
BP 827
EP 828
PG 2
WC Computer Science, Artificial Intelligence; Engineering, Biomedical;
   Instruments & Instrumentation; Radiology, Nuclear Medicine & Medical
   Imaging
SC Computer Science; Engineering; Instruments & Instrumentation; Radiology,
   Nuclear Medicine & Medical Imaging
GA BV84T
UT WOS:000180194800398
DA 2018-10-20
ER

PT S
AU McKenzie, JL
   Cardona, BE
   Shi, R
   Webster, TJ
AF McKenzie, JL
   Cardona, BE
   Shi, R
   Webster, TJ
GP IEEE
   IEEE
   IEEE
TI Cytocompatibility of carbon nanofibers for use as a neural biomaterial
SO SECOND JOINT EMBS-BMES CONFERENCE 2002, VOLS 1-3, CONFERENCE
   PROCEEDINGS: BIOENGINEERING - INTEGRATIVE METHODOLOGIES, NEW
   TECHNOLOGIES
SE PROCEEDINGS OF ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING
   IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT 24th Annual International Conference of the
   Engineering-in-Medicine-and-Biology-Society/Annual Fall Meeting of the
   Biomedical-Engineering-Society (EMBS 2002 BMES)
CY OCT 23-26, 2002
CL HOUSTON, TX
SP Engn Med & Biol Soc, Biomed Engn Soc, Natl Sci Fdn, Natl Inst Hlth, Natl Inst Biomed Imaging & Bioengn, Whitaker Fdn
DE carbon nanofibers; neural biomaterial; cytocompatibility; astrocytes;
   neurons
ID NANOPHASE CERAMICS; OSTEOBLAST
AB Carbon nanoribers possess excellent conductivity properties, which may be beneficial in the design of more effective neural prostheses. The objective of the present in vitro study was to determine cytocompatibility properties of carbon nanofibers pertinent for neuronal prosthetic applications. Carbon fibers were compacted in a manual hydraulic press via a uniaxial loading cycle. The substrates were prepared from four different types of carbon fibers, two with nanoscale diameters and two with microscale diameters. In these two categories, both a high and a low surface energy fiber were investigated. Astrocytes (glial scar tissue-forming cells) were seeded onto the substrates for adhesion, proliferation, and long-term function studies. Astrocytes preferentially adhered, proliferated, and showed the greatest alkaline phosphatase activity on the carbon fiber that had the largest diameter and the lowest surface energy. For this reason, carbon fibers in the nanometer regime with high surface energies may limit astrocyte interactions. Positive interactions with neurons, and, at the same time, limited astrocyte functions leading to scar tissue formation are essential for increased neuronal implant efficacy.
C1 Purdue Univ, Dept Biomed Engn, W Lafayette, IN 47907 USA.
RP McKenzie, JL (reprint author), Purdue Univ, Dept Biomed Engn, W Lafayette, IN 47907 USA.
CR Kam L, 1999, BIOMATERIALS, V20, P2343, DOI 10.1016/S0142-9612(99)00163-5
   PULEO DA, 1991, J BIOMED MATER RES, V25, P711, DOI 10.1002/jbm.820250603
   Webster TJ, 2000, BIOMATERIALS, V21, P1803, DOI 10.1016/S0142-9612(00)00075-2
   Webster TJ, 1999, BIOMATERIALS, V20, P1221, DOI 10.1016/S0142-9612(99)00020-4
   XINYAN C, 2001, J BIOMED MATER RES, V56, P261
NR 5
TC 0
Z9 0
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1094-687X
BN 0-7803-7612-9
J9 P ANN INT IEEE EMBS
PY 2002
BP 2119
EP 2120
DI 10.1109/IEMBS.2002.1053197
PG 2
WC Computer Science, Artificial Intelligence; Engineering, Biomedical;
   Instruments & Instrumentation; Radiology, Nuclear Medicine & Medical
   Imaging
SC Computer Science; Engineering; Instruments & Instrumentation; Radiology,
   Nuclear Medicine & Medical Imaging
GA BV84T
UT WOS:000180194801039
DA 2018-10-20
ER

PT S
AU Simpson, KH
   Bowden, MG
   Hook, M
   Anvari, B
AF Simpson, KH
   Bowden, MG
   Hook, M
   Anvari, B
GP IEEE
   IEEE
   IEEE
TI Quantification of S-aureus adhesion to fibronectin using optical
   tweezers
SO SECOND JOINT EMBS-BMES CONFERENCE 2002, VOLS 1-3, CONFERENCE
   PROCEEDINGS: BIOENGINEERING - INTEGRATIVE METHODOLOGIES, NEW
   TECHNOLOGIES
SE PROCEEDINGS OF ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING
   IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT 24th Annual International Conference of the
   Engineering-in-Medicine-and-Biology-Society/Annual Fall Meeting of the
   Biomedical-Engineering-Society (EMBS 2002 BMES)
CY OCT 23-26, 2002
CL HOUSTON, TX
SP Engn Med & Biol Soc, Biomed Engn Soc, Natl Sci Fdn, Natl Inst Hlth, Natl Inst Biomed Imaging & Bioengn, Whitaker Fdn
DE bacterial adhesion; biofilm; extracellular matrix; infection
ID FORCES
AB Biomaterial infection, a common cause of medical device failure, is initiated by bacterial adhesion to an adsorbed protein layer on the implant surface. This adhesion is thought to be mediated by specific molecules present on the bacterial cell surface. We have used optical tweezers to measure the adhesive force between a single bacterium and a protein-coated surface. A bacterium was optically trapped and brought in contact with a 10-mum diameter polystyrene microsphere coated with fibronectin. The minimum force required to detach the cell from the bead was determined over a range of fibronectin concentrations. The detachment forces were integer multiples of a 25-pN base value that was independent of coating concentration; we propose that the variation in force is related to the number of bonds formed.
C1 Rice Univ, Dept Bioengn, Houston, TX 77251 USA.
RP Simpson, KH (reprint author), Rice Univ, Dept Bioengn, Houston, TX 77251 USA.
CR FELGNER H, 1995, APPL OPTICS, V34, P977, DOI 10.1364/AO.34.000977
   Fischetti VA, 2000, GRAM-POSITIVE PATHOGENS, P11
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Neuman KC, 1999, BIOPHYS J, V77, P2856, DOI 10.1016/S0006-3495(99)77117-1
   SMELTZER MS, 2000, HDB BACTERIAL ADHESI, P411
   SVOBODA K, 1994, ANNU REV BIOPH BIOM, V23, P247, DOI 10.1146/annurev.bb.23.060194.001335
   WRIGHT WH, 1994, APPL OPTICS, V33, P1735, DOI 10.1364/AO.33.001735
NR 7
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1094-687X
BN 0-7803-7612-9
J9 P ANN INT IEEE EMBS
PY 2002
BP 2277
EP 2278
DI 10.1109/IEMBS.2002.1053280
PG 2
WC Computer Science, Artificial Intelligence; Engineering, Biomedical;
   Instruments & Instrumentation; Radiology, Nuclear Medicine & Medical
   Imaging
SC Computer Science; Engineering; Instruments & Instrumentation; Radiology,
   Nuclear Medicine & Medical Imaging
GA BV84T
UT WOS:000180194801116
DA 2018-10-20
ER

PT S
AU Yi, YB
   Wang, H
   Sastry, AM
   Lamberson, L
AF Yi, YB
   Wang, H
   Sastry, AM
   Lamberson, L
BE McGowan, AMR
TI Network formation and percolation: biomaterial-inspired probabilistic
   modeling
SO SMART STRUCTURES AND MATERIALS 2002: INDUSTRIAL AND COMMERCIAL
   APPLICATIONS OF SMART STRUCTURES TECHNOLOGIES
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Smart Structures and Materials 2002 Conference
CY MAR 18-21, 2002
CL SAN DIEGO, CA
SP SPIE, Amer Soc Mech Engineers, Soc Exptl Mech, Boeing Co, Rhombus Consultants Grp, CSA Engn, ISIS Canada, USAF Off Sci Res, Def Adv Res Projects Agcy, Intelligent Mat Forum, USA Res OFf, Jet Propuls Lab, Natl Sci Fdn, Ceram Soc Japan, USN Off Naval Res, Nav Res Lab
DE percolation; network; fiber; ellipse; conduction; optimization; sea
   urchin; battery
ID EGG EXTRACELLULAR LAYERS; SHEAR-STRESS
AB The extracellular layers ("jelly coat,,) of the sea urchin egg are used as a model system for understanding the role of stochastically-placed fibers in providing reinforcement. We present preliminary results of deformation of the egg, and at a smaller scale, some results on percolation modeling of fibrous materials to determine percolation points in closed-form. We suggest some general methodologies for analysis of extracellular matrices based on this work, with implications for design in engineered structures.
C1 Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA.
RP Yi, YB (reprint author), 2250 GG Brown Bldg,2350 Hayward St, Ann Arbor, MI 48109 USA.
CR BONNELL BS, 1994, DEV BIOL, V162, P313, DOI 10.1006/dbio.1994.1088
   CONIGLIO A, 1977, J PHYS A-MATH GEN, V10, P219, DOI 10.1088/0305-4470/10/2/011
   CONIGLIO A, 1977, J PHYS A-MATH GEN, V10, P1123, DOI 10.1088/0305-4470/10/7/011
   Drory A, 1997, PHYS REV E, V55, P3878, DOI 10.1103/PhysRevE.55.3878
   Gartner L. P., 1997, COLOR TXB HISTOLOGY
   MEAD KS, 1995, BIOL BULL-US, V188, P46, DOI 10.2307/1542066
   PIKE GE, 1974, PHYS REV B, V10, P1421, DOI 10.1103/PhysRevB.10.1421
   SYKES MF, 1963, PHYS REV LETT, V10, P3, DOI 10.1103/PhysRevLett.10.3
   Thomas FIM, 1999, BIOL BULL, V197, P7, DOI 10.2307/1542991
   Thomas FIM, 2001, J EXP BIOL, V204, P815
   Thomas FIM, 1999, J EXP BIOL, V202, P3111
NR 11
TC 0
Z9 0
U1 0
U2 0
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-4446-4
J9 P SOC PHOTO-OPT INS
PY 2002
VL 4698
BP 212
EP 219
DI 10.1117/12.475067
PG 8
WC Engineering, Aerospace; Engineering, Electrical & Electronic;
   Instruments & Instrumentation; Materials Science, Composites
SC Engineering; Instruments & Instrumentation; Materials Science
GA BV06K
UT WOS:000177732700021
DA 2018-10-20
ER

PT B
AU Gupta, N
   Mallik, H
   Sarkar, A
AF Gupta, N
   Mallik, H
   Sarkar, A
BE Chowdari, BVR
   Prabaharan, SRS
   Yahaya, M
   Talib, IA
TI An experimental syudy of electrical character of proteins
SO SOLID STATE IONICS: TRENDS IN THE NEW MILLENNIUM, PROCEEDINGS
LA English
DT Proceedings Paper
CT 8th Asian Conference on Solid State Ionics
CY DEC 15-19, 2002
CL LANGKAWI, MALAYSIA
SP Asian Soc Solid State Ion
AB Various experimental studies on biomaterials are carried so far. The electrical and thermodynamic studies show that many biomaterial or biopolymers in solid state like a class of plant gum, animal glue, membranes, natural silk, bird feathers etc are solid ionic conductors. Their total electrical conductivity are comparable to that of synthetic polymers doped with inorganic salts. This present work is carried over various protenous biomaterials namely natural silk, animal gum, membranes, bird feathers and powdered enzyme and bacteria. The results of electrical measurements thus obtained exhibit special characteristics in its electrical conductivity sigma(omega) namely some anomalous behavior in their frequency dispersion. Each of the mentioned element exhibit a common discontinuity of sigma(omega), which have been identified as characteristics of conduction through structural protein. A possible theoretical explanation of the observed phenomenon has also been attempted here.
C1 BK Girls Coll, Dept Phys, Howrah 711101, India.
RP Sarkar, A (reprint author), BK Girls Coll, Dept Phys, Howrah 711101, India.
EM alokesarkar@vsnl.net
CR COLOMBAN P, 1992, PROTON CONDUCTORS, P389
   FANCKHON E, 2000, STRUCTURE DYNAMICS B, pCH1
   HODGE IM, 1977, J CHEM PHYS, V67, P1647, DOI 10.1063/1.434997
   Ichiye T, 1999, AIP CONF PROC, V492, P431, DOI 10.1063/1.1301541
   Jonscher A.K., 1983, DIELECTRICS RELAXATI
   KRISHNASWAMY S, 1996, SERICULTURE MANUAL, V3
   LOFTLER G, 1997, J MOL BIOL, V270, P520
   PENNINGTON SR, 2001, PROTEOMICS, pCH3
   POHORILLE A, 1999, SIMULATION THEORY EL, P49492
   SMITH PE, 1993, J PHYS CHEM-US, V97, P2009, DOI 10.1021/j100111a046
   WAGNER JB, 1957, J CHEM PHYS, V26, P1597, DOI 10.1063/1.1743590
   Zhang LY, 1999, AIP CONF PROC, V492, P451, DOI 10.1063/1.1301542
   1998, BIO ELECT HDB MOSFET, P101
NR 13
TC 1
Z9 1
U1 1
U2 1
PU WORLD SCIENTIFIC PUBL CO PTE LTD
PI SINGAPORE
PA PO BOX 128 FARRER RD, SINGAPORE 9128, SINGAPORE
BN 981-238-248-8
PY 2002
BP 823
EP 829
DI 10.1142/9789812776259_0098
PG 7
WC Electrochemistry; Materials Science, Multidisciplinary; Physics,
   Condensed Matter
SC Electrochemistry; Materials Science; Physics
GA BX43Z
UT WOS:000185284700098
DA 2018-10-20
ER

PT J
AU Pudney, PDA
   Hancewicz, TM
   Cunningham, DG
AF Pudney, PDA
   Hancewicz, TM
   Cunningham, DG
TI The use of confocal Raman spectroscopy to characterise the
   microstructure of complex biomaterials: foods
SO SPECTROSCOPY-AN INTERNATIONAL JOURNAL
LA English
DT Article; Proceedings Paper
CT 1st International Conference on Biomedical Spectroscopy
CY JUL 07-10, 2002
CL CARDIFF, WALES
ID DEPTH RESOLUTION; MICROSCOPY
AB The properties and behaviour of many biomaterials often depends crucially on their microstructure. This is especially true of the largest class of biomaterials in use, foods. They include general properties, e.g., food texture, and others, such as spreadability of margarine/butter, pourablity of ketchup, scoopablity of ice cream, and also flavour release (a problem that has much in common with drug delivery), to name but a few. Thus, most food laboratories do a large amount of work in rheology and microscopy to relate structure and properties. However, a knowledge gap exists, i.e., what is the location and quantity of ingredients/molecules within a structure? Both of these questions need to be answered if a complete understanding is to be obtained. The "what is where" question can sometimes be answered by using various microscopic labelling techniques, although there can be many problems with these methods. Bulk separation is often attempted, followed by some kind of more classical analysis, but this is often either not possible or may cause some kind of uncontrolled perturbation. Thus, the ability to obtain quantitative information in situ within a microstructure has been an unobtained goal in much of food science research. These types of questions are, of course, also asked in many related fields of research.
   This paper will illustrate how the advances in confocal Raman spectroscopy have allowed this problem to be tackled, in a non-invasive way. It will show how careful development of experimental procedures and advances in data analysis methods, allow even quantitative maps of microstructures to be obtained. The details of this approach will be described including a discussion of the limitations of current methods, especially depth resolution, and how these were overcome. The use of these methods will be illustrated with a gelled mixture of two carbohydrate polymers, kappa-carageenan and gellan. Despite being similar polymers, and hence having highly overlapping spectra, the pure spectral components can be separated using a chemometrics based method, multivariate curve resolution (MCR). The principles of this method will be described. Under certain concentration regimes these two biopolymers phase separate. This property can be used to produce different microstructures. Two different microstructures were produced and mapped using Raman spectroscopy. This data was analysed using the MCR method to show the relative locations of the two polymers within the microstructure. Furthermore, by augmenting the data from these maps with calibration data for the two bioploymers, quantitative maps were produced. The resultant concentrations can then be used to produce tie lines for the kappa-carageenan/gellan phase diagram, which is essential for understanding and manipulating the structure and properties in a systematic way. This methodology can be readily extended to much more complex multicomponent systems, such as complete food products.
   This paper shows that the combination of the confocal Raman spectroscopy and MCR data analysis methodology is very powerful and is readily applicable in many areas of research, especially the biomaterial/biomedical fields.
C1 Unilever Bestfoods R&D, Colworth Lab, Sharnbrook MK44 1LQ, Beds, England.
   Unilever R&D US Edgewater Lab, Edgewater, NJ USA.
CR Andrew JJ, 1998, APPL SPECTROSC, V52, P797, DOI 10.1366/0003702981944526
   Baldwin KJ, 2001, APPL SPECTROSC, V55, P517, DOI 10.1366/0003702011952190
   Durrani CM, 1995, CARBOHYD POLYM, V28, P297, DOI 10.1016/0144-8617(95)00107-7
   Everall NJ, 2000, APPL SPECTROSC, V54, P1515, DOI 10.1366/0003702001948439
   Everall NJ, 2000, APPL SPECTROSC, V54, P773, DOI 10.1366/0003702001950382
   HANCEWICZ TM, UNPUB
   Malinowski E. R., 1987, J CHEMOMETR, V1, P33
   MALINOWSKI ER, 1977, ANAL CHEM, V49, P612, DOI 10.1021/ac50012a027
   MALINOWSKI ER, 1977, ACS S SER, V52, pCH3
   Normand V, 2000, J APPL POLYM SCI, V77, P1465, DOI 10.1002/1097-4628(20000815)77:7<1465::AID-APP8>3.0.CO;2-F
   Otto C, 1997, J RAMAN SPECTROSC, V28, P143
   PUDNEY PDA, UNPUB FOOD HYDROCOLL
   PUDNEY PDA, 2000, P 17 C RAM SPECTR
   WILLIAMS KPJ, 1995, J RAMAN SPECTROSC, V26, P427, DOI 10.1002/jrs.1250260606
NR 14
TC 22
Z9 22
U1 0
U2 11
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0712-4813
J9 SPECTROSC-INT J
JI Spectr.-Int. J.
PY 2002
VL 16
IS 3-4
SI SI
BP 217
EP 225
DI 10.1155/2002/726874
PG 9
WC Biochemical Research Methods; Spectroscopy
SC Biochemistry & Molecular Biology; Spectroscopy
GA 618WA
UT WOS:000179439200014
OA Other Gold, Bronze
DA 2018-10-20
ER

PT J
AU Mansur, H
   Orefice, R
   Pereira, M
   Lobato, Z
   Vasconcelos, W
   Machado, L
AF Mansur, H
   Orefice, R
   Pereira, M
   Lobato, Z
   Vasconcelos, W
   Machado, L
TI FTIR and UV-vis study of chemically engineered biomaterial surfaces for
   protein immobilization
SO SPECTROSCOPY-AN INTERNATIONAL JOURNAL
LA English
DT Article; Proceedings Paper
CT 1st International Conference on Biomedical Spectroscopy
CY JUL 07-10, 2002
CL CARDIFF, WALES
ID BOVINE SERUM-ALBUMIN; PORCINE INSULIN; GEL; ENCAPSULATION; ADSORPTION;
   SILICATE; NETWORKS; GLASS
AB The biomaterials research field has broadened in the last 3 decades, including replacement of diseased or damaged parts, assist in healing, correct and improve functional abnormality, drug delivery systems, immunological kits and biosensors. Proteins play crucial role in almost every biological system. They are involved in enzymatic catalysis, transport and storage, coordinated motion, mechanical support, immune protection, control of growth and cell differentiation among many others. The immobilization of proteins onto surface functionalized substrates has been one of the most promising areas in bioengineering field. It is important to note that the term immobilization can refer either to a temporary or to a permanent localization of the biomolecule on or within a support. Proteins have very particular chain configurations and conformations that promote high levels of specificity during chemical interactions. In the present work, we aimed to study the phenomenon of protein immobilization onto biomaterial with chemically engineered surface. We have tailored the surface of the porous gels of SiO2 with 5 different silane surface modifying agents: tetraethoxysilane (TEOS), 3-mercaptopropyltrimethoxysilane (MPTMS) and 3-aminopropyltriethoxysilane (APTES), 3-glycidoxypropyltrimethoxysilane (GPTMS) and 3-isocyanatopropyltriethoxysilane (ICPES). Fourier Transform Infrared Spectroscopy (FTIR) was used to characterize the presence of all specific chemical groups in the materials. The surface functionalized gels were then immersed in porcine insulin (PI) solutions for protein immobilization. The incorporation of protein within the gels was also monitored by FTIR spectroscopy. The kinetics of protein adsorption and desorption from the gel matrix in vitro tests were monitored by UV-visible spectroscopy. We could not observe any evidence of denaturation of insulin after its desorption from gel matrices using UV-visible spectroscopy technique. In vivo tests with adult male rats were used to verify the immobilized insulin bioactivity after implantation of different biomaterial with functionalized surfaces. Plasma glucose levels were obtained by using the Glucose GOD-ANA Colorimetric Assay. All surface modified materials have presented acute hypoglycemic peak response associated with the insulin bioactivity.
C1 Univ Fed Minas Gerais, Dept Met & Mat Engn, Belo Horizonte, MG, Brazil.
   Univ Fed Minas Gerais, Dept Vet Med, Belo Horizonte, MG, Brazil.
   Univ Fed Minas Gerais, Sch Med, Dept Internal Med, Belo Horizonte, MG, Brazil.
RI Orefice, Rodrigo/N-8055-2018
OI Orefice, Rodrigo/0000-0002-6046-4056; Mansur,
   Herman/0000-0002-3032-495X; Lobato, Zelia/0000-0002-9399-3691
CR Chittur KK, 1998, BIOMATERIALS, V19, P357, DOI 10.1016/S0142-9612(97)00223-8
   Copeland R. A., 1994, METHODS PROTEIN ANAL
   DAVE BC, 1994, ANAL CHEM, V66, pA1120, DOI 10.1021/ac00094a001
   ELLERBY LM, 1992, SCIENCE, V255, P1113, DOI 10.1126/science.1312257
   Gill I, 1998, J AM CHEM SOC, V120, P8587, DOI 10.1021/ja9814568
   HENCH LL, 1990, CHEM REV, V90, P33, DOI 10.1021/cr00099a003
   Hlady V, 1996, CURR OPIN BIOTECH, V7, P72, DOI 10.1016/S0958-1669(96)80098-X
   LIVAGE J, 1994, P SOC PHOTO-OPT INS, V2288, P493, DOI 10.1117/12.188984
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   LU CF, 1994, J COLLOID INTERF SCI, V168, P152, DOI 10.1006/jcis.1994.1404
   MALMSTEN M, 1998, BIOPOLYMERS INTERFAC, P143
   Mansur HS, 2001, ADSORPTION, V7, P105, DOI 10.1023/A:1011687706161
   Mansur HS, 2000, BIOMACROMOLECULES, V1, P789, DOI 10.1021/bm0056198
   McDonagh C, 1998, ANAL CHEM, V70, P45, DOI 10.1021/ac970461b
   Ratner B. D., 1996, BIOMATERIALS SCI INT
   YAMAGUCHI N, 1992, CAN J PHYSIOL PHARM, V70, P167, DOI 10.1139/y92-024
   ZUSMAN R, 1992, ANAL BIOCHEM, V201, P103, DOI 10.1016/0003-2697(92)90180-F
NR 17
TC 36
Z9 37
U1 1
U2 16
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0712-4813
J9 SPECTROSC-INT J
JI Spectr.-Int. J.
PY 2002
VL 16
IS 3-4
SI SI
BP 351
EP 360
DI 10.1155/2002/183053
PG 10
WC Biochemical Research Methods; Spectroscopy
SC Biochemistry & Molecular Biology; Spectroscopy
GA 618WA
UT WOS:000179439200029
OA Bronze, Other Gold
DA 2018-10-20
ER

PT S
AU Xu, LY
   Hou, ZD
   Qin, YW
AF Xu, LY
   Hou, ZD
   Qin, YW
BE Wu, X
   Qin, YW
   Fang, J
   Ke, JT
TI The measurement of the Young's modulus of thin or flexible specimen with
   digital image correlation method
SO THIRD INTERNATIONAL CONFERENCE ON EXPERIMENTAL MECHANICS
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT 3rd International Conference on Experimental Mechanics
CY OCT 15-17, 2001
CL BEIJING, PEOPLES R CHINA
SP Chinese Soc Theoret & Appl Mech, Soc Exptl Mech, Japan Soc Mech Engineers, Mat & Mech Div, British Soc Strain Measurement, SPIE, Int Measurement Confederat, Chinese Soc Theoret & Appl Mech, Comm Exptl Stress Anal
DE dgital image; correlation; Young's modulus; flexible materials;
   bi-image; thin film; composite material
ID FILMS
AB Because some composite material, thin film material, and biomaterial, are very thin and some of them are flexible, the classical methods for measuring their Young's moduli, by mounting extensometers on specimens, are not available. A bi-image (two vision field) method based on image correlation for measuring Young's moduli is developed in this paper. The measuring precision achieved is one order enhanced with general digital image (single vision field) correlation or called single image method. By this way, the Young's modulus of a SS301 stainless steel thin tape, with thickness 0.067mm,is measured, and the moduli of polyester fiber films, a kind of flexible sheet with thickness 0.25mm, are also measured.
C1 Tianjin Univ, Dept Mech, Tianjin 300072, Peoples R China.
RP Xu, LY (reprint author), Tianjin Univ, Dept Mech, Tianjin 300072, Peoples R China.
CR HOU ZD, 2000, P SOC PHOTO-OPT INS, V4317, P32
   Huber N, 2000, INT J SOLIDS STRUCT, V37, P6499, DOI 10.1016/S0020-7683(99)00270-X
   Jin G C, 1997, COMPUTER AIDED OPTIC, P143
   Schneider D, 2000, SURF COAT TECH, V126, P136, DOI 10.1016/S0257-8972(99)00672-6
NR 4
TC 0
Z9 0
U1 0
U2 4
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-4261-5
J9 P SOC PHOTO-OPT INS
PY 2002
VL 4537
BP 406
EP 409
DI 10.1117/12.468877
PG 4
WC Instruments & Instrumentation; Mechanics; Materials Science,
   Characterization & Testing; Optics
SC Instruments & Instrumentation; Mechanics; Materials Science; Optics
GA BU73C
UT WOS:000176853900097
DA 2018-10-20
ER

PT J
AU Holmes, TC
AF Holmes, TC
TI Novel peptide-based biomaterial scaffolds for tissue engineering
SO TRENDS IN BIOTECHNOLOGY
LA English
DT Review
ID NONPOLAR AMINO-ACIDS; CELL ATTACHMENT; BONE; CARTILAGE; POLAR; VIVO
AB Biomaterial scaffolds are components of cell-laden artificial tissues and transplantable biosensors. Some of the most promising new synthetic biomaterial scaffolds are composed of self-assembling peptides that can be modified to contain biologically active motifs. Peptide-based biomaterials can be fabricated to form two- and three-dimensional structures. Recent studies show that biomaterial promotion of multi-dimensional cell-cell interactions and cell density are crucial for proper cellular differentiation and for subsequent tissue formation. Other refinements in tissue engineering include the use of stem cells, cell pre-selection and growth factor pre-treatment of cells that are used for seeding scaffolds. These cell-culture technologies, combined with improved processes for defining the dimensions of peptide-based scaffolds, might lead to further improvements in tissue engineering. Novel peptide-based biomaterial scaffolds seeded with cells show promise for tissue repair and for other medical applications.
C1 NYU, Dept Biol, New York, NY 10003 USA.
RP Holmes, TC (reprint author), NYU, Dept Biol, New York, NY 10003 USA.
CR Aggeli A, 1997, NATURE, V386, P259, DOI 10.1038/386259a0
   Atala A, 2000, J ENDOUROL, V14, P49, DOI 10.1089/end.2000.14.49
   BANKER G, 1991, CULTURING NERVE CELL, P41
   Broome BM, 2000, J MOL BIOL, V296, P961, DOI 10.1006/jmbi.2000.3514
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Dan N, 2000, TRENDS BIOTECHNOL, V18, P370, DOI 10.1016/S0167-7799(00)01482-7
   Ellis DL, 1996, BIOMATERIALS, V17, P291, DOI 10.1016/0142-9612(96)85567-0
   Fournier AE, 2001, CURR OPIN NEUROBIOL, V11, P89, DOI 10.1016/S0959-4388(00)00178-1
   Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   HYNES RO, 1992, CELL, V68, P303, DOI 10.1016/0092-8674(92)90472-O
   HYNES RO, 1999, TRENDS CELL BIOL, V9, P33
   Kale S, 2000, NAT BIOTECHNOL, V18, P954
   Lanza R. P., 1997, PRINCIPLES TISSUE EN
   Lashuel HA, 2000, J AM CHEM SOC, V122, P5262, DOI 10.1021/ja9937831
   Liszewski K, 2000, GENET ENG NEWS, V20, P1
   Mrksich M, 1996, P NATL ACAD SCI USA, V93, P10775, DOI 10.1073/pnas.93.20.10775
   Nitabach MN, 2001, P NATL ACAD SCI USA, V98, P705, DOI 10.1073/pnas.031446198
   Oberpenning F, 1999, NAT BIOTECHNOL, V17, P149
   Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449
   PRIETO AL, 1993, P NATL ACAD SCI USA, V90, P10154, DOI 10.1073/pnas.90.21.10154
   Schachner M, 2000, NATURE, V405, P747, DOI 10.1038/35015648
   Scott MR, 1999, P NATL ACAD SCI USA, V96, P15137, DOI 10.1073/pnas.96.26.15137
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   West MW, 1999, P NATL ACAD SCI USA, V96, P11211, DOI 10.1073/pnas.96.20.11211
   XIONG HY, 1995, P NATL ACAD SCI USA, V92, P6349, DOI 10.1073/pnas.92.14.6349
   Xu GF, 2001, P NATL ACAD SCI USA, V98, P3652, DOI 10.1073/pnas.071400098
   ZHANG SG, 1993, P NATL ACAD SCI USA, V90, P3334, DOI 10.1073/pnas.90.8.3334
   Zhang SG, 1999, BIOMATERIALS, V20, P1213, DOI 10.1016/S0142-9612(99)00014-9
   ZHANG SG, 1995, BIOMATERIALS, V16, P1385, DOI 10.1016/0142-9612(95)96874-Y
NR 30
TC 215
Z9 236
U1 1
U2 59
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0167-7799
J9 TRENDS BIOTECHNOL
JI Trends Biotechnol.
PD JAN
PY 2002
VL 20
IS 1
BP 16
EP 21
DI 10.1016/S0167-7799(01)01840-6
PG 6
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 505AU
UT WOS:000172889400009
PM 11742673
DA 2018-10-20
ER

PT J
AU Crigel, MH
   Balligand, M
AF Crigel, MH
   Balligand, M
TI Critical size defect model on the femur in rabbits
SO VETERINARY AND COMPARATIVE ORTHOPAEDICS AND TRAUMATOLOGY
LA English
DT Article
DE rabbit; bone; segmental; critical size defect
ID SEGMENTAL BONE DEFECTS; MORPHOGENETIC PROTEIN-2; INTRAMEDULLARY PIN;
   PLATE STRAIN; MARROW; NONUNION; REPAIR
AB The study purposed to elaborate a model of non-union to test a now biomaterial enhancing bone healing in large segmental defects. The authors' concern was to develop a model of osteosynthesis capable of maintaining the stability of a femur that sustained a segmental defect. Also, they intended to determine the length of a defect that would create a nonunion. The model was a 20-mm segmental bone defect coupled with an appropriate osteosynthesis in the rabbit femur. Two groups of rabbits underwent a mid-shaft ostectomy. Osteosynthesis was mode by two superposed 15 holes 2-mm cuttable plates with cordage wires. In one group, an additional intramedullary pin was inserted. The experiment lasted 16 weeks. The rabbits of the control group suffered fracture of the plates before the end of the experiment. The rabbits of the test group showed stability of the implants and nonunion of the defect. It was concluded that a mid-shaft segmental defect of 20 mm, coupled with an osteosynthesis combining plates, wires and intramedullary pin, is a valid critical size defect model in the rabbit femur.
C1 Univ Liege, Fac Vet, Dept Small Anim Clin Sci, B-4000 Liege, Belgium.
RP Crigel, MH (reprint author), Ecole Natl Vet, 7 Av Gen De Gaulle, F-94704 Maisons Alfort, France.
CR Baltzer AWA, 1999, KNEE SURG SPORT TR A, V7, P197, DOI 10.1007/s001670050147
   Beck LS, 1998, J PHARM SCI, V87, P1379, DOI 10.1021/js9800883
   Bruder SP, 1998, J BONE JOINT SURG AM, V80A, P985, DOI 10.2106/00004623-199807000-00007
   Bruder SP, 1998, CLIN ORTHOP RELAT R, V355, P247
   Chakkalakal DA, 1999, BONE, V25, P321, DOI 10.1016/S8756-3282(99)00167-2
   Concannon MJ, 1997, PLAST RECONSTR SURG, V99, P1983, DOI 10.1097/00006534-199706000-00025
   Cook SD, 1999, ORTHOPEDICS, V22, P669
   COOK SD, 1994, J BONE JOINT SURG AM, V76A, P827, DOI 10.2106/00004623-199406000-00006
   Cook SD, 1998, J ORTHOP TRAUMA, V12, P407, DOI 10.1097/00005131-199808000-00007
   Gugala Z, 1999, J ORTHOP TRAUMA, V13, P187, DOI 10.1097/00005131-199903000-00006
   Hietaniemi K, 1995, INJURY, V26, P681, DOI 10.1016/0020-1383(95)00135-2
   Hulse D, 2000, VET COMP ORTHOPAED, V13, P185
   Hulse D, 1997, VET SURG, V26, P451, DOI 10.1111/j.1532-950X.1997.tb00516.x
   Inui K, 1998, CALCIFIED TISSUE INT, V63, P490, DOI 10.1007/s002239900563
   Itoh T, 1998, J VET MED SCI, V60, P451, DOI 10.1292/jvms.60.451
   Johnson KD, 1996, J ORTHOP TRAUMA, V10, P28, DOI 10.1097/00005131-199601000-00005
   Kaderly RE, 1993, TXB SMALL ANIMAL SUR, P1676
   Kato T, 1998, J ORTHOP RES, V16, P654, DOI 10.1002/jor.1100160605
   Key JA, 1934, J BONE JOINT SURG, V16, P176
   KIKERHEAD CA, 1998, CLIN ORTHOP RELAT R, V349, P205
   KITSUGI T, 1989, J BONE JOINT SURG AM, V71A, P264, DOI 10.2106/00004623-198971020-00014
   Kraus KH, 1999, J INVEST SURG, V12, P115
   Lieberman JR, 1999, J BONE JOINT SURG AM, V81A, P905, DOI 10.2106/00004623-199907000-00002
   MATHEWS F, 1998, J CHILD YOUTH CARE, V11, P1
   Moxham JP, 1996, J OTOLARYNGOL, V25, P388
   NIYIBIZI C, 1998, CLIN ORTHOP RELAT R, V355, P148
   NUNAMAKER DM, 1998, CLIN ORTHOP S, V355, pS56
   OKADA Y, 1999, J BIOMED MATER RES, V48, P689
   PARDO AD, 1993, TXB SMALL ANIMAL SUR, P1634
   Rhinelander F.W., 1982, BONE CLIN ORTHOPAEDI, P81
   Sciadini MF, 1997, J ORTHOPAED RES, V15, P844, DOI 10.1002/jor.1100150609
   Sebecic B, 1999, BONE, V24, P195, DOI 10.1016/S8756-3282(98)00180-X
   TEIXEIRA JO, 1998, ARCH ORTHOP TRAUMA S, V117, P103
   TOOMBS JP, 1985, AM J VET RES, V46, P513
   TOOMBS JP, 1985, AM J VET RES, V46, P519
   VOLPON JB, 1997, ARCH TRAUMA SURG, V113, P312
   Wheeler DI, 1998, J BIOMED MATER RES, V43, P365, DOI 10.1002/(SICI)1097-4636(199824)43:4<365::AID-JBM4>3.0.CO;2-6
   Wippermann B, 1999, ANN CHIR GYNAECOL FE, V88, P194
   YUEHUEI H, 1999, P ORTH AN MOD DES EF, P28
   Zegzula HD, 1997, J BONE JOINT SURG AM, V79A, P1778, DOI 10.2106/00004623-199712000-00003
NR 40
TC 7
Z9 9
U1 1
U2 4
PU SCHATTAUER GMBH-VERLAG MEDIZIN NATURWISSENSCHAFTEN
PI STUTTGART
PA HOLDERLINSTRASSE 3, D-70174 STUTTGART, GERMANY
SN 0932-0814
J9 VET COMP ORTHOPAED
JI Vet. Comp. Orthop. Traumatol.
PY 2002
VL 15
IS 3
BP 158
EP 163
PG 6
WC Veterinary Sciences; Zoology
SC Veterinary Sciences; Zoology
GA 589VM
UT WOS:000177781600006
DA 2018-10-20
ER

PT J
AU Favia, P
   d'Agostino, R
AF Favia, P
   d'Agostino, R
TI Plasma processed surfaces for biomedical devices: PEO-like, Ag/PEO-like,
   -COOH functional and micro-patterned coatings
SO VIDE-SCIENCE TECHNIQUE ET APPLICATIONS
LA English
DT Article
DE plasma processes; biomaterials; non fouling; antibacterial coatings;
   micro-patterning
ID POLYMERIZATION; GROWTH; CELLS
AB Plasma deposition and treatment processes, of interest for different applications in the,field of biomaterial surfaces, are briefly reviewed in this paper. In particular details are given on processes developed in our laboratory, namely : the deposition of non fouling (PEO-like) and bacterial resistant (Ag/PEO-like) coatings. that of -COOH functional coatings. and combined processes utilized for obtaining micro-patterned polymer surfaces.
C1 Univ Bari, Dept Chem, Ctr Studio Chim Plasmi, CNR, I-70126 Bari, Italy.
RP Favia, P (reprint author), Univ Bari, Dept Chem, Ctr Studio Chim Plasmi, CNR, Via Orabona 4, I-70126 Bari, Italy.
CR BIEDERMAN H, 1990, PLASMA DEPOSITION TR
   Campbell C E, 1989, J Invest Surg, V2, P51, DOI 10.3109/08941938909016503
   CARTER SB, 1965, NATURE, V208, P1183, DOI 10.1038/2081183a0
   CHAWLA AS, 1975, ART ORG, V3, P92
   CHEHROUDI B, 1990, J BIOMED MATER RES, V24, P1203, DOI 10.1002/jbm.820240906
   CLARK P, 1990, DEVELOPMENT, V108, P635
   Curtis A, 2001, TRENDS BIOTECHNOL, V19, P97, DOI 10.1016/S0167-7799(00)01536-5
   DAGOSTINO R, 1991, PLASMA CHEM PLASMA P, V11, P1, DOI 10.1007/BF01447031
   DAI L, 1996, SURFACE MODIFICATION
   Daw R., 1999, PLASMAS POLYM, V4, P113
   DENBRABER ET, 1995, J BIOMED MATER RES, V29, P511, DOI 10.1002/jbm.820290411
   *EUR COMM, 2000, BRPRCT970415 EUR COM
   FAVIA P, 2001, IN PRESS SURF COAT T
   Favia P., 2000, PLASMAS POLYM, DOI [10.1023/A:1009517408368, DOI 10.1023/A:1009517408368]
   Favia P, 1996, PLASMAS POLYM, V1, P91, DOI DOI 10.1007/BF02532821
   FAVIA P, 1998, PLASMAS POLYM, V3, P77, DOI DOI 10.1023/B:PAPO.0000005940.30092.58
   GOMBOTZ WR, 1987, CRC CRITICAL REV BIO, V4
   GRIESSER HJ, 1994, J BIOMAT SCI-POLYM E, V5, P531, DOI 10.1163/156856294X00194
   HOLLAHAN JR, 1969, J APPL POLYM SCI, V13, P807, DOI 10.1002/app.1969.070130419
   Johnston E.E., 1997, NATO ASI SERIES E, V346
   Kratzmuller T, 1999, ADV MATER, V11, P555, DOI 10.1002/(SICI)1521-4095(199905)11:7<555::AID-ADMA555>3.0.CO;2-E
   LAROUGE S, 2001, IN PRESS PLASMAS POL
   LOPEZ GP, 1992, J BIOMED MATER RES, V26, P415, DOI 10.1002/jbm.820260402
   Muller M, 1999, SURF COAT TECH, V116, P802, DOI 10.1016/S0257-8972(99)00268-6
   Ohl A, 1999, J MATER SCI-MATER M, V10, P747, DOI 10.1023/A:1008943625715
   OHL K, 1999, SURF COAT TECH, V116, P820
   PALUMBO F, 1999, PLASMAS POLYM, V4, P133
   PALUMBO F, 2001, IN PRESS PLASMAS POL
   PRIME KL, 1993, J AM CHEM SOC, V115, P10714, DOI 10.1021/ja00076a032
   Ratner BD, 1990, PLASMA DEPOSITION TR
   RATNER BD, 1997, NATO ASI SERIES E, V346
   Smith L, 1975, ACS POLYM PREP, V16, P187
   WU YJ, 2001, IN PRESS PLASMAS POL
   Wu YLJ, 2000, COLLOID SURFACE B, V18, P235, DOI 10.1016/S0927-7765(99)00150-2
   Xia YN, 1999, CHEM REV, V99, P1823, DOI 10.1021/cr980002q
   YASUDA H, 1975, J BIOMED MATER RES, V9, P629, DOI 10.1002/jbm.820090609
   YASUDA H, 1974, PREMEABILITY PLASTIC
NR 37
TC 9
Z9 9
U1 1
U2 6
PU SOC FRANCAISE DU VID
PI PARIS
PA 19 RUE DU RENARD, 75004 PARIS, FRANCE
SN 1266-0167
J9 VIDE
JI Vide-Sci. Techn. Appl.
PY 2002
VL 57
IS 303
BP 40
EP 48
PG 9
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 535PF
UT WOS:000174652300005
DA 2018-10-20
ER

PT J
AU Elifantz, H
   Tel-Or, E
AF Elifantz, H
   Tel-Or, E
TI Heavy metal biosorption by plant biomass of the macrophyte Ludwigia
   stolonifera
SO WATER AIR AND SOIL POLLUTION
LA English
DT Article
DE biofilter; biosorption; cadmium; Ludwigia stolonifera; metal binding
   capacity; nickel; pectin
ID PECTIC SUBSTANCES; IONS; CADMIUM; WATER; BINDING
AB Ludwigia stolonifera biomass of roots, floating roots and leaves were tested for their performance as heavy metal biofilters. Cadmium (Cd) and nickel (Ni) (50 ppm) solutions were filtered through 0.5-1.5 g packed columns with each biomaterial, to determine their metal removal efficiency. Root column was more efficient in removing Ni (as low as 6 ppb in the effluent) than of Cd (as low as to 22 ppb in the effluent). This tendency was also observed upon treatment of a mixed solution of both metals. Floating roots column reduced Cd content to the same level as the root column, but its metal binding capacity was higher; 93 mg Cd g(-1) DW in floating roots in comparison to 43 mg Cd g(-1) DW in the roots biofilter. Leaf biomass column demonstrated the best metal binding capacity; 128 mg Cd g(-1) DW, and Cd concentration in the effluent was 17 ppb. Pectin content was 5, 8 and 10% W/W in roots, leaves and floating roots biofilters, respectively. It seems that ion exchange is the major mechanism by which the metal is biosorbed. Evidence for the exchange of the bound heavy metal ions against the discharge of light metal ions such as calcium (Ca), magnesium (Mg), potassium (K) and sodium (Na) was provided.
C1 Hebrew Univ Jerusalem, Fac Agr Food & Environm Qual Sci, Dept Agr Bot, IL-76100 Rehovot, Israel.
RP Elifantz, H (reprint author), Hebrew Univ Jerusalem, Fac Agr Food & Environm Qual Sci, Dept Agr Bot, IL-76100 Rehovot, Israel.
CR Bailey SE, 1999, WATER RES, V33, P2469, DOI 10.1016/S0043-1354(98)00475-8
   BENARIE R, 1979, J AM SOC HORTIC SCI, V104, P500
   BREWSTER MD, 1994, ENVIRON PROG, V13, P143
   Dronnet VM, 1996, CARBOHYD POLYM, V30, P253, DOI 10.1016/S0144-8617(96)00107-5
   ELLMORE GS, 1981, AM J BOT, V68, P227
   GARG P, 1997, ENVIRON MONIT ASSESS, V47, P163
   HOCH PC, 1993, SYST BOT, V18, P31, DOI 10.2307/2419786
   Kahkonen MA, 1998, CHEMOSPHERE, V36, P1381, DOI 10.1016/S0045-6535(97)10022-4
   Kamnev AA, 1998, FOOD HYDROCOLLOID, V12, P263, DOI 10.1016/S0268-005X(98)00014-9
   KE HYD, 1992, ENVIRON SCI TECHNOL, V26, P782, DOI 10.1021/es00028a018
   Kratochvil D, 1998, TRENDS BIOTECHNOL, V16, P291, DOI 10.1016/S0167-7799(98)01218-9
   Kurt G.E., 1996, ENVIRON SCI TECHNOL, V29, P2496
   Lee HS, 1997, WATER RES, V31, P3082, DOI 10.1016/S0043-1354(97)00022-5
   Maine MA, 2001, WATER RES, V35, P2629, DOI 10.1016/S0043-1354(00)00557-1
   MARCUS Y, 1969, ION EXCHANGE SOLVENT, P321
   RAI UN, 1995, ECOL ENG, V5, P5, DOI 10.1016/0925-8574(95)00011-7
   RAMELOW GJ, 1992, MICROBIOS, V72, P81
   REBHUN M, 1990, MANAGEMENT OF HAZARDOUS SUBSTANCES IN THE ENVIRONMENT, P85
   REJMANKOVA E, 1992, AQUAT BOT, V43, P283, DOI 10.1016/0304-3770(92)90073-R
   Schneider IAH, 1999, ENVIRON SCI TECHNOL, V33, P2213, DOI 10.1021/es981090z
   Spinti M, 1995, WATER ENVIRON RES, V67, P943, DOI 10.2175/106143095X133176
   THIBAULT JF, 1979, LEBENSM WISS TECHNOL, V12, P247
   Thompson ES, 1997, ARCH ENVIRON CON TOX, V32, P161, DOI 10.1007/s002449900169
   TOBIN JM, 1984, APPL ENVIRON MICROB, V47, P821
   Webster EA, 1997, BIOMETALS, V10, P105, DOI 10.1023/A:1018379106700
NR 25
TC 27
Z9 29
U1 0
U2 9
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0049-6979
J9 WATER AIR SOIL POLL
JI Water Air Soil Pollut.
PY 2002
VL 141
IS 1-4
BP 207
EP 218
DI 10.1023/A:1021343804220
PG 12
WC Environmental Sciences; Meteorology & Atmospheric Sciences; Water
   Resources
SC Environmental Sciences & Ecology; Meteorology & Atmospheric Sciences;
   Water Resources
GA 621YT
UT WOS:000179619300013
DA 2018-10-20
ER

PT J
AU Yourtee, DM
   Smith, RE
   Russo, KA
   Burmaster, S
   Cannon, JM
   Eick, JD
   Kostoryz, EL
AF Yourtee, DM
   Smith, RE
   Russo, KA
   Burmaster, S
   Cannon, JM
   Eick, JD
   Kostoryz, EL
TI The stability of methacrylate biomaterials when enzyme challenged:
   Kinetic and systematic evaluations
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE biomaterial hydrolysis; monomer leaching; esterases; dental resins;
   methacrylates; biocompatibility; biodurability
ID POLYMERS; DEGRADATION; COMPONENTS; INVITRO; RESINS
AB This study addressed whether methacrylate monomers and polymers used in dentistry might degrade from enzymolysis by acetylcholinesterase (ACHE), cholesterol esterase (CHE), porcine liver esterase (PRLE), and a pancreatic lipase (PNL). Short (hour) and long-term (day) exposures were performed. Product ratios were used to determine surface hydrolysis of the polymeric materials. Enzyme kinetics were studied for the monomers when challenged by ACHE, CHE, and PRLE. In the case of PRLE, the V-max for the dimethacrylate substrates varied slightly, but amounted to as much as 10% of that of p-nitrophenylacetate. The K-m for triethylene glycol dimethacrylate (TEGDMA) was 197 muM for ACHE and 1107 muM for CHE. The V-max was 2.7 nmol/min for ACHE and 3.5 nmol/min for CHE. TEGDMA was converted by CHE at 2% the rate of cholesteryl oleate. Long-term incubations of monomers with CHE and ACHE produced degrees of hydrolysis that evidenced structure dependency in the ability of the enzymes to effect hydrolysis. Particularly resistant were aromativ derivatives and those with branching in methacrylate linkages. Overall, the study confirms the ability of physiologically important esterases to catalyze the hydrolysis of biomaterial methacrylates. (C) 2001 John Wiley & Sons, Inc.
C1 Univ Missouri, Sch Pharm, Div Pharmacol, Toxicore Lab, Kansas City, MO 64108 USA.
   Aventis Pharma, Kansas City, MO 64134 USA.
   US FDA, Kansas City Dist Off, Off Regulatory Affairs, Lenexa, KS 66061 USA.
   Univ Missouri, Sch Dent, Div Oral Biol, Kansas City, MO 64108 USA.
RP Yourtee, DM (reprint author), Univ Missouri, Sch Pharm, Div Pharmacol, Toxicore Lab, Med Sch Bldg M5-C04,2411 Holmes St, Kansas City, MO 64108 USA.
FU NIDCR NIH HHS [P01-DE09696]
CR BEAN TA, 1994, J BIOMED MATER RES, V28, P59, DOI 10.1002/jbm.820280108
   DIXON M, 1979, ENZYMES, P251
   FERRACANE JL, 1985, J DENT RES, V64, P1332, DOI 10.1177/00220345850640111701
   FERRACANE JL, 1984, J DENT RES, V63, P1093, DOI 10.1177/00220345840630081901
   FREUND M, 1990, SCAND J DENT RES, V98, P351
   Gerzina TM, 1996, J DENT, V24, P125, DOI 10.1016/0300-5712(95)00036-4
   HALLSTROM U, 1993, J DENT CHILD, V60, P143
   HANKS CT, 1991, J DENT RES, V70, P1450, DOI 10.1177/00220345910700111201
   HEYMANN E, 1980, ENZYMATIC BASIS DETO, V2, P291
   HORSTED PB, 1986, SCAND J DENT RES, V94, P154
   Hume WR, 1996, CRIT REV ORAL BIOL M, V7, P172, DOI 10.1177/10454411960070020501
   MUNKSGAARD EC, 1990, SCAND J DENT RES, V98, P261
   ROULET JF, 1987, DEGRADATION DENT BAS, P193
   SIEBERT S, 1988, ENZYMATIC ATTACK MET
   SMITH R, 1987, J BIOMED MATER RES, V21, P991, DOI 10.1002/jbm.820210805
   Tong PY, 1996, J DENT RES, V75, P315
   VANGROENINGEN G, 1986, DENT MATER, V2, P225, DOI 10.1016/S0109-5641(86)80018-5
   VANKERCKHOVEN H, 1982, J DENT RES, V61, P791, DOI 10.1177/00220345820610062801
   Yourtee DM, 1997, IN VITRO TOXICOL, V10, P245
NR 19
TC 55
Z9 55
U1 1
U2 17
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD DEC 15
PY 2001
VL 57
IS 4
BP 522
EP 531
DI 10.1002/1097-4636(20011215)57:4<522::AID-JBM1198>3.0.CO;2-9
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 478YQ
UT WOS:000171376800006
PM 11553882
DA 2018-10-20
ER

PT J
AU Loebsack, A
   Greene, K
   Wyatt, S
   Culberson, C
   Austin, C
   Beiler, R
   Roland, W
   Eiselt, P
   Rowley, J
   Burg, K
   Mooney, D
   Holder, W
   Halberstadt, C
AF Loebsack, A
   Greene, K
   Wyatt, S
   Culberson, C
   Austin, C
   Beiler, R
   Roland, W
   Eiselt, P
   Rowley, J
   Burg, K
   Mooney, D
   Holder, W
   Halberstadt, C
TI In vivo characterization of a porous hydrogel material for use as a
   tissue bulking agent
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE soft-tissue engineering; hydrogel; RGD peptides; alginate; surgical
   implantation; animal model; rodent; confocal microscopy
ID ALGINATE HYDROGELS; GORE-TEX; IMPLANTS; AUGMENTATION; WRINKLES; ZYPLAST;
   SMOOTH; FACE
AB Tissue engineered biomaterial constructs are needed for plastic and reconstructive applications. To successfully form a space-filling tissue, the construct should induce a minimal inflammatory response, create minimal or no fibrotic capsule, and establish a vascular bed within the first few days after implantation to ensure survival of the implanted cells. In addition, the biomaterial should support cellular adhesion and induce tissue ingrowth. A macroporous hydrogel bead using sodium alginate covalently coupled with an arginine, glycine, and aspartic acid-containing peptide was created. A 6-month subcutaneous rat model study was performed to determine if the implanted material induced tissue ingrowth throughout the implantation area and maintained a three-dimensional vascular bed. The implanted materials produced a vascular bed, minimal inflammation and capsule formation, and good tissue ingrowth throughout the experiment. The material retained its bulking capacity by demonstration of no significant change of the cross-sectional area as measured from the center of the implants after the 2-week time point. In addition, the granulation tissue formed around the implant was loosely organized, and the surrounding tissue had integrated well with the implant. These results indicate that this material has the desired properties for the development of soft-tissue-engineering constructs. (C) 2001 John Wiley & Sons, Inc.
C1 Carolinas Med Ctr, Cannon Res Ctr, Dept Gen Surg, Charlotte, NC 28232 USA.
   Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA.
   Clemson Univ, Dept Bioengn, Clemson, SC USA.
RP Halberstadt, C (reprint author), Carolinas Med Ctr, Cannon Res Ctr, Dept Gen Surg, Cannon Res Bldg,POB 32861, Charlotte, NC 28232 USA.
CR Basse P, 1992, Acta Chir Plast, V34, P92
   Brown AN, 2000, TISSUE ENG, V6, P297, DOI 10.1089/107632700418029
   BURG KJL, 2000, P 6 WORLD BIOM C
   CISNEROS JL, 1993, J DERMATOL SURG ONC, V19, P539, DOI 10.1111/j.1524-4725.1993.tb00387.x
   DeVos P, 1997, BIOMATERIALS, V18, P273, DOI 10.1016/S0142-9612(96)00135-4
   Eiselt P, 2000, BIOMATERIALS, V21, P1921, DOI 10.1016/S0142-9612(00)00033-8
   EPPLEY BL, 1994, ANN PLAS SURG, V32, P463, DOI 10.1097/00000637-199405000-00004
   GREENE KG, 1999, P 3 N CAR TISS ENG G
   GREENE KG, 2000, P 6 WORLD BIOM C
   Lemperle G, 1998, AESTHET PLAST SURG, V22, P356, DOI 10.1007/s002669900217
   MATTI BA, 1990, AESTHET PLAST SURG, V14, P227, DOI 10.1007/BF01578354
   MOLE B, 1992, PLAST RECONSTR SURG, V90, P200, DOI 10.1097/00006534-199290020-00007
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Sayag J, 1996, J Wound Care, V5, P357
   STEGMAN SJ, 1987, ARCH DERMATOL, V123, P1644, DOI 10.1001/archderm.123.12.1644
   Wyatt LE, 1998, PLAST RECONSTR SURG, V102, P1922, DOI 10.1097/00006534-199811000-00017
NR 16
TC 54
Z9 56
U1 4
U2 19
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD DEC 15
PY 2001
VL 57
IS 4
BP 575
EP 581
DI 10.1002/1097-4636(20011215)57:4<575::AID-JBM1204>3.0.CO;2-9
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 478YQ
UT WOS:000171376800012
PM 11553888
DA 2018-10-20
ER

PT J
AU Lee, WF
   Chen, YJ
AF Lee, WF
   Chen, YJ
TI Graft copolymerization of N-isopropylacrylamide on
   styrene-butadiene-styrene block copolymer
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE styrene-butadiene-styrene; N-isopropylacrylamide; grafting
   copolymerization; thermosensitivity
ID SBS-G-VP; OXYGEN PERMEATION; POLY(ETHYLENE-TEREPHTHALATE) FIBERS;
   POLY(VINYL CHLORIDE); METHYL-METHACRYLATE; BENZOYL-PEROXIDE;
   ACRYLIC-ACID; POLYETHYLENE SURFACE; TRIBLOCK COPOLYMER; BIOMATERIAL
   USAGE
AB Graft polymerization of N-isopropylacrylamide (NIPA-Am) onto styrene-butadiene-styrene (SBS) block copolymer using benzoyl peroxide was studied to improve the water absorptivity and thermosensitivity of SBS. The influence of various grafting reaction factors on the conversion of NIPAAm and the grafting percentage of SBS-g-NIPAAm were also investigated in the study. The experimental results showed that the conversion of SBS-g-NIPAAm was enhanced as the monomers of NIPAAm were increased. The maximum conversion of SBS-g-NIPAAm was observed when the molar ratio of NIPAAm to butadiene was 1.25. In addition, increasing the reaction time enhanced the conversion of SBS-g-NIPAAm; the maximum grafting percentage was obtained with a 4-h reaction. The optimal concentration of the initiator was 3 X 10(-4) mol/20 mL of toluene, and the grafting reaction occurred at over 65 degreesC. The test results of the hydrophilicity of the grafted membranes showed that the hydrophilicity and thermosensitivity were significantly enhanced by grafting NIPAAm onto SBS. (C) 2001 John Wiley & Sons, Inc.
C1 Tatung Univ, Dept Chem Engn, Taipei 10451, Taiwan.
RP Lee, WF (reprint author), Tatung Univ, Dept Chem Engn, Taipei 10451, Taiwan.
CR COHN D, 1988, J MACROMOL SCI CHEM, VA25, P373, DOI 10.1080/00222338808053375
   DONG L C, 1986, Journal of Controlled Release, V4, P223, DOI 10.1016/0168-3659(86)90006-4
   FRELTAS RFS, 1987, SEPAR SCI TECHNOL, V22, P911
   FUJIMOTO K, 1993, J BIOMED MATER RES, V27, P1559, DOI 10.1002/jbm.820271213
   FUJIMOTO K, 1993, J POLYM SCI POL CHEM, V31, P1035, DOI 10.1002/pola.1993.080310426
   FUJIMOTO K, 1993, BIOMATERIALS, V14, P441
   HEIEH Y, 1984, J APPL POLYM SCI, V29, P2547
   Heskins M., 1968, J MACROMOL SCI CHEM, V2, P1441, DOI [10.1080/10601326808051910, DOI 10.1080/10601326808051910]
   HIROTSU S, 1987, J PHYS SOC JPN, V56, P233, DOI 10.1143/JPSJ.56.233
   HOIDEN G, 1969, J POLYM SCI C, V26, P37
   HSIUE GH, 1991, MAKROMOL CHEM, V192, P2687
   HSIUE GH, 1988, J BIOMED MATER RES, V22, P405, DOI 10.1002/jbm.820220504
   IKADA Y, 1994, BIOMATERIALS, V15, P725, DOI 10.1016/0142-9612(94)90025-6
   ISHIGAKI I, 1982, J APPL POLYM SCI, V27, P1033, DOI 10.1002/app.1982.070270322
   KOCHWA S, 1977, ANN NY ACAD SCI, V283, P37, DOI 10.1111/j.1749-6632.1977.tb41751.x
   KOSTOV GK, 1993, J APPL POLYM SCI, V47, P361, DOI 10.1002/app.1993.070470216
   KULIK EA, 1993, BIOMATERIALS, V14, P763, DOI 10.1016/0142-9612(93)90041-Y
   Lee HS, 1997, POLYMER, V38, P4505, DOI 10.1016/S0032-3861(96)01050-6
   LEE WF, 1995, J APPL POLYM SCI, V55, P1197, DOI 10.1002/app.1995.070550807
   Lee WF, 1999, J APPL POLYM SCI, V74, P1234
   LEE WF, 1994, J APPL POLYM SCI, V51, P2175, DOI 10.1002/app.1994.070511309
   MEMETEA T, 1979, POLYMER, V20, P465, DOI 10.1016/0032-3861(79)90072-7
   MINGHONG W, 1999, RADIAT PHYS CHEM, V56, P341
   MINGHONG W, 1996, RADIAT PHYS CHEM, V48, P525
   NEEDLES HL, 1978, J APPL POLYM SCI, V22, P3405, DOI 10.1002/app.1978.070221206
   OKADA T, 1992, J BIOMED MATER RES, V26, P2569
   ONEILL T, 1972, J POLYM SCI A1, V10, P569, DOI 10.1002/pol.1972.150100221
   PRADHAN AK, 1982, J APPL POLYM SCI, V27, P1873, DOI 10.1002/app.1982.070270602
   SACAK M, 1989, J APPL POLYM SCI, V38, P539, DOI 10.1002/app.1989.070380313
   SACAK M, 1992, J APPL POLYM SCI, V44, P1737, DOI 10.1002/app.1992.070441006
   SANLI O, 1993, J APPL POLYM SCI, V47, P1, DOI 10.1002/app.1993.070470101
   SAROOP UK, 1988, EUR POLYM J, V24, P689, DOI 10.1016/0014-3057(88)90035-3
   SCHAMBER.E, 1970, J POLYM SCI A1, V8, P693, DOI 10.1002/pol.1970.150080312
   SUZUKI M, 1986, MACROMOLECULES, V19, P1804, DOI 10.1021/ma00161a005
   TOMITA N, 1994, J APPL BIOMATER, V5, P175, DOI 10.1002/jab.770050211
   TSENG YC, 1992, J BIOMED MATER RES, V26, P373, DOI 10.1002/jbm.820260308
   TSUBOKAWA N, 1992, J POLYM SCI POL CHEM, V30, P2241, DOI 10.1002/pola.1992.080301020
   TSUBOKAWA N, 1993, J POLYM SCI POL CHEM, V31, P563, DOI 10.1002/pola.1993.080310229
   UCHIDA E, 1990, J APPL POLYM SCI, V41, P677, DOI 10.1002/app.1990.070410317
   UCHIDA E, 1993, J APPL POLYM SCI, V47, P417, DOI 10.1002/app.1993.070470305
   UYAMA Y, 1990, J APPL POLYM SCI, V39, P489, DOI 10.1002/app.1990.070390301
   WANG CC, 1993, J POLYM SCI POL CHEM, V31, P1307, DOI 10.1002/pola.1993.080310526
   YANG JM, 1990, ANGEW MAKROMOL CHEM, V179, P99, DOI 10.1002/apmc.1990.051790108
   Yang JM, 1996, J BIOMED MATER RES, V31, P281
   Yang JM, 1998, J MEMBRANE SCI, V138, P19
   Yang JM, 1997, J BIOMED MATER RES, V35, P175, DOI 10.1002/(SICI)1097-4636(199705)35:2<175::AID-JBM5>3.0.CO;2-K
   Yang JM, 1997, J APPL POLYM SCI, V65, P109
   YANG JM, 1995, ANGEW MAKROMOL CHEM, V231, P1, DOI 10.1002/apmc.1995.052310101
   YANG JM, 1990, J APPL POLYM SCI, V39, P1475, DOI 10.1002/app.1990.070390706
   Yang JM, 1997, J MEMBRANE SCI, V128, P133, DOI 10.1016/S0376-7388(96)00312-2
   Yang JM, 1998, J BIOMED MATER RES, V39, P86, DOI 10.1002/(SICI)1097-4636(199801)39:1<86::AID-JBM11>3.0.CO;2-M
   Yang JM, 1999, J MEMBRANE SCI, V153, P175, DOI 10.1016/S0376-7388(98)00261-0
   YANG JM, 1990, J APPL POLYM SCI, V41, P1141, DOI 10.1002/app.1990.070410523
   Yasuda H., 1985, PLASMA POLYM
   Yuan GX, 1997, POLYMER, V38, P119, DOI 10.1016/S0032-3861(96)00491-0
NR 55
TC 9
Z9 10
U1 0
U2 8
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD DEC 9
PY 2001
VL 82
IS 11
BP 2641
EP 2650
DI 10.1002/app.2117
PG 10
WC Polymer Science
SC Polymer Science
GA 483CK
UT WOS:000171616000006
DA 2018-10-20
ER

PT J
AU Shen, MC
   Horbett, TA
AF Shen, MC
   Horbett, TA
TI The effects of surface chemistry and adsorbed proteins on
   monocyte/macrophage adhesion to chemically modified polystyrene surfaces
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE monocyte adhesion; protein adsorption; fibrinogen; polystyrene; surface
   analysis
ID HUMAN-MONOCYTES; MESSENGER-RNA; INFLAMMATORY RESPONSES; FIBRINOGEN
   ADSORPTION; CYTOKINE PRODUCTION; ADHERENCE; CELLS; MACROPHAGES;
   EXPRESSION; BIOMATERIALS
AB Monocytes and macrophages play critical roles in inflammatory responses to implanted biomaterials. Monocyte adhesion may lead to macrophage activation and the foreign body response. We report that surface chemistry, preadsorbed proteins, and adhesion time all play important roles during monocyte adhesion bi vitro. The surface chemistry of tissue culture polystyrene (TCPS), polystyrene, Primaria, and ultra low attachment (ULA) used for adhesion studies was characterized by electron spectroscopy for chemical analysis. Fibrinogen adsorption measured by I-125-labeled fibrinogen was the lowest on ULA, higher on TCPS, and the highest on polystyrene or Primaria. Monocyte adhesion on protein preadsorbed surfaces for 2 h or 1 day was measured with a lactate-dehydrogenase method. Monocyte adhesion decreased over time. The ability of preadsorbed proteins to modulate monocyte adhesion was surface dependent. Adhesion was the lowest on ULA, higher and similar on TCPS or polystyrene, and the highest on Primaria. Monocyte adhesion on plasma or fibrinogen adsorbed surfaces correlated positively and linearly to the amount of adsorbed fibrinogen. Preadsorbed fibronectin, immunoglobulin G, plasma, or serum also promoted adhesion compared with albumin preadsorbed or uncoated surfaces. Overall, biomaterial surface chemistry, the type and amount of adsorbed proteins, and adhesion time all affected monocyte adhesion in vitro. (C) 2001 John Wiley & Sons, Inc.
C1 Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.
   Univ Washington, Dept Chem Engn, Seattle, WA 98195 USA.
RP Horbett, TA (reprint author), Univ Washington, Dept Bioengn, Box 351750, Seattle, WA 98195 USA.
EM horbett@cheme.washington.edu
CR ALTIERI DC, 1986, J CLIN INVEST, V78, P968, DOI 10.1172/JCI112687
   ALTIERI DC, 1991, J IMMUNOL, V147, P1891
   ALTIERI DC, 1988, J BIOL CHEM, V263, P7007
   Anderson J.M., 1994, PROB GEN SURG, V11, P147
   ANDERSON JM, 1984, BIOMATERIALS, V5, P5, DOI 10.1016/0142-9612(84)90060-7
   BEHLING CA, 1986, J BIOMED MATER RES, V20, P653, DOI 10.1002/jbm.820200509
   BROWN DL, 1989, J CLIN INVEST, V84, P366, DOI 10.1172/JCI114166
   DAVIS GE, 1992, EXP CELL RES, V200, P242, DOI 10.1016/0014-4827(92)90170-D
   DEFIFE KM, 1995, J BIOMED MATER RES, V29, P431, DOI 10.1002/jbm.820290403
   EIERMAN DF, 1989, J IMMUNOL, V142, P1970
   FRIEDMAN A, 1987, IMMUNOLOGY, V61, P469
   Gordon S, 1988, J Cell Sci Suppl, V9, P1
   GRABBE J, 1994, J INVEST DERMATOL, V103, P504, DOI 10.1111/1523-1747.ep12395649
   HARADA A, 1994, J LEUKOCYTE BIOL, V56, P559
   HASKILL S, 1988, J IMMUNOL, V140, P1690
   HORBETT TA, 1993, CARDIOVASC PATHOL, V2, pS137
   HORBETT TA, 1981, J BIOMED MATER RES, V15, P673, DOI 10.1002/jbm.820150506
   HORSBURGH CR, 1987, J LEUKOCYTE BIOL, V41, P14
   Jenney CR, 2000, J BIOMED MATER RES, V49, P435
   Jenney CR, 1998, J BIOMED MATER RES, V41, P171, DOI 10.1002/(SICI)1097-4636(199808)41:2<171::AID-JBM1>3.0.CO;2-F
   Jenney CR, 2000, J BIOMED MATER RES, V50, P281, DOI 10.1002/(SICI)1097-4636(20000605)50:3<281::AID-JBM1>3.0.CO;2-5
   KRUSKAL BA, 1987, J CELL BIOL, V105, P2685, DOI 10.1083/jcb.105.6.2685
   Mattana J, 1997, KIDNEY INT, V52, P1478, DOI 10.1038/ki.1997.478
   MCNALLY AK, 1994, P NATL ACAD SCI USA, V91, P10119, DOI 10.1073/pnas.91.21.10119
   MELLMAN I, 1988, J CELL SCI, P45
   MONTESANO R, 1985, J CELL PHYSIOL, V122, P424, DOI 10.1002/jcp.1041220313
   NATHAN CF, 1987, J CLIN INVEST, V79, P319, DOI 10.1172/JCI112815
   PEREZ RL, 1995, J IMMUNOL, V154, P1879
   RABINOVITCH M, 1973, EXP CELL RES, V77, P323, DOI 10.1016/0014-4827(73)90584-3
   RATNER BD, 1993, J BIOMED MATER RES, V27, P837, DOI 10.1002/jbm.820270702
   SALTHOUSE TN, 1984, J BIOMED MATER RES, V18, P395, DOI 10.1002/jbm.820180407
   SCHMIDT JA, 1982, J IMMUNOL, V128, P2177
   SCHMIERER AS, 1998, THESIS U WASHINGTON
   SHAW RJ, 1990, J CELL BIOL, V111, P2139, DOI 10.1083/jcb.111.5.2139
   SHEN M, IN PRESS J BIOMED MA
   SHEN M, IN PRESS J BIOMATER
   SLACK SM, 1987, ANN NY ACAD SCI, V516, P223, DOI 10.1111/j.1749-6632.1987.tb33044.x
   SPORN SA, 1990, J IMMUNOL, V144, P4434
   TANG LP, 1993, J LAB CLIN MED, V122, P292
   TANG LP, 1993, J EXP MED, V178, P2147, DOI 10.1084/jem.178.6.2147
   THORENS B, 1987, CELL, V48, P671, DOI 10.1016/0092-8674(87)90245-5
   TOBIAS JW, 1987, BLOOD, V69, P1265
   TRIGLIA T, 1985, BLOOD, V65, P921
   Tsai WB, 1999, J BIOMED MATER RES, V44, P130, DOI 10.1002/(SICI)1097-4636(199902)44:2<130::AID-JBM2>3.0.CO;2-9
   UEDA T, 1994, P NATL ACAD SCI USA, V91, P10680, DOI 10.1073/pnas.91.22.10680
   WEBB DSA, 1990, SCIENCE, V249, P1295, DOI 10.1126/science.1697984
   WRIGHT SD, 1988, J CELL SCI, P99
   YUN JK, 1995, J BIOMED MATER RES, V29, P257, DOI 10.1002/jbm.820290217
   ZHAO Q, 1991, J BIOMED MATER RES, V25, P177, DOI 10.1002/jbm.820250205
   ZIATS NP, 1988, BIOMATERIALS, V9, P5, DOI 10.1016/0142-9612(88)90063-4
NR 50
TC 147
Z9 150
U1 2
U2 23
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD DEC 5
PY 2001
VL 57
IS 3
BP 336
EP 345
DI 10.1002/1097-4636(20011205)57:3<336::AID-JBM1176>3.0.CO;2-E
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 472AE
UT WOS:000170960200003
PM 11523028
DA 2018-10-20
ER

PT J
AU Ohgaki, M
   Kizuki, T
   Katsura, M
   Yamashita, K
AF Ohgaki, M
   Kizuki, T
   Katsura, M
   Yamashita, K
TI Manipulation of selective cell adhesion and growth by surface charges of
   electrically polarized hydroxyapatite
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE hydroxyapatite; surface charge; manipulation; cell adhesion;
   polarization; tissue engineering
ID CRYSTAL-GROWTH; BINDING; BIOMATERIALS; SUBUNIT
AB Adherence of cells to a surface, such as a biomaterial surface, can be significantly influenced by the surface charge on that material. The applicability of electrically charged hydroxyapatite ceramics to selective cell adhesion was examined, and we show that polarized hydroxyapatite has significant effects on cell growth and adhesion. The surface charge applied to polarized hydroxyapatite promotes (i) enhanced colon), formation of osteoblast-like cells, (ii) activation of gap junctions, and (iii) specific orienting of neuroblastoma cells. These findings will be of great utility and have significance in applications of tissue engineering, for example, in potential treatments for osteoporosis. (C) 2001 John Wiley & Sons, Inc.
C1 Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Tokyo 1010062, Japan.
   Chiba Inst Technol, Chiba 2750016, Japan.
RP Ohgaki, M (reprint author), Tokyo Med & Dent Univ, Inst Biomat & Bioengn, 2-3-10 Kanda Surugadai, Tokyo 1010062, Japan.
EM ohgaki.bcr@tmd.ac.jp
CR ABBOTT A, 1983, J GEN MICROBIOL, V129, P439
   Aizawa M, 1999, ELECTROCHEMISTRY, V67, P118
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   BASSETT CAL, 1974, SCIENCE, V184, P575
   BUSER D, 1991, J BIOMED MATER RES, V25, P889, DOI 10.1002/jbm.820250708
   Calvert P, 1997, NATURE, V386, P127, DOI 10.1038/386127a0
   DOILLON CJ, 1987, BIOMATERIALS, V8, P195, DOI 10.1016/0142-9612(87)90063-9
   DSOUZA SE, 1994, CELL, V79, P659, DOI 10.1016/0092-8674(94)90551-7
   EDWARDS JG, 1988, J CELL SCI, V89, P507
   Hamann CS, 1998, PROTEIN ENG, V11, P219, DOI 10.1093/protein/11.3.219
   HARKES G, 1991, BIOMATERIALS, V12, P853, DOI 10.1016/0142-9612(91)90074-K
   HOGT AH, 1985, J GEN MICROBIOL, V131, P2485
   LAVINE LS, 1972, SCIENCE, V175, P1118, DOI 10.1126/science.175.4026.1118
   OVERDUIN M, 1995, SCIENCE, V267, P386, DOI 10.1126/science.7824937
   PASQUALINI R, 1995, J CELL BIOL, V130, P1189, DOI 10.1083/jcb.130.5.1189
   PERSON BS, 1988, J DENT RES, V67, P515
   Ruoslahti E, 1996, EXP CELL RES, V227, P1, DOI 10.1006/excr.1996.0243
   SCHWARTZ Z, 1994, J CELL BIOCHEM, V56, P340, DOI 10.1002/jcb.240560310
   SHAPIRO L, 1995, NATURE, V374, P327, DOI 10.1038/374327a0
   SHIMABAYASHI S, 1981, CHEM PHARM BULL, V29, P3090
   WEIS WI, 1992, NATURE, V360, P127, DOI 10.1038/360127a0
   Yamashita K, 1996, CHEM MATER, V8, P2697, DOI 10.1021/cm9602858
   Zheng JQ, 2000, NATURE, V403, P89, DOI 10.1038/47501
   ZIATS NP, 1988, BIOMATERIALS, V9, P5, DOI 10.1016/0142-9612(88)90063-4
   Zreiqat H, 1999, J BIOMED MATER RES, V44, P389, DOI 10.1002/(SICI)1097-4636(19990315)44:4<389::AID-JBM4>3.0.CO;2-O
NR 25
TC 136
Z9 138
U1 0
U2 57
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD DEC 5
PY 2001
VL 57
IS 3
BP 366
EP 373
DI 10.1002/1097-4636(20011205)57:3<366::AID-JBM1179>3.0.CO;2-X
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 472AE
UT WOS:000170960200006
PM 11523031
DA 2018-10-20
ER

PT J
AU Kraft, CN
   Burian, B
   Perlick, L
   Wimmer, MA
   Wallny, T
   Schmitt, O
   Diedrich, O
AF Kraft, CN
   Burian, B
   Perlick, L
   Wimmer, MA
   Wallny, T
   Schmitt, O
   Diedrich, O
TI Impact of a nickel-reduced stainless steel implant on striated muscle
   microcirculation: A comparative in vivo study
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE nickel; stainless steel; osteosynthesis materials; microcirculation;
   biocompatibility
ID MICROVASCULAR RESPONSE; ORTHOPEDIC IMPLANTS; METAL-IONS; TOXICITY;
   TISSUE; MICROSCOPY; LEUKOCYTES; PRODUCTS; TITANIUM; ADHESION
AB The impairment of skeletal muscle microcirculation by a biomaterial may have profound consequences. With moderately good physical and corrosion characteristics, implant-quality stainless steel is particularly popular in orthopedic surgery. However, due to the presence of a considerable amount of nickel in the alloy, concern has been voiced in respect to local tissue responses. More recently a stainless steel alloy with a significant reduction of nickel has become commercially available. We, therefore, studied bi vivo nutritive perfusion and leukocytic response of striated muscle to this nickel-reduced alloy, and compared these results with those of the materials conventional stainless steel and titanium. Using the hamster dorsal skinfold chamber preparation and intravital microscopy, we could demonstrate that reduction of the nickel quantity in a stainless steel implant has a positive effect on local microvascular parameters. Although the implantation of a conventional stainless steel sample led to a distinct and persistent activation of leukocytes combined with disruption of the microvascular endothelial integrity, marked leukocyte extravasation, and considerable venular dilation, animals with a nickel-reduced stainless steel implant showed only a moderate increase of these parameters, with a clear tendency of recuperation. Titanium implants merely caused a transient increase of leukocyte-endothelial cell interaction within the first 120 min, and no significant change in macromolecular leakage, leukocyte extravasation, or venular diameter. Pending biomechanical and corrosion testing, nickel-reduced stainless steel may be a viable alternative to conventional implant-quality stainless steel for biomedical applications. Concerning tolerance by the local vascular system, titanium currently remains unsurpassed, (C) 2001 John Wiley & Sons, Inc.
C1 Univ Bonn, Dept Orthopaed Surg, D-53105 Bonn, Germany.
   Univ Regensburg, Dept Orthopaed Surg, D-93077 Bad Abbach, Germany.
   AO Res Inst, CH-7270 Davos, Switzerland.
RP Kraft, CN (reprint author), Univ Bonn, Dept Orthopaed Surg, D-53105 Bonn, Germany.
CR Abreu A. M., 1995, Biomedical Letters, V52, P133
   Arens S, 1996, J BONE JOINT SURG BR, V78B, P647
   BergerGorbet M, 1996, J BIOMED MATER RES, V32, P243, DOI 10.1002/(SICI)1097-4636(199610)32:2<243::AID-JBM14>3.0.CO;2-K
   BLACK J, 1988, J BONE JOINT SURG BR, V70, P517
   Brunner J, 2000, MICROCIRCULATION, V7, P103, DOI 10.1038/sj.mn.7300094
   Chen FS, 1999, J BIOMED MATER RES, V48, P904, DOI 10.1002/(SICI)1097-4636(1999)48:6<904::AID-JBM21>3.0.CO;2-5
   CIGADA A, 1994, COMPATIBILITY BIOMED, P185
   COTRAN RS, 1989, ROBBINS PATHOLOGIC B, P39
   DISEGI JA, 2000, P SOC BIOMATER, V6, P816
   Doran A, 1998, BIOMATERIALS, V19, P751, DOI 10.1016/S0142-9612(97)00209-3
   ENDRICH B, 1980, RES EXP MED, V177, P125, DOI 10.1007/BF01851841
   FANTONE JC, 1982, AM J PATHOL, V107, P397
   GALANTE JO, 1991, J ORTHOPAED RES, V9, P760, DOI 10.1002/jor.1100090516
   GRANGER DN, 1994, J LEUKOCYTE BIOL, V55, P662
   HENNIG FF, 1992, J TRACE ELEM ELECT H, V6, P239
   HIERHOLZER S, 1992, INTERNAL FIXATION ME
   Hosokawa Y, 1997, X-RAY SPECTROM, V26, P380
   Intergovernmental Oceanographic Commission, 1997, IARC HDB CANC PREV N, P1
   International Agency for Research on Cancer, 1995, IARC MON EV CARC RIS, P1
   JACOBS JJ, 1996, CLIN ORTHOP S, V329, P256
   Kraft CN, 2000, J BIOMED MATER RES, V49, P192, DOI 10.1002/(SICI)1097-4636(200002)49:2<192::AID-JBM6>3.0.CO;2-C
   LAING PATRICK G., 1967, J BIOMED MAT RES, V1, P135, DOI 10.1002/jbm.820010113
   McKay GC, 1996, BIOMATERIALS, V17, P1339, DOI 10.1016/0142-9612(96)88681-9
   MENGER MD, 1993, IMMUNOL TODAY, V14, P519, DOI 10.1016/0167-5699(93)90179-O
   Menger MD, 1996, BRIT J SURG, V83, P588, DOI 10.1002/bjs.1800830506
   MERRITT K, 1993, BRIS MYER Z, P147
   MERRITT K, 1993, TECHN ORTHOP, V8, P228
   MERRITT K, 1996, CLIN ORTHOP RELAT R, V329, P233
   NIEBOER E, 1980, NICKEL TOXICOLOGY, P359
   Pereira MC, 1998, J BIOMED MATER RES, V40, P40, DOI 10.1002/(SICI)1097-4636(199804)40:1<40::AID-JBM5>3.0.CO;2-R
   PRIES AR, 1988, INT J MICROCIRC, V7, P327
   Schaser KD, 1999, J ORTHOPAED RES, V17, P678, DOI 10.1002/jor.1100170509
   Shettlemore MG, 1999, J BIOMED MATER RES, V45, P395
   Sun ZL, 1997, J BIOMED MATER RES, V34, P29, DOI 10.1002/(SICI)1097-4636(199701)34:1<29::AID-JBM5>3.0.CO;2-P
   TAKAMURA K, 1994, J BIOMED MATER RES, V28, P583, DOI 10.1002/jbm.820280508
   Takeshita F, 1997, BIOMATERIALS, V18, P21, DOI 10.1016/S0142-9612(96)00051-8
   Uo M, 1999, BIOMATERIALS, V20, P747, DOI 10.1016/S0142-9612(98)00224-5
   VOLLMAR B, 1993, ZBL CHIR, V118, P691
   WATAHA JC, 1993, J BIOMED MATER RES, V27, P227, DOI 10.1002/jbm.820270212
   WILLIAMS D, 1990, ENCY MED DENT MAT
   WILLIAMS DF, 1981, SYSTEMIC ASPECTS BIO, V2
   WILLIAMS DF, 1981, SYSTEMIC ASPECTS BIO, V1
NR 42
TC 30
Z9 30
U1 0
U2 4
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD DEC 5
PY 2001
VL 57
IS 3
BP 404
EP 412
DI 10.1002/1097-4636(20011205)57:3<404::AID-JBM1183>3.0.CO;2-W
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 472AE
UT WOS:000170960200010
PM 11523035
DA 2018-10-20
ER

PT J
AU Kumar, N
   Ravikumar, MNV
   Domb, AJ
AF Kumar, N
   Ravikumar, MNV
   Domb, AJ
TI Biodegradable block copolymers
SO ADVANCED DRUG DELIVERY REVIEWS
LA English
DT Review
DE biodegradable; block copolymer; star-block copolymer; poly(esters);
   poly(ether-b-ester); poly(ether ester amide); surface modification;
   micelles; hydrogels; nanoparticles; microparticles; drug-targeting
ID ABA TRIBLOCK COPOLYMERS; POLYMERIC ANTICANCER DRUG; IN-VITRO
   DEGRADATION; POLY(ETHYLENE GLYCOL); POLY(L-LACTIC ACID); POLYETHYLENE
   OXIDE; L-LACTIDE; POLY(LACTIC-GLYCOLIC ACID); COMPRISING
   POLY(L-LACTIDE); THERMOREVERSIBLE GELATION
AB Recently, block copolymers have got tremendous impetus on the ongoing research in the area of drug delivery technology, due to their capability to provide a biomaterial having a broad range of amphiphilic characteristics, as well as targeting the drugs to specific site. This article is an attempt to review applications of block copolymers in surface modification, drug targeting, nano and microparticles, hydrogels, micelles etc. The physicochemical properties of block copolymers and various synthetic routes for block copolymers are also discussed. (C) 2001 Elsevier Science B.V. All rights reserved.
C1 Hebrew Univ Jerusalem, Dept Med Chem & Nat Prod, IL-91120 Jerusalem, Israel.
   Univ Kentucky, Med Ctr, Dept Prevent Med & Environm Hlth, Lexington, KY 40536 USA.
RP Domb, AJ (reprint author), Hebrew Univ Jerusalem, Dept Med Chem & Nat Prod, IL-91120 Jerusalem, Israel.
RI Xu, Qingguo/C-1962-2014; Kumar, M N V R/D-6286-2011
OI Xu, Qingguo/0000-0003-3191-0771; Kumar, M N V R/0000-0001-5606-401X
CR ABADIE MSM, 1980, INFORMATIONS CHIMIE, V208, P135
   AMIJI M, 1993, J BIOMAT SCI-POLYM E, V4, P217, DOI 10.1163/156856293X00537
   ANDRADE J D, 1992, Clinical Materials, V11, P67, DOI 10.1016/0267-6605(92)90031-N
   BADER H, 1984, ANGEW CHEM, V123
   BAZEMER JM, 2000, J CONTROL RELEASE, V64, P179
   BAZILE D, 1995, J PHARM SCI, V84, P493, DOI 10.1002/jps.2600840420
   BEDELLS AD, 1993, J CHEM SOC FARADAY T, V89, P1243, DOI 10.1039/ft9938901243
   BERGSTROM K, 1994, J BIOMAT SCI-POLYM E, V6, P123
   Bezemer JM, 2000, J BIOMED MATER RES, V52, P8, DOI 10.1002/1097-4636(200010)52:1<8::AID-JBM2>3.0.CO;2-3
   Black FE, 1999, LANGMUIR, V15, P3157, DOI 10.1021/la9803575
   Bouillot P, 1998, J APPL POLYM SCI, V68, P1695, DOI 10.1002/(SICI)1097-4628(19980606)68:10<1695::AID-APP19>3.0.CO;2-W
   Bronich TK, 1997, MACROMOLECULES, V30, P3519, DOI 10.1021/ma970197o
   Cammas S, 1997, J CONTROL RELEASE, V48, P157, DOI 10.1016/S0168-3659(97)00040-0
   Cammas S, 1996, NATO ADV SCI INST SE, V327, P83
   Cao XD, 1999, BIOMATERIALS, V20, P329, DOI 10.1016/S0142-9612(98)00172-0
   Cha Y., 1997, US Patent, Patent No. 5702717
   Cho CS, 2000, POLYMER, V41, P5185, DOI 10.1016/S0032-3861(99)00746-6
   Choi SW, 1999, J POLYM SCI POL CHEM, V37, P2207, DOI 10.1002/(SICI)1099-0518(19990701)37:13<2207::AID-POLA35>3.0.CO;2-0
   Choi YK, 1996, P INT S CONTR REL BI, V23, P349
   Choi YR, 1998, MACROMOLECULES, V31, P8766, DOI 10.1021/ma981069i
   Chung JE, 1999, J CONTROL RELEASE, V62, P115, DOI 10.1016/S0168-3659(99)00029-2
   COHEN D, 1988, J BIOMED METER RES, V22, P992
   Dee KC, 1998, J BIOMED MATER RES, V40, P371, DOI 10.1002/(SICI)1097-4636(19980605)40:3<371::AID-JBM5>3.3.CO;2-G
   DENG XM, 1990, J POLYM SCI POL LETT, V28, P411, DOI 10.1002/pol.1990.140281303
   DENG XM, 1995, J APPL POLYM SCI, V55, P1193, DOI 10.1002/app.1995.070550806
   DESIMONE V, 1992, J APPL POLYM SCI, V46, P1813, DOI 10.1002/app.1992.070461013
   Feast W.J, 1987, POLYM SURFACES INTER
   FERRUTI P, 1995, BIOMATERIALS, V16, P1423, DOI 10.1016/0142-9612(95)96879-5
   Gopferich A, 1999, J BIOMED MATER RES, V46, P390
   GREF R, 1994, SCIENCE, V263, P1600, DOI 10.1126/science.8128245
   Guerra GD, 2001, J MATER SCI-MATER M, V12, P313, DOI 10.1023/A:1011243003712
   HAGAN SA, 1995, LANGMUIR, V11, P1482, DOI 10.1021/la00005a013
   Harada A, 1999, SCIENCE, V283, P65, DOI 10.1126/science.283.5398.65
   Hiki S, 2000, POLYMER, V41, P7369, DOI 10.1016/S0032-3861(00)00086-0
   HOES C J T, 1985, Journal of Controlled Release, V2, P205, DOI 10.1016/0168-3659(85)90046-X
   HU DSG, 1993, J APPL POLYM SCI, V50, P1391, DOI 10.1002/app.1993.070500810
   Hubbell JA, 1996, J CONTROL RELEASE, V39, P305, DOI 10.1016/0168-3659(95)00162-X
   HVIDT S, 1994, J PHYS CHEM-US, V98, P12320, DOI 10.1021/j100098a030
   ILLUM L, 1984, FEBS LETT, V167, P79, DOI 10.1016/0014-5793(84)80836-4
   ILLUM L, 1987, LIFE SCI, V40, P367, DOI 10.1016/0024-3205(87)90138-X
   Izhar U, 2001, J SURG RES, V95, P152, DOI 10.1006/jsre.2000.6042
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P149, DOI 10.1016/0021-9797(91)90043-8
   Jeong B, 1999, MACROMOLECULES, V32, P7064, DOI 10.1021/ma9908999
   JURGENS CH, 1998, GHIM WALENKAMP BIOMA, P112
   Kabanov AV, 1996, MACROMOLECULES, V29, P6797, DOI 10.1021/ma960120k
   Kataoka K, 1998, MACROMOLECULES, V31, P6071, DOI 10.1021/ma971838i
   KATAOKA K, 1993, J CONTROL RELEASE, V24, P119
   Kataoka K, 2001, ADV DRUG DELIVER REV, V47, P113, DOI 10.1016/S0169-409X(00)00124-1
   KENNEDY JP, 1992, ACS SYM SER, V496, P258
   Kim DK, 1996, POLYM-KOREA, V20, P431
   KIMURA Y, 1989, POLYMER, V30, P1342, DOI 10.1016/0032-3861(89)90058-X
   Kissel T, 1996, J CONTROL RELEASE, V39, P315, DOI 10.1016/0168-3659(95)00163-8
   KITAYAMA T, 1991, POLYM BULL, V26, P513, DOI 10.1007/BF01032676
   Kreuter J., 1994, COLLOIDAL DRUG DELIV, P219
   KRICHELDORF HR, 1993, MAKROMOL CHEM, V194, P715
   KRICHELDORF HR, 1993, MAKROMOL CHEM-M SYMP, V73, P47, DOI 10.1002/masy.19930730107
   KWON G, 1993, LANGMUIR, V9, P945, DOI 10.1021/la00028a012
   Kwon GS, 1996, ADV DRUG DELIVER REV, V21, P107, DOI 10.1016/S0169-409X(96)00401-2
   KWON GS, 1995, ADV DRUG DELIVER REV, V16, P295, DOI 10.1016/0169-409X(95)00031-2
   KWON GS, 1993, PHARMACEUT RES, V10, P970, DOI 10.1023/A:1018998203127
   LAM KH, 1995, J APPL BIOMATER, V6, P191, DOI 10.1002/jab.770060308
   Lee CW, 1996, B CHEM SOC JPN, V69, P1787, DOI 10.1246/bcsj.69.1787
   Lee CW, 1996, SEN-I GAKKAISHI, V52, P405, DOI 10.2115/fiber.52.8_405
   LEE CW, 1995, KOBUNSHI RONBUNSHU, V52, P692, DOI 10.1295/koron.52.692
   LEE JH, 1995, PROG POLYM SCI, V20, P1043, DOI 10.1016/0079-6700(95)00011-4
   LEENSLAG JW, 1987, BIOMATERIALS, V8, P70, DOI 10.1016/0142-9612(87)90034-2
   Li H, 1997, MACROMOLECULES, V30, P1347, DOI 10.1021/ma961520a
   Li XH, 1999, INT J PHARM, V178, P245, DOI 10.1016/S0378-5173(98)00379-2
   Li XW, 1997, J APPL POLYM SCI, V66, P583, DOI 10.1002/(SICI)1097-4628(19971017)66:3<583::AID-APP20>3.0.CO;2-V
   Li YX, 1998, POLYMER, V39, P4421, DOI 10.1016/S0032-3861(97)10362-7
   LI YX, 1993, J CONTROL RELEASE, V27, P247
   LI YX, 1994, J CONTROL RELEASE, V32, P121
   LLANOS GR, 1993, J BIOMAT SCI-POLYM E, V4, P381
   Lucke A, 2000, BIOMATERIALS, V21, P2361, DOI 10.1016/S0142-9612(00)00103-4
   Lysenko EA, 1998, MACROMOLECULES, V31, P4511, DOI 10.1021/ma980366k
   Ma J, 2001, COLLOID POLYM SCI, V279, P387, DOI 10.1007/s003960000467
   Mader K, 1998, PHARMACEUT RES, V15, P787, DOI 10.1023/A:1011939607573
   MALSTOM M, 1992, MACROMOLECULES, V25, P5440
   Martinez MB, 1997, MACROMOLECULES, V30, P3197
   Moghimi S. Moein, 1993, Biochemical Society Transactions, V21, p128S
   MOGHIMI SM, 1988, FEBS LETT, V233, P143, DOI 10.1016/0014-5793(88)81372-3
   Morlock M, 1998, J CONTROL RELEASE, V56, P105, DOI 10.1016/S0168-3659(98)00070-4
   NATHAN A, 1994, J BIOACT COMPAT POL, V9, P239, DOI 10.1177/088391159400900301
   NICOLAS CV, 1993, POLYMER, V34, P138
   Nishiyama N, 1999, LANGMUIR, V15, P377, DOI 10.1021/la980572l
   OSTERBERG E, 1995, J BIOMED MATER RES, V29, P741, DOI 10.1002/jbm.820290610
   Otsuka H, 2001, CURR OPIN COLLOID IN, V6, P3, DOI 10.1016/S1359-0294(00)00082-0
   Otsuka H, 2000, BIOMACROMOLECULES, V1, P39, DOI 10.1021/bm990005s
   Park YH, 1999, POLYM-KOREA, V23, P163
   Park YH, 1998, POLYM-KOREA, V22, P559
   PATEL HM, 1992, CRIT REV THER DRUG, V9, P39
   Pechar M, 1997, MACROMOL CHEM PHYSIC, V198, P1009, DOI 10.1002/macp.1997.021980408
   Pechar M, 1995, COLLECT CZECH CHEM C, V60, P1765, DOI 10.1135/cccc19951765
   Pechar M, 2000, BIOCONJUGATE CHEM, V11, P131, DOI 10.1021/bc990092l
   Penco M, 1996, BIOMATERIALS, V17, P1583, DOI 10.1016/0142-9612(95)00323-1
   Peppas N. A., 1986, HYDROGELS MED PHARM, VI, P1
   PEPPAS NA, 1976, J POLYM SCI POL CHEM, V14, P441, DOI 10.1002/pol.1976.170140215
   PEPPAS NA, 1976, J APPL POLYM SCI, V20, P1457, DOI 10.1002/app.1976.070200604
   POZNANSKY MJ, 1984, PHARMACOL REV, V36, P277
   PRATTEN MK, 1985, MAKROMOL CHEM, V186, P725
   Quellec P, 1999, J BIOMED MATER RES, V47, P388, DOI 10.1002/(SICI)1097-4636(19991205)47:3<388::AID-JBM14>3.0.CO;2-V
   Ratner B. D., 1976, ACS SYM SER, V31, P1, DOI [DOI 10.1021/SYMPOSIUM, 10.1021/bk-1976-0031.ch001]
   RAVIKUMAR MNV, 2001, DRUG DEV IND PHARM, V27, P1
   Richards R. W., 1993, POLYM SURFACES INTER
   SATO N, 2001, NAT BIOTECHNOL, V19, P332
   SCHILD HG, 1992, PROG POLYM SCI, V17, P163, DOI 10.1016/0079-6700(92)90023-R
   Scholes P. D., 1997, CONTROLLED DRUG DELI, P73
   Serres A, 1996, PHARMACEUT RES, V13, P196, DOI 10.1023/A:1016026711364
   Shi FY, 1996, MACROMOLECULES, V29, P10, DOI 10.1021/ma950707j
   Shi FY, 1996, MACROMOLECULES, V29, P7753, DOI 10.1021/ma960805k
   SHIELDS R, 1968, GASTROENTEROLOGY, V54, P331
   STOLNIK S, 1995, ADV DRUG DELIVER REV, V16, P195, DOI 10.1016/0169-409X(95)00025-3
   STOLNIK S, 1994, PHARMACEUT RES, V11, P1800, DOI 10.1023/A:1018931820564
   TOMLINSON E, 1986, SITE SPECIFIC DRUG D, pCH6
   Trollsas M, 1998, MACROMOLECULES, V31, P3439, DOI 10.1021/ma980241f
   Trollsas M, 1997, MACROMOLECULES, V30, P8508, DOI 10.1021/ma970798f
   Trollsas M, 1998, J AM CHEM SOC, V120, P4644, DOI 10.1021/ja973678w
   Trollsas M, 1999, MACROMOLECULES, V32, P4917, DOI 10.1021/ma990054x
   TSUKADA Y, 1984, JNCI-J NATL CANCER I, V73, P721
   UCHIDA T, 1995, CHEM PHARM BULL, V43, P1569
   Uhrich KE, 1999, CHEM REV, V99, P3181, DOI 10.1021/cr940351u
   Vakkalanka SK, 1996, J BIOMAT SCI-POLYM E, V8, P119, DOI 10.1163/156856296X00192
   XIONG CD, 1995, J APPL POLYM SCI, V55, P865, DOI 10.1002/app.1995.070550604
   Yamaoka T, 1999, J POLYM SCI POL CHEM, V37, P1513, DOI 10.1002/(SICI)1099-0518(19990515)37:10<1513::AID-POLA13>3.0.CO;2-9
   Yasugi K, 1999, J CONTROL RELEASE, V62, P89, DOI 10.1016/S0168-3659(99)00028-0
   YOKOYAMA M, 1992, CRIT REV THER DRUG, V9, P213
   YOKOYAMA M, 1987, MAKROMOL CHEM-RAPID, V8, P431
   YOKOYAMA M, 1991, CANCER RES, V51, P3229
   YOKOYAMA M, 1990, J CONTROL RELEASE, V11, P269
   YOKOYAMA M, 1994, J CONTROL RELEASE, V32, P269, DOI 10.1016/0168-3659(94)90237-2
   YOKOYAMA M, 1990, CANCER RES, V50, P1693
   YOKOYAMA M, 1993, DRUG DELIV, V1, P11
   YOUNES H, 1987, J BIOMED MATER RES, V21, P1301, DOI 10.1002/jbm.820211103
   Youxin L., 1994, J CONTROL RELEASE, V32, P121
   Zambaux MF, 2001, INT J PHARM, V212, P1, DOI 10.1016/S0378-5173(00)00548-2
   Zhang XC, 1996, INT J PHARM, V132, P195, DOI 10.1016/0378-5173(95)04386-1
   Zhu ZX, 1999, EUR POLYM J, V35, P1821, DOI 10.1016/S0014-3057(98)00265-1
NR 137
TC 215
Z9 232
U1 4
U2 67
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-409X
J9 ADV DRUG DELIVER REV
JI Adv. Drug Deliv. Rev.
PD DEC 3
PY 2001
VL 53
IS 1
BP 23
EP 44
DI 10.1016/S0169-409X(01)00219-8
PG 22
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 501XZ
UT WOS:000172712500003
PM 11733116
DA 2018-10-20
ER

PT J
AU Luyten, FP
   Dell'Accio, F
   De Bari, C
AF Luyten, FP
   Dell'Accio, F
   De Bari, C
TI Skeletal tissue engineering: opportunities and challenges
SO BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
LA English
DT Article
DE joint resurfacing; skeletal engineering; stem cells; morphogens;
   biomaterials
ID MESENCHYMAL STEM-CELLS; ARTICULAR CHONDROCYTES; MORPHOGENETIC PROTEINS;
   EXTRACELLULAR-MATRIX; BONE DIFFERENTIATION; GROWTH-FACTOR; CARTILAGE;
   REGENERATION; OSTEOGENIN; REGULATORS
AB Tissue engineering is a field of biomedicine that is growing rapidly and is critically driven by scientific advances in the areas of developmental and cell biology and biomaterial sciences. Regeneration of skeletal tissues is among the most promising areas of biological tissue repair and is providing a broad spectrum of potential clinical applications, including joint resurfacing. The availability of novel tools such as pluripotent stem cells, morphogens, smart biomaterials and gene transfer technologies, makes us dream of many exciting novel therapeutic approaches. Despite these opportunities in regenerative medicine, good clinical practice requires the clinician to question the consistency, reproducibility, validation and appropriate regulation of these new biological treatments.
C1 KU, Univ Hosp, Lab Skeletal Dev & Joint Disorders, Onderwijs & Navorsin,Dept Rheumatol, Louvain, Belgium.
RP Luyten, FP (reprint author), KU, Univ Hosp, Lab Skeletal Dev & Joint Disorders, Onderwijs & Navorsin,Dept Rheumatol, Herestr 49, Louvain, Belgium.
RI Dell'Accio, Francesco/A-2923-2013
CR BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   Caplan AI, 2000, TISSUE ENG, V6, P1, DOI 10.1089/107632700320838
   CAPLAN AI, 2000, CLIN ORTHOP S, V379, pS67
   De Bari C, 2001, ARTHRITIS RHEUM, V44, P85, DOI 10.1002/1529-0131(200101)44:1<85::AID-ANR12>3.0.CO;2-6
   De Bari C, 2001, ARTHRITIS RHEUM, V44, P1928, DOI 10.1002/1529-0131(200108)44:8<1928::AID-ART331>3.0.CO;2-P
   Dee KC, 1996, BIOMATERIALS, V17, P209, DOI 10.1016/0142-9612(96)85765-6
   Dell'Accio F, 2001, ARTHRITIS RHEUM, V44, P1608, DOI 10.1002/1529-0131(200107)44:7<1608::AID-ART284>3.0.CO;2-T
   Dell'Accio F, 1999, JPN J RHEUMATOL, V9, P17
   DOMINICE J, 1986, Mechanisms of Ageing and Development, V37, P231
   Evans CH, 2001, ARTHRITIS RES, V3, P142, DOI 10.1186/ar291
   FROGERGAILLARD B, 1989, EXP CELL RES, V183, P388, DOI 10.1016/0014-4827(89)90399-6
   Gilbert J E, 1998, Am J Knee Surg, V11, P42
   Goossens PH, 2001, ARTHRITIS RHEUM, V44, P48, DOI 10.1002/1529-0131(200101)44:1<48::AID-ANR7>3.0.CO;2-D
   HARRISON ET, 1991, EXP CELL RES, V192, P340, DOI 10.1016/0014-4827(91)90050-5
   Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580
   HOMMINGA GN, 1990, J BONE JOINT SURG BR, V72, P1003
   Hunziker EB, 1996, J BONE JOINT SURG AM, V78A, P721, DOI 10.2106/00004623-199605000-00012
   Hynes M, 2000, NEURON, V28, P11, DOI 10.1016/S0896-6273(00)00079-9
   Jorgensen C, 2001, ANN RHEUM DIS, V60, P305, DOI 10.1136/ard.60.4.305
   Lebaron RG, 2000, TISSUE ENG, V6, P85, DOI 10.1089/107632700320720
   Liechty KW, 2000, NAT MED, V6, P1282
   Lind M, 2000, J ARTHROPLASTY, V15, P339, DOI 10.1016/S0883-5403(00)90693-4
   LUYTEN FP, 1989, J BIOL CHEM, V264, P13377
   Luyten FP, 1997, ORAL SURG ORAL MED O, V83, P167, DOI 10.1016/S1079-2104(97)90109-8
   LUYTEN FP, 2001, IN PRESS BONE MORPHO
   Marinova-Mutafchieva L, 2000, ARTHRITIS RHEUM-US, V43, P2046, DOI 10.1002/1529-0131(200009)43:9<2046::AID-ANR16>3.0.CO;2-8
   Minas T, 1997, ORTHOPEDICS, V20, P525
   Nakagawa S, 1996, J RHEUMATOL, V23, P2098
   NAKAHARA H, 1991, J ORTHOP RES, V9, P465, DOI 10.1002/jor.1100090402
   Nehrer S, 1999, CLIN ORTHOP RELAT R, P149
   Peterson L, 2000, CLIN ORTHOP RELAT R, P212
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Reddi AH, 1998, NAT BIOTECHNOL, V16, P247, DOI 10.1038/nbt0398-247
   SAMPATH TK, 1984, J CELL BIOL, V98, P2192, DOI 10.1083/jcb.98.6.2192
   SAMPATH TK, 1990, J BIOL CHEM, V265, P13198
   Schultz O, 2000, ARTHRITIS RES, V2, P433, DOI 10.1186/ar123
   Shortkroff S, 1996, BIOMATERIALS, V17, P147, DOI 10.1016/0142-9612(96)85759-0
   SPIRO RC, 2000, INT C BON MORPH PROT
   Tsumaki N, 1999, J CELL BIOL, V144, P161, DOI 10.1083/jcb.144.1.161
   van den Bergh JPA, 2000, J CLIN PERIODONTOL, V27, P627, DOI 10.1034/j.1600-051x.2000.027009627.x
   VONDERMARK K, 1977, NATURE, V267, P431
   Wang H L, 2000, Compend Contin Educ Dent, V21, P399
   WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241
   Zvaifler NJ, 2000, ARTHRITIS RES, V2, P477, DOI 10.1186/ar130
NR 45
TC 31
Z9 37
U1 0
U2 1
PU BAILLIERE TINDALL
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 1521-6942
J9 BEST PRACT RES CL RH
JI Best Pract. Res. Clin. Rheumatol.
PD DEC
PY 2001
VL 15
IS 5
BP 759
EP 769
DI 10.1053/berh.2001.0192
PG 11
WC Rheumatology
SC Rheumatology
GA 515AD
UT WOS:000173472500008
PM 11812020
DA 2018-10-20
ER

PT J
AU Bet, MR
   Goissis, G
   Lacerda, CA
AF Bet, MR
   Goissis, G
   Lacerda, CA
TI Characterization of polyanionic collagen prepared by selective
   hydrolysis of asparagine and glutamine carboxyamide side chains
SO BIOMACROMOLECULES
LA English
DT Article
ID ANIONIC COLLAGEN; BIOCOMPATIBILITY; COMPOSITES; MATRICES; RELEASE; WATER
AB Acellular polyanionic collagen materials intended for biomaterial and tissue engineering uses were prepared by the selective and controlled hydrolysis of carboxyamides from asparagine and glutamine residues of type I collagen present in pericardium, tendon, and intestinal submucosa, all from bovine origin. The increase in carboxyl groups was from 26 +/- 14 (12 h of hydrolysis) to 134 12 (144 h of hydrolysis). Although collagen triple helix structure of polyanionic materials was preserved in all cases, a decrease in thermal stability and a gradual loss in the ability of collagen molecules to form fibrils were detected with increasing carboxyl content, probably as a result of changes in the pattern of electrostatic interaction, The resulting materials were basically acellular polyanionic collagen matrixes associated with an elastin content dependent on the time of hydrolysis. The results showed that the procedure described in this work may be a useful process for preparation of collagen biomaterials with variable physicochemical properties and macromolecular arrangement with respect to fibril formation and with potential use in tissue engineering.
C1 Univ Sao Paulo, Inst Quim, Dept Quim & Fis Mol, BR-13560970 Sao Paulo, Brazil.
RP Goissis, G (reprint author), Univ Sao Paulo, Inst Quim, Dept Quim & Fis Mol, Av Trabalhador Saocarlense 400,CP 780, BR-13560970 Sao Paulo, Brazil.
CR Bouaziz A, 1997, BIOMATERIALS, V18, P107, DOI 10.1016/S0142-9612(96)00114-7
   CHAPMAN JA, 1990, ELECTRON MICROSC REV, V3, P143, DOI 10.1016/0892-0354(90)90018-N
   Chen YS, 2000, BIOMATERIALS, V21, P1541, DOI 10.1016/S0142-9612(00)00028-4
   Chevallay B, 2000, J BIOMED MATER RES, V49, P448, DOI 10.1002/(SICI)1097-4636(20000315)49:4<448::AID-JBM3>3.0.CO;2-L
   Chvapil M, 1980, BIOL COLLAGEN, P313
   CROSS HR, 1973, J AGR FOOD CHEM, V21, P716, DOI 10.1021/jf60188a033
   Eastoe JE, 1967, TREATISE COLLAGEN, V1, P1
   FLANDIN F, 1984, BIOCHIM BIOPHYS ACTA, V791, P205, DOI 10.1016/0167-4838(84)90010-4
   GIUSTI P, 1994, MACROMOL SYMP, V78, P285, DOI 10.1002/masy.19940780124
   Goissis G, 1999, BIOMATERIALS, V20, P27, DOI 10.1016/S0142-9612(97)00198-1
   Goissis G, 1998, ARTIF ORGANS, V22, P203, DOI 10.1046/j.1525-1594.1998.06109.x
   GOISSIS G, 1994, PROCESS EXTRACTION C
   GRIMM M, 1992, SURGERY, V111, P74
   Hu XW, 1996, TISSUE CELL, V28, P215
   MAHLLER HR, 1996, BIOL CHEM, P87
   Martins VCA, 1998, ARTIF ORGANS, V22, P215, DOI 10.1046/j.1525-1594.1998.06004.x
   Nezu T, 2000, BIOMATERIALS, V21, P415, DOI 10.1016/S0142-9612(99)00204-5
   Plepis AMD, 1996, POLYM ENG SCI, V36, P2932
   Radhika M, 1999, COMP BIOCHEM PHYS C, V124, P131, DOI 10.1016/S0742-8413(99)00042-0
   RAMIREZ F, 1988, COLLAGEN, V4, P21
   RAO KP, 1988, COLLAGEN, V3, P63
   REID JRW, 1993, KOWARI, V4, P1
   RENUGOPALAKRISHNAN V, 1989, MACROMOLECULES, V22, P4121, DOI 10.1021/ma00200a054
   Sai P, 2000, BURNS, V26, P54
   SCHERRER SA, 1986, Patent No. 0214853
   Shenoy V, 1995, MACROMOLECULES, V28, P8751, DOI 10.1021/ma00130a007
   SILVESTER MF, 1989, THROMB RES, V55, P135
   SINGH MP, 1995, PHARMACEUT RES, V12, P1205, DOI 10.1023/A:1016272212833
   STEGEMAN.H, 1967, CLIN CHIM ACTA, V18, P267, DOI 10.1016/0009-8981(67)90167-2
NR 29
TC 34
Z9 35
U1 1
U2 7
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD WIN
PY 2001
VL 2
IS 4
BP 1074
EP 1079
DI 10.1021/bm0001188
PG 6
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 528RH
UT WOS:000174256400003
PM 11777376
DA 2018-10-20
ER

PT J
AU Yamada, M
   Kato, K
   Shindo, K
   Nomizu, M
   Haruki, M
   Sakairi, N
   Ohkawa, K
   Yamamoto, H
   Nishi, N
AF Yamada, M
   Kato, K
   Shindo, K
   Nomizu, M
   Haruki, M
   Sakairi, N
   Ohkawa, K
   Yamamoto, H
   Nishi, N
TI UV-irradiation-induced DNA immobilization and functional utilization of
   DNA on nonwoven cellulose fabric
SO BIOMATERIALS
LA English
DT Article
DE immobilized DNA; intercalation; UV irradiation; antibacterial activity;
   endocrine disruptor; functional biomaterial
ID SILVER SULFADIAZINE; LIPID COMPLEX; BIOSENSORS; BURNS
AB Immobilization of double-stranded DNA onto nonwoven cellulose fabric by UV irradiation and utilization of DNA-immobilized cloth were examined. The immobilized DNA was found to be stable in water, with the maximum amount of fabric-immobilized DNA being approximately 20 mg/g of nonwoven fabric. The DNA-immobilized cloth could effectively accumulate endocrine disruptors and harmful DNA intercalating pollutants, such as dibenzo-p-dioxin, dibenzofuran, biphenyl, benzo[a]pyrene and ethidium bromide. Additionally, DNA-immobilized cloth was found to bind metal ions, such as Ag+, Cu2+, and Zn2+. The maximum amounts of bound Ag+, Cu2+, and Zn2+ onto DNA-immobilized cloth (1 g) were approximately 5, 2, and 1 mg, respectively. DNA-immobilized cloth containing Ag+ showed antibacterial activity against Escherichia coli and Staphylococcus aureus. DNA-immobilized cloth without metal ion and with Cu2+ or Zn2+ did not show antibacterial activity. These results suggest that immobilized DNA imparts useful functionality to cloth. DNA-immobilized cloth prepared by UV irradiation has potential to serve as a useful biomaterial for medical, engineering, and environmental application. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Hokkaido Univ, Grad Sch Environm Earth Sci, Div Biosci, Lab Biomat Chem,Kita Ku, Sapporo, Hokkaido 0600810, Japan.
   Shinshu Univ, Fac Text Sci & Technol, Ueda, Nagano 3868567, Japan.
RP Nishi, N (reprint author), Hokkaido Univ, Grad Sch Environm Earth Sci, Div Biosci, Lab Biomat Chem,Kita Ku, Sapporo, Hokkaido 0600810, Japan.
RI Ohkawa, Kousaku/E-1497-2014
OI Ohkawa, Kousaku/0000-0001-5199-092X
CR BEUKERS R, 1960, BIOCHIM BIOPHYS ACTA, V41, P550, DOI 10.1016/0006-3002(60)90063-9
   BEUKERS R, 1958, RECL TRAV CHIM PAY B, V77, P729
   BOECKX W, 1992, BURNS, V18, P456, DOI 10.1016/0305-4179(92)90177-V
   BUK KFS, 1975, J AM CHEM SOC, V97, P1241
   CAVALIERI LF, 1970, P NATL ACAD SCI USA, V67, P807, DOI 10.1073/pnas.67.2.807
   EICHHORN GL, 1968, J AM CHEM SOC, V90, P7323, DOI 10.1021/ja01028a024
   FULLER W, 1964, BERICH BUNSEN GESELL, V68, P805, DOI 10.1002/bbpc.19640680830
   GEACINTOV NE, 1976, J AM CHEM SOC, V98, P6444, DOI 10.1021/ja00437a002
   GLISIN VR, 1967, BIOCHIM BIOPHYS ACTA, V142, P314, DOI 10.1016/0005-2787(67)90614-4
   HOFFMANN S, 1984, SCAND J PLAST RECONS, V18, P119, DOI 10.3109/02844318409057413
   IJIRO K, 1992, J CHEM SOC CHEM COMM, P1339, DOI 10.1039/c39920001339
   Iwata K, 1996, INT J BIOL MACROMOL, V18, P149, DOI 10.1016/0141-8130(95)01073-4
   Kitamura H, 1997, INT J BIOL MACROMOL, V20, P75, DOI 10.1016/S0141-8130(97)01146-X
   Kitamura H, 1997, INT J BIOL MACROMOL, V20, P241, DOI 10.1016/S0141-8130(97)00021-4
   KITAMURA H, 1997, NUCL ACIDS S SER, V37, P273
   LITMAN RM, 1968, J BIOL CHEM, V243, P6222
   MIZUTANI T, 1983, J BIOCHEM-TOKYO, V94, P163
   NAGATA C, 1967, B CHEM SOC JPN, V40, P2564, DOI 10.1246/bcsj.40.2564
   RICKWOOD D, 1972, BIOCHIM BIOPHYS ACTA, V269, P47, DOI 10.1016/0005-2787(72)90072-X
   Skuridin SG, 1996, BIOSENS BIOELECTRON, V11, P903, DOI 10.1016/0956-5663(96)89439-5
   Tanaka K, 1996, J AM CHEM SOC, V118, P10679, DOI 10.1021/ja9617855
   TSO POP, 1964, P NATL ACAD SCI USA, V51, P17, DOI 10.1073/pnas.51.1.17
   Wang J, 1997, ANAL CHIM ACTA, V347, P1, DOI 10.1016/S0003-2670(96)00598-3
   YAMAGUCHI S, 1993, ANAL CHEM, V65, P1925, DOI 10.1021/ac00062a019
   ZIMMER C, 1974, BIOPOLYMERS, V13, P425, DOI 10.1002/bip.1974.360130302
NR 25
TC 57
Z9 62
U1 2
U2 16
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2001
VL 22
IS 23
BP 3121
EP 3126
DI 10.1016/S0142-9612(01)00061-8
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 476UE
UT WOS:000171246500006
PM 11603583
DA 2018-10-20
ER

PT J
AU Manwaring, ME
   Biran, R
   Tresco, PA
AF Manwaring, ME
   Biran, R
   Tresco, PA
TI Characterization of rat meningeal cultures on materials of differing
   surface chemistry
SO BIOMATERIALS
LA English
DT Article
DE meningeal cells; synthetic materials; cell adhesion; cell surface area;
   DNA synthesis
ID CENTRAL NERVOUS-SYSTEM; ENDOTHELIAL-CELLS; ASTROCYTES; LEPTOMENINGEAL;
   REGENERATION; INVITRO; PROTEIN; FIBRONECTIN; ANTIBODIES; MOLECULES
AB To better understand the interactions of cells derived from meningeal tissues with the surfaces of devices used for the treatment of central nervous system disorders, the behavior of primary postnatal day 1 rat meningeal cultures was evaluated on biomaterials of differing surface chemistry. Meningeal cultures in serum containing media were analyzed for attachment, spread cell area, proliferation, the production of extracellular matrix (ECM), and neuronal outgrowth. In general, both cell attachment as well as cell spread area decreased with increasing substrate hydrophobicity, whereas cell division as indicated by BrdU incorporation and time to confluence, was lower on the most hydrophobic materials. We suggest that such differences immediately after cell seeding were most likely mediated by differences in surface adsorption of proteins. In longer-term experiments, most of the materials were colonized by meningeal cultures irrespective of surface chemistry, and all cultures were equally inhibitory to neuronal outgrowth suggesting that over time, cells can modify the substrate perhaps by secretion of extracellular matrix molecule proteins. Our data suggests that cell type-specific differences in response to different biomaterials may play an important role in determining the Ultimate nature and composition of the CNS at the host-biomaterial interface. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Univ Utah, Dept Bioengn, Keck Ctr Tissue Engn, Salt Lake City, UT 84112 USA.
RP Tresco, PA (reprint author), Univ Utah, Dept Bioengn, Keck Ctr Tissue Engn, 20 S 2030 E Bldg 570,Room 108D, Salt Lake City, UT 84112 USA.
EM patrick.tresco@m.cc.utah.edu
CR ABNET K, 1991, DEV BRAIN RES, V59, P187, DOI 10.1016/0165-3806(91)90099-5
   ALCOLADO R, 1988, NEUROPATH APPL NEURO, V14, P1, DOI 10.1111/j.1365-2990.1988.tb00862.x
   ANDRADE JD, 1986, ADV POLYM SCI, V79, P1
   Biran R, 1999, J BIOMED MATER RES, V46, P150, DOI 10.1002/(SICI)1097-4636(199908)46:2<150::AID-JBM3>3.3.CO;2-K
   BROWN WJ, 1977, J NEUROSURG, V47, P366, DOI 10.3171/jns.1977.47.3.0366
   CARBONELL AL, 1988, BRAIN RES, V439, P337, DOI 10.1016/0006-8993(88)91491-6
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   CRUL BJP, 1991, REGION ANESTH, V16, P209
   DEBUS E, 1983, EMBO J, V2, P2305, DOI 10.1002/j.1460-2075.1983.tb01738.x
   DELBIGIO MR, 1992, J BIOMED MATER RES, V26, P979, DOI 10.1002/jbm.820260802
   DUIJVESTIJN AM, 1992, LAB INVEST, V66, P459
   FEURER DJ, 1991, NEUROPATH APPL NEURO, V17, P391, DOI 10.1111/j.1365-2990.1991.tb00739.x
   Grinnell F, 1978, Int Rev Cytol, V53, P65
   Hirsch S, 1999, GLIA, V26, P36, DOI 10.1002/(SICI)1098-1136(199903)26:1<36::AID-GLIA4>3.0.CO;2-C
   Hoke A, 1996, PROG BRAIN RES, V108, P149, DOI 10.1016/S0079-6123(08)62538-8
   HORBETT TA, 1985, J COLLOID INTERF SCI, V104, P28, DOI 10.1016/0021-9797(85)90006-2
   KNOX P, 1980, J CELL SCI, V46, P97
   KRUGER S, 1986, J COMP NEUROL, V249, P103, DOI 10.1002/cne.902490108
   LEWANDOWSKA K, 1992, J BIOMED MATER RES, V26, P1343, DOI 10.1002/jbm.820261007
   Li MS, 1996, GLIA, V18, P306, DOI 10.1002/(SICI)1098-1136(199612)18:4<306::AID-GLIA5>3.0.CO;2-V
   LYDON MJ, 1985, BIOMATERIALS, V6, P396, DOI 10.1016/0142-9612(85)90100-0
   MATTHIESSEN HP, 1991, J NEUROCHEM, V56, P759, DOI 10.1111/j.1471-4159.1991.tb01989.x
   MAXWELL WL, 1990, PHILOS T R SOC B, V328, P479, DOI 10.1098/rstb.1990.0121
   MCKEON RJ, 1991, J NEUROSCI, V11, P3398
   McMenamin PG, 1999, J COMP NEUROL, V405, P553, DOI 10.1002/(SICI)1096-9861(19990322)405:4<553::AID-CNE8>3.0.CO;2-6
   MURPHY M, 1991, J NEUROSCI RES, V30, P475, DOI 10.1002/jnr.490300304
   NABESHIMA S, 1975, J COMP NEUROL, V164, P127, DOI 10.1002/cne.901640202
   Ness R, 1997, GLIA, V19, P47, DOI 10.1002/(SICI)1098-1136(199701)19:1<47::AID-GLIA5>3.0.CO;2-7
   REIER PJ, 1983, SPINAL CORD RECONSTR, P163
   REYNOLDS AF, 1983, NEUROSURGERY, V13, P63, DOI 10.1227/00006123-198307000-00013
   RODRIGUEZPERALTA LA, 1957, J COMP NEUROL, V107, P455, DOI 10.1002/cne.901070308
   ROGERS SL, 1983, DEV BIOL, V98, P212, DOI 10.1016/0012-1606(83)90350-0
   RUDGE JS, 1989, EXP NEUROL, V103, P1, DOI 10.1016/0014-4886(89)90180-5
   RUTKA JT, 1986, J NEUROPATH EXP NEUR, V45, P285, DOI 10.1097/00005072-198605000-00012
   Schwab ME, 1996, PHYSIOL REV, V76, P319
   SEKHAR LN, 1982, J NEUROSURG, V56, P411, DOI 10.3171/jns.1982.56.3.0411
   SIEVERS J, 1994, J NEUROCYTOL, V23, P135, DOI 10.1007/BF01183867
   Takamiya Y, 1988, Brain Res, V466, P201
   Turner JN, 1999, EXP NEUROL, V156, P33, DOI 10.1006/exnr.1998.6983
   Vandenabeele F, 1996, J ANAT, V189, P417
   VANWACHEM PB, 1985, BIOMATERIALS, V6, P403, DOI 10.1016/0142-9612(85)90101-2
   WAGGENER JD, 1967, J NEUROPATH EXP NEUR, V26, P412, DOI 10.1097/00005072-196707000-00005
   Webb K, 1998, J BIOMED MATER RES, V41, P422, DOI 10.1002/(SICI)1097-4636(19980905)41:3<422::AID-JBM12>3.0.CO;2-K
   WEBB K, 2001, UNPUB BIOMATERIALS
   WILLIAMS RL, 1995, J BIOMED MATER RES, V29, P1545, DOI 10.1002/jbm.820291211
NR 45
TC 19
Z9 19
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2001
VL 22
IS 23
BP 3155
EP 3168
DI 10.1016/S0142-9612(01)00068-0
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 476UE
UT WOS:000171246500011
PM 11603588
DA 2018-10-20
ER

PT J
AU Bruce, AS
   Mainstone, JC
   Golding, TR
AF Bruce, AS
   Mainstone, JC
   Golding, TR
TI Analysis of tear film breakup on Etafilcon A hydrogel lenses
SO BIOMATERIALS
LA English
DT Article
DE tear film breakup; tear film stability; tear film meniscus; hydrogel
   lens; Acuvue
ID STABILITY; WEAR; RUPTURE; TIME
AB Purpose: There is a need to understand better the biomaterial characteristics responsible for tear film stability during hydrogel lens wear. The underlying cause of pre-lens tear film instability may be indicated by the distribution of sites of breakup. The purpose of this study was to compare the distribution of rupture sites during wear of a common biomaterial to that without lenses. Methods: A videokeratography unit, the Topographic Modeling System(TM), was used to capture an image of the tear film at the moment of breakup. Forty measurements were made for each of ten subjects, and the resultant rupture site distributions evaluated. The pre-lens tear film breakup locations were studied for Acuvue (Etafilcon A) disposable contact lenses using the same technique. Results: There was a statistically significant trend for pre-corneal tear film breaks to occur more commonly in parameniscal zones than in areas overlying the central cornea (ANOVA, p = 0.002). With the Etafilcon A lenses, a significant difference in breakup frequency between the two regions was not observed. Conclusions: The pre-corneal tear film findings are consistent with the meniscus model of tear film stability; however, the biomaterial surface characteristics of Etafilcon A give other factors a more dominant role in tear film rupture. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Univ Melbourne, Victorian Coll Optometry, Melbourne, Vic 3053, Australia.
   Univ Melbourne, Dept Optometry & Vis Sci, Carlton, Vic 3053, Australia.
   Queensland Univ Technol, Sch Optometry, Ctr Eye Res, Kelvin Grove, Qld 4059, Australia.
RP Bruce, AS (reprint author), Univ Melbourne, Victorian Coll Optometry, Cnr Keppel & Cardigan St, Melbourne, Vic 3053, Australia.
CR Bitton E, 1998, ADV EXP MED BIOL, V438, P381
   CHO P, 1992, OPTOMETRY VISION SCI, V69, P879, DOI 10.1097/00006324-199211000-00007
   Creech JL, 1998, CURR EYE RES, V17, P1058, DOI 10.1076/ceyr.17.11.1058.5233
   Dillehay S. M., 2000, CLIN MANUAL CONTACT, P239
   DOANE MG, 1988, T BRIT CONT LENS ASS, P110
   FABER E, 1991, OPTOMETRY VISION SCI, V68, P380, DOI 10.1097/00006324-199105000-00010
   FATT I, 1991, CLAO Journal, V17, P267
   Golding TR, 1997, CORNEA, V16, P649
   Guillon J, 1994, CONTACT LENS PRACTIC, P453
   GUILLON JP, 1990, OPHTHAL PHYSL OPT, V10, P343, DOI 10.1111/j.1475-1313.1990.tb00880.x
   Guillon JP, 1998, ADV EXP MED BIOL, V438, P859
   Guillon JP, 1986, PREOCULAR TEAR FILM, P914
   Guillon M, 1992, ICLC, V19, P104
   HOLLY FJ, 1973, EXP EYE RES, V15, P515, DOI 10.1016/0014-4835(73)90064-X
   KORB DR, 1994, ADV EXP MED BIOL, V350, P403
   LEMP MA, 1973, ARCH OPHTHALMOL-CHIC, V89, P103
   MCDONALD JE, 1971, AM J OPHTHALMOL, V72, P139, DOI 10.1016/0002-9394(71)91604-7
   McMonnies C W, 1986, J Am Optom Assoc, V57, P512
   MENGHER LS, 1985, CURR EYE RES, V4, P1, DOI 10.3109/02713688508999960
   NORN MS, 1969, ACTA OPHTHALMOL, V47, P865
   PATEL S, 1987, AM J OPTOM PHYS OPT, V64, P167
   PATEL S, 1985, AM J OPTOM PHYS OPT, V62, P188
   RENGSTORFF RH, 1974, AM J OPTOM PHYS OPT, V51, P765
   Sharma A, 1998, ADV EXP MED BIOL, V438, P425
   Tomlinson A, 1992, COMPLICATIONS CONTAC, P159
   Vajdic C, 1999, OPTOMETRY VISION SCI, V76, P705, DOI 10.1097/00006324-199910000-00022
   YOUNG G, 1991, OPHTHAL PHYSL OPT, V11, P53, DOI 10.1016/0275-5408(91)90011-7
NR 27
TC 16
Z9 16
U1 0
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2001
VL 22
IS 24
SI SI
BP 3249
EP 3256
DI 10.1016/S0142-9612(01)00162-4
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 485NB
UT WOS:000171759500005
PM 11700796
DA 2018-10-20
ER

PT J
AU Singh, S
   Woerly, S
   Mclaughlin, BJ
AF Singh, S
   Woerly, S
   Mclaughlin, BJ
TI Natural and artificial substrates for retinal pigment epithelial
   monolayer transplantation
SO BIOMATERIALS
LA English
DT Article
DE retinal pigment epithelium; transplantation; lens capsule; hydrogel
ID HUMAN BRUCHS MEMBRANE; MACULAR DEGENERATION; LENS CAPSULE; CELLS;
   REATTACHMENT; CULTURE; LAYERS; RPE
AB The aim of this study was to culture retinal pigment epithelial (RPE) cells on natural and synthetic substrates for future use in RPE monolayer transplantation in the eye. The extracellular capsules surrounding the human lens and a hydrogel biomaterial were used as substrates for monolayer culture. All materials were seeded with either pig or human retinal pigment epithelial cells and were maintained in tissue culture conditions. Upon confluency, the cell density was calculated and cell viability determined. All monolayers were stained with phalloidin-rhodamine for F-actin and antibodies to tight junction-associated protein, ZO(1). The final cell density of human RPE monolayers on the hydrogel and lens capsule was 3200 +/- 187 and 3350 +/- 120 cells/mm(2) respectively. Pig RPE cells had a final cell density of 3740 +/- 205 cells/mm(2) on the lens capsule and 3025 +/- + cells/mm(2) on the hydrogel. F-actin staining revealed a circumferential ring of actin filaments in all the cells grown on substrates. ZO(1) immunohistochemistry demonstrated staining along the lateral cell borders of all cell types. The successful culture of RPE cells on these substrates may have the potential for transplanting cell monolayers in the eye to improve outcomes for degenerative diseases in the retina. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Univ Louisville, Sch Med, Dept Ophthalmol & Visual Sci, Louisville, KY 40202 USA.
   Organogel Canada Ltec, Quebec City, PQ G1P 4R70, Canada.
RP Mclaughlin, BJ (reprint author), Univ Louisville, Sch Med, Dept Ophthalmol & Visual Sci, Louisville, KY 40202 USA.
FU NEI NIH HHS [EY02853]
CR Algvere PV, 1999, EUR J OPHTHALMOL, V9, P217
   BHATT NS, 1994, AM J OPHTHALMOL, V117, P214, DOI 10.1016/S0002-9394(14)73079-X
   BINDER PS, 1984, OPHTHALMOLOGY, V91, P806
   CAMMARATA PR, 1986, TISSUE CELL, V18, P83, DOI 10.1016/0040-8166(86)90009-1
   CHANG CW, 1990, INVEST OPHTHALMOL SC, V5, P879
   CURTIS ASG, 1986, J CELL SCI, V86, P9
   Del Priore LV, 1998, ARCH OPHTHALMOL-CHIC, V116, P335, DOI 10.1001/archopht.116.3.335
   DelPriore LV, 1997, INVEST OPHTH VIS SCI, V38, P1207
   DELPRIORE LV, RESURFACING INNER LA, V41, P4562
   Farrokh-Siar L, 1999, CURR EYE RES, V19, P89, DOI 10.1076/ceyr.19.2.89.5331
   FERRIS FL, 1983, AM J EPIDEMIOL, V118, P132, DOI 10.1093/oxfordjournals.aje.a113624
   GLASER BM, 1985, ARCH OPHTHALMOL-CHIC, V103, P1870
   Green W R, 1977, Trans Am Ophthalmol Soc, V75, P180
   Hadlock T, 1999, TISSUE ENG, V5, P187, DOI 10.1089/ten.1999.5.187
   Hartmann U, 1999, GRAEF ARCH CLIN EXP, V237, P940, DOI 10.1007/s004170050390
   Ho TC, 1997, INVEST OPHTH VIS SCI, V38, P1110
   Kiilgaard J. F., 1998, IOVS, V39, pS100
   LIU Y, 1992, INVEST OPHTH VIS SCI, V33, P2180
   MARMOR MF, 1998, RETINAL PIGMENT EPIT, P672
   MCKEEHAN WL, 1976, J CELL BIOL, V71, P727, DOI 10.1083/jcb.71.3.727
   MOHAY J, 1994, CORNEA, V13, P173, DOI 10.1097/00003226-199403000-00011
   Oganesian A, 1997, INVEST OPHTH VIS SCI, V38, P1568
   PEYMAN GA, 1991, OPHTHALMIC SURG LAS, V22, P102
   REZAI KA, 1999, INVEST OPHTH VIS SCI, V40, P3137
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   SAMPLES JR, 1984, INVEST OPHTH VIS SCI, V25, P843
   SARKS SH, 1976, BRIT J OPHTHALMOL, V60, P324, DOI 10.1136/bjo.60.5.324
   Tezel TH, 1997, GRAEF ARCH CLIN EXP, V235, P41, DOI 10.1007/BF01007836
   Tezel TH, 1999, INVEST OPHTH VIS SCI, V40, P467
   Weisz JM, 1999, RETINA-J RET VIT DIS, V19, P540, DOI 10.1097/00006982-199911000-00011
   Woerly S, 1999, TISSUE ENG, V5, P467, DOI 10.1089/ten.1999.5.467
   WOERLY S, 1993, BRAIN RES BULL, V30, P423, DOI 10.1016/0361-9230(93)90274-F
   YAVIN E, 1974, J CELL BIOL, V62, P540, DOI 10.1083/jcb.62.2.540
NR 33
TC 33
Z9 35
U1 0
U2 17
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2001
VL 22
IS 24
SI SI
BP 3337
EP 3343
DI 10.1016/S0142-9612(01)00171-5
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 485NB
UT WOS:000171759500015
PM 11700806
DA 2018-10-20
ER

PT J
AU Grant, GGS
   Koktysh, DS
   Yun, BG
   Matts, RL
   Kotov, NA
AF Grant, Gregory G. S.
   Koktysh, Dmitry S.
   Yun, BoGeon
   Matts, Robert L.
   Kotov, Nicholas A.
TI Layer-By-Layer Assembly of Collagen Thin Films: Controlled Thickness and
   Biocompatibility
SO BIOMEDICAL MICRODEVICES
LA English
DT Article
DE layer-by-layer assembly; thin films; polyelectrolytes; collagen;
   biocompatibility
AB The extracellular matrix molecular collagen is the one of the most widely utilized scaffolding materials in tissue engineering. However, obtaining uniform bioactive collagen films in the nanoscale range and precisely controlling the physical and chemical properties of these biological films is still a challenge for biomedical engineering. Layer-by-layer assembly, i.e., sequential adsorption of oppositely charged macromolecular species, is a powerful new film preparation technique that can be applied to the design of versatile biomaterials, with well-controlled interfacial, mechanical and biological functions. To demonstrate the feasibility of biomaterial design by means of layer-by-layer assembly, type-I collagen thin films were prepared by using this technique with poly(styrene) sulfonate as a partner polyelectrolyte. The gradual build-up of the collagen films was confirmed by UV-vis spectroscopy and ellipsometry, while their surface morphology was assessed by atomic force microscopy. The thickness of the collagen layers can be changed by increasing the number of bilayers adsorbed with an increment of 13 nm. It was found that the layer-by-layer assembled collagen scaffolds can support the attachment and growth of C2C12 myoblast cells and PC12 pheochromocytoma cells. Accurate thickness control and compatibility with nerve cell precursors indicate the utility of layer-by-layer assembled films in neuroprosthesis.
C1 [Grant, Gregory G. S.; Koktysh, Dmitry S.; Kotov, Nicholas A.] Oklahoma State Univ, Dept Chem, Stillwater, OK 74078 USA.
   [Yun, BoGeon; Matts, Robert L.] Oklahoma State Univ, Noble Res Ctr, Dept Biochem & Mol Biol, Stillwater, OK 74078 USA.
RP Kotov, NA (reprint author), Oklahoma State Univ, Dept Chem, 107 PS I, Stillwater, OK 74078 USA.
OI Kotov, Nicholas/0000-0002-6864-5804
FU NSF [CHE-9876265]; AFOSR [F49620-99-C-0072]; OCAST, NSF/NATO (NSF-NATO)
   OSU Sensor Center [DGE-9902637]; NSF/NATO (NSF-NATO) [DGE-9902637]
FX N.A.K. thanks NSF CAREER (CHE-9876265), AFOSR (F49620-99-C-0072), and
   OCAST, NSF/NATO (NSF-NATO Grant # DGE-9902637) OSU Sensor Center, for
   partial financial support of this research. D.S.K. acknowledges support
   from the NSF/NATO (NSF-NATO Grant # DGE-9902637) for the postdoctoral
   fellowship.
CR Aliev FG, 1999, ADV MATER, V11, P1006, DOI 10.1002/(SICI)1521-4095(199908)11:12<1006::AID-ADMA1006>3.0.CO;2-2
   Angelova N, 1999, TRENDS BIOTECHNOL, V17, P409, DOI 10.1016/S0167-7799(99)01356-6
   Carrino DA, 1996, CONNECT TISSUE RES, V35, P325, DOI 10.3109/03008209609029207
   Christiansen DL, 2000, MATRIX BIOL, V19, P409, DOI 10.1016/S0945-053X(00)00089-5
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   DECHER G, 1991, MAKROMOL CHEM-M SYMP, V46, P321, DOI 10.1002/masy.19910460145
   Elbert DL, 1999, LANGMUIR, V15, P5355, DOI 10.1021/la9815749
   Falini G, 1998, CHEM-EUR J, V4, P1048, DOI 10.1002/(SICI)1521-3765(19980615)4:6<1048::AID-CHEM1048>3.0.CO;2-U
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   Koktysh D.S., 2001, UNPUB
   Mamedov A, 2000, LANGMUIR, V16, P3941, DOI 10.1021/la990957j
   Nakamura O., 1994, J BONE MINER METAB, V12, P17
   Ngankam PA, 2000, J AM CHEM SOC, V122, P8998, DOI 10.1021/ja000783o
   Pachence JM, 1996, J BIOMED MATER RES, V33, P35, DOI 10.1002/(SICI)1097-4636(199621)33:1<35::AID-JBM6>3.0.CO;2-N
   Pachence JM, 1987, MED DEVICE DIAGN IND, V9, P49
   Pins GD, 1995, MAT SCI ENG C-BIOMIM, V3, P101, DOI 10.1016/0928-4931(95)00109-3
   Silver F.H., 1997, HDB BIODEGRADABLE PO, V7, P319
   Uemura T, 1997, MAT SCI ENG C-BIO S, V4, P303, DOI 10.1016/S0928-4931(97)00015-5
NR 18
TC 51
Z9 53
U1 1
U2 17
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1387-2176
EI 1572-8781
J9 BIOMED MICRODEVICES
JI Biomed. Microdevices
PD DEC
PY 2001
VL 3
IS 4
BP 301
EP 306
DI 10.1023/A:1012456714628
PG 6
WC Engineering, Biomedical; Nanoscience & Nanotechnology
SC Engineering; Science & Technology - Other Topics
GA V33KX
UT WOS:000209018800006
DA 2018-10-20
ER

PT J
AU Zanchetta, P
   Guezennec, J
AF Zanchetta, P
   Guezennec, J
TI Surface thermodynamics of osteoblasts: relation between hydrophobicity
   and bone active biomaterials
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE thermodynamics; biomaterial; surface tension
ID IN-VITRO; BACTERIAL ADHESION; CELL-CULTURE; FIBRONECTIN; ATTACHMENT
AB Surface tensions of rat calvaria osteoblasts were determined by measuring the cell-liquid-vapor contact angle with sessile drops of water on the cell monolayer. The results indicated the hydrophobic character of osteoblastic cells with a contact angle of 26.89 degrees (0.29 degrees). This value could explain the ability of osteoblasts to specifically attach onto hydrophobic surfaces like titanium or hydroxyapatite. The first cellular step of bone healing requires the presence of osteoblasts and their adhesion to biomaterial surfaces is the crucial phase of the osteointegration process. The presence of a monolayer of a newly discovered hydrophobic bacterial exopolysaccharide on coverglass slides appeared to strongly encourage adhesion of osteoblastic cells. In that, providing surfaces with this hydrophobic material induced a selective adsorption of osteoblast cells and might enhance osteo integration. (C) 2001 Elsevier Science B.V. All rights reserved.
C1 Dent Univ, F-29200 Brest, France.
   IFREMER, Dept DRV, VP, BMM, Plouzane, France.
CR ABSOLOM DR, 1983, APPL ENVIRON MICROB, V46, P90
   ABSOLOM DR, 1980, CELL BIOPHYS, V2, P113, DOI 10.1007/BF02795838
   ABSOLOM DR, 1982, J COLLOID INTERF SCI, V85, P168, DOI 10.1016/0021-9797(82)90245-4
   ABSOLOM DR, 1979, T AM SOC ART INT ORG, V25, P152
   AMARA M, 1991, EUROPHYS LETT, V16, P153, DOI 10.1209/0295-5075/16/2/006
   Barnes GL, 1999, J BONE MINER RES, V14, P1805, DOI 10.1359/jbmr.1999.14.11.1805
   Bartee B K, 1995, J Oral Implantol, V21, P88
   Blanquaert F, 1999, J BIOMED MATER RES, V44, P63, DOI 10.1002/(SICI)1097-4636(199901)44:1<63::AID-JBM7>3.0.CO;2-S
   BOSCH C, 1995, CLEFT PALATE-CRAN J, V32, P311, DOI 10.1597/1545-1569(1995)032<0311:GBRICB>2.3.CO;2
   BUSER D, 1991, J BIOMED MATER RES, V25, P889, DOI 10.1002/jbm.820250708
   CUISINIER F, 1996, SOLID STATE MATER SI, V1, P10
   DALTON BA, 1995, J CELL SCI, V108, P2083
   Dee KC, 1998, J BIOMED MATER RES, V40, P371, DOI 10.1002/(SICI)1097-4636(19980605)40:3<371::AID-JBM5>3.3.CO;2-G
   DEXTER SC, 1979, J COLLOID INTERF SCI, V70, P346, DOI 10.1016/0021-9797(79)90038-9
   DUBOIS JC, 1996, J BIOMATER DENTAIRES, V11, P85
   EICK JD, 1975, J COLLOID INTERF SCI, V53, P235, DOI 10.1016/0021-9797(75)90010-7
   Fletcher M, 1996, BACTERIAL ADHESION M, P1
   Frost HM, 1989, CLIN ORTHOP RELAT R, P283, DOI DOI 10.1097/00003086-198911000-00045
   Globus RK, 1998, J CELL SCI, V111, P1385
   Good R. J., 1993, CONTACT ANGLE WETTAB
   GRZESIK WJ, 1994, J BONE MINER RES, V9, P487, DOI 10.1002/jbmr.5650090408
   GUEZENNEC JG, 1994, CARBOHYD POLYM, V24, P287, DOI 10.1016/0144-8617(94)90073-6
   HILL PA, 1994, J CELL SCI, V107, P3055
   HOWLETT CR, 1994, BIOMATERIALS, V15, P213, DOI 10.1016/0142-9612(94)90070-1
   ISAKSSON S, 1993, INT J ORAL MAX SURG, V22, P375, DOI 10.1016/S0901-5027(05)80673-3
   ISRAELACHVILI JN, 1992, INTERMOLECULAR SURFA
   IVESARO J, 1999, J BONE MINER RES, V14, P1338
   KASEMO B, 1988, IMPLANTS OSTEOINTEGR, P99
   KLEIN G, 1994, MATRIX BIOL, V14, P457
   MACK D, 1992, AM J PHYSIOL, V25, pG171
   MACK DR, 1994, PEDIATR RES, V35, P209, DOI 10.1203/00006450-199402000-00017
   Mackie EJ, 1996, J CELL SCI, V109, P1597
   Moursi AM, 1997, J CELL SCI, V110, P2187
   NEFUSSI JR, 1993, CR SOC BIOL, V187, P620
   Quinquis P., 1993, J BIOM DENT, V8, P31
   Raguenes G, 1996, APPL ENVIRON MICROB, V62, P67
   STUBLEY GD, 1987, HYDRODYNAMICS, V8, P221
   THASVEERI J, 1995, APPL ENVIRON MICROB, V61, P3681
   ZINGG W, 1991, BIOFOULING, V4, P293
NR 39
TC 35
Z9 36
U1 0
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD DEC
PY 2001
VL 22
IS 4
BP 301
EP 307
DI 10.1016/S0927-7765(01)00200-4
PG 7
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA 479NE
UT WOS:000171409800004
DA 2018-10-20
ER

PT J
AU Dalton, BA
   Steele, JG
AF Dalton, BA
   Steele, JG
TI Migration mechanisms: Corneal epithelial tissue and dissociated cells
SO EXPERIMENTAL EYE RESEARCH
LA English
DT Article
DE corneal epithelium; tissue migration; cell migration
ID SURFACE-TOPOGRAPHY; LEADING-EDGE; MICROTUBULES; MOVEMENT; COLCHICINE;
   FILAMENTS; ADHESION; POLYMER; MODULATION; LOCOMOTION
AB The migratory mechanism of intact bovine corneal epithelial tissue and individual corneal epithelial cells over synthetic surfaces in vitro were compared. In migrating tissue, adhesion between component cells was demonstrated by immunostaining for desmoplakin and identification of desmosomes by electron microscopy. The apparent intermeshing of microtubules within the tissue and interdigitation of cytoplasmic membranes showed the close association of cells. Portions of the advancing edge of the tissue contained actin filaments that were orientated parallel to the leading tissue front. These filaments appeared to span adjacent cells suggesting that migration partially involved the contraction of the actin cable, similar to the 'purse-string' mechanism originally identified in the closure of fetal skin wounds. Intact actin filaments and microtubules were necessary to maintain optimum migration rates for tissue and cells. However, tissue morphology was not dependent on microtubule integrity. During the migration of individual epithelial cells, no staining for desmoplakin was observed and there were clear divisions between the microtubules of adjacent cells. Actin filaments tended to be arranged parallel to the direction of cell movement.
   Therefore, migration of epithelial tissue sheets over synthetic surfaces occurs by mechanisms that differ from the migration of individual epithelial cells, Model systems based on the migration of intact tissue would give a more realistic assessment of the suitability of a material for biomaterial applications than the use of separate epithelial cells.
C1 CSIRO, Mol Sci & Cooperat Res Ctr Eye Res & Technol, N Ryde, NSW 1670, Australia.
RP Dalton, BA (reprint author), CSIRO, Mol Sci & Cooperat Res Ctr Eye Res & Technol, Riverside Corp Pk,POB 184, N Ryde, NSW 1670, Australia.
CR BEMENT WM, 1993, J CELL BIOL, V121, P565, DOI 10.1083/jcb.121.3.565
   BURRIDGE K, 1988, ANNU REV CELL BIOL, V4, P487, DOI 10.1146/annurev.cb.04.110188.002415
   Chung JH, 1998, OPHTHALMOLOGICA, V212, P46, DOI 10.1159/000027259
   Dalton BA, 1999, J BIOMED MATER RES, V45, P384, DOI 10.1002/(SICI)1097-4636(19990615)45:4<384::AID-JBM14>3.0.CO;2-O
   Dalton BA, 2001, J BIOMED MATER RES, V56, P83, DOI 10.1002/1097-4636(200107)56:1<83::AID-JBM1071>3.0.CO;2-H
   Danjo Y, 1998, J CELL SCI, V111, P3323
   DIPASQUALE A, 1975, EXP CELL RES, V94, P191, DOI 10.1016/0014-4827(75)90545-5
   DIPASQUALE A, 1975, EXP CELL RES, V95, P425, DOI 10.1016/0014-4827(75)90568-6
   DUA HS, 1994, BRIT J OPHTHALMOL, V78, P401, DOI 10.1136/bjo.78.5.401
   EUTENEUER U, 1986, ANN NY ACAD SCI, V466, P867, DOI 10.1111/j.1749-6632.1986.tb38473.x
   Evans MDM, 2000, INVEST OPHTH VIS SCI, V41, P1674
   Evans MDM, 1997, EXP CELL RES, V233, P88, DOI 10.1006/excr.1997.3523
   FISHER EG, 1990, J IMMUNOL METHODS, V128, P235
   Fitton JH, 1998, J BIOMED MATER RES, V42, P245
   GIPSON IK, 1982, INVEST OPHTH VIS SCI, V22, P643
   GIPSON IK, 1982, INVEST OPHTH VIS SCI, V22, P633
   GIPSON IK, 1977, INVEST OPHTH VIS SCI, V16, P161
   GIPSON IK, 1994, PRINCIPLES PRACTICE, P3
   GOLDMAN RD, 1971, J CELL BIOL, V51, P752, DOI 10.1083/jcb.51.3.752
   GOTLIEB AI, 1983, J CELL BIOL, V96, P1266, DOI 10.1083/jcb.96.5.1266
   GUNDERSEN GG, 1987, J CELL BIOL, V105, P251, DOI 10.1083/jcb.105.1.251
   GUNDERSEN GG, 1988, P NATL ACAD SCI USA, V85, P5946, DOI 10.1073/pnas.85.16.5946
   HOGAN MJ, 1971, HIST HUMAN EYE
   HUTTENLOCHER A, 1995, CURR OPIN CELL BIOL, V7, P697, DOI 10.1016/0955-0674(95)80112-X
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   Krendel MF, 1999, CELL MOTIL CYTOSKEL, V43, P296, DOI 10.1002/(SICI)1097-0169(1999)43:4<296::AID-CM3>3.0.CO;2-U
   Latkany R, 1997, J BIOMED MATER RES, V36, P29, DOI 10.1002/(SICI)1097-4636(199707)36:1<29::AID-JBM4>3.3.CO;2-3
   Lee Juliet, 1993, Trends in Cell Biology, V3, P366, DOI 10.1016/0962-8924(93)90084-E
   LIAO GJ, 1995, J CELL SCI, V108, P3473
   MAHAN JT, 1986, J EXP ZOOL, V237, P35, DOI 10.1002/jez.1402370107
   MARTIN P, 1992, NATURE, V360, P179, DOI 10.1038/360179a0
   Mikhailov A, 1998, CELL MOTIL CYTOSKEL, V41, P325, DOI 10.1002/(SICI)1097-0169(1998)41:4<325::AID-CM5>3.0.CO;2-D
   Nodder S, 1997, ANAT EMBRYOL, V195, P215, DOI 10.1007/s004290050041
   SANDVIG KU, 1994, ACTA OPHTHALMOL, V72, P43
   Schliwa Manfred, 1993, Trends in Cell Biology, V3, P377
   UNDERWOOD PA, 1989, J CELL SCI, V93, P641
   VAUGHAN RB, 1966, J CELL SCI, V1, P407
NR 37
TC 7
Z9 7
U1 0
U2 2
PU ACADEMIC PRESS LTD ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0014-4835
J9 EXP EYE RES
JI Exp. Eye Res.
PD DEC
PY 2001
VL 73
IS 6
BP 797
EP 814
DI 10.1006/exer.2001.1090
PG 18
WC Ophthalmology
SC Ophthalmology
GA 517HK
UT WOS:000173604900006
PM 11846511
DA 2018-10-20
ER

PT J
AU Guzzardella, GA
   Torricelli, P
   Aldini, NN
   Giardino, R
AF Guzzardella, GA
   Torricelli, P
   Aldini, NN
   Giardino, R
TI Laser technology in orthopedics: preliminary study on low power laser
   therapy to improve the bone-biomaterial interface
SO INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Article
DE diode laser; biomaterial; bone-biomaterial interface; low-power laser
ID HYDROXYAPATITE; IRRADIATION; RATS; BIOSTIMULATION; CO2-LASER; SURGERY;
   TISSUE; REPAIR
AB Low Power Laser (LPL) seems to enhance the healing of bone defects and fractures, The effect of LPL in other orthopedic areas such as osteointegration of implanted prosthetic bone devices is still unclear. In the present study, 12 rabbits were used to evaluate whether Ga-Al-As (780 nm) LPL stimulation has positive effects on osteointegration. Hydroxyapatite (HA) cylindrical nails were drilled into both distal femurs of rabbits. From postoperative day I and for 5 consecutive days, the left femura of all rabbits were given LPL treatment (Laser Group-LG) with the following parameters: 300 Joule/cm(2), 1 Watt, 300 Hertz, pulsating emission, 10 minutes, The right femura were sham-treated (Control Group-CG), At 4 and 8 weeks after implantation, histologic and histomorphometric investigations evaluated bone-biomaterial-con tact. Histomorphometry showed a higher degree of osteointegration at the HA-bone interface in the LG Group at 4 (p<0.0005) and 8 weeks (p<0.001), These preliminary positive results seem to support the hypothesis that LPL treatment can be considered a good tool to enhance the bone-implant interface in orthopedic surgery.
C1 Rizzoli Orthoped Inst, Res Inst Codivilla Putti, Expt & Surg Dept, Serv Chirurg Sperimentale, I-40136 Bologna, Italy.
   Univ Bologna, Sch Med, Chair Surg Pathophysiol, Bologna, Italy.
RP Guzzardella, GA (reprint author), Rizzoli Orthoped Inst, Res Inst Codivilla Putti, Expt & Surg Dept, Serv Chirurg Sperimentale, Via Barbiano 1-10, I-40136 Bologna, Italy.
EM gaetanoantonio.guzzardella@ior.it
RI TORRICELLI, PAOLA/J-5298-2016
OI TORRICELLI, PAOLA/0000-0001-7494-9970
CR ALFAROADRIAN J, 1998, HIP INT, V8, P62
   Capello WN, 1998, CLIN ORTHOP RELAT R, P200, DOI 10.1097/00003086-199810000-00021
   CEDER L, 1998, HIP INT, V8, P99
   DEW DK, 1993, ORTHOPEDICS, V16, P581
   Dorr LD, 1998, J ARTHROPLASTY, V13, P729, DOI 10.1016/S0883-5403(98)90023-7
   Dortbudak O, 2000, CLIN ORAL IMPLAN RES, V11, P540, DOI 10.1034/j.1600-0501.2000.011006540.x
   el-Montaser M, 1999, Implant Dent, V8, P79, DOI 10.1097/00008505-199901000-00010
   ENWEMEKA C S, 1991, Journal of Orthopaedic and Sports Physical Therapy, V14, P198
   Fini M, 2000, INT J ARTIF ORGANS, V23, P275
   Fini M, 1997, INT J ARTIF ORGANS, V20, P291
   GUILLEMIN F, 2000, HIP INT, V10, P108
   Guzzardella G A, 1996, Acta Biomed Ateneo Parmense, V67, P55
   GUZZARDELLA GA, 2001, BLOOD SUBS IMMOB BIO, V29, P235
   HALL RR, 1971, NATURE, V232, P131, DOI 10.1038/232131a0
   Kawasaki K, 2000, LASER SURG MED, V26, P282, DOI 10.1002/(SICI)1096-9101(2000)26:3<282::AID-LSM6>3.3.CO;2-O
   Lee JJ, 2000, J ORAL MAXIL SURG, V58, P1372, DOI 10.1053/joms.2000.18269
   LEGEROS RZ, 1993, J BONE MINER RES, V8, pS583
   Lewandrowski KU, 1996, LASER SURG MED, V19, P40, DOI 10.1002/(SICI)1096-9101(1996)19:1<40::AID-LSM6>3.3.CO;2-3
   Luger EJ, 1998, LASER SURG MED, V22, P97, DOI 10.1002/(SICI)1096-9101(1998)22:2<97::AID-LSM5>3.0.CO;2-R
   Meffert R M, 1999, Adv Dent Res, V13, P170
   Morrone G, 2000, ARTIF CELL BLOOD SUB, V28, P321, DOI 10.3109/10731190009119362
   Ong JL, 2000, CRIT REV BIOMED ENG, V28, p667A
   Parker M J, 1998, HIP INT, V8, P10
   Rocca M, 1998, INT J ARTIF ORGANS, V21, P553
   Rocca M, 2000, INT J ARTIF ORGANS, V23, P824
   Rokkum M, 1999, J ARTHROPLASTY, V14, P689, DOI 10.1016/S0883-5403(99)90224-3
   Romanos GE, 2000, J PERIODONTOL, V71, P810, DOI 10.1902/jop.2000.71.5.810
   SHEWALE SB, 2001, HIP INT, V11, P158
   SOBALLE K, 2000, HIP INT, V10, P181
   TANG XM, 1986, LASER SURG MED, V6, P346, DOI 10.1002/lsm.1900060309
   Toni A., 2001, HIP INT, V11, P1
   TORIYAMA M, 1995, J MATER SCI, V30, P3216, DOI 10.1007/BF01209240
   TRELLES MA, 1987, LASER SURG MED, V7, P36, DOI 10.1002/lsm.1900070107
   Tsai CL, 1997, LASER SURG MED, V20, P172
   TUNER J, 1999, LEVEL LASER THERAPY, P169
   WILLMANN G, 2000, HIP INT, V10, P193
NR 36
TC 14
Z9 17
U1 0
U2 3
PU WICHTIG PUBLISHING
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 0391-3988
EI 1724-6040
J9 INT J ARTIF ORGANS
JI Int. J. Artif. Organs
PD DEC
PY 2001
VL 24
IS 12
BP 898
EP 902
PG 5
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 510YC
UT WOS:000173234300010
PM 11831596
DA 2018-10-20
ER

PT J
AU Lamghari, M
   Antonietti, P
   Berland, S
   Laurent, A
   Lopez, E
AF Lamghari, M
   Antonietti, P
   Berland, S
   Laurent, A
   Lopez, E
TI Arthrodesis of lumbar spine transverse processes using nacre in rabbit
SO JOURNAL OF BONE AND MINERAL RESEARCH
LA English
DT Article
DE biomaterial; nacre; osteogenesis; orthopaedic surgery; axial correction
ID OSTEOBLASTS MAINTAINED INVITRO; NONHUMAN PRIMATE; BONE-DEVELOPMENT;
   PROTEIN; MATRIX; FUSION; PROTEOGLYCAN; INTERFACE; INDUCTION; CARTILAGE
AB This study compares the osteogenic effects of nacre and autogenous bone grafts in a rabbit model of lumbar spine transverse process arthrodesis. A total of 15 rabbits were processed for arthrodesis between the fifth and sixth lumbar vertebrae using nacre powder mixed with autologous blood or autogenous iliac crest bone. Control rabbits were sham operated. Sample vertebrae were removed from the nacre-implanted rabbits at 2, 5, and 11 weeks postsurgery. The autogenous bone graft and sham-operated groups were processed for histological study 11 weeks postsurgery. The results for the three groups were compared at 11 weeks. The nacre-implanted samples taken at 2 weeks showed that the nacre was well tolerated by the host tissue. Endochondral bone formation was seen in the region of the dissolving nacre particles by 5 weeks. The newly formed bone formed a solid fusion between the transverse processes in one-third of the rabbits. There was still new bone formation at 11 weeks at the nacre implant site. Two-thirds of the rabbits had formed a solid fusion. Light microscopy also showed new bone formation 11 weeks after the autologous bone graft. All rabbits had a solid fusion. This initial study indicates that nacre can induce spinal fusion in an acceptable percentage of cases.
C1 Museum Natl Hist Nat, Lab Physiol Gen & Comparee, CNRS, UMR 8572, F-75231 Paris 05, France.
   Clin Jouvenet, Dept Chirurg Orthoped, Paris, France.
   Hop Lariboisiere, Serv Neuroradiol Diagnost & Intervent, Paris, France.
RP Lopez, E (reprint author), Museum Natl Hist Nat, Lab Physiol Gen & Comparee, CNRS, UMR 8572, 7 Rue Cuvier, F-75231 Paris 05, France.
RI Lamghari, Meriem/K-2159-2013
OI Lamghari, Meriem/0000-0002-2500-4548
CR Almeida MJ, 2000, J EXP ZOOL, V288, P327, DOI 10.1002/1097-010X(20001215)288:4<327::AID-JEZ5>3.0.CO;2-#
   Atlan G, 1997, CR ACAD SCI III-VIE, V320, P253, DOI 10.1016/S0764-4469(97)86933-8
   Atlan G, 1999, BIOMATERIALS, V20, P1017, DOI 10.1016/S0142-9612(98)90212-5
   Boden SD, 1999, SPINE, V24, P1179, DOI 10.1097/00007632-199906150-00002
   Boden SD, 1999, SPINE, V24, P320, DOI 10.1097/00007632-199902150-00003
   BODEN SD, 1995, J BONE JOINT SURG AM, V77, P1404, DOI 10.2106/00004623-199509000-00017
   FRENKEL SR, 1993, SPINE, V18, P1634, DOI 10.1097/00007632-199309000-00011
   Guicheux J, 1998, J BONE MINER RES, V13, P793
   HAGEN JW, 1992, J BIOMED MATER RES, V26, P897, DOI 10.1002/jbm.820260706
   Lamghari M, 1999, BONE, V25, p91S, DOI 10.1016/S8756-3282(99)00141-6
   LEFAOU A, 1995, CALCIF TISSUE INT S, V56, pA461
   LOPEZ E, 1992, TISSUE CELL, V24, P667, DOI 10.1016/0040-8166(92)90037-8
   LOPEZ E, Patent No. 9724133
   MALININ TI, 1981, CLIN ORTHOP RELAT R, P68
   Martin GJ, 1999, J SPINAL DISORD, V12, P179, DOI 10.1097/00002517-199906000-00001
   MUTAHIR F, 2001, J MATER SCI-MATER M, V12, P1
   POOLE AR, 1982, DEV BIOL, V89, P532, DOI 10.1016/0012-1606(82)90343-8
   REDDI AH, 1978, J BIOL CHEM, V253, P2429
   SCHIMANDLE JH, 1995, SPINE, V20, P1326, DOI 10.1097/00007632-199506000-00002
   SILVE C, 1992, CALCIFIED TISSUE INT, V51, P363, DOI 10.1007/BF00316881
   URIST MARSHALL R., 1967, CLIN ORTHOP RELATED RESIN COMPLICATIONS OF ORTHOPAEDIC SURGERY, V53, P243
   URIST MR, 1994, BONE GRAFTS, DERIVATIVES AND SUBSTITUTES, P315
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   Villas C, 1996, Rev Med Univ Navarra, V40, P15
   WANG JS, 1993, ACTA ORTHOP SCAND, V64, P557, DOI 10.3109/17453679308993692
   Westbroek P, 1998, NATURE, V392, P861, DOI 10.1038/31798
   WOLFINBARGER L, 1993, IN VITRO CELL DEV-AN, V29A, P914
NR 27
TC 21
Z9 24
U1 0
U2 3
PU AMER SOC BONE & MINERAL RES
PI WASHINGTON
PA 2025 M ST, N W, STE 800, WASHINGTON, DC 20036-3309 USA
SN 0884-0431
J9 J BONE MINER RES
JI J. Bone Miner. Res.
PD DEC
PY 2001
VL 16
IS 12
BP 2232
EP 2237
DI 10.1359/jbmr.2001.16.12.2232
PG 6
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 495BP
UT WOS:000172320600008
PM 11760836
OA Bronze
DA 2018-10-20
ER

PT J
AU Voggenreiter, G
   Hartl, K
   Assenmacher, S
   Chatzinikolaidou, M
   Rumpf, HM
   Jennissen, HP
AF Voggenreiter, G
   Hartl, K
   Assenmacher, S
   Chatzinikolaidou, M
   Rumpf, HM
   Jennissen, HP
TI Assesment of the biological activity of chemically immobilized rhBMP-2
   on titanium surfaces in vivo
SO MATERIALWISSENSCHAFT UND WERKSTOFFTECHNIK
LA English
DT Article
ID IMPLANTS
AB Previously it has been shown that recombinant human bone morphogenetic protein (rhBMP-2) can be chemically immobilized by anchor molecules" on titanium surfaces for serving as a drug delivery device. This opened the question of whether the insoluble immobilized rhBMP-2 retained its activity in comparison to the same amount of soluble rhBMP-2 included with the implant samples. Electropolished titanium miniplates (10 x 6 X 0.8 mm) were 11 surface -enhanced" by a novel treatment with chromosulfuric acid and then coated with a total amount of 150 - 200 ng rhBMP-2 prepared by recombinant technology. Periosteal flaps (7 x 20 mm) were detached and isolated front the anterior surface of the tibiac of adult rabbit,, and scrapped around the titanium sample plates which were then implanted in the M. gastrocnemius. In the first experimental group various controls without rhBMP-2 were combined (n - 12). In the second experimental group implants with chemically immobilized rhBMP-2 ( n = 8) were compared with implants to which non-immobilized soluble rhBMP-2 was added (n = 8). Animals were sacrificed after 28 days and a quantitative evaluation vas carried out by means of serial sections. Untreated control plates showed bone formation in 2/12 implants. rhBMP-2 coated implants in 6/8 and implants,kith free rhBMP-2 administered subperiostally in 8/8 cases. In the case of rhBMP-2 coated implants the induced bone had direct contact to the implant in all cases while in the group with free administered rhBMP-2 the bone had no contact to the implant in two cases, but was separated by a fibrous capsule. Bone volume. bone surface area, and trabecular number displayed no difference between the two rhBMP-2-groups. However, in the biocoated group a tendency to an increase in the bone-implant contact area was evident, No differences in osteoid area, osteoid perimeter and eroded perimeter were detected. We conclude that in the case of non-immobilized rhBMP-2 there is the danger for formation of fibrous tissue between the implant and the newly formed bone and in addition the generation of ectopic bone at inappropriate places. In contrast chemically immobilized rhBMP-2 does not have these drawbacks and at the same time displays a biological activity on surfaces similar to that of soluble rhBMP-2 demonstrating that biomaterial surface,, can be tailored for a,elective and specific interaction with the target tissue.
C1 Univ Heidelberg, Klinikum Mannheim, Dept Trauma Surg, D-68165 Mannheim, Germany.
   Bethesda Hosp, Dept Trauma Surg, Duisburg, Germany.
   Univ Essen Gesamthsch Klinikum, Inst Physiol Chem, D-4300 Essen, Germany.
RP Voggenreiter, G (reprint author), Univ Heidelberg, Klinikum Mannheim, Dept Trauma Surg, Theodor Kutzer Ufer 1-3, D-68165 Mannheim, Germany.
RI Chatzinikolaidou, Maria/H-1061-2014
OI Chatzinikolaidou, Maria/0000-0002-2749-2506
CR ASSENMACHER S, 2000, CHIRUG FORUM, V29, P433
   Barnes GL, 1999, J BONE MINER RES, V14, P1805, DOI 10.1359/jbmr.1999.14.11.1805
   Bessho K, 1999, CLIN ORAL IMPLAN RES, V10, P212, DOI 10.1034/j.1600-0501.1999.100304.x
   Heckman JD, 1999, J BONE JOINT SURG AM, V81A, P1717, DOI 10.2106/00004623-199912000-00009
   Jennissen H. P., 2000, DVM BERICHT, V313, P127
   Jennissen HP, 1999, MATERIALWISS WERKST, V30, P838, DOI 10.1002/(SICI)1521-4052(199912)30:12<838::AID-MAWE838>3.0.CO;2-W
   JENNISSEN HP, 2001, BIOMATERIALIEN, V2, P45
   JENNISSEN HP, 2000, Patent No. 10037852
   Lian J, 1999, PRIMER METABOLIC BON, P14
   Lind M, 2000, J ARTHROPLASTY, V15, P339, DOI 10.1016/S0883-5403(00)90693-4
   Nimni ME, 1997, BIOMATERIALS, V18, P1201, DOI 10.1016/S0142-9612(97)00050-1
   Riley EH, 1996, CLIN ORTHOP RELAT R, P39, DOI 10.1097/00003086-199603000-00006
   Uludag H, 2000, J BIOMED MATER RES, V50, P227, DOI 10.1002/(SICI)1097-4636(200005)50:2<227::AID-JBM18>3.0.CO;2-2
   Uludag H, 2001, J BONE JOINT SURG AM, V83A, pS128
   WIEMANN M, 2001, WERKSTOFFTECH, V32, P931
   Zegzula HD, 1997, J BONE JOINT SURG AM, V79A, P1778, DOI 10.2106/00004623-199712000-00003
NR 16
TC 20
Z9 20
U1 0
U2 2
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 0933-5137
J9 MATERIALWISS WERKST
JI Materialwiss. Werkstofftech.
PD DEC
PY 2001
VL 32
IS 12
BP 942
EP 948
DI 10.1002/1521-4052(200112)32:12<942::AID-MAWE942>3.0.CO;2-9
PG 7
WC Materials Science, Multidisciplinary
SC Materials Science
GA 510YD
UT WOS:000173234400009
DA 2018-10-20
ER

PT J
AU Wissler, JH
AF Wissler, JH
TI Engineering of blood vessel patterns by angio-morphogens [angiotropins]:
   Non-mitogenic copper-ribonucleoprotein cytokines [CuRNP ribokines] with
   their metalloregulated constituents of RAGE-binding S100-EF-hand
   proteins and extracellular RNA bioaptamers in vascular remodeling of
   tissue and angiogenesis in vitro
SO MATERIALWISSENSCHAFT UND WERKSTOFFTECHNIK
LA English
DT Review
ID CAPILLARY ENDOTHELIAL-CELLS; INDUCED CORNEAL VASCULARIZATION;
   LOW-DENSITY LIPOPROTEIN; TUMOR ANGIOGENESIS; IN-VITRO; THERAPEUTIC
   IMPLICATIONS; COLLAGEN SUBSTRATUM; NUCLEASE ACTIVITY; GENETIC ALPHABET;
   GROWTH-FACTORS
AB Tissue vascularization is requisite to successful cell-based therapies, biomaterial design and implant integration. Thus, known problems in ossointegration of avascular implants in connection with the generation of bone tissue reflect arrays of general problem,. of socio-economic relevance existing in reparative medicine still waiting for to be solved. For this purpose. morphogenesis and remodeling of endothelial angio-architectures in tissue and in vitro by isolated non-mitogenic angio-morphogens [angiotropins] are considered in terms of their structure, function and action mechanisms. Extracellular angiotropins are secreted by activated leukocytes/monocytes/macrophages. They are a family of cytokines with morphogen bioactivity selectively directed to endothelial cells. Their Structure as deciphered as metalloregulated copper-ribonucleoproteins [CuRNP ribokines]. The) are built up of angiotropin-related S100-EF-hand protein [ARP] and highly modified and edited 5'end-phosphorylated RNA [ARNA]. complexed together by copper ions. Oxidant-sensitive ARNA and their precursors represent novel tapes in a RNA world: The are the first isolated and sequenced forms of extracellular RNA [eRNA], may act as cytokine and bioaptamer. contain isoguanosine [crotonoside] as modified nucleoside and show up copper as RNA-structuring transition metal ion. By metalloregulated bioaptamer functions, ARNA impart novel biofunctions to RAGE-binding S100-EF-hand proteins. Angiotropin morphogens were shown suitable for neointiation and remodeling of blood vessel patterns in different. adult, embryonal and artificial tissues. These neovascular patterns manifest regulated hemodynamics for preventing tissue necrosis, supporting tissue functions and promoting wound healing, As evaluatcd in skin and muscle vascularization, the neovascular patterns are integrated into homeostatic control mechanisms of tissue, Thus, the morphogens show up beneficial perspectives and are suggested Useful tools for further investigations in angiotherapy engineering of blood vessel patterns in tissues and biocompatible artificial organs as well as in the preparation of novel implants with morphogen-coated surfaces.
C1 ARCONS Appl Res, D-61231 Bad Nauheim, Germany.
RP Wissler, JH (reprint author), ARCONS Appl Res, Postfach 1327, D-61231 Bad Nauheim, Germany.
CR ACKERS GK, 1962, ACTA, V69, P137
   ALPERNELRAN H, 1989, J NEUROSURG, V70, P942, DOI 10.3171/jns.1989.70.6.0942
   ALTMAN S, 1989, ENZYMOL RELAT AREAS, V62, P1
   ANDREWS P, 1964, BIOCHEM J, V91, P222, DOI 10.1042/bj0910222
   Auerbach R, 2000, CANCER METAST REV, V19, P167, DOI 10.1023/A:1026574416001
   AUERBACH W, 1994, PHARMACOL THERAPEUT, V63, P265, DOI 10.1016/0163-7258(94)90027-2
   BANDA MJ, 1982, P NATL ACAD SCI-BIOL, V79, P7773, DOI 10.1073/pnas.79.24.7773
   BANDA MJ, 1985, J CELL BIOCHEM, V29, P183, DOI 10.1002/jcb.240290303
   BENNER SA, 1989, TRENDS BIOCHEM SCI, V14, P396, DOI 10.1016/0968-0004(89)90282-X
   BENNER SA, 1988, FEBS LETT, V233, P225, DOI 10.1016/0014-5793(88)80431-9
   BERNAUER W, 1972, INT ARCH ALLER A IMM, V42, P136, DOI 10.1159/000230599
   BILLROTH T, 1986, ED UNTERSUCHUNGEN EN
   Brem S, 1999, CANC CONTROL, V6, P436
   BRILLOUIN L, 1962, SCI INFORMATION THEO
   BURDACH SE, 1984, PROTIDES BIOL FLUIDS, V32, P1181
   BURDACH SEG, 1984, RES CLIN LAB, V14, P565
   BURKE JF, 1981, ANN SURG, V194, P413, DOI 10.1097/00000658-198110000-00005
   CARMICHAEL PL, 1992, CARCINOGENESIS, V13, P1127, DOI 10.1093/carcin/13.7.1127
   Carreira CM, 1998, J BIOL CHEM, V273, P22224, DOI 10.1074/jbc.273.35.22224
   Carreira CM, 2001, GROWTH FACTORS, V18, P277, DOI 10.3109/08977190109029116
   Cavallaro U, 2001, J CELL BIOCHEM, V82, P619, DOI 10.1002/jcb.1190
   CECH TR, 1989, BIOCHEM INT, V18, P7
   CHEN CHB, 1993, P NATL ACAD SCI USA, V90, P4206, DOI 10.1073/pnas.90.9.4206
   CRICK F, 1970, NATURE, V225, P420, DOI 10.1038/225420a0
   Crick F. H C., 1971, Symp Soc Exp Biol, V25, P429
   DAMORE PA, 1987, ANNU REV PHYSIOL, V49, P453
   Darland DC, 2001, CURR TOP DEV BIOL, V52, P107, DOI 10.1016/S0070-2153(01)52010-4
   DAVIS JT, 1995, J ORG CHEM, V60, P4167, DOI 10.1021/jo00118a038
   Davis S, 1996, CELL, V87, P1161, DOI 10.1016/S0092-8674(00)81812-7
   DELLANGELICA EC, 1994, J BIOL CHEM, V269, P28929
   DESHPANDE R G, 1989, Indian Journal of Medical Research Section B, V90, P241
   DODD NJF, 1984, J CELL SCI, V68, P153
   Donato R, 1999, BBA-MOL CELL RES, V1450, P191, DOI 10.1016/S0167-4889(99)00058-0
   EDMAN P, 1956, ACTA CHEM SCAND, V10, P761, DOI 10.3891/acta.chem.scand.10-0761
   EDMAN P, 1950, ACTA CHEM SCAND, V4, P283, DOI 10.3891/acta.chem.scand.04-0283
   EDMAN P, 1967, EUR J BIOCHEM, V1, P80, DOI 10.1111/j.1432-1033.1967.tb00047.x
   Edman P, 1970, Mol Biol Biochem Biophys, V8, P211
   ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0
   ERROI AL, 1986, ANTICANCER RES, V6, P1045
   Fabbrizzi L, 1999, ACCOUNTS CHEM RES, V32, P846, DOI 10.1021/ar990013l
   FAVARD C, 1991, BIOL CELL, V73, P1, DOI 10.1016/0248-4900(91)90002-5
   FENSELAU A, 1981, J BIOL CHEM, V256, P9605
   FENSELAU A, 1981, J MICROVASC RES, V22, P58
   FERRARA N, 1989, BIOCHEM BIOPH RES CO, V161, P851, DOI 10.1016/0006-291X(89)92678-8
   FETT JW, 1985, BIOCHEMISTRY-US, V24, P5480, DOI 10.1021/bi00341a030
   FOLKMAN J, 1971, J EXP MED, V133, P275, DOI 10.1084/jem.133.2.275
   FOLKMAN J, 1980, NATURE, V288, P551, DOI 10.1038/288551a0
   FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182
   Folkman J, 1997, EXS, V79, P1
   Folkman J, 1996, CELL, V87, P1153, DOI 10.1016/S0092-8674(00)81810-3
   FROMER CH, 1976, AM J PATHOL, V82, P157
   FROMER CH, 1975, AM J PATHOL, V81, P531
   FROMER CH, 1975, AM J PATHOL, V79, P537
   FULTON GEORGE P., 1960, PHYSIOL REVS, V40, P57
   Garrett KL, 2001, J GENE MED, V3, P373, DOI 10.1002/jgm.197
   Gesteland R.F., 1999, RNA WORLD
   Giordano FJ, 2001, CURR OPIN GENET DEV, V11, P35, DOI 10.1016/S0959-437X(00)00153-2
   Gospodarowicz D, 1976, Prog Clin Biol Res, V9, P1
   GOTTWIK M, 1982, H-S Z PHYSIOL CHEM, V363, P938
   GROSJEAN H, 1998, MODIFICATION EDITON
   GULLINO PM, 1990, CANCER METAST REV, V9, P239, DOI 10.1007/BF00046363
   HOCKEL M, 1985, FED PROC, V44, P1880
   HOCKEL M, 1984, INT J TISSUE REACT, V6, P323
   HOCKEL M, 1987, J CELL PHYSIOL, V133, P1, DOI 10.1002/jcp.1041330102
   HOCKEL M, 1989, ARCH SURG-CHICAGO, V124, P693
   HOCKEL M, 1988, J CLIN INVEST, V82, P1075, DOI 10.1172/JCI113664
   HOCKEL M, 1985, KLIN FORSCH GYN GEBU, V10, P122
   HOCKEL M, 1986, PROTIDES BIOL FLUIDS, V34, P517
   HOCKEL M, 1984, PROTIDES BIOL FLUIDS, V31, P1161
   Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6
   Ilan N, 1999, CURR OPIN BIOTECH, V10, P536, DOI 10.1016/S0958-1669(99)00026-9
   IRUELAARISPE ML, 1993, J CELL BIOCHEM, V52, P414, DOI 10.1002/jcb.240520406
   IRUELAARISPE ML, 1997, THROMB HAEMOSTASIS, V78, P6272
   KAMINSKI M, 1988, P SOC EXP BIOL MED, V188, P440
   KASTNER M, 1984, Z NATURFORSCH C, V39, P639
   KEEGAN A, 1982, J CELL SCI, V55, P261
   KELLER H, 1980, J IMMUNOL METHODS, V36, P41, DOI 10.1016/0022-1759(80)90092-7
   KELLER HU, 1979, EXPERIENTIA, V35, P1669, DOI 10.1007/BF01953261
   KELLER HU, 1977, EXPERIENTIA, V33, P534, DOI 10.1007/BF01922257
   KELLER HU, 1981, IMMUNOLOGY, V42, P379
   Kersten JR, 1999, CARDIOVASC RES, V43, P44, DOI 10.1016/S0008-6363(99)00077-2
   Kiesewetter S., 1995, Biological Chemistry Hoppe-Seyler, V376, pS115
   KIESEWETTER S, 1995, FASEB J, V9, pA1369
   KOLODNY G M, 1974, P97
   KOLODNY GM, 1971, EXP CELL RES, V65, P313, DOI 10.1016/0014-4827(71)90007-3
   KOLODNY GM, 1972, EXP CELL RES, V73, P65, DOI 10.1016/0014-4827(72)90102-4
   KOLODNY GM, 1972, J CELL PHYSL, V79, P177
   KUHN E, 1996, BIOL CHEM, V377, pS195
   KUMAR S, 1980, JNCI-J NATL CANCER I, V64, P683
   KUMAR S, 1987, DIFFERENTIATION, V36, P57, DOI 10.1111/j.1432-0436.1987.tb00181.x
   KUWABARA M, 1986, BIOCHEMISTRY-US, V25, P7401, DOI 10.1021/bi00371a023
   Kuwano M, 2001, INTERNAL MED, V40, P565, DOI 10.2169/internalmedicine.40.565
   Landriscina M, 2001, J BIOL CHEM, V276, P22544, DOI 10.1074/jbc.M100546200
   LANDRISCINA M, 1981, J BIOL CHEM, V276, P25549
   LANE TF, 1994, J CELL BIOL, V125, P929, DOI 10.1083/jcb.125.4.929
   Lanza R. P., 1997, PRINCIPLES TISSUE EN
   Leenders WPJ, 1997, MECH DEVELOP, V67, P193, DOI 10.1016/S0925-4773(97)00121-4
   LIEBOW AA, 1963, HANDBOOK PHYSIOLOG 2, V2, P1251
   Lindner V, 2001, AM J PATHOL, V159, P875, DOI 10.1016/S0002-9440(10)61763-4
   Liss C, 2001, INT J CANCER, V93, P781, DOI 10.1002/ijc.1407
   LOEWENSTEIN WR, 1971, HDB SENSORY PHYSL, V1, P226
   Long EC, 1999, ACCOUNTS CHEM RES, V32, P827, DOI 10.1021/ar980072j
   LUCCHESI BR, 1986, ANNU REV PHARMACOL, V26, P201, DOI 10.1146/annurev.pa.26.040186.001221
   Malonne H, 1999, CLIN EXP METASTAS, V17, P1, DOI 10.1023/A:1026443925807
   Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700
   MAURER HR, 1981, Z PHYSL CHEM, V362, P221
   Mauro A, 1979, MUSCLE REGENERATION
   MEINHARDT H, MODELS BIOL PATTERNS, P82
   MENEGHINI R, 1995, CANCER J, V8, P109
   MIDY V, 1994, BIOCHEM BIOPH RES CO, V199, P380, DOI 10.1006/bbrc.1994.1240
   Milkiewicz M, 2001, MICROCIRCULATION, V8, P229, DOI 10.1038/sj.mn.7800074
   MODAK AS, 1991, J AM CHEM SOC, V113, P283, DOI 10.1021/ja00001a041
   MONTESANO R, 1986, P NATL ACAD SCI USA, V83, P7297, DOI 10.1073/pnas.83.19.7297
   MOROWITZ HJ, 1971, ENTROPY BIOL
   MOYON D, 2001, MECH DEVELOP, V103, P133
   MULVIHILL DA, 1931, NEW ENGL J MED, V104, P1032
   NEUMEIER R, 1982, H-S Z PHYSIOL CHEM, V363, P193
   OREILLY MS, 1994, COLD SPRING HARB SYM, V59, P471, DOI 10.1101/SQB.1994.059.01.052
   OREILLY MS, 1994, CELL, V79, P315, DOI 10.1016/0092-8674(94)90200-3
   OReilly MS, 1997, CELL, V88, P277, DOI 10.1016/S0092-8674(00)81848-6
   ORGEL LE, 1990, NATURE, V343, P18, DOI 10.1038/343018a0
   ORLIDGE A, 1987, J CELL BIOL, V105, P1455, DOI 10.1083/jcb.105.3.1455
   OSHEA PS, 1988, EXPERIENTIA, V44, P631, DOI 10.1007/BF01941022
   PAPPENHEIMER JR, 1951, AM J PHYSIOL, V167, P13
   Patan S, 2000, J NEURO-ONCOL, V50, P1, DOI 10.1023/A:1006493130855
   Peitsch MC, 1996, BIOCHEM SOC T, V24, P274, DOI 10.1042/bst0240274
   PETERSON HI, 1979, TUMOR BLOOD CIRCULAT
   PICCIRILLI JA, 1990, NATURE, V343, P33, DOI 10.1038/343033a0
   POLAKOWSKI IJ, 1993, AM J PATHOL, V143, P507
   Polverini P J, 1997, EXS, V79, P11
   POLVERINI PJ, 1984, LAB INVEST, V51, P635
   POLVERINI PJ, 1977, NATURE, V269, P804, DOI 10.1038/269804a0
   Potter JD, 2001, CANCER EPIDEM BIOMAR, V10, P161
   PRIGOGINE I, 1978, ANGEW CHEM, V90, P704
   RAINES RT, 1995, J BIOL CHEM, V270, P17180, DOI 10.1074/jbc.270.29.17180
   RAJU KS, 1982, J NATL CANCER I, V69, P1183
   Ramirez-Bergeron DL, 2001, STEM CELLS, V19, P279, DOI 10.1634/stemcells.19-4-279
   Reilly W, 1988, Adv Exp Med Biol, V242, P221
   RENKIN EM, 1954, J GEN PHYSIOL, V38, P225
   Rich A, 1962, HORIZONS BIOCH, P103
   ROONEY P, 1995, INT J CANCER, V60, P632, DOI 10.1002/ijc.2910600511
   Rosenthal AM, 1990, CELL CULTURE TECHNIQ, P117
   Rudman SM, 1997, J INVEST DERMATOL, V109, P770, DOI 10.1111/1523-1747.ep12340934
   RUSSMANN E, 1985, IMMUNOBIOLOGY, V169, P389, DOI 10.1016/S0171-2985(85)80019-X
   RUSSMANN E, 1986, CELL IMMUNOL, V100, P167
   RUSSMANN E, 1984, VERH DTSCH KREBSGESE, V5, P146
   RUSSMANN E, 1985, TREATMENT METASTASIS, P161
   RUTT GT, 1989, ONKOL, V165, P508
   Sambrook J., 2001, MOL CLONING
   SAUER E, 1980, MYOCARD VENTRIKELSZI
   SCHOR AM, 1979, INT J CANCER, V24, P225, DOI 10.1002/ijc.2910240215
   SIGMAN DS, 1993, CHEM REV, V93, P2295, DOI 10.1021/cr00022a011
   SIMORREPINATEL V, 1994, INVEST OPHTH VIS SCI, V35, P3393
   Spemann H, 1924, ARCH MIKROSK ANAT EN, V100, P599, DOI 10.1007/BF02108133
   STEIN O, 1980, BIOCHIM BIOPHYS ACTA, V620, P631, DOI 10.1016/0005-2760(80)90155-1
   STEINER R, 1992, ANGIJOGENESIS
   STOKES RH, 1950, J AM CHEM SOC, V72, P763, DOI 10.1021/ja01158a032
   STOKES RH, 1950, J AM CHEM SOC, V72, P2243, DOI 10.1021/ja01161a101
   Tabata T, 2001, NAT REV GENET, V2, P620, DOI 10.1038/35084577
   TARR GE, 1978, ANAL BIOCHEM, V84, P622, DOI 10.1016/0003-2697(78)90086-6
   TARR GE, 1981, ANAL BIOCHEM, V111, P27, DOI 10.1016/0003-2697(81)90223-2
   THESLEFF I, 1983, CANCER RES, V43, P5902
   TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121
   Vallee BL, 1997, CELL MOL LIFE SCI, V53, P803, DOI 10.1007/s000180050101
   VOYTA JC, 1984, J CELL BIOL, V99, P2034, DOI 10.1083/jcb.99.6.2034
   WAKELEY C, 1955, Ann R Coll Surg Engl, V16, P69
   Wang ZB, 2001, BIOCHEM BIOPH RES CO, V285, P669, DOI 10.1006/bbrc.2001.5232
   WEISSMAN SM, 1983, METHODS DNA RNA SEQU
   Wissler J. H., 1997, Molecular Biology of the Cell, V8, p231A
   Wissler JH, 2000, FASEB J, V14, pA1420
   Wissler JH, 2000, FASEB J, V14, pA20
   WISSLER JH, 1991, BIOL CHEM H-S, V372, P780
   WISSLER JH, 1989, BIOL CHEM H-S, V370, P975
   Wissler JH, 1999, MOL BIOL CELL, V10, p449A
   Wissler JH, 1998, MOL BIOL CELL, V9, p71A
   WISSLER JH, 1990, BIOL CHEM H-S, V371, P827
   WISSLER JH, 1972, INT ARCH ALLER A IMM, V42, P722, DOI 10.1159/000230652
   Wissler JH, 1998, FASEB J, V12, pA1463
   WISSLER JH, 1981, IMMUNOBIOLOGY, V160, P131
   WISSLER JH, 1981, Z PHYSL CHEM, V362, P244
   WISSLER JH, 1982, ENTZUNDUNGSMEDIATORE, P1
   WISSLER JH, 1989, MODERN TRENDS IMMUNO, P174
   WISSLER JH, 1984, PROTIDES BIOL FLUIDS, V32, P1167
   WISSLER JH, 1985, PROTIDES BIOL FLUIDS, V33, P643
   WISSLER JH, 1980, J PHYSL CHEM, V361, P351
   WISSLER JH, 2000, BIOL CHEM, V381, pS246
   WISSLER JH, 1982, Z PHYSL CHEM, V363, P941
   WISSLER JH, 2001, MOL BIOL CELL S, V12, P2304
   WISSLER JH, 1984, BLOOD CELLS NUCL M 2, P41
   WISSLER JH, 1980, INFLAMMATION MECH TR, P591
   WISSLER JH, 1982, KFA, P293
   WISSLER JH, 1986, PROTIDES BIOL FLUIDS, V34, P525
   WISSLER JH, 1982, BIOCH DIFFERENTIATIO, P257
   WISSLER JH, 1984, BLOOD CELLS NUCL 2, P393
   WISSLER JH, 1993, ERKRANKUNGEN IMMUNOP, P1
   WISSLER JH, 2001, BIOL CHEM, V382, pS99
   WISSLER JH, 1984, PROTIDES BIOL FLUIDS, V32, P1165
   WISSLER JH, 1975, GRAM NEGATIVE BACTER, P91
   WISSLER JH, 2000, FASEB J, V14, pS1392
   WOLPERT L, 1969, J THEOR BIOL, V25, P1, DOI 10.1016/S0022-5193(69)80016-0
   Yancopoulos GD, 1998, CELL, V93, P661, DOI 10.1016/S0092-8674(00)81426-9
   Zetter BR, 1998, ANNU REV MED, V49, P407, DOI 10.1146/annurev.med.49.1.407
   Zhao Hui, 1999, Journal of Cellular Biochemistry, V76, P109
   Zimrin AB, 1996, J BIOL CHEM, V271, P32499, DOI 10.1074/jbc.271.51.32499
   Zuker M., 1999, V70, P11
NR 205
TC 4
Z9 4
U1 0
U2 9
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 0933-5137
J9 MATERIALWISS WERKST
JI Materialwiss. Werkstofftech.
PD DEC
PY 2001
VL 32
IS 12
BP 984
EP 1008
DI 10.1002/1521-4052(200112)32:12<984::AID-MAWE984>3.0.CO;2-M
PG 25
WC Materials Science, Multidisciplinary
SC Materials Science
GA 510YD
UT WOS:000173234400015
DA 2018-10-20
ER

PT J
AU Song, F
   Bai, YL
AF Song, F
   Bai, YL
TI Analysis of the strengthening and toughening of a biomaterial interface
SO SCIENCE IN CHINA SERIES A-MATHEMATICS PHYSICS ASTRONOMY
LA English
DT Article
DE organic matrix interface; mineral bridge; nacre; microstructure;
   fracture toughness
ID CERAMICS; NACRE
AB Based on the transmission electron micrographs of nacre, the existence of mineral bridges in the organic matrix interface is confirmed. It is proposed that the microarchitecture of nacre should be considered as a "brick-bridge-mortar" (BBM) arrangement rather than traditional "brick and mortar" (BM) one. Experiments and analyses indicate that the mineral bridges effectively affect the strength and toughness of the interfaces in nacre. Comparison with a laminated composite with BM structure, SiC/BN, shows that the pattern of the crack extension and the toughening mechanism of the two materials are different. This reveals that the mineral bridges play a key role in the toughening mechanisms of nacre, which gives a conceptual guidance in material synthesis.
C1 Chinese Acad Sci, Inst Mech, LNM, Beijing 100080, Peoples R China.
RP Song, F (reprint author), Chinese Acad Sci, Inst Mech, LNM, Beijing 100080, Peoples R China.
RI Bai, Yilong/B-7781-2013
CR Addadi L, 1997, NATURE, V389, P912, DOI 10.1038/40010
   CLEGG WJ, 1990, NATURE, V347, P455, DOI 10.1038/347455a0
   CURREY JD, 1977, PROC R SOC SER B-BIO, V196, P443, DOI 10.1098/rspb.1977.0050
   Feng Q. L., 1995, Biomimetics, V3, P159
   HEUER AH, 1992, SCIENCE, V255, P1098, DOI 10.1126/science.1546311
   JACKSON AP, 1988, PROC R SOC SER B-BIO, V234, P415, DOI 10.1098/rspb.1988.0056
   JACKSON AP, 1986, J MATER SCI LETT, V5, P975, DOI 10.1007/BF01730253
   Schaffer TE, 1997, CHEM MATER, V9, P1731, DOI 10.1021/cm960429i
   Smith BL, 1999, NATURE, V399, P761, DOI 10.1038/21607
   SONG F, 2000, ACTA MECH SOLIDI SIN, V21, P171
   Stupp SI, 1997, SCIENCE, V277, P1242, DOI 10.1126/science.277.5330.1242
   Szuromi P, 1997, SCIENCE, V277, P1183, DOI 10.1126/science.277.5330.1183
   Vincent JFV., 1982, STRUCTURAL BIOMATERI
   WANG RZ, 1995, J MATER SCI, V30, P2299, DOI 10.1007/BF01184577
   WATABE N, 1981, PROG CRYST GROWTH CH, V4, P99, DOI 10.1016/0146-3535(81)90050-2
NR 15
TC 3
Z9 4
U1 1
U2 7
PU SCIENCE CHINA PRESS
PI BEIJING
PA 16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA
SN 1006-9283
J9 SCI CHINA SER A
JI Sci. China Ser. A-Math. Phys. Astron.
PD DEC
PY 2001
VL 44
IS 12
BP 1596
EP 1601
DI 10.1007/BF02880799
PG 6
WC Mathematics, Applied; Mathematics
SC Mathematics
GA 542DX
UT WOS:000175029200012
DA 2018-10-20
ER

PT J
AU Gruessner, U
   Clemens, M
   Pahlplatz, PV
   Sperling, P
   Witte, E
   Rosen, HR
AF Gruessner, U
   Clemens, M
   Pahlplatz, PV
   Sperling, P
   Witte, E
   Rosen, HR
CA Septocoll Study Grp
TI Improvement of perineal wound healing by local administration of
   gentamicin-impregnated collagen fleeces after abdominoperineal excision
   of rectal cancer
SO AMERICAN JOURNAL OF SURGERY
LA English
DT Article
DE rectal cancers; abdominoperineal excision; sacral cavity; wound
   infection; gentamycin; collagen fleece
ID SURGERY; INFECTION
AB Background: Despite significant advancements in rectal surgery, poor perineal wound healing after abdominoperineal resection (APR) of the anorectum continues to be a potential complication of the procedure. The aim of this prospective randomized multicenter study was to investigate the efficacy of a new mode of local antibiotic administration.
   Patients and methods: Ninety-seven patients who had to undergo APR for low rectal carcinoma either received sacral drainage plus primary wound closure (control group, n = 48) or the same treatment and supplementary application of three resorbable gentamicin-impregnated collagen fleeces (Septocoll; Merck Biomaterial GmbH, Darmstadt, Germany; Genta group, 49). The following target criteria were investigated: bacteriologic efficacy with respect to the eradication of Enterobacteriaceae, Staphlylococcus, and Pseudomonas organisms, and clinical efficacy with respect to perineal wound healing.
   Results: The Genta group showed a marked reduction in the investigated pathogens from the secretion obtained by sacral drainage on da 1 and 3, as well as high gentamicin concentrations (day 1, median 126.2 mug/mL; day 3, median 97.6 mug/mL). In total, bacteriologic efficacy amounted to 83.7% in the Genta group (41 of 49 patients) versus 60.4% (29 of 48 patients) in controls (P = 0.013). In concurrence with these bacteriologic results, the postoperative infection rate was significantly higher in controls: 10 patients (20.83%) in the control a cup versus 3 (6.1%) in the Genta group developed perineal or sacral infection (P <0.05). Postoperative complications in the recruited patients revealed no indication of gentamicin-induced adverse reactions.
   Conclusions: The results of the study show that the specified dose of 3 Septocoll fleeces in patients with APR is liable to significantly eliminate enterobacteria, staphylococci, and pseudomonads. The clinical course is improved as a result of the bactericidal effect exerted by the gentamicin fleece. The use of Septocoll reduced the incidence of postoperative perineal and sacral infections. Local antibiotic carriers seem to be of great advantage in poorly perfused areas such as the sacral cavity or anatomically problematic regions as the rima ani. In locally contaminated or infected areas, local antibiotic carriers achieve greater concentrations of the active substance than those achieved with systemic antibiotics, even if the latter are administered by the parenteral route. (C) 2001 Excerpta Medica, Inc. All rights reserved.
C1 Danube Hosp SMZ Ost, Ludwig Boltzmann Res Inst Surg Oncol, Vienna Med Sch, A-1220 Vienna, Austria.
   Merck Biomat GmbH, Abt Forsch & Entwicklung, D-64271 Darmstadt, Germany.
   Stadt Kliniken Osnabruck, D-49076 Osnabruck, Germany.
   Ziekenhuis Leyenburg, Chirurg Abt, NL-2545 CH The Hague, Netherlands.
   St Marien Krankenhaus Berlin Lankwitz, Chirurg Klin, D-12249 Berlin, Germany.
   Zent Klinikum, Chirurg Klin 2, D-86156 Augsburg, Germany.
RP Rosen, HR (reprint author), Danube Hosp SMZ Ost, Ludwig Boltzmann Res Inst Surg Oncol, Vienna Med Sch, Langobardenstr 122, A-1220 Vienna, Austria.
CR ALTEMEIER WA, 1974, AM J SURG, V127, P215, DOI 10.1016/0002-9610(74)90160-3
   ANDERSEN B, 1972, ANN SURG, V176, P129, DOI 10.1097/00000658-197208000-00001
   AUBREY DA, 1986, PHARMATHERAPEUTICA, V4, P536
   BERRY AR, 1980, CLIN ONCOL, V6, P231
   DAVIES OVL, 1957, P ROY SOC MED, V50, P1047
   DINGELDEIN E, 1990, 1190 ZPD
   ECKERT P, 1993, ENTWICKLUNGEN UNFALL, P214
   HARSHAW DH, 1974, SURG GYNECOL OBSTET, V139, P756
   HOFFMANN CEJ, 1981, ANN SURG, V193, P353, DOI 10.1097/00000658-198103000-00018
   IRVIN TT, 1975, BRIT J SURG, V62, P287, DOI 10.1002/bjs.1800620409
   KAYSER H, 1988, RECONST SURG TRAUMA, V20, P1
   Lutje H C, 1988, Reconstr Surg Traumatol, V20, P112
   MARTI MC, 1983, SURGERY, V93, P190
   MCDONALD PJ, 1983, DIS COLON RECTUM, V6, P661
   MCLACHLIN AD, 1970, CAN J SURG, V13, P350
   Miles WE, 1908, LANCET, V2, P1812
   Muhleder H, 1988, Reconstr Surg Traumatol, V20, P105
   *NAT COMM CLIN LAB, 1988, PERF STAND ANT DISK, V4, P16
   PETRELLI N, 1986, J SURG ONCOL, V32, P138, DOI 10.1002/jso.2930320303
   Renner K, 1999, DIS COLON RECTUM, V42, P1160, DOI 10.1007/BF02238568
   Robson MC, 1999, AM J SURG, V178, P399, DOI 10.1016/S0002-9610(99)00208-1
   ROSEN HR, 1991, AM J SURG, V162, P438, DOI 10.1016/0002-9610(91)90256-D
   Sachweh D, 1988, Reconstr Surg Traumatol, V20, P63
NR 23
TC 56
Z9 59
U1 0
U2 1
PU EXCERPTA MEDICA INC
PI NEW YORK
PA 650 AVENUE OF THE AMERICAS, NEW YORK, NY 10011 USA
SN 0002-9610
J9 AM J SURG
JI Am. J. Surg.
PD NOV
PY 2001
VL 182
IS 5
BP 502
EP 509
DI 10.1016/S0002-9610(01)00762-0
PG 8
WC Surgery
SC Surgery
GA 506YL
UT WOS:000172999300013
PM 11754859
DA 2018-10-20
ER

PT J
AU Phaneuf, MD
   Bide, MJ
   Szycher, M
   Gale, MB
   Huang, HX
   Yang, CQ
   LoGerfo, FW
   Quist, WC
AF Phaneuf, MD
   Bide, MJ
   Szycher, M
   Gale, MB
   Huang, HX
   Yang, CQ
   LoGerfo, FW
   Quist, WC
TI Development of infection resistant polyurethane biomaterials using
   textile dyeing technology
SO ASAIO JOURNAL
LA English
DT Article
ID VASCULAR PROSTHETIC INFECTION; GRAFT INFECTION; DRUG DELIVERY; DACRON
   GRAFT; PREVENTION; PROTECTION; SURFACE; POLYTETRAFLUOROETHYLENE;
   PROPHYLAXIS; ADHESION
AB Infection is a major complication when using biomaterials such as polyurethane in the clinical setting. The purpose of this study was to develop a novel infection resistant polyurethane biomaterial using textile dyeing technology. This procedure results in incorporation of the antibiotic into the polymer, resulting in a slow, sustained release of antibiotic from the material over time, without the use of exogenous binder agents. Polycarbonate based urethanes were synthesized that contained either a non-ionic (bdPU) or anionic (cPU) chain extender within the polymer backbone and cast into films. The fluoroquinolone antibiotic ciprofloxacin (Cipro) was applied to bdPU and cPU using textile dyeing technology, with Cipro uptake determined by absorbance reduction of the "dyebath." These dyed bdPU/cPU samples were then evaluated for prolonged Cipro release and antimicrobial activity by means of spectrophotometric and zone of inhibition assays, respectively. Cipro release and antimicrobial activity by dyed cPU segments that were aggressively washed persisted over 9 days, compared with dyed bdPU and dipped cPU control segments that lasted < 24 hours. Dyed cPU segments, which remained in a static wash solution, maintained antimicrobial activity for 11 days (length of study), whereas controls again lost antimicrobial activity within 24 hours. Thus, application of Cipro to the cPU polymer by means of dyeing technology results in a slow sustained release of antibiotic with persistent bacteriocidal properties over extended periods of time.
C1 Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA.
   Univ Rhode Isl, Dept Text, Kingston, RI USA.
   Cardiotech Int Inc, Woburn, MA USA.
RP Phaneuf, MD (reprint author), Beth Israel Deaconess Med Ctr, 4 Blackfan Circle,Room 131, Boston, MA 02115 USA.
FU NHLBI NIH HHS [R41 HL62764]
CR BANDYK DF, 1991, J VASC SURG, V13, P575
   BENVENISTY AI, 1988, J SURG RES, V44, P1, DOI 10.1016/0022-4804(88)90116-3
   BIDE M, 1993, TEXT CHEM COLOR, V25, P15
   BUDE MJ, 1999, P AM ASS TEXT CHEM C
   CHERVU A, 1991, J VASC SURG, V14, P521, DOI 10.1016/0741-5214(91)90246-Q
   EDWARDS LD, 1976, ANN SURG, V184, P758, DOI 10.1097/00000658-197612000-00017
   Fujimoto K, 1995, JPN J PHARMACOL, V69, P443, DOI 10.1254/jjp.69.443
   GoeauBrissonniere O, 1996, J MAL VASCUL, V21, P146
   GOLOMB G, 1991, J BIOMED MATER RES, V25, P937, DOI 10.1002/jbm.820250803
   GRECO F, 1991, J BIOMED MATER RES, V25, P39, DOI 10.1002/jbm.820250104
   GRECO RS, 1985, ARCH SURG-CHICAGO, V120, P71
   GRECO RS, 1991, J VASC SURG, V13, P753
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   HARVEY RA, 1981, ANN SURG, V194, P642, DOI 10.1097/00000658-198111000-00015
   HARVEY RA, 1984, AM J SURG, V147, P205, DOI 10.1016/0002-9610(84)90089-8
   HARVEY RA, 1982, SURGERY, V92, P504
   HAVERICH A, 1992, J VASC SURG, V15, P187, DOI 10.1016/0741-5214(92)70027-I
   Johnson A, 1989, THEORY COLORATION TE
   KAISER AB, 1978, ANN SURG, V188, P283, DOI 10.1097/00000658-197809000-00003
   KRAJICEK M, 1969, J CARDIOVASC SURG, V10, P453
   McDougal E G, 1986, J Vasc Surg, V4, P5
   MODAK SM, 1987, SURG GYNECOL OBSTET, V164, P143
   MOORE WS, 1977, INFECT PROSTHETIC HE
   Muhl E, 1996, ANN VASC SURG, V10, P244, DOI 10.1007/BF02001890
   Nunn D. M., 1979, DYEING SYNTHETIC POL
   OKAHARA K, 1995, EUR J VASC ENDOVASC, V9, P408, DOI 10.1016/S1078-5884(05)80008-5
   Phaneuf MD, 1997, J BIOMATER APPL, V12, P100, DOI 10.1177/088532829701200202
   POWELL TW, 1983, SURGERY, V94, P765
   Sardelic F, 1996, Cardiovasc Surg, V4, P389, DOI 10.1016/0967-2109(95)00075-5
   SHENK JS, 1989, J SURG RES, V47, P487, DOI 10.1016/0022-4804(89)90125-X
   Shore J., 1990, COLORANTS AUXILIARIE
   SHUE WB, 1988, J VASC SURG, V8, P600, DOI 10.1067/mva.1988.avs0080600
   Strachan C J, 1991, Eur J Vasc Surg, V5, P627, DOI 10.1016/S0950-821X(05)80896-5
   TOLLEFSON DF, 1987, ARCH SURG-CHICAGO, V122, P38
   Tweden KS, 1997, ASAIO J, V43, pM475
   *US DHHS, 1995, INF CONTR S INFL MED
   WEBB LX, 1986, J VASC SURG, V4, P16
   Whalen RL, 1997, ASAIO J, V43, pM842
   WHITE JV, 1984, J VASC SURG, V1, P372, DOI 10.1067/mva.1984.avs0010372
NR 39
TC 11
Z9 13
U1 0
U2 6
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1058-2916
J9 ASAIO J
JI Asaio J.
PD NOV-DEC
PY 2001
VL 47
IS 6
BP 634
EP 640
DI 10.1097/00002480-200111000-00013
PG 7
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 493TZ
UT WOS:000172240700012
PM 11730202
OA Bronze
DA 2018-10-20
ER

PT J
AU Charriere, E
   Terrazzoni, S
   Pittet, C
   Mordasini, P
   Dutoit, M
   Lemaitre, J
   Zysset, P
AF Charriere, E
   Terrazzoni, S
   Pittet, C
   Mordasini, P
   Dutoit, M
   Lemaitre, J
   Zysset, P
TI Mechanical characterization of brushite and hydroxyapatite cements
SO BIOMATERIALS
LA English
DT Article
DE brushite; calcium phosphate cement; elasticity; hydroxyapatite;
   mechanical properties; strength criterion
ID CALCIUM-PHOSPHATE CEMENTS; COMPRESSIVE PROPERTIES; ANISOTROPIC
   MATERIALS; BONE; STRENGTH; TISSUE; REINFORCEMENT; BEHAVIOR; TENSILE;
   MODULI
AB Compression, tension and torsion tests were designed and completed successfully on a brushite and a precipitated hydroxyapatite cement in moist condition. Elastic and strength properties were measured for these three loading cases. For each cement, the full set of strength data was fitted to an isotropic Tsai-Wu criterion and the associated coefficients identified. Since the compressive Young's moduli were about 10% larger than the tensile moduli, the full set of elastic data of each cement was fitted to a conewise linear elastic model. Hysteresis of the stress-strain curves was also observed, indicating dissipation mechanisms within these cement microstructures. A comparison of the measured mechanical properties with human cancellous bone confirmed the indication of brushite as a bone filling material and the potential of the hydroxyapatite cement as a structural biomaterial. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Swiss Fed Inst Technol, Lab Appl Mech & Reliabil Anal, Dept Mech Engn, EPFL, CH-1015 Lausanne, Switzerland.
   Swiss Fed Inst Technol, Powder Technol Lab, Dept Mat Sci, EPFL, CH-1015 Lausanne, Switzerland.
   Hop Orthoped Suisse Romande, CH-1005 Lausanne, Switzerland.
RP Charriere, E (reprint author), Swiss Fed Inst Technol, Lab Appl Mech & Reliabil Anal, Dept Mech Engn, EPFL, CH-1015 Lausanne, Switzerland.
EM eric.charriere@epfl.ch
RI Zysset, Philippe/B-2997-2018
OI Zysset, Philippe/0000-0002-4712-7047
CR Bednar N, 1999, COMPOS PART A-APPL S, V30, P147, DOI 10.1016/S1359-835X(98)00101-8
   BENZEGGAGH ML, 1995, COMPOS SCI TECHNOL, V55, P145, DOI 10.1016/0266-3538(95)00098-4
   BERMUDEZ O, 1994, J MATER SCI-MATER M, V5, P67, DOI 10.1007/BF00121693
   BERMUDEZ O, 1993, J MATER SCI-MATER M, V4, P389, DOI 10.1007/BF00122197
   BRUYEREGARNIER K, 2000, THESIS INSA LYON
   Chaboche J.L., 1990, DAMAGE MECH ENG MAT, P153
   COWIN S, 1991, BONE MECH
   CURNIER A, 1995, J ELASTICITY, V37, P1, DOI 10.1007/BF00043417
   DRIESSENS FCM, 1992, ADV BIOMAT, V10, P123
   GOULET RW, 1994, J BIOMECH, V27, P375, DOI 10.1016/0021-9290(94)90014-0
   HILL R, 1950, MATH THEORY PLASTICI
   HOFFMAN O, 1967, J COMPOS MATER, V1, P200, DOI DOI 10.1177/002199836700100210
   HORII H, 1983, J MECH PHYS SOLIDS, V31, P155, DOI 10.1016/0022-5096(83)90048-0
   Hou FJ, 1998, J BIOMECH, V31, P1009, DOI 10.1016/S0021-9290(98)00110-9
   JIANG ZQ, 1989, J COMPOS MATER, V23, P208
   KUHN JL, 1989, J ORTHOPAED RES, V7, P876, DOI 10.1002/jor.1100070614
   MARTIN RI, 1995, J MATER SCI-MATER M, V6, P138, DOI 10.1007/BF00120289
   MATTOS HC, 1992, INT J SOLIDS STRUCT, V29, P3185, DOI 10.1016/0020-7683(92)90035-R
   MAZARS J, 1990, ENG FRACT MECH, V35, P629, DOI 10.1016/0013-7944(90)90145-7
   Mente PL, 1987, T 33 ANN M ORTH RES, P49
   MIRTCHI AA, 1991, BIOMATERIALS, V12, P505, DOI 10.1016/0142-9612(91)90150-9
   MIRTCHI AA, 1989, BIOMATERIALS, V10, P634, DOI 10.1016/0142-9612(89)90120-8
   NAHLA K, 1996, COMPOS B, V27, P339
   Pittet C, 2000, J BIOMED MATER RES, V53, P769, DOI 10.1002/1097-4636(2000)53:6<769::AID-JBM19>3.0.CO;2-P
   PRIDDY TG, 1974, J ENG MATER-T ASME, V96, P91, DOI 10.1115/1.3443201
   REILLY DT, 1975, J BIOMECH, V8, P393, DOI 10.1016/0021-9290(75)90075-5
   RHO JY, 1993, J BIOMECH, V26, P111, DOI 10.1016/0021-9290(93)90042-D
   ROHL L, 1991, J BIOMECH, V24, P1143, DOI 10.1016/0021-9290(91)90006-9
   Roschke P, 1996, J ENG MATER-T ASME, V118, P207, DOI 10.1115/1.2804888
   Runkle J C, 1975, Bull Hosp Joint Dis, V36, P2
   TENNYSON RC, 1983, 72192 NASA CR
   TOWNSEND PR, 1975, J BIOMECH, V8, P199, DOI 10.1016/0021-9290(75)90025-1
   TSAI SW, 1971, J COMPOS MATER, V5, P58, DOI 10.1177/002199837100500106
   Van Landuyt P, 1999, BONE, V25, p95S, DOI 10.1016/S8756-3282(99)00142-8
   Van Landuyt P, 1997, BIOCERAMICS, V10, P477
NR 35
TC 103
Z9 106
U1 1
U2 36
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD NOV
PY 2001
VL 22
IS 21
BP 2937
EP 2945
DI 10.1016/S0142-9612(01)00041-2
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 469MT
UT WOS:000170820000014
PM 11561900
DA 2018-10-20
ER

PT J
AU Faucheux, N
   Correze, C
   Haye, B
   Nagel, MD
AF Faucheux, N
   Correze, C
   Haye, B
   Nagel, MD
TI Accumulation of cyclic AMP in Swiss 3T3 cells adhering to a cellulose
   biomaterial substratum through interaction with adenylyl cyclase
SO BIOMATERIALS
LA English
DT Article
DE Cuprophan; cAMP-dependent aggregation; cell shape
ID G-PROTEIN; GEOMETRIC CONTROL; CAMP; ACTIVATION; ALPHA; RECEPTOR;
   CYTOSKELETON; ORGANIZATION; FIBROBLASTS; FORSKOLIN
AB Controlling cell shape induced by cell-substrata interaction appears of prime importance to influence subsequent biological processes such as cell migration, proliferation, differentiation or apoptosis. Studies on Swiss 3T3 fibroblasts have recently provided evidence that cell spreading is mediated by integrins and RhoA. Our previous studies showed that on Cuprophan, a cellulose membrane (CU) to which vitronectin adhesive protein is poorly adsorbed, Swiss 3T3 cells are rounded and undergo cAMP-dependent aggregation. In contrast, on a polyacrylonitrile membrane (AN69) that favours the adsorption of vitronectin and fibronectin, cells spread out and contain low concentrations of cAMP. We have now examined the parts played by the three components in the cAMP pathway (receptors, G-proteins and adenylyl cyclase itself) in cAMP-dependent cell aggregation on CU. Experiments with intact cells showed no interaction between the CU and receptors, or between the CU and G-proteins. Assays on membrane preparations plus the Mn-ATP substrate, which uncouples G-proteins and adenylyl cyclase, demonstrated that activation of the cAMP pathway by CU depends primarily on the catalytic activity of the adenylyl cyclase. These investigations provide essential data for the development of biomaterials that favour cell functionality. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Univ Technol Compiegne, CNRS, UMR 6600, F-60205 Compiegne, France.
   Fac Pharm Chatenay Malabry, INSERM, U486, Unite Rech Transduct Hormonale & Regulat Cellulai, Malabry, France.
   UFR Sci Exactas & Nat, Biochim Lab, IFR Biomol 53, CNRS,UPRES A 6021, Reims, France.
RP Nagel, MD (reprint author), Univ Technol Compiegne, CNRS, UMR 6600, BP 20529,Domaine Biomat Biocompatibil, F-60205 Compiegne, France.
CR CASSEL D, 1977, P NATL ACAD SCI USA, V74, P3307, DOI 10.1073/pnas.74.8.3307
   Chen CS, 1998, BIOTECHNOL PROGR, V14, P356, DOI 10.1021/bp980031m
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Dike LE, 1999, IN VITRO CELL DEV-AN, V35, P441
   Dong JM, 1998, J BIOL CHEM, V273, P22554, DOI 10.1074/jbc.273.35.22554
   Faucheux N, 2000, BIOMATERIALS, V21, P1031, DOI 10.1016/S0142-9612(99)00277-X
   FAUCHEUX N, 1999, BIOMATERIALS, V20, P150
   Han JD, 1996, J BIOL CHEM, V271, P29211, DOI 10.1074/jbc.271.46.29211
   Holm I, 1999, EUR J CELL BIOL, V78, P856, DOI 10.1016/S0171-9335(99)80087-9
   Kane RS, 1999, BIOMATERIALS, V20, P2363, DOI 10.1016/S0142-9612(99)00165-9
   LAMPUGNANI MG, 1990, LAB INVEST, V63, P521
   LAURENZA A, 1989, TRENDS PHARMACOL SCI, V10, P442, DOI 10.1016/S0165-6147(89)80008-2
   LeVine H, 1999, MOL NEUROBIOL, V19, P111, DOI 10.1007/BF02743657
   LIMBIRD LE, 1979, J BIOL CHEM, V254, P2677
   MARTINY L, 1991, FEBS LETT, V286, P105, DOI 10.1016/0014-5793(91)80951-X
   McClary KB, 2000, J BIOMED MATER RES, V50, P428, DOI 10.1002/(SICI)1097-4636(20000605)50:3<428::AID-JBM18>3.0.CO;2-H
   McClary KB, 1999, BIOMATERIALS, V20, P2435, DOI 10.1016/S0142-9612(99)00171-4
   MURAYAMA T, 1989, J BIOL CHEM, V264, P15186
   ODONNELL JK, 1991, MOL PHARMACOL, V39, P702
   Patel N, 1998, FASEB J, V12, P1447
   SALOMON Y, 1974, ANAL BIOCHEM, V58, P541, DOI 10.1016/0003-2697(74)90222-X
   Schoenwaelder SM, 1999, CURR OPIN CELL BIOL, V11, P274, DOI 10.1016/S0955-0674(99)80037-4
   Schonbrunn A, 1999, ANN ONCOL, V10, pS17, DOI 10.1093/annonc/10.suppl_2.S17
   SEAMON KB, 1981, P NATL ACAD SCI-BIOL, V78, P3363, DOI 10.1073/pnas.78.6.3363
   Simonds WF, 1999, TRENDS PHARMACOL SCI, V20, P66, DOI 10.1016/S0165-6147(99)01307-3
   SIMONDS WF, 1989, FEBS LETT, V249, P189, DOI 10.1016/0014-5793(89)80622-2
   TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350
   WANG YJ, 1995, J CELL SCI, V108, P3501
   WATSON PA, 1990, J BIOL CHEM, V265, P6569
   Watson PA, 1995, BIOCHEM CELL BIOL, V73, P367, DOI 10.1139/o95-044
   ZACHARY I, 1990, BIOCHEM BIOPH RES CO, V168, P1184, DOI 10.1016/0006-291X(90)91154-K
   Zeiders JL, 1997, J MOL CELL CARDIOL, V29, P603, DOI 10.1006/jmcc.1996.0303
NR 32
TC 9
Z9 10
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD NOV
PY 2001
VL 22
IS 22
BP 2993
EP 2998
DI 10.1016/S0142-9612(01)00045-X
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 474FD
UT WOS:000171094900005
PM 11575473
DA 2018-10-20
ER

PT J
AU Mazzobre, MF
   Longinotti, MP
   Corti, HR
   Buera, MP
AF Mazzobre, MF
   Longinotti, MP
   Corti, HR
   Buera, MP
TI Effect of salts on the properties of aqueous sugar systems, in relation
   to biomaterial stabilization. 1. Water sorption behavior and ice
   crystallization/melting
SO CRYOBIOLOGY
LA English
DT Article
ID GLASS-TRANSITION; TREHALOSE; CRYOPRESERVATION; VITRIFICATION;
   TEMPERATURES; STABILITY; GLYCEROL; SUCROSE; CATIONS; FROZEN
AB Trehalose and sucrose, two sugars that are involved in the protection of living organisms under extreme conditions, and their mixtures with salts were employed to prepare supercooled or freeze-dried glassy systems. The objective of the present work was to explore the effects of different salts on water sorption, glass transition temperature (T,), and formation and melting of ice in aqueous sugar systems. In the sugar-salt mixtures, water adsorption was higher than expected on the basis of the water uptake by each pure component. In systems with a reduced mass fraction of water (w less than or equal to 0.4), salts delayed water crystallization, probably due to ion-water interactions. In systems where w > 0.6, water crystallization could be explained by the known colligative properties of the solutes, The glass transition temperature of the maximally concentrated matrix (T(g)') was decreased by the presence of salts. However, the actual T, values of the systems were not modified. Thus, the effect of salts on sorption behavior and formation of ice may reflect dynamic water-salt-sugar interactions which take place at a molecular level and are related to the charge/mass ratio of the cation present without affecting supramolecular or macroscopic properties. (C) 2001 Elsevier Science (USA).
C1 Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Ind, RA-1428 Buenos Aires, DF, Argentina.
   Comis Nacl Energia Atom, Unidad Actividad Quim, RA-1650 San Martin, Buenos Aires, Argentina.
   Univ Nacl Gen San Martin, Escuela Ciencia & Tecnol, RA-1650 San Martin, Buenos Aires, Argentina.
RP Mazzobre, MF (reprint author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Ind, RA-1428 Buenos Aires, DF, Argentina.
OI Buera, Pilar/0000-0001-9290-7299
CR ABLETT S, 1992, J CHEM SOC FARADAY T, V88, P789, DOI 10.1039/ft9928800789
   ANGELL CA, 1994, J FOOD ENG, V22, P115, DOI 10.1016/0260-8774(94)90028-0
   ARAKAWA T, 1982, BIOCHEMISTRY-US, V21, P6536, DOI 10.1021/bi00268a033
   CARPENTER JF, 1990, J DAIRY SCI, V73, P3627, DOI 10.3168/jds.S0022-0302(90)79065-0
   Cerrutti P, 2000, APPL MICROBIOL BIOT, V54, P575, DOI 10.1007/s002530000428
   CHANG BS, 1992, CRYOBIOLOGY, V29, P632, DOI 10.1016/0011-2240(92)90067-C
   Chen TN, 2000, CRYOBIOLOGY, V40, P277, DOI 10.1006/cryo.2000.2244
   COHEN MD, 1987, J PHYS CHEM-US, V91, P4563, DOI 10.1021/j100301a029
   COOK WJ, 1973, CARBOHYD RES, V31, P265, DOI 10.1016/S0008-6215(00)86191-1
   Crowe JH, 1998, ANNU REV PHYSIOL, V60, P73, DOI 10.1146/annurev.physiol.60.1.73
   FLINK J M, 1983, P473
   GOETZE W, 1999, J PHYS CONDENS MATT, V11, pA1
   GOLDBERG RN, 1978, J PHYS CHEM REF DATA, V7, P263, DOI 10.1063/1.555569
   HEMMINGA MA, 1993, GLASSY STATE IN FOODS, P157
   HER LM, 1995, PHARMACEUT RES, V12, P768, DOI 10.1023/A:1016280113800
   Iglesias HA, 1997, J SCI FOOD AGR, V75, P183, DOI 10.1002/(SICI)1097-0010(199710)75:2<183::AID-JSFA860>3.0.CO;2-T
   KAREL M, 1981, WATER RELATIONS FOOD, P639
   Lammert AM, 1998, FOOD CHEM, V61, P139, DOI 10.1016/S0308-8146(97)00132-5
   LEVINE H, 1988, J CHEM SOC FARAD T 1, V84, P2619, DOI 10.1039/f19888402619
   Mazzobre MF, 1999, BBA-GEN SUBJECTS, V1473, P337, DOI 10.1016/S0304-4165(99)00207-X
   Miller DP, 1997, PHARMACEUT RES, V14, P578, DOI 10.1023/A:1012192725996
   Miller DP, 1998, PHARM RES-DORDR, V15, P1215, DOI 10.1023/A:1011987707515
   MORELDESROSIERS N, 1991, J CHEM SOC FARADAY T, V87, P2173, DOI 10.1039/ft9918702173
   Obendorf RL, 1997, SEED SCI RES, V7, P63
   PITZER KS, 1973, J PHYS CHEM-US, V77, P268, DOI 10.1021/j100621a026
   RASMUSSEN D, 1969, BIODYNAMICA, V10, P319
   ROBINSON RA, 1955, ELECTROLYTE SOLUTION, P23
   ROOS YH, 1991, CRYO-LETT, V12, P367
   ROOS YH, 1991, INT J FOOD SCI TECH, V26, P553
   ROOS YH, 1991, FOOD TECHNOL-CHICAGO, V45, P66
   ROOS YH, 1993, CARBOHYD RES, V238, P39, DOI 10.1016/0008-6215(93)87004-C
   SIMATOS D, 1993, GLASSY STATE IN FOODS, P395
   SIMATOS D, 1991, ADV EXP MED BIOL, P139
   SLADE L, 1991, CRIT REV FOOD SCI, V30, P115, DOI 10.1080/10408399109527543
   STOKES RH, 1948, J AM CHEM SOC, V70, P1870, DOI 10.1021/ja01185a065
   Storey BT, 1998, CRYOBIOLOGY, V37, P46, DOI 10.1006/cryo.1998.2097
   Sun WQ, 1997, COMP BIOCHEM PHYS A, V117, P327, DOI 10.1016/S0300-9629(96)00271-X
   Suzuki T, 1997, J CHEM ENG JPN, V30, P609, DOI 10.1252/jcej.30.609
   Turner S, 2001, PLANT SCI, V160, P489, DOI 10.1016/S0168-9452(00)00420-9
NR 39
TC 39
Z9 40
U1 0
U2 11
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0011-2240
J9 CRYOBIOLOGY
JI Cryobiology
PD NOV
PY 2001
VL 43
IS 3
BP 199
EP 210
DI 10.1006/cryo.2001.2345
PG 12
WC Biology; Physiology
SC Life Sciences & Biomedicine - Other Topics; Physiology
GA 533AQ
UT WOS:000174507600002
PM 11888214
DA 2018-10-20
ER

PT J
AU Nuttelman, CR
   Mortisen, DJ
   Henry, SM
   Anseth, KS
AF Nuttelman, CR
   Mortisen, DJ
   Henry, SM
   Anseth, KS
TI Attachment of fibronectin to poly(vinyl alcohol) hydrogels promotes
   NIH3T3 cell adhesion, proliferation, and migration
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE tissue engineering; hydrogel; poly(vinyl alcohol); polymer scaffold;
   fibronectin
ID BIOMATERIALS; INTEGRINS; SURFACES; BINDING
AB Hydrogels have been used in biology and medicine for many years, and they possess many properties that make them advantageous for tissue engineering applications. Their high water content and tissue-like elasticity are similar to the native extracellular matrix of many tissues. In this work, we investigated the potential of a modified poly(vinyl alcohol) (PVA) hydrogel as a biomaterial for tissue engineering applications. First, the ability of NIH3T3 fibroblast cells to attach to PVA hydro-els was evaluated. Because of PVA's extremely hydrophilic nature, important cell adhesion proteins do not adsorb to PVA hydrogels, and consequently, cells are unable to adhere to the hydrogel. By covalently attaching the important cell adhesion protein fibronectin onto the PVA hydrogel surface, the rate of fibroblast attachment and proliferation was dramatically improved, and promoted two-dimensional cell migration. These studies illustrate that a fibronectin-modified PVA hydrogel is a potential biomaterial for tissue engineering applications. (C) 2001 John Wiley & Sons, Inc.
C1 Univ Colorado, Dept Chem Engn, Boulder, CO 80309 USA.
   Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA.
RP Anseth, KS (reprint author), Univ Colorado, Dept Chem Engn, Boulder, CO 80309 USA.
FU NIDCR NIH HHS [DE12998]
CR Altankov G, 1996, J BIOMED MATER RES, V30, P385, DOI 10.1002/(SICI)1097-4636(199603)30:3<385::AID-JBM13>3.0.CO;2-J
   AYAD S, 1994, EXTRACELLULAR MATRIX, P104
   Biran R, 2001, J BIOMED MATER RES, V55, P1
   Chinn J. A., 1995, BIOMEDICAL ENG HDB, P1597
   Faucheux N, 2000, BIOMATERIALS, V21, P1031, DOI 10.1016/S0142-9612(99)00277-X
   Griffith LG, 2000, ACTA MATER, V48, P263, DOI 10.1016/S1359-6454(99)00299-2
   GRINNELL F, 1981, J BIOMED MATER RES, V15, P363, DOI 10.1002/jbm.820150308
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   Jen AC, 1996, BIOTECHNOL BIOENG, V50, P357, DOI 10.1002/(SICI)1097-0290(19960520)50:4<357::AID-BIT2>3.0.CO;2-K
   JULIANO DJ, 1993, J BIOMED MATER RES, V27, P1103
   Maury F, 1997, J MATER SCI-MATER M, V8, P571, DOI 10.1023/A:1018502915904
   OXLEY HR, 1993, BIOMATERIALS, V14, P1064, DOI 10.1016/0142-9612(93)90207-I
   Peppas N. A., 1986, HYDROGELS MED PHARM, P1
   PETTIT DK, 1992, J BIOMED MATER RES, V26, P1259, DOI 10.1002/jbm.820261002
   RATNER BD, 1993, J BIOMED MATER RES, V27, P837, DOI 10.1002/jbm.820270702
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   RUOSLAHTI E, 1994, CELL, V77, P477, DOI 10.1016/0092-8674(94)90209-7
   SAWHNEY AS, 1993, MACROMOLECULES, V26, P581, DOI 10.1021/ma00056a005
   SMETANA K, 1993, BIOMATERIALS, V14, P1046, DOI 10.1016/0142-9612(93)90203-E
   Tabata Y, 1999, J BIOMAT SCI-POLYM E, V10, P79, DOI 10.1163/156856299X00298
   TAMADA Y, 1993, J COLLOID INTERF SCI, V155, P334, DOI 10.1006/jcis.1993.1044
   WICHTERLE O, 1960, NATURE, V185, P117, DOI 10.1038/185117a0
   Yaylaoglu MB, 1999, BIOMATERIALS, V20, P1513, DOI 10.1016/S0142-9612(99)00062-9
NR 23
TC 185
Z9 189
U1 6
U2 60
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD NOV
PY 2001
VL 57
IS 2
BP 217
EP 223
DI 10.1002/1097-4636(200111)57:2<217::AID-JBM1161>3.0.CO;2-I
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 466QP
UT WOS:000170656500008
PM 11484184
DA 2018-10-20
ER

PT J
AU Radin, S
   Ducheyne, P
   Kamplain, T
   Tan, BH
AF Radin, S
   Ducheyne, P
   Kamplain, T
   Tan, BH
TI Silica sol-gel for the controlled release of antibiotics. I. Synthesis,
   characterization, and in vitro release
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE drug delivery; controlled release; sol-gels; antibiotics; in vitro
ID DRUG-DELIVERY SYSTEM; CALCIUM-PHOSPHATE; TRANSFORMING
   GROWTH-FACTOR-BETA-1; BONE-CEMENT; GLASS; OSTEOMYELITIS; VANCOMYCIN;
   CARRIER; BIOMATERIAL; GENTAMICIN
AB Room temperature processed silica sol-gel (xerogel) was investigated as a novel controlled release carrier of antibiotics (vancomycin). Xerogel characteristics, in vitro release properties, and bactericidal efficacy of the released antibiotic were determined. The xerogel/vancomycin composite showed a long-term sustained release (up to 6 weeks). In addition, bactericidal efficacy of released vancomycin was retained. The kinetics of release and the amount released were dose dependent. The initial, first-order release was followed by a near-zero-order release. The time to transition from the first- to zero-order release increased with vancomycin load (from 2 to 3 weeks with load increase from 2.2 to 11.1 mg/g). Regardless of the load, about 70% of the original vancomycin content was released by the transitional point, and the cumulative release after 6 weeks of immersion was about 90%. This study, combined with other reports documenting biocompatibility and controlled resorbability of the xerogel/drug, composite in vivo, suggests that silica xerogel is a promising controlled release material for the treatment of bone infections. (C) 2001 John Wiley & Sons, Inc.
C1 Univ Penn, Dept Bioengn, Ctr Biomat & Tissue Engn, Philadelphia, PA 19104 USA.
RP Radin, S (reprint author), Univ Penn, Dept Bioengn, Ctr Biomat & Tissue Engn, 3320 Smith Walk, Philadelphia, PA 19104 USA.
CR ACAR JF, 1991, ANTIBIOTICS LAB MED, P17
   AGRAWAL CM, 1994, J BIOMED MATER RES, V28, P851, DOI 10.1002/jbm.820280803
   AUGHENBAUGH W, 2001, IN PRESS J BIOMED MA
   Benoit MA, 1997, INT ORTHOP, V21, P403
   BRAUN S, 1992, J NON-CRYST SOLIDS, V147, P739, DOI 10.1016/S0022-3093(05)80708-2
   BRINKER CJ, 1990, SOL GEL SCI PHYSICS
   Brunauer S, 1940, J AM CHEM SOC, V62, P1723, DOI 10.1021/ja01864a025
   Brunauer S, 1938, J AM CHEM SOC, V60, P309, DOI 10.1021/ja01269a023
   BUCHHOLZ HW, 1984, CLIN ORTHOP RELAT R, V190, P96
   Chohfi M, 1998, INT ORTHOP, V22, P171, DOI 10.1007/s002640050235
   CORNELL CN, 1993, J ORTHOPAED RES, V11, P619, DOI 10.1002/jor.1100110502
   DANHERS LE, 1987, CLIN ORTHOP RELAT R, V219, P278
   Debeaumont D., 1982, CLIN ORTHOPAEDICS, V167, P263
   Ducheyne P, 1992, Clin Orthop Relat Res, P102
   Falaize S, 1999, J AM CERAM SOC, V82, P969, DOI 10.1111/j.1151-2916.1999.tb01861.x
   GARVIN KL, 1988, ORTHOP CLIN N AM, V19, P605
   Gautier H, 2000, BIOMATERIALS, V21, P243, DOI 10.1016/S0142-9612(99)00139-8
   GERACI JE, 1983, MAYO CLIN PROC, V58, P88
   GOMBOTZ WR, 1994, J APPL BIOMATER, V5, P141, DOI 10.1002/jab.770050207
   Heller J., 1987, CONTROLLED DRUG DELI, P139
   Henry S L, 1991, Orthop Rev, V20, P242
   HOFF SF, 1981, J BONE JOINT SURG AM, V63, P798, DOI 10.2106/00004623-198163050-00015
   ITOKAZU M, 1995, J APPL BIOMATER, V6, P167, DOI 10.1002/jab.770060304
   Kimakhe S, 1999, J BIOMED MATER RES, V47, P18, DOI 10.1002/(SICI)1097-4636(199910)47:1<18::AID-JBM3>3.0.CO;2-T
   Kokubo T., 1993, BONE BONDING BIOMATE, P31
   KORKUSUZ F, 1993, J BONE JOINT SURG BR, V75, P111
   LANGLAIS F, 1988, J ORTHOP SURG, V2, P300
   LEONG KW, 1985, J BIOMED MATER RES, V19, P941, DOI 10.1002/jbm.820190806
   MAJID SA, 1985, ACTA ORTHOP SCAND, V56, P265, DOI 10.3109/17453678508993010
   Nicoll SB, 1997, BIOMATERIALS, V18, P853, DOI 10.1016/S0142-9612(97)00008-2
   OTSUKA M, 1995, J BIOMED MATER RES, V29, P33, DOI 10.1002/jbm.820290106
   Radin S, 1997, BIOMATERIALS, V18, P777, DOI 10.1016/S0142-9612(96)00190-1
   RADIN S, 1998, BIOCERAMICS, V2, P529
   RADIN S, UNPUB BIOMATERIALS
   RADIN SR, 1993, J BIOMED MATER RES, V27, P35, DOI 10.1002/jbm.820270106
   Santos EM, 1999, BIOMATERIALS, V20, P1695, DOI 10.1016/S0142-9612(99)00066-6
   SHINTO Y, 1992, J BONE JOINT SURG BR, V74, P600
   TAN BH, 1996, P 5 WORLD BIOM C 29, P161
   WU SG, 1993, CHEM MATER, V5, P115, DOI 10.1021/cm00025a022
   YAMAMURA K, 1992, J BIOMED MATER RES, V26, P1053, DOI 10.1002/jbm.820260807
   YING JY, 1993, J AM CERAM SOC, V76, P2571, DOI 10.1111/j.1151-2916.1993.tb03983.x
NR 41
TC 125
Z9 128
U1 3
U2 31
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD NOV
PY 2001
VL 57
IS 2
BP 313
EP 320
DI 10.1002/1097-4636(200111)57:2<313::AID-JBM1173>3.0.CO;2-E
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 466QP
UT WOS:000170656500020
PM 11484196
DA 2018-10-20
ER

PT J
AU Nemcova, S
   Noel, AA
   Jost, CJ
   Gloviczki, P
   Miller, VM
   Brockbank, KGM
AF Nemcova, S
   Noel, AA
   Jost, CJ
   Gloviczki, P
   Miller, VM
   Brockbank, KGM
TI Evaluation of a xenogeneic acellular collagen matrix as a small-diameter
   vascular graft in dogs - Preliminary observations
SO JOURNAL OF INVESTIGATIVE SURGERY
LA English
DT Article
DE arterial reconstruction; biomaterial; blood flow; graft patency
ID ENDOTHELIAL GROWTH-FACTOR; AUTOLOGOUS SAPHENOUS-VEIN; RAT
   CAROTID-ARTERY; AUTOGENOUS VEIN; INTIMAL HYPERPLASIA; BLOOD-FLOW;
   ACCELERATES REENDOTHELIALIZATION; POLYTETRAFLUOROETHYLENE GRAFTS;
   INTESTINAL SUBMUCOSA; CELL-PROLIFERATION
AB Autogenous veins are the materials of choice for arterial reconstruction. In the absence of autogenous material, prosthetic materials are used. However, vascular prostheses of less than 0.4 cm in diameter have low long-term patency. This study was designed to determine if cells would infiltrate an engineered xenogeneic biomaterial used as a small-diameter arterial graft in dogs and, if so, to determine the phenotype of the infiltrating cells. Nine acellular xenogeneic grafts (0.4 cm in diameter, 5 cm long), composed of porcine collagen derived from the submucosa of the small intestine and type I bovine collagen, were implanted as end-to-end interposition grafts in femoral arteries of five male mongrel dogs (total of nine grafts). All dogs received daily aspirin (325 mg). Patency of implanted grafts was monitored weekly by Duplex ultrasonography. After 9 weeks, or earlier in case of blood flow reduction by at least 75%, grafts were explanted and prepared for light or electron microscopy to evaluate cellularization. Eight of nine grafts remained patent up to 9 weeks. At explant, diameters were 0.31+/-0.02 cm at the midgraft, and 0.14+/-0.01 and 0.19+/-0.01 cm at the proximal and distal anastomoses. At explant, cells of mesenchymal origin (endothelial cells, smooth muscle cells, myofibroblasts) were embedded in the extracellular matrix of the graft scaffold. Minimal evidence of cellular inflammatory reaction and no aneurysmal dilatation or thrombus formation was detected. Variable degrees of hyperplasia were present at proximal and distal anastomoses. This preliminary study demonstrates that a collagen-based xenogeneic biomaterial provides a scaffold for cellularization when used for arterial reconstruction in dogs.
C1 Mayo Clin & Mayo Fdn, Dept Surg, Rochester, MN 55905 USA.
   KGB Associates Inc, Charleston, SC USA.
RP Miller, VM (reprint author), Mayo Clin & Mayo Fdn, Dept Surg, 200 1St St SW, Rochester, MN 55905 USA.
CR Abbott WM, 1997, J VASC SURG, V25, P19, DOI 10.1016/S0741-5214(97)70317-3
   Abraham GA, 2000, J BIOMED MATER RES, V51, P442, DOI 10.1002/1097-4636(20000905)51:3<442::AID-JBM19>3.3.CO;2-W
   ANDERSON JS, 1987, SURGERY, V101, P577
   ASAHARA T, 1995, CIRCULATION, V91, P2793, DOI 10.1161/01.CIR.91.11.2793
   BAUTERS C, 1995, CIRCULATION, V91, P2802, DOI 10.1161/01.CIR.91.11.2802
   BERGAN JJ, 1982, SURGERY, V92, P921
   Bilder G, 1999, CIRCULATION, V99, P3292, DOI 10.1161/01.CIR.99.25.3292
   CAMBRIA RA, 1994, J VASC SURG, V20, P765, DOI 10.1016/S0741-5214(94)70164-4
   CASSCELLS W, 1995, CIRCULATION, V91, P2699, DOI 10.1161/01.CIR.91.11.2699
   Chen DH, 1999, CIRCULATION, V100, P849, DOI 10.1161/01.CIR.100.8.849
   Conte MS, 1998, FASEB J, V12, P43
   Dalsing M C, 1989, Ann Vasc Surg, V3, P127, DOI 10.1016/S0890-5096(06)62005-0
   DAVIDS L, 1999, TISSUE ENG PROSTHETI, P3
   FOGLE MA, 1987, J VASC SURG, V5, P46, DOI 10.1067/mva.1987.avs0050046
   Gittenberger-de Groot AC, 1999, ARTERIOSCL THROM VAS, V19, P1589
   GRAHAM LM, 1991, J BIOMED MATER RES, V25, P525, DOI 10.1002/jbm.820250409
   Halayko AJ, 2001, J APPL PHYSIOL, V90, P358
   Hart CE, 1999, CIRCULATION, V99, P564, DOI 10.1161/01.CIR.99.4.564
   HERRING MB, 1991, SURG ANN, V2, P157
   HILES MC, 1995, J BIOMED MATER RES, V29, P883, DOI 10.1002/jbm.820290714
   Hu YH, 1999, CIRCULATION, V100, P861, DOI 10.1161/01.CIR.100.8.861
   Huynh T, 1999, NAT BIOTECHNOL, V17, P1083
   ISHIKAWA T, 1988, AM J PHYSIOL, V255, P970
   JOHNSON WC, 1988, ARCH SURG-CHICAGO, V123, P434
   Kalra M, 2000, J VASC RES, V37, P576, DOI 10.1159/000054091
   KESLER KA, 1986, J VASC SURG, V3, P58
   KOHLER TR, 1991, CIRC RES, V69, P1557, DOI 10.1161/01.RES.69.6.1557
   L'Heureux N, 1998, FASEB J, V12, P47
   Lantz G C, 1990, J Invest Surg, V3, P217, DOI 10.3109/08941939009140351
   Lantz G C, 1993, J Invest Surg, V6, P297, DOI 10.3109/08941939309141619
   LAWLER MR, 1971, AM J SURG, V122, P517, DOI 10.1016/0002-9610(71)90478-8
   LEWIS DA, 1997, J VASC SURG, V1, P187
   LONDREY GL, 1991, J VASC SURG, V13, P631
   Mensink A, 1996, EUR J PHARMACOL, V310, P73, DOI 10.1016/0014-2999(96)00368-8
   Niklason LE, 1999, SCIENCE, V284, P489, DOI 10.1126/science.284.5413.489
   Noishiki Y, 1993, J Invest Surg, V6, P231, DOI 10.3109/08941939309141614
   OBrien JE, 1997, J THORAC CARDIOV SUR, V114, P38, DOI 10.1016/S0022-5223(97)70115-6
   SANDUSKY GE, 1995, J SURG RES, V58, P415, DOI 10.1006/jsre.1995.1064
   Scott NA, 1996, CIRCULATION, V93, P2178, DOI 10.1161/01.CIR.93.12.2178
   Seifalian A. M., 1999, TISSUE ENG VASCULAR, P45
   Shi Y, 1997, CIRCULATION, V95, P2684, DOI 10.1161/01.CIR.95.12.2684
   Teebken O E, 1998, Langenbecks Arch Chir Suppl Kongressbd, V115, P1256
   VEITH FJ, 1986, J VASC SURG, V3, P104
   Weatherford DA, 1996, SURGERY, V120, P433, DOI 10.1016/S0039-6060(96)80320-5
   Williams S K, 1989, Ann Vasc Surg, V3, P146, DOI 10.1016/S0890-5096(06)62008-6
   WILLIAMS SK, 1994, J BIOMED MATER RES, V28, P203, DOI 10.1002/jbm.820280210
   WILLIAMS SK, 1995, CELL TRANSPLANT, V4, P401, DOI 10.1016/0963-6897(95)00023-Q
   YAMAMURA S, 1994, J SURG RES, V56, P155, DOI 10.1006/jsre.1994.1026
NR 48
TC 26
Z9 26
U1 0
U2 8
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA
SN 0894-1939
J9 J INVEST SURG
JI J. Invest. Surg.
PD NOV-DEC
PY 2001
VL 14
IS 6
BP 321
EP 330
DI 10.1080/089419301753435693
PG 10
WC Surgery
SC Surgery
GA 521ZR
UT WOS:000173871700005
PM 11905500
DA 2018-10-20
ER

PT J
AU Chow, LC
   Takagi, S
AF Chow, LC
   Takagi, S
TI A natural bone cement - A laboratory novelty led to the development of
   revolutionary new biomaterials
SO JOURNAL OF RESEARCH OF THE NATIONAL INSTITUTE OF STANDARDS AND
   TECHNOLOGY
LA English
DT Article
DE biomaterial; bone graft; bone repair; dicalcium phosphate anhydrous;
   hydroxyapatite; self-setting calcium phosphate cement; tetracalcium
   phosphate
ID CALCIUM-PHOSPHATE CEMENT; HYDROXYAPATITE CEMENT; RECONSTRUCTION;
   DEFECTS; SURGERY; REPAIR
AB Research on calcium phosphate chemistry at NIST led to the discovery of the worlds first self-hardening calcium phosphate cements (CPC) in 1987. Laboratory, animal, and clinical studies were conducted to develop CPC into clinically useful biomaterials. The combination of self-hardening capability and high biocompatibility makes CPC a unique material for repairing bone defects. Near perfect adaptation of the cement to the tissue surfaces in a defect, and a gradual resorption followed by new bone formation are some of the other distinctive advantages of this biomaterial. In 1996 a CPC, consisting of tetracalcium phosphate and dicalcium phosphate anhydrous, was approved by the Food and Drug Administration ( FDA) for repairing cranial defects in humans, thus becoming the first material of its kind available for clinical use. This paper will review the course of the development, the physical and chemical properties, and clinical applications of CPC.
C1 NIST, Amer Dent Assoc Hlth Fdn, Paffenbarger Res Ctr, Dent Chem Div, Gaithersburg, MD 20899 USA.
   NIST, Amer Dent Assoc Hlth Fdn, Paffenbarger Res Ctr, Cariol Div,Polymer Div,Mat Sci & Engn Lab, Gaithersburg, MD 20899 USA.
RP Chow, LC (reprint author), NIST, Amer Dent Assoc Hlth Fdn, Paffenbarger Res Ctr, Dent Chem Div, Gaithersburg, MD 20899 USA.
EM laurence.chow@nist.gov; shozo.takagi@nist.gov
FU NIDCR NIH HHS [R01 DE011789]
CR BAUER G, 1985, BIOAKTIVE WERKSTOFFE, V6, P103
   BROWN WE, 1965, J RES NBS A PHYS CH, VA 69, P547, DOI 10.6028/jres.069A.059
   Brown WE, 1987, CEMENTS RES PROGR 19, P352
   Cherng A, 1997, J BIOMED MATER RES, V35, P273, DOI 10.1002/(SICI)1097-4636(19970605)35:3<273::AID-JBM1>3.0.CO;2-E
   Chow LC, 1998, CEMENTS RESEARCH PROGRESS 1996, P215
   Chow LC, 2000, J BIOMED MATER RES, V53, P511, DOI 10.1002/1097-4636(200009)53:5<511::AID-JBM10>3.3.CO;2-5
   CHOW LC, 1991, MATER RES SOC SYMP P, V179, P3
   CHOW LC, 1996, CEMENTS RES PROGR 19, P189
   COSTANTINO PD, 1991, ARCH OTOLARYNGOL, V117, P379
   COSTANTINO PD, 1992, PLAST RECONSTR SURG, V90, P174, DOI 10.1097/00006534-199290020-00003
   Friedman C D, 2000, Arch Facial Plast Surg, V2, P124, DOI 10.1001/archfaci.2.2.124
   FRIEDMAN CD, 1991, ARCH OTOLARYNGOL, V117, P385
   Fujikawa K, 1995, Dent Mater J, V14, P45
   FUKASE Y, 1990, J DENT RES, V69, P1852, DOI 10.1177/00220345900690121201
   HONG YC, 1991, J BIOMED MATER RES, V25, P485, DOI 10.1002/jbm.820250406
   ISHIKAWA K, 1995, J MATER SCI-MATER M, V6, P528, DOI 10.1007/BF00151034
   KAMERER DB, 1994, AM J OTOL, V15, P47
   KVETON JF, 1995, LARYNGOSCOPE, V105, P156, DOI 10.1288/00005537-199502000-00008
   KVETON JF, 1995, AM J OTOL, V16, P465
   LEGEROS RZ, 1994, ORAL BIOL MED, P162
   Lew D, 1997, J ORAL MAXIL SURG, V55, P1441, DOI 10.1016/S0278-2391(97)90647-9
   SHINDO ML, 1993, ARCH OTOLARYNGOL, V119, P185
   SUGAWARA A, 1990, J ENDODONT, V16, P162, DOI 10.1016/S0099-2399(06)81963-1
   Sugawara A, 1992, Dent Mater J, V11, P11
   Sugawara A., 1995, J HARD TISSUE BIOL, V4, P1
   Sugawara A, 1993, J SOC MAT DEVICES, V12, P691
   Sugawara A, 1990, TOKYO SHIKA ISHIKAI, V38, P348
   TAKAGI S, 2000, T 6 WORLD BIOM C, P19
   TAKAGI S, 1999, J DENT RES, V78, P152
   Weissman JL, 1996, AM J NEURORADIOL, V17, P1569
   XU HHK, 2002, IN PRESS J DENT RES
NR 31
TC 40
Z9 42
U1 0
U2 18
PU US GOVERNMENT PRINTING OFFICE
PI WASHINGTON
PA SUPERINTENDENT DOCUMENTS,, WASHINGTON, DC 20402-9325 USA
SN 1044-677X
J9 J RES NATL INST STAN
JI J. Res. Natl. Inst. Stand. Technol.
PD NOV-DEC
PY 2001
VL 106
IS 6
BP 1029
EP 1033
DI 10.6028/jres.106.053
PG 5
WC Instruments & Instrumentation; Physics, Applied
SC Instruments & Instrumentation; Physics
GA 527WM
UT WOS:000174211000009
PM 27500062
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU Yasuda, HY
   Mahara, S
   Umakoshi, Y
AF Yasuda, HY
   Mahara, S
   Umakoshi, Y
TI Microstructure and mechanical property of
   hydroxyapatite/calcium-deficient hydroxyapatite composites prepared by a
   colloidal process
SO MATERIALS TRANSACTIONS
LA English
DT Article
DE hydroxyapatite; calcium-deficient hydroxyapatite; biomaterial; colloidal
   process; bone; mechanical property; microstructure
ID TRICALCIUM PHOSPHATE; BONE; CERAMICS
AB Calcium-deficient hydroxyapatite (DAp) having a rod-like or thin-blade-like shape was produced by hydrolysis of alpha -tricalcium phosphate (alpha -TCP) at different pH values. Mixed powder composed of 40 mass%DAp and 60 mass% stoichiometric hydroxyapatite (HAp) was suspended in an aqueous solution containing a small amount of dispersant by colloidal process, After dehydration, HAp-40 mass%, DAp consolidated samples were sintered at 1473 K for 2 h. Rheological behaviour of the slurry, microstructure and bending strength of HAp-40 mass%DAp prepared by this process depended strongly on quantity of the dispersant. Good dispersion of HAp and DAp powders at an optimum quantity of the dispersant resulted in high relative density of HAp/DAp composites with homogeneous microstructure, DAp starting powder readily decomposed to alpha -TCP and HAp at 1473 K. while the formation of alpha -TCP phase took place less intensively in HAp-40 mass%DAp composites sintered at that temperature. In contrast to HAp/alpha -TCP composites, an interdiffusion of ions between HAp and DAp during sintering may result in the increase in the thermal stability of DAp. HAp-40 mass%DAp composites prepared by a suitable colloidal process exhibited higher bending strength than HAp-40 mass%alpha -TCP composites and stoichiometric HAp alone.
C1 Osaka Univ, Grad Sch Engn, Dept Mat Sci & Engn, Suita, Osaka 5650871, Japan.
RP Yasuda, HY (reprint author), Osaka Univ, Grad Sch Engn, Dept Mat Sci & Engn, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.
CR AKSAY IA, 1983, J AM CERAM SOC C, V66, P190
   CESARANO J, 1988, J AM CERAM SOC, V71, P250, DOI 10.1111/j.1151-2916.1988.tb05855.x
   Daculsi G, 1998, BIOMATERIALS, V19, P1473, DOI 10.1016/S0142-9612(98)00061-1
   DACULSI G, 1990, J BIOMED MATER RES, V24, P379, DOI 10.1002/jbm.820240309
   DEWITH G, 1981, J MATER SCI, V16, P1592
   Elliott JC, 1994, STRUCTURE CHEM APATI, V18, P1
   FAYSSINET P, 1993, BIOMATERIALS, V14, P423
   HARADA Y, 1989, J TOKYO DENT COLL SO, V89, P263
   JARCHO M, 1976, J MATER SCI, V11, P2027, DOI 10.1007/BF02403350
   KLEIN C, 1994, BIOMATERIALS, V15, P31, DOI 10.1016/0142-9612(94)90193-7
   MONMA H, 1981, J CHEM TECHNOL BIOT, V31, P15, DOI 10.1002/jctb.280310105
   Monma H., 1978, Yogyo-Kyokai-Shi, V86, P73
   MONMA H, 1987, NIPPON SERAM KYO GAK, V95, P814
   MONMA H, 1978, YOGYO-KYOKAI-SHI, V86, P209
   MONMA H, 1978, YOGYO-KYOKAI-SHI, V86, P590
   PREMACHANDRAN RS, 1994, POWDER TECHNOL, V79, P53, DOI 10.1016/0032-5910(93)02793-A
   UMAKOSHI Y, 2000, EUROMAT 99, V2, P46
   YASUDA H, IN PRESS SCI TECH AD
   Yasuda HY, 2000, BIOMATERIALS, V21, P2045, DOI 10.1016/S0142-9612(00)00090-9
   Yaszemski MJ, 1996, BIOMATERIALS, V17, P175, DOI 10.1016/0142-9612(96)85762-0
NR 20
TC 4
Z9 5
U1 0
U2 4
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD NOV
PY 2001
VL 42
IS 11
SI SI
BP 2392
EP 2397
DI 10.2320/matertrans.42.2392
PG 6
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 504EM
UT WOS:000172844400042
OA Bronze
DA 2018-10-20
ER

PT J
AU Dick, HB
   Frohn, A
   Augustin, AJ
   Wolters, B
   Pakula, T
   Pfeiffer, N
AF Dick, HB
   Frohn, A
   Augustin, AJ
   Wolters, B
   Pakula, T
   Pfeiffer, N
TI Physicochemical surface properties of various intraocular lenses
SO OPHTHALMIC RESEARCH
LA English
DT Article
DE intraocular lenses; surface characteristics; contact angle;
   biocompatibility
ID IN-VITRO ADHERENCE; STAPHYLOCOCCUS-EPIDERMIDIS; CELL ADHESION;
   CONTACT-ANGLE; HEPARIN
AB Purpose: It is of major interest to understand how intraocular lens (IOL) surfaces interact with aqueous humor or tissues after implantation. Important parameters to describe the physicochemical surface properties are the contact angle and critical surface tension. Therefore, we performed measurements of the contact angle and critical surface tension of several commercially available IOLs. Setting: Department of Ophthalmology, Johannes Gutenberg University, Mainz, University Eye Hospital, Tubingen, and Max Planck Institute for Polymer Research, Mainz, Germany. Methods: A total of 17 commercially available standard quality IOL types (6 of each) of different materials from several manufacturers were studied. Scanning electron microscopy and contact angle measurements using the sessile drop method were made. Results: The sessile drop method differentiated all materials based on their surface forces. The contact angle (mean SD) ranged from 56.5 +/- 3.8 degrees (CeeOn 811C, Pharmacia) to 119.0 +/- 3 degrees (Silens 6, Bausch & Lomb). Conclusion: Contact angles differed between the IOLs depending on the IOL material with the lowest contact angle in the heparin-surface-modified IOL. The contact angle measurement method generates useful information about the material surface and its potential biomaterial interactions. Copyright (C) 2001 S. Karger AG, Basel.
C1 Johannes Gutenberg Univ Mainz, Dept Ophthalmol, D-55131 Mainz, Germany.
   Univ Tubingen, Hosp Eye, Tubingen, Germany.
   Max Planck Inst Polymer Res, D-55128 Mainz, Germany.
RP Dick, HB (reprint author), Johannes Gutenberg Univ Mainz, Dept Ophthalmol, Langenbeckstr 1, D-55131 Mainz, Germany.
EM bdick@mail.uni-mainz.de
CR Andrade J D, 1973, Med Instrum, V7, P110
   ANDRADE JD, 1979, J POLYM SCI POL SYM, P313
   ANDRADE JD, 1986, ADV POLYM SCI, V79, P1
   BAIER RE, 1970, ADHESION BIOLOGICAL, pCH2
   Chan A W, 1999, Cloning, V1, P25, DOI 10.1089/15204559950020076
   CHRIST FR, 1992, J BIOMED MATER RES, V26, P607
   Cunanan CM, 1998, J CATARACT REFR SURG, V24, P341, DOI 10.1016/S0886-3350(98)80322-2
   CUNANAN CM, 1991, J CATARACT REFR SURG, V17, P767
   Dick B, 1997, KLIN MONATSBL AUGENH, V211, P192, DOI 10.1055/s-2008-1035121
   Dick B, 1997, OPHTHALMOLOGICA, V211, P75, DOI 10.1159/000310762
   EISENBERGER P, 1996, J BIOMED MATER RES, V32, P143
   Gabriel MM, 1998, J CATARACT REFR SURG, V24, P124, DOI 10.1016/S0886-3350(98)80085-0
   GRIFFITHS PG, 1989, BRIT J OPHTHALMOL, V73, P402, DOI 10.1136/bjo.73.6.402
   HORBETT TA, 1985, J COLLOID INTERF SCI, V104, P28, DOI 10.1016/0021-9797(85)90006-2
   JANSEN JA, 1983, ADV BIOMATER, P259
   KAELBLE DH, 1977, POLYMER, V18, P475, DOI 10.1016/0032-3861(77)90164-1
   KINLOCH AJ, 1980, J MATER SCI, V15, P2141, DOI 10.1007/BF00552302
   LYDON MJ, 1985, BIOMATERIALS, V6, P396, DOI 10.1016/0142-9612(85)90100-0
   MATEO NB, 1989, INVEST OPHTH VIS SCI, V30, P853
   NAVASCUES G, 1981, CHEM PHYS LETT, V82, P586, DOI 10.1016/0009-2614(81)85446-2
   Pinna A, 2000, OPHTHALMOLOGY, V107, P1042, DOI 10.1016/S0161-6420(00)00080-4
   Prosdocimo G, 1997, Eur J Ophthalmol, V7, P241
   RUCKENSTEIN E, 1987, J COLLOID INTERF SCI, V120, P153, DOI 10.1016/0021-9797(87)90334-1
   SCHURCH S, 1981, BIOCHIM BIOPHYS ACTA, V640, P557, DOI 10.1016/0005-2736(81)90480-6
   TABOR D, 1977, J COLLOID INTERF SCI, V58, P2, DOI 10.1016/0021-9797(77)90366-6
   Trocme SD, 2000, OPHTHALMOLOGY, V107, P1031, DOI 10.1016/S0161-6420(00)00098-1
   WEAST RC, 1984, CRC HDB CHEM PHYSICS, pF33
   Wise D. L., 1995, ENCY HDB BIOMATERI A, V1
   Young T, 1804, PHILOS T R SOC LONDO, V95, P65, DOI DOI 10.1098/RSTL.1805.0005
   Zisman WA, 1972, J PAINT TECH, V44, P42
NR 30
TC 12
Z9 14
U1 1
U2 2
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0030-3747
J9 OPHTHALMIC RES
JI Ophthalmic Res.
PD NOV-DEC
PY 2001
VL 33
IS 6
BP 303
EP 309
DI 10.1159/000055685
PG 7
WC Ophthalmology
SC Ophthalmology
GA 498MV
UT WOS:000172515800001
PM 11721181
DA 2018-10-20
ER

PT J
AU Leatherman, BD
   Dornhoffer, JL
   Fan, CY
   Mukunyadzi, P
AF Leatherman, BD
   Dornhoffer, JL
   Fan, CY
   Mukunyadzi, P
TI Demineralized bone matrix as an alternative for mastoid obliteration and
   posterior canal wall reconstruction: Results in an animal model
SO OTOLOGY & NEUROTOLOGY
LA English
DT Article
DE biomaterial; cholesteatoma; canal wall reconstruction; mastoid cavity
   obliteration; human demineralized bone matrix; implant
ID AUDITORY-EVOKED-POTENTIALS; DEFECTS; RAT; PATE
AB Hypothesis: This study was conducted to evaluate the use of Grafton human demineralized bone matrix as a graft material for mastoid cavity obliteration and canal wall reconstruction in an animal model.
   Background: Canal wall down procedures in the treatment of cholesteatoma may result in a problematic mastoid cavity. Elimination of the mastoid cavity by obliteration or canal wall reconstruction can prevent or correct this problem. Many techniques and implant materials have been used for this application, yet no single material has proven to be ideal.
   Methods: Athymic rats received tympanic bulla obliteration and lateral bulla wall reconstruction utilizing the Grafton Putty and Flex formulations, respectively. Wound healing was monitored twice a week. Auditory brainstem evoked responses were obtained 8 weeks after implantation. Nine weeks after implantation, the animals were killed, and histologic sections were prepared. A histologic bone formation score (range 0-4) was determined for each implant.
   Results: Wound healing occurred without complication. Auditory brainstem response thresholds (average 23.5) fell within the normal range for all ears tested. The average histologic bone formation score for all implants was 3.7 The average scores for obliteration implants and wall reconstruction implants were 3.5 and 3.9, respectively. All wall reconstruction implants underwent partial or total collapse into the bulla.
   Conclusions: The high level of bone formation obtained by the use of Grafton implants in this study makes this material a promising resource for use in mastoid obliteration. The use of the material for canal wall reconstruction will likely require a sturdier preparation to prevent collapse into the mastoid cavity.
C1 Univ Arkansas Med Sci, Dept Otolaryngol Head & Neck Surg, Little Rock, AR 72205 USA.
   Univ Arkansas Med Sci, Dept Pathol, Little Rock, AR 72205 USA.
RP Leatherman, BD (reprint author), Univ Arkansas Med Sci, Dept Otolaryngol Head & Neck Surg, 4301 W Markham,Slot 543, Little Rock, AR 72205 USA.
CR AN HS, 1995, SPINE, V20, P2211, DOI 10.1097/00007632-199510001-00006
   Black B, 1995, LARYNGOSCOPE, V105, P1, DOI 10.1288/00005537-199512000-00023
   BURKARD R, 1990, AUDIOLOGY, V29, P146
   CHEN TJ, 1990, ACTA PHYSIOL SCAND, V138, P529, DOI 10.1111/j.1748-1716.1990.tb08881.x
   Chesmel KD, 1998, J ORAL MAXIL SURG, V56, P857, DOI 10.1016/S0278-2391(98)90015-5
   Dornhoffer JL, 1999, OTOLARYNG HEAD NECK, V120, P361, DOI 10.1016/S0194-5998(99)70276-7
   Edwards JT, 1998, CLIN ORTHOP RELAT R, P219
   Estrem SA, 1999, OTOLARYNG HEAD NECK, V120, P345, DOI 10.1016/S0194-5998(99)70273-1
   Groeneveld EHJ, 1999, CLIN ORAL IMPLAN RES, V10, P499, DOI 10.1034/j.1600-0501.1999.100608.x
   Groeneveld EHJ, 1999, J BIOMED MATER RES, V48, P393, DOI 10.1002/(SICI)1097-4636(1999)48:4<393::AID-JBM1>3.3.CO;2-3
   GUILFORD F, 1958, T AM ACAD OPHTHALMOL, P455
   HOHMANN A, 1969, LARYNGOSCOPE, V79, P1618, DOI 10.1288/00005537-196909000-00007
   IRVING RM, 1994, CLIN OTOLARYNGOL, V19, P158, DOI 10.1111/j.1365-2273.1994.tb01202.x
   Jackson CG, 1996, AM J OTOL, V17, P7
   KABAN LB, 1982, J ORAL MAXIL SURG, V40, P623, DOI 10.1016/0278-2391(82)90109-4
   Killian JT, 1998, J PEDIATR ORTHOPED, V18, P621, DOI 10.1097/00004694-199809000-00013
   Ladd A L, 1999, J Am Acad Orthop Surg, V7, P279
   Martin GJ, 1999, SPINE, V24, P637, DOI 10.1097/00007632-199904010-00005
   MINATOGAWA T, 1995, AM J OTOL, V16, P99
   MOFFAT DA, 1994, CLIN OTOLARYNGOL, V19, P149, DOI 10.1111/j.1365-2273.1994.tb01201.x
   MULLIKEN JB, 1981, ANN SURG, V194, P366, DOI 10.1097/00000658-198109000-00015
   PALVA T, 1979, ACTA OTO-LARYNGOL, P152
   POU JW, 1977, LARYNGOSCOPE, V87, P1826
   SADE J, 1982, J LARYNGOL OTOL, V96, P869, DOI 10.1017/S0022215100093221
   SHAPIRO SM, 1984, ELECTROEN CLIN NEURO, V58, P266, DOI 10.1016/0013-4694(84)90112-3
   Shea M C Jr, 1972, Otolaryngol Clin North Am, V5, P161
   SHEA M C JR, 1972, Transactions of the American Academy of Ophthalmology and Oto-Laryngology, V76, P160
   SHEA MC, 1970, ARCHIV OTOLARYNGOL, V92, P358
   Tiedeman JJ, 1995, ORTHOPEDICS, V18, P1153
NR 29
TC 10
Z9 12
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1531-7129
EI 1537-4505
J9 OTOL NEUROTOL
JI Otol. Neurotol.
PD NOV
PY 2001
VL 22
IS 6
BP 731
EP 736
DI 10.1097/00129492-200111000-00004
PG 6
WC Clinical Neurology; Otorhinolaryngology
SC Neurosciences & Neurology; Otorhinolaryngology
GA 494CG
UT WOS:000172260700004
PM 11698788
DA 2018-10-20
ER

PT J
AU Huang, L
   Apkarian, RP
   Chaikof, EL
AF Huang, L
   Apkarian, RP
   Chaikof, EL
TI High-resolution analysis of engineered type I collagen nanofibers by
   electron microscopy
SO SCANNING
LA English
DT Article
DE collagen; polyethylene oxide; nanofiber; biomimetic; biomaterial
ID DIAMETER FIBERS
AB Collagen nanofibers were generated at ambient temperature and pressure by electrospinning a 1 wt% solution of type 1 collagen and polyethylene oxide. Products were imaged with high-resolution scanning electron microscopy (HRSEM) at medium (similar to 30,000 x) and high magnifications (similar to 100,000 x) and with transmission electron microscopy (TEM). The capacity to produce collagen nanofibers may lead to the generation of extracellular matrix-based fabrics with applications in the fields of wound healing and tissue engineering.
C1 Emory Univ, Dept Surg, Atlanta, GA 30322 USA.
   Emory Univ, Integrated Microscopy & Microanalyt Facil Chem, Atlanta, GA 30322 USA.
   Georgia Inst Technol, Sch Chem Engn, Atlanta, GA 30332 USA.
RP Chaikof, EL (reprint author), Emory Univ, Dept Surg, 1639 Pierce Dr,Room 5105, Atlanta, GA 30322 USA.
RI Liu, Yifei/L-7828-2014
OI Liu, Yifei/0000-0002-1087-9827
CR Apkarian RP, 1999, MICROSC MICROANAL, V5, P197, DOI 10.1017/S1431927699000148
   DOSHI J, 1995, J ELECTROSTAT, V35, P151, DOI 10.1016/0304-3886(95)00041-8
   Entov V. M., 1997, Fluid Dynamics, V32, P696
   Fang X, 1997, J MACROMOL SCI PHYS, VB36, P169, DOI 10.1080/00222349708220422
   Fong H, 1999, POLYMER, V40, P4585, DOI 10.1016/S0032-3861(99)00068-3
   Huang L, 2000, MACROMOLECULES, V33, P2989, DOI 10.1021/ma991858f
   JOY DC, 1994, PROC ANN MEET MSA, P1032
   PETERS KR, 1985, SCANNING ELECTRON MI, V4, P1519
   Reneker DH, 1996, NANOTECHNOLOGY, V7, P216, DOI 10.1088/0957-4484/7/3/009
   SILVER FH, 1980, J BIOL CHEM, V255, P9427
   YARIN AL, 1993, HYDRODYNAMICS RHEOLO
   ZHU KJ, 1990, J APPL POLYM SCI, V39, P1, DOI 10.1002/app.1990.070390101
NR 12
TC 52
Z9 57
U1 0
U2 13
PU FAMS INC
PI MAHWAH
PA BOX 832, MAHWAH, NJ 07430-0832 USA
SN 0161-0457
J9 SCANNING
JI Scanning
PD NOV-DEC
PY 2001
VL 23
IS 6
BP 372
EP 375
PG 4
WC Instruments & Instrumentation; Microscopy
SC Instruments & Instrumentation; Microscopy
GA 499WT
UT WOS:000172594100003
PM 11770932
DA 2018-10-20
ER

PT J
AU Ono, K
   Ishihara, M
   Ozeki, Y
   Deguchi, H
   Sato, M
   Saito, Y
   Yura, H
   Sato, M
   Kikuchi, M
   Kurita, A
   Maehara, T
AF Ono, K
   Ishihara, M
   Ozeki, Y
   Deguchi, H
   Sato, M
   Saito, Y
   Yura, H
   Sato, M
   Kikuchi, M
   Kurita, A
   Maehara, T
TI Experimental evaluation of photocrosslinkable chitosan as a biologic
   adhesive with surgical applications
SO SURGERY
LA English
DT Article
ID FIBRIN GLUE; POLY(L-GLUTAMIC ACID); CYTOKINE PRODUCTION; CHITIN;
   BIOMATERIAL; STIMULATION; OPERATIONS; SURGERY; GELATIN; DOGS
AB Background. In various surgical cases, effective tissue adhesives are required for both hemostasis (eg, intraoperative bleeding) and air sealing (eg, thoracic surgery). We have designed a chitosan molecule (Az-CH-LA) that can be photocrosslinked by ultraviolet (UV) light irradiation, thereby forming a hydrogel. The purpose of this work was to evaluate the effectiveness and safely of the photocrosslinkable chitosan hydrogel as an adhesive with surgical applications.
   Methods. The sealing ability of the chitosan hydrogel, determined as a bursting pressure, was assessed with removed thoracic aorta, trachea, and lung of farm pigs and in a rabbit model. The carotid artery and lung of rabbits were punctured with a needle, and the chitosan hydrogel was applied to, respectively, stop the bleeding and the air leakage. In vivo chitosan degradability and biologic responses were histologically assessed in animal models.
   Results. The bursting pressure of chitosan hydrogel (30 mg/mL) and fibrin glue, respectively, was 225 +/- 25 mm Hg (mean +/- SD) and 80 +/- 20 mm fg in the thoracic aorta; 77 +/- 29 mm Hg and 48 +/- 21 mm Hg in the trachea; and in the lung, 51 +/- 11 mm Hg (chitosan hydrogel), 62 +/- 4 min Hg (fibrin glue, rubbing method), and 12 +/- 2 mm Hg (fibrin glue, laver method). The sealing ability of the chitosan hydrogel was stronger than that of fibrin glue. All rabbits with a carotid artery (n = 8) or lung (n = 8) that was punctured with a needle and then sealed with chitosan hydrogel survived the 1-month observation period without any bleeding or air leakage from the puncture sites. Histologic examinations demonstrated that 30 days after application, a fraction of the chitosan hydrogel was phagocytosed by macrophages, had partially degraded, and had induced the formation of fibrous tissues around the hydrogel.
   Conclusions. A newly developed photocrosslinkable chitosan has demonstrated strong sealing ability and a great potential for use as an adhesive in surgical operations.
C1 Natl Def Med Coll, Res Inst, Div Biomed Engn, Tokorozawa, Saitama 3598513, Japan.
   Natl Def Med Coll, Dept Med Engn, Dept Orthoped Surg, Dept Surg 2, Tokorozawa, Saitama 3598513, Japan.
   NeTech Inc, Kanagawa, Japan.
RP Ishihara, M (reprint author), Natl Def Med Coll, Res Inst, Div Biomed Engn, 3-2 Namiki, Tokorozawa, Saitama 3598513, Japan.
OI Sato, Masato/0000-0003-4049-7325
CR BORST HG, 1982, J THORAC CARDIOV SUR, V84, P548
   BRAUNWALD NS, 1966, SURGERY, V59, P1024
   CHANDY T, 1990, BIOMATER ARTIF CELL, V18, P1, DOI 10.3109/10731199009117286
   Cho YW, 1999, BIOMATERIALS, V20, P2139, DOI 10.1016/S0142-9612(99)00116-7
   JESSEN C, 1985, ANN THORAC SURG, V39, P521, DOI 10.1016/S0003-4975(10)61991-1
   KOCH AE, 1992, SCIENCE, V258, P1798, DOI 10.1126/science.1281554
   KOEHNLEIN HE, 1969, SURGERY, V66, P377
   MINAMI S, 1992, ADVANCES IN CHITIN AND CHITOSAN, P61
   Mori T, 1997, BIOMATERIALS, V18, P947, DOI 10.1016/S0142-9612(97)00017-3
   Morikawa T, 1999, EUR SURG RES, V31, P180, DOI 10.1159/000008637
   MOY OJ, 1988, J HAND SURG-AM, V13A, P273, DOI 10.1016/S0363-5023(88)80063-7
   MUZZARELLI RAA, 1993, CARBOHYD POLYM, V20, P7, DOI 10.1016/0144-8617(93)90027-2
   NISHIMURA K, 1986, VACCINE, V4, P151, DOI 10.1016/0264-410X(86)90002-2
   OKAMOTO Y, 1995, J VET MED SCI, V57, P851, DOI 10.1292/jvms.57.851
   Ono K, 2000, J BIOMED MATER RES, V49, P289
   Otani Y, 1996, J BIOMED MATER RES, V31, P157
   Otani Y, 1996, BIOMATERIALS, V17, P1387, DOI 10.1016/0142-9612(96)87279-6
   PELUSO G, 1994, BIOMATERIALS, V15, P1215, DOI 10.1016/0142-9612(94)90272-0
   PRUDDEN JF, 1970, AM J SURG, V119, P560, DOI 10.1016/0002-9610(70)90175-3
   Rao SB, 1997, J BIOMED MATER RES, V34, P21, DOI 10.1002/(SICI)1097-4636(199701)34:1<21::AID-JBM4>3.0.CO;2-P
   ROUSOU JA, 1984, ANN THORAC SURG, V38, P409, DOI 10.1016/S0003-4975(10)62297-7
   SHIGEMASA Y, 1995, BIOTECHNOL GENET ENG, V13, P383
   STARK J, 1984, ANN THORAC SURG, V38, P411, DOI 10.1016/S0003-4975(10)62298-9
   THETTER O, 1981, THORAC CARDIOV SURG, V29, P290, DOI 10.1055/s-2007-1023498
   TSENG YC, 1990, BIOMATERIALS, V11, P73, DOI 10.1016/0142-9612(90)90055-U
   Ueno H, 1999, BIOMATERIALS, V20, P1407, DOI 10.1016/S0142-9612(99)00046-0
   VANHOLDER R, 1993, BIOMATERIALS, V14, P737, DOI 10.1016/0142-9612(93)90037-3
NR 27
TC 77
Z9 83
U1 1
U2 30
PU MOSBY, INC
PI ST LOUIS
PA 11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA
SN 0039-6060
J9 SURGERY
JI Surgery
PD NOV
PY 2001
VL 130
IS 5
BP 844
EP 850
DI 10.1067/msy.2001.117197
PG 7
WC Surgery
SC Surgery
GA 490AL
UT WOS:000172026000011
PM 11685194
DA 2018-10-20
ER

PT J
AU Wu, PK
   Ringeisen, BR
   Callahan, J
   Brooks, M
   Bubb, DM
   Wu, HD
   Pique, A
   Spargo, B
   McGill, RA
   Chrisey, DB
AF Wu, PK
   Ringeisen, BR
   Callahan, J
   Brooks, M
   Bubb, DM
   Wu, HD
   Pique, A
   Spargo, B
   McGill, RA
   Chrisey, DB
TI The deposition, structure, pattern deposition, and activity of
   biomaterial thin-films by matrix-assisted pulsed-laser evaporation
   (MAPLE) and MAPLE direct write
SO THIN SOLID FILMS
LA English
DT Article; Proceedings Paper
CT 28th International Conference on Metallurgical Coatings and Thin Films
CY APR 30-MAY 05, 2001
CL SAN DIEGO, CA
SP AVS Sci & Technol Soc, Adv Surface Engn Div
DE biomaterials; biosensors; cells; polymers; direct-write; laser ablation;
   physical vapor deposition (PVD); pulsed-laser; matrix-assisted
   pulsed-laser evaporation (MAPLE)
ID ELECTROCHEMICAL BIOSENSOR; MEMBRANE; GLUCOSE
AB Two techniques, Matrix-Assisted Pulsed-Laser Evaporation (MAPLE) and MAPLE Direct Write (MDW) were developed to deposit biomaterial thin-films. MAPLE involves dissolving or suspending the biomaterial in a volatile solvent, freezing the mixture to create a solid target, and using a low fluence pulsed laser to evaporate the target for deposition of the solute inside a vacuum system. Using simple shadow masks, i.e. lines, dots and arrays, pattern features with length scales as small as 20 mum can be deposited using multiple materials on different types of substrates. MDW uses pulsed laser to directly transfer material from a ribbon to a substrate. Patterns with a spatial resolution of similar to 10 mum can be written directly. Biomaterials ranging from polyethylene glycol to eukaryotic cells, i.e. Chinese hamster ovaries, were deposited with no measurable damage to their structures or genotype. Deposits of immobilized horseradish peroxidase, an enzyme, in the form of a polymer composite with a protective coating, i.e. polyurethane, retained their enzymatic functions. A dopamine electrochemical sensor was fabricated by MDW using a natural tissues/graphite composite. These examples and the unique features of MAPLE and MDW for biosensor fabrication have been discussed. (C) 2001 Elsevier Science B.V. All rights reserved.
C1 USN, Res Lab, Washington, DC 20375 USA.
   So Oregon Univ, Dept Phys, Ashland, OR 97520 USA.
RP Wu, PK (reprint author), USN, Res Lab, Code 6372,Bldg 74,4555 Overlook Ave SW, Washington, DC 20375 USA.
EM wup@ccf.nrl.navy.mil
CR ADAMS RN, 1976, ANAL CHEM, V48, P1126
   ANTONISSE MMG, 1996, CHEMOSENSORS ION MOL, P23
   Ballantine D., 1997, ACOUSTIC WAVE SENSOR
   BELLI SL, 1986, ANAL LETT, V19, P403
   BUBB DM, 2001, IN PRESS APPL PHYS L
   Chen Q, 1998, ELECTROANAL, V10, P94, DOI 10.1002/(SICI)1521-4109(199802)10:2<94::AID-ELAN94>3.0.CO;2-A
   CLARK C, 1987, BIOSENSORS FUNDAMENT, pCH1
   CLARK LC, 1962, ANN NY ACAD SCI, V102, P29, DOI 10.1111/j.1749-6632.1962.tb13623.x
   DANIELSSON B, 1987, BIOSENSORS FUNDAMENT, pCH29
   DIAMOND D, 1996, CHEMOSENSORS ION MOL, P91
   Eggins B., 1996, BIOSENSORS INTRO
   ElRhazi M, 1997, QUIM ANAL, V16, P49
   Fitz-Gerald JM, 2000, INTEGR FERROELECTR, V29, P13
   HALL EAH, 1990, BIOSENSORS, pCH2
   Harmer A., 1996, CHEM BIOCH SENSING O
   HARRIS JM, 1991, ACS SYM SER, V467, P418
   HAWKESWORTH K, 1993, ANALYST, V118, P395, DOI 10.1039/an9931800395
   Henry CM, 2000, CHEM ENG NEWS, V78, P49, DOI 10.1021/cen-v078n028.p049
   KARUBE I, 1987, BIOSENSORS FUNDAMENT, pCH2
   LEECH D, 1994, CHEM SOC REV, V23, P205, DOI 10.1039/cs9942300205
   Mar MN, 1999, SENSOR ACTUAT B-CHEM, V54, P125, DOI 10.1016/S0925-4005(98)00330-X
   Nakaya T, 1999, PROG POLYM SCI, V24, P143, DOI 10.1016/S0079-6700(98)00015-X
   NEWMAN JD, 1992, ANAL CHIM ACTA, V262, P13, DOI 10.1016/0003-2670(92)80002-O
   PALMER JK, 1963, PLANT PHYSIOL, V38, P508, DOI 10.1104/pp.38.5.508
   Pique A, 2000, P SOC PHOTO-OPT INS, V3933, P105, DOI 10.1117/12.387545
   Pique A, 1999, THIN SOLID FILMS, V355, P536, DOI 10.1016/S0257-8972(99)00376-X
   PONCHON JL, 1979, ANAL CHEM, V51, P1483, DOI 10.1021/ac50045a030
   Rechnitz GA, 1978, CHEM ENG NEWS, V56, P16
   RINGEISEN BR, 2001, IN PRESS BIOMATERIAL
   RINGEISEN BR, 2001, MODELLING SIMULATION
   Roda A, 2000, BIOTECHNIQUES, V28, P492, DOI 10.2144/00283st07
   SIDWELL JS, 1985, BIOTECHNOL LETT, V7, P419, DOI 10.1007/BF01166215
   Sirkar K, 2000, ANAL CHEM, V72, P2930, DOI 10.1021/ac991041k
   Stamford JA, 1996, ANAL CHEM, V68, pA359, DOI 10.1021/ac961943a
   Suggs L.J., 1998, POLYM TISSUE ENG, P99
   Tortora GJ, 1995, MICROBIOLOGY INTRO
   TSIEN RY, 1996, CHEMOSENSORS ION MOL, P17
   TURNER AFP, 1997, ANN CHIM, V87, P244
   VADGAMA P, 1992, ANALYST, V117, P1657, DOI 10.1039/an9921701657
   Vaidya R, 1998, BIOTECHNOL PROGR, V14, P371, DOI 10.1021/bp980039w
   WANG J, 1988, ANAL CHEM, V60, P1545, DOI 10.1021/ac00166a014
   WANG J, 2000, ANAL ELECTROCHEMISTY
   WARNER PG, 1987, BIOSENSORS FUNDAMENT, pCH7
   Wisniewski N, 2000, COLLOID SURFACE B, V18, P197, DOI 10.1016/S0927-7765(99)00148-4
   WU PK, 2000, MAT RES SOC S P, V617
   Zhang S, 2000, BIOSENS BIOELECTRON, V15, P273, DOI 10.1016/S0956-5663(00)00076-2
NR 46
TC 98
Z9 102
U1 1
U2 21
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0040-6090
J9 THIN SOLID FILMS
JI Thin Solid Films
PD NOV 1
PY 2001
VL 398
BP 607
EP 614
DI 10.1016/S0040-6090(01)01347-5
PG 8
WC Materials Science, Multidisciplinary; Materials Science, Coatings &
   Films; Physics, Applied; Physics, Condensed Matter
SC Materials Science; Physics
GA 505GZ
UT WOS:000172906200105
DA 2018-10-20
ER

PT J
AU Ishihara, M
   Ono, K
   Sato, M
   Nakanishi, K
   Saito, Y
   Yura, H
   Matsui, T
   Hattori, H
   Fujita, M
   Kikuchi, M
   Kurita, A
AF Ishihara, M
   Ono, K
   Sato, M
   Nakanishi, K
   Saito, Y
   Yura, H
   Matsui, T
   Hattori, H
   Fujita, M
   Kikuchi, M
   Kurita, A
TI Acceleration of wound contraction and healing with a photocrosslinkable
   chitosan hydrogel
SO WOUND REPAIR AND REGENERATION
LA English
DT Article
ID FIBROBLAST-GROWTH-FACTOR; DEACETYLATED CHITIN; CYTOKINE PRODUCTION;
   BIOMATERIAL; STIMULATION; MIGRATION; CELLS; MICE; DOGS
AB Application of ultraviolet light irradiation to a photocrosslinkable chitosan aqueous solution resulted in an insoluble, flexible hydrogel like soft rubber within 60 seconds. In order to evaluate its accelerating effect on wound healing, full-thickness skin incisions were made on the backs of mice and subsequently a photocrosslinkable chitosan aqueous solution was added into the wound and irradiated with UV light for 90 seconds. Application of the chitosan hydrogel significantly induced wound contraction and accelerated wound closure and healing compared with the untreated controls. Histological examination also showed an advanced contraction rate on the first 2 days and tissue fill rate on days 2 to 4 in the chitosan hydrogel-treated wounds. Furthermore, in cell culture studies, chitosan hydrogel culture medium supplemented with 5% fetal-bovine serum was found to be chemoattractant for human dermal fibroblasts in an invasion chamber assay using filters coated with Matrigel and in a cell migration assay. Due to its ability to accelerate wound contraction and healing, chitosan hydrogel may become accepted as an occlusive dressing for wound management.
C1 Natl Def Med Coll, Res Inst, Div Biomed Engn, Tokorozawa, Saitama 3598513, Japan.
   Natl Def Med Coll, Res Inst, Dept Surg 2, Tokorozawa, Saitama 3598513, Japan.
   Natl Def Med Coll, Res Inst, Dept Orthoped Surg, Tokorozawa, Saitama 3598513, Japan.
   Natl Def Med Coll, Res Inst, Dept Med Engn, Tokorozawa, Saitama 3598513, Japan.
   NeTech Inc, Tokorozawa, Saitama, Japan.
RP Ishihara, M (reprint author), Natl Def Med Coll, Res Inst, Div Biomed Engn, 3-2 Namiki, Tokorozawa, Saitama 3598513, Japan.
OI Sato, Masato/0000-0003-4049-7325
CR ALBINI A, 1987, CANCER RES, V47, P3239
   CHANDY T, 1990, BIOMATER ARTIF CELL, V18, P1, DOI 10.3109/10731199009117286
   Cho YW, 1999, BIOMATERIALS, V20, P2139, DOI 10.1016/S0142-9612(99)00116-7
   FUKASAWA M, 1992, SURG TODAY, V22, P333, DOI 10.1007/BF00308742
   GILMAN TH, 1994, OSTOMY WOUND MANAGE, V41, P6
   KOCH AE, 1992, SCIENCE, V258, P1798, DOI 10.1126/science.1281554
   Mori T, 1997, BIOMATERIALS, V18, P947, DOI 10.1016/S0142-9612(97)00017-3
   MUZZARELLI RAA, 1993, CARBOHYD POLYM, V20, P7, DOI 10.1016/0144-8617(93)90027-2
   NISHIMURA K, 1986, VACCINE, V4, P151, DOI 10.1016/0264-410X(86)90002-2
   OKAMOTO Y, 1995, J VET MED SCI, V57, P851, DOI 10.1292/jvms.57.851
   Ono I, 1999, J BIOMED MATER RES, V48, P621, DOI 10.1002/(SICI)1097-4636(1999)48:5<621::AID-JBM5>3.0.CO;2-1
   Ono K, 2000, J BIOMED MATER RES, V49, P289
   ONO K, IN PRESS SURGERY
   PELUSO G, 1994, BIOMATERIALS, V15, P1215, DOI 10.1016/0142-9612(94)90272-0
   PRUDDEN JF, 1970, AM J SURG, V119, P560, DOI 10.1016/0002-9610(70)90175-3
   Radhakrishnan VV, 1991, BIOMEDICINE, V2, P3
   Rao SB, 1997, J BIOMED MATER RES, V34, P21, DOI 10.1002/(SICI)1097-4636(199701)34:1<21::AID-JBM4>3.0.CO;2-P
   SHIGEMASA Y, 1995, BIOTECHNOL GENET ENG, V13, P383
   TSUBOI R, 1990, J EXP MED, V172, P245, DOI 10.1084/jem.172.1.245
   Ueno H, 1999, BIOMATERIALS, V20, P1407, DOI 10.1016/S0142-9612(99)00046-0
   USAMI Y, 1994, J VET MED SCI, V56, P761, DOI 10.1292/jvms.56.761
   USAMI Y, 1994, J VET MED SCI, V56, P1215, DOI 10.1292/jvms.56.1215
NR 22
TC 86
Z9 94
U1 4
U2 26
PU BLACKWELL PUBLISHING INC
PI MALDEN
PA 350 MAIN ST, MALDEN, MA 02148 USA
SN 1067-1927
J9 WOUND REPAIR REGEN
JI Wound Repair Regen.
PD NOV-DEC
PY 2001
VL 9
IS 6
BP 513
EP 521
DI 10.1046/j.1524-475x.2001.00513.x
PG 9
WC Cell Biology; Dermatology; Medicine, Research & Experimental; Surgery
SC Cell Biology; Dermatology; Research & Experimental Medicine; Surgery
GA 536NT
UT WOS:000174709400011
PM 11896994
DA 2018-10-20
ER

PT J
AU Ozawa, T
   Weisel, RD
   Mickle, DAG
   Ohno, N
   Matsubayashi, K
   Kitagawa, A
   Li, GM
   Tumiati, L
   Ozawa, S
   Morita, S
   Ikada, Y
   Li, RK
AF Ozawa, T
   Weisel, RD
   Mickle, DAG
   Ohno, N
   Matsubayashi, K
   Kitagawa, A
   Li, GM
   Tumiati, L
   Ozawa, S
   Morita, S
   Ikada, Y
   Li, RK
TI The optimal biomaterial for autologous cardiac grafts to repair
   congenital heart defects
SO CIRCULATION
LA English
DT Meeting Abstract
C1 Toronto Gen Hosp, Toronto, ON, Canada.
   GUNZE Ltd, Kyoto, Japan.
   Suzuka Univ, Sch Med, Suzuka, Mie, Japan.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0009-7322
J9 CIRCULATION
JI Circulation
PD OCT 23
PY 2001
VL 104
IS 17
SU S
MA 2053
BP 433
EP 433
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA 487UW
UT WOS:000171895002035
DA 2018-10-20
ER

PT J
AU Chu, CL
   Zhu, JC
   Yin, ZD
   Lin, PH
AF Chu, CL
   Zhu, JC
   Yin, ZD
   Lin, PH
TI Structure optimization and properties of hydroxyapatite-Ti symmetrical
   functionally graded biomaterial
SO MATERIALS SCIENCE AND ENGINEERING A-STRUCTURAL MATERIALS PROPERTIES
   MICROSTRUCTURE AND PROCESSING
LA English
DT Article
DE functionally graded biomaterial; structure optimization; titanium;
   hydroxyapatite
AB The hydroxyapatite(HA)-Ti/Ti/HA-Ti symmetrical functionally graded biomaterial (FGM) combining the excellent biocompatible properties of hydroxyapatite ceramic and the good mechanical properties of titanium component is a very promising biomaterial for hard tissue replacement implant. The optimized distribution function of components of this FGM has been obtained based on the classical lamination theory and thermo-elastic mechanics to overcome the tendency toward microcracking in earlier samples firstly. The perfect FGM sample without any microcracks on the surfaces was fabricated by hot pressing successfully whose actual distributions of compositions and thermal residual stress have been analyzed by electron probe microanalyser (EPMA) and X-ray diffraction method, which are consistent with those designed theoretically. Its integral apparent bending strength can reach to 158.9 MPa, which is higher than that of human bone. HA-Ti/Ti/Ti-HA symmetrical FGM behaved integral-fracture without falling apart or delaminating under two different loading modes. As a result, the pure titanium layer could provide an effective support of mechanical properties for the whole functionally graded biomaterial. (C) 2001 Elsevier Science B.V. All rights reserved.
C1 SE Univ, Dept Mech Engn, Nanjing 210018, Peoples R China.
   Harbin Inst Technol, Sch Mat Sci & Engn, Harbin 150001, Peoples R China.
RP Chu, CL (reprint author), SE Univ, Dept Mech Engn, Nanjing 210018, Peoples R China.
RI Zhu, Jingchuan/B-3573-2018
OI Zhu, Jingchuan/0000-0002-6075-2373
CR BISHOP A, 1993, J MATER SCI LETT, V12, P1516
   Chu CL, 1999, J INORG MATER, V14, P775
   Chu CL, 1999, MAT SCI ENG A-STRUCT, V271, P95, DOI 10.1016/S0921-5093(99)00152-5
   Chu CL, 2000, T NONFERR METAL SOC, V10, P505
   CHU CL, 2000, THESIS HARBIN I TECH
   CHU CL, 1999, T NONFERROUS METALS, V9, P57
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Neubrand A, 1997, Z METALLKD, V88, P358
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   Suresh S, 1997, INT MATER REV, V42, P85, DOI 10.1179/imr.1997.42.3.85
   Tang X.F., 1994, J CHINESE CERAMIC SO, V22, P44
   Watari F, 1998, J JPN I MET, V62, P1095, DOI 10.2320/jinstmet1952.62.11_1095
NR 12
TC 26
Z9 34
U1 0
U2 5
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0921-5093
J9 MAT SCI ENG A-STRUCT
JI Mater. Sci. Eng. A-Struct. Mater. Prop. Microstruct. Process.
PD OCT 15
PY 2001
VL 316
IS 1-2
BP 205
EP 210
DI 10.1016/S0921-5093(01)01239-4
PG 6
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Science & Technology - Other Topics; Materials Science; Metallurgy &
   Metallurgical Engineering
GA 477EB
UT WOS:000171269200026
DA 2018-10-20
ER

PT J
AU Hayashi, M
   Tomita, M
   Yoshizato, K
AF Hayashi, M
   Tomita, M
   Yoshizato, K
TI Production of EGF-collagen chimeric protein which shows the mitogenic
   activity
SO BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
LA English
DT Article
DE recombinant protein; fusion protein; type III collagen; biomaterial;
   growth factor
ID EPIDERMAL GROWTH-FACTOR; BACULOVIRUS EXPRESSION SYSTEM; HUMAN
   PROCOLLAGEN-I; DELIVERY SYSTEM; EXTRACELLULAR-MATRIX; HUMAN-FIBROBLASTS;
   CARRIER MATERIAL; ARTIFICIAL SKIN; FUSION PROTEIN; BINDING DOMAIN
AB Collagen has been utilized as a natural biomaterial because of its high biocompatibility, adhesiveness to cells and tissues, and biodegradability. The present study developed a recombinant technology to confer a mitogenic activity on type III collagen by fusing it to epidermal growth factor (EGF) at the collagen's N-terminus. The chimeric protein of EGF-collagen was synthesized in insect cells by the baculovirus-insect cell expression system. The fusion protein was shown to hold the triple helical conformation of collagen and the mitogenic activity of EGF. It was also demonstrated that the chimeric protein can be immobilized on tissue culture dishes as a fibrous form and in collagen fibrils without abolishing the original mitogenic, activity of EGF. This fusion protein can be utilized as a biocompatible, biodegradable, and adhesive fibrous mitogen for a variety of purposes in the area of tissue engineering. (C) 2001 Elsevier Science B.V. All rights reserved.
C1 Hiroshima Univ, Dev Biol Lab, Dept Biol Sci, Grad Sch Sci, Hiroshima 7398526, Japan.
   Japan Sci & Technol Corp, Hiroshima Tissue Regenerat Project, Hiroshima Prefecture Collaborat Reg Ent Advanceme, Hiroshima Prefecture Inst Ind Sci & Technol, Hiroshima 7390046, Japan.
   Terumo Co Ltd, Ctr Res & Dev, Nakai, Kanagawa 2590151, Japan.
RP Yoshizato, K (reprint author), Hiroshima Univ, Dev Biol Lab, Dept Biol Sci, Grad Sch Sci, 1-3-1 Kagamiyama, Hiroshima 7398526, Japan.
CR ADAMS JC, 1993, DEVELOPMENT, V117, P1183
   ALAKOKKO L, 1989, BIOCHEM J, V260, P509, DOI 10.1042/bj2600509
   Annunen P, 1997, J BIOL CHEM, V272, P17342, DOI 10.1074/jbc.272.28.17342
   ARTURSON G, 1984, SCAND J PLAST RECONS, V18, P33, DOI 10.3109/02844318409057400
   Asahina K, 1999, DEV DYNAM, V216, P59, DOI 10.1002/(SICI)1097-0177(199909)216:1<59::AID-DVDY8>3.0.CO;2-B
   Bailey AJ, 2000, WOUND REPAIR REGEN, V8, P5, DOI 10.1046/j.1524-475x.2000.00005.x
   BENNETT NT, 1993, AM J SURG, V166, P74, DOI 10.1016/S0002-9610(05)80589-6
   BROWN GL, 1991, PLAST RECONSTR SURG, V88, P189, DOI 10.1097/00006534-199108000-00001
   BROWN GL, 1986, J EXP MED, V163, P1319
   BROWN GL, 1989, NEW ENGL J MED, V321, P76, DOI 10.1056/NEJM198907133210203
   BUCKLEY A, 1985, P NATL ACAD SCI USA, V82, P7340, DOI 10.1073/pnas.82.21.7340
   BURKE KE, 1985, ANN PLAS SURG, V14, P515, DOI 10.1097/00000637-198506000-00004
   Chen GP, 1997, BBA-MOL CELL RES, V1358, P200, DOI 10.1016/S0167-4889(97)00065-7
   FUJIOKA K, 1995, J CONTROL RELEASE, V33, P307, DOI 10.1016/0168-3659(94)00107-6
   GRAY A, 1983, NATURE, V303, P722, DOI 10.1038/303722a0
   GREAVES MW, 1980, CLIN EXP DERMATOL, V5, P101, DOI 10.1111/j.1365-2230.1980.tb01675.x
   Hall FL, 2000, INT J MOL MED, V6, P635
   Ishikawa T, 2001, J BIOCHEM-TOKYO, V129, P627, DOI 10.1093/oxfordjournals.jbchem.a002900
   Ishino K, 1998, JPN J CANCER RES, V89, P1126, DOI 10.1111/j.1349-7006.1998.tb00507.x
   ISHIYAMA M, 1993, CHEM PHARM BULL, V41, P1118
   Ito Y, 1997, J BIOCHEM-TOKYO, V121, P514
   Kadler KE, 1996, BIOCHEM J, V316, P1
   KAWASE Y, 1992, FEBS LETT, V298, P126, DOI 10.1016/0014-5793(92)80037-H
   Kivirikko KI, 1998, MATRIX BIOL, V16, P357, DOI 10.1016/S0945-053X(98)90009-9
   KOIDE M, 1993, J BIOMED MATER RES, V27, P79, DOI 10.1002/jbm.820270111
   Kuhl PR, 1996, NAT MED, V2, P1022, DOI 10.1038/nm0996-1022
   Lamberg A, 1996, J BIOL CHEM, V271, P11988, DOI 10.1074/jbc.271.20.11988
   Maeda M, 1999, J CONTROL RELEASE, V62, P313, DOI 10.1016/S0168-3659(99)00156-X
   MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8
   MIDDELKOOP E, 1995, CELL TISSUE RES, V280, P447, DOI 10.1007/BF00307818
   Nimni ME, 1997, BIOMATERIALS, V18, P1201, DOI 10.1016/S0142-9612(97)00050-1
   Nishi N, 1998, P NATL ACAD SCI USA, V95, P7018, DOI 10.1073/pnas.95.12.7018
   NISHIKAWA A, 1987, EXP CELL RES, V171, P164, DOI 10.1016/0014-4827(87)90259-X
   Ochiya T, 1999, NAT MED, V5, P707
   PROCKOP DJ, 1995, ANNU REV BIOCHEM, V64, P403, DOI 10.1146/annurev.biochem.64.1.403
   Prockop DJ, 1998, MATRIX BIOL, V16, P399, DOI 10.1016/S0945-053X(98)90013-0
   RAMSHAW JAM, 1995, BIOTECHNOL GENET ENG, V13, P335
   ROMANIC AM, 1991, J BIOL CHEM, V266, P12703
   Scopes RK, 1999, NAT BIOTECHNOL, V17, P21, DOI 10.1038/5190
   SCOTT J, 1983, SCIENCE, V221, P236, DOI 10.1126/science.6602382
   SODEK J, 1988, COLLAGEN REL RES, V1, P11
   Taipale J, 1997, FASEB J, V11, P51
   Tanaka Y, 1998, P ASSOC AM PHYSICIAN, V110, P118
   TESSIER DC, 1991, GENE, V98, P177, DOI 10.1016/0378-1119(91)90171-7
   Tomita M, 1995, BIOCHEM J, V312, P847, DOI 10.1042/bj3120847
   Tomita M, 1997, J BIOCHEM-TOKYO, V121, P1061
   Tomita M, 1999, J BIOCHEM, V126, P1118, DOI 10.1093/oxfordjournals.jbchem.a022557
   WEISSMAN BE, 1983, CELL, V32, P599, DOI 10.1016/0092-8674(83)90479-8
   YANNAS IV, 1980, J BIOMED MATER RES, V14, P65, DOI 10.1002/jbm.820140108
   YOSHIZATO K, 1988, BIOMED RES-TOKYO, V9, P33, DOI 10.2220/biomedres.9.33
   YOSHIZATO K, 1985, BIOMED RES-TOKYO, V6, P61
   YOSHIZATO K, 1984, ANN PLAS SURG, V13, P9, DOI 10.1097/00000637-198407000-00002
NR 52
TC 18
Z9 20
U1 1
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-4165
J9 BBA-GEN SUBJECTS
JI Biochim. Biophys. Acta-Gen. Subj.
PD OCT 3
PY 2001
VL 1528
IS 2-3
BP 187
EP 195
DI 10.1016/S0304-4165(01)00187-8
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 490DM
UT WOS:000172035200016
PM 11687306
DA 2018-10-20
ER

PT J
AU Szyk, L
   Schaaf, P
   Gergely, C
   Voegel, JC
   Tinland, B
AF Szyk, L
   Schaaf, P
   Gergely, C
   Voegel, JC
   Tinland, B
TI Lateral mobility of proteins adsorbed on or embedded in polyelectrolyte
   multilayers
SO LANGMUIR
LA English
DT Article
ID SURFACE-DIFFUSION; SERUM-ALBUMIN; ADSORPTION; FILMS; INTERFACES; NEUTRON
AB We present the first results relative to the diffusion process of proteins (human serum albumin) adsorbed on or embedded in poly(sodium 4-styrenesulfonate)/poly(allylamine hydrochloride) polyelectrolyte multilayer films by using fluorescence recovery after photobleaching. At least two populations of adsorbed proteins exist on the top or within the multilayer architectures. One population, which typically represents 50-70% of the adsorbed proteins, corresponds to proteins that are able to diffuse laterally along the surface or in the multilayers, whereas the others diffuse more slowly or seem almost immobile over the experimental time scale. This constitutes a key result for the practical applications of the polyelectrolyte multilayers as targeted biomaterial coatings. Surprisingly, the diffusion coefficients of the mobile proteins that are embedded in the multilayers are comparable with the diffusion coefficients of the mobile proteins adsorbed on top of the multilayers. The diffusion coefficients, which are 1 order of magnitude smaller than on rigid substrates such as silica or poly(methyl methacrylate), are of the order of 10(-10) and 10(-11) cm(2)/s.
C1 Inst Charles Sadron, CNRS ULP, F-67083 Strasbourg, France.
   Univ Strasbourg 1, INSERM Unite 4245, UFR Odontol, F-67085 Strasbourg, France.
RP Schaaf, P (reprint author), Inst Charles Sadron, CNRS ULP, 6 Rue Boussingault, F-67083 Strasbourg, France.
RI SCHAAF, Pierre/J-2751-2016
OI SCHAAF, Pierre/0000-0001-7423-5492
CR Chan V, 1997, LANGMUIR, V13, P320, DOI 10.1021/la960670b
   COHN EJ, 1947, J AM CHEM SOC, V69, P1753, DOI 10.1021/ja01199a051
   DAVOUST J, 1982, EMBO J, V1, P1233, DOI 10.1002/j.1460-2075.1982.tb00018.x
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   DECHER G, 1991, MAKROMOL CHEM-M SYMP, V46, P321, DOI 10.1002/masy.19910460145
   HAMMOND PT, 2000, CURR OPIN COLLOID IN, V4, P430
   HAYNES CA, 1994, COLLOID SURFACE B, V2, P517
   Hubbell JA, 1999, CURR OPIN BIOTECH, V10, P123, DOI 10.1016/S0958-1669(99)80021-4
   Kusumi A, 1999, CURR OPIN CELL BIOL, V11, P582, DOI 10.1016/S0955-0674(99)00020-4
   Ladam G, 2000, BIOMACROMOLECULES, V1, P674, DOI 10.1021/bm005572q
   Ladam G, 2001, LANGMUIR, V17, P878, DOI 10.1021/la0013087
   Ladam G, 2000, LANGMUIR, V16, P1249, DOI 10.1021/la990650k
   Losche M, 1998, MACROMOLECULES, V31, P8893, DOI 10.1021/ma980910p
   Onda M, 1997, JPN J APPL PHYS 2, V36, pL1608, DOI 10.1143/JJAP.36.L1608
   PETERS T, 1985, ADV PROTEIN CHEM, V37, P161, DOI 10.1016/S0065-3233(08)60065-0
   Picart C, 2001, J CHEM PHYS, V115, P1086, DOI 10.1063/1.1375156
   RAMSDEN JJ, 1995, THIN SOLID FILMS, V254, P246, DOI 10.1016/0040-6090(94)06262-J
   RAMSDEN JJ, 1994, J PHYS CHEM-US, V98, P5376, DOI 10.1021/j100071a031
   SCHMITT J, 1993, MACROMOLECULES, V26, P7058, DOI 10.1021/ma00077a052
   SCHWINTE P, IN PRESS J PHYS CHEM
   Serizawa T, 1998, LANGMUIR, V14, P4088, DOI 10.1021/la9713661
   TILTON RD, 1990, BIOPHYS J, V58, P1321, DOI 10.1016/S0006-3495(90)82473-5
   TILTON RD, 1998, BIOPOLYMERS INTERFAC, pCH11
   VANBLAADEREN A, 1992, J CHEM PHYS, V96, P4591, DOI 10.1063/1.462795
NR 24
TC 40
Z9 40
U1 0
U2 13
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD OCT 2
PY 2001
VL 17
IS 20
BP 6248
EP 6253
DI 10.1021/la0104469
PG 6
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 477VV
UT WOS:000171305700037
DA 2018-10-20
ER

PT J
AU D'Souza, SF
AF D'Souza, SF
TI Immobilization and stabilization of biomaterials for biosensor
   applications
SO APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY
LA English
DT Article; Proceedings Paper
CT National Symposium on Biomolecular Electronics-Interfacing Physics and
   Chemistry with Biology (BEIPCB)
CY SEP 16-17, 1999
CL NATL PHYS LAB, NEW DELHI, INDIA
SP Council Sci & Ind Res, Indian Natl Sci Acad
HO NATL PHYS LAB
DE biosensors; immobilization; stabilization; permeabilized cells;
   microbial sensors
ID RADIATION POLYMERIZED POLYACRYLAMIDE; OXIDASE ENZYME ELECTRODE; WHITE
   FOAM MATRIX; YEAST-CELLS; GLUCOSE-OXIDASE; CROSS-LINKING; COTTON CLOTH;
   HORSERADISH-PEROXIDASE; PERMEABILIZED CELLS; ESCHERICHIA-COLI
AB Biosensors are finding applications in a variety of analytical fields. A biosensor basically consists of a transducer in conjunction with a biologically active molecule that converts a biochemical signal into a quantifiable electric response. The specificity of the biosensor depends on the selection of the biomaterial. Enzymes, antibodies, DNA, receptors, organelles, microorganisms as well as animal and plant cells or tissues have been used as biologic sensing materials. Advances in biochemistry, molecular biology, and immunochemistry are expected to lead to a rapid expansion in the range of biologic recognition elements to be used in the field of biosensors. Biomaterials that are stable and function even in highly acidic, alkaline, hydrophobic, or oxidizing environments as well as stable to high temperature and immune to toxic substrates in the processing stream will play an important role. Techniques for immobilization of the biomaterials have played a significant role in the biosensor field. Immobilization not only brings about the intimate contact of the biologic catalysts with the transducer, but also helps in the stabilization of the biologic system, thus enhancing its operational and storage stability. A number of techniques have been developed in our laboratory for the immobilization of enzymes, multienzyme systems, cells, and enzyme-cell conjugates. Some of these aspects that are of significance in biosensor applications have been highlighted.
C1 Bhabha Atom Res Ctr, Nucl Agr & Biotechnol Div, Trombay 400085, Mumbai, India.
RP D'Souza, SF (reprint author), Bhabha Atom Res Ctr, Nucl Agr & Biotechnol Div, Trombay 400085, Mumbai, India.
CR AHLUWALIA A, 1992, THIN SOLID FILMS, V210, P726, DOI 10.1016/0040-6090(92)90386-P
   Araujo AM, 1997, BIOTECHNOL TECH, V11, P67, DOI 10.1023/A:1018404103626
   Arnold FH, 1998, P NATL ACAD SCI USA, V95, P2035, DOI 10.1073/pnas.95.5.2035
   Bart JC, 1997, ENVIRON SCI TECHNOL, V31, P1505, DOI 10.1021/es960777l
   BENKOVIC SJ, 1992, ANNU REV BIOCHEM, V61, P29
   BICKERSTAFF GF, 1997, IMMOBILIZATION ENYME
   BLANCO RM, 1989, ENZYME MICROB TECH, V11, P353, DOI 10.1016/0141-0229(89)90019-7
   Blum L. J., 1991, BIOSENSOR PRINCIPLES
   BONNINGTON LS, 1995, ENZYME MICROB TECH, V17, P746, DOI 10.1016/0141-0229(95)00001-L
   Brenchley JE, 1996, J IND MICROBIOL BIOT, V17, P432, DOI 10.1007/BF01574774
   Chen JY, 2000, ACTA MATH SIN, V16, P541
   Corbisier P, 1996, ENVIRON TOXIC WATER, V11, P171, DOI 10.1002/(SICI)1098-2256(1996)11:3<171::AID-TOX1>3.0.CO;2-6
   D'souza S. F., 1989, INDIAN J MICROBIOL, V29, P83
   D'Souza SF, 1999, CURR SCI INDIA, V77, P69
   D'Souza SF, 1999, BIOTECHNOL TECH, V13, P375, DOI 10.1023/A:1008979709047
   Daniel RM, 1996, ENZYME MICROB TECH, V19, P74, DOI 10.1016/0141-0229(95)00174-3
   DANIEL RM, 1990, BIOCATALYSIS, P243
   Das N, 1997, BIOTECHNOL BIOENG, V54, P329, DOI 10.1002/(SICI)1097-0290(19970520)54:4<329::AID-BIT5>3.0.CO;2-M
   DESHPANDE A, 1987, Biotechnology Techniques, V1, P55, DOI 10.1007/BF00156288
   DESHPANDE A, 1986, INDIAN J BIOCHEM BIO, V23, P353
   DESHPANDE A, 1987, J BIOSCIENCE, V11, P137, DOI 10.1007/BF02704664
   DOMINGUEZ E, 1993, BIOSENS BIOELECTRON, V8, P229, DOI 10.1016/0956-5663(93)85038-P
   DORDICK JS, 1989, ENZYME MICROB TECH, V11, P194, DOI 10.1016/0141-0229(89)90094-X
   DSouza SE, 1997, WORLD J MICROB BIOT, V13, P561, DOI 10.1023/A:1018521510665
   DSOUZA SE, 1992, J BIOCHEM BIOPH METH, V24, P239, DOI 10.1016/0165-022X(94)90076-0
   DSOUZA SF, 1981, BIOTECHNOL BIOENG, V23, P431, DOI 10.1002/bit.260230217
   DSOUZA SF, 1980, BIOTECHNOL BIOENG, V22, P2191, DOI 10.1002/bit.260221015
   DSOUZA SF, 1989, BIOTECHNOL LETT, V11, P211, DOI 10.1007/BF01026061
   DSOUZA SF, 1983, BIOTECHNOL BIOENG, V25, P1661, DOI 10.1002/bit.260250619
   DSOUZA SF, 1991, ENZYME MICROB TECH, V13, P508, DOI 10.1016/0141-0229(91)90011-X
   DSOUZA SF, 1985, BIOTECHNOL LETT, V7, P589, DOI 10.1007/BF01026454
   DSOUZA SF, 1988, APPL MICROBIOL BIOT, V29, P136
   DSOUZA SF, 1986, BIOTECHNOL LETT, V8, P643, DOI 10.1007/BF01025974
   DSOUZA SF, 1980, ENZYME MICROB TECH, V2, P217, DOI 10.1016/0141-0229(80)90050-2
   DSOUZA SF, 1990, FOOD BIOTECHNOL, V4, P373
   DSOUZA SF, 1999, ADV BIOPROCESSING R, P107
   DSOUZA SF, 2000, IN PRESS APPL BIOCH
   DUrso EM, 1996, ENZYME MICROB TECH, V18, P482, DOI 10.1016/0141-0229(95)00153-0
   FODOR SPA, 1991, SCIENCE, V251, P767, DOI 10.1126/science.1990438
   Fojta M, 1997, ANAL CHIM ACTA, V342, P1, DOI 10.1016/S0003-2670(96)00551-X
   Gerlach CL, 1996, ENVIRON SCI TECHNOL, V30, P486
   GODBOLE SS, 1990, ENZYME MICROB TECH, V12, P214, DOI 10.1016/0141-0229(90)90041-N
   GODBOLE SS, 1983, ENZYME MICROB TECH, V5, P125, DOI 10.1016/0141-0229(83)90046-7
   GODBOLE SS, 1980, ENZYME MICROB TECH, V2, P223, DOI 10.1016/0141-0229(80)90051-4
   GODBOLE SS, 1983, BIOTECHNOL BIOENG, V25, P217, DOI 10.1002/bit.260250117
   Gu MB, 1996, BIOTECHNOL PROGR, V12, P393, DOI 10.1021/bp9600142
   GUILBAULT GG, 1989, BIO-TECHNOL, V7, P349, DOI 10.1038/nbt0489-349
   Gupte A, 1999, J BIOCHEM BIOPH METH, V40, P39, DOI 10.1016/S0165-022X(99)00015-9
   Hatti-Kaul R., 2000, AQUEOUS 2 PHASE SYST
   Huang XL, 1996, ENZYME MICROB TECH, V19, P378, DOI 10.1016/S0141-0229(96)00015-4
   Husain S, 1995, BIOCHEM MOL BIOL INT, V36, P669
   Janson JC, 1998, PROTEIN PURIFICATION
   Joshi NT, 1999, J ENVIRON SCI HEAL A, V34, P1689, DOI 10.1080/10934529909376921
   KAMATH N, 1988, APPL BIOCHEM BIOTECH, V19, P251, DOI 10.1007/BF02921497
   Kamath N, 1992, ENZYME MICROB TECHNO, V13, P935
   KAMATH N, 1991, TRENDS BIOMATER ARTI, V54, P67
   Katrlik J, 1996, ANAL CHIM ACTA, V331, P225, DOI 10.1016/0003-2670(96)00209-7
   KAUL R, 1983, BIOTECHNOL BIOENG, V25, P887, DOI 10.1002/bit.260250325
   KAUL R, 1986, J MICROBIOL BIOTECHN, V1, P12
   KLEINFELD D, 1988, J NEUROSCI, V8, P4098
   Koyano T, 1996, BIOTECHNOL PROGR, V12, P141, DOI 10.1021/bp9500573
   KUMAR SD, 1992, BIOELECTROCH BIOENER, V27, P153, DOI 10.1016/0302-4598(92)87039-W
   KUMAR SD, 1994, BIOELECTROCH BIOENER, V34, P195, DOI 10.1016/0302-4598(94)80036-7
   MAROLIA KZ, 1994, J FOOD SCI TECH MYS, V31, P153
   Marolia KZ, 1999, J BIOCHEM BIOPH METH, V39, P115, DOI 10.1016/S0165-022X(98)00021-9
   MARSHALL RC, 1984, MICROBIAL ADHESION A
   Marty JL, 1997, ENVIRON TECHNOL, V18, P333, DOI 10.1080/09593331808616544
   MATTIASSON B, 1982, APPL BIOCHEM BIOTECH, V7, P121, DOI 10.1007/BF02798633
   MAZZEI F, 1995, ANAL CHIM ACTA, V316, P79, DOI 10.1016/0003-2670(95)00343-X
   MELO JS, 1992, FOOD BIOTECHNOL, V6, P175, DOI 10.1080/08905439209549830
   MELO JS, 1992, APPL BIOCHEM BIOTECH, V32, P159, DOI 10.1007/BF02922156
   MELO JS, 1999, WORLD J MICROB BIOT, V15, P25
   Miland E, 1996, ENZYME MICROB TECH, V19, P63, DOI 10.1016/0141-0229(95)00169-7
   Mulchandani A, 1998, ANAL CHEM, V70, P4140, DOI 10.1021/ac9805201
   Mulchandani A, 1998, ENZYME MICROBIAL BIO
   Murai T, 1997, APPL MICROBIOL BIOT, V48, P499, DOI 10.1007/s002530051086
   Nandakumar R, 1999, ANAL LETT, V32, P2379, DOI 10.1080/00032719908542976
   Nandakumar R, 1999, BIOTECHNOL TECH, V13, P689, DOI 10.1023/A:1008963730069
   NIKOLELIS D, 1998, BIOSENSORS DIRECT MO
   Patil AR, 1997, J GEN APPL MICROBIOL, V43, P163, DOI 10.2323/jgam.43.163
   RAMSAY G, 1998, COMMERICAL BIOSENSOR
   RAO BYK, 1988, BIOTECHNOL LETT, V10, P427, DOI 10.1007/BF01087444
   Rella R, 1996, BIOTECHNOL APPL BIOC, V24, P83
   Rogers K. R., 1998, AFFINITY BIOSENSORS
   RYAN O, 1994, ENZYME MICROB TECH, V16, P501, DOI 10.1016/0141-0229(94)90021-3
   SANKARAN K, 1989, ENZYME MICROB TECH, V11, P617, DOI 10.1016/0141-0229(89)90091-4
   SCHOMBURG D, 1990, FOOD BIOTECHNOL, V4, P329, DOI 10.1080/08905439009549745
   Simkus RA, 1996, ANAL LETT, V29, P1907
   SIVARAMAN H, 1982, BIOTECHNOL LETT, V4, P359, DOI 10.1007/BF00135422
   Skladal P, 1997, ELECTROANAL, V9, P737, DOI 10.1002/elan.1140091002
   SMIDSROD O, 1990, TRENDS BIOTECHNOL, V8, P71, DOI 10.1016/0167-7799(90)90139-O
   SRINIVASAN MC, 1994, CURR SCI INDIA, V66, P137
   STCLAIR NL, 1992, J AM CHEM SOC, V114, P7314, DOI 10.1021/ja00044a064
   Sung WJ, 2000, ANAL CHEM, V72, P2177, DOI 10.1021/ac9908041
   Svitel J, 1998, BIOTECHNOL APPL BIOC, V27, P153
   TANAKA A, 1991, PROTEIN IMMOBILIZATI, P183
   Tomalia D, 1985, ENCY POLYM SCI ENG, V1, P680
   Trojanowicz M, 1996, TRAC-TREND ANAL CHEM, V15, P38, DOI 10.1016/0165-9936(96)88036-8
   Tyagi R, 1999, ENZYME MICROB TECH, V24, P348, DOI 10.1016/S0141-0229(98)00131-8
   Uhlich Thhomas, 1996, Enzyme and Microbial Technology, V19, P124, DOI 10.1016/0141-0229(95)00190-5
   Ulbricht M, 1997, ENZYME MICROB TECH, V20, P61, DOI 10.1016/S0141-0229(96)00085-3
   Walcerz I, 1996, ANAL LETT, V29, P1939
NR 102
TC 59
Z9 59
U1 1
U2 29
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA
SN 0273-2289
J9 APPL BIOCHEM BIOTECH
JI Appl. Biochem. Biotechnol.
PD OCT-DEC
PY 2001
VL 96
IS 1-3
BP 225
EP 238
DI 10.1385/ABAB:96:1-3:225
PG 14
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
GA 503UW
UT WOS:000172820600023
PM 11783889
DA 2018-10-20
ER

PT J
AU Sikavitsas, VI
   Temenoff, JS
   Mikos, AG
AF Sikavitsas, VI
   Temenoff, JS
   Mikos, AG
TI Biomaterials and bone mechanotransduction
SO BIOMATERIALS
LA English
DT Review
DE adhesion; biomaterial; bone biology; bone mechanotransduction;
   cell-surface interaction; cytoskeleton; fluid flow; gap junction;
   mechanosensory cell; microgravity; osteoblast; osteocyte; shear stress;
   tissue engineering
ID MESSENGER-RNA EXPRESSION; BIODEGRADABLE POLYMER MICROPARTICLES;
   STRAIN-RELATED CHANGES; OSTEOBLAST-LIKE CELLS; GROWTH-FACTOR BETA-1;
   FLUID SHEAR-STRESS; C-FOS EXPRESSION; IN-VITRO; MECHANICAL STIMULATION;
   GENE-EXPRESSION
AB Bone is an extremely complex tissue that provides many essential functions in the body. Bone tissue engineering holds great promise in providing strategies that will result in complete regeneration of bone and restoration of its function. Currently, such strategies include the transplantation of highly porous scaffolds seeded with cells. Prior to transplantation the seeded cells are cultured in vitro in order for the cells to proliferate, differentiate and generate extracellular matrix. Factors that can affect cellular function include the cell-biomaterial interaction, as well as the biochemical and the mechanical environment. To optimize culture conditions, good understanding of these parameters is necessary. The new developments in bone biology, bone cell mechanotransduction, and cell-surface interactions are reviewed here to demonstrate that bone mechanotransduction is strongly influenced by the biomaterial properties. (C) 2001 Published by Elsevier Science Ltd.
C1 Rice Univ, Dept Bioengn, Inst Biosci & Bioengn, Houston, TX 77005 USA.
RP Mikos, AG (reprint author), Rice Univ, Dept Bioengn, Inst Biosci & Bioengn, 6100 Main,MS-142, Houston, TX 77005 USA.
EM mikos@rice.edu
FU NIAMS NIH HHS [R29-AR42639]
CR Ajubi NE, 1996, BIOCHEM BIOPH RES CO, V225, P62, DOI 10.1006/bbrc.1996.1131
   Akhouayri O, 2000, J CELL BIOCHEM, V76, P217, DOI 10.1002/(SICI)1097-4644(20000201)76:2<217::AID-JCB6>3.3.CO;2-B
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Babensee JE, 2000, PHARMACEUT RES, V17, P497, DOI 10.1023/A:1007502828372
   Baron Roland, 1993, P3
   Bronckers ALJJ, 1996, J BONE MINER RES, V11, P1281
   BUCKWALTER JA, 1995, J BONE JOINT SURG AM, V77A, P1256, DOI 10.2106/00004623-199508000-00019
   Burger EH, 1999, FASEB J, V13, pS101
   Caplan AI, 1997, PRINCIPLES TISSUE EN, P603
   Caplan AI, 1994, BONE, P1
   Carmeliet G, 1999, FASEB J, V13, pS129
   Carvalho RS, 1998, J CELL BIOCHEM, V70, P376, DOI 10.1002/(SICI)1097-4644(19980901)70:3<376::AID-JCB11>3.0.CO;2-J
   CHAMBERS TJ, 1993, BONE MINER, V20, P167, DOI 10.1016/S0169-6009(08)80025-6
   Cooper LF, 1998, INT J ORAL MAX IMPL, V13, P163
   Cowin SC, 1999, J BIOMECH, V32, P217, DOI 10.1016/S0021-9290(98)00161-4
   COWIN SC, 1995, J BIOMECH, V28, P1281, DOI 10.1016/0021-9290(95)00058-P
   Cowin SC, 1998, AM J MED SCI, V316, P184, DOI 10.1097/00000441-199809000-00006
   CRANE GM, 1995, NAT MED, V1, P1322, DOI 10.1038/nm1295-1322
   Currey J. D., 1984, MECH ADAPTATION BONE, P3
   DALLAS SL, 1993, J BONE MINER RES, V8, P251
   Damsky CH, 1997, KIDNEY INT, V51, P1427, DOI 10.1038/ki.1997.195
   Dodd JS, 1999, AM J PHYSIOL-CELL PH, V277, pC598, DOI 10.1152/ajpcell.1999.277.3.C598
   Donahue HJ, 2000, BONE, V26, P417, DOI 10.1016/S8756-3282(00)00245-3
   EANES E, 1992, CALCIFICATION BIOL S, P2
   Fitzgerald J, 1996, EXP CELL RES, V228, P168, DOI 10.1006/excr.1996.0313
   Fitzgerald J, 1999, FASEB J, V13, P553
   Globus RK, 1998, J CELL SCI, V111, P1385
   Goldstein AS, 2001, BIOMATERIALS, V22, P1279, DOI 10.1016/S0142-9612(00)00280-5
   Harris SA, 2000, BONE, V26, P325, DOI 10.1016/S8756-3282(00)00234-9
   HILLSLEY MV, 1994, BIOTECHNOL BIOENG, V43, P573, DOI 10.1002/bit.260430706
   HUBBELL JA, 2000, PRINCIPLES TISSUE EN, P237
   Hughes-Fulford M, 1999, FASEB J, V13, pS121
   INAOKA T, 1995, BIOCHEM BIOPH RES CO, V217, P264, DOI 10.1006/bbrc.1995.2773
   Ingber D, 1999, FASEB J, V13, pS3
   IshaugRiley SL, 1997, J BIOMED MATER RES, V36, P1, DOI 10.1002/(SICI)1097-4636(199707)36:1<1::AID-JBM1>3.0.CO;2-P
   Jacobs CR, 1998, J BIOMECH, V31, P969, DOI 10.1016/S0021-9290(98)00114-6
   Jo S, 2000, POLYMER, V41, P7595, DOI 10.1016/S0032-3861(00)00117-8
   JOHNSON DL, 1996, AM J PHYSIOL, V271, P205
   Klein-Nulend J, 1998, BIOCHEM BIOPH RES CO, V250, P108, DOI 10.1006/bbrc.1998.9270
   KleinNulend J, 1995, BIOCHEM BIOPH RES CO, V217, P640, DOI 10.1006/bbrc.1995.2822
   KLEINNULEND J, 1995, FASEB J, V9, P441
   Kostenuik PJ, 1997, AM J PHYSIOL-ENDOC M, V273, pE1133
   KUFAHL RH, 1990, J BIOMECH, V23, P171, DOI 10.1016/0021-9290(90)90350-C
   Kumei Y, 1996, J BIOTECHNOL, V47, P313, DOI 10.1016/0168-1656(96)01412-5
   KUMEI Y, 1998, J APPL PHYSIOL, V45, P139
   Langer R, 2000, AICHE J, V46, P1286, DOI 10.1002/aic.690460702
   LEAN JM, 1995, AM J PHYSIOL-ENDOC M, V268, pE318
   LIAN JB, 1992, CRIT REV ORAL BIOL M, V3, P269, DOI 10.1177/10454411920030030501
   Lu L, 2000, J BIOMED MATER RES, V50, P440, DOI 10.1002/(SICI)1097-4636(20000605)50:3<440::AID-JBM19>3.0.CO;2-G
   Mason DJ, 1996, J BONE MINER RES, V11, P350
   McAllister TN, 1999, J BONE MINER RES, V14, P930, DOI 10.1359/jbmr.1999.14.6.930
   Mueller SM, 1999, J BONE MINER RES, V14, P2118, DOI 10.1359/jbmr.1999.14.12.2118
   MURRAY D, 1990, CALCIFIED TISSUE INT, V37, P411
   Nimni ME, 1997, BIOMATERIALS, V18, P1201, DOI 10.1016/S0142-9612(97)00050-1
   Ogata T, 2000, J CELL BIOCHEM, V76, P529, DOI 10.1002/(SICI)1097-4644(20000315)76:4<529::AID-JCB1>3.0.CO;2-5
   Owan I, 1997, AM J PHYSIOL-CELL PH, V273, pC810
   Parfitt AM, 1984, CALCIF TISSUE INT S, V36, P37
   Pavalko FM, 1998, AM J PHYSIOL-CELL PH, V275, pC1591, DOI 10.1152/ajpcell.1998.275.6.C1591
   Peter SJ, 2000, J BIOMED MATER RES, V50, P452, DOI 10.1002/(SICI)1097-4636(20000605)50:3<452::AID-JBM20>3.3.CO;2-S
   Puleo DA, 1998, J BIOMED MATER RES, V41, P104, DOI 10.1002/(SICI)1097-4636(199807)41:1<104::AID-JBM13>3.0.CO;2-N
   REICH KM, 1990, J CELL PHYSIOL, V143, P100, DOI 10.1002/jcp.1041430113
   REICH KM, 1991, AM J PHYSIOL, V261, pC429
   Rezania A, 1999, BIOTECHNOL PROGR, V15, P19, DOI 10.1021/bp980083b
   Richards M, 1999, J BIOMECH ENG-T ASME, V121, P348, DOI 10.1115/1.2798331
   Richards M, 1999, J ORTHOP RES, V17, P900, DOI 10.1002/jor.1100170615
   ROBEY PG, 1989, ENDOCRIN METAB CLIN, V18, P859, DOI 10.1016/S0889-8529(18)30347-5
   Rosen V., 1995, CELLULAR MOL BASIS B, P97
   Salter DM, 1997, J BONE MINER RES, V12, P1133, DOI 10.1359/jbmr.1997.12.7.1133
   SALZSTEIN RA, 1987, J BIOMECH, V20, P261, DOI 10.1016/0021-9290(87)90293-4
   Schmitt JM, 1999, J ORTHOPAED RES, V17, P269, DOI 10.1002/jor.1100170217
   Shah AK, 1999, BIOL CELL, V91, P131, DOI 10.1016/S0248-4900(99)80037-9
   SKERRY TM, 1989, J BONE MINER RES, V4, P783, DOI 10.1002/jbmr.5650040519
   Smalt R, 1997, AM J PHYSIOL-ENDOC M, V273, pE751, DOI 10.1152/ajpendo.1997.273.4.E751
   TANAKA K, 1995, MINER ELECTROL METAB, V21, P189
   Tate MLK, 1998, AM J MED SCI, V316, P189, DOI 10.1097/00000441-199809000-00007
   Toma CD, 1997, J BONE MINER RES, V12, P1626, DOI 10.1359/jbmr.1997.12.10.1626
   Turner CH, 1996, AM J PHYSIOL-ENDOC M, V270, pE634
   VANDERPLAS A, 1994, J BONE MINER RES, V9, P1697
   Vico L, 1998, BONE, V22, p95S, DOI 10.1016/S8756-3282(98)00017-9
   WEINBAUM S, 1994, J BIOMECH, V27, P339, DOI 10.1016/0021-9290(94)90010-8
   Wolff J, 1892, GASETZ TRANSFORMATIO
   Yaszemski MJ, 1996, BIOMATERIALS, V17, P175, DOI 10.1016/0142-9612(96)85762-0
   Yellowley CE, 2000, J BONE MINER RES, V15, P209, DOI 10.1359/jbmr.2000.15.2.209
   Ziambaras K, 1998, J BONE MINER RES, V13, P218, DOI 10.1359/jbmr.1998.13.2.218
NR 84
TC 277
Z9 290
U1 2
U2 97
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2001
VL 22
IS 19
BP 2581
EP 2593
DI 10.1016/S0142-9612(01)00002-3
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 463HE
UT WOS:000170470400001
PM 11519777
DA 2018-10-20
ER

PT J
AU Mueller, HJ
   Hirthe, RW
AF Mueller, HJ
   Hirthe, RW
TI Electrochemical characterization and immersion corrosion of a
   consolidated silver dental biomaterial
SO BIOMATERIALS
LA English
DT Article
DE silver particle consolidation; artificial saliva; corrosion;
   electrochemical polarization; impedance spectroscopy
ID IMPEDANCE; SPECTROSCOPY; AMALGAMS; MODEL
AB A consolidated silver (CS) material, an alternative to dental amalgam, was studied for corrosion. Chemically precipitated silver particles were acid activated and pressure consolidated to a volume porosity of 25%. In selected tests comparisons were made between CS and melted and cast silver particles (MS), silver with a known mass fraction purity of 99.998% (FS), a silver-palladium alloy (SP), and a dispersed-phase amalgam (DA). Fusayama artificial saliva was used with controlled variations in pH, sulfide content, mucin content, and absorbed oxygen content. Electrochemical polarization, electrochemical impedance spectroscopy, and immersion methods were used. Results revealed differences in the zero current potentials E(I = 0) from forward polarization between CS and MS (or FS) in deaerated solution, By superposition of the cathodic polarization curves, the area for CS was increased by 7.3 times and was enclosed within an outer shell of material 5.5 mum thick. Polarization resistance was significantly the highest for SP, followed in order by MS (or FS) and CS or DA. With scanning electron microscopy, CS was shown to be significantly more susceptible than MS to long-term immersion corrosion. The modeled equivalent electrical circuits for CS and DA involved a double layer capacitance, a charge transfer resistance, and an element attributed to adsorption. The active pore depth for CS from the transmission line model for porous solids revealed satisfactory agreement with polarization results. It is concluded that the corrosion susceptibility of CS in Fusayama solution, while similar to that for DA, is greater than it is for MS. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Natl Inst Stand & Technol, Amer Dent Assoc Hlth Fdn, Paffenbarger Res Ctr, Gaithersburg, MD 20899 USA.
   Marquette Univ, Coll Engn, Milwaukee, WI 53233 USA.
RP Mueller, HJ (reprint author), Natl Inst Stand & Technol, Amer Dent Assoc Hlth Fdn, Paffenbarger Res Ctr, Gaithersburg, MD 20899 USA.
FU NIDCR NIH HHS [P50 DE 09322]
CR Annergren I, 1997, J ELECTROCHEM SOC, V144, P1208, DOI 10.1149/1.1837574
   BOUKAMP BA, 1988, EQUIVALENT CIRCUIT E
   Brady J M, 1975, J Endod, V1, P205, DOI 10.1016/S0099-2399(75)80198-1
   CHANA MS, 1984, J DENT, V12, P319
   DELEVIE R, 1967, ADV ELECTROCHEMISTRY, V6, P321
   Goon W W, 1995, Quintessence Int, V26, P629
   HANAWA T, 1991, BIOMATERIALS, V12, P767, DOI 10.1016/0142-9612(91)90028-9
   Johnson C. E., 1998, U.S. Patent, Patent No. [5,711,866, 5711866]
   LEMAITRE L, 1989, J BIOMED MATER RES, V23, P241, DOI 10.1002/jbm.820230208
   LEMAITRE L, 1989, J ORAL REHABIL, V16, P543, DOI 10.1111/j.1365-2842.1989.tb01376.x
   LIDE DR, 1997, CRC HDB CHEM PHYSICS
   MARGELOS J, 1991, J ENDODONT, V17, P282, DOI 10.1016/S0099-2399(06)81868-6
   Mcdonald J R, 1987, IMPEDANCE SPECTROSCO
   Mueller HJ, 2001, DENT MATER, V17, P60, DOI 10.1016/S0109-5641(00)00061-0
   Nakamoto K., 1996, INFRARED RAMAN SPECT
   Olsson S, 1997, J DENT RES, V76, P1869, DOI 10.1177/00220345970760121001
   OLSSON S, 1994, J DENT RES, V73, P33, DOI 10.1177/00220345940730010501
   PALAGHIAS G, 1985, Dental Materials, V1, P139, DOI 10.1016/S0109-5641(85)80006-3
   Seitz MA, 1996, MATER RES SOC SYMP P, V411, P57
   SELTZER S, 1972, ORAL SURG ORAL MED O, V33, P589, DOI 10.1016/0030-4220(72)90373-8
   Shoesmith D.W., 1987, METALS HDB, V13, P29
   Sridhar N, 1997, J ELECTROCHEM SOC, V144, P4243, DOI 10.1149/1.1838173
   Tomashov N.D., 1966, THEORY CORROSION PRO, P133
   VAIDYANATHAN TK, 1981, J DENT RES, V60, P707, DOI 10.1177/00220345810600030601
NR 24
TC 8
Z9 9
U1 0
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2001
VL 22
IS 19
BP 2635
EP 2646
DI 10.1016/S0142-9612(01)00004-7
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 463HE
UT WOS:000170470400007
PM 11519783
DA 2018-10-20
ER

PT J
AU Record, RD
   Hillegonds, D
   Simmons, C
   Tullius, R
   Rickey, FA
   Elmore, D
   Badylak, SF
AF Record, RD
   Hillegonds, D
   Simmons, C
   Tullius, R
   Rickey, FA
   Elmore, D
   Badylak, SF
TI In vivo degradation of C-14-labeled small intestinal submucosa (SIS)
   when used for urinary bladder repair
SO BIOMATERIALS
LA English
DT Article
DE small intestinal submucosa; SIS; AMS; extracellular matrices;
   augmentation cystoplasty
ID ACELLULAR MATRIX GRAFT; DOG-MODEL; BIOSCAFFOLD; RAT
AB The rate of in vivo degradation was determined for a naturally occurring biomaterial derived from the extracellular matrix of the small intestinal submucosa (SIS). The SIS was labeled by giving weekly intravenous injections of 10 mu Ci of C-14-proline to piglets from 3 weeks of age until the time of sacrifice at 26 weeks. The resultant SIS prepared from these pigs contained approximately 10(3) fold more C-14 than unlabeled tissues. The labeled SIS was used to repair experimental defects in the urinary bladder of 10 dogs. The animals were sacrificed at post-operative times ranging from 3 days to I year and the remodeled urinary bladder tissue was harvested for evaluation of C-14 by a combination of liquid scintillation counting and accelerator mass spectrometry. The remodeled tissue contained less than 10% of the C-14 (disintegrations per minute/gram tissue wet weight) at 3 months post-surgery compared to the SIS biomaterial that was originally implanted. The SIS scaffold was replaced by host tissue that resembled normal bladder both in structure and function. After implantation, C-14 was detected in highest concentrations in the blood and the urine. The SIS bioscaffold provides a temporary scaffold for tissue remodeling with rapid host tissue remodeling, degradation, and elimination via the urine when used as a urinary bladder repair device. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Purdue Univ, Dept Biol Engn, W Lafayette, IN 47907 USA.
   Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA.
   Purdue Univ, Dept Phys, PRIME Lab, W Lafayette, IN 47907 USA.
RP Record, RD (reprint author), Purdue Univ, Dept Biol Engn, 1296 Potter Ctr, W Lafayette, IN 47907 USA.
EM rrecord@ecn.purdue.edu
OI Badylak, Stephen/0000-0003-3555-0689; Ritchie, Rae/0000-0002-0693-0693
CR ALLMAN AJ, IN PRESS TRANSPLANTA
   Badylak S, 1999, CLIN ORTHOP RELAT R, pS333, DOI 10.1097/00003086-199910001-00032
   Badylak S, 2000, J PEDIATR SURG, V35, P1097, DOI 10.1053/jpsu.2000.7834
   Badylak SF, 1998, TISSUE ENG, V4, P379, DOI 10.1089/ten.1998.4.379
   BADYLAK SF, 1989, J SURG RES, V47, P74, DOI 10.1016/0022-4804(89)90050-4
   Chen F, 1999, UROLOGY, V54, P407, DOI 10.1016/S0090-4295(99)00179-X
   Dahms SE, 1998, BRIT J UROL, V82, P411
   HILES MC, 1995, J BIOMED MATER RES, V29, P883, DOI 10.1002/jbm.820290714
   Horrocks D., 1974, APPL LIQUID SCINTILL
   JACKSON GS, 2000, CURR SEP, V19, P3
   KLEIN L, 1972, SURG GYNECOL OBSTETR, V135, P49
   Kropp BP, 1996, J UROLOGY, V155, P2098, DOI 10.1016/S0022-5347(01)66117-2
   Piechota HJ, 1999, UROL RES, V27, P206, DOI 10.1007/s002400050111
   Rickey FA, 2000, NUCL INSTRUM METH B, V172, P904, DOI 10.1016/S0168-583X(00)00344-X
   STETTEN MR, 1949, J BIOL CHEM, V181, P31
NR 15
TC 146
Z9 163
U1 1
U2 12
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2001
VL 22
IS 19
BP 2653
EP 2659
DI 10.1016/S0142-9612(01)00007-2
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 463HE
UT WOS:000170470400009
PM 11519785
DA 2018-10-20
ER

PT J
AU Alferiev, I
   Vyavahare, N
   Song, CX
   Connolly, J
   Hinson, JT
   Lu, ZB
   Tallapragada, S
   Bianco, R
   Levy, R
AF Alferiev, I
   Vyavahare, N
   Song, CX
   Connolly, J
   Hinson, JT
   Lu, ZB
   Tallapragada, S
   Bianco, R
   Levy, R
TI Bisphosphonate derivatized polyurethanes resist calcification
SO BIOMATERIALS
LA English
DT Article
DE heart valves; prostheses; mineralization; biomaterials
ID BIOPROSTHETIC HEART-VALVES; DIPHOSPHONATES; ALENDRONATE; PROSTHESES;
   INHIBITION
AB Calcification of polyurethane cardiovascular implants is an important disease process that has the potential to compromise the long-term function of devices such as polymer heart valves and ventricular assist systems In this study we report the successful formulation and characterization of bisphosphonate-derivatized polyurethanes, hypothesized to resist implant calcification based on the pharmacologic activity of the immobilized bisphosphonate. Fully polymerized polyurethanes (a polyurea-polyurethane and a polycarbonate polyurethane) were modified (post-polymerization) with bromoalkylation of the hard segments followed by attachment of a bisphosphonate group at the bromine site. These bisphosphonate-polyurethanes resisted calcification in rat 60 day subdermal implants compared to nonmodified control polyurethane implants, that calcify. Bisphosphonates-modified polyurethanes were also studied in circulatory implants using a pulmonary valve cusp replacement model in sheep. Polyurethane cusps modified with bisphosphonate did not calcify in 90 day implants, compared to control polyurethane cusps implants, that demonstrated nodular surface oriented calcific deposits. It is concluded that bisphosphonate modified polyurethanes resist calcification both in subdermal implants and in the circulation. This novel biomaterial approach offers great promise for long-term blood stream implantation with calcification resistance. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Childrens Hosp Philadelphia, Div Cardiol, Philadelphia, PA 19104 USA.
   Univ Minnesota, Dept Surg, Minneapolis, MN 55455 USA.
RP Levy, R (reprint author), Childrens Hosp Philadelphia, Div Cardiol, Abramson Res Bldg,3516 Civ Ctr Blvd, Philadelphia, PA 19104 USA.
OI Bianco, Richard/0000-0003-1294-1599
FU NHLBI NIH HHS [HL59730]
CR Alferiev IS, 2001, J POLYM SCI POL CHEM, V39, P105, DOI 10.1002/1099-0518(20010101)39:1<105::AID-POLA120>3.3.CO;2-#
   Bernacca GM, 1997, J BIOMED MATER RES, V34, P371
   Bernacca GM, 1998, INT J ARTIF ORGANS, V21, P814
   BILLY GG, 1995, ARTIF ORGANS, V19, P339, DOI 10.1111/j.1525-1594.1995.tb02338.x
   Bone HG, 2000, CLIN THER, V22, P15, DOI 10.1016/S0149-2918(00)87974-6
   BOSKEY AL, 1992, CELL MATER, V2, P209
   BRAUNWALD NS, 1972, B NEW YORK ACAD MED, V48, P357
   BRAUNWALD NS, 1989, ANN THORAC SURG, V48, pS1, DOI 10.1016/0003-4975(89)90615-2
   CHEN PS, 1956, ANAL CHEM, V28, P1756, DOI 10.1021/ac60119a033
   Clift S E, 1996, Proc Inst Mech Eng H, V210, P267, DOI 10.1243/PIME_PROC_1996_210_423_02
   Downs RW, 2000, J CLIN ENDOCR METAB, V85, P1783, DOI 10.1210/jc.85.5.1783
   FISHBEIN MC, 1975, AM HEART J, V89, P443, DOI 10.1016/0002-8703(75)90149-0
   FLEISCH H, 1987, CLIN ORTHOP RELAT R, P72
   Fleisch H, 1989, Recent Results Cancer Res, V116, P1
   Fleisch H, 1987, BONE S, V8, P23
   GOLOMB G, 1986, Journal of Controlled Release, V4, P181, DOI 10.1016/0168-3659(86)90002-7
   GOLOMB G, 1987, J PHARM SCI-US, V76, P271, DOI 10.1002/jps.2600760402
   HIRSCH D, 1993, BIOMATERIALS, V14, P371, DOI 10.1016/0142-9612(93)90057-9
   Joshi RR, 1996, J BIOMED MATER RES, V31, P201
   JOSHI RR, 1994, J APPL BIOMATER, V5, P65, DOI 10.1002/jab.770050109
   KAY EB, 1989, ANN THORAC SURG, V48, pS24, DOI 10.1016/0003-4975(89)90625-5
   LEVY RJ, 1987, J THORAC CARDIOV SUR, V94, P551
   LEVY RJ, 1985, SCIENCE, V228, P190, DOI 10.1126/science.3919445
   Park Y, 1999, ARTIF ORGANS, V23, P210, DOI 10.1046/j.1525-1594.1999.06013.x
   Robin J, 1998, J THORAC CARDIOV SUR, V115, P898, DOI 10.1016/S0022-5223(98)70372-1
   Wheatley DJ, 2000, EUR J CARDIO-THORAC, V17, P440, DOI 10.1016/S1010-7940(00)00381-X
NR 26
TC 21
Z9 22
U1 0
U2 11
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2001
VL 22
IS 19
BP 2683
EP 2693
DI 10.1016/S0142-9612(01)00010-2
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 463HE
UT WOS:000170470400012
PM 11519788
DA 2018-10-20
ER

PT J
AU Paez, JMG
   Jorge-Herrero, E
   Carrera, A
   Millan, I
   Rocha, A
   Calero, P
   Cordon, A
   Sainz, N
   Castillo-Olivares, JL
AF Paez, JMG
   Jorge-Herrero, E
   Carrera, A
   Millan, I
   Rocha, A
   Calero, P
   Cordon, A
   Sainz, N
   Castillo-Olivares, JL
TI Ostrich pericardium, a biomaterial for the construction of valve
   leaflets for cardiac bioprostheses: mechanical behaviour, selection and
   interaction with suture materials
SO BIOMATERIALS
LA English
DT Article
DE ostrich pericardium; cardiac bioprostheses; biaxial testing;
   biomaterials; mechanical properties; sutures
ID PHOTOOXIDIZED BOVINE PERICARDIUM; HEART-VALVES; SUPRAANNULAR PORCINE;
   FIBER ARCHITECTURE; CALF PERICARDIUM; TISSUE; CALCIFICATION;
   POLYURETHANE; PROSTHESES; DURABILITY
AB The mechanical behavior of ostrich pericardium was studied for the purpose of assessing its utility in the construction of bioprosthetic cardiac valve leaflets. The tissue was tested biaxially using a hydraulic simulator that subjected it to increasing stress until rupture. One hundred eighty trials were performed, 36 with unsutured pericardium and four series of 36 trials each with pericardium sutured with silk, Prolene, nylon or Gore-Tex. The samples were tested in pairs from three different pericardial regions. One sample from each pair (the predictive specimen) was assessed according to morphological and mechanical criteria, while the other (the predicted or selectable specimen) was subjected only to morphological analysis. The findings show that ostrich pericardium treated with glutaraldehyde according to standard methods has an excellent resistance to rupture in biaxial testing, withstanding stresses of up to 100 M Pa, and never lower than 30 M Pa. Its resistance to rupture is lowered by suturing, a loss that is less pronounced when silk sutures are used. The results with Gore-Tex are very homogeneous and the elastic behavior of the pericardium/suture unit appears to be similar to that of unsutured tissue, suggesting that the interaction between the two biomaterials is minor. Similar results were observed in the series sutured with Prolene and nylon. The use of paired samples makes it possible to closely estimate the mechanical behavior of the tissue in a given zone by determining that of its mate. The statistical study shows that this estimation is not conditioned by the suture employed, thus validating this approach and providing more precise criteria for tissue selection. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Clin Puerta Hierro, Serv Med Prevent, Madrid 28035, Spain.
   Escuela Tecn Super Ingn Ind, Madrid, Spain.
RP Paez, JMG (reprint author), Clin Puerta Hierro, Serv Med Prevent, C San Martin de Porres 4, Madrid 28035, Spain.
RI Jorge Herrero, EDUARDO/F-7240-2010
CR Bernacca GM, 1998, INT J ARTIF ORGANS, V21, P814
   Braile DM, 1998, J HEART VALVE DIS, V7, P202
   Butany J, 1999, Semin Thorac Cardiovasc Surg, V11, P157
   Butterfield M, 2000, J HEART VALVE DIS, V9, P161
   DATO GMA, 1999, MINERVA CARDIOANGIOL, V47, P275
   Ellsmere JC, 1999, BIOMATERIALS, V20, P1143, DOI 10.1016/S0142-9612(99)00013-7
   GARCIAPAEZ JM, 1996, J BIOMED MATER RES, V30, P47
   GLOWER DD, 1994, J THORAC CARDIOV SUR, V107, P381
   GUERRA F, 1990, J THORAC CARDIOV SUR, V99, P838
   Hiester ED, 1998, J BIOMED MATER RES, V39, P215, DOI 10.1002/(SICI)1097-4636(199802)39:2<215::AID-JBM7>3.0.CO;2-S
   Hiester ED, 1998, J BIOMED MATER RES, V39, P207, DOI 10.1002/(SICI)1097-4636(199802)39:2<207::AID-JBM6>3.0.CO;2-T
   Hyde JAJ, 1999, J HEART VALVE DIS, V8, P331
   Jamieson WRE, 1999, ANN THORAC SURG, V67, P10, DOI 10.1016/S0003-4975(98)01056-X
   Jamieson WRE, 1999, J THORAC CARDIOV SUR, V118, P297
   Jorge-Herrero E, 1999, BIOMATERIALS, V20, P539, DOI 10.1016/S0142-9612(98)90205-8
   JORGEHERRERO E, 1991, BIOMATERIALS, V12, P683, DOI 10.1016/0142-9612(91)90117-S
   Kent PD, 1998, CARDIOVASC PATHOL, V7, P9, DOI 10.1016/S1054-8807(97)00040-9
   Moore MA, 1998, ANN THORAC SURG, V66, pS245, DOI 10.1016/S0003-4975(98)01118-7
   Munro AI, 1995, ANN THORAC SURG S2, V60, P470
   Paez JMG, 2000, J BIOMATER APPL, V15, P47
   PAEZ JMG, 1990, J THORAC CARDIOV SUR, V100, P580
   PAEZ JMG, 1994, BIOMATERIALS, V15, P172, DOI 10.1016/0142-9612(94)90063-9
   Paez JMG, 1999, J BIOMATER APPL, V13, P351, DOI 10.1177/088532829901300404
   Paez JMG, 1996, BIOMATERIALS, V17, P1677, DOI 10.1016/0142-9612(96)87647-2
   PAEZ JMG, 1994, BIOMATERIALS, V15, P981, DOI 10.1016/0142-9612(94)90078-7
   Sacks M S, 1994, ASAIO J, V40, pM632, DOI 10.1097/00002480-199407000-00075
   San Martin AC, 1998, J BIOMED MATER RES, V39, P568, DOI 10.1002/(SICI)1097-4636(19980315)39:4<568::AID-JBM10>3.0.CO;2-3
   Schmidt CE, 2000, BIOMATERIALS, V21, P2215, DOI 10.1016/S0142-9612(00)00148-4
   Schoen FJ, 1998, J HEART VALVE DIS, V7, P174
   Schoen FJ, 1999, J BIOMED MATER RES, V47, P439, DOI 10.1002/(SICI)1097-4636(19991215)47:4<439::AID-JBM1>3.0.CO;2-O
   SESTAFE JVG, 1994, J BIOMED MATER RES, V28, P755, DOI 10.1002/jbm.820280613
   Talman EA, 1996, J HEART VALVE DIS, V5, P152
   TROWBRIDGE EA, 1989, CRIT REV BIOCOMPAT, V5, P105
   TYERS GFO, 1995, ANN THORAC SURG, V60, pS464
   Wheatley DJ, 2000, EUR J CARDIO-THORAC, V17, P440, DOI 10.1016/S1010-7940(00)00381-X
NR 35
TC 14
Z9 14
U1 0
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2001
VL 22
IS 20
BP 2731
EP 2740
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 466CR
UT WOS:000170627200004
PM 11545307
DA 2018-10-20
ER

PT J
AU Gorman, SP
   McGovern, JG
   Woolfson, AD
   Adair, CG
   Jones, DS
AF Gorman, SP
   McGovern, JG
   Woolfson, AD
   Adair, CG
   Jones, DS
TI The concomitant development of poly(vinyl chloride)-related biofilm and
   antimicrobial resistance in relation to ventilator-associated pneumonia
SO BIOMATERIALS
LA English
DT Article
DE biomaterial; medical device; AFM; pneumonia; biofilm; antibiotic
ID ATOMIC-FORCE MICROSCOPY; ENDOTRACHEAL-TUBES; BACTERIAL; ELECTRON;
   SURFACE
AB Ventilator-associated pneumonia is a major cause of death in intensive care patients and the endotracheal tube, commonly fabricated from poly(vinyl chloride) (PVC), is acknowledged as a significant factor in this. Bacteria colonise the biomaterial, thereby adopting a sessile mode of growth that progresses to the establishment of an antibiotic-resistant biofilm by the accretion of a protective glycocalyx. This study examined the sequential steps involved in the formation of biofilm on PVC by atomic force microscopy and the concomitant development of resistance to an antibiotic (ceftazidime) and to a non-antibiotic antimicrobial agent (hexetidine). Staphylococcus aureus and Pseudomonas aeruginosa isolated from ET tube biofilm were employed. The surface microrugosity of bacteria growing in sessile mode on PVC decreased significantly (p < 0.05) over the period 4, 24 48 h and 5 d. The progressive accretion of bacterial glycocalyx was readily visualised in micrographs leading to a smoother surface topography with time. The minimum inhibitory concentrations (MIC) and minimum bactericidal concentrations (MBC) for ceftazidime and hexetidine against planktonic (suspension) S. aureus were lower than for Ps. aeruginosa. Furthermore, sessile populations of S. aureus and Ps. aeruginosa on PVC exhibited greater resistance to both ceftazidime and hexetidine when compared to planktonic bacterial growth. The efficacy of the agents, determined by kill kinetics, against sessile bacteria was dependent on age, with established biofilms (greater than or equal to 24 h) significantly more resistant (p < 0.05) than early sessile populations (less than or equal to 4 h). Importantly, for practice, even newly colonised bacteria (1 h) were significantly more resistant to antibiotic than planktonic bacteria. Hexetidine was significantly more active (p < 0.05) than ceftazidime on biofilms of both isolates, irrespective of age, with total kill within 24 h treatment. Hexetidine may offer promise in the resolution of infection associated with PVC endotracheal tubes. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Queens Univ Belfast, Ctr Med Biol, Sch Pharm, Med Devices Grp, Belfast BT9 7BL, Antrim, North Ireland.
RP Gorman, SP (reprint author), Queens Univ Belfast, Ctr Med Biol, Sch Pharm, Med Devices Grp, Belfast BT9 7BL, Antrim, North Ireland.
CR Adair CG, 1999, INTENS CARE MED, V25, P1072, DOI 10.1007/s001340051014
   Adair CG, 2000, HDB BACTERIAL ADHESI, P249
   Bradshaw DJ, 1996, J APPL BACTERIOL, V80, P124, DOI 10.1111/j.1365-2672.1996.tb03199.x
   BREMER PJ, 1992, CURR MICROBIOL, V24, P223, DOI 10.1007/BF01579285
   BROWN MRW, 1993, J APPL BACTERIOL, V74, pS87, DOI 10.1111/j.1365-2672.1993.tb04345.x
   DeRiso A, 1996, CHEST, V109, P1556, DOI 10.1378/chest.109.6.1556
   GORMAN S, 1993, EUR J CLIN MICROBIOL, V12, P9, DOI 10.1007/BF01997050
   GORMAN SP, 1987, J CLIN PHARM THER, V12, P393, DOI 10.1111/j.1365-2710.1987.tb00552.x
   GORMAN SP, 1994, EPIDEMIOL INFECT, V112, P551, DOI 10.1017/S0950268800051256
   Gorman SP, 1991, MECH ACTION CHEM BIO, P271
   GRISTINA AG, 1993, INT J ARTIF ORGANS, V16, P755
   Gunning PA, 1996, J APPL BACTERIOL, V81, P276, DOI 10.1111/j.1365-2672.1996.tb04329.x
   INGLIS TJJ, 1995, J HOSP INFECT, V30, P409, DOI 10.1016/0195-6701(95)90045-4
   Jones DS, 1997, BIOMATERIALS, V18, P503, DOI 10.1016/S0142-9612(96)00170-6
   LAWRENCE JR, 1991, J BACTERIOL, V173, P6558, DOI 10.1128/jb.173.20.6558-6567.1991
   LEVINE SA, 1991, CLIN CHEST MED, V12, P523
   MAWHINNEY WM, 1993, INT J PHARM PRACT, V1, P136
   McGovern JG, 1997, INT J PHARM, V149, P251, DOI 10.1016/S0378-5173(97)04883-7
   Miles AA, 1938, J HYG-CAMBRIDGE, V38, P732, DOI 10.1017/S002217240001158X
   NAYLOR PT, 1990, CLIN ORTHOP RELAT R, P126
   RUBENSTEIN JS, 1992, CRIT CARE MED, V20, P1544, DOI 10.1097/00003246-199211000-00011
   SOTTILE FD, 1986, CRIT CARE MED, V14, P265, DOI 10.1097/00003246-198604000-00001
   TUNNEY MM, 1996, REV MED MICROBIOL, V7, P195
   WILE DB, 1986, CURR MED RES OPIN, V10, P82, DOI 10.1185/03007998609110423
   WILLIAMS MJR, 1987, BRIT DENT J, V163, P300, DOI 10.1038/sj.bdj.4806275
NR 25
TC 39
Z9 39
U1 1
U2 16
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2001
VL 22
IS 20
BP 2741
EP 2747
DI 10.1016/S0142-9612(01)00017-5
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 466CR
UT WOS:000170627200005
PM 11545308
DA 2018-10-20
ER

PT J
AU Iooss, P
   Le Ray, AM
   Grimandi, G
   Daculsi, G
   Merle, C
AF Iooss, P
   Le Ray, AM
   Grimandi, G
   Daculsi, G
   Merle, C
TI A new injectable bone substitute combining poly(epsilon-caprolactone)
   microparticles with biphasic calcium phosphate granules
SO BIOMATERIALS
LA English
DT Article
DE microparticles; solvent evaporation process; poly(epsilon-caprolactone);
   texture analysis; biphasic calcium phosphate; injectability
ID DRUG-DELIVERY SYSTEM; IN-VITRO; GROWTH-HORMONE; EPSILON-CAPROLACTONE;
   VACUUM METHOD; RELEASE; HYDROXYAPATITE; MICROSPHERES; CERAMICS;
   BIOMATERIALS
AB Previous studies have shown the effectiveness of an injectable bone substitute (IBS) composed of biphasic calcium phosphate in 2% hydroxypropyl methylcellulose gel (50/50 w/w). A therapeutic agent in the form of a drug can be added to the biomaterial by encapsulation into microparticles to protect the active agent, control its release and preserve the material rheological properties. Poly(epsilon -caprolactone) was used in this study because of its biocompatibility and resorbability, as tested in orthopaedic implants and surgical sutures. Particles (80-200 mum) were manufactured by a solvent evaporation-extraction process (1 g of polymer, 11-15 ml methylene chloride, with a stirring speed of 400-600 rpm) and introduced into the IBS in a 5-50% (V/V) range. Injectability was evaluated by texture analysis. With less than 45% of particles, the material had rheological properties similar to those of the reference IBS, whereas injectability decreased markedly with more than 45% of particles. A preliminary in vitro release study showed that this type of triphasic IBS could be efficient for drug delivery systems with osteoconduction properties. (C) 2001 Published by Elsevier Science Ltd.
C1 Fac Pharm, Pharm Galen Lab, F-44035 Nantes, France.
   Fac Chirurg Dent, Equipe INSERM 99 03, Ctr Rech Mat Interet Biol, F-44042 Nantes, France.
RP Le Ray, AM (reprint author), Fac Pharm, Pharm Galen Lab, BP 53508,1 Rue Gaston Veil, F-44035 Nantes, France.
RI Xu, Qingguo/C-1962-2014; Daculsi, Guy/P-1320-2014
OI Xu, Qingguo/0000-0003-3191-0771; Daculsi, Guy/0000-0003-1030-3446
CR Aftabrouchard D., 1992, STP PHARMA SCI, V2, P365
   ARSHADY R, 1991, J CONTROL RELEASE, V17, P1, DOI 10.1016/0168-3659(91)90126-X
   Bai B, 1999, SPINE, V24, P1521, DOI 10.1097/00007632-199908010-00004
   BAJPAI PK, 1988, J BIOMED MATER RES, V22, P1245, DOI 10.1002/jbm.820221212
   Benoit MA, 1997, INT ORTHOP, V21, P403
   BENOIT MA, 1995, P 1 WORLD M APGI APV, P431
   BEZWADA RS, 1995, BIOMATERIALS, V16, P1141, DOI 10.1016/0142-9612(95)93577-Z
   Bouler JM, 1996, J BIOMED MATER RES, V32, P603, DOI 10.1002/(SICI)1097-4636(199612)32:4<603::AID-JBM13>3.0.CO;2-E
   BREWER E, 1995, J PHARM SCI, V84, P499, DOI 10.1002/jps.2600840421
   Calvo P, 1996, J PHARM PHARMACOL, V48, P1147, DOI 10.1111/j.2042-7158.1996.tb03911.x
   Chang CM, 1996, INT J PHARM, V130, P187, DOI 10.1016/0378-5173(95)04287-3
   CHANG RK, 1986, DRUG DEV IND PHARM, V12, P2355, DOI 10.3109/03639048609063187
   Daculsi G, 1998, BIOMATERIALS, V19, P1473, DOI 10.1016/S0142-9612(98)00061-1
   Daculsi G, 1997, INT REV CYTOL, V172, P129, DOI 10.1016/S0074-7696(08)62360-8
   DACULSI G, 1995, CAHIER ENSEIGNEMENT, P5
   Daculsi G, 1995, CNRS patent, Patent No. [9521634, WO 95/21634]
   DOWNES S, 1991, CELL MATER, V1, P171
   DOWNES S, 1991, J MATER SCI-MATER M, V2, P176, DOI 10.1007/BF00692977
   DOWNES S, 1995, J BIOMED MATER RES, V29, P1053, DOI 10.1002/jbm.820290905
   DOWNES S, 1992, BONE BONDING, P101
   DUBERNET C, 1987, INT J PHARM, V35, P145, DOI 10.1016/0378-5173(87)90083-4
   DUBERNETPRUDHON C, 1986, INT TECHNOL PHARM, V11, P173
   Dupraz A, 1996, J MATER SCI-MATER M, V7, P52, DOI 10.1007/BF00121190
   Ekholm M, 1999, J MATER SCI-MATER M, V10, P69, DOI 10.1023/A:1008912802263
   ENGELBERG I, 1991, BIOMATERIALS, V12, P292, DOI 10.1016/0142-9612(91)90037-B
   ESPUELAS MS, 1995, 10 J SCI GTRV ANG DE
   Fernandez E, 1999, J MATER SCI-MATER M, V10, P169, DOI 10.1023/A:1008937507714
   Gautier H, 2000, BIOMATERIALS, V21, P243, DOI 10.1016/S0142-9612(99)00139-8
   Gautier H, 1998, J BIOMED MATER RES, V40, P606, DOI 10.1002/(SICI)1097-4636(19980615)40:4<606::AID-JBM12>3.0.CO;2-D
   GILLARD J, 1998, P 2 WORLD M APGI APV, P359
   Grimandi G, 1998, J BIOMED MATER RES, V39, P660, DOI 10.1002/(SICI)1097-4636(19980315)39:4<660::AID-JBM22>3.0.CO;2-9
   GRIMANDI G, 1996, THESIS U NANTES FRAN
   Guicheux J, 1997, J BIOMED MATER RES, V34, P165, DOI 10.1002/(SICI)1097-4636(199702)34:2<165::AID-JBM4>3.0.CO;2-O
   Guzman M, 1996, J MICROENCAPSUL, V13, P25, DOI 10.3109/02652049609006801
   HUATAN H, 1995, J MICROENCAPSUL, V12, P557, DOI 10.3109/02652049509006786
   Itokazu M, 1998, BIOMATERIALS, V19, P817, DOI 10.1016/S0142-9612(97)00237-8
   Itokazu M, 1999, J MATER SCI-MATER M, V10, P249, DOI 10.1023/A:1008966314075
   Itokazu M, 1998, J BIOMED MATER RES, V39, P536, DOI 10.1002/(SICI)1097-4636(19980315)39:4<536::AID-JBM5>3.0.CO;2-K
   ITOKAZU M, 1994, J ORTHOP SURG, V2, P47
   Jameela SR, 1997, J BIOMAT SCI-POLYM E, V8, P457, DOI 10.1163/156856297X00380
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   Legeros Racquel Z., 1993, Clinical Materials, V14, P65, DOI 10.1016/0267-6605(93)90049-D
   LEGEROS RZ, 1994, HYDROXYAPATITE AND RELATED MATERIALS, P3
   LEGEROS RZ, 1991, CALCIUM PHOSPHATES O, P3
   Lowry KJ, 1997, J BIOMED MATER RES, V36, P536
   MCDOUGALL KE, 1998, 14 EUR C BIOM THE HA
   Menei P, 1997, STP PHARMA SCI, V7, P53
   MENEI P, 1994, J BIOMED MATER RES, V28, P1079, DOI 10.1002/jbm.820280913
   MICLAU T, 1993, J ORTHOPAED RES, V11, P627, DOI 10.1002/jor.1100110503
   MOUSSET B, 1995, INT ORTHOP, V19, P157
   OTSUKA M, 1992, CHEM PHARM BULL, V40, P3346, DOI 10.1248/cpb.40.3346
   Pasquier G, 1996, J MATER SCI-MATER M, V7, P683, DOI 10.1007/BF00123407
   Radin S, 1997, BIOMATERIALS, V18, P777, DOI 10.1016/S0142-9612(96)00190-1
   REY C, 1990, Biomaterials, V11, P13
   RIPAMONTI U, 1992, MATRIX, V12, P202, DOI 10.1016/S0934-8832(11)80063-6
   SHINTO Y, 1992, J BONE JOINT SURG BR, V74, P600
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   THIES C, 1952, MICROCAPSULES NANOPA, P48
   THIES C, 1981, INT J PHARM TECH PRO, V2, P25
   TOTH JM, 1991, J APPL BIOMATER, V2, P37, DOI 10.1002/jab.770020106
   UCHIDA A, 1992, J ORTHOPAED RES, V10, P440, DOI 10.1002/jor.1100100317
   Weiss P, 1999, BONE, V25, p67S, DOI 10.1016/S8756-3282(99)00146-5
   WEISS P, 1997, THESIS U NANTES FRAN
   Youan B. B. C., 1997, Journal of Controlled Release, V48, P339
   YU D, 1992, J PHARM SCI, V81, P529, DOI 10.1002/jps.2600810611
   1993, MAT CHIRURG DETERMIN
NR 66
TC 51
Z9 54
U1 0
U2 9
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2001
VL 22
IS 20
BP 2785
EP 2794
DI 10.1016/S0142-9612(01)00022-9
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 466CR
UT WOS:000170627200010
PM 11545313
DA 2018-10-20
ER

PT J
AU Solchaga, LA
   Goldberg, VM
   Caplan, AI
AF Solchaga, LA
   Goldberg, VM
   Caplan, AI
TI Cartilage regeneration using principles of tissue engineering
SO CLINICAL ORTHOPAEDICS AND RELATED RESEARCH
LA English
DT Article
ID ARTICULAR-CARTILAGE; HYALURONIC-ACID; REPAIR; DEFECTS; CELLS; BONE;
   CHONDROGENESIS; CULTURE; TRANSPLANTATION; DIFFERENTIATION
AB It is well known that articular cartilage in adults has a limited ability for self-repair. Numerous methods have been devised to augment its natural heating response, but these methods generally lead to filling of the defect with fibrous tissue or fibrocartilage, which lacks the mechanical characteristics of articular cartilage and fails with time. Recently, tissue engineering has emerged as a new discipline that amalgamates aspects from biology, engineering, materials science, and surgery and that has as a goal the fabrication of functional new tissues to replace damaged tissues. The emergence of tissue engineering has facilitated the generation of new concepts and the revival of old ideas all of which has allowed a fresh approach to the repair or regeneration of tissues such as cartilage. The collaborations between scientists with different backgrounds and expertise has allowed the identification of some key principles that serve as the basis for the development of therapeutic approaches that now are less empiric and more hypothesis-driven than ever before. The current authors review some of the considerations regarding the various models used to test and validate the above repair methods and to address different aspects of the cartilage repair paradigm. Also, some key principles identified from past and current research, the need for the development of new biomaterials, and considerations in scale-up of cell-biomaterial constructs are summarized.
C1 Case Western Reserve Univ, Dept Orthopaed, Sch Med, Cleveland, OH 44106 USA.
   Univ Hosp Cleveland, Cleveland, OH 44106 USA.
   Case Western Reserve Univ, Dept Biol, Skeletal Res Ctr, Cleveland, OH 44106 USA.
RP Goldberg, VM (reprint author), Case Western Reserve Univ, Dept Orthopaed, Sch Med, 11100 Euclid Ave, Cleveland, OH 44106 USA.
OI Caplan, Arnold/0000-0002-8677-6621
CR AMIEL D, 1985, J BONE JOINT SURG AM, V67A, P911, DOI 10.2106/00004623-198567060-00013
   Buckwalter J A, 1997, Iowa Orthop J, V17, P1
   Buckwalter JA, 1998, ARTHRITIS RHEUM-US, V41, P1331, DOI 10.1002/1529-0131(199808)41:8<1331::AID-ART2>3.0.CO;2-J
   Campoccia D, 1998, BIOMATERIALS, V19, P2101, DOI 10.1016/S0142-9612(98)00042-8
   Caplan A I, 1999, Clin Orthop Relat Res, pS12, DOI 10.1097/00003086-199910001-00003
   Caplan AI, 1997, CLIN ORTHOP RELAT R, P254
   CAPLAN AI, 1994, CLIN PLAST SURG, V21, P429
   CAPLAN AI, 1983, SCIENCE, V221, P921, DOI 10.1126/science.6348946
   Caplan AI, 2000, TISSUE ENG, V6, P1, DOI 10.1089/107632700320838
   CAPLAN AI, 1986, BIOESSAYS, V5, P129, DOI 10.1002/bies.950050309
   Deng CX, 1996, CELL, V84, P911, DOI 10.1016/S0092-8674(00)81069-7
   Dennis J E, 1992, Cell Transplant, V1, P23
   FEINBERG RN, 1983, SCIENCE, V220, P1177, DOI 10.1126/science.6857242
   FREED LE, 1993, J BIOMED MATER RES, V27, P11, DOI 10.1002/jbm.820270104
   FREED LE, 1993, J CELL BIOCHEM, V51, P257, DOI 10.1002/jcb.240510304
   Freed LE, 1998, EXP CELL RES, V240, P58, DOI 10.1006/excr.1998.4010
   Goldberg VM, 1998, J SPORT TRAUMATOL, V20, P81
   GOLDBERG VM, 1999, SEMIN ARTHROPLASTY, V10, P30
   GRANDE DA, 1987, ANAT REC, V218, P142, DOI 10.1002/ar.1092180208
   HUIBREGTSE BA, 1998, T ORTHOP RES SOC, V23, P796
   Hunziker EB, 1996, J BONE JOINT SURG AM, V78A, P721, DOI 10.2106/00004623-199605000-00012
   Hunziker EB, 1999, OSTEOARTHR CARTILAGE, V7, P15, DOI 10.1053/joca.1998.0159
   KUJAWA MJ, 1986, DEV BIOL, V114, P504, DOI 10.1016/0012-1606(86)90214-9
   KUJAWA MJ, 1986, DEV BIOL, V114, P519, DOI 10.1016/0012-1606(86)90215-0
   LINSENMA.TF, 1973, DEV BIOL, V35, P232, DOI 10.1016/0012-1606(73)90020-1
   Mankin HJ, 1996, J BONE JOINT SURG AM, V78A, P1
   MANKIN HJ, 1982, J BONE JOINT SURG AM, V64, P460, DOI 10.2106/00004623-198264030-00022
   MAOR G, 1989, ENDOCRINOLOGY, V125, P1239, DOI 10.1210/endo-125-3-1239
   MITCHELL N, 1976, J BONE JOINT SURG AM, V58, P230, DOI 10.2106/00004623-197658020-00012
   O'Driscoll SW, 1998, J BONE JOINT SURG AM, V80A, P1795, DOI 10.2106/00004623-199812000-00011
   ROBINSON D, 1990, CALCIFIED TISSUE INT, V46, P246, DOI 10.1007/BF02555003
   Sellers RS, 1997, J BONE JOINT SURG AM, V79A, P1452, DOI 10.2106/00004623-199710000-00002
   SHAPIRO F, 1993, J BONE JOINT SURG AM, V75A, P532, DOI 10.2106/00004623-199304000-00009
   Solchaga LA, 1999, J ORTHOPAED RES, V17, P205, DOI 10.1002/jor.1100170209
   Solchaga LA, 2000, J ORTHOP RES, V18, P773, DOI 10.1002/jor.1100180515
   Toole BP, 1997, J INTERN MED, V242, P35, DOI 10.1046/j.1365-2796.1997.00171.x
   VACANTI JP, 1999, LANCET S1, V354, pS132
   Wakitani S, 1998, TISSUE ENG, V4, P429, DOI 10.1089/ten.1998.4.429
   WAKITANI S, 1994, J BONE JOINT SURG AM, V76A, P579, DOI 10.2106/00004623-199404000-00013
   Walsh CJ, 1999, TISSUE ENG, V5, P327, DOI 10.1089/ten.1999.5.327
   WANG EA, 1993, GROWTH FACTORS, V9, P57, DOI 10.3109/08977199308991582
   Wei XC, 1997, J BIOMED MATER RES, V34, P63, DOI 10.1002/(SICI)1097-4636(199701)34:1<63::AID-JBM9>3.0.CO;2-L
   Wennberg JE, 1996, DARTMOUTH ATLAS HLTH, P113
   WEST DC, 1989, EXP CELL RES, V183, P179, DOI 10.1016/0014-4827(89)90428-X
   WEST DC, 1985, SCIENCE, V228, P1324, DOI 10.1126/science.2408340
NR 45
TC 68
Z9 70
U1 0
U2 7
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0009-921X
J9 CLIN ORTHOP RELAT R
JI Clin. Orthop. Rel. Res.
PD OCT
PY 2001
IS 391
SU S
BP S161
EP S170
PG 10
WC Orthopedics; Surgery
SC Orthopedics; Surgery
GA 483GD
UT WOS:000171624500016
PM 11603701
DA 2018-10-20
ER

PT J
AU Nygren, H
   Broberg, M
   Eriksson, C
   Sahlin, H
   Yahyapour, N
AF Nygren, H
   Broberg, M
   Eriksson, C
   Sahlin, H
   Yahyapour, N
TI The respiratory burst response of surface-adhering leukocytes. A key to
   tissue engineering
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Review
DE biomaterials; cellular signalling pathways; extra/intracellular redox
   states; respiratory burst response; surface-adhering leukocytes
ID CELL-FREE SYSTEM; FC-GAMMA-RIIIB; HUMAN POLYMORPHONUCLEAR LEUKOCYTES;
   DEPENDENT SUPEROXIDE PRODUCTION; RECEPTOR-MEDIATED PHAGOCYTOSIS;
   TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; HUMAN-NEUTROPHILS; NADPH-OXIDASE;
   TYROSINE PHOSPHORYLATION
AB Biomaterials implanted into tissue will participate in the complex signalling between cells during wound healing. Recent studies have revealed that crucial cellular signalling pathways are regulated by the extra- and intracellular redox states and that reactive oxygen species function as intercellular signal molecules. Biomaterials have been shown to affect the respiratory burst response of surface-adhering leukocytes, thus interfering with major regulatory functions of cells also in surrounding tissues. The respiratory burst of surface-adhering leukocytes may thus be a key event in the understanding of biomaterial interaction with tissues, and the aim of this review is to highlight this field of research. (C) 2001 Elsevier Science B.V. All rights reserved.
C1 Univ Gothenburg, Inst Anat & Cell Biol, Dept Appl Cell Biol, SE-40530 Gothenburg, Sweden.
EM hakan.nygren@anatcell.gu.se
CR AGWU DE, 1991, J CLIN INVEST, V88, P531, DOI 10.1172/JCI115336
   ANDRADE JD, 1987, ANN NY ACAD SCI, V516, P158, DOI 10.1111/j.1749-6632.1987.tb33038.x
   Babior BM, 1999, BLOOD, V93, P1464
   BACUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141
   BAIER RE, 1982, J BIOMECH ENG-T ASME, V104, P257, DOI 10.1115/1.3138358
   Berton G, 1999, CELL SIGNAL, V11, P621, DOI 10.1016/S0898-6568(99)00003-0
   BEUTH J, 1990, INFECTION, V18, P36, DOI 10.1007/BF01644181
   Blouin E, 1999, EUR J IMMUNOL, V29, P3419, DOI 10.1002/(SICI)1521-4141(199911)29:11<3419::AID-IMMU3419>3.3.CO;2-T
   BRASH JL, 1987, ANN NY ACAD SCI, V516, P206, DOI 10.1111/j.1749-6632.1987.tb33043.x
   BROMBERG Y, 1984, CELL IMMUNOL, V88, P213, DOI 10.1016/0008-8749(84)90066-2
   BROMBERG Y, 1985, J BIOL CHEM, V260, P3539
   Bulkley GB, 1997, BIOCHEM SOC T, V25, P804, DOI 10.1042/bst0250804
   Cario E, 1999, SCAND J GASTROENTERO, V34, P485, DOI 10.1080/003655299750026218
   Chambers RC, 1998, BIOCHEM J, V333, P121, DOI 10.1042/bj3330121
   Coffer PJ, 1998, BIOCHEM J, V329, P121
   DAHINDEN CA, 1983, J CLIN INVEST, V72, P113, DOI 10.1172/JCI110948
   De La Cruz C, 1998, J SURG RES, V80, P28, DOI 10.1006/jsre.1998.5262
   DELLABIANCA V, 1993, J LEUKOCYTE BIOL, V53, P427
   Demaurex N, 1996, J CELL BIOL, V133, P1391, DOI 10.1083/jcb.133.6.1391
   Edwards SW, 1997, ANN NY ACAD SCI, V832, P341, DOI 10.1111/j.1749-6632.1997.tb46262.x
   ElBenna J, 1996, ARCH BIOCHEM BIOPHYS, V334, P395
   English D, 1996, CELL SIGNAL, V8, P341, DOI 10.1016/0898-6568(95)00076-3
   Eriksson C, 2001, J LAB CLIN MED, V137, P56, DOI 10.1067/mlc.2001.111470
   ERIKSSON C, IN PRESS J LAB CLIN
   Exton JH, 1997, PHYSIOL REV, V77, P303
   Fernandez R, 1998, J IMMUNOL, V160, P5154
   FUORTES M, 1993, J CELL BIOL, V120, P777, DOI 10.1083/jcb.120.3.777
   GARNOTEL R, 1995, J BIOL CHEM, V270, P27495, DOI 10.1074/jbc.270.46.27495
   Glaser K B, 1990, Adv Exp Med Biol, V275, P1
   GOLDSTEIN IM, 1975, J CLIN INVEST, V56, P1155, DOI 10.1172/JCI108191
   Gorodetsky R, 1998, J LAB CLIN MED, V131, P269, DOI 10.1016/S0022-2143(98)90100-7
   GRESHAM HD, 1990, J BIOL CHEM, V265, P7819
   GRETZER C, 2000, THESIS GOTEBORG U
   HIDAKA H, 1996, ADV PHARM, V36
   Hirota K, 1999, J BIOL CHEM, V274, P27891, DOI 10.1074/jbc.274.39.27891
   HORBETT TA, 1982, ADV CHEM SER, P233
   HYSLOP PA, 1995, FREE RADICAL BIO MED, V19, P31, DOI 10.1016/0891-5849(95)00005-I
   Inanami O, 1998, J BIOL CHEM, V273, P9539, DOI 10.1074/jbc.273.16.9539
   INDIK ZK, 1995, BLOOD, V86, P4389
   JabrilCuenod B, 1996, J BIOL CHEM, V271, P16268, DOI 10.1074/jbc.271.27.16268
   JESAITIS AJ, 1990, J CLIN INVEST, V85, P821, DOI 10.1172/JCI114509
   JOHANSSON A, 1995, CELL IMMUNOL, V161, P61, DOI 10.1006/cimm.1995.1009
   JOHNSTON RB, 1976, J CLIN INVEST, V57, P836, DOI 10.1172/JCI108359
   Kalltorp M, 1999, BIOMATERIALS, V20, P2123, DOI 10.1016/S0142-9612(99)00115-5
   Kamata H, 1999, CELL SIGNAL, V11, P1, DOI 10.1016/S0898-6568(98)00037-0
   Kanagaraja S, 1996, BIOMATERIALS, V17, P2225, DOI 10.1016/0142-9612(95)00311-8
   KASAMA T, 1989, CLIN IMMUNOL IMMUNOP, V53, P439, DOI 10.1016/0090-1229(89)90006-8
   Kaul N, 1998, FREE RADICAL BIO MED, V24, P202, DOI 10.1016/S0891-5849(97)00209-8
   LENARDO MJ, 1989, CELL, V58, P227, DOI 10.1016/0092-8674(89)90833-7
   Lofgren R, 1999, BBA-MOL CELL RES, V1452, P46, DOI 10.1016/S0167-4889(99)00112-3
   MACKENZIE SJ, 1995, BIOCHEM J, V306, P519, DOI 10.1042/bj3060519
   Madesh M, 1997, ARCH BIOCHEM BIOPHYS, V346, P187, DOI 10.1006/abbi.1997.0288
   Matsuo T, 1996, BIOCHEM J, V315, P505, DOI 10.1042/bj3150505
   MCPHAIL LC, 1983, J CLIN INVEST, V72, P192, DOI 10.1172/JCI110957
   METINKO AP, 1992, J CLIN INVEST, V90, P791, DOI 10.1172/JCI115953
   MILLER RA, 1995, J INVEST MED, V43, P39
   Model MA, 1998, IMMUNOBIOLOGY, V199, P39, DOI 10.1016/S0171-2985(98)80062-4
   MOLLINEDO F, 1993, FEBS LETT, V326, P209, DOI 10.1016/0014-5793(93)81792-X
   Movitz C, 1997, INFLAMMATION, V21, P531, DOI 10.1023/A:1027363730746
   Muller M, 1997, PROSTAGLANDINS, V54, P493, DOI 10.1016/S0090-6980(97)00060-9
   Muszbek L, 1999, THROMB RES, V94, P271, DOI 10.1016/S0049-3848(99)00023-7
   Nakamura R, 1998, EUR J BIOCHEM, V251, P583, DOI 10.1046/j.1432-1327.1998.2510583.x
   NATHAN C, 1989, J CELL BIOL, V109, P1341, DOI 10.1083/jcb.109.3.1341
   Nick JA, 1997, J CLIN INVEST, V99, P975, DOI 10.1172/JCI119263
   Nisimoto Y, 1997, J BIOL CHEM, V272, P18834, DOI 10.1074/jbc.272.30.18834
   Nygren H, 1998, J BIOMAT SCI-POLYM E, V9, P817, DOI 10.1163/156856298X00172
   Nygren H, 1997, J LAB CLIN MED, V129, P35, DOI 10.1016/S0022-2143(97)90159-1
   NYGREN H, 1982, ACTA PHYSIOL SCAND, V116, P201, DOI 10.1111/j.1748-1716.1982.tb07130.x
   Nygren H, 1999, J BIOMED MATER RES, V45, P117
   OCLURA M, 1998, AM SOC NEPHR 31 ANN, pA429
   Park JW, 1998, EXP HEMATOL, V26, P37
   Rane MJ, 1997, J IMMUNOL, V159, P5070
   RAVETCH JV, 1991, ANNU REV IMMUNOL, V9, P457, DOI 10.1146/annurev.iy.09.040191.002325
   Reilly TJ, 1996, J BIOL CHEM, V271, P10973, DOI 10.1074/jbc.271.18.10973
   Sakane F, 1997, INT J BIOCHEM CELL B, V29, P1139, DOI 10.1016/S1357-2725(97)00037-X
   SALMON JE, 1995, J CLIN INVEST, V95, P2877, DOI 10.1172/JCI117994
   Schlaepfer DD, 1999, PROG BIOPHYS MOL BIO, V71, P435, DOI 10.1016/S0079-6107(98)00052-2
   STOCKL J, 1995, J IMMUNOL, V154, P5452
   Stocum DL, 1999, CURR BIOL, V9, pR644, DOI 10.1016/S0960-9822(99)80413-8
   Sun QA, 1999, J BIOL CHEM, V274, P24522, DOI 10.1074/jbc.274.35.24522
   Suzuki YJ, 1997, FREE RADICAL BIO MED, V22, P269, DOI 10.1016/S0891-5849(96)00275-4
   Thelen M, 1997, ANN NY ACAD SCI, V832, P368, DOI 10.1111/j.1749-6632.1997.tb46265.x
   Tilton B, 1997, J BIOL CHEM, V272, P28096, DOI 10.1074/jbc.272.44.28096
   TURNER NC, 1994, EUR RESPIR J, V7, P934
   VROMAN L, 1980, BLOOD, V55, P156
   Williams MA, 1999, J LEUKOCYTE BIOL, V65, P725
   Wymann MP, 2000, IMMUNOL TODAY, V21, P260, DOI 10.1016/S0167-5699(00)01649-2
   YAN SR, 1995, J LEUKOCYTE BIOL, V58, P595
   ZHOU MJ, 1994, J CELL BIOL, V125, P1407, DOI 10.1083/jcb.125.6.1407
   Zu YL, 1998, J IMMUNOL, V160, P1982
NR 90
TC 10
Z9 11
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
EI 1873-4367
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD OCT
PY 2001
VL 22
IS 2
BP 87
EP 97
DI 10.1016/S0927-7765(00)00216-2
PG 11
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA 509TB
UT WOS:000173164800001
DA 2018-10-20
ER

PT J
AU Minamide, A
   Tamaki, T
   Yoshida, M
   Hashizume, H
   Nakagawa, Y
AF Minamide, A
   Tamaki, T
   Yoshida, M
   Hashizume, H
   Nakagawa, Y
TI The use of sintered bone in spinal surgery
SO EUROPEAN SPINE JOURNAL
LA English
DT Article
DE animal model; biomaterials; biomechanics; sintered bone; spinal fusion
ID BOVINE BONE; OSTEOPOROSIS
AB The sintered bovine bone True Bone Ceramics (TBC) is one of the biomaterials based on calcium phosphate, an organized crystal of bone mineral and a biomaterial possessing a natural trabecular structure. We examined whether the sintered bovine bone can integrate with recipient bone and adjust to the strength of recipient bone for anterior spinal fusion in an animal model. Based on radiographic evaluation, manual palpation, biomechanical testing, and histological examination, spinal fusion with TBC resulted in a composition and structure similar to that of autograft (and to no implantation). TBC, with its moderate strength, tended to adjust to the bone stiffness of the host bone in the respective specimens as new bone growth developed. Our observations warrant further clinical investigation of the use of sintered bone as an effective spinal arthrodesis, especially in patients who have fragile vertebrae, as in osteoporosis.
C1 Wakayama Med Coll, Dept Orthopaed Surg, Wakayama 6418157, Japan.
RP Minamide, A (reprint author), Wakayama Med Coll, Dept Orthopaed Surg, 811-1 Kimiidera, Wakayama 6418157, Japan.
CR ABUMI K, 1998, RINSHO SEIKEIGEKA, V33, P495
   Hashizume H, 1998, J Orthop Sci, V3, P42, DOI 10.1007/s007760050020
   KANEDA K, 1992, SPINE S, V17, P295
   KATOH T, 1993, CLIN ORTHOP RELAT R, P266
   KURZ LT, 1989, SPINE, V14, P1324, DOI 10.1097/00007632-198912000-00009
   LEONG JCY, 1994, CLIN ORTHOP RELAT R, P52
   Matsumoto T, 1999, J ORTHOP RES, V17, P586, DOI 10.1002/jor.1100170419
   Minamide A, 2000, J SPINAL DISORD, V13, P156, DOI 10.1097/00002517-200004000-00011
   Myers ER, 1997, SPINE, V22, p25S, DOI 10.1097/00007632-199712151-00005
   Nibu K, 1997, J SPINAL DISORD, V10, P357
   SHIKATA J, 1990, SPINE, V15, P485, DOI 10.1097/00007632-199006000-00010
   TAMAKI T, 1994, BONE GRAFTS, DERIVATIVES AND SUBSTITUTES, P235
   UENO Y, 1985, BESSATSU SEIKEIGEKA, V8, P85
NR 13
TC 6
Z9 7
U1 0
U2 2
PU SPRINGER-VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010 USA
SN 0940-6719
J9 EUR SPINE J
JI Eur. Spine J.
PD OCT
PY 2001
VL 10
SU 2
BP S185
EP S188
DI 10.1007/s005860100274
PG 4
WC Clinical Neurology; Orthopedics
SC Neurosciences & Neurology; Orthopedics
GA 488MA
UT WOS:000171937900015
PM 11716017
OA Green Published
DA 2018-10-20
ER

PT J
AU Granados, DL
   Jimenez, A
   Cuadrado, TR
AF Granados, DL
   Jimenez, A
   Cuadrado, TR
TI Assessment of parameters associated to the risk of PVC catheter reuse
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE catheter; catheter reprocessing; poly(vinyl chloride); reuse risk
   factors
ID SUPERCRITICAL-FLUID EXTRACTION; POLY(VINYL CHLORIDE); PLASTICIZER;
   INFECTION
AB The practice of single use devices (SUD) recycling raises public health concerns, primarily with regard to the potential risks of infection and device malfunction. These concerns have led to a Food and Drug Administration (FDA) revision of the present regulations. The purpose of our work is to identify different material parameters that could contribute to the health risks associated with the practice of reprocessing PVC catheters for use in other patients. Ethylene oxide hospital-reprocessed central venous Catheter samples were obtained from the stock of a health-care institution. One device trademark was selected, and samples that had been used 8 and 24 times were compared with new ones. In order to determine the total percentage of extractables, supercritical fluid extraction (SFE) was used, and off-line gas-chromatography-flame-ionization detection (GC-FID) was employed for identification and quantitation of bis-(2-ethyl hexil)phthalate (DEHP). Storage modulus (E ') and dissipation factor (tan delta curves were obtained by dynamic mechanical analysis (DMA). Successive catheter recycles produced increased plasticizer loss, increased glass transition temperature (T-g) and E ', widening of tan delta curve with a simultaneous shift to higher temperature, small decrease of weight average molecular weight (M-w), increased surface roughness, and increased appearance of surface grooves (severe damage). The magnitude of biomaterial parameter changes measured suggests that reuse could alter the original device performance. Examples of possible adverse clinical events include leaching of toxic agents, device rigidization or breakage, increased catheter protein retention, or the promotion of bacterial adhesion by device topography modification. (C) 2001 John Wiley & Sons, Inc.
C1 Univ Mar del Plata, Natl Res Council, Inst Mat Sci & Technol, RA-7600 Mar Del Plata, Argentina.
   Natl Univ San Juan, Inst Chem Engn, RA-5400 Oeste, San Juan, Argentina.
   Univ Alicante, Dept Analyt Chem, E-03080 Alicante, Spain.
RP Cuadrado, TR (reprint author), Univ Mar del Plata, Natl Res Council, Inst Mat Sci & Technol, Juan B Justo 4302, RA-7600 Mar Del Plata, Argentina.
RI Jimenez, Alfonso/L-2211-2014
OI Jimenez, Alfonso/0000-0003-1043-6759
CR Abraham GA, 1997, J APPL POLYM SCI, V65, P1193, DOI 10.1002/(SICI)1097-4628(19970808)65:6<1193::AID-APP15>3.0.CO;2-V
   ALAVA JI, 2000, P BIOAV 2000 FIRST C, P75
   Collins J L, 1991, Oncol Nurs Forum, V18, P819
   DUMITRIU S, 1994, POLYM BIOMATERIALS, pCH1
   Goetz AM, 1998, INFECT CONT HOSP EP, V19, P842
   HEINRICH J, 2000, SINGLE USE MED DEVIC, P1
   HERMANSON N, 1991, SOC PLAST ENG MED RE
   HERMANSON NJ, 1997, MED DEVICE DIAGN AUG, P1
   Jayakrishnan K, 1998, NATURE, V396, P638
   Lakshmi S, 1998, POLYMER, V39, P151, DOI 10.1016/S0032-3861(97)00244-9
   LEROUGE S, 1999, 25 ANN M T SOC BIOM, P195
   MA N, 2000, T 6 WORLD BIOM C, P37
   Maki DG, 1997, ANN INTERN MED, V127, P257, DOI 10.7326/0003-4819-127-4-199708150-00001
   Marin ML, 1998, J SUPERCRIT FLUID, V12, P271, DOI 10.1016/S0896-8446(98)00086-2
   Marin ML, 1996, J CHROMATOGR A, V750, P183, DOI 10.1016/0021-9673(96)00393-7
   MCALLISTER EW, 1993, GASTROINTEST ENDOSC, V39, P422, DOI 10.1016/S0016-5107(93)70120-0
   Raad II, 1997, INFECT CONT HOSP EP, V18, P227
   RAAD II, 1996, INFECT MED, V13, P807
   STOERMER WB, 1999, MED DEVICE DIAGN IND, V21, P38
   STUDERVANT M, 1990, SOC PLAST ENG ANN C
   Szycher M., 1991, BLOOD COMPATIBLE MAT
   Wickham R, 1992, Semin Oncol Nurs, V8, P133, DOI 10.1016/0749-2081(92)90029-3
   Yin HQ, 1999, J MATER SCI-MATER M, V10, P527, DOI 10.1023/A:1008912213420
NR 23
TC 10
Z9 11
U1 0
U2 7
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD OCT
PY 2001
VL 58
IS 5
BP 505
EP 510
DI 10.1002/jbm.1047
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 472VR
UT WOS:000171006100005
PM 11505424
DA 2018-10-20
ER

PT J
AU Verdonschot, N
   van Hal, CTH
   Schreurs, BW
   Buma, P
   Huiskes, R
   Slooff, TJJH
AF Verdonschot, N
   van Hal, CTH
   Schreurs, BW
   Buma, P
   Huiskes, R
   Slooff, TJJH
TI Time-dependent mechanical properties of HA/TCP particles in relation to
   morsellized bone grafts for use in impaction grafting
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE total hip replacement; revision; biomaterials; mechanical testing
ID ALLOGRAFTS
AB In reconstructive surgery human bone defects are sometimes filled with the use of the impaction bone grafting technique. Currently different types of biomaterial particles are being developed as bone-substitute materials. Before these biomaterials can be applied their mechanical and biological behavior should be characterized. In this study the time-dependent mechanical behavior of biomaterial particles with different tri-calcium-phosphate/hydroxy-apatite (TCP:HA) ratios, particle sizes, and porosities is determined and compared to the behavior of human bone grafts, the latter being the standard material currently used to augment bone defects. The mechanical properties were assessed with the use of dynamic confined compression creep tests with a loading and unloading phase. Different graft material groups were tested, consisting of 100% human bone grafts, 100% biomaterial particles, and 50:50 weight mixtures of human grafts and biomaterial particles. No damage to the particles was observed by the impaction in the test chamber or by the dynamic load. Relative to the human graft material, the biomaterial particles hardly deformed under loading, were much stiffer, and showed almost no viscoelastic behavior. The mixtures showed intermediate results. Particle size and porosity influenced the behavior of the biomaterial particles. TCP:HA ratio did not have a great effect. The conclusion is that the application of these particles should be done with great care, as their mechanical behavior is drastically different than that of the human graft material. Mixing it with human bone grafts gave the material some biphasic, viscoelastic behavior that may be important for its biological response. (C) 2001 John Wiley & Sons, Inc.
C1 Univ Nijmegen, Orthopaed Res Lab, Ctr Med, NL-6500 HB Nijmegen, Netherlands.
RP Verdonschot, N (reprint author), Univ Nijmegen, Orthopaed Res Lab, Ctr Med, POB 9101, NL-6500 HB Nijmegen, Netherlands.
RI Verdonschot, N.J.J./H-8104-2014; Schreurs, B.W./L-4639-2015; Buma,
   P./H-8019-2014; Buma, Pieter/C-9828-2013
CR DALSTRA M, 1995, J BIOMECH, V28, P715, DOI 10.1016/0021-9290(94)00125-N
   DUNLOP DG, 2000, J BONE JOINT SU B S1, V82, P78
   Eldridge JDJ, 1997, J BONE JOINT SURG BR, V79, P364
   GIE GA, 1993, J BONE JOINT SURG BR, V75, P14
   Giesen EBW, 1999, J BONE JOINT SURG BR, V81B, P1052, DOI 10.1302/0301-620X.81B6.8742
   KANG JD, 1991, J BONE JOINT SURG AM, V73A, P93, DOI 10.2106/00004623-199173010-00012
   KUIPER JH, 1998, T EORS, V8, P60
   MOORE DC, 1987, J ORTHOP RES, V5, P356, DOI 10.1002/jor.1100050307
   OHASHI H, 1999, T ORS
   Schreurs BW, 1998, J BONE JOINT SURG BR, V80B, P391, DOI 10.1302/0301-620X.80B3.8534
   Ullmark G, 1999, J ARTHROPLASTY, V14, P1019, DOI 10.1016/S0883-5403(99)90019-0
   VERDONSCHOT N, 1999, T ORS, V24, P867
   Voor MJ, 2000, J BIOMECH, V33, P1683, DOI 10.1016/S0021-9290(00)00156-1
   Wallace IW, 1997, J BONE JOINT SURG BR, V79, P366
   WEINANS H, 1992, J ORTHOPAED RES, V10, P845, DOI 10.1002/jor.1100100614
NR 15
TC 51
Z9 53
U1 0
U2 3
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD OCT
PY 2001
VL 58
IS 5
BP 599
EP 604
DI 10.1002/jbm.1058
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 472VR
UT WOS:000171006100016
PM 11505435
DA 2018-10-20
ER

PT J
AU Branda, F
   Costantini, A
   Luciani, G
   Ambrosio, L
AF Branda, F
   Costantini, A
   Luciani, G
   Ambrosio, L
TI Improvement of swelling properties of poly(2-hydroxyethyl methacrylate)
   hydrogel by means of biomimetic method
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE poly(2-hydroxyethyl methacrylate); swelling; biomimetic method;
   thermogravimetric analysis
ID HYDROXYAPATITE
AB Poly(2-hydroxyethyl methacrylates) (PHEMAs) structurally modified by means of polymer blends and ran dom copolymers are intensively studied in order to improve mechanical properties. It was recently shown that a hydroxyapatite coating, which should improve the bonding of this biomaterial to the bone, can be obtained by means of the biomimetic method. When PHEMA is submitted to the biomimetic method, its swelling ratio is improved. This can be ascribed to the deposition of a silicatic layer, which improves the hydrophilicity, on the surface of the internal pores during the first stage of the method. This appears to be a valuable result for producing modified PHEMAs with improved mechanical properties and good swelling. The experimental results indicate the following: stronger interactions with the water molecules are set up, an induction period is observed that is linked to the rate of the reactions occurring at the surface of the glass and the establishment of a convenient concentration of the silicate ions at the external surface of the polymer, and the diffusion of simulated body fluid into the pores is the limiting stage of the process. (C) 2001 John Wiley & Sons, Inc.
C1 Univ Naples Federico II, Dipartimento Ingn Mat & Prod, I-80125 Naples, Italy.
   Univ Naples Federico II, Ist Tecnol Mat Compositi, CNR, I-80125 Naples, Italy.
   Univ Naples Federico II, Ctr Interdipartimentale Ric Biomat, I-80125 Naples, Italy.
RP Branda, F (reprint author), Univ Naples Federico II, Dipartimento Ingn Mat & Prod, Piazzale Tecchio 80, I-80125 Naples, Italy.
OI AMBROSIO, LUIGI/0000-0002-8367-2405
CR Branda F, 1999, J MATER SCI, V34, P1319, DOI 10.1023/A:1004550131705
   DAVIS PA, 1991, HIGH PERFORMANCE BIO, P343
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   KOKUBO T, P 16 INT C GLASS MAD, V1, P113
   Kokubo T, 1991, BIOCERAMICS, V4, P113
   NETTI PA, 1993, BIOMATERIALS, V14, P14
   Paul A., 1990, CHEM GLASSES
   Peppas N. A., 1987, HYDROGELS MED PHARM, V1-3
   Rawson H., 1980, PROPERTIES APPL GLAS
   Taguchi T, 1999, J BIOMAT SCI-POLYM E, V10, P19, DOI 10.1163/156856299X00252
   TANAHASHI M, 1995, J MATER SCI-MATER M, V6, P319, DOI 10.1007/BF00120299
   Tanahashi M., 1992, BIOCERAMICS, P57
   WICHTERLE O, 1960, NATURE, V185, P117, DOI 10.1038/185117a0
NR 13
TC 12
Z9 12
U1 0
U2 3
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD OCT
PY 2001
VL 57
IS 1
BP 79
EP 83
DI 10.1002/1097-4636(200110)57:1<79::AID-JBM1144>3.0.CO;2-6
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 452DY
UT WOS:000169842900011
PM 11416852
DA 2018-10-20
ER

PT J
AU Clarke, SA
   Revell, PA
AF Clarke, SA
   Revell, PA
TI Integrin expression at the bone/biomaterial interface
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE integrins; interface; wear debris; aseptic loosening; transmigration
ID CELL-ADHESION MOLECULES; HUMAN ENDOTHELIAL-CELLS; ORTHOPEDIC IMPLANTS;
   RHEUMATOID-ARTHRITIS; ALPHA-V; EXTRACELLULAR-MATRIX; IN-VITRO; RECEPTOR;
   LIGANDS; LAYER
AB The aim of this study was to visualize integrin expression by cells in interface tissue in relation to their ligands. Tissue samples were obtained from 25 patients undergoing revision of aseptically loose total joint replacements. Serial sections were immunolabeled for the integrins alpha (2)beta (1) alpha (v)beta (3), alpha (4)beta (1) alpha (L)beta (2) (CD11a), alpha (M)beta (2) (CD11b), and alpha (x)beta (2) (CD11c), and the ligands fibronectin, laminin, vitronectin, intercellular adhesion molecule-1, and vascular adhesion molecule-1. Most cells were found to express alpha (2)beta (1) most macrophages and giant cells expressed CD11b, and the majority of CD11a was found on perivascular T lymphocytes. From the small amount of alpha (4)beta (1) and vascular adhesion molecule-1 expression in the interface tissue and the combination of CD11a, CD11b, and intercellular adhesion molecule-1 expression, it would seem that macrophages use beta (2) integrins to transmigrate. (C) 2001 John Wiley & Sons, Inc.
C1 Addenbrookes Hosp, Orthopaed Res Unit, Cambridge CB2 2QQ, England.
   UCL Royal Free & Univ Coll Med Sch, Interdisciplinary Res Ctr Biomed Mat, London NW3 2PF, England.
RP Clarke, SA (reprint author), Addenbrookes Hosp, Orthopaed Res Unit, Box 180,Hills Rd, Cambridge CB2 2QQ, England.
EM sac42@cam.ac.uk
CR AlSaffar N, 1996, AM J CLIN PATHOL, V105, P628
   ALSAFFAR N, 1994, J MATER SCI-MATER M, V5, P813, DOI 10.1007/BF00213140
   AlSaffar N, 1997, J MATER SCI-MATER M, V8, P641, DOI 10.1023/A:1018575504518
   ALSAFFAR N, 1995, ANN RHEUM DIS, V54, P201, DOI 10.1136/ard.54.3.201
   ARNAOUT MA, 1990, BLOOD, V75, P1037
   Aspenberg P, 1996, J BONE JOINT SURG BR, V78B, P641
   BARBADILLO C, 1995, SPRINGER SEMIN IMMUN, V16, P427
   BENTON LD, 1993, SURG GYNECOL OBSTET, V177, P311
   BROWN EJ, 1995, BIOESSAYS, V17, P109, DOI 10.1002/bies.950170206
   CARLOS T, 1991, BLOOD, V77, P2266
   CHEN D, 1992, J BIOL CHEM, V267, P23502
   DAVIS GE, 1992, EXP CELL RES, V200, P242, DOI 10.1016/0014-4827(92)90170-D
   ElGabalawy H, 1996, ARTHRITIS RHEUM-US, V39, P1913, DOI 10.1002/art.1780391119
   ELICES MJ, 1995, CIBA F SYMP, V189, P79
   Featherstone C, 1996, LANCET, V347, P1106, DOI 10.1016/S0140-6736(96)90297-4
   HAAS TA, 1994, CURR OPIN CELL BIOL, V6, P656, DOI 10.1016/0955-0674(94)90091-4
   Hammes HP, 1996, NAT MED, V2, P529, DOI 10.1038/nm0596-529
   HEMLER ME, 1990, ANNU REV IMMUNOL, V8, P365, DOI 10.1146/annurev.iy.08.040190.002053
   HENCH L, 1994, BONE BIOMATERIAL INT, P33
   HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661
   HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9
   IWAKI H, 1999, T 45 ANN M ORTH RES
   JASTY M, 1984, T ORTHOP RES SOC, V9, P125
   KIM KJ, 1993, CLIN ORTHOP RELAT R, P142
   Kubota Y, 1996, J DERMATOL SCI, V12, P36, DOI 10.1016/0923-1811(95)00462-9
   LARSON RS, 1990, IMMUNOL REV, V114, P181, DOI 10.1111/j.1600-065X.1990.tb00565.x
   LUSCINSKAS FW, 1994, FASEB J, V8, P929
   MALCHAU H, 1998, 65 AADS M 1998 FEB 1, P595
   Mohanty M, 1996, BIO-MED MATER ENG, V6, P165
   MONDAL K, 1995, BIOCHEM SOC T, V23, P460, DOI 10.1042/bst0230460
   MullerLadner U, 1997, J RHEUMATOL, V24, P1873
   MYONES BL, 1988, J CLIN INVEST, V82, P640, DOI 10.1172/JCI113643
   Newham P, 1996, MOL MED TODAY, V2, P304, DOI 10.1016/1357-4310(96)10021-6
   NIKKARI L, 1995, J RHEUMATOL, V22, P16
   PACIFICI R, 1994, J IMMUNOL, V153, P2222
   Polak JM, 1986, IMMUNOCYTOCHEMISTRY
   POLLOCK LE, 1990, RHEUMATOL INT, V9, P277, DOI 10.1007/BF00541324
   QUINN JMW, 1991, HISTOCHEMISTRY, V96, P169, DOI 10.1007/BF00315989
   Rankin SM, 2000, MOL MED TODAY, V6, P20, DOI 10.1016/S1357-4310(99)01635-4
   REVELL P, 1994, BONE BIOMATERIAL INT, P438
   Revell PA, 1997, P I MECH ENG H, V211, P187, DOI 10.1243/0954411971534304
   REVELL PA, 1995, ANN RHEUM DIS, V54, P404, DOI 10.1136/ard.54.5.404
   REVELL PA, 1995, BIOCERAMICS, V8, P11
   Rinaldi N, 1997, ANN RHEUM DIS, V56, P729, DOI 10.1136/ard.56.12.729
   RUOSLAHTI E, 1991, J CLIN INVEST, V87, P1, DOI 10.1172/JCI114957
   RUOSLAHTI E, 1994, CELL, V77, P477, DOI 10.1016/0092-8674(94)90209-7
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   RYAN US, 1992, CURR OPIN IMMUNOL, V4, P33, DOI 10.1016/0952-7915(92)90120-4
   Samanen J, 1997, CURR PHARM DESIGN, V3, P545
   Sjaastad MD, 1997, BIOESSAYS, V19, P47, DOI 10.1002/bies.950190109
   SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9
   VanderVieren M, 1995, IMMUNITY, V3, P683, DOI 10.1016/1074-7613(95)90058-6
   WEBER C, 1995, BIOCHEM BIOPH RES CO, V206, P621, DOI 10.1006/bbrc.1995.1088
   Xu JW, 1996, CLIN EXP RHEUMATOL, V14, P643
NR 54
TC 13
Z9 13
U1 0
U2 3
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD OCT
PY 2001
VL 57
IS 1
BP 84
EP 91
DI 10.1002/1097-4636(200110)57:1<84::AID-JBM1145>3.0.CO;2-5
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 452DY
UT WOS:000169842900012
PM 11416853
DA 2018-10-20
ER

PT J
AU Gao, TJ
   Uludag, H
AF Gao, TJ
   Uludag, H
TI Effect of molecular weight of thermoreversible polymer on in vivo
   retention of rhBMP-2
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE thermoreversible polymers; recombinant human bone morphogenetic
   protein-2; molecular weight; in vivo retention; gel microstructure
ID RAT ECTOPIC MODEL; N-ISOPROPYLACRYLAMIDE; BIOMATERIAL CARRIERS;
   IN-VITRO; PHARMACOKINETICS; PROTEINS; RELEASE
AB To investigate the effect of polymer molecular weight (MW) on rhBMP-2 delivery by thermoreversible polymers, four polymers with similar lower critical solution temperatures (20 degrees -22 degreesC) but different MWs were studied. Thermoreversible polymers were based on N-isopropyl-acrylamide (NiPAM), ethyl methacrylate (EMA), and N-acryloxvsuccinimide (NASI), and had MWs of either similar to 49 kDa or similar to 400 kDa. The NASI content was either 0 or 1-1.6%. High MW polymers, irrespective of their NASI content, formed a stable gel with significantly lower water uptake and exhibited a dense micelle with average pore size smaller than the low MW polymers. NiPAM/EMA polymers without NASI did not conjugate with recombinant human bone morphogenetic protein-2 (rhBMP-2). NiPAM/EMA polymers containing NASI, however, gave conjugation with rh-BMP-2. For polymers without NASI, a high MW was essential for rhBMP-2 retention when injected intramuscularly in Sprague-Dawley rats. For NASI-containing polymers, the MW of the polymer did not make a significant difference because rhBMP-2 retention was equivalent for different size polymers. We conclude that polymer MW affects rhBMP-2 retention in vivo in polymers designed for physical entrapment of rhBMP-2, but not in polymers designed for chemical conjugation with rhBMP-2. (C) 2001 John Wiley & Sons, Inc.
C1 Univ Alberta, Fac Med, Dept Biomed Engn, Edmonton, AB T6G 2V2, Canada.
RP Gao, TJ (reprint author), Univ Alberta, Fac Med, Dept Biomed Engn, 1098 RTF Bldg, Edmonton, AB T6G 2V2, Canada.
CR Boyne P J, 1997, Int J Periodontics Restorative Dent, V17, P11
   Bromberg LE, 1998, ADV DRUG DELIVER REV, V31, P197, DOI 10.1016/S0169-409X(97)00121-X
   COOK SD, 1994, J BONE JOINT SURG AM, V76A, P827, DOI 10.2106/00004623-199406000-00006
   GAO TJ, IN PRESS BIOMATERIAL
   GAO TJ, 1996, BONE MORPHOGENETIC P, P121
   GAO TJ, IN PRESS MAT SCI ENG
   GRAESSLEY WW, 1986, POLYM SOLUTION, P145
   GUTOWSKA A, 1995, J BIOMED MATER RES, V29, P811, DOI 10.1002/jbm.820290705
   MIRON T, 1982, ANAL BIOCHEM, V126, P433, DOI 10.1016/0003-2697(82)90540-1
   PITT CG, 1995, J CONTROL RELEASE, V33, P397, DOI 10.1016/0168-3659(94)00098-F
   Ramkissoon-Ganorkar C, 1999, PHARMACEUT RES, V16, P819, DOI 10.1023/A:1018813700535
   Riley EH, 1996, CLIN ORTHOP RELAT R, P39, DOI 10.1097/00003086-199603000-00006
   SCHILD HG, 1992, PROG POLYM SCI, V17, P163, DOI 10.1016/0079-6700(92)90023-R
   Shah SS, 1997, J CONTROL RELEASE, V45, P95, DOI 10.1016/S0168-3659(96)01550-7
   Shimizu S, 1996, ARTIF ORGANS, V20, P1232
   Stile RA, 1999, MACROMOLECULES, V32, P7370, DOI 10.1021/ma990130w
   Uludag H, 2000, J BIOMED MATER RES, V50, P227, DOI 10.1002/(SICI)1097-4636(200005)50:2<227::AID-JBM18>3.0.CO;2-2
   Uludag H, 2000, J APPL POLYM SCI, V75, P583, DOI 10.1002/(SICI)1097-4628(20000124)75:4<583::AID-APP15>3.0.CO;2-L
   Uludag H, 1999, J BIOMED MATER RES, V46, P193, DOI 10.1002/(SICI)1097-4636(199908)46:2<193::AID-JBM8>3.0.CO;2-1
   ULUDAG H, IN PRESS BIOTECHNOL
   ULUDAG H, 2000, DRUG DELIVERY 21ST C, P253
   Wen J, 1996, ANAL BIOCHEM, V240, P155, DOI 10.1006/abio.1996.0345
   Winn SR, 1998, ADV DRUG DELIVER REV, V31, P303, DOI 10.1016/S0169-409X(97)00126-9
   WOZNEY J, 1988, SCIENCE, V241, P1528
NR 24
TC 21
Z9 22
U1 0
U2 6
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD OCT
PY 2001
VL 57
IS 1
BP 92
EP 100
DI 10.1002/1097-4636(200110)57:1<92::AID-JBM1146>3.0.CO;2-1
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 452DY
UT WOS:000169842900013
PM 11416854
DA 2018-10-20
ER

PT J
AU Schierholz, JM
   Beuth, J
AF Schierholz, JM
   Beuth, J
TI Implant infections: a haven for opportunistic bacteria
SO JOURNAL OF HOSPITAL INFECTION
LA English
DT Review
DE implant infection; prevention; drug-delivery system; host defence
   mechanism
ID CENTRAL VENOUS CATHETER; FOREIGN-BODY INFECTION;
   STAPHYLOCOCCUS-EPIDERMIDIS; BIOMATERIAL INFECTION; NOSOCOMIAL
   INFECTIONS; ANTIBIOTICS; SURFACES; GROWTH; PATHOGENESIS; ADHESION
AB The insertion of implants and medical devices has emerged as a common and often life-saving procedure. A current estimate of the rate of total hip replacement in the world is approximately one million a year, and knee replacements more than 250 000. More than 30% of hospitalized patients have one or more vascular catheters in place. More than 10% of hospitalized patients have an indwelling urinary catheter. Some patients require multiple joint replacements. In the United States, approximately 2 million nosocomial infections cost nearly $11 billion annually. Exposure to invasive medical devices is one of the most important risk factors.' Devices predispose to infection by damaging or invading epithelial or mucosal barriers and by supporting growth of micro-organisms, thus serving as reservoirs. Invasive medical devices impair host defence mechanisms and, when contaminated, can result in resistant chronic infection or tissue necrosis, the major objections to extended use of implant devices. Implant devices today account for approximately 45% of all nosocomial infections.(2) Implant infections are extremely resistant to antibiotics and host defences and frequently persist until the implant is removed, which is the standard therapy. Tissue damage caused by surgery and foreign body implantation further increases the susceptibility to infections, activates host defences and stimulates the generation of inflammatory mediators; these are enhanced by bacterial activity and toxins.(3) The ability of bacteria such as Staphylococcus epidermidis, which are otherwise virtually avirulent, to escape from host defences and antibiotic therapy, has led to the development of alternative methods of control such as infection-resistant materials acting as antimicrobial drug-delivery systems. By these methods, there is a sustained delivery of antimicrobial drugs into the local micro-environment of implants, which avoids systemic side-effects and exceeds usual systemic concentrations by several orders of magnitude. Bioengineering of hybrid implant materials in order to achieve optimal performance and to prevent inflammatory reactions and interface cellular disorganization is a field undergoing rapid development. Biomimetic hybrid materials that slowly deliver antimicrobial drugs may reduce implant infections in the future. (C) 2001 The Hospital Infection Society.
C1 Caesar Ctr Adv European Studies & Res, D-53111 Bonn, Germany.
   Univ Cologne, Inst Sci Evaluat Naturopathy, D-50931 Cologne, Germany.
RP Schierholz, JM (reprint author), Caesar Ctr Adv European Studies & Res, Friedenspl 16, D-53111 Bonn, Germany.
CR AHN SS, 1994, J VASC SURG, V20, P202, DOI 10.1016/0741-5214(94)90007-8
   BAIER RE, 1984, J BIOMED MATER RES, V18, P337, DOI 10.1002/jbm.820180404
   BAIER RE, 1982, J BIOMECH ENG-T ASME, V104, P257, DOI 10.1115/1.3138358
   BAMBERGER DM, 1990, J INFECT DIS, V162, P186, DOI 10.1093/infdis/162.1.186
   BERGAMINI TM, 1995, ARCH SURG-CHICAGO, V130, P1345
   BERGAMINI TM, 1988, J VASC SURG, V7, P21, DOI 10.1067/mva.1988.avs0070021
   Bouhadir KH, 1998, ANN NY ACAD SCI, V842, P188, DOI 10.1111/j.1749-6632.1998.tb09647.x
   CHRISTENSEN GD, 1990, J INFECT DIS, V161, P1153, DOI 10.1093/infdis/161.6.1153
   COOPER M, 1995, LIFE DEATH BIOFILM, P93
   Craven D E, 1996, Semin Respir Infect, V11, P32
   Eiselt P, 1998, BIOTECHNOL PROGR, V14, P134, DOI 10.1021/bp970135h
   Feldman C, 1999, EUR RESPIR J, V13, P546, DOI 10.1183/09031936.99.13354699
   Fridkin SK, 1996, INFECT CONT HOSP EP, V17, P150
   GARRISON JR, SOC U SURG 1995 37 A
   GOMER R, 1982, SCI AM, V247, P98, DOI 10.1038/scientificamerican0882-98
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   GRISTINA AG, 1994, CLIN ORTHOP RELAT R, P106
   Haxhe JJ, 1998, J HOSP INFECT, V40, P166, DOI 10.1016/S0195-6701(98)90101-3
   Henke PK, 1997, J SURG RES, V69, P372, DOI 10.1006/jsre.1997.5088
   Henke PK, 1998, J SURG RES, V74, P17, DOI 10.1006/jsre.1997.5210
   Henke PK, 1997, ARCH SURG-CHICAGO, V132, P894
   Jarvis WR, 1996, INFECT CONT HOSP EP, V17, P552
   JOHNSON GM, 1986, INFECT IMMUN, V54, P13
   Kaplan S S, 1990, ASAIO Trans, V36, pM172
   KASCHKE O, 1995, HNO, V43, P80
   KLOCK JC, 1976, BLOOD, V48, P149
   Livermore D M, 1990, Scand J Infect Dis Suppl, V74, P15
   Loh J H, 1999, Med Device Technol, V10, P24
   MODUN B, 1992, INFECT IMMUN, V60, P2551
   Myrvik Q N, 1989, J Invest Surg, V2, P381, DOI 10.3109/08941938909018263
   NELSON CL, 1979, ARCH SURG-CHICAGO, V114, P778
   NOBLE MA, 1990, J INFECT DIS, V162, P909, DOI 10.1093/infdis/162.4.909
   NOONAN JR, 1986, SCIENCE, V234, P310, DOI 10.1126/science.234.4774.310
   OAKES JA, 1986, N ENGL J, V315, P1129
   RAAD I, 1997, ANN INTERN MED, V15, P1
   Sapatnekar S, 1997, J BIOMED MATER RES, V35, P409, DOI 10.1002/(SICI)1097-4636(19970615)35:4<409::AID-JBM1>3.0.CO;2-L
   Schierholz JM, 1999, J ANTIMICROB CHEMOTH, V43, P158, DOI 10.1093/jac/43.1.158
   Schierholz JM, 1998, ANTICANCER RES, V18, P3629
   Schierholz JM, 2000, J ANTIMICROB CHEMOTH, V46, P45, DOI 10.1093/jac/46.1.45
   Schierholz JM, 1997, BIOMATERIALS, V18, P839, DOI 10.1016/S0142-9612(96)00199-8
   SHANBHAG A, 1992, J BIOMED MATER RES, V26, P185, DOI 10.1002/jbm.820260205
   SIPEHIA R, 1993, BIOMAT ARTIF CELL IM, V21, P455, DOI 10.3109/10731199309117651
   STAMM WE, 1978, ANN INTERN MED, V89, P764, DOI 10.7326/0003-4819-89-5-764
   TANG LP, 1995, AM J CLIN PATHOL, V103, P466
   WAGMAN GH, 1975, J ANTIMICROBIAL AGEN, V7, P316
   ZIMMERLI W, 1984, J CLIN INVEST, V73, P1191, DOI 10.1172/JCI111305
   ZIMMERLI W, 1982, J INFECT DIS, V146, P487, DOI 10.1093/infdis/146.4.487
NR 47
TC 234
Z9 248
U1 6
U2 78
PU W B SAUNDERS CO LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0195-6701
J9 J HOSP INFECT
JI J. Hosp. Infect.
PD OCT
PY 2001
VL 49
IS 2
BP 87
EP 93
DI 10.1053/jhin.2001.1052
PG 7
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA 481TF
UT WOS:000171535600001
PM 11567552
DA 2018-10-20
ER

PT J
AU Jandt, KD
AF Jandt, KD
TI Atomic force microscopy of biomaterials surfaces and interfaces
SO SURFACE SCIENCE
LA English
DT Article; Proceedings Paper
CT 2nd Internatinal Conference on Scanning Probe Microscopy in Biomaterials
   Science
CY JUN   23, 2000
CL BRISTOL, ENGLAND
DE surface structure, morphology, roughness. and topography; biological
   molecules - proteins; titanium; etching; surface chemical reaction;
   physical adsorption; solid-liquid interfaces
ID SCANNING PROBE MICROSCOPY; SELF-ASSEMBLED MONOLAYERS;
   VON-WILLEBRAND-FACTOR; AQUEOUS CONDITIONS; HUMAN DENTIN; IN-SITU;
   NANOMECHANICAL PROPERTIES; 3-DIMENSIONAL STRUCTURE; COLLAGEN
   CONFORMATION; MOLECULAR COMPOSITION
AB The use of atomic force microscopy (AFM) in biomaterials science and engineering applications has increased rapidly over the last few years. Beyond being merely a tool for measuring surface topography, AFM has made significant contributions to various biomaterials research areas dealing with the structure, properties, dynamics and manipulation of biomaterials surfaces and interfaces. This paper critically reviews methodological approaches and presents aspects of this research. Selected examples presented include micro and nanostructure and properties of biomaterials surfaces, molecular level interactions at biomaterial-biomolecule interfaces, interfaces between biomaterials and mineralised tissues as well as advances of mineralised tissue research. In these areas, AFM is shown to be a useful and versatile tool to study micro and nanostructure, to probe mechanical properties or to investigate dynamic process at biomaterials surfaces and interfaces. (C) 2001 Elsevier Science B.V. All rights reserved.
C1 Univ Bristol, Biomed Engn & Biomat Sci Sect, Dept Oral & Dent Sci, Bristol BS1 2LY, Avon, England.
RP Jandt, KD (reprint author), Univ Bristol, Biomed Engn & Biomat Sci Sect, Dept Oral & Dent Sci, Lower Maudling St, Bristol BS1 2LY, Avon, England.
RI Jandt, Klaus/C-8077-2016
OI Jandt, Klaus/0000-0002-7537-5603
CR ALBRECHT TR, 1990, J VAC SCI TECHNOL A, V8, P3386, DOI 10.1116/1.576520
   Balooch M, 1998, J BIOMED MATER RES, V40, P539, DOI 10.1002/(SICI)1097-4636(19980615)40:4<539::AID-JBM4>3.3.CO;2-O
   Baretzky B, 1996, Z METALLKD, V87, P332
   BASELT DR, 1994, J APPL PHYS, V76, P33, DOI 10.1063/1.357150
   BHUSHAN B, 1994, APPL PHYS LETT, V64, P1653, DOI 10.1063/1.111949
   Bhushan B, 1996, PHILOS MAG A, V74, P1117, DOI 10.1080/01418619608239712
   BINNIG G, 1986, IBM J RES DEV, V30, P355
   BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930
   BINNIG G, 1986, REV SCI INSTRUM, V57, P1688, DOI 10.1063/1.1139196
   BOLAND T, 1995, P NATL ACAD SCI USA, V92, P5297, DOI 10.1073/pnas.92.12.5297
   Bonnell D., 2000, SCANNING PROBE MICRO
   Braem MJA, 1997, J DENT RES, V76, P493
   Browne M, 1996, J MATER SCI-MATER M, V7, P323, DOI 10.1007/BF00154543
   BURNHAM NA, 1989, J VAC SCI TECHNOL A, V7, P2906, DOI 10.1116/1.576168
   BUSHAN B, 1998, HDB MICRONANOTRIBOLO
   Cacciafesta P, 2001, SURF SCI, V491, P405, DOI 10.1016/S0039-6028(01)01303-6
   Cacciafesta P, 2000, LANGMUIR, V16, P8167, DOI 10.1021/la000362k
   CASSINELLI C, 1994, J MATER SCI-MATER M, V5, P606, DOI 10.1007/BF00120339
   CASSINELLI C, 1994, J BIOMED MATER RES, V28, P1427, DOI 10.1002/jbm.820281207
   Chen C. J., 1993, INTRO SCANNING TUNNE
   Chen X, 1998, MACROMOLECULES, V31, P2278, DOI 10.1021/ma9704525
   CLEVELAND JP, 1993, REV SCI INSTRUM, V64, P403, DOI 10.1063/1.1144209
   Colton RJ, 1997, CURR OPIN CHEM BIOL, V1, P370, DOI 10.1016/S1367-5931(97)80076-2
   Corneillie S, 1998, POLYM INT, V46, P251, DOI 10.1002/(SICI)1097-0126(199807)46:3<251::AID-PI6>3.0.CO;2-Z
   Costa KD, 1999, J BIOMECH ENG-T ASME, V121, P462, DOI 10.1115/1.2835074
   Denhardt D T, 1998, J Cell Biochem Suppl, V30-31, P92
   DeRose JA, 1998, THIN SOLID FILMS, V331, P194, DOI 10.1016/S0040-6090(98)00919-5
   *DIG INSTR, 1996, MULT SCANN PROB MICR
   *DIG INSTR, 1997, NAN HARDN TEST NAN S
   *DIG INSTR, 1995, PHAS IM BEYOND TOP D
   Disley DM, 1998, BIOSENS BIOELECTRON, V13, P1213, DOI 10.1016/S0956-5663(98)00059-1
   DRAKE B, 1989, SCIENCE, V243, P1586, DOI 10.1126/science.2928794
   Eckert R, 1997, CELL BIOL INT, V21, P707, DOI 10.1006/cbir.1997.0215
   Eick JD, 1997, CRIT REV ORAL BIOL M, V8, P306, DOI 10.1177/10454411970080030501
   El Feninat F, 1998, J BIOMED MATER RES, V42, P549, DOI 10.1002/(SICI)1097-4636(19981215)42:4<549::AID-JBM10>3.0.CO;2-L
   Eliades G, 1997, DENT MATER, V13, P24, DOI 10.1016/S0109-5641(97)80005-X
   Eliades G, 1999, DENT MATER, V15, P310, DOI 10.1016/S0109-5641(99)00050-0
   EMCH R, 1992, ULTRAMICROSCOPY, V42, P1155, DOI 10.1016/0304-3991(92)90417-I
   Engel A, 1997, J STRUCT BIOL, V119, P83, DOI 10.1006/jsbi.1997.3894
   Farina M, 1999, J STRUCT BIOL, V125, P39, DOI 10.1006/jsbi.1998.4069
   Finke M, 2000, J COLLOID INTERF SCI, V232, P156, DOI 10.1006/jcis.2000.7200
   Finke M, 2001, SURF SCI, V491, P456, DOI 10.1016/S0039-6028(01)01311-5
   FINKE M, 2000, J DENT RES, V79, P3687
   FLORIN EL, 1994, SCIENCE, V264, P415, DOI 10.1126/science.8153628
   Fong H, 2000, MAT SCI ENG C-BIO S, V7, P119, DOI 10.1016/S0928-4931(99)00133-2
   FRISBIE CD, 1994, SCIENCE, V265, P2071, DOI 10.1126/science.265.5181.2071
   FRITZ M, 1995, P SOC PHOTO-OPT INS, V2384, P150, DOI 10.1117/12.205923
   FRITZ M, 1995, LANGMUIR, V11, P3529, DOI 10.1021/la00009a040
   Garrison MD, 2000, ULTRAMICROSCOPY, V82, P193, DOI 10.1016/S0304-3991(99)00150-3
   Giancarlo LC, 1998, ANNU REV PHYS CHEM, V49, P297, DOI 10.1146/annurev.physchem.49.1.297
   GIRARD C, 1989, PHYS REV B, V40, P12133, DOI 10.1103/PhysRevB.40.12133
   GRUTTER P, 1992, ULTRAMICROSCOPY, V47, P393, DOI 10.1016/0304-3991(92)90170-O
   Hans D, 1993, Eur J Med, V2, P157
   Harada Y, 2000, LANGMUIR, V16, P708, DOI 10.1021/la990236k
   HEGNER M, 1993, SURF SCI, V291, P39, DOI 10.1016/0039-6028(93)91474-4
   HEINZELMANN H, 1990, NATO ASI SER, V184, P449
   Hemmerle J, 1999, P NATL ACAD SCI USA, V96, P6705, DOI 10.1073/pnas.96.12.6705
   HLADY V, 1998, BIOPOLYMERS INTERFAC, P181
   Holland NB, 2000, J BIOMED MATER RES, V51, P307, DOI 10.1002/1097-4636(20000905)51:3<307::AID-JBM3>3.0.CO;2-H
   Holland NB, 1998, NATURE, V392, P799
   Horbett TA, 1993, CARDIOVASC PATHOL, V2, P137, DOI DOI 10.1016/1054-8807(93)90054-6)
   HORBETT TA, 1996, BIOMATERIALS SCI INT, pCH3
   HORBETT TA, 1982, ADV CHEM SER, V199, P233
   Hosoi H, 2000, APPL SURF SCI, V157, P218, DOI 10.1016/S0169-4332(99)00529-2
   Hostetler MJ, 1997, CURR OPIN COLLOID IN, V2, P42, DOI 10.1016/S1359-0294(97)80007-6
   HUES SM, 1994, J VAC SCI TECHNOL B, V12, P2211, DOI 10.1116/1.587743
   HUES SM, 1994, REV SCI ISNTR, V65
   Humphris ADL, 2000, LANGMUIR, V16, P7891, DOI 10.1021/la000766c
   HUTTER JL, 1993, REV SCI INSTRUM, V64, P1868, DOI 10.1063/1.1143970
   ISHIDA H, 1985, MOL CHARACTERIZATION, P25
   ISRAELACHVILI J, 1991, INTERMOLECULAR SURFA, pCH16
   Jandt KD, 1996, ADV MATER, V8, P660, DOI 10.1002/adma.19960080813
   JANDT KD, 1994, POLYMER, V35, P2458, DOI 10.1016/0032-3861(94)90789-7
   Jandt KD, 2000, COLLOID SURFACE B, V19, P301, DOI 10.1016/S0927-7765(00)00139-9
   JANDT KD, 1993, MACROMOLECULES, V26, P6552, DOI 10.1021/ma00076a037
   JANDT KD, 1999, PROBE MICROSCOPY, V1, P323
   JANDT KD, 1989, MAT SCI ENG, V21
   Johannson O. K., 1967, J COMPOS MATER, V1, P278
   KAAS S, 1997, INT J IMAG SYST TECH, V8, P151
   Kanno T, 2000, JPN J APPL PHYS 2, V39, pL269, DOI 10.1143/JJAP.39.L269
   KASAS S, 1993, P SOC PHOTO-OPT INS, V1855, P17, DOI 10.1117/12.146381
   KIKUKAWA A, 1995, REV SCI INSTRUM, V66, P101, DOI 10.1063/1.1145274
   Kilpadi DV, 1998, COLLOID SURFACE A, V135, P89, DOI 10.1016/S0927-7757(97)00237-9
   Kinney JH, 1996, J BIOMECH ENG-T ASME, V118, P133, DOI 10.1115/1.2795939
   Kirkham J, 1997, J DENT RES, V76, P1029
   KIRKHAM J, 1998, CONNECT TISSUE RES, V39, P91
   Klinov DV, 1998, NUCLEIC ACIDS RES, V26, P4603, DOI 10.1093/nar/26.20.4603
   KULKARNI AV, 1996, THIN SOLID FILMS, V291, P206
   LACHMANN PJ, 1985, COMPLEMENT, P147
   LATOUR RA, 1999, HDB BIOMATERIALS EVA, pCH3
   Li HB, 2000, MACROMOLECULES, V33, P465, DOI 10.1021/ma990878e
   Liu L, 2000, PHYS REV LETT, V84, P4950, DOI 10.1103/PhysRevLett.84.4950
   LYUBCHENKO Y, 1993, P NATL ACAD SCI USA, V90, P2137, DOI 10.1073/pnas.90.6.2137
   MacDonald DE, 1998, J BIOMED MATER RES, V41, P120
   MAIWALD P, 1991, NANOTECHNOLOGY, V2, P103
   Marchant RE, 1997, THROMB HAEMOSTASIS, V77, P1048
   MARSHALL GW, 1993, DENT MATER, V9, P265, DOI 10.1016/0109-5641(93)90072-X
   Marshall GW, 1997, DENT MATER, V13, P338, DOI 10.1016/S0109-5641(97)80104-2
   MARSHALL GW, 1995, J BIOMED MATER RES, V29, P1381, DOI 10.1002/jbm.820291109
   Marshall GW, 1999, AM J DENT, V12, P271
   Martin FE, 1996, J DENT RES, V75, P2197
   MARTIN Y, 1987, J APPL PHYS, V61, P4723, DOI 10.1063/1.338807
   MATE CM, 1987, PHYS REV LETT, V59, P1942, DOI 10.1103/PhysRevLett.59.1942
   MCKNEE MD, 1996, CONNECT TISSUE RES, V35, P197
   MECHOLSKY JJ, 1995, DENT MATER, V11, P113, DOI 10.1016/0109-5641(95)80045-X
   MEYER D, 1993, THROMB HAEMOSTASIS, V70, P99
   MOKOTOFF GF, 1990, ELECT MICROSCOPY LAB
   Oberhauser AF, 1999, NAT STRUCT BIOL, V6, P1025
   Ohnesorge FM, 1999, SURF INTERFACE ANAL, V27, P379, DOI 10.1002/(SICI)1096-9918(199905/06)27:5/6<379::AID-SIA506>3.0.CO;2-D
   OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564
   Orisaka S, 1999, APPL SURF SCI, V140, P243, DOI 10.1016/S0169-4332(98)00534-0
   Ortega-Vinuesa JL, 1998, J COLLOID INTERF SCI, V207, P228, DOI 10.1006/jcis.1998.5624
   Parbhu AN, 1999, BIOCHEMISTRY-US, V38, P11755, DOI 10.1021/bi990746d
   PARKER DM, 1998, J DENT RES, V77, P1708
   Perdigao J, 1999, AM J DENT, V12, P250
   Phrukkanon S, 2000, DENT MATER, V16, P255, DOI 10.1016/S0109-5641(00)00015-4
   Placko HE, 2000, INT J ORAL MAX IMPL, V15, P355
   Porte-Durrieu MC, 2000, J BIOMED MATER RES, V52, P119, DOI 10.1002/1097-4636(200010)52:1<119::AID-JBM15>3.0.CO;2-Q
   QUATE CF, 1994, SURF SCI, V300, P980
   QUIST AP, 1995, SURF SCI, V325, pL406, DOI 10.1016/0039-6028(94)00809-4
   RADMACHER M, 1994, LANGMUIR, V10, P3809, DOI 10.1021/la00022a068
   Raghavachari M, 2000, THROMB RES, V98, P351, DOI 10.1016/S0049-3848(00)00185-7
   Raghavan D, 2000, MACROMOLECULES, V33, P2573, DOI 10.1021/ma991206r
   RASMUSSON JR, 1994, SCANNING MICROSCOPY, V8, P481
   RATNER BD, 1996, BIOMATERIALS SCI, P445
   Resch R, 2000, ULTRAMICROSCOPY, V82, P135, DOI 10.1016/S0304-3991(99)00152-7
   Rief M, 1999, NAT STRUCT BIOL, V6, P346
   Rosales JI, 1999, J DENT RES, V78, P1554, DOI 10.1177/00220345990780091001
   RUGAR D, 1994, SCIENCE, V264, P1560, DOI 10.1126/science.264.5165.1560
   SADER JE, 1995, REV SCI INSTRUM, V66, P3789, DOI 10.1063/1.1145439
   SARID D, 1991, J VAC SCI TECHNOL B, V9, P431, DOI 10.1116/1.585585
   SAWYERS LC, 1996, POLYM MICROSCOPY
   SCHAAD P, 1993, SCANNING MICROSCOPY, V7, P1149
   SENDEN TJ, 1994, LANGMUIR, V10, P1003, DOI 10.1021/la00016a600
   SHAKESHEFF KM, 1995, LANGMUIR, V11, P2447
   Shi HQ, 1999, NATURE, V398, P593
   Siedlecki CA, 1996, BLOOD, V88, P2939
   Silikas N, 1999, J DENT, V27, P137, DOI 10.1016/S0300-5712(98)00032-3
   Sit PS, 1999, THROMB HAEMOSTASIS, V82, P1053
   *SOC BIOM US, 2000, 6 WORLD BIOM C 15 20, V1
   SODERHOLM KJM, 1993, J DENT RES, V72, P1050, DOI 10.1177/00220345930720061001
   SOLLBOHMER O, 1995, THIN SOLID FILMS, V264, P176, DOI 10.1016/0040-6090(95)05847-8
   Ta TC, 1998, LANGMUIR, V14, P2435, DOI 10.1021/la9712348
   Taborelli M, 1997, CLIN ORAL IMPLAN RES, V8, P208, DOI 10.1034/j.1600-0501.1997.080307.x
   UHLMAN A, 1998, THIN FILMS SELF ASSE, V24
   VONRECUM AF, 1999, HDB BIOMATERIALS EVA, pCH13
   WAGNER P, 1995, LANGMUIR, V11, P3867, DOI 10.1021/la00010a043
   WAGNER P, 1994, FEBS LETT, V356, P267, DOI 10.1016/0014-5793(94)01296-2
   Walivaara B, 1997, J COLLOID INTERF SCI, V187, P121, DOI 10.1006/jcis.1996.4673
   Watari F, 1999, J ELECTRON MICROSC, V48, P537, DOI 10.1093/oxfordjournals.jmicro.a023713
   WEISENHORN AL, 1991, LANGMUIR, V7, P8, DOI 10.1021/la00049a003
   WEISS HJ, 1989, J CLIN INVEST, V83, P288, DOI 10.1172/JCI113871
   West NX, 2000, TOOTH WEAR SENSITIVI, P105
   WICKRAMASINGHE HK, 1992, AIP CONF PROC, V241, P9
   Wiesendanger R, 1995, SCANNING PROBE MICRO
   WIGREN R, 1991, FEBS LETT, V280, P225, DOI 10.1016/0014-5793(91)80298-H
   Williams D., 1990, CONCISE ENCY MED DEN
   Yang YZ, 2000, J BIOMED MATER RES, V52, P333, DOI 10.1002/1097-4636(200011)52:2<333::AID-JBM12>3.3.CO;2-K
   Yoshida Y, 1999, J BIOMED MATER RES, V47, P85, DOI 10.1002/(SICI)1097-4636(199910)47:1<85::AID-JBM12>3.0.CO;2-H
   YU J, 1994, BIOMATERIALS, V15, P805, DOI 10.1016/0142-9612(94)90035-3
   ZENHAUSERN F, 1993, J ELECTRON MICROSC, V42, P378
   Zhang WK, 2000, LANGMUIR, V16, P4305, DOI 10.1021/la991230y
   Zhong Q, 1993, SURF SCI LETT, V290, P688
NR 163
TC 150
Z9 152
U1 2
U2 64
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0039-6028
J9 SURF SCI
JI Surf. Sci.
PD OCT 1
PY 2001
VL 491
IS 3
BP 303
EP 332
DI 10.1016/S0039-6028(01)01296-1
PG 30
WC Chemistry, Physical; Physics, Condensed Matter
SC Chemistry; Physics
GA 482DQ
UT WOS:000171559900002
DA 2018-10-20
ER

PT J
AU Fischbach, C
   Tessmar, J
   Lucke, A
   Schnell, E
   Schmeer, G
   Blunk, T
   Gopferich, A
AF Fischbach, C
   Tessmar, J
   Lucke, A
   Schnell, E
   Schmeer, G
   Blunk, T
   Gopferich, A
TI Does UV irradiation affect polymer properties relevant to tissue
   engineering?
SO SURFACE SCIENCE
LA English
DT Article; Proceedings Paper
CT 2nd Internatinal Conference on Scanning Probe Microscopy in Biomaterials
   Science
CY JUN   23, 2000
CL BRISTOL, ENGLAND
DE photoelectron spectroscopy; atomic force microscopy; surface structure,
   morphology, roughness, and topography; biological molecules - proteins;
   adhesion
ID CELL-ADHESION; BIOMATERIALS; SURFACES; PEG; DEGRADATION; MIGRATION;
   OXIDE
AB For most tissue engineering approaches aiming at the repair or generation of living tissues the interaction of cells and polymeric biomaterials is of paramount importance. Prior to contact with cells or tissues, biomaterials have to be sterilized. However, many sterilization procedures such as steam autoclave or heat sterilization are known to strongly affect polymer properties. UV irradiation is used as an alternative sterilization method in many tissue engineering laboratories on a routine basis, however, potential alterations of polymer properties have not been extensively considered,
   In this study we investigated the effects of UV irradiation on spin-cast films made from biodegradable poly(D,L-lactic acid)-poly(ethylene glycol)-monomethyl ether diblock copolymers (Me.PEG-PLA) which have recently been developed for controlled cell-biomaterial interaction. After 2 h of UV irradiation, which is sufficient for sterilization, no alterations in cell adhesion to polymer films were detected, as demonstrated with 3T3-L1 preadipocytes. This correlated with unchanged film topography and molecular weight distribution. However, extended UV irradiation for 5-24 h elicited drastic responses regarding Me.PEG-PLA polymer properties and interactions with biological elements: Large increases in unspecific protein adsorption and subsequent cell adhesion were observed, Changes in polymer surface properties could be correlated with the observed alterations in cell/protein-polymer interactions. Atomic force microscopy analysis of polymer films revealed a marked "smoothing" of the polymer surface after UV irradiation. Investigations using GPC, H-1-NMR, mass spectrometry, and a PEG-specific colorimetric assay demonstrated that polymer film composition was time-dependently affected by exposure to UV irradiation, i.e., that large amounts of PEG were lost from the copolymer surface.
   The data indicate that sterilization using UV irradiation for 2 h is an appropriate technique for the recently synthesized Me.PEG-PLA diblock copolymers. However, the study also serves as an example that it is indispensable to control the duration of exposure to UV irradiation for a given biomaterial in order not to compromise polymer properties relevant to tissue engineering purposes. (C) 2001 Elsevier Science B.V. All rights reserved.
C1 Univ Regensburg, Dept Pharmaceut Technol, D-93040 Regensburg, Germany.
   Univ Regensburg, Dept Phys & Theoret Chem, D-93040 Regensburg, Germany.
RP Gopferich, A (reprint author), Univ Regensburg, Dept Pharmaceut Technol, D-93040 Regensburg, Germany.
RI Tessmar, Joerg/H-3606-2012; Fischbach, Claudia/C-8550-2009
OI Tessmar, Joerg/0000-0001-7057-5369; Fischbach,
   Claudia/0000-0002-9368-0150
CR ABSHIRE RL, 1981, APPL ENVIRON MICROB, V41, P1419
   BALEUX B, 1972, CR ACAD SCI C CHIM, V274, P1617
   Bittner B, 1999, J CONTROL RELEASE, V59, P23, DOI 10.1016/S0168-3659(98)00170-9
   BOUSQUET J, 1991, CLIN REV ALLERG, V9, P357
   CIMA LG, 1994, J CELL BIOCHEM, V56, P155, DOI 10.1002/jcb.240560206
   Fu K, 2000, NAT BIOTECHNOL, V18, P24, DOI 10.1038/71875
   Gopferich A, 1996, BIOMATERIALS, V17, P103, DOI 10.1016/0142-9612(96)85755-3
   Gopferich A, 1999, J BIOMED MATER RES, V46, P390
   Gref R, 2000, COLLOID SURFACE B, V18, P301, DOI 10.1016/S0927-7765(99)00156-3
   Holy CE, 2001, BIOMATERIALS, V22, P25, DOI 10.1016/S0142-9612(00)00136-8
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P149, DOI 10.1016/0021-9797(91)90043-8
   Kim BS, 1999, EXP CELL RES, V251, P318, DOI 10.1006/excr.1999.4595
   Lampin M, 1997, J BIOMED MATER RES, V36, P99, DOI 10.1002/(SICI)1097-4636(199707)36:1<99::AID-JBM12>3.0.CO;2-E
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lucke A, 2000, BIOMATERIALS, V21, P2361, DOI 10.1016/S0142-9612(00)00103-4
   MCKELLAR JF, 1979, PHOTOCHEMISTRY MAN M
   Praschak D, 1998, APPL PHYS A-MATER, V66, P69, DOI 10.1007/s003390050639
   Schwendeman S.P., 1996, MICROPARTICULATE SYS, P1
   Staiger H, 1998, EUR J CELL BIOL, V77, P220, DOI 10.1016/S0171-9335(98)80110-6
   TESSMAR J, 2000, 6 WORLD BIOM C T, P595
   Tziampazis E, 2000, BIOMATERIALS, V21, P511, DOI 10.1016/S0142-9612(99)00212-4
   *UV TECHN SPEZ GMB, 1999, DES UV STRAHL STRAHL
   Zhang MQ, 1998, BIOMATERIALS, V19, P953, DOI 10.1016/S0142-9612(98)00026-X
NR 24
TC 55
Z9 57
U1 4
U2 24
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0039-6028
J9 SURF SCI
JI Surf. Sci.
PD OCT 1
PY 2001
VL 491
IS 3
BP 333
EP 345
DI 10.1016/S0039-6028(01)01297-3
PG 13
WC Chemistry, Physical; Physics, Condensed Matter
SC Chemistry; Physics
GA 482DQ
UT WOS:000171559900003
DA 2018-10-20
ER

PT J
AU Cacciafesta, P
   Hallam, KR
   Watkinson, AC
   Allen, GC
   Miles, MJ
   Jandt, KD
AF Cacciafesta, P
   Hallam, KR
   Watkinson, AC
   Allen, GC
   Miles, MJ
   Jandt, KD
TI Visualisation of human plasma fibrinogen adsorbed on titanium implant
   surfaces with different roughness
SO SURFACE SCIENCE
LA English
DT Article; Proceedings Paper
CT 2nd Internatinal Conference on Scanning Probe Microscopy in Biomaterials
   Science
CY JUN   23, 2000
CL BRISTOL, ENGLAND
DE atomic force microscopy; X-ray photoelectron spectroscopy; secondary ion
   mass spectroscopy; physical adsorption; surface structure, morphology,
   roughness, and topography; titanium; titanium oxide; biological
   molecules - proteins
ID ATOMIC-FORCE MICROSCOPY; DIFFERENT OXIDE THICKNESSES; ELECTROPOLISHED
   IMPLANTS; BONE RESPONSE; BIOLOGICAL PROPERTIES; ENERGY-DISSIPATION;
   PROTEIN ADSORPTION; TISSUE-RESPONSE; PHASE-CONTRAST; ORAL IMPLANTS
AB Direct visualisation of adsorbed human plasma proteins on biomaterial surfaces may help the understanding of the performance of implants, The aim of this study was the visualisation of human plasma fibrinogen (HPF) adsorbed on different titanium implants with characterised surface properties. Seven types of titanium samples were used: mechanically polished (P); mechanically ground (G); sand blasted with alumina (B); sand blasted with alumina and etched in HF/HNO3 (BN); sand blasted with alumina and etched in HCl/H2SO4 (SLA); mechanically polished and etched in HCl/H2SO4 (PSLA); and plasma sprayed (TPS). The surface morphology and roughness of these surfaces were analysed by atomic force microscopy (AFM), The surface chemical composition of the implants was analysed by X-ray photoelectron spectroscopy (XPS) and time of flight secondary ion mass spectrometry (ToF-SIMS). The seven processing methods influenced the roughness and produced distinct morphologies of the implant surfaces, The main chemical constituent of all surfaces was TiO2, with some samples showing the presence of other elements. HPF adsorbed on the titanium surfaces was visualised by AFM phase imaging. Visualisation of the adsorbed HPF was successfully achieved on samples P and G, but not on the other five samples. Differences in the dimensions and in the phase contrast of HPF molecules adsorbed on P and G surfaces were observed and discussed. No correlation between surface topography and morphology of the adsorbed proteins was observed on surfaces P and G. Possible reasons for not detecting HPF with AFM on five of the seven sample types were attributed to the surface physico-chemical properties of these samples. (C) 2001 Elsevier Science B.V. All rights reserved.
C1 Univ Bristol, Biomed Engn & Biomat Sci Sect, Dept Oral & Dent Sci, Bristol BS1 2LY, Avon, England.
   Univ Bristol, HH Wills Phys Lab, Bristol BS8 1TL, Avon, England.
   Univ Bristol, Interface Anal Ctr, Bristol BS2 8BS, Avon, England.
RP Jandt, KD (reprint author), Univ Bristol, Biomed Engn & Biomat Sci Sect, Dept Oral & Dent Sci, Lower Maudlin St, Bristol BS1 2LY, Avon, England.
RI Jandt, Klaus/C-8077-2016
OI Jandt, Klaus/0000-0002-7537-5603; Miles, Mervyn/0000-0001-7762-6827
CR Ahariz M, 2000, J BIOMED MATER RES, V52, P567, DOI 10.1002/1097-4636(20001205)52:3<567::AID-JBM16>3.0.CO;2-K
   ALBREKTSSON T, 1983, ANN BIOMED ENG, V11, P1, DOI 10.1007/BF02363944
   Andrade J. D., 1985, SURFACE INTERFACIAL, V2
   Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   Briggs D, 1977, HDB XRAY ULTRAVIOLET
   BUSER D, 1991, J BIOMED MATER RES, V25, P889, DOI 10.1002/jbm.820250708
   Cacciafesta P, 2000, LANGMUIR, V16, P8167, DOI 10.1021/la000362k
   Chen YL, 1999, J COLLOID INTERF SCI, V214, P38
   Cleveland JP, 1998, APPL PHYS LETT, V72, P2613, DOI 10.1063/1.121434
   Cochran DL, 1999, J PERIODONTOL, V70, P1523, DOI 10.1902/jop.1999.70.12.1523
   Cooper LF, 1999, INT J ORAL MAX IMPL, V14, P37
   *DIG INSTR INC, 1997, NAN COMM REF MAN, P68
   *DIG INSTR INC, 1997, NAN COMM REF MAN, P41
   Francois P, 1997, CLIN ORAL IMPLAN RES, V8, P217, DOI 10.1034/j.1600-0501.1997.080308.x
   Garcia R, 1999, SURF INTERFACE ANAL, V27, P312, DOI 10.1002/(SICI)1096-9918(199905/06)27:5/6<312::AID-SIA496>3.0.CO;2-Y
   Giacomelli CE, 1999, J COLLOID INTERF SCI, V218, P404, DOI 10.1006/jcis.1999.6434
   HANTGAN RR, 1994, HEMOSTASIS THROMBOSI, pCH14
   Holland NB, 2000, J BIOMED MATER RES, V51, P307, DOI 10.1002/1097-4636(20000905)51:3<307::AID-JBM3>3.0.CO;2-H
   Hong J, 1999, THROMB HAEMOSTASIS, V82, P58
   Horbett Thomas A., 1996, P133
   Jackson DR, 2000, LANGMUIR, V16, P5449, DOI 10.1021/la991497x
   Jandt KD, 1998, MAT SCI ENG R, V21, P221, DOI 10.1016/S0927-796X(97)00012-0
   Kanagaraja S, 1996, BIOMATERIALS, V17, P2225, DOI 10.1016/0142-9612(95)00311-8
   KASEMO B, 1986, CRIT REV BIOCOMPAT, V2, P335
   KASEMO B, 1983, J PROSTHET DENT, V49, P832, DOI 10.1016/0022-3913(83)90359-1
   Kasemo B, 1985, TISSUE INTEGRATED PR, P99
   Kieswetter K, 1996, CRIT REV ORAL BIOL M, V7, P329, DOI 10.1177/10454411960070040301
   Klinger A, 1997, J BIOMED MATER RES, V36, P387, DOI 10.1002/(SICI)1097-4636(19970905)36:3<387::AID-JBM13>3.0.CO;2-B
   Larsson C, 1996, BIOMATERIALS, V17, P605, DOI 10.1016/0142-9612(96)88711-4
   Larsson C, 1997, J MATER SCI-MATER M, V8, P721, DOI 10.1023/A:1018548225899
   LARSSON C, 1994, BIOMATERIALS, V15, P1062, DOI 10.1016/0142-9612(94)90092-2
   Lausmaa J, 1996, J ELECTRON SPECTROSC, V81, P343, DOI 10.1016/0368-2048(95)02530-8
   LI J, 1994, J MATER SCI-MATER M, V5, P760, DOI 10.1007/BF00120372
   MacDonald DE, 1998, J BIOMED MATER RES, V41, P120
   MacDonald DE, 1998, COLLOID SURFACE B, V11, P131, DOI 10.1016/S0927-7765(98)00030-7
   Magonov SN, 1997, SURF SCI, V375, P385
   Nagao E, 1999, BIOPHYS J, V76, P3289, DOI 10.1016/S0006-3495(99)77481-3
   NEWCOMBE JR, UNPUB
   Nygren H, 1997, J LAB CLIN MED, V129, P35, DOI 10.1016/S0022-2143(97)90159-1
   Nygren H, 1997, J BIOMED MATER RES, V34, P487, DOI 10.1002/(SICI)1097-4636(19970315)34:4<487::AID-JBM9>3.3.CO;2-6
   Roddick-Lanzilotta AD, 1998, LANGMUIR, V14, P6479, DOI 10.1021/la980425n
   Schwartz Z, 1997, J PERIODONTAL RES, V32, P166, DOI 10.1111/j.1600-0765.1997.tb01399.x
   SEVASTIANOV VI, 1988, CRIT REV BIOCOMPAT, V4, P109
   Siedlecki CA, 1998, BIOMATERIALS, V19, P441, DOI 10.1016/S0142-9612(97)00222-6
   SINGHVI R, 1994, BIOTECHNOL BIOENG, V43, P764, DOI 10.1002/bit.260430811
   SIPEHIA R, 1993, BIOMAT ARTIF CELL IM, V21, P647, DOI 10.3109/10731199309117389
   SIPEHIA R, 1989, ACS SYM SER, V392, pCH12
   Sittig C, 1999, J MATER SCI-MATER M, V10, P35, DOI 10.1023/A:1008840026907
   SODHI RNS, 1991, J VAC SCI TECHNOL A, V9, P1329, DOI 10.1116/1.577621
   Taborelli M, 1997, CLIN ORAL IMPLAN RES, V8, P208, DOI 10.1034/j.1600-0501.1997.080307.x
   Tamayo J, 1998, APPL PHYS LETT, V73, P2926, DOI 10.1063/1.122632
   Tamayo J, 1996, LANGMUIR, V12, P4430, DOI 10.1021/la960189l
   Trisi P, 1999, INT J ORAL MAX IMPL, V14, P689
   WAHLBECK PG, 1966, J AM CERAM SOC, V49, P180, DOI 10.1111/j.1151-2916.1966.tb13229.x
   Walivaara B, 1996, J BIOMAT SCI-POLYM E, V8, P41, DOI 10.1163/156856297X00560
   WALIVAARA B, 1994, BIOMATERIALS, V15, P827, DOI 10.1016/0142-9612(94)90038-8
   Webster TJ, 1999, BIOMATERIALS, V20, P1221, DOI 10.1016/S0142-9612(99)00020-4
   Wennerberg A, 1998, CLIN ORAL IMPLAN RES, V9, P11, DOI 10.1034/j.1600-0501.1998.090102.x
   ZENHAUSERN F, 1993, J ELECTRON MICROSC, V42, P378
NR 59
TC 69
Z9 69
U1 2
U2 26
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0039-6028
J9 SURF SCI
JI Surf. Sci.
PD OCT 1
PY 2001
VL 491
IS 3
BP 405
EP 420
DI 10.1016/S0039-6028(01)01303-6
PG 16
WC Chemistry, Physical; Physics, Condensed Matter
SC Chemistry; Physics
GA 482DQ
UT WOS:000171559900009
DA 2018-10-20
ER

PT J
AU Denes, AR
   Somers, EB
   Wong, ACL
   Denes, F
AF Denes, AR
   Somers, EB
   Wong, ACL
   Denes, F
TI 12-crown-4-ether and tri(ethylene glycol) dimethyl-ether plasma-coated
   stainless steel surfaces and their ability to reduce bacterial biofilm
   deposition
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE bacterial attachment; biofilm formation; cold-plasma-induced surface
   modification; PEG-like structures; surface chemistry
ID ADHESION; POLYMERIZATION; BIOMATERIAL; PEG
AB It has been demonstrated that surfaces coated with poly(ethylene glycol) (PEG) are capable of reducing protein adsorption, bacterial attachment, and biofilm formation. In this communication cold-plasma-enhanced processes were employed for the deposition of PEG-like structures onto stainless steel surfaces. Stainless steel samples were coated under 1,4,7,10-tetraoxacyclododecane (12-crown-4)-ether and tri(ethylene glycol) dimethyl ether (triglyme)-radio frequency (RF)-plasma conditions. The chemistry and characteristics of plasma-coated samples and biofilms were investigated using electron spectroscopy for chemical analysis (ESCA), atomic force microscopy (AFM), and water contact angle analysis. ESCA analysis indicated that the plasma modification resulted in the deposition of PEG-like structures, built up mainly of -CH2-CH2-O- linkages. Plasma-coated stainless steel surfaces were more hydrophilic and had lower surface roughness values compared to those of unmodified substrates. Compared to the unmodified surfaces, they not only significantly reduced bacterial attachment and biofilm formation in the presence of a mixed culture of Salmonella typhimurium, Staphylococcus epidermidis, and Pseudomonas fluorescens but also influenced the chemical characteristics of the biofilm. Thus, plasma deposition of PEG-like structures will be of use to the food-processing and medical industries searching for new technologies to reduce bacterial contamination. (C) 2001 John Wiley & Sons, Inc.
C1 Univ Wisconsin, Food Res Inst, Madison, WI 53706 USA.
   Univ Wisconsin, Ctr Plasma Aided Mfg, Madison, WI 53706 USA.
RP Wong, ACL (reprint author), Univ Wisconsin, Food Res Inst, 1925 Willow Dr, Madison, WI 53706 USA.
CR AMIJI M, 1993, J BIOMAT SCI-POLYM E, V4, P217, DOI 10.1163/156856293X00537
   Characklis W. G., 1990, BIOFILMS, P195
   Chen XL, 1996, CHEM MATER, V8, P1067, DOI 10.1021/cm9504854
   Denes F, 1997, TRENDS POLYM SCI, V5, P23
   Denes F, 1999, J APPL POLYM SCI, V71, P1627, DOI 10.1002/(SICI)1097-4628(19990307)71:10<1627::AID-APP10>3.0.CO;2-D
   *DIG INSTR, DIG INSTR NAN 3 SCAN
   Flint SH, 2000, J FOOD ENG, V43, P235, DOI 10.1016/S0260-8774(99)00157-0
   GOMBOTZ WR, 1992, POLYETHYLENE GLYCOL, P47
   Han LM, 1998, CHEM MATER, V10, P1422, DOI 10.1021/cm970779k
   Harris JM, 1997, ACS S SERIES, V680
   Hendricks SK, 2000, J BIOMED MATER RES, V50, P160, DOI 10.1002/(SICI)1097-4636(200005)50:2<160::AID-JBM10>3.0.CO;2-M
   HOLMBREG K, 1993, CONTACT ANGLE WETTAB, P813
   Hsiue GH, 1998, J BIOMED MATER RES, V42, P134, DOI 10.1002/(SICI)1097-4636(199810)42:1<134::AID-JBM17>3.0.CO;2-L
   Ista LK, 1996, FEMS MICROBIOL LETT, V142, P59
   JOHNSTON EE, 1996, SURFACE MODIFICATION, P35
   LECHEVALLIER MW, 1988, APPL ENVIRON MICROB, V54, P649
   LEE JH, 1989, J BIOMED MATER RES, V23, P351, DOI 10.1002/jbm.820230306
   LOPEZ GP, 1992, J BIOMED MATER RES, V26, P415, DOI 10.1002/jbm.820260402
   MAGNUSSON KE, 1977, STUD BIOPHYS, V66, P145
   Morra M, 1996, J BIOMED MATER RES, V31, P149
   OSTERBERG E, 1995, J BIOMED MATER RES, V29, P741, DOI 10.1002/jbm.820290610
   PANCHALINGAM V, 1993, ASAIO J, V30, P305
   Park KD, 1998, BIOMATERIALS, V19, P851, DOI 10.1016/S0142-9612(97)00245-7
   Rad AY, 1998, J BIOMED MATER RES, V41, P349, DOI 10.1002/(SICI)1097-4636(19980905)41:3<349::AID-JBM2>3.0.CO;2-C
   RATNER BD, 1995, BIOSENS BIOELECTRON, V10, P797, DOI 10.1016/0956-5663(95)99218-A
   RATNER BD, 1992, J BIOMAT SCI-POLYM E, V4, P3
   Rinsch CL, 1996, LANGMUIR, V12, P2995, DOI 10.1021/la950685u
   Sarmadi M, 1996, TEXT CHEM COLOR, V28, P17
   SHAMAMIAN V, IN PRESS J APPL PHYS
   Shi FF, 1996, SURF COAT TECH, V82, P1, DOI 10.1016/0257-8972(95)02621-5
   Tang LP, 1998, J BIOMED MATER RES, V42, P156, DOI 10.1002/(SICI)1097-4636(199810)42:1<156::AID-JBM19>3.3.CO;2-E
   Taylor RL, 1998, J MATER SCI-MATER M, V9, P17, DOI 10.1023/A:1008874326324
   VANDERMEI HC, 2000, J SURF SCI REP, V39, P1
   WEST RC, 1976, HDB CHEM PHYSICS, pF156
NR 34
TC 37
Z9 40
U1 1
U2 12
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD SEP 29
PY 2001
VL 81
IS 14
BP 3425
EP 3438
DI 10.1002/app.1799
PG 14
WC Polymer Science
SC Polymer Science
GA 454RC
UT WOS:000169984700009
DA 2018-10-20
ER

PT J
AU Dixit, P
   Hern-Anderson, D
   Ranieri, J
   Schmidt, CE
AF Dixit, P
   Hern-Anderson, D
   Ranieri, J
   Schmidt, CE
TI Vascular graft endothelialization: Comparative analysis of canine and
   human endothelial cell migration on natural biomaterials
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE endothelial cell migration; natural biomaterials; growth factors;
   adhesion proteins
ID FIBROBLAST GROWTH-FACTOR; DYE-MEDIATED PHOTOOXIDATION;
   POLYTETRAFLUOROETHYLENE GRAFTS; ARTERIAL PROSTHESES; PERICARDIAL TISSUE;
   DACRON GRAFTS; HEPARIN; PROLIFERATION; MOTILITY; INVIVO
AB Canines are typically used as the standard preclinical model to gauge the success of vascular graft materials. However, canines spontaneously re-endothelialize vascular grafts, whereas humans do not, even after years. This raises questions of why there are differences in vascular healing between humans and other species and whether the canine is the appropriate preclinical model. In the present study we evaluated human and canine endothelial cell (EC) migration on the novel cross-linked collagen biomaterial PhotoFix (TM) pericardium. We compared in vitro migration of these cells on PhotoFix alone and on PhotoFix adsorbed with various growth factors (aFGF and bFGF) and adhesion proteins (fibronectin, collagen IV, vitronectin, and laminin). We also compared human and canine ECs in terms of their morphologies and prostacyclin production. We found that human umbilical vein ECs (HUVECs) and canine ECs (CECs) migrated well on PhotoFix, suggesting that this biomaterial may be a good vascular graft candidate. Both cell types responded similarly to different growth factors and adhesive proteins, but HUVEC migration was consistently higher than that for CECs. This suggested that human in vivo graft re-endothelialization is likely not hindered by poor endothelial migration but is hindered by other cellular or graft properties. (C) 2001 John Wiley & Sons, Inc.
C1 Univ Texas, Dept Chem Engn, Austin, TX 78712 USA.
   Sulzer Biol, Austin, TX 78752 USA.
RP Schmidt, CE (reprint author), Univ Texas, Dept Chem Engn, 26th & Speedway,MC C0400, Austin, TX 78712 USA.
RI Schmidt, Christine/P-1613-2016
CR ASHTON AW, 1995, GROWTH FACTORS, V12, P111, DOI 10.3109/08977199509028957
   AUGUSTINVOSS HG, 1993, J CELL PHYSIOL, V157, P279, DOI 10.1002/jcp.1041570210
   BERGER K, 1972, ANN SURG, V175, P118, DOI 10.1097/00000658-197201000-00018
   BULL DA, 1995, J SURG RES, V58, P58, DOI 10.1006/jsre.1995.1010
   CASSCELLS W, 1992, CIRCULATION, V86, P723, DOI 10.1161/01.CIR.86.3.723
   Consigny PM, 2000, J LONG-TERM EFF MED, V10, P79
   FASOL R, 1989, J VASC SURG, V9, P432, DOI 10.1067/mva.1989.vs0090432
   Gillis C, 1995, CELL MOL BIOL, V41, P1131
   GILLISHAEGERSTR.C, 1995, THESIS LAROLINSKA I
   GREISLER HP, 1992, SURGERY, V112, P244
   HESS F, 1988, J CARDIOVASC SURG, V29, P458
   KENT KC, 1989, J VASC SURG, V9, P271, DOI 10.1067/mva.1989.vs0090271
   KLAGSBRUN M, 1985, P NATL ACAD SCI USA, V82, P805, DOI 10.1073/pnas.82.3.805
   LEE Y, 1994, BIOTECHNOL BIOENG, V43, P622, DOI 10.1002/bit.260430712
   MACIAG T, 1984, SCIENCE, V225, P932, DOI 10.1126/science.6382607
   MADRI JA, 1991, J CELL BIOCHEM, V45, P123, DOI 10.1002/jcb.240450202
   MCNEIL PL, 1989, GASTROENTEROLOGY, V96, P1238, DOI 10.1016/S0016-5085(89)80010-1
   MOORE MA, 1994, J BIOMED MATER RES, V28, P611, DOI 10.1002/jbm.820280511
   Moore MA, 1997, J HEART VALVE DIS, V6, P307
   Ohtake S, 1997, Hokkaido Igaku Zasshi, V72, P43
   Onuki Y, 1997, ANN VASC SURG, V11, P141, DOI 10.1007/s100169900024
   ORTENWALL P, 1990, J VASC SURG, V11, P403
   RAMALANJAONA G, 1986, J VASC SURG, V3, P264, DOI 10.1067/mva.1986.avs0030264
   ROSEN EM, 1989, IN VITRO CELL DEV B, V25, P1079
   SAUVAGE LR, 1974, ARCH SURG-CHICAGO, V109, P698
   Schmidt CE, 2000, BIOMATERIALS, V21, P2215, DOI 10.1016/S0142-9612(00)00148-4
   SCOTT SM, 1994, J VASC SURG, V19, P585, DOI 10.1016/S0741-5214(94)70030-3
   SHAREFKIN JB, 1983, J SURG RES, V34, P33, DOI 10.1016/0022-4804(83)90019-7
   SHI Q, 1994, J VASC SURG, V20, P546, DOI 10.1016/0741-5214(94)90279-8
   Tomizawa Y, 1996, ASAIO J, V42, pM698, DOI 10.1097/00002480-199609000-00077
   TRACHTENBERG JD, 1994, IMPLANTATION BIOL HO
   WESOLOW A, 1982, THORAC CARDIOV SURG, V30, P196, DOI 10.1055/s-2007-1022388
   ZILLA P, 1993, J CARDIAC SURG, V8, P32, DOI 10.1111/j.1540-8191.1993.tb00574.x
NR 33
TC 34
Z9 34
U1 0
U2 8
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD SEP 15
PY 2001
VL 56
IS 4
BP 545
EP 555
DI 10.1002/1097-4636(20010915)56:4<545::AID-JBM1126>3.0.CO;2-V
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 447EZ
UT WOS:000169559500010
PM 11400132
DA 2018-10-20
ER

PT J
AU Ferrari, A
   Hannouche, D
   Oudina, K
   Bourguignon, M
   Meunier, A
   Sedel, L
   Petite, H
AF Ferrari, A
   Hannouche, D
   Oudina, K
   Bourguignon, M
   Meunier, A
   Sedel, L
   Petite, H
TI In vivo tracking of bone marrow fibroblasts with fluorescent
   carbocyanine dye
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE carbocyanines; fluorescent dyes; transplantation; tissue engineering;
   mesenchymal stem cells
ID STROMAL CELLS; IN-VIVO; EXPRESSION; GROWTH; CORAL
AB Recent advances in the field of tissue engineering have culminated in new tissue substitutes that combine a biomaterial and precursor cells. The effectiveness of these materials is generally assessed in animals, but few studies explore the fate of the transplanted cells in vivo, despite its paramount importance for understanding the function of the engineered tissues. Current methods that use reporter genes or chimeric animals are not always well suited to solving tissue-engineering problems. We therefore developed a new method for irreversible labeling of cells to track their fate in oho. We used a fluorescent lipophilic probe, CM-Dil, that avidly binds to the cell membrane. Human bone marrow stromal fibroblasts could be labeled with 20 muM CM-Dil in 30 min. The CM-Dil was nor cytotoxic and did not affect cell proliferation in vitro. Cells could be monitored for up to 30 days when placed in a coral scaffold and implanted intramuscularly or in a bony site. However, the fluorescence intensity decreased roughly in parallel with the number of cell divisions. This fact needs to be taken into account during the design and interpretation of experiments. We believe that this technique is also of interest for other cell types. (C) 2001 John Wiley & Sons, inc.
C1 Univ D Diderot, Fac Med Lariboisiere, Lab Rech Orthoped, CNRS UPRESA 7052, F-75010 Paris, France.
RP Petite, H (reprint author), Univ D Diderot, Fac Med Lariboisiere, Lab Rech Orthoped, CNRS UPRESA 7052, 10 Ave de Verdun, F-75010 Paris, France.
RI Bourguignon, Marianne/O-5854-2017; Petite, Herve/E-3478-2016
OI Bourguignon, Marianne/0000-0001-9824-1248; Petite,
   Herve/0000-0003-1694-5060
CR Allay JA, 1997, HUM GENE THER, V8, P1417, DOI 10.1089/hum.1997.8.12-1417
   Andrade W, 1996, J IMMUNOL METHODS, V194, P181, DOI 10.1016/0022-1759(96)00083-X
   ASHTON BA, 1985, BONE, V6, P313, DOI 10.1016/8756-3282(85)90321-7
   ButnariuEphrat M, 1996, CLIN ORTHOP RELAT R, P234
   GOSHIMA J, 1991, CLIN ORTHOP RELAT R, P274
   GUILLEMIN G, 1993, J MATER SCI-MATER M, V4, P575, DOI 10.1007/BF00125596
   Hebda PA, 1999, OTOLARYNG HEAD NECK, V121, P245, DOI 10.1016/S0194-5998(99)70179-8
   HONIG MG, 1986, J CELL BIOL, V103, P171, DOI 10.1083/jcb.103.1.171
   HORAN PK, 1989, NATURE, V340, P167, DOI 10.1038/340167a0
   IRIGARAY JL, 1993, J THERM ANAL CALORIM, V39, P3, DOI 10.1007/BF02235441
   Kadiyala S, 1997, TISSUE ENG, V3, P173, DOI 10.1089/ten.1997.3.173
   Krebsbach PH, 1997, TRANSPLANTATION, V63, P1059, DOI 10.1097/00007890-199704270-00003
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Louisia S, 1999, J BONE JOINT SURG BR, V81B, P719, DOI 10.1302/0301-620X.81B4.9358
   NAUGHTON BA, 1992, SOMAT CELL MOLEC GEN, V18, P451, DOI 10.1007/BF01233085
   OHGUSHI H, 1989, ACTA ORTHOP SCAND, V60, P334, DOI 10.3109/17453678909149289
   Owen M, 1985, J CELL SCI S, V10, P63
   Petite H, 1996, J MATER SCI-MATER M, V7, P665, DOI 10.1007/BF00123405
   Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71
   Triffitt James T., 1996, P39
   WAKITANI S, 1994, J BONE JOINT SURG AM, V76A, P579, DOI 10.2106/00004623-199404000-00013
NR 21
TC 46
Z9 47
U1 0
U2 6
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD SEP 5
PY 2001
VL 56
IS 3
BP 361
EP 367
DI 10.1002/1097-4636(20010905)56:3<361::AID-JBM1104>3.0.CO;2-4
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 442DV
UT WOS:000169270700006
PM 11372053
DA 2018-10-20
ER

PT J
AU Massia, SP
   Stark, J
AF Massia, SP
   Stark, J
TI Immobilized RGD peptides on surface-grafted dextran promote biospecific
   cell attachment
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE surface modification; immobilized dextran; biospecific cell adhesion;
   engineered biomaterials
ID PLASMA-PROTEINS; ADHESION; POLYSACCHARIDE; ADSORPTION; COATINGS;
   RECEPTOR
AB Dextran has recently been investigated as an alternative to poly(ethylene glycol) (PEG) for low protein-binding, cell-resistant coatings on biomaterial surfaces. Although antifouling properties of surface-grafted dextran and PEG are quite similar, surface-bound dextran has multiple reactive sites for high-density surface immobilization of biologically active molecules. We recently reported nontoxic aqueous methods to covalently immobilize dextran on material surfaces. These dextran coatings effectively limited cell adhesion and spreading in the presence of serum-borne cell adhesion proteins. In this study we utilized the same nontoxic aqueous methods to graft cell adhesion peptides on low protein-binding dextran monolayer surfaces. Chemical composition of all modified surfaces was verified by X-ray photoelectron spectroscopy (XPS). Surface-grafted cell adhesion peptides stimulated endothelial cell, fibroblast, and smooth muscle cell attachment and spreading in vitro. In contrast, surface-grafted inactive peptide sequences did not promote high levels of cell interaction. Surface-grafted high affinity cyclic RGD peptides promoted cell type-dependent interactions. With dextran-based surface coatings, it will be possible to develop well-defined surface modifications that promote specific cell interactions and perhaps better performance in long-term biomaterial implants. (C) 2001 John Wiley & Sons, Inc.
C1 Arizona State Univ, Dept Bioengn, Tempe, AZ 85287 USA.
RP Massia, SP (reprint author), Arizona State Univ, Dept Bioengn, POB 879709, Tempe, AZ 85287 USA.
RI Zhou, Feng/E-9510-2011
FU NHLBI NIH HHS [HL60450]
CR BRANDLEY BK, 1988, ANAL BIOCHEM, V172, P270, DOI 10.1016/0003-2697(88)90442-3
   BRANDLEY BK, 1989, DEV BIOL, V135, P74, DOI 10.1016/0012-1606(89)90159-0
   CIMA LG, 1994, J CELL BIOCHEM, V56, P155, DOI 10.1002/jcb.240560206
   Dai LM, 2000, SURF INTERFACE ANAL, V29, P46, DOI 10.1002/(SICI)1096-9918(200001)29:1<46::AID-SIA692>3.0.CO;2-6
   Harris J.M., 1992, POLYETHYLENE GLYCOL
   Hern DL, 1998, J BIOMED MATER RES, V39, P266, DOI 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B
   Hirtenstein M, 1980, Dev Biol Stand, V46, P109
   HUBBELL JA, 1991, BIO-TECHNOL, V9, P568, DOI 10.1038/nbt0691-568
   IKADA Y, 1994, BIOMATERIALS, V15, P725, DOI 10.1016/0142-9612(94)90025-6
   Kao WYJ, 1998, BIOTECHNOL BIOENG, V59, P2, DOI 10.1002/(SICI)1097-0290(19980705)59:1<2::AID-BIT2>3.0.CO;2-G
   KONDOH A, 1993, J APPL POLYM SCI, V47, P1983, DOI 10.1002/app.1993.070471108
   MARCHANT RE, 1994, J BIOMAT SCI-POLYM E, V6, P549, DOI 10.1163/156856294X00509
   MASSIA SP, 2000, IN PRESS BIOMATERIAL
   Merrill EW, 1983, AM SOC ARTIF INTERN, V6, P60
   NAKAJIMA K, 1990, POLYM J, V22, P985, DOI 10.1295/polymj.22.985
   Neff JA, 1998, J BIOMED MATER RES, V40, P511, DOI 10.1002/(SICI)1097-4636(19980615)40:4<511::AID-JBM1>3.3.CO;2-M
   OLBRICH KC, 1996, BIOMATERIALS, V17, P144
   OSTERBERG E, 1995, J BIOMED MATER RES, V29, P741, DOI 10.1002/jbm.820290610
   OSTERBERG E, 1993, COLLOID SURFACE A, V77, P159, DOI 10.1016/0927-7757(93)80112-R
   PIERSCHBACHER MD, 1987, J BIOL CHEM, V262, P17294
   ROWLAND SA, 1995, J APPL BIOMATER, V6, P1, DOI 10.1002/jab.770060102
   SOSA JM, 1980, ANAL CHEM, V52, P910, DOI 10.1021/ac50056a031
   WEETALL HH, 1993, APPL BIOCHEM BIOTECH, V41, P157, DOI 10.1007/BF02916421
   WILSON MB, 1976, J IMMUNOL METHODS, V12, P171
   Xiao Y, 1996, BIOPHYS J, V71, P2869, DOI 10.1016/S0006-3495(96)79484-5
NR 25
TC 141
Z9 147
U1 3
U2 38
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD SEP 5
PY 2001
VL 56
IS 3
BP 390
EP 399
DI 10.1002/1097-4636(20010905)56:3<390::AID-JBM1108>3.0.CO;2-L
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 442DV
UT WOS:000169270700010
PM 11372057
DA 2018-10-20
ER

PT J
AU Ramage, G
   vande Walle, K
   Wickes, BL
   Lopez-Ribot, JL
AF Ramage, G
   vande Walle, K
   Wickes, BL
   Lopez-Ribot, JL
TI Standardized method for in vitro antifungal susceptibility testing of
   Candida albicans biofilms
SO ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
LA English
DT Article
ID CLINICAL-LABORATORY-STANDARDS; IN-VITRO; BACTERIAL BIOFILMS;
   GROWTH-RATE; PSEUDOMONAS-AERUGINOSA; STAPHYLOCOCCUS-AUREUS;
   ANTIBIOTIC-RESISTANCE; ANTIMICROBIAL AGENTS; NATIONAL-COMMITTEE;
   ESCHERICHIA-COLI
AB Candida albicans is implicated in many biomaterial-related infections. Typically, these infections are associated with biofilm formation. Cells in biofilms display phenotypic traits that are dramatically different from those of their free-floating planktonic counterparts and are notoriously resistant to antimicrobial agents. Consequently, biofilm-related infections are inherently difficult to treat and to fully eradicate with normal treatment regimens. Here, we report a rapid and highly reproducible microtiter-based colorimetric assay for the susceptibility testing of fungal biofilms, based on the measurement of metabolic activities of the sessile cells by using a formazan salt reduction assay. The assay was used for in vitro antifungal susceptibility testing of several C. albicans strains grown as biofilms against amphotericin B and fluconazole and the increased resistance of C albicans biofilms against these antifungal agents was demonstrated. Because of its simplicity, compatibility with a widely available 96-well microplate platform, high throughput, and automation potential, we believe this assay represents a promising tool for the standardization of in vitro antifungal susceptibility testing of fungal biofilms.
C1 Univ Texas, Hlth Sci Ctr, Dept Med, Div Infect Dis,S Texas Ctr Biol Med, San Antonio, TX 78245 USA.
   Univ Texas, Hlth Sci Ctr, Dept Microbiol, San Antonio, TX 78245 USA.
RP Lopez-Ribot, JL (reprint author), Univ Texas, Hlth Sci Ctr, Dept Med, Div Infect Dis,S Texas Ctr Biol Med, Texas Res Pk,15355 Lambda Dr, San Antonio, TX 78245 USA.
RI Lopez-Ribot, Jose/D-2048-2010
CR Amorena B, 1999, J ANTIMICROB CHEMOTH, V44, P43, DOI 10.1093/jac/44.1.43
   Baillie GS, 1999, METHOD ENZYMOL, V310, P644
   Baillie GS, 1998, ANTIMICROB AGENTS CH, V42, P1900, DOI 10.1128/AAC.42.8.1900
   Baillie GS, 1998, ANTIMICROB AGENTS CH, V42, P2146, DOI 10.1128/AAC.42.8.2146
   BROWN R, 1989, PRACTICAL MED MICROB, P240
   Cannon RD, 1999, CRIT REV ORAL BIOL M, V10, P359, DOI 10.1177/10454411990100030701
   Ceri H, 1999, J CLIN MICROBIOL, V37, P1771
   Chaffin WL, 1998, MICROBIOL MOL BIOL R, V62, P130
   CHALLACOMBE SJ, 1994, ORAL SURG ORAL MED O, V78, P202, DOI 10.1016/0030-4220(94)90148-1
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Crump JA, 2000, EUR J CLIN MICROBIOL, V19, P1, DOI 10.1007/s100960050001
   DOMINGUE G, 1994, J CLIN MICROBIOL, V32, P2564
   Ell SR, 1996, J LARYNGOL OTOL, V110, P240
   Espinel-Ingroff A, 1998, MED MYCOL, V36, P68
   EVANS DJ, 1991, J ANTIMICROB CHEMOTH, V27, P177, DOI 10.1093/jac/27.2.177
   EVANS DJ, 1990, J ANTIMICROB CHEMOTH, V25, P585, DOI 10.1093/jac/25.4.585
   Gander S, 1997, J ANTIMICROB CHEMOTH, V40, P329, DOI 10.1093/jac/40.3.329
   Gander S, 1996, J ANTIMICROB CHEMOTH, V37, P1047, DOI 10.1093/jac/37.6.1047
   Ghannoum MA, 1997, J CHEMOTHERAPY, V9, P19
   Ghannoum MA, 1996, J CLIN MICROBIOL, V34, P489
   Gilbert P, 1997, Adv Dent Res, V11, P160
   GILBERT P, 1990, ANTIMICROB AGENTS CH, V34, P1865, DOI 10.1128/AAC.34.10.1865
   Gracia E, 1999, LUMINESCENCE, V14, P23, DOI 10.1002/(SICI)1522-7243(199901/02)14:1<23::AID-BIO513>3.0.CO;2-M
   GRISTINA AG, 1987, BIOMATERIALS, V8, P423, DOI 10.1016/0142-9612(87)90077-9
   Hawser S, 1996, J MED VET MYCOL, V34, P407
   Hawser S, 1996, J MED VET MYCOL, V34, P149
   HAWSER SP, 1995, ANTIMICROB AGENTS CH, V39, P2128, DOI 10.1128/AAC.39.9.2128
   Hawser SP, 1998, J CLIN MICROBIOL, V36, P1450
   Hoyle B D, 1991, Prog Drug Res, V37, P91
   HOYLE BD, 1990, J ANTIMICROB CHEMOTH, V26, P1, DOI 10.1093/jac/26.1.1
   HOYLE BD, 1993, INFECT IMMUN, V61, P777
   HOYLE BD, 1992, ANTIMICROB AGENTS CH, V36, P2054, DOI 10.1128/AAC.36.9.2054
   Lewis K, 2001, ANTIMICROB AGENTS CH, V45, P999, DOI 10.1128/AAC.45.4.999-1007.2001
   Maira-Litran T, 2000, J APPL MICROBIOL, V88, P243, DOI 10.1046/j.1365-2672.2000.00963.x
   *NAT COMM CLIN LAB, 1997, M27A NCCLS
   Rex JH, 1997, CLIN INFECT DIS, V24, P235, DOI 10.1093/clinids/24.2.235
   Schierholz JM, 1999, ZBL BAKT-INT J MED M, V289, P165
   Stickler D, 1999, CURR OPIN MICROBIOL, V2, P270, DOI 10.1016/S1369-5274(99)80047-2
   TELLIER R, 1992, ANTIMICROB AGENTS CH, V36, P1619, DOI 10.1128/AAC.36.8.1619
NR 39
TC 408
Z9 464
U1 4
U2 33
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0066-4804
J9 ANTIMICROB AGENTS CH
JI Antimicrob. Agents Chemother.
PD SEP
PY 2001
VL 45
IS 9
BP 2475
EP 2479
DI 10.1128/AAC.45.9.2475-2479.2001
PG 5
WC Microbiology; Pharmacology & Pharmacy
SC Microbiology; Pharmacology & Pharmacy
GA 465KQ
UT WOS:000170588500012
PM 11502517
OA Bronze, Green Published
DA 2018-10-20
ER

PT J
AU Praetorius, M
   Limberger, A
   Muller, M
   Lehner, R
   Schick, B
   Zenner, HP
   Plinkert, P
   Knipper, M
AF Praetorius, M
   Limberger, A
   Muller, M
   Lehner, R
   Schick, B
   Zenner, HP
   Plinkert, P
   Knipper, M
TI A novel microperfusion system for the long-term local supply of drugs to
   the inner ear: Implantation and function in the rat model
SO AUDIOLOGY AND NEURO-OTOLOGY
LA English
DT Article
DE cochlea; microperfusion system; inner ear therapy; drug delivery
ID ROUND WINDOW MEMBRANE; GUINEA-PIG; COCHLEA; PERMEABILITY; INFUSION
AB Local therapy is practiced for middle and inner ear diseases but is usually restricted to cases of ear drum perforation or repeated invasive intratympanic drug application. Perfusion of drugs on the round window or through the scalae of animals using a pump system suggests that the chronic local drug treatment might also be feasible in humans. However, drug delivery systems that are currently on the market involve repeated reimplantation if they are to be used for long-term drug supply. A bone-anchored, totally implantable micro-drug delivery system (MDS) for patient-controlled drug supply has been developed [Lehner et al., 1997]. In this study, we show the first successful long-term in vivo test of the MDS micro-pump in rats. The process of implantation and first functional tests will be described. The biomaterial used to manufacture the delivery system did not cause any inflammation reaction in any of the 9 animals successfully implanted. After activation of the micro-pump, the drug reservoir and port was found to be fluid-tight. Bolus applications of tetrodotoxin (TTX) to the round window induced a transient decrease of evoked brainstem responses. In 2 animals which carried the MDS for more than 8 months the proper functioning of the pumping device was examined in a 2-3 week interval over a 3 month period. The MDS can be autoclaved even after long-term implantation and can then be reused for subsequent implantations. Designed for life-long implantation in humans, the demonstration of an effective longterm drug supply to the inner ear using the MDS provides an encouraging first step towards future long-term drug treatment of the inner ear in humans. Copyright (C) 2001 S. Karger AG, Basel.
C1 Univ Tubingen, THRC, D-72076 Tubingen, Germany.
   Univ Homburg, Hosp Saarland, Dept Otorhinolaryngol, Homburg, Germany.
RP Knipper, M (reprint author), Univ Tubingen, THRC, Rontgenweg 11, D-72076 Tubingen, Germany.
RI Muller, Marcus/B-3877-2016
OI Muller, Marcus/0000-0001-5881-7708
CR BROWN JN, 1993, HEARING RES, V70, P167, DOI 10.1016/0378-5955(93)90155-T
   Ernfors P, 1996, NAT MED, V2, P463, DOI 10.1038/nm0496-463
   Goycoolea MV, 1997, MICROSC RES TECHNIQ, V36, P201, DOI 10.1002/(SICI)1097-0029(19970201)36:3<201::AID-JEMT8>3.3.CO;2-F
   HONRUBIA V, 1965, Acta Otolaryngol, V60, P105, DOI 10.3109/00016486509126993
   IGARASHI Y, 1985, ARCH OTO-RHINO-LARYN, V242, P167, DOI 10.1007/BF00454417
   Iguchi H, 1998, ORL J OTO-RHINO-LARY, V60, P181, DOI 10.1159/000027591
   Juhn SK, 1989, ACTA OTO-LARYNGOL, V457, P43
   JUNG W, 1971, ARCH KLIN EXP OHR, V199, P473
   Keithley EM, 1998, NEUROREPORT, V9, P2183, DOI 10.1097/00001756-199807130-00007
   KINGMA GG, 1992, J NEUROSCI METH, V45, P127, DOI 10.1016/0165-0270(92)90050-N
   Knipper M, 1997, NEUROCHEM INT, V31, P659, DOI 10.1016/S0197-0186(97)00009-0
   Knipper M, 1997, HNO, V45, P181
   Konishi T, 1966, Acta Otolaryngol, V62, P393, DOI 10.3109/00016486609119584
   KUIJPERS W, 1969, ACTA OTOLARYNGOL STO, V67, P202
   Lehner R, 1997, Ear Nose Throat J, V76, P567
   LUNDMAN LA, 1987, ACTA OTO-LARYNGOL, V104, P472, DOI 10.3109/00016488709128277
   MORI N, 1986, ACTA OTO-LARYNGOL, V101, P217, DOI 10.3109/00016488609132830
   MORIZONO T, 1987, REC ADV OT MED P 4 I, P1
   NUTTALL AL, 1977, ACTA OTO-LARYNGOL, V83, P393, DOI 10.3109/00016487709128863
   Oestreicher E, 2000, EUR J NEUROSCI, V12, P1584, DOI 10.1046/j.1460-9568.2000.00049.x
   PASIC TR, 1989, J COMP NEUROL, V283, P474, DOI 10.1002/cne.902830403
   RYAN AF, 1987, J COMP NEUROL, V255, P606, DOI 10.1002/cne.902550411
   SCHACHERN PA, 1987, ARCH OTOLARYNGOL, V113, P625
   SCHNIEDER EA, 1974, ANN OTO RHINOL LARYN, V83, P76, DOI 10.1177/000348947408300113
   STAECKER H, 1997, OTOLARYNGOL HEAD NEC, V119, P7
   TASAKI I, 1952, J NEUROPHYSIOL, V15, P497
   THEEUWES F, 1976, ANN BIOMED ENG, V4, P343, DOI 10.1007/BF02584524
NR 27
TC 20
Z9 21
U1 0
U2 5
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 1420-3030
J9 AUDIOL NEURO-OTOL
JI Audiol. Neuro-Otol.
PD SEP-OCT
PY 2001
VL 6
IS 5
BP 250
EP 258
DI 10.1159/000046130
PG 9
WC Audiology & Speech-Language Pathology; Neurosciences;
   Otorhinolaryngology
SC Audiology & Speech-Language Pathology; Neurosciences & Neurology;
   Otorhinolaryngology
GA 503EJ
UT WOS:000172785400002
PM 11729327
DA 2018-10-20
ER

PT J
AU Chluba, J
   Voegel, JC
   Decher, G
   Erbacher, P
   Schaaf, P
   Ogier, J
AF Chluba, J
   Voegel, JC
   Decher, G
   Erbacher, P
   Schaaf, P
   Ogier, J
TI Peptide hormone covalently bound to polyelectrolytes and embedded into
   multilayer architectures conserving full biological activity
SO BIOMACROMOLECULES
LA English
DT Article
ID GROWTH-FACTOR; MELANOMA-CELLS; ADSORPTION; RECEPTORS; SURFACES; SYSTEMS;
   HEPARIN; FILMS; MODEL
AB We report the development of new bioactive coatings of biomaterials based on the alternate deposition of oppositely charged polyelectrolytes. We selected polylysine (PLL) and poly(glutamic acid) (PGA) for the polyelectrolytes and murine melanoma cells as a biological test model system. These cells respond specifically to a small peptide hormone, alpha-melanocortin, which is a potent stimulator of melanogenesis. We show that a synthetic alpha-melanocortin derivative, covalently coupled to PLL forming the outer layer of a multilayer film remains as biologically active as the free hormone. Furthermore, the long time activity of the hormone is maintained when embedded in multilayer architectures whereas its short time activity depends on integration depth. The embedding of bioactive molecules not only anchors them irreversibly on the biomaterial, but opens also the possibility to control their activity. In comparison to conventional coating methods, polyelectrolyte multilayers are easy to prepare and retain their biological activity after storage as dry material. These very flexible systems allow broad medical applications for implant and tissue engineering.
C1 INSERM U424, Ctr Rech Odontol, F-67085 Strasbourg, France.
   ULP, CNRS, Inst Charles Sadron, F-67083 Strasbourg, France.
   Fac Pharm, UMR 7514 CNRS, F-67400 Illkirch Graffenstaden, France.
RP Chluba, J (reprint author), INSERM U424, Ctr Rech Odontol, 11 Rue Humann, F-67085 Strasbourg, France.
RI SCHAAF, Pierre/J-2751-2016; Decher, Gero/E-7665-2011
OI SCHAAF, Pierre/0000-0001-7423-5492; Decher, Gero/0000-0002-7976-8818;
   Chluba, Johanna/0000-0001-8779-8016
CR Caruso F, 1997, LANGMUIR, V13, P3427, DOI 10.1021/la9608223
   Chluba-de Tapia J, 1996, J CELL SCI, V109, P2023
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   EBERLE AN, 1993, ANN NY ACAD SCI, V680, P320, DOI 10.1111/j.1749-6632.1993.tb19693.x
   EBERLE AN, 1988, MELANOTROPINS CHEM P, P128
   Elbert DL, 1999, LANGMUIR, V15, P5355, DOI 10.1021/la9815749
   FIDLER IJ, 1973, NATURE-NEW BIOL, V242, P148
   FORTIER G, 1990, BIOSENS BIOELECTRON, V5, P473, DOI 10.1016/0956-5663(90)80036-D
   Haller MF, 1998, J CONTROL RELEASE, V53, P1, DOI 10.1016/S0168-3659(97)00232-0
   Ito Y, 1996, P NATL ACAD SCI USA, V93, P3598, DOI 10.1073/pnas.93.8.3598
   Ito Y, 1998, BIOCONJUGATE CHEM, V9, P277, DOI 10.1021/bc970190b
   LUKOSZ W, 1991, BIOSENS BIOELECTRON, V6, P215, DOI 10.1016/0956-5663(91)80006-J
   MOUNTJOY KG, 1992, SCIENCE, V257, P1248, DOI 10.1126/science.1325670
   PRIME KL, 1991, SCIENCE, V252, P1164, DOI 10.1126/science.252.5009.1164
   RAMSDEN JJ, 1994, J PHYS CHEM-US, V98, P5376, DOI 10.1021/j100071a031
   Sakiyama-Elbert SE, 2000, J CONTROL RELEASE, V65, P389, DOI 10.1016/S0168-3659(99)00221-7
   Schense JC, 2000, NAT BIOTECHNOL, V18, P415
   SOLCA FF, 1993, FEBS LETT, V322, P177, DOI 10.1016/0014-5793(93)81563-F
   WAGNER E, 1990, P NATL ACAD SCI USA, V87, P3410, DOI 10.1073/pnas.87.9.3410
   Zarge JI, 1997, J VASC SURG, V25, P840, DOI 10.1016/S0741-5214(97)70213-1
   ZASADZINSKI JA, 1994, SCIENCE, V263, P1726, DOI 10.1126/science.8134836
NR 21
TC 200
Z9 202
U1 0
U2 23
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD FAL
PY 2001
VL 2
IS 3
BP 800
EP 805
DI 10.1021/bm015529i
PG 6
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 528RG
UT WOS:000174256300023
PM 11710034
DA 2018-10-20
ER

PT J
AU Broberg, M
   Nygren, H
AF Broberg, M
   Nygren, H
TI Von Willebrand factor, a key protein in the exposure of CD62P on
   platelets
SO BIOMATERIALS
LA English
DT Article
DE platelets; vWF; CD62P; granule release
ID PLATELET/POLYMORPHONUCLEAR LEUKOCYTE INTERACTION; VIII-VONWILLEBRAND
   FACTOR; P-SELECTIN; ACTIVATED PLATELETS; ENDOTHELIAL-CELLS; GLYCOPROTEIN
   LIGAND; ALPHA-GRANULE; SHEAR-STRESS; GPIIB-IIIA; ADHESION
AB When a biomaterial is introduced into the body water, electrolytes, and proteins adsorb to the surface. Platelets are then the first cells to interact with the surface adsorbed protein layer. We have studied the role of von Willebrand factor (vWF) for platelet-protein interaction by measuring different platelet responses to protein- and plasma-coated hydrophobic glass surfaces. A high exposure of CD62P on the platelet surface was seen after 10 min of incubation on platelets interacting with vWF and normal plasma-coated surfaces (79 and 67%, respectively). On the surfaces coated with albumin and factor VIII deficient plasma, the exposure was low (11 and 27%, respectively). A higher formation of filipodial extensions on the platelets was seen on the surfaces coated with vWF and normal plasma than on the surfaces coated with albumin or factor VIII deficient plasma. No significant differences were seen between the surfaces regarding the platelet release of PF4, ATP, or phospholipids. As shown by these results, vWF is a specific regulator of the exposure of CD62P by platelets and hence important for the interaction between platelets and later arriving neutrophils at biomaterial surfaces. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Univ Gothenburg, Dept Anat & Cell Biol, S-40530 Gothenburg, Sweden.
RP Broberg, M (reprint author), Univ Gothenburg, Dept Anat & Cell Biol, Box 420, S-40530 Gothenburg, Sweden.
CR AZIZ KA, 1995, BRIT J HAEMATOL, V91, P846, DOI 10.1111/j.1365-2141.1995.tb05399.x
   BROBERG M, UNPUB PLATELET RELEA
   BUSCH C, 1980, THROMB RES, V19, P129, DOI 10.1016/0049-3848(80)90412-0
   BUTTRUM SM, 1993, BLOOD, V82, P1165
   CAPITANIO AM, 1985, BIOCHIM BIOPHYS ACTA, V839, P161, DOI 10.1016/0304-4165(85)90033-9
   CRAMER EM, 1994, BLOOD, V84, P1722
   Cunningham JG, 1996, J BIOL CHEM, V271, P11581, DOI 10.1074/jbc.271.19.11581
   DAHLGREN C, 1981, J IMMUNOL METHODS, V40, P171, DOI 10.1016/0022-1759(81)90064-8
   Du X, 1997, THROMB HAEMOSTASIS, V78, P96
   EICHHOLTZ T, 1993, BIOCHEM J, V291, P677, DOI 10.1042/bj2910677
   Eriksson C, 1997, J BIOMED MATER RES, V37, P130, DOI 10.1002/(SICI)1097-4636(199710)37:1<130::AID-JBM16>3.0.CO;2-K
   ERIKSSON C, 2000, THESIS
   Evangelista V, 1999, BLOOD, V93, P876
   Evangelista V, 1996, BLOOD, V88, P4183
   Falati S, 1999, BLOOD, V94, P1648
   Frojmovic MM, 1997, THROMB HAEMOSTASIS, V77, P568
   FURIE B, 1995, THROMB HAEMOSTASIS, V74, P224
   Furlan M, 1996, ANN HEMATOL, V72, P341, DOI 10.1007/s002770050184
   FURLAN M, 1987, BIOCHIM BIOPHYS ACTA, V924, P27, DOI 10.1016/0304-4165(87)90067-5
   GEORGE JN, 1982, BLOOD, V59, P194
   HORNE MK, 1993, THROMB RES, V70, P91
   HOUDIJK WPM, 1986, ARTERIOSCLEROSIS, V6, P24, DOI 10.1161/01.ATV.6.1.24
   IKEDA Y, 1991, J CLIN INVEST, V87, P1234, DOI 10.1172/JCI115124
   JAFFE EA, 1974, P NATL ACAD SCI USA, V71, P1906, DOI 10.1073/pnas.71.5.1906
   KAPLAN KL, 1979, BLOOD, V53, P604
   KLINGER MHF, 1995, INT ARCH ALLERGY IMM, V107, P541, DOI 10.1159/000237097
   KORTH R, 1993, LIPIDS, V28, P193, DOI 10.1007/BF02536639
   MOORE KL, 1994, J BIOL CHEM, V269, P23318
   NAGATA K, 1993, J IMMUNOL, V151, P3267
   Nygren H, 1998, J BIOMAT SCI-POLYM E, V9, P817, DOI 10.1163/156856298X00172
   Nygren H, 1997, J LAB CLIN MED, V129, P35, DOI 10.1016/S0022-2143(97)90159-1
   OSTERMAN DG, 1982, BIOCHEM BIOPH RES CO, V107, P130, DOI 10.1016/0006-291X(82)91679-5
   PEERSCHKE EIB, 1993, J EXP MED, V178, P579, DOI 10.1084/jem.178.2.579
   RIKSSON C, 2001, J LAB CLIN MED, V137, P56
   SAKARIASSEN KS, 1979, NATURE, V279, P636, DOI 10.1038/279636a0
   SAKO D, 1993, CELL, V75, P1179, DOI 10.1016/0092-8674(93)90327-M
   Savage B, 1998, CELL, V94, P657, DOI 10.1016/S0092-8674(00)81607-4
   SAVAGE B, 1992, J BIOL CHEM, V267, P11300
   STEL HV, 1985, BLOOD, V65, P85
   VROMAN L, 1988, B NEW YORK ACAD MED, V64, P352
   Wu YP, 1996, ARTERIOSCL THROM VAS, V16, P611, DOI 10.1161/01.ATV.16.5.611
   YEO EL, 1994, BLOOD, V83, P2498
   Yuan YP, 1999, J BIOL CHEM, V274, P36241, DOI 10.1074/jbc.274.51.36241
NR 43
TC 14
Z9 17
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD SEP
PY 2001
VL 22
IS 17
BP 2403
EP 2409
DI 10.1016/S0142-9612(00)00427-0
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 460GT
UT WOS:000170300400010
PM 11511037
DA 2018-10-20
ER

PT J
AU Grigolo, B
   Roseti, L
   Fiorini, M
   Fini, M
   Giavaresi, G
   Aldini, NN
   Giardino, R
   Facchini, A
AF Grigolo, B
   Roseti, L
   Fiorini, M
   Fini, M
   Giavaresi, G
   Aldini, NN
   Giardino, R
   Facchini, A
TI Transplantation of chondrocytes seeded on a hyaluronan derivative (Hyaff
   (R)-11) into cartilage defects in rabbits
SO BIOMATERIALS
LA English
DT Article
DE chondrocytes; transplantation; articular cartilage; Hyaff (R)-11
ID ARTICULAR-CARTILAGE; OSTEOCHONDRAL DEFECTS; ALLOGRAFT CHONDROCYTES;
   PERIOSTEAL GRAFTS; COLLAGEN GEL; CANINE MODEL; KNEE-JOINT; REPAIR;
   RECONSTRUCTION; ALGINATE
AB Different methods have been used to improve chondrocyte transplantation for the repair of articular cartilage defects. Several groups of biomaterials have been proposed as support for in vitro cell growth and for in vivo implantation. Here, we describe a new approach investigating the healing of rabbit cartilage by means of autologous chondrocytes seeded on a hyaluronan derivative referred to as Hyaff(R)-11. Full thickness defects were created bilaterally in the weight-bearing Surface of the medial femoral condyle of both femora of New Zealand male rabbits. The wounds were then repaired using both chondrocytes seeded on the biomaterial and biomaterial alone. Controls were similarly treated but received either no treatment or implants of the delivery substance. Histologic samples from in and around the defect sites were examined 1, 3 and 6 months after surgery and were scored from 0 to 16. Statistically significant differences in the quality of the regenerated tissue were found between the grafts carried out with biomaterial carrying chondrocyte cells compared to the biomaterial alone or controls. This study demonstrates the efficacy of this hyaluronan-based scaffold for autologous chondrocytes transplantation. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Ist Ortoped Rizzoil, Ist Ric Codivilla Putti, Lab Immunol & Genet, I-40136 Bologna, Italy.
   Ist Ortoped Rizzoil, Ist Ric Codivilla Putti, Serv Chirurg Sperimentale, I-40136 Bologna, Italy.
   Univ Bologna, Dipartimento Med Interna & Gastroenterol, I-40138 Bologna, Italy.
RP Facchini, A (reprint author), Ist Ortoped Rizzoil, Ist Ric Codivilla Putti, Lab Immunol & Genet, Via Barbiano 1-10, I-40136 Bologna, Italy.
RI Grigolo, Brunella/J-5417-2016
OI Grigolo, Brunella/0000-0002-3990-6745; Giavaresi,
   Gianluca/0000-0001-7843-5969; Fini, Milena/0000-0002-3732-3570
CR BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7
   BONAVENTURE J, 1994, EXP CELL RES, V212, P97, DOI 10.1006/excr.1994.1123
   Breinan HA, 1997, J BONE JOINT SURG AM, V79A, P1439, DOI 10.2106/00004623-199710000-00001
   Brittberg M, 1997, BIOMATERIALS, V18, P235, DOI 10.1016/S0142-9612(96)00117-2
   Brittberg M, 1996, CLIN ORTHOP RELAT R, P270
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   BUCKWALTER JA, 1994, J BONE JOINT SURG AM, V76A, P1405, DOI 10.2106/00004623-199409000-00019
   CAMPOCCIA D, 1993, BIOMATERIALS, V14, P1135, DOI 10.1016/0142-9612(93)90156-V
   Carranza-Bencano A, 1999, CALCIFIED TISSUE INT, V65, P402, DOI 10.1007/s002239900721
   Chu CR, 1997, CLIN ORTHOP RELAT R, P220
   COLETTI JM, 1972, J BONE JOINT SURG AM, VA 54, P147, DOI 10.2106/00004623-197254010-00014
   FREED LE, 1993, J BIOMED MATER RES, V27, P11, DOI 10.1002/jbm.820270104
   FREED LE, 1994, J BIOMED MATER RES, V28, P891, DOI 10.1002/jbm.820280808
   Fujimoto E, 1999, ARCH ORTHOP TRAUM SU, V119, P139, DOI 10.1007/s004020050377
   GOMARSANCHO F, 1987, INT ORTHOP, V11, P65, DOI 10.1007/BF00266060
   GRANDE DA, 1987, ANAT REC, V218, P142, DOI 10.1002/ar.1092180208
   GRANDE DA, 1989, J ORTHOP RES, V7, P208, DOI 10.1002/jor.1100070208
   Guzzardella GA, 2000, J APPL ANIM RES, V17, P217, DOI 10.1080/09712119.2000.9706305
   HENDRICKSON DA, 1994, J ORTHOP RES, V12, P484
   HOMMINGA GN, 1989, ACTA ORTHOP SCAND, V60, P326, DOI 10.3109/17453678909149287
   Kawamura S, 1998, ACTA ORTHOP SCAND, V69, P56, DOI 10.3109/17453679809002358
   KIM HKW, 1991, J BONE JOINT SURG AM, V73A, P1301, DOI 10.2106/00004623-199173090-00004
   MANKIN HJ, 1982, J BONE JOINT SURG AM, V64, P460, DOI 10.2106/00004623-198264030-00022
   MILLER D V, 1989, Arthroscopy, V5, P245, DOI 10.1016/0749-8063(89)90137-0
   Morrone G, 2000, ARTIF CELL BLOOD SUB, V28, P321, DOI 10.3109/10731190009119362
   Nehrer S, 1998, BIOMATERIALS, V19, P2313, DOI 10.1016/S0142-9612(98)00143-4
   ODRISCOLL SW, 1988, J BONE JOINT SURG AM, V70A, P595, DOI 10.2106/00004623-198870040-00017
   RASTRELLI A, 1990, CLIN IMPLANT MAT, V9, P199
   RUBAK JM, 1982, ACTA ORTHOP SCAND, V53, P175, DOI 10.3109/17453678208992197
   Shortkroff S, 1996, BIOMATERIALS, V17, P147, DOI 10.1016/0142-9612(96)85759-0
   Stanton JS, 1995, J MATER SCI-MATER M, V6, P739
   TRIPPEL SB, 1995, NEW ENGL J MED, V332, P539
   VACHON AM, 1991, AM J VET RES, V52, P317
   vanSusante JLC, 1995, ACTA ORTHOP SCAND, V66, P549, DOI 10.3109/17453679509002314
   WAKITANI S, 1989, J BONE JOINT SURG BR, V71, P74
   Wei XC, 1999, J BIOMED MATER RES, V46, P539, DOI 10.1002/(SICI)1097-4636(19990915)46:4<539::AID-JBM12>3.0.CO;2-S
   Wei XC, 1997, J BIOMED MATER RES, V34, P63, DOI 10.1002/(SICI)1097-4636(199701)34:1<63::AID-JBM9>3.0.CO;2-L
   WRIGHT JG, 1995, NEW ENGL J MED, V332, P540
NR 38
TC 179
Z9 190
U1 0
U2 13
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD SEP
PY 2001
VL 22
IS 17
BP 2417
EP 2424
DI 10.1016/S0142-9612(00)00429-4
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 460GT
UT WOS:000170300400012
PM 11511039
DA 2018-10-20
ER

PT J
AU Andersson, J
   Larsson, R
   Richter, R
   Ekdahl, KN
   Nilsson, B
AF Andersson, J
   Larsson, R
   Richter, R
   Ekdahl, KN
   Nilsson, B
TI Binding of a model regulator of complement activation (RCA) to a
   biomaterial surface: surface-bound factor H inhibits complement
   activation
SO BIOMATERIALS
LA English
DT Article
DE biocompatibility; blood; complement activation; factor H
ID IN-VITRO MODEL; CARDIOPULMONARY BYPASS; EXTRACORPOREAL-CIRCULATION;
   PROTEIN BETA-1H; WHOLE-BLOOD; PURIFICATION; ADSORPTION; INTERFACES;
   GENERATION; PLATELET
AB The complement system is an important inflammatory mediator during procedures such as cardiopulmonary bypass and hemodialysis when blood is exposed to large areas of biomaterial surface. This contact between blood and the biomaterials of implants and extracorporeal circuits leads to an inflammatory response mediated by the complement system. The aim of this study was to assess the ability of a complement regulator (factor H) immobilised on a biomaterial surface to inhibit complement cascade mediated inflammatory responses. The cross-linker-N-succinimidyl 3-(2-pyridyldithio) propionate was used to immobilise factor H on a model biomaterial surface without affecting the biological activity of the inhibitor. Binding of factor H was then characterised using quartz crystal micro balance-dissipation (QCM-D) and enzyme immunoassays for products of complement activation: bound C3 fragments and soluble C3a, sC5b-9, and C1s-C1INA. Immobilised factor H reduced the amount C3 fragments deposited on the biomaterial surface after incubation with serum, plasma, or whole blood. In addition, lower levels of soluble C3a, and sC5b-9 were generated after incubation with whole blood. In summary, we have demonstrated that complement activation on a highly activating model surface can be inhibited by immobilised factor H and have defined prerequisites for the preparation of future biomaterial surfaces with immobilised regulators of complement activation. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Univ Hosp, Clin Immunol Sect, S-75185 Uppsala, Sweden.
   Q Sense AB, S-41292 Gothenburg, Sweden.
   Univ Kalmar, Dept Chem & Biomed Sci, S-39182 Kalmar, Sweden.
RP Nilsson, B (reprint author), Univ Hosp, Clin Immunol Sect, S-75185 Uppsala, Sweden.
RI Nilsson Ekdahl, Kristina/B-5301-2012; Richter, Ralf Peter/B-3343-2013;
   Nilsson, Bo/B-3102-2012
OI Richter, Ralf Peter/0000-0003-3071-2837; Nilsson, Bo/0000-0003-0057-2730
CR Caruso F, 1997, J COLLOID INTERF SCI, V186, P129, DOI 10.1006/jcis.1996.4625
   COURTNEY JM, 1994, BIOMATERIALS, V15, P737, DOI 10.1016/0142-9612(94)90026-4
   DECORDOBA SR, 1987, IMMUNOGENETICS, V25, P267
   DISCIPIO RG, 1992, J IMMUNOL, V149, P2592
   EASTERBROOKSMITH SB, 1992, MOL IMMUNOL, V29, P1203, DOI 10.1016/0161-5890(92)90056-4
   Efendic E, 1999, Lakartidningen, V96, P4538
   EKDAHL KN, 1992, SCAND J IMMUNOL, V35, P85, DOI 10.1111/j.1365-3083.1992.tb02837.x
   Gong J, 1996, J CLIN IMMUNOL, V16, P222, DOI 10.1007/BF01541228
   GREELEY WJ, 1991, ANN THORAC SURG, V52, P417, DOI 10.1016/0003-4975(91)90900-B
   HAMMER CH, 1981, J BIOL CHEM, V256, P3995
   HIMMELFARB J, 1995, J LAB CLIN MED, V126, P392
   HOLERS VM, 1992, IMMUNOL TODAY, V13, P231
   HOLME ER, 1992, MOL IMMUNOL, V29, P957, DOI 10.1016/0161-5890(92)90134-J
   Hong J, 1999, BIOMATERIALS, V20, P603, DOI 10.1016/S0142-9612(98)00210-5
   Hook F, 1998, P NATL ACAD SCI USA, V95, P12271, DOI 10.1073/pnas.95.21.12271
   Hook F, 1998, J COLLOID INTERF SCI, V208, P63, DOI 10.1006/jcis.1998.5774
   HOOK F, 2001, UNPUB J AM CHEM SOC
   KIRKLIN JK, 1989, CARDIOPULMONARY BYPA, P3026
   Larsson R, 1997, IMMUNOPHARMACOLOGY, V38, P119, DOI 10.1016/S0162-3109(97)00064-7
   MCALEER MA, 1988, GENOME S, V30, P136
   Mollnes TE, 1998, VOX SANG, V74, P303, DOI 10.1111/j.1423-0410.1998.tb05435.x
   MOLLNES TE, 1985, SCAND J IMMUNOL, V22, P197, DOI 10.1111/j.1365-3083.1985.tb01871.x
   Nangaku M, 1998, KIDNEY INT, V54, P1419, DOI 10.1046/j.1523-1755.1998.00130.x
   Nilsson B, 1998, BLOOD, V92, P1661
   NILSSON UR, 1965, J EXP MED, V122, P277, DOI 10.1084/jem.122.2.277
   NILSSON UR, 1993, SCAND J IMMUNOL, V37, P349, DOI 10.1111/j.1365-3083.1993.tb02564.x
   PANGBURN MK, 1977, J EXP MED, V146, P257, DOI 10.1084/jem.146.1.257
   PEKNA M, 1993, CLIN EXP IMMUNOL, V91, P404
   RATNER BD, 1996, BIOMATERIALS SCI INT, P484
   Rauterberg E W, 1988, Adv Exp Med Biol, V240, P365
   RINDER CS, 1995, J CLIN INVEST, V96, P1564, DOI 10.1172/JCI118195
   RIPOCHE J, 1988, BIOCHEM J, V249, P593, DOI 10.1042/bj2490593
   RODAHL M, 1995, REV SCI INSTRUM, V66, P3924, DOI 10.1063/1.1145396
   Rodahl M, 1997, FARADAY DISCUSS, V107, P229, DOI 10.1039/a703137h
   Sahu A, 1996, J IMMUNOL, V157, P884
   SAUERBREY G, 1959, Z PHYS, V155, P206, DOI 10.1007/BF01337937
   SEYA T, 1995, MICROBIOL IMMUNOL, V39, P295, DOI 10.1111/j.1348-0421.1995.tb02205.x
   STORM KE, 1992, VET IMMUNOL IMMUNOP, V34, P47, DOI 10.1016/0165-2427(92)90151-F
   Voinova MV, 1999, PHYS SCRIPTA, V59, P391, DOI 10.1238/Physica.Regular.059a00391
   Wanner C, 1997, Kidney Int Suppl, V62, pS53
   WEILER JM, 1976, P NATL ACAD SCI USA, V73, P3268, DOI 10.1073/pnas.73.9.3268
   WHALEY K, 1976, J EXP MED, V144, P1147, DOI 10.1084/jem.144.5.1147
NR 42
TC 34
Z9 37
U1 1
U2 12
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD SEP
PY 2001
VL 22
IS 17
BP 2435
EP 2443
DI 10.1016/S0142-9612(00)00431-2
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 460GT
UT WOS:000170300400014
PM 11511041
DA 2018-10-20
ER

PT J
AU Alferiev, IS
   Hinson, JT
   Ogle, M
   Breuer, E
   Levy, RJ
AF Alferiev, IS
   Hinson, JT
   Ogle, M
   Breuer, E
   Levy, RJ
TI High reactivity of alkyl sulfides towards epoxides under conditions of
   collagen fixation - a convenient approach to 2-amino-4-butyrolactones
SO BIOMATERIALS
LA English
DT Article
DE alkylations; oxiranes; tissue fixation; bioorganic chemistry;
   2-amino-4-butyrolactones
ID ACID
AB Epoxy crosslinking agents have been investigated for use in the fabrication of bioprosthetic devices, such as heterograft heart valve prostheses. It has been generally assumed that epoxy crosslinking takes place via amino-epoxy reactions. The present study investigated the hypothesis that the reactions of methionine residues with epoxides also can occur in biomaterial crosslinking. A series of model reactions were studied in which a mono-epoxide was combined with individual alkyl sulfides. In the present studies epoxides rapidly alkylate aliphatic sulfides, including methionine derivatives, in buffered aqueous solutions at room temperature and pH close to neutral, forming sulfonium compounds, which are stable at pH 5-7 at temperatures up to 50 degreesC, except for cases in which methionine derivatives with non-protected carboxy groups are used. The rate of reaction remains practically unchanged within the range of pH from 5 to 12, whereas in strongly alkaline media the reverse reaction occurs. This discovery can provide a better understanding of processes occurring in the fixation of bioprosthetic tissues with polyepoxides. It can also develop into a site-specific method to label methionine residues in proteins. The carboxy group-containing sulfonium betaines derived from N-protected methionines undergo cyclization in unexpectedly mild conditions, which can be used as an efficient method for preparation of N-protected 2-amino-4-butyrolactones with sensitive protective groups. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Childrens Hosp Philadelphia, Div Cardiol, Abramson Res Ctr, Philadelphia, PA 19104 USA.
   St Jude Med Inc, St Paul, MN 55117 USA.
   Hebrew Univ Jerusalem, Dept Med Chem, IL-91120 Jerusalem, Israel.
RP Levy, RJ (reprint author), Childrens Hosp Philadelphia, Div Cardiol, Abramson Res Ctr, Suite 702,3516 Civic Ctr Blvd, Philadelphia, PA 19104 USA.
RI Breuer, Eli/E-8382-2011
FU NHLBI NIH HHS [HL59730]
CR Alferiev IS, 2001, J POLYM SCI POL CHEM, V39, P105, DOI 10.1002/1099-0518(20010101)39:1<105::AID-POLA120>3.3.CO;2-#
   Berkowitz DB, 1996, SYNTHESIS-STUTTGART, P39, DOI 10.1055/s-1996-4177
   Karnbrock W, 1996, J AM CHEM SOC, V118, P913, DOI 10.1021/ja953222j
   KRIEF A, 1989, SYNTHETIC COMMUN, V19, P1203, DOI 10.1080/00397918908054524
   MATSUURA F, 1994, TETRAHEDRON, V50, P265, DOI 10.1016/S0040-4020(01)80749-3
   Moore MA, 1996, J BIOMED MATER RES, V32, P209, DOI 10.1002/(SICI)1097-4636(199610)32:2<209::AID-JBM9>3.0.CO;2-X
   OKUMA K, 1987, HETEROCYCLES, V26, P2343, DOI 10.3987/R-1987-09-2343
   OZINSKAS AJ, 1986, J ORG CHEM, V51, P5047, DOI 10.1021/jo00376a001
   PATTENDEN G, 1991, TETRAHEDRON LETT, V32, P259, DOI 10.1016/0040-4039(91)80870-C
   Snyder HR, 1942, J AM CHEM SOC, V64, P2082, DOI 10.1021/ja01261a022
   Tang Z, 1995, ASAIO J, V41, P72, DOI 10.1097/00002480-199501000-00012
   TU R, 1994, J BIOMED MATER RES, V28, P677, DOI 10.1002/jbm.820280604
   TU R, 1993, INT J ARTIF ORGANS, V16, P537
   WANG E, 1993, INT J ARTIF ORGANS, V16, P530
   Weitz IS, 1997, J ORG CHEM, V62, P2527, DOI 10.1021/jo962257e
NR 15
TC 10
Z9 10
U1 1
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD SEP
PY 2001
VL 22
IS 18
BP 2501
EP 2506
DI 10.1016/S0142-9612(00)00440-3
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 460GV
UT WOS:000170300600009
PM 11516082
DA 2018-10-20
ER

PT J
AU Gottenbos, B
   Klatter, F
   Van Der Mei, HC
   Busscher, HJ
   Nieuwenhuis, P
AF Gottenbos, B
   Klatter, F
   Van Der Mei, HC
   Busscher, HJ
   Nieuwenhuis, P
TI Late hematogenous infection of subcutaneous implants in rats
SO CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY
LA English
DT Article
ID BACTERIAL TRANSLOCATION; PSEUDOMONAS-AERUGINOSA; STAPHYLOCOCCUS-AUREUS;
   BIOMEDICAL POLYMERS; ADHESION; COLONIZATION
AB Late biomaterial-centered infection is a major complication associated with the use of biomaterial implants. In this study biomaterials that had been implanted subcutaneously in rats were hematogenously challenged with bacteria 4 weeks after implantation. Bacteria were spread either by intravenous injection or by stimulation of bacterial translocation. It was found that none of the biomaterials was infected by hematogenous spread, whereas 5% of the implants were infected by perioperative contamination. We conclude that late hematogenous infection of subcutaneous biomaterials does not occur in the rat. For humans as well, there are growing doubts whether implants actually become infected through hematogenous routes; it is thought that late infections may be caused by delayed appearance of perioperatively introduced bacteria.
C1 Univ Groningen, Fac Med Sci, Dept Biomed Engn, NL-9713 AV Groningen, Netherlands.
   Univ Groningen, Fac Med Sci, Dept Cell Biol, Immunol Sect, NL-9713 AV Groningen, Netherlands.
RP Busscher, HJ (reprint author), Univ Groningen, Fac Med Sci, Dept Biomed Engn, Antonius Deusinglaan 1, NL-9713 AV Groningen, Netherlands.
CR AHLBERG A, 1978, CLIN ORTHOP RELAT R, P69
   BENGTSON S, 1987, ACTA ORTHOP SCAND, V58, P529, DOI 10.3109/17453678709146393
   BERG RD, 1975, INFECT IMMUN, V11, P320
   BLACKBURN WD, 1991, ARTHRITIS RHEUM, V34, P110, DOI 10.1002/art.1780340118
   BLOMGREN G, 1980, CLIN ORTHOP RELAT R, P308
   BLOMGREN G, 1981, CLIN ORTHOP RELAT R, P244
   DANKERT J, 1986, CRIT REV BIOCOMPAT, V2, P219
   Deitch EA, 1994, GUT               S1, V35, pS23
   Duchmann R, 1996, EUR J IMMUNOL, V26, P934, DOI 10.1002/eji.1830260432
   EDMISTON CE, 1991, SURG GYNECOL OBSTET, V173, P73
   Gottenbos B, 2000, J BIOMED MATER RES, V50, P208, DOI 10.1002/(SICI)1097-4636(200005)50:2<208::AID-JBM16>3.0.CO;2-D
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   GUO W, 1993, SCAND J GASTROENTERO, V28, P393, DOI 10.3109/00365529309098238
   LaPorte DM, 1999, J BONE JOINT SURG BR, V81B, P56, DOI 10.1302/0301-620X.81B1.8608
   MANILOFF G, 1987, CLIN ORTHOP RELAT R, P194
   MERRITT K, 1979, J BIOMED MATER RES, V13, P101, DOI 10.1002/jbm.820130111
   MOORE WS, 1980, ARCH SURG-CHICAGO, V115, P1379
   MORA EM, 1991, ARCH SURG-CHICAGO, V126, P157
   *NIH, 1985, NIH PUBL, V8623
   O'Boyle CJ, 1998, GUT, V42, P29, DOI 10.1136/gut.42.1.29
   POSS R, 1984, CLIN ORTHOP RELAT R, P117
   Printzen G, 1996, INJURY, V27, P9
   Smith RP, 2000, J ANTIMICROB CHEMOTH, V45, P483, DOI 10.1093/jac/45.4.483
   SOUTHWOOD RT, 1985, J BONE JOINT SURG BR, V67, P229
   VANLEEUWEN PAM, 1994, GUT, V35, pS28, DOI 10.1136/gut.35.1_Suppl.S28
   WIEDERMANN U, 1995, INFECT IMMUN, V63, P3062
   ZDANOWSKI Z, 1994, ARTIF ORGANS, V18, P448, DOI 10.1111/j.1525-1594.1994.tb02231.x
NR 27
TC 5
Z9 5
U1 0
U2 2
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 1071-412X
J9 CLIN DIAGN LAB IMMUN
JI Clin. Diagn. Lab. Immunol.
PD SEP
PY 2001
VL 8
IS 5
BP 980
EP 983
DI 10.1128/CDLI.8.5.980-983.2001
PG 4
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA 471ZR
UT WOS:000170959000024
PM 11527814
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU Luo, Y
   Prestwich, GD
AF Luo, Y
   Prestwich, GD
TI Novel biomaterials for drug delivery
SO EXPERT OPINION ON THERAPEUTIC PATENTS
LA English
DT Review
DE biodegradable; biomaterials; drug delivery; hybrid; inorganic; natural;
   polymer; synthetic
ID HUMAN GROWTH-HORMONE; CALCIUM-PHOSPHATE BIOMATERIAL;
   LACTIDE-CO-GLYCOLIDE; CONTROLLED-RELEASE; IN-VITRO; BIODEGRADABLE
   MICROSPHERES; HYDROLYTIC DEGRADATION; POLY(ETHYLENE GLYCOL);
   BLOCK-COPOLYMERS; POLYMERIC DRUGS
AB Safety and efficacy of pharmaceutical agents can be greatly improved by encapsulation within, or covalent attachment to, a biomaterial carrier. Such drug delivery systems differ from conventional drug dosage forms (pills, tablets, ointments, creams, injectables and 'tiny time capsules') in that a localised depot of drug provides patterned release of the active agent with a predetermined time course. The pattern of drug release may be constant, oscillating, declining continuously, or even pulsatile. The need to engineer different release patterns for drugs of different molecular sizes, potency, stability and hydrophobicity provides the impetus for active study of the design of new biomaterials, intelligent delivery systems and approaches for delivery through different portals in the body. The field of controlled drug delivery provides a driving force for current innovations in biomaterials. For most drug delivery systems, polymers function simply as inert, biocompatible carriers. In other systems, polymers can be designed with targeting or pathology-responsive functions. This review summarises some of the recently developed intellectual property in the field of biomaterials applied to drug delivery systems. Included are implantable ceramics and other inorganic materials, nondegradable and degradable synthetic polymers, natural polymers and hybrid biomaterials derived from synthetic and natural polymers.
C1 Univ Utah, Dept Med Chem, Salt Lake City, UT 84112 USA.
RP Prestwich, GD (reprint author), Univ Utah, Dept Med Chem, 30 South 2000 East,Room 201, Salt Lake City, UT 84112 USA.
CR ALLCOCK HR, 1983, MACROMOLECULES, V16, P1401, DOI 10.1021/ma00243a001
   ANDARIS LTD, 1997, Patent No. 9710850
   Bell CL, 1996, J BIOMAT SCI-POLYM E, V7, P671, DOI 10.1163/156856296X00444
   Bellini D., 2000, [No title captured], Patent No. [W00001733 (Al), 0001733, WO0001733A1]
   BEMOIT MA, 1997, INT ORTHOP, V21, P403
   BOARD TRUSTEES U ILL, 1997, Patent No. 9737680
   BOUHADIR KH, 1999, 217 ACS NAT M AN CAL
   BOUHADIR KH, 1998, 216 ACS NAT M BOST A
   Bruining MJ, 1999, J BIOMED MATER RES, V47, P189, DOI 10.1002/(SICI)1097-4636(199911)47:2<189::AID-JBM8>3.0.CO;2-M
   CAMPBELL P, 1980, ARCH BIOCHEM BIOPHYS, V203, P676, DOI 10.1016/0003-9861(80)90225-8
   Campoccia D, 1998, BIOMATERIALS, V19, P2101, DOI 10.1016/S0142-9612(98)00042-8
   Chaput C, 1995, MATER RES SOC SYMP P, V385, P49, DOI 10.1557/PROC-385-49
   Cleland JL, 1997, PHARMACEUT RES, V14, P420, DOI 10.1023/A:1012031012367
   Cleland JL, 1996, PHARMACEUT RES, V13, P1464, DOI 10.1023/A:1016063109373
   DAHIYAT BI, 1995, J CONTROL RELEASE, V33, P13, DOI 10.1016/0168-3659(94)00039-W
   DANBIOSYST UK LTD, 1997, Patent No. 9735562
   DROHAN WN, 1996, Patent No. 9641818
   DUCHEYNE P, 1997, Patent No. 5591453
   DV TECH INC, 1997, Patent No. 9721441
   E KARLS U TUBINGEN, 1997, Patent No. 9707204
   Egilmez NK, 2000, CANCER RES, V60, P3832
   Eligio T, 1999, ANGEW MAKROMOL CHEM, V270, P69
   ELSAYED M, 2000, POLYM PREPR, V41, P1726
   EMISPHERE TECH INC, 1997, Patent No. 5601846
   ENGELBERG J, 1991, BIOMATERIALS, V12, P290
   FEIJEN J, 1994, EUR J PHARM SCI, V2, P7, DOI 10.1016/0928-0987(94)90050-7
   Feng Y, 1999, MATERIALWISS WERKST, V30, P862, DOI 10.1002/(SICI)1521-4052(199912)30:12<862::AID-MAWE862>3.3.CO;2-Z
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Gaspar MM, 1998, J CONTROL RELEASE, V52, P53
   Gautier H, 1998, J BIOMED MATER RES, V40, P606, DOI 10.1002/(SICI)1097-4636(19980615)40:4<606::AID-JBM12>3.0.CO;2-D
   Gautier H, 2000, J BIOMED MATER RES, V52, P308, DOI 10.1002/1097-4636(200011)52:2<308::AID-JBM9>3.0.CO;2-6
   Goodwin CJ, 1998, J BIOMED MATER RES, V40, P204
   Griffith LG, 2000, ACTA MATER, V48, P263, DOI 10.1016/S1359-6454(99)00299-2
   Guicheux J, 1998, J BIOMED MATER RES, V40, P79, DOI 10.1002/(SICI)1097-4636(199804)40:1<79::AID-JBM9>3.0.CO;2-O
   Guicheux J, 1998, J BONE MINER RES, V13, P739, DOI 10.1359/jbmr.1998.13.4.739
   GURSEL I, 1997, P INT S CONTR REL BI, P1045
   Hanes J, 1998, BIOMATERIALS, V19, P163, DOI 10.1016/S0142-9612(97)00221-4
   Hassan CM, 2000, EUR J PHARM BIOPHARM, V49, P161, DOI 10.1016/S0939-6411(99)00056-9
   HELLER J, 1987, Journal of Controlled Release, V6, P217, DOI 10.1016/0168-3659(87)90078-2
   HELLER J, 1990, BIOMATERIALS, V11, P659, DOI 10.1016/0142-9612(90)90024-K
   HELLER J, 2001, 10 INT S REC ADV DRU, P49
   HOFFMAN AS, 1984, POLYM MAT ARTIFICIAL, P13
   Inukai M, 2000, CHEM PHARM BULL, V48, P850
   JALIL RU, 1990, DRUG DEV IND PHARM, V16, P2353, DOI 10.3109/03639049009058535
   Jeong B, 1999, J CONTROL RELEASE, V62, P109, DOI 10.1016/S0168-3659(99)00061-9
   Jeong B, 1997, NATURE, V388, P860, DOI 10.1038/42218
   JEONG S Y, 1986, Archives of Pharmacal Research (Seoul), V9, P63, DOI 10.1007/BF02857213
   Jo S, 1999, J BIOACT COMPAT POL, V14, P457, DOI 10.1177/088391159901400602
   John G, 1999, MACROMOLECULES, V32, P1853, DOI 10.1021/ma981729j
   Kim DD, 1998, PHARMACEUT RES, V15, P783
   Kim Y, 1999, CHEM-EUR J, V5, P2133, DOI 10.1002/(SICI)1521-3765(19990702)5:7<2133::AID-CHEM2133>3.0.CO;2-J
   Kimakhe S, 1999, J BIOMED MATER RES, V47, P18, DOI 10.1002/(SICI)1097-4636(199910)47:1<18::AID-JBM3>3.0.CO;2-T
   Kishida A, 1998, J BIOACT COMPAT POL, V13, P270, DOI 10.1177/088391159801300403
   Kishida A, 1998, J BIOACT COMPAT POL, V13, P222, DOI 10.1177/088391159801300305
   KOBAYASHI H, 1992, J BIOMED MATER RES, V26, P1463, DOI 10.1002/jbm.820261106
   KOHN J, 1986, BIOMATERIALS, V7, P176, DOI 10.1016/0142-9612(86)90098-0
   KOHN J, 1991, POLYM PREPR, V32, P223
   Kreitz MR, 1997, BIOMATERIALS, V18, P1645, DOI 10.1016/S0142-9612(97)00106-3
   Kuijpers AJ, 2000, J BIOMAT SCI-POLYM E, V11, P225, DOI 10.1163/156856200743670
   Kurisawa M, 1997, J BIOMAT SCI-POLYM E, V8, P691, DOI 10.1163/156856297X00506
   Lambotte J C, 1998, Chirurgie, V123, P572, DOI 10.1016/S0001-4001(99)80006-3
   Langer R, 2000, ACCOUNTS CHEM RES, V33, P94, DOI 10.1021/ar9800993
   Langer R, 1995, CHEM ENG SCI, V50, P4109, DOI 10.1016/0009-2509(95)00226-X
   LANGER R, 1995, MRS BULL, V20, P18
   Langer R, 1998, NATURE, V392, P5
   Lee KY, 2000, NATURE, V408, P998
   Lemons JE, 1996, BONE, V19, pS121, DOI 10.1016/S8756-3282(96)00128-7
   Li C, 1998, CANCER RES, V58, P2404
   Li SM, 1999, J BIOMED MATER RES, V48, P342, DOI 10.1002/(SICI)1097-4636(1999)48:3<342::AID-JBM20>3.0.CO;2-7
   Li SM, 2000, J MATER SCI-MATER M, V11, P227, DOI 10.1023/A:1008920326988
   LMOLINA I, 2001, BIOMATERIALS, V22, P363
   Lu L, 2000, J BIOMED MATER RES, V50, P440, DOI 10.1002/(SICI)1097-4636(20000605)50:3<440::AID-JBM19>3.0.CO;2-G
   LUCKE A, 2000, BIOMATERIALS, V21, P2371
   Luo Y, 2000, J CONTROL RELEASE, V69, P169, DOI 10.1016/S0168-3659(00)00300-X
   Luo Y, 1999, BIOCONJUGATE CHEM, V10, P755, DOI 10.1021/bc9900338
   Luo Y, 2000, BIOMACROMOLECULES, V1, P208, DOI 10.1021/bm000283n
   MACROMED INC, 1999, Patent No. 9918142
   MASSACHUSETTS I TECH, 1999, Patent No. 5955343
   Mathiowitz E, 1997, NATURE, V386, P410, DOI 10.1038/386410a0
   MAXIM PHARM, 1997, Patent No. 9705267
   MERKLI A, 1995, EUR J PHARM BIOPHARM, V41, P271
   Meyer DE, 2001, CANCER RES, V61, P1548
   Morita T, 2000, J CONTROL RELEASE, V69, P435, DOI 10.1016/S0168-3659(00)00326-6
   MULLER HM, 1993, ANGEW CHEM INT EDIT, V32, P477, DOI 10.1002/anie.199304771
   NAGARSEKAR A, 2000, AM CHEM SOC 220
   NOBES GAR, 1998, DRUG DELIV, V5, P161
   NUTTELMAN CR, 2000, POLYM PREPR, V41, P1685
   Ooya T., 2000, ACS SYM SER, V752, P375
   Pean JM, 1999, PHARMACEUT RES, V16, P1294, DOI 10.1023/A:1014818118224
   Peppas NA, 1999, J CONTROL RELEASE, V62, P81, DOI 10.1016/S0168-3659(99)00027-9
   Pettit DK, 1997, PHARMACEUT RES, V14, P1422, DOI 10.1023/A:1012176823155
   POINT BIOMEDICAL COR, 1999, Patent No. 9911196
   POUYANI T, 1997, Patent No. 5616568
   Prestwich GD, 2000, INT CONGR SER, V1196, P181
   PRESTWICH GD, 2001, GLCOFORUM
   Radice M, 2000, J BIOMED MATER RES, V50, P101, DOI 10.1002/(SICI)1097-4636(200005)50:2<101::AID-JBM2>3.0.CO;2-M
   Ramchandani M, 1998, J CONTROL RELEASE, V54, P167, DOI 10.1016/S0168-3659(97)00113-2
   Ramchandani M, 1997, J CONTROL RELEASE, V43, P161, DOI 10.1016/S0168-3659(96)01481-2
   Rao KP, 1995, J BIOMAT SCI-POLYM E, V7, P623
   Remunan-Lopez C, 1998, EUR J PHARM BIOPHARM, V45, P49, DOI 10.1016/S0939-6411(97)00122-7
   RodriguezLorenzo LM, 1996, J BIOMED MATER RES, V30, P515, DOI 10.1002/(SICI)1097-4636(199604)30:4<515::AID-JBM10>3.0.CO;2-G
   Rosa G D, 2000, J Control Release, V69, P283, DOI 10.1016/S0168-3659(00)00315-1
   Saito N, 1999, J BIOMED MATER RES, V47, P104, DOI 10.1002/(SICI)1097-4636(199910)47:1<104::AID-JBM15>3.0.CO;2-7
   Sanchez A, 1996, J PHARM SCI, V85, P547, DOI 10.1021/js960069y
   Sastry TP, 1997, J MACROMOL SCI PURE, VA34, P915, DOI 10.1080/10601329708014341
   SCHWARTE LM, 1998, ACS SYM SER, V709, P56
   Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569
   Serizawa T, 1999, J BIOMAT SCI-POLYM E, V10, P391, DOI 10.1163/156856299X00441
   SMITHKLINE BEECHAM P, 1997, Patent No. 9720579
   Suh HR, 1998, J BIOMED MATER RES, V42, P331, DOI 10.1002/(SICI)1097-4636(199811)42:2<331::AID-JBM19>3.0.CO;2-L
   SUPRATEK PHARM INC, 1999, Patent No. 9943343
   TAGAI T, 1997, KOBUTSUGAKU ZASSHI, V26, P59
   U GUELPH, 1997, Patent No. 9705899
   U UTAH RES FDN, 1999, Patent No. 9915151
   Vercruysse KP, 1998, CRIT REV THER DRUG, V15, P513
   VOURNAKIS JN, 1997, Patent No. 5624679
   WADE CWR, 1977, J TEST EVAL, V5, P397
   Wang C, 1999, NATURE, V397, P417, DOI 10.1038/17092
   Wang GJ, 1999, J ORG CHEM, V64, P4140, DOI 10.1021/jo9902852
   Won CY, 1996, MACROMOL RAPID COMM, V17, P653, DOI 10.1002/marc.1996.030170907
   YOSHIDA M, 1993, HOSHASEN, V19, P27
   Yu C, 1999, BIOMATERIALS, V20, P253, DOI 10.1016/S0142-9612(98)00169-0
   Yu YC, 1998, J AM CHEM SOC, V120, P9979, DOI 10.1021/ja981654z
   Zhang S., 1997, [No title captured], Patent No. [US5670483 A, 5670483]
   Zhu GZ, 2000, NAT BIOTECHNOL, V18, P52
   1997, Patent No. 9720575
   1997, Patent No. 9738731
   2000, Patent No. 0004924
   2000, Patent No. 0019976
NR 129
TC 23
Z9 23
U1 1
U2 30
PU ASHLEY PUBLICATIONS LTD
PI LONDON
PA UNITEC HOUSE, 3RD FL, 2 ALBERT PLACE FINCHLEY CENTRAL, LONDON N3 1QB,
   ENGLAND
SN 1354-3776
J9 EXPERT OPIN THER PAT
JI Expert Opin. Ther. Patents
PD SEP
PY 2001
VL 11
IS 9
BP 1395
EP 1410
PG 16
WC Chemistry, Medicinal; Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 468WU
UT WOS:000170781800003
DA 2018-10-20
ER

PT J
AU von Stechow, D
   Gaulthier, O
   Bouler, J
   Daculsi, G
   Aguado, E
   Muller, R
AF von Stechow, D
   Gaulthier, O
   Bouler, J
   Daculsi, G
   Aguado, E
   Muller, R
TI 3D micro-computed tomography assessment of injectable calcium phosphate
   biomaterial in vivo.
SO JOURNAL OF BONE AND MINERAL RESEARCH
LA English
DT Meeting Abstract
C1 Beth Israel Deaconess Med Ctr, Orthoped Biomech Lab, Boston, MA 02215 USA.
   Harvard Univ, Sch Med, Boston, MA USA.
   Ecole Natl Vet, Lab Chirurg, Nantes, France.
   Fac Chirurg Dent, Lab Rech Mat Interet Biol, Nantes, France.
   Inst Biomed Engn, Zurich, Switzerland.
   ETH Zurich, Zurich, Switzerland.
   Univ Zurich, CH-8006 Zurich, Switzerland.
RI Daculsi, Guy/P-1320-2014
OI Daculsi, Guy/0000-0003-1030-3446
NR 0
TC 0
Z9 0
U1 0
U2 3
PU AMER SOC BONE & MINERAL RES
PI WASHINGTON
PA 2025 M ST, N W, STE 800, WASHINGTON, DC 20036-3309 USA
SN 0884-0431
J9 J BONE MINER RES
JI J. Bone Miner. Res.
PD SEP
PY 2001
VL 16
SU 1
BP S343
EP S343
PG 1
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 467MU
UT WOS:000170709000848
DA 2018-10-20
ER

PT J
AU Ruan, JM
   Grant, MH
AF Ruan, JM
   Grant, MH
TI Biocompatibility evaluation in vitro. Part III: Cytotoxicity expression
   of human and animal osteoblasts on the biomaterials
SO JOURNAL OF CENTRAL SOUTH UNIVERSITY OF TECHNOLOGY
LA English
DT Article
DE biomaterial; cytotoxicity; biological molecular technique
ID CELLS; GROWTH
AB Exclusion and inflammation in the clinic are observed for various reasons including material chemical composition, physical properties as well as macro- and micro-structure of the implants, surface condition of the implants, and also patient dependent factors. Cytotoxicity expression of cells is a central issue in current biocompatibility to screen the potential implant materials and drugs. This study was aimed at investigation reaction between the potential implant materials and surround tissue. Cytotoxicity of human and rat osteoblast in the material extracts was determinated by testing standards such as GHS assay, MIT assay, alkaline phosphatase activity assay, LDH assay, and Lowry assay. Research results demonstrated that compared with the control condition polystyrene culture plate both human and rat osteoblast cells have normal phenotypic expression in hydroxyapatite extract, and this expression was statistically restricted in hydroxyapatite-spinel extract. However, this restrict, e. g. cytotoxicity could be partially eliminated by immersion treatment of the materials in culture medium.
C1 Cent S Univ, State Key Lab Powder Met, Changsha 410083, Peoples R China.
   Univ Strathclyde, Bioengn Unit, Glasgow G4 0NW, Lanark, Scotland.
RP Ruan, JM (reprint author), Cent S Univ, State Key Lab Powder Met, Changsha 410083, Peoples R China.
CR ANGERER J, 1999, ANAL HAZARDOUS SUBST, V6, P1
   ANUFORO DC, 1978, IN VITRO CELL DEV B, V14, P981
   GREGOIRE M, 1990, J BIOMED MATER RES, V24, P165, DOI 10.1002/jbm.820240204
   HISSIN PJ, 1976, ANAL BIOCHEM, V74, P214, DOI 10.1016/0003-2697(76)90326-2
   JEFFERY EH, 1995, TOXICOLOGY METALS C, P138
   Letzel S, 1996, OCCUP HYG, V3, P271
   Macnab G, 1996, SIGHT SOUND, V6, P71
   MACNAIR RA, 1997, J MATER SCI-MATER M, V47, P105
   Prigent H, 1998, J BIOMED MATER RES, V39, P200, DOI 10.1002/(SICI)1097-4636(199802)39:2<200::AID-JBM5>3.0.CO;2-T
   Rodgers EH, 1998, CHEM-BIOL INTERACT, V116, P213, DOI 10.1016/S0009-2797(98)00092-1
   RUAN J, 1993, FOUNCTIONAL MATES, V24, P561
   RUAN J, 1992, J CSUT, V23, P60
   RUAN J, 1993, J CSUT, V24, P509
   Ruan JM, 2001, J CENT SOUTH UNIV T, V8, P1, DOI 10.1007/s11771-001-0015-6
   Shi Q, 1998, ARTIF ORGANS, V22, P1023
   WILLIAMS DF, 1981, SYSTEMIC ASPECTS BIO, V1, P49
NR 16
TC 3
Z9 4
U1 0
U2 2
PU JOURNAL OF CENTRAL SOUTH UNIV TECHNOLOGY
PI HUNAN
PA EDITORIAL OFFICE, CHANGSHA, HUNAN 410083, PEOPLES R CHINA
SN 1005-9784
J9 J CENT SOUTH UNIV T
JI J. Cent. South Univ. Technol.
PD SEP
PY 2001
VL 8
IS 3
BP 147
EP 155
DI 10.1007/s11771-001-0044-1
PG 9
WC Metallurgy & Metallurgical Engineering
SC Metallurgy & Metallurgical Engineering
GA 477UB
UT WOS:000171301700001
DA 2018-10-20
ER

PT J
AU Yuan, HP
   De Bruijn, JD
   Zhang, XD
   Van Blitterswijk, CA
   De Groot, K
AF Yuan, HP
   De Bruijn, JD
   Zhang, XD
   Van Blitterswijk, CA
   De Groot, K
TI Use of an osteoinductive biomaterial as a bone morphogenetic protein
   carrier
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID CALCIUM-PHOSPHATE CERAMICS; INDUCED OSTEOGENESIS; IN-VIVO;
   HYDROXYAPATITE; INDUCTION; LAMINECTOMY; IMPLANTS; KINDS; RATS; DOGS
AB A porous calcium phosphate ceramic, which induced bone formation in soft tissues of dogs, was termed as osteoinductive biomaterial and studied as a carrier of bone morphogenetic protein (rhBMP-2). Cylinder implants (empty set 4x5 mm) impregnated with 0, 1, 10 and 40 mug rhBMP-2 were implanted in dorsal muscles of rabbits for five weeks. Histological observation and histomorphometric analysis were performed on thin un-decalcified sections. No bone formation was detected in the implants without rhBMP-2, while mature lamellar bone was found inside the implants with 1 mug rhBMP-2, both on the outer surface and inside the implants with 10 mug and 40 mug rhBMP-2. Little difference in formed bone was found between 1 mug and 10 mug rhBMP-2, but no difference was found between 10 mug and 40 mug rhBMP-2. A significant difference in bone marrow formation was found among 1, 10 and 40 mug rhBMP-2. The more rhBMP-2, the more bone marrow formed. The present results indicate that osteoinductive biomaterial is a good carrier of BMP and high dose of BMP is not necessary for bone formation in clinic. (C) 2001 Kluwer Academic Publishers.
C1 Leiden Univ, Biomat Res Grp, NL-2300 RA Leiden, Netherlands.
   IsoTis BV, NL-3723 MB Bilthoven, Netherlands.
   Sichuan Univ, Inst Mat Sci & Technol, Chengdu 610064, Peoples R China.
RP Yuan, HP (reprint author), Leiden Univ, Biomat Res Grp, NL-2300 RA Leiden, Netherlands.
EM huipin.yuan@isotis.com
OI van Blitterswijk, Clemens/0000-0003-2371-4615
CR Aspenberg P, 1996, ACTA ORTHOP SCAND, V67, P3, DOI 10.3109/17453679608995598
   Boden SD, 1999, SPINE, V24, P1179, DOI 10.1097/00007632-199906150-00002
   BODEN SD, 1999, CLIN ORTHOP S, V367, P84
   Bruder SP, 1999, CLIN ORTHOP RELAT R, pS68
   Cook SD, 1996, CLIN ORTHOP RELAT R, P29
   DAMIEN CJ, 1991, J APPL BIOMATER, V2, P187, DOI 10.1002/jab.770020307
   de Bruijn J.D., 1999, T 25 ANN M SOC BIOM, P235
   de Groot K, 1998, TISSUE ENG, V4, P337
   GREEN JP, 1995, AM J OPHTHALMOL, V120, P681, DOI 10.1016/S0002-9394(14)72222-6
   Herr G, 1996, ACTA ORTHOP SCAND, V67, P606, DOI 10.3109/17453679608997765
   HOTZ G, 1994, INT J ORAL MAX SURG, V23, P413, DOI 10.1016/S0901-5027(05)80033-5
   Ijiri S, 1997, J BIOMED MATER RES, V35, P421
   Isobe M, 1996, J BIOMED MATER RES, V32, P433
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   KAWAI T, 1993, CLIN ORTHOP RELAT R, V290, P296
   KLEIN C, 1994, BIOMATERIALS, V15, P31, DOI 10.1016/0142-9612(94)90193-7
   Kuboki Y, 1998, J BIOMED MATER RES, V39, P190, DOI 10.1002/(SICI)1097-4636(199802)39:2<190::AID-JBM4>3.0.CO;2-K
   Mehler MF, 1997, TRENDS NEUROSCI, V20, P309, DOI 10.1016/S0166-2236(96)01046-6
   Meyer RA, 1999, SPINE, V24, P747, DOI 10.1097/00007632-199904150-00004
   MIZUTANI H, 1982, CLIN ORTHOP RELAT R, P213
   OHGUSHI H, 1995, BIOCERAMICS, V8, P61
   ONO I, 1992, PLAST RECONSTR SURG, V90, P870, DOI 10.1097/00006534-199211000-00023
   REDDI AH, 1995, CLIN ORTHOP RELAT R, P115
   Ripamonti U, 1996, BIOMATERIALS, V17, P31, DOI 10.1016/0142-9612(96)80752-6
   RIPAMONTI U, 1991, J BONE JOINT SURG AM, V73A, P692, DOI 10.2106/00004623-199173050-00007
   TAKAOKA K, 1988, CLIN ORTHOP RELAT R, V234, P250
   Takita H, 1997, EUR J ORAL SCI, V105, P588, DOI 10.1111/j.1600-0722.1997.tb00222.x
   TOTH JM, 1993, BIOCERAMICS, V6, P9
   URIST MR, 1971, J DENT RES, V50, P1392, DOI 10.1177/00220345710500060601
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   URIST MR, 1984, CLIN ORTHOP RELAT R, V187, P277
   Vargervik K., 1992, BONE GRAFTS BONE SUB, P112
   VolekSmith H, 1996, P SOC EXP BIOL MED, V211, P265
   WANG EA, 1990, P NATL ACAD SCI USA, V87, P2220, DOI 10.1073/pnas.87.6.2220
   Winn SR, 1998, ADV DRUG DELIVER REV, V31, P303, DOI 10.1016/S0169-409X(97)00126-9
   Winn SR, 1999, CLIN ORTHOP RELAT R, pS95
   WONZEY JM, 1988, SCIENCE, V242, P1528
   Wozney JM, 1998, CLIN ORTHOP RELAT R, P26
   Yamamoto M, 1996, Tissue Eng, V2, P315, DOI 10.1089/ten.1996.2.315
   YAMASAKI H, 1992, BIOMATERIALS, V13, P308, DOI 10.1016/0142-9612(92)90054-R
   Yamasaki H., 1990, JPN J ORAL BIOL, V32, P190, DOI DOI 10.2330/JORALBIOSCI1965.32.190
   Yang ZJ, 1997, J MATER SCI-MATER M, V8, P697, DOI 10.1023/A:1018540024082
   Yang ZJ, 1996, BIOMATERIALS, V17, P2131, DOI 10.1016/0142-9612(96)00044-0
   YUAN H, 1997, BIOMEDICAL MAT RES F, P228
   YUAN H, 2000, T 6 WBC HAW US, P114
   Yuan HP, 2001, J MATER SCI-MATER M, V12, P7, DOI 10.1023/A:1026792615665
   Yuan HP, 1998, J MATER SCI-MATER M, V9, P717, DOI 10.1023/A:1008998817977
   Yuan HP, 1998, J MATER SCI-MATER M, V9, P723, DOI 10.1023/A:1008950902047
   Yuan HP, 1999, BIOMATERIALS, V20, P1799, DOI 10.1016/S0142-9612(99)00075-7
   Zhang XD, 1991, BIOCERAMICS HUMAN BO, P408
NR 50
TC 42
Z9 44
U1 0
U2 5
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD SEP
PY 2001
VL 12
IS 9
BP 761
EP 766
DI 10.1023/A:1013957431372
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 471XV
UT WOS:000170954700002
PM 15348221
DA 2018-10-20
ER

PT J
AU Yaszay, B
   Trindade, MCD
   Lind, M
   Goodman, SB
   Smith, RL
AF Yaszay, B
   Trindade, MCD
   Lind, M
   Goodman, SB
   Smith, RL
TI Fibroblast expression of C-C chemokines in response to orthopaedic
   biomaterial particle challenge in vitro
SO JOURNAL OF ORTHOPAEDIC RESEARCH
LA English
DT Article
ID MONOCYTE CHEMOATTRACTANT PROTEIN-1; MACROPHAGE INFLAMMATORY
   PROTEIN-1-ALPHA; TOTAL HIP-ARTHROPLASTY; IN-VITRO;
   POLYMETHYLMETHACRYLATE PARTICLES; PERIPROSTHETIC OSTEOLYSIS; ENZYMATIC
   AMPLIFICATION; CHEMOTACTIC CYTOKINES; TITANIUM PARTICLES;
   GENE-EXPRESSION
AB C-C chemokines are soluble mediators that occur in a periprosthetic granuloma and influence recruitment, localization and activation of inflammatory cells. This studs, tested effects of titanium and polymethylmethacrylate (PMMA) particles on expression of selected C-C chemokines in cultured human fibroblasts. The C-C chemokines analyzed included monocyte chemoattractant protein-1. 2 (MCP-1. 2). monocyte inflammatory protein-1 alpha (MIP-1 alpha), and regulated on activation, normal T-cell expressed and secreted protein (RANTES). Interleukin-1 beta (IL-1 beta) served Lis a known stimulator of chemokine release while interleukin-6 (IL-6) expression served as a marker for fibroblast activation. Protein and mRNA signal levels were determined by ELISA and RT-PCR. respectively. The results demonstrated that exposure of fibroblasts to titanium and PMMA particles resulted in increased release of MCP-1 in a dose- and time-dependent manner. After 24 h. titanium particles maximally upregulated MCP-1 release 7-fold while PMMA particles increased MCP-1 levels 2-fold. when compared to unchallenged fibroblasts. MCP-2, MIP-1 alpha and RANTES levels remained unchanged Following exposure of fibroblasts to titanium or PMMA particles at any concentration or time point tested. However. IL-1 beta stimulated release of MCP-1, MCP-2. and RANTES. but not MIP-1 alpha from the fibroblasts. IL-1 beta, not particles, exhibited the most prominent effect on MCP-1 mRNA levels. Increased release of MCP-1 front fibroblasts exposed to titanium and PMMA particles coincided with increased release of IL-6. This study suggests that release of chemoattractant factors from fibroblasts localized in periprosthetic membranes enhances the chronic inflammatory process leading to bone resorption and implant loosening. (C) 2001 Orthopaedic Research Society. Published by Elsevier Science Ltd. All rights reserved.
C1 Stanford Univ, Sch Med, Orthopaed Res Lab, Stanford, CA 94305 USA.
RP Smith, RL (reprint author), Stanford Univ, Sch Med, Orthopaed Res Lab, 300 Pasteur Dr,R-144, Stanford, CA 94305 USA.
CR AKAHOSHI T, 1993, ARTHRITIS RHEUM-US, V36, P762, DOI 10.1002/art.1780360605
   BEDARD PA, 1993, J CELL PHYSIOL, V154, P433, DOI 10.1002/jcp.1041540227
   FROKJAER J, 1995, ACTA ORTHOP SCAND, V66, P303, DOI 10.3109/17453679508995549
   FRONDOZA CG, 1993, J BIOMED MATER RES, V27, P611, DOI 10.1002/jbm.820270508
   GharaeeKermani M, 1996, J BIOL CHEM, V271, P17779, DOI 10.1074/jbc.271.30.17779
   GOLDRING SR, 1983, J BONE JOINT SURG AM, V65, P575, DOI 10.2106/00004623-198365050-00001
   Gonzalez O, 1996, J BIOMED MATER RES, V30, P463, DOI 10.1002/(SICI)1097-4636(199604)30:4<463::AID-JBM4>3.3.CO;2-I
   Goodman SB, 1996, J BIOMED MATER RES, V31, P421, DOI 10.1002/(SICI)1097-4636(199607)31:3<421::AID-JBM17>3.0.CO;2-L
   Hogaboam C M, 1999, J Immunol, V163, P2193
   Hogaboam CM, 1998, KIDNEY INT, V54, P2152, DOI 10.1046/j.1523-1755.1998.00176.x
   Horowitz SM, 1997, J ORTHOP RES, V15, P50, DOI 10.1002/jor.1100150108
   Ishiguro N, 1997, J BIOMED MATER RES, V35, P399, DOI 10.1002/(SICI)1097-4636(19970605)35:3<399::AID-JBM14>3.0.CO;2-A
   JIANG YL, 1992, J IMMUNOL, V148, P2423
   JIRANEK WA, 1993, J BONE JOINT SURG AM, V75A, P863, DOI 10.2106/00004623-199306000-00007
   JOHNSTON RF, 1990, ELECTROPHORESIS, V11, P355, DOI 10.1002/elps.1150110503
   Lee SH, 1997, J ORTHOP RES, V15, P40, DOI 10.1002/jor.1100150107
   Lind M, 1999, J BIOMED MATER RES, V48, P246, DOI 10.1002/(SICI)1097-4636(1999)48:3<246::AID-JBM7>3.0.CO;2-X
   Lind M, 1998, J BONE JOINT SURG BR, V80B, P924, DOI 10.1302/0301-620X.80B5.8710
   LUKACS NW, 1993, J EXP MED, V177, P1551, DOI 10.1084/jem.177.6.1551
   LUKACS NW, 1994, AM J PATHOL, V144, P711
   MALONEY WJ, 1995, J BONE JOINT SURG AM, V77, P1448, DOI 10.2106/00004623-199509000-00022
   MALONEY WJ, 1995, J BONE JOINT SURG AM, V77, P1301, DOI 10.2106/00004623-199509000-00002
   MALONEY WJ, 1993, J BONE JOINT SURG AM, V75A, P835, DOI 10.2106/00004623-199306000-00005
   Manlapaz M, 1996, J ORTHOP RES, V14, P465, DOI 10.1002/jor.1100140317
   Meyer JE, 1998, INT ARCH ALLERGY IMM, V117, P60, DOI 10.1159/000023991
   MILLER MD, 1992, CRIT REV IMMUNOL, V12, P17
   Nakashima Y, 1999, J BONE JOINT SURG AM, V81A, P603, DOI 10.2106/00004623-199905000-00002
   Nakashima Y, 1999, J BONE JOINT SURG BR, V81B, P155, DOI 10.1302/0301-620X.81B1.8884
   NELSON PJ, 1993, J IMMUNOL, V151, P2601
   NIWA M, 1969, J BACTERIOL, V97, P1069
   NOONAN KE, 1988, NUCLEIC ACIDS RES, V16, P10366, DOI 10.1093/nar/16.21.10366
   RAGAB AA, 1998, T ORTHOP RES SOC, V23, P355
   SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875
   SANTAVIRTA S, 1990, J BONE JOINT SURG AM, V72A, P252, DOI 10.2106/00004623-199072020-00014
   SHANBHAG AS, 1995, J ORTHOPAED RES, V13, P792, DOI 10.1002/jor.1100130520
   SMITH RE, 1995, J LEUKOCYTE BIOL, V57, P782
   TAUB DD, 1993, CYTOKINE, V5, P175, DOI 10.1016/1043-4666(93)90001-L
   UGUCCIONI M, 1995, EUR J IMMUNOL, V25, P64, DOI 10.1002/eji.1830250113
   VANDAMME J, 1994, J IMMUNOL, V152, P5495
   VU TH, 1994, NATURE, V371, P714, DOI 10.1038/371714a0
   WOLPE SD, 1989, FASEB J, V3, P2565
   YAO JL, 1995, J BONE MINER RES, V10, P1417
   YOSHIMURA T, 1990, J IMMUNOL, V144, P2377
   ZHOU LJ, 1995, BLOOD, V86, P3295
   Zickus C, 1998, MEDIAT INFLAMM, V7, P269, DOI 10.1080/09629359890956
NR 45
TC 32
Z9 32
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0736-0266
J9 J ORTHOPAED RES
JI J. Orthop. Res.
PD SEP
PY 2001
VL 19
IS 5
BP 970
EP 976
DI 10.1016/S0736-0266(01)00003-1
PG 7
WC Orthopedics
SC Orthopedics
GA 468RC
UT WOS:000170771100032
PM 11562149
OA Bronze
DA 2018-10-20
ER

PT J
AU Takenaka, K
   Kawamoto, Y
AF Takenaka, K
   Kawamoto, Y
TI Fabrication of hybrid material by coating of bioactive glass-ceramic on
   alumina substrate through porcelain enamel process
SO JOURNAL OF THE CERAMIC SOCIETY OF JAPAN
LA English
DT Article
DE bioactive glass-ceramics; biomaterial; adhesion-glass; porcelain enamel
   technique
AB In artificial bones, a steady bioactivity over long-term service, no dissolution of harmful ions and a sufficient mechanical strength are required, though the relative importance of the above factors depends upon the implantation place. In general, bioactive materials have no sufficient mechanical strength and, on the other hand, materials with high mechanical strength are not bioactive. In the present study, a porcelain enamel technique was applied to produce a hybrid material whose both bioactivity and high mechanical strength, which merely consists of inorganic materials. High-strength alumina and bioactive glass-ceramics were used as substrate and coating material, respectively, and an adhesion-glass was employed to achieve a tight bond between alumina and the bioactive glass-ceramic. Appropriate heat-treatments of the alumina, adhesion-glass and bioactive glass-ceramic composite resulted in the successful production of a hybrid material that has about 2.5 times stronger in bending-strength than that of an apatite precipitation-type glass-ceramic. This technique gives a useful process on production of ceramic-ceramic hybrid materials with high mechanical strength and bioactivity for bone substitution.
C1 Kobe Univ, Grad Sch Sci & Technol, Div Mol Sci, Nada Ku, Kobe, Hyogo 6578501, Japan.
   Minolta Co Ltd, R&D Headquarters, Opt Technol Div, Takatsuki, Osaka 5698503, Japan.
RP Takenaka, K (reprint author), Kobe Univ, Grad Sch Sci & Technol, Div Mol Sci, Nada Ku, 1-1,Rokkodai Cho, Kobe, Hyogo 6578501, Japan.
CR ANDERSSON OH, 1991, J NON-CRYST SOLIDS, V129, P145, DOI 10.1016/0022-3093(91)90090-S
   BROMER H, Patent No. 5021015
   Han Y, 1999, J BIOMED MATER RES, V45, P198, DOI 10.1002/(SICI)1097-4636(19990605)45:3<198::AID-JBM6>3.0.CO;2-Q
   Hench LL, 1998, BIOMATERIALS, V19, P1419, DOI 10.1016/S0142-9612(98)00133-1
   HENCH LL, 1999, MRS BULL, P13
   Jiang GW, 1999, J BIOMED MATER RES, V48, P117, DOI 10.1002/(SICI)1097-4636(1999)48:2<117::AID-JBM4>3.0.CO;2-B
   KOKUBO T, 1991, NIPPON SERAM KYO GAK, V99, P965
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P331, DOI 10.1002/jbm.820240306
   OHTSUKI C, 1992, J MATER SCI-MATER M, V3, P119, DOI 10.1007/BF00705279
   Schrooten J, 1999, J BIOMED MATER RES, V44, P243, DOI 10.1002/(SICI)1097-4636(19990305)44:3<243::AID-JBM2>3.0.CO;2-O
   URATSUJI M, 1983, THESIS KOBE U, P1
   URATSUJI M, 1983, P 3 ORTH CER IMPL ST, P17
NR 12
TC 0
Z9 1
U1 1
U2 2
PU CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI
PI TOKYO
PA 22-17, HYAKUNIN-CHO 2-CHOME, SHINJUKU-KU, TOKYO, 169-0073, JAPAN
SN 1882-0743
EI 1348-6535
J9 J CERAM SOC JPN
JI J. Ceram. Soc. Jpn.
PD SEP
PY 2001
VL 109
IS 9
BP 733
EP 737
DI 10.2109/jcersj.109.1273_733
PG 5
WC Materials Science, Ceramics
SC Materials Science
GA 475AY
UT WOS:000171140500003
OA Bronze
DA 2018-10-20
ER

PT J
AU Zhang, SM
   Li, SP
   Yan, YH
   Wan, T
   Jiang, X
   Han, CR
   Song, XP
AF Zhang, SM
   Li, SP
   Yan, YH
   Wan, T
   Jiang, X
   Han, CR
   Song, XP
TI Surface modification of hydroxyapatite by using gamma-aminopropyl silane
SO JOURNAL OF WUHAN UNIVERSITY OF TECHNOLOGY-MATERIALS SCIENCE EDITION
LA English
DT Article
DE biomaterial; hydroxyapatite; surface modification; r-aminopropyl silane;
   characterization
ID MECHANICAL-PROPERTIES
AB Surface modification of hydroxyapatite ( IR) powder was performed with r-aminopropyl silane in toluent solvent. The modification effects were characterized by using XPS and FT-IR methods. The results indicated that the P2p electron binding energy of the modified HA decreases 0.4eV compared to that of HA. Furthermore, a new peak, 998 cm(-1) absorption appeared in IR differential spectra of modified HA and HA, which is due to a stretching vibration of structure P-O-Si, meaning that a direct covalent bonding between hydroxyl group on HA surface and the organic silane molecule was realized after modification, and the chemical bonding type was P-O-Si. The formation of the above structure suggested that the more effective interfacial adhesion between the modified HA and polymer matrix could be carried out.
C1 Wuhan Univ Technol, Sch Mat Sci & Engn, Wuhan 430070, Peoples R China.
   Hainan Normal Univ, Hainan, Peoples R China.
CR ANDRIANO KP, 1992, J APPL BIOMATER, V3, P197, DOI 10.1002/jab.770030306
   BO YH, 1999, ACTA SCIANTIARUM NAT, V38, P36
   OGISO M, 1992, J LONG-TERM EFF MED, V2, P137
   Shikinami Y, 1996, BIOCERAMICS, V9, P391
   Suchanek W, 1997, J AM CERAM SOC, V80, P2805, DOI 10.1111/j.1151-2916.1997.tb03197.x
   VERHEYEN CCP, 1993, THESIS U LEIDEN LEID
NR 6
TC 3
Z9 4
U1 0
U2 1
PU JOURNAL WUHAN UNIV TECHNOLOGY
PI WUHAN
PA WUHAN UNIV TECHNOLOGY, WUHAN 430070, PEOPLES R CHINA
SN 1000-2413
J9 J WUHAN UNIV TECHNOL
JI J. Wuhan Univ. Technol.-Mat. Sci. Edit.
PD SEP
PY 2001
VL 16
IS 3
BP 37
EP 38
PG 2
WC Materials Science, Multidisciplinary
SC Materials Science
GA 576PC
UT WOS:000177012800010
DA 2018-10-20
ER

PT J
AU Nyman, R
   Sennerby, L
   Nyman, S
   Lundgren, D
AF Nyman, R
   Sennerby, L
   Nyman, S
   Lundgren, D
TI Influence of bone marrow on membrane-guided bone regeneration of
   segmental long-bone defects in rabbits
SO SCANDINAVIAN JOURNAL OF PLASTIC AND RECONSTRUCTIVE SURGERY AND HAND
   SURGERY
LA English
DT Article
DE biomaterial; e-PTFE membrane; guided bone regeneration; guided tissue
   regeneration; histology; long-bone defects; radiography; radius
AB Defects 10 mm long were created in long bone in the diaphysis of both radii of 18 rabbits (test and control side). On the test side, ingrowth of bone marrow into the defects was hindered or delayed by: plugging the opening of the cut bone ends with gutta-percha points (n = 7); plugging with Gelfoam (n = 6); or by removing the bone marrow by flushing with saline (n = 5). The defects on both test and control side were covered with an expanded polytetrafluoroethylene membrane, shaped as a tube. Healing was followed with radiographs for four to five months, after which the animals were killed and ground sections of the areas of the defects were prepared for histological examination. On the control side, nine of 18 animals had complete osseous bridging of the defect, and a small transverse non-mineralised zone remained in the centre of the healed defect in the other animals. This zone consisted of loose connective and cartilagenous tissue as well as connective tissue obviously derived from the outside of the membrane. By preventing-or delaying the ingrowth of bone marrow we retarded the regeneration of mineralised bone, particularly in the gutta-percha and flushed bone marrow groups. The principle of guided tissue regeneration may be used to achieve regeneration of extensive long-bone defects. Any attempts to delay or prevent bone marrow ingrowth into the defects did retard regeneration of segmental long-bone defects.
C1 Univ Hosp, Dept Radiol, SE-75185 Uppsala, Sweden.
   Univ Gothenburg, Dept Biomat Handicap Res, Gothenburg, Sweden.
RP Nyman, R (reprint author), Univ Hosp, Dept Diagnost Radiol, SE-75185 Uppsala, Sweden.
CR BLUHM AE, 1995, J ORAL MAXIL SURG, V53, P163, DOI 10.1016/0278-2391(95)90395-X
   Karring T, 1993, Periodontol 2000, V1, P26, DOI 10.1111/j.1600-0757.1993.tb00204.x
   NIELSEN FF, 1992, THESIS ROYAL DENT CO
   NYMAN R, 1995, ACTA ORTHOP SCAND, V66, P169, DOI 10.3109/17453679508995515
   Nyman S R, 1994, Periodontol 2000, V4, P109, DOI 10.1111/j.1600-0757.1994.tb00011.x
   Owen M, 1985, J CELL SCI S, V10, P63
   REDDI AH, 1987, ORTHOP CLIN N AM, V18, P207
   Zellin G, 1997, SCAND J PLAST RECONS, V31, P97, DOI 10.3109/02844319709085475
NR 8
TC 8
Z9 9
U1 0
U2 2
PU TAYLOR & FRANCIS AS
PI OSLO
PA CORT ADELERSGT 17, PO BOX 2562, SOLLI, 0202 OSLO, NORWAY
SN 0284-4311
J9 SCAND J PLAST RECONS
JI Scand. J. Plast. Reconstr. Surg. Hand Surg.
PD SEP
PY 2001
VL 35
IS 3
BP 239
EP 246
PG 8
WC Surgery
SC Surgery
GA 479VX
UT WOS:000171425200003
PM 11680392
DA 2018-10-20
ER

PT J
AU Aizenberg, J
   Tkachenko, A
   Weiner, S
   Addadi, L
   Hendler, G
AF Aizenberg, J
   Tkachenko, A
   Weiner, S
   Addadi, L
   Hendler, G
TI Calcitic microlenses as part of the photoreceptor system in brittlestars
SO NATURE
LA English
DT Article
ID OPHIUROIDEA; ECHINODERMATA; BIOMINERALIZATION; LOCALIZATION
AB Photosensitivity in most echinoderms has been attributed to 'diffuse' dermal receptors(1-3). Here we report that certain single calcite crystals used by brittlestars for skeletal construction(4,5) are also a component of specialized photosensory organs, conceivably with the function of a compound eye. The analysis of arm ossicles in Ophiocoma(6) showed that in light-sensitive species, the periphery of the labyrinthic calcitic skeleton extends into a regular array of spherical microstructures that have a characteristic double-lens design. These structures are absent in light-indifferent species. Photolithographic experiments in which a photoresist film was illuminated through the lens array showed selective exposure of the photoresist under the lens centres. These results provide experimental evidence that the microlenses are optical elements that guide and focus the light inside the tissue. The estimated focal distance (4-7 mum below the lenses) coincides with the location of nerve bundles-the presumed primary photoreceptors. The lens array is designed to minimize spherical aberration and birefringence and to detect light from a particular direction. The optical performance is further optimized by phototropic chromatophores that regulate the dose of illumination reaching the receptors. These structures represent an example of a multifunctional biomaterial that fulfills both mechanical and optical functions.
C1 Bell Labs, Lucent Technol, Murray Hill, NJ 07974 USA.
   Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel.
   Natl Hist Museum Los Angeles Cty, Los Angeles, CA 90007 USA.
RP Aizenberg, J (reprint author), Bell Labs, Lucent Technol, 600 Mt Ave, Murray Hill, NJ 07974 USA.
RI Tkachenko, Alexei/I-9040-2012
OI Tkachenko, Alexei/0000-0003-1291-243X
CR Aizenberg J, 1997, APPL PHYS LETT, V71, P3773, DOI 10.1063/1.120502
   Ameye L, 1999, J HISTOCHEM CYTOCHEM, V47, P1189, DOI 10.1177/002215549904700911
   Belcher AM, 1998, ACTA MATER, V46, P733, DOI 10.1016/S1359-6454(97)00253-X
   CLARKSON ENK, 1975, NATURE, V254, P663, DOI 10.1038/254663a0
   COBB JLS, 1990, COMP BIOCHEM PHYS A, V97, P329, DOI 10.1016/0300-9629(90)90619-4
   COBB JLS, 1986, J NEUROCYTOL, V15, P97, DOI 10.1007/BF02057908
   Cowles RP, 1910, J EXP ZOOL, V9, P387, DOI 10.1002/jez.1400090209
   Doderlein L., 1898, DENKSCHR MED NAT GES, V8, P491
   DONNAY G, 1969, SCIENCE, V166, P1147, DOI 10.1126/science.166.3909.1147
   FLINT HT, 1936, GEOMETRICAL OPTICS
   Gal J, 2000, VISION RES, V40, P843, DOI 10.1016/S0042-6989(99)00216-3
   HENDLER G, 1984, PSZNI MAR ECOL, V5, P379, DOI 10.1111/j.1439-0485.1984.tb00131.x
   HENDLER G, 1987, ZOOMORPHOLOGY, V107, P261, DOI 10.1007/BF00312172
   Hyman LH, 1955, INVERTEBRATES, V4
   Johnsen S, 1997, BIOL BULL, V193, P97, DOI 10.2307/1542739
   LAND MF, 1981, COMP PHYSL EVOLUTI B, V1, P471
   Lowenstam H. A., 1989, BIOMINERALISATION, P123
   Mann S, 1996, NATURE, V382, P313, DOI 10.1038/382313a0
   MILLOTT N, 1975, ADV MAR BIOL, V13, P1, DOI 10.1016/S0065-2881(08)60279-5
   Smith A, 1980, SPEC PAP PALAEONTOL, V25, P1
   Stubbs T.R., 1982, Echinoderms, P403
   TOWE KM, 1973, SCIENCE, V179, P1007, DOI 10.1126/science.179.4077.1007
   Wainwright SA, 1976, MECH DESIGN ORGANISM
   Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153
   Yoshida M., 1984, PHOTORECEPTION VISIO, P743
NR 25
TC 376
Z9 385
U1 11
U2 154
PU MACMILLAN PUBLISHERS LTD
PI LONDON
PA PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
J9 NATURE
JI Nature
PD AUG 23
PY 2001
VL 412
IS 6849
BP 819
EP 822
DI 10.1038/35090573
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 465ET
UT WOS:000170577200037
PM 11518966
DA 2018-10-20
ER

PT J
AU Kowalski, ZW
AF Kowalski, ZW
TI Ion sputter induced surface morphology - biomedical implications
SO VACUUM
LA English
DT Article; Proceedings Paper
CT International Symposium on Ion Implantation and Other Applications of
   IOns and Electrons (ION 2000)
CY JUN 12-15, 2000
CL KAZIMIERS DOLNY, POLAND
SP Inst Phys, Maria Curie Sklodowska Univ, Tech Univ Lublin, Tech Univ Wroclaw
DE ion sputtering; ion etching; surface morphology; surface topography;
   surface roughness; biocompatible materials; biomaterials; implants;
   biological response
ID LINE-EDGE ROUGHNESS; CELL-ADHESION; BOMBARDMENT; BIOMATERIALS; IMPLANTS;
   PROTEIN; BONE; SI
AB This is a short review of surface morphological changes induced by ion sputtering of solids (mainly biocompatible materials) as well as potential and practical biomedical applications of the sputtering process. Usually changes of two aspects of surface morphology are studied, i.e. surface topography and roughness. It can be generally accepted that, among other factors which affect the so-called biological response to biomaterial, surface morphology is one of the more important. Depending on surface topography and/or roughness various biological responses could be expected, generally, changes in: (a) attachment of the surrounding tissue or thrombus to the material in question and (b) cell attachment kinetics that can influence the heating process resulting from the presence of the sputtered implant and/or tissue inflammatory in the tissue surrounding the implanted material. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Wroclaw Univ Technol, Inst Microsyst Technol, PL-50372 Wroclaw, Poland.
RP Kowalski, ZW (reprint author), Wroclaw Univ Technol, Inst Microsyst Technol, Z Janiszewskiego 11-17, PL-50372 Wroclaw, Poland.
EM zwkoval@wtm.ite.pwr.wroc.pl
CR Auciello O., 1984, ION BOMBARDMENT MODI
   BEHRISCH R, 1983, TOPICS APPL PHYSICS, V52
   Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   Carter G, 1996, VACUUM, V47, P409, DOI 10.1016/0042-207X(95)00239-1
   CHASON E, 1994, PHYS REV LETT, V72, P3040, DOI 10.1103/PhysRevLett.72.3040
   EKLUND EA, 1991, PHYS REV LETT, V67, P1759, DOI 10.1103/PhysRevLett.67.1759
   EKLUND EA, 1993, SURF SCI, V285, P157, DOI 10.1016/0039-6028(93)90427-L
   Hallab NJ, 1995, J LONG-TERM EFF MED, V5, P209
   HAUFFE W, 1991, TOP APPL PHYS, V64, P305
   Henry S, 1998, MICRO ELECTRO MECHANICAL SYSTEMS - IEEE ELEVENTH ANNUAL INTERNATIONAL WORKSHOP PROCEEDINGS, P494, DOI 10.1109/MEMSYS.1998.659807
   Henry S, 1998, J PHARM SCI, V87, P922, DOI 10.1021/js980042+
   Ivanova OP, 1996, VACUUM, V47, P67, DOI 10.1016/0042-207X(95)00180-8
   Iwaki M, 1995, NUCL INSTRUM METH B, V106, P618, DOI 10.1016/0168-583X(96)80035-8
   Kowalski Z. W., 1998, Electron Technology, V31, P477
   KOWALSKI ZW, 1985, J MATER SCI, V20, P1521, DOI 10.1007/BF00555259
   KOWALSKI ZW, 1989, MONOGRAPHS TU WOCL, V13
   LARSSON C, 1994, BIOMATERIALS, V15, P1062, DOI 10.1016/0142-9612(94)90092-2
   Leitao E, 1998, J MATER SCI-MATER M, V9, P543, DOI 10.1023/A:1008896106994
   Lhoest JB, 1995, NUCL INSTRUM METH B, V105, P322, DOI 10.1016/0168-583X(95)00524-2
   Loesing R, 2000, J VAC SCI TECHNOL B, V18, P509, DOI 10.1116/1.591222
   MARTIN JY, 1995, J BIOMED MATER RES, V29, P389, DOI 10.1002/jbm.820290314
   MAZOLDI P, 1987, ION BEAM MODIFICATIO
   Namatsu H, 1998, J VAC SCI TECHNOL B, V16, P3315, DOI 10.1116/1.590375
   Nelson C, 1999, J VAC SCI TECHNOL B, V17, P2488, DOI 10.1116/1.591117
   NOWICKI B, 1991, STRUKTURA GEOMETRYCZ
   Otte K, 1999, J VAC SCI TECHNOL A, V17, P19, DOI 10.1116/1.581548
   Reynolds GW, 1999, J VAC SCI TECHNOL B, V17, P2723, DOI 10.1116/1.591053
   Saitoh H, 1996, J MATER SCI, V31, P603, DOI 10.1007/BF00367874
   SIGMUND P, 1995, APPL PHYS LETT, V66, P433, DOI 10.1063/1.114047
   Verdonschot N, 1998, J BIOMED MATER RES, V42, P554, DOI 10.1002/(SICI)1097-4636(19981215)42:4<554::AID-JBM11>3.3.CO;2-B
   VISHNYAKOV V, 1995, VACUUM, V46, P637, DOI 10.1016/0042-207X(95)00003-8
   WILK J, 1997, 27 ITE TUW
   Wittmaack K, 2000, J VAC SCI TECHNOL B, V18, P524, DOI 10.1116/1.591225
NR 33
TC 11
Z9 11
U1 0
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0042-207X
J9 VACUUM
JI Vacuum
PD AUG 16
PY 2001
VL 63
IS 4
BP 603
EP 608
DI 10.1016/S0042-207X(01)00247-0
PG 6
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 470TH
UT WOS:000170886900028
DA 2018-10-20
ER

PT J
AU Hu, WJ
   Eaton, JW
   Tang, LP
AF Hu, WJ
   Eaton, JW
   Tang, LP
TI Molecular basis of biomaterial-mediated foreign body reactions
SO BLOOD
LA English
DT Article
ID GLYCOPROTEIN-GPIIB-IIIA; ADSORBED FIBRINOGEN; PROTEIN ADSORPTION;
   CELL-ADHESION; POLYMERIC BIOMATERIALS; INFLAMMATORY RESPONSES;
   CONFORMATIONAL-CHANGES; ARTERIAL PROSTHESES; PLATELET-ADHESION;
   ANTIBODY-BINDING
AB Despite being inert and nontoxic, implanted biomaterials often trigger adverse foreign body reactions such as inflammation, fibrosis, infection, and thrombosis. With regard to the inflammatory responses to biomaterial implants, it was previously found that a crucial precedent event was the spontaneous adsorption and denaturation of fibrinogen on implant surfaces. It was further found that interactions between the phagocyte integrin Mac-1 (CD11b/CD18) and one short sequence within the fibrinogen D domain (gamma 190-202; P1) at least partially explained phagocyte accumulation on implant surfaces. However, the reason that adsorbed fibrinogen is proinflammatory-while soluble fibrinogen clearly is not-remained obscure. In this study, therefore, the question of how fibrinogen is converted to a proinflammatory state when adsorbed to biomaterial surfaces is investigated. In soluble fibrinogen, the 13 amino acid P1 sequence was found to be hidden. However, the adsorption and denaturation of fibrinogen on the surfaces of commonly used biomaterials lead to the exposure of P1 and a second neo-epitope, gamma 377-395 (P2), which also interacts with Mac-1 and is similarly occult in the soluble protein. The extent of biomaterial-mediated PI and P2 exposure appears directly related to the severity of inflammatory responses to a test panel of biomaterials. Finally, thrombin-mediated conversion of fibrinogen to fibrin also exposes both P1 and P2 epitopes. These observations may help explain both the inflammation caused by many types of implanted biomaterials and that which occurs naturally following thrombotic events.
C1 Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA.
RP Tang, LP (reprint author), Univ Texas, Biomed Engn Program, Box 19138, Arlington, TX 76019 USA.
FU NHLBI NIH HHS [R01-HL60787, R01-HL63199, R01-HL56187]
CR ALTIERI DC, 1993, J BIOL CHEM, V268, P1847
   ANDRADE JD, 1984, PURE APPL CHEM, V56, P1345, DOI 10.1351/pac198456101345
   Bailly AL, 1996, J BIOMED MATER RES, V30, P101, DOI 10.1002/(SICI)1097-4636(199601)30:1<101::AID-JBM13>3.0.CO;2-R
   BASSET F, 1986, AM J PATHOL, V122, P443
   BEHLING CA, 1986, J BIOMED MATER RES, V20, P653, DOI 10.1002/jbm.820200509
   Bennett JS, 1999, J BIOL CHEM, V274, P25301, DOI 10.1074/jbc.274.36.25301
   BOHNERT JL, 1986, J COLLOID INTERF SCI, V111, P363, DOI 10.1016/0021-9797(86)90040-8
   BRANDSTEDT S, 1980, ACTA CHIR SCAND, V146, P483
   BUDZYNSKI AZ, 1986, CRC CR REV ONCOL-HEM, V6, P97, DOI 10.1016/S1040-8428(86)80019-1
   CHAN SC, 1991, CLIN CHEM, V37, P756
   CHINN JA, 1992, J BIOMED MATER RES, V26, P757, DOI 10.1002/jbm.820260606
   CHRISTENSON L, 1989, J BIOMED MATER RES, V23, P705, DOI 10.1002/jbm.820230704
   COLMAN RW, 1984, J CLIN INVEST, V73, P1249, DOI 10.1172/JCI111326
   DOBKE MK, 1995, ANN PLAS SURG, V34, P563, DOI 10.1097/00000637-199506000-00001
   DOMANSKIS EJ, 1976, PLAST RECONSTR SURG, V58, P689, DOI 10.1097/00006534-197612000-00006
   DONOVAN JW, 1974, P NATL ACAD SCI USA, V71, P4125, DOI 10.1073/pnas.71.10.4125
   DOOLITTLE RF, 1967, ARCH BIOCHEM BIOPHYS, V118, P456, DOI 10.1016/0003-9861(67)90374-8
   DOUGHERTY SH, 1988, REV INFECT DIS, V10, P1102
   FAIR DS, 1981, J BIOL CHEM, V256, P8018
   FENG L, 1994, J BIOMED MATER RES, V28, P735, DOI 10.1002/jbm.820280611
   GORDON M, 1982, J BONE JOINT SURG AM, V64, P574, DOI 10.2106/00004623-198264040-00013
   GRABAREK Z, 1990, ANAL BIOCHEM, V185, P131, DOI 10.1016/0003-2697(90)90267-D
   GRISTINA A G, 1988, Medical Progress Through Technology, V14, P205
   Grunkemeier JM, 2000, BIOMATERIALS, V21, P2243, DOI 10.1016/S0142-9612(00)00150-2
   HAUGEN PK, 1990, J CELL BIOL, V111, P2733, DOI 10.1083/jcb.111.6.2733
   HIMMELHOCH SR, 1969, BIOCHEMISTRY-US, V8, P914, DOI 10.1021/bi00831a022
   HOGT AH, 1986, J BIOMED MATER RES, V20, P533, DOI 10.1002/jbm.820200409
   HORBETT TA, 1994, J BIOMAT SCI-POLYM E, V6, P15, DOI 10.1163/156856295X00724
   HUMPHRIES MJ, 1987, J BIOL CHEM, V262, P6886
   Jansen B, 1988, J Biomater Appl, V2, P520
   KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0
   KOSSOVSKY N, 1991, J BIOMED MATER RES, V25, P1287, DOI 10.1002/jbm.820251009
   KOTTKEMARCHANT K, 1989, BIOMATERIALS, V10, P147, DOI 10.1016/0142-9612(89)90017-3
   KOTTKEMARCHANT K, 1986, BIOMATERIALS, V7, P441, DOI 10.1016/0142-9612(86)90032-3
   LEE RG, 1974, J BIOMED MATER RES, V8, P251, DOI 10.1002/jbm.820080507
   LENK TJ, 1991, LANGMUIR, V7, P1755, DOI 10.1021/la00056a030
   LU DR, 1991, J COLLOID INTERF SCI, V144, P271, DOI 10.1016/0021-9797(91)90258-A
   MARCHANT RE, 1984, J BIOMED MATER RES, V18, P1169, DOI 10.1002/jbm.820180917
   MCCARTHY JB, 1990, J CELL BIOL, V110, P777, DOI 10.1083/jcb.110.3.777
   MORRISSEY BW, 1976, T AM SOC ART INT ORG, V22, P278
   NELSON GD, 1981, PLAST RECONSTR SURG, V68, P969, DOI 10.1097/00006534-198112000-00027
   NIEWIAROWSKI S, 1983, ANN NY ACAD SCI, V408, P536, DOI 10.1111/j.1749-6632.1983.tb23271.x
   Parise LV, 1999, CURR OPIN CELL BIOL, V11, P597, DOI 10.1016/S0955-0674(99)00018-6
   PICHA GJ, 1990, PLAST RECONSTR SURG, V85, P903, DOI 10.1097/00006534-199006000-00011
   PITT WG, 1986, J COLLOID INTERF SCI, V111, P343, DOI 10.1016/0021-9797(86)90039-1
   PLOW EF, 1992, J LAB CLIN MED, V120, P198
   REINER E, 1989, ENZYMES HYDROLYSING, P266
   SCHIELEN WJG, 1991, BLOOD, V77, P2169
   SHIBA E, 1991, AM J PHYSIOL, V260, pC965
   SLACK SM, 1989, J COLLOID INTERF SCI, V133, P148, DOI 10.1016/0021-9797(89)90288-9
   SLAUSON DO, 1982, ADV VET SCI COMP MED, V26, P99
   SMAHEL J, 1979, BRIT J PLAST SURG, V32, P35, DOI 10.1016/0007-1226(79)90058-4
   SPENCER H, 1975, PROGR RESPIR RES, V8, P34
   STAROS JV, 1986, ANAL BIOCHEM, V156, P220, DOI 10.1016/0003-2697(86)90176-4
   SUTHERLAND K, 1993, J CLIN INVEST, V92, P2360, DOI 10.1172/JCI116841
   TANG L, 1997, T SOC BIOMATER, V23, pA261
   Tang LP, 1998, J BIOMAT SCI-POLYM E, V9, P1257
   TANG LP, 1993, J LAB CLIN MED, V122, P292
   TANG LP, 1993, J EXP MED, V178, P2147, DOI 10.1084/jem.178.6.2147
   Tang LP, 1996, J CLIN INVEST, V97, P1329, DOI 10.1172/JCI118549
   Tang LP, 1998, J BIOMED MATER RES, V42, P156, DOI 10.1002/(SICI)1097-4636(199810)42:1<156::AID-JBM19>3.3.CO;2-E
   TORRES JL, 1988, ARCH BIOCHEM BIOPHYS, V267, P271, DOI 10.1016/0003-9861(88)90032-X
   Tsai WB, 1999, J BIOMED MATER RES, V44, P130, DOI 10.1002/(SICI)1097-4636(199902)44:2<130::AID-JBM2>3.0.CO;2-9
   Ugarova TP, 1998, J BIOL CHEM, V273, P22519, DOI 10.1074/jbc.273.35.22519
   UGAROVA TP, 1993, J BIOL CHEM, V268, P21080
   VISTNES LM, 1978, PLAST RECONSTR SURG, V62, P580, DOI 10.1097/00006534-197810000-00015
   VROMAN L, 1977, ANN NY ACAD SCI, V283, P65, DOI 10.1111/j.1749-6632.1977.tb41753.x
   Ward CM, 2000, BLOOD, V96, P161
   YAM LT, 1971, AM J CLIN PATHOL, V55, P283
   YATES SG, 1973, SURG GYNECOL OBSTET, V136, P12
   Yung LYL, 1999, BLOOD, V94, P2716
   ZHAO Q, 1990, J BIOMED MATER RES, V24, P621, DOI 10.1002/jbm.820240508
   ZHAO Q, 1991, J BIOMED MATER RES, V25, P177, DOI 10.1002/jbm.820250205
NR 73
TC 245
Z9 246
U1 2
U2 59
PU AMER SOC HEMATOLOGY
PI WASHINGTON
PA 1900 M STREET. NW SUITE 200, WASHINGTON, DC 20036 USA
SN 0006-4971
J9 BLOOD
JI Blood
PD AUG 15
PY 2001
VL 98
IS 4
BP 1231
EP 1238
DI 10.1182/blood.V98.4.1231
PG 8
WC Hematology
SC Hematology
GA 461KU
UT WOS:000170364100047
PM 11493475
DA 2018-10-20
ER

PT J
AU Hughes, TC
   Meijs, GF
   Chaouk, H
   Steele, JG
   Johnson, G
AF Hughes, TC
   Meijs, GF
   Chaouk, H
   Steele, JG
   Johnson, G
TI Porous perfluoroalkyl acrylates: A potential ophthalmic biomaterial.
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
C1 CSIRO, Clayton, Vic 3169, Australia.
RI Hughes, Timothy/A-9319-2011
OI Hughes, Timothy/0000-0002-7990-4509
NR 0
TC 0
Z9 0
U1 0
U2 2
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD AUG
PY 2001
VL 222
MA 417-POLY
BP U318
EP U318
PN 2
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA 467EU
UT WOS:000170690101747
DA 2018-10-20
ER

PT J
AU Sanborn, TJ
   Messersmith, PB
   Barron, AE
AF Sanborn, TJ
   Messersmith, PB
   Barron, AE
TI Enzymatically crosslinked PEG-peptide hydrogel for biomaterial
   applications.
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
C1 Northwestern Univ, Evanston, IL 60208 USA.
   Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA.
RI Barron, Annelise/B-7639-2009; Messersmith, Phil/B-6695-2009
NR 0
TC 0
Z9 0
U1 1
U2 3
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD AUG
PY 2001
VL 222
MA 22-MACR
BP U421
EP U421
PN 2
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA 467EU
UT WOS:000170690102366
DA 2018-10-20
ER

PT J
AU Stayton, PS
AF Stayton, PS
TI Biomaterial interfaces that instruct cell behavior.
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
C1 Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.
RI Stayton, Patrick/C-1975-2018
OI Stayton, Patrick/0000-0001-6939-6371
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD AUG
PY 2001
VL 222
MA 282-COLL
BP U374
EP U374
PN 1
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA 467ET
UT WOS:000170690001869
DA 2018-10-20
ER

PT J
AU Zhu, XL
   Kim, KH
   Jeong, YS
AF Zhu, XL
   Kim, KH
   Jeong, YS
TI Anodic oxide films containing Ca and P of titanium biomaterial
SO BIOMATERIALS
LA English
DT Article
DE titanium; anodic oxide film; surface composition; structure and
   roughness; calcium glycerophosphate; calcium acetate
ID SURFACE; BONE; BEHAVIOR; LAYERS; METAL; IMPLANTS; INVITRO; TI6AL4V;
   GROWTH; ALLOY
AB Anodic oxidation and oxide films of titanium in the new electrolyte of calcium glycerophosphate (Ca-GP) and calcium acetate (CA) were investigated by galvanostatic mode, SEM, XRD and EPMA. The anodic oxide film displayed porosity, intermediate roughness, and high crystallinity. Also, the oxide film is enriched with Ca and P and high in thickness without microcracks. According to the surface properties of the oxide film, the optimum condition was that the concentration of the electrolyte was 0.02 M Ca-GP and 0.15 M CA, and current density and final voltage were 70 A/m(2) and ca. 350 V. The oxide film formed in the condition is 0.98 mum (R-a) rough, 5-7 mum thick, adhesive to the underlying substrate, and near 1.67 Ca/P ratio in the oxide film. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Kyungpook Natl Univ, Coll Dent, Inst Biomat Res, Taegu 700422, South Korea.
   Kyungpook Natl Univ, Coll Dent, Dept Dent Biomat, Taegu 700422, South Korea.
   Korea Inst Machinery & Mat, Dept Surface Engn, Changwon, South Korea.
RP Kim, KH (reprint author), Kyungpook Natl Univ, Coll Dent, Inst Biomat Res, 2-101 Dongin Dong, Taegu 700422, South Korea.
CR ALBREKTSSON T, 1981, ACTA ORTHOP SCAND, V52, P155, DOI 10.3109/17453678108991776
   ALBREKTSSON T, 1987, J PROSTHET DENT, V57, P597, DOI 10.1016/0022-3913(87)90344-1
   Blendeau G., 1977, J LESS-COMMON MET, V56, P215
   Bowers K T, 1992, Int J Oral Maxillofac Implants, V7, P302
   CAMARA OR, 1984, ELECTROCHIM ACTA, V29, P1111, DOI 10.1016/0013-4686(84)87163-7
   CAMERON HU, 1973, J BIOMED MATER RES, V7, P301, DOI 10.1002/jbm.820070404
   CHEHROUDI B, 1989, J BIOMED MATER RES, V23, P1067, DOI 10.1002/jbm.820230907
   CIGADA A, 1992, J MATER SCI-MATER M, V3, P408, DOI 10.1007/BF00701236
   EFFAH EAB, 1995, J BIOMED MATER RES, V29, P73, DOI 10.1002/jbm.820290111
   FELSKE A, 1989, ELECTROCHIM ACTA, V34, P75, DOI 10.1016/0013-4686(89)80012-X
   Fini M, 1999, BIOMATERIALS, V20, P1587, DOI 10.1016/S0142-9612(99)00060-5
   GROESSNERSCHREIBER B, 1992, J CELL SCI, V101, P209
   HAZAN R, 1993, BIOMATERIALS, V14, P570, DOI 10.1016/0142-9612(93)90172-X
   ISHIZAWA H, 1995, J BIOMED MATER RES, V29, P65, DOI 10.1002/jbm.820290110
   ISHIZAWA H, 1995, J BIOMED MATER RES, V29, P1071, DOI 10.1002/jbm.820290907
   Kasemo B, 1988, Int J Oral Maxillofac Implants, V3, P247
   KURZE P, 1986, CRYST RES TECHNOL, V21, P1603, DOI 10.1002/crat.2170211224
   Lausmaa J, 1986, MATER RES SOC S P, V55, P351
   Lee TM, 2000, J BIOMED MATER RES, V50, P499, DOI 10.1002/(SICI)1097-4636(20000615)50:4<499::AID-JBM5>3.0.CO;2-U
   Lemons J E, 1988, J Dent Educ, V52, P748
   Letic-Gavrilovic A, 2000, Dent Mater J, V19, P99
   McAlarney M E, 1996, Int J Oral Maxillofac Implants, V11, P73
   Ohtsuka T, 1998, CORROS SCI, V40, P951, DOI 10.1016/S0010-938X(98)00032-8
   Ong J L, 1996, Implant Dent, V5, P83, DOI 10.1097/00008505-199600520-00002
   ONG JL, 1995, J MATER SCI-MATER M, V6, P113, DOI 10.1007/BF00120418
   Pouilleau J, 1997, MAT SCI ENG B-SOLID, V47, P235, DOI 10.1016/S0921-5107(97)00043-3
   RICCI JL, 1991, BONE-BIOMATERIAL INTERFACE, P334
   Shackelford JF, 1999, MATER SCI FORUM, V293, P1, DOI 10.4028/www.scientific.net/MSF.293.1
   Sviridov VV, 1998, RUSS J APPL CHEM+, V71, P2026
   Van N. R., 1987, J MATER RES, V22, P3801
   Weng J, 1997, BIOMATERIALS, V18, P1027, DOI 10.1016/S0142-9612(97)00022-7
   WILLIAMS DF, 1990, INTERDISCIPL SCI REV, V15, P20
   Zwilling V, 1999, SURF INTERFACE ANAL, V27, P629, DOI 10.1002/(SICI)1096-9918(199907)27:7<629::AID-SIA551>3.0.CO;2-0
NR 33
TC 171
Z9 179
U1 1
U2 21
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2001
VL 22
IS 16
BP 2199
EP 2206
DI 10.1016/S0142-9612(00)00394-X
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 448TQ
UT WOS:000169646400003
PM 11456059
DA 2018-10-20
ER

PT J
AU Yamada, K
   Imamura, K
   Itoh, H
   Iwata, H
   Maruno, S
AF Yamada, K
   Imamura, K
   Itoh, H
   Iwata, H
   Maruno, S
TI Bone bonding behavior of the hydroxyapatite containing glass-titanium
   composite prepared by the Cullet method
SO BIOMATERIALS
LA English
DT Article
DE implant; hydroxyapatite-containing glass; biomaterial; bone bonding;
   artificial joint
ID FUNCTIONALLY GRADIENT COMPOSITE; COATED TITANIUM; IMPLANTS; PHOSPHATE;
   SURFACE
AB Bioactive composites composed of hydroxyapatite containing glass (HA-G) as a coating and titanium (Ti) or titanium alloy implants as a substrate were prepared by the Cullet method. This method results in the HA-G coating layer on the substrate with a compositional gradient in HA concentration. The results of in vitro and in vivo experiments investigating the characteristics of the composite materials are reported and discussed in this article. In vitro evaluations confirmed that the Cullet method was suitable for the preparation of the functionally gradient composite implants with higher reliable quality. In vivo experiments permitted evaluation of bonding strength of these composite implants to living bone tissue. Mechanical pull-out tests indicated that the implants bonded to living bone at least as firmly as those by the conventional method, and that the adhesion between the HA-G coating layer and metal substrate was well integrated and strongly maintained in vivo. SEM observations with EDX and a histological study of the interface between the HA-G-Ti composite implants and bone tissue revealed not only that the implants bonded to bone directly without any intervening tissue but that bone ingrowth into the HA-G layer occurred. The HA-G-Ti composite implants demonstrate both biocompatible and osteoconductive characteristics, and may be expected to obtain good and lasting results when applied clinically. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Nagoya Univ, Sch Med, Dept Orthoped Surg, Showa Ku, Nagoya, Aichi 4668550, Japan.
   Nagoya Inst Technol, Dept Elect & Comp Engn, Showa Ku, Nagoya, Aichi 4668555, Japan.
   Tokyo Kouseinenkin Hosp, Dept Orthoped Surg, Shinjuku Ku, Tokyo 1620821, Japan.
RP Yamada, K (reprint author), Aichi Canc Ctr Hosp, Dept Orthopaed Surg, Chikusa Ku, 1-1 Kanokoden, Nagoya, Aichi 4648681, Japan.
CR BAN S, 1994, J BIOMED MATER RES, V28, P65, DOI 10.1002/jbm.820280109
   BAN S, 1991, BIOMATERIALS, V12, P205, DOI 10.1016/0142-9612(91)90201-K
   BAN SJ, 1991, JPN J APPL PHYS 2, V30, pL1333, DOI 10.1143/JJAP.30.L1333
   BAUER TW, 1991, J BONE JOINT SURG AM, V73A, P1439, DOI 10.2106/00004623-199173100-00001
   BLOEBAUM RD, 1993, J ARTHROPLASTY, V8, P195
   COOK SD, 1988, CLIN ORTHOP RELAT R, P225
   DELANGE GL, 1989, BIOMATERIALS, V10, P121, DOI 10.1016/0142-9612(89)90044-6
   FRAYSSINET P, 1992, BIOMATERIALS, V13, P668, DOI 10.1016/0142-9612(92)90126-9
   GEESINK RGT, 1995, J BONE JOINT SURG BR, V77B, P534
   Ishikawa Tomoji, 1993, Clinical Materials, V14, P277, DOI 10.1016/0267-6605(93)90014-X
   JANSEN JA, 1991, J BIOMED MATER RES, V25, P973, DOI 10.1002/jbm.820250805
   KLEIN CPAT, 1994, BIOMATERIALS, V15, P146, DOI 10.1016/0142-9612(94)90264-X
   Maruno S., 1999, Materials Science Forum, V308-311, P344
   MARUNO S, 1991, BIOMATERIALS, V12, P225, DOI 10.1016/0142-9612(91)90204-N
   MARUNO S, 1992, NIPPON SERAM KYO GAK, V100, P362
   PASCHALIS EP, 1995, J BIOMED MATER RES, V29, P1499, DOI 10.1002/jbm.820291206
   Shen W J, 1992, J Arthroplasty, V7, P43, DOI 10.1016/0883-5403(92)90031-K
   Soballe K, 1993, Acta Orthop Scand Suppl, V255, P1
   SOBALLE K, 1991, CLIN ORTHOP RELAT R, P300
   YAMADA K, 1996, BIOCERAMICS, V9, P285
NR 20
TC 13
Z9 15
U1 0
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2001
VL 22
IS 16
BP 2207
EP 2214
DI 10.1016/S0142-9612(00)00402-6
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 448TQ
UT WOS:000169646400004
PM 11456060
DA 2018-10-20
ER

PT J
AU Elizabeth, A
   Joseph, C
   Ittyachen, MA
AF Elizabeth, A
   Joseph, C
   Ittyachen, MA
TI Growth and micro-topographical studies of gel grown cholesterol crystals
SO BULLETIN OF MATERIALS SCIENCE
LA English
DT Article
DE cholesterol; gel method; organic solvents; micro-topographical studies;
   layered growth
AB Cholesterol (C27H46O) is the most abundant and best-known steroid in the animal kingdom. The in vitro crystallization of this important biomaterial has been attempted by few researchers. Here we are reporting crystallization of pure cholesterol monohydrate crystals in gel medium. It is found that the morphology of the crystals depends on various parameters. The effect of solvent has been studied in detail. The different morphologies observed are fibrous, needle, platelet, dendrite etc. Micro topographical studies have been made and it is found that the crystals grow, at least in the last stage, by spreading of layers. However, at initial stage microcrystals formed and developed into dendrite or needle forms. These one-dimensional crystals developed into platelets and finally thickened. Further studies reveal that micro impurities play a vital role in the development of these crystals as seen by dissolution figures on the crystals. These crystals are characterized by using the XRD and IR spectroscopic methods.
C1 Mahatma Gandhi Univ, Sch Pure & Appl Phys, Kottayam 686560, India.
RP Ittyachen, MA (reprint author), Mahatma Gandhi Univ, Sch Pure & Appl Phys, Kottayam 686560, India.
CR ADMIRAND WH, 1968, J CLIN INVEST, V4, P1045
   BAR LK, 1984, J CHEM ENG DATA, V29, P440, DOI 10.1021/je00038a023
   GARTI N, 1981, J LIPID RES, V22, P785
   GARTI N, 1980, THERMOCHIM ACTA, V35, P343, DOI 10.1016/0040-6031(80)87134-6
   Henisch H. K., 1988, CRYSTAL GROWTH GELS
   KALKURA SN, 1986, J MATER SCI LETT, V5, P741, DOI 10.1007/BF01730234
   KALKURA SN, 1987, J CRYST GROWTH, V83, P446, DOI 10.1016/0022-0248(87)90308-3
   LABOWITZ LC, 1972, THERMOCHIM ACTA, V3, P419
   PAL S, 1987, INDIAN J BIOCHEM BIO, V24, P24
NR 9
TC 16
Z9 17
U1 0
U2 3
PU INDIAN ACADEMY SCIENCES
PI BANGALORE
PA P B 8005 C V RAMAN AVENUE, BANGALORE 560 080, INDIA
SN 0250-4707
J9 B MATER SCI
JI Bull. Mat. Sci.
PD AUG
PY 2001
VL 24
IS 4
BP 431
EP 434
DI 10.1007/BF02708643
PG 4
WC Materials Science, Multidisciplinary
SC Materials Science
GA 461KL
UT WOS:000170363400014
DA 2018-10-20
ER

PT J
AU Tong, HH
   Monteiro, OR
   MacGill, RA
   Brown, IG
   Yin, GF
   Luo, JM
AF Tong, H. H.
   Monteiro, O. R.
   MacGill, R. A.
   Brown, I. G.
   Yin, G. F.
   Luo, J. M.
TI Fabrication and characteristics of ta-C biomaterial coatings on
   Ti-6Al-4V using metal plasma immersion ion implantation and deposition
SO CURRENT APPLIED PHYSICS
LA English
DT Article
DE ta-C; Biomaterials; Metal plasma immersion ion implantation and
   deposition; Diamond-like carbon; Hard coatings
AB We have formed amorphous diamond (ta-C) coatings on Ti-6Al-4V substrates using a metal plasma immersion ion implantation and deposition (MEPIIID) technique, and characterized the mechanical properties and biological compatibility of the coating material. The hemocompatibility of the coating compared favorably with that of low temperature isotropic (LTI) carbon, with kinetic clotting time and hemolysis rate approximately the same as for LTI carbon, and platelet consumption about twice that of the latter. The mechanical properties were good, with a microhardness greater than that of the uncoated metal substrates, and high adhesion of >0.75 GPa (interface shear stress) as estimated from a thermal quench method. Glancing-angle X-ray diffraction measurements indicated the presence of a TiC transition layer, suggesting the formation of a Ti/TiC/ta-C multilayer structure, leading in turn to good film-substrate adhesion. We conclude that this kind of amorphous diamond coating could provide benefit as a biocompatible hard coating for Ti-6Al-4V substrate material. (c) 2001 Elsevier Science B.V. All rights reserved.
C1 [Tong, H. H.] SW Inst Phys, Chengdu 610041, Sichuan, Peoples R China.
   [Monteiro, O. R.; MacGill, R. A.; Brown, I. G.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA.
   [Yin, G. F.; Luo, J. M.] Sichuan Univ, Dept Inorgan Mat, Chengdu 610065, Peoples R China.
RP Tong, HH (reprint author), SW Inst Phys, Chengdu 610041, Sichuan, Peoples R China.
EM thonghui@hotmail.com
FU IAEA; US Department of Energy, Office of Energy Research
   [DE-AC03-76SF00098]
FX One of us (H.H. Tong) was supported at LBNL by an IAEA Fellowship, for
   which he would like to express his appreciation. This work was supported
   in part by the US Department of Energy, Office of Energy Research, under
   Contract Number DE-AC03-76SF00098.
CR Alonso F, 1996, SURF COAT TECH, V83, P301, DOI 10.1016/0257-8972(96)02767-3
   ANDERS A, 1995, PLASMA SOURCES SCI T, V4, P1, DOI 10.1088/0963-0252/4/1/001
   Anders A, 1997, SURF COAT TECH, V93, P158, DOI 10.1016/S0257-8972(97)00037-6
   ANDERS S, 1997, DATA STORAGE, V4, P31
   Andreazza P, 1998, THIN SOLID FILMS, V319, P62, DOI 10.1016/S0040-6090(97)01086-9
   Baba K, 1998, SURF COAT TECH, V104, P235, DOI 10.1016/S0257-8972(98)00401-0
   BIERSACK JP, 1991, NUCL INSTRUM METH B, V59, P21, DOI 10.1016/0168-583X(91)95167-C
   BLECH IA, 1993, J VAC SCI TECHNOL A, V11, P728, DOI 10.1116/1.578800
   Brown IG, 1998, ANNU REV MATER SCI, V28, P243, DOI 10.1146/annurev.matsci.28.1.243
   BROWN IG, 1993, NUCL INSTRUM METH B, V80-1, P1281, DOI 10.1016/0168-583X(93)90782-2
   De Barros MI, 1999, DIAM RELAT MATER, V8, P1022, DOI 10.1016/S0925-9635(98)00439-7
   de Souza TM, 1997, THIN SOLID FILMS, V308, P254, DOI 10.1016/S0040-6090(97)00378-7
   Dowling DP, 1997, DIAM RELAT MATER, V6, P390, DOI 10.1016/S0925-9635(96)00687-5
   Fan QH, 1998, J APPL PHYS, V83, P5588, DOI 10.1063/1.367399
   Grill A, 1999, DIAM RELAT MATER, V8, P428, DOI 10.1016/S0925-9635(98)00262-3
   IMAI Y, 1972, J BIOMED MATER RES, V6, P165, DOI 10.1002/jbm.820060305
   Jones MI, 1999, DIAM RELAT MATER, V8, P457, DOI 10.1016/S0925-9635(98)00426-9
   Lifshitz Y., 1999, DIAM RELAT MATER, V8, P779
   Lin CR, 1997, THIN SOLID FILMS, V308, P273, DOI 10.1016/S0040-6090(97)00392-1
   Littmark U., 1985, STOPPING RANGE IONS, V1
   Loinaz A, 1998, SURF COAT TECH, V104, P262, DOI 10.1016/S0257-8972(98)00411-3
   MacGill RA, 1998, REV SCI INSTRUM, V69, P801, DOI 10.1063/1.1148718
   Miji M., 1992, BIOMATERIALS, V13, P682
   Monteiro OR, 1999, NUCL INSTRUM METH B, V148, P12, DOI 10.1016/S0168-583X(98)00685-5
   Pharr GM, 1996, APPL PHYS LETT, V68, P779, DOI 10.1063/1.116530
   Ran J.G., 1992, 1 AS PAC C PLASM SCI, V1, P179
   Rinner M, 1998, SURF COAT TECH, V100, P366, DOI 10.1016/S0257-8972(97)00650-6
   Sioshansi P, 1996, SURF COAT TECH, V83, P175, DOI 10.1016/0257-8972(95)02838-2
   Sonoda T, 1998, SURF SCI, V402, P241, DOI 10.1016/S0039-6028(98)00032-6
   TOULOUKIAN YS, 1975, THERMALOPHYSICAL PRO, V12, P1272
   Viviente JL, 1999, APPL SURF SCI, V144-45, P249, DOI 10.1016/S0169-4332(98)00806-X
   Voevodin AA, 1997, THIN SOLID FILMS, V298, P107, DOI 10.1016/S0040-6090(96)09145-6
   Wilson AD, 1999, SURF COAT TECH, V114, P70, DOI 10.1016/S0257-8972(99)00024-9
   Yin GF, 1999, THIN SOLID FILMS, V345, P67, DOI 10.1016/S0040-6090(99)00076-0
   Zhang F, 1998, SURF COAT TECH, V104, P146, DOI 10.1016/S0257-8972(98)00434-4
NR 35
TC 5
Z9 6
U1 0
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1567-1739
EI 1878-1675
J9 CURR APPL PHYS
JI Curr. Appl. Phys.
PD AUG
PY 2001
VL 1
IS 2-3
BP 197
EP 201
AR PII S1567-1739(01)00016-5
DI 10.1016/S1567-1739(01)00016-5
PG 5
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA V23BZ
UT WOS:000208319600015
DA 2018-10-20
ER

PT J
AU Schoof, H
   Apel, J
   Heschel, I
   Rau, G
AF Schoof, H
   Apel, J
   Heschel, I
   Rau, G
TI Control of pore structure and size in freeze-dried collagen sponges
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE collagen sponge; pore structure; unidirectional solidification;
   freeze-drying; tissue engineering
ID ARTIFICIAL SKIN; MORPHOLOGY; MATRICES; TISSUE
AB Because of many suitable properties, collagen sponges are used as an acellular implant or a biomaterial in the field of tissue engineering. Generally, the inner three-dimensional structure of the sponges influences the behavior of cells. To investigate this influeuce, it is necessary to develop a process to produce sponges with a defined, adjustable, and homogeneous pore structure, Collagen sponges can be produced by freeze-drying of collagen suspensions. The pore structure of the freeze-dried sponges mirrors the ice-crystal morphology after freezing. In industrial production, the collagen suspensions are solidified under time- and space-dependent freezing conditions, resulting in an inhomogeneous pore structure. In this investigation, unidirectional solidification was applied during the freezing process to produce collagen sponges with a homogeneous pore structure. Using this technique the entire sample can be solidified under thermally constant freezing conditions, The ice-crystal morphology and size can be adjusted by varying the solute concentration in the collagen suspension, Collagen sponges with a very uniform and defined pore structure can be produced. Furthermore, the pore size can be adjusted between 20-40 mum. The thickness of the sponges prepared during this research was 10 mm, (C) 2001 John Wiley & Sons. Inc.
C1 Aachen Univ Technol, Rhein Westfal TH Aachen, Helmholtz Inst Biomed engn, D-52074 Aachen, Germany.
RP Heschel, I (reprint author), Aachen Univ Technol, Rhein Westfal TH Aachen, Helmholtz Inst Biomed Engn, Pauwelsstr 20, D-52074 Aachen, Germany.
CR AUBOURG P, 1978, THESIS MIT CAMBRIDGE
   BECKMANN J, 1990, CRYOBIOLOGY, V27, P279, DOI 10.1016/0011-2240(90)90027-2
   CHVAPIL M, 1977, J BIOMED MATER RES, V11, P721, DOI 10.1002/jbm.820110508
   CHVAPIL M, 1982, J BIOMED MATER RES, V16, P245, DOI 10.1002/jbm.820160306
   DAGALAKIS N, 1980, J BIOMED MATER RES, V14, P511, DOI 10.1002/jbm.820140417
   DOILLON CJ, 1986, J BIOMED MATER RES, V20, P1219, DOI 10.1002/jbm.820200811
   Ehlers EM, 1999, ANN ANAT, V181, P513, DOI 10.1016/S0940-9602(99)80055-7
   Ellis DL, 1996, BIOMATERIALS, V17, P291, DOI 10.1016/0142-9612(96)85567-0
   Frenkel SR, 1997, J BONE JOINT SURG BR, V79B, P831, DOI 10.1302/0301-620X.79B5.7278
   HESCHEL I, 1996, ADV CRYOGEN ENG, P13
   HOBBS PV, 1974, ICE PHYSICS
   KURZ W, 1989, FUNDAMENTALS SOLIDIF, P7
   MARKS MG, 1991, J BIOMED MATER RES, V25, P683, DOI 10.1002/jbm.820250510
   MATSUDA K, 1990, BIOMATERIALS, V11, P351, DOI 10.1016/0142-9612(90)90113-5
   Mueller SM, 1999, BIOMATERIALS, V20, P701, DOI 10.1016/S0142-9612(98)00189-6
   MULLINS WW, 1964, J APPL PHYS, V35, P444, DOI 10.1063/1.1713333
   Nachf O. S., 1990, German Pat., Patent No. [DE 40 28 622 C2, 4028622]
   OLIVER RF, 1985, BIOCOMPATIBILITY TIS
   RODKEY WG, 1999, CLIN ORTHOP S, V367, P281
   RUTTER JW, 1953, CAN J PHYS, V31, P15, DOI 10.1139/p53-003
   Schlegel AK, 1997, BIOMATERIALS, V18, P535, DOI 10.1016/S0142-9612(96)00175-5
   Schoof H, 2000, J CRYST GROWTH, V209, P122, DOI 10.1016/S0022-0248(99)00519-9
   Tsuruga E, 1997, J BIOCHEM-TOKYO, V121, P317
   WINTER G, 1973, BIOL FIBROBLAST, P104
   YANNAS IV, 1982, SCIENCE, V215, P174, DOI 10.1126/science.7031899
   YANNAS IV, 1989, Patent No. 8910728
   YANNAS IV, 1988, COLLAGEN BIOTECHNOLO, P87
   YAYALAOGLU MB, 1999, BIOMATER, V20, P1513
NR 28
TC 218
Z9 222
U1 5
U2 87
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD AUG
PY 2001
VL 58
IS 4
BP 352
EP 357
DI 10.1002/jbm.1028
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 452CL
UT WOS:000169839500003
PM 11410892
DA 2018-10-20
ER

PT J
AU Dexter, SJ
   Pearson, RG
   Davies, MC
   Camara, M
   Shakesheff, KM
AF Dexter, SJ
   Pearson, RG
   Davies, MC
   Camara, M
   Shakesheff, KM
TI A comparison of the adhesion of mammalian cells and Staphylococcus
   epidermidis on fibronectin-modified polymer surfaces
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE cell adhesion; fibronectin; bacteria; fibroblast; tissue engineering
   scaffold
ID AUREUS; BINDING; TISSUE; ADHERENCE; BIOMATERIALS; INFECTIONS; RECEPTOR;
   BIOFILMS; PROTEINS; MATRICES
AB The modification of polymer surfaces to mimic the extracellular matrix, and therefore, stimulate cell growth via receptor-mediated interactions, is one approach used to promote the integration of tissue-engineering scaffolds and biomaterials into the body. However, by optimizing surfaces for tissue integration it is likely that bacterial adhesion may also be affected, resulting in a greater risk of biomaterial-related infection. This could be detrimental to both the implant and the patient because biomaterial related infections are particularly resistant to host defenses and antibiotics. In this study, we analyzed the adhesion of a Staphylococcus epidermidis clinical isolate and 3T3 rat fibroblasts to tissue culture plastic coated with varying concentrations of fibronectin (Fn). Bacterial adhesion was always lower than tissue culture plastic and appeared to decrease with increasing Fn concentrations. Mammalian cell adhesion to Fn Exceeded adhesion to tissue culture plastic but did not differ significantly over the range of protein concentrations or between 1 and 4 h of incubation. In most casts, the total surface coverage did not vary with time or Fn concentration, indicating that maximal cell adhesion and spreading occurred rapidly and at low protein concentrations. This study suggests that, by controlling the density of proteins or ligands on a surface, we can potentially optimize mammalian cell adhesion without stimulating bacterial adhesion, hence reducing the likelihood of infection. (C) 2001 John Wiley Sons, Inc. J Biomed Mater Res 56: 222-227, 2001.
C1 Univ Nottingham, Sch Pharmaceut Sci, Nottingham NG7 2RD, England.
RP Shakesheff, KM (reprint author), Univ Nottingham, Sch Pharmaceut Sci, Univ Pk, Nottingham NG7 2RD, England.
RI Shakesheff, Kevin/O-6371-2018
OI Shakesheff, Kevin/0000-0003-3236-2439; Davies,
   Martyn/0000-0001-7695-0596; Pearson, Richard/0000-0002-5241-9810
CR BOZZINI S, 1992, EUR J BIOCHEM, V207, P327, DOI 10.1111/j.1432-1033.1992.tb17054.x
   CIMA LG, 1993, CHEM ENG PROG, V89, P46
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   DRUMHELLER PD, 1995, BIOMEDICAL ENG HDB, pCH106
   DUNNE WM, 1993, J APPL BACTERIOL, V74, P411, DOI 10.1111/j.1365-2672.1993.tb05147.x
   ESPERSEN F, 1982, INFECT IMMUN, V37, P526
   FROMAN G, 1987, J BIOL CHEM, V262, P6564
   Garcia AJ, 1999, BIOMATERIALS, V20, P2427, DOI 10.1016/S0142-9612(99)00170-2
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Habash M, 1999, J CLIN PHARMACOL, V39, P887, DOI 10.1177/00912709922008506
   HEALY KE, 1999, BIOARTIFICIAL ORGANS, V2, P24
   HERRMANN M, 1988, J INFECT DIS, V158, P693, DOI 10.1093/infdis/158.4.693
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   JONSSON K, 1991, EUR J BIOCHEM, V202, P1041, DOI 10.1111/j.1432-1033.1991.tb16468.x
   Kim BS, 1998, TRENDS BIOTECHNOL, V16, P224, DOI 10.1016/S0167-7799(98)01191-3
   Marler JJ, 1998, ADV DRUG DELIVER REV, V33, P165, DOI 10.1016/S0169-409X(98)00025-8
   MOSHER DF, 1980, SCIENCE, V209, P927, DOI 10.1126/science.7403857
   PATTI JM, 1994, ANNU REV MICROBIOL, V48, P585, DOI 10.1146/annurev.mi.48.100194.003101
   Ratner BD, 1996, J MOL RECOGNIT, V9, P617, DOI 10.1002/(SICI)1099-1352(199634/12)9:5/6<617::AID-JMR310>3.0.CO;2-D
   SOTTILE J, 1991, J BIOL CHEM, V266, P12840
   VAUDAUX P, 1984, J INFECT DIS, V150, P546, DOI 10.1093/infdis/150.4.546
   VERCELLOTTI GM, 1985, AM J PATHOL, V120, P13
NR 23
TC 25
Z9 25
U1 0
U2 3
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD AUG
PY 2001
VL 56
IS 2
BP 222
EP 227
DI 10.1002/1097-4636(200108)56:2<222::AID-JBM1087>3.0.CO;2-L
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 438BJ
UT WOS:000169033600008
PM 11340592
DA 2018-10-20
ER

PT J
AU Itala, A
   Nordstrom, EG
   Ylanen, H
   Aro, HT
   Hupa, M
AF Itala, A
   Nordstrom, EG
   Ylanen, H
   Aro, HT
   Hupa, M
TI Creation of microrough surface on sintered bioactive glass microspheres
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE bioactive glass; microspheres; microroughness; atomic force microscopy;
   scanning electron microscopy
ID TITANIUM IMPLANTS; ELECTRON-MICROSCOPY; MINIATURE PIGS; BONE CELL;
   BIOMATERIALS; ROUGHNESS; CERAMICS; BEHAVIOR; COATINGS; ALLOY
AB Bioactive glasses are surface-active, generally silica-based, synthetic materials that form a firm chemical bond to bone. The aim of this study was to further enhance the bioactivity of glasses by creating a microroughness on their surface. Microroughness increases potential surface area for cell attachment and biomaterial-cell interactions. Three bioactive glasses of different composition were studied. Each material was flame-sprayed into microspheres, and a selected fraction of the spheres (250-300 mum) was sintered to form porous bioactive glass specimens. To create microrough surfaces, different acid etching techniques were tested. Atomic force microscopy (AFM) and back-scattered electron imaging of scanning electron microscopy (BEI-SEM) were used to characterize surface roughness. The degree of roughness was measured by AFM. A novel chemical-etching method, developed through intensive screening of different options, was found consistently to create the desired microroughness, with an average roughness value (R-a) of 0.35-0.52 mum and a root mean-square roughness value (R-rms) of 0.42-0.64 mum. Microroughening of the glass surface was obtained even in the internal parts of the porous glass matrices. Measured by BEI-SEM, the etching of a bioactive glass surface did not interfere with the formation of the characteristic surface reactions of bioactive glasses. This was confirmed by immersing the etched and control glass bodies in a simulated body fluid and tris(hydroxymethyl) aminomethane/HCl. The etching process did not significantly affect the mechanical strength of the sintered bioactive glass structures. Based on these experiments, it stems possible to create a reproducible microroughness of appropriate size on the surface of porous bioactive glass. The biologic benefits of such a surface treatment need to be validated with in vivo experiments. (C) 2001 John Wiley & Sons, Inc. J Biomed Mater Res 56: 282-288, 2001.
C1 Univ Turku, Dept Surg, FIN-20520 Turku, Finland.
   Abo Akad Univ, Proc Chem Grp, SF-20500 Turku, Finland.
RP Aro, HT (reprint author), Univ Turku, Dept Surg, FIN-20520 Turku, Finland.
OI Aro, Hannu/0000-0003-3118-9144
CR ALBREKTSSON T, 1981, ACTA ORTHOP SCAND, V52, P155, DOI 10.3109/17453678108991776
   BARO AM, 1986, BIOMATERIALS, V7, P463, DOI 10.1016/0142-9612(86)90036-0
   Bowers K T, 1992, Int J Oral Maxillofac Implants, V7, P302
   Boyan BD, 1998, J BIOMED MATER RES, V39, P77, DOI 10.1002/(SICI)1097-4636(199801)39:1<77::AID-JBM10>3.0.CO;2-L
   Brink M, 1996, BIOCERAMICS, V9, P127
   Brunette D M, 1988, Int J Oral Maxillofac Implants, V3, P231
   Buser D, 1999, J BIOMED MATER RES, V45, P75, DOI 10.1002/(SICI)1097-4636(199905)45:2<75::AID-JBM1>3.0.CO;2-P
   BUSER D, 1991, J BIOMED MATER RES, V25, P889, DOI 10.1002/jbm.820250708
   Carlsson L, 1988, Int J Oral Maxillofac Implants, V3, P21
   Ducheyne P, 1999, BIOMATERIALS, V20, P2287, DOI 10.1016/S0142-9612(99)00181-7
   DUNN GA, 1976, EXP CELL RES, V101, P1, DOI 10.1016/0014-4827(76)90405-5
   GAPPI C, 1995, BIOMATERIALS, V16, P515
   Gomez-Vega JM, 1999, J BIOMED MATER RES, V46, P549, DOI 10.1002/(SICI)1097-4636(19990915)46:4<549::AID-JBM13>3.0.CO;2-M
   Grossner-Schreiber B, 1991, Dtsch Zahnarztl Z, V46, P691
   HENCH LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   JONES SJ, 1985, SCANNING, V7, P5, DOI 10.1002/sca.4950070101
   KARLSSON KH, 1999, ANN CHIR GYNAECOL, V88, P237
   KASEMO B, 1983, J PROSTHET DENT, V49, P832, DOI 10.1016/0022-3913(83)90359-1
   Kitsugi T, 1996, J BIOMED MATER RES, V30, P261, DOI 10.1002/(SICI)1097-4636(199602)30:2<261::AID-JBM17>3.0.CO;2-P
   LACEFIELD WR, 1986, BIOMATERIALS, V7, P104, DOI 10.1016/0142-9612(86)90064-5
   LARSSON C, 1994, BIOMATERIALS, V15, P1062, DOI 10.1016/0142-9612(94)90092-2
   MICHAELS C M, 1989, Journal of Dental Research, V68, P276
   NEO M, 1993, J BIOMED MATER RES, V27, P999, DOI 10.1002/jbm.820270805
   Ohgushi H, 1996, J BIOMED MATER RES, V32, P341, DOI 10.1002/(SICI)1097-4636(199611)32:3<341::AID-JBM6>3.0.CO;2-S
   Oliva A, 1998, BIOMATERIALS, V19, P1019, DOI 10.1016/S0142-9612(97)00249-4
   PAJAMAKI J, 1995, ARCH ORTHOP TRAUM SU, V114, P119, DOI 10.1007/BF00422839
   PITKANEN V, 1995, J AEROSOL SCI, V26, P831
   RATNER BD, 1983, ANN BIOMED ENG, V11, P313, DOI 10.1007/BF02363290
   Schrooten J, 1999, J BIOMED MATER RES, V44, P243, DOI 10.1002/(SICI)1097-4636(19990305)44:3<243::AID-JBM2>3.0.CO;2-O
   TAKADAMA H, 1999, BIOCERAMICS, V12, P109
   THOMAS KA, 1985, J BIOMED MATER RES, V19, P875, DOI 10.1002/jbm.820190802
   Virolainen P, 1997, J BIOMED MATER RES, V35, P9, DOI 10.1002/(SICI)1097-4636(199704)35:1<9::AID-JBM2>3.3.CO;2-H
   Wen XJ, 1996, BIO-MED MATER ENG, V6, P173
   Ylanen H, 2000, J NON-CRYST SOLIDS, V275, P107, DOI 10.1016/S0022-3093(00)00245-3
   Ylanen HO, 1999, ANN CHIR GYNAECOL FE, V88, P237
NR 35
TC 24
Z9 24
U1 0
U2 6
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD AUG
PY 2001
VL 56
IS 2
BP 282
EP 288
DI 10.1002/1097-4636(200108)56:2<282::AID-JBM1096>3.0.CO;2-5
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 438BJ
UT WOS:000169033600016
PM 11340600
DA 2018-10-20
ER

PT J
AU Hong, J
   Larsson, A
   Ekdahl, KN
   Elgue, G
   Larsson, R
   Nilsson, B
AF Hong, J
   Larsson, A
   Ekdahl, KN
   Elgue, G
   Larsson, R
   Nilsson, B
TI Contact between a polymer and whole blood: Sequence of events leading to
   thrombin generation
SO JOURNAL OF LABORATORY AND CLINICAL MEDICINE
LA English
DT Article
ID IN-VITRO MODEL; PLATELET ACTIVATION; FACTOR-XII; IMMOBILIZED HEPARIN;
   ARTIFICIAL SURFACES; FLOWING BLOOD; P-SELECTIN; COAGULATION;
   ERYTHROCYTES; PHOSPHORYLATION
AB The mechanism by which thrombin is generated on a polymer surface in an extracorporeal circuit is not yet fully understood. To address this question we have developed an in vitro chamber model in which whole blood containing heparin (I IU/mL) comes in contact with a commonly used biomaterial, polyvinyl chloride (PVC). Incubation of blood in the chamber for 60 minutes at 37 degreesC resulted in the binding of platelets to the material surface and the generation of thrombin-antithrombin complexes. Corn trypsin inhibitor, a specific inhibitor of factor XIIa, inhibited this thrombin-antithrombin complex generation in blood in contact with PVC, which is not considered an efficient activator of factor XII. The addition of the glycoprotein IIb/IIIa inhibitor Ro44-9883 abrogated platelet binding and aggregation and resulted in decreased generation of thrombin-antithrombin complexes. Thrombin-antithrombin generation was also negligible in platelet-rich plasma but could be partially restored in the presence of erythrocytes. Taken together, these data are compatible with a model in which thrombin generation is triggered by factor XII. The response to contact with PVC appears to begin with a low-grade generation of thrombin that involves both erythrocytes and leukocytes and that activates platelets, followed by the activation of a platelet-dependent amplification loop that produces most of the thrombin.
C1 Univ Uppsala Hosp, Dept Oncol Radiol & Clin Immunol, Uppsala, Sweden.
   Univ Hosp, Dept Med Sci, Uppsala, Sweden.
   Univ Kalmar, Dept Chem & Nat Sci, Kalmar, Sweden.
RP Nilsson, B (reprint author), Univ Uppsala Hosp, Dept Clin Immunol & Transfus Med, S-75185 Uppsala, Sweden.
RI Nilsson Ekdahl, Kristina/B-5301-2012; Nilsson, Bo/B-3102-2012
OI Nilsson, Bo/0000-0003-0057-2730
CR AARTS PAMM, 1988, ARTERIOSCLEROSIS, V8, P819, DOI 10.1161/01.ATV.8.6.819
   Amirkhosravi A, 1996, THROMB HAEMOSTASIS, V75, P87
   Baglia FA, 2000, J BIOL CHEM, V275, P20514, DOI 10.1074/jbc.M000464200
   Basmadjian D, 1997, BIOMATERIALS, V18, P1511, DOI 10.1016/S0142-9612(97)00101-4
   Carroll RC, 1997, THROMB RES, V88, P109, DOI 10.1016/S0049-3848(97)00223-5
   Colman RW, 1997, BLOOD, V90, P3819
   Dery O, 1998, AM J PHYSIOL-CELL PH, V274, pC1429, DOI 10.1152/ajpcell.1998.274.6.C1429
   EGBERG N, 1983, THROMB RES, V31, P875, DOI 10.1016/0049-3848(83)90118-4
   Ekdahl KN, 1999, THROMB HAEMOSTASIS, V82, P1283
   ELAM JH, 1992, BIOMATERIALS, V13, P3, DOI 10.1016/0142-9612(92)90086-4
   ELGUE G, 1993, ARTIF ORGANS, V17, P721
   Gong J, 1996, J CLIN IMMUNOL, V16, P222, DOI 10.1007/BF01541228
   Helley D, 1996, THROMB HAEMOSTASIS, V76, P322
   Hong J, 1999, BIOMATERIALS, V20, P603, DOI 10.1016/S0142-9612(98)00210-5
   Hong J, 1999, THROMB HAEMOSTASIS, V82, P58
   Hunt BJ, 1997, BLOOD COAGUL FIBRIN, V8, P223, DOI 10.1097/00001721-199706000-00003
   Kirchhofer D, 1997, BLOOD, V89, P1270
   Koenig A, 1998, J CLIN INVEST, V101, P877, DOI 10.1172/JCI1509
   Lamba NMK, 2000, BIOMATERIALS, V21, P89, DOI 10.1016/S0142-9612(99)00145-3
   Li N, 1998, BLOOD COAGUL FIBRIN, V9, P507, DOI 10.1097/00001721-199809000-00008
   Li NL, 2000, ARTERIOSCL THROM VAS, V20, P2702, DOI 10.1161/01.ATV.20.12.2702
   Lindmark E, 2000, ARTERIOSCL THROM VAS, V20, P2322, DOI 10.1161/01.ATV.20.10.2322
   MATSUDA T, 1997, INT J ORAL MAXILLIFA, V12, P472
   Matsumoto Y, 1999, THROMB RES, V95, P19, DOI 10.1016/S0049-3848(98)00189-3
   NELSON RM, 1993, BLOOD, V82, P3253
   Nilsson B, 1998, BLOOD, V92, P1661
   Ostrovsky L, 1998, BLOOD, V91, P3028
   Peyrou V, 1999, THROMB HAEMOSTASIS, V81, P400
   SALZMAN EW, 1987, ANN NY ACAD SCI, V516, P184, DOI 10.1111/j.1749-6632.1987.tb33040.x
   Sanchez J, 1998, THROMB RES, V89, P41, DOI 10.1016/S0049-3848(97)00310-1
   SANTOS MT, 1991, J CLIN INVEST, V87, P571, DOI 10.1172/JCI115032
   VALLES J, 1991, BLOOD, V78, P154
   Walsh PN, 1999, THROMB HAEMOSTASIS, V82, P234
   WICKI AN, 1985, EUR J BIOCHEM, V153, P1, DOI 10.1111/j.1432-1033.1985.tb09259.x
NR 34
TC 39
Z9 39
U1 0
U2 5
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0022-2143
J9 J LAB CLIN MED
JI J. Lab. Clin. Med.
PD AUG
PY 2001
VL 138
IS 2
BP 139
EP 145
DI 10.1067/mlc.2001.116486
PG 7
WC Medical Laboratory Technology; Medicine, General & Internal; Medicine,
   Research & Experimental
SC Medical Laboratory Technology; General & Internal Medicine; Research &
   Experimental Medicine
GA 459YT
UT WOS:000170279600008
PM 11477381
DA 2018-10-20
ER

PT J
AU Sabokbar, A
   Pandey, R
   Diaz, J
   Quinn, JMW
   Murray, DW
   Athanasou, NA
AF Sabokbar, A
   Pandey, R
   Diaz, J
   Quinn, JMW
   Murray, DW
   Athanasou, NA
TI Hydroxyapatite particles are capable of inducing osteoclast formation
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID BONE-RESORBING CELLS; MACROPHAGES DIFFERENTIATE; IN-VITRO; RESORPTION;
   IMPLANTS
AB Hydroxyapatite (HA) coatings have been used to improve implant fixation by promoting bone formation around the prosthesis. A macrophage response to HA particulates has been noted around loosened HA-coated prostheses. As biomaterial wear particle-associated macrophages are known to be capable of differentiating into osteoclasts that are capable of bone resorption, we examined whether particulate HA could similarly induce macrophage-osteoclast differentiation. HA-associated macrophages were isolated from granulomas, formed by subcutaneous implantation of HA, and co-cultured with UMR 106 osteoblast-like cells in the presence of 1,25-dihydroxyvitamin D-3 for up to 14 days on glass coverslips and bone slices. HA-associated macrophage-osteoclast differentiation was evidenced by the formation of numerous multinucleated tartrate resistant acid phosphatase (TRAP)-positive cells which formed lacunar resorption pits on bone slices. Polymethylmethacrylate (PMMA) particle-associated macrophages, isolated from subcutaneous PMMA-containing granulomas, caused significantly more osteoclast formation and bone resorption than HA-associated macrophages. These results indicate that macrophages responding to HA particles are capable of osteoclast differntiation. They also suggest that particles derived from uncemented (HA-coated) implants are likely to induce less osteoclast formation and osteolysis than cemented implants. (C) 2001 Kluwer Academic Publishers.
C1 Univ Oxford, Nuffield Orthopaed Ctr, Nuffield Dept Orthopaed Surg, Dept Pathol, Oxford OX3 7LD, England.
RP Athanasou, NA (reprint author), Univ Oxford, Nuffield Orthopaed Ctr, Nuffield Dept Orthopaed Surg, Dept Pathol, Oxford OX3 7LD, England.
RI Murray, David/D-7117-2011
CR ATHANASOU NA, 1992, J BONE JOINT SURG BR, V74, P57
   Athanasou NA, 1996, J BONE JOINT SURG AM, V78A, P1096, DOI 10.2106/00004623-199607000-00016
   AUSTYN JM, 1981, EUR J IMMUNOL, V11, P805, DOI 10.1002/eji.1830111013
   BAUER TW, 1994, CLIN ORTHOP RELAT R, P11
   BLOEBAUM RD, 1993, J ARTHROPLASTY, V8, P195
   BLOEBAUM RD, 1994, CLIN ORTHOP RELAT R, P19
   BULLOUGH PG, 1988, ORTHOP CLIN N AM, V19, P611
   EVANS JJ, 1991, CLIN MATER, V7, P241
   GLOWACKI J, 1986, CALCIFIED TISSUE INT, V39, P97, DOI 10.1007/BF02553297
   Harada Y, 1996, J BIOMED MATER RES, V31, P19, DOI 10.1002/(SICI)1097-4636(199605)31:1<19::AID-JBM3>3.3.CO;2-L
   Jaffe WL, 1996, J BONE JOINT SURG AM, V78A, P1918, DOI 10.2106/00004623-199612000-00018
   JIRANEK WA, 1993, J BONE JOINT SURG AM, V75A, P863, DOI 10.2106/00004623-199306000-00007
   KIM KJ, 1993, CLIN ORTHOP RELAT R, P142
   Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X
   LENNOX DW, 1987, CLIN ORTHOP RELAT R, P171
   MARKS SC, 1991, J BONE MINER RES, V6, P395
   MINKIN C, 1982, CALCIFIED TISSUE INT, V34, P285, DOI 10.1007/BF02411252
   MURRAY DW, 1990, J BONE JOINT SURG BR, V72, P988
   NAGASE M, 1988, J RHEUMATOL, V15, P1334
   Neale SD, 2000, J ARTHROPLASTY, V15, P654, DOI 10.1054/arth.2000.6622
   Pandey R, 1996, ANN RHEUM DIS, V55, P388, DOI 10.1136/ard.55.6.388
   QUINN J, 1992, J BONE JOINT SURG BR, V74, P652
   Quinn JMW, 1997, CALCIFIED TISSUE INT, V60, P63, DOI 10.1007/s002239900187
   REVELL PA, 1982, CURRENT TRENDS PATHO, P137
   Sabokbar A, 1997, ANN RHEUM DIS, V56, P414, DOI 10.1136/ard.56.7.414
   SABOKBAR A, 1998, ARCH ORTHOP TRAUMA S, V184, P31
   SOBALLE K, 1991, CLIN ORTHOP RELAT R, P255
   Sun JS, 1999, J BIOMED MATER RES, V45, P311
   WANG W, 1999, HIP INT, V9, P178
NR 29
TC 29
Z9 31
U1 1
U2 6
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD AUG
PY 2001
VL 12
IS 8
BP 659
EP 664
DI 10.1023/A:1011267005465
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 459AG
UT WOS:000170227200001
PM 15348234
DA 2018-10-20
ER

PT J
AU Garcia Paez, JM
   Jorge-Herrero, E
   Carrera, A
   Millan, I
   Rocha, A
   Cordon, A
   Salvador, J
   Sainz, N
   Mendez, J
   Castillo-Olivares, JL
AF Garcia Paez, JM
   Jorge-Herrero, E
   Carrera, A
   Millan, I
   Rocha, A
   Cordon, A
   Salvador, J
   Sainz, N
   Mendez, J
   Castillo-Olivares, JL
TI A new method for selecting calf pericardium for use in cardiac
   bioprostheses on the basis of morphological and mechanical criteria
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID PROSTHETIC HEART-VALVES; BOVINE PERICARDIUM; TISSUE SELECTION; PORCINE
   BIOPROSTHESES; FIBER ARCHITECTURE; FAILURE; INVIVO; SITES
AB The durability of existing calf pericardium bioprostheses is limited by phenomena such as mechanical stress and calcification, the factors most frequently implicated in valve failure. Varying the preferred direction of the collagen fibers influences the mechanical behavior of the pericardial membrane. Given this possible variation, a strict control of the selection of the biomaterial employed in the construction of valve leaflets is essential, but a reliable method of selection has yet to be established.
   This study describes the development of a new system of in vitro selection involving a hydraulic simulator that reproduces the mechanical behavior of pericardial membranes subjected to the stress of continuous flow.
   By combining morphological criteria such as thickness and homogeneity with those of mechanical behavior, and by selecting paired samples from different parts of the pericardium, we obtained excellent mathematical fits. Linear regression analysis provided the mode of predicting the tensile strength in a given sample when this value had been determined in its twin. The upper zones of calf pericardium, corresponding to either right or left ventricle but at a distance from ligamentous structures, showed the best mean results at rupture (60 MPa) and permitted the most reliable prediction. The expected stress for an elongation of 30% was 1.12 MPa, as was previously observed, with a 95% confidence interval of between 1.11 and 1.14 MPa.
   These trials, together with the careful selection of the pairs, should help to establish definitive selection criteria. (C) 2001 Kluwer Academic Publishers.
C1 Clin Puerta Hierro, Serv Med Prevent, Madrid 28035, Spain.
   Clin Puerta Hierro, Serv Expt Surg, Madrid 28035, Spain.
   Clin Puerta Hierro, Serv Biostat, Madrid 28035, Spain.
   Super Tech Sch Ind Engn, Madrid, Spain.
RP Garcia Paez, JM (reprint author), Clin Puerta Hierro, Serv Med Prevent, San Martin Porres 4, Madrid 28035, Spain.
RI Jorge Herrero, EDUARDO/F-7240-2010; Sainz, Nekane/G-3136-2016
OI Sainz, Nekane/0000-0002-8438-6929
CR BLOOMFIELD P, 1991, NEW ENGL J MED, V324, P573, DOI 10.1056/NEJM199102283240901
   Bortolotti U, 1988, Eur J Cardiothorac Surg, V2, P458, DOI 10.1016/1010-7940(88)90052-8
   Braile DM, 1998, J HEART VALVE DIS, V7, P202
   Bustamante John, 1996, Archivos del Instituto de Cardiologia de Mexico, V66, P229
   Carrera San Martin A., 1993, Biomaterials, V14, P76, DOI 10.1016/0142-9612(93)90079-H
   Carrera San Martin A, 1998, J Biomed Mater Res, V39, P568
   GABBAY S, 1984, J THORAC CARDIOV SUR, V87, P836
   GRUNKEMEIER GL, 1994, J THORAC CARDIOV SUR, V108, P709
   Haziza F, 1996, J HEART VALVE DIS, V5, P35
   Hiester ED, 1998, J BIOMED MATER RES, V39, P215, DOI 10.1002/(SICI)1097-4636(199802)39:2<215::AID-JBM7>3.0.CO;2-S
   Hiester ED, 1998, J BIOMED MATER RES, V39, P207, DOI 10.1002/(SICI)1097-4636(199802)39:2<207::AID-JBM6>3.0.CO;2-T
   JORGEHERRERO E, 1991, BIOMATERIALS, V12, P683, DOI 10.1016/0142-9612(91)90117-S
   Kent PD, 1998, CARDIOVASC PATHOL, V7, P9, DOI 10.1016/S1054-8807(97)00040-9
   Levy R J, 1994, J Heart Valve Dis, V3, P101
   MUNRO AI, 1995, ANN THORAC SURG, V60, pS470
   Sacks M S, 1994, ASAIO J, V40, pM632, DOI 10.1097/00002480-199407000-00075
   Sacks MS, 1997, ANN BIOMED ENG, V25, P678, DOI 10.1007/BF02684845
   SCHOEN FJ, 1985, HUM PATHOL, V16, P549, DOI 10.1016/S0046-8177(85)80103-9
   SIMIONESCU D, 1993, J BIOMED MATER RES, V27, P697, DOI 10.1002/jbm.820270602
   THUBRIKAR M, 1982, J THORAC CARDIOV SUR, V84, P282
   TIMOSHENKO S, 1970, RESISTENCIA MAT, V1, P163
   TYERS GFO, 1995, ANN THORAC SURG, V60, pS464
   VONFRAUNHOFER JA, 1988, BIOMATERIALS, V9, P324, DOI 10.1016/0142-9612(88)90027-0
   Vongpatanasin W, 1996, NEW ENGL J MED, V335, P407, DOI 10.1056/NEJM199608083350607
NR 24
TC 0
Z9 0
U1 0
U2 2
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD AUG
PY 2001
VL 12
IS 8
BP 665
EP 671
DI 10.1023/A:1011252022303
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 459AG
UT WOS:000170227200002
PM 15348235
DA 2018-10-20
ER

PT J
AU Yanagisawa, N
   Li, DQ
   Ljungh, A
AF Yanagisawa, N
   Li, DQ
   Ljungh, A
TI The N-terminal of thrombospondin-1 is essential for coagulase-negative
   staphylococcal binding
SO JOURNAL OF MEDICAL MICROBIOLOGY
LA English
DT Article
ID EXTRACELLULAR-MATRIX PROTEINS; VON-WILLEBRAND-FACTOR; HEPARIN-BINDING;
   AFFINITY-CHROMATOGRAPHY; CELL-SURFACE; HUMAN-PLASMA; AUREUS; DOMAIN;
   VITRONECTIN; INFECTIONS
AB Bacterial binding was studied to determine whether thrombospondin-l (TSP) acts as a ligand in attachment of coagulase-negative staphylococci (CNS), Twenty-five of 27 CNS strains bound soluble TSP, Staphylococcus epidermidis J9P bound I-125-labelled TSP in a dose-dependent manner. Scatchard plot analysis of the binding of TSP by strain J9P revealed two Kd values of 6.4 x 10(-9) h4 and 2.9 x 10(-8)M. The binding structures of strain J9P were sensitive to protease and were resistant to heat treatment. Unlabelled TSP and recombinant von Willebrand factor inhibited binding of TSP by strain J9P, but other proteins or monosaccharides did not. Heparin inhibited binding of TSP to strain J9P and two other S. epidermidis strains, BD5703 and BD969, Fusion proteins of the type 1 repeats, type 2 repeats, type 3 repeats and C-terminal domain of TSP or the synthetic Arg-Gly-Asp peptide did not inhibit binding of TSP to bacteria. TSP promoted adhesion of S. epidermidis strains when it was immobilised on polymer surfaces. These results indicate that the specific interaction between CNS and TSP may contribute to bacterial adhesion on biomaterial surfaces. The N-terminal heparin-binding domain of TSP appears to be the major region for recognition by CNS.
C1 Univ Lund, Dept Med Microbiol Dermatol & Infect, Lund, Sweden.
RP Ljungh, A (reprint author), Univ Lund, Dept Med Microbiol Dermatol & Infect, Lund, Sweden.
CR Allignet J, 1999, MICROBIOL-UK, V145, P2033, DOI 10.1099/13500872-145-8-2033
   BANDYK DF, 1992, INFECT DIS CLIN N AM, V6, P719
   Barabino GA, 1997, BLOOD, V89, P2560
   BORNSTEIN P, 1994, METHOD ENZYMOL, V245, P62
   Clezardin P, 1997, BIOCHEM J, V321, P819, DOI 10.1042/bj3210819
   GUO NH, 1992, P NATL ACAD SCI USA, V89, P3040, DOI 10.1073/pnas.89.7.3040
   HERRMANN M, 1991, INFECT IMMUN, V59, P279
   Hotchkiss KA, 1998, BBA-PROTEIN STRUCT M, V1388, P478, DOI 10.1016/S0167-4838(98)00211-8
   Incardona F, 1996, J CELL BIOCHEM, V62, P431, DOI 10.1002/(SICI)1097-4644(19960915)62:4<431::AID-JCB1>3.0.CO;2-N
   Kang JK, 1999, CHILD NERV SYST, V15, P711, DOI 10.1007/s003810050460
   LAWLER J, 1992, BIOCHEMISTRY-US, V31, P1173, DOI 10.1021/bi00119a029
   Li DQ, 2000, J MED MICROBIOL, V49, P217, DOI 10.1099/0022-1317-49-3-217
   LIANG OD, 1992, INFECT IMMUN, V60, P899
   Ljungh A, 1996, ADV EXP MED BIOL, V408, P129
   Lundberg F, 1997, ACTA NEUROCHIR, V139, P734, DOI 10.1007/BF01420046
   MAMO W, 1988, VET MICROBIOL, V18, P163, DOI 10.1016/0378-1135(88)90062-4
   MCGAVIN MH, 1993, INFECT IMMUN, V61, P2479
   Mikhailenko I, 1997, J BIOL CHEM, V272, P6784, DOI 10.1074/jbc.272.10.6784
   Modun B, 1999, INFECT IMMUN, V67, P1086
   Nakamura T, 1999, FEMS MICROBIOL LETT, V175, P267, DOI 10.1016/S0378-1097(99)00205-0
   PARRODI F, 1990, INT J PARASITOL, V20, P899, DOI 10.1016/0020-7519(90)90028-L
   Partridge SR, 1996, INFECT IMMUN, V64, P4324
   PAULSSON M, 1993, J MED MICROBIOL, V38, P96, DOI 10.1099/00222615-38-2-96
   REED MJ, 1993, J HISTOCHEM CYTOCHEM, V41, P1467, DOI 10.1177/41.10.8245406
   Riessen R, 1998, AM HEART J, V135, P357, DOI 10.1016/S0002-8703(98)70105-X
   Rubin B G, 1993, Ann Vasc Surg, V7, P200, DOI 10.1007/BF02001017
   SHEN W, 1995, GUT, V36, P401, DOI 10.1136/gut.36.3.401
   Urban BC, 1999, NATURE, V400, P73, DOI 10.1038/21900
   von Eiff C, 1999, EUR J CLIN MICROBIOL, V18, P843, DOI 10.1007/s100960050417
   VUENTO M, 1979, BIOCHEM J, V183, P331, DOI 10.1042/bj1830331
   Vuong C, 2000, INFECT IMMUN, V68, P1048, DOI 10.1128/IAI.68.3.1048-1053.2000
   WISNIOWSKI P, 1995, J LAB CLIN MED, V125, P38
   YATOHGO T, 1988, CELL STRUCT FUNCT, V13, P281, DOI 10.1247/csf1975.13.281
   Yu HN, 2000, ARCH BIOCHEM BIOPHYS, V374, P13, DOI 10.1006/abbi.1999.1597
   ZARDI L, 1980, J IMMUNOL METHODS, V34, P155, DOI 10.1016/0022-1759(80)90169-6
   Zareba TW, 1997, CURR MICROBIOL, V34, P6, DOI 10.1007/s002849900135
NR 36
TC 7
Z9 7
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0022-2615
J9 J MED MICROBIOL
JI J. Med. Microbiol.
PD AUG
PY 2001
VL 50
IS 8
BP 712
EP 719
DI 10.1099/0022-1317-50-8-712
PG 8
WC Microbiology
SC Microbiology
GA 454UE
UT WOS:000169989500010
PM 11478675
OA Bronze
DA 2018-10-20
ER

PT J
AU Badylak, S
   Kokini, M
   Tullius, B
   Whitson, B
AF Badylak, S
   Kokini, M
   Tullius, B
   Whitson, B
TI Strength over time of a resorbable bioscaffold for body wall repair in a
   dog model
SO JOURNAL OF SURGICAL RESEARCH
LA English
DT Article
DE tissue engineering; extracellular matrix; resorbable bioscaffold;
   scaffold; body wall repair; mechanical properties
ID SMALL-INTESTINAL SUBMUCOSA; ACHILLES-TENDON REPAIR; DERMAL SHEEP
   COLLAGEN; ABDOMINAL-WALL; AUGMENTATION CYSTOPLASTY; MESH; BIOMATERIAL;
   DEFECTS; GRAFT; HERNIA
AB The change in strength over time of a biomaterial derived from the small intestinal submucosa (SIS) was determined in a dog model of body wall repair. Full-thickness body wall defects measuring 8 x 12 cm were surgically created and then repaired with a multilaminate eight-layer form of SIS in 40 dogs. Five dogs were sacrificed at each of the following time points: 1 day, 4 days, 7 days, 10 days, and 1, 3, 6, and 24 months. Ball burst tests that measured biaxial ultimate load-bearing capability were performed on the device prior to implantation and on the device/implant site at the time of sacrifice. The strength of the device at the time of implant was approximately 73 +/- 12 pounds. The strength of the implant site diminished to 40 +/- 18 pounds at 10 days, and then progressively increased to a value of 156 +/- 26 pounds at 24 months (P < 0.05). The clinical utility of a degradable biomaterial such as SIS depends on a balance between the rate of degradation and the rate of host remodeling. Naturally occuring extracellular matrix scaffolds such as SIS show rapid degradation with associated and subsequent remodeling to a tissue with strength that exceeds that of the native tissue when used as a body wall repair device. (C) 2001 Academic Press.
C1 Purdue Univ, Dept Biomed Engn, W Lafayette, IN 47907 USA.
   Purdue Univ, Dept Mech Engn, W Lafayette, IN 47907 USA.
RP Badylak, S (reprint author), Purdue Univ, Dept Biomed Engn, W Lafayette, IN 47907 USA.
OI Badylak, Stephen/0000-0003-3555-0689
CR Abraham GA, 2000, J BIOMED MATER RES, V51, P442, DOI 10.1002/1097-4636(20000905)51:3<442::AID-JBM19>3.3.CO;2-W
   BADYLAK SF, 1995, J BIOMED MATER RES, V29, P977, DOI 10.1002/jbm.820290809
   BADYLAK SF, 1993, TISSUE ENGINEERING, P179
   Badylak SF, 1998, TISSUE ENG, V4, P379, DOI 10.1089/ten.1998.4.379
   BADYLAK SF, 1989, J SURG RES, V47, P74, DOI 10.1016/0022-4804(89)90050-4
   Clarke KM, 1996, J SURG RES, V60, P107, DOI 10.1006/jsre.1996.0018
   Cobb MA, 1996, SURG NEUROL, V46, P389, DOI 10.1016/S0090-3019(96)00202-9
   Cobb MA, 1999, SURG NEUROL, V51, P99, DOI 10.1016/S0090-3019(97)00475-8
   DEJARDIN LM, IN PRESS AM J SPORTS
   Gloeckner DC, 2000, J BIOMED MATER RES, V52, P365, DOI 10.1002/1097-4636(200011)52:2<365::AID-JBM17>3.0.CO;2-3
   HILES MC, 1995, J BIOMED MATER RES, V29, P883, DOI 10.1002/jbm.820290714
   Hodde JP, 1997, TISSUE ENG, V3, P27, DOI 10.1089/ten.1997.3.27
   JAMES NL, 1991, BIOMATERIALS, V12, P801, DOI 10.1016/0142-9612(91)90065-I
   JENKINS SD, 1983, SURGERY, V94, P392
   KNAPP PM, 1994, J ENDOUROL, V8, P125, DOI 10.1089/end.1994.8.125
   Kropp B P, 1995, Urology, V46, P396, DOI 10.1016/S0090-4295(99)80227-1
   Kropp BP, 1996, J UROLOGY, V155, P2098, DOI 10.1016/S0022-5347(01)66117-2
   LAMB JP, 1983, SURGERY, V93, P643
   Lantz G C, 1993, J Invest Surg, V6, P297, DOI 10.3109/08941939309141619
   LEWIS RT, 1984, CAN J SURG, V27, P155
   Luijendijk RW, 2000, NEW ENGL J MED, V343, P392, DOI 10.1056/NEJM200008103430603
   PREVEL CD, 1995, ANN PLAS SURG, V35, P374, DOI 10.1097/00000637-199510000-00008
   PREVEL CD, 1995, ANN PLAS SURG, V35, P381, DOI 10.1097/00000637-199510000-00009
   RECORD RD, IN PRESS BIOMATERILS
   SANDUSKY GE, 1995, J SURG RES, V58, P415, DOI 10.1006/jsre.1995.1064
   TYRELL J, 1989, SURG GYNECOL OBSTET, V168, P227
   VANDERLAAN JS, 1991, INT J ARTIF ORGANS, V14, P661
   VANWACHEM PB, 1994, INT J ARTIF ORGANS, V17, P230
   Vaught JD, 1996, J UROLOGY, V155, P374, DOI 10.1016/S0022-5347(01)66663-1
   Whitson BA, 1998, J BIOMED MATER RES, V43, P277, DOI 10.1002/(SICI)1097-4636(199823)43:3<277::AID-JBM8>3.3.CO;2-M
NR 30
TC 150
Z9 158
U1 3
U2 19
PU ACADEMIC PRESS INC
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0022-4804
J9 J SURG RES
JI J. Surg. Res.
PD AUG
PY 2001
VL 99
IS 2
BP 282
EP 287
DI 10.1006/jsre.2001.6176
PG 6
WC Surgery
SC Surgery
GA 460GE
UT WOS:000170299200017
PM 11469898
DA 2018-10-20
ER

PT J
AU Konig, DP
   Schierholz, JM
   Hilgers, RD
   Bertram, C
   Perdreau-Remington, F
   Rutt, A
AF Konig, DP
   Schierholz, JM
   Hilgers, RD
   Bertram, C
   Perdreau-Remington, F
   Rutt, A
TI In vitro adherence and accumulation of Staphylococcus epidermidis RP 62
   A and Staphylococcus epidermidis M7 on four different bone cements
SO LANGENBECKS ARCHIVES OF SURGERY
LA English
DT Article
DE bone cement; Staphylococcus epidermidis; biomaterials; exopolysaccharide
   slime production
ID BACTERIAL ADHERENCE; INVITRO; SURFACES; ADHESION; SURGERY; AUREUS;
   STRAIN
AB Bacterial resistance of Staphylococcus epidermidis, a serious pathogen of implant-related infections, to antibiotics is related to the production of a glycocalyx slime that impairs antibiotic access and the killing by host defense mechanisms. In vitro studies of different bone cements containing antibiotics, developed for the prevention of biomaterial-associated infection, could not always demonstrate complete eradication of biomaterial-adherent bacteria. We have investigated four different bone cements in regard to bacterial accumulation of a slime-producing strain RP 62 A and its isogenic mutant M7 lacking the ability to produce exopolysaccharide slime using a bacterial adhesion assay and modified Kirby-Bauer technique. A significant effect of exopolysaccharide production for the accumulation on bone cement could be demonstrated. The gentamicin/clindamycin bone cement was the only tested biomaterial that produced a large zone of bacterial inhibition in the inoculated area adjacent to the biomaterial. The bacterial adhesion was not reduced significantly and there was no correlation between zones of inhibition on blood agar plates and the quantitative adhesion assay. The clinical efficacy of the gentamicin/clindamycin bone cement must be proven in vivo.
C1 Univ Cologne, Dept Orthopaed Surg, D-50924 Cologne, Germany.
   Univ Calif San Francisco, San Francisco, CA 94143 USA.
   Univ Cologne, Dept Med Stat, D-5000 Cologne, Germany.
   Ctr Adv European Studies & Res, Bonn, Germany.
RP Konig, DP (reprint author), Univ Cologne, Dept Orthopaed Surg, Joseph Stelzmann Str 9, D-50924 Cologne, Germany.
RI Hilgers, Ralf-Dieter/C-7090-2013
OI Hilgers, Ralf-Dieter/0000-0002-5945-1119
CR ARIZONO T, 1992, ACTA ORTHOP SCAND, V63, P661
   BARTH E, 1989, BIOMATERIALS, V10, P325, DOI 10.1016/0142-9612(89)90073-2
   CHANG CC, 1992, J BIOMED MATER RES, V26, P197, DOI 10.1002/jbm.820260206
   Chohfi M, 1998, INT ORTHOP, V22, P171, DOI 10.1007/s002640050235
   CHRISTENSEN GD, 1982, INFECT IMMUN, V37, P318
   Espehaug B, 1997, J BONE JOINT SURG BR, V79B, P590, DOI 10.1302/0301-620X.79B4.7420
   GARVIN KL, 1994, CLIN ORTHOP RELAT R, P97
   Gracia E, 1997, INT ORTHOP, V21, P46, DOI 10.1007/s002640050116
   Gristina A. G., 1987, ZENTRALBL BAKTERIO S, V16, P143
   Hanssen AD, 1998, J BONE JOINT SURG AM, V80A, P910, DOI 10.2106/00004623-199806000-00016
   Konig DP, 1998, ACTA ORTHOP SCAND, V69, P523, DOI 10.3109/17453679808997791
   Masri BA, 1998, J ARTHROPLASTY, V13, P331, DOI 10.1016/S0883-5403(98)90179-6
   NAYLOR P, 1988, ORTHOP T, V12, P524
   OGA M, 1992, ACTA ORTHOP SCAND, V63, P301, DOI 10.3109/17453679209154787
   OGA M, 1993, ACTA ORTHOP SCAND, V64, P273, DOI 10.3109/17453679308993623
   Ozaki T, 1998, J Orthop Sci, V3, P163, DOI 10.1007/s007760050037
   RUCKELSHAUSEN MC, 1987, VERWENDUNG POLYMETHY, P15
   Scherertz J, 1990, J CLIN MICROBIOL, V28, P76
   SCHERERTZ RJ, 1996, INFECT CONT HOSP EP, V17, P746
   Schierholz JM, 1999, ZBL BAKT-INT J MED M, V289, P165
   SCHUMACHERPERDREAU F, 1994, FEMS MICROBIOL LETT, V117, P71
   Tunney MM, 1998, ANTIMICROB AGENTS CH, V42, P3002, DOI 10.1128/AAC.42.11.3002
   VERHEYEN CCPM, 1993, J BIOMED MATER RES, V27, P775, DOI 10.1002/jbm.820270610
   Voos K, 1999, J ORTHOP TRAUMA, V13, P98, DOI 10.1097/00005131-199902000-00005
   Yaniv M, 1999, CLIN ORTHOP RELAT R, P232
NR 25
TC 20
Z9 21
U1 0
U2 1
PU SPRINGER-VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010 USA
SN 1435-2443
J9 LANGENBECK ARCH SURG
JI Langenbecks Arch. Surg.
PD AUG
PY 2001
VL 386
IS 5
BP 328
EP 332
DI 10.1007/s004230100229
PG 5
WC Surgery
SC Surgery
GA 477GU
UT WOS:000171275700004
PM 11685562
DA 2018-10-20
ER

PT J
AU Al-Abdullat, Y
   Tsutsumi, S
   Nakajima, N
   Ohta, M
   Kuwahara, H
   Ikeuchi, K
AF Al-Abdullat, Y
   Tsutsumi, S
   Nakajima, N
   Ohta, M
   Kuwahara, H
   Ikeuchi, K
TI Surface modification of magnesium by NaHCO3 and corrosion behavior in
   Hank's solution for new biomaterial applications
SO MATERIALS TRANSACTIONS
LA English
DT Article
DE magnesium; biomaterials; corrosion; surface modification;
   whitlockite-like; sodium hydrogen carbonate; Hank's solution
ID SUPPLEMENTATION
AB The present study was carried out to improve the corrosion resistance of pure magnesium in Hank's Balanced Salt Solution (HBSS) through the surface modification. Three kinds of alkaline compounds, such as sodium hydrogen carbonate, sodium carbonate, and lithium hydroxide, were used for treatment. Only magnesium treated with aqueous sodium hydrogen carbonate solution gave a good corrosion resistance in HBSS solution at 25 degreesC up to 75 days, while almost no effect in sodium carbonate and lithium hydroxide. It was likely that hydrogen carbonate ions were essential for the surface improvement of magnesium. X-ray diffraction patterns of modified magnesium showed now peaks of magnesium carbonate and others on the surface. New surface structure of needle-shaped crystals was observed by scanning electron microscopy (SEM). Both elemental mapping, and energy dispersive (EDX) techniques in SEM showed the precipitation of calcium magnesium phosphate (low crystallinity whitlockite:(Ca,Mg)(3)(PO4)(2)) on the surface of magnesium specimen. It could be concluded that surface modification with sodium hydrogen carbonate made it possible to apply metal magnesium in biomedical, dental, and other industrial usage.
C1 Kyoto Univ, Inst Frontier Med Sci, Kyoto 6068507, Japan.
   Res Inst Appl Sci, Kyoto 6068203, Japan.
RP Al-Abdullat, Y (reprint author), Kyoto Univ, Inst Frontier Med Sci, Kyoto 6068507, Japan.
RI Ohta, Makoto/I-7104-2018
OI Ohta, Makoto/0000-0001-8571-6400
CR Al-Abdullat Y, 2000, J DENT RES, V79, P618
   ALABDULLAT Y, 2000, J JAPAN DENT MAT, V19, P95
   Barrere F, 2000, MATER RES SOC SYMP P, V599, P135
   EKTESSABI AM, 1994, INT J PIXE, V4, P81
   GHALI E, 2000, CORROSION PROTECTION, P261
   Haferkamp H, 2000, MATER SCI FORUM, V350-3, P31, DOI 10.4028/www.scientific.net/MSF.350-351.31
   *JCPDS, 1988, JCPDS INT CTR DIFFR, V201
   *JCPDS, 1998, JCPDS INT CTR DIFFR, V201
   Kumar TSS, 2000, BIOMATERIALS, V21, P1623
   Kuwahara H, 2000, MATER SCI FORUM, V350-3, P349, DOI 10.4028/www.scientific.net/MSF.350-351.349
   MAKAR GL, 1993, INT MATER REV, V38, P138, DOI 10.1179/imr.1993.38.3.138
   MARIE PJ, 1983, CALCIFIED TISSUE INT, V35, P755, DOI 10.1007/BF02405119
   MAYER I, 1995, J SOLID STATE CHEM, V56, P230
   POURBAIX M, 1966, ATLAS ELECTROCHEMICA, P139
   SOJKA JE, 1995, NUTR REV, V53, P71
   TAKAYA M, 1998, J JPN I LIGHT METALS, V48, P352
NR 16
TC 59
Z9 70
U1 1
U2 27
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD AUG
PY 2001
VL 42
IS 8
BP 1777
EP 1780
DI 10.2320/matertrans.42.1777
PG 4
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 474NF
UT WOS:000171112800059
OA Bronze
DA 2018-10-20
ER

PT J
AU Griguer, F
   Raymond, I
   Regnier, A
AF Griguer, F
   Raymond, I
   Regnier, A
TI Preliminary evaluation of the biocompatibility of the small intestinal
   submucosa (SIS) biomaterial with the rabbit cornea
SO REVUE DE MEDECINE VETERINAIRE
LA English
DT Article
DE small intestinal submucosa; corneal tolerance; lamellar keratoplasty;
   rabbit
ID BLADDER AUGMENTATION; DOG-MODEL; LONG-TERM; IN-VIVO; REPAIR;
   NEOVASCULARIZATION; RELEASE; ULCERS; GRAFT; BETA
AB The early stages of the ocular response to porcine small intestinal submucosa (SIS) transplantation were assessed in a model of anterior keratectomy in the rabbit. After surgery, the operated eyes (n = 17) were examined on a regular basis over a 15-day period and animals were sacrified at predetermined times for histopathologic evaluation. In all but one animal, the biomaterial was well tolerated, and the corneal response was restricted to a localized neovascularization. The grafted material was epithelialised within 7 days and incorporated into the corneal tissue without inducing granuloma formation. In one rabbit, the corneal inflammation was severe but the biomaterial was maintained in place. Although further studies with longer follow-up periods are needed, these preliminary observations suggest that porcine SIS can be incorporated into the corneal tissue during healing process and may represent a promising graft material for lamellar keratoplasty.
C1 Ecole Natl Vet Toulouse, Clin Ophthalmol, Dept Sci Biol & Fonctionnelles, F-31076 Toulouse 03, France.
   Ecole Natl Vet Toulouse, Dept Clin Sci, F-31076 Toulouse, France.
RP Regnier, A (reprint author), Ecole Natl Vet Toulouse, Clin Ophthalmol, Dept Sci Biol & Fonctionnelles, 23 Chemin Capelles, F-31076 Toulouse 03, France.
CR Antrade AL, 1999, VET OPHTHALMOL, V2, P79
   Badylak S, 1999, BIOMATERIALS, V20, P2257, DOI 10.1016/S0142-9612(99)00156-8
   BADYLAK SF, 1995, J BIOMED MATER RES, V29, P977, DOI 10.1002/jbm.820290809
   BADYLAK SF, 1993, TISSUE ENGINEERING, P179
   BADYLAK SF, 1989, J SURG RES, V47, P74, DOI 10.1016/0022-4804(89)90050-4
   BADYLAK SF, 1994, J VASC SURG, V19, P465, DOI 10.1016/S0741-5214(94)70073-7
   Barros Paulo S. M., 1998, Veterinary Ophthalmology, V1, P119, DOI 10.1046/j.1463-5224.1998.00026.x
   BARROS PSM, 1993, 24 ANN M AM COLL VET, P23
   Benelli U, 1997, INVEST OPHTH VIS SCI, V38, P274
   CAPRIOLI J, 1985, P257
   Clarke KM, 1996, J SURG RES, V60, P107, DOI 10.1006/jsre.1996.0018
   Cobb MA, 1999, SURG NEUROL, V51, P99, DOI 10.1016/S0090-3019(97)00475-8
   Cook JL, 1999, AM J SPORT MED, V27, P658, DOI 10.1177/03635465990270051901
   DEAN DC, 1988, J CELL BIOL, V106, P2159, DOI 10.1083/jcb.106.6.2159
   Featherstone H, 2000, VET REC, V146, P136, DOI 10.1136/vr.146.5.136
   GELATT KN, 1995, HDB SMALL ANIMAL OPH, V2, P43
   HACKER DV, 1991, J AM ANIM HOSP ASSOC, V27, P387
   HAKANSON NE, 1987, J AM ANIM HOSP ASSOC, V23, P641
   KNAPP PM, 1994, J ENDOUROL, V8, P125, DOI 10.1089/end.1994.8.125
   KOBAYASHI H, 1992, J BIOMED MATER RES, V26, P1463, DOI 10.1002/jbm.820261106
   Kropp B P, 1995, Urology, V46, P396, DOI 10.1016/S0090-4295(99)80227-1
   Kropp BP, 1998, WORLD J UROL, V16, P262, DOI 10.1007/s003450050064
   Kropp BP, 1996, J UROLOGY, V155, P2098, DOI 10.1016/S0022-5347(01)66117-2
   Kropp BP, 2000, J ENDOUROL, V14, P59, DOI 10.1089/end.2000.14.59
   Kruse FE, 1999, OPHTHALMOLOGY, V106, P1504, DOI 10.1016/S0161-6420(99)90444-X
   Lewin GA, 1999, J SMALL ANIM PRACT, V40, P340, DOI 10.1111/j.1748-5827.1999.tb03094.x
   LI WW, 1991, INVEST OPHTH VIS SCI, V32, P2906
   LIN MT, 1992, INVEST OPHTH VIS SCI, V33, P558
   MELLES GRJ, 1994, ARCH OPHTHALMOL-CHIC, V112, P100, DOI 10.1001/archopht.1994.01090130110027
   POLACK FM, 1962, J EXP MED, V116, P709, DOI 10.1084/jem.116.5.709
   VoytikHarbin SL, 1997, J CELL BIOCHEM, V67, P478, DOI 10.1002/(SICI)1097-4644(19971215)67:4<478::AID-JCB6>3.0.CO;2-P
   WAHL SM, 1989, IMMUNOL TODAY, V10, P258, DOI 10.1016/0167-5699(89)90136-9
   Whitson BA, 1998, J BIOMED MATER RES, V43, P277, DOI 10.1002/(SICI)1097-4636(199823)43:3<277::AID-JBM8>3.3.CO;2-M
   WICKSTROM K, 1991, CURR EYE RES, V10, P463, DOI 10.3109/02713689109001753
   Wilkie DA, 1997, VET CLIN N AM-SMALL, V27, P1067, DOI 10.1016/S0195-5616(97)50104-5
   Xie RZ, 1997, AUST NZ J OPHTHALMOL, V25, pS46
   ZIESKE JD, 1987, INVEST OPHTH VIS SCI, V28, P1668
NR 37
TC 11
Z9 11
U1 0
U2 0
PU ECOLE NATIONALE VETERINAIRE TOULOUSE
PI TOULOUSE CEDEX 3
PA 23 CHEMIN DES CAPELLES, 31076 TOULOUSE CEDEX 3, FRANCE
SN 0035-1555
J9 REV MED VET-TOULOUSE
JI Rev. Med. Vet.
PD AUG-SEP
PY 2001
VL 152
IS 8-9
BP 597
EP 604
PG 8
WC Veterinary Sciences
SC Veterinary Sciences
GA 489UP
UT WOS:000172011100002
DA 2018-10-20
ER

PT J
AU Bing, S
   Hong, L
AF Bing, S
   Hong, L
TI Tribological applications of biomaterials: an overview
SO SCIENCE IN CHINA SERIES A-MATHEMATICS
LA English
DT Article
DE biomaterials; tribological materials
ID HIP PROSTHESES; DNA; CORROSION; COMPONENTS; MICROSCOPY; MOLECULES;
   FAILURE
AB Tribological research is the study of lubrication, friction, and wear. Tribology of biomaterials is to study how the materials work and fail. This will help us to produce better biomaterials. Tribology plays a very important role in improving the design and making successful biomaterials for medical purposes. Joints of human body, such as hip, knee, jaw, dental parts etc., all need to consider the wear and lubrication problem. In this paper, we give a general introduction of biomaterial research in tribological applications. Materials, the synthetic characterization, and their failure are introduced.
C1 Univ Alaska Fairbanks, Dept Mech Engn, Fairbanks, AK 99775 USA.
RP Bing, S (reprint author), Univ Alaska Fairbanks, Dept Mech Engn, Fairbanks, AK 99775 USA.
CR Alivisatos AP, 1996, NATURE, V382, P609, DOI 10.1038/382609a0
   AMSTUTZ HC, 1992, CLIN ORTHOP RELAT R, V276, P7
   BACH D, 1966, BIOCHIM BIOPHYS ACTA, V114, P311, DOI 10.1016/0005-2787(66)90312-1
   BOSS JH, 1992, AM SOC TEST MATER, V1144, P90, DOI 10.1520/STP14856S
   BUCKLEY CA, 1992, T SOC BIOMATER IMPLA, V15, P58
   CHEN JH, 1991, NATURE, V350, P631, DOI 10.1038/350631a0
   CHERYL RB, 1995, TECHNOLOGY TODAY FAL
   COLLIER JP, 1992, J BONE JOINT SURG BR, V74, P511
   COLLIER JP, 1991, CLIN ORTHOP RELAT R, V271, P305
   DICARLO E F, 1992, Clinical Materials, V9, P235, DOI 10.1016/0267-6605(92)90104-2
   DOWSON D, 1997, PRGRESS TRIBOLOGY HI, P3
   ESSNER WA, 1997, NEW DIRECTIONS TRIBO, P443
   FELGNER PL, 1987, P NATL ACAD SCI USA, V84, P7413, DOI 10.1073/pnas.84.21.7413
   Gilbert JL, 1997, AM SOC TEST MATER, V1301, P45, DOI 10.1520/STP12020S
   GILBERT JL, 1993, J BIOMED MATER RES, V27, P1357, DOI 10.1002/jbm.820271103
   GILBERT JL, 1994, J BONE JOINT SURG AM, V76A, P110, DOI 10.2106/00004623-199401000-00014
   GILBERT JL, 1995, TOTAL HIP REVISION S
   GILBERT JL, 1992, T 4 WORLD BIOM C BER, P267
   Goldberg JR, 1997, J BIOMED MATER RES, V37, P421, DOI 10.1002/(SICI)1097-4636(19971205)37:3<421::AID-JBM13>3.0.CO;2-E
   KOSSOVSKY N, 1991, HIP ARTHROPLASTY, P571
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Lu XC, 2000, SURF COAT TECH, V128, P341, DOI 10.1016/S0257-8972(00)00602-2
   Lu XC, 1996, CHINESE SCI BULL, V41, P1873
   Luo J, 2000, INT J NONLINEAR SCI, V1, P419
   Luo JB, 1999, TRIBOL T, V42, P912, DOI 10.1080/10402009908982301
   MATHIESEN EB, 1991, J BONE JOINT SURG BR, V73, P569
   MCLAUGHLIN J, 1994, ANN M AM AC ORTH SUR
   MILLER IR, 1968, BIOPOLYMERS, V6, P169, DOI 10.1002/bip.1968.360060202
   Mirkin CA, 1996, NATURE, V382, P607, DOI 10.1038/382607a0
   Mirra J M, 1976, Clin Orthop Relat Res, P221
   Niemeyer CM, 1997, ANGEW CHEM INT EDIT, V36, P585, DOI 10.1002/anie.199705851
   NIEMEYER CM, 1997, ANGEW CHEM, V109, P603
   Nygren H, 1997, J BIOMED MATER RES, V34, P487, DOI 10.1002/(SICI)1097-4636(19970315)34:4<487::AID-JBM9>3.3.CO;2-6
   NYQUIST RA, 1971, INFRARED SPECTRA INO, P171
   PIZZOFERRATO A, 1991, Clinical Materials, V7, P51, DOI 10.1016/0267-6605(91)90057-M
   RITTER MA, 1995, CLIN ORTHOP RELAT R, P79
   Sarikaya M, 1999, MATER SCI FORUM, V293, P83, DOI 10.4028/www.scientific.net/MSF.293.83
   Seeman NC, 1997, ACCOUNTS CHEM RES, V30, P357, DOI 10.1021/ar9601407
   SMITH SM, WINTER, V2, P11
   SPANIER S, 1991, HISTOLOGY PAHTOLOGY, P165
   SPECTOR M, 1992, ORTHOP CLIN N AM, V23, P211
   Tour JM, 1996, CHEM REV, V96, P537, DOI 10.1021/cr9500287
   URBAN RM, 1994, J BONE JOINT SURG AM, V76A, P1345, DOI 10.2106/00004623-199409000-00009
   URBAN RM, 1993, T ORTHOP RES SOC, V18, P81
   VOLLENWEIDER HJ, 1975, P NATL ACAD SCI USA, V72, P83, DOI 10.1073/pnas.72.1.83
   WHITESIDES GM, 1991, SCIENCE, V254, P1312, DOI 10.1126/science.1962191
   WILLERT HG, 1990, CLIN ORTHOP RELAT R, P95
   WILLERT HG, 1977, J BIOMED MATER RES, V11, P157, DOI 10.1002/jbm.820110202
   WILLERT HG, 1990, FAILURE MODES ARTIFI
   WOODRUFF LL, 1951, FDN BIOL
   WU C, 1996, SCI NEWS, V150
NR 51
TC 1
Z9 1
U1 1
U2 5
PU SCIENCE PRESS
PI BEIJING
PA 16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA
SN 1006-9283
J9 SCI CHINA SER A
JI Sci. China Ser. A-Math.
PD AUG
PY 2001
VL 44
SU S
BP 297
EP 306
PG 10
WC Mathematics, Applied; Mathematics
SC Mathematics
GA 485ZH
UT WOS:000171793000048
DA 2018-10-20
ER

PT J
AU Mathieu, HJ
AF Mathieu, HJ
TI Bioengineered material surfaces for medical applications
SO SURFACE AND INTERFACE ANALYSIS
LA English
DT Article; Proceedings Paper
CT Asia-Pacific Surface and Interface Analysis Conference (APSIAC 2000)
CY OCT 23-26, 2000
CL BEIJING, PEOPLES R CHINA
SP Natl Nat Sci Fdn China, Chinese Acad Sci
DE biomaterials; XPS; ToF-SIMS; surface functionalization
ID ION MASS-SPECTROMETRY; POLYMERIC BIOMATERIALS; TOF-SIMS; MICROSCOPY; XPS
AB Man-made materials are increasingly being applied as substitutes for defective functions in human hosts. These biomaterials may be non-viable materials used in medical devices interacting with biological systems. Such engineered materials should be biocompatible, i.e. with minimal non-specific protein adsorption. This paper describes the functionalization of soft biomaterial surfaces and diamond-covered silicon wafers controlled by surface spectroscopies such as x-ray photoelectron spectroscopy (XPS) and time-of-flight secondary ion mass spectrometry (ToF-SIMS), as well as contact angle measurements and scanning force microscopy (SFM). Surface functionalization is obtained with molecules such as phosphorylcholine, carbohydrates, dextran or peptides added to various soft and hard materials. Surface analytical tools are able to control the chemistry, energy and topography of surfaces and thin films with high sensitivity down to the femtomole range and nanometer resolution. Copyright (C) 2001 John Wiley & Sons, Ltd.
C1 Ecole Polytech Fed Lausanne, Dept Mat, LMCH, CH-1015 Lausanne, Switzerland.
RP Mathieu, HJ (reprint author), Ecole Polytech Fed Lausanne, Dept Mat, LMCH, CH-1015 Lausanne, Switzerland.
CR AEBISCHER P, 1992, MED SCI TECHNOLOGY, P131
   Aleyamma A. J., 1991, BLOOD COMPATIBLE MAT, P123
   ANDERSON AB, 1994, 20 ANN M SOC BIOMATE
   BAI C, 1995, SCANNING TUNNELING M
   Barthlott W., 1990, APPL SCANNING EM TAX, P69
   Benninghoven A., 1987, SECONDARY ION MASS S
   Bertrand P., 1996, MIKROCHIM ACTA S, V13, P167
   BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930
   BINNING G, 1982, PHYS REV LETT, V49, P57, DOI 10.1103/PhysRevLett.49.57
   BLETSOS IV, 1985, ANAL CHEM, V57, P2384, DOI 10.1021/ac00289a049
   BRIGGS D, 1992, PRACTICAL SURFACE AN, V2
   BRIGGS D, 1992, PRACTICAL SURFACE AN, V2, P367
   BUSTAMANTE C, 1995, PHYS TODAY, V48, P32, DOI 10.1063/1.881478
   CHAPMAN D, 1993, LANGMUIR, V9, P39, DOI 10.1021/la00025a012
   CHAPMAN D, 1987, Patent No. 4689386
   Chevolot Y, 1999, BIOCONJUGATE CHEM, V10, P169, DOI 10.1021/bc980050h
   CHEVOLOT Y, 1999, THESIS ECOLE POLYTEC
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   Curtis ASG, 1998, J BIOMAT SCI-POLYM E, V9, P1313, DOI 10.1163/156856298X00415
   DAVIES MC, 1990, CRIT REV BIOCOMPAT, V5, P297
   GAO H, 1995, BIOSENS BIOELECTRON, V10, P317, DOI 10.1016/0956-5663(95)96850-X
   GARBASSI F, 1994, POLYM SURFACES PHYSI, P161
   GOODE R, 1993, COMMERCIAL AND CONSUMER LAW, P3
   GRISTINA AG, 1991, HIGH PERFORMANCE BIO, P143
   Gunther H., 1996, NMR SPECTROSCOPY BAS
   HAYWARD JA, 1984, BIOMATERIALS, V5, P135, DOI 10.1016/0142-9612(84)90047-4
   HUBBELL JA, 1995, CHEM ENG NEWS, V73, P42, DOI 10.1021/cen-v073n011.p042
   ISHIHARA K, 1990, J BIOMED MATER RES, V24, P1069, DOI 10.1002/jbm.820240809
   ISHIHARA K, 1990, POLYM J, V22, P355, DOI 10.1295/polymj.22.355
   ISHIHARA K, 1990, J JPN SOC BIOMATER, V8, P231
   ISRAELACHVILI JN, 1992, INTERMOLECULAR SURFA
   LARSSON PH, 1987, J IMMUNOL METHODS, V98, P129, DOI 10.1016/0022-1759(87)90446-7
   Lelah M. D., 1986, POLYURETHANES MED
   Leonard D, 1999, FRESEN J ANAL CHEM, V365, P3, DOI 10.1007/s002160051437
   Leonard D, 1998, SURF INTERFACE ANAL, V26, P793, DOI 10.1002/(SICI)1096-9918(199810)26:11<793::AID-SIA421>3.0.CO;2-K
   LEONARD D, 1996, THESIS U CATHOLIQUE
   Magonov S. N., 1996, SURFACE ANAL STM AFM
   Makohliso SA, 1999, LANGMUIR, V15, P2940, DOI 10.1021/la980688h
   MAKOHLISO SA, 1999, THESIS ECOLE POLYTEC
   Marchant RE, 1997, THROMB HAEMOSTASIS, V77, P1048
   Marieb E. N., 1998, HUMAN ANATOMY PHYSL
   RATNER B D, 1992, Clinical Materials, V11, P25, DOI 10.1016/0267-6605(92)90027-Q
   Ratner B. D., 1996, BIOMATERIALS SCI INT
   RATNER BD, 1993, J BIOMED MATER RES, V27, P837, DOI 10.1002/jbm.820270702
   Ruiz L, 1998, BIOMATERIALS, V19, P987, DOI 10.1016/S0142-9612(97)00197-X
   Ruiz L, 1999, J BIOMAT SCI-POLYM E, V10, P931, DOI 10.1163/156856299X00540
   RUIZ L, 1997, THESIS ECOLE POLYTEC
   Sabbatini L, 1996, J ELECTRON SPECTROSC, V81, P285, DOI 10.1016/0368-2048(95)02528-6
   SIDOUNI F, 1999, THESIS U PARIS 8 PAR
   SIGRIST H, 1995, OPT ENG, V34, P2339, DOI 10.1117/12.201815
   SIGRIST H, 2000, Patent No. 9911242232110
   SZYCHER M, 1991, HIGH PERFORMANCE BIO, P3
   VARGO TG, 1991, J POLYM SCI POL CHEM, V29, P555, DOI 10.1002/pola.1991.080290412
   Vickerman J. C., 1997, SURFACE ANAL PRINCIP
   WANG X, 1993, J APPL POLYM SCI, V49, P2179, DOI 10.1002/app.1993.070491214
   WEAST RC, 1973, HDB CHEM PHYSICS
   WIESENDANGER R, 1996, SCANNING TUNNELING M, V29
   WIESENDANGER R, 1992, SCANNING TUNNELING M, V20
   WIESENDANGER R, 1995, SCANNING TUNNELING M, V28
   Williams D. H., 1995, SPECTROSCOPIC METHOD
   WILLIAMS DF, 1987, PROGR BIOMEDICAL ENG
   WILLIAMS JL, 1984, POLYM BIOMATERIALS, P33
   ZALM PC, 1994, VACUUM, V45, P753, DOI 10.1016/0042-207X(94)90113-9
NR 63
TC 89
Z9 89
U1 1
U2 9
PU JOHN WILEY & SONS LTD
PI W SUSSEX
PA BAFFINS LANE CHICHESTER, W SUSSEX PO19 1UD, ENGLAND
SN 0142-2421
J9 SURF INTERFACE ANAL
JI Surf. Interface Anal.
PD AUG
PY 2001
VL 32
IS 1
BP 3
EP 9
DI 10.1002/sia.995
PG 7
WC Chemistry, Physical
SC Chemistry
GA 464VE
UT WOS:000170551800002
DA 2018-10-20
ER

PT J
AU Bennet, W
   Bjorkland, A
   Sundberg, B
   Brandhorst, D
   Brendel, MD
   Richards, A
   White, DJ
   Nilsson, B
   Groth, CG
   Korsgren, O
AF Bennet, W
   Bjorkland, A
   Sundberg, B
   Brandhorst, D
   Brendel, MD
   Richards, A
   White, DJ
   Nilsson, B
   Groth, CG
   Korsgren, O
TI Expression of complement regulatory proteins on islets of langerhans: A
   comparison between human islets and islets isolated from normal and hDAF
   transgenic pigs'
SO TRANSPLANTATION
LA English
DT Article
ID DECAY-ACCELERATING FACTOR; PORCINE ISLETS; HUMAN BLOOD; IN-VITRO;
   TRANSPLANTATION; FETAL; XENOTRANSPLANTATION; PANCREAS; MODEL;
   BIOMATERIAL
AB Background. The expression of regulators of complement activity (RCAs) on islet cells may be of great importance for protecting them against complement-mediated lysis in the immediate posttransplant period after intraportal islet transplantation. We examined porcine and human islet cells for expression of RCA. We also examined to what extent human decay accelerating factor (hDAF) is expressed on adult and fetal islet cells isolated from hDAF transgenic (TG) pigs having a high transgene expression on endothelial cells. Moreover, the susceptibility of the various types of cells to lysis in human serum and blood was investigated.
   Methods. Adult human islets (n = 5), normal adult and fetal porcine islets (n = 9 and n = 8, respectively), and islets from adult and fetal hDAF TG pigs (n = 5 and n = 6, respectively) were examined. With islet single-cell suspensions and flow cytometry, adult human islet cells were examined for expression of hDAF (CD55), hCD59, and human membrane cofactor protein (hMCP; CD46), while porcine islet cells were examined for expression of pCD59 and pMCP. Islet cells from hDAF TG pigs were also examined for hDAF expression. Porcine peripheral blood lymphocytes, normal and hDAF TG porcine endothelial cell lines, a human endothelial cell line, and the human cell line, U937 served as controls. Islet cytotoxicity was assayed after incubation of the islet cells with fresh human serum. Furthermore, adult islets from normal control pigs and hDAF TG pigs were exposed to fresh human blood in vitro for 60 min, and the inflammatory reaction elicited was compared between the different types of islets.
   Results. All human islet cell preparations expressed hCD59, two of five expressed hMCP, but none expressed hDAF. Porcine islet cells expressed both pCD59 and pMCP. Normal adult porcine islet cells exposed to fresh human serum resulted in 74 +/- 5.4% cell lysis (mean +/- SEM, n = 16). In comparison, only 1.3 +/- 2.8% (n = 20, P < 0.001) of human islet cells were lysed in the human serum. One islet cell preparation from an hDAF TG pig expressed small amounts of hDAF. This preparation from hDAF TG pigs bound significantly less C3c than did normal control islets (mean fluorescence ratio 16 +/- 2.2 and 58 +/- 4.3, respectively; P = 0.046) and were partially protected from cell lysis in fresh human serum (47 +/- 10% and 78 +/- 18% cell lysis, respectively; P = 0.046). The other four preparations from hDAF TG pigs were negative for hDAF and were equally susceptible to lysis as normal control islets. All fetal pancreatic islet cells from hDAF TG pigs analyzed were negative for hDAF expression. When exposed to fresh human blood in vitro, adult and fetal islets from hDAF TG pigs elicited equally strong inflammatory changes as did the normal control islets. The inflammatory changes were characterized by activation of the complement and coagulation systems, resulting in islet damage with "dumping" of insulin into the blood.
   Conclusions. Porcine and human islet cells express species-restricted complement regulatory proteins, with the human islet cells expressing mainly hCD59. A low expression of hDAF was detected on islet cells from one of five hDAF TG pigs. These islet cells displayed reduced islet cell cytotoxicity in fresh human serum. We conclude that protection from complement-mediated lysis will be important in the context of intraportal pig-to-human islet transplantation, and expression of a human RCA on islet cells should be beneficial in this context.
C1 Huddinge Hosp, Karolinska Inst, Dept Transplantat Surg, S-14186 Huddinge, Sweden.
   Univ Uppsala Hosp, Dept Oncol Radiol & Clin Immunol, Uppsala, Sweden.
   Univ Giessen, Dept Med 3, Giessen, Germany.
   Policlin Univ Giessen, Giessen, Germany.
   Imutran Ltd, Cambridge, England.
RP Bennet, W (reprint author), Huddinge Hosp, Karolinska Inst, Dept Transplantat Surg, S-14186 Huddinge, Sweden.
RI Nilsson, Bo/B-3102-2012
OI Nilsson, Bo/0000-0003-0057-2730
CR ANDERSON SP, 1989, J IND ECON, V38, P1, DOI 10.2307/2098395
   Bennet W, 1999, DIABETES, V48, P1907, DOI 10.2337/diabetes.48.10.1907
   Bennet W, 2000, TRANSPLANTATION, V69, P711
   Bennet W, 2000, TRANSPLANTATION, V69, P1711
   BENNET W, 2001, XENOTRANSPLANTATION, V8, P1
   Brandhorst H, 1998, CELL TRANSPLANT, V7, P489, DOI 10.1016/S0963-6897(98)00028-1
   Byrne G, 1997, TRANSPLANTATION, V63, P149, DOI 10.1097/00007890-199701150-00027
   Cozzi E, 1997, TRANSPLANTATION, V64, P1383, DOI 10.1097/00007890-199711270-00002
   COZZI E, 1995, NAT MED, V1, P964, DOI 10.1038/nm0995-964
   DALMASSO AP, 1992, IMMUNOPHARMACOLOGY, V24, P149, DOI 10.1016/0162-3109(92)90020-D
   EKDAHL KN, 1992, SCAND J IMMUNOL, V35, P85, DOI 10.1111/j.1365-3083.1992.tb02837.x
   FODOR WL, 1994, P NATL ACAD SCI USA, V91, P11153, DOI 10.1073/pnas.91.23.11153
   Gong J, 1996, J CLIN IMMUNOL, V16, P222, DOI 10.1007/BF01541228
   GROTH CG, 1994, LANCET, V344, P1402, DOI 10.1016/S0140-6736(94)90570-3
   GROTTING JC, 1978, AM J PATHOL, V92, P653
   KOHNERT KD, 1986, J BIOCHEM BIOPH METH, V12, P81, DOI 10.1016/0165-022X(86)90053-9
   KOOYMAN DL, 1995, SCIENCE, V269, P89, DOI 10.1126/science.7541557
   KORSGREN O, 1988, TRANSPLANTATION, V45, P509, DOI 10.1097/00007890-198803000-00001
   Kuipers HW, 1997, TRANSGENIC RES, V6, P253, DOI 10.1023/A:1018402510471
   LACHMANN PJ, 1991, IMMUNOL TODAY, V12, P312, DOI 10.1016/0167-5699(91)90005-E
   LANGFORD GA, 1994, TRANSPLANT P, V26, P1400
   Larsson R, 1997, IMMUNOPHARMACOLOGY, V38, P119, DOI 10.1016/S0162-3109(97)00064-7
   MOLLNES T, 1985, SCAND J IMMUNOL, V22, P703
   RICORDI C, 1986, DIABETES, V35, P649, DOI 10.2337/diabetes.35.6.649
   ROLLINS SA, 1991, J IMMUNOL, V146, P2345
   SANDBERG JO, 1995, TRANSPLANTATION, V59, P1665, DOI 10.1097/00007890-199506270-00004
   Schmoeckel M, 1998, TRANSPLANTATION, V65, P1570, DOI 10.1097/00007890-199806270-00006
   SHIN ML, 1986, J IMMUNOL, V136, P1777
   Zaidi A, 1998, TRANSPLANTATION, V65, P1584, DOI 10.1097/00007890-199806270-00008
NR 29
TC 41
Z9 45
U1 1
U2 4
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0041-1337
J9 TRANSPLANTATION
JI Transplantation
PD JUL 27
PY 2001
VL 72
IS 2
BP 312
EP 319
DI 10.1097/00007890-200107270-00026
PG 8
WC Immunology; Surgery; Transplantation
SC Immunology; Surgery; Transplantation
GA 461AK
UT WOS:000170342600026
PM 11477359
DA 2018-10-20
ER

PT J
AU Wagner, MS
   Castner, DG
AF Wagner, MS
   Castner, DG
TI Characterization of adsorbed protein films by time-of-flight secondary
   ion mass spectrometry with principal component analysis
SO LANGMUIR
LA English
DT Article
ID SELF-ASSEMBLED MONOLAYERS; ABSORPTION FINE-STRUCTURE; ATOMIC-FORCE
   MICROSCOPY; BIOMATERIAL SURFACES; TOF-SIMS; PLASMA DEPOSITION;
   SOLID-SURFACES; CELL-ADHESION; ADSORPTION; POLYMERS
AB Characterization of the adsorbed protein film that forms upon implantation of a biomedical device is a long-standing interest in biomaterials research. Time-of-flight secondary ion mass spectrometry (ToF-SIMS) is a powerful method for the characterization of adsorbed proteins on biomaterial surfaces due to its chemical specificity and surface sensitivity. However, the SIMS fragmentation patterns for proteins are quite complex due to the heterogeneity of the protein sequence; Therefore, the multivariate analysis technique principal components analysis (PCA) was used to obtain a more detailed interpretation of the protein SIMS spectra. This study utilizes single component adsorbed protein films on three model substrates and multivariate analysis of the ToF-SIMS data to determine the identity of protein films. Furthermore, ToF-SIMS and PCA were used to give insight into the composition of a 1% bovine plasma protein film. The single component spectra from 13 different proteins were readily distinguishable using PCA. The major component of the 1% bovine plasma film was found to shift from fibrinogen to gamma -globulins over the course of 2 h, in agreement with the current literature. This study shows how combination of ToF-SIMS and PCA provides new insights into the composition of adsorbed protein films on biomaterial surfaces.
C1 Univ Washington, Natl ESCA & Surface Anal Ctr Biomed Problems, Dept Chem Engn, Seattle, WA 98195 USA.
   Univ Washington, Natl ESCA & Surface Anal Ctr Biomed Problems, Dept Bioengn, Seattle, WA 98195 USA.
RP Castner, DG (reprint author), Univ Washington, Natl ESCA & Surface Anal Ctr Biomed Problems, Dept Chem Engn, Box 351750, Seattle, WA 98195 USA.
CR An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   Baier R E, 1969, J Biomed Mater Res, V3, P191, DOI 10.1002/jbm.820030115
   Bartiaux S., 1995, THESIS U CATHOLIQUE
   Benninghoven A, 1993, ANAL CHEM, V65, P630
   Boeckl MS, 1998, BIOPOLYMERS, V47, P185, DOI 10.1002/(SICI)1097-0282(1998)47:2<185::AID-BIP8>3.0.CO;2-Q
   BOHNERT J L, 1990, Journal of Biomaterials Science Polymer Edition, V1, P279
   BOUCHONNET S, 1992, ANAL CHEM, V64, P743, DOI 10.1021/ac00031a009
   BRASH JL, 1984, THROMB HAEMOSTASIS, V51, P326
   BRYERS JD, 1994, COLLOID SURFACE B, V2, P9, DOI 10.1016/0927-7765(94)80013-8
   Chittur KK, 1998, BIOMATERIALS, V19, P301, DOI 10.1016/S0142-9612(97)00107-5
   Chittur KK, 1998, BIOMATERIALS, V19, P357, DOI 10.1016/S0142-9612(97)00223-8
   Chowdhury PB, 1998, COLLOID SURFACE A, V143, P53, DOI 10.1016/S0927-7757(98)00408-7
   Clerc J, 1997, CELL BIOL INT, V21, P619, DOI 10.1006/cbir.1998.0205
   Colliver TL, 1997, ANAL CHEM, V69, P2225, DOI 10.1021/ac9701748
   Dannenberger O, 1997, THIN SOLID FILMS, V307, P183, DOI 10.1016/S0040-6090(97)00280-0
   Deng L, 1996, J AM CHEM SOC, V118, P5136, DOI 10.1021/ja960461d
   Derue C, 1999, J TRACE MICROPROBE T, V17, P451
   EASTMENT HT, 1982, TECHNOMETRICS, V24, P73, DOI 10.2307/1267581
   Elwing H, 1998, BIOMATERIALS, V19, P397, DOI 10.1016/S0142-9612(97)00112-9
   ERTEL SI, 1994, J BIOMED MATER RES, V28, P667, DOI 10.1002/jbm.820280603
   Favia P, 1998, SURF COAT TECH, V98, P1102, DOI 10.1016/S0257-8972(97)00285-5
   Fischer D, 1997, J VAC SCI TECHNOL A, V15, P2173, DOI 10.1116/1.580529
   Fourre C, 1997, J ANAL ATOM SPECTROM, V12, P1105, DOI 10.1039/a700777i
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Harder P, 1998, J PHYS CHEM B, V102, P426, DOI 10.1021/jp972635z
   HEALD SM, 1988, XRAY ABSORPTION PRIN
   HORBETT TA, 1994, COLLOID SURFACE B, V2, P225, DOI 10.1016/0927-7765(94)80037-5
   HORBETT TA, 1984, THROMB HAEMOSTASIS, V51, P174
   HORBETT TA, 1986, TECHNIQUES BIOCOMPAT
   Hotelling H, 1931, ANN MATH STAT, V2, P360, DOI 10.1214/aoms/1177732979
   Jackson J.E., 1991, USERS GUIDE PRINCIPA
   John CM, 1997, INT J MASS SPECTROM, V161, P47, DOI 10.1016/S0168-1176(96)04505-3
   Kao WJ, 1999, J MATER SCI-MATER M, V10, P601, DOI 10.1023/A:1008971222932
   KARGACIN ME, 1986, ANAL CHEM, V58, P2300, DOI 10.1021/ac00124a041
   KIAEI D, 1992, J BIOMAT SCI-POLYM E, V4, P35
   Leonard D, 1999, FRESEN J ANAL CHEM, V365, P3, DOI 10.1007/s002160051437
   Lhoest JB, 1998, J BIOMED MATER RES, V41, P95, DOI 10.1002/(SICI)1097-4636(199807)41:1<95::AID-JBM12>3.0.CO;2-G
   LHOEST JB, IN PRESS J BIOMED MA
   LOPEZ GP, 1992, J BIOMED MATER RES, V26, P415, DOI 10.1002/jbm.820260402
   Lundberg F, 1997, INFECT IMMUN, V65, P897
   Mallet Y, 1996, CHEMOMETR INTELL LAB, V35, P157, DOI 10.1016/S0169-7439(96)00050-0
   MANTUS DS, 1993, ANAL CHEM, V65, P1431, DOI 10.1021/ac00058a021
   MARLETTA G, 1990, SURF INTERFACE ANAL, V16, P407, DOI 10.1002/sia.740160185
   McDevitt D, 1997, EUR J BIOCHEM, V247, P416, DOI 10.1111/j.1432-1033.1997.00416.x
   Montanaro L, 1999, BIOMATERIALS, V20, P1945, DOI 10.1016/S0142-9612(99)00099-X
   Morra M., 1993, Clinical Materials, V14, P255, DOI 10.1016/0267-6605(93)90010-5
   Ohrlund A, 1997, SURF INTERFACE ANAL, V25, P105, DOI 10.1002/(SICI)1096-9918(199702)25:2<105::AID-SIA213>3.0.CO;2-R
   Ohta T, 1998, J ELECTRON SPECTROSC, V92, P131, DOI 10.1016/S0368-2048(98)00114-5
   PAYNTER RW, 1984, J COLLOID INTERF SCI, V101, P233, DOI 10.1016/0021-9797(84)90023-7
   PAYNTER RW, 1985, SURFACE INTERFACIAL
   RATNER B D, 1992, Clinical Materials, V11, P25, DOI 10.1016/0267-6605(92)90027-Q
   RATNER BD, 1995, SURF INTERFACE ANAL, V23, P521, DOI 10.1002/sia.740230712
   RATNER BD, 1993, CLIN MATER, V13, P71, DOI 10.1016/0267-6605(93)90093-M
   RATNER BD, 1994, COLLOID SURFACE B, V2, P333, DOI 10.1016/0927-7765(94)80048-0
   RATNER BD, 1996, 5WORLD BIOM C TOR CA, P577
   RATNER BD, 1995, THIN FILMS SURFACES, P195
   RATNER BD, 1996, POLYM PREPR, V37, P843
   Rudnicka W, 1997, FEMS IMMUNOL MED MIC, V19, P7, DOI 10.1016/S0928-8244(97)00045-X
   SHEU MS, 1993, CLIN MATER, V13, P41, DOI 10.1016/0267-6605(93)90088-O
   SHEU MS, 1993, J ADHES SCI TECHNOL, V7, P1065, DOI 10.1163/156856193X00583
   Shi HQ, 1999, NATURE, V398, P593
   Siedlecki CA, 1998, BIOMATERIALS, V19, P441, DOI 10.1016/S0142-9612(97)00222-6
   Thomas CH, 1997, J BIOMED MATER RES, V37, P81, DOI 10.1002/(SICI)1097-4636(199710)37:1<81::AID-JBM10>3.0.CO;2-T
   THOMPSON PM, 1991, ANAL CHEM, V63, P2447, DOI 10.1021/ac00021a012
   TIDWELL CD, 2001, IN PRESS SURF INTERF
   UNIYAL S, 1982, THROMB HAEMOSTASIS, V47, P285
   Vandeginste B. G. M., 1998, HDB CHEMOMETRICS Q B
   Vanden Eynde X, 1999, APPL SURF SCI, V141, P1, DOI 10.1016/S0169-4332(98)00626-6
   Vanden-Eynde X, 1997, SURF INTERFACE ANAL, V25, P878
   Vasin SL, 1998, J BIOMED MATER RES, V39, P491, DOI 10.1002/(SICI)1097-4636(19980305)39:3<491::AID-JBM21>3.3.CO;2-Z
   Wagner M., UNPUB
   Wise B. M., 1998, PLS TOOLBOX VERSION
   WOLD S, 1978, TECHNOMETRICS, V20, P397, DOI 10.2307/1267639
   WOLD S, 1976, PATTERN RECOGN, V8, P127, DOI 10.1016/0031-3203(76)90014-5
   WOLD S, 1987, CHEMOMETR INTELL LAB, V2, P37, DOI 10.1016/0169-7439(87)80084-9
   Yu JL, 1997, FEMS IMMUNOL MED MIC, V19, P247, DOI 10.1016/S0928-8244(97)00092-8
NR 76
TC 294
Z9 295
U1 3
U2 81
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD JUL 24
PY 2001
VL 17
IS 15
BP 4649
EP 4660
DI 10.1021/la001209t
PG 12
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 455LX
UT WOS:000170029300031
DA 2018-10-20
ER

PT J
AU Kaiitani, M
   Wadia, Y
   Hinds, MT
   Teach, J
   Swartz, KR
   Gregory, KW
AF Kaiitani, M
   Wadia, Y
   Hinds, MT
   Teach, J
   Swartz, KR
   Gregory, KW
TI Successful repair of esophageal injury using an elastin based
   biomaterial patch
SO ASAIO JOURNAL
LA English
DT Article
ID GUNSHOT WOUNDS; MANAGEMENT; PERFORATION
AB An esophageal injury with significant tissue loss is very difficult to repair. We conducted an in vivo study to test our elastin based acellular biomaterial patch to repair such defect. The patch was made from porcine aorta, by decellularization and sterilization. Collagen fibers were preserved to retain mechanical strength and enhance cellular in-growth. Ten domestic pigs underwent right thoracotomy. A 2 cm circular defect was made on the distal esophagus, excising half its circumference, and was repaired using the biomaterial patch and sutures. Soon after the procedure, the animals resumed oral feeding. They were followed for clinical status, weight gain, barium studies, and endoscopic studies, and were killed after 6 weeks to 4 months. All ten animals survived long term, with a procedure success rate of 100% (10 of 10). With the exception of one pneumothorax, no complications occurred, and all animals resumed oral feeding and gained weight. Endoscopic studies showed mucosal coverage by 6 weeks, with minimal stricture at the repair site. Excised specimens showed complete mucosal coverage with regeneration of all three layers. Our biomaterial patch can be used safely and reliably for repair of esophageal injury with significant tissue loss when repaired immediately as in our experiment.
C1 Oregon Med Laser Ctr, Portland, OR 97225 USA.
RP Gregory, KW (reprint author), Oregon Med Laser Ctr, 9205 SW Barnes Rd, Portland, OR 97225 USA.
CR BANECKO RM, 1994, GEN THORACIC SURG, P1514
   DEMEESTER TR, 1986, ANN THORAC SURG, V42, P231, DOI 10.1016/S0003-4975(10)62723-3
   GRILLO HG, 1975, ANN THORAC SURG, V29, P387
   Kajitani M, 2000, ASAIO J, V46, P409, DOI 10.1097/00002480-200007000-00007
   PASS LJ, 1987, ANN THORAC SURG, V44, P253, DOI 10.1016/S0003-4975(10)62066-8
   POPOVSKY J, 1976, J THORAC CARDIOV SUR, V72, P609
   POPOVSKY J, 1984, J TRAUMA, V24, P337, DOI 10.1097/00005373-198404000-00010
   THAL AP, 1965, ARCH SURG-CHICAGO, V90, P464
   TRIGGIANI E, 1977, THORAX, V32, P241, DOI 10.1136/thx.32.3.241
   URSCHEL HC, 1974, ANN SURG, V179, P587, DOI 10.1097/00000658-197405000-00010
NR 10
TC 35
Z9 39
U1 0
U2 2
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1058-2916
J9 ASAIO J
JI Asaio J.
PD JUL-AUG
PY 2001
VL 47
IS 4
BP 342
EP 345
DI 10.1097/00002480-200107000-00009
PG 4
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 451XE
UT WOS:000169827200009
PM 11482483
OA Bronze
DA 2018-10-20
ER

PT J
AU Fowers, KD
   Janatova, J
AF Fowers, KD
   Janatova, J
TI Specific inhibition of C3 to facilitate general complement inhibition on
   endotoxin affinity sorbents for apheresis applications
SO BIOMATERIALS
LA English
DT Article
DE complement activation; apheresis; endotoxin adsorption; C3 inhibition
ID POLYSTYRENE SURFACES; ACTIVATION; MEMBRANES; PLASMA; CIRCULATION;
   PROTEINS; BLOOD; BIOCOMPATIBILITY; ADSORPTION; COPOLYMERS
AB Complement activation, as a result of human blood exposure to biomaterial surfaces, continues to be a concern in medical applications. The purpose of this study was to identify sorbent(s) and surface modification(s) that allow specific removal of endotoxin, while minimizing complement activation. Maleic anhydride (MA) modification of Sepharose CL-4B, cellulose, and Toyopearl HW-65F resulted in reduced generation of C3a, a marker of complement activation, by two orders of magnitude over unmodified surfaces. Surfaces modified with both MA and polymyxin B (PMB), utilized for binding endotoxin, reduced complement activation in a similar manner. Western Blot analysis of the larger C3 cleavage product C3dg showed a similar reduction, for all MA-modified sorbents, as observed for C3a by ELISA. C3 alpha 43 levels (constituent of iC3b and C3c) were also reduced, although only MA-Sepharose CL-4B levels were similar to C3a. Activation of C5, measured as the SC5b-9 complex, was also reduced by two orders of magnitude after MA modification of Sepharose CL-4B; the decrease was similar to all chemical modifications tested. PMB immobilized via CNBr on MA-modified cellulose maintained its endotoxin-binding capacity, while the latter was eliminated when PMB was immobilized via CNBr to MA-modified Sepharose CL-4B and Toyopearl HW-65F. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA.
   Ctr Biopolymers Interfaces, Salt Lake City, UT 84112 USA.
RP Janatova, J (reprint author), Univ Utah, Dept Bioengn, 50 S Cent Campus Dr,Rm 2480, Salt Lake City, UT 84112 USA.
CR Baufreton C, 1998, ANN THORAC SURG, V66, P1837, DOI 10.1016/S0003-4975(98)00726-7
   Fadul JEM, 1998, J CLIN APHERESIS, V13, P167, DOI 10.1002/(SICI)1098-1101(1998)13:4<167::AID-JCA5>3.0.CO;2-N
   GOLANDER CG, 1992, J BIOMAT SCI-POLYM E, V4, P25
   Hermanson G T, 1992, IMMOBILIZED AFFINITY, P454
   Jaber BL, 1998, BLOOD PURIFICAT, V16, P325, DOI 10.1159/000014352
   JANATOVA J, 2000, ASAIO J, V46, P553
   JOHNSON RJ, 1990, BLOOD PURIFICAT, V8, P318, DOI 10.1159/000169986
   JOHNSON RJ, 1989, MED PROG TECHNOL, V15, P77
   JOZEFONVICZ J, 1990, Journal of Biomaterials Science Polymer Edition, V1, P147
   KIRKLIN JK, 1983, J THORAC CARDIOV SUR, V86, P845
   KISHIDA A, 1992, BIOMATERIALS, V13, P113, DOI 10.1016/0142-9612(92)90006-A
   KOTTKEMARCHANT K, 1987, J BIOMED MATER RES, V21, P379, DOI 10.1002/jbm.820210310
   Larsson R, 1997, IMMUNOPHARMACOLOGY, V38, P119, DOI 10.1016/S0162-3109(97)00064-7
   LIN YS, 1992, BIOMATERIALS, V13, P497
   MONTDARGENT B, 1993, BIOMATERIALS, V14, P203, DOI 10.1016/0142-9612(93)90024-V
   Nilsson B, 1998, BLOOD, V92, P1661
   NILSSON UR, 1993, SCAND J IMMUNOL, V37, P349, DOI 10.1111/j.1365-3083.1993.tb02564.x
   NORMAN ME, 1993, BIOMATERIALS, V14, P193, DOI 10.1016/0142-9612(93)90023-U
   PAUL D, 1990, ARTIF ORGANS, V14, P122
   Rosenkranz AR, 1999, J AM SOC NEPHROL, V10, P128
   SAWHNEY AS, 1992, BIOMATERIALS, V13, P863, DOI 10.1016/0142-9612(92)90180-V
   Shiga Y, 1998, ARTIF ORGANS, V22, P1067, DOI 10.1046/j.1525-1594.1998.06170.x
   SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7
   Watkins NJ, 1997, IMMUNOPHARMACOLOGY, V38, P111, DOI 10.1016/S0162-3109(97)00068-4
   Yang V C, 1991, ASAIO Trans, V37, pM229
NR 25
TC 1
Z9 2
U1 0
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUL
PY 2001
VL 22
IS 13
BP 1749
EP 1761
DI 10.1016/S0142-9612(00)00335-5
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 435YE
UT WOS:000168909100007
PM 11396878
DA 2018-10-20
ER

PT J
AU Lauto, A
   Ohebshalom, M
   Esposito, M
   Mingin, J
   Li, PS
   Felsen, D
   Goldstein, M
   Poppas, DP
AF Lauto, A
   Ohebshalom, M
   Esposito, M
   Mingin, J
   Li, PS
   Felsen, D
   Goldstein, M
   Poppas, DP
TI Self-expandable chitosan stent: design and preparation
SO BIOMATERIALS
LA English
DT Article
DE elasticity; cylindrical helix; biopolymers; laser solder
ID DL-LACTIC ACID; URETERAL STENT; METAL STENTS; LASER; BIOMATERIAL;
   OBSTRUCTION; PREVENTION; EXPERIENCE; INSERTION; PROSTATE
AB Stents are largely used in surgical procedures to relieve pathological obstructions. The purpose of the present study was to design and prepare a biocompatible stent with a self-expandable mechanism. Thin films were prepared from deacetylated chitosan (4% w/v) dissolved in acetic acid solution (2% v/v). The chitosan films were tested by a calibrated tensiometer to measure the Young's module (E). The films were used to manufacture stents by pulling and winding them around a cylindrical rod in a helical fashion. Thirteen stents (diameter = 0.5 +/- 0.05 mm, length similar to4 mm) were inserted into the vas deferens of wistar rats. Upon stent insertion, the vasal anastomosis was achieved with a laser-soldering technique. The animals were sacrificied 8 weeks later. The stress test showed that the chitosan film was elastic (maximum strain = 105% +/- 6%, E = 0.7655 +/- 0.0288 Mpa). The stents self-expanded by releasing their elastic energy. All the stents but one remained open inside the vasa despite high incidence of sperm granuloma. A biocompatible and self-expandable stent with a helical design is proposed. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Cornell Univ, New York Presbyterian Hosp, Weill Med Coll,Dept Urol, Ctr Pediat Urol & Minimal Invas Urol Surg, New York, NY 10021 USA.
RP Lauto, A (reprint author), Mem Hosp, Dept Med Phys, Room F1134,1275 York Ave, New York, NY 10021 USA.
CR Benoit G, 1996, J UROLOGY, V156, P881, DOI 10.1016/S0022-5347(01)65647-7
   Braf Z, 1996, J ENDOUROL, V10, P555, DOI 10.1089/end.1996.10.555
   Caldwell J C, 1996, Clin Anat, V9, P302, DOI 10.1002/(SICI)1098-2353(1996)9:5<302::AID-CA3>3.0.CO;2-E
   Costain DJ, 1997, SURGERY, V121, P314, DOI 10.1016/S0039-6060(97)90360-3
   Cozzi G, 1994, Radiol Med, V88, P272
   HOLMES SAV, 1992, BRIT J UROL, V69, P383, DOI 10.1111/j.1464-410X.1992.tb15564.x
   Lauto A, 1998, MICROSURG, V18, P60, DOI 10.1002/(SICI)1098-2752(1998)18:1<60::AID-MICR13>3.0.CO;2-Q
   Lauto A, 1998, LASER SURG MED, V22, P120, DOI 10.1002/(SICI)1096-9101(1998)22:2<120::AID-LSM8>3.0.CO;2-R
   Lauto A, 1999, LASER SURG MED, V25, P250, DOI 10.1002/(SICI)1096-9101(1999)25:3<250::AID-LSM9>3.3.CO;2-M
   LEE BH, 1995, J VASC INTERV RADIOL, V6, P635, DOI 10.1016/S1051-0443(95)71151-4
   Marsman J W, 1996, Australas Radiol, V40, P80
   MUZZARELLI R, 1990, ANTIMICROB AGENTS CH, V34, P2019, DOI 10.1128/AAC.34.10.2019
   OKAMOTO Y, 1995, J VET MED SCI, V57, P765, DOI 10.1292/jvms.57.765
   OKAMOTO Y, 1995, J VET MED SCI, V57, P851, DOI 10.1292/jvms.57.851
   Okamura Takehiko, 1995, Acta Urologica Japonica, V41, P289
   Petas A, 1997, BRIT J UROL, V80, P439, DOI 10.1046/j.1464-410X.1997.00308.x
   Petas A, 1997, BRIT J UROL, V80, P903, DOI 10.1046/j.1464-410X.1997.00476.x
   Rao SB, 1997, J BIOMED MATER RES, V34, P21, DOI 10.1002/(SICI)1097-4636(199701)34:1<21::AID-JBM4>3.0.CO;2-P
   SANFORD PA, 1990, AM CHEM SOC DIV POLY, V31, P628
   Sauter ER, 1996, J SURG ONCOL, V62, P10
   Schlick RW, 1997, BRIT J UROL, V80, P908, DOI 10.1046/j.1464-410X.1997.00484.x
   Shigemasa Y, 1996, BIOTECHNOL GENET ENG, V13, P383, DOI 10.1080/02648725.1996.10647935
   SMITS M, 1995, ENDOSCOPY, V27, P505, DOI 10.1055/s-2007-1005756
   SUZUKI K, 1984, MICROBIOL IMMUNOL, V28, P909
   Trickett RI, 1998, MICROSURG, V18, P414, DOI 10.1002/(SICI)1098-2752(1998)18:7<414::AID-MICR5>3.0.CO;2-W
   TSCHADA RK, 1994, J ENDOUROL, V8, P119, DOI 10.1089/end.1994.8.119
   VANSONNENBERG E, 1994, RADIOLOGY, V191, P765, DOI 10.1148/radiology.191.3.8184060
   YOUNG GPH, 1995, SURG MALE INFERTILIT, P297
NR 28
TC 29
Z9 29
U1 3
U2 10
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUL
PY 2001
VL 22
IS 13
BP 1869
EP 1874
DI 10.1016/S0142-9612(00)00371-9
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 435YE
UT WOS:000168909100021
PM 11396892
DA 2018-10-20
ER

PT J
AU Zoulgami, M
   Lucas, A
   Briard, P
   Gaude, J
AF Zoulgami, M
   Lucas, A
   Briard, P
   Gaude, J
TI A self-setting single-component calcium phosphate cement
SO BIOMATERIALS
LA English
DT Article
DE phosphate cement; self-setting; biomaterial; apatite
ID FIBROBLASTIC CELLS; BONE; HYDROXYAPATITE; CARBONATE; CERAMICS
AB Following an original synthesis route, we have prepared a single-component calcium phosphate apatite-like powder which settles and hardens when mixed with deionized water in an approximative 1.2g : 1ml ratio. This paper describes the first physico-chemical studies and characterizations of the material. Observations of its in vitro behavior show a slight volume contraction and toxicity against fibroblasts bone marrow cells on disks of compacted powder. It is suggested that after an improvement of the powder characters such as grain size, and the choice of another hardening liquid, to name a few, this material should be a potential - or an ingredient of - bone cement. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 LCSIM, UMR 6511, Grp Cristallochim & Biomat, F-35042 Rennes, France.
RP Gaude, J (reprint author), LCSIM, UMR 6511, Grp Cristallochim & Biomat, Batiment 10B,Campus Beaulieu 263,Ave Gen Leclerc,, F-35042 Rennes, France.
CR BOULTIF A, 1991, J APPL CRYSTALLOGR, V24, P987, DOI 10.1107/S0021889891006441
   CONSTANTZ BR, 1994, Patent No. 5336264
   CONSTANTZ BR, 1998, Patent No. 08356681
   Daculsi G, 1998, BIOMATERIALS, V19, P1473, DOI 10.1016/S0142-9612(98)00061-1
   DRIESSENS FMC, 1999, 15 EUR C BIOM ESB 99
   ELLIOTT JC, 1994, STUDIES INORGANIC CH, V18, P54
   Frayssinet P, 1997, J BIOMED MATER RES, V35, P337, DOI 10.1002/(SICI)1097-4636(19970605)35:3<337::AID-JBM8>3.3.CO;2-H
   HYAKUNA K, 1989, J BIOMED MATER RES, V23, P1049, DOI 10.1002/jbm.820230906
   HYAKUNA K, 1990, J BIOMED MATER RES, V24, P471, DOI 10.1002/jbm.820240406
   Kawachi EY, 1998, BIOMATERIALS, V19, P2329, DOI 10.1016/S0142-9612(98)00148-3
   Khairoun I, 1997, BIOMATERIALS, V18, P1535, DOI 10.1016/S0142-9612(97)80005-1
   Khairoun I, 1999, BIOMATERIALS, V20, P393, DOI 10.1016/S0142-9612(98)00202-6
   LEE DD, 1996, Patent No. 9636562
   LEE DD, 1998, Patent No. 9816209
   LEMAITRE J, 15 C BIOM ESB 99 SEP
   Malard O, 1999, J BIOMED MATER RES, V46, P103, DOI 10.1002/(SICI)1097-4636(199907)46:1<103::AID-JBM12>3.0.CO;2-Z
   Oreffo ROC, 1998, TISSUE ENG, V4, P293, DOI 10.1089/ten.1998.4.293
   POSNER A S, 1975, Seminars in Arthritis and Rheumatism, V4, P267, DOI 10.1016/0049-0172(75)90013-X
   Redey SA, 1999, J BIOMED MATER RES, V45, P140, DOI 10.1002/(SICI)1097-4636(199905)45:2<140::AID-JBM9>3.3.CO;2-9
   REY C, 1990, Biomaterials, V11, P13
   REY C, 1995, MINERAL OSSEUX BIOMA, P41
   RUDIN VN, 1994, Patent No. 06641331
   RUDIN VN, 1998, Patent No. 9818719
   SCHEICHER H, 1990, Patent No. 4917702
   Schmitz JP, 1999, J ORAL MAXIL SURG, V57, P1122, DOI 10.1016/S0278-2391(99)90338-5
   URIST MR, 1984, P NATL ACAD SCI-BIOL, V81, P371, DOI 10.1073/pnas.81.2.371
   Wieliczka DM, 1996, J DENT RES, V75, P1865, DOI 10.1177/00220345960750110801
   WIRONEN JF, 1998, Patent No. 9840113
NR 28
TC 15
Z9 16
U1 0
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUL
PY 2001
VL 22
IS 13
BP 1933
EP 1937
DI 10.1016/S0142-9612(00)00384-7
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 435YE
UT WOS:000168909100029
PM 11396900
DA 2018-10-20
ER

PT J
AU Daamen, WF
   Hafmans, T
   Veerkamp, JH
   van Kuppevelt, TH
AF Daamen, WF
   Hafmans, T
   Veerkamp, JH
   van Kuppevelt, TH
TI Comparison of five procedures for the purification of insoluble elastin
SO BIOMATERIALS
LA English
DT Article
DE insoluble elastin; purification; ligamentum nuchae; calcification
ID VASCULAR BIOPROSTHESES; CALCIFICATION; MICROFIBRILS; FIBRILLIN; TISSUES;
   DOMAINS
AB Elastin is an insoluble. highly cross-linked protein. providing elasticity to organs like lung, aorta, and ligaments. Despite its remarkable mechanical properties, elastin has Found little use as a biomaterial. Purification of intact elastin from elastic fibres presents a major challenge, among others for the intimate interwoveness of elastin and microfibrils. Insoluble elastin preparations tend to calcify, which may be due to calcium-binding microfibrillar (e.g. fibrillin). In this study, elastin was purified from horse ligamentum nuchae using five different procedures. One procedure is based on treatment with 0.1 M NaOH, another on autoclaving and treatment with cyanogen bromide. Three other procedures are based on combinations of extraction steps and enzyme digestions. Purity of preparations was assessed by sodium dodecyl sulphate polyacrylamide gel electrophoresis. amino acid analysis, bright held immunofluorescence and transmission electron microscopy. The procedure involving extracrions/enzymes combined with an early application of 2-mercaptoethanol and cyanogen bromide gives a highly pure elastin preparation. Electron microscopic analysis showed that this preparation is: devoid of microfibrillar components. This procedure is therefore the method of choice for preparation of insoluble elastin as a biomaterial for tissue engineering. (C) 2001 Elsevier Science Ltd. AH rights reserved.
C1 Univ Nijmegen, Ctr Med, Dept Biochem 160, NL-6500 HB Nijmegen, Netherlands.
RP van Kuppevelt, TH (reprint author), Univ Nijmegen, Ctr Med, Dept Biochem 160, POB 9101, NL-6500 HB Nijmegen, Netherlands.
RI Kuppevelt, A.H.M.S.M./L-4463-2015; Daamen, Willeke/D-5854-2015
OI Daamen, Willeke/0000-0003-3155-3030
CR Ashworth JL, 1999, BIOCHEM J, V340, P171, DOI 10.1042/0264-6021:3400171
   Atkinson J, 1999, PATHOL BIOL, V47, P677
   AYAD S, 1994, EXTRACELLULAR MATRIX
   Bisaccia F, 1998, BIOCHEMISTRY-US, V37, P11128, DOI 10.1021/bi9802566
   BOBRYSHEV YV, 1995, ATHEROSCLEROSIS, V118, P9, DOI 10.1016/0021-9150(95)05588-N
   Bradbury P, 1990, THEORY PRACTICE HIST, P119
   BrownAugsburger P, 1996, BIOCHEM J, V318, P149, DOI 10.1042/bj3180149
   Cardy CM, 1998, J MOL BIOL, V276, P855, DOI 10.1006/jmbi.1997.1593
   Chanda J, 1999, BIOMATERIALS, V20, P1753, DOI 10.1016/S0142-9612(98)00078-7
   Chanda J, 1998, BIOMATERIALS, V19, P1651, DOI 10.1016/S0142-9612(98)00038-6
   de Chalain T, 1999, J BIOMED MATER RES, V44, P280, DOI 10.1002/(SICI)1097-4636(19990305)44:3<280::AID-JBM6>3.0.CO;2-H
   Debelle L, 1999, INT J BIOCHEM CELL B, V31, P261, DOI 10.1016/S1357-2725(98)00098-3
   Fauvel-Lafeve F, 1999, INT REV CYTOL, V188, P1
   JOHN R, 1972, BIOCHEM J, V127, P261, DOI 10.1042/bj1270261
   Knott V, 1996, J MOL BIOL, V255, P22, DOI 10.1006/jmbi.1996.0003
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lamme EN, 1996, J HISTOCHEM CYTOCHEM, V44, P1311, DOI 10.1177/44.11.8918906
   LANSING AI, 1952, ANAT RECORD, V114, P555, DOI 10.1002/ar.1091140404
   Nimni ME, 1997, J BIOMED MATER RES, V35, P531
   PAULE WJ, 1992, J BIOMED MATER RES, V26, P1169, DOI 10.1002/jbm.820260907
   RASMUSSEN BL, 1975, ANAL BIOCHEM, V64, P255, DOI 10.1016/0003-2697(75)90426-1
   Reinhardt DP, 1997, J BIOL CHEM, V272, P7368, DOI 10.1074/jbc.272.11.7368
   RIDDLES PW, 1983, METHOD ENZYMOL, V91, P49
   Robinson PN, 2000, J MED GENET, V37, P9, DOI 10.1136/jmg.37.1.9
   ROSE JR, 1993, FASEB J, V7, pA1208
   SAKAI LY, 1991, J BIOL CHEM, V266, P14763
   Samouillan V, 1999, J BIOMED MATER RES, V46, P531, DOI 10.1002/(SICI)1097-4636(19990915)46:4<531::AID-JBM11>3.0.CO;2-2
   SOSKEL NT, 1983, EXP LUNG RES, V4, P109, DOI 10.3109/01902148309055008
   STARCHER BC, 1976, ANAL BIOCHEM, V74, P4417
   VACCA LL, 1985, LAB MANUAL HISTOCHEM, P297
   Vyavahare N, 1999, AM J PATHOL, V155, P973, DOI 10.1016/S0002-9440(10)65197-8
NR 31
TC 72
Z9 73
U1 0
U2 18
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUL
PY 2001
VL 22
IS 14
BP 1997
EP 2005
DI 10.1016/S0142-9612(00)00383-5
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 439WU
UT WOS:000169141200006
PM 11426877
DA 2018-10-20
ER

PT J
AU Pavcnik, D
   Uchida, B
   Timmermans, H
   Keller, FS
   Rosch, J
AF Pavcnik, D
   Uchida, B
   Timmermans, H
   Keller, FS
   Rosch, J
TI Square stent: A new self-expandable endoluminal device and its
   applications
SO CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY
LA English
DT Review
DE stents and prostheses; filters, interventional procedures; embolism,
   pulmonary; embolization; endovascular stent graft; venous valve; aortic
   valve; biomaterial
ID SMALL-INTESTINAL SUBMUCOSA; GRAFT; DOG
AB The square stent is a new, simply constructed, self-expanding device that has recently been described. Compared with other stents, the square stent has a minimal amount of metal and thus requires a smaller-diameter catheter for introduction. Despite the small amount of metal present, the square stent has adequate expansile force. We have been evaluating the square stent for various interventional. applications. In addition to the basic square stent, combinations of square stents and coverings for square stents were developed and evaluated to expand its uses and indications. One of the coverings tested is a new biomaterial: small intestinal submucosa (SIS). This paper will discuss the various applications of the square stent, which include a retrievable inferior vena cava filter, vascular occluder, graft adapter, and venous and aortic valves. In addition, we will review the important properties of SIS as a covering for the square stent.
C1 Oregon Hlth Sci Univ, Dotter Intervent Inst, Portland, OR 97201 USA.
RP Pavcnik, D (reprint author), Oregon Hlth Sci Univ, Dotter Intervent Inst, L342,3181 SW Sam Jackson Pk Rd, Portland, OR 97201 USA.
CR AIKEN SW, 1994, VET COMP ORTHOPAED, V7, P124
   BADYLAK SF, 1993, TISSUE ENGINEERING, P179
   BADYLAK SF, 1989, J SURG RES, V47, P74, DOI 10.1016/0022-4804(89)90050-4
   HILES MC, 1995, J BIOMED MATER RES, V29, P883, DOI 10.1002/jbm.820290714
   KNAPP PM, 1994, J ENDOUROL, V8, P125, DOI 10.1089/end.1994.8.125
   Lantz G C, 1993, J Invest Surg, V6, P297, DOI 10.3109/08941939309141619
   MCGEE P, 1998, ORTHOPEDICS TODAY, V18, P43
   Park JW, 2000, J VASC INTERV RADIOL, V11, P1325, DOI 10.1016/S1051-0443(07)61310-4
   Pavcnik D, 1999, CARDIOVASC INTER RAD, V22, P239, DOI 10.1007/s002709900374
   Pavcnik D, 2000, MINIM INVASIV THER, V9, P287, DOI 10.1080/13645700009169659
   Pavcnik D, 2000, J VASC INTERV RADIOL, V11, P1227, DOI 10.1016/S1051-0443(07)61369-4
   PAVCNIK D, 2001, Patent No. 6200336
   Peel SAF, 1998, TISSUE ENG, V4, P143, DOI 10.1089/ten.1998.4.143
   Pfister ME, 2001, J VASC INTERV RADIOL, V12, P235, DOI 10.1016/S1051-0443(07)61831-4
   PREVEL CD, 1995, ANN PLAS SURG, V35, P381, DOI 10.1097/00000637-199510000-00009
   PREVEL CD, 1995, ANN PLAST SURG, V35, P347
   Sakaguchi S, 1999, J VASC INTERV RADIOL, V10, P1092, DOI 10.1016/S1051-0443(99)70197-1
   VoytikHarbin SL, 1997, J CELL BIOCHEM, V67, P478, DOI 10.1002/(SICI)1097-4644(19971215)67:4<478::AID-JCB6>3.0.CO;2-P
   YAMADA K, 2001, CARDIOVASC INTERVENT, V2, P99
NR 19
TC 17
Z9 19
U1 0
U2 4
PU SPRINGER-VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010 USA
SN 0174-1551
J9 CARDIOVASC INTER RAD
JI Cardiovasc. Interv. Radiol.
PD JUL-AUG
PY 2001
VL 24
IS 4
BP 207
EP 217
DI 10.1007/s00270-001-0041-7
PG 11
WC Cardiac & Cardiovascular Systems; Radiology, Nuclear Medicine & Medical
   Imaging
SC Cardiovascular System & Cardiology; Radiology, Nuclear Medicine &
   Medical Imaging
GA 481WE
UT WOS:000171542800001
PM 11779008
DA 2018-10-20
ER

PT J
AU Arkharov, IA
   Navasardyan, ES
   Luk'yanov, PA
AF Arkharov, IA
   Navasardyan, ES
   Luk'yanov, PA
TI Equipment for biomaterial storage systems
SO CHEMICAL AND PETROLEUM ENGINEERING
LA English
DT Article
C1 NE Bauman Moscow State Tech Univ, Moscow, Russia.
RP Arkharov, IA (reprint author), NE Bauman Moscow State Tech Univ, Moscow, Russia.
CR AZAROV AI, 2 INT C EC DEV NW RU, P7
   Piralishvili Sh. A., 2000, VORTEX EFFECT EXPT T
   Suslov A. D., 1985, VORTEX EQUIPMENTS
NR 3
TC 1
Z9 1
U1 0
U2 0
PU CONSULTANTS BUREAU
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0009-2355
J9 CHEM PETROL ENG+
JI Chem. Pet. Eng.
PD JUL-AUG
PY 2001
VL 37
IS 7-8
BP 428
EP 433
DI 10.1023/A:1012567916724
PG 6
WC Engineering, Chemical
SC Engineering
GA 509JB
UT WOS:000173143700020
DA 2018-10-20
ER

PT J
AU Gottenbos, B
   Grijpma, DW
   van der Mei, HC
   Feijen, J
   Busscher, HJ
AF Gottenbos, B
   Grijpma, DW
   van der Mei, HC
   Feijen, J
   Busscher, HJ
TI Antimicrobial effects of positively charged surfaces on adhering
   Gram-positive and Gram-negative bacteria
SO JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
LA English
DT Article
ID MICROBIAL ADHESION; METHACRYLATE POLYMERS; INITIAL ADHESION;
   IMAGE-ANALYSIS; FLOW CHAMBER; GROWTH; STAPHYLOCOCCI; COPOLYMERS
AB The infection of biomaterials is determined by an interplay of adhesion and surface growth of the infecting organisms. In this study, the antimicrobial effects on adhering bacteria of a positively charged poly(methacrylate) surface ( potential +12 mV) were compared with those of negatively charged poly(methyl methacrylate) (-12 mV) and a highly negatively charged poly(methacrylate) (-18 mV) surface. Initial adhesion of Staphylococcus aureus ATCC 12600, Staphylococcus epidermidis HBH2 102, Escherichia coli O2K2 and Pseudomonas aeruginosa AK1 to these surfaces was measured in a parallel plate flow chamber in phosphate-buffered saline. Adhering bacteria were allowed to multiply by perfusing the flow chamber with growth medium. All bacteria adhered most rapidly to the positively charged surface, but there was no subsequent surface growth of the Gram-negative strains. On the negatively charged surfaces, despite a slower initial adhesion, surface growth of the adhering bacteria was exponential for both Gram-positive and Gram-negative strains. These results suggest that positively charged biomaterial surfaces exert an antimicrobial effect on adhering Gram-negative bacteria, but not on Gram-positive ones.
C1 Univ Groningen, Dept Biomed Engn, NL-9713 AV Groningen, Netherlands.
   Univ Twente, Dept Chem Technol, NL-7500 AE Enschede, Netherlands.
   Univ Twente, Inst Biomed Technol, NL-7500 AE Enschede, Netherlands.
RP Busscher, HJ (reprint author), Univ Groningen, Dept Biomed Engn, Antonius Deusinglaan 1, NL-9713 AV Groningen, Netherlands.
RI Hori, Katsutoshi/K-5289-2012
OI Hori, Katsutoshi/0000-0003-1994-3124
CR Barton AJ, 1996, J BIOMED MATER RES, V32, P271, DOI 10.1002/(SICI)1097-4636(199610)32:2<271::AID-JBM17>3.0.CO;2-M
   BUSSCHER HJ, 1995, METHOD ENZYMOL, V253, P455
   BUSSCHER HJ, 1995, FEMS MICROBIOL LETT, V128, P229, DOI 10.1016/0378-1097(95)00103-C
   Domagk G, 1935, DEUT MED WOCHENSCHR, V61, P829, DOI 10.1055/s-0028-1129654
   Everaert EPJM, 1998, J MATER SCI-MATER M, V9, P147, DOI 10.1023/A:1008867619481
   Gottenbos B, 2000, J BIOMED MATER RES, V50, P208, DOI 10.1002/(SICI)1097-4636(200005)50:2<208::AID-JBM16>3.0.CO;2-D
   Gottenbos B, 1999, METHODS ENZYMOL, V310, P523
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   HARKES G, 1992, J BIOMAT SCI-POLYM E, V3, P403, DOI 10.1163/156856292X00213
   Hiemenz P.C, 1977, PRINCIPLES COLLOID S, P452
   HOGT AH, 1986, J BIOMED MATER RES, V20, P533, DOI 10.1002/jbm.820200409
   HOGT AH, 1985, J COLLOID INTERF SCI, V106, P289, DOI 10.1016/S0021-9797(85)80002-3
   Jucker BA, 1996, J BACTERIOL, V178, P5472, DOI 10.1128/jb.178.18.5472-5479.1996
   Kenawy ER, 1998, J CONTROL RELEASE, V50, P145, DOI 10.1016/S0168-3659(97)00126-0
   LAWRENCE C A, 1968, DISINFECTION STERILI, P430
   MORTIMER GA, 1965, J ORG CHEM, V30, P1632, DOI 10.1021/jo01016a074
   NOORDMANS J, 1993, J COLLOID INTERF SCI, V156, P394, DOI 10.1006/jcis.1993.1128
   SPEIER JL, 1982, J COLLOID INTERF SCI, V89, P68, DOI 10.1016/0021-9797(82)90121-7
   VANDERMEI HC, 1992, J DISPER SCI TECHNOL, V13, P447, DOI 10.1080/01932699208943327
   VANLOOSDRECHT MCM, 1990, MICROBIOL REV, V54, P75
   VANWAGENEN RA, 1980, J COLLOID INTERF SCI, V76, P305, DOI 10.1016/0021-9797(80)90374-4
   Verkerke GJ, 1997, ARTIF ORGANS, V21, P413
NR 22
TC 229
Z9 231
U1 9
U2 76
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-7453
J9 J ANTIMICROB CHEMOTH
JI J. Antimicrob. Chemother.
PD JUL
PY 2001
VL 48
IS 1
BP 7
EP 13
DI 10.1093/jac/48.1.7
PG 7
WC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
SC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
GA 456HW
UT WOS:000170077900002
PM 11418507
OA Bronze
DA 2018-10-20
ER

PT J
AU Morgan, TD
   Wilson, M
AF Morgan, TD
   Wilson, M
TI The effects of surface roughness and type of denture acrylic on biofilm
   formation by Streptococcus oralis in a constant depth film fermentor
SO JOURNAL OF APPLIED MICROBIOLOGY
LA English
DT Article
ID BACTERIAL ADHESION; PLAQUE ACCUMULATION; CANDIDA-ALBICANS; ADHERENCE;
   RETENTION; SUSCEPTIBILITY; BIOMATERIAL; TOPOGRAPHY; FINISHES; GROWTH
AB Aims: To investigate the effects of surface roughness and type of denture acrylic on the early development of a Streptococcus oralis biofilm in a constant depth film fermenter (CDFF).
   Methods and Results: Streptococcus oralis was incubated with acrylic of known surface roughness in the CDFF. Adherent Strep. oralis were enumerated by viable counting. Cold-cure acrylic was rougher (P < 0.01) than heat-cure acrylic after polishing with abrasive paper of any given grit-grade. Heat-cure acrylic was colonized by fewer (P < 0.001) bacteria than cold-cure acrylic at any given surface roughness. The number of bacteria adhering to heat-cure and cold-cure acrylic increased linearly with mean surface roughness after 2 h incubation, the increase being greater (P < 0.001) for the cold-cure compared with the heat-cure acrylic. However, after 4 h incubation, surface roughness appeared to have no effect on the number of adherent bacteria.
   Conclusions: The type of acrylic used, and its roughness, affect the early stages of biofilm formation by Strep. oralis.
   Significance and Impact of the Study: Choosing an appropriate type of smooth acrylic could lead to reduced biofilm formation in vivo.
C1 UCL, Eastman Dent Inst Oral Hlth Care Sci, Dept Microbiol, London WC1X 8LD, England.
RP Wilson, M (reprint author), UCL, Eastman Dent Inst Oral Hlth Care Sci, Dept Microbiol, 256 Grays Inn Rd, London WC1X 8LD, England.
EM M.Wilson@eastman.ucl.ac.uk
RI Wilson, Michael/D-2085-2009
CR ABSOLOM DR, 1983, APPL ENVIRON MICROB, V46, P90
   An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   An Yuehuei H., 1996, P19
   Bollen CML, 1996, CLIN ORAL IMPLAN RES, V7, P201, DOI 10.1034/j.1600-0501.1996.070302.x
   Bollen CML, 1997, DENT MATER, V13, P258, DOI 10.1016/S0109-5641(97)80038-3
   BRECX M, 1983, J PERIODONTAL RES, V18, P177, DOI 10.1111/j.1600-0765.1983.tb00351.x
   BUSSCHER HJ, 1992, FEMS MICROBIOL LETT, V88, P199, DOI 10.1111/j.1574-6968.1992.tb04988.x
   BUSSCHER HJ, 1992, J DENT RES, V71, P491, DOI 10.1177/00220345920710031301
   DANKERT J, 1986, CRIT REV BIOCOMPAT, V2, P219
   Embleton JV, 1998, APPL ENVIRON MICROB, V64, P3503
   Fletcher M, 1996, BACTERIAL ADHESION M, P1
   GIBBONS RJ, 1975, ANNU REV MICROBIOL, V29, P19, DOI 10.1146/annurev.mi.29.100175.000315
   Gurgan S, 1997, J ORAL REHABIL, V24, P624, DOI 10.1046/j.1365-2842.1997.00534.x
   HOGT AH, 1985, J GEN MICROBIOL, V131, P2485
   JANSEN B, 1997, CATHETER RELATED INF, P411
   Kerr A, 1999, J MAR BIOL ASSOC UK, V79, P357, DOI 10.1017/S002531549800040X
   Lampin M, 1997, J BIOMED MATER RES, V36, P99, DOI 10.1002/(SICI)1097-4636(199707)36:1<99::AID-JBM12>3.0.CO;2-E
   LIE T, 1979, ACTA ODONTOL SCAND, V37, P73, DOI 10.3109/00016357909027575
   Merritt K., 2000, HDB BACTERIAL ADHESI, P53
   Mittelman M. W., 1996, BACTERIAL ADHESION M, P89
   Neill DJ, 1968, BRIT DENT J, V124, P107
   OLSSON J, 1982, FEMS MICROBIOL LETT, V15, P319
   QUIRYNEN M, 1995, J CLIN PERIODONTOL, V22, P1, DOI 10.1111/j.1600-051X.1995.tb01765.x
   Quirynen M, 2000, HDB BACTERIAL ADHESI, P91
   QUIRYNEN M, 1991, BIOFOULING, V4, P187
   Radford DR, 1998, J DENT, V26, P577, DOI 10.1016/S0300-5712(97)00034-1
   Steinberg D, 1998, CLIN ORAL IMPLAN RES, V9, P67, DOI 10.1034/j.1600-0501.1998.090201.x
   Taylor R, 1998, J PROSTHET DENT, V80, P592, DOI 10.1016/S0022-3913(98)70037-X
   Taylor RL, 1998, J MATER SCI-MATER M, V9, P17, DOI 10.1023/A:1008874326324
   TEBBS SE, 1994, BRIT J ANAESTH, V72, P587, DOI 10.1093/bja/72.5.587
   ULUSOY M, 1986, J PROSTHET DENT, V56, P107, DOI 10.1016/0022-3913(86)90292-1
   Vacheethasanee K., 2000, HDB BACTERIAL ADHESI, P73
   VANLOOSDRECHT MCM, 1987, APPL ENVIRON MICROB, V53, P1893
   Verran J., 1991, Biofouling, V3, P183
   Verran J, 1997, J PROSTHET DENT, V77, P535, DOI 10.1016/S0022-3913(97)70148-3
   WEITMAN RT, 1975, J AM DENT ASSOC, V91, P101, DOI 10.14219/jada.archive.1975.0294
   Wilson M, 1996, J MED MICROBIOL, V44, P79, DOI 10.1099/00222615-44-2-79
   Wilson M, 1999, METHOD ENZYMOL, V310, P264
NR 38
TC 80
Z9 83
U1 1
U2 5
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1364-5072
J9 J APPL MICROBIOL
JI J. Appl. Microbiol.
PD JUL
PY 2001
VL 91
IS 1
BP 47
EP 53
DI 10.1046/j.1365-2672.2001.01338.x
PG 7
WC Biotechnology & Applied Microbiology; Microbiology
SC Biotechnology & Applied Microbiology; Microbiology
GA 453AD
UT WOS:000169891300005
PM 11442713
OA Bronze
DA 2018-10-20
ER

PT J
AU Weber, N
   Wendel, HP
   Ziemer, G
AF Weber, N
   Wendel, HP
   Ziemer, G
TI Gene monitoring of surface-activated monocytes in circulating whole
   blood using duplex RT-PCR
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE hemocompatibility; heparin coating; Duplex RT-PCR; hsp70; cytokines
ID MESSENGER-RNA EXPRESSION; HEAT-SHOCK PROTEINS; POLYMERIC BIOMATERIALS;
   CARDIOPULMONARY BYPASS; PROCOAGULANT ACTIVITY; BIOLOGICAL RESPONSES;
   CYTOKINE PRODUCTION; HSP70; CELLS; INTERLEUKIN-1
AB Previous studies have shown that blood-contacting materials activate blood monocytes. The aim of this study is to evaluate a highly sensitive technique for detecting changes at the mRNA level in circulating monocytes and to find suitable "gene markers" for assessing the hemocompatibility of biomaterials. Human blood was recirculated in a modified Chandler Loop formed of test tubes. Five groups of biomaterials were compared. Monocytes were separated by using magnetic beads, and gene expression analyses were performed using RT-PCR. We investigated the mRNA expression of stress proteins (hsp70) and inflammatory markers (IL-1 alpha, IL-1 beta, IL-6, TNF-alpha). mRNAs for cytokines were highly upregulated in LPS-stimulated monocytes. Hsp70 transcripts were upregulated after heat shock but were not influenced by treatment with LPS. The gene expression of the cytokines was affected by various biomaterials. The intensity of the inflammatory response increased in the following order: heparin coatings (PVC) < uncoated PVC < silicone, polypeptide-coated PVC. No change was seen in the expression of the hsp70 genes. An inhibitory effect of systemic heparin on surface-activated monocytes was observed for the mRNA expression of the cytokines. The recirculation of human blood in an in vitro model in combination with the immunomagnetic separation of monocytes and the Duplex RT-PCR method is a powerful tool for getting reliable results. Our data demonstrate that hsp70 genes cannot be recommended for short-term, biomaterial-induced mRNA expression studies. Conversely, mRNAs for IL-1 alpha, IL-1 beta, IL-6, and TNF-alpha were expressed in a material-dependent manner. Thus om model provides an effective tool for assessing the hemocompatibility of biomaterials before their clinical application and it also can serve as a safety control during the industrial manufacturing process. This method can be applied to various blood cell populations and numerous gene expression studies and may enable a more fundamental understanding of the biologic processes involved in blood-material interactions. (C) 2001 John Wiley & Sons, Inc.
C1 Univ Tubingen, Dept Surg, Div Thorac Cardiac & Vasc Surg, D-72076 Tubingen, Germany.
RP Wendel, HP (reprint author), Univ Tubingen, Dept Surg, Div Thorac Cardiac & Vasc Surg, Hopper Seyler Str 3, D-72076 Tubingen, Germany.
RI Weber, Norbert/E-8701-2011; Wendel, Hans/C-5687-2009
CR Altankov G, 1996, J BIOMED MATER RES, V30, P385, DOI 10.1002/(SICI)1097-4636(199603)30:3<385::AID-JBM13>3.0.CO;2-J
   ANDERSON JM, 1995, J BIOMAT SCI-POLYM E, V7, P159, DOI 10.1163/156856295X00670
   Asea A, 2000, NAT MED, V6, P435
   Attanasio M, 1998, THROMB HAEMOSTASIS, V79, P959
   Balasubramanian V, 1998, J BIOMAT SCI-POLYM E, V9, P1349, DOI 10.1163/156856298X00433
   BLUM GE, 1993, ANAL BIOCHEM, V210, P235
   CHANDLER AB, 1958, LAB INVEST, V7, P110
   CHOU Q, 1992, NUCLEIC ACIDS RES, V20, P1717, DOI 10.1093/nar/20.7.1717
   DAYER JM, 1994, EUR CYTOKINE NETW, V5, P563
   DESAI NP, 1991, BIOMATERIALS, V12, P144, DOI 10.1016/0142-9612(91)90193-E
   Dinarello CA, 1996, BLOOD, V87, P2095
   Hill GE, 1998, J CARDIOTHOR VASC AN, V12, P21
   HOMAN DJF, 1991, J BIOMAT SCI-POLYM E, V3, P27
   HORBETT TA, 1988, J BIOMED MATER RES, V22, P383, DOI 10.1002/jbm.820220503
   Housby JN, 1999, CYTOKINE, V11, P347, DOI 10.1006/cyto.1998.0437
   Hu J, 1997, J CLIN INVEST, V99, P2312, DOI 10.1172/JCI119410
   Jenney CR, 2000, J BIOMED MATER RES, V49, P435
   Kato S, 1998, BIOMATERIALS, V19, P821, DOI 10.1016/S0142-9612(97)00240-8
   Kato S, 1997, J BIOMAT SCI-POLYM E, V8, P809, DOI 10.1163/156856297X00335
   KELLOGG DE, 1994, BIOTECHNIQUES, V16, P1134
   Kirchhofer D, 1996, CURR OPIN BIOTECH, V7, P386, DOI 10.1016/S0958-1669(96)80112-1
   Kruse N, 1997, J IMMUNOL METHODS, V210, P195, DOI 10.1016/S0022-1759(97)00188-9
   Mackman N, 1996, HAEMOSTASIS, V26, P17
   Mangurten AB, 1997, CELL STRESS CHAPERON, V2, P168, DOI 10.1379/1466-1268(1997)002<0168:HAHAPE>2.3.CO;2
   Mayer MP, 1998, BIOL CHEM, V379, P261
   MINOTA S, 1988, J EXP MED, V168, P1475, DOI 10.1084/jem.168.4.1475
   MOLDAWER LL, 1994, CRIT CARE MED, V22, pS3
   NADLER SG, 1992, SCIENCE, V258, P484, DOI 10.1126/science.1411548
   Osnes LTN, 1996, CYTOKINE, V8, P822, DOI 10.1006/cyto.1996.0110
   Parra B, 1997, VIROLOGY, V233, P260, DOI 10.1006/viro.1997.8613
   Rodenburg RJT, 1998, J IMMUNOL METHODS, V221, P169, DOI 10.1016/S0022-1759(98)00183-5
   SCHMIDT JA, 1988, J IMMUNOL, V141, P2027
   Sporri B, 1996, CYTOKINE, V8, P631, DOI 10.1006/cyto.1996.0084
   Wan S, 1997, CHEST, V112, P676, DOI 10.1378/chest.112.3.676
   Wendel HP, 1999, EUR J CARDIO-THORAC, V16, P342, DOI 10.1016/S1010-7940(99)00210-9
   Zimmermann R, 1996, BIOTECHNIQUES, V21, P824
NR 36
TC 11
Z9 11
U1 0
U2 2
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JUL
PY 2001
VL 56
IS 1
BP 1
EP 8
DI 10.1002/1097-4636(200107)56:1<1::AID-JBM1024>3.0.CO;2-C
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 431AB
UT WOS:000168608600001
PM 11405188
DA 2018-10-20
ER

PT J
AU Koob, TJ
   Willis, TA
   Qiu, YS
   Hernandez, DJ
AF Koob, TJ
   Willis, TA
   Qiu, YS
   Hernandez, DJ
TI Biocompatibility of NDGA-polymerized collagen fibers. II. Attachment,
   proliferation, and migration of tendon fibroblasts in vitro
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE biomaterials; tendon; NDGA; fibroblasts; polymerization; bioprosthesis
ID FLEXOR TENDON; REPAIR; RECONSTRUCTION; LIGAMENT; GRAFTS; DOGS
AB The material properties of collagen fibers polymerized with nordihydroguaiaretic acid (NDGA) are equivalent to native tendon, suggesting that NDGA crosslinking may provide a viable approach to stabilizing collagenous materials for use in repairing ruptured, lacerated, or surgically transected fibrous tissues, such as tendons and ligaments (Koob & Hemandez, Biomaterials, in press). The present study evaluated the biocompatibility of these fibers with cultured bovine tendon fibroblasts. Fibroblast attachment, migration, and proliferation on NDGA-crosslinked materials were compared to those on prepolymerized type I tendon collagen constructs as well as on tissue-culture-treated plastic. Fibroblast attachment on NDGA-crosslinked collagen fibrils was equivalent to attachment on plates coated with collagen alone. Over a period of 8 days in culture, attached fibroblasts proliferated on NDGA-crosslinked collagen at a rate identical to that of fibroblasts attached to native collagen, in order for the biomaterial effectively to bridge gaps in fibrous tissues, fibroblasts must be able to migrate and replicate on the bridging fiber. Control and crosslinked fibers were inserted in calf tendon explants, with a portion of the fiber extending out of the sectioned end of the tendon. Explants were cultured for 9 weeks, and the number of cells was measured at weekly intervals. Cells appeared on the fibers after 1 week of culture. By 2 weeks, cells had colonized the entire fiber. The number of cells continued to increase throughout the 9 weeks in culture, forming a layer several cells thick. Histologic analysis indicated that the fibroblasts populating the fibers appeared to originate in the epitenon. There was no difference in the rate of fibroblast migration and replication, nor in the ultimate number of colonizing cells, between control collagen fibers and NDGA-crosslinked fibers. NDGA-crosslinked fibers may provide a means of bridging gaps in ruptured, lacerated, or surgically transected tendons by providing a mechanically competent scaffold on which tendon fibroblasts can migrate, attach, and proliferate. (C) 2001 John Wiley & Sons, Inc.
C1 Shriners Hosp Children, Ctr Res Skeletal Dev & Pediat Orthopaed, Skeletal Biol Sect, Tampa, FL 33612 USA.
RP Koob, TJ (reprint author), Shriners Hosp Children, Ctr Res Skeletal Dev & Pediat Orthopaed, Skeletal Biol Sect, 12502 N Pine Dr, Tampa, FL 33612 USA.
CR ABRAHAMSSON SO, 1995, J ORTHOPAED RES, V13, P58, DOI 10.1002/jor.1100130110
   ABRAHAMSSON SO, 1994, J HAND SURG-AM, V19A, P259, DOI 10.1016/0363-5023(94)90016-7
   AMIEL D, 1995, J ORTHOPAED RES, V13, P459, DOI 10.1002/jor.1100130321
   AOKI M, 1994, J HAND SURG-AM, V19A, P984, DOI 10.1016/0363-5023(94)90102-3
   ARK JW, 1994, J HAND SURG-AM, V19A, P249, DOI 10.1016/0363-5023(94)90015-9
   Awad HA, 1999, TISSUE ENG, V5, P267, DOI 10.1089/ten.1999.5.267
   BECKER H, 1981, J HAND SURG-AM, V6, P616, DOI 10.1016/S0363-5023(81)80146-3
   Butler DL, 1999, CLIN ORTHOP RELAT R, pS324
   DOCKERY G L, 1986, Journal of Foot Surgery, V25, P469
   DUNN MG, 1993, J BIOMED MATER RES, V27, P1545, DOI 10.1002/jbm.820271211
   GELBERMAN R H, 1984, Journal of Orthopaedic Research, V2, P39, DOI 10.1002/jor.1100020107
   GELBERMAN RH, 1992, J BONE JOINT SURG AM, V74A, P1207, DOI 10.2106/00004623-199274080-00011
   GELBERMAN RH, 1992, J HAND SURG-AM, V17A, P551, DOI 10.1016/0363-5023(92)90370-5
   GOLDSTEIN JD, 1989, J BONE JOINT SURG AM, V71A, P1183, DOI 10.2106/00004623-198971080-00010
   Huang LLH, 1998, J BIOMED MATER RES, V42, P568, DOI 10.1002/(SICI)1097-4636(19981215)42:4<568::AID-JBM13>3.0.CO;2-7
   HUNTER JM, 1988, J HAND SURG-AM, V13A, P849, DOI 10.1016/0363-5023(88)90259-6
   IANNACE S, 1995, BIOMATERIALS, V16, P675, DOI 10.1016/0142-9612(95)99693-G
   KAIN CC, 1988, J ORTHOPAED RES, V6, P871, DOI 10.1002/jor.1100060611
   KATO YP, 1989, BIOMATERIALS, V10, P38, DOI 10.1016/0142-9612(89)90007-0
   KATO YP, 1991, J BONE JOINT SURG AM, V73A, P561, DOI 10.2106/00004623-199173040-00013
   KOOB TJ, IN PRESS BIOCOMPATIB, V1
   KOOB TJ, IN PRESS BIOMATERIAL
   Lundborg G, 1978, J Hand Surg Am, V3, P21
   LUNDBORG G, 1980, HAND, V12, P3, DOI 10.1016/S0072-968X(80)80023-4
   MANSKE PR, 1984, J BONE JOINT SURG AM, V66A, P385, DOI 10.2106/00004623-198466030-00011
   MANSKE PR, 1984, J HAND SURG-BRIT EUR, V9B, P117, DOI 10.1016/S0266-7681(84)80005-4
   MANSKE PR, 1984, CLIN ORTHOP RELAT R, P297
   MCMASTER WC, 1986, B HOSP JOINT DIS ORT, V46, P174
   MENDES DG, 1986, J BIOMED MATER RES, V20, P699, DOI 10.1002/jbm.820200604
   MILTHORPE BK, 1994, BIOMATERIALS, V15, P745, DOI 10.1016/0142-9612(94)90027-2
   Noguchi M, 1997, J HAND SURG-AM, V22A, P457, DOI 10.1016/S0363-5023(97)80013-5
   ROE S C, 1992, Clinical Materials, V9, P149, DOI 10.1016/0267-6605(92)90094-A
   ROGERS GT, 1995, BIOMATERIALS, V16, P803, DOI 10.1016/0142-9612(95)99643-Z
   RUSSELL JE, 1990, J ORTHOPAED RES, V8, P13, DOI 10.1002/jor.1100080103
   SEILER JG, 1995, J HAND SURG-AM, V20A, P492, DOI 10.1016/S0363-5023(05)80115-7
   SEILER JG, 1993, J BONE JOINT SURG AM, V75A, P1004, DOI 10.2106/00004623-199307000-00006
   SMITH DJ, 1986, J HAND SURG-AM, V11A, P97, DOI 10.1016/S0363-5023(86)80114-9
   Strickland JW, 2000, J HAND SURG-AM, V25A, P214
   Sung HW, 2000, BIOMATERIALS, V21, P1353, DOI 10.1016/S0142-9612(00)00017-X
   Woo SLY, 1999, CLIN ORTHOP RELAT R, pS312
   YOUNG RG, 1940, J ORTHOPAED RES, P16
NR 41
TC 37
Z9 37
U1 1
U2 7
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JUL
PY 2001
VL 56
IS 1
BP 40
EP 48
DI 10.1002/1097-4636(200107)56:1<40::AID-JBM1066>3.3.CO;2-9
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 431AB
UT WOS:000168608600006
PM 11309789
DA 2018-10-20
ER

PT J
AU Hung, WS
   Fang, CL
   Su, CH
   Lai, WFT
   Chang, YC
   Tsai, YH
AF Hung, WS
   Fang, CL
   Su, CH
   Lai, WFT
   Chang, YC
   Tsai, YH
TI Cytotoxicity and immunogenicity of SACCHACHITIN and its mechanism of
   action on skin wound healing
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE SACCHACHITIN; wound healing; inflammatory effect; chemotactic effect;
   angiogenesis; granulation tissue; scar formation
ID FUNGAL MYCELIA; SUBSTITUTES; TISSUE
AB SACCHACHITIN membrane, a weavable skin substitute made from the residual fruiting body of Ganoderma tsugae, has been demonstrated to promote skin wound healing. Prior to its clinical application, it is critical to learn more about any possible cytotoxicity, immunogenicity, or allergy response, and at least some of its mechanism(s) of action(s). In the present studies, it has been found that SACCHACHITIN suspension at less than 0.05% shows no cytotoxicity to the primary culture of rat fibroblasts. However, at higher concentrations (greater than or equal to0.1%), it does reduce the growth of fibroblasts, based on MTT assays. This might be caused by positive charges on chitin molecules that are too strong, and may be harmful to the cell membrane. SACCHACHITIN showed no immunogenicity after it was inoculated into rats three times; however, the unmodified, purified rabbit type I and type II collagens did. Subcutaneous injection of SACCHACHITIN suspension into rats showed no gross allergic responses on skin. Nevertheless, it did cause local acute inflammation, as observed by histological investigation. This is similar to what occurred in the wound site covered with SACCHACHITIN membrane. The chemotactic effect of SACCHACHITIN was exhibited in both intact and wounded skin tissues. This may be one of the initial beneficial effects of SACCHACHITIN membrane to wound healing. The rapid acute inflammatory process was followed by the appearance of angiogenesis and granulation tissue formation, which occurred earlier than it normally would. Coverage of the wound area with SACCHACHITIN membrane also induced an earlier formation of scar tissue to replace the granulation tissue. A 1.5 x 1.5 cm(2) wound area covered by SACCHACHITIN completely healed by 21 days, while that covered with cotton gauze did not. Therefore, SACCHACHITIN is a safe biomaterial for use as a wound dressing for skin healing. Its promoting action for wound healing might be due to its chemotactic effect for inflammatory cells. This, in turn, may facilitate subsequent angiogenesis, granulation tissue formation, and faster new tissue formation, leading to faster wound healing. (C) 2001 John Wiley & Sons, Inc.
C1 Taipei Med Univ, Grad Inst Cell & Mol Biol, Taipei 110, Taiwan.
   Taipei Med Univ, Dept Pathol, Taipei 110, Taiwan.
   Taipei Med Univ, Grad Inst Biomed Mat, Taipei 110, Taiwan.
   Taipei Med Univ, Grad Inst Med Sci, Taipei 110, Taiwan.
RP Tsai, YH (reprint author), Taipei Med Univ, Grad Inst Cell & Mol Biol, 250 Wu Hsing St, Taipei 110, Taiwan.
RI leu, borwen/K-8547-2012
CR ARTURO T, 1976, SURG GYNECOL OBSTET, V142, P537
   BLACK J, 1984, BIOMATERIALS, V5, P11, DOI 10.1016/0142-9612(84)90061-9
   BLACK J, 1981, BIOL PERFORMANCE MAT
   CHUNG LY, 1994, J BIOMED MATER RES, V28, P463, DOI 10.1002/jbm.820280409
   Clark RA., 1995, MOL CELLULAR BIOL WO, P3
   Damsky Caroline H., 1992, Current Opinion in Cell Biology, V4, P772, DOI 10.1016/0955-0674(92)90100-Q
   HUNT TK, 1979, WOUND HEALING WOUND
   KALLUS T, 1983, J BIOMED MATER RES, V17, P741, DOI 10.1002/jbm.820170503
   KURKINEN M, 1980, LAB INVEST, V43, P47
   LEOF EB, 1986, P NATL ACAD SCI USA, V83, P2453, DOI 10.1073/pnas.83.8.2453
   MERRITT K, 1984, BIOMATERIALS, V5, P47, DOI 10.1016/0142-9612(84)90066-8
   NATHAN C, 1991, J CELL BIOL, V113, P981, DOI 10.1083/jcb.113.5.981
   ROBBIN SL, 1979, PATHOLOGIC BASIC DIS
   Su CH, 1997, BIOMATERIALS, V18, P1169, DOI 10.1016/S0142-9612(97)00048-3
   Su CH, 1999, BIOMATERIALS, V20, P61, DOI 10.1016/S0142-9612(98)00139-2
NR 15
TC 24
Z9 25
U1 1
U2 6
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JUL
PY 2001
VL 56
IS 1
BP 93
EP 100
DI 10.1002/1097-4636(200107)56:1<93::AID-JBM1072>3.0.CO;2-B
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 431AB
UT WOS:000168608600012
PM 11309795
DA 2018-10-20
ER

PT J
AU Billiar, K
   Murray, J
   Laude, D
   Abraham, G
   Bachrach, N
AF Billiar, K
   Murray, J
   Laude, D
   Abraham, G
   Bachrach, N
TI Effects of carbodiimide crosslinking conditions on the physical
   properties of laminated intestinal submucosa
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE repair biomaterial; collagen; crosslinking; mechanical properties;
   multilayer composite
ID DERMAL SHEEP COLLAGEN; WATER-SOLUBLE CARBODIIMIDE; ABDOMINAL-WALL;
   CROSS-LINKING; BOVINE PERICARDIUM; DOG-MODEL; REPAIR; GLUTARALDEHYDE;
   BIOPROSTHESES; MESH
AB Functional tissue engineering of load-bearing repair tissues requires the design and production of biomaterials that provide a remodelable scaffold for host infiltration and tissue regeneration while maintaining the repair function throughout the remodeling process. Layered constructs have been fabricated from chemically and mechanically cleaned porcine intestinal collagen using ethyl-3(3dimethylamino) propyl carbodiimide (EDC) and an acetone solvent. By varying the concentration of the crosslinker from 1 to 10 mM and the solvent from 0 to 90% acetone, the strength, stiffness, maximum strain, thermal stability, lamination strength, and suture retention strength can be adjusted. These parameters have either functional importance or the potential to modify the remodeling kinetics, or they have both. This study investigates the interdependence of these parameters, the specific effects that variations in concentration can achieve, and how the two crosslinking variables interact. The results demonstrate that there is substantial latitude in the design of these constructs by these straightforward crosslinking modifications. These data provide the basis for studying the in vivo response to crosslinking conditions that will supply the requisite strength while still allowing host cell infiltration and remodeling. (C) 2001 John Wiley & Sons, Inc.
C1 Organogenesis Inc, Canton, MA 02021 USA.
RP Bachrach, N (reprint author), Organogenesis Inc, 150 Dan Rd, Canton, MA 02021 USA.
CR ABRAHAM G, 1999, SOC BIOMATER, V22, P589
   Abraham GA, 2000, J BIOMED MATER RES, V51, P442, DOI 10.1002/1097-4636(20000905)51:3<442::AID-JBM19>3.3.CO;2-W
   BADYLAK S, 1998, TISSUE ENG, V42, P379
   BADYLAK SF, 1995, J BIOMED MATER RES, V29, P977, DOI 10.1002/jbm.820290809
   BADYLAK SF, 1994, J VASC SURG, V19, P465, DOI 10.1016/S0741-5214(94)70073-7
   CHEUNG DT, 1985, CONNECT TISSUE RES, V13, P109, DOI 10.3109/03008208509152389
   Choi YS, 1999, BIOMATERIALS, V20, P409, DOI 10.1016/S0142-9612(98)00180-X
   Clarke KM, 1996, J SURG RES, V60, P107, DOI 10.1006/jsre.1996.0018
   Cobb MA, 1996, SURG NEUROL, V46, P389, DOI 10.1016/S0090-3019(96)00202-9
   Damink LHHO, 1996, BIOMATERIALS, V17, P679, DOI 10.1016/0142-9612(96)86737-8
   Damink LHHO, 1996, BIOMATERIALS, V17, P765, DOI 10.1016/0142-9612(96)81413-X
   FISHER J, 1987, LIFE SUPPORT SYST, V5, P189
   GABELLA G, 1987, CELL TISSUE RES, V248, P491, DOI 10.1007/BF00216474
   Goissis G, 1999, BIOMATERIALS, V20, P27, DOI 10.1016/S0142-9612(97)00198-1
   GOLOMB G, 1987, AM J PATHOL, V127, P122
   HILES MC, 1995, J BIOMED MATER RES, V29, P883, DOI 10.1002/jbm.820290714
   Jayakrishnan A, 1996, BIOMATERIALS, V17, P471, DOI 10.1016/0142-9612(96)82721-9
   Kemp P D, 1995, Tissue Eng, V1, P71, DOI 10.1089/ten.1995.1.71
   Khor E, 1997, BIOMATERIALS, V18, P95, DOI 10.1016/S0142-9612(96)00106-8
   Klinge U, 1998, EUR J SURG, V164, P951
   Kropp BP, 1996, J UROLOGY, V156, P599, DOI 10.1016/S0022-5347(01)65761-6
   Lantz G C, 1993, J Invest Surg, V6, P297, DOI 10.3109/08941939309141619
   LAUN A, 1990, ACTA NEUROCHIR, V107, P16, DOI 10.1007/BF01402607
   MATLOUB HS, 1992, ANN PLAS SURG, V29, P508, DOI 10.1097/00000637-199212000-00005
   MATSUMOTO T, 1966, ANN SURG, V164, P845
   ORBERG J, 1983, CONNECT TISSUE RES, V11, P285, DOI 10.3109/03008208309004861
   PREVEL CD, 1995, ANN PLAS SURG, V35, P374, DOI 10.1097/00000637-199510000-00008
   QUILICI PJ, 1985, SURG GYNECOL OBSTET, V161, P47
   SCHOEN FJ, 1994, J CARDIAC SURG, V9, P222, DOI 10.1111/j.1540-8191.1994.tb00932.x
   SCHOEN FJ, 1991, SECONDARY CALCIFICAT, P125
   TROWBRIDGE EA, 1989, CRIT REV BIOCOMPAT, V5, P105
   VANWACHEM PB, 1994, INT J ARTIF ORGANS, V17, P230
   Whitson BA, 1998, J BIOMED MATER RES, V43, P277, DOI 10.1002/(SICI)1097-4636(199823)43:3<277::AID-JBM8>3.3.CO;2-M
   Zeeman R, 1999, BIOMATERIALS, V20, P921, DOI 10.1016/S0142-9612(98)00242-7
NR 34
TC 73
Z9 77
U1 0
U2 19
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JUL
PY 2001
VL 56
IS 1
BP 101
EP 108
DI 10.1002/1097-4636(200107)56:1<101::AID-JBM1074>3.0.CO;2-6
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 431AB
UT WOS:000168608600013
PM 11309796
DA 2018-10-20
ER

PT J
AU Ram, J
   Pandey, SK
   Apple, DJ
   Werner, L
   Brar, GS
   Singh, R
   Chaudhary, KP
   Gupta, A
AF Ram, J
   Pandey, SK
   Apple, DJ
   Werner, L
   Brar, GS
   Singh, R
   Chaudhary, KP
   Gupta, A
TI Effect of in-the-bag intraocular lens fixation on the prevention of
   posterior capsule opacification
SO JOURNAL OF CATARACT AND REFRACTIVE SURGERY
LA English
DT Article; Proceedings Paper
CT 56th All India Ophthalmological-Society Conference
CY FEB, 1998
CL GAUHATI, INDIA
SP All India Ophthalmol Soc
ID 75 AUTOPSY EYES; SURGICAL PREVENTION; CATARACT-SURGERY; PART 1;
   POLYMETHYLMETHACRYLATE; SILICONE; SERIES; DECENTRATION; BARRIER; UPDATE
AB Purpose: To compare the incidence of posterior capsule opacification (PCO) after extracapsular cataract extraction (ECCE) and phacoemulsification and to evaluate the role of posterior chamber intraocular lens (PC IOL) haptic fixation and biomaterial/design in reducing the incidence.
   Setting: Postgraduate Institute of Medical Education and Research, Chandigarh, India; Center for Research on Ocular Therapeutics and Biodevices, Storm Eye Institute, Medical University of South Carolina, Charleston, South Carolina, USA.
   Methods. This study comprised 278 eyes of 263 patients having ECCE and 318 eyes of 297 patients having phacoemulsification with PC IOL implantation. Posterior capsule opacification leading to a decrease in Snellen visual acuity of 2 or more lines was considered visually significant. The presence of PCO and IOL haptic fixation were evaluated postoperatively using slitlamp biomicroscopy. Haptic position was noted as in-the-bag (B-B), 1 haptic in the bag and 1 in the sulcus (bag-sulcus [B-S]), or both haptics out of the bag (sulcus-sulcus [S-S]). In addition, the rate of visually significant PCO was compared among 3 IOL biomaterials: poly(methyl methacrylate), silicone, and hydrophobic acrylic.
   Results: Visually significant PCO occurred in 42.45% of eyes having ECCE and 19.18% of eyes having phacoemulsification (P < .001, chi-square test) after a mean follow-up of 2.4 years +/- 0.7 (SID). In both groups, visually significant PCO was significantly less in eyes with B-B fixation than in those with B-S or S-S fixation (P < .001). The rate of visually significant PCO in all eyes in the phacoemulsification group with B-B fixation was low (11.90%) and was significantly lower in eyes with a hydrophobic acrylic IOL (2.22%; P < .05, chi-square test).
   Conclusions. In-the-bag PC IOL fixation is required to consistently reduce the incidence of PCO. Thorough removal of lens substance, including hydrodissection-assisted cortical cleanup, and in-the-bag PC IOL fixation seem to be the most important factors in reducing PCO, regardless of surgical procedure or IOL type used. Intraocular lens biomaterial and design also help prevent PCO. (C) 2001 ASCRS and ESCRS.
C1 Postgrad Inst Med Educ & Res, Dept Ophthalmol, Chandigarh 160012, India.
   Indira Gandhi Med Coll Shimla, Shimla, India.
   Med Univ S Carolina, Storm Eye Inst, Ctr Res Ocular Therapeut & Biodevices, Charleston, SC 29425 USA.
RP Ram, J (reprint author), Postgrad Inst Med Educ & Res, Dept Ophthalmol, Chandigarh 160012, India.
OI Gupta, Amod/0000-0001-8427-5738
CR Apple D J, 1985, J Am Intraocul Implant Soc, V11, P44
   Apple D. J., 2000, FOLDABLE INTRAOCULAR
   APPLE DJ, 1992, SURV OPHTHALMOL, V37, P73, DOI 10.1016/0039-6257(92)90073-3
   APPLE DJ, 1984, SURV OPHTHALMOL, V29, P1, DOI 10.1016/0039-6257(84)90113-9
   Apple DJ, 1999, OPHTHALMOLOGY, V106, P1861, DOI 10.1016/S0161-6420(99)90393-7
   Apple DJ, 2001, OPHTHALMOLOGY, V108, P505, DOI 10.1016/S0161-6420(00)00589-3
   APPLE DJ, 1986, J CATARACT REFR SURG, V12, P358, DOI 10.1016/S0886-3350(86)80095-5
   Apple DJ, 2000, J CATARACT REFR SURG, V26, P180, DOI 10.1016/S0886-3350(99)00353-3
   APPLE DJ, 2000, SURV OPHTHALMOL S1, V45, P451
   HANSEN SO, 1988, OPHTHALMOLOGY, V95, P344
   Hayashi H, 1998, ARCH OPHTHALMOL-CHIC, V116, P1579, DOI 10.1001/archopht.116.12.1579
   Hollick EJ, 1999, OPHTHALMOLOGY, V106, P49, DOI 10.1016/S0161-6420(99)90047-7
   Linnola RJ, 2000, J CATARACT REFR SURG, V26, P1792, DOI 10.1016/S0886-3350(00)00748-3
   LINNOLA RJ, 2000, J CATARACT REFR SURG, V26, P1087
   LINNOLA RJ, 1997, J CATARACT REFR SURG, V23, P527
   MIYAKE K, 1984, AM J OPHTHALMOL, V98, P451, DOI 10.1016/0002-9394(84)90130-2
   MIYAKE K, 1984, OPHTHALMIC SURG LAS, V15, P658
   Nagata T, 1998, J CATARACT REFR SURG, V24, P367, DOI 10.1016/S0886-3350(98)80325-8
   Nishi O, 1999, J CATARACT REFR SURG, V25, P106, DOI 10.1016/S0886-3350(99)80020-0
   Oshika T, 1998, BRIT J OPHTHALMOL, V82, P549, DOI 10.1136/bjo.82.5.549
   Oshika T, 1996, J CATARACT REFR SURG, V22, P104, DOI 10.1016/S0886-3350(96)80278-1
   PARK SB, 1986, J CATARACT REFR SURG, V12, P363, DOI 10.1016/S0886-3350(86)80096-7
   Peng Q, 2000, J CATARACT REFR SURG, V26, P198, DOI 10.1016/S0886-3350(99)00352-1
   Peng Q, 2000, J CATARACT REFR SURG, V26, P188, DOI 10.1016/S0886-3350(99)00354-5
   Ram J, 1999, OPHTHALMOLOGY, V106, P883, DOI 10.1016/S0161-6420(99)00505-9
   Ram J, 1999, OPHTHALMOLOGY, V106, P891, DOI 10.1016/S0161-6420(99)00506-0
   Schaumberg DA, 1998, OPHTHALMOLOGY, V105, P1213, DOI 10.1016/S0161-6420(98)97023-3
   Tetz MR, 1999, J CATARACT REFR SURG, V25, P1662, DOI 10.1016/S0886-3350(99)00259-X
   TETZ MR, 1988, J CATARACT REFR SURG, V14, P614, DOI 10.1016/S0886-3350(88)80028-2
   Ursell PG, 1998, J CATARACT REFR SURG, V24, P352, DOI 10.1016/S0886-3350(98)80323-4
   Werner L, 2000, CATARACT SURG COMPLI, P399
NR 31
TC 50
Z9 52
U1 0
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA
SN 0886-3350
J9 J CATARACT REFR SURG
JI J. Cataract. Refract. Surg.
PD JUL
PY 2001
VL 27
IS 7
BP 1039
EP 1046
DI 10.1016/S0886-3350(00)00841-5
PG 8
WC Ophthalmology; Surgery
SC Ophthalmology; Surgery
GA 459VK
UT WOS:000170272000025
PM 11489573
DA 2018-10-20
ER

PT J
AU Chiou, SH
   Wu, WT
   Huang, YY
   Chung, TW
AF Chiou, SH
   Wu, WT
   Huang, YY
   Chung, TW
TI Effects of the characteristics of chitosan on controlling drug release
   of chitosan coated PLLA microspheres
SO JOURNAL OF MICROENCAPSULATION
LA English
DT Article
DE chitosan; PLLA; microsphere; controlled drug release
ID WALLED POLYMER MICROSPHERES; IN-VIVO DEGRADATION; CONTROLLED DELIVERY;
   PREPARED CAPSULE; CHITIN; MOLECULES; MEMBRANES; LYSOZYME; INVITRO;
   COMPLEX
AB Chitosan has been shown to be a biomaterial with good biocompatibility, and is highly biodegradable. This study investigated the effect of post-coating PLLA microspheres with different chitosans on the initial burst and controlling the drug release of the microspheres. Without chitosan, 19.2% of encapsulated lidocaine would release from PLLA microspheres within the first hour. (R-1), and the time of 50% release. (T-50) was 25 h. After the microspheres were coated with chitosan of viscosity. (eta) 384 +/- 10 cp, R-1 and T-50 could be reduced and prolonged to 14.6% and 90 h, respectively, for all tested molecular weights (Mw) of chitosan. In the case of the same Mw of chitosan being applied, the efficacy of reducing the initial burst of drug release was higher for a lower degree of deacetylation (D.D.). With chitosan in acetic acid solution, coating the microspheres with high Mw and high viscosity could most effectively reduce the initial burst and control drug release of PLLA microspheres. For example, the microspheres coated with chitosan solution of Mw 800 kDa and eta of 1479 cp, R-1 and T-50 could be reduced and prolonged to 7.4% and 245 h, respectively. The study indicated that manipulating the viscosity of the chitosan solution was the most important factor in contributing to controlling the drug release of chitosan post-coated PLLA microspheres.
C1 Chung Yuan Christian Univ, Dept Biomed Engn, Chungli, Taiwan.
   Natl Taiwan Univ, Inst Biomed Engn, Taipei 10764, Taiwan.
   Natl Tsing Hua Univ, Dept Chem Engn, Hsinchu, Taiwan.
RP Chung, TW (reprint author), Chung Yuan Christian Univ, Dept Biomed Engn, Chungli, Taiwan.
CR AKBUGA J, 1994, INT J PHARM, V111, P217, DOI 10.1016/0378-5173(94)90344-1
   CHANDY T, 1992, BIOMATERIALS, V13, P949, DOI 10.1016/0142-9612(92)90119-9
   CHANDY T, 1990, BIOMATER ARTIF CELL, V18, P1, DOI 10.3109/10731199009117286
   Chang SJ, 1996, PLANT MOL BIOL, V31, P693, DOI 10.1007/BF00042242
   CHEN RH, 1994, CARBOHYD POLYM, V24, P41, DOI 10.1016/0144-8617(94)90115-5
   Chen RH, 1997, J APPL POLYM SCI, V66, P161, DOI 10.1002/(SICI)1097-4628(19971003)66:1<161::AID-APP19>3.0.CO;2-4
   Chen RH, 1996, CARBOHYD POLYM, V31, P141, DOI 10.1016/S0144-8617(96)00047-1
   Chung TW, 1998, DIABETIC MED, V15, P380, DOI 10.1002/(SICI)1096-9136(199805)15:5<380::AID-DIA592>3.3.CO;2-#
   GEOLWSKI S, 1993, J BIOMEDICAL MAT RES, V27, P1135
   Gupta RK, 1997, VACCINE, V15, P1716, DOI 10.1016/S0264-410X(97)00116-3
   HIRANO S, 1989, AGR BIOL CHEM TOKYO, V53, P3065, DOI 10.1080/00021369.1989.10869777
   Huang YY, 1999, INT J PHARM, V182, P93, DOI 10.1016/S0378-5173(99)00060-5
   Jameela SR, 1998, J CONTROL RELEASE, V52, P17, DOI 10.1016/S0168-3659(97)00187-9
   JAMEELA SR, 1995, BIOMATERIALS, V16, P769, DOI 10.1016/0142-9612(95)99639-4
   Kreitz MR, 1997, BIOMATERIALS, V18, P1645, DOI 10.1016/S0142-9612(97)00106-3
   Leach KJP, 1998, BIOMATERIALS, V19, P1981
   LEHR CM, 1992, INT J PHARM, V78, P43, DOI 10.1016/0378-5173(92)90353-4
   Mi FL, 1997, J APPL POLYM SCI, V66, P2495, DOI 10.1002/(SICI)1097-4628(19971226)66:13<2495::AID-APP12>3.0.CO;2-X
   MUZZARELLI R, 1990, ANTIMICROB AGENTS CH, V34, P2019, DOI 10.1128/AAC.34.10.2019
   OKAMOTO Y, 1993, J VET MED SCI, V55, P743, DOI 10.1292/jvms.55.743
   PANGBURN SH, 1982, BIOMATERIALS, V3, P105, DOI 10.1016/0142-9612(82)90043-6
   PEKAREK KJ, 1994, NATURE, V367, P258, DOI 10.1038/367258a0
   POLK AE, 1994, AQUACULT ENG, V13, P311, DOI 10.1016/0144-8609(94)90018-3
   SEZER AD, 1995, INT J PHARM, V121, P113, DOI 10.1016/0378-5173(94)00413-Y
   SHIRAISHI S, 1993, J CONTROL RELEASE, V25, P217, DOI 10.1016/0168-3659(93)90080-O
   Singh DK, 1999, J MEMBRANE SCI, V155, P107, DOI 10.1016/S0376-7388(98)00311-1
   SINGH PC, 1996, CHEM ENG PROCESS, V35, P342
   Yamamoto H, 1997, MACROMOLECULES, V30, P3936, DOI 10.1021/ma961766f
   YAMAMOTO H, 1984, MACROMOLECULAR CHEM, V186, P1613
   Yang YY, 2000, CHEM ENG SCI, V55, P2223, DOI 10.1016/S0009-2509(99)00503-5
   YAO KD, 1995, J MACROMOL SCI R M C, VC35, P155, DOI 10.1080/15321799508014592
NR 31
TC 35
Z9 37
U1 5
U2 21
PU TAYLOR & FRANCIS LTD
PI LONDON
PA 11 NEW FETTER LANE, LONDON EC4P 4EE, ENGLAND
SN 0265-2048
J9 J MICROENCAPSUL
JI J. Microencapsul.
PD JUL
PY 2001
VL 18
IS 5
BP 613
EP 625
PG 13
WC Chemistry, Applied; Engineering, Chemical; Pharmacology & Pharmacy
SC Chemistry; Engineering; Pharmacology & Pharmacy
GA 459FM
UT WOS:000170240400007
PM 11508767
DA 2018-10-20
ER

PT J
AU Kojima, Y
AF Kojima, Y
TI Project of platform science and technology for advanced magnesium alloys
SO MATERIALS TRANSACTIONS
LA English
DT Article
DE advanced magnesium alloys; platform science; platform technology;
   microstructure control; surface modification; ecomaterial; environmental
   burden; structural space material; new functionality; biomaterial
AB The four year project on "Platform Science and Technology for Advanced Magnesium-Alloys" started in September 1999 with financial support from the Ministry of Education, Science, Sports and Culture of Japan. The project members consisting mainly of Professors in Japanese Universities are going to make various efforts for the advancement of studies on magnesium alloys. The background and concept of the research project is described, and then the contents and practical activities of the group are briefly explained.
C1 Nagaoka Univ Technol, Dept Mech Engn, Nagaoka, Niigata 9402188, Japan.
RP Kojima, Y (reprint author), Nagaoka Univ Technol, Dept Mech Engn, Nagaoka, Niigata 9402188, Japan.
CR AGHION E, 1998, P 1 ISR INT C MAGN S, P1
   AGHION E, 2000, P 2 ISR INT C MAGN S, P1
   Aizawa T, 1999, J ALLOY COMPD, V291, P248, DOI 10.1016/S0925-8388(99)00263-7
   AIZAWA T, 1999, J JAPAN SOC POWDER P, V46, P1097
   BAKER C, 1987, MAGNESIUM TECHNOLOGY, P1
   EMLEY EF, 1966, PRINCIPLES MAGNESIUM, P25
   KAMADO S, 1999, MAT JAPAN, V38, P285
   KOJIMA Y, 2000, MAGNESIUM ALLOYS 200, V350, P1
   LORIMER GW, 1997, P 3 INT MAGN C, P1
   Mabuchi M, 1997, SCRIPTA MATER, V36, P681, DOI 10.1016/S1359-6462(96)00444-7
   Mabuchi M, 1997, MATER SCI TECH SER, V13, P825, DOI 10.1179/mst.1997.13.10.825
   Mordike B. L., 2000, MAGNESIUM EIGENSCHAF, P1
   MORDIKE BL, 1998, MAGNESIUM ALLOYS THE, P1
   MORDIKE BL, 1992, MAGNESIUM ALLOYS THE, P1
   POLMEAR IJ, 1995, LIGHT ALLOYS, P17
   Yamada Y, 1999, J MATER SCI LETT, V18, P1477, DOI 10.1023/A:1006677930532
   Yamada Y, 1999, MAT SCI ENG A-STRUCT, V272, P455, DOI 10.1016/S0921-5093(99)00484-0
NR 17
TC 95
Z9 123
U1 0
U2 17
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD JUL
PY 2001
VL 42
IS 7
BP 1154
EP 1159
DI 10.2320/matertrans.42.1154
PG 6
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 462EW
UT WOS:000170408600002
OA Bronze
DA 2018-10-20
ER

PT J
AU Kuwahara, H
   Al-Abdullat, Y
   Mazaki, N
   Tsutsumi, S
   Aizawa, T
AF Kuwahara, H
   Al-Abdullat, Y
   Mazaki, N
   Tsutsumi, S
   Aizawa, T
TI Precipitation of magnesium apatite on pure magnesium surface during
   immersing in Hank's solution
SO MATERIALS TRANSACTIONS
LA English
DT Article
DE biomaterial; artificial bone design; precipitation; magnesium apatite;
   heat treatment; Hank's solution
AB A new artificial bone concept by magnesium alloys is proposed to think much importance on its homogenization with a surrounding natural hard and soft tissue. Magnesium is an essential element for human body, so that magnesium bone implants can be expected to be toxicity free even though magnesium dissolved into human soft tissue. In addition, magnesium base artificial bone has vivo-adaptively to growing bone cells once vivo-coating is formed on the surface of magnesium in the inside of soft tissue. In the present paper, its chemical behavior in Hank's solution (HBSS (+)) is described to simulate biochemical reactions of magnesium in the human body. An effect of heat treatment of magnesium on its chemical behavior is also investigated. Specimens of 10 x 20 x 2 mm(3) were used for examining chemical behaviors of commercial grade pure magnesium (3N-Mg) in a HBSS (+) for various holding time (25-700h). Specific mass gain of each specimen was measured, the surface microstructure was observed by a scanning electron microscope, identification of reaction products were examined by x-ray diffraction measurements. Chemical compositions of reaction products were also analyzed by an energy dispersion x-ray spectrometry. Mass change of heat-treated 3N-Mg, which was heat-treated at 803 K for 90 ks increased with immersing time in HBSS (+) though that of other heat-treated 3N-Mg unstably decreased in HBSS (+). Magnesium reacted with HBSS (+) and then a magnesium apatite was precipitated on the heat-treated 3N-Mg specimen surface. The magnesium apatite should be described as (Ca0.86Mg0.14)(10)(PO4)(6)(OH)(2).
C1 Res Inst Appl Sci, Kyoto 6068202, Japan.
   Kyoto Univ, Grad Sch Engn, Kyoto 6068507, Japan.
   Kyoto Univ, Inst Frontier Med Sci, Kyoto 6068507, Japan.
   Univ Tokyo, Adv Sci & Technol Res Ctr, Tokyo 1538904, Japan.
RP Kuwahara, H (reprint author), Res Inst Appl Sci, Kyoto 6068202, Japan.
CR Kawamura Y, 2000, MATER SCI FORUM, V350-3, P111, DOI 10.4028/www.scientific.net/MSF.350-351.111
   KAWAMURA Y, 2000, MATER SCI FORUM, V3500, P117
   Kim HM, 1997, J CERAM SOC JPN, V105, P111, DOI 10.2109/jcersj.105.111
   Koike J, 2000, MATER SCI FORUM, V350-3, P105, DOI 10.4028/www.scientific.net/MSF.350-351.105
   KOKUBO T, 1983, CHEM IND, V36, P533
   KOKUBO T, 1999, MAT INTEGRATION, V12, P39
   KUROKAWA M, 1994, J JPN PLASTIC RECONS, V16, P75
   KUROKAWA M, 1994, J JPN PLASTIC RECONS, V14, P238
   Kuwahara H, 2000, MATER SCI FORUM, V350-3, P349, DOI 10.4028/www.scientific.net/MSF.350-351.349
   OKAZAKI M, 1992, CHEM APATITE CONSTRU, P10
   SUDA T, 1993, SCI BONE, P121
   SUZUKI K, 1999, COMMUNICATION
   WEN CE, 2000, IN PRESS P THERMEC 2
NR 13
TC 126
Z9 154
U1 0
U2 33
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD JUL
PY 2001
VL 42
IS 7
BP 1317
EP 1321
DI 10.2320/matertrans.42.1317
PG 5
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 462EW
UT WOS:000170408600028
OA Bronze
DA 2018-10-20
ER

PT J
AU Uludag, H
   Norrie, B
   Kousinioris, N
   Gao, TJ
AF Uludag, H
   Norrie, B
   Kousinioris, N
   Gao, TJ
TI Engineering temperature-sensitive poly(N-isopropylacrylamide) polymers
   as carriers of therapeutic proteins
SO BIOTECHNOLOGY AND BIOENGINEERING
LA English
DT Article
DE thermosensitive polymers; rhBMP-2; protein conjugation; bone
   regeneration; protein delivery
ID N-HYDROXYSUCCINIMIDE ESTERS; BONE MORPHOGENETIC PROTEIN-2; RAT ECTOPIC
   MODEL; LIGHT-SCATTERING; BIOMATERIAL CARRIERS; AQUEOUS-SOLUTIONS;
   CRYSTAL-STRUCTURE; PHASE-TRANSITION; DRUG-DELIVERY; IN-VITRO
AB This study was carried out to engineer N-isopropylacrylamide (NiPAM) polymers that contain protein-reactive N-acryloxysuccinimide (NASI) and hydrophobic alkylmethacrylates (AMAs). These thermoreversible, protein-conjugating polymers hold potential for retention of therapeutic proteins at an application site where tissue regeneration is desired. The lower critical solution temperatures (LCST) of the polymers were effectively controlled by the AMA mole content. The AMAs with longer side-chains were more effective in lowering the LCST. Polymers without NASI exhibited a stable LCST in phosphate buffer and in serum over a 10-day study period. The LCST of polymers containing NASI was found to increase over time in phosphate buffer, but not in serum-containing medium. The LCST increase in phosphate buffer was proportional to the AMA content. The feasibility of localizing a therapeutic protein, recombinant human bone morphogenetic protein-2 (rhBMP-2), to a site of application was explored in a rat intramuscular injection model. The results indicated that polymers capable of conjugating to rhBMP-2 were most effective in localizing the protein irrespective of the LCST (13-25 degreesC). For polymers with no NASI groups, a lower LCST resulted in a better rhBMP-2 localization. We conclude that thermosensitive polymers can be engineered for delivery of therapeutic proteins to improve their therapeutic efficacy. (C) 2001 John Wiley & Sons, Inc.
C1 Univ Alberta, Fac Med & Dent, Dept Biomed Engn, Edmonton, AB T6G 2V2, Canada.
RP Uludag, H (reprint author), Univ Alberta, Fac Med & Dent, Dept Biomed Engn, 1098 EDC Bldg, Edmonton, AB T6G 2V2, Canada.
CR Brar AS, 1998, POLYM J, V30, P664, DOI 10.1295/polymj.30.664
   BRAZEL CS, 1995, MACROMOLECULES, V28, P8016, DOI 10.1021/ma00128a007
   Bromberg LE, 1998, ADV DRUG DELIVER REV, V31, P197, DOI 10.1016/S0169-409X(97)00121-X
   CHEN JP, 1990, BIOMATERIALS, V11, P625, DOI 10.1016/0142-9612(90)90019-M
   CLINE GW, 1987, J AM CHEM SOC, V109, P3087, DOI 10.1021/ja00244a035
   CLINE GW, 1988, J ORG CHEM, V53, P3583, DOI 10.1021/jo00250a031
   Davidenko N, 1998, POLYMER, V39, P917, DOI 10.1016/S0032-3861(97)00407-2
   Ding ZL, 1998, J BIOMED MATER RES, V39, P498, DOI 10.1002/(SICI)1097-4636(19980305)39:3<498::AID-JBM22>3.0.CO;2-5
   FEIL H, 1993, MACROMOLECULES, V26, P2496, DOI 10.1021/ma00062a016
   GAO TJ, 2001, UNPUB TISSUE ENG
   GUTOWSKA A, 1995, J BIOMED MATER RES, V29, P811, DOI 10.1002/jbm.820290705
   Hahn M, 1998, MACROMOLECULES, V31, P5616, DOI 10.1021/ma9800010
   HORBETT TA, 1996, BIOMATERIALS SCI, P135
   Idziak I, 1999, MACROMOLECULES, V32, P1260, DOI 10.1021/ma981171f
   Israel D I, 1992, Growth Factors, V7, P139, DOI 10.3109/08977199209046403
   Kawasaki H, 1998, LANGMUIR, V14, P773, DOI 10.1021/la970886t
   KENLEY RA, 1993, PHARMACEUT RES, V10, P1393, DOI 10.1023/A:1018902720816
   Kirsch T, 2000, NAT STRUCT BIOL, V7, P492
   Kirsch T, 2000, FEBS LETT, V468, P215, DOI 10.1016/S0014-5793(00)01214-X
   KORENBROT JI, 1987, ANAL BIOCHEM, V161, P187, DOI 10.1016/0003-2697(87)90671-3
   Kwon GS, 1999, PHARMACEUT RES, V16, P597, DOI 10.1023/A:1011991617857
   Matsukata M, 1996, BIOCONJUGATE CHEM, V7, P96, DOI 10.1021/bc950082u
   MIRON T, 1982, ANAL BIOCHEM, V126, P433, DOI 10.1016/0003-2697(82)90540-1
   POLLAK A, 1980, J AM CHEM SOC, V102, P6324, DOI 10.1021/ja00540a026
   Qiu X.P., 1998, POLYMER, V39, P1749
   RINGSDORF H, 1991, MACROMOLECULES, V24, P1678, DOI 10.1021/ma00007a034
   Ruppert R, 1996, EUR J BIOCHEM, V237, P295, DOI 10.1111/j.1432-1033.1996.0295n.x
   Scheufler C, 1999, J MOL BIOL, V287, P103, DOI 10.1006/jmbi.1999.2590
   Shah SS, 1997, J CONTROL RELEASE, V45, P95, DOI 10.1016/S0168-3659(96)01550-7
   Shimizu S, 1996, ARTIF ORGANS, V20, P1232
   Stile RA, 1999, MACROMOLECULES, V32, P7370, DOI 10.1021/ma990130w
   Tong Z, 1999, MACROMOLECULES, V32, P4488, DOI 10.1021/ma990062d
   Uludag H, 2000, J BIOMED MATER RES, V50, P227, DOI 10.1002/(SICI)1097-4636(200005)50:2<227::AID-JBM18>3.0.CO;2-2
   Uludag H, 2000, J APPL POLYM SCI, V75, P583, DOI 10.1002/(SICI)1097-4628(20000124)75:4<583::AID-APP15>3.0.CO;2-L
   Uludag H, 1999, J BIOMED MATER RES, V46, P193, DOI 10.1002/(SICI)1097-4636(199908)46:2<193::AID-JBM8>3.0.CO;2-1
   ULUDAG H, 2000, DRUG DELIVERY 21ST C, P253
   Wang XH, 1999, MACROMOLECULES, V32, P4299, DOI 10.1021/ma9902450
   Wen J, 1996, ANAL BIOCHEM, V240, P155, DOI 10.1006/abio.1996.0345
   Winn SR, 1999, J BONE MINER RES, V14, P1721, DOI 10.1359/jbmr.1999.14.10.1721
   WINNIK FM, 1990, MACROMOLECULES, V23, P233, DOI 10.1021/ma00203a040
   WU C, 1995, MACROMOLECULES, V28, P8381, DOI 10.1021/ma00128a056
NR 41
TC 51
Z9 55
U1 0
U2 14
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0006-3592
J9 BIOTECHNOL BIOENG
JI Biotechnol. Bioeng.
PD JUN 20
PY 2001
VL 73
IS 6
BP 510
EP 521
DI 10.1002/bit.1086
PG 12
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 436NC
UT WOS:000168941100010
PM 11344456
DA 2018-10-20
ER

PT J
AU Lee, CH
   Singla, A
   Lee, Y
AF Lee, CH
   Singla, A
   Lee, Y
TI Biomedical applications of collagen
SO INTERNATIONAL JOURNAL OF PHARMACEUTICS
LA English
DT Review
DE collagen; biomaterial; drug/protein/gene delivery; tissue engineering
ID DRUG-DELIVERY SYSTEM; CROSS-LINKED COLLAGEN; BIOPROSTHETIC HEART-VALVES;
   CULTURED SKIN SUBSTITUTES; SOLID LIPID NANOPARTICLES; FIBROBLAST
   GROWTH-FACTOR; RECOMBINANT HUMAN BMP-2; SOFT CONTACT-LENSES; IN-VITRO;
   CORNEAL SHIELDS
AB Collagen is regarded as one of the most useful biomaterials. The excellent biocompatibility and safety due to its biological characteristics. such as biodegradability and weak antigenecity, made collagen the primary resource in medical applications. The main applications of collagen as drug delivery systems are collagen shields in ophthalmology, sponges for burns/wounds, mini-pellets and tablets for protein delivery, gel formulation in combination with liposomes for sustained drug delivery, as controlling material for transdermal delivery, and nanoparticles for gene delivery and basic matrices for cell culture systems. wt was also used for tissue engineering including skin replacement, bone substitutes, and artificial blood vessels and valves. This article reviews biomedical applications of collagen including the collagen film, which we have developed as a matrix system fur evaluation of tissue calcification and for the embedding of a single cell suspension for tumorigenic study. The advantages and disadvantages of each system are also discussed. (C) 2001 Elsevier Science B.V. All rights reserved.
C1 Univ Missouri, Coll Pharm, Dept Pharmaceut, Kansas City, MO 64110 USA.
   Univ Missouri, Sch Interdisciplinary Comp & Engn, Kansas City, MO 64110 USA.
RP Lee, CH (reprint author), Univ Missouri, Coll Pharm, Dept Pharmaceut, 5005 Rockhill Rd Katz Bdg 108, Kansas City, MO 64110 USA.
CR Abraham GA, 2000, J BIOMED MATER RES, V51, P442, DOI 10.1002/1097-4636(20000905)51:3<442::AID-JBM19>3.3.CO;2-W
   Aebischer P, 1996, NAT MED, V2, P696, DOI 10.1038/nm0696-696
   ALHENDY A, 1995, HUM GENE THER, V6, P165, DOI 10.1089/hum.1995.6.2-165
   Angella GJ, 2000, INVEST OPHTH VIS SCI, V41, P4158
   AQUAVELLA JV, 1988, J CATARACT REFR SURG, V14, P492, DOI 10.1016/S0886-3350(88)80004-X
   ASSIL KK, 1992, AM J OPHTHALMOL, V113, P418, DOI 10.1016/S0002-9394(14)76165-3
   Auger FA, 1998, MED BIOL ENG COMPUT, V36, P801, DOI 10.1007/BF02518887
   Bank RA, 2000, ARTHRITIS RHEUM-US, V43, P2202, DOI 10.1002/1529-0131(200010)43:10<2202::AID-ANR7>3.0.CO;2-E
   BARBANI N, 1995, J BIOMAT SCI-POLYM E, V7, P461
   BARR E, 1991, SCIENCE, V254, P1507, DOI 10.1126/science.1962212
   BAZIUK N, 1992, INT OPHTHALMOL, V16, P101, DOI 10.1007/BF00918940
   BELL E, 1983, J INVEST DERMATOL, V81, P2
   Bender AR, 1996, ANTIMICROB AGENTS CH, V40, P1467, DOI 10.1128/AAC.40.6.1467
   Bergeon M T, 1967, J Okla State Med Assoc, V60, P330
   Berthold A, 1998, EUR J PHARM BIOPHARM, V45, P23, DOI 10.1016/S0939-6411(97)00119-7
   BLOOMFIELD SE, 1978, ARCH OPHTHALMOL-CHIC, V96, P885
   BOYCE ST, 1993, ANTIMICROB AGENTS CH, V37, P1890, DOI 10.1128/AAC.37.9.1890
   BOYCE ST, 1992, J BIOMED MATER RES, V26, P547, DOI 10.1002/jbm.820260410
   BOYCE ST, 1988, J BIOMED MATER RES, V22, P939, DOI 10.1002/jbm.820221008
   BOYCE ST, 1995, ANN SURG, V222, P743, DOI 10.1097/00000658-199512000-00008
   Boyce ST, 1998, MED BIOL ENG COMPUT, V36, P791, DOI 10.1007/BF02518886
   BRADLEY WG, 1977, BIOMATER ARTIF CELL, V5, P159, DOI 10.3109/10731197709118671
   BRAUKER J, 1995, J CELL BIOCH B, V21, pD1
   BROWDER IW, 1986, AM SURGEON, V52, P492
   BURGE RE, 1964, P NATO ADV STUDY GRO, P2
   CAMERON WJ, 1978, OBSTET GYNECOL, V51, P118
   CARROLL RE, 1989, J HAND SURG-BRIT EUR, V14B, P218, DOI 10.1016/0266-7681(89)90131-9
   CASCONE MG, 1995, BIOMATERIALS, V16, P569, DOI 10.1016/0142-9612(95)91131-H
   CHEN JM, 1995, J BIOMOL STRUCT DYN, V12, P1129, DOI 10.1080/07391102.1995.10508804
   CHEN YF, 1990, AM J OPHTHALMOL, V109, P132, DOI 10.1016/S0002-9394(14)75976-8
   Chevallay B, 2000, MED BIOL ENG COMPUT, V38, P211, DOI 10.1007/BF02344779
   CHVAPIL M, 1993, J BIOMED MATER RES, V27, P313, DOI 10.1002/jbm.820270305
   CHVAPIL M, 1985, AM J OBSTET GYNECOL, V151, P325, DOI 10.1016/0002-9378(85)90296-0
   Clarke KM, 1996, J SURG RES, V60, P107, DOI 10.1006/jsre.1996.0018
   Cochran DI, 2000, J PERIODONTOL, V71, P1241, DOI 10.1902/jop.2000.71.8.1241
   Coester CJ, 2000, J MICROENCAPSUL, V17, P187
   DANIELSEN CC, 1990, BIOCHEM J, V272, P697, DOI 10.1042/bj2720697
   DEATHERAGE JR, 1987, COLLAGEN REL RES, V7, P225
   Desgrandchamps F, 2000, Curr Opin Urol, V10, P201, DOI 10.1097/00042307-200005000-00003
   DOILLON CJ, 1986, BIOMATERIALS, V7, P3, DOI 10.1016/0142-9612(86)90080-3
   DORIGO MT, 1995, CHEMOTHERAPY, V41, P1, DOI 10.1159/000239317
   DORR RT, 1982, J BIOMED MATER RES, V16, P839, DOI 10.1002/jbm.820160609
   ELSAMALIGY MS, 1983, J PHARM PHARMACOL, V35, P537, DOI 10.1111/j.2042-7158.1983.tb04831.x
   Farrugia CA, 1999, J PHARM PHARMACOL, V51, P643, DOI 10.1211/0022357991772925
   FELL JT, 1970, J PHARM SCI, V59, P688, DOI 10.1002/jps.2600590523
   FERKOL T, 1993, J CLIN INVEST, V92, P2394, DOI 10.1172/JCI116845
   FINKELSTEIN I, 1991, CAN J OPHTHALMOL, V26, P129
   Fonseca MJ, 1996, BBA-BIOMEMBRANES, V1279, P259
   FRIEDBERG ML, 1991, OPHTHALMOLOGY, V98, P725
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Fujioka K, 1998, ADV DRUG DELIVER REV, V31, P247, DOI 10.1016/S0169-409X(97)00119-1
   FUJIOKA K, 1995, J CONTROL RELEASE, V33, P307, DOI 10.1016/0168-3659(94)00107-6
   GEBHARDT BM, 1995, J OCUL PHARMACOL TH, V11, P319, DOI 10.1089/jop.1995.11.319
   Geesin JC, 1996, J BIOMED MATER RES, V33, P1
   Girton TS, 2000, J BIOMECH ENG-T ASME, V122, P216, DOI 10.1115/1.429652
   GLOECKNER DC, 2000, BIOMATERIALS, V52, P365
   GORHAM SD, 1992, INT J BIOL MACROMOL, V14, P129, DOI 10.1016/S0141-8130(05)80002-9
   Grammer JB, 1996, CURR EYE RES, V15, P815, DOI 10.3109/02713689609017622
   GROSS J., 1963, COMP BIOCHEM, V5, P307
   GUSSLER JR, 1990, J CATARACT REFR SURG, V16, P719, DOI 10.1016/S0886-3350(13)81013-9
   HARKNESS RD, 1966, SCI PROGRESS-UK, V54, P257
   HARKNESS RD, 1961, BIOL REV, V36, P399, DOI 10.1111/j.1469-185X.1961.tb01596.x
   Harriger MD, 1997, J BIOMED MATER RES, V35, P137, DOI 10.1002/(SICI)1097-4636(199705)35:2<137::AID-JBM1>3.0.CO;2-O
   HARRIS PT, 1989, CORAL REEFS, V8, P97
   HEARTLEIN MW, 1994, P NATL ACAD SCI USA, V91, P10967, DOI 10.1073/pnas.91.23.10967
   HOBDEN JA, 1988, ARCH OPHTHALMOL-CHIC, V106, P1605, DOI 10.1001/archopht.1988.01060140773053
   Huynh T, 1999, NAT BIOTECHNOL, V17, P1083
   HWANG DG, 1989, ARCH OPHTHALMOL-CHIC, V107, P1375, DOI 10.1001/archopht.1989.01070020445052
   Jerome A., 1992, BIOMATERIALS, V9, P137
   JEYANTHI R, 1991, J PHARM PHARMACOL, V43, P60, DOI 10.1111/j.2042-7158.1991.tb05453.x
   JEYANTHI R, 1990, BIOMATERIALS, V11, P238, DOI 10.1016/0142-9612(90)90004-A
   Katsube K, 2000, ARCH ORTHOP TRAUM SU, V120, P121, DOI 10.1007/PL00021232
   KAUFMAN HE, 1994, J OCUL PHARMACOL, V10, P17, DOI 10.1089/jop.1994.10.17
   KAUFMAN HE, 1988, J CATARACT REFR SURG, V14, P487, DOI 10.1016/S0886-3350(88)80002-6
   Kemp PD, 2000, METH MOL B, V139, P287
   KIMURA M, 2000, J PLAST RECONSTR SUR, V34, P289
   Kobayashi Y, 2000, Hinyokika Kiyo, V46, P869
   Kohmura E, 1999, BRAIN RES, V849, P235, DOI 10.1016/S0006-8993(99)02163-0
   KOIDE M, 1993, J BIOMED MATER RES, V27, P79, DOI 10.1002/jbm.820270111
   Kuwano M, 1997, J OCUL PHARMACOL TH, V13, P31, DOI 10.1089/jop.1997.13.31
   KUZUYA M, 1994, EXP CELL RES, V215, P310, DOI 10.1006/excr.1994.1347
   Lam PK, 1999, ANN PLAS SURG, V43, P523, DOI 10.1097/00000637-199911000-00010
   LEADERS F E, 1973, Annals of Ophthalmology, V5, P513
   Lee CH, 1998, J BIOMED MATER RES, V42, P30, DOI 10.1002/(SICI)1097-4636(199810)42:1<30::AID-JBM5>3.0.CO;2-P
   LEE VHL, 1990, J OCUL PHARMACOL, V6, P157, DOI 10.1089/jop.1990.6.157
   LEFEBVRE F, 1992, BIOMATERIALS, V13, P28, DOI 10.1016/0142-9612(92)90091-2
   Lefebvre F, 1996, BIOMATERIALS, V17, P1813, DOI 10.1016/0142-9612(95)00346-0
   LEIPZIGER LS, 1985, J AM ACAD DERMATOL, V12, P409, DOI 10.1016/S0190-9622(85)80004-9
   LIANG FQ, 1992, INVEST OPHTH VIS SCI, V33, P2194
   LIU HW, 1993, HUM GENE THER, V4, P291, DOI 10.1089/hum.1993.4.3-291
   LUCAS PA, 1989, J BIOMED MATER RES-A, V23, P23, DOI 10.1002/jbm.820231306
   Maeda M, 1999, J CONTROL RELEASE, V62, P313, DOI 10.1016/S0168-3659(99)00156-X
   MARKS MG, 1991, J BIOMED MATER RES, V25, P683, DOI 10.1002/jbm.820250510
   MARMER RH, 1988, J CATARACT REFR SURG, V14, P496, DOI 10.1016/S0886-3350(88)80005-1
   MARTY JJ, 1978, PHARM ACTA HELV, V53, P17
   MATINCHOULY CA, 1999, INVEST RADIOL, V34, P663
   Matsuoka J, 1988, T AM SOC ART INT ORG, V34, P729
   MCPHERSON J M, 1986, Journal of Biomedical Materials Research, V20, P93, DOI 10.1002/jbm.820200109
   Meaney D F, 1995, Clin Podiatr Med Surg, V12, P363
   Mendicute Javier, 1995, CLAO Journal, V21, P252
   MILANI JK, 1993, AM J OPHTHALMOL, V116, P622, DOI 10.1016/S0002-9394(14)73206-4
   MILLER JM, 1964, ARCH SURG-CHICAGO, V88, P167, DOI 10.1001/archsurg.1964.01310200005002
   MINABE M, 1989, J PERIODONTOL, V60, P113, DOI 10.1902/jop.1989.60.2.113
   MINABE M, 1989, J PERIODONTOL, V60, P552, DOI 10.1902/jop.1989.60.10.552
   MIYATA T, 1992, Clinical Materials, V9, P139, DOI 10.1016/0267-6605(92)90093-9
   MIYATA T, 1971, BIOCHIM BIOPHYS ACTA, V229, P672, DOI 10.1016/0005-2795(71)90283-2
   MONDINO BJ, 1991, AM J OPHTHALMOL, V112, P587, DOI 10.1016/S0002-9394(14)76863-1
   MOULLIER P, 1993, NAT GENET, V4, P154, DOI 10.1038/ng0693-154
   MOULLIER P, 1995, NAT MED, V1, P353, DOI 10.1038/nm0495-353
   MOULLIER P, 1993, TRANSPLANTATION, V56, P427, DOI 10.1097/00007890-199308000-00034
   Muller RH, 2000, EUR J PHARM BIOPHARM, V50, P161, DOI 10.1016/S0939-6411(00)00087-4
   Mullins RJ, 1996, AUST NZ J OPHTHALMOL, V24, P257, DOI 10.1111/j.1442-9071.1996.tb01589.x
   Muniruzzaman M, 1998, J BIOMAT SCI-POLYM E, V9, P459, DOI 10.1163/156856298X00569
   Murata M, 1999, INT J ORAL MAX SURG, V28, P232, DOI 10.1034/j.1399-0020.1999.283280316.x
   Murata M, 2000, CLIN ORAL IMPLAN RES, V11, P289, DOI 10.1034/j.1600-0501.2000.011004289.x
   MURRAY TG, 1990, ARCH OPHTHALMOL-CHIC, V108, P104, DOI 10.1001/archopht.1990.01070030110039
   Nakagawa T, 2000, ORAL DIS, V6, P172
   NARAZAKI H, 1994, INT J APPROX REASON, V11, P1, DOI 10.1016/0888-613X(94)90017-5
   NICHOLAS FL, 1997, BIOMATERIALS, V18, P815
   NIMNI ME, 1988, COLLAGEN, V1, P1
   Nimni ME, 1988, COLLAGEN, VIII, P1
   OBRIEN TP, 1988, J CATARACT REFR SURG, V14, P505, DOI 10.1016/S0886-3350(88)80007-5
   Ochiya T, 1999, NAT MED, V5, P707
   Orwin EJ, 2000, TISSUE ENG, V6, P307, DOI 10.1089/107632700418038
   Pachence JM, 1987, MED DEVICE DIAGN IND, V9, P49
   PAJEAN M, 1993, INT J PHARM, V91, P209, DOI 10.1016/0378-5173(93)90340-L
   PALMER RM, 1995, J CATARACT REFR SURG, V21, P125, DOI 10.1016/S0886-3350(13)80497-X
   Park JC, 2000, J BIOMED MATER RES, V52, P669, DOI 10.1002/1097-4636(20001215)52:4<669::AID-JBM11>3.3.CO;2-L
   PENG YM, 1986, INVEST NEW DRUG, V4, P245
   PETITE H, 1990, J BIOMED MATER RES, V24, P179, DOI 10.1002/jbm.820240205
   PHINNEY RB, 1988, ARCH OPHTHALMOL-CHIC, V106, P1599, DOI 10.1001/archopht.1988.01060140767052
   PIEZ KA, 1984, EXTRACELLULAR MATRIX, P1
   PLEYER U, 1994, CURR EYE RES, V13, P177, DOI 10.3109/02713689408995775
   PODOS SM, 1972, AM J OPHTHALMOL, V73, P336, DOI 10.1016/0002-9394(72)90062-1
   POLAND DE, 1988, J CATARACT REFR SURG, V14, P489, DOI 10.1016/S0886-3350(88)80003-8
   Ponticiello MS, 2000, J BIOMED MATER RES, V52, P246, DOI 10.1002/1097-4636(200011)52:2<246::AID-JBM2>3.0.CO;2-W
   Prajapati RT, 2000, WOUND REPAIR REGEN, V8, P226, DOI 10.1046/j.1524-475x.2000.00226.x
   RAMACHANDRAN GN, 1965, BIOCHIM BIOPHYS ACTA, V109, P314, DOI 10.1016/0926-6585(65)90119-6
   Rao KP, 1995, J BIOMAT SCI-POLYM E, V7, P623
   RAO KP, 1992, J MEMBRANE SCI, V71, P161, DOI 10.1016/0376-7388(92)85015-B
   Reddi AH, 2000, TISSUE ENG, V6, P351, DOI 10.1089/107632700418074
   REIDY JJ, 1990, CORNEA, V9, P196
   REMACLE M, 1995, ANN OTO RHINOL LARYN, V104, P437, DOI 10.1177/000348949510400604
   ROBIN JB, 1990, INVEST OPHTH VIS SCI, V31, P1294
   Rosenthal FM, 1997, ANTICANCER RES, V17, P1179
   ROSSLER B, 1995, J MICROENCAPSUL, V12, P49, DOI 10.3109/02652049509051126
   ROSSLER B, 1994, PHARMAZIE, V49, P175
   ROYCE PM, 1995, J DERMATOL SCI, V10, P42, DOI 10.1016/0923-1811(95)93713-B
   RUBIN AL, 1973, J CLIN PHARMACOL, V13, P309, DOI 10.1002/j.1552-4604.1973.tb00217.x
   RUDERMAN RJ, 1973, J BIOMED MATER RES, V7, P263, DOI 10.1002/jbm.820070213
   Sahai A., 1995, Pharmaceutical Research (New York), V12, pS227
   Samuel CS, 1998, J ENDOCRINOL, V159, P117, DOI 10.1677/joe.0.1590117
   SASTRY TP, 1991, COMPREHENSIVE GUIDE, P171
   Sato H, 1996, PHARMACEUT RES, V13, P1565, DOI 10.1023/A:1016096016642
   SAWUSCH MR, 1988, AM J OPHTHALMOL, V106, P279, DOI 10.1016/0002-9394(88)90361-3
   SAWUSCH MR, 1988, J CATARACT REFR SURG, V14, P625
   SCHARFMANN R, 1991, P NATL ACAD SCI USA, V88, P4626, DOI 10.1073/pnas.88.11.4626
   SCHOEN FJ, 1992, J THORAC CARDIOV SUR, V104, P1285
   SCHWARTZ SD, 1990, AM J OPHTHALMOL, V109, P701, DOI 10.1016/S0002-9394(14)72439-0
   Sekine T, 2001, J BIOMED MATER RES, V54, P305, DOI 10.1002/1097-4636(200102)54:2<305::AID-JBM18>3.0.CO;2-B
   Sela J, 2000, INFLAMM RES, V49, P679, DOI 10.1007/s000110050646
   SHAKER GJ, 1989, INVEST OPHTH VIS SCI, V30, P1565
   SHANTHA KL, 1993, J BIOACT COMPAT POL, V8, P142, DOI 10.1177/088391159300800204
   SHORTLIFFE LMD, 1989, J UROLOGY, V141, P538
   SOBOLEWSKI K, 1995, ACTA BIOCHIM POL, V42, P301
   Stemberger A, 1997, EUR J SURG, V163, P17
   STENZEL KH, 1969, SCIENCE, V164, P1282, DOI 10.1126/science.164.3885.1282
   STOMPRO BE, 1989, J SURG RES, V46, P413, DOI 10.1016/0022-4804(89)90153-4
   Suh H, 2001, BIOMATERIALS, V22, P219, DOI 10.1016/S0142-9612(00)00177-0
   Supp AP, 1999, WOUND REPAIR REGEN, V7, P226, DOI 10.1046/j.1524-475X.1999.00226.x
   Suzuki S, 2000, BRIT J PLAST SURG, V53, P659, DOI 10.1054/bjps.2000.3426
   TAKAOKA K, 1988, CLIN ORTHOP RELAT R, P250
   TAKENAKA H, 1986, PHARM TECH JAPAN, V2, P1083
   TANI K, 1989, BLOOD, V74, P1274
   Taravella MJ, 1999, J CATARACT REFR SURG, V25, P562, DOI 10.1016/S0886-3350(99)80056-X
   Thacharodi D, 1996, BIOMATERIALS, V17, P1307, DOI 10.1016/0142-9612(96)88676-5
   Timpl R, 1984, EXTRACELLULAR MATRIX, P159
   Trasciatti S, 1998, BIOMATERIALS, V19, P897, DOI 10.1016/S0142-9612(97)00175-0
   Traub W, 1971, ADV PROTEIN CHEM, V25, P245
   TU R, 1993, J BIOMED MATER RES, V27, P3, DOI 10.1002/jbm.820270103
   Uchio Y, 2000, J BIOMED MATER RES, V50, P138, DOI 10.1002/(SICI)1097-4636(200005)50:2<138::AID-JBM7>3.0.CO;2-K
   Uitterlinden AG, 2001, J BONE MINER RES, V16, P379, DOI 10.1359/jbmr.2001.16.2.379
   Ulrich U, 2001, ARCH GYNECOL OBSTET, V264, P186, DOI 10.1007/s004040000105
   UNTERMAN SR, 1988, J CATARACT REFR SURG, V14, P500, DOI 10.1016/S0886-3350(88)80006-3
   VANDERLAAN JS, 1991, INT J ARTIF ORGANS, V14, P661
   Vaneerdeweg W, 1998, EUR J SURG, V164, P617
   Vaneerdeweg W, 2000, EUR J SURG, V166, P959
   Vardaxis NJ, 1996, BIOMATERIALS, V17, P1489, DOI 10.1016/0142-9612(96)89773-0
   WacholDrewek Z, 1996, BIOMATERIALS, V17, P1733, DOI 10.1016/0142-9612(96)87654-X
   Wada T, 1999, CIRC RES, V84, P166, DOI 10.1161/01.RES.84.2.166
   WALTMAN SR, 1970, INVEST OPHTH VISUAL, V9, P250
   WANG CL, 1978, BIOCHIM BIOPHYS ACTA, V544, P555, DOI 10.1016/0304-4165(78)90330-6
   WEBSTER RC, 1984, ARCH OTOLARYNGOL, V110, P652
   WEDGE CI, 1992, CAN J OPHTHALMOL, V27, P295
   WEINER AL, 1985, J PHARM SCI, V74, P922, DOI 10.1002/jps.2600740903
   WILLEY DE, 1991, CURR EYE RES, V10, P167, DOI 10.3109/02713689109020374
   Woolley D. E., 1984, EXTRACELLULAR MATRIX, P119
   Yamada N, 1999, SCAND J PLAST RECONS, V33, P147
   YAMAHIRA Y, 1991, Patent No. 841123136
   Yang SC, 1999, J CONTROL RELEASE, V59, P299, DOI 10.1016/S0168-3659(99)00007-3
   YANNAS IV, 1990, ANGEW CHEM INT EDIT, V29, P20, DOI 10.1002/anie.199000201
   YANNAS IV, 1989, P NATL ACAD SCI USA, V86, P933, DOI 10.1073/pnas.86.3.933
NR 202
TC 970
Z9 1046
U1 24
U2 460
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0378-5173
J9 INT J PHARM
JI Int. J. Pharm.
PD JUN 19
PY 2001
VL 221
IS 1-2
BP 1
EP 22
DI 10.1016/S0378-5173(01)00691-3
PG 22
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 443XJ
UT WOS:000169368300001
PM 11397563
DA 2018-10-20
ER

PT J
AU Rizzi, SC
   Heath, DT
   Coombes, AGA
   Bock, N
   Textor, M
   Downes, S
AF Rizzi, SC
   Heath, DT
   Coombes, AGA
   Bock, N
   Textor, M
   Downes, S
TI Biodegradable polymer/hydroxyapatite composites: Surface analysis and
   initial attachment of human osteoblasts
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE hydroxyapatite; biodegradable polymers; ESEM; human osteoblasts; bone
ID HUMAN BONE; POLYMERS; BIOCOMPATIBILITY; HYDROXYAPATITE; PROLIFERATION;
   DEGRADATION; CHEMISTRY; MATRICES; INVITRO; CELLS
AB Biodegradable polymer/hydroxyapatite (HA) composites have potential application as bone graft substitutes. Thin films of polymer/HA composites were produced, and the initial attachment of Primary human osteoblasts (HOBs) was assessed to investigate the biocompatibility of the materials. Poly(epsilon -caprolactone) (PCL) and poly(L-lactic acid) (PLA) were used as matrix materials for two types of HA particles, 50-mum sintered and submicron nonsintered. Using ESEM, cell morphology on the surfaces of samples was investigated after 90 min, 4 h, and 24 h of cell culture. Cell activity and viability were assessed after 24 h of cell culture using Alamar blue and DNA assays. Surface morphology of the polymer/HA composites and HA exposure were investigated using ESEM and EDXA, respectively. ESEM enabled investigation of both cell and material surface morphology in the hydrated condition. Combined with EDXA it permitted chemical and visual examination of the composite. Differences in HA exposure were observed on the different composite surfaces that affected the morphology of attached cells. In the first Ih of cell culture, the cells were spread to a higher degree on exposed HA regions of the composites and on PLA than they were on PCL. After 24 h the cells were spread equally on all the samples. The cell activity after 22 h was significantly higher on the polymer/ HA composites than on the polymer films. There was no significant difference in the activity of the cells on the various composite materials. However, cells on PCL showed higher activity compared to those on PLA. A polymer surface exhibiting "point exposure" of HA appeared to provide a novel and favorable substrate for primary cell attachment. The cell morphology and activity results indicate a favorable cell/material interaction and suggest that PLA and PCL and their composites with HA may be candidate materials for the reconstruction of bony tissue. Further investigations regarding long-term biomaterial/cell interactions and the effects of acidic degradation products from the biodegradable polymers are required to confirm their utility. (C) 2001 John Wiley & Sons, Inc.
C1 Univ Zurich, Inst Biomed Engn, CH-8044 Zurich, Switzerland.
   Univ Nottingham Hosp, Sch Biomed Sci, Sch Med, Queens Med Ctr, Nottingham NG7 2UH, England.
   ETH Zurich, Inst Biomed Engn, CH-8044 Zurich, Switzerland.
   Univ Nottingham Hosp, Sch Engn Mat & Manag, Nottingham NG7 2UH, England.
   ETH, Lab Surface Anal& Technol, Zurich, Switzerland.
   Smith & Nephew Grp Res Ctr, York Sci Pk, York YO1 5DD, N Yorkshire, England.
RP Rizzi, SC (reprint author), Univ Zurich, Inst Biomed Engn, Moussonstr 18, CH-8044 Zurich, Switzerland.
RI Textor, Marcus/A-6200-2012
OI Textor, Marcus/0000-0002-0178-1801
CR Athanasiou KA, 1996, BIOMATERIALS, V17, P93, DOI 10.1016/0142-9612(96)85754-1
   ATTAWIA MA, 1995, BIOCHEM BIOPH RES CO, V213, P639, DOI 10.1006/bbrc.1995.2179
   BENICEWICZ BC, 1991, J BIOACT COMPAT POL, V6, P64, DOI 10.1177/088391159100600106
   BLOTTIERE HM, 1995, BIOMATERIALS, V16, P497, DOI 10.1016/0142-9612(95)98824-X
   BONFIGLIO M, 1972, CLIN ORTHOP RELAT R, P19
   Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   Coombes A. G. A., 1994, Clinical Materials, V17, P35, DOI 10.1016/0267-6605(94)90046-9
   Coombes AGA, 1998, BIOMATERIALS, V19, P1073, DOI 10.1016/S0142-9612(98)00035-0
   Corden TJ, 2000, BIOMATERIALS, V21, P713, DOI 10.1016/S0142-9612(99)00236-7
   DEBOER HH, 1988, CLIN ORTHOP RELAT R, P292
   DISILVIO L, 1995, THESIS U LONDON UK
   ELGENDY HM, 1993, BIOMATERIALS, V14, P263, DOI 10.1016/0142-9612(93)90116-J
   FEWSTER SD, 1994, NANOBIOLOGY, V3, P201
   GURAV N, 1997, THESIS U LONDON UK
   Healy KE, 1996, BIOMATERIALS, V17, P195, DOI 10.1016/0142-9612(96)85764-4
   HOLLAND S J, 1986, Journal of Controlled Release, V4, P155, DOI 10.1016/0168-3659(86)90001-5
   HOWLETT CR, 1994, BIOMATERIALS, V15, P213, DOI 10.1016/0142-9612(94)90070-1
   HUANG J, 1997, BIOCERAMICS, V10, P519
   HUNTER A, 1995, BIOMATERIALS, V16, P287, DOI 10.1016/0142-9612(95)93256-D
   ISHAUG SL, 1994, J BIOMED MATER RES, V28, P1445, DOI 10.1002/jbm.820281210
   Kikuchi M., 1997, BIOCERAMICS, V10, P407
   KIRKPATRICK CJ, 1992, ADV BIOMAT, V10, P31
   LEONG KW, 1985, J BIOMED MATER RES, V19, P941, DOI 10.1002/jbm.820190806
   MALIK MA, 1992, BIOMATERIALS, V13, P123, DOI 10.1016/0142-9612(92)90008-C
   Mayer U., 1993, CELLS MAT, V3, P129
   MUSTER D, 1990, BIOMATERIALS, V11, P57
   Piattelli A, 1997, BIOMATERIALS, V18, P629, DOI 10.1016/S0142-9612(96)00163-9
   RAGO R, 1990, ANAL BIOCHEM, V191, P31
   Reis RL, 1997, BIOCERAMICS, V10, P415
   Saad B, 1996, J BIOMED MATER RES, V32, P355
   Scotchford CA, 1998, BIOMATERIALS, V19, P1, DOI 10.1016/S0142-9612(97)00236-6
   STEELE JG, 1993, J BIOMAT SCI-POLYM E, V5, P245
   Wintermantel E, 1996, BIOKOMPATIBLE WERKST
   Yaszemski MJ, 1996, BIOMATERIALS, V17, P175, DOI 10.1016/0142-9612(96)85762-0
NR 34
TC 221
Z9 230
U1 5
U2 55
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JUN 15
PY 2001
VL 55
IS 4
BP 475
EP 486
DI 10.1002/1097-4636(20010615)55:4<475::AID-JBM1039>3.0.CO;2-Q
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 423VZ
UT WOS:000168199600005
PM 11288075
DA 2018-10-20
ER

PT J
AU Tomazic-Jezic, VJ
   Merritt, K
   Umbreit, TH
AF Tomazic-Jezic, VJ
   Merritt, K
   Umbreit, TH
TI Significance of the type and the size of biomaterial particles on
   phagocytosis and tissue distribution
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE biomaterials; particles; tissue distribution; histology; immune
   responses
ID MACROPHAGES IN-VITRO; BONE-RESORPTION; POLYMETHYLMETHACRYLATE PARTICLES;
   STIMULATED MACROPHAGES; INFLAMMATORY RESPONSE; PARTICULATE DEBRIS;
   SURFACE-AREA; RECRUITMENT; OSTEOBLASTS; EXPOSURE
AB Particulates generated by dissolution or wear of injected or implanted biomaterials may migrate into various tissues and lead to activation of the host's inflammatory and immune responses. The purpose of this study was to evaluate the relevance of size and chemical composition of biomaterial particles on the pattern of particle distribution in host tissues. Adult female B6C3F1 mice were injected intraperitoneally with polymethylmethacrylate (PMMA) particles (size 1.4 and 6.4 mu in diameter) and polystyrene (PS) particles (size 1.2, 5.2, and 12.5 mu in diameter), and euthanized 1, 7 and 28 days later. Peritoneal exudate cells (PECs) were collected and the number of cells and percentage of actively phagocytic cells was determined. Macroscopic examination of the tissues in the peritoneal cavity peritoneum revealed visible accumulations of the colored PS particles in the adipose tissues adjacent to the spleen and pancreas, and caudal to the stomach. Distribution of the FS particles appeared similar regardless of the particle size. The location of PMMA particles, which were not colored, could not be distinguished from host tissue and could not be observed in this manner. Intensive phagocytosis of the small and medium sized particles by peritoneal macrophages was observed on day 1, and was diminishing by day 7 after injection. The largest PS particles (12.5 CL) were not engulfed bp the peritoneal macrophages. Histological examination of the spleen, lymph nodes, and the adjacent adipose tissues revealed a marked difference in the deposition patterns of the two polymers used. PS particles, regardless of size, were accumulated primarily in the white adipose tissues adjacent to the spleen and pancreas gland, but very few particles were observed in the splenic tissue. On the other hand, mice injected with PMMA particles of either size had enlarged and activated spleens with marked deposits of particles in the red pulp. These results indicate that these PS and PMMA particles induce different patterns and intensities of the host response. The chemical makeup of the particle is more important in the distribution pattern than is the size of the particle. (C) 2001 John Wiley & Sons, Inc.
C1 Food & Drug Admin, Ctr Devices & Radiol Hlth, Div Life Sci, Rockville, MD 20852 USA.
RP Tomazic-Jezic, VJ (reprint author), Food & Drug Admin, Ctr Devices & Radiol Hlth, Div Life Sci, HFZ-112,12709 Twinbrook Pkwy, Rockville, MD 20852 USA.
CR Algan SM, 1996, J ORTHOP RES, V14, P30, DOI 10.1002/jor.1100140107
   DAVIS RG, 1993, J BIOMED MATER RES, V27, P1039, DOI 10.1002/jbm.820270809
   FRONDOZA CG, 1993, J BIOMED MATER RES, V27, P611, DOI 10.1002/jbm.820270508
   GELB H, 1994, J ORTHOP RES, V12, P83, DOI 10.1002/jor.1100120111
   GLANT TT, 1994, J ORTHOPAED RES, V12, P720, DOI 10.1002/jor.1100120515
   GLANT TT, 1993, J BONE MINER RES, V8, P1071
   Gonzalez O, 1996, J BIOMED MATER RES, V30, P463, DOI 10.1002/(SICI)1097-4636(199604)30:4<463::AID-JBM4>3.3.CO;2-I
   Hitchins VM, 1999, J BIOMED MATER RES, V46, P434
   HITCHINS VM, 1999, T SOC BIOMATER, V22, P128
   HOROWITZ SM, 1991, J ORTHOPAED RES, V9, P406, DOI 10.1002/jor.1100090313
   HOROWITZ SM, 1995, J BIOMED MATER RES, V29, P477, DOI 10.1002/jbm.820290407
   HOROWITZ SM, 1995, CALCIFIED TISSUE INT, V57, P301, DOI 10.1007/BF00298886
   HOROWITZ SM, 1994, CALCIFIED TISSUE INT, V54, P320, DOI 10.1007/BF00295957
   ISHIMI Y, 1990, J IMMUNOL, V145, P3297
   KLEIN DC, 1970, ENDOCRINOLOGY, V86, P1436, DOI 10.1210/endo-86-6-1436
   LAZARUS MD, 1994, J ORTHOPAED RES, V12, P532, DOI 10.1002/jor.1100120410
   MURRAY DW, 1990, J BONE JOINT SURG BR, V72, P988
   PAPATHEOFANIS FJ, 1991, J BIOMED MATER RES, V25, P761, DOI 10.1002/jbm.820250606
   POLLICE PF, 1995, J ORTHOPAED RES, V13, P325, DOI 10.1002/jor.1100130305
   SHANBHAG AS, 1995, J ORTHOPAED RES, V13, P792, DOI 10.1002/jor.1100130520
   THOMSON BM, 1987, J IMMUNOL, V138, P775
NR 21
TC 55
Z9 57
U1 0
U2 3
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JUN 15
PY 2001
VL 55
IS 4
BP 523
EP 529
DI 10.1002/1097-4636(20010615)55:4<523::AID-JBM1045>3.0.CO;2-G
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 423VZ
UT WOS:000168199600010
PM 11288080
DA 2018-10-20
ER

PT J
AU Lee, DH
   Park, JC
   Suh, H
AF Lee, DH
   Park, JC
   Suh, H
TI Synergistic induction of cyclooxygenase-II by bacterial
   lipopolysaccharide in combination with particles of medical device
   materials in a murine macrophage cell medical device line J774A.1
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE biomaterials; cyclooxygenase-II; synergistic; inflammation; macrophage;
   J774A1; arachidonic acid; prostaglandin
ID RECEPTOR-MEDIATED PHAGOCYTOSIS; ARACHIDONIC-ACID; PROSTAGLANDIN;
   INHIBITION; RELEASE; GAMMA; DRUGS
AB Corrosion and wear of implanted medical devices may produce particulate debris, leading to acute and chronic inflammatory responses in the host. In the presence of biomaterial wear particles, host monocytes/macrophages are activated to synthesize or secrete mediators of inflammation. In order to understand the mechanisms underlying the host response to particulates and device-associated infections, we have focused on the effects of medical device particles on macrophage function, because these cells play a pivotal role in the body's response to foreign bodies and their interaction with other cellular components of the immune system. In order to evaluate the effects of particles of medical device materials on functional activities of macrophages, we developed a cyclooxygenase-II (COX-II) assay system using J774A.1 macrophages. Constitutive cyclooxygenase (COX-I) is present in cells under physiological conditions, whereas inducible COX-II is induced by some cytokines, mitogens, and endotoxin, presumably in pathological conditions such as inflammation. We have evaluated the inductive effects of implant materials, i.e., particles of poly-methylmethacrylate (PMMA), hydroxyapatite (HA), titanium oxide, and silica, on the activity of COX-II using thin layer chromatography of prostaglandin D, (PGD,) formed from [1-C-14]-labeled arachidonic acid (AA). Also, we have assessed the synergistic effects of these particles on lipopolysaccharide (LPS)-mediated macrophage activation. Addition of LPS to these particles increased PGD, production severalfold greater than the addition of any inducer alone. Our results indicated that device-associated infections could enhance inflammatory responses to the wear particles in subjects with medical implants or in whom particulate biomaterials are used for clinical purposes. The use of this model COX-II assay system may lead to the identification of inflammatory potentials for implant materials more specifically than present in vivo assays. (C) 2001 John Wiley & Sons, Inc. T Biomed Mater Res 55: 547-553, 2001.
C1 Yonsei Univ, Coll Med, Dept Med Engn, Seodaemun Ku, Seoul 120752, South Korea.
RP Suh, H (reprint author), Yonsei Univ, Coll Med, Dept Med Engn, Seodaemun Ku, 134 Shinchon Dong, Seoul 120752, South Korea.
CR Anderson James M., 1996, P165
   ANDERSON JM, 1984, BIOMATERIALS, V5, P5, DOI 10.1016/0142-9612(84)90060-7
   ANTHONY AG, 1996, BIOMATERIALS SCI, P205
   ARIAS NS, 1995, BIOCHEM BIOPH RES CO, V17, P582
   CHAPEKAR MS, 1996, J BIOMED MATER RES, V31, P151
   CHRISTENSEN GD, 1985, PRINCIPLES PRACTICE, P6
   DAVIES P, 1984, ANNU REV IMMUNOL, V2, P335, DOI 10.1146/annurev.immunol.2.1.335
   ESTENSEN RD, 1974, NATURE, V248, P347, DOI 10.1038/248347a0
   FARRAR MA, 1993, ANNU REV IMMUNOL, V11, P571, DOI 10.1146/annurev.iy.11.040193.003035
   GOLDSTEIN IM, 1992, INFLAMMATION BASIC P, P1127
   HERSCHMAN HR, 1993, J LIPID MEDIATOR, V6, P89
   HLA T, 1992, P NATL ACAD SCI USA, V89, P7384, DOI 10.1073/pnas.89.16.7384
   Hukkanen M, 1997, J BONE JOINT SURG BR, V79B, P467, DOI 10.1302/0301-620X.79B3.7469
   IMAMICHI T, 1991, MOL IMMUNOL, V28, P359
   Lee DH, 1997, NAT PROD SCI, V3, P19
   LEE DH, 1999, BIOMATER RES, V3, P112
   LENNARTZ MR, 1991, J IMMUNOL, V147, P621
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MARMOR L, 1978, SURGERY, V83, P291
   MOHR C, 1992, AM J RESP CELL MOL, V6, P390, DOI 10.1165/ajrcmb/6.4.390
   OBAYASHI T, 1985, CLIN CHIM ACTA, V149, P55, DOI 10.1016/0009-8981(85)90273-6
   OSULLIVAN MG, 1992, BIOCHEM BIOPH RES CO, V187, P1123, DOI 10.1016/0006-291X(92)91313-F
   Prabhu A, 1998, J BIOMED MATER RES, V42, P655, DOI 10.1002/(SICI)1097-4636(19981215)42:4<655::AID-JBM23>3.3.CO;2-2
   RAAHAVE D, 1976, ACTA ORTHOP SCAND, V47, P28, DOI 10.3109/17453677608998968
   SCHLONDORFF D, 1993, KIDNEY INT, V44, P643, DOI 10.1038/ki.1993.293
   SCHWACHA MG, 1993, J IMMUNOL, V150, P236
   SHAYNE CG, 1997, SAFETY EVALUATION ME, P117
   SMITH WL, 1994, CURR OPIN INVEST DR, V3, P1
   Song YT, 1999, J MED CHEM, V42, P1151, DOI 10.1021/jm9805081
   VANDEROUDERAA FJ, 1977, BIOCHIM BIOPHYS ACTA, V487, P315, DOI 10.1016/0005-2760(77)90008-X
   VANE JR, 1971, NATURE-NEW BIOL, V231, P232, DOI 10.1038/newbio231232a0
   WHITTLE BJR, 1980, NATURE, V284, P271, DOI 10.1038/284271a0
NR 32
TC 13
Z9 13
U1 0
U2 3
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JUN 15
PY 2001
VL 55
IS 4
BP 547
EP 553
DI 10.1002/1097-4636(20010615)55:4<547::AID-JBM1048>3.0.CO;2-Y
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 423VZ
UT WOS:000168199600013
PM 11288083
DA 2018-10-20
ER

PT J
AU Lindfors, NC
   Klockars, M
AF Lindfors, NC
   Klockars, M
TI Immunoglobulin enhances the bioactive-glass-induced chemiluminescence
   response of human polymorphonuclear leukocytes
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE bioactive glass; polymorphonuclear leukocyte; chemiluminescence;
   immunoglobulin; albumin
ID MONOSODIUM URATE CRYSTALS; IN-VIVO; NEUTROPHILS; SURFACE; GENERATION;
   SERUM
AB Bioactive glasses are bone substitutes that chemically bind to bone. Implanted materials always elicit a response from surrounding tissues and thereby can activate inflammatory cells, with subsequent release of biomaterial and tissue-damaging agents. Bioactive glasses call activate polymorphonuclear leukocytes (PMNL) and induce a release of reactive oxygen metabolites (ROM). Adsorption of proteins on the surface of the implanted material may influence the subsequent inflammatory cell response. The effect of Sandoglobulin (R) (SG) and albumin on the ROM release by PMNLs induced by a bioactive glass M as studied by a chemiluminescence (CL) assay. An enhanced effect for SG and inhibitory effect for albumin on the CL response of PMNLs was observable. The CL response of the PMNLs was dependent on the incubation time of the glass in solution. (C) 2001 John Wiley & Sons, Inc. J Biomed Mater Res 55: 613-617, 2001.
RP Lindfors, NC (reprint author), Missnebacken 9 02, Espoo 02180, Finland.
CR ABRAMSON S, 1982, ARTHRITIS RHEUM, V25, P174, DOI 10.1002/art.1780250210
   ANDERSSON OH, 1990, J NON-CRYST SOLIDS, V119, P290, DOI 10.1016/0022-3093(90)90301-2
   BABIOR BM, 1978, NEW ENGL J MED, V298, P659, DOI 10.1056/NEJM197803232981205
   BRINK M, BIOCERAMICS, V8, P471
   DENKO CW, 1979, J RHEUMATOL, V6, P117
   DIEPPE PA, 1976, LANCET, V7, P266
   GATTI AM, 1993, CELL MATER, V3, P283
   HASSELBACHER P, 1978, ARTHRITIS RHEUM, V21, P353, DOI 10.1002/art.1780210311
   HEDENBORG M, 1998, INT ARCH OCC ENV HEA, V61, P1
   Hench L L, 1988, Ann N Y Acad Sci, V523, P54, DOI 10.1111/j.1749-6632.1988.tb38500.x
   Hench L.L., 1973, J BIOMED MATER RES S, V4, P25
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   HENCH LL, 1984, SCIENCE, V226, P630, DOI 10.1126/science.6093253
   HIGSON FK, 1984, J RHEUMATOL, V11, P735
   KAPLAN SS, 1994, J BIOMED MATER RES, V28, P377, DOI 10.1002/jbm.820280313
   KLOCKARS M, 1992, CLIN EXP IMMUNOL, V90, P68
   KOZIN F, 1979, J RHEUMATOL, V6, P519
   Lindfors NC, 1999, J BIOMED MATER RES, V47, P91, DOI 10.1002/(SICI)1097-4636(199910)47:1<91::AID-JBM13>3.0.CO;2-F
   LINDFORS NC, BIOCERAMICS, V8, P107
   NAGASE M, 1989, J RHEUMATOL, V16, P971
   NEO M, 1993, J BIOMED MATER RES, V27, P999, DOI 10.1002/jbm.820270805
   PLATT P, 1983, ANN RHEUM DIS, V42, P111, DOI 10.1136/ard.42.Suppl_1.111
   SACHS T, 1978, J CLIN INVEST, P1161
   SCHUMACHER HR, 1977, ANN INTERN MED, V87, P411, DOI 10.7326/0003-4819-87-4-411
   TERKELTAUB R, 1983, ARTHRITIS RHEUM, V26, P775, DOI 10.1002/art.1780260612
   TERKELTAUB RA, 1988, ARTHRITIS RHEUM, V31, P1081, DOI 10.1002/art.1780310901
   VALLYATHAN V, 1988, AM REV RESPIR DIS, V138, P1213, DOI 10.1164/ajrccm/138.5.1213
   WELSS SJ, 1986, ACTA PHYSL SCAND, V548, P9
   WITZMAN SA, 1990, BLOOD, V76, P663
NR 29
TC 1
Z9 1
U1 0
U2 0
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JUN 15
PY 2001
VL 55
IS 4
BP 613
EP 617
DI 10.1002/1097-4636(20010615)55:4<613::AID-JBM1055>3.0.CO;2-H
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 423VZ
UT WOS:000168199600020
PM 11288090
DA 2018-10-20
ER

PT J
AU Brodbeck, WG
   Shive, MS
   Colton, E
   Nakayama, Y
   Matsuda, T
   Anderson, JM
AF Brodbeck, WG
   Shive, MS
   Colton, E
   Nakayama, Y
   Matsuda, T
   Anderson, JM
TI Influence of biomaterial surface chemistry on the apoptosis of adherent
   cells
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE apoptosis; biocompatibility; foreign-body giant cells; IL-4; macrophages
ID MULTINUCLEATED GIANT-CELLS; MACROPHAGES; ADHESION; INVITRO; MONOCYTES;
   CRACKING; INVIVO; DEATH; FORM
AB A common component of the foreign-body response to implanted materials is the presence of adherent macrophages that fuse to form foreign-body giant cells (FBGCs). These multinucleated cells have been shown to concentrate the phagocytic and degradative properties of macrophages at the implant surface and are responsible for the damage and failure of the implant. Therefore, the modulation of the presence or actions of macrophages and FBGCs at the material-tissue interface is an extensive area of recent investigations. A possible mechanism to achieve this is through the induction of the apoptosis of adherent macrophages, which results in no inflammatory consequence. We hypothesize that the induction of the apoptosis of biomaterial adherent cells can be influenced by the chemistry of the surface of adhesion. Herein, we demonstrate that Surfaces displaying hydrophilic and anionic chemistries induce apoytosis of adherent macrophages at a higher magnitude than hydrophobic or cationic surfaces. Additionally, the level of apoptosis for a given surface is inversely related to that surface's ability to promote the fusion of macrophages into FBGCs. This suggests that macrophages fuse into FBGCs to escape apoptosis. (C) 2001 John Wiley & Sons, Inc.
C1 Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA.
   Kyushu Univ, Dept Biomed Engn, Fukuoka 812, Japan.
   Natl Cardiovasc Ctr, Dept Bioengn, Osaka, Japan.
   Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
RP Anderson, JM (reprint author), Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA.
FU NHLBI NIH HHS [HL-55714]; NIGMS NIH HHS [GM-20380]
CR ANDERSON JM, 1996, IMPLANT RETRIEVAL EV, P451
   Collier TO, 2000, J BIOMED MATER RES, V49, P141, DOI 10.1002/(SICI)1097-4636(200001)49:1<141::AID-JBM18>3.0.CO;2-A
   DeFife KM, 1999, J BIOMED MATER RES, V45, P148, DOI 10.1002/(SICI)1097-4636(199905)45:2<148::AID-JBM10>3.0.CO;2-U
   ENELOW RI, 1992, J INFECT DIS, V166, P664, DOI 10.1093/infdis/166.3.664
   FESUS L, 1993, FEBS LETT, V328, P1, DOI 10.1016/0014-5793(93)80952-Q
   Fraser A, 1996, CELL, V85, P781, DOI 10.1016/S0092-8674(00)81005-3
   GORCZEYOA W, 1993, LEUKEMIA, V14, P659
   HASSAN NF, 1989, J IMMUNOL, V143, P2179
   Huppertz B, 1999, ANAT EMBRYOL, V200, P1, DOI 10.1007/s004290050254
   KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33
   KREIPE H, 1988, AM J PATHOL, V130, P232
   MAJNO G, 1995, AM J PATHOL, V146, P3
   MANAGAN DF, 1991, J IMMUNOL, V147, P3408
   MANAGAN DF, 1991, J IMMUNOL, V146, P1541
   MARTIN SJ, 1995, J EXP MED, V182, P1545, DOI 10.1084/jem.182.5.1545
   MCINNES A, 1988, J EXP MED, V167, P598, DOI 10.1084/jem.167.2.598
   MCNALLY AK, 1994, P NATL ACAD SCI USA, V91, P10119, DOI 10.1073/pnas.91.21.10119
   MURCH AR, 1982, J PATHOL, V137, P177, DOI 10.1002/path.1711370302
   Nakayama Y, 1996, MACROMOLECULES, V29, P8622, DOI 10.1021/ma9606014
   OGASAWARA J, 1993, NATURE, V364, P806, DOI 10.1038/364806a0
   SUTTON JS, 1966, J CELL BIOL, V28, P303, DOI 10.1083/jcb.28.2.303
   WEINBERG JB, 1984, P NATL ACAD SCI USA, V81, P454
   WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0
   ZHAO Q, 1991, J BIOMED MATER RES, V25, P177, DOI 10.1002/jbm.820250205
   ZHAO QH, 1993, J BIOMED MATER RES, V27, P379, DOI 10.1002/jbm.820270311
NR 25
TC 128
Z9 133
U1 3
U2 26
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JUN 15
PY 2001
VL 55
IS 4
BP 661
EP 668
DI 10.1002/1097-4636(20010615)55:4<661::AID-JBM1061>3.0.CO;2-F
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 423VZ
UT WOS:000168199600026
PM 11288096
DA 2018-10-20
ER

PT J
AU Yang, JM
   Lin, HT
AF Yang, JM
   Lin, HT
TI Wettability and protein adsorption on HTPB-based polyurethane films
SO JOURNAL OF MEMBRANE SCIENCE
LA English
DT Article
DE hydroxyl-terminated polybutadiene; polyurethane; dimethyol propionic
   acid; wettability; protein adsorption
ID SBS-G-VP; DMAEMA COPOLYMER MEMBRANE; BIOMATERIAL USAGE; UV-RADIATION;
   HEPARIN
AB Hydroxyl-terminated polybutadiene-based (HTPB) polyurethane (PU) with different molar ratios of dimethyol propionic acid and 1,4-butane diol as the chain extender was synthesized by solution polymerization. The present PU was then cast into a membrane and subsequently characterized by the Fourier transform infrared spectroscopy. It was found that the participation of carbonyl group in hydrogen bonding increased with the content of dimethyol propionic acid in PU. The properties of the PU films including tensile strength and dynamic mechanical analysis (DMA) were studied. The tensile strength of PU films increased whereas the storage modulus decreased with increasing dimethyol propionic acid content. The glass transition temperature (T-g) Of the PU film with only 1,4-butane diol as the chain extender was 4 degreesC, while that of the films with dimethyol propionic acid as the chain extender was at about -15 degreesC. Wettability and protein adsorption on the films were evaluated from the water content, contact angle, and protein adsorptions of fibrinogen and albumin on the PU films. The diffusion coefficient of water in the membrane was determined in accordance with the Fickian diffusion mechanism. No significant difference in the diffusion coefficient was observed for all the specimens. By using the Kaelble's equation and the contact angle data, the surface tensions of the PU films with different amounts of dimethyol propionic acid were determined. The surface tension of PU film was found to increase with increasing dimethyol propionic acid content, while the opposite trend was observed for the contact angle and the amount of protein adsorption. (C) 2001 Elsevier Science B.V. All rights reserved.
C1 Chang Gung Univ, Dept Chem & Mat Engn, Tao Yuan 333, Taiwan.
RP Yang, JM (reprint author), Chang Gung Univ, Dept Chem & Mat Engn, Tao Yuan 333, Taiwan.
CR Abusafieh A, 1997, J APPL POLYM SCI, V63, P75, DOI 10.1002/(SICI)1097-4628(19970103)63:1<75::AID-APP8>3.0.CO;2-P
   ADAMSON AW, 1990, PHYSICAL CHEM SURFAC
   ANDRADE JD, 1985, SURFACE CHEM PHYSICS, V1
   COLEMAN MM, 1988, MACROMOLECULES, V21, P59, DOI 10.1021/ma00179a014
   KAELBLE DH, 1977, POLYMER, V18, P475, DOI 10.1016/0032-3861(77)90164-1
   LAI JY, 1991, J APPL POLYM SCI, V43, P1431, DOI 10.1002/app.1991.070430804
   LEE YM, 1994, POLYMER, V35, P1095, DOI 10.1016/0032-3861(94)90958-X
   LYMAN DJ, 1974, T AM SOC ART INT ORG, VB 20, P474
   MINOURA N, 1993, BIOMEDICAL APPL POLY, P118
   Ratner BD, 1996, BIOMATERIALS SCI, P133
   SEYMOUR RW, 1970, MACROMOLECULES, V3, P579, DOI 10.1021/ma60017a021
   TAKAHARA A, 1990, Artificial Organs, V14, P87
   TAKAHARA A, 1991, J BIOMED MATER RES, V25, P341, DOI 10.1002/jbm.820250306
   Yang JM, 1996, J BIOMED MATER RES, V31, P281
   Yang JM, 1998, J MEMBRANE SCI, V138, P19
   Yang JM, 1997, J BIOMED MATER RES, V35, P175, DOI 10.1002/(SICI)1097-4636(199705)35:2<175::AID-JBM5>3.0.CO;2-K
   Yang JM, 1997, J APPL POLYM SCI, V65, P109
   Yang JM, 1997, J MEMBRANE SCI, V128, P133, DOI 10.1016/S0376-7388(96)00312-2
   Yang JM, 1998, J BIOMED MATER RES, V39, P86, DOI 10.1002/(SICI)1097-4636(199801)39:1<86::AID-JBM11>3.0.CO;2-M
   Yang JM, 1999, J BIOMED MATER RES, V45, P133, DOI 10.1002/(SICI)1097-4636(199905)45:2<133::AID-JBM8>3.3.CO;2-4
   Yang JM, 2001, J MEMBRANE SCI, V183, P37, DOI 10.1016/S0376-7388(00)00550-0
NR 21
TC 37
Z9 37
U1 3
U2 13
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0376-7388
J9 J MEMBRANE SCI
JI J. Membr. Sci.
PD JUN 15
PY 2001
VL 187
IS 1-2
BP 159
EP 169
DI 10.1016/S0376-7388(01)00340-4
PG 11
WC Engineering, Chemical; Polymer Science
SC Engineering; Polymer Science
GA 435JY
UT WOS:000168879400017
DA 2018-10-20
ER

PT J
AU Gourlay, T
   Stefanou, DC
   Asimakopoulos, G
   Taylor, KM
AF Gourlay, T
   Stefanou, DC
   Asimakopoulos, G
   Taylor, KM
TI The effect of circuit surface area on CD11b(mac-1) expression in a rat
   recirculation model
SO ARTIFICIAL ORGANS
LA English
DT Article
DE inflammatory response; cardiopulmonary bypass; miniaturized
   cardiopulmonary bypass circuits
ID CARDIOPULMONARY BYPASS; INFLAMMATORY RESPONSE; LEUKOCYTE; COMPLEMENT;
   ACTIVATION; ADHESION
AB The aim of the study was to assess the effect of exposed surface area of diethylhexylphthalate plasticized polyvinylchloride (PVC) on the expression of the adhesion molecule CD11b(mac-1) on neutrophils and to determine whether there is any apparent advantage in the current trend in reducing circuit surface area in terms of neutrophil activation. The study was carried out using a parallel plate rodent recirculation biomaterial testing model on 4 groups of 10 adult male Sprague Dawley rats weighing between 350 and 450 g. One group comprised the control group in which there was no biomaterial exposure. In the remaining 3 groups, the animals were subjected to either high (48 cm(2)), intermediate (24 cm(2)), or low (12 cm(2)) biomaterial surface area exposure. The parallel plate test cell was connected to the right femoral circulation and recirculation initiated at a flow rate of 1.5 ml/min for a period of 60 min. Blood samples were taken at 0, 30, and 60 min for the assessment of CD11b expression. Cd11b was assessed using flow cytometric analysis on neutrophils. The results demonstrated that there was a surface area related effect in the upregulation of CD11b. The difference at the terminal sample point between the highest surface area group (293.95 +/- 18.57%) and the low surface area group (133.80 +/- 49.31%) was highly statistically significant (p < 0.001). These results demonstrate that there may be some gain in terms of reduced inflammatory response from reducing the exposed surface area of PVC in extracorporeal perfusion circuits.
C1 Natl Heart & Lung Inst, Imperial Coll Med Sch, Hammersmith Hosp, Dept Cardiac Surg, London W12 0NN, England.
RP Gourlay, T (reprint author), Natl Heart & Lung Inst, Imperial Coll Med Sch, Hammersmith Hosp, Dept Cardiac Surg, 2nd Floor B Block,DuCane Rd, London W12 0NN, England.
CR Asimakopoulos G, 1998, ANN THORAC SURG, V66, P2135, DOI 10.1016/S0003-4975(98)00727-9
   Asimakopoulos G, 2000, ANN THORAC SURG, V69, P1192, DOI 10.1016/S0003-4975(99)01553-2
   Asimakopoulos G, 1999, PERFUSION-UK, V14, P269, DOI 10.1177/026765919901400406
   BONE RC, 1992, CRIT CARE MED, V20, P864
   BUTLER J, 1993, ANN THORAC SURG, V55, P552, DOI 10.1016/0003-4975(93)91048-R
   Darling E, 1998, J Extra Corpor Technol, V30, P184
   GAKINANES M, 1996, CIRCULATION, V94, P364
   HILL GE, 1994, ANAESTH ANALG, V79, P1201
   LEDEIST F, 1995, CIRCULATION, V92, P354, DOI 10.1161/01.CIR.92.9.354
   MATHEW JP, 1995, J THORAC CARDIOV SUR, V109, P448, DOI 10.1016/S0022-5223(95)70275-X
   Moen O, 1997, ANN THORAC SURG, V63, P105
   TAGGART DP, 1994, ANN THORAC SURG, V57, P376, DOI 10.1016/0003-4975(94)91000-6
   Taketani S, 1998, ARTIF ORGANS, V22, P337, DOI 10.1046/j.1525-1594.1998.06007.x
NR 13
TC 16
Z9 16
U1 0
U2 0
PU BLACKWELL SCIENCE INC
PI MALDEN
PA 350 MAIN ST, MALDEN, MA 02148 USA
SN 0160-564X
J9 ARTIF ORGANS
JI Artif. Organs
PD JUN
PY 2001
VL 25
IS 6
BP 475
EP 479
DI 10.1046/j.1525-1594.2001.025006475.x
PG 5
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 452RT
UT WOS:000169873100009
PM 11453878
DA 2018-10-20
ER

PT J
AU van Luyn, MJA
   Plantinga, JA
   Brouwer, LA
   Khouw, IMSL
   de Leij, LFMH
   van Wachem, PB
AF van Luyn, MJA
   Plantinga, JA
   Brouwer, LA
   Khouw, IMSL
   de Leij, LFMH
   van Wachem, PB
TI Repetitive subcutaneous implantation of different types of
   (biodegradable) biomaterials alters the foreign body reaction
SO BIOMATERIALS
LA English
DT Article
DE biomaterials; repetitive implantation; plasma cells
ID DERMAL SHEEP COLLAGEN; INFLAMMATORY RESPONSES; MACROPHAGE;
   BIOCOMPATIBILITY; HETEROGENEITY; SUBSETS; RATS
AB In the present study two biodegradable materials (cross-linked collagens) and two non-biodegradable materials (polyurethane and silicone) were applied in a repetitive subcutaneous implantation model in rats. In contrast to the first challenge, the second challenge with the same type of material, but at a different subcutaneous site of the same animal, induced an increase of macrophages and giant cells inside the biodegradable materials. Additionally, only after the second challenge clusters and accumulations of plasma cells were present in the surrounding tissue of each type of material. Tn the same areas an increase of MHC II expression was measured by immunocytochemistry. Differences in the numbers of macrophages and T cells were not observed around the explants. Undifferentiated B cells or NK cells were not present at any time point. The results indicate that alterations observed after the second challenge did not depend on biodegradation of the materials. Significance of these Endings should be considered in view of increased and repetitive use of the same type of biomaterial (possibly for different application sites) for implantation in patients. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Univ Groningen, Fac Med Sci, Dept Pathol & Lab Med, NL-9713 GZ Groningen, Netherlands.
RP van Luyn, MJA (reprint author), Univ Groningen, Fac Med Sci, Dept Pathol & Lab Med, Hanzepl 1,Entrance 25, NL-9713 GZ Groningen, Netherlands.
CR ANDERSON JM, 1988, ASAIO, V11, P101
   Bar-Or RL, 1998, J THEOR BIOL, V190, P161
   Damink LHHO, 1996, BIOMATERIALS, V17, P765, DOI 10.1016/0142-9612(96)81413-X
   DIJKSTRA CD, 1993, PROG HISTOCHEM CYTOC, V27, P1
   DIJKSTRA CD, 1985, IMMUNOLOGY, V54, P589
   HOWIE DW, 1988, J BONE JOINT SURG AM, V70A, P257, DOI 10.2106/00004623-198870020-00015
   HUNIG T, 1989, J EXP MED, V169, P73, DOI 10.1084/jem.169.1.73
   KAO WYJ, 1995, J BIOMED MATER RES, V29, P1267, DOI 10.1002/jbm.820291014
   Khouw IMSL, 2000, J BIOMED MATER RES, V49, P297, DOI 10.1002/(SICI)1097-4636(20000305)49:3<297::AID-JBM1>3.0.CO;2-0
   McClelland M, 1997, PLAST RECONSTR SURG, V100, P1466, DOI 10.1097/00006534-199711000-00014
   Moghimi SM, 1997, CLIN SCI, V93, P371, DOI 10.1042/cs0930371
   Naoum C, 1998, DERMATOL SURG, V24, P867, DOI 10.1111/j.1524-4725.1998.tb04264.x
   TANG LP, 1993, J EXP MED, V178, P2147, DOI 10.1084/jem.178.6.2147
   TANG LP, 1995, AM J CLIN PATHOL, V103, P466
   van Luyn MJA, 1998, J BIOMED MATER RES, V39, P398
   VANGULIK TM, 1987, NETH J SURG, V39, P90
   VANWACHEM PB, 1994, J BIOMED MATER RES, V28, P353, DOI 10.1002/jbm.820280310
NR 17
TC 9
Z9 10
U1 0
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2001
VL 22
IS 11
BP 1385
EP 1391
DI 10.1016/S0142-9612(00)00295-7
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 425ZU
UT WOS:000168325200022
PM 11336312
DA 2018-10-20
ER

PT J
AU ten Koppel, PGJ
   van Osch, GJVM
   Verwoerd, CDA
   Verwoerd-Verhoef, HL
AF ten Koppel, PGJ
   van Osch, GJVM
   Verwoerd, CDA
   Verwoerd-Verhoef, HL
TI A new in vivo model for testing cartilage grafts and biomaterials: the
   'rabbit pinna punch-hole' model
SO BIOMATERIALS
LA English
DT Article
DE cartilage graft; tissue engineering; demineralized bone matrix;
   perichondrium; animal model
ID TISSUE-ENGINEERED CARTILAGE; TRABECULAR DEMINERALIZED BONE; IN-VIVO;
   PERICHONDRIUM; CHONDROCYTES; SURGERY; RECONSTRUCTION; CYANOACRYLATE;
   REGENERATION; COLLAGEN
AB In this study an animal model was developed for evaluation of the feasibility of cartilage grafts. In the cartilage of the external ear of the rabbit multiple holes, 6 mm in diameter, were punched, leaving the adherent skin intact. Different experimental groups were evaluated. First, the punch-hole model was validated under various conditions to study spontaneous or perichondrial initiated regeneration of the cartilage defect. When both cartilage and perichondrium was excised no spontaneous repair of the cartilage defect was observed. When perichondrium is present, variable patch-like closure of the punch hole was found. As 'golden standard' a punched out piece of cartilage was reimplanted directly. This condition showed adequate closure of the punch hole, however, no perfect integration of graft and surrounding cartilage was observed. Secondly, to evaluate the 'punch-hole model' a biomaterial, trabecular demineralized bovine bone matrix (DBM), was implanted and tested as a scaffold for tissue engineering techniques in vivo and in vitro. Direct implantation of DBM did not lead to any cartilage formation to close the defect. In vivo engineered cartilage, generated by enveloping DBM in perichondrium for 3 weeks, could adequately close the punch hole. When DBM was seeded with isolated chondrocytes in vitro before implantation in the defect, a highly fragmented graft, with some islets of viable cells was seen. To promote an efficient and reliable evaluation of cartilage grafts a semi-quantitative grading system was developed. Items such as quality, quantity and integrity of the cartilage graft were included in a histomorphological grading system to provide information about the properties of a specific cartilage graft. To validate the grading system, all conditions were scored by two independent observers. An excellent reliability (R = 0.96) was seen between the observers. In summary, the rabbit pinna punch-hole model is a reliable and efficient method for first evaluation of cartilage grafts. The results can be easily analyzed using a semi-quantitative grading system. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Erasmus Univ, Ctr Med, Dept Otorhinolaryngol Head & Neck Surg, NL-3000 DR Rotterdam, Netherlands.
RP van Osch, GJVM (reprint author), Erasmus Univ, Ctr Med, Dept Otorhinolaryngol Head & Neck Surg, Room EE1659,POB 1738, NL-3000 DR Rotterdam, Netherlands.
CR AGUADO DL, 1992, ACTA OTO-LARYNGOL, V112, P539, DOI 10.3109/00016489209137437
   Aigner J, 1998, J BIOMED MATER RES, V42, P172, DOI 10.1002/(SICI)1097-4636(199811)42:2<172::AID-JBM2>3.0.CO;2-M
   BEAN JK, 1993, INT J PEDIATR OTORHI, V25, P163, DOI 10.1016/0165-5876(93)90050-D
   BEAN JK, 1991, CHONDROGENESIS COLLA, P113
   Brown PN, 1996, ARCH OTOLARYNGOL, V122, P873
   BUJIA J, 1994, LARYNGO RHINO OTOL, V73, P577, DOI 10.1055/s-2007-997199
   Cao YL, 1997, PLAST RECONSTR SURG, V100, P297, DOI 10.1097/00006534-199708000-00001
   DUNCAN MJ, 1984, PLAST RECONSTR SURG, V73, P916, DOI 10.1097/00006534-198406000-00010
   EISEMANN ML, 1983, ARCH OTOLARYNGOL, V109, P469
   ENGKVIST O, 1979, SCAND J PLAST RECONS, V13, P275, DOI 10.3109/02844317909013070
   Haisch A, 1996, HNO, V44, P624, DOI 10.1007/s001060050067
   HARPER MC, 1988, CLIN ORTHOP RELAT R, P272
   HOMMINGA GN, 1989, ACTA ORTHOP SCAND, V60, P326, DOI 10.3109/17453678909149287
   JEFFRIES DJR, 1984, J LARYNGOL OTOL, V98, P577, DOI 10.1017/S0022215100147139
   JOSEPH J, 1966, BRIT J SURG, V53, P372, DOI 10.1002/bjs.1800530415
   Jurgensen K, 1997, J BONE JOINT SURG AM, V79A, P185, DOI 10.2106/00004623-199702000-00004
   MADSEN K, 1983, DEV BIOL, V96, P63, DOI 10.1016/0012-1606(83)90311-1
   MANKIN HJ, 1971, J BONE JOINT SURG AM, VA 53, P523, DOI 10.2106/00004623-197153030-00009
   Marijnissen WJCM, 2000, BIOMATERIALS, V21, P571, DOI 10.1016/S0142-9612(99)00218-5
   MATSUDA K, 1995, J BIOMAT SCI-POLYM E, V7, P221
   MEEUWIS J, 1993, ACTA OTO-LARYNGOL, V113, P379, DOI 10.3109/00016489309135829
   NEHRER S, 1997, BIOMATERIALS, V18, P797
   ODRISCOLL SW, 1986, J BONE JOINT SURG AM, V68A, P1017, DOI 10.2106/00004623-198668070-00008
   Ostergaard K, 1997, ARTHRITIS RHEUM, V40, P1766, DOI 10.1002/art.1780401007
   PETRUSON B, 1986, Rhinology (Utrecht), V24, P147
   PUELACHER WC, 1994, BIOMATERIALS, V15, P774, DOI 10.1016/0142-9612(94)90031-0
   QUATELA VC, 1993, LARYNGOSCOPE, V103, P798
   Rotter N, 1998, J BIOMED MATER RES, V42, P347, DOI 10.1002/(SICI)1097-4636(19981205)42:3<347::AID-JBM2>3.0.CO;2-J
   SKOOG T, 1972, SCAND J PLAST RECONS, V6, P123, DOI 10.3109/02844317209036711
   STAFFEL G, 1995, OTOLARYNG CLIN N AM, V28, P295
   ten Koppel PGJ, 1998, PLAST RECONSTR SURG, V102, P2012, DOI 10.1097/00006534-199811000-00031
   Urist MR, 1997, PLAST RECONSTR SURG, V99, P1382, DOI 10.1097/00006534-199704001-00028
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   VACANTI CA, 1994, J PEDIATR SURG, V29, P201, DOI 10.1016/0022-3468(94)90318-2
   van Osch GJVM, 1999, BIOMATERIALS, V20, P233, DOI 10.1016/S0142-9612(98)00165-3
NR 35
TC 11
Z9 11
U1 0
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2001
VL 22
IS 11
BP 1407
EP 1414
DI 10.1016/S0142-9612(00)00298-2
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 425ZU
UT WOS:000168325200025
PM 11336315
DA 2018-10-20
ER

PT J
AU Dillow, AK
   Ochsenhirt, SE
   McCarthy, JB
   Fields, GB
   Tirrell, M
AF Dillow, AK
   Ochsenhirt, SE
   McCarthy, JB
   Fields, GB
   Tirrell, M
TI Adhesion of alpha(5)beta(1) receptors to biomimetic substrates
   constructed from peptide amphiphiles
SO BIOMATERIALS
LA English
DT Article
DE biomimetic materials; peptides; surface modification; RGD; adhesion
ID FIBRONECTIN; ACTIVATION; ATTACHMENT; BINDING; CELLS; RGD; RECOGNITION;
   BIOMATERIAL; SEQUENCE; SURFACES
AB Biomimetic membrane surfaces functionalized with Fragments of the extracellular matrix protein, fibronectin, are constructed from mixtures of peptide and polyethylene glycol(PEG) amphiphiles. Peptides from the primary binding loop, GRGDSP, were used in conjunction with the synergy site peptide, PHSRN, in the III9-10 sites of human fibronectin. These peptides were attached to dialkyl lipid tails to form peptide amphiphiles. PEG amphiphiles were mixed in the layer to minimize non-specific adhesion in the background. GRGDSP acid PEG amphiphiles or GRGDSP, PHSRN- and PEG amphiphiles were mixed in various ratios and deposited on solid substrates from the air-water interface using Langmuir-Blodgett techniques. In this method, peptide composition, density, and presentation could be controlled accurately. The effectiveness of these substrates to mimic native fibronectin is evaluated by their ability to generate adhesive forces when they are in contact with purified activated alpha (5)beta (1) integrin receptors that are immobilized on an opposing surface. Adhesion is measured using a contact mechanical approach (JKR experiment). The effects of membrane composition, density, temperature, and peptide conformation on adhesion to activated integrins in this simulated cell adhesion setup were determined. Addition of the synergy site, PHSRN, was found to increase adhesion of alpha (5)beta (1) to biomimetic substrates markedly. Increased peptide mobility (due to increased experimental temperature) increased integrin adhesion markedly at low peptide concentrations. A balance between peptide density and steric accessibility of the receptor binding race to alpha (5)beta (1), integrin was required for highest adhesion. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Univ Minnesota, Dept Chem Engn & Mat Sci, Minneapolis, MN 55455 USA.
   Univ Minnesota, Dept Pathol & Lab Med, Minneapolis, MN 55455 USA.
   Florida Atlantic Univ, Dept Chem & Biochem, Boca Raton, FL 33431 USA.
RP Tirrell, M (reprint author), Univ Calif Santa Barbara, Coll Engn, Santa Barbara, CA 93106 USA.
FU NHLBI NIH HHS [HL62427-01]
CR Baneres JL, 1998, J BIOL CHEM, V273, P24744, DOI 10.1074/jbc.273.38.24744
   BARERRA DA, 1993, J AM CHEM SOC, V115, P11010
   BERNDT P, 1995, J AM CHEM SOC, V117, P9515, DOI 10.1021/ja00142a019
   Cook AD, 1997, J BIOMED MATER RES, V35, P513
   Davison E, 1997, J VIROL, V71, P6204
   DERUELLE M, 1995, MACROMOLECULES, V28, P7419, DOI 10.1021/ma00126a021
   Dillow AK, 1998, CURR OPIN SOLID ST M, V3, P252, DOI 10.1016/S1359-0286(98)80099-5
   DILLOW AK, 2001, UNPUB BIOPHYS J
   Dori Y, 2000, J BIOMED MATER RES, V50, P75, DOI 10.1002/(SICI)1097-4636(200004)50:1<75::AID-JBM11>3.0.CO;2-A
   Faull RJ, 1996, J BIOL CHEM, V271, P25099, DOI 10.1074/jbc.271.41.25099
   FAULL RJ, 1995, STEM CELLS, V13, P38, DOI 10.1002/stem.5530130106
   Garcia AJ, 1998, J BIOL CHEM, V273, P34710, DOI 10.1074/jbc.273.52.34710
   Garcia AJ, 1998, J BIOL CHEM, V273, P10988, DOI 10.1074/jbc.273.18.10988
   Glass JR, 1996, BIOMATERIALS, V17, P1101, DOI 10.1016/0142-9612(96)85911-4
   Grant RP, 1997, J BIOL CHEM, V272, P6159, DOI 10.1074/jbc.272.10.6159
   Griffith LG, 1998, BIOMATERIALS, V19, P979, DOI 10.1016/S0142-9612(97)00185-3
   Hern DL, 1998, J BIOMED MATER RES, V39, P266, DOI 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B
   Hocking DC, 1998, J CELL BIOL, V141, P241, DOI 10.1083/jcb.141.1.241
   Hubbell JA, 1999, CURR OPIN BIOTECH, V10, P123, DOI 10.1016/S0958-1669(99)80021-4
   Humphries MJ, 1999, BIOCHEM SOC SYMP, V65, P63
   Johansson Staffan, 1997, Frontiers in Bioscience (online), V2, pD126
   JOHNSON KL, 1971, PROC R SOC LON SER-A, V324, P301, DOI 10.1098/rspa.1971.0141
   KUGO K, 1994, J BIOMAT SCI-POLYM E, V5, P325, DOI 10.1163/156856294X00059
   Lahiri J, 1999, LANGMUIR, V15, P2055, DOI 10.1021/la9811970
   LASIC DD, 1995, STEALTH LIPOSOMES
   Mangipudi VS, 1998, RUBBER CHEM TECHNOL, V71, P407, DOI 10.5254/1.3538490
   MANNGIPUDI VS, 1996, MACROMOL S, V102, P131
   Mould AP, 1997, J BIOL CHEM, V272, P17283, DOI 10.1074/jbc.272.28.17283
   Mould AP, 1998, BIOCHEM J, V331, P821, DOI 10.1042/bj3310821
   OCHSENHIRT SE, 2001, UNPUB
   OCHSENHIRT SE, 1999, UNPUB
   Pakalns T, 1999, BIOMATERIALS, V20, P2265, DOI 10.1016/S0142-9612(99)00157-X
   Porte-Durrieu MC, 1999, J BIOMED MATER RES, V46, P368
   Rezania A, 1997, J BIOMED MATER RES, V37, P9, DOI 10.1002/(SICI)1097-4636(199710)37:1<9::AID-JBM2>3.0.CO;2-W
   Roberts C, 1998, J AM CHEM SOC, V120, P6548, DOI 10.1021/ja972467o
   Schense JC, 1999, BIOCONJUGATE CHEM, V10, P75, DOI 10.1021/bc9800769
   Shakesheff KM, 1998, J BIOMAT SCI-POLYM E, V9, P507, DOI 10.1163/156856298X00596
   Winger TM, 1996, BIOMATERIALS, V17, P437, DOI 10.1016/0142-9612(96)89661-X
   Yu YC, 1996, J AM CHEM SOC, V118, P12515, DOI 10.1021/ja9627656
   Zhang SG, 1999, BIOMATERIALS, V20, P1213, DOI 10.1016/S0142-9612(99)00014-9
NR 40
TC 56
Z9 60
U1 0
U2 13
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2001
VL 22
IS 12
BP 1493
EP 1505
DI 10.1016/S0142-9612(00)00304-5
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 431MD
UT WOS:000168634300006
PM 11374448
DA 2018-10-20
ER

PT J
AU Peng, Q
   Apple, DJ
   Arthur, SN
   Merritt, JH
   Escobar-Gomez, M
   Hoddinott, DSM
AF Peng, Q
   Apple, DJ
   Arthur, SN
   Merritt, JH
   Escobar-Gomez, M
   Hoddinott, DSM
TI Snowflake opacification of poly(methyl methacrylate) intraocular lens
   optic biomaterial: A newly described syndrome
SO INTERNATIONAL OPHTHALMOLOGY CLINICS
LA English
DT Article
ID GLISTENINGS; SURFACES
C1 Med Univ S Carolina, Dept Ophthalmol, Storm Eye Inst, Ctr Res Ocular Therapeut & Biodevices, Charleston, SC 29425 USA.
RP Peng, Q (reprint author), Med Univ S Carolina, Dept Ophthalmol, Storm Eye Inst, Ctr Res Ocular Therapeut & Biodevices, 171 Ashley Ave, Charleston, SC 29425 USA.
CR Apple DJ, 2000, J CATARACT REFR SURG, V26, P796, DOI 10.1016/S0886-3350(00)00517-4
   APPLE DJ, 1984, SURV OPHTHALMOL, V29, P1, DOI 10.1016/0039-6257(84)90113-9
   APPLE DJ, 2000, FOLDABLE INTRAOCULAR, P103
   APPLE DJ, 2001, IN PRESS AM J OPHTHA
   APPLE DJ, 1995, SURV OPHTHALMOL, V40, P279
   APPLE DJ, 1984, AM INTRA-OCUL IMPL J, V10, P53
   CHRIST FR, 1995, ENCY HDB BIOMATERIAL, P1277
   DAVIS D, 1993, OPHTHALMOLOGY TIMES, V18, P6
   DAVIS D, 1993, OCULAR NEWS, V11, P3
   Dhaliwal DK, 1996, J CATARACT REFR SURG, V22, P452, DOI 10.1016/S0886-3350(96)80041-1
   Omar O, 1998, J CATARACT REFR SURG, V24, P107, DOI 10.1016/S0886-3350(98)80082-5
   PARK JB, 1979, BIOMATERIALS INTRO, P88
   RIDLEY H, 1951, T OPHTHAL SOC UK, V71, P617
   RIDLEY NHL, 1951, ST THOMAS HOSP REPOR, V7, P12
   Sugaya H, 1999, CONTRIB NEPHROL, V125, P1
   Werner L, 2000, OPHTHALMOLOGY, V107, P2179, DOI 10.1016/S0161-6420(00)00416-4
NR 16
TC 7
Z9 8
U1 0
U2 2
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0020-8167
J9 INT OPHTHALMOL CLIN
JI Int. Ophthalmol. Clin.
PD SUM
PY 2001
VL 41
IS 3
BP 91
EP 107
DI 10.1097/00004397-200107000-00009
PG 17
WC Ophthalmology
SC Ophthalmology
GA 463WZ
UT WOS:000170501400007
PM 11481542
DA 2018-10-20
ER

PT J
AU Neut, D
   van de Belt, H
   Stokroos, I
   van Horn, JR
   van der Mei, HC
   Busscher, HJ
AF Neut, D
   van de Belt, H
   Stokroos, I
   van Horn, JR
   van der Mei, HC
   Busscher, HJ
TI Biomaterial-associated infection of gentamicin-loaded PMMA beads in
   orthopaedic revision surgery
SO JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
LA English
DT Article
ID HIP; REPLACEMENT
AB In two-stage orthopaedic revision surgery, high local levels of antibiotics are achieved after removal of an infected prosthesis through temporary implantation of gentamicin-loaded beads. However, despite their antibiotic release, these beads act as a biomaterial surface to which bacteria preferentially adhere, grow and potentially develop antibiotic resistance. Gentamicin-loaded beads were retrieved from 20 patients with prosthesis-related infections. Excised tissue samples were taken for routine culture, while beads were analysed in an extensive laboratory procedure. Extensive culture procedures indicated the presence of bacteria on gentamicin-loaded beads in 18 of the 20 patients involved, while 12 of these 18 patients were considered free of infection by routine culture. Nineteen of 28 bacterial strains isolated were gentamicin resistant and cultures from three patients yielded highly gentamicin-resistant sub-populations. It is concluded that routine culture of excised tissues in orthopaedic revision surgery is inadequate to ascertain full eradication of infection, especially as infecting, antibiotic-resistant bacteria preferentially adhere to and grow on gentamicin-loaded beads. Extensive examination of the bead surfaces is proposed as a more reliable indication that infection has been eradicated.
C1 Univ Groningen, Dept Biomed Engn, NL-9713 AV Groningen, Netherlands.
   Univ Groningen Hosp, Dept Orthopaed Surg, NL-9713 GZ Groningen, Netherlands.
   Univ Groningen, Dept Cell Biol & Electron Microscopy, NL-9713 EZ Groningen, Netherlands.
RP Busscher, HJ (reprint author), Univ Groningen, Dept Biomed Engn, Antonius Deusinglaan 1, NL-9713 AV Groningen, Netherlands.
CR ANTTIPOIKA I, 1990, ACTA ORTHOP SCAND, V61, P163, DOI 10.3109/17453679009006513
   DANKERT J, 1986, CRIT REV BIOCOMPAT, V2, P219
   GRISTINA AG, 1985, J BONE JOINT SURG AM, V67A, P264, DOI 10.2106/00004623-198567020-00014
   HARRIS WH, 1990, NEW ENGL J MED, V323, P801, DOI 10.1056/NEJM199009203231206
   Kendall RW, 1996, CLIN ORTHOP RELAT R, P273
   LATTIMER GL, 1979, JAMA-J AM MED ASSOC, V242, P2213, DOI 10.1001/jama.242.20.2213
   SPELLER DCE, 1976, LANCET, V1, P464
   Tunney MM, 1998, ANTIMICROB AGENTS CH, V42, P3002, DOI 10.1128/AAC.42.11.3002
   van de Belt H, 1999, NAT MED, V5, P358, DOI 10.1038/7330
   von Eiff C, 1998, Z ORTHOP GRENZGEB, V136, P268, DOI 10.1055/s-2008-1054234
   WAHLIG H, 1978, J BONE JOINT SURG BR, V60, P270
NR 11
TC 135
Z9 139
U1 1
U2 13
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-7453
J9 J ANTIMICROB CHEMOTH
JI J. Antimicrob. Chemother.
PD JUN
PY 2001
VL 47
IS 6
BP 885
EP 891
DI 10.1093/jac/47.6.885
PG 7
WC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
SC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
GA 442UA
UT WOS:000169302300020
PM 11389124
OA Bronze
DA 2018-10-20
ER

PT J
AU Tsujimoto, K
   Takagi, H
   Takahashi, M
   Yamada, H
   Nakamori, S
AF Tsujimoto, K
   Takagi, H
   Takahashi, M
   Yamada, H
   Nakamori, S
TI Cryoprotective effect of the serine-rich repetitive sequence in silk
   protein sericin
SO JOURNAL OF BIOCHEMISTRY
LA English
DT Article
DE Bombyx mori; cryoprotection; freezing tolerance; repetitive sequence;
   sericin
ID CHLORELLA-VULGARIS C-27; SACCHAROMYCES-CEREVISIAE; BOMBYX-MORI; FREEZING
   TOLERANCE; MESSENGER-RNAS; LEA PROTEINS; GENE; PROLINE; DESICCATION;
   EXPRESSION
AB The silk proteins, fibroin and sericin, are produced in the silk gland of Bombyx mori, and hydrophilic sericin envelops fibroin with successive sticky layers in the formation of a cocoon. To study the biological functions of sericin, we focused on the serine-rich sericin peptide consisting of 38 amino acids, which is a highly conserved and internally repetitive sequence of a sericin protein. The corresponding gene was chemically synthesized, and the PCR-amplified gene was ligated to oligomerize sericin peptide and fused at the amino terminus to a His-tagged and proteolytic cleavage sequence in an inducible expression vector, When the dimers of sericin peptides were overexpressed in Escherichia coli, the transformants showed a prominent increase in cell viability after freezing in medium, Further, the purified dimeric sericin peptide from E. coli was found to be effective in protecting lactate dehydrogenase from denaturation caused by freeze-thaw. Both of these protective effects against freezing stress in cells and proteins were also observed with sericin hydrolysate. These results indicate that this unique sericin peptide, like sericin, has a high cryoprotective activity and will be valuable as a new biomaterial for industrial use.
C1 Fukui Prefectural Univ, Dept Biosci, Matsuoka, Fukui 9101195, Japan.
   Seiren Co Ltd, Dept Technol, Fukui 9188560, Japan.
RP Takagi, H (reprint author), Fukui Prefectural Univ, Dept Biosci, 4-1-1 Kenjojima, Matsuoka, Fukui 9101195, Japan.
CR DURE L, 1989, PLANT MOL BIOL, V12, P475, DOI 10.1007/BF00036962
   DURE L, 1993, PLANT J, V3, P363, DOI 10.1046/j.1365-313X.1993.t01-19-00999.x
   GALAU GA, 1986, PLANT MOL BIOL, V7, P155, DOI 10.1007/BF00021327
   GAMO T, 1982, BIOCHEM GENET, V20, P165, DOI 10.1007/BF00484944
   GAMO T, 1977, INSECT BIOCHEM, V7, P285, DOI 10.1016/0020-1790(77)90026-9
   Garel A, 1997, INSECT BIOCHEM MOLEC, V27, P469, DOI 10.1016/S0965-1748(97)00022-2
   Goller K, 1999, J MOL CATAL B-ENZYM, V7, P37, DOI 10.1016/S1381-1177(99)00043-0
   GRIFFITHS JB, 1978, CRYOBIOLOGY, V15, P517, DOI 10.1016/0011-2240(78)90073-1
   HINSON DL, 1988, BIOTECHNIQUES, V6, P14
   Honjoh K, 1999, J PLANT PHYSIOL, V155, P509, DOI 10.1016/S0176-1617(99)80046-7
   Honjoh K, 2000, BIOSCI BIOTECH BIOCH, V64, P1656, DOI 10.1271/bbb.64.1656
   Imai R, 1996, GENE, V170, P243, DOI 10.1016/0378-1119(95)00868-3
   JOH T, 1995, PLANT CELL PHYSIOL, V36, P85
   Kato N, 1998, BIOSCI BIOTECH BIOCH, V62, P145, DOI 10.1271/bbb.62.145
   Komatsu K., 1985, P 7 INT WOOL TEXT RE, V1, P373
   MAKER JC, 1988, PLANT MOL BIOL, V11, P277
   MAZUR P, 1977, CRYOBIOLOGY, V14, P251, DOI 10.1016/0011-2240(77)90175-4
   Meijer PJ, 1996, PROTEIN ENG, V9, P1051, DOI 10.1093/protein/9.11.1051
   MICHAILLE JJ, 1990, GENE, V86, P177, DOI 10.1016/0378-1119(90)90277-X
   MICHAILLE JJ, 1986, BIOCHIMIE, V68, P1165, DOI 10.1016/S0300-9084(86)80060-8
   OKAMOTO H, 1982, J BIOL CHEM, V257, P5192
   Prudhomme J.C., 1985, COMPREHENSIVE INSECT, V10, P571
   RUDOLPH AS, 1985, CRYOBIOLOGY, V22, P367, DOI 10.1016/0011-2240(85)90184-1
   Sambrook J, 1989, MOL CLONING LAB MANU
   Shima J, 1999, APPL ENVIRON MICROB, V65, P2841
   Swire-Clark GA, 1999, PLANT MOL BIOL, V39, P117, DOI 10.1023/A:1006106906345
   Takagi H, 1997, APPL MICROBIOL BIOT, V47, P405, DOI 10.1007/s002530050948
   Takagi H, 2000, FEMS MICROBIOL LETT, V184, P103, DOI 10.1016/S0378-1097(00)00023-9
   TAMIYA T, 1985, CRYOBIOLOGY, V22, P446, DOI 10.1016/0011-2240(85)90156-7
   VANDIJCK P, 1995, APPL ENVIRON MICROB, V61, P109
   Zhang L, 2000, J BIOCHEM, V127, P611, DOI 10.1093/oxfordjournals.jbchem.a022648
NR 31
TC 47
Z9 51
U1 0
U2 15
PU JAPANESE BIOCHEMICAL SOC
PI TOKYO
PA ISHIKAWA BLDG-3F, 25-16 HONGO-5-CHOME, BUNKYO-KU, TOKYO, 113, JAPAN
SN 0021-924X
J9 J BIOCHEM-TOKYO
JI J. Biochem. (Tokyo)
PD JUN
PY 2001
VL 129
IS 6
BP 979
EP 986
DI 10.1093/oxfordjournals.jbchem.a002946
PG 8
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 440LM
UT WOS:000169176800018
PM 11388915
DA 2018-10-20
ER

PT J
AU Koike, M
   Fujii, H
AF Koike, M
   Fujii, H
TI In vitro assessment of corrosive properties of titanium as a biomaterial
SO JOURNAL OF ORAL REHABILITATION
LA English
DT Article
DE biocompatibility; organic acid; titanium
ID METAL-ION RELEASE; HUMAN TISSUES; SENSITIVITY; DEPOSITION; TI-6A1-4V;
   IMPLANTS; INVITRO
AB Titanium (Ti) is thought to be a highly biocompatible material, and its clinical applications are becoming increasingly frequent. However, there have recently been some clinical papers reporting hypersensitivity and allergic reactions to Ti. The purpose of this study was to assess the corrosive properties of Ti in the intra-oral environment in vitro. Cast pure Ti specimens were immersed in artificial saliva, physiological saline solution, and 128 mmol L-1 of lactic, formic and acetic acids for 3 weeks at 37 degreesC with shaking. The colour, weight, surface morphologies and chemical binding state of specimens were observed before and after immersion. Marked discoloration was recognized on the surface of specimens immersed in formic acid, and a significant difference was found between the immersion solutions. Weight changes also varied with solutions; a tendency to increase in formic acid and to decrease in lactic acid. A slight loss was observed in specimens immersed in lactic acid and artificial saliva. The oxide layer composed mainly of Ti-oxide on the surface of the immersed specimens was thinnest in lactic acid, and thickest in formic acid. The present study indicates that both hydrogen evolution type and oxygen diffusion type corrosion on Ti surfaces are possible in the living body. (Our results also confirm some clinical studies reporting Ti accumulation in surrounding tissues and Ti causing allergic reactions.)
C1 Nagasaki Univ, Sch Dent, Dept Removable Prosthodont, Nagasaki 8528588, Japan.
RP Koike, M (reprint author), Nagasaki Univ, Sch Dent, Dept Removable Prosthodont, 1-7-1 Sakamoto, Nagasaki 8528588, Japan.
CR AGINS HJ, 1988, J BONE JOINT SURG AM, V70A, P347, DOI 10.2106/00004623-198870030-00005
   ARAGON PJ, 1972, J BIOMED MATER RES, V6, P155, DOI 10.1002/jbm.820060304
   ASAMI K, 1993, CORROS SCI, V35, P43, DOI 10.1016/0010-938X(93)90131-Y
   BESSHO K, 1995, J BIOMED MATER RES, V29, P901, DOI 10.1002/jbm.820290716
   Bessho Kazuhisa, 1993, Clinical Materials, V14, P223, DOI 10.1016/0267-6605(93)90006-S
   BREME J, 1988, BIOMATERIALS, V9, P310, DOI 10.1016/0142-9612(88)90024-5
   BROWN SA, 1988, J BIOMED MATER RES, V22, P321, DOI 10.1002/jbm.820220406
   BRUNE D, 1982, SCAND J DENT RES, V90, P168
   CASTLEMAN LS, 1976, J BIOMED MATER RES, V10, P695, DOI 10.1002/jbm.820100505
   CLARK GCF, 1982, J BIOMED MATER RES, V16, P125, DOI 10.1002/jbm.820160205
   *COMM INT ECL, 1986, TECHN REP COLORIMETR, P74
   CORNELIUS L, 1981, GEIGY SCI TABLES, V1, P111
   CORNELIUS L, 1983, GEIGY SCI TABLES, V3, P107
   DAMEN JJM, 1991, J DENT RES, V70, P1346, DOI 10.1177/00220345910700100601
   DUCHEYNE P, 1984, J BIOMED MATER RES, V18, P293, DOI 10.1002/jbm.820180306
   EASTOE JE, 1968, BIOCH HDB, P907
   ERWIN K, 1970, INTRO MATH STAT PRIN
   FERGUSON AB, 1960, J BONE JOINT SURG AM, V42, P77, DOI 10.2106/00004623-196042010-00007
   GEDDES DA, 1981, FRONTIERS ORAL PHYSL, V3, P78
   HANAWA T, 1991, BIOMATERIALS, V12, P767, DOI 10.1016/0142-9612(91)90028-9
   HANSSON HA, 1983, J PROSTHET DENT, V50, P108, DOI 10.1016/0022-3913(83)90175-0
   HEALY KE, 1992, J BIOMED MATER RES, V26, P319, DOI 10.1002/jbm.820260305
   HILLE GH, 1966, J MATER, V1, P373
   Jacobs JJ, 1998, J BONE JOINT SURG AM, V80A, P1447, DOI 10.2106/00004623-199810000-00006
   Jorgenson DS, 1997, PLAST RECONSTR SURG, V99, P976, DOI 10.1097/00006534-199704000-00006
   KELLER J C, 1985, Dental Materials, V1, P41, DOI 10.1016/S0109-5641(85)80022-1
   Klinger A, 1997, J BIOMED MATER RES, V36, P387, DOI 10.1002/(SICI)1097-4636(19970905)36:3<387::AID-JBM13>3.0.CO;2-B
   Koike M., 1997, J JPN PROSTHODONT SO, V41, P675
   LAING PATRICK G., 1967, J BIOMED MAT RES, V1, P135, DOI 10.1002/jbm.820010113
   LALOR PA, 1991, J BONE JOINT SURG BR, V73, P25
   LEBUGLE A, 1981, PHYS SCRIPTA, V23, P825, DOI 10.1088/0031-8949/23/5A/013
   MIMURA H, 1996, JPN J DENT MAT DEV, V15, P283
   MITCHELL D L, 1990, International Journal of Oral and Maxillofacial Implants, V5, P79
   Miyakawa O, 1995, J J DENT MAT, V14, P560
   MORAN CA, 1991, HUM PATHOL, V22, P450, DOI 10.1016/0046-8177(91)90130-H
   PETERS MS, 1984, CONTACT DERMATITIS, V11, P214, DOI 10.1111/j.1600-0536.1984.tb00986.x
   PORTE L, 1977, J LESS-COMMON MET, V56, P183, DOI 10.1016/0022-5088(77)90040-6
   QUALE JL, 1992, RADIOLOGY, V182, P855, DOI 10.1148/radiology.182.3.1535907
   RAE T, 1975, J BONE JOINT SURG BR, V57, P444
   RAE T, 1981, J BONE JOINT SURG BR, V63, P435
   RAMQVIST L, 1969, J PHYS CHEM SOLIDS, V30, P1835, DOI 10.1016/0022-3697(69)90252-2
   REDLINE S, 1986, BRIT J IND MED, V43, P652
   REVIE R W, 1969, Journal of Biomedical Materials Research, V3, P465, DOI 10.1002/jbm.820030308
   ROSENBERG A, 1993, INT J ORAL MAX SURG, V22, P185, DOI 10.1016/S0901-5027(05)80249-8
   Solar R. J., 1979, ASTM STP, V684, P161
   SPECK KM, 1980, J DENT RES, V59, P1590, DOI 10.1177/00220345800590100601
   WEINGART D, 1994, INT J ORAL MAX SURG, V23, P450, DOI 10.1016/S0901-5027(05)80045-1
NR 47
TC 25
Z9 25
U1 1
U2 14
PU BLACKWELL SCIENCE LTD
PI OXFORD
PA P O BOX 88, OSNEY MEAD, OXFORD OX2 0NE, OXON, ENGLAND
SN 0305-182X
J9 J ORAL REHABIL
JI J. Oral Rehabil.
PD JUN
PY 2001
VL 28
IS 6
BP 540
EP 548
DI 10.1046/j.1365-2842.2001.00690.x
PG 9
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 445WM
UT WOS:000169481600007
PM 11422680
DA 2018-10-20
ER

PT J
AU Kyriakides, TR
   Hartzel, T
   Huynh, G
   Bornstein, P
AF Kyriakides, TR
   Hartzel, T
   Huynh, G
   Bornstein, P
TI Regulation of angiogenesis and matrix remodeling by localized,
   matrix-mediated antisense gene delivery
SO MOLECULAR THERAPY
LA English
DT Article
DE local gene therapy; gene-activated matrix; extracellular matrix;
   thrombospondin; foreign body reaction; biomaterial implants;
   angiogenesis; antisense DNA
ID ENDOTHELIAL GROWTH-FACTOR; FOREIGN-BODY REACTION; IN-VIVO; MATRICELLULAR
   PROTEINS; MICE; THROMBOSPONDIN-1; BIOMATERIALS; APOPTOSIS; COLLAGEN;
   INHIBITION
AB Implantation of biomaterials, such as glucose sensors, leads to the formation of a poorly vascularized collagenous capsule that can lead to implant failure. This process, known as the foreign body reaction (FBR), develops in response to almost all biomaterials and consists of overlapping phases similar to those in wound healing. Implantation of porous biomaterials, such as polyvinyl alcohol sponges, also leads to granuloma formation within the interstices of the sponge prior to encapsulation by the FBR. We asked whether delivery of an antisense cDNA for the potent angiogenesis inhibitor thrombospondin (TSP) 2 would enhance blood vessel formation and alter collagen fibrillogenesis in the sponge granuloma and capsule. Collagen solutions were mixed with plasmid to generate gene-activated matrices (GAMs) and applied to biomaterials that were then implanted subcutaneously. Sustained expression of plasmid-encoded proteins was observed at 2 weeks and a month following implantation. In vivo delivery of plasmids, encoding either sense or antisense TSP2 cDNA, altered blood vessel formation and collagen deposition in TSP2-null and wild-type mice, respectively. Untreated implants, implanted next to CAM-treated implants, did not show exogenous gene expression and did not elicit altered responses, suggesting that gene delivery was limited to implant sites. This method of antisense DNA delivery has the potential to improve the performance and life span of implantable delivery devices and biosensors.
C1 Univ Washington, Dept Biochem, Seattle, WA 98195 USA.
   Univ Washington, Dept Med, Seattle, WA 98195 USA.
RP Bornstein, P (reprint author), Univ Washington, Dept Biochem, Box 357350, Seattle, WA 98195 USA.
FU NHLBI NIH HHS [HL18645]; NIAMS NIH HHS [AR45418]
CR Andrade SP, 1997, MICROVASC RES, V54, P253, DOI 10.1006/mvre.1997.2047
   ANDRADE SP, 1992, BRIT J CANCER, V66, P821, DOI 10.1038/bjc.1992.367
   Bein K, 2000, J BIOL CHEM, V275, P32167, DOI 10.1074/jbc.M003834200
   Bonadio J, 2000, J MOL MED-JMM, V78, P303, DOI 10.1007/s001090000118
   Bonadio J, 1999, NAT MED, V5, P753, DOI 10.1038/10473
   Bornstein P, 2000, MATRIX BIOL, V19, P557, DOI 10.1016/S0945-053X(00)00104-9
   BORNSTEIN P, 1995, J CELL BIOL, V130, P503, DOI 10.1083/jcb.130.3.503
   Carmeliet P, 2000, NAT MED, V6, P1102, DOI 10.1038/80430
   Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220
   Chandler LA, 2000, MOL THER, V2, P153, DOI 10.1006/mthe.2000.0102
   DAVIDSON JM, 1985, J CELL BIOL, V100, P1219, DOI 10.1083/jcb.100.4.1219
   Fang JM, 1996, P NATL ACAD SCI USA, V93, P5753, DOI 10.1073/pnas.93.12.5753
   GOLDSTEIN SA, 1998, CLIN ORTHOPAEDICS, V355, P5154
   Guo NH, 1997, CANCER RES, V57, P1735
   Hubbell JA, 1999, CURR OPIN BIOTECH, V10, P123, DOI 10.1016/S0958-1669(99)80021-4
   Im SA, 1999, CANCER RES, V59, P895
   Jimenez B, 2000, NAT MED, V6, P41, DOI 10.1038/71517
   Khouw IMSL, 2000, J BIOMED MATER RES, V50, P259, DOI 10.1002/(SICI)1097-4636(200005)50:2<259::AID-JBM21>3.0.CO;2-B
   Kyriakides TR, 1999, J INVEST DERMATOL, V113, P782, DOI 10.1046/j.1523-1747.1999.00755.x
   Kyriakides TR, 1998, J CELL BIOL, V140, P419, DOI 10.1083/jcb.140.2.419
   Kyriakides TR, 1999, P NATL ACAD SCI USA, V96, P4449, DOI 10.1073/pnas.96.8.4449
   Labhasetwar V, 1998, J PHARM SCI, V87, P1347, DOI 10.1021/js980077+
   Lauffenburger DA, 1999, NAT MED, V5, P733, DOI 10.1038/10451
   Lawler J, 2000, CURR OPIN CELL BIOL, V12, P634, DOI 10.1016/S0955-0674(00)00143-5
   Maheshwari A, 2000, MOL THER, V2, P121, DOI 10.1006/mthe.2000.0105
   MOREHEAD JM, 1994, OTOLARYNG CLIN N AM, V27, P195
   Nakashima T, 2000, HEAD NECK-J SCI SPEC, V22, P483, DOI 10.1002/1097-0347(200008)22:5<483::AID-HED7>3.3.CO;2-8
   Nor JE, 2000, J VASC RES, V37, P209, DOI 10.1159/000025733
   Ochiya T, 1999, NAT MED, V5, P707
   Ratner BD, 1996, J MOL RECOGNIT, V9, P617, DOI 10.1002/(SICI)1099-1352(199634/12)9:5/6<617::AID-JMR310>3.0.CO;2-D
   Shea LD, 1999, NAT BIOTECHNOL, V17, P551
   Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006
   Werb Z, 1999, APMIS, V107, P11, DOI 10.1111/j.1699-0463.1999.tb01521.x
   WILLIAMS DF, 1989, J BIOMED ENG, V11, P185, DOI 10.1016/0141-5425(89)90138-6
   Yang ZT, 2000, MOL BIOL CELL, V11, P3353, DOI 10.1091/mbc.11.10.3353
NR 35
TC 40
Z9 42
U1 0
U2 3
PU ACADEMIC PRESS INC
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1525-0016
J9 MOL THER
JI Mol. Ther.
PD JUN
PY 2001
VL 3
IS 6
BP 842
EP 849
DI 10.1006/mthe.2001.0336
PG 8
WC Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine,
   Research & Experimental
SC Biotechnology & Applied Microbiology; Genetics & Heredity; Research &
   Experimental Medicine
GA 444TZ
UT WOS:000169417300005
PM 11407897
OA Other Gold
DA 2018-10-20
ER

PT J
AU Holgers, KM
   Branemark, PI
AF Holgers, KM
   Branemark, PI
TI Immunohistochemical study of clinical skin-penetrating titanium implants
   for orthopaedic prostheses compared with implants in the craniofacial
   area
SO SCANDINAVIAN JOURNAL OF PLASTIC AND RECONSTRUCTIVE SURGERY AND HAND
   SURGERY
LA English
DT Article
DE biomaterial; artificial devices; percutaneous; skin-penetrating;
   titanium; orthopaedic; rehabilitation; prostheses; craniofacial
AB The technique of using osseointrgrated bone-anchored percutaneous titanium implants in the rehabilitation of patients with amputated limbs has recently been introduced at the Branemark Osseointegration Centre in Gotteborg. The new method is based on an implantation technique that is well-established for anchorage of bone-conductive hearing aids and craniofacial prostheses. The soft tissues around skin-penetrating titanium implants used to anchor orthopaedic prostheses were evaluated histochemically using quantitative analyses. The implants had been in clinical use for beta;ren 6 to 24 months. The number of inflammatory cells was higher in the area close to the interface than in the area distant from the skin-penetrating site, and higher than in the corresponding controls. The current data was also compared with corresponding data from tissue around skin-penetrating craniofacial implants. The number of inflammatory cells was lower in the orthopaedic samples than in the craniofacial specimens. We conclude that skin-penetrating of orthopaedic implants is as safe as when titanium implants are used for craniofacial rehabilitation, which is a clinically well-established procedure.
C1 Univ Gothenburg, Sahlgrens Univ Hosp, Dept Audiol, SE-41345 Gothenburg, Sweden.
   Univ Gothenburg, Dept Anat & Cell Biol, Gothenburg, Sweden.
   Carlanderska Hosp, Branemark Osseointegrat Ctr, Gothenburg, Sweden.
RP Holgers, KM (reprint author), Univ Gothenburg, Sahlgrens Univ Hosp, Dept Audiol, SE-41345 Gothenburg, Sweden.
CR BLACK J, 1992, BIOL PERFORMANCE MAT
   Branemark PI, 1997, OSSEOINTEGRATION IN SKELETAL RECONSTRUCTION AND JOINT REPLACEMENT, P1
   BRANEMARK PI, 1977, SCAND J PLAST RECO S, V16
   GRISTINA AG, 1990, PATHOGENESIS OF WOUND AND BIOMATERIAL-ASSOCIATED INFECTIONS, P193
   Holgers K M, 1987, Int J Oral Maxillofac Implants, V2, P35
   HOLGERS KM, 1992, CONTACT DERMATITIS, V27, P1, DOI 10.1111/j.1600-0536.1992.tb05189.x
   HOLGERS KM, 1988, AM J OTOL, V9, P56
   HOLGERS KM, 1995, BIOMATERIALS, V16, P611, DOI 10.1016/0142-9612(95)93858-B
   HOLGERS KM, 1999, IN PRESS BIOMATERIAL
   HOLGERS KM, 1994, THESIS U GOTEBORG GO
   HOLGERS KM, 1998, CRANIOFACIAL RECONST, P277
   Holgers KM, 1994, INT J ORAL MAXILLOF, V9, P689
   LJUNGH A, 1985, INFECT IMMUN, V47, P522
   Rydevik BL, 1997, OSSEOINTEGRATION IN SKELETAL RECONSTRUCTION AND JOINT REPLACEMENT, P175
   Siegel S, 1956, NONPARAMETRIC STAT, P75
   THOMSEN P, 1991, BONE BIOMATERIAL INT, P153
   TJELLSTROM A, 1981, AM J OTOL, V2, P4
   TWARDOWSKI ZJ, 1991, PERITON DIALYSIS INT, V11, P237
   VONRECUM AF, 1984, J BIOMED MATER RES, V18, P323, DOI 10.1002/jbm.820180403
   Weibel ER, 1979, STEREOLOGICAL METHOD, VI
NR 20
TC 5
Z9 5
U1 0
U2 5
PU TAYLOR & FRANCIS AS
PI OSLO
PA CORT ADELERSGT 17, PO BOX 2562, SOLLI, 0202 OSLO, NORWAY
SN 0284-4311
J9 SCAND J PLAST RECONS
JI Scand. J. Plast. Reconstr. Surg. Hand Surg.
PD JUN
PY 2001
VL 35
IS 2
BP 141
EP 148
PG 8
WC Surgery
SC Surgery
GA 449AU
UT WOS:000169662800006
PM 11484523
DA 2018-10-20
ER

PT J
AU De Ruijter, JE
   Ter Brugge, PJ
   Dieudonne, SC
   Van Vliet, SJ
   Torensma, R
   Jansen, JA
AF De Ruijter, JE
   Ter Brugge, PJ
   Dieudonne, SC
   Van Vliet, SJ
   Torensma, R
   Jansen, JA
TI Analysis of integrin expression in U2OS cells cultured on various
   calcium phosphate ceramic substrates
SO TISSUE ENGINEERING
LA English
DT Article
ID ORTHOPEDIC IMPLANT MATERIALS; EXTRACELLULAR-MATRIX; IN-VITRO; HUMAN
   OSTEOBLASTS; ADHESION; BONE; DIFFERENTIATION; MINERALIZATION;
   HYDROXYAPATITE; GLYCOPROTEINS
AB Earlier we observed that calcium phosphate (Ca-P)-coated implant substrates stimulated the differentiation of osteoblast-like cells compared to uncoated substrates. This suggests that this difference in osteogenic induction is due to the chemical composition of the substratum. We hypothesized that Ca-P coatings modulate integrin expression patterns, because those receptors are the sensors of the cell. Therefore, in the present study we quantitatively analyzed integrin expression of osteosarcoma cells and their proliferation behavior on various well-defined Ca-P substrates. For this study we used the osteosarcoma cell line U2OS. Five groups of substrates were used: thermanox (Th), uncoated titanium (Ti), dense sintered hydroxyapatite (HA), and two Ca-P-coated titanium discs (TiHA-O% and TiHA-5%). At day 5, cell numbers were significantly lower (p< 0.05) for both types of Ca-P-coated titanium substrates compared to the other substrates. There were no significant differences between HA and uncoated titanium. From day 5 to 8, accumulated cell number was ranking highest to lowest HA > Th = Ti > TiHA-0% > TiHA-5%. Integrin expression at day 5 and day 8 of incubation was analyzed by flow cytometry for integrin subunits alpha1, alpha3, alpha4, alpha5, alpha6, and alphav. Fluorescence-activated cell sorting (FACS) analysis showed that the cells express high levels of beta1, low levels of alpha4, alpha5, and alpha6, and moderate levels of alpha3 and alphav integrin subunits on the various biomaterial substrates. Minor differences in integrin expression between the various substrates were seen. Therefore, the observed differences in proliferation between the coatings may reside in modulating the functional properties of integrins.
C1 Univ Med Ctr Nijmegen, Coll Dent Sci, Dept Biomat, NL-6500 HB Nijmegen, Netherlands.
   Univ Med Ctr Nijmegen, Dept Tumor Immunol, Nijmegen, Netherlands.
RP Jansen, JA (reprint author), Univ Med Ctr Nijmegen, Coll Dent Sci, Dept Biomat, POB 9101, NL-6500 HB Nijmegen, Netherlands.
EM j.jansen@dent.kun.nl
RI Torensma, Ruurd/H-3830-2015; Jansen, John/H-8055-2014
OI Torensma, Ruurd/0000-0002-0555-7903; 
CR ADAMS JC, 1993, DEVELOPMENT, V117, P1183
   ALBERTS B, 1994, MOL BIOL CELL
   CAMPANERO MR, 1990, J CELL BIOL, V110, P2157, DOI 10.1083/jcb.110.6.2157
   CLOVER J, 1994, BONE, V15, P585, DOI 10.1016/8756-3282(94)90305-0
   CLOVER J, 1992, J CELL SCI, V103, P267
   Cooper LF, 1998, INT J ORAL MAX IMPL, V13, P163
   Damsky CH, 1999, BONE, V25, P95, DOI 10.1016/S8756-3282(99)00106-4
   DELCOMMENNE M, 1995, J BIOL CHEM, V270, P26794, DOI 10.1074/jbc.270.45.26794
   FRADET Y, 1984, P NATL ACAD SCI-BIOL, V81, P224, DOI 10.1073/pnas.81.1.224
   Garratt AN, 1995, ACTA ANAT, V154, P34
   Gronowicz G, 1996, J ORTHOPAED RES, V14, P878, DOI 10.1002/jor.1100140606
   GRZESIK WJ, 1994, J BONE MINER RES, V9, P487, DOI 10.1002/jbmr.5650090408
   HAAS TA, 1994, CURR OPIN CELL BIOL, V6, P656, DOI 10.1016/0955-0674(94)90091-4
   Healy KE, 1996, BIOMATERIALS, V17, P195, DOI 10.1016/0142-9612(96)85764-4
   HEMLER ME, 1984, J IMMUNOL, V132, P3011
   HUGHES DE, 1993, J BONE MINER RES, V8, P527
   Hulshoff JEG, 1998, J BIOMED MATER RES, V40, P464, DOI 10.1002/(SICI)1097-4636(19980605)40:3<464::AID-JBM18>3.0.CO;2-J
   HULSHOFF JEG, 1995, J BIOMED MATER RES, V29, P967, DOI 10.1002/jbm.820290808
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   KAWAGUCHI S, 1993, J ORTHOPAED RES, V11, P386, DOI 10.1002/jor.1100110310
   Kostenuik PJ, 1996, CLIN EXP METASTAS, V14, P19, DOI 10.1007/BF00157682
   LIN CQ, 1993, FASEB J, V7, P737
   Lisignoli G, 1995, Boll Soc Ital Biol Sper, V71, P309
   LYNCH MP, 1995, EXP CELL RES, V216, P35, DOI 10.1006/excr.1995.1005
   MASSAS R, 1993, J DENT RES, V72, P1005, DOI 10.1177/00220345930720060201
   Meredith JE, 1996, ENDOCR REV, V17, P207, DOI 10.1210/er.17.3.207
   Pistone M, 1996, CELL BIOL INT, V20, P471, DOI 10.1006/cbir.1996.0062
   Pommerenke H, 1996, EUR J CELL BIOL, V70, P157
   PULEO DA, 1991, J BIOMED MATER RES, V25, P711, DOI 10.1002/jbm.820250603
   RODRIGUEZFERNAN.JL, 1989, DIFFERENTIATION, V42, P65
   SAITO T, 1993, J ORTHOP RES, V11, P386
   SINGER II, 1988, J CELL BIOL, V106, P2171, DOI 10.1083/jcb.106.6.2171
   Sinha RK, 1996, BONE, V18, P451, DOI 10.1016/8756-3282(96)00044-0
   Sjaastad MD, 1997, BIOESSAYS, V19, P47, DOI 10.1002/bies.950190109
   STUIVER I, 1995, STEM CELLS, V13, P250, DOI 10.1002/stem.5530130306
   TUAN RS, 1994, SCRIPTA METALL MATER, V31, P971, DOI 10.1016/0956-716X(94)90512-6
   Van Dijk K., 1995, Journal of Biomedical Materials Research, V29, P269
NR 37
TC 27
Z9 27
U1 0
U2 2
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 2152-4947
J9 TISSUE ENG
JI Tissue Eng.
PD JUN
PY 2001
VL 7
IS 3
BP 279
EP 289
DI 10.1089/10763270152044143
PG 11
WC Cell & Tissue Engineering
SC Cell Biology
GA 444PB
UT WOS:000169407700003
PM 11429148
DA 2018-10-20
ER

PT J
AU Cook, JL
   Tomlinson, JL
   Arnoczky, SP
   Fox, DB
   Cook, CR
   Kreeger, JM
AF Cook, JL
   Tomlinson, JL
   Arnoczky, SP
   Fox, DB
   Cook, CR
   Kreeger, JM
TI Kinetic study of the replacement of porcine small intestinal submucosa
   grafts and the regeneration of meniscal-like tissue in large avascular
   meniscal defects in dogs
SO TISSUE ENGINEERING
LA English
DT Article; Proceedings Paper
CT 46th Annual Meeting of the Orthopedic-Research-Society
CY MAR 12-15, 2000
CL ORLANDO, FLORIDA
SP Orthoped Res Soc
ID BIOMATERIAL; REPAIR
AB Porcine small intestinal submucosa (SIS) was used to replace large, avascular defects in the medial menisci of dogs. Twelve dogs received SIS grafts and 3 dogs were left untreated as controls. Dogs were evaluated at 4, 8, and 12 weeks by means of lameness scoring and ultrasonography. Dogs were sacrificed at 1, 6, or 12 weeks after implantation, and the tissue at the site of meniscal resection was evaluated for gross and histologic appearance, cross-sectional and surface area, and collagen types I and II. The femoral and tibial condyles were assessed for articular cartilage damage. Control dogs were significantly more lame than grafted dogs 8 and 12 weeks after instrumentation. Grafted dogs' replacement tissue appeared meniscal-like when evaluated grossly and ultrasonographically 12 weeks after instrumentation. The amount of replacement tissue was significantly greater in both cross-sectional and surface area for grafted dogs than for controls at all time points. Histologically, the SIS biomaterial could be identified in all grafted dogs at 1 week post-implantation, but in none at 6 weeks post-implantation. Subjectively, grafted dogs' replacement tissue was histologically superior to that of controls with respect to tissue type, organization, and architecture. Collagen types I and II immunoreactivity in grafted menisci were similar to that of normal menisci. Control dogs had significantly more articular cartilage damage than grafted dogs. SIS appears to induce regeneration of meniscal-like tissue in large, avascular meniscal defects in dogs, resulting in superior clinical function and articular cartilage protection compared to ungrafted controls.
C1 Univ Missouri, Comparat Orthopaed Lab, Columbia, MO 65211 USA.
   Michigan State Univ, Lab Comparat Orthopaed Res, E Lansing, MI 48824 USA.
RP Cook, JL (reprint author), Univ Missouri, Comparat Orthopaed Lab, 379 E Campus Dr, Columbia, MO 65211 USA.
OI Cook, James/0000-0002-0862-995X
CR AIKEN SW, 1994, VET COMP ORTHOPAED, V7, P124
   Arnoczky S P, 1985, Arthroscopy, V1, P247, DOI 10.1016/S0749-8063(85)80092-X
   ARNOCZKY SP, 1988, J BONE JOINT SURG AM, V70A, P1209, DOI 10.2106/00004623-198870080-00012
   BADYLAK SF, 1995, J BIOMED MATER RES, V29, P977, DOI 10.1002/jbm.820290809
   BADYLAK SF, 1996, 1 SIS S ORL
   Collier S, 1996, VET COMP ORTHOPAED, V9, P60
   COOK CR, 1997, AM COLL VET RAD ANN
   Cook JL, 1999, AM J SPORT MED, V27, P658, DOI 10.1177/03635465990270051901
   COOK JL, 1996, 1 SIS S ORL
   DIMENT MT, 1993, ORTHOPEDICS, V16, P973
   GALLOWAY MT, 1994, B RHEUM DIS, V43, P3
   Hardin G T, 1992, Orthop Rev, V21, P1311
   HAZEL WA, 1993, CLIN ORTHOP RELAT R, P232
   Lantz G C, 1993, J Invest Surg, V6, P297, DOI 10.3109/08941939309141619
   MESSNER K, 1994, BIOMATERIALS, V15, P243, DOI 10.1016/0142-9612(94)90046-9
   METELMAN LA, 1995, VET COMP ORTHOPAED, V8, P118
   NEWMAN AP, 1993, ARTHROSCOPY, V9, P33, DOI 10.1016/S0749-8063(05)80342-1
   O'Meara P M, 1993, Orthop Rev, V22, P681
   STONE KR, 1992, AM J SPORT MED, V20, P104, DOI 10.1177/036354659202000202
   VELTRI DM, 1994, CLIN ORTHOP RELAT R, P44
   WILLIAMS J, 1994, VET MED          JAN, P42
NR 21
TC 39
Z9 45
U1 3
U2 4
PU MARY ANN LIEBERT INC PUBL
PI LARCHMONT
PA 2 MADISON AVENUE, LARCHMONT, NY 10538 USA
SN 1076-3279
J9 TISSUE ENG
JI Tissue Eng.
PD JUN
PY 2001
VL 7
IS 3
BP 321
EP 334
DI 10.1089/10763270152044189
PG 14
WC Cell & Tissue Engineering
SC Cell Biology
GA 444PB
UT WOS:000169407700007
PM 11429152
DA 2018-10-20
ER

PT J
AU Willner, I
   Willner, B
AF Willner, I
   Willner, B
TI Biomaterials integrated with electronic elements: en route to
   bioelectronics
SO TRENDS IN BIOTECHNOLOGY
LA English
DT Review
ID CHEMICALLY MODIFIED ELECTRODES; OLIGONUCLEOTIDE-DNA INTERACTIONS; DIRECT
   ELECTRICAL COMMUNICATION; REDOX POLYMER-FILMS; GLUCOSE-OXIDASE; ENZYME
   ELECTRODES; AMPEROMETRIC BIOSENSORS; BIOELECTROCATALYZED REDUCTION;
   ELECTROCATALYTIC OXIDATION; IMMUNOSENSOR ELECTRODES
AB Bioelectronics is a progressing interdisciplinary research field that involves the integration of biomaterials with electronic transducers, such as electrodes, field-effect-transistors or piezoelectric crystals. Surface engineering of biomaterials, such as enzymes, antigen-antibodies or DNA on the electronic supports, controls the electrical properties of the biomaterial-transducer interface and enables the electronic transduction of biorecognition events, or biocatalyzed transformation, on the transducers, Bioelectronic sensing devices, biosensors of tailored sensitivities and specificities, are being developed.
C1 Hebrew Univ Jerusalem, Inst Chem, IL-91904 Jerusalem, Israel.
RP Willner, I (reprint author), Hebrew Univ Jerusalem, Inst Chem, IL-91904 Jerusalem, Israel.
CR ABRUNA HD, 1988, COORDIN CHEM REV, V86, P135, DOI 10.1016/0010-8545(88)85013-6
   ALBERY WJ, 1982, ANNU REP PROG CHEM C, V78, P377
   Alzari P, 1996, J AM CHEM SOC, V118, P6788, DOI 10.1021/ja960197o
   BADIA A, 1993, J AM CHEM SOC, V115, P7053, DOI 10.1021/ja00069a001
   Bardea A, 1999, CHEM COMMUN, P21, DOI 10.1039/a808319c
   Bardea A, 1998, CHEM COMMUN, P839, DOI 10.1039/a800215k
   Bardea A, 2000, ELECTROANAL, V12, P1097, DOI 10.1002/1521-4109(200010)12:14<1097::AID-ELAN1097>3.3.CO;2-O
   Bardea A, 1997, J AM CHEM SOC, V119, P9114, DOI 10.1021/ja971192+
   BenDov I, 1997, ANAL CHEM, V69, P3506, DOI 10.1021/ac970216s
   Berggren C, 1997, ANAL CHEM, V69, P3651, DOI 10.1021/ac970203e
   BIXON M, 1986, J PHYS CHEM-US, V90, P3795, DOI 10.1021/j100407a055
   Blonder R, 1996, ANAL CHEM, V68, P3151, DOI 10.1021/ac960290v
   Blonder R, 1997, J AM CHEM SOC, V119, P10467, DOI 10.1021/ja971980z
   BUTTRY DA, 1992, CHEM REV, V92, P1355, DOI 10.1021/cr00014a006
   CARUANA DJ, 1999, J AM CHEM SOC, V121, P768
   CASS AEG, 1984, ANAL CHEM, V56, P667, DOI 10.1021/ac00268a018
   Cohen Y, 1996, J ELECTROANAL CHEM, V417, P65, DOI 10.1016/S0022-0728(96)04760-2
   Cosnier S, 1997, ELECTROANAL, V9, P894, DOI 10.1002/elan.1140091206
   DEASY B, 1994, ANAL CHIM ACTA, V294, P291, DOI 10.1016/0003-2670(94)80312-9
   DEGANI Y, 1988, J AM CHEM SOC, V110, P2615, DOI 10.1021/ja00216a040
   DEGANI Y, 1987, J PHYS CHEM-US, V91, P1285, DOI 10.1021/j100290a001
   Ekins R, 1999, TRENDS BIOTECHNOL, V17, P217, DOI 10.1016/S0167-7799(99)01329-3
   Fernandez-Sanchez C, 2000, BIOSENS BIOELECTRON, V14, P917, DOI 10.1016/S0956-5663(99)00065-2
   Finklea HO, 1996, ELECTROANAL CHEM, V19, P109
   GOPEL W, 1995, BIOSENS BIOELECTRON, V10, P853, DOI 10.1016/0956-5663(95)99225-A
   GREGG BA, 1991, J PHYS CHEM-US, V95, P5970, DOI 10.1021/j100168a046
   GREGG BA, 1990, ANAL CHEM, V62, P258, DOI 10.1021/ac00202a007
   GREGG BA, 1991, J PHYS CHEM-US, V95, P5976, DOI 10.1021/j100168a047
   HALE PD, 1989, J AM CHEM SOC, V111, P3482, DOI 10.1021/ja00191a084
   HALE PD, 1991, ANAL CHEM, V63, P677, DOI 10.1021/ac00007a006
   HELLER A, 1990, ACCOUNTS CHEM RES, V23, P128, DOI 10.1021/ar00173a002
   HELLER A, 1992, J PHYS CHEM-US, V96, P3579, DOI 10.1021/j100188a007
   HILL HAO, 1981, PHILOS T R SOC A, V302, P267, DOI 10.1098/rsta.1981.0166
   JESTER CP, 1980, J ELECTROCHEM SOC, V127, P1979, DOI 10.1149/1.2130048
   KAKU T, 1994, ANAL CHEM, V66, P1231, DOI 10.1021/ac00080a006
   KATZ E, 1994, J ELECTROANAL CHEM, V373, P189, DOI 10.1016/0022-0728(94)03328-5
   Katz E, 1999, J ELECTROANAL CHEM, V479, P64, DOI 10.1016/S0022-0728(99)00425-8
   KATZ E, 1993, J ELECTROANAL CHEM, V354, P129, DOI 10.1016/0022-0728(93)80329-G
   Katz E, 1999, ANAL CHIM ACTA, V385, P45, DOI 10.1016/S0003-2670(98)00688-6
   KHARITONOV AB, IN PRESS SENS ACTU B
   KINNEAR KT, 1993, LANGMUIR, V9, P2255, DOI 10.1021/la00033a002
   Kranz C, 1998, ELECTROANAL, V10, P546, DOI 10.1002/(SICI)1521-4109(199807)10:8<546::AID-ELAN546>3.0.CO;2-#
   KULYS JJ, 1983, ANAL LETT PT B, V16, P197, DOI 10.1080/00032718308065162
   MARCUS RA, 1985, BIOCHIM BIOPHYS ACTA, V811, P265, DOI 10.1016/0304-4173(85)90014-X
   MARXTIBBON S, 1995, J AM CHEM SOC, V117, P9925, DOI 10.1021/ja00144a025
   Mikkelsen Susan R., 1996, Electroanalysis, V8, P15, DOI 10.1002/elan.1140080104
   MILLAN KM, 1994, ANAL CHEM, V66, P2943, DOI 10.1021/ac00090a023
   MURAMATSU H, 1989, ANAL LETT, V22, P2155
   MURAMATSU H, 1986, ANAL CHIM ACTA, V188, P257, DOI 10.1016/S0003-2670(00)86049-3
   MURRAY RW, 1984, ELECTROANAL CHEM, V13, P191
   MURRAY RW, 1980, ACCOUNTS CHEM RES, V13, P135, DOI 10.1021/ar50149a002
   NIWA O, 1991, ELECTROANAL, V3, P163, DOI 10.1002/elan.1140030305
   Pardo-Yissar V, 2000, FARADAY DISCUSS, V116, P119, DOI 10.1039/b001508n
   Patolsky F, 1999, LANGMUIR, V15, P3703, DOI 10.1021/la981682v
   Patolsky F, 2001, NAT BIOTECHNOL, V19, P253, DOI 10.1038/85704
   Patolsky F, 1998, CHEM-EUR J, V4, P1068, DOI 10.1002/(SICI)1521-3765(19980615)4:6<1068::AID-CHEM1068>3.3.CO;2-H
   PATOLSKY F, IN PRESS ANGEW CHEM
   PEASE AC, 1994, P NATL ACAD SCI USA, V91, P5022, DOI 10.1073/pnas.91.11.5022
   Pinkel D, 1998, NAT GENET, V20, P207, DOI 10.1038/2524
   PIUNNO PAE, 1994, ANAL CHIM ACTA, V288, P205, DOI 10.1016/0003-2670(93)E0611-A
   RIKLIN A, 1995, ANAL CHEM, V67, P4118, DOI 10.1021/ac00118a014
   Ryabov AD, 1998, CHEM-EUR J, V4, P806, DOI 10.1002/(SICI)1521-3765(19980515)4:5<806::AID-CHEM806>3.0.CO;2-B
   SCHUHMANN W, 1991, J AM CHEM SOC, V113, P1394, DOI 10.1021/ja00004a048
   SCHUHMANN W, 1995, BIOSENS BIOELECTRON, V10, P181, DOI 10.1016/0956-5663(95)96805-9
   SHOHAM B, 1995, BIOSENS BIOELECTRON, V10, P341, DOI 10.1016/0956-5663(95)96852-P
   STUTTS KJ, 1983, ANAL CHEM, V55, P1576, DOI 10.1021/ac00260a029
   Takenaka S, 2000, ANAL CHEM, V72, P1334, DOI 10.1021/ac991031j
   Tiefenauer LX, 1997, BIOSENS BIOELECTRON, V12, P213, DOI 10.1016/S0956-5663(97)85339-0
   TSIONSKY M, 1994, ANAL CHEM, V66, P1747, DOI 10.1021/ac00082a024
   Walcarius A, 1998, ELECTROANAL, V10, P1217, DOI 10.1002/(SICI)1521-4109(199812)10:18<1217::AID-ELAN1217>3.0.CO;2-X
   WANG J, 1994, ELECTROANAL, V6, P571, DOI 10.1002/elan.1140060707
   Warsinke A, 2000, FRESEN J ANAL CHEM, V366, P622, DOI 10.1007/s002160051557
   WILLNER I, 1992, BIOELECTROCH BIOENER, V29, P29, DOI 10.1016/0302-4598(92)80051-H
   Willner I, 1999, J AM CHEM SOC, V121, P6455, DOI 10.1021/ja983182u
   Willner I, 1996, J AM CHEM SOC, V118, P10321, DOI 10.1021/ja9608611
   WILLNER I, 1993, ADV MATER, V5, P912, DOI 10.1002/adma.19930051206
   WILLNER I, 1994, ANAL CHEM, V66, P1535, DOI 10.1021/ac00081a028
   Willner I, 2000, ANGEW CHEM INT EDIT, V39, P1180, DOI 10.1002/(SICI)1521-3773(20000403)39:7<1180::AID-ANIE1180>3.0.CO;2-E
   Willner I, 1997, ELECTROANAL, V9, P965, DOI 10.1002/elan.1140091302
   WILLNER I, 1994, J AM CHEM SOC, V116, P1428, DOI 10.1021/ja00083a031
   WRIGHTON MS, 1986, SCIENCE, V231, P32, DOI 10.1126/science.231.4733.32
   Yang MS, 1997, ANAL CHIM ACTA, V346, P259
   ZHONG CJ, 1995, ANAL CHEM, V67, P709
   ZOU CF, 1990, J AM CHEM SOC, V112, P7578, DOI 10.1021/ja00177a020
NR 84
TC 158
Z9 161
U1 1
U2 59
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0167-7799
J9 TRENDS BIOTECHNOL
JI Trends Biotechnol.
PD JUN
PY 2001
VL 19
IS 6
BP 222
EP 230
DI 10.1016/S0167-7799(01)01634-1
PG 9
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 432VR
UT WOS:000168716900007
PM 11356284
DA 2018-10-20
ER

PT J
AU Dorner, A
   Schurer, C
   Reisel, G
   Irmer, G
   Seidel, O
   Muller, E
AF Dorner, A
   Schurer, C
   Reisel, G
   Irmer, G
   Seidel, O
   Muller, E
TI Diamond-like carbon-coated Ti6Al4V: influence of the coating thickness
   on the structure and the abrasive wear resistance
SO WEAR
LA English
DT Article
DE diamond-like carbon; abrasive wear; titanium-alloy; biomaterial; Raman
   spectroscopy; atomic force microscopy
ID AMORPHOUS-CARBON; THIN-FILMS; DEPOSITION; BEHAVIOR
AB Diamond-like carbon (DLC) coatings of 0.7, 1.5 and 3.0 mum thickness were deposited on the titanium-alloy Ti6Al4V by a direct current discharge using benzene as gaseous precursor. Scanning electron microscopy, Raman spectroscopy, atomic force microscopy were utilised for gaining information about the micro-structural features and the composition. Hardness measurements, scratch and simple abrasion wear tests (ball-cratering apparatus with an abrasive fluid) were carried out for describing the tribological performance of the DLC.
   The fractures cross-sections of the DLC seems to be featureless and smooth. The universal hardness (HU) amounts to values of between approximately 12.8 and 22.2 GPa and the Young's modulus of between nearly 133 and 213 GPa. Raman spectroscopy points microstructural changes in dependence of the coating thickness. Although, the cohesive failure of the DLC is dependent on the coating thickness, the DLC spallation at the lateral edges of the scratch occurs at approximately 35 N for all coatings. The worn surfaces exhibit a very heterogeneous DLC damage due to the abrasive loading which also points to the micro-structural differences within the DLC film. (C) 2001 Elsevier Science B.V. All rights reserved.
C1 Freiberg Univ Min & Technol, Inst Ceram Mat, Freiberg, Germany.
   Inst Phys & Mech Technol, Chemnitz, Germany.
   Tech Univ Chemnitz, Inst Composite Mat & Surface Technol, Chemnitz, Germany.
   Freiberg Univ Min & Technol, Inst Theoret Phys, Freiberg, Germany.
RP Dorner, A (reprint author), Freiberg Univ Min & Technol, Inst Ceram Mat, Freiberg, Germany.
EM dorner@anw.ikw.tu-freiberg.de
CR BLIZNAKOVSKA B, 1994, SCI SERIES INT BUREA, V23
   Collins M, 2000, DIAM RELAT MATER, V9, P781, DOI 10.1016/S0925-9635(99)00325-8
   Deng JG, 1996, DIAM RELAT MATER, V5, P478, DOI 10.1016/0925-9635(96)80063-X
   DORNER A, 1999, THIN SOLID FILMS, V351, P1
   Du C, 1998, BIOMATERIALS, V19, P651, DOI 10.1016/S0142-9612(97)00159-2
   ENDEMIR A, 1995, SURF COAT TECH, V36, P692
   Fung MK, 2000, DIAM RELAT MATER, V9, P815, DOI 10.1016/S0925-9635(99)00201-0
   Grill A, 1999, DIAM RELAT MATER, V8, P428, DOI 10.1016/S0925-9635(98)00262-3
   JEHN H, 1993, CHARAKTERISIERUNG DU, P210
   Jiu JT, 1999, J MATER SCI, V34, P5205, DOI 10.1023/A:1004711913325
   Li D, 1995, TRIBOL LETT, V1, P87, DOI 10.1007/BF00157978
   Logothetidis S, 2000, NATO SCI S PRT 3 HI, V78, P297
   LUI Y, 1996, SURF COAT TECH, V82, P48
   Maharizi M, 1999, DIAM RELAT MATER, V8, P1050, DOI 10.1016/S0925-9635(99)00003-5
   MITURA E, 1994, DIAM RELAT MATER, V3, P896, DOI 10.1016/0925-9635(94)90295-X
   OLBORSKA A, 1994, DIAM RELAT MATER, V3, P899, DOI 10.1016/0925-9635(94)90296-8
   ROBERTSON J, 1992, SURF COAT TECH, V50, P185, DOI 10.1016/0257-8972(92)90001-Q
   ROBERTSON J, 1986, ADV PHYS, V35, P317, DOI 10.1080/00018738600101911
   Ronkainen H, 1998, WEAR, V222, P120, DOI 10.1016/S0043-1648(98)00314-7
   ROTHER B, 1992, PLASMABESCHICHTUNGSV, P36
   Rutherford KL, 1997, J TEST EVAL, V25, P250
   Schroeder A, 2000, BIOMATERIALS, V21, P449, DOI 10.1016/S0142-9612(99)00135-0
   SCHULTRICH BHJ, 1996, P WORKSH ANW MOD OB
   WIELAGE B, 1996, METALLOBERFLACHE, V51, P163
   Yoon ES, 1998, WEAR, V217, P262, DOI 10.1016/S0043-1648(98)00163-X
NR 25
TC 32
Z9 32
U1 0
U2 12
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0043-1648
EI 1873-2577
J9 WEAR
JI Wear
PD JUN
PY 2001
VL 249
IS 5-6
BP 489
EP 497
DI 10.1016/S0043-1648(01)00587-7
PG 9
WC Engineering, Mechanical; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA 445WR
UT WOS:000169482000020
DA 2018-10-20
ER

PT J
AU Elfick, APD
   Smith, SL
   Green, SM
   Unsworth, A
AF Elfick, APD
   Smith, SL
   Green, SM
   Unsworth, A
TI The quantitative assessment of UHMWPE wear debris produced in hip
   simulator testing: the influence of head material and roughness, motion
   and loading
SO WEAR
LA English
DT Article
DE UHMWPE; wear debris; hip simulator
ID MOLECULAR-WEIGHT POLYETHYLENE; TOTAL JOINT REPLACEMENTS;
   SURFACE-ROUGHNESS; ACETABULAR CUPS; FEMORAL HEADS; IN-VITRO; SIZE;
   PARTICLES; TOPOGRAPHY; PROSTHESES
AB Biomaterial wear particles are known to provoke a foreign-body reaction when released from total joint prostheses. Considerable effort is being invested in the search for materials which, by wearing less, will release fewer particles. In this research the role of joint wear simulators is paramount.
   The wear debris from 26 simulator tests of hip prostheses was extracted from the bovine serum lubricant and sized using a laser diffraction technique. The influence on particle size of a broad range of parameters was examined. The parameters considered included the bedding-in phenomenon, the femoral head material and roughness and physiological versus simplified load cycles and wear paths.
   The physiological wear simulators produced a similar size distribution of wear particles to that produced by implanted joints. Head material had no effect on this observation. Simplifying the loading cycle or wear path independently made no impact on this finding. This remained the case when simplified load and wear path were combined in one test.
   The effect of head roughness was pronounced with an increase in minimum particle size with increasing roughness.
   Joint simulators remain the optimal method for assessing new:joint materials and designs. However, their use to characterise joints in terms of wear rate solely should be guarded against. Instead focus should be concentrated on a combination of the size and amount of the wear debris created. In this way the "loosening hazard" of a joint can be distilled. (C) 2001 Elsevier Science B.V. All rights reserved.
C1 Univ Durham, Ctr Biomed Engn, Durham DH1 3LE, England.
RP Elfick, APD (reprint author), Univ Durham, Ctr Biomed Engn, South Rd, Durham DH1 3LE, England.
OI green, sarah/0000-0002-8392-8159
CR BARBOUR PSM, 1999, P I MECH ENG H, V213, P445
   Besong AA, 1998, J BONE JOINT SURG BR, V80B, P340, DOI 10.1302/0301-620X.80B2.8234
   BIGGS SA, 1998, T ORTHOP RES SOC, V23, P73
   Bowden F.P., 1973, FRICTION INTRO TRIBO
   Boynton EL, 2000, J BIOMED MATER RES, V52, P239, DOI 10.1002/1097-4636(200011)52:2<239::AID-JBM1>3.0.CO;2-R
   Campbell P, 1996, Proc Inst Mech Eng H, V210, P167, DOI 10.1243/PIME_PROC_1996_210_409_02
   CAMPBELL P, 1995, J BIOMED MATER RES, V29, P127, DOI 10.1002/jbm.820290118
   DOWSON D, 1985, ACS SYM SER, V287, P171
   Elfick AP, 2000, J MATER SCI-MATER M, V11, P267, DOI 10.1023/A:1008992911775
   Elfick AP, 1998, J MATER SCI LETT, V17, P1085, DOI 10.1023/A:1006623830833
   Elfick APD, 1999, J BIOMED MATER RES, V48, P712, DOI 10.1002/(SICI)1097-4636(1999)48:5<712::AID-JBM17>3.0.CO;2-R
   Elfick APD, 2000, J ARTHROPLASTY, V15, P901, DOI 10.1054/arth.2000.9194
   ELFICK APD, 2001, T ORTHOP RES SOC, V26, P1032
   GORE TA, 1980, THESIS U DURHAM DURH
   Green TR, 1998, BIOMATERIALS, V19, P2297, DOI 10.1016/S0142-9612(98)00140-9
   JOHNSTON RC, 1969, J BONE JOINT SURG AM, VA 51, P1083, DOI 10.2106/00004623-196951060-00003
   KLAPPERICH CM, 1999, J TRIB, V12, P394
   Kobayashi A, 1997, P I MECH ENG H, V211, P11, DOI 10.1243/0954411971534638
   MCKELLOP HA, 1995, CLIN ORTHOP RELAT R, P3
   Mie G, 1908, ANN PHYS-BERLIN, V25, P377
   MURRAY DW, 1990, J BONE JOINT SURG BR, V72, P988
   Paul J. P, 1967, P I MECH ENG, V181, P8
   Pienkowski D, 1996, J BIOMED MATER RES, V33, P65, DOI 10.1002/(SICI)1097-4636(199622)33:2<65::AID-JBM2>3.0.CO;2-J
   Rader CP, 1999, J ARTHROPLASTY, V14, P840, DOI 10.1016/S0883-5403(99)90035-9
   SAIKKO V, 1993, WEAR, V166, P169, DOI 10.1016/0043-1648(93)90259-O
   SCHMALZRIED TP, 1994, J APPL BIOMATER, V5, P185, DOI 10.1002/jab.770050302
   SCHOLES SC, 2000, MED ENG PHYS, V45, P1
   SHANBHAG AS, 1994, J BONE JOINT SURG BR, V76B, P60
   SHANBHAG AS, 1994, J BIOMED MATER RES, V28, P81, DOI 10.1002/jbm.820280111
   Shanbhag AS, 2000, J BIOMED MATER RES, V53, P100, DOI 10.1002/(SICI)1097-4636(2000)53:1<100::AID-JBM14>3.0.CO;2-4
   SHANBHAG AS, 1997, T ORTHOP RES SOC, V22, P118
   Smith SL, 1999, J MATER SCI, V34, P5159, DOI 10.1023/A:1004737526529
   Smith SL, 1999, P I MECH ENG H, V213, P475, DOI 10.1243/0954411991535086
   SMITH SL, 1999, THESIS U DURHAM DURH
   SMITH SL, IN PRESS P I MECH H
   SMITH SL, 2000, P I MECH ENG H, V214, P238
   SMITH SL, 2000, J BONE JOINT SURG BR, V82, P137
   Streicher RM, 1998, J ARTHROPLASTY, V13, P343, DOI 10.1016/S0883-5403(98)90181-4
   TIPPER JL, 1997, T ORTHOP RES SOC, V22, P355
   Unsworth A, 1995, WEAR, V190, P226, DOI 10.1016/0043-1648(95)06653-5
   Wang A, 1996, Proc Inst Mech Eng H, V210, P141, DOI 10.1243/PIME_PROC_1996_210_407_02
   WANG A, 1995, WEAR, V181, P241, DOI 10.1016/0043-1648(94)07027-X
   Wang A, 1998, J ARTHROPLASTY, V13, P615, DOI 10.1016/S0883-5403(98)80002-8
   Wroblewski BM, 1996, J BONE JOINT SURG BR, V78B, P280
NR 44
TC 30
Z9 33
U1 0
U2 10
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0043-1648
J9 WEAR
JI Wear
PD JUN
PY 2001
VL 249
IS 5-6
BP 517
EP 527
DI 10.1016/S0043-1648(01)00589-0
PG 11
WC Engineering, Mechanical; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA 445WR
UT WOS:000169482000024
DA 2018-10-20
ER

PT J
AU Blazewicz, M
   Paluszkiewicz, C
AF Blazewicz, M
   Paluszkiewicz, C
TI Characterization of biomaterials used for bone regeneration by FTIR
   spectroscopy
SO JOURNAL OF MOLECULAR STRUCTURE
LA English
DT Article
DE biomaterial; vibrational spectroscopy; regeneration of bunt; integrated
   area of bands
ID CARBON
AB FTIR spectroscopy has been used to analyse the process of bone regeneration taking place in the presence of surface modified carbon materials. Two types of carbon implant materials differing in their surface properties have been examined: an oxidized carbon fabric and a carbon fabric coated with a pyrolytic carbon layer. Samples of bone tissue have been retrieved at different times after implantation for spectroscopic study. The ratio of bone components has been calculated from the FTIR spectra of the samples. based on the integrated areas of the bands brought about by the vibrations of phosphates and amide groups. Additionally: the analysis of the shape and intensity of these bands provided information on developing and on the rate of bone mineralization. The investigation has shown that healing is faster in the presence of the carbon fabric coated with a pyrolytic carbon layer used as an implant material. (C) 2001 Elsevier Science B.V. All rights reserved.
C1 Acad Min & Met, Dept Special Ceram, PL-30059 Krakow, Poland.
   Jagiellonian Univ, Reg Lab, PL-30060 Krakow, Poland.
RP Blazewicz, M (reprint author), Acad Min & Met, Dept Special Ceram, Al Mickiewicza 30, PL-30059 Krakow, Poland.
CR BLAZEWICZ M, 1994, CERAM INT, V20, P99
   BOHEM HP, 1966, ADV CATAL, V16, P179
   BOKROS JC, 1977, CARBON, V15, P355
   BUTTAZZONI B, 1987, BIOMECANIQUE ORTHOPE, P106
   CONSTANTZ BR, 1995, SCIENCE, V267, P1796, DOI 10.1126/science.7892603
   Czajkowska B, 1997, BIOMATERIALS, V18, P69, DOI 10.1016/S0142-9612(96)00103-2
   FORSTER IW, 1978, CLIN ORTHOP RELAT R, P299
   LOUIS JP, 1996, BIOMATERIALS, V11, P525
   Paschalis EP, 1996, CALCIFIED TISSUE INT, V59, P480, DOI 10.1007/s002239900161
   PLESHKO NL, 1992, CALCIFIED TISSUE INT, V51, P72, DOI 10.1007/BF00296221
   REHMAN I, 1994, BIOMATERIALS, V15, P865, DOI 10.1016/0142-9612(94)90044-2
NR 11
TC 11
Z9 11
U1 0
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-2860
J9 J MOL STRUCT
JI J. Mol. Struct.
PD MAY 28
PY 2001
VL 563
SI SI
BP 147
EP 152
DI 10.1016/S0022-2860(00)00956-X
PG 6
WC Chemistry, Physical
SC Chemistry
GA 439UP
UT WOS:000169136200019
DA 2018-10-20
ER

PT J
AU Bettencourt, A
   Calado, A
   Amaral, J
   Vale, FM
   Rico, JMT
   Monteiro, J
   Castro, M
AF Bettencourt, A
   Calado, A
   Amaral, J
   Vale, FM
   Rico, JMT
   Monteiro, J
   Castro, M
TI The influence of vacuum mixing on methylmethacrylate liberation from
   acrylic cement powder
SO INTERNATIONAL JOURNAL OF PHARMACEUTICS
LA English
DT Article
DE poly(methylmethacrylate); methylmethacrylate; biomaterial; bone cement;
   release model; vacuum mixing
ID BONE-CEMENT
AB Polymethylmethacrylate (PMMA) bone cement is a biomaterial used to anchor prostheses during joint replacement surgery. Residual methylmethacrylate monomer (MNA) may be related with the cytotoxic effect of PM MA. The aim of the present paper was to investigate the effect of two different cement mixing methods: hand stirring at atmospheric pressure and under partial vacuum (0.330 and 0.154 bar) on residual monomer liberation in phosphate buffer saline solution from acrylic cement powder. Residual MMA content was determined by high-performance liquid chromatography. Mathematical models were applied to experimental dissolution data revealing that monomer release was significantly reduced in bone cement powder obtained at 0.154 bar vacuum pressure compared to the other mixing conditions. The kinetic models applied are consistent with a simple diffusion mechanism of the monomer from the polymer matrix. (C) 2001 Elsevier Science B.V. All rights reserved.
C1 Univ Lisbon, Fac Farm, P-1600083 Lisbon, Portugal.
   Univ Lisbon, CECUL, Ctr Electroquim & Cinet, P-1699 Lisbon, Portugal.
   Univ Lisbon, Ctr Farmacol Expt & Clin, P-1699 Lisbon, Portugal.
   Hosp Santa Maria, Serv Ortopedia, Lisbon, Portugal.
RP Bettencourt, A (reprint author), Fac Farm, Av Prof Gama Pinto, P-1649003 Lisbon, Portugal.
RI Castro, Matilde/A-9468-2014; Bettencourt, Ana/M-4219-2013; iMed.ULisboa,
   iMed.ULisboa/C-6292-2014; iMed.ULisboa, CBT/B-4215-2014; Calado,
   Antonio/M-4647-2014
OI Castro, Matilde/0000-0002-6314-8251; Bettencourt,
   Ana/0000-0002-8498-5892; Calado, Antonio/0000-0003-4110-0182; Monteiro,
   Jacinto Manuel de Melo Oliveira/0000-0002-4067-200X
CR Bettencourt A, 2000, INT J PHARM, V197, P161, DOI 10.1016/S0378-5173(99)00468-8
   Brossard C., 1990, STP PHARM, V6, P728
   DONBROW M, 1992, MICROCAPSULES NANOPA, P193
   Lewis G, 1997, J BIOMED MATER RES, V38, P155, DOI 10.1002/(SICI)1097-4636(199722)38:2<155::AID-JBM10>3.0.CO;2-C
   Smeds S, 1997, CLIN ORTHOP RELAT R, P326
   *US PHARM CONV INC, 1995, NAT FORM US, V18, P2265
   Vale FM, 1997, BIOMATERIALS, V18, P1133, DOI 10.1016/S0142-9612(97)00043-4
   WIJN JRD, 1975, ACTA ORTHOP SCAND, V46, P38
   WILLIAMS RP, 1992, CLIN ORTHOP RELAT R, P174
   WIXSON RL, 1992, CLIN ORTHOP RELAT R, P84
NR 10
TC 11
Z9 13
U1 0
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0378-5173
J9 INT J PHARM
JI Int. J. Pharm.
PD MAY 21
PY 2001
VL 219
IS 1-2
BP 89
EP 93
DI 10.1016/S0378-5173(01)00630-5
PG 5
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 433JE
UT WOS:000168755600009
PM 11337169
DA 2018-10-20
ER

PT J
AU Kharitonov, AB
   Wasserman, J
   Katz, E
   Willner, I
AF Kharitonov, AB
   Wasserman, J
   Katz, E
   Willner, I
TI The use of impedance spectroscopy for the characterization of
   protein-modified ISFET devices: Application of the method for the
   analysis of biorecognition processes
SO JOURNAL OF PHYSICAL CHEMISTRY B
LA English
DT Article
ID FIELD-EFFECT TRANSISTORS; ION-SELECTIVE ELECTRODES; BIOSENSOR; MEMBRANE;
   IMMUNOSENSOR; INTEGRATION; SENSORS; SYSTEM
AB Impedance spectroscopy is used to characterize the structure of biomaterial layers on the gate surface of ISFET devices, and to elucidate antigen-antibody binding interactions on the gate interface. The method is based on the recording of the transfer function of the system as a function of frequency and on the extraction of the respective iota (1) and iota (2) values of the systems. From the experimental values, the film thicknesses of the respective protein layers are estimated. The method is applied to elucidate the structures of a glucose oxidase, GOx, multilayer assembly, and of a di-biotin-cross-linked avidin multilayer system. The method is also used to sense the dinitrophenyl antibody by following the formation of the antigen-antibody complex on the gate surface.
C1 Hebrew Univ Jerusalem, Inst Chem, IL-91904 Jerusalem, Israel.
RP Willner, I (reprint author), Hebrew Univ Jerusalem, Inst Chem, IL-91904 Jerusalem, Israel.
CR Antonisse MMG, 2000, ANAL CHEM, V72, P343, DOI 10.1021/ac990721k
   ARMSTRONG RD, 1990, ELECTROCHIM ACTA, V35, P1, DOI 10.1016/0013-4686(90)85028-L
   BERGVELD P, 1989, SENSOR ACTUATOR, V18, P309, DOI 10.1016/0250-6874(89)87038-6
   BOUSSE L, 1983, J ELECTROANAL CHEM, V152, P25, DOI 10.1016/S0022-0728(83)80030-8
   CHOVELON JM, 1991, SENSOR ACTUAT B-CHEM, V3, P43, DOI 10.1016/0925-4005(91)85006-5
   DEMOZ A, 1995, J ELECTROANAL CHEM, V389, P71, DOI 10.1016/0022-0728(95)03836-6
   DRUISE J, 1992, SENSOR ACTUAT B-CHEM, V6, P101
   Dzyadevich SV, 1999, BIOSENS BIOELECTRON, V14, P283, DOI 10.1016/S0956-5663(99)00007-X
   Friebe A., 1993, Sensors and Materials, V5, P65
   GARRETT RH, 1995, BIOCHEMISTRY-US, P495
   HENDJI AMN, 1993, ANAL CHIM ACTA, V281, P3, DOI 10.1016/0003-2670(93)85333-F
   IZQUIERDO A, 1995, ELECTROANAL, V7, P505, DOI 10.1002/elan.1140070602
   Kharitonov AB, 2000, SENSOR ACTUAT B-CHEM, V70, P222, DOI 10.1016/S0925-4005(00)00573-6
   Koncki R, 1998, SENSOR ACTUAT B-CHEM, V47, P246, DOI 10.1016/S0925-4005(98)00031-8
   LIONDAGAN M, 1995, ANGEW CHEM INT EDIT, V34, P1604, DOI 10.1002/anie.199516041
   Lugtenberg RJW, 1998, J ELECTROANAL CHEM, V452, P69, DOI 10.1016/S0022-0728(98)00080-1
   Maupas H, 1996, J ELECTROANAL CHEM, V406, P53, DOI 10.1016/0022-0728(95)04443-4
   Pijanowska DG, 1997, SENSOR ACTUAT B-CHEM, V44, P370, DOI 10.1016/S0925-4005(97)00194-9
   Prasad B, 1999, MEAS SCI TECHNOL, V10, P1097, DOI 10.1088/0957-0233/10/11/321
   SCHELLER FW, 1991, BIOSENS BIOELECTRON, V6, P245, DOI 10.1016/0956-5663(91)80010-U
   Schroth P, 1999, ELECTROCHIM ACTA, V44, P3821, DOI 10.1016/S0013-4686(99)00088-2
   SCHYBERG C, 1995, SENSOR ACTUAT B-CHEM, V27, P457, DOI 10.1016/0925-4005(94)01639-Y
   Sekiguchi T, 2000, SENSOR ACTUAT B-CHEM, V67, P265, DOI 10.1016/S0925-4005(00)00522-0
   Senillou A, 1999, TALANTA, V50, P219, DOI 10.1016/S0039-9140(99)00122-8
   Souteyrand E, 1997, J PHYS CHEM B, V101, P2980, DOI 10.1021/jp963056h
   Volotovsky V, 1998, ELECTROANAL, V10, P512, DOI 10.1002/(SICI)1521-4109(199806)10:7<512::AID-ELAN512>3.0.CO;2-V
   Volotovsky V, 1996, ANAL CHIM ACTA, V322, P77, DOI 10.1016/0003-2670(95)00592-7
   Willner I, 2000, ANGEW CHEM INT EDIT, V39, P1180, DOI 10.1002/(SICI)1521-3773(20000403)39:7<1180::AID-ANIE1180>3.0.CO;2-E
   Willner I, 1997, ELECTROANAL, V9, P965, DOI 10.1002/elan.1140091302
   Zayats M, 2000, BIOSENS BIOELECTRON, V15, P671, DOI 10.1016/S0956-5663(00)00120-2
NR 30
TC 65
Z9 65
U1 2
U2 20
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1089-5647
J9 J PHYS CHEM B
JI J. Phys. Chem. B
PD MAY 17
PY 2001
VL 105
IS 19
BP 4205
EP 4213
DI 10.1021/jp0045383
PG 9
WC Chemistry, Physical
SC Chemistry
GA 434FE
UT WOS:000168803800025
DA 2018-10-20
ER

PT J
AU Ramamurthi, A
   Robson, SC
   Lewis, RS
AF Ramamurthi, A
   Robson, SC
   Lewis, RS
TI Effects of nitric oxide (NO) and soluble nucleoside triphosphate
   diphosphohydrolase (NTPDase) on inhibition of platelet deposition in
   vitro
SO THROMBOSIS RESEARCH
LA English
DT Article
DE platelet inhibition; nitric oxide; NTPDase; aspirin; apyrase
ID ATP-DIPHOSPHOHYDROLASE; ADENINE-NUCLEOTIDES; DONOR SIN-1; HUMAN-BLOOD;
   AGGREGATION; ASPIRIN; ERYTHROCYTES; HEMOSTASIS; THROMBOSIS; ADHESION
AB Vascular thrombosis is regulated via the release of several constituents from the vascular endothelium, including nucleoside triphosphate diphosphohydrolases (NTPDases or ectonucleotidases), nitric oxide (NO), and eicosanoids. Currently, it is unknown how these constituents interact in the inhibition of platelet aggregation and adhesion. To investigate the combined effects of NO and NTPDase on platelet deposition sequestration, an in vitro study was performed to compare inhibition of platelet deposition to a biomaterial by NO in the absence or presence of soluble NTPDase. Results of the platelet inhibition studies with NO and NTPDase conclusively show that the inhibitory effects of NTPDase and NO are additive. The platelet inhibitory potency in the presence of NO was enhanced by NTPDase in a dose-dependent manner, for a given NO exposure. This augmentation is independent of aspirin; the ability of NTPDase or NO alone to inhibit platelet deposition is also independent of aspirin. Clearly, NO and NTPDase independently contribute to platelet inhibition via different mechanisms. The inaction of NO on the activity of NTPDase confirmed that NO or reaction products in the presence of O-2 do not interact with NTPDase directly. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Oklahoma State Univ, Sch Chem Engn, Stillwater, OK 74078 USA.
   Cleveland Clin Fdn, Dept Biomed Engn, Cleveland, OH 44195 USA.
   Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA.
RP Lewis, RS (reprint author), Oklahoma State Univ, Sch Chem Engn, 423 EN, Stillwater, OK 74078 USA.
EM randyl@okstate.edu
FU NHLBI NIH HHS [HL57307, HL63972]
CR BASSENGE E, 1992, BRIT J CLIN PHARMACO, V34, pS37, DOI 10.1111/j.1365-2125.1992.tb04147.x
   BAYKOV AA, 1988, ANAL BIOCHEM, V171, P266, DOI 10.1016/0003-2697(88)90484-8
   Becker BF, 2000, Z KARDIOL, V89, P160, DOI 10.1007/PL00007320
   Bozzo J, 1999, EUR J CLIN INVEST, V29, P438
   Broeders MAW, 1998, ARTERIOSCL THROM VAS, V18, P139, DOI 10.1161/01.ATV.18.1.139
   Brown AS, 1998, CARDIOVASC RES, V40, P380, DOI 10.1016/S0008-6363(98)00182-5
   BUSSE R, 1993, EUR HEART J, V14, P2
   CAZENAVE JP, 1973, J LAB CLIN MED, V82, P978
   COADE SB, 1989, CIRC RES, V65, P531, DOI 10.1161/01.RES.65.3.531
   FISCH A, 1995, EUR J PHARM-MOLEC PH, V289, P455, DOI 10.1016/0922-4106(95)90154-X
   GELADOPOULOS TP, 1991, ANAL BIOCHEM, V192, P112, DOI 10.1016/0003-2697(91)90194-X
   GORDON EL, 1989, J BIOL CHEM, V264, P18986
   GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X
   HUIE RE, 1993, FREE RADICAL RES COM, V18, P195, DOI 10.3109/10715769309145868
   IGNARRO LJ, 1993, THROMB HAEMOSTASIS, V70, P148
   Kaczmarek E, 1996, J BIOL CHEM, V271, P33116, DOI 10.1074/jbc.271.51.33116
   LANGE NA, 1967, LANGES HDB CHEM, P1101
   LARSSON R, 1987, ANN NY ACAD SCI, V516, P102, DOI 10.1111/j.1749-6632.1987.tb33034.x
   LEWIS RS, 1994, CHEM RES TOXICOL, V7, P568, DOI 10.1021/tx00040a013
   LUTHJE J, 1988, EUR J BIOCHEM, V175, P285, DOI 10.1111/j.1432-1033.1988.tb14195.x
   Makita K, 1998, INT J HEMATOL, V68, P297
   MARCUS AJ, 1995, THROMB HAEMOSTASIS, V74, P213
   MARCUS AJ, 1993, FASEB J, V7, P516
   NEGRESCU EV, 1995, CARDIOVASC DRUG THER, V9, P619, DOI 10.1007/BF00878095
   PATRONO C, 1989, TRENDS PHARMACOL SCI, V10, P453, DOI 10.1016/S0165-6147(89)80010-0
   Provost P, 1997, ARTERIOSCL THROM VAS, V17, P1806, DOI 10.1161/01.ATV.17.9.1806
   Ramamurthi A, 2000, ANN BIOMED ENG, V28, P174, DOI 10.1114/1.242
   Ramamurthi A, 1998, ANN BIOMED ENG, V26, P1036, DOI 10.1114/1.34
   Ramamurthi A, 1999, ANN BIOMED ENG, V27, P411, DOI 10.1114/1.184
   RAO GHR, 1990, BIOCHEM MED METAB B, V43, P271, DOI 10.1016/0885-4505(90)90034-X
   REIMERS HJ, 1985, PLATELETS PHYSL PHAR, P85
   ROBSON RC, 2000, EMERGING THER TARGET, V4, P1
   Robson SC, 1997, J EXP MED, V185, P153, DOI 10.1084/jem.185.1.153
   RUGGERI ZM, 1993, THROMB HAEMOSTASIS, V70, P119
   Stamler JS, 1997, SCIENCE, V276, P2034, DOI 10.1126/science.276.5321.2034
   STEINER M, 1970, BLOOD, V25, P727
   VALLES J, 1993, THROMB HAEMOSTASIS, V69, P633
NR 37
TC 13
Z9 13
U1 0
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0049-3848
J9 THROMB RES
JI Thromb. Res.
PD MAY 15
PY 2001
VL 102
IS 4
BP 331
EP 341
DI 10.1016/S0049-3848(01)00244-4
PG 11
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA 434YW
UT WOS:000168844300005
PM 11369426
DA 2018-10-20
ER

PT J
AU Zisch, AH
   Schenk, U
   Schense, JC
   Sakiyama-Elbert, SE
   Hubbell, JA
AF Zisch, AH
   Schenk, U
   Schense, JC
   Sakiyama-Elbert, SE
   Hubbell, JA
TI Covalently conjugated VEGF-fibrin matrices for endothelialization
SO JOURNAL OF CONTROLLED RELEASE
LA English
DT Article; Proceedings Paper
CT 6th European Symposium on Controlled Drug Delivery
CY APR 12-14, 2000
CL NOORDWIJK AAN ZEE, NETHERLANDS
SP Alza Corp, Inst Biomed Technol, Univ Twente, Janssen Pharmaceut, Novartis Pharma AG, NV Organon Akzo Nobel, Sam Yang Corp
ID FIBROBLAST GROWTH-FACTOR; EXPANDED POLYTETRAFLUOROETHYLENE GRAFTS;
   INTRAMUSCULAR GENE-TRANSFER; ENHANCES NEURITE EXTENSION; SMOOTH-MUSCLE;
   MYOCARDIAL ANGIOGENESIS; ISCHEMIC MYOCARDIUM; CELL-PROLIFERATION; VESSEL
   DEVELOPMENT; GLUE SUSPENSIONS
AB Vascular endothelial growth factor (VEGF) is a key factor in endothelial cell biology and blood vessel formation and a candidate therapeutic for the stimulation of angiogenesis-dependent tissue regeneration. The objective of this study was to confer the angiogenic activity of VEGF(121) upon the biomaterial fibrin, a natural substrate for endothelial cell growth and clinically accepted as 'fibrin glue'. To achieve this, we engineered fibrin-based hydrogels that were covalently modified with VEGF(121). Our laboratory has recently developed novel methodology that allows the covalent incorporation of exogenous bioactive peptides by the transglutominase activity of factor XIIIa into fibrin during cogulation. Here, this ability of factor XIIIa to crosslink additional proteins within fibrin was employed to covalently incorporate VEGF(121). By recombinant DNA methodology, a mutant VEGF(121) variant, alpha (2)-PI1-8-VEGF(121), which contains an additional factor XIIIa substrate sequence NQEQVSPL at the aminoterminus, was expressed in E. coli. In soluble form, the mutant protein fully retained its mitogenic activity for endothelial cells. Using I-125-labeled alpha (2)-PI1-8-VEGF(121), its covalent incorporation and the efficiency of incorporation into fibrin was demonstrated and characterized. The immobilized, fibrin-conjugated VEGF(121) protein remained an active and very efficient mitogen for human endothelial cells grown on two-dimensional VEGF(121)-modified fibrin surfaces, and the incorporation of increasing amounts of alpha (2)-PI1-8-VEGF(121) resulted in dose-dependent enhancement of endothelial cell growth. The VEGF-modified fibrin matrices can be formed as injectable gels in a single-step reaction under physiological conditions in vivo. When used as a ingrowth matrix, such VEGF incorporating materials could be useful in a variety of clinical situations that require an angiogenic response into an ischemic region or inplant. (C) 2001 Elsevier Science B.V. All rights reserved.
C1 ETH Zurich, Dept Mat, CH-8044 Zurich, Switzerland.
   ETH Zurich, Inst Biomed Engn, CH-8044 Zurich, Switzerland.
   Univ Zurich, CH-8044 Zurich, Switzerland.
RP Zisch, AH (reprint author), ETH Zurich, Dept Mat, Moussonstr 18, CH-8044 Zurich, Switzerland.
RI Hubbell, Jeffrey/A-9266-2008; Sakiyama-Elbert, Shelly/A-6753-2008
OI Hubbell, Jeffrey/0000-0003-0276-5456; Sakiyama-Elbert,
   Shelly/0000-0003-4832-5851
CR ASAHARA T, 1995, CIRCULATION, V91, P2793, DOI 10.1161/01.CIR.91.11.2793
   ASAHARA T, 1996, CIRCULATION, V94, P2892
   BANAI S, 1994, CIRCULATION, V89, P2183, DOI 10.1161/01.CIR.89.5.2183
   Baumgartner I, 1998, CIRCULATION, V97, P1114, DOI 10.1161/01.CIR.97.12.1114
   Birkenhager R, 1996, BIOCHEM J, V316, P703, DOI 10.1042/bj3160703
   Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0
   CLOWES AW, 1986, AM J PATHOL, V123, P220
   Deutsch M, 1997, J VASC SURG, V25, P757, DOI 10.1016/S0741-5214(97)70307-0
   FASOL R, 1994, J THORAC CARDIOV SUR, V107, P1432
   Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0
   Ferrara N, 1999, J MOL MED, V77, P527, DOI 10.1007/s001099900019
   Ferrara N, 1999, NAT MED, V5, P1359, DOI 10.1038/70928
   GOLDEN MA, 1990, J VASC SURG, V11, P838, DOI 10.1067/mva.1990.18047
   GREISLER HP, 1992, SURGERY, V112, P244
   HOUCK KA, 1992, J BIOL CHEM, V267, P26031
   KANG SS, 1995, SURGERY, V118, P280, DOI 10.1016/S0039-6060(05)80335-6
   Keyt BA, 1996, J BIOL CHEM, V271, P7788, DOI 10.1074/jbc.271.13.7788
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Losordo DW, 1998, CIRCULATION, V98, P2800, DOI 10.1161/01.CIR.98.25.2800
   LOSORDO DW, 1999, AM HEART J, V138, P132
   PEARLMAN JD, 1995, NAT MED, V1, P1085, DOI 10.1038/nm1095-1085
   PU LQ, 1993, CIRCULATION, V88, P208, DOI 10.1161/01.CIR.88.1.208
   Rosengart TK, 1999, CIRCULATION, V100, P468, DOI 10.1161/01.CIR.100.5.468
   Sakiyama SE, 1999, FASEB J, V13, P2214
   Sakiyama-Elbert SE, 2000, J CONTROL RELEASE, V65, P389, DOI 10.1016/S0168-3659(99)00221-7
   Schense JC, 2000, NAT BIOTECHNOL, V18, P415
   Schense JC, 1999, BIOCONJUGATE CHEM, V10, P75, DOI 10.1021/bc9800769
   Schumacher B, 1998, CIRCULATION, V97, P645, DOI 10.1161/01.CIR.97.7.645
   Shireman PK, 1999, J VASC SURG, V29, P852, DOI 10.1016/S0741-5214(99)70213-2
   TAKESHITA S, 1994, CIRCULATION, V90, P228
   TAKESHITA S, 1994, J CLIN INVEST, V93, P662, DOI 10.1172/JCI117018
   THOMPSON JA, 1988, SCIENCE, V241, P1349, DOI 10.1126/science.2457952
   Tsurumi Y, 1996, CIRCULATION, V94, P3281, DOI 10.1161/01.CIR.94.12.3281
   VanBelle E, 1997, J AM COLL CARDIOL, V29, P1371, DOI 10.1016/S0735-1097(97)00049-1
   VanBelle E, 1997, CIRCULATION, V95, P438
   Wang JS, 1996, J ORTHOP RES, V14, P316, DOI 10.1002/jor.1100140222
   Weatherford DA, 1996, SURGERY, V120, P433, DOI 10.1016/S0039-6060(96)80320-5
   Wissink MJB, 2000, J CONTROL RELEASE, V64, P103, DOI 10.1016/S0168-3659(99)00145-5
   YANAGISAWAMIWA A, 1992, SCIENCE, V257, P1401, DOI 10.1126/science.1382313
   ZILLA P, 1994, SURGERY, V116, P524
   ZILLA P, 1989, SURGERY, V105, P515
NR 41
TC 246
Z9 251
U1 3
U2 47
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-3659
J9 J CONTROL RELEASE
JI J. Control. Release
PD MAY 14
PY 2001
VL 72
IS 1-3
BP 101
EP 113
DI 10.1016/S0168-3659(01)00266-8
PG 13
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA 445MZ
UT WOS:000169462800011
PM 11389989
DA 2018-10-20
ER

PT J
AU Tiller, JC
   Bonner, G
   Pan, LC
   Klibanov, AM
AF Tiller, JC
   Bonner, G
   Pan, LC
   Klibanov, AM
TI Improving biomaterial properties of collagen films by chemical
   modification
SO BIOTECHNOLOGY AND BIOENGINEERING
LA English
DT Article
DE collagen; chemical modification; fibroblast cell attachment; endothelial
   cell attachment; bacterial adhesion; biomaterials
ID BACTERIAL ADHESION; POLYETHYLENE OXIDE; CELL-ADHESION; SURFACES;
   BIOCOMPATIBILITY; STENTS
AB Films of bovine collagen were chemically modified with the goal of improving their biomaterial properties. The modified films were investigated with respect to their affinity to fibroblast and endothelial cells, as well as their antibacterial properties tested by adhesion of Staphylococcus aureus. Modifications that only change the net charge of collagen, such as acetylation, succinylation, and treatment with glutaraldehyde tall increase the negative charge), and amination with ethylenediamine (EDA), N,N-dimethyl-EDA (DMEDA), or butylamine tall increase the positive charge), did not dramatically alter the mammalian cell attachment to the film. In contrast, derivatization of collagen using methoxypoly(ethylene glycol) (PEG] diminished the attachment of fibroblasts by 98 +/- 1% and of endothelial cells by more than 99% compared to unmodified collagen. Moreover, the rate of growth of fibroblasts dropped by 97 +/- 1% and that of endothelial cells by 88 +/- 3% as a result of PEGylation of collagen. Adhesion of S. aureus cells also plummeted by 93 +/- 2% as a result of this PEGylation. With these antifouling properties, PEG-collagen may be a promising coating material for coronary stents. Subsequent derivatization of PEG-collagen with EDA or DMEDA abolished its mammalian cell-repelling ability, whereas bacterial cell repulsion was partially retained: for example, DMEDA-modified PEG-collagen exhibits up to a 5-fold lower bacterial adhesion than collagen. It is worth noting that a material that allows mammalian cell attachment but reduces bacterial adhesion could be useful as an implant or coating. (C) 2001 John Wiley & Sons, Inc.
C1 MIT, Dept Chem, Cambridge, MA 02139 USA.
   Ind Technol Res Inst, Ctr Biomed Engn, Chu Tung 300, Taiwan.
RP Klibanov, AM (reprint author), MIT, Dept Chem, Cambridge, MA 02139 USA.
RI Tiller, Joerg/S-2010-2016
CR Ahmed K, 2000, MICROB PATHOGENESIS, V28, P203, DOI 10.1006/mpat.1999.0342
   Altankov G, 1996, J BIOMAT SCI-POLYM E, V8, P299
   Atala A, 2000, J ENDOUROL, V14, P49, DOI 10.1089/end.2000.14.49
   Bailey AJ, 2000, WOUND REPAIR REGEN, V8, P5, DOI 10.1046/j.1524-475x.2000.00005.x
   BORDIN S, 1984, J PERIODONTAL RES, V19, P642, DOI 10.1111/j.1600-0765.1984.tb01332.x
   Cloft HJ, 2000, RADIOLOGY, V214, P557, DOI 10.1148/radiology.214.2.r00fe21557
   Cunliffe D, 1999, APPL ENVIRON MICROB, V65, P4995
   Damink L. H. H. O., 1994, J MATER SCI-MATER M, V6, P460
   Damink LHHO, 1996, BIOMATERIALS, V17, P765, DOI 10.1016/0142-9612(96)81413-X
   Deible CR, 1998, BIOMATERIALS, V19, P1885, DOI 10.1016/S0142-9612(98)00098-2
   DESAI NP, 1992, BIOMATERIALS, V13, P417, DOI 10.1016/0142-9612(92)90160-P
   DESAI NP, 1991, J BIOMED MATER RES, V25, P829, DOI 10.1002/jbm.820250704
   Doyle Ron J., 1994, Trends in Microbiology, V2, P57, DOI 10.1016/0966-842X(94)90127-9
   DRUMHELLER PD, 1995, J BIOMED MATER RES, V29, P207, DOI 10.1002/jbm.820290211
   FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0
   Gotoh Y, 1997, BIOMATERIALS, V18, P267, DOI 10.1016/S0142-9612(96)00137-8
   Grewe PH, 2000, Z KARDIOL, V89, P21, DOI 10.1007/s003920050004
   Han DK, 1998, J BIOMAT SCI-POLYM E, V9, P163
   HOGT AH, 1986, J BIOMED MATER RES, V20, P533, DOI 10.1002/jbm.820200409
   JACOBSON BS, 1982, TISSUE CELL, V14, P69, DOI 10.1016/0040-8166(82)90008-8
   KAHALEH MB, 1992, CLIN EXP RHEUMATOL, V10, P51
   KARESH JW, 1991, OPHTHALMIC PLAST REC, V7, P278, DOI 10.1097/00002341-199112000-00008
   Khor E, 1997, BIOMATERIALS, V18, P95, DOI 10.1016/S0142-9612(96)00106-8
   KSANDER GA, 1985, ANN PLAS SURG, V14, P351, DOI 10.1097/00000637-198504000-00009
   Lifshitz DA, 1999, J ENDOUROL, V13, P735, DOI 10.1089/end.1999.13.735
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   OKADA T, 1992, BIOMATERIALS, V13, P448, DOI 10.1016/0142-9612(92)90165-K
   Park KD, 1998, BIOMATERIALS, V19, P851, DOI 10.1016/S0142-9612(97)00245-7
   RHEE W, 1997, ACS SYM SER, P420
   Rozenman Y, 1996, J INVASIVE CARDIOL, V8, P438
   SRIVASTAVA S, 1990, BIOMATERIALS, V11, P161
   Tziampazis E, 2000, BIOMATERIALS, V21, P511, DOI 10.1016/S0142-9612(99)00212-4
   VANWACHEM PB, 1985, BIOMATERIALS, V6, P403, DOI 10.1016/0142-9612(85)90101-2
   Vladkova T, 1999, J BIOMAT SCI-POLYM E, V10, P609, DOI 10.1163/156856299X00838
NR 34
TC 50
Z9 53
U1 4
U2 23
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0006-3592
J9 BIOTECHNOL BIOENG
JI Biotechnol. Bioeng.
PD MAY 5
PY 2001
VL 73
IS 3
BP 246
EP 252
DI 10.1002/bit.1057
PG 7
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 422ZY
UT WOS:000168151500009
PM 11257607
DA 2018-10-20
ER

PT J
AU Webb, K
   Budko, E
   Neuberger, TJ
   Chen, SZ
   Schachner, M
   Tresco, PA
AF Webb, K
   Budko, E
   Neuberger, TJ
   Chen, SZ
   Schachner, M
   Tresco, PA
TI Substrate-bound human recombinant L1 selectively promotes neuronal
   attachment and outgrowth in the presence of astrocytes and fibroblasts
SO BIOMATERIALS
LA English
DT Article
DE cell adhesion molecules; L1; neurons; astrocytes
ID CENTRAL-NERVOUS-SYSTEM; RAT SPINAL-CORD; ADHESION MOLECULE L1;
   CORTICOSPINAL AXONAL GROWTH; ADULT PARAPLEGIC RATS; CELL-ADHESION;
   NEURITE EXTENSION; SCHWANN-CELLS; EXTRACELLULAR-MATRIX; SURFACE
   MODIFICATION
AB Axonal pathfinding is a complex process that is mediated through cell-matrix and cell-cell interactions. A large number of studies have demonstrated that ECM and ECM-derived proteins and peptides are potent promoters of neurite outgrowth, however much less attention is given to the fact that these same ligands also elicit responses in a wide variety of non-neuronal cell types. We examined the use of a substrate-bound recombinant form of human LI, an integral membrane protein, as a ligand for bridging materials for repairing the CNS by studying its effectiveness in promoting specific responses of neuronal cells in the presence of astrocytes and fibroblasts. LI, a cell adhesion molecule expressed in the developing CNS and PNS, has strong neurite promoting activity, and contributes to axonal guidance and axonal fasciculation during development. In this study, substrates treated with L1-Fc were compared to subtrates treated with fibronectin and poly-lysine (PDL) with respect to their interaction with a variety of cell types, including three types of neurons (DRG neurons, cerebellar granule neurons, and hippocampal neurons), astrocytes, dermal fibroblasts, and meningeal cells. L1-Fc-treated substrates supported significantly higher levels of neurite outgrowth relative to fibronectin and PDL, while inhibiting the attachment of astrocytes, meningeal cells, and fibroblasts. We also show that neuronal cells attach to and extend neurites on 30 mum diameter L l-Fc-treated filaments as an example of a potentially useful bridging substrate. The high level of biological specificity displayed by surface-bound L1, along with the fact that it is a potent promoter of neurite outgrowth, is normally expressed on axons and regulates axonal fasciculation during normal development bodes well for its use on bridging materials For the repair of the CNS, and suggests that cell adhesion molecules, in general, may be useful for biomaterial modification. Moreover, small diameter filaments coated with L1-Fc may function in an analogous way to pioneering axons that guide the growth of axons to distal targets during development. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Univ Utah, Dept Bioengn, Keck Ctr Tissue Engn, Salt Lake City, UT 84112 USA.
   Acorda Therapeut, Hawthorne, NY 10532 USA.
   Univ Hamburg, Zentrum Mol Neurobiol, D-20246 Hamburg, Germany.
RP Tresco, PA (reprint author), Univ Utah, Dept Bioengn, Keck Ctr Tissue Engn, 20 South 2030 East, Salt Lake City, UT 84112 USA.
CR Anderson PN, 1998, PROG BRAIN RES, V117, P211
   BEBBINGTON C R, 1991, Methods (Orlando), V2, P136, DOI 10.1016/S1046-2023(05)80214-2
   BELLAMKONDA R, 1995, J NEUROSCI RES, V41, P501, DOI 10.1002/jnr.490410409
   Brummendorf T, 1998, CURR OPIN NEUROBIOL, V8, P87, DOI 10.1016/S0959-4388(98)80012-3
   CARLSSON J, 1978, BIOCHEM J, V173, P723, DOI 10.1042/bj1730723
   Chen S, 1999, J NEUROBIOL, V38, P428, DOI 10.1002/(SICI)1097-4695(19990215)38:3<428::AID-NEU10>3.0.CO;2-6
   Cheng H, 1996, SCIENCE, V273, P510, DOI 10.1126/science.273.5274.510
   Cheng HR, 1997, EXP NEUROL, V148, P544, DOI 10.1006/exnr.1997.6708
   COHEN NR, 1997, CURR BIOL, V8, P26
   DAVID S, 1981, SCIENCE, V214, P931, DOI 10.1126/science.6171034
   Davies SJA, 1999, J NEUROSCI, V19, P5810, DOI 10.1523/JNEUROSCI.19-14-05810.1999
   Duczmal A, 1997, BIOCHEM BIOPH RES CO, V232, P236, DOI 10.1006/bbrc.1997.6265
   Edelman GM, 1998, BRAIN RES REV, V26, P337, DOI 10.1016/S0165-0173(97)00034-9
   Fawcett JW, 1997, CELL TISSUE RES, V290, P371, DOI 10.1007/s004410050943
   Fitch MT, 1997, CELL TISSUE RES, V290, P379, DOI 10.1007/s004410050944
   Grill R, 1997, J NEUROSCI, V17, P5560
   HLAVIN ML, 1991, GENOMICS, V11, P416, DOI 10.1016/0888-7543(91)90150-D
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   JOOSTEN EAJ, 1995, J NEUROSCI RES, V41, P481, DOI 10.1002/jnr.490410407
   Joosten EAJ, 1997, PROG NEUROBIOL, V53, P1, DOI 10.1016/S0301-0082(97)00024-5
   Kadmon G, 1997, DIFFERENTIATION, V61, P143, DOI 10.1046/j.1432-0436.1997.6130143.x
   Kadmon G, 1998, Dev Immunol, V6, P205, DOI 10.1155/1998/23451
   Kenwrick S, 1998, BIOESSAYS, V20, P668, DOI 10.1002/(SICI)1521-1878(199808)20:8<668::AID-BIES10>3.0.CO;2-X
   KHAN T, 1991, BRAIN RES, V541, P139, DOI 10.1016/0006-8993(91)91087-H
   KLEITMAN N, 1988, EXP NEUROL, V102, P298, DOI 10.1016/0014-4886(88)90223-3
   KOBAYASHI S, 1995, NEUROSCI LETT, V188, P191, DOI 10.1016/0304-3940(95)11429-Z
   LAGENAUR C, 1987, P NATL ACAD SCI USA, V84, P7753, DOI 10.1073/pnas.84.21.7753
   LEMMON V, 1992, J NEUROSCI, V12, P818
   Li JT, 1996, BIOCONJUGATE CHEM, V7, P592, DOI 10.1021/bc960048v
   Liu Y, 1999, J NEUROSCI, V19, P4370
   MARCHAND R, 1990, NEUROSCIENCE, V36, P45, DOI 10.1016/0306-4522(90)90350-D
   Martinez-Morales JR, 1997, DEVELOPMENT, V124, P5139
   MARTINI R, 1994, GLIA, V10, P70, DOI 10.1002/glia.440100109
   MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890
   MCKEON RJ, 1991, J NEUROSCI, V11, P3398
   MCKEON RJ, 1995, EXP NEUROL, V136, P32, DOI 10.1006/exnr.1995.1081
   Montgomery AMP, 1996, J CELL BIOL, V132, P475, DOI 10.1083/jcb.132.3.475
   Nakahara Y, 1996, CELL TRANSPLANT, V5, P191, DOI 10.1016/0963-6897(95)02028-4
   Neff JA, 1999, BIOMATERIALS, V20, P2377, DOI 10.1016/S0142-9612(99)00166-0
   Oleszewski M, 1999, J BIOL CHEM, V274, P24602, DOI 10.1074/jbc.274.35.24602
   Ramon-Cueto A, 1998, J NEUROSCI, V18, P3803
   RAMONCUETO A, 1995, GLIA, V14, P163, DOI 10.1002/glia.440140302
   RANIERI JP, 1995, J BIOMED MATER RES, V29, P779, DOI 10.1002/jbm.820290614
   REICHARDT LF, 1991, ANNU REV NEUROSCI, V14, P531, DOI 10.1146/annurev.neuro.14.1.531
   RICHARDSON PM, 1980, NATURE, V284, P264, DOI 10.1038/284264a0
   ROGERS SL, 1983, DEV BIOL, V98, P212, DOI 10.1016/0012-1606(83)90350-0
   RUDGE JS, 1989, EXP NEUROL, V103, P1, DOI 10.1016/0014-4886(89)90180-5
   Ruppert M, 1995, J CELL BIOL, V131, P1881, DOI 10.1083/jcb.131.6.1881
   Saneinejad S, 1998, J BIOMED MATER RES, V42, P13, DOI 10.1002/(SICI)1097-4636(199810)42:1<13::AID-JBM3>3.0.CO;2-R
   SCHNELL L, 1990, NATURE, V343, P269, DOI 10.1038/343269a0
   Schwab ME, 1996, PHYSIOL REV, V76, P319
   SMITH GM, 1986, J COMP NEUROL, V251, P23, DOI 10.1002/cne.902510103
   SMITH GV, 1988, EXP BRAIN RES, V69, P299
   SOMMER I, 1981, DEV BIOL, V83, P311, DOI 10.1016/0012-1606(81)90477-2
   Stichel CC, 1998, PROG NEUROBIOL, V56, P119, DOI 10.1016/S0301-0082(98)00033-1
   Tong YW, 1998, J BIOMED MATER RES, V42, P85, DOI 10.1002/(SICI)1097-4636(199810)42:1<85::AID-JBM11>3.3.CO;2-R
   Tong YW, 1998, J BIOMAT SCI-POLYM E, V9, P713, DOI 10.1163/156856298X00109
   Walsh FS, 1997, ANNU REV CELL DEV BI, V13, P425, DOI 10.1146/annurev.cellbio.13.1.425
   WEBB K, IN PRESS J BIOMED MA
   Woerly S, 1999, TISSUE ENG, V5, P467, DOI 10.1089/ten.1999.5.467
   Woolhead CL, 1998, J COMP NEUROL, V391, P259
   Xu XM, 1999, EUR J NEUROSCI, V11, P1723, DOI 10.1046/j.1460-9568.1999.00591.x
   Xu XM, 1997, J NEUROCYTOL, V26, P1, DOI 10.1023/A:1018557923309
   Yu XJ, 1999, TISSUE ENG, V5, P291, DOI 10.1089/ten.1999.5.291
   ZHANG Y, 1995, J COMP NEUROL, V361, P193, DOI 10.1002/cne.903610202
   ZHANG Y, MOL CELL NEUROSCI
NR 66
TC 44
Z9 45
U1 0
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2001
VL 22
IS 10
BP 1017
EP 1028
DI 10.1016/S0142-9612(00)00353-7
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 425ZT
UT WOS:000168325100002
PM 11352083
DA 2018-10-20
ER

PT J
AU Yuan, HP
   de Bruijn, JD
   Zhang, XD
   van Blitterswijk, CA
   de Groot, K
AF Yuan, HP
   de Bruijn, JD
   Zhang, XD
   van Blitterswijk, CA
   de Groot, K
TI Bone induction by porous glass ceramic made from Bioglass (R) (45S5)
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE calcium phosphate-based biomaterials; glass ceramic; osteoconduction;
   osteoinduction; soft tissue implantation
ID CALCIUM-PHOSPHATE CERAMICS; HYDROXYAPATITE ORBITAL IMPLANTS; BIOACTIVE
   GLASS; OSTEOINDUCTION; BIOMATERIALS; DOGS; OSTEOGENESIS; PARTICLES;
   RESPONSES; TISSUE
AB Porous glass ceramic, which was prepared from Bioglass(R) powder (45S5, U.S. Biomaterials) by foaming with diluted H2O2 solution and sintering at 1000 degreesC for 2 h. was implanted as cylinders (5 mm in diameter and 6 mm in length) in thigh muscles of dogs for 3 months. Histological observation was made on thin un-decalcified sections. Bone formation was histologically found in pores of all implants (X16) retrieved from 16 dogs. The bone tissue was also identified with backscattered scanning electron microscopy observation (BSE) and energy dispersive X-ray microanalysis (EDX). This is the first report of hone induction in soft tissues of animals by glass ceramic that has long been recognized as a bioactive (osteoconductive) biomaterial. The present results justify the impetus to investigate the osteoinductivity of calcium phosphate-based biomaterials, to study the mechanism of bone induction (osteoinduction) by calcium phosphate-based biomaterials, to develop osteoinductive calcium phosphate-based biomaterials, and to examine the relation between osteoinduction and osteoconduction. (C) 2001 John Wiley & Sons, Inc.
C1 IsoTis NV, NL-3723 MB Bilthoven, Netherlands.
   Leiden Univ, Biomat Res Grp, NL-2300 RA Leiden, Netherlands.
   Sichuan Univ, Inst Mat Sci & Technol, Chengdu, Peoples R China.
RP Yuan, HP (reprint author), IsoTis NV, Prof Bronkhotstlaan 10, NL-3723 MB Bilthoven, Netherlands.
OI van Blitterswijk, Clemens/0000-0003-2371-4615
CR BOUABBOUD NN, 1994, BIOMATERIALS, V15, P201, DOI 10.1016/0142-9612(94)90068-X
   BRUDER SP, 1999, CLIN ORTHOP S, V367, P68
   DAMIEN CJ, 1991, J APPL BIOMATER, V2, P187, DOI 10.1002/jab.770020307
   de Bruijn J D, 1999, Adv Dent Res, V13, P74
   DEBRUIJN JD, 1999, P 25 ANN M SOC BIOM, P235
   Ducheyne P, 1997, TISSUE ENG, V3, P219, DOI 10.1089/ten.1997.3.219
   ElGhannam A, 1997, BIOMATERIALS, V18, P295, DOI 10.1016/S0142-9612(96)00059-2
   GREEN JP, 1995, AM J OPHTHALMOL, V120, P681, DOI 10.1016/S0002-9394(14)72222-6
   HENCH LL, 1984, SCIENCE, V226, P630, DOI 10.1126/science.6093253
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   KLEIN C, 1994, BIOMATERIALS, V15, P31, DOI 10.1016/0142-9612(94)90193-7
   LANE JM, 1999, CLIN ORTHOP S, V367, P107
   Ohgushi H., 1996, BIOCERAMICS, V9, P49
   OSBORN JF, 1991, BIOMATERIALS DEGRADA, P185
   Ripamonti U, 1996, BIOMATERIALS, V17, P31, DOI 10.1016/0142-9612(96)80752-6
   RIPAMONTI U, 1991, J BONE JOINT SURG AM, V73A, P692, DOI 10.2106/00004623-199173050-00007
   Schepers EJG, 1997, J ORAL REHABIL, V24, P171
   Sires BS, 1997, OPHTHALMIC PLAST REC, V13, P244, DOI 10.1097/00002341-199712000-00003
   TOTH JM, 1993, BIOCERAMICS, V6, P9
   Vargervik K., 1992, BONE GRAFTS BONE SUB, P112
   WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241
   YAMASAKI H, 1992, BIOMATERIALS, V13, P308, DOI 10.1016/0142-9612(92)90054-R
   Yamasaki H., 1990, JPN J ORAL BIOL, V32, P190, DOI DOI 10.2330/JORALBIOSCI1965.32.190
   Yang ZJ, 1997, J MATER SCI-MATER M, V8, P697, DOI 10.1023/A:1018540024082
   Yang ZJ, 1996, BIOMATERIALS, V17, P2131, DOI 10.1016/0142-9612(96)00044-0
   YUAN H, 1997, BIOMEDICAL MAT RES F, P228
   YUAN H, IN PRESS J MATER SCI
   Yuan H, 1997, BIOMED ENG-APP BAS C, V9, P274
   Yuan HP, 1998, J MATER SCI-MATER M, V9, P717, DOI 10.1023/A:1008998817977
   Yuan HP, 1998, J MATER SCI-MATER M, V9, P723, DOI 10.1023/A:1008950902047
   Yuan HP, 2000, BIOMATERIALS, V21, P1283, DOI 10.1016/S0142-9612(00)00016-8
   Yuan HP, 1999, BIOMATERIALS, V20, P1799, DOI 10.1016/S0142-9612(99)00075-7
   Zhang XD, 1991, BIOCERAMICS HUMAN BO, P408
NR 33
TC 140
Z9 150
U1 1
U2 32
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD MAY 1
PY 2001
VL 58
IS 3
BP 270
EP 276
DI 10.1002/1097-4636(2001)58:3<270::AID-JBM1016>3.0.CO;2-2
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 432HX
UT WOS:000168687100007
PM 11319740
DA 2018-10-20
ER

PT J
AU Bowen, WR
   Lovitt, RW
   Wright, CJ
AF Bowen, WR
   Lovitt, RW
   Wright, CJ
TI Atomic force microscopy study of the adhesion of Saccharomyces
   cerevisiae
SO JOURNAL OF COLLOID AND INTERFACE SCIENCE
LA English
DT Article
DE adhesion; atomic force microscopy; saccharomyces cerevisiae
ID SURFACE-PROPERTIES; STAPHYLOCOCCUS-EPIDERMIDIS; BIOMATERIAL SURFACES;
   BIOLOGICAL ADHESION; BACTERIAL ADHESION; ORAL STREPTOCOCCI; SOLID
   SUBSTRATA; CELL; MECHANISMS; YEASTS
AB An atomic force microscope (AFM) has been used to quantify directly the adhesion of metabolically active Saccharomyces cerevisiae cells at a hydrophilic mica surface, a mica surface with a hydrophobic coating, and a protein-coated mica surface in an aqueous environment. The measurements used "cell probes" constructed by immobilizing a single cell at the apex of a tipless AFM cantilever. Adhesion was quantified from force-distance data for the retraction of the cell from the surface. The data indicated stretching and sequential bond-breaking as the cell probe was retracted from all of the surfaces. Detailed studies were made for physiologically active cells, which were shown to have different adhesion properties to glutaraldehyde-treated cells. Greatest cell adhesion was measured at the hydrophobic surface. Prior adsorption of a bovine serum albumin protein layer at the hydrophilic surface did not significantly affect cell adhesion. Changes in yeast surface hydrophobicity and zeta-potential with yeast cell age were correlated with differences in adhesion. Cells from the stationary phase adhered most strongly to a mica surface. Time of surface contact was demonstrated to be important. Both the force needed to detach a cell from a hydrophilic mica surface and the length of the adhesive interaction increased after 5 min contact. The AFM cell probe technique gives unique insights into primary colonization events in biofilm formation. It will continue to aid both fundamental studies and the assessment of new procedures that are designed to lower cell adhesion at surfaces relevant to biotechnology, medicine, and dentistry. (C) 2001 Academic Press.
C1 Univ Wales, Dept Chem & Biol Proc Engn, Ctr Complex Fluids Proc, Swansea SA2 8PP, W Glam, Wales.
RP Bowen, WR (reprint author), Univ Wales, Dept Chem & Biol Proc Engn, Ctr Complex Fluids Proc, Swansea SA2 8PP, W Glam, Wales.
OI Lovitt, robert/0000-0002-5587-2776; Wright, Chris/0000-0003-2375-8159
CR AMORY DE, 1988, J I BREWING, V94, P79, DOI 10.1002/j.2050-0416.1988.tb04561.x
   An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   Azeredo J, 1999, COLLOID SURFACE B, V14, P141, DOI 10.1016/S0927-7765(99)00031-4
   BELLONFONTAINE MN, 1990, CELL BIOPHYS, V17, P93, DOI 10.1007/BF02989805
   Bowen WR, 1999, COLLOID SURFACE A, V157, P117, DOI 10.1016/S0927-7757(99)00045-X
   Bowen WR, 2000, J COLLOID INTERF SCI, V228, P428, DOI 10.1006/jcis.2000.6969
   Bowen WR, 1998, J COLLOID INTERF SCI, V197, P348, DOI 10.1006/jcis.1997.5247
   Bowen WR, 1999, J MEMBRANE SCI, V154, P205
   Bowen WR, 1998, COLLOID SURFACE A, V136, P231, DOI 10.1016/S0927-7757(97)00243-4
   Bowen WR, 2001, J MATER SCI, V36, P623, DOI 10.1023/A:1004864219379
   BOWEN WR, 1990, J MEMBRANE SCI, V51, P189, DOI 10.1016/S0376-7388(00)80902-3
   BOWEN WR, 1992, BIOTECHNOL BIOENG, V40, P1309, DOI 10.1002/bit.260401104
   CAMPBELL I, 1988, YEAST PRACTICAL APPR, P277
   Cereghino GPL, 1999, CURR OPIN BIOTECH, V10, P422, DOI 10.1016/S0958-1669(99)00004-X
   Chang KC, 1996, LANGMUIR, V12, P2271, DOI 10.1021/la950690y
   CLEVELAND JP, 1993, REV SCI INSTRUM, V64, P403, DOI 10.1063/1.1144209
   COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431
   DENGIS PB, 1995, APPL ENVIRON MICROB, V61, P718
   DOUGLAS LJ, 1987, YEASTS, V2, P240
   DUCKER WA, 1991, NATURE, V353, P239, DOI 10.1038/353239a0
   Hammer DA, 1996, ANNU REV MATER SCI, V26, P651
   Hazen KC, 1990, MICROBIAL CELL SURFA, P249
   Heinz WF, 1999, TRENDS BIOTECHNOL, V17, P143, DOI 10.1016/S0167-7799(99)01304-9
   Hermansson M, 1999, COLLOID SURFACE B, V14, P105, DOI 10.1016/S0927-7765(99)00029-6
   HOH JH, 1994, J CELL SCI, V107, P1105
   Loosdrecht M, 1990, AQUAT SCI, V52, P103
   LUCKHAM PF, 1994, ADV COLLOID INTERFAC, V49, P341, DOI 10.1016/0001-8686(94)80019-7
   Millsap KW, 1999, J COLLOID INTERF SCI, V212, P495, DOI 10.1006/jcis.1998.6054
   Millsap KW, 1998, FEMS MICROBIOL REV, V21, P321, DOI 10.1111/j.1574-6976.1998.tb00356.x
   Ming F, 1998, ENZYME MICROB TECH, V22, P94, DOI 10.1016/S0141-0229(97)00136-1
   Mittelman M. W., 1996, BACTERIAL ADHESION M, P89
   Ong YL, 1999, LANGMUIR, V15, P2719, DOI 10.1021/la981104e
   PRATTTERPSTRA IH, 1988, CURR MICROBIOL, V16, P311, DOI 10.1007/BF01568537
   Razatos A, 1998, J BIOMAT SCI-POLYM E, V9, P1361, DOI 10.1163/156856298X00442
   ROSENBERG M, 1980, FEMS MICROBIOL LETT, V9, P29, DOI 10.1016/0378-1097(80)90106-8
   Sagvolden G, 1999, P NATL ACAD SCI USA, V96, P471, DOI 10.1073/pnas.96.2.471
   SJOLLEMA J, 1990, J ADHES SCI TECHNOL, V4, P765, DOI 10.1163/156856190X00658
   SMART KA, 1995, J AM SOC BREW CHEM, V53, P33
   Stanier R. Y., 1968, GEN MICROBIOLOGY
   Toikka G, 1996, J COLLOID INTERF SCI, V180, P329, DOI 10.1006/jcis.1996.0311
   Vacheethasanee K, 1998, J BIOMED MATER RES, V42, P425, DOI 10.1002/(SICI)1097-4636(19981205)42:3<425::AID-JBM12>3.0.CO;2-F
   Veeramasuneni S, 1996, J COLLOID INTERF SCI, V184, P594, DOI 10.1006/jcis.1996.0656
   VERNHET A, 1995, COLLOID SURFACE B, V3, P255
   WANG IW, 1995, J BIOMED MATER RES, V29, P485, DOI 10.1002/jbm.820290408
   Whittaker CJ, 1996, ANNU REV MICROBIOL, V50, P513, DOI 10.1146/annurev.micro.50.1.513
   WOJCIECHOWSKI PW, 1996, INTERFACIAL PHENOMEN, P1
   WRIGHT CJ, 1995, THESIS U WALES SWANS
NR 47
TC 110
Z9 115
U1 1
U2 41
PU ACADEMIC PRESS INC
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0021-9797
J9 J COLLOID INTERF SCI
JI J. Colloid Interface Sci.
PD MAY 1
PY 2001
VL 237
IS 1
BP 54
EP 61
DI 10.1006/jcis.2001.7437
PG 8
WC Chemistry, Physical
SC Chemistry
GA 428CE
UT WOS:000168442900008
DA 2018-10-20
ER

PT J
AU Quirk, RA
   Davies, MC
   Tendler, SJB
   Chan, WC
   Shakesheff, KM
AF Quirk, RA
   Davies, MC
   Tendler, SJB
   Chan, WC
   Shakesheff, KM
TI Controlling biological interactions with poly(lactic acid) by surface
   entrapment modification
SO LANGMUIR
LA English
DT Article
ID POLYMERIC BIOMATERIALS; POLY(ETHYLENE GLYCOL); POLYETHYLENE-GLYCOL;
   ADHESION; COPOLYMERS; RESOLUTION; OXIDE); FILMS; XPS
AB Poly(ethylene glycol) (PEG)-modified poly(lactic acid) (PLA) systems were created by physically entrapping the modifying species at the PLA surface. The surface characterization and biological performance of these materials are described. This modification strategy is performed by reversible gelation of the PLA surface following exposure to a solvent/nonsolvent mixture. PEG is then able to diffuse into the swollen surface region, before it is collapsed by the addition of more nonsolvent. This results in the localized physical entrapment of the diffused material. We have demonstrated by high-resolution X-ray photoelectron spectroscopy that control over the PEG surface density may be achieved by using predetermined process conditions, such as a particular solvent/nonsolvent ratio or a set polymer treatment time, and that surface coverage of around 75% is possible. Cell adhesion studies have shown that even in serum-containing media PEG entrapment will prevent attachment, with a 95% reduction in cell number compared to unmodified PLA. This modification strategy was also used to coentrap both PEG and poly(L-lysine)-RGD within the PLA surface region. The attachment of cells to this material shows that the entrapment approach may be used to create highly selective biomaterial surfaces that are able to prevent unwanted cell or protein adhesion yet actively promote specific cellular interaction.
C1 Univ Nottingham, Sch Pharmaceut Sci, Nottingham NG7 2RD, England.
RP Shakesheff, KM (reprint author), Univ Nottingham, Sch Pharmaceut Sci, Univ Pk, Nottingham NG7 2RD, England.
RI Chan, Weng/O-2045-2015; Shakesheff, Kevin/O-6371-2018
OI Chan, Weng/0000-0002-0488-825X; Shakesheff, Kevin/0000-0003-3236-2439;
   Davies, Martyn/0000-0001-7695-0596
CR BEAMSON G, 1990, SURF INTERFACE ANAL, V15, P541, DOI 10.1002/sia.740150908
   Bearinger JP, 1998, J BIOMAT SCI-POLYM E, V9, P629, DOI 10.1163/156856298X00064
   Burg KJL, 1999, J BIOMAT SCI-POLYM E, V10, P147, DOI 10.1163/156856299X00108
   Carlisle ES, 2000, TISSUE ENG, V6, P45, DOI 10.1089/107632700320883
   CIMA LG, 1991, BIOTECHNOL BIOENG, V38, P145, DOI 10.1002/bit.260380207
   CUMPSON PJ, 1995, J ELECTRON SPECTROSC, V73, P25, DOI 10.1016/0368-2048(94)02270-4
   Deible CR, 1998, BIOMATERIALS, V19, P1885, DOI 10.1016/S0142-9612(98)00098-2
   DESAI NP, 1992, MACROMOLECULES, V25, P226, DOI 10.1021/ma00027a038
   DESAI NP, 1991, BIOMATERIALS, V12, P144, DOI 10.1016/0142-9612(91)90193-E
   Dunn SE, 1997, J CONTROL RELEASE, V44, P65, DOI 10.1016/S0168-3659(96)01504-0
   Elbert DL, 1996, ANNU REV MATER SCI, V26, P365, DOI 10.1146/annurev.ms.26.080196.002053
   GELIUS U, 1990, J ELECTRON SPECTROSC, V52, P747, DOI 10.1016/0368-2048(90)85063-F
   GOMBOTZ WR, 1991, J BIOMED MATER RES, V25, P1547, DOI 10.1002/jbm.820251211
   Grifftih I. G., 2000, ACTA MAT, V48, P263
   Han DK, 1997, MACROMOLECULES, V30, P6077, DOI 10.1021/ma970302u
   Hern DL, 1998, J BIOMED MATER RES, V39, P266, DOI 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B
   HUBBELL JA, 1991, BIO-TECHNOL, V9, P568, DOI 10.1038/nbt0691-568
   Huh KM, 1999, POLYMER, V40, P6147, DOI 10.1016/S0032-3861(98)00822-2
   Park A, 1998, J BIOMAT SCI-POLYM E, V9, P89, DOI 10.1163/156856298X00451
   Quirk RA, 2001, BIOMATERIALS, V22, P865, DOI 10.1016/S0142-9612(00)00250-7
   Quirk RA, 2000, MACROMOLECULES, V33, P258, DOI 10.1021/ma9916133
   Shard AG, 1997, MACROMOLECULES, V30, P3051, DOI 10.1021/ma9519021
   Sheth M, 1997, J APPL POLYM SCI, V66, P1495, DOI 10.1002/(SICI)1097-4628(19971121)66:8<1495::AID-APP10>3.0.CO;2-3
   TASHIRO K, 1989, J BIOL CHEM, V264, P16174
NR 24
TC 54
Z9 58
U1 2
U2 16
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD MAY 1
PY 2001
VL 17
IS 9
BP 2817
EP 2820
DI 10.1021/la001509a
PG 4
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 426XD
UT WOS:000168373000043
DA 2018-10-20
ER

PT J
AU Burden, DL
   Poppen, SD
   Elliott, JT
   Woodward, JT
   Sehgal, A
AF Burden, DL
   Poppen, SD
   Elliott, JT
   Woodward, JT
   Sehgal, A
TI Probing surface diffusion heterogeneity at biomaterial interfaces with
   single-event histograms.
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
C1 Wheaton Coll, Dept Chem, Wheaton, IL 60187 USA.
   Natl Inst Stand & Technol, Wheaton, IL 60187 USA.
   Natl Inst Stand & Technol, Div Biotechnol, Wheaton, IL 60187 USA.
   Natl Inst Stand & Technol, Div Polymers, Wheaton, IL 60187 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD APR 1
PY 2001
VL 221
MA 145-PHYS
BP U249
EP U249
PN 2
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA 434PJ
UT WOS:000168824801469
DA 2018-10-20
ER

PT J
AU Stammen, JA
   Williams, S
   Ku, DN
   Guldberg, RE
AF Stammen, JA
   Williams, S
   Ku, DN
   Guldberg, RE
TI Mechanical properties of a novel PVA hydrogel in shear and unconfined
   compression
SO BIOMATERIALS
LA English
DT Article
DE biomaterial; cartilage; properties; compression; shear; hydrogel
ID ARTICULAR-CARTILAGE; DRUG-DELIVERY; STRENGTH
AB Poly(vinyl alcohol) (PVA) hydrogels have been proposed as promising biomaterials to replace diseased or damaged articular cartilage. A critical barrier to their use as load-bearing tissue replacements is a lack of sufficient mechanical properties. The purpose of this study was to characterize the functional compressive and shear mechanical properties of a novel PVA hydrogel. Two formulations of the biomaterial were tested, one with a lower water content (75% water), and the other with higher water content (80% water). The compressive tangent modulus varied with biomaterial formulation and was found to be statistically strain magnitude and rate dependent. Over a strain range of 10-60%, the compressive modulus increased from approximately 1-18 MPa, which is within the range of the modulus of articular cartilage. The shear tangent modulus (0.1-0.4 MPa) was also found to be strain magnitude dependent and within the range of normal human articular cartilage, but it was not statistically dependent on strain rate. This behavior was attributed to the dominance of fluid flow and related frictional drag on the viscoelastic behavior. Compressive failure of the hydrogels was found to occur between 45 and 60% strain, depending on water content. (C) 2001 Published by Elsevier Science Ltd.
C1 Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.
   Restore Therapeut, Atlanta, GA 30318 USA.
RP Guldberg, RE (reprint author), Georgia Inst Technol, George W Woodruff Sch Mech Engn, 315 Ferst Dr NW,IBB Bldg,Room 2311, Atlanta, GA 30332 USA.
CR Ambrosio L, 1998, P I MECH ENG H, V212, P93, DOI 10.1243/0954411981533863
   Anseth KS, 1996, BIOMATERIALS, V17, P1647, DOI 10.1016/0142-9612(96)87644-7
   *ARTHR FDN, 1999, DEM EC INF
   BRAY JC, 1973, J BIOMED MATER RES, V7, P431, DOI 10.1002/jbm.820070506
   BUCKWALTER JA, 1994, J BONE JOINT SURG AM, V76A, P1405, DOI 10.2106/00004623-199409000-00019
   CauichRodriguez JV, 1996, BIOMATERIALS, V17, P2259, DOI 10.1016/0142-9612(96)00058-0
   Corkhill P H, 1990, Proc Inst Mech Eng H, V204, P147, DOI 10.1243/PIME_PROC_1990_204_249_02
   CORKHILL PH, 1993, J BIOMAT SCI-POLYM E, V4, P615, DOI 10.1163/156856293X00834
   DiTizio V, 1998, BIOMATERIALS, V19, P1877, DOI 10.1016/S0142-9612(98)00096-9
   Kerin AJ, 1998, P I MECH ENG H, V212, P273, DOI 10.1243/0954411981534051
   Ku DN, 1999, [US Patent, Poly(vinyl alcohol) Cryogel Patent], Patent No. 5981826
   Li JK, 1998, J CONTROL RELEASE, V56, P117, DOI 10.1016/S0168-3659(98)00089-3
   LOPOUR P, 1993, BIOMATERIALS, V14, P1051, DOI 10.1016/0142-9612(93)90204-F
   Mow Van C., 1997, P113
   OKA M, 1990, Clinical Materials, V6, P361, DOI 10.1016/0267-6605(90)90053-X
   Peppas NA, 1999, J CONTROL RELEASE, V62, P81, DOI 10.1016/S0168-3659(99)00027-9
   Vijayasekaran S, 1998, BIOMATERIALS, V19, P2255, DOI 10.1016/S0142-9612(98)00128-8
   WILLIAMS S, 1998, THESIS GEORGIA ITECH
   Young CD, 1998, BIOMATERIALS, V19, P1745, DOI 10.1016/S0142-9612(98)00083-0
   Zheng-Qiu G, 1998, BIO-MED MATER ENG, V8, P75
NR 20
TC 343
Z9 356
U1 18
U2 269
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD APR
PY 2001
VL 22
IS 8
BP 799
EP 806
DI 10.1016/S0142-9612(00)00242-8
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 404UK
UT WOS:000167120000006
PM 11246948
DA 2018-10-20
ER

PT J
AU Yamauchi, K
   Takeuchi, N
   Kurimoto, A
   Tanabe, T
AF Yamauchi, K
   Takeuchi, N
   Kurimoto, A
   Tanabe, T
TI Films of collagen crosslinked by S-S bonds: preparation and
   characterization
SO BIOMATERIALS
LA English
DT Article
DE biomaterial; collagen; collagenase; disulfide bond; fibroblast cell;
   thiolation
ID EPIDERMAL-CELLS; TISSUE; GROWTH; SKIN; EPITHELIUM; SUBSTRATA; CULTURES;
   ADHESION; INVITRO
AB Collagen (type I from calf-skin) was chemically modified by 4-butyrothiolactone to obtain the mercapto group-bearing collagen (collagenSH), which possessed SH groups in 8-19 M% of a total amino acid residues. The triple helical strands of the collagen was not completely perturbed to exhibit the rotary dispersion [theta](221), which was as much as 70% of an original intensity of the collagen. In the presence of the oxygen dissolved in water, the collagenSH was cross-linked by disulfide bonds to afford the collagenSS. The collagenSS could preserve about 15 and 40% of an original helix structure at 55-70 degreesC and in 2 mm sodium dodecyl sulfate, respectively. The film made of the collagenSS exhibited the tensile strength as high as 36 MPa and was insoluble in most organic solvents including water. The collagenSS film was more resistant to degradation by collagenase (type I) than the collagen film. The collagenSS film supported the growth of L929 fibroblast cell in a manner similar to a collagen film. (C) 2001 Published by Elsevier Science Ltd.
C1 Osaka City Univ, Fac Engn, Dept Bioappl Chem, Sumiyoshi Ku, Osaka 5588585, Japan.
RP Yamauchi, K (reprint author), Osaka City Univ, Fac Engn, Dept Bioappl Chem, Sumiyoshi Ku, Osaka 5588585, Japan.
EM yamauchi@bioa.eng.osaka-cu.ac.jp
CR BELL E, 1979, P NATL ACAD SCI USA, V76, P1274, DOI 10.1073/pnas.76.3.1274
   BENESCH R, 1962, BIOCHIM BIOPHYS ACTA, V63, P166, DOI 10.1016/0006-3002(62)90349-9
   BENESCH R, 1958, P NATL ACAD SCI USA, V44, P848, DOI 10.1073/pnas.44.9.848
   BRUICE TC, 1964, J AM CHEM SOC, V86, P4886, DOI 10.1021/ja01076a032
   BUTTERWORTH PH, 1967, ARCH BIOCHEM BIOPHYS, V118, P716, DOI 10.1016/0003-9861(67)90409-2
   CHVAPIL M, 1979, BIOL COLLAGEN, V1, P247
   DUNN MW, 1969, ARCH OPHTHALMOL-CHIC, V82, P840
   DUNN MW, 1967, SCIENCE, V157, P1329, DOI 10.1126/science.157.3794.1329
   ELSDALE T, 1972, J CELL BIOL, V54, P626, DOI 10.1083/jcb.54.3.626
   EMERMAN JT, 1977, P NATL ACAD SCI USA, V74, P4466, DOI 10.1073/pnas.74.10.4466
   FEENEY RE, 1982, ADV CHEM SER, P3
   FEUGHELMAN M, 1985, ENCY POLYM SCI ENG, V8, P566
   GALLICO GG, 1984, NEW ENGL J MED, V311, P448, DOI 10.1056/NEJM198408163110706
   Grab B, 1996, J BIOL CHEM, V271, P12234, DOI 10.1074/jbc.271.21.12234
   GREEN H, 1979, P NATL ACAD SCI USA, V76, P5665, DOI 10.1073/pnas.76.11.5665
   GRNAT DS, 1986, J CELL BIOL, V108, P1567
   HARRINGTON WF, 1966, ANNU REV BIOCHEM, V35, P599, DOI 10.1146/annurev.bi.35.070166.003123
   HEIDEMANN E, 1982, ADV POLYM SCI, V43, P143
   HUBBELL JA, 1995, TISSUE ENG, P42
   KENDALL PA, 1969, BIOCHIM BIOPHYS ACTA, V188, P10, DOI 10.1016/0005-2795(69)90040-3
   KLOTZ IM, 1964, BIOCHIM BIOPHYS ACTA, V86, P100, DOI 10.1016/0304-4165(64)90163-1
   Lesage A, 1996, BIOCHEMISTRY-US, V35, P9647, DOI 10.1021/bi952666p
   LOWRY TH, 1976, MECH THEORY ORGANIC, P177
   MARINKOVICH MP, 1986, J CELL PHYSIOL, V128, P61, DOI 10.1002/jcp.1041280111
   Matsuda S, 1999, J BIOMED MATER RES, V45, P20, DOI 10.1002/(SICI)1097-4636(199904)45:1<20::AID-JBM3>3.0.CO;2-6
   MIYATA T, 1974, Patent No. 4939174
   MIYATA T, 1980, Patent No. 4260228
   NIMNI ME, 1988, COLLAGEN BIOTECHNOLO, V3
   NUSGENS B, 1984, COLLAGEN REL RES, V4, P351
   Piez K. A., 1985, ENCY POLYM SCI ENG, P699
   ROJKIND M, 1980, J CELL BIOL, V87, P255, DOI 10.1083/jcb.87.1.255
   RUBIN K, 1977, EXP CELL RES, V109, P413, DOI 10.1016/0014-4827(77)90021-0
   STENZEL KH, 1974, ANNU REV BIOPHYS BIO, V3, P231, DOI 10.1146/annurev.bb.03.060174.001311
   STENZEL RH, 1969, T AM SOC ART INT ORG, V15, P114
   STROM SC, 1982, METHOD ENZYMOL, V82, P544
   STRYER L, 1988, BIOCHEMISTRY
   TAKADA M, 1992, Patent No. 450369
   TOBOLSKY AV, 1971, POLYM SCI MAT, P83
   WICHA MS, 1979, EXP CELL RES, V124, P181, DOI 10.1016/0014-4827(79)90268-4
   Yamauchi K, 1998, J BIOMAT SCI-POLYM E, V9, P259, DOI 10.1163/156856298X00640
   Yamauchi K, 1996, J BIOMED MATER RES, V31, P439, DOI 10.1002/(SICI)1097-4636(199608)31:4<439::AID-JBM1>3.0.CO;2-M
   YANNAS IV, 1982, SCIENCE, V215, P174, DOI 10.1126/science.7031899
   YANNAS IV, 1980, J BIOMED MATER RES, V14, P107, DOI 10.1002/jbm.820140203
   YOSHIZATO K, 1988, J CELL SCI, V91, P491
   YOSHIZATO K, 1986, BIOMED RES-TOKYO, V7, P219
NR 45
TC 24
Z9 25
U1 1
U2 11
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD APR
PY 2001
VL 22
IS 8
BP 855
EP 863
DI 10.1016/S0142-9612(00)00249-0
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 404UK
UT WOS:000167120000012
PM 11246954
DA 2018-10-20
ER

PT J
AU Werkmeister, JA
   Tebb, TA
   White, JF
   Ramshaw, JAM
AF Werkmeister, JA
   Tebb, TA
   White, JF
   Ramshaw, JAM
TI Collagenous tissue formation in association with medical implants
SO CURRENT OPINION IN SOLID STATE & MATERIALS SCIENCE
LA English
DT Review
DE collagens; extracellular matrix; immunohistology; connective tissue;
   implant
ID ABDOMINAL-WALL DEFECTS; VASCULAR PROSTHESIS; BOVINE COLLAGEN;
   MONOCLONAL-ANTIBODIES; CAPSULAR CONTRACTURE; BREAST AUGMENTATION;
   BIOMATERIAL IMPLANT; TEXTURED SILICONE; FIBROUS CAPSULE; SMOOTH SILICONE
AB The host response to a biomaterial includes assembly of an effective collagenous matrix that is critical for the long-term performance of a medical implant. Despite the development of methods that allow detailed examination of the non-cellular matrix components, particularly collagens, relatively little information is available on the extent of molecular variability in the collagen matrix that is associated with various alternative implant materials. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 CSIRO Mol Sci, Parkville, Vic 3052, Australia.
RP Werkmeister, JA (reprint author), CSIRO Mol Sci, 343 Royal Parade, Parkville, Vic 3052, Australia.
CR ALBREKTSSON T, 1985, BIOMATERIALS, V6, P97, DOI 10.1016/0142-9612(85)90070-5
   Asplund O, 1996, PLAST RECONSTR SURG, V97, P1200, DOI 10.1097/00006534-199605000-00015
   Bisucci T, 2000, METH MOL B, V123, P291
   BRODSKY B, 1994, INT J BIOL MACROMOL, V16, P27, DOI 10.1016/0141-8130(94)90007-8
   BROHIM RM, 1992, ANN PLAS SURG, V28, P354, DOI 10.1097/00000637-199204000-00010
   BUCKY LP, 1994, PLAST RECONSTR SURG, V93, P1123, DOI 10.1097/00006534-199405000-00002
   Bujan J, 1997, HISTOL HISTOPATHOL, V12, P683
   BURKE KE, 1985, ANN PLAS SURG, V14, P515, DOI 10.1097/00000637-198506000-00004
   Chirila TV, 1996, GRAEF ARCH CLIN EXP, V234, P193, DOI 10.1007/BF00462032
   Clark RAF, 1988, MOL CELLULAR BIOL WO
   Drubaix I, 1996, EXP EYE RES, V62, P367, DOI 10.1006/exer.1996.0042
   Hakelius L, 1997, PLAST RECONSTR SURG, V100, P1566, DOI 10.1097/00006534-199711000-00030
   Hammerstad M, 1996, SCAND J PLAST RECONS, V30, P33, DOI 10.3109/02844319609072402
   HASSON JE, 1986, J VASC SURG, V4, P243, DOI 10.1067/mva.1986.avs0040243
   HERING TM, 1986, CONNECT TISSUE RES, V15, P141, DOI 10.3109/03008208609167139
   HUNT JA, 1993, J BIOMED ENG, V15, P39, DOI 10.1016/0141-5425(93)90091-C
   Jacob JT, 1996, J BIOMED MATER RES, V32, P181, DOI 10.1002/(SICI)1097-4636(199610)32:2<181::AID-JBM5>3.0.CO;2-P
   KASPER CS, 1994, AM J CLIN PATHOL, V102, P655, DOI 10.1093/ajcp/102.5.655
   KEEFE J, 1992, Clinical Materials, V9, P155, DOI 10.1016/0267-6605(92)90095-B
   KETHARNATHAN V, 1980, ARCH SURG-CHICAGO, V115, P967
   Koch G, 1997, AUST NZ J SURG, V67, P637, DOI 10.1111/j.1445-2197.1997.tb04614.x
   KOHRI M, 1990, J ORAL MAXIL SURG, V48, P1265, DOI 10.1016/0278-2391(90)90480-P
   Legeais JM, 1997, J BIOMED MATER RES, V36, P49
   LEGEROS RZ, 1993, J BONE MINER RES, V8, pS583
   LINDER L, 1983, ACTA ORTHOP SCAND, V54, P45, DOI 10.3109/17453678308992868
   MARCACCI M, 1991, CLIN ORTHOP RELAT R, P115
   MARSHALL WR, 1989, ANN PLAS SURG, V23, P401, DOI 10.1097/00000637-198911000-00004
   McFarland CD, 1999, J BIOMED MATER RES, V44, P1
   Moreschini O, 1997, J ARTHROPLASTY, V12, P695, DOI 10.1016/S0883-5403(97)90144-3
   OKADA T, 1993, J BIOMED MATER RES, V27, P1509, DOI 10.1002/jbm.820271207
   OONO T, 1993, J INVEST DERMATOL, V100, P329, DOI 10.1111/1523-1747.ep12470022
   PRESCOTT RJ, 1994, J CLIN PATHOL, V47, P375, DOI 10.1136/jcp.47.4.375
   Ramshaw JAM, 1999, J BIOMED MATER RES, V47, P309, DOI 10.1002/(SICI)1097-4636(19991205)47:3<309::AID-JBM4>3.0.CO;2-R
   RAMSHAW JAM, 1988, J BIOMED MATER RES, V23, P649
   Ramshaw John A. M., 1994, Clinical Materials, V16, P9, DOI 10.1016/0267-6605(94)90086-8
   Rosengren A, 1996, BIOMATERIALS, V17, P1779, DOI 10.1016/0142-9612(95)00358-4
   SCHINDHELM K, 1991, CLIN ORTHOP RELAT R, P278
   Schneider U, 1998, J ARTHROPLASTY, V13, P687, DOI 10.1016/S0883-5403(98)80014-4
   SCHREUDERS PD, 1988, J BIOMED MATER RES, V22, P121, DOI 10.1002/jbm.820220205
   Shanklin DR, 1999, EXP MOL PATHOL, V67, P26, DOI 10.1006/exmp.1999.2269
   Shannon C, 1997, J BIOMED MATER RES, V34, P401, DOI 10.1002/(SICI)1097-4636(19970305)34:3<401::AID-JBM15>3.0.CO;2-I
   STEGMAN SJ, 1987, ARCH DERMATOL, V123, P1644, DOI 10.1001/archderm.123.12.1644
   Tarpila E, 1997, PLAST RECONSTR SURG, V99, P1934, DOI 10.1097/00006534-199706000-00019
   Trumpy IG, 1997, SCAND J PLAST RECONS, V31, P295, DOI 10.3109/02844319709008975
   Ungersbock A, 1996, BIOMATERIALS, V17, P797, DOI 10.1016/0142-9612(96)81417-7
   VIALLEPRESLES MJ, 1989, HISTOCHEMISTRY, V91, P177, DOI 10.1007/BF00490129
   VONRECUM AF, 1993, J BIOMED MATER RES, V27, P757, DOI 10.1002/jbm.820270608
   Wallace D. G., 1988, COLLAGEN, V3, P117
   WALLACE DG, 1992, J BIOMED MATER RES, V26, P1517, DOI 10.1002/jbm.820261110
   Werkmeister J A, 1991, J Long Term Eff Med Implants, V1, P107
   WERKMEISTER JA, 1993, J HISTOCHEM CYTOCHEM, V41, P1701, DOI 10.1177/41.11.8409376
   WERKMEISTER JA, 1991, J HISTOCHEM CYTOCHEM, V39, P1215, DOI 10.1177/39.9.1918939
   WERKMEISTER JA, 1994, MED PROG TECHNOL, V20, P231
   WERKMEISTER JA, 1995, J LONG-TERM EFF MED, V5, P1
   WERKMEISTER JA, 1990, EUR J BIOCHEM, V187, P439, DOI 10.1111/j.1432-1033.1990.tb15323.x
   Werkmeister JA, 1998, J BIOMED MATER RES, V39, P429, DOI 10.1002/(SICI)1097-4636(19980305)39:3<429::AID-JBM12>3.0.CO;2-5
   WERKMEISTER JA, 1991, BIOCHEM J, V274, P895, DOI 10.1042/bj2740895
   Werkmeister JA, 2000, BIOMATERIALS ENG DEV, V1, P121
   White Jacinta F., 1993, Clinical Materials, V14, P271, DOI 10.1016/0267-6605(93)90013-W
   Wyatt LE, 1998, PLAST RECONSTR SURG, V102, P1922, DOI 10.1097/00006534-199811000-00017
   Zaffagnini S, 1997, Knee Surg Sports Traumatol Arthrosc, V5, P89, DOI 10.1007/s001670050033
NR 61
TC 8
Z9 8
U1 0
U2 3
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1359-0286
J9 CURR OPIN SOLID ST M
JI Curr. Opin. Solid State Mat. Sci.
PD APR-JUN
PY 2001
VL 5
IS 2-3
BP 185
EP 191
DI 10.1016/S1359-0286(01)00007-9
PG 7
WC Materials Science, Multidisciplinary; Physics, Applied; Physics,
   Condensed Matter
SC Materials Science; Physics
GA 451CJ
UT WOS:000169783300011
DA 2018-10-20
ER

PT J
AU Malouf, AJ
   Vaizey, CJ
   Norton, CS
   Kamm, MA
AF Malouf, AJ
   Vaizey, CJ
   Norton, CS
   Kamm, MA
TI Internal anal sphincter augmentation for fecal incontinence using
   injectable silicone biomaterial
SO DISEASES OF THE COLON & RECTUM
LA English
DT Article
DE silicone; sphincter; augmentation
ID DYNAMIC GRACILOPLASTY; AUTOLOGOUS FAT; INJECTION; MICROIMPLANTS;
   STIMULATION; MANAGEMENT
AB PURPOSE: A disrupted or weak internal anal sphincter can lead to passive fecal incontinence. This muscle is not amenable to direct surgical repair. Previous preliminary at tempts to restore functional continuity have included a cutaneous flap to fill an anal canal defect, and injection therapy using polytetrafluoroethylene, collagen, or autologous fat. Urologists have also used injections of collagen or silicone to enhance bladder neck function. This pilot study aimed to assess the efficacy of single or multiple injections of the silicone-based product Bioplastique(TM) for the symptoms of passive fecal incontinence caused by an anatomically disrupted or intact but weak internal anal sphincter. PATIENTS AND METHODS: Ten patients (6 females; median age, 64; range, 41-80 years) with passive incontinence secondary to a weak (n = 6) or disrupted (n = 4) internal anal sphincter a ere injected either circumferentially or at a single site, respectively. Patients were assessed before and six weeks after treatment by clinical assessment, two-week bowel diary card, anorectal physiologic testing, and endoanal ultrasound. Patients failing to show improvement after the first injection were offered a second injection six weeks after the first injection. Clinical assessment was further repeated at six months, and five patients had a further ultrasound examination. RESULTS: At six weeks, six of ten patients showed either marked improvement (n = 3) or complete cessation of leakage (n = 3). A further patient was greatly improved after a second injection. Three patients were not improved. At six months, two of the seven patients had maintained marked improvement, and one patient had maintained minor improvement; all of these three patients had circumferential multiple injections. Maximum resting and squeeze anal pressures did not differ significantly between before vs, six weeks after vs. six months after injection. At six weeks endoanal ultrasound (n = 9) confirmed the presence and correct position of the silicone in all but one patient who had experienced obvious external leakage of the product. At six months the silicone remained in the correct position in the five endosonographically assessed patients. Five of the initial patients experienced pain or minor ulceration at the injection site. CONCLUSIONS: Although clinically effective immediately after injection, the benefit of an injectable biomaterial was maintained in only a minority of patients. This occurred despite the continued presence of material in the correct anatomical site. Patients With diffuse weakness treated by circumferential injection seemed to be the most responsive, but further studies are required to clarify this.
C1 St Marks Hosp, London EC1V 2PS, England.
RP Malouf, AJ (reprint author), St Marks Hosp, City Rd, London EC1V 2PS, England.
CR BEISANG AA, 1992, AESTHET PLAST SURG, V16, P83, DOI 10.1007/BF00455154
   Bernardi C, 1998, PLAST RECONSTR SURG, V102, P1626, DOI 10.1097/00006534-199810000-00046
   BURNETT SJD, 1991, INT J COLORECTAL DIS, V6, P2, DOI 10.1007/BF00703951
   DUTHIE LH, 1965, GUT, V6, P64
   ENGEL AF, 1995, INT J COLORECTAL DIS, V10, P152, DOI 10.1007/BF00298538
   ENGEL AF, 1994, GUT, V35, P857, DOI 10.1136/gut.35.6.857
   ENGEL AF, 1994, BRIT J SURG, V81, P1069, DOI 10.1002/bjs.1800810749
   ERSEK RA, 1991, PLAST RECONSTR SURG, V87, P693, DOI 10.1097/00006534-199104000-00014
   FRENCKNER B, 1975, GUT, V16, P482, DOI 10.1136/gut.16.6.482
   Geerdes BP, 1996, DIS COLON RECTUM, V39, P912, DOI 10.1007/BF02053991
   Harriss DR, 1996, BRIT J UROL, V78, P722, DOI 10.1046/j.1464-410X.1996.17510.x
   Kumar D, 1998, BRIT J SURG, V85, P978
   Lehur PA, 1996, DIS COLON RECTUM, V39, P1352, DOI 10.1007/BF02054523
   Leroi AM, 1997, INT J COLORECTAL DIS, V12, P243, DOI 10.1007/s003840050098
   LESTAR B, 1989, INT J COLORECTAL DIS, V4, P118, DOI 10.1007/BF01646870
   LODER PB, 1994, BRIT J SURG, V81, P946, DOI 10.1002/bjs.1800810707
   MALOUF A, 1999, DIS COLON RECTUM, V42, pA12
   MATZEL KE, 1995, LANCET, V346, P1124, DOI 10.1016/S0140-6736(95)91799-3
   Morgan R, 1997, BRIT J SURG, V84, P226, DOI 10.1002/bjs.1800840225
   SHAFIK A, 1993, INT SURG, V78, P159
   SHAFIK A, 1995, DIS COLON RECTUM, V38, P583, DOI 10.1007/BF02054115
   Sielezneff I, 1999, BRIT J SURG, V86, P61
   Vaizey CJ, 1997, LANCET, V349, P612, DOI 10.1016/S0140-6736(96)09188-X
   Vaizey CJ, 1999, GUT, V44, P407, DOI 10.1136/gut.44.3.407
   WILLIAMS N, 1995, DIS COLON RECTUM, V38, P700, DOI 10.1007/BF02048025
   Wong WD, 1996, DIS COLON RECTUM, V39, P1345
NR 26
TC 61
Z9 63
U1 0
U2 3
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0012-3706
J9 DIS COLON RECTUM
JI Dis. Colon Rectum
PD APR
PY 2001
VL 44
IS 4
BP 595
EP 600
DI 10.1007/BF02234337
PG 6
WC Gastroenterology & Hepatology; Surgery
SC Gastroenterology & Hepatology; Surgery
GA 424PX
UT WOS:000168241600022
PM 11330591
DA 2018-10-20
ER

PT J
AU Reid, G
   Habash, M
   Vachon, D
   Denstedt, J
   Riddell, J
   Beheshti, M
AF Reid, G
   Habash, M
   Vachon, D
   Denstedt, J
   Riddell, J
   Beheshti, M
TI Oral fluoroquinolone therapy results in drug adsorption on ureteral
   stents and prevention of biofilm formation
SO INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
LA English
DT Article; Proceedings Paper
CT 6th International Symposium on Clinical Evaluation of Drug Efficacy in
   Urinary Tract Infection held at the 21st International Chemotherapy
   Congress
CY JUL, 1999
CL BIRMINGHAM, ENGLAND
DE ciprofloxacin; ofloxacin; medical devices; biofilms
ID URINARY CATHETER; CIPROFLOXACIN; ADHESION; SYSTEMS
AB The oral administration of ciprofloxacin (250mg bid) and ofloxacin (300mg bid) in 40 patients with ureteral stents, led to drug levels on all the device surfaces that were higher than the minimum inhibitory concentration (MIC) of Escherichia coli (0.004-0.015 mg/l). the most common uropathogen. The drug levels in the film were higher than the MIC of other common pathogens, namely Psuedomonas aeruginosa (0.25-1.0 mg/l), E,Enterococcus faecalis (0.25-2.0 mg/l) and Staphylococcus aureus (0.12-0.5 mg/l) in a few cases (six, three and 14 cases out of 40, respectively). For both antibiotics, the concentrations were greater than the MIC of many uropathogens on the film surrounding the devices (0.89) vs 0.31 mg/l respectively, (P = 0.05), and on the devices themselves (0.22 vs. 0.12 mg/l. P=0.207). Adsorption of the antibiotics was higher to the film than to the stent (P < 0.0001). Ciprofloxacin concentration on the film surrounding the stents was significantly higher than that of ofloxacin (P = 0.05), while there was no statistical concentration difference between the two antibiotics adsorbed onto the actual devices (P = 0.207). No bacteria were found in patients' urine and no biofilms were detected. This is the first report of an oral antibiotic being adsorbed onto medical devices. it potentially provides a new approach of preventing infection, and avoids the need to pre-coat devices with agents whose use will be restricted once bacteria develop resistance to them. If biomaterial properties can be enhanced to increase further the adsorptive concentration of drug, the risk of infections and recalcitrant biofilm formation could be significantly reduced in a highly susceptible patient population, <(c)> 2001 Elsevier Science B.V. and International Society of Chemotherapy. All rights reserved.
C1 Lawson Hlth Res Inst, Div Urol, London, ON N6A 4V2, Canada.
   Univ Western Ontario, Dept Microbiol & Immunol, London, ON, Canada.
   Univ Western Ontario, Dept Surg, London, ON N6A 3K7, Canada.
   Peele Mem Hosp, Dept Urol, Brampton, ON, Canada.
RP Reid, G (reprint author), Lawson Hlth Res Inst, Div Urol, 268 Grosvenor St, London, ON N6A 4V2, Canada.
CR BROWN MRW, 1988, J ANTIMICROB CHEMOTH, V22, P777, DOI 10.1093/jac/22.6.777
   JOHNSON JR, 1990, J INFECT DIS, V162, P1145, DOI 10.1093/infdis/162.5.1145
   *NAT COMM CLIN LAB, 1997, M7A4 NCCLS, V17
   Pearle MS, 1997, UROLOGY, V49, P679, DOI 10.1016/S0090-4295(96)00626-7
   Raad I, 1996, J INFECT DIS, V173, P418, DOI 10.1093/infdis/173.2.418
   REID G, 1994, ANTIMICROB AGENTS CH, V38, P1490, DOI 10.1128/AAC.38.7.1490
   REID G, 1992, J UROLOGY, V148, P1592, DOI 10.1016/S0022-5347(17)36976-8
   REID G, 1998, BIOFILMS, P423
   RUSS BR, 1994, ANAESTH INTENS CARE, V22, P611
   Schierholz JM, 1997, ARZNEIMITTEL-FORSCH, V47, P70
   SHERERTZ RJ, 1989, ANTIMICROB AGENTS CH, V33, P1174, DOI 10.1128/AAC.33.8.1174
   STAMM WE, 1991, AM J MED, V91, pS65, DOI 10.1016/0002-9343(91)90345-X
   Stickler DJ, 1996, BRIT J UROL, V78, P579, DOI 10.1046/j.1464-410X.1996.16915.x
NR 13
TC 36
Z9 36
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0924-8579
J9 INT J ANTIMICROB AG
JI Int. J. Antimicrob. Agents
PD APR
PY 2001
VL 17
IS 4
BP 317
EP 320
DI 10.1016/S0924-8579(00)00353-8
PG 4
WC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
SC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
GA 421DH
UT WOS:000168046500016
PM 11295415
DA 2018-10-20
ER

PT J
AU Pariente, JL
   Kim, BS
   Atala, A
AF Pariente, JL
   Kim, BS
   Atala, A
TI In vitro biocompatibility assessment of naturally derived and synthetic
   biomaterials using normal human urothelial cells
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE biocompatibility; urothelial cells; natural biomaterials; synthetic
   polymers
ID SMALL-INTESTINAL SUBMUCOSA; VESICOURETERAL REFLUX; COLORIMETRIC ASSAY;
   IN-VITRO; COLLAGEN MATRIX; URINARY-BLADDER; CYTO-TOXICITY; INVITRO;
   CULTURE; CHONDROCYTES
AB The reconstruction of urinary tissues often employs various types of biomaterials, and adequate material biocompatibility is essential for the successful reconstruction of urinary tissues. In this study we utilized a primary normal human urothelial cell culture system to evaluate the in vitro biocompatibility of a number of naturally derived biomaterials [i.e., bladder submucosa, small intestinal submucosa, collagen, and alginate] and polymeric biomaterials [i.e., poly(glycolic acid), poly(L-lactic acid), poly(lactic-co-glycolic acid), and silicone] that are either experimentally or clinically used in urinary reconstructive surgery. To determine the cytotoxic and bioactive effects of these biomaterials, the cell-viability, metabolic activity, apoptotic properties, and DNA-synthesis activity were measured with four types of assays [Neutral Red, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide, apoptotic activity, and tritiated thymidine incorporation assays] using extract and direct contact methods. Most of the biomaterials tested did not induce significant cytotoxic effects and exhibited normal metabolic function and cell growth in vitro. This normal primary human urothelial cell culture model is suitable for in vitro biocompatibility assessments and is able to provide information on the cell-biomaterial interactions and the ability of biomaterials to support bioactive cell functions. (C) 2000 John Wiley & Sons, Inc.
C1 Childrens Hosp, Lab Tissue Engn & Cellular Therapeut, Boston, MA 02115 USA.
   Harvard Univ, Sch Med, Boston, MA 02115 USA.
RP Atala, A (reprint author), Childrens Hosp, Lab Tissue Engn & Cellular Therapeut, Boston, MA 02115 USA.
RI Kim, Byung-Soo/O-2352-2013
OI Atala, Anthony/0000-0001-8186-2160
CR [Anonymous], 1992, ISO109935
   [Anonymous], 1991, ANN BOOK ASTM
   Atala A, 1999, J UROLOGY, V162, P1148, DOI 10.1016/S0022-5347(01)68105-9
   ATALA A, 1992, J UROLOGY, V148, P658, DOI 10.1016/S0022-5347(17)36685-5
   ATALA A, 1993, J UROLOGY, V150, P608, DOI 10.1016/S0022-5347(17)35561-1
   ATALA A, 1993, J UROLOGY, V150, P745, DOI 10.1016/S0022-5347(17)35603-3
   ATALA A, 1994, J UROLOGY, V152, P641, DOI 10.1016/S0022-5347(17)32671-X
   BAZEED MA, 1983, UROLOGY, V21, P53, DOI 10.1016/0090-4295(83)90123-1
   BONNAR J, 1977, LANCET, V2, P1161
   Brauers A, 1998, Tech Urol, V4, P214
   Chen F, 1999, UROLOGY, V54, P407, DOI 10.1016/S0090-4295(99)00179-X
   CIAPETTI G, 1993, BIOMATERIALS, V14, P359, DOI 10.1016/0142-9612(93)90055-7
   CILENTO BG, 1994, J UROLOGY, V152, P665, DOI 10.1016/S0022-5347(17)32676-9
   Diamond DA, 1999, J UROLOGY, V162, P1185, DOI 10.1016/S0022-5347(01)68124-2
   Gilding D., 1981, BIOCOMPATIBILITY CLI, V2, P209
   HENLY DR, 1995, J UROLOGY, V153, P2039, DOI 10.1016/S0022-5347(01)67398-1
   Ignatius AA, 1996, BIOMATERIALS, V17, P831, DOI 10.1016/0142-9612(96)81421-9
   Kassaby El A., 2000, Journal of Urology, V163, P70
   Kim B. -S., 2000, PRINCIPLES TISSUE EN, P655
   Kim BS, 1999, EXP CELL RES, V251, P318, DOI 10.1006/excr.1999.4595
   Kim BS, 2000, WORLD J UROL, V18, P2, DOI 10.1007/s003450050002
   Kirkpatrick CJ, 1998, P I MECH ENG H, V212, P75, DOI 10.1243/0954411981533845
   Kropp BP, 1996, J UROLOGY, V155, P2098, DOI 10.1016/S0022-5347(01)66117-2
   Lattari Vincent, 1997, Journal of Burn Care and Rehabilitation, V18, P147, DOI 10.1097/00004630-199703000-00010
   MOHAMMED R, 1987, UROL RES, V15, P239
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Oberpenning F, 1999, NAT BIOTECHNOL, V17, P149
   OZTURK SS, 1990, BIOTECHNOL PROGR, V6, P121, DOI 10.1021/bp00002a005
   Pariente JL, 1998, J BIOMED MATER RES, V40, P31, DOI 10.1002/(SICI)1097-4636(199804)40:1<31::AID-JBM4>3.0.CO;2-S
   Pariente JL, 1998, UROLOGY, V52, P524, DOI 10.1016/S0090-4295(98)00198-8
   Pariente JL, 2000, BIOMATERIALS, V21, P835, DOI 10.1016/S0142-9612(99)00253-7
   PARISH CR, 1983, J IMMUNOL METHODS, V58, P225, DOI 10.1016/0022-1759(83)90277-6
   Pizzoferrato Arturo, 1994, Clinical Materials, V15, P173, DOI 10.1016/0267-6605(94)90081-7
   Pope JC, 1997, J UROLOGY, V158, P1105, DOI 10.1016/S0022-5347(01)64398-2
   SGOURAS D, 1990, J MATER SCI-MATER M, V1, P61, DOI 10.1007/BF00839070
   Shapiro L, 1997, BIOMATERIALS, V18, P583, DOI 10.1016/S0142-9612(96)00181-0
   TACHIBANA M, 1985, J UROLOGY, V133, P866, DOI 10.1016/S0022-5347(17)49268-8
   UPHILL PF, 1990, MED DEVICE TECHN NOV, P24
   Winfrey M E, 1999, Dimens Crit Care Nurs, V18, P14, DOI 10.1097/00003465-199901000-00003
   Yoo JJ, 1998, UROLOGY, V51, P221, DOI 10.1016/S0090-4295(97)00644-4
NR 40
TC 134
Z9 146
U1 0
U2 20
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD APR
PY 2001
VL 55
IS 1
BP 33
EP 39
DI 10.1002/1097-4636(200104)55:1<33::AID-JBM50>3.3.CO;2-Z
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 398JM
UT WOS:000166753400005
PM 11426395
DA 2018-10-20
ER

PT J
AU Jones, LC
   Frondoza, C
   Hungerford, DS
AF Jones, LC
   Frondoza, C
   Hungerford, DS
TI Effect of PMMA particles and movement on an implant interface in a
   canine model
SO JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME
LA English
DT Article
ID TOTAL HIP-ARTHROPLASTY; CEMENTED ACETABULAR COMPONENTS; LOCALIZED
   BONE-RESORPTION; POLYETHYLENE WEAR DEBRIS; SYNOVIAL-LIKE MEMBRANE;
   IN-VITRO; FEMORAL COMPONENTS; METALLIC DEBRIS; PARTICULATE
   POLYMETHYLMETHACRYLATE; MECHANICAL FAILURE
AB The pathogenesis of aseptic loosening of total joint prostheses is not clearly understood, Two features are associated with loosened prostheses, namely, particulate debris and movement of the implant. While numerous studies have evaluated the cellular response to particulate biomaterials, few have investigated the influence of movement of the implant on the biological response to particles. Our aim was therefore to test the hypothesis that excessive mechanical stimulation of the periprosthetic tissues induces an inflammatory response and that the addition of particulate biomaterials intensifies this.
   We allocated 66 adult Beagle dogs to four groups as follows: stable implants with (I) and without (II) particulate polymethylmethacrylate (PMMA) and moving implants with (III) and without (IV) particulate PMMA, They were then evaluated at 2, 4, 6, 12 and 24 weeks.
   The stable implants were well tolerated and a thin, fibrous membrane of connective tissue was observed. There was evidence of positive staining in some cells for interleukin-6 (IL-6), Addition of particulate PMMA around the stable implants resulted in an increase in the fibroblastic response and positive staining for IL-6 and tumour necrosis factor-alpha (TNF-alpha). By contrast, movement of the implant resulted in an immediate inflammatory response characterised by large numbers of histiocytes and cytokine staining for IL-1 beta, TNF-alpha and IL-6, Introduction of particulate PMMA aggravated this response. Animals with particulate PMMA and movement of the implant have an intense inflammatory response associated with accelerated bone loss.
   Our results indicate that the initiation of the inflammatory response to biomaterial particles was much slower than that to gross mechanical instability. Furthermore, when there was both particulate debris and movement, there was an amplification of the adverse tissue response as evidenced by the presence of osteolysis and increases in the presence of inflammatory cells and their associated cytokines.
C1 Johns Hopkins Univ, Sch Med, Dept Orthopaed Surg, Baltimore, MD 21239 USA.
RP Jones, LC (reprint author), Johns Hopkins Univ, Sch Med, Dept Orthopaed Surg, Suite 201,Good Samaritan Profess Bldg, Baltimore, MD 21239 USA.
FU NIEHS NIH HHS [ES 07141]
CR ALSAFFAR N, 1994, BRIT J RHEUMATOL, V33, P309
   Aspenberg P, 1996, J BONE JOINT SURG BR, V78B, P641
   BECHTOLD JE, 1996, T ORS, V21, P71
   BLOEBAUM RD, 1994, CLIN ORTHOP RELAT R, P19
   CAMPBELL P, 1995, J BIOMED MATER RES, V29, P127, DOI 10.1002/jbm.820290118
   CARLSSON AS, 1983, ACTA ORTHOP SCAND, V54, P396, DOI 10.3109/17453678308996591
   CHIBA J, 1994, CLIN ORTHOP RELAT R, V300, P304
   Cila E, 1994, J Arthroplasty, V9, P67, DOI 10.1016/0883-5403(94)90139-2
   CLARKE IC, 1992, AM SOC TEST MATER, V1144, P7, DOI 10.1520/STP14848S
   CUCKLER JM, 1992, AM SOC TEST MATER, V1144, P118, DOI 10.1520/STP14858S
   DAVIS RG, 1993, J BIOMED MATER RES, V27, P1039, DOI 10.1002/jbm.820270809
   DORR LD, 1990, CLIN ORTHOP RELAT R, V261, P82
   DOWD JE, 1995, CLIN ORTHOP RELAT R, V319, P106
   EMMANUAL J, 1992, AM SOC TEST MATER, V1144, P143, DOI 10.1520/STP14861S
   EMMANUAL J, 1987, SOC BIOM S RETR AN S
   FRONDOZA C, 1994, T 40 ANN M ORTH RES, V19, P154
   GALANTE JO, 1991, J ORTHOPAED RES, V9, P760, DOI 10.1002/jor.1100090516
   GLANT TT, 1993, J BONE MINER RES, V8, P1071
   GOLDRING SR, 1983, J BONE JOINT SURG AM, V65, P575, DOI 10.2106/00004623-198365050-00001
   GOLDRING SR, 1992, AM SOC TEST MATER, V1144, P136, DOI 10.1520/STP14860S
   GOODMAN S, 1993, ACTA ORTHOP SCAND, V64, P627, DOI 10.3109/17453679308994585
   GOODMAN S, 1995, J APPL BIOMATER, V6, P161, DOI 10.1002/jab.770060303
   Goodman SB, 1996, J BIOMED MATER RES, V31, P421, DOI 10.1002/(SICI)1097-4636(199607)31:3<421::AID-JBM17>3.0.CO;2-L
   GOODMAN SB, 1991, ARCH ORTHOP TRAUM SU, V110, P123, DOI 10.1007/BF00395792
   GOODMAN SB, 1988, CLIN ORTHOP RELAT R, V232, P255
   GOODMAN SB, 1989, CLIN ORTHOP RELAT R, V244, P182
   GRUEN TA, 1979, CLIN ORTHOP RELAT R, P17
   HARRIS WH, 1995, CLIN ORTHOP RELAT R, P46
   HARRIS WH, 1976, J BONE JOINT SURG AM, V58, P612, DOI 10.2106/00004623-197658050-00005
   HAYNES DR, 1993, J BONE JOINT SURG AM, V75A, P825, DOI 10.2106/00004623-199306000-00004
   HEIMKE G, 1981, ARCH ORTHOP TRAUM SU, V98, P165, DOI 10.1007/BF00632973
   HERMAN JH, 1989, J BONE JOINT SURG AM, V71A, P1530, DOI 10.2106/00004623-198971100-00012
   HOROWITZ SM, 1991, J ORTHOPAED RES, V9, P406, DOI 10.1002/jor.1100090313
   HOROWITZ SM, 1993, J BONE JOINT SURG AM, V75A, P802, DOI 10.2106/00004623-199306000-00002
   HOROWITZ SM, 1995, J BIOMED MATER RES, V29, P477, DOI 10.1002/jbm.820290407
   HOWIE DW, 1988, J BONE JOINT SURG AM, V70A, P257, DOI 10.2106/00004623-198870020-00015
   HOWIE DW, 1993, ORTHOP CLIN N AM, V24, P571
   HUDDLESTON HD, 1994, SEMINARS ARTHROPLAST, V4, P2
   JASTY M, 1991, J BONE JOINT SURG BR, V73, P551
   JASTY M, 1993, J APPL BIOMATER, V4, P273, DOI 10.1002/jab.770040310
   JIRANEK WA, 1993, J BONE JOINT SURG AM, V75A, P863, DOI 10.2106/00004623-199306000-00007
   KIM KJ, 1994, J BONE JOINT SURG AM, V76A, P172, DOI 10.2106/00004623-199402000-00002
   KIM KJ, 1993, CLIN ORTHOP RELAT R, P142
   Kozinn S C, 1986, J Arthroplasty, V1, P249, DOI 10.1016/S0883-5403(86)80015-8
   La Budde J K, 1994, J Arthroplasty, V9, P291, DOI 10.1016/0883-5403(94)90084-1
   LEE JM, 1992, J BONE JOINT SURG BR, V74, P380
   LENNOX DW, 1987, T SOC BIOMATERIALS, V10, P133
   LENNOX DW, 1987, CLIN ORTHOP RELAT R, V225, P171
   MALONEY WJ, 1995, J BONE JOINT SURG AM, V77, P1448, DOI 10.2106/00004623-199509000-00022
   MALONEY WJ, 1995, J BONE JOINT SURG AM, V77, P1301, DOI 10.2106/00004623-199509000-00002
   MALONEY WJ, 1990, J BONE JOINT SURG BR, V72, P966
   MALONEY WJ, 1993, J BONE JOINT SURG AM, V75A, P835, DOI 10.2106/00004623-199306000-00005
   Manlapaz M, 1996, J ORTHOP RES, V14, P465, DOI 10.1002/jor.1100140317
   MARGEVICIUS KJ, 1994, J BONE JOINT SURG AM, V76A, P1664, DOI 10.2106/00004623-199411000-00010
   MCDONALD DJ, 1988, J BONE JOINT SURG AM, V70A, P728, DOI 10.2106/00004623-198870050-00014
   MIRRA JM, 1982, CLIN ORTHOP RELAT R, V170, P175
   MULROY RD, 1990, J BONE JOINT SURG BR, V72, P757
   Mulroy WF, 1995, J BONE JOINT SURG AM, V77A, P1845, DOI 10.2106/00004623-199512000-00008
   MURRAY DW, 1990, J BONE JOINT SURG BR, V72, P988
   PIERMATTEL DL, 1979, ATLAS SURG APPROACHE
   RAE T, 1975, J BONE JOINT SURG BR, V57, P444
   Sabokbar A, 1995, J ARTHROPLASTY, V10, P810, DOI 10.1016/S0883-5403(05)80080-4
   SALVATI EA, 1993, CLIN ORTHOP RELAT R, V293, P160
   SCHMALZRIED TP, 1992, CLIN ORTHOP RELAT R, P60
   SCHMALZRIED TP, 1992, J BONE JOINT SURG AM, V74A, P849, DOI 10.2106/00004623-199274060-00006
   SCHMALZRIED TP, 1993, J APPL BIOMATER, V4, P119, DOI 10.1002/jab.770040202
   SCHULLER HM, 1993, ACTA ORTHOP SCAND, V64, P613, DOI 10.3109/17453679308994583
   SCHWENDEMAN L, 1993, T ORS, V18, P511
   SHANBHAG AS, 1995, J ARTHROPLASTY, V10, P498, DOI 10.1016/S0883-5403(05)80152-4
   SHANBHAG AS, 1994, J BONE JOINT SURG BR, V76B, P60
   SHANBHAG AS, 1995, J ORTHOPAED RES, V13, P792, DOI 10.1002/jor.1100130520
   SOBALLE K, 1992, J ORTHOPAED RES, V10, P285, DOI 10.1002/jor.1100100216
   SPECTOR M, 1990, CLIN ORTHOP RELAT R, V261, P140
   STJOHN K, 1992, PARTICULATE DEBRIS M
   TAKAGI M, 1995, J ORTHOP RES, V13, P296, DOI 10.1002/jor.1100130218
   TSAO A, 1993, T 19 ANN M SOC BIOM, V16, P239
   WANG JT, 1993, BRIS MYER Z, P119
   WRIGHT T, 1995, IMPLANT WEAR FUTURE
NR 78
TC 33
Z9 34
U1 0
U2 2
PU BRITISH EDITORIAL SOC BONE JOINT SURGERY
PI LONDON
PA 22 BUCKINGHAM STREET, LONDON WC2N 6ET, ENGLAND
SN 0301-620X
EI 2044-5377
J9 J BONE JOINT SURG BR
JI J. Bone Joint Surg.-Br. Vol.
PD APR
PY 2001
VL 83B
IS 3
BP 448
EP 458
DI 10.1302/0301-620X.83B3.10734
PG 11
WC Orthopedics; Surgery
SC Orthopedics; Surgery
GA 426KK
UT WOS:000168348200027
PM 11341436
OA Bronze
DA 2018-10-20
ER

PT J
AU Chauvel-Lebret, DJ
   Pellen-Mussi, P
   Auroy, P
   Bonnaure-Mallet, M
AF Chauvel-Lebret, DJ
   Pellen-Mussi, P
   Auroy, P
   Bonnaure-Mallet, M
TI Adaptation of the comet test to the assessment of biomaterial
   genotoxicity
SO JOURNAL OF DENTAL RESEARCH
LA English
DT Meeting Abstract
C1 Univ Rennes 1, Fac Med, Lab Biomat Site Osseux, F-35014 Rennes, France.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU INT AMER ASSOC DENTAL RESEARCHI A D R/A A D R
PI ALEXANDRIA
PA 1619 DUKE ST, ALEXANDRIA, VA 22314-3406 USA
SN 0022-0345
J9 J DENT RES
JI J. Dent. Res.
PD APR
PY 2001
VL 80
IS 4
BP 1238
EP 1238
PG 1
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 497VL
UT WOS:000172476102051
DA 2018-10-20
ER

PT J
AU Kim, HM
AF Kim, HM
TI Bone-biomaterial interface.
SO JOURNAL OF DENTAL RESEARCH
LA English
DT Meeting Abstract
C1 Seoul Natl Univ, Dept Oral Anat, Coll Dent, Intellectual Biointerface Engn Ctr, Seoul, South Korea.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU INT AMER ASSOC DENTAL RESEARCHI A D R/A A D R
PI ALEXANDRIA
PA 1619 DUKE ST, ALEXANDRIA, VA 22314-3406 USA
SN 0022-0345
J9 J DENT RES
JI J. Dent. Res.
PD APR
PY 2001
VL 80
IS 4
BP 1348
EP 1348
PG 1
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 497VL
UT WOS:000172476102769
DA 2018-10-20
ER

PT J
AU Midy, V
   Hollande, E
   Rey, C
   Dard, M
   Plouet, J
AF Midy, V
   Hollande, E
   Rey, C
   Dard, M
   Plouet, J
TI Adsorption of vascular endothelial growth factor to two different
   apatitic materials and its release
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID CELLS; HYDROXYAPATITE; OSTEOBLASTS; INDUCTION; PROTEIN
AB The aim of our study was to assess the ability of calcium phosphate powders to serve as growth factor carriers. Vascular endothelial growth factor (VEGF), in particular, is locally involved in the bone formation process throughout osteoblast differentiation. Two different apatitic substrates were tested: hydroxyapatite (HA), widely used as biomaterial, and nanocrystalline carbonated apatite (CA), which has a composition similar to bone mineral crystals. These materials have been compared for their VEGF adsorption and release properties. The adsorption of the growth factor was higher on CA than on HA probably due to differences of both the proteins and the powders involved. The specific activity of the VEGF released was also tested to determine the available activity for cells in contact with these materials. Interestingly, the bioactivity of the VEGF released from CA quantified on fetal bovine aortic endothelial cells (FBAE) by evaluating the proliferation activity, exhibited no marked difference compared to native VEGF. Qualitatively, VEGF adsorbed on CA material induced well-defined collagen type I immunostaining on osteoblast cells compared to the staining obtained after VEGF adsorption on HA. (C) 2001 Kluwer Academic Publishers.
C1 Lab Cytophysiol Cellules Eucaryotes, JE 1962, F-31400 Toulouse, France.
   Lab Mat & Interfaces Phosphates & Biomat, CNRS, UPRESA 5071, F-31400 Toulouse, France.
   Merck Biomat Res, D-64271 Darmstadt, Germany.
   Lab Biol Mol Eucaryotes, CNRS, UPR 9006, F-31062 Toulouse, France.
RP Midy, V (reprint author), Lab Cytophysiol Cellules Eucaryotes, JE 1962, 38 Rue 36 Ponts, F-31400 Toulouse, France.
CR BARON J, 1994, ENDOCRINOLOGY, V135, P2790, DOI 10.1210/en.135.6.2790
   BARRITAULT D, 1982, J NEUROSCI RES, V8, P477, DOI 10.1002/jnr.490080235
   BOSKEY AL, 1993, BONE MINER, V22, P147, DOI 10.1016/S0169-6009(08)80225-5
   BRUDER SP, 1989, CONNECT TISSUE RES, V20, P65, DOI 10.3109/03008208909023875
   CANALIS E, 1988, J CLIN INVEST, V81, P1572, DOI 10.1172/JCI113490
   COLLINOSDOBY P, 1994, J CELL BIOCHEM, V55, P304, DOI 10.1002/jcb.240550306
   CONNOLLY DT, 1989, J BIOL CHEM, V264, P20017
   CUEVAS P, 1988, BIOCHEM BIOPH RES CO, V156, P611, DOI 10.1016/S0006-291X(88)80887-8
   ELLIOTT JC, 1994, STRUCTURE CHEM APATI, P259
   FERRARA N, 1989, BIOCHEM BIOPH RES CO, V161, P851, DOI 10.1016/0006-291X(89)92678-8
   GIROUX TA, 1991, J COLLOID INTERF SCI, V146, P179, DOI 10.1016/0021-9797(91)90015-Z
   GLOBUS RK, 1989, ENDOCRINOLOGY, V124, P1539, DOI 10.1210/endo-124-3-1539
   HARADA S, 1994, J CLIN INVEST, V93, P2490, DOI 10.1172/JCI117258
   Midy V, 1998, J BIOMED MATER RES, V41, P405, DOI 10.1002/(SICI)1097-4636(19980905)41:3<405::AID-JBM10>3.0.CO;2-H
   MIDY V, 1994, BIOCHEM BIOPH RES CO, V199, P380, DOI 10.1006/bbrc.1994.1240
   MISRA DN, 1994, J ADHES SCI TECHNOL, V8, P87, DOI 10.1163/156856194X00087
   MONTEL G, 1981, J CRYST GROWTH, V53, P74, DOI 10.1016/0022-0248(81)90057-9
   MORENO EC, 1984, CALCIFIED TISSUE INT, V36, P48, DOI 10.1007/BF02405293
   MURA M J, 1990, Clinical Materials, V5, P285, DOI 10.1016/0267-6605(90)90028-T
   NELSON DGA, 1981, J DENT RES, V60, P1621, DOI 10.1177/002203458106000312011
   NELSON DGA, 1982, CALCIFIED TISSUE INT, V34, pS69
   NORDE W, 1985, SURFACE INTERFACIAL, V2, P241
   Ortega N, 1998, BIOL CELL, V90, P381, DOI 10.1016/S0248-4900(98)80087-7
   Plouet J, 1997, J BIOL CHEM, V272, P13390, DOI 10.1074/jbc.272.20.13390
   PLOUET J, 1989, EMBO J, V8, P3801, DOI 10.1002/j.1460-2075.1989.tb08557.x
   REY C, 1991, CALCIFIED TISSUE INT, V49, P251, DOI 10.1007/BF02556214
   REY C, 1994, B I OCEANOGRAPHIQUE, V14, P55
   RODAN SB, 1989, CONNECT TISSUE RES, V20, P283, DOI 10.3109/03008208909023898
   RODAN SB, 1987, CANCER RES, V47, P4961
   ROLLA G, 1975, CARIES RES, V9, P66
   SCHEVILL WE, 1965, NATURE, V205, P373, DOI 10.1038/205373a0
   TABATA Y, 1994, J CONTROL RELEASE, V31, P189, DOI 10.1016/0168-3659(94)00035-2
NR 32
TC 24
Z9 24
U1 0
U2 4
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD APR
PY 2001
VL 12
IS 4
BP 293
EP 298
DI 10.1023/A:1011286818733
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 419DN
UT WOS:000167934200002
PM 15348289
DA 2018-10-20
ER

PT J
AU Mebouta-Nkamgueu, E
   Adnet, JJ
   Ittelet, D
   Laurent-Maquin, D
   Bouthors, S
   Potron, G
   Guenounou, M
   Bernard, J
AF Mebouta-Nkamgueu, E
   Adnet, JJ
   Ittelet, D
   Laurent-Maquin, D
   Bouthors, S
   Potron, G
   Guenounou, M
   Bernard, J
TI Human monocyte-derived macrophages and dendritic cells as targets for
   biomaterial cytocompatibility studies using an improved in vitro culture
   system
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID IN-VITRO; INTERLEUKIN-1 GENERATION; BIOMEDICAL POLYMERS;
   MONONUCLEAR-CELLS; BLOOD MONOCYTES; BONE-RESORPTION; INVITRO;
   IMMUNOTHERAPY; REPLACEMENTS; DEGRADATION
AB Since macrophage plays a key role in the biocompatibility process, neoplastic macrophage cell lines and human blood monocytes are commonly used as target cells for in vitro biomaterial tolerance evaluation. However, tumor cells profoundly differ from normal tissue cells and monocytes are only precursors of macrophages. It has become possible to generate recently, under adherent-free conditions, fully mature macrophages and dendritic cells from human blood monocytes in the presence of GM-CSF and GM-CSF + IL4 respectively. In the present work, we examined the effects of titanium-alloy on morphology, adhesion, cell phenotype and TNF-alpha release activity of such differentiated cells grown in hydrophobic teflon bags. Scanning electron microscopy showed that macrophages substantially adhered and spread on titanium-alloy surface throughout the culture period, whereas only a few dendritic cells were adherent. The phenotype of both cell types remained unchanged in the presence of the tested material. However, titanium-alloy stimulated the secretion of TNF-alpha by the macrophages of some donors. This model of culture may offer new insights into the biomaterial evaluation and may be useful for studying individual responses induced by biomaterials. (C) 2001 Kluwer Academic Publishers.
C1 UFR Med, Lab Histol Embryol Cytogenet, F-51095 Reims, France.
   Inst Jean Godinot, Immunol Lab, F-51100 Reims, France.
   Ctr Etud Biomat & Interfaces, EA 2068, F-51095 Reims, France.
   CHU, Hematol Lab, F-51092 Reims, France.
   UFR Pharm, Immunol Lab, F-51095 Reims, France.
RP Mebouta-Nkamgueu, E (reprint author), UFR Med, Lab Histol Embryol Cytogenet, 51 Rue Cognacq Jay, F-51095 Reims, France.
CR ADAMS DO, 1979, METHOD ENZYMOL, V58, P4
   ANDREESEN R, 1990, CANCER RES, V50, P7450
   Benahmed M, 1997, J BIOMED MATER RES, V34, P115, DOI 10.1002/(SICI)1097-4636(199701)34:1<115::AID-JBM15>3.0.CO;2-J
   Bender A, 1996, J IMMUNOL METHODS, V196, P121, DOI 10.1016/0022-1759(96)00079-8
   Bernard J, 1998, HEMATOL CELL THER, V40, P17
   Bernatchez SF, 1996, BIOMATERIALS, V17, P2077, DOI 10.1016/0142-9612(96)00014-2
   BHARDWAJ N, 1988, CELL IMMUNOL, V114, P405, DOI 10.1016/0008-8749(88)90332-2
   CARDONA MA, 1992, J BIOMED MATER RES, V26, P851, DOI 10.1002/jbm.820260703
   Caux C, 1996, HEMATOL CELL THER, V38, P463, DOI 10.1007/s00282-996-0463-4
   CHIBA J, 1994, CLIN ORTHOP RELAT R, P304
   DARVILLE T, 1992, IMMUNOL INVEST, V21, P539, DOI 10.3109/08820139209069389
   FREUNDLICH B, 1984, J IMMUNOL, V132, P1255
   GLANT TT, 1993, J BONE MINER RES, V8, P1071
   GLANT TT, 1994, T ORTHOP RES SOC, V19, P152
   GOLDRING SR, 1983, J BONE JOINT SURG AM, V65, P575, DOI 10.2106/00004623-198365050-00001
   GOODMAN SB, 1989, CLIN ORTHOP RELAT R, P182
   HASKILL S, 1988, J IMMUNOL, V140, P1690
   Haynes DR, 1998, CLIN ORTHOP RELAT R, P223
   HELFGOTT DC, 1989, J IMMUNOL, V142, P948
   ISHIMI Y, 1990, J IMMUNOL, V145, P3297
   JIRANEK WA, 1993, J BONE JOINT SURG AM, V75A, P863, DOI 10.2106/00004623-199306000-00007
   Koerten H. K., 1997, Cells and Materials, V7, P191
   Lee SH, 1997, J ORTHOP RES, V15, P40, DOI 10.1002/jor.1100150107
   LOPEZ M, 1992, J IMMUNOTHER, V11, P209, DOI 10.1097/00002371-199204000-00008
   LOPEZ M, 1993, J IMMUNOL METHODS, V159, P29, DOI 10.1016/0022-1759(93)90138-W
   Maloney WJ, 1996, CLIN ORTHOP RELAT R, P268
   MILLER KM, 1989, BIOMATERIALS, V10, P187, DOI 10.1016/0142-9612(89)90023-9
   MILLER KM, 1988, J BIOMED MATER RES, V22, P713, DOI 10.1002/jbm.820220805
   MILLER KM, 1989, J BIOMED MATER RES, V23, P911, DOI 10.1002/jbm.820230808
   MURRAY DW, 1990, J BONE JOINT SURG BR, V72, P988
   NAVARRO S, 1989, J IMMUNOL, V142, P4339
   Nivbrant B, 1999, J BONE JOINT SURG BR, V81B, P163, DOI 10.1302/0301-620X.81B1.8664
   RAE T, 1975, J BONE JOINT SURG BR, V57, P444
   Rogers SD, 1997, J BONE JOINT SURG BR, V79B, P311, DOI 10.1302/0301-620X.79B2.7192
   ROMANI N, 1994, J EXP MED, V180, P83, DOI 10.1084/jem.180.1.83
   ROSENSTREICH DL, 1978, IMMUNOL REV, V40, P102, DOI 10.1111/j.1600-065X.1978.tb00403.x
   Saad B, 1996, J BIOMED MATER RES, V32, P355
   Saad B, 1996, J BIOMED MATER RES, V30, P429, DOI 10.1002/(SICI)1097-4636(199604)30:4<429::AID-JBM1>3.3.CO;2-D
   SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109
   SHANBHAG AS, 1995, J ORTHOPAED RES, V13, P792, DOI 10.1002/jor.1100130520
   SHANBHAG AS, 1994, J BIOMED MATER RES, V28, P81, DOI 10.1002/jbm.820280111
   SNYDERMAN R, 1971, J IMMUNOL, V119, P926
   THOMAS R, 1994, J IMMUNOL, V152, P2613
   Wang JY, 1996, BIOMATERIALS, V17, P2233, DOI 10.1016/0142-9612(96)00072-5
   WATAHA JC, 1995, DENT MATER, V11, P239, DOI 10.1016/0109-5641(95)80056-5
   ZVAIFLER NJ, 1985, J CLIN INVEST, V76, P76
NR 46
TC 4
Z9 5
U1 1
U2 3
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD APR
PY 2001
VL 12
IS 4
BP 351
EP 357
DI 10.1023/A:1011255406438
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 419DN
UT WOS:000167934200011
PM 15348298
DA 2018-10-20
ER

PT J
AU Einmahl, S
   Behar-Cohen, FF
   Savoldelli, M
   D'Hermies, E
   Chauvaud, D
   Tabatabay, C
   Gurny, R
AF Einmahl, S
   Behar-Cohen, FF
   Savoldelli, M
   D'Hermies, E
   Chauvaud, D
   Tabatabay, C
   Gurny, R
TI Evaluation of a new biomaterial injected in the suprachoroidal space of
   the rabbit eye.
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Meeting Abstract
C1 Univ Geneva, Sch Pharm, Geneva, Switzerland.
   Hop Hotel Dieu, F-75181 Paris, France.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0146-0404
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD MAR 15
PY 2001
VL 42
IS 4
SU S
MA 933
BP S174
EP S174
PG 1
WC Ophthalmology
SC Ophthalmology
GA 427EP
UT WOS:000168392100924
DA 2018-10-20
ER

PT J
AU Malkar, NB
   Neimczyk, N
   Fields, GB
AF Malkar, NB
   Neimczyk, N
   Fields, GB
TI Peptide-amphiphile induction of alpha-helical protein-like molecular
   architecture and interaction with biomaterial surfaces
SO FASEB JOURNAL
LA English
DT Meeting Abstract
C1 Florida Atlantic Univ, Boca Raton, FL 33431 USA.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
J9 FASEB J
JI Faseb J.
PD MAR 7
PY 2001
VL 15
IS 4
BP A532
EP A532
PN 1
PG 1
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA 410KA
UT WOS:000167438103042
DA 2018-10-20
ER

PT J
AU Powis, S
   Kidd, KR
   Williams, SK
AF Powis, S
   Kidd, KR
   Williams, SK
TI Orthogonal polarization spectral imaging of microvascular responses to
   biomaterial implants
SO FASEB JOURNAL
LA English
DT Meeting Abstract
C1 Univ Arizona, Tucson, AZ 85724 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
J9 FASEB J
JI Faseb J.
PD MAR 7
PY 2001
VL 15
IS 4
BP A38
EP A38
PN 1
PG 1
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA 410KA
UT WOS:000167438100213
DA 2018-10-20
ER

PT J
AU Bainbridge, JA
   Revell, PA
   Al-Saffar, N
AF Bainbridge, JA
   Revell, PA
   Al-Saffar, N
TI Costimulatory molecule expression following exposure to orthopaedic
   implants wear debris
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE costimulation; inflammatory response; macrophage T-cell interactions;
   wear particles; multinucleated giant cells
ID MYELOID CELL-DIFFERENTIATION; TOTAL HIP-REPLACEMENT; PELVIC LYMPH-NODES;
   MHC CLASS-II; IN-VITRO; CYTOKINE PRODUCTION; T-CELLS; AUTOIMMUNITY;
   TITANIUM; TISSUE
AB Patients with long-term orthopedic implants may develop inflammatory reactions due to the accumulation of biomaterial particles both around the implant and in distant organs. The exact impact of these particles on the normal immune cell function still remain relatively unclear. Activation of T-cells following exposure to biomaterial par tides is driven by macrophages and requires synergistic signals primed by both antigen presentation and costimulation. The:pattern of costimulatory molecule expression (CD80,CD86) was primarily examined using immunohistochemistry on tissue specimens of bone/implant interface membranes taken from sites of bone erosion. Additionally, costimulatory molecule expression was also assessed in the monocytic leukemia cell Line U937 following exposure to clinically relevant titanium aluminum vanadium (TiAlV) and-stainless steel particles (FeCrNi) cultured in vitro. This study:demonstrates the induction and prominent expression of CD86 on almost all macrophage subsets at the bone/implant interface, including fused forms and large multinucleated giant cells (MNGC). In vitro analysis also indicated phagocytosis of metal particles by differentiated U937 caused significant induction of both CD80 and CD86 (p < 0.01), although the expression of CD86 dominated following prolonged exposure. The data presented highlights that CD86 is the predominant costimulatory molecule ligating to the complementary CD28 molecule at the inflammatory lesion of the interface. We propose that the intracellular presence of indigestible implant material, in addition to elevated costimulatory molecule expression, may promote T-cell inflammatory reactions at sites close to and distant from the orthopedic implant. (C) 2000 John Wiley & Sons, Inc. J Biomed Mater Res 54: 328-334, 2001.
C1 UCL Royal Free & Univ Coll Med Sch, Dept Histopathol, London NW3 2PQ, England.
RP Al-Saffar, N (reprint author), UCL Royal Free & Univ Coll Med Sch, Dept Histopathol, Rowland Hill St, London NW3 2PQ, England.
EM alsaffar@rfc.ucl.ac.uk
CR AGINS HJ, 1988, J BONE JOINT SURG AM, V70A, P347, DOI 10.2106/00004623-198870030-00005
   Al-Saffar N, 1998, J MATER SCI-MATER M, V9, P849, DOI 10.1023/A:1008952329788
   ALBORESSAAVEDRA J, 1994, AM J SURG PATHOL, V18, P83, DOI 10.1097/00000478-199401000-00008
   AlSaffar N, 1996, AM J CLIN PATHOL, V105, P628
   Balsa A, 1996, BRIT J RHEUMATOL, V35, P33
   BAUER TW, 1993, J BONE JOINT SURG AM, V75, P107
   DRUET P, 1995, HUM EXP TOXICOL, V14, P120, DOI 10.1177/096032719501400129
   ELVES MW, 1974, BRIT MED J, V15, P376
   EVANS EM, 1974, J BONE JOINT SURG BR, VB 56, P626
   FREEDMAN AS, 1991, CELL IMMUNOL, V137, P429, DOI 10.1016/0008-8749(91)90091-O
   FREEMAN GJ, 1993, SCIENCE, V262, P909, DOI 10.1126/science.7694363
   Garcia A, 1999, EXP HEMATOL, V27, P353, DOI 10.1016/S0301-472X(98)00038-1
   GILLESPIE WJ, 1988, J BONE JOINT SURG BR, V70, P539
   Goodman SB, 1998, J BONE JOINT SURG BR, V80B, P531, DOI 10.1302/0301-620X.80B3.8158
   Hicks DG, 1996, J BONE JOINT SURG AM, V78A, P482, DOI 10.2106/00004623-199604000-00002
   Hmama Z, 1999, J EXP MED, V190, P1583, DOI 10.1084/jem.190.11.1583
   JIRANEK WA, 1993, J BONE JOINT SURG AM, V75A, P863, DOI 10.2106/00004623-199306000-00007
   KAUFMAN PA, 1992, J CLIN INVEST, V90, P121, DOI 10.1172/JCI115824
   Kobayashi A, 1997, J BONE JOINT SURG BR, V79B, P844, DOI 10.1302/0301-620X.79B5.7602
   KOULOVA L, 1991, J EXP MED, V173, P759, DOI 10.1084/jem.173.3.759
   LALOR PA, 1991, J BONE JOINT SURG BR, V73, P25
   LANGKAMER VG, 1992, J BONE JOINT SURG BR, V74, P831
   LARSEN CP, 1992, J EXP MED, V176, P1215, DOI 10.1084/jem.176.4.1215
   Lu P, 1997, CURR OPIN IMMUNOL, V9, P858, DOI 10.1016/S0952-7915(97)80190-2
   Moulon C, 1995, EUR J IMMUNOL, V25, P3308, DOI 10.1002/eji.1830251216
   NEPOM GT, 1991, ANNU REV IMMUNOL, V9, P493
   RAE T, 1981, J BONE JOINT SURG BR, V63, P435
   Reiser H, 1996, NEW ENGL J MED, V335, P1369, DOI 10.1056/NEJM199610313351807
   Revell PA, 1997, P I MECH ENG H, V211, P187, DOI 10.1243/0954411971534304
   RUBIO MA, 1995, BLOOD, V86, P3715
   Saito K, 1996, Kokubyo Gakkai Zasshi, V63, P53
   SANSOM DM, 1993, EUR J IMMUNOL, V23, P295, DOI 10.1002/eji.1830230148
   SANTOS M, 1994, CELL IMMUNOL, V154, P498, DOI 10.1006/cimm.1994.1094
   Schultze J, 1996, BLOOD REV, V10, P111, DOI 10.1016/S0268-960X(96)90040-5
   TODD JA, 1988, SCIENCE, V240, P1003, DOI 10.1126/science.3368786
   Voronov I, 1998, J BIOMED MATER RES, V39, P40, DOI 10.1002/(SICI)1097-4636(199801)39:1<40::AID-JBM6>3.3.CO;2-Y
   WAPNER KL, 1991, CLIN ORTHOP RELAT R, P12
   WATAHA JC, 1995, DENT MATER, V11, P239, DOI 10.1016/0109-5641(95)80056-5
   Xu JW, 1998, RHEUMATOL INT, V17, P215, DOI 10.1007/s002960050037
NR 39
TC 24
Z9 25
U1 0
U2 2
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD MAR 5
PY 2001
VL 54
IS 3
BP 328
EP 334
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 387NG
UT WOS:000166128200003
PM 11189037
DA 2018-10-20
ER

PT J
AU van Kooten, TG
   Klein, CL
   Kirkpatrick, CJ
AF van Kooten, TG
   Klein, CL
   Kirkpatrick, CJ
TI Western blotting as a method for studying cell-biomaterial interactions:
   The role of protein collection
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE biocompatibility; Western blot; endothelial cells; p53; cadherin-5;
   phosphotyrosine
ID FOCAL ADHESION KINASE; STRESS FIBER FORMATION; TYROSINE PHOSPHORYLATION;
   IN-VITRO; ORGANIZATION; CYTOSKELETON; STIMULATION; FIBROBLASTS;
   APOPTOSIS; SURVIVAL
AB Research of cell-biomaterial interactions is building on knowledge and methods available in cell and molecular biology. Western blotting is one of the options to characterize protein expression in cell populations. Method transfer to biomaterial model systems is not trivial because of the structure that exists in many biomaterials, preventing the collection of cell lysate by mechanical means. In this technical resort, we describe the influence of different protein collection methods in a model system for cell-biomaterial interactions, consisting of endothelial cells exposed to different stimuli. In particular, the influence of trypsinization before lysis, and handling complexity were determined. The results of this study indicate that many changes in proteins occur because of the intermediate enzymatic treatment, despite the use of ice-cold solutions and protease and tyrosine phosphatase inhibitors throughout the procedure. Protein degradation and slight depressions in molecular weight were observed. The enzymatic treatment induced a changed cell status associated with detachment from the substratum. Western blotting of lysates of cells obtained through enzymatic harvest therefore can only be used with internal controls for the assessment of artifacts introduced by trypsinization, or alternative methods should be sought. (C) 2000 John Wiley & Sons, Inc. J Biomed Mater Res 54: 385-389, 2001.
C1 Univ Mainz, Inst Pathol, D-55101 Mainz, Germany.
RP van Kooten, TG (reprint author), Univ Groningen, Dept Biomed Engn, A Deusingln 1, NL-9713 AV Groningen, Netherlands.
CR Ayalon O, 1997, J CELL SCI, V110, P547
   Baksh D, 1998, J MATER SCI-MATER M, V9, P743, DOI 10.1023/A:1008959103864
   Cattelino A, 1997, Cell Adhes Commun, V4, P457, DOI 10.3109/15419069709004461
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   CHRZANOWSKAWODNICKA M, 1994, J CELL SCI, V107, P3643
   Clark EA, 1998, J CELL BIOL, V142, P573, DOI 10.1083/jcb.142.2.573
   Ferber D, 1999, SCIENCE, V284, P422, DOI 10.1126/science.284.5413.422
   Frisch SM, 1996, J CELL BIOL, V134, P793, DOI 10.1083/jcb.134.3.793
   Hungerford JE, 1996, J CELL BIOL, V135, P1383, DOI 10.1083/jcb.135.5.1383
   Hunt JA, 1997, BIOMATERIALS, V18, P1449, DOI 10.1016/S0142-9612(97)00091-4
   Ilic D, 1998, J CELL BIOL, V143, P547
   Kirkpatrick CJ, 1998, P I MECH ENG H, V212, P75, DOI 10.1243/0954411981533845
   LAMPUGNANI MG, 1995, J CELL BIOL, V129, P203, DOI 10.1083/jcb.129.1.203
   Lewis JM, 1996, J CELL BIOL, V134, P1323, DOI 10.1083/jcb.134.5.1323
   Lin MC, 1997, J CLIN INVEST, V99, P737, DOI 10.1172/JCI119219
   Marois Y, 1996, BIOMATERIALS, V17, P1289, DOI 10.1016/0142-9612(96)88674-1
   MIYAMOTO S, 1995, J CELL BIOL, V131, P791, DOI 10.1083/jcb.131.3.791
   Niklason LE, 1999, SCIENCE, V284, P489, DOI 10.1126/science.284.5413.489
   Oberpenning F, 1999, NAT BIOTECHNOL, V17, P149
   Ohgushi H, 1996, J BIOMED MATER RES, V32, P341, DOI 10.1002/(SICI)1097-4636(199611)32:3<341::AID-JBM6>3.0.CO;2-S
   Peter SJ, 1998, J BIOMED MATER RES, V43, P422, DOI 10.1002/(SICI)1097-4636(199824)43:4<422::AID-JBM9>3.3.CO;2-T
   REGEN CM, 1992, J CELL BIOL, V119, P1347, DOI 10.1083/jcb.119.5.1347
   Retta SF, 1996, EXP CELL RES, V229, P307, DOI 10.1006/excr.1996.0376
   RIDLEY AJ, 1994, EMBO J, V13, P2600, DOI 10.1002/j.1460-2075.1994.tb06550.x
   SEGER R, 1995, FASEB J, V9, P726
   VANKOOTEN TG, 1999, TISSUE ENG, V5, P213
   Zreiqat H, 1996, J BIOMED MATER RES, V33, P217, DOI 10.1002/(SICI)1097-4636(199624)33:4<217::AID-JBM2>3.0.CO;2-S
NR 27
TC 1
Z9 1
U1 0
U2 9
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD MAR 5
PY 2001
VL 54
IS 3
BP 385
EP 389
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 387NG
UT WOS:000166128200010
PM 11189044
DA 2018-10-20
ER

PT J
AU Itoh, S
   Kikuchi, M
   Takakuda, K
   Koyama, Y
   Matsumoto, HN
   Ichinose, S
   Tanaka, J
   Kawauchi, T
   Shinomiya, K
AF Itoh, S
   Kikuchi, M
   Takakuda, K
   Koyama, Y
   Matsumoto, HN
   Ichinose, S
   Tanaka, J
   Kawauchi, T
   Shinomiya, K
TI The biocompatibility and osteoconductive activity of a novel
   hydroxyapatite/collagen composite biomaterial, and its function as a
   carrier of rhBMP-2
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE hydroxyapatite; type I collagen; hydroxyapatite/type I collagen
   (HAp/Col) composite; recombinant human bone morphogenetic protein
   (rhBMP); bone-remodeling unit
ID BONE MORPHOGENETIC PROTEIN; POROUS HYDROXYAPATITE; GRAFT SUBSTITUTE;
   SURGERY; PHOSPHATASE; INDUCTION
AB A hydroxyapatite/type I collagen (HAp/Col) composite, in which the hydroxyapatite nanocrystals align along the collagen molecules, has been prepared. The biocompatibility, osteoconductive activity, and efficacy as a carrier of recombinant human bone morphogenetic proteins (rhBMFs) of this novel biomaterial were examined. The composite material was implanted in the backs of Wistar rats, and specimens were collected for histological observations until week 24. In a second experiment, other samples of the composite material (5 x 5 x 10 mm(3)) were drilled and immersed in a solution of rhBMP-2 (0, 200, 400 mug/mL), and subsequently grafted in radii and ulnae in beagle dogs. As a control, three unfilled holes were left in one radius and ulna. X-ray images were prepared, and specimens collected for histological observation at weeks 8 and 12. Histological findings of the composites grafted in rats showed that the surface of the material was eroded as a result of macrophage infiltration. X-ray images and histological findings for the composites implanted in dogs support the idea that HAp/Col has a high osteoconductive activity and is able to induce bone-remodeling units. In cases where the implants are grafted at weight bearing sites, treatment with rhBMP-2 at a dose of 400 mug/mL may be useful to shorten the time needed until bone union has occurred. (C) 2000 John Wiley & Sons, Inc. J Biomed Mater Res 54: 445-453, 2001.
C1 Tokyo Med & Dent Univ, Dept Orthopaed Surg, Bunkyo Ku, Tokyo 1138519, Japan.
   Tokyo Med & Dent Univ, Dept Biomech Engn, Bunkyo Ku, Tokyo 1138519, Japan.
   Tokyo Med & Dent Univ, Ctr Electron Microscopy, Bunkyo Ku, Tokyo 1138519, Japan.
   Natl Inst Res Inorgan Mat, Tsukuba, Ibaraki 3050044, Japan.
RP Shinomiya, K (reprint author), Tokyo Med & Dent Univ, Dept Orthopaed Surg, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.
EM shinomiya.orth@med.tmd.ac.jp
RI Kikuchi, Masanori/B-5993-2008; Matsumoto, Hiroko/B-8335-2011
OI Kikuchi, Masanori/0000-0002-9451-8147; 
CR Aoki H, 1994, MED APPL HYDROXYAPAT, P156
   BYRD HS, 1993, PLAST RECONSTR SURG, V91, P15, DOI 10.1097/00006534-199301000-00003
   CHVAPIL M, 1981, FUNDAMENTAL ASPECTS, V1, P88
   COLE AA, 1987, J HISTOCHEM CYTOCHEM, V35, P203, DOI 10.1177/35.2.3540104
   FINN RA, 1980, J MAXILLOFAC SURG, V8, P217, DOI 10.1016/S0301-0503(80)80104-4
   HORISAKA Y, 1991, CLIN ORTHOP RELAT R, V268, P303
   INOUE O, 1993, CLIN ORTHOP RELAT R, V293, P287
   KAWAI T, 1993, CLIN ORTHOP RELAT R, V290, P296
   LIN C-J, 1989, Bulletin of Tokyo Medical and Dental University, V36, P1
   MINEGISHI D, 1988, INT J PERIODONT REST, V8, P51
   MIYAMOTO S, 1993, CLIN ORTHOP RELAT R, P333
   NAKANO K, 1992, SPINE, V17, pS41
   Oda Shigeru, 1997, Journal of Medical and Dental Sciences, V44, P53
   ONO I, 1995, PLAST RECONSTR SURG, V95, P1265, DOI 10.1097/00006534-199506000-00019
   ONO I, 1992, PLAST RECONSTR SURG, V90, P870, DOI 10.1097/00006534-199211000-00023
   OZAKI M, 1989, BIOMATERIALS, V10, P561
   ROSEN HM, 1989, PLAST RECONSTR SURG, V83, P985, DOI 10.1097/00006534-198906000-00009
   SALYER KE, 1989, PLAST RECONSTR SURG, V84, P236, DOI 10.1097/00006534-198908000-00008
   STEVENSON S, 1994, J BONE JOINT SURG AM, V76A, P1676, DOI 10.2106/00004623-199411000-00011
   TAKAOKA K, 1991, J ORTHOPAED RES, V9, P902, DOI 10.1002/jor.1100090617
   TAKAOKA K, 1998, CLIN ORTHOP RELAT R, V234, P250
   UCHIDA A, 1990, J BONE JOINT SURG BR, V72, P298
   URIST MR, 1984, CLIN ORTHOP RELAT R, V187, P277
   VILLANUEVA AR, 1974, STAIN TECHNOL, V49, P1, DOI 10.3109/10520297409116928
   WANG EA, 1990, P NATL ACAD SCI USA, V87, P2220, DOI 10.1073/pnas.87.6.2220
   YASKO AW, 1992, J BONE JOINT SURG AM, V74A, P659, DOI 10.2106/00004623-199274050-00005
   YOSHIKI S, 1972, HISTOCHEMISTRY, V29, P296
NR 27
TC 118
Z9 130
U1 1
U2 17
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD MAR 5
PY 2001
VL 54
IS 3
BP 445
EP 453
DI 10.1002/1097-4636(20010305)54:3<445::AID-JBM190>3.0.CO;2-9
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 387NG
UT WOS:000166128200019
PM 11189053
DA 2018-10-20
ER

PT J
AU Casaletto, MP
   Ingo, GM
   Kaciulis, S
   Mattogno, G
   Pandolfi, L
   Scavia, G
AF Casaletto, MP
   Ingo, GM
   Kaciulis, S
   Mattogno, G
   Pandolfi, L
   Scavia, G
TI Surface studies of in vitro biocompatibility of titanium oxide coatings
SO APPLIED SURFACE SCIENCE
LA English
DT Article
DE biomaterial; titanium oxide; titanium; XPS; SEM; STM
ID SPECTROSCOPIC CHARACTERIZATION; IMPLANT MATERIALS
AB Titanium oxide coatings are normally used for orthopaedic and dental prostheses. Nevertheless, their chemical, biological and mechanical properties can be still improved by the development of new preparation technologies. In this paper a surface characterisation of the titanium oxide layer, grown on commercial Ti substrates by metal organic chemical vapour deposition (MOCVD) technique, is reported. The biocompatibility of the samples is tested upon in vitro treatment as a function of the exposure time. The surface characterisation of the titanium substrate and the oxide coatings is performed by using different analytical techniques. Surface chemical composition and morphology of the coatings are investigated by X-ray photoelectron spectroscopy (XPS), scanning electron microscopy (SEM) and scanning tunnelling microscopy (STM). Quantitative XPS analysis and surface physical images show a good quality (cleanness, homogeneity, roughness) of the oxide coating deposited by MOCVD and the surface modifications induced by the interaction with osteoblast cells. (C) 2001 Elsevier Science B.V. All rights reserved.
C1 CNR, Inst Mat Chem, I-00016 Monterotondo, Rome, Italy.
RP Mattogno, G (reprint author), CNR, Inst Mat Chem, POB 10, I-00016 Monterotondo, Rome, Italy.
RI Casaletto, Maria Pia/P-6715-2017; Kaciulis, Saulius/G-5252-2010
OI Casaletto, Maria Pia/0000-0002-2236-5671; Kaciulis,
   Saulius/0000-0002-9868-7626; INGO, Gabriel Maria/0000-0002-5414-2077
CR BATTISTON GA, 1994, THIN SOLID FILMS, V239, P186, DOI 10.1016/0040-6090(94)90849-4
   Battiston GA, 2000, MATER SCI FORUM, V352, P151, DOI 10.4028/www.scientific.net/MSF.352.151
   BATTISTONI C, IN PRESS SURF INTERF
   Bowers K T, 1992, Int J Oral Maxillofac Implants, V7, P302
   BRUNETTE DM, 1988, SURFACE CHARACTERIZA
   CIRILLI F, 1997, P ECASIA 97, P1063
   Demri B, 1997, APPL SURF SCI, V108, P245, DOI 10.1016/S0169-4332(96)00576-4
   Gardella JA, 1996, J ELECTRON SPECTROSC, V81, P227, DOI 10.1016/0368-2048(96)03054-X
   HANAWA T, 1991, BONE-BIOMATERIAL INTERFACE, P49
   HENCH L, 1993, INTRO BIOCERAMICS
   HUAXIA JI, 1992, J MATER SCI-MATER M, V3, P283
   Kaciulis S, 1999, APPL SURF SCI, V151, P1, DOI 10.1016/S0169-4332(99)00267-6
   Kaciulis S, 1998, J ELECTRON SPECTROSC, V95, P61, DOI 10.1016/S0368-2048(98)00202-3
   Lausmaa J, 1996, J ELECTRON SPECTROSC, V81, P343, DOI 10.1016/0368-2048(95)02530-8
   LAUSMAA J, 1990, APPL SURF SCI, V44, P133, DOI 10.1016/0169-4332(90)90100-E
   LAUSMAA J, 1988, SURFACE CHARACTERIZA
   LeGeros RZ, 1993, INTRO BIOCERAMICS
   MICHAELS C M, 1989, Journal of Dental Research, V68, P276
   MONTENERO A, 2000, J MATER SCI, V35, P1
   Moulder J.F., 1995, HDB XRAY PHOTOELECTR
   RATNER BD, 1993, J BIOMED MATER RES, V27, P837, DOI 10.1002/jbm.820270702
   RIMONDINI L, 1999, REPORT CNR MSTA2 FIN
   RIMONDINI L, 1998, BIL M IT UN KINGD BI
   Vogler EA, 1996, J ELECTRON SPECTROSC, V81, P237, DOI 10.1016/0368-2048(96)02526-1
   WAGNER CD, 1986, SURF INTERFACE ANAL, V2, P53
   WILSON J, 1994, BIOCERAMICS, V8
NR 26
TC 62
Z9 67
U1 1
U2 27
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD MAR 1
PY 2001
VL 172
IS 1-2
BP 167
EP 177
DI 10.1016/S0169-4332(00)00844-8
PG 11
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 399UQ
UT WOS:000166831100022
DA 2018-10-20
ER

PT J
AU Lamghari, M
   Berland, S
   Laurent, A
   Huet, H
   Lopez, E
AF Lamghari, M
   Berland, S
   Laurent, A
   Huet, H
   Lopez, E
TI Bone reactions to nacre injected percutaneously into the vertebrae of
   sheep
SO BIOMATERIALS
LA English
DT Article
DE nacre; PMMA; vertebral bone; injectable biomaterial; sheep
ID OSTEOBLASTS MAINTAINED INVITRO; CEMENT; POLYMETHYLMETHACRYLATE;
   RECONSTRUCTION; VERTEBROPLASTY; MODEL
AB We have studied the osteogenic effects of nacre (mother of pearl) placed in experimental cavities prepared in the lumbar Vertebrae of sheep. Some of cavities were filled with nacre, some with PMMA, and some were left empty. The Vertebrae were removed 1, 8, 12 weeks after surgery, and assessed histologically and morphometrically. The nacre particles in the bone cavity and the surrounding intertrabecular spaces gradually dissolved beginning at 8 weeks after surgery. There were layers of newly formed bone, both woven and lamellar, in various stages of maturation in contact with or adjacent to the dissolving nacre. Quantitative assessment of the activation of bone formation adjacent to the cavities filled with nacre indicated significant activation of bone formation, which continued until week 12. There was also increased mineralization of the host bone at this time. There was no new bone formation in the empty cavities, or in those filled with PMMA. PMMA also caused necrosis of surrounding bone cells with a change in bone architecture and significant reductions in bone formation and mineralization. This study demonstrates that nacre stimulates bone-forming cells in vertebrae and appears to result in new bone formation. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Museum Natl Hist Nat, Lab Physiol Gen & Comparee, CNRS, UMR 8572, F-75231 Paris 05, France.
   Hop Lariboisiere, Serv Neuroradiol Diagnost & Intervent, F-75475 Paris, France.
   CHU Caen, Serv Neuroradiol, F-14000 Caen, France.
RP Lopez, E (reprint author), Museum Natl Hist Nat, Lab Physiol Gen & Comparee, CNRS, UMR 8572, 7 Rue Cuvier, F-75231 Paris 05, France.
RI Lamghari, Meriem/K-2159-2013
OI Lamghari, Meriem/0000-0002-2500-4548
CR Atlan G, 1997, CR ACAD SCI III-VIE, V320, P253, DOI 10.1016/S0764-4469(97)86933-8
   Atlan G, 1999, BIOMATERIALS, V20, P1017, DOI 10.1016/S0142-9612(98)90212-5
   Balmain J, 1999, J BIOMED MATER RES, V48, P749, DOI 10.1002/(SICI)1097-4636(1999)48:5<749::AID-JBM22>3.0.CO;2-P
   Boivin G., 1984, METHODS CALCIFIED TI, P391
   Bostrom MP, 1997, SPINE S, V22, P38
   CERASI P, 1997, ITBM, V16, P15
   Chiras J, 1997, J NEURORADIOLOGY, V24, P45
   CHOW LC, 1997, INNOV TECH BIOL MED, V18, P11
   CONSTANTZ BR, 1995, SCIENCE, V267, P1796, DOI 10.1126/science.7892603
   Daculsi G, 1998, BIOMATERIALS, V19, P1473, DOI 10.1016/S0142-9612(98)00061-1
   DEBUSSCHEDEPRIE.C, 1991, NEURORADIOLOGY, V33, P149
   Deramond H, 1998, RADIOL CLIN N AM, V36, P533, DOI 10.1016/S0033-8389(05)70042-7
   DERAMOND H, 1990, RADIOLOGY, V117, P352
   DERAMOND H, 1989, RACHIS, V1, P143
   Dupraz A, 1999, BIOMATERIALS, V20, P663, DOI 10.1016/S0142-9612(98)00222-1
   Gauthier O, 1999, J BIOMED MATER RES, V47, P28, DOI 10.1002/(SICI)1097-4636(199910)47:1<28::AID-JBM4>3.0.CO;2-P
   Gauthier O, 1999, J PERIODONTOL, V70, P375, DOI 10.1902/jop.1999.70.4.375
   GRIMANDI G, 1998, J BIOMED MATER RES, V39, P606
   Jensen ME, 1997, AM J NEURORADIOL, V18, P1897
   KAEMMERLEN P, 1989, Journal de Radiologie (Paris), V70, P557
   Lamghari M, 1999, BIOMATERIALS, V20, P2107, DOI 10.1016/S0142-9612(99)00113-1
   Lamghari M, 1999, BONE, V25, p91S, DOI 10.1016/S8756-3282(99)00141-6
   LEFAOU A, 1995, CALCIF TISSUE INT S, V56, pA461
   LOPEZ E, 1992, TISSUE CELL, V24, P667, DOI 10.1016/0040-8166(92)90037-8
   LOPEZ E, 1995, Patent No. 951565028
   Meunier PJ, 1997, BONE, V21, P373, DOI 10.1016/S8756-3282(97)00170-1
   MOUTAHIRBELQASM.F, 2000, IN PRESS J MAT SCI M
   Pasquier G, 1996, J MATER SCI-MATER M, V7, P683, DOI 10.1007/BF00123407
   Pinkert R, 1979, Zahn Mund Kieferheilkd Zentralbl, V67, P603
   RASMUSSEN H, 1974, BONE CELLS MORPHOLOG, P8
   REID SA, 1987, J BONE MINER RES, V2, P13
   Schildhauer TA, 1999, J ORTHOPAED RES, V17, P67, DOI 10.1002/jor.1100170111
   SILVE C, 1992, CALCIFIED TISSUE INT, V51, P363, DOI 10.1007/BF00316881
   Stankewich CJ, 1996, J ORTHOP RES, V14, P786, DOI 10.1002/jor.1100140516
   Vale FM, 1997, BIOMATERIALS, V18, P1133, DOI 10.1016/S0142-9612(97)00043-4
   Weill A, 1996, RADIOLOGY, V199, P241, DOI 10.1148/radiology.199.1.8633152
   Westbroek P, 1998, NATURE, V392, P861, DOI 10.1038/31798
NR 37
TC 45
Z9 58
U1 0
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 2001
VL 22
IS 6
BP 555
EP 562
DI 10.1016/S0142-9612(00)00213-1
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 399YN
UT WOS:000166842000006
PM 11219719
DA 2018-10-20
ER

PT J
AU Ignjatovic, N
   Savic, V
   Najman, S
   Plavsic, M
   Uskokovic, D
AF Ignjatovic, N
   Savic, V
   Najman, S
   Plavsic, M
   Uskokovic, D
TI A study of HAp/PLLA composite as a substitute for bone powder, using
   FT-IR spectroscopy
SO BIOMATERIALS
LA English
DT Article
DE hydroxyapatite/poly-L-lactide composite biomaterial; in vivo; FT-IR
   spectroscopy; absorption band; collagen; autologous bone
ID INFRARED-SPECTROSCOPY; IN-VIVO; BIOMATERIALS; HYDROXYAPATITE;
   POLYLACTIDES; DEGRADATION
AB Chemically synthesized hydroxyapatite/poly-L-lactide (HAp/PLLA) composite biomaterial was studied in vivo. The biocomposite was implanted into Balb/c Singen mice and after 1 and 3 weeks removed from their organisms and analyzed by the FT-IR spectroscopy. After 1 week of testing in vivo the implanted sample gave a spectrum in which absorption bands arising from newly formed functional groups of amine and peptide can be seen. After 3 weeks, a spectrum with pronounced absorption bands at 3420 and 1650 cm(-1) assigned to newly generated collagen, a component of the extracellular connective-tissue matrix, was registered. Also, decrease of the intensity absorption band at 1760 cm(-1) originating from the C=O group of PLLA indicates bioresorption of the PLLA used. Analysis of the microstructure of the sample surface by scanning electron microscopy before and after implantation revealed bioresorption of the PLLA polymer phase and generation of collagen fibers at the sites of implanted bioresorptive PLLA. A mixture of autologous bone powder and HAp/PLLA biocomposite was also examined. After implantation, the same final products as in the case of HAp/PLLA composite biomaterial used alone were found. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Serbian Acad Sci & Arts, Inst Tech Sci, YU-11000 Belgrade, Yugoslavia.
   Univ Nis, Fac Med, YU-18000 Nis, Yugoslavia.
   Fac Technol & Met Belgrade, YU-11000 Belgrade, Yugoslavia.
RP Uskokovic, D (reprint author), Serbian Acad Sci & Arts, Inst Tech Sci, Knez Mihailova 35-IV, YU-11000 Belgrade, Yugoslavia.
RI Uskokovic, Dragan/B-4129-2008; Ignjatovic, Nenad/C-4489-2008
OI Uskokovic, Dragan/0000-0002-0421-4968; Ignjatovic,
   Nenad/0000-0002-5749-094X; Najman, Stevo/0000-0002-2411-9802
CR AGRAWAL M, 1998, JOM              JAN, P31
   AKAMATSU N, 1993, ASIAN MED J, V36, P621
   BELLAMY LJ, 1975, INFRARED SPECTRA COM, P247
   Chittur KK, 1998, BIOMATERIALS, V19, P357, DOI 10.1016/S0142-9612(97)00223-8
   CHO S, 1997, KEY ENG MATER, V132, P802
   COLARUSSO BP, 1998, APPL SPECTROSC, V52, P106
   Francioso O, 1998, APPL SPECTROSC, V52, P270, DOI 10.1366/0003702981943347
   FREED LE, 1994, BIO-TECHNOL, V12, P689, DOI 10.1038/nbt0794-689
   Fujii T, 1997, APPL SPECTROSC, V51, P1682, DOI 10.1366/0003702971939352
   HARAKE WA, 1998, AM J PHYSIOL, V274, pE586
   HUMMEL DO, 1984, ATLAS POLYM PLASTICS, P373
   Ignjatovic N, 1999, BIOMATERIALS, V20, P809, DOI 10.1016/S0142-9612(98)00234-8
   Ignjatovic NL, 1999, J MICROSC-OXFORD, V196, P243
   KURASHINA K, 1995, BIOMATERIALS, V16, P119, DOI 10.1016/0142-9612(95)98273-H
   Lindner J, 1977, Clin Plast Surg, V4, P425
   Liu Q, 1997, BIOMATERIALS, V18, P1263, DOI 10.1016/S0142-9612(97)00069-0
   MainilVarlet P, 1996, J MATER SCI-MATER M, V7, P713, DOI 10.1007/BF00121406
   MainilVarlet P, 1997, J BIOMED MATER RES, V36, P360, DOI 10.1002/(SICI)1097-4636(19970905)36:3<360::AID-JBM11>3.0.CO;2-I
   MANTSCH H, 1995, J MOL STRUCT, V347, P187, DOI 10.1016/0022-2860(95)08545-7
   MANTSCH HH, 1990, J MOL STRUCT, V217, P347, DOI 10.1016/0022-2860(90)80374-S
   Pohjonen T, 1997, J MATER SCI-MATER M, V8, P311, DOI 10.1023/A:1018516529591
   RodriguezLorenzo LM, 1996, J BIOMED MATER RES, V30, P515, DOI 10.1002/(SICI)1097-4636(199604)30:4<515::AID-JBM10>3.0.CO;2-G
   Rosengren A, 1997, BIOMATERIALS, V18, P979, DOI 10.1016/S0142-9612(97)00012-4
   SCHRADER B, 1996, 23 EUR C MOL SPECTR
   STRYER L, 1981, BIOCHEMISTRY-US, P186
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   VERHEYEN CCPM, 1993, J MATER SCI-MATER M, V4, P58, DOI 10.1007/BF00122979
NR 27
TC 98
Z9 104
U1 3
U2 23
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 2001
VL 22
IS 6
BP 571
EP 575
DI 10.1016/S0142-9612(00)00215-5
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 399YN
UT WOS:000166842000008
PM 11219721
DA 2018-10-20
ER

PT J
AU Fonseca, C
   Barbosa, MA
AF Fonseca, C
   Barbosa, MA
TI Corrosion behaviour of titanium in biofluids containing H2O2 studied by
   electrochemical impedance spectroscopy
SO CORROSION SCIENCE
LA English
DT Article
DE titanium; EIS; corrosion; biomaterials
ID HYDROGEN-PEROXIDE; BIOMATERIAL; GROWTH; FILMS; CELL; XPS
AB This work aims at studying the electrochemical behaviour of titanium in the presence of an artificial biofluid containing H2O2, mimicing the situation, where the metal is implanted in the human body and hydrogen peroxide is generated by an inflammatory reaction. A phosphate buffered saline (PBS) solution and two PBS/H2O2 solutions containing 50 and 150 mM of H2O2 were used to simulate the body fluids. The behaviour of the metal was monitored as a function of time by electrochemical impedance spectroscopy (EIS) for three weeks. After one week, the PBS/H2O2 solutions were replaced by fresh PBS solutions in order to simulate the end of the inflammatory process and recovery of the system. All the experiments were carried out at a constant temperature of 37 degreesC. From the simulation of the experimental EIS spectra, it was concluded that the corrosion resistance of titanium is strongly affected by the presence of H2O2 and when the peroxide is removed, the metal displays a sharp resistance increase. Furthermore, the oxides formed in H2O2 are rougher and display higher ionic conductivities than the oxides Formed in the absence of peroxide. The study was complemented with potentiostatic experiments and scanning electron microscopy observation of the metal surfaces. (C) 2001 Elsevier Science Ltd. All lights reserved.
C1 INEB, Lab Biomat, P-4150180 Porto, Portugal.
   Univ Porto, Dept Met & Mat Engn, Fac Engn, P-4099 Oporto, Portugal.
RP Fonseca, C (reprint author), INEB, Lab Biomat, Rua Campo Alegre 823, P-4150180 Porto, Portugal.
RI Barbosa, Mario/F-5964-2011
OI Barbosa, Mario/0000-0003-3568-7482; Fonseca, Carlos/0000-0002-2759-0384
CR AMSNFELD F, 1991, ASTM STP
   ARMSTRONG RD, 1973, ELECTROCHIM ACTA, V18, P937, DOI 10.1016/0013-4686(73)87025-2
   Boukamp B.A., 1989, EQUIVALENT CIRCUIT U
   CHAO CY, 1982, J ELECTROCHEM SOC, V129, P1874, DOI 10.1149/1.2124318
   Cole KS, 1941, J CHEM PHYS, V9, P341, DOI 10.1063/1.1750906
   DELEVIE, ADV ELECTROCHEMISTRY, V6
   DORR LD, 1990, CLIN ORTHOP RELAT R, P82
   HANAWA T, 1992, APPL SURF SCI, V55, P269, DOI 10.1016/0169-4332(92)90178-Z
   HANAWA T, 1991, BIOMATERIALS, V12, P767, DOI 10.1016/0142-9612(91)90028-9
   HUGOTLEGOFF A, 1986, THIN SOLID FILMS, V142, P193, DOI 10.1016/0040-6090(86)90004-0
   Kader J. M. A., 1981, BR CORROS J, V16, P111
   KADER JMAE, 1979, BRIT CORROS J, V14, P40, DOI 10.1179/000705979798276022
   LAING PATRICK G., 1967, J BIOMED MAT RES, V1, P135, DOI 10.1002/jbm.820010113
   LEMEHAUTE A, 1984, J STAT PHYS, V36, P665, DOI 10.1007/BF01012930
   MACDONALD DD, 1985, J ELECTROCHEM SOC, V133, P2018
   MACDONALD JR, 1987, IMPEDANCE SPECTROSCO, P154
   McQueen D, 1982, CLIN APPLICATIONS BI, P179
   MEACHIM G, 1973, J BIOMED MATER RES, V7, P555, DOI 10.1002/jbm.820070607
   Mu Y, 2000, J BIOMED MATER RES, V49, P238, DOI 10.1002/(SICI)1097-4636(200002)49:2<238::AID-JBM12>3.0.CO;2-J
   Pan J, 1996, ELECTROCHIM ACTA, V41, P1143, DOI 10.1016/0013-4686(95)00465-3
   Pan J, 1996, J BIOMED MATER RES, V30, P393
   PAN J, 1994, J BIOMED MATER RES, V28, P113, DOI 10.1002/jbm.820280115
   PARK JR, 1983, CORROS SCI, V23, P295, DOI 10.1016/0010-938X(83)90063-X
   PASCAL P, 1963, NOUVEAU TRAITE CHIMI, V14
   RAMMELT U, 1987, CORROS SCI, V27, P373, DOI 10.1016/0010-938X(87)90079-5
   SCHEPERS E, 1987, IMPLANT MAT BIOFUNCT, P79
   Sun ZL, 1997, J BIOMED MATER RES, V34, P29, DOI 10.1002/(SICI)1097-4636(199701)34:1<29::AID-JBM5>3.0.CO;2-P
   SUNDGREN JE, 1986, J COLLOID INTERF SCI, V10, P9
   TENGVALL P, 1992, Clinical Materials, V9, P115, DOI 10.1016/0267-6605(92)90056-Y
   TENGVALL P, 1989, J COLLOID INTERF SCI, V130, P405, DOI 10.1016/0021-9797(89)90117-3
   TENGVALL P, 1989, BIOMATERIALS, V10, P118, DOI 10.1016/0142-9612(89)90043-4
   Wang JY, 1996, J BIOMED MATER RES, V32, P655, DOI 10.1002/(SICI)1097-4636(199612)32:4<655::AID-JBM19>3.0.CO;2-C
NR 32
TC 110
Z9 115
U1 1
U2 23
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0010-938X
J9 CORROS SCI
JI Corrosion Sci.
PD MAR
PY 2001
VL 43
IS 3
BP 547
EP 559
DI 10.1016/S0010-938X(00)00107-4
PG 13
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 411EX
UT WOS:000167486100010
DA 2018-10-20
ER

PT J
AU McNamara, BP
   Murphy, H
   Morshed, MM
AF McNamara, BP
   Murphy, H
   Morshed, MM
TI Adhesion properties of diamond-like coated orthopaedic biomaterials
SO DIAMOND AND RELATED MATERIALS
LA English
DT Article; Proceedings Paper
CT 11th European Conference on Diamond, Diamond-like Materials, Carbon
   Nanotubes, Nitrides and Silicon Carbide (Diamond 2000)
CY SEP 03-08, 2000
CL OPORTO, PORTUGAL
SP De Beers Ind Diamonds (UK) Ltd, GFD Gesell Diamantprod mbH, Philips Res Labs, Elsevier Sci
DE adhesion strength; diamond-like carbon; biomaterial; wear
ID CARBON-FILMS; COATINGS; TOOLS; CVD
AB This study details an experimental analysis to investigate the most suitable orthopaedic alloy for diamond-like carbon deposition using a saddle field neutral beam deposition process. The paper specifically identifies the adhesion strength properties of diamond-like coatings and its dependence on process parameters for application to orthopaedic steels and polymer substrates. Sub-micron thickness films were deposited directly on stainless steel, cobalt chrome alloy, titanium alloy and ultra high mel. wt. polyethylene substrates. It was found from Rockwell and pull-off adhesion tests that superior adhesion is acquired for stainless steel substrates followed by cobalt chrome and titanium alloys. Adhesion strength was also shown to be inversely related to increases in deposition pressure and to increase with time up to a threshold. The maximum adhesion strength of coatings deposited on the polymer substrates was 60% of the value for stainless steel. Surface roughness was also inversely related to adhesion strength for the substrates examined. It is demonstrated that stainless steel offers a superior substrate material for the application of diamond-like thin-films where wear mechanisms and mechanical constraints are operational such as in orthopaedic articulating joint replacements. (C) 2001 Elsevier Science B.V. All rights reserved.
C1 Dublin City Univ, Sch Mech & Mfg Engn, Dublin 9, Ireland.
RP McNamara, BP (reprint author), Dublin City Univ, Sch Mech & Mfg Engn, Dublin 9, Ireland.
CR Barth J, 1991, HDB OPTICAL CONSTANT, VII
   Black J., 1988, ORTHOPAEDIC BIOMATER
   Clay KJ, 1998, DIAM RELAT MATER, V7, P1100, DOI 10.1016/S0925-9635(98)00159-9
   DING XZ, 1999, THIN SOLID FILMS, V246, P82
   Dowling DP, 1997, DIAM RELAT MATER, V6, P390, DOI 10.1016/S0925-9635(96)00687-5
   DRORY DM, 1995, MECH BEHAV DIAMOND O
   EVANS AC, 1991, MED DEVICE TECHNOL, V5, P26
   Hakovirta M, 1996, DIAM RELAT MATER, V5, P186, DOI 10.1016/0925-9635(95)00497-1
   KUMAR S, 1999, THIN SOLID FILMS, V34, P130
   Lappalainen R, 1998, DIAM RELAT MATER, V7, P482, DOI 10.1016/S0925-9635(98)80003-4
   Mallika K, 1999, WEAR, V224, P245, DOI 10.1016/S0043-1648(98)00337-8
   McLaughlin JA, 1996, DIAM RELAT MATER, V5, P486, DOI 10.1016/0925-9635(96)80065-3
   Morrison NA, 1996, DIAM RELAT MATER, V5, P1118, DOI 10.1016/0925-9635(96)00532-8
   OLEARY A, 1995, KEY ENG MAT, V99-1, P301, DOI 10.4028/www.scientific.net/KEM.99-100.301
   SHEEJA D, 2000, 11 EUR C PORT PORT 2
   Sleptsov VV, 1996, DIAM RELAT MATER, V5, P483, DOI 10.1016/0925-9635(96)80064-1
   STEINMANN PA, 1989, J VAC SCI TECHNOL A, V7, P2267, DOI 10.1116/1.575926
   TANG L, 1995, BIOMATERIALS, V16, P483, DOI 10.1016/0142-9612(95)98822-V
   Thomann UI, 2000, WEAR, V239, P48, DOI 10.1016/S0043-1648(99)00372-5
   Voevodin AA, 1996, CERAM INT, V22, P1, DOI 10.1016/0272-8842(95)00020-8
   WOOTEN F, 1972, OPTICAL PROPERTIES S, P78
NR 21
TC 21
Z9 21
U1 1
U2 6
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0925-9635
J9 DIAM RELAT MATER
JI Diam. Relat. Mat.
PD MAR-JUL
PY 2001
VL 10
IS 3-7
SI SI
BP 1098
EP 1102
DI 10.1016/S0925-9635(00)00567-7
PG 5
WC Materials Science, Multidisciplinary; Materials Science, Coatings &
   Films; Physics, Applied; Physics, Condensed Matter
SC Materials Science; Physics
GA 432ZJ
UT WOS:000168730600152
DA 2018-10-20
ER

PT J
AU Zippel, R
   Wilhelm, L
   Marusch, F
   Koch, A
   Urban, G
   Schlosser, M
AF Zippel, R
   Wilhelm, L
   Marusch, F
   Koch, A
   Urban, G
   Schlosser, M
TI Antigenicity of polyester (Dacron) vascular prostheses in an animal
   model
SO EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY
LA English
DT Article
DE antigenicity; biocompatibility; polyester; vascular prosthesis
ID INFLAMMATORY RESPONSES; BIOCOMPATIBILITY; ANTIBODIES; BIOMATERIALS;
   ELASTOMERS; EXPRESSION; ADHERENCE; IMPLANTS; SURFACE; TISSUE
AB Objectives: to investigate the specific humoral immune response to three different polyester (Dacron) prostheses in pigs.
   Design, materials and methods: twenty-four growing pigs were randomly divided into three groups. The infrarenal aorta was replaced by a segment of collagen-impregnated woven polyester prosthesis (low, medium and high porosity). Serum antibodies were detected by modified enzyme immunoassay using non-impregnated prosthesis as the target for the blood samples taken on experimental days 1, 10, 17, 24, 62 and 116 of the 22 pigs followed over the whole observation period.
   Results: significantly enhanced (p<0.05) mean Ige antibody binding against polyester was detected on experimental days 10, 17, 24 and 62 with antibody prevalences of 41%, 41%, 32% and 37%, resppectively. Antibody positive pigs were divided into early responders (n=9) and late responders (n=5) with antibody detection on lilly 10 and/or 17 vs day 62 and/or 116. No significant differences between the three different prostheses were found. The formation of specific IgG against polyester in the animals investigated demonstrates a broad individual variability.
   Conclusions: polyester is art antigenic polymer. Specific antibodies, reflecting the inflammatory response, might be not only a parameter for testing biomaterials bat also for determining individual bio(in)compatibility for long-term biomaterial function.
C1 Carl Thiem Hosp, Dept Surg, D-03048 Cottbus, Germany.
   Univ Greifswald, Dept Surg, Greifswald, Germany.
   Univ Greifswald, Inst Pathophysiol, Greifswald, Germany.
RP Zippel, R (reprint author), Carl Thiem Hosp, Dept Surg, Thiem St 3, D-03048 Cottbus, Germany.
CR ALI SAM, 1994, BIOMATERIALS, V15, P779, DOI 10.1016/0142-9612(94)90032-9
   ANDERSON JM, 1984, BIOMATERIALS, V5, P5, DOI 10.1016/0142-9612(84)90060-7
   ANDERSON JM, 1993, CARDIOVASC PATHOL S, V2, P33
   Aoyagi M, 1997, HISTOCHEM CELL BIOL, V107, P11, DOI 10.1007/s004180050084
   BAKKER D, 1990, J BIOMED MATER RES, V24, P277, DOI 10.1002/jbm.820240302
   BRETT T, 1992, MED DEVICE TECHNOL, V3, P25
   CREPON B, 1991, BIOMATERIALS, V12, P551
   GLASER ZR, 1993, PHARMACOPEIAL FORUM, V19, P5035
   GOLDBLUM RM, 1992, LANCET, V340, P510, DOI 10.1016/0140-6736(92)91710-P
   Gong G, 1993, J Heart Valve Dis, V2, P684
   Hicks DG, 1996, J BONE JOINT SURG AM, V78A, P482, DOI 10.2106/00004623-199604000-00002
   HOLGERS KM, 1995, BIOMATERIALS, V16, P611, DOI 10.1016/0142-9612(95)93858-B
   KOCH AE, 1995, NATURE, V376, P517, DOI 10.1038/376517a0
   LODI M, 1988, INT ANGIOL, V7, P344
   MARGIOTTA MS, 1992, ANN SURG, V216, P600, DOI 10.1097/00000658-199211000-00013
   MATURRI L, 1991, INT SURG, V76, P115
   MAURIN N, 1995, J BIOMED MATER RES, V29, P1439
   MULLER KM, 1994, CURRENT TOPICS PATHO, V86
   SCHLOSSER M, 1991, J IMMUNOL METHODS, V140, P101, DOI 10.1016/0022-1759(91)90131-X
   Schlosser M, 1994, Diabetes Res, V26, P67
   SCHLOSSER M, 1994, HORM METAB RES, V26, P534, DOI 10.1055/s-2007-1001751
   SCHLOSSER M, 1994, P 8 INT C BIOM ENG, P482
   Schlosser M., 1997, BIOSENSORS BODY CONT, P139
   SMITH DJ, 1990, J SURG RES, V48, P13, DOI 10.1016/0022-4804(90)90138-R
   SUTHERLAND K, 1993, J CLIN INVEST, V92, P2360, DOI 10.1172/JCI116841
   Swartbol P, 1996, J BIOMED MATER RES, V32, P669, DOI 10.1002/(SICI)1097-4636(199612)32:4<669::AID-JBM21>3.0.CO;2-7
   TANG LP, 1995, AM J CLIN PATHOL, V103, P466
   Tardito E, 1993, Minerva Cardioangiol, V41, P59
   Toumbis CA, 1997, SEMIN ARTHRITIS RHEU, V27, P44, DOI 10.1016/S0049-0172(97)80036-4
   VOLLMAR J, 1996, REKONSTRUKTIVE CHIRU, P34
   WARD RA, 1994, NEPHROL DIAL TRANSPL, V9, P46
   YAMAMOTO K, 1993, ARTIF ORGANS, V17, P1010, DOI 10.1111/j.1525-1594.1993.tb03183.x
   YANG J, 1994, J BIOMED MATER RES, V28, P1249, DOI 10.1002/jbm.820281102
   ZIEGLER M, 1994, BIOMATERIALS, V15, P859, DOI 10.1016/0142-9612(94)90043-4
   Zippel R, 1999, GEFASSCHIRURGIE, V4, P91
NR 35
TC 8
Z9 8
U1 0
U2 1
PU W B SAUNDERS CO LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 1078-5884
J9 EUR J VASC ENDOVASC
JI Eur. J. Vasc. Endovasc. Surg.
PD MAR
PY 2001
VL 21
IS 3
BP 202
EP 207
DI 10.1053/ejvs.2000.1298
PG 6
WC Surgery; Peripheral Vascular Disease
SC Surgery; Cardiovascular System & Cardiology
GA 422CK
UT WOS:000168100200002
PM 11352677
OA Bronze
DA 2018-10-20
ER

PT J
AU Malmonge, SM
AF Malmonge, SM
TI Artificial articular cartilage: developments and challenges
SO INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Editorial Material
ID OSTEOCHONDRAL DEFECTS; HISTOLOGICAL-EVALUATION; POLYMER SYSTEM; RABBIT
   KNEE; REPAIR; CHONDROCYTES; IMPLANTS; REGENERATION; BIOMATERIAL;
   DEPOSITION
C1 Univ Metodista Piracicaba, FECQ, BR-13450000 Santa Barbara DOeste, SP, Brazil.
RP Malmonge, SM (reprint author), Univ Metodista Piracicaba, FECQ, Rod Sta Barbara Iracemacpolis,KM 01, BR-13450000 Santa Barbara DOeste, SP, Brazil.
EM smmalmon@unimep.br
RI Malmonge, Sonia/I-4610-2012
CR Aigner J, 1998, J BIOMED MATER RES, V42, P172, DOI 10.1002/(SICI)1097-4636(199811)42:2<172::AID-JBM2>3.0.CO;2-M
   BRAY JC, 1973, J BIOMED MATER RES, V7, P431, DOI 10.1002/jbm.820070506
   BUCKWALTER JA, 1994, J BONE JOINT SURG AM, V76A, P1405, DOI 10.2106/00004623-199409000-00019
   Buckwalter JA, 1997, J BONE JOINT SURG AM, V79A, P612, DOI 10.2106/00004623-199704000-00022
   Campoccia D, 1998, BIOMATERIALS, V19, P2101, DOI 10.1016/S0142-9612(98)00042-8
   Corkhill P H, 1990, Proc Inst Mech Eng H, V204, P147, DOI 10.1243/PIME_PROC_1990_204_249_02
   DOWNES S, 1994, J MATER SCI-MATER M, V5, P88, DOI 10.1007/BF00121696
   EFTEKHAR NS, 1987, CLIN ORTHOP RELAT R, V225, P207
   FREED LE, 1993, J BIOMED MATER RES, V27, P11, DOI 10.1002/jbm.820270104
   FREED LE, 1995, TISSUE ENG CARTILAGE, P1788
   HANFF G, 1990, SCAND J PLAST RECONS, V24, P217, DOI 10.3109/02844319009041282
   Hasegawa M, 1999, BIOMATERIALS, V20, P1969, DOI 10.1016/S0142-9612(99)00106-4
   HEINEKEN FG, 1991, J BIOMECH ENG-T ASME, V113, P111, DOI 10.1115/1.2891223
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   KIMURA T, 1984, CLIN ORTHOP RELAT R, V186, P231
   KON M, 1981, PLAST RECONSTR SURG, V67, P289, DOI 10.1097/00006534-198103000-00002
   KREDER HJ, 1994, CLIN ORTHOP RELAT R, P288
   LAI WM, 1991, J BIOMECH ENG-T ASME, V113, P245, DOI 10.1115/1.2894880
   LIVECCHI AB, 1994, J BIOMED MATER RES, V28, P839, DOI 10.1002/jbm.820280802
   MAINARD D, 1992, 4 WORLD BIOM C
   Malmonge SM, 2000, BRAZ J MED BIOL RES, V33, P307, DOI 10.1590/S0100-879X2000000300008
   MALMONGE SM, 2000, INT J ARTIF ORGANS, V24, P174
   MESSNER K, 1993, BIOMATERIALS, V14, P513, DOI 10.1016/0142-9612(93)90240-3
   MINNS RJ, 1982, BIOMATERIALS, V3, P81, DOI 10.1016/0142-9612(82)90038-2
   MITCHELL N, 1976, J BONE JOINT SURG AM, V58, P230, DOI 10.2106/00004623-197658020-00012
   MORAN ME, 1992, J BONE JOINT SURG BR, V74, P659
   MOW VC, 1992, BIOMATERIALS, V13, P67, DOI 10.1016/0142-9612(92)90001-5
   MOW VC, 1991, T ASME, V113, P193
   Newman AP, 1998, AM J SPORT MED, V26, P309, DOI 10.1177/03635465980260022701
   Niederauer GG, 2000, BIOMATERIALS, V21, P2561, DOI 10.1016/S0142-9612(00)00124-1
   OKA M, 1990, Clinical Materials, V6, P361, DOI 10.1016/0267-6605(90)90053-X
   Oka M, 2000, P I MECH ENG H, V214, P59, DOI 10.1243/0954411001535246
   Pedley DG, 1980, BRIT POLYM J, V12, P99
   PRIDIE KH, 1959, J BONE JOINT SURG BR, V41, P618
   Quinn TM, 1998, J CELL SCI, V111, P573
   RANAWAT CS, 1984, J BONE JOINT SURG AM, V66A, P745, DOI 10.2106/00004623-198466050-00014
   RATNER BD, 1976, ACS SYM SER, P1
   SHAPIRO F, 1996, J BONE JOINT SURG, V78, P721
   Sittinger M, 1996, J BIOMED MATER RES, V33, P57, DOI 10.1002/(SICI)1097-4636(199622)33:2<57::AID-JBM1>3.0.CO;2-K
   Solchaga L, 1996, REV CHIR ORTHOP, V82, P101
   SPEER DP, 1979, CLIN ORTHOP RELAT R, P326
   STOCKWELL RA, 1990, METHODS CARTILAGE RE, P61
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   SUTHERLAND CJ, 1982, J BONE JOINT SURG AM, V64, P970, DOI 10.2106/00004623-198264070-00002
   Temenoff JS, 2000, BIOMATERIALS, V21, P431, DOI 10.1016/S0142-9612(99)00213-6
   VACANTI CA, 1991, PLAST RECONSTR SURG, V88, P753, DOI 10.1097/00006534-199111000-00001
   WAKITANI S, 1989, J BONE JOINT SURG BR, V71, P74
   Wyre RM, 2000, BIOMATERIALS, V21, P335, DOI 10.1016/S0142-9612(99)00185-4
NR 48
TC 0
Z9 0
U1 0
U2 1
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0391-3988
EI 1724-6040
J9 INT J ARTIF ORGANS
JI Int. J. Artif. Organs
PD MAR
PY 2001
VL 24
IS 3
BP 119
EP 122
PG 4
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 419RH
UT WOS:000167962100001
PM 11314803
DA 2018-10-20
ER

PT J
AU Bohic, S
   Weiss, P
   Roger, P
   Daculsi, G
AF Bohic, S
   Weiss, P
   Roger, P
   Daculsi, G
TI Light scattering experiments on aqueous solutions of selected cellulose
   ethers: contribution to the study of polymer-mineral interactions in a
   new injectable biomaterial
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID CALCIUM-PHOSPHATE CERAMICS; THERMAL GELATION; METHYLCELLULOSE;
   THERMOGELATION; SUBSTITUTE; COMPOSITE; WATER; BONE
AB Hydroxypropylmethylcellulose (HPMC) is used as a ligand for a bioactive calcium phosphate ceramic (the filler) in a ready-to-use injectable sterilized biomaterial for bone and dental surgery. Light scattering experiments were usually used to study high water-soluble polymers and to determine the basic macromolecular parameters. In order to gain a deeper understanding of polymer/mineral interactions in this type of material, we have investigated the effect of divalent and trivalent ions (Ca2+, PO43-) and steam sterilization on dilute solutions of HPMC and hydroxyethylcellulose (HEC). The sterilization process may cause some degradation of HEC taking into account its high molecular weight and some rigidity of the polymer chain. Moreover, in the case of HPMC, the changes in the conformations rather than degradation process are supposed. These effects of degradation and flocculation are strengthened in alkaline medium. Experimental data suggested the formation of chelate complexes between Ca2+ and HPMC which improve its affinity to the mineral blend and consolidate the injectable biomaterial even in the case of its hydration by biological fluid. (C) 2001 Kluwer Academic Publishers.
C1 Fac Chirurg Dent Nantes, Ctr REch Mat Internet Biol, INSERM, E9903, F-44042 Nantes 01, France.
   INRA, Lab Biochim & Technol Glucides, F-44316 Nantes, France.
RP Bohic, S (reprint author), Fac Chirurg Dent Nantes, Ctr REch Mat Internet Biol, INSERM, E9903, 1 Pl A Ricordeau, F-44042 Nantes 01, France.
RI BOHIC, Sylvain/F-6464-2013; Daculsi, Guy/P-1320-2014; Weiss,
   Pierre/P-1372-2014
OI BOHIC, Sylvain/0000-0001-6355-7592; Daculsi, Guy/0000-0003-1030-3446;
   Weiss, Pierre/0000-0002-6159-8590
CR Beignon M, 1998, J MOL STRUCT, V443, P233, DOI 10.1016/S0022-2860(97)00391-8
   BROWN W, 1963, MAKROMOLEKUL CHEM, V64, P49
   BROWN W, 1961, ARK KEMI, V18, P2600
   BURCHARD W, 1982, INT S PLANT POL CARB, P215
   CARLSSON A, 1990, COLLOID SURFACE, V47, P147, DOI 10.1016/0166-6622(90)80069-G
   CHEMTOB C, 1988, STP PHARM, V4, P764
   DACULIS G, 1996, 5 WORLD BIOM C MAY 2
   DACULSI G, 1990, CALCIFIED TISSUE INT, V46, P20, DOI 10.1007/BF02555820
   DACULSI G, 1989, J BIOMED MATER RES, V23, P883, DOI 10.1002/jbm.820230806
   Daculsi G, 1995, CNRS patent, Patent No. [9521634, WO 95/21634]
   Dupraz A, 1996, J MATER SCI-MATER M, V7, P52, DOI 10.1007/BF00121190
   GREMINGER GK, 1981, HDB WATER SOLUBLE RE, P1
   GROVER JA, 1986, FOOD HYDROCOLLOIDS, V3, P121
   HAQUE A, 1993, CARBOHYD POLYM, V22, P175, DOI 10.1016/0144-8617(93)90138-T
   HAQUE A, 1993, CARBOHYD POLYM, V22, P161, DOI 10.1016/0144-8617(93)90137-S
   Huglin M. B., 1972, LIGHT SCATTERING POL, P165
   HUIKARI A, 1986, ACTA PHARM FENN, V95, P105
   HUNKELER D, 1992, POLYM INT, V27, P23, DOI 10.1002/pi.4990270105
   KHAN WU, 1991, RES IND, V36, P214
   Khomutov LI, 1993, POLYM SCI, V35, P320
   LANG P, 1993, J BIOMAT SCI-POLYM E, V4, P517, DOI 10.1163/156856293X00753
   NEELY WB, 1963, J POLYM SCI PART A, V1, P311, DOI 10.1002/pol.1963.100010128
   OWEN SR, 1992, J FOOD ENG, V16, P39, DOI 10.1016/0260-8774(92)90019-3
   ROGER P, 1992, CARBOHYD RES, V227, P73, DOI 10.1016/0008-6215(92)85061-4
   SARKAR N, 1979, J APPL POLYM SCI, V24, P1073, DOI 10.1002/app.1979.070240420
   SCHULZ L, 1993, PAPIER, V46, P1
   SPERLING LH, 1993, INTRO PHYSICAL POLYM, P78
   *TECHN INF, 1990, AQ PROD LIT
   WALES M, 1951, J PHYS COLLOID CHEM, V55, P203, DOI 10.1021/j150485a007
   Weiss P, 1997, J MATER SCI-MATER M, V8, P621, DOI 10.1023/A:1018519419539
   WEISS P, 1996, P INT POL SEM TRZEB, P181
   1986, J AM COLL TOXICOL, V5
NR 32
TC 12
Z9 12
U1 0
U2 9
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD MAR
PY 2001
VL 12
IS 3
BP 201
EP 205
DI 10.1023/A:1008902829840
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 403LW
UT WOS:000167045100003
PM 15348303
DA 2018-10-20
ER

PT J
AU Midy, V
   Dard, M
   Hollande, E
AF Midy, V
   Dard, M
   Hollande, E
TI Evaluation of the effect of three calcium phosphate powders on
   osteoblast cells
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID BOVINE PARATHYROID CELLS; FIBROBLAST-GROWTH-FACTOR; BONE; INVITRO;
   HYDROXYAPATITE; PROLIFERATION; INHIBITION; CRYSTALS; HORMONE; MATRIX
AB The aim of the present study was to assess the effect of three calcium phosphate powders entering in the composition of bone substitute materials on osteoblast-cells activity. These powders were hydroxyapatite (HA) widely used as a biomaterial, nanocrystalline carbonate apatite (C A) very close to bone mineral crystals, and an experimental one: calcium phosphate cement-1 (CPC-1) composed of an amorphous Ca-P phase and brushite. The powders were physico-chemically characterized. The very reactive CPC-1 powder became transformed in cell culture medium: recrystallization of amorphous precursors and hydrolysis of brushite into poorly crystalline apatite occurred. Osteoblast-cells activity was evaluated: for low level of calcium phosphates (> 100 mug/ml) CPC-1 enhanced proliferation and, to a lesser degree, differentiation on alkaline phosphatase activity. For 100 mug/ml of powders we observed a great alteration of biological activity of the osteoblasts: evaluation of proliferation indicated an inhibition for all samples, and a decrease of two differentiation markers: alkaline phosphatase activity and osteocalcin release were noticed, suggesting a down regulation due to the presence of large amount of mineral powder. (C) 2001 Kluwer Academic Publishers.
C1 Lab Cytophysiol Cellules Eucaryotes, F-31400 Toulouse, France.
   Merck Biomat Res, D-64271 Darmstadt, Germany.
RP Midy, V (reprint author), Lab Cytophysiol Cellules Eucaryotes, JE 1962,38 Rue 36 Ponts, F-31400 Toulouse, France.
CR ALLIOTLICHT B, 1991, BIOMATERIALS, V12, P752, DOI 10.1016/0142-9612(91)90025-6
   DACULSI G, 1990, CALCIFIED TISSUE INT, V46, P20, DOI 10.1007/BF02555820
   EVANS EJ, 1991, P BIOCERAMICS HUMAN, P48
   GENGE BR, 1988, J BIOL CHEM, V263, P18513
   GLOBUS RK, 1988, ENDOCRINOLOGY, V123, P98, DOI 10.1210/endo-123-1-98
   HARMAND MF, 1984, J CELL PHYSIOL, V119, P359, DOI 10.1002/jcp.1041190315
   HAWA NS, 1993, J MOL ENDOCRINOL, V10, P43, DOI 10.1677/jme.0.0100043
   KANAZIRSKA MPV, 1995, ENDOCRINOLOGY, V136, P2238, DOI 10.1210/en.136.5.2238
   KOBAYASHI N, 1988, P NATL ACAD SCI USA, V85, P4857, DOI 10.1073/pnas.85.13.4857
   MAJESKA RJ, 1982, CALCIFIED TISSUE INT, V34, P59, DOI 10.1007/BF02411210
   Midy V, 1998, J BIOMED MATER RES, V41, P405, DOI 10.1002/(SICI)1097-4636(19980905)41:3<405::AID-JBM10>3.0.CO;2-H
   MIDY V, IN PRESS
   NAKAHARA H, 1991, J ORTHOP RES, V9, P465, DOI 10.1002/jor.1100090402
   OWEN TA, 1990, J CELL PHYSIOL, V143, P420, DOI 10.1002/jcp.1041430304
   Prudhommeaux F, 1996, ARTHRITIS RHEUM, V39, P1319, DOI 10.1002/art.1780390809
   REY C, 1990, CALCIFIED TISSUE INT, V46, P384, DOI 10.1007/BF02554969
   Rey C, 1995, CELL MATER, V5, P345
   RODAN SB, 1987, CANCER RES, V47, P4961
   ROMBERG RW, 1986, BIOCHEMISTRY-US, V25, P1176, DOI 10.1021/bi00353a035
   STEIN GS, 1990, FASEB J, V4, P3111
   WEINER S, 1989, CONNECT TISSUE RES, V21, P589, DOI 10.3109/03008208909050015
NR 21
TC 21
Z9 21
U1 0
U2 2
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD MAR
PY 2001
VL 12
IS 3
BP 259
EP 265
DI 10.1023/A:1008971317544
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 403LW
UT WOS:000167045100010
PM 15348310
DA 2018-10-20
ER

PT J
AU Patel, JV
   Soni, PK
   Sinha, VK
AF Patel, JV
   Soni, PK
   Sinha, VK
TI A novelty finish prepared from polyurethane of biomaterial base
SO JOURNAL OF POLYMER MATERIALS
LA English
DT Article
DE polyurethane; bagasse; argemone oil
AB Argemone oil and its transesterified derivatives namely liquid polyol have been employed as back bone for the preparation of polyurethane. Hydroxyl functionalized polyol were obtained by esterification of glycol glycoside with argemone oil. The polyol were analyzed by the end group analysis, GPC, infrared spectroscopy to confirm their formation. Polyols were reacted with 4-4' Methylene Diphenylene Isocyanate (MDI) in different ratios to form polyurethane resin. Polyurethane resin thus prepared was coated on test panels and were examined for flexibility, scratch resistance, impact hardness, adhesion and chemical resistance. Thermal stability of polyurethane resin was evaluated by TGA and functional groups by infrared spectroscopy.
C1 VP & RPTP Sci Coll, Dept Ind Chem, Vallabh Vidyanagar 388120, Gujarat, India.
RP Sinha, VK (reprint author), VP & RPTP Sci Coll, Dept Ind Chem, Vallabh Vidyanagar 388120, Gujarat, India.
CR BLOUNT DH, 1983, Patent No. 4367326
   BLOUNT H, 1982, Patent No. 4339366
   BRYDSON JA, 1989, PLASTIC MAT, P452
   COCK LV, 1966, LAB HDB OIL FAT ANAL, P69
   *COUNC SCI IND RES, 1972, WEALTH IND RAW MAT, V2, P43
   DONELLY MJ, 1984, THESIS MANCHESTER U
   FRISCH KC, 1986, PLAST RUFF INT, V8, P1
   HUI YH, 1996, BAILLEYS IND OIL FAT, V3, P66
   *IND STAND, 1011964 IS, P38
   *IND STAND, IS1976 IND STAND, P27
   KLEINGWAYS RW, 1989, ADHESIVES RENEWABLE, P487
   KONTANST F, 1985, ORGANIC COATING PROP, P57
   OERTEL G, 1985, POLYURETHANE HDB, P58
   OTEY FH, 1963, J AM OIL CHEM SOC, V40, P76, DOI 10.1007/BF02654748
   OTEY FH, 1969, IND ENG CHEM PROD RD, V3, P267
   OTEY FH, 1963, IND ENG CHEM PROD RD, V4, P256
   PALTON JT, 1967, Patent No. 3336291
   PATTON JT, 1971, Patent No. 3567661
   SINGH P, 1991, J POLYM MATER, V8, P275
   URBANSKI J, 1977, HDB ANAL SYNTHETIC P, P287
   WHISTER RL, 1963, METHODS CARBOHYDRATE, V3, P112
   WHISTER RL, 1965, METHODS CARBOHYDRATE, V5, P365
   WICKS ZW, 1992, ORGANIC COATINGS SCI, P221
NR 23
TC 7
Z9 7
U1 0
U2 2
PU OXFORD & IBH PUBL CO PVT LTD
PI NEW DELHI
PA 66 JANPATH, NEW DELHI 110 001, INDIA
SN 0970-0838
J9 J POLYM MATER
JI J. Polym. Mater.
PD MAR
PY 2001
VL 18
IS 1
BP 103
EP 109
PG 7
WC Polymer Science
SC Polymer Science
GA 433BZ
UT WOS:000168736600015
DA 2018-10-20
ER

PT J
AU Chow, KS
   Khor, E
   Wan, ACA
AF Chow, KS
   Khor, E
   Wan, ACA
TI Porous chitin matrices for tissue engineering: Fabrication and in vitro
   cytotoxic assessment
SO JOURNAL OF POLYMER RESEARCH
LA English
DT Article
DE porous chitin matrices; lyophilization; tissue engineering; MTT assays;
   in vitro cytotoxicity assessment
ID RAPID COLORIMETRIC ASSAY; POLYMER SCAFFOLDS; ARTIFICIAL SKIN; PORE
   STRUCTURE; CHITOSAN; BIOMATERIAL; MORPHOLOGY; DELIVERY; GROWTH; FOAMS
AB A series of porous chitin matrices were fabricated by freezing and lyophilization of chitin gels cast from a 5% N,N-dimethylacetamide (DMAc)/lithium chloride (LiCl) solvent system. The porous chitin matrices were found to have uniform pore structure in the micron range. Scanning electron microscopy (SEM) revealed that the pore size of the porous chitin matrices varied according to the freezing method prior to lyophilization. By subjecting the chitin gels to dry-ice/ acetone (-38 degreesC), the final porous chitin matrix pave pore dimensions measuring 300-500 mum with 69% porosity. A smaller pore dimension of 100-200 mum with 61% porosity was produced when the chitin gels were frozen by liquid nitrogen (-196 degreesC) and 10 mum pores with 54% porosity were produced when the gels were placed in a freezer (-20 degreesC) for 20 min. In comparison. lower porosity structures of ca. 10% porosity were obtained from both air-dried and critical point dried chitin gels. Furthermore. a low gel concentration (<0.5%, w/w) also produced porous morphology by vacuum drying without any freezing and lyophilization. The resulting pore properties influenced the water uptake profile of the materials in water. These porous chitin matrices are found to be non-cytotoxic and to hold promise as potential structural scaffolds for cell growth and proliferation in vitro.
C1 Natl Univ Singapore, Dept Chem, Singapore 117543, Singapore.
   Natl Univ Singapore, Inst Mat Res & Engn, Singapore 117543, Singapore.
RP Khor, E (reprint author), Natl Univ Singapore, Dept Chem, 3 Sci Dr 3, Singapore 117543, Singapore.
EM chmkhore@nus.edu.sg
RI Wan, Andrew/B-8525-2014
CR AUBERT JH, 1991, CHEMTECH, V21, P234
   BAXTER A, 1992, INT J BIOL MACROMOL, V166, P14
   BERTHOD F, 1994, CLIN MATER, V15, P259, DOI 10.1016/0267-6605(94)90055-8
   DAGALAKIS N, 1980, J BIOMED MATER RES, V14, P511, DOI 10.1002/jbm.820140417
   Davis MW, 1996, BIOMATERIALS, V17, P365, DOI 10.1016/0142-9612(96)85575-X
   DeGroot JH, 1997, J MATER SCI-MATER M, V8, P707, DOI 10.1023/A:1018544124990
   DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6
   DOILLON CJ, 1986, J BIOMED MATER RES, V20, P1219, DOI 10.1002/jbm.820200811
   Eser ECCI, 1998, NEUROL RES, V20, P648
   FREED LE, 1993, J BIOMED MATER RES, V27, P11, DOI 10.1002/jbm.820270104
   GALLARDO A, 1979, REV PLAST MOD, V77, P60
   Grande DA, 1997, J BIOMED MATER RES, V34, P211, DOI 10.1002/(SICI)1097-4636(199702)34:2<211::AID-JBM10>3.0.CO;2-L
   GREEN LM, 1984, J IMMUNOL METHODS, V70, P257, DOI 10.1016/0022-1759(84)90190-X
   HEEG K, 1985, J IMMUNOL METHODS, V77, P237, DOI 10.1016/0022-1759(85)90036-5
   HIRANO S, 1979, CARBOHYD RES, V71, P344
   Klokkevold PR, 1999, J ORAL MAXIL SURG, V57, P49, DOI 10.1016/S0278-2391(99)90632-8
   LILIA S, 1997, BIOMATERIALS, V18, P583
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   MADIHALLY SV, 1996, P 5 WORLD BIOM C, P238
   Mi FL, 1999, BIOMATERIALS, V20, P1603, DOI 10.1016/S0142-9612(99)00064-2
   MIKOS AG, 1994, POLYMER, V35, P1068, DOI 10.1016/0032-3861(94)90953-9
   MIKOS AG, 1992, POLYM MAT SCI ENG, V66, P34
   Mooney DJ, 1996, BIOMATERIALS, V17, P1417, DOI 10.1016/0142-9612(96)87284-X
   Mosmann T., 1983, J IMMUNOL METHODS, V55, P65
   NICOLL SB, 1998, MATER RES SOC S P, V3, P530
   Paul W, 2000, STP PHARMA SCI, V10, P5
   Rao SB, 1997, J BIOMED MATER RES, V34, P21, DOI 10.1002/(SICI)1097-4636(199701)34:1<21::AID-JBM4>3.0.CO;2-P
   SANDFORD PA, 1991, ACS SYM SER, V467, P430
   Shah S, 1999, J PHARM PHARMACOL, V51, P667, DOI 10.1211/0022357991772952
   Sonomoto K, 2000, J MOL CATAL B-ENZYM, V10, P325, DOI 10.1016/S1381-1177(00)00133-8
   Thomson RC, 1995, ADV POLYM SCI, V122, P245
   Whang K, 1998, J BIOMED MATER RES, V42, P491, DOI 10.1002/(SICI)1097-4636(19981215)42:4<491::AID-JBM3>3.0.CO;2-F
   Widmer MS, 1998, BIOMATERIALS, V19, P1945, DOI 10.1016/S0142-9612(98)00099-4
   WILLIAMS JM, 1989, J MATER SCI, V24, P4062, DOI 10.1007/BF01168975
   WINTERMANTEL E, 1995, ENCY HDB BIOMATERIAL, V3
   YANNAS IV, 1990, ANGEW CHEM INT EDIT, V29, P20, DOI 10.1002/anie.199000201
   Zhang RY, 1999, J BIOMED MATER RES, V44, P446
NR 37
TC 33
Z9 33
U1 1
U2 7
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1022-9760
EI 1572-8935
J9 J POLYM RES
JI J. Polym. Res.
PD MAR
PY 2001
VL 8
IS 1
BP 27
EP 35
PG 9
WC Polymer Science
SC Polymer Science
GA 432KB
UT WOS:000168689800004
DA 2018-10-20
ER

PT J
AU Burdick, JA
   Philpott, LM
   Anseth, KS
AF Burdick, JA
   Philpott, LM
   Anseth, KS
TI Synthesis and characterization of tetrafunctional lactic acid oligomers:
   A potential in situ forming degradable orthopaedic biomaterial
SO JOURNAL OF POLYMER SCIENCE PART A-POLYMER CHEMISTRY
LA English
DT Article
DE photopolymerization; poly(lactic acid); orthopaedic biomaterials;
   bone-tissue engineering
ID BIODEGRADABLE POLYMERS; POLYANHYDRIDES; ADHESION
AB Tetrafunctional lactic acid oligomers with low molecular weight ethylene glycol cores were synthesized and characterized to assess their applicability to orthopaedics. Utilizing a visible light photoinitiating system, these oligomers polymerize within minutes to form highly crosslinked networks and, thus, have potential for in situ formation. Varying the oligomer structure readily alters the physical properties of the resultant polymer networks. For instance, mechanical properties were highly dependent on the number of lactic acid and ethylene glycol units in the oligomer backbone. Additionally, polymer mass loss ranged from similar to 30 to 60% within 8 weeks of degradation time depending on the oligomer chemistry. Mechanical properties decreased with degradation of these polymers, indicating a bulk degradation mechanism. Finally, scaffolds with a controlled architecture were fabricated from these oligomers that show potential for tissue-engineering applications. (C) 2001 John Wiley & Sons, Inc.
C1 Univ Colorado, Dept Chem Engn, Boulder, CO 80309 USA.
   Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA.
RP Anseth, KS (reprint author), Univ Colorado, Dept Chem Engn, ECCH 111, Boulder, CO 80309 USA.
CR ANSETH KS, 1995, MACROMOLECULES, V28, P2491, DOI 10.1021/ma00111a050
   Anseth KS, 1999, NAT BIOTECHNOL, V17, P156
   Bauer TW, 2000, CLIN ORTHOP RELAT R, P10
   BEHRAVESH E, 1999, CLIN ORTHOP S, V367, pS118
   BERCHTOLD KA, 1999, RADT EUR 99 C P BERL, P767
   BOS GD, 1983, J BONE JOINT SURG AM, V65, P239, DOI 10.2106/00004623-198365020-00015
   Boyan BD, 1999, J BIOMED MATER RES, V46, P51, DOI 10.1002/(SICI)1097-4636(199907)46:1<51::AID-JBM6>3.3.CO;2-9
   Bryant SJ, 2000, J BIOMAT SCI-POLYM E, V11, P439, DOI 10.1163/156856200743805
   BURDICK JA, IN PRESS BIOMATERIAL
   Griffith LG, 2000, ACTA MATER, V48, P263, DOI 10.1016/S1359-6454(99)00299-2
   Han DK, 1997, MACROMOLECULES, V30, P6077, DOI 10.1021/ma970302u
   HILL L W, 1992, J COATING TECHNOL, V64, P29
   HOROWITZ MC, 1987, ORTHOP CLIN N AM, V18, P227
   Ishaug SL, 1996, BIOTECHNOL BIOENG, V50, P443, DOI 10.1002/(SICI)1097-0290(19960520)50:4<443::AID-BIT12>3.0.CO;2-K
   ISHAUG SL, 1994, J BIOMED MATER RES, V28, P1445, DOI 10.1002/jbm.820281210
   Ishaug-Riley SL, 1998, BIOMATERIALS, V19, P1405, DOI 10.1016/S0142-9612(98)00021-0
   Kim BS, 2000, BIOMATERIALS, V21, P259, DOI 10.1016/S0142-9612(99)00174-X
   KLOOSTERBOER JG, 1988, ADV POLYM SCI, V84, P1
   Li SM, 1999, J BIOMED MATER RES, V48, P342, DOI 10.1002/(SICI)1097-4636(1999)48:3<342::AID-JBM20>3.0.CO;2-7
   Lu LC, 2000, BIOMATERIALS, V21, P1595, DOI 10.1016/S0142-9612(00)00048-X
   Metters AT, 2000, POLYMER, V41, P3993, DOI 10.1016/S0032-3861(99)00629-1
   MIKOS AG, 1994, POLYMER, V35, P1068, DOI 10.1016/0032-3861(94)90953-9
   MIYAZAKI K, 1988, J BIOMED MATER RES, V22, P1011, DOI 10.1002/jbm.820221105
   Muggli DS, 1998, MACROMOLECULES, V31, P4120, DOI 10.1021/ma980108n
   SAWHNEY AS, 1993, MACROMOLECULES, V26, P581, DOI 10.1021/ma00056a005
   SAWHNEY AS, 1994, J BIOMED MATER RES, V28, P831, DOI 10.1002/jbm.820280710
   SVALDIMUGGLI D, 1998, J BIOMED MATER RES, V36, P271
   TAMADA Y, 1993, J COLLOID INTERF SCI, V155, P334, DOI 10.1006/jcis.1993.1044
NR 28
TC 58
Z9 59
U1 1
U2 7
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0887-624X
J9 J POLYM SCI POL CHEM
JI J. Polym. Sci. Pol. Chem.
PD MAR 1
PY 2001
VL 39
IS 5
BP 683
EP 692
DI 10.1002/1099-0518(20010301)39:5<683::AID-POLA1040>3.0.CO;2-Z
PG 10
WC Polymer Science
SC Polymer Science
GA 400YZ
UT WOS:000166901400011
DA 2018-10-20
ER

PT J
AU Park, HK
   Dujovny, M
   Agner, C
   Diaz, FG
AF Park, HK
   Dujovny, M
   Agner, C
   Diaz, FG
TI Biomechanical properties of calvarium prosthesis
SO NEUROLOGICAL RESEARCH
LA English
DT Article
DE calvarial defect; cranioplasty; bone graft; hydroxyapatite; metallic
   graft; polymer graft; polymethylmethacrylate; finite element analysis
ID CEREBRAL BLOOD-FLOW; SKULL DEFECTS; CRANIOPLASTY; RECONSTRUCTION;
   STEREOLITHOGRAPHY; IMPLANTS; SURGERY; REPAIR; CT
AB There are many materials available for the reconstruction of calvarial defects. Even though their biomaterial properties are well known, the biomechanical properties as part of the calvarium have not been investigated. In this article, calvarial implants are reviewed with their historic development into modern cranioplasty. Materials for trephined skulls are classified by their category. Individual parameters to describe their mechanical properties are collected and revealed in detail. The laboratory testing methodology for cranioplasty material is introduced to understand each parameter. At last, we discuss an engineering technique to look into the implant behavior. Since there is no standard goal for the biomechanical and biomaterial point of view for cranioplasty, this article suggests the finite element method for evaluation of the implant behavior and the degree of damage upon the impact injury.
C1 Wayne State Univ, Sch Med, Dept Neurosurg, Biomech Lab, Detroit, MI 48201 USA.
   Albany Med Sch, Dept Neurol, New York, NY USA.
RP Park, HK (reprint author), Wayne State Univ, Sch Med, Dept Neurosurg, Biomech Lab, 550 E Canfield Ave,Rm 38, Detroit, MI 48201 USA.
CR ADAMS JS, 1991, APPL BIOMATERIALS FA, P271
   Agner C, 1997, CRIT REV NEUROSURG, V7, P365, DOI 10.1007/s003290050048
   Agner C, 1998, SKULL BASE SURG, V8, P81, DOI 10.1055/s-2008-1058580
   Asenjo A, 1963, NEUROSURGICAL TECHNI
   BELLOSTE A, 1732, HOSP SURG
   BENZEL EC, 1990, NEURORADIOLOGY, V32, P151, DOI 10.1007/BF00588566
   BILL JS, 1995, INT J ORAL MAX SURG, V24, P98, DOI 10.1016/S0901-5027(05)80869-0
   Broca P, 1875, B SOC ANTHR, V10, P326
   BROTHWELL D, 1967, SURVEY DIS INJURIES
   BURRELL HL, 1888, BOSTON MED SURG J, V118, P313
   Costantino P D, 1993, Facial Plast Surg, V9, P1, DOI 10.1055/s-2008-1064591
   COURVILLE C B, 1959, Bull Los Angel Neuro Soc, V24, P1
   DATTILO DJ, 1994, J TRAUMA, V36, P691, DOI 10.1097/00005373-199405000-00016
   Dujovny M, 1997, SURG NEUROL, V47, P238, DOI 10.1016/S0090-3019(96)00013-4
   Dujovny M, 1997, NEUROL RES, V19, P311, DOI 10.1080/01616412.1997.11740818
   DUJOVNY M, 1998, NEUROSURGICAL TOPIC, P77
   DUJOVNY M, 1997, SURG NEUROL 1997, V43
   Ella S, 1874, MED TIMES, V1, P50
   ENGLAND I, 1962, RADIOGRAPHY, V27, P301
   EUFINGER H, 1995, INT J ORAL MAX SURG, V24, P104, DOI 10.1016/S0901-5027(05)80870-7
   EUFINGER H, 1995, J CRANIO MAXILL SURG, V23, P175, DOI 10.1016/S1010-5182(05)80007-1
   FODSTAD H, 1984, ACTA NEUROCHIR, V70, P21, DOI 10.1007/BF01406039
   Freeman L, 1918, J AMER MED ASSOC, V70, P443, DOI 10.1001/jama.1918.02600070017007
   Gerster A., 1895, T AM SURG ASS, V13, P485
   Gore R, 1996, NATL GEOGR, V189, P2
   Granthan E, 1947, J NEUROSURG, V5, P19
   GUARDJIAN ES, 1947, AM J SURG, V73, P269
   HAMER S, 1993, AM J OTOL, V14, P552
   HAMER SG, 1995, NEUROSURGERY, V36, P1097
   Hrdlicka A., 1939, CIBA F S, V1, P170
   Jacobs P., 1996, STEREOLITHOGRAPHY OT
   Jacobs PF, 1992, RAPID PROTOTYPING MA
   Keeley L. H, 1996, WAR BEFORE CIVILIZAT
   Kevles BH, 1997, NAKED BONE MED IMAGI
   Kubler N, 1995, J CRANIO MAXILL SURG, V23, P337, DOI 10.1016/S1010-5182(05)80128-3
   KVETON JF, 1995, LARYNGOSCOPE, V105, P156, DOI 10.1288/00005537-199502000-00008
   LINNEY A, BIOSTEREOMETRIC TECH, V1990, P190
   MALLIN R, 1976, B NEW YORK ACAD MED, V52, P782
   MEEKEREN J. J., 1682, OBSERVATIONES MEDICO
   Mitchell AB, 1917, BRIT J SURG, V5, P40, DOI 10.1002/bjs.1800051705
   MOODIE R, 1919, SURG CLIN CHIC, V3, P481
   Morton S.G., 1839, CRANIA AMERICANA COM
   MUNIZ M, 1894, ANN REP BUR ETHNOL, V16, P1
   Mynors R, 1785, HIST PRACTICE TREPAN
   NAHUM AM, 1975, LARYNGOSCOPE, V85, P140, DOI 10.1288/00005537-197501000-00011
   Oakley K, 1959, MAN, V59, P92
   Ortner D. J., 1981, IDENTIFICATION PATHO
   Park H, 1999, P SOC PHOTO-OPT INS, V3870, P354, DOI 10.1117/12.373203
   Park HK, 2001, CHILD NERV SYST, V17, P87, DOI 10.1007/s003819900245
   PARK HK, 2000, 19 SO BIOM ENG C 200, P73
   PARK HK, 2000, MED PHYS, V27, P1446
   PARK HK, 1999, IMPACT DISPLACEMENT, P93
   PARK HK, 1999, IMPACT ABSORPTION PA, P359
   PARK HK, 2000, BIOMECHANICAL ANAL P
   PARK HK, BIOMEDICALS SCI INST, V36, P269
   PARRY T, 1931, LANCET, V2, P1388
   Parry TW, 1936, MAN, V36, P170, DOI 10.2307/2789927
   Piggott S., 1940, P PREHIST SOC, V6, P112
   PROLO DJ, 1991, CLIN ORTHOP RELAT R, P270
   RICHARDS GD, 1995, AM J PHYS ANTHROPOL, V98, P203, DOI 10.1002/ajpa.1330980209
   RICHAUD J, 1985, NEUROCHIRURGIE, V31, P183
   Rogers S L, 1985, PRIMITIVE SURG SKILL
   Ruffer MA, 1918, J PATHOL BACTERIOL, V22, P90
   SADLER L, BIOSTEREOMETRIC TECH, V1990, P137
   Sanan A, 1997, NEUROSURGERY, V40, P588, DOI 10.1097/00006123-199703000-00033
   SAUNDERS RC, 1993, J NEUROSCI METH, V47, P163, DOI 10.1016/0165-0270(93)90078-6
   SCALES J T, 1953, Proc R Soc Med, V46, P647
   SCHESSEL DA, 1992, OTOLARYNG HEAD NECK, V107, P424, DOI 10.1177/019459989210700314
   STEWART TD, 1957, ANN REP SMITHSONIAN, P469
   TABADDOR K, 1976, J NEUROSURG, V44, P506, DOI 10.3171/jns.1976.44.4.0506
   Tello Julio C., 1929, ANTIGUO PERU PRIMERA
   TYSON R, 1980, 357 SAN DIEG MUS MAN
   VANPUTTEN MC, 1992, J PROSTHET DENT, V68, P103, DOI 10.1016/0022-3913(92)90294-K
   WITHINGTON E, 1927, HIPPOCRATES
   WOOD JL, 1971, J BIOMECH, V4, P1, DOI 10.1016/0021-9290(71)90010-8
   Woolf J, 1945, INT ABSTR SURG, V81, P1
   Yoshida K, 1996, J NEUROL NEUROSUR PS, V61, P166, DOI 10.1136/jnnp.61.2.166
NR 77
TC 40
Z9 40
U1 0
U2 4
PU MANEY PUBLISHING
PI LEEDS
PA STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND
SN 0161-6412
J9 NEUROL RES
JI Neurol. Res.
PD MAR-APR
PY 2001
VL 23
IS 2-3
BP 267
EP 276
DI 10.1179/016164101101198424
PG 10
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 422DX
UT WOS:000168104200020
PM 11320607
DA 2018-10-20
ER

PT J
AU Goldenberg, RA
   Emmet, JR
AF Goldenberg, RA
   Emmet, JR
TI Current use of implants in middle ear surgery
SO OTOLOGY & NEUROTOLOGY
LA English
DT Article
DE implants; middle ear surgery; ossiculoplasty; stapedectomy
ID OSSICULAR RECONSTRUCTION; REPLACEMENT PROSTHESES; TYMPANOPLASTY;
   HYDROXYLAPATITE; EXPERIENCE; INCUS
AB Objective: The authors report the results of a survey of members of the American Otological Society (AOS) and the American Neurotology Society (ANS) regarding their use of prostheses currently available for ossiculoplasty and stapedectomy. These findings are compared with a similar study presented by one of the authors in 1989.
   Methods: Questionnaires were sent to the entire membership of the AOS and ANS with questions regarding biomaterial and prosthesis usage for stapes and chronic ear surgery, as well as satisfaction with each type of prosthesis used. Of the 575 questionnaires mailed, 274 (47%) were returned. Only 248 of the respondents performed middle ear surgery (43%), and their responses constitute the database for this study.
   Results: For those respondents performing stapes surgery in both 1989 and 1999, the mean number of cases per year has increased from 32 to 37 (p less than or equal to 0.004). The mean number of chronic ear cases has also increased from 95 in 1989 to 110 in 1999 (p less than or equal to 0.001), As a biomaterial, hydroxyapatite prostheses are used by most surgeons (82%), followed by autograft and homograft bone (72%), autograft and homograft cartilage (62%), and Plastipore (59%). (Although 62% of respondents use cartilage, only 4.4% ranked it first in preference.) In 1989, bone was used most (93%), followed by cartilage (78%) and Plastipore (81%). Hydroxyapatite, which had just been introduced as a biomaterial, was used by only 9% of respondents. For stapes prostheses in 1999, the majority of respondents used stainless steel/platinum (71%), bucket handle (69%), or partial fluoroplastic (56%) prostheses. There was a high overall satisfaction rate in the use of most of these prostheses (> 85%), with several exceptions. The lowest satisfaction rate was 71% for Plastipore partial ossicular replacement prosthesis and total ossicular replacement prosthesis. Usage and satisfaction rates are presented for specific types of implants and compared with the earlier survey findings.
   Conclusion: The current use of implants in middle ear surgery demonstrates a specific pattern with a high degree of user satisfaction. The preference for implants by respondents has remained stable over the past 10 years; there has been a decrease in the percentage of use of bone, cartilage, and Plastipore with a corresponding increase in the use of hydroxyapatite.
C1 Wright State Univ, Sch Med, Dept Otolaryngol, Dayton, OH 45435 USA.
   Univ N Carolina, Sch Med, Dept Otolaryngol, Chapel Hill, NC 27514 USA.
   Univ Tennessee, Ctr Hlth Sci, Sch Med, Dept Otolaryngol, Memphis, TN 38163 USA.
RP Goldenberg, RA (reprint author), 111 W 1st St,Suite 600, Dayton, OH 45402 USA.
CR ARMSTRONG BW, 1969, ANN OTO RHINOL LARYN, V78, P939, DOI 10.1177/000348946907800503
   Austin D F, 1972, Otolaryngol Clin North Am, V5, P145
   AUSTIN D F, 1961, Laryngoscope, V71, P596
   AUSTIN DF, 1971, ARCHIV OTOLARYNGOL, V94, P525
   AUSTIN DF, 1963, OTOLRAYNGOL HEAD NEC, V67, P198
   BAUER M, 1966, ARCHIV OTOLARYNGOL, V83, P335
   BLACK B, 1990, AM J OTOL, V11, P85
   BRACKMANN DE, 1979, LARYNGOSCOPE, V89, P108
   BROCKMAN SJ, 1965, LARYNGOSCOPE, V75, P1452
   Colletti V, 1999, OTOLARYNG HEAD NECK, V120, P437, DOI 10.1016/S0194-5998(99)70288-3
   DEMANE CQ, 1995, OTOLARYNG CLIN N AM, V28, P225
   EMMETT JR, 1989, AM J OTOL, V10, P215
   EMMETT JR, 1986, OTOLARYNG HEAD NECK, V94, P611
   FARRIOR JB, 1960, ARCHIV OTOLARYNGOL, V71, P443
   FREDERICKSON J, 1985, AM OTOLOGICAL SOC
   GARCIAIBANEZ L, 1965, ARCHIV OTOLARYNGOL, V82, P340
   GOLDENBERG RA, 1990, LARYNGOSCOPE, V100, P693
   GOLDENBERG RA, 1992, OPER TECH OTOLARYNGO, V3, P225
   GOODHILL V, 1967, ARCHIV OTOLARYNGOL, V85, P480
   GROTE JJ, 1984, ARCH OTOLARYNGOL, V110, P197
   GROTE JJ, 1995, AM J OTOL, V16, P797
   GROTE JJ, 1986, ANN OTO RHINOL LARYN, V95, P1
   GUILFORD FR, 1965, LARYNGOSCOPE, V75, P236
   HALL A, 1957, Acta Otolaryngol, V47, P318
   HARRIS I, 1967, LARYNGOSCOPE, V77, P1191, DOI 10.1288/00005537-196707000-00011
   HARRISON JH, 1956, ARCH SURG-CHICAGO, V82, P138
   HARRISON WH, 1959, ARCHIV OTOLARYNGOL, V69, P661
   HARRISON WH, 1969, ARCH OTOLARYNGOL, V96, P525
   HAYDEN GD, LARYNGOSCOPE, V71, P5054
   HICKS GW, 1978, LARYNGOSCOPE, V88, P1024, DOI 10.1288/00005537-197806000-00015
   Homsy C A, 1973, Orthop Clin North Am, V4, P295
   HOMSY CA, 1972, CLIN ORTHOP RELAT R, P220
   HOMSY CA, 1973, J AM DENT ASSOC, V86, P817, DOI 10.14219/jada.archive.1973.0166
   HOUSE HP, 1960, ARCHIV OTOLARYNGOL, V71, P926
   HOUSE WF, 1966, ARCHIV OTOLARYNGOL, V84, P148
   HOUSE WF, 1963, ARCH OTOLARYNGOL, V78, P98
   HUGHES GB, 1989, P 3 INT C CHOL MAST, P1127
   Jansen C, 1972, Otolaryngol Clin North Am, V5, P97
   JANSEN C, 1963, Laryngoscope, V73, P1288
   JANSEN C, 1958, S B FORTBILD AZTEK O, V2, P18
   LESINSKI SG, 1977, OTOLARYNG CLIN N AM, V10, P613
   MULLISON EG, 1966, ARCH OTOLARYNGOL, V84, P113
   PALVA T, 1973, ARCH OTOLARYNGOL, V98, P340
   PALVA T, 1971, ANN OTO RHINOL LARYN, V80, P760, DOI 10.1177/000348947108000519
   Perkins R, 1970, Trans Am Acad Ophthalmol Otolaryngol, V74, P278
   PLESTER D, 1961, LARYNGOL OTOL, V75, P879
   PULEC JL, 1973, LARYNGOSCOPE, V83, P448, DOI 10.1288/00005537-197304000-00002
   SCHURING AG, 1982, OTOLARYNG HEAD NECK, V90, P629, DOI 10.1177/019459988209000523
   SHEA J, 1976, LARYNGOSCOPE, V86, P239, DOI 10.1288/00005537-197602000-00015
   SHEA J J, 1960, Northwest Med, V59, P770
   SHEA JJ, 1974, LARYNGOSCOPE, V84, P1835, DOI 10.1288/00005537-197410000-00014
   SHEA JJ, 1977, ORL DIGEST, V39, P9
   SHEA JJ, 1958, MEMPHIS MED, V33, P271
   SHEEHY JL, 1973, LARYNGOSCOPE, V83, P1144, DOI 10.1288/00005537-197307000-00018
   SHEEHY JL, 1965, ARCHIV OTOLARYNGOL, V81, P115
   SILVERSTEIN H, 1985, TRIOLOGICAL SOC MIAM
   SMITH M F W, 1972, Transactions of the American Academy of Ophthalmology and Oto-Laryngology, V76, P134
   SMYTH DGL, 1972, OTOLARYNGOL CLIN N A, V5, P111
   SMYTH GDL, 1977, OTOLARYNG CLIN N AM, V10, P563
   WALTNER JG, 1966, ARCHIV OTOLARYNGOL, V83, P339
   WEHRS RE, 1974, ARCH OTOLARYNGOL, V100, P251
   WEHRS RE, 1985, LARYNGOSCOPE, V95, P1301
   WEHRS RE, 1982, LARYNGOSCOPE, V92, P540
   WEHRS RE, 1995, OTOLARYNG CLIN N AM, V28, P273
   WEHRS RE, 1989, AM J OTOL, V10, P181
   WOLFERMAN A, 1970, RECONSTRUCTIVE SURG, P143
   WULLSTEIN H, 1956, Laryngoscope, V66, P1076
   ZOLLNER F, 1955, J Laryngol Otol, V69, P637, DOI 10.1017/S0022215100051240
NR 68
TC 43
Z9 47
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1531-7129
EI 1537-4505
J9 OTOL NEUROTOL
JI Otol. Neurotol.
PD MAR
PY 2001
VL 22
IS 2
BP 145
EP 152
DI 10.1097/00129492-200103000-00005
PG 8
WC Clinical Neurology; Otorhinolaryngology
SC Neurosciences & Neurology; Otorhinolaryngology
GA 413GE
UT WOS:000167601300005
PM 11300260
DA 2018-10-20
ER

PT J
AU Yang, JM
   Lai, WC
   Lin, HT
AF Yang, JM
   Lai, WC
   Lin, HT
TI Properties of HTPB based polyurethane membrane prepared by epoxidation
   method
SO JOURNAL OF MEMBRANE SCIENCE
LA English
DT Article
DE hydroxyl terminated polybutadiene; polyurethane; epoxidation; surface
   tension; protein adsorption; gas permeation
ID SBS-G-VP; STYRENE BLOCK-COPOLYMER; HYDROXYL-TERMINATED POLYBUTADIENE;
   OXYGEN PERMEATION; BIOMATERIAL USAGE; GAS-PERMEABILITY; RADIATION;
   HEPARIN
AB Hydroxyl-terminated polybutadiene (HTPB) based polyurethane (PU) was synthesized by solution polymerization. The PU was then cast into membrane. The epoxidation of HTPB based PU membrane by an in situ generated peracid method is discussed. The chemical composition of the epoxidized PU membrane was studied by infrared spectroscopy. The absorption peak at 970 cm(-1) for the C=C double bond decreased with epoxidation time whereas the absorption peak at 1183 cm(-1) for oxirane group increased. The absorption peak at about 1700-1740 cm(-1) for the C=O group and -OH group at about 3200-3700 cm(-1) increased with epoxidation time that indicated the side reaction of epoxidation took place. The oxirane weight content was determined by titration method. The density, tensile strength, elongations, and decomposition temperature of the epoxidized PU membranes were measured. The molecular weight between crosslinking points PU membrane was calculated. Contact angle and protein absorption of fibrinogen and albumin experiments were also determined. It was found that the density and the tensile strength of epoxidized PU membrane increased with increasing epoxidation time whereas the molecular weight between crosslinking points, elongation and the amount of protein adsorption on the epoxidized PU membrane decreased. By using Kaelble's equation and the contact angle data, the surface tension of epoxidized PU membrane was determined. It was found that the surface tension of epoxidized PU membrane increased whereas the contact angle decreased with epoxidation time. The property changes reduced the permeability of gas through epoxidized PU membrane, but increased the gas selectivity between oxygen and nitrogen. The activation energies (E-p) for gas diffusing through various epoxidized PU membranes were obtained by the Arrhenius law; it is evident that E-p increased with the extent of epoxidation. (C) 2001 Elsevier Science B.V. All rights reserved.
C1 Chang Gung Univ, Dept Chem & Mat Engn, Tao Yuan 333, Taiwan.
RP Yang, JM (reprint author), Chang Gung Univ, Dept Chem & Mat Engn, Tao Yuan 333, Taiwan.
CR GALLAND G, 1993, J APPL POLYM SCI, V50, P1041, DOI 10.1002/app.1993.070500613
   HSIUE GH, 1990, J POLYM SCI POL CHEM, V28, P3363, DOI 10.1002/pola.1990.080281215
   HSIUE GH, 1990, J POLYM SCI POL CHEM, V28, P3761, DOI 10.1002/pola.1990.080281319
   HSIUE GH, 1991, MAKROMOL CHEM, V192, P2687
   HUANG SL, 1995, J MEMBRANE SCI, V105, P137, DOI 10.1016/0376-7388(94)00319-T
   HUANG SL, 1995, J APPL POLYM SCI, V58, P1913, DOI 10.1002/app.1995.070581029
   KAELBLE DH, 1977, POLYMER, V18, P475, DOI 10.1016/0032-3861(77)90164-1
   Machin D., 1970, ENCY POLYM SCI TECHN, V12, P679
   MINOURA Y, 1978, J APPL POLYM SCI, V22, P1817, DOI 10.1002/app.1978.070220707
   NINAN KN, 1991, POLYMER, V32, P628, DOI 10.1016/0032-3861(91)90474-W
   REGAN PR, 1985, BRIT POLYM J, V17, P22, DOI 10.1002/pi.4980170106
   TRELOAR LRG, 1958, PHYSICS RUBBER ELAST
   YANG JM, 1991, MACROMOLECULES, V24, P4010, DOI 10.1021/ma00014a007
   YANG JM, 1994, J MEMBRANE SCI, V87, P233, DOI 10.1016/0376-7388(94)87030-6
   YANG JM, 1990, ANGEW MAKROMOL CHEM, V179, P99, DOI 10.1002/apmc.1990.051790108
   Yang JM, 1996, J BIOMED MATER RES, V31, P281
   Yang JM, 1998, J MEMBRANE SCI, V138, P19
   Yang JM, 1997, J BIOMED MATER RES, V35, P175, DOI 10.1002/(SICI)1097-4636(199705)35:2<175::AID-JBM5>3.0.CO;2-K
   Yang JM, 1997, J APPL POLYM SCI, V65, P109
   YANG JM, 1990, J APPL POLYM SCI, V39, P1475, DOI 10.1002/app.1990.070390706
   Yang JM, 1997, J MEMBRANE SCI, V128, P133, DOI 10.1016/S0376-7388(96)00312-2
   Yang JM, 1998, J BIOMED MATER RES, V39, P86, DOI 10.1002/(SICI)1097-4636(199801)39:1<86::AID-JBM11>3.0.CO;2-M
   Yang JM, 1999, J MEMBRANE SCI, V153, P175, DOI 10.1016/S0376-7388(98)00261-0
   YANG JM, 1990, J APPL POLYM SCI, V41, P1141, DOI 10.1002/app.1990.070410523
   YASUDA H, 1968, ENCY POLYM SCI TECHN, V9, P794
NR 25
TC 33
Z9 39
U1 2
U2 20
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0376-7388
J9 J MEMBRANE SCI
JI J. Membr. Sci.
PD FEB 28
PY 2001
VL 183
IS 1
BP 37
EP 47
DI 10.1016/S0376-7388(00)00550-0
PG 11
WC Engineering, Chemical; Polymer Science
SC Engineering; Polymer Science
GA 401UW
UT WOS:000166947500004
DA 2018-10-20
ER

PT J
AU Tong, HH
   Monteiro, OR
   Brown, IG
AF Tong, HH
   Monteiro, OR
   Brown, IG
TI Effects of carbon ion pre-implantation on the mechanical properties of
   ta-C coatings on Ti-6Al-4V
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT 5th International Workshop on Plasma-Based Ion Implantation (PBII-99)
CY DEC 13-16, 1999
CL SEIKA, JAPAN
SP Sci & Technol Agcy, Japan Int Sci & Technol Exchange Ctr, Osaka Natl Res Inst
DE ion implantation; ta-c; biomaterial coatings; cathodic arc deposition;
   ion mixing; diamond-like carbon
ID CATHODIC-ARC DEPOSITION; DIAMOND-LIKE CARBON; METAL PLASMA;
   ELASTIC-MODULUS; THIN-FILMS; VACUUM
AB We report on our investigations of the effects of carbon ion implantation into Ti-6Al-4V as a pre-treatment process prior to deposition of ra-C coatings using a filtered cathodic are plasma method. A transition layer is formed that can be either TiC or TiC + C, providing an excellent interface for highly adherent ta-C coatings. We find that a smoothly-graded interface leads to good film-substrate adhesion, while ta-C films formed without a graded interface show poor adhesion. The film microhardness and wear performance are related to the implantation parameters via the thickness of the transition layer. Carbon ion implantation provides an effective pre-treatment method for ta-C coated Ti-6Al-4V substrate material. (C) 2001 Elsevier Science B.V. All rights reserved.
C1 Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA.
RP Brown, IG (reprint author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA.
EM igbrown@lbl.gov
CR Anders A, 1997, SURF COAT TECH, V93, P158, DOI 10.1016/S0257-8972(97)00037-6
   ANDERS S, 1994, SURF COAT TECH, V68, P388, DOI 10.1016/0257-8972(94)90191-0
   ANDERS S, 1997, DATA STORAGE, V4, P31
   Baba K, 1998, SURF COAT TECH, V104, P235, DOI 10.1016/S0257-8972(98)00401-0
   BIERSACK JP, 1991, NUCL INSTRUM METH B, V59, P21, DOI 10.1016/0168-583X(91)95167-C
   BLECH IA, 1993, J VAC SCI TECHNOL A, V11, P728, DOI 10.1116/1.578800
   Brown IG, 1998, ANNU REV MATER SCI, V28, P243, DOI 10.1146/annurev.matsci.28.1.243
   BROWN IG, 1993, NUCL INSTRUM METH B, V80-1, P1281, DOI 10.1016/0168-583X(93)90782-2
   BROWN IG, 1994, REV SCI INSTRUM, V65, P3061, DOI 10.1063/1.1144756
   BROWN IG, 1992, SURF COAT TECH, V51, P529, DOI 10.1016/0257-8972(92)90293-J
   Brown IG, 1999, SURF COAT TECH, V112, P271, DOI 10.1016/S0257-8972(98)00769-5
   Chiang SS, 1981, SURFACES INTERFACES, P603
   Delplancke-Ogletree MP, 1998, SURF COAT TECH, V108, P484, DOI 10.1016/S0257-8972(98)00572-6
   EVANS HE, 1984, CORROS SCI, V24, P209, DOI 10.1016/0010-938X(84)90051-9
   Fan QH, 1998, J APPL PHYS, V83, P5588, DOI 10.1063/1.367399
   Ignatius MJ, 1998, J BIOMED MATER RES, V40, P264, DOI 10.1002/(SICI)1097-4636(199805)40:2<264::AID-JBM11>3.3.CO;2-N
   Lifshitz Y, 1999, DIAM RELAT MATER, V8, P1659, DOI 10.1016/S0925-9635(99)00087-4
   Littmark U., 1985, STOPPING RANGE IONS, V1
   MacGill RA, 1998, REV SCI INSTRUM, V69, P801, DOI 10.1063/1.1148718
   Monteiro OR, 1999, NUCL INSTRUM METH B, V148, P12, DOI 10.1016/S0168-583X(98)00685-5
   Pharr GM, 1996, APPL PHYS LETT, V68, P779, DOI 10.1063/1.116530
   Tay BK, 1997, THIN SOLID FILMS, V308, P199, DOI 10.1016/S0040-6090(97)00430-6
   TOULOUKIAN YS, 1975, THERMALOPHYSICAL PRO, V12, P1272
   Viviente JL, 1999, APPL SURF SCI, V144-45, P249, DOI 10.1016/S0169-4332(98)00806-X
   Voevodin AA, 1997, THIN SOLID FILMS, V298, P107, DOI 10.1016/S0040-6090(96)09145-6
   Yin GF, 1999, THIN SOLID FILMS, V345, P67, DOI 10.1016/S0040-6090(99)00076-0
NR 26
TC 15
Z9 16
U1 0
U2 2
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD FEB 2
PY 2001
VL 136
IS 1-3
BP 211
EP 216
DI 10.1016/S0257-8972(00)01058-6
PG 6
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 393JF
UT WOS:000166464900044
DA 2018-10-20
ER

PT J
AU Gastel, JA
   Muirhead, WR
   Lifrak, JT
   Fadale, PD
   Hulstyn, MJ
   Labrador, DP
AF Gastel, JA
   Muirhead, WR
   Lifrak, JT
   Fadale, PD
   Hulstyn, MJ
   Labrador, DP
TI Meniscal tissue regeneration using a collagenous biomaterial derived
   from porcine small intestine submucosa
SO ARTHROSCOPY-THE JOURNAL OF ARTHROSCOPIC AND RELATED SURGERY
LA English
DT Article
DE meniscus; meniscal regeneration; meniscal repair; animal study;
   collagenous graft; small intestine submucosa
ID MENISCECTOMY; KNEE; REPAIR; RABBITS; INVIVO; GRAFT; DOG
AB Purpose: The present investigation is a preliminary study designed to evaluate the use of a collagen-based biomaterial, chemically unaltered porcine small intestine submucosa (SIS), as a scaffold for meniscal tissue regeneration. Type of Study: Basic research. Methods: Surgical defects were created in the lateral menisci of 12 mature New Zealand white rabbits. The defects were repaired with a similarly shaped and sized wedge of a new collagenous biomaterial (SIS) and sutured in place. The opposite knees served as controls by creating a defect in the lateral meniscus without filling with SIS graft. Full cage activity was allowed until the animals were killed at 4, 12, and 24 weeks. Results: At 4 weeks, the graft material retained its physical position and grossly appeared soft and translucent. Histologically, cellular elements had infiltrated between the laminates of the graft. At 12 weeks, the graft grossly appeared more solid and opaque. Histologically, the host meniscal fibrochondrocytes were seen streaming into the peripheral margin of the graft. Early repopulation of the graft with apparently differentiated meniscal tissue was observed. At 24 weeks, the meniscus defect was grossly healed across and looked virtually normal: the normal meniscal shape, contour, consistency, and color had been replicated. Histologically, the healing tissue showed infiltration of what appeared to be meniscal fibrochondrocytes and connective tissue resembling the host meniscal tissue. The graft was nearly totally replaced by host tissue. Conclusions: This pilot animal study demonstrates that the multilaminated collagenous graft is conducive for cellular repopulation with host meniscal elements, and, by 24 weeks, is capable of supporting complete healing of a large meniscal defect.
C1 Brown Univ, Rhode Isl Hosp, Dept Orthopaed, Providence, RI 02903 USA.
RP Fadale, PD (reprint author), 2 Dudley St, Providence, RI 02903 USA.
CR AIKEN SW, 1994, VCOT, V37, P124
   ARNOCZKY SP, 1988, J BONE JOINT SURG AM, V70A, P1209, DOI 10.2106/00004623-198870080-00012
   ARNOCZKY SP, 1988, J ORTHOP RES, V6, P1, DOI 10.1002/jor.1100060102
   ARNOCZKY SP, 1988, ORTHOP T, V12, P431
   Arnoczky SP, 1988, INJURY REPAIR MUSCUL, P487
   ARNOCZKY SP, 1990, ARTICULAR CARTILAGE
   BADYLAK SF, 1989, J SURG RES, V47, P74, DOI 10.1016/0022-4804(89)90050-4
   BARATZ ME, 1986, AM J SPORT MED, V14, P270, DOI 10.1177/036354658601400405
   CANNON WD, 1992, AM J SPORT MED, V20, P176, DOI 10.1177/036354659202000214
   CISA J, 1995, ACTA ORTHOP SCAND, V66, P38, DOI 10.3109/17453679508994636
   CZITROM AA, 1990, J BONE JOINT SURG AM, V72A, P574, DOI 10.2106/00004623-199072040-00016
   FAIRBANK TJ, 1948, J BONE JOINT SURG BR, V30, P664
   JACKSON DW, 1992, J BONE JOINT SURG AM, V74A, P112, DOI 10.2106/00004623-199274010-00014
   King D, 1936, J BONE JOINT SURG, V18, P333
   KRAUSE WR, 1976, J BONE JOINT SURG AM, V58, P599, DOI 10.2106/00004623-197658050-00003
   Kropp B P, 1995, Urology, V46, P396, DOI 10.1016/S0090-4295(99)80227-1
   Lantz G C, 1990, J Invest Surg, V3, P217, DOI 10.3109/08941939009140351
   LANTZ GC, 1992, J SURG RES, V53, P175, DOI 10.1016/0022-4804(92)90031-T
   LEVY IM, 1982, J BONE JOINT SURG AM, V64, P883, DOI 10.2106/00004623-198264060-00011
   MCGINTY JB, 1977, J BONE JOINT SURG AM, V59, P763, DOI 10.2106/00004623-197759060-00008
   MILACHOWSKI KA, 1989, INT ORTHOP, V13, P1
   PREVEL CD, 1995, ANN PLAS SURG, V35, P374, DOI 10.1097/00000637-199510000-00008
   SANDUSKY GE, 1992, AM J PATHOL, V140, P317
   SEEDHOM BB, 1974, J BONE JOINT SURG BR, VB 56, P381
   SHOEMAKER SC, 1986, J BONE JOINT SURG AM, V68A, P71, DOI 10.2106/00004623-198668010-00009
   Shrive N G, 1978, Clin Orthop Relat Res, P279
   SOMMERLATH K, 1992, AM J SPORT MED, V20, P73, DOI 10.1177/036354659202000117
   STONE KR, 1992, AM J SPORT MED, V20, P104, DOI 10.1177/036354659202000202
   Walker P S, 1975, Clin Orthop Relat Res, P184, DOI 10.1097/00003086-197506000-00027
   YANNAS IV, 1980, J BIOMED MATER RES, V14, P65, DOI 10.1002/jbm.820140108
NR 30
TC 51
Z9 60
U1 0
U2 7
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0749-8063
EI 1526-3231
J9 ARTHROSCOPY
JI Arthroscopy
PD FEB
PY 2001
VL 17
IS 2
BP 151
EP 159
DI 10.1053/jars.2001.20959
PG 9
WC Orthopedics; Sport Sciences; Surgery
SC Orthopedics; Sport Sciences; Surgery
GA 399ZF
UT WOS:000166843600006
PM 11172244
DA 2018-10-20
ER

PT J
AU Trindade, MCD
   Lind, M
   Sun, D
   Schurman, DJ
   Goodman, SB
   Smith, RL
AF Trindade, MCD
   Lind, M
   Sun, D
   Schurman, DJ
   Goodman, SB
   Smith, RL
TI In vitro reaction to orthopaedic biomaterials by macrophages and
   lymphocytes isolated from patients undergoing revision surgery
SO BIOMATERIALS
LA English
DT Article
DE orthopaedic biomaterials; macrophages; lymphocytes; fibroblasts;
   revision surgery
ID BONE-RESORPTION; IN-VITRO; INFLAMMATORY RESPONSE; PARTICULATE DEBRIS;
   TITANIUM PARTICLES; INHIBITORY FACTOR; HIP-ARTHROPLASTY;
   POLYMETHYLMETHACRYLATE; CEMENT; INTERLEUKIN-4
AB Periprosthetic tissues observed at sites of loose total joint implants exhibit abundant macrophages, lymphocytes, fibroblasts and particulate debris. Macrophages phagocytose orthopaedic debris and release proinflammatory cytokines, chemokines, matrix metalloproteinases and other substances. In addition, other cell types present in tissues harvested from the bone-implant interface are thought to influence periprosthetic bone resorption. The present study examined the effects of polymethylmethacrylate (PMMA), cobalt chrome molybdenum alloy (CoCr), and titanium-alloy particle challenge on macrophages co-cultured with lymphocytes in vitro. Potential synergistic effects of lymphocytes on macrophage activation were determined by measuring interleukin-6 and tumor necrosis factor-a release following exposure to orthopaedic biomaterial particles. Exposure of macrophages or macrophages co-cultured with lymphocytes to all three types of particles resulted in increased release of interleukin-6 and tumor necrosis factor-a! at 48 h, when compared to macrophages or macrophages co-cultured with lymphocytes, respectively, cultured in the absence of particles. Lymphocytes isolated from periprosthetic tissues secreted increased basal levels of cytokines relative to peripheral blood lymphocytes. Higher doses of PMMA and titanium-alloy particles stimulated increased levels of cytokine release in the macrophage and macrophage/lymphocyte groups. In contrast, a higher dose of CoCr particles (0.075% v/v) was not as effective as the 0.015% v/v dose, indicating probable CoCr toxicity. The macrophage/lymphocyte co-culture did not show synergism between the two types of cells with respect to cytokine release. T-cells at the bone-implant interface may alter the biological response to particulate debris. (C) 2000 Elsevier Science Ltd. All rights reserved.
C1 Stanford Univ, Sch Med, Orthopaed Res Lab, Stanford, CA 94305 USA.
RP Goodman, SB (reprint author), Stanford Univ, Sch Med, Orthopaed Res Lab, 300 Pasteur Dr,R144, Stanford, CA 94305 USA.
CR Cassatella MA, 1997, EUR J IMMUNOL, V27, P111, DOI 10.1002/eji.1830270117
   CHIBA J, 1994, CLIN ORTHOP RELAT R, V300, P304
   DAVIS RG, 1993, J BIOMED MATER RES, V27, P1039, DOI 10.1002/jbm.820270809
   FREEMAN MAR, 1982, J BONE JOINT SURG BR, V64, P489
   GELB H, 1994, J ORTHOP RES, V12, P83, DOI 10.1002/jor.1100120111
   GILALBAROVA J, 1992, J BONE JOINT SURG BR, V74, P825
   GLANT TT, 1994, J ORTHOPAED RES, V12, P720, DOI 10.1002/jor.1100120515
   GLANT TT, 1993, J BONE MINER RES, V8, P1071
   GOLDRING SR, 1993, J BONE JOINT SURG AM, V75A, P799, DOI 10.2106/00004623-199306000-00001
   GONZALEZ O, 1995, T ORTHOP RES SOC, V20, P774
   GONZALEZ O, 1997, T ORTHOP RES SOC, V21, P504
   Goodman SB, 1996, J BIOMED MATER RES, V31, P421, DOI 10.1002/(SICI)1097-4636(199607)31:3<421::AID-JBM17>3.0.CO;2-L
   Goodman SB, 1997, CLIN ORTHOP RELAT R, P149, DOI 10.1097/00003086-199704000-00017
   Granchi D, 1998, J BONE JOINT SURG BR, V80B, P912, DOI 10.1302/0301-620X.80B5.8513
   GREIS PE, 1994, J ORTHOPAED RES, V12, P286, DOI 10.1002/jor.1100120219
   Haddad FS, 1996, J BONE JOINT SURG BR, V78B, P546
   HARRIS WH, 1976, J BONE JOINT SURG AM, V58, P612, DOI 10.2106/00004623-197658050-00005
   HERMAN JH, 1989, J BONE JOINT SURG AM, V71A, P1530, DOI 10.2106/00004623-198971100-00012
   Hernigou P, 1999, CLIN ORTHOP RELAT R, P147
   Hitchins VM, 1999, J BIOMED MATER RES, V46, P434
   Horowitz SM, 1996, CALCIFIED TISSUE INT, V59, P392, DOI 10.1007/s002239900145
   HOROWITZ SM, 1995, CALCIFIED TISSUE INT, V57, P301, DOI 10.1007/BF00298886
   HOROWITZ SM, 1988, J ORTHOPAED RES, V6, P827, DOI 10.1002/jor.1100060606
   Howie D W, 1990, J Arthroplasty, V5, P337, DOI 10.1016/S0883-5403(08)80093-9
   HSU JC, 1998, T ORTHOP RES SOC, V23, P125
   JAMES RE, 1995, T ORTHOP RES SOC, V20, P775
   JASTY MJ, 1986, J BONE JOINT SURG AM, V68A, P912, DOI 10.2106/00004623-198668060-00014
   JOHANSON NA, 1987, CLIN ORTHOP RELAT R, V218, P123
   KIM KJ, 1994, J BONE JOINT SURG AM, V76A, P172, DOI 10.2106/00004623-199402000-00002
   Lee SH, 1997, J ORTHOP RES, V15, P40, DOI 10.1002/jor.1100150107
   LEWIS DB, 1993, P NATL ACAD SCI USA, V90, P11618, DOI 10.1073/pnas.90.24.11618
   LIND M, 1995, CYTOKINE, V7, P78, DOI 10.1006/cyto.1995.1010
   Lind M, 1999, J BIOMED MATER RES, V48, P246, DOI 10.1002/(SICI)1097-4636(1999)48:3<246::AID-JBM7>3.0.CO;2-X
   Lind M, 1998, J BONE JOINT SURG BR, V80B, P924, DOI 10.1302/0301-620X.80B5.8710
   MALONEY WJ, 1995, J BONE JOINT SURG AM, V77, P1448, DOI 10.2106/00004623-199509000-00022
   MALONEY WJ, 1995, J BONE JOINT SURG AM, V77, P1301, DOI 10.2106/00004623-199509000-00002
   Maloney WJ, 1998, J BIOMED MATER RES, V41, P371, DOI 10.1002/(SICI)1097-4636(19980905)41:3<371::AID-JBM5>3.3.CO;2-A
   Mirra J M, 1976, Clin Orthop Relat Res, P221
   Moreschini O, 1997, J ARTHROPLASTY, V12, P695, DOI 10.1016/S0883-5403(97)90144-3
   MUNDY GR, 1993, J BONE MINER RES, V8, pS505
   MUNDY GR, 1995, HUMAN CYTOKINES THEI, P285
   Nakashima Y, 1998, J BONE JOINT SURG BR, V80B, P694, DOI 10.1302/0301-620X.80B4.8374
   Nakashima Y, 1999, J BONE JOINT SURG AM, V81A, P603, DOI 10.2106/00004623-199905000-00002
   Nakashima Y, 1999, J BONE JOINT SURG BR, V81B, P155, DOI 10.1302/0301-620X.81B1.8884
   POLLICE P, 1997, T ORTHOP RES SOC, V22, P728
   Pollice PF, 1998, J ORTHOP RES, V16, P697, DOI 10.1002/jor.1100160611
   RAGAB AA, 1998, T ORTHOP RES SOC, V23, P355
   Sabokbar A, 1996, ACTA ORTHOP SCAND, V67, P593, DOI 10.3109/17453679608997763
   SANTAVIRTA S, 1990, J BONE JOINT SURG AM, V72A, P252, DOI 10.2106/00004623-199072020-00014
   SANTAVIRTA S, 1991, J BONE JOINT SURG BR, V73, P38
   SCHMALZRIED TP, 1992, J BONE JOINT SURG AM, V74A, P849, DOI 10.2106/00004623-199274060-00006
   SCHMALZRIED TP, 1993, J ARTHROPLASTY, V8, P179
   SHANBHAG AS, 1995, J ORTHOPAED RES, V13, P792, DOI 10.1002/jor.1100130520
   SUN DH, 1997, T ORTHOP RES SOC, V22, P324
   SUN DH, 1997, T SOC BIOMATER, V20, P259
   Trindade MCD, 1999, J ORTHOP RES, V17, P797, DOI 10.1002/jor.1100170602
   Trindade MCD, 1999, J BIOMED MATER RES, V47, P1
   Trindade MCD, 1999, J BIOMED MATER RES, V48, P434, DOI 10.1002/(SICI)1097-4636(1999)48:4<434::AID-JBM6>3.0.CO;2-Y
   TRINDADE MCD, 1998, T ORTHOP RES SOC, V23, P176
   UENO K, 1992, BIOCHEM BIOPH RES CO, V189, P1521, DOI 10.1016/0006-291X(92)90248-J
   VAES G, 1988, CLIN ORTHOP RELAT R, P239
   WILLERT HG, 1981, TRIBOLOGY NATURAL AR
NR 62
TC 53
Z9 55
U1 0
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2001
VL 22
IS 3
BP 253
EP 259
DI 10.1016/S0142-9612(00)00181-2
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 390NR
UT WOS:000166303300008
PM 11197500
DA 2018-10-20
ER

PT J
AU Ma, JB
   Wang, HJ
   He, BL
   Chen, JT
AF Ma, JB
   Wang, HJ
   He, BL
   Chen, JT
TI A preliminary in vitro study on the fabrication and tissue engineering
   applications of a novel chitosan bilayer material as a scaffold of human
   neofetaf dermal fibroblasts
SO BIOMATERIALS
LA English
DT Article
DE chitosan; bilayer biomaterial; human neofetal dermal fibroblast; skin
   tissue engineering
ID ARTIFICIAL SKIN; DESIGN
AB The bilayer structure of chitosan him and sponge was designed as a scaffold of skin tissue engineering and a dermis substitute. It was processed successively via the formation of a dense chitosan him by casting method and a porous chitosan sponge by lyophilization. The dry thickness of the him layer was 19.6 mum and that of the sponge layer was controlled at 60-80 mum. Porogens such as sodium chloride, glucose, and sucrose were used to create large pores of the chitosan sponge layer. Human neofetal dermal fibroblasts were seeded in the chitosan sponge layer and cultured for 4 weeks. It was found that the cells could grow and proliferate well in an extended shape on the flat bottom of large pores with 15-100 mum width and in spherical form on the rough pore walls or at the edges of micropores less than 5 mum. Fibroblasts after the culture could bind tightly with the sponge layer via newly formed extracellular matrices to give a living cell-matrix-chitosan composite. The bilayer chitosan material remained stable in shape and size during the cell culture. The results suggested that the bilayer chitosan material would be an alternative of collagen materials which was obviously contracted during cell culture. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Nankai Univ, Inst Polymer Chem, State Key Lab Funct Polymer Mat Adsorpt & Separat, Tianjin 300071, Peoples R China.
   Nankai Univ, Inst Mol Biol, Tianjin 300071, Peoples R China.
RP Ma, JB (reprint author), Nankai Univ, Inst Polymer Chem, State Key Lab Funct Polymer Mat Adsorpt & Separat, Tianjin 300071, Peoples R China.
CR Brine CJ, 1992, ADV CHITIN CHITOSAN, P9
   BURKE JF, 1981, ANN SURG, V194, P413, DOI 10.1097/00000658-198110000-00005
   BURKE JF, 1983, J TRAUMA, V23, P543, DOI 10.1097/00005373-198307000-00001
   COOPER ML, 1991, BIOMATERIALS, V12, P243, DOI 10.1016/0142-9612(91)90207-Q
   DAGALAKIS N, 1980, J BIOMED MATER RES, V14, P511, DOI 10.1002/jbm.820140417
   HEIMBACH D, 1988, ANN SURG, V208, P313, DOI 10.1097/00000658-198809000-00008
   RIVARD CH, 1995, J APPL BIOMATER, V6, P65, DOI 10.1002/jab.770060109
   Sparkes BG, 1986, Patent, Patent No. [4572906, USA, 4572906]
   SUZUKI S, 1990, BIOMATERIALS, V11, P356, DOI 10.1016/0142-9612(90)90114-6
   SUZUKI S, 1990, BRIT J PLAST SURG, V43, P47, DOI 10.1016/0007-1226(90)90044-Z
   YANNAS IV, 1981, T AM SOC ART INT ORG, V27, P19
   YANNAS IV, 1980, J BIOMED MATER RES, V14, P65, DOI 10.1002/jbm.820140108
   YANNAS IV, 1982, SCIENCE, V215, P174, DOI 10.1126/science.7031899
   YANNAS IV, 1980, J BIOMED MATER RES, V14, P107, DOI 10.1002/jbm.820140203
   YANNAS IV, 1984, J TRAUMA, V24, pS31
   YANNAS IV, 1977, Patent No. 2631909
NR 16
TC 201
Z9 228
U1 2
U2 43
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2001
VL 22
IS 4
BP 331
EP 336
DI 10.1016/S0142-9612(00)00188-5
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 392TH
UT WOS:000166428300005
PM 11205436
DA 2018-10-20
ER

PT J
AU Ball, MD
   Downes, S
   Scotchford, CA
   Antonov, EN
   Bagratashvili, VN
   Popov, VK
   Lo, WJ
   Grant, DM
   Howdle, SM
AF Ball, MD
   Downes, S
   Scotchford, CA
   Antonov, EN
   Bagratashvili, VN
   Popov, VK
   Lo, WJ
   Grant, DM
   Howdle, SM
TI Osteoblast growth on titanium foils coated with hydroxyapatite by pulsed
   laser ablation
SO BIOMATERIALS
LA English
DT Article
DE osteoblast; hydroxyapatite; laser deposition; crystallinity
ID CALCIUM-PHOSPHATE CERAMICS; PLASMA-SPRAYED COATINGS;
   CHEMICAL-COMPOSITION; CELL; DEPOSITION; APATITE; DISSOLUTION; CULTURE;
   FILMS; WATER
AB Pulsed laser ablation is a new method for deposition of thin layers of hydroxyapatite (HA) on to biomaterial surfaces. In this paper, we report activity and morphology of osteoblasts grown on HA surfaces fabricated using different laser conditions. Two sets of films were deposited from dense HA targets, at three different laser fluences: 3, 6 and 9 J cm(-2). One set of the surfaces was annealed at 575 degreesC to increase the crystallinity of the deposited films. Primary human osteoblasts were seeded onto the material surfaces and cytoskeletal actin organisation was examined using confocal laser scanning microscopy. The annealed surfaces supported greater cell attachment and more defined cytoskeletal actin organisation. Cell activity, measured using the alamar Blue assay, was also found to be significantly higher on the annealed samples. In addition, our results show distinct trends that correlate with the laser fluence used for deposition. The cell activity increases with increasing fluence. This pattern was repeated for alkaline phosphatase production by the cells. Differences in cell spreading were apparent which were correlated with the fluence used to deposit the HA. The optimum surface for initial attachment and spreading of osteoblasts was one of the HA films deposited using 9 J cm-2 laser fluence and subsequently annealed at 575 degreesC (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Univ Nottingham, Queens Med Ctr, Sch Biomed Sci, Biomat Grp, Nottingham NG7 2UH, England.
   Russian Acad Sci, Inst Laser & Informat Technol, Troitsk 142190, Russia.
   Univ Nottingham, Sch Chem, Nottingham NG7 2RD, England.
   Sch Mech Mat & Mfg Engn & Management, Biomat Grp, Nottingham, England.
RP Scotchford, CA (reprint author), Univ Nottingham, Queens Med Ctr, Sch Biomed Sci, Biomat Grp, Clifton Blvd, Nottingham NG7 2UH, England.
RI Howdle, Steven/A-2954-2010
OI Howdle, Steven/0000-0001-5901-8342; Grant, David/0000-0002-6786-7720;
   Scotchford, Colin/0000-0003-1937-6692
CR Antonov EN, 1997, BIOMATERIALS, V18, P1043, DOI 10.1016/S0142-9612(97)00030-6
   ANTONOV EN, 1994, J PHYS IV, V4, P183, DOI 10.1051/jp4:1994441
   Antonov EN, 1996, SPECTROCHIM ACTA A, V52, P123, DOI 10.1016/0584-8539(95)01597-3
   ARCHER RS, 1992, CELL MATER, V2, P113
   Arias JL, 1997, J MATER SCI-MATER M, V8, P873, DOI 10.1023/A:1018553821781
   BAGRATASHVILI VN, 1995, APPL PHYS LETT, V66, P2451, DOI 10.1063/1.113992
   BALL MD, 1997, T 23 ANN M SOC BIOM, P135
   Best S, 1997, J MATER SCI-MATER M, V8, P97, DOI 10.1023/A:1018558816871
   CHEN QM, 1994, J BIOL CHEM, V269, P26602
   Cheung H. S., 1984, ARTHRITIS RHEUM, V27, P665
   CHEUNG HS, 1985, EXP CELL RES, V157, P63, DOI 10.1016/0014-4827(85)90152-1
   Chrisey D., 1994, PULSED LASER DEPOSIT
   COURTENEYHARRIS RG, 1995, BIOMATERIALS, V16, P489, DOI 10.1016/0142-9612(95)98823-W
   DEBRUIJN JD, 1993, CELLS MAT, V3, P113
   Ducheyne P, 1999, BIOMATERIALS, V20, P2287, DOI 10.1016/S0142-9612(99)00181-7
   FRAYSSINET P, 1994, J MATER SCI-MATER M, V5, P11, DOI 10.1007/BF00121147
   GarciaSanz FJ, 1997, J MATER SCI-MATER M, V8, P861, DOI 10.1023/A:1018549720873
   Garrity J A, 1994, Curr Opin Ophthalmol, V5, P39
   Gross KA, 1998, J AM CERAM SOC, V81, P106
   KLEIN CPAT, 1994, J BIOMED MATER RES, V28, P961, DOI 10.1002/jbm.820280815
   Knabe C, 1997, BIOMATERIALS, V18, P1339, DOI 10.1016/S0142-9612(97)00078-1
   LEGEROS RZ, 1991, BONE-BIOMATERIAL INTERFACE, P76
   LIU DM, 1994, J MATER SCI-MATER M, V5, P147, DOI 10.1007/BF00053335
   Lo WJ, 2000, J BIOMED MATER RES, V50, P536, DOI 10.1002/(SICI)1097-4636(20000615)50:4<536::AID-JBM9>3.3.CO;2-L
   MAXIAN SH, 1994, J BIOMED MATER RES, V28, P1311, DOI 10.1002/jbm.820281109
   MAXIAN SH, 1993, J BIOMED MATER RES, V27, P111, DOI 10.1002/jbm.820270114
   MCFARLAND CD, 1995, T 41 ORTH RES SOC TO, P486
   PARKER TL, 1996, CELL ENG, V1, P91
   RADIN SR, 1992, J MATER SCI-MATER M, V3, P33, DOI 10.1007/BF00702942
   RAGO R, 1990, ANAL BIOCHEM, V191, P31
   SAMMONS RL, 1994, BIOMATERIALS, V15, P842, DOI 10.1016/0142-9612(94)90040-X
   SCHAKENRAAD JM, 1986, J BIOMED MATER RES, V20, P773, DOI 10.1002/jbm.820200609
   THOMAS KA, 1994, ORTHOPEDICS, V17, P267
   TRANQUILLI PL, 1994, J MATER SCI-MATER M, V5, P345, DOI 10.1007/BF00058960
   Tucker BE, 1996, BIOMATERIALS, V17, P631, DOI 10.1016/0142-9612(96)88714-X
   Wang CK, 1997, BIOMATERIALS, V18, P1331, DOI 10.1016/S0142-9612(97)00024-0
   Zreiqat H., 1996, Cells and Materials, V6, P45
NR 37
TC 71
Z9 78
U1 1
U2 9
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2001
VL 22
IS 4
BP 337
EP 347
DI 10.1016/S0142-9612(00)00189-7
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 392TH
UT WOS:000166428300006
PM 11205437
DA 2018-10-20
ER

PT J
AU Tan, JCH
AF Tan, James C. H.
TI Capsulotomy
SO CURRENT OPINION IN OPHTHALMOLOGY
LA English
DT Article
AB Research is continually seeking to better describe the relationship between pseudophakic capsular opacification and underlying cell biology, surgical technique, and intra-ocular lens biomaterial and design. Outcomes are reviewed from prospective, randomized studies that investigate the importance of capsulorhexis size, pharmacological treatment, and lens material in influencing capsular opacification and the need for capsulotomy. The results of several studies support the role of lens edge profile in inhibiting lens epithelial cell migration. A large post-mortem study also examines how lens type may affect anterior capsular opacification formation. Of particular interest is a histological report that sheds additional light on understanding cellular processes in posterior capsular opacification. (C) 2001 Lippincott Williams & Wilkins, Inc.
C1 [Tan, James C. H.] Moorfields Eye Hosp, Glaucoma Res Unit, City Rd, London EC1V 2PD, England.
RP Tan, JCH (reprint author), Moorfields Eye Hosp, Glaucoma Res Unit, City Rd, London EC1V 2PD, England.
EM oranghutan@aol.com
CR APPLE DJ, 1992, SURV OPHTHALMOL, V37, P73, DOI 10.1016/0039-6257(92)90073-3
   Apple DJ, 2000, J CATARACT REFR SURG, V26, P180, DOI 10.1016/S0886-3350(99)00353-3
   Birinci H, 1999, J CATARACT REFR SURG, V25, P1140, DOI 10.1016/S0886-3350(99)00119-4
   Cochener B, 1999, J CATARACT REFR SURG, V25, P1362, DOI 10.1016/S0886-3350(99)00227-8
   Coombes A, 1999, BRIT J OPHTHALMOL, V83, P640, DOI 10.1136/bjo.83.6.640
   DAVISON JA, 1993, J CATARACT REFR SURG, V19, P582, DOI 10.1016/S0886-3350(13)80004-1
   Friedman DS, 1999, INVEST OPHTH VIS SCI, V40, P1715
   Gallagher SP, 1999, J CATARACT REFR SURG, V25, P1356, DOI 10.1016/S0886-3350(99)00228-X
   Gillies M, 1998, ARCH OPHTHALMOL-CHIC, V116, P90, DOI 10.1001/archopht.116.1.90
   Hollick EJ, 1999, AM J OPHTHALMOL, V128, P271, DOI 10.1016/S0002-9394(99)00157-9
   Hollick EJ, 1999, ARCH OPHTHALMOL-CHIC, V117, P872
   Hollick EJ, 2000, AM J OPHTHALMOL, V129, P577, DOI 10.1016/S0002-9394(99)00447-X
   JAVITT JC, 1992, OPHTHALMOLOGY, V99, P1487
   Koch MU, 1999, J CATARACT REFR SURG, V25, P1637, DOI 10.1016/S0886-3350(99)00267-9
   Kruger AJ, 2000, J CATARACT REFR SURG, V26, P566, DOI 10.1016/S0886-3350(00)00323-0
   Marcantonio JM, 2000, INVEST OPHTH VIS SCI, V41, P1130
   Marcantonio JM, 1999, EYE, V13, P484
   Meacock WR, 2000, J CATARACT REFR SURG, V26, P716, DOI 10.1016/S0886-3350(00)00326-6
   Meacock WR, 2000, BRIT J OPHTHALMOL, V84, P332, DOI 10.1136/bjo.84.3.332
   Nagata T, 1996, JPN J OPHTHALMOL, V40, P397
   Nishi O, 1999, J CATARACT REFR SURG, V25, P521, DOI 10.1016/S0886-3350(99)80049-2
   Nishi O, 1998, OPHTHALMIC SURG LAS, V29, P119
   Peng Q, 2000, J CATARACT REFR SURG, V26, P198, DOI 10.1016/S0886-3350(99)00352-1
   Peng Q, 2000, J CATARACT REFR SURG, V26, P188, DOI 10.1016/S0886-3350(99)00354-5
   Ravalico G, 1996, J CATARACT REFR SURG, V22, P98, DOI 10.1016/S0886-3350(96)80277-X
   Schaumberg DA, 1998, OPHTHALMOLOGY, V105, P1213, DOI 10.1016/S0161-6420(98)97023-3
   Spalton DJ, 1999, EYE, V13, P489
   STEINBERG EP, 1993, ARCH OPHTHALMOL-CHIC, V111, P1041, DOI 10.1001/archopht.1993.01090080037016
   THYLEFORS B, 1995, B WORLD HEALTH ORGAN, V73, P115
   Werner L, 2000, OPHTHALMOLOGY, V107, P463, DOI 10.1016/S0161-6420(99)00088-3
NR 30
TC 2
Z9 2
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1040-8738
EI 1531-7021
J9 CURR OPIN OPHTHALMOL
JI Curr. Opin. Ophthalmol.
PD FEB
PY 2001
VL 12
IS 1
BP 82
EP 85
DI 10.1097/00055735-200102000-00014
PG 4
WC Ophthalmology
SC Ophthalmology
GA V40ZD
UT WOS:000209515600014
PM 11150086
DA 2018-10-20
ER

PT J
AU Harper, C
AF Harper, C
TI Permacol (TM): clinical experience with a new biomaterial
SO HOSPITAL MEDICINE
LA English
DT Article
ID REPAIR; MESHES
AB Permacol(TM) (Tissue Science Laboratories plc, Aldershot, Hants) is a new biomaterial which combines the strength and permanence of synthetic surgical repair materials with the biocompatibility of natural materials. This article examines the clinical application of Permacol(TM) in a range of different surgical procedures.
C1 Tissue Sci Labs PLC, Aldershot GU11 1EJ, Hants, England.
RP Harper, C (reprint author), Tissue Sci Labs PLC, Victoria House,Victoria Rd, Aldershot GU11 1EJ, Hants, England.
CR Barrington J. W., 1998, Journal of Obstetrics and Gynaecology (Abingdon), V18, P61
   BARRINGTON JW, 2000, INT UROGYNAECOL SU, V11, pS122
   Baykal A, 1999, WORLD J SURG, V23, P625, DOI 10.1007/PL00012359
   Chvapil M, 1980, BIOL COLLAGEN, P313
   Clarke KM, 1996, J SURG RES, V60, P107, DOI 10.1006/jsre.1996.0018
   COOKE A, 1983, BRIT J EXP PATHOL, V64, P172
   ELLIS AF, 2000, CURR OPIN OTOLARYNGO, V8, P337
   GADACZ TR, 1994, SEMIN LAPAROSC SURG, V1, P123
   Ghimenton F, 2000, BRIT J SURG, V87, P106, DOI 10.1046/j.1365-2168.2000.01337.x
   GRIFFITHS RW, 1982, BRIT J PLAST SURG, V35, P519, DOI 10.1016/0007-1226(82)90056-X
   Klinge U, 1999, EUR J SURG, V165, P665
   LLOYD SN, 2000, BR J UROL S5, V85, pP38
   LOEWE O, 1913, MUNCHEN MED WCHNSCHR, V24, P1320
   Luijendijk RW, 2000, NEW ENGL J MED, V343, P392, DOI 10.1056/NEJM200008103430603
   MCPHERSON J M, 1986, Journal of Biomedical Materials Research, V20, P93, DOI 10.1002/jbm.820200109
   Meyer W, 1978, Curr Probl Dermatol, V7, P39
   MONTEIRORIVIERE NA, 1986, ULTRASTRUCTURAL EVAL, P641
   OLIVER R F, 1987, Burns, V13, pS49, DOI 10.1016/0305-4179(87)90094-5
   OLIVER RF, 1982, BIOMATERIALS, V3, P38, DOI 10.1016/0142-9612(82)90059-X
   OLIVER RF, 1975, NATURE, V258, P537, DOI 10.1038/258537a0
   OLIVER RF, 1976, CLIN ORTHOP RELAT R, P291
   OLIVER RF, 1972, BRIT J EXP PATHOL, V53, P540
   OLIVER RF, 1980, BRIT J EXP PATHOL, V61, P544
   OLIVER RF, 1986, IN VITRO GROWTH ADUL
   RUPARELIA BA, 2000, INT UROGYNAECOL S11, V11
   SHAKESPEARE PG, 1980, LANCET, V1, P795
   SPEAKMAN MJ, 2000, BR J UROL S5, V85, P42
   THOMPSON N, 1960, Plast Reconstr Surg Transplant Bull, V26, P1
NR 28
TC 87
Z9 90
U1 0
U2 10
PU MARK ALLEN PUBLISHING LTD
PI LONDON
PA CROXTED MEWS, 286A-288 CROXTED ROAD, LONDON SE24 9BY, ENGLAND
SN 1462-3935
J9 HOSP MED
JI Hosp. Med
PD FEB
PY 2001
VL 62
IS 2
BP 90
EP 95
DI 10.12968/hosp.2001.62.2.2379
PG 6
WC Medicine, General & Internal
SC General & Internal Medicine
GA 404BU
UT WOS:000167078200007
PM 11236624
DA 2018-10-20
ER

PT J
AU Mitchell, SB
   Sanders, JE
   Garbini, JL
   Schuessler, PK
AF Mitchell, SB
   Sanders, JE
   Garbini, JL
   Schuessler, PK
TI A device to apply user-specified strains to biomaterials in culture
SO IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING
LA English
DT Article
DE biaxial strain; biomechanics; cell proliferation; in-plane tension;
   PGE-2
ID MECHANICAL-PROPERTIES; SKIN; PROSTAGLANDIN-E2; RELEASE; SYSTEM; STRESS;
   MOTION
AB An apparatus was developed to apply user-specified displacements to biomaterial samples in culture, The device allowed cyclic waveforms of bandwidth 0 Hz to 20 Wt to be applied under physiologic thermal (37.5 degreesC) and [CO2] (5%) conditions. For a 0 Hz to 20 Hz bandwidth signal similar in shape to a ventricular pressure waveform, the mean displacement error was 0.26% of the full-scale output, The maximum overshoot was 0.700%. Environmental system evaluation tests demonstrated a specimen cartridge temperature of 37.20 +/- 0.15 degreesC during cyclic loading and 37.23 +/- 0.21 degreesC during static conditions. [CO2] was 5.29 +/- 0.54% during cyclic loading and 5.25 +/- 0.61% during static conditions. Laminar flow applied at the loading rod entrances to the specimen cartridge ensured the sample remained sterile during testing. As a preliminary evaluation, polyurethane samples were seeded with fetal foreskin fibroblasts and subject to intermittent cyclic displacements. Results demonstrated enhanced cell proliferation and increased [PGE(2)] for samples subjected to 10% strain compared with unstrained controls, ii next step will be to evaluate cell response sensitivity to strain magnitude, duration, direction, and frequency. The long-term intent is to establish mechanical loading configurations that induce acceptable or adaptation-inducing responses for use in implant design and tissue engineering applications.
C1 Univ Washington, UWEB Program, Dept Bioengn, Seattle, WA 98195 USA.
   Univ Washington, UWEB Program, Dept Mech Engn, Seattle, WA 98195 USA.
RP Sanders, JE (reprint author), Univ Washington, UWEB Program, Dept Bioengn, Seattle, WA 98195 USA.
CR ALEXANDER H, 1977, J INVEST DERMATOL, V69, P310, DOI 10.1111/1523-1747.ep12507731
   BAREIS DL, 1983, P NATL ACAD SCI-BIOL, V80, P2514, DOI 10.1073/pnas.80.9.2514
   BELL E, 1993, TISSUE ENG
   Cadzow JA, 1973, DISCRETE TIME SYSTEM
   Carver SE, 1999, TISSUE ENG, V5, P1, DOI 10.1089/ten.1999.5.1
   CHANG MH, 1994, J VASC SURG, V20, P6
   CHEW PH, 1986, J MOL CELL CARDIOL, V18, P567, DOI 10.1016/S0022-2828(86)80965-8
   CHRISTMAN JW, 1991, PROSTAGLANDINS, V41, P251, DOI 10.1016/0090-6980(91)90045-H
   DICK JC, 1951, J PHYSIOL-LONDON, V112, P102, DOI 10.1113/jphysiol.1951.sp004512
   Dorf R. C., 1995, MODERN CONTROL SYSTE
   Gibbons D. F., 1994, Clinical Materials, V15, P37, DOI 10.1016/0267-6605(94)90007-8
   KENEDI RM, 1975, PHYS MED BIOL, V20, P699, DOI 10.1088/0031-9155/20/5/001
   Kenedi RM, 1965, BIOMECHANICS RELATED
   LANIR Y, 1974, J BIOMECH, V7, P29, DOI 10.1016/0021-9290(74)90067-0
   MARTIJN A, 1995, AM J PHYSIOL, V26, pH2531
   NARA AR, 1993, BIOPHYSICAL MEASUREM
   PATEL DJ, 1963, J APPL PHYSIOL, V18, P1111
   RAUD J, 1988, P NATL ACAD SCI USA, V85, P2315, DOI 10.1073/pnas.85.7.2315
   Regamey R H, 1974, Dev Biol Stand, V23, P71
   RICHARDSON PDI, 1976, BRIT J PHARMACOL, V57, P581, DOI 10.1111/j.1476-5381.1976.tb10388.x
   SACKS MS, 1993, J BIOMECH ENG-T ASME, V115, P202, DOI 10.1115/1.2894122
   SANDERS JE, 1995, J REHABIL RES DEV, V32, P214
   SCHAFFER JL, 1994, J ORTHOP RES, V12, P709, DOI 10.1002/jor.1100120514
   VANROYEN BJ, 1986, PLAST RECONSTR SURG, V78, P360, DOI 10.1097/00006534-198609000-00013
   VITO RP, 1980, J BIOMECH, V13, P947, DOI 10.1016/0021-9290(80)90165-7
   Yun JK, 1999, TISSUE ENG, V5, P67, DOI 10.1089/ten.1999.5.67
NR 26
TC 14
Z9 15
U1 0
U2 0
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017-2394 USA
SN 0018-9294
J9 IEEE T BIO-MED ENG
JI IEEE Trans. Biomed. Eng.
PD FEB
PY 2001
VL 48
IS 2
BP 268
EP 273
DI 10.1109/10.909648
PG 6
WC Engineering, Biomedical
SC Engineering
GA 408VF
UT WOS:000167347600015
PM 11296883
DA 2018-10-20
ER

PT J
AU Takagi, S
   Chow, LC
   Markovic, M
   Friedman, CD
   Costantino, PD
AF Takagi, S
   Chow, LC
   Markovic, M
   Friedman, CD
   Costantino, PD
TI Morphological and phase characterizations of retrieved calcium phosphate
   cement implants
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE self-hardening calcium phosphate cement; calcium phosphate cement
   implant; carbonated hydroxyapatite; tetracalcium phosphate; dicalcium
   phosphate anhydrous; CPC characterization
ID HYDROXYAPATITE CEMENT; RECONSTRUCTION; PRECIPITATION; BIOMATERIAL;
   BEHAVIOR; SYSTEM; BONE
AB A self-hardening calcium phosphate cement (CPC), consisting of equimolar amounts of tetracalcium phosphate and dicalcium phosphate anhydrous, hardens when mixed with water and forms a resorbable hydroxyapatite (HA) as the end-product. The objective of this study was to investigate the changes of the phase and morphology of the CPC during hardening and aging under in vivo conditions. CPC samples retrieved 12 h after hardening in vivo had already contained carbonated HA (type B), even though the initial cement mixture did not contain carbonate as one of the solid components. The mass fraction of carbonate in the 12-h sample was about 1%. The results suggested that under in vivo conditions carbonate is readily available and this allows formation of carbonated HA in favor of carbonate-free HA, The carbonate content of the CPC samples retrieved 3 months after implantation was similar to that of the 12-h samples, and the exterior surfaces of the 3-month samples appeared less crystalline than that of the 12-h samples, (C) 2000 John Wiley & Sons. Inc. J Biomed Mater Res (Appl Biomater) 58: 36-41. 2001.
C1 NIST, Amer Dent Assoc Hlth Fdn, Paffenbarger Res Ctr, Gaithersburg, MD 20899 USA.
   Fox Chase Canc Ctr, Dept Surg Oncol, Philadelphia, PA 19111 USA.
   Mt Sinai Med Ctr, Dept Otolaryngol Head & Neck Surg, New York, NY 10029 USA.
RP Takagi, S (reprint author), NIST, Amer Dent Assoc Hlth Fdn, Paffenbarger Res Ctr, Gaithersburg, MD 20899 USA.
FU NIDCR NIH HHS [DE11789]
CR Cherng A, 1997, J BIOMED MATER RES, V35, P273, DOI 10.1002/(SICI)1097-4636(19970605)35:3<273::AID-JBM1>3.0.CO;2-E
   CHOW LC, 1994, HYDROXYAPATITE AND RELATED MATERIALS, P127
   CONSTANTZ BR, 1995, SCIENCE, V267, P1796, DOI 10.1126/science.7892603
   Conway E. J., 1962, MICRODIFFUSION ANAL, P201
   COSTANTINO PD, 1992, PLAST RECONSTR SURG, V90, P174, DOI 10.1097/00006534-199290020-00003
   Fernandez E, 1998, J BIOMED MATER RES, V41, P560, DOI 10.1002/(SICI)1097-4636(19980915)41:4<560::AID-JBM7>3.0.CO;2-A
   Fernandez E, 1999, J BIOMED MATER RES, V47, P466, DOI 10.1002/(SICI)1097-4636(19991215)47:4<466::AID-JBM2>3.3.CO;2-I
   Friedman C D, 2000, Arch Facial Plast Surg, V2, P124, DOI 10.1001/archfaci.2.2.124
   Friedman CD, 1998, J BIOMED MATER RES, V43, P428, DOI 10.1002/(SICI)1097-4636(199824)43:4<428::AID-JBM10>3.0.CO;2-0
   FRIEDMAN CD, 1991, ARCH OTOLARYNGOL, V117, P385
   FUKASE Y, 1990, J DENT RES, V69, P1852, DOI 10.1177/00220345900690121201
   ISHIKAWA K, 1994, DENT MATER, V10, P26, DOI 10.1016/0109-5641(94)90018-3
   Ishikawa K, 1999, J BIOMED MATER RES, V46, P504, DOI 10.1002/(SICI)1097-4636(19990915)46:4<504::AID-JBM8>3.0.CO;2-H
   ISHIKAWA K, 1996, BIOCERAM P INT S CER, V9, P255
   LEGEROS RZ, 1991, MONOGRAPHS ORAL SCI, P82
   Markovic M, 1996, J DENT RES, V75, P25
   RADIN SR, 1993, J BIOMED MATER RES, V27, P35, DOI 10.1002/jbm.820270106
   TERMINE JD, 1974, CALC TISS RES, V15, P55, DOI 10.1007/BF02059043
   Uludag H, 1999, J BIOMED MATER RES, V46, P193, DOI 10.1002/(SICI)1097-4636(199908)46:2<193::AID-JBM8>3.0.CO;2-1
NR 19
TC 37
Z9 38
U1 0
U2 2
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD FEB
PY 2001
VL 58
IS 1
BP 36
EP 41
DI 10.1002/1097-4636(2001)58:1<36::AID-JBM50>3.3.CO;2-R
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 398JQ
UT WOS:000166753700005
PM 11152995
DA 2018-10-20
ER

PT J
AU Butler, CE
   Navarro, FA
   Orgill, DP
AF Butler, CE
   Navarro, FA
   Orgill, DP
TI Reduction of abdominal adhesions using composite collagen-GAG implants
   for ventral hernia repair
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID ARTIFICIAL SKIN; INCISIONAL HERNIA; MARLEX MESH; WALL REPLACEMENT;
   MODEL; DESIGN; MATRICES; KERATINOCYTES; REGENERATION; PREVENTION
AB Structural biomaterials can restore abdominal wall integrity but may cause adhesions to the underlying viscera, Collagen-glycosaminoglycan (CG) matrices induce the formation of connective tissue and mag reduce adhesion formation to permanent biomaterials such as polypropylene (PP) mesh, Composite implants were created by interposing PP mesh within a porous CG matrix created composite implants. The implants were cross-linked with glutaraldehyde one group (CG-G/PP) or left untreated (CG-nG/PP) and compared to PP mesh. At 4 weeks, the abdominal wall was assessed for the degree of adhesions. The composite implants developed a nascent connective tissue-like structure that reduced adhesions to the bowel, The thickest connective tissue developed in the CG-G/PP group (0.7 +/- 0.1 mm) and thinnest in the PP mesh (0.05 +/- 0.01 mm). The surface area covered with adhesions was greatest in the PP group (72 +/- 17%) compared with the CG-G/PP group (28 +/- 15%) or the CG-nG/PP group (21 +/- 8%). Bowel preferentially adhered to the PP mesh, whereas omentum had some adherence to all constructs. Integrating a biodegradable extracellular matrix analog with a permanent structural biomaterial reduced adhesions in this animal model. Alterations in cross-linking of the CG matrix altered the biological response, This technology may be useful in reconstructive surgery by reducing adhesion formation, while maintaining the strength of permanent structural biomaterials. (C) 2000 John Wiley & Sons. Inc. J Biomed Mater Res (Appl Biomater) 58. 75-80. 2001.
C1 Brigham & Womens Hosp, Div Plast Surg, Boston, MA 02115 USA.
   Univ Texas, MD Anderson Canc Ctr, Dept Plast Surg, Houston, TX 77030 USA.
RP Orgill, DP (reprint author), Brigham & Womens Hosp, Div Plast Surg, 75 Francis St, Boston, MA 02115 USA.
CR Alponat A, 1997, AM SURGEON, V63, P818
   AMID PK, 1994, LANGENBECK ARCH CHIR, V379, P168, DOI 10.1007/BF00680113
   Becker JM, 1996, J AM COLL SURGEONS, V183, P297
   BOYD WC, 1977, SURG GYNECOL OBSTET, V144, P251
   Butler CE, 1998, PLAST RECONSTR SURG, V101, P1572, DOI 10.1097/00006534-199805000-00021
   Butler CE, 1999, BRIT J PLAST SURG, V52, P127, DOI 10.1054/bjps.1997.3047
   Butler Charles E., 1996, Surgical Forum, V47, P752
   CAPOZZI JA, 1988, SURG GYNECOL OBSTET, V167, P124
   Compton CC, 1998, J INVEST DERMATOL, V110, P908, DOI 10.1046/j.1523-1747.1998.00200.x
   Cristoforoni PM, 1996, AM SURGEON, V62, P935
   DAGALAKIS N, 1980, J BIOMED MATER RES, V14, P511, DOI 10.1002/jbm.820140417
   DEGUZMAN LJ, 1995, ENDOSCOPY, V27, P257
   ELLIOTT MP, 1979, AM J SURG, V137, P342, DOI 10.1016/0002-9610(79)90063-1
   FUKASAWA M, 1991, INT J FERTIL, V36, P296
   GILBERT AI, 1987, SOUTHERN MED J, V80, P191, DOI 10.1097/00007611-198702000-00013
   Harriger MD, 1997, J BIOMED MATER RES, V35, P137, DOI 10.1002/(SICI)1097-4636(199705)35:2<137::AID-JBM1>3.0.CO;2-O
   LAMB JP, 1983, SURGERY, V93, P643
   MOLLOY RG, 1991, BRIT J SURG, V78, P242, DOI 10.1002/bjs.1800780237
   MURPHY GF, 1990, LAB INVEST, V63, P305
   Nehrer S, 1998, BIOMATERIALS, V19, P2313, DOI 10.1016/S0142-9612(98)00143-4
   Orgill DP, 1998, J BIOMED MATER RES, V39, P531, DOI 10.1002/(SICI)1097-4636(19980315)39:4<531::AID-JBM4>3.3.CO;2-P
   Orgill DP, 1998, PLAST RECONSTR SURG, V102, P423, DOI 10.1097/00006534-199808000-00020
   Orgill DP, 1996, WOUNDS, V8, P151
   SCALES J T, 1953, Proc R Soc Med, V46, P647
   TALBERT JL, 1977, J PEDIATR SURG, V12, P63, DOI 10.1016/0022-3468(77)90297-4
   TURKCAPAR AG, 1995, INT SURG, V80, P92
   VOYLES CR, 1981, ANN SURG, V194, P219, DOI 10.1097/00000658-198108000-00017
   YANNAS IV, 1980, J BIOMED MATER RES, V14, P65, DOI 10.1002/jbm.820140108
   YANNAS IV, 1980, J BIOMED MATER RES, V14, P107, DOI 10.1002/jbm.820140203
NR 29
TC 44
Z9 46
U1 0
U2 3
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD FEB
PY 2001
VL 58
IS 1
BP 75
EP 80
DI 10.1002/1097-4636(2001)58:1<75::AID-JBM110>3.0.CO;2-J
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 398JQ
UT WOS:000166753700011
PM 11153001
DA 2018-10-20
ER

PT J
AU Wiese, KG
   Heinemann, DEH
   Ostermeier, D
   Peters, JH
AF Wiese, KG
   Heinemann, DEH
   Ostermeier, D
   Peters, JH
TI Biomaterial properties and biocompatibility in cell culture of a novel
   self-inflating hydrogel tissue expander
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE hydrogel; tissue expander; osmosis; hydrostatic pressure;
   biocompatibility; cytotoxicity; mutagenicity; monocyte differentiation
ID EXPANSION
AB The aim of this study was to investigate the swelling properties and the biocompatibility of a novel tissue expander material. The self-inflating material is a hydrogel consisting of a modified copolymer of methylmethacrylate and N-vinyl-2-pyrrolidone, which takes up water by osmosis. To increase the swelling volume, the primarily neutral gel material was modified by converting it into an ionized gel. To study the swelling and pressure behavior of the material, the anhydrous gel cylinders were equilibrated in distilled water, saline, and sugar solutions. The biocompatibility was investigated in cell culture. We tested the hydrogel eluate after swelling for cytotoxicity and mutagenicity using the cell lines MRC-5 and P3X63 Ag8 653 (Ag8). Furthermore, particles of the material were added to cell cultures to induce foreign body reactions and to verify its influence on monocyte differentiation. The material has a swelling capacity (Q = maximum swelling volume/anhydrous volume) of 5 to 50 depending on the degree of ionization of the polymer network. In this study, two polymer modifications with a swelling equilibrium of Q = 11.1 and 30 in water were tested. The swelling ratio also depends on concentration and ion content of the equilibration medium. The highest swelling capacity was found in water, the lowest in Ringer's solution. The swelling of the anhydrous material with the swelling capacity of Q = 11.1 fits best the average purpose of material properties for tissue expansion and generates a maximal hydrostatic pressure of approximately 235 mmHg. Effects on cell proliferation were detected only at the highest eluate concentration tested (i.e., eluate: culture medium = 1:1), which was far beyond physiological values, whereas mutagenicity was absent. Monocytes neither mi,orated nor tightly attached to the hydrogel. They neither phagocytose the material nor did they show any sign of a foreign body reaction, e.g., formation of multinucleated giant cells or monocyte proliferation. In the presence of hydrogel material, the differentiation processes of monocytes to macrophages or dendritic cells, respectively, were found to be undisturbed. From these results, we conclude that there is a high biocompatibility of the expander material, which may be a favorable and interesting candidate for further clinical applications. (C) 2000 John Wiley & Sons, Inc.
C1 Dept Maxillofacial Surg, D-37075 Gottingen, Niedersachsen, Germany.
   Univ Gottingen, Dept Immunol, Lower Saxony, Germany.
RP Wiese, KG (reprint author), Dept Maxillofacial Surg, Robert Koch Str 40, D-37075 Gottingen, Niedersachsen, Germany.
CR Andrade JD, 1976, ACS S SERIES, V31
   ARGENTA LC, 1984, CLIN PLAST SURG, V11, P257
   AUSTAD ED, 1982, PLAST RECONSTR SURG, V70, P588, DOI 10.1097/00006534-198211000-00011
   BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77
   GOLDNER RD, 1977, AM J PATHOL, V89, P335
   GREGONIS DE, 1976, ACS SYM SER, V31, P37
   Hauptmann S, 1996, J MATER SCI-MATER M, V7, P345, DOI 10.1007/BF00154546
   Heinemann DEH, 1997, SCAND J IMMUNOL, V45, P596, DOI 10.1046/j.1365-3083.1997.d01-435.x
   HEINEMANN DEH, 1997, OSTEOLOGIE, V6, P112
   HENZE U, 1999, DTSCH ARZTEBLATT, V96, P687
   HUNDHAUSEN T, 1990, UNTERSUCHUNGEN HERST
   KEARNEY JF, 1979, J IMMUNOL, V123, P1548
   Kozinn S C, 1986, J Arthroplasty, V1, P249, DOI 10.1016/S0883-5403(86)80015-8
   LENZER S, 1992, MONOCLONAL ANTIBODIE, P176
   NEUMANN C G, 1957, Plast Reconstr Surg (1946), V19, P124, DOI 10.1097/00006534-195702000-00004
   OCKLIND G, 1988, J IMMUNOL METHODS, V112, P169, DOI 10.1016/0022-1759(88)90353-5
   Peppas N. A., 1986, HYDROGELS MED PHARM, V2
   PETERS JH, 1993, ADV EXP MED BIOL, V329, P275
   PETERS JH, 1985, MONOKLONALE ANTIKOER, P118
   RADOVAN C, 1979, PLAST SURG FORUM, V2, P62
   REFOJO M F, 1973, International Ophthalmology Clinics, V13, P263, DOI 10.1097/00004397-197301310-00020
   REFOJO MF, 1976, ACS SYM SER, V31, P37
   ROSEN JJ, 1976, ACS S SERIES, V31
   RUPPERT J, 1991, EUR J CELL BIOL, V55, P352
   TANAKA T, 1981, SPEKTRUM WISSENSCHAF, V3, P78
   WIESE KG, 1993, J CRANIO MAXILL SURG, V21, P309, DOI 10.1016/S1010-5182(05)80353-1
   WIESE KG, 1998, THESIS FACHBEREICH M
   Wooley PH, 1996, CLIN ORTHOP RELAT R, P63
   Xu H, 1995, ADV EXP MED BIOL, V378, P75
   ZYBALSKI W, 1962, NATL CANC I MONOGR, V7, P75
NR 30
TC 41
Z9 43
U1 3
U2 19
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD FEB
PY 2001
VL 54
IS 2
BP 179
EP 188
DI 10.1002/1097-4636(200102)54:2<179::AID-JBM4>3.0.CO;2-C
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 378UF
UT WOS:000165602500004
PM 11093177
DA 2018-10-20
ER

PT J
AU Peng, CY
   Tsutsumi, S
   Matsumura, K
   Nakajima, N
   Hyon, SH
AF Peng, CY
   Tsutsumi, S
   Matsumura, K
   Nakajima, N
   Hyon, SH
TI Morphologic study and syntheses of type I collagen and fibronectin of
   human periodontal ligament cells cultured on poly(ethylene-co-vinyl
   alcohol) (EVA) with collagen immobilization
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE regeneration of periodontium; dental implant; periodontal ligament cell;
   type I collagen; fibronectin; poly(ethylene-co-vinyl alcohol) (EVA)
ID BIOMATERIAL; RAT
AB The purpose of this study was to regenerate the human periodontal ligament (PDL) around dental implants by using a hybrid structure of cells with materials, such as PDL cells + collagen + poly(ethylene-ca-vinyl alcohol) (EVA) on titanium implant. Human PDL cells were cultured on the EVA surface coated with type I collagen and the cell adhesion and extension were investigated. Furthermore, collagen type I and fibronectin syntheses were analyzed. The serum free culture was also tried, to investigate the role of collagen in detail. The results showed that: 1. Satisfactory adhesion, extension, and proliferation of the PDL cells on the EVA films coated with collagen were observed, but were not good without collagen. 2. Immunostaining of cultured PDL cells revealed the syntheses of type I collagen, when cultured on the EVA coated with collagen or conventional culture dish, though fibronectin synthesis was observed even in the EVA without collagen. 3. Only PDL cells on the EVA coated with collagen proliferated well in the absence of serum. These results indicate that our novel implant material (EVA coated with collagen) provides a possibility of PDL regeneration on dental implants. (C) 2000 John Wiley & Sons, Inc.
C1 Kyoto Univ, Inst Frontier Med Sci, Sakyo Ku, Kyoto 6068507, Japan.
RP Tsutsumi, S (reprint author), Kyoto Univ, Inst Frontier Med Sci, Sakyo Ku, 53 Kawahara Cho, Kyoto 6068507, Japan.
RI Matsumura, Kazuaki/I-1627-2014
OI Matsumura, Kazuaki/0000-0001-9484-3073
CR CHUNG KM, 1990, J PERIODONTOL, V61, P732, DOI 10.1902/jop.1990.61.12.732
   ITO T, 1995, J JPN SOC CLIN BIOME, V16, P443
   ITO T, 1996, J JPN SOC CLIN BIOME, V17, P369
   Matsumura K, 2000, J BIOMED MATER RES, V50, P512, DOI 10.1002/(SICI)1097-4636(20000615)50:4<512::AID-JBM6>3.3.CO;2-7
   Mutter D, 1996, BIOMATERIALS, V17, P1411, DOI 10.1016/0142-9612(96)87283-8
   OHTA M, 1998, J JPN SOC CLIN BIOME, V19, P303
   Oros J, 1996, J VET MED SCI, V58, P1219, DOI 10.1292/jvms.58.12_1219
   RAO KP, 1988, COLLAGEN, V3, P63
   Serre CM, 1998, J BIOMED MATER RES, V42, P626
   Sisken BF, 1993, J CELL BIOCHEM, V52, P404
   WERKMEISTER JA, 1993, J HISTOCHEM CYTOCHEM, V41, P1701, DOI 10.1177/41.11.8409376
   Young TH, 1998, BIOMATERIALS, V19, P717, DOI 10.1016/S0142-9612(98)00187-2
NR 12
TC 17
Z9 18
U1 0
U2 1
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD FEB
PY 2001
VL 54
IS 2
BP 241
EP 246
DI 10.1002/1097-4636(200102)54:2<241::AID-JBM11>3.0.CO;2-P
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 378UF
UT WOS:000165602500011
PM 11093184
DA 2018-10-20
ER

PT J
AU Ono, I
   Zhou, LJ
   Tateshita, T
AF Ono, I
   Zhou, LJ
   Tateshita, T
TI Effects of a collagen matrix containing prostaglandin E-1 on wound
   contraction
SO JOURNAL OF DERMATOLOGICAL SCIENCE
LA English
DT Article
DE wound healing; wound contraction; rabbit model; dermal substitute;
   prostaglandin E-1; collagen gel contraction
ID FIBROBLAST-GROWTH-FACTOR; DERMAL FIBROBLASTS; ARTIFICIAL DERMIS;
   CYTOKINES; SKIN; BIOMATERIAL; SPONGE; REPAIR; MODEL; FLUID
AB In this study, we evaluated the effectiveness of prostaglandin (PG) E-1 in inhibiting wound contraction, both alone and in combination with collagen matrix, using a in vivo full thickness skin defect model. To clarify the mechanisms involved in this inhibition we also used a fibroblast-populated collagen gel contraction in vitro model. We demonstrated that collagen matrix alone significantly inhibited wound contraction PG E-1 alone did not. Interestingly, their combination was much more effective than either collagen matrix or PG E-1 alone, a finding which was also supported by histopathological examination. Wounds treated with collagen matrix, but not control wounds, showed horizontal rearrangement of collagen fibers in the dermal part as well as evidence of active fibroblast proliferation which was not observed in scar regions surrounded by normal dermis. With the fibroblast-populated collagen gel contraction in vitro model, we found that PG E-1 significantly inhibited contraction at a high dose. It was concluded that collagen matrix combined with PG E-1 is effective for preventing contracture producing so called neodermis than collagen matrix alone, which remains one of the most challenging problems in treating full thickness type wounds. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.
C1 Fukushima Med Univ, Dept Dermatol, Sch Med, Fukushima 9601295, Japan.
RP Ono, I (reprint author), Fukushima Med Univ, Dept Dermatol, Sch Med, Hikarigaoka 1, Fukushima 9601295, Japan.
RI ZHOU, LIJUN/K-1120-2015
OI ZHOU, LIJUN/0000-0001-6461-1247
CR ABRAMO AC, 1992, BRIT J PLAST SURG, V45, P117, DOI 10.1016/0007-1226(92)90170-3
   Alaish Samuel M., 1996, Wound Repair and Regeneration, V4, P477, DOI 10.1046/j.1524-475X.1996.40412.x
   BENNETT NT, 1993, AM J SURG, V165, P728, DOI 10.1016/S0002-9610(05)80797-4
   BENNETT NT, 1993, AM J SURG, V166, P74, DOI 10.1016/S0002-9610(05)80589-6
   COOPER DM, 1994, ANN SURG, V219, P688, DOI 10.1097/00000658-199406000-00012
   DAVIDSON JM, 1991, ANN NY ACAD SCI, V638, P306, DOI 10.1111/j.1749-6632.1991.tb49041.x
   DOILLON CJ, 1988, SCANNING MICROSCOPY, V2, P985
   FANG C, 1983, J TRAUMA, V23, P300, DOI 10.1097/00005373-198304000-00005
   FIDDES JC, 1991, ANN NY ACAD SCI, V638, P316
   FORD HR, 1989, ARCH SURG-CHICAGO, V124, P1422
   Grotendorst G. R., 1992, WOUND HEALING BIOCH, P237
   Gunji H, 1996, BURNS, V22, P399, DOI 10.1016/0305-4179(95)00170-0
   INOUE M, 1996, WOUND REPAIR REGEN, V6, P213
   Inoue Masayuki, 1996, Wound Repair and Regeneration, V4, P426, DOI 10.1046/j.1524-475X.1996.40406.x
   KOIDE M, 1993, J BIOMED MATER RES, V27, P79, DOI 10.1002/jbm.820270111
   LEIPZIGER LS, 1985, J AM ACAD DERMATOL, V12, P409, DOI 10.1016/S0190-9622(85)80004-9
   Mast Bruce A., 1996, Wound Repair and Regeneration, V4, P411, DOI 10.1046/j.1524-475X.1996.40404.x
   Matsui R, 1996, BIOMATERIALS, V17, P989, DOI 10.1016/0142-9612(96)84673-4
   Matsui R, 1996, BIOMATERIALS, V17, P995, DOI 10.1016/0142-9612(96)84674-6
   MONCADA S, 1976, NATURE, V263, P663, DOI 10.1038/263663a0
   Ono I, 1999, J BIOMED MATER RES, V48, P621, DOI 10.1002/(SICI)1097-4636(1999)48:5<621::AID-JBM5>3.0.CO;2-1
   ONO I, 1995, J DERMATOL SCI, V10, P241, DOI 10.1016/0923-1811(95)00454-Z
   ONO I, 1995, BURNS, V21, P352, DOI 10.1016/0305-4179(95)00005-4
   Orgill DP, 1998, PLAST RECONSTR SURG, V102, P423, DOI 10.1097/00006534-199808000-00020
   PIERCE GF, 1992, AM J PATHOL, V140, P1375
   Robson M. C., 1994, Wound Repair and Regeneration, V2, P177, DOI 10.1046/j.1524-475X.1994.20307.x
   Robson MC, 1998, AM J SURG, V176, p80S, DOI 10.1016/S0002-9610(98)00186-X
   ROBSON MC, 1992, WOUND HEALING BIOCH, P292
   Sato T, 1997, J INVEST DERMATOL, V109, P334, DOI 10.1111/1523-1747.ep12335935
   STENZEL KH, 1974, ANNU REV BIOPHYS BIO, V3, P231, DOI 10.1146/annurev.bb.03.060174.001311
   STERN R, 1990, Journal of Burn Care and Rehabilitation, V11, P7, DOI 10.1097/00004630-199001000-00003
   Talwar M, 1996, ANN CLIN LAB SCI, V26, P451
   Tarnuzzer Roy W., 1996, Wound Repair and Regeneration, V4, P321, DOI 10.1046/j.1524-475X.1996.40307.x
   UNEMORI EN, 1994, EXP CELL RES, V210, P166, DOI 10.1006/excr.1994.1025
   Zhang J Z, 1994, Exp Dermatol, V3, P164, DOI 10.1111/j.1600-0625.1994.tb00273.x
   Zhou LJ, 1997, J DERMATOL SCI, V14, P217, DOI 10.1016/S0923-1811(96)00577-4
NR 36
TC 5
Z9 6
U1 0
U2 0
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0923-1811
J9 J DERMATOL SCI
JI J. Dermatol. Sci.
PD FEB
PY 2001
VL 25
IS 2
BP 106
EP 115
DI 10.1016/S0923-1811(00)00126-2
PG 10
WC Dermatology
SC Dermatology
GA 397VV
UT WOS:000166719200002
PM 11164707
DA 2018-10-20
ER

PT J
AU Bhardwaj, RS
   Eblenkamp, M
   Berndt, T
   Tietze, L
   Klosterhalfen, B
AF Bhardwaj, RS
   Eblenkamp, M
   Berndt, T
   Tietze, L
   Klosterhalfen, B
TI Role of HSP70i in regulation of biomaterial-induced activation of human
   monocytes-derived macrophages in culture
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; COLONY-STIMULATING FACTOR; HEAT-SHOCK
   PROTEINS; ALVEOLAR MACROPHAGES; GENE-EXPRESSION; TRANSCRIPTION FACTORS;
   ENDOTHELIAL-CELLS; MESSENGER-RNA; FACTOR-ALPHA
AB The functioning of an implant depends on the material properties and the wound-healing process. The latter is led by an inflammatory reaction guided mainly by monocyte/macrophage activity. This in vitro study investigated human monocytes/macrophages in culture from 2 h to 10 days on silicone, polyurethane, teflon and TCPS. Analysis of cytokine release by ELISA showed that maturing macrophages have different capacities to produce cytokines TNF alpha, IL10, IL8 and GM-CSF. The long culture-mature macrophages on all polymers produced comparable low levels of TNF alpha, IL10 and IL8. Monocytes/macrophages on polyurethane and teflon, and those on silicone only in long culture-time produced high GM-CSF amounts, where as those on TCPS exhibited low levels of GM-CSF. FACS analysis revealed that HSP70i was highly inducible after short time culture yet this high level was maintained in long culture-mature macrophages on TCPS only, whereas on other polymers the mature macrophages showed a high reduction in HSP70i level, which demonstrated a high stress-response by cells on TCPS. Accordingly, CLSM-analysis revealed low nuclear NF-kappaB in cells on TCPS and high nuclear NF-kappaB in mature macrophages on silicone and polyurethane, showing a high cellular activation on the latter two polymers. This corresponded also to the high mitochondrial activity by XTT metabolism displayed by the mature macrophages on polyurethane greater than or equal to silicone > teflon > TCPS. These data show a correlation of (1) cytokines (TNF alpha, GM-CSF) and HSP70i, (2) NF-kappaB and HSP70i by monocytes/macrophages after contact with polymers. Thus, HSP70i might be a useful molecular candidate for exploring biomaterial-induced inflammatory reaction. (C) 2001 Kluwer Academic Publishers.
C1 Aachen Tech Univ, Fac Med, IZKF BIOMAT, D-52057 Aachen, Germany.
   Aachen Tech Univ, DWI, D-52057 Aachen, Germany.
   Aachen Tech Univ, Inst Pathol, D-52057 Aachen, Germany.
RP Bhardwaj, RS (reprint author), Aachen Tech Univ, Fac Med, IZKF BIOMAT, Pauwels Str 30, D-52057 Aachen, Germany.
EM rbhardwaj@post.klinikum.rwth-aachen.de
CR ADAMS DO, 1989, IMMUNOL TODAY, V10, P33, DOI 10.1016/0167-5699(89)90298-3
   ALI SAM, 1994, BIOMATERIALS, V15, P779, DOI 10.1016/0142-9612(94)90032-9
   Altankov G, 1996, J BIOMED MATER RES, V30, P385, DOI 10.1002/(SICI)1097-4636(199603)30:3<385::AID-JBM13>3.0.CO;2-J
   ANDERSON JM, 1993, CARDIOVASC PATHOL, V2
   BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.iy.12.040194.001041
   BECKER S, 1987, J IMMUNOL, V139, P3703
   BENSAUDE O, 1983, NATURE, V305, P331, DOI 10.1038/305331a0
   BHARDWAJ RS, 1992, EUR J IMMUNOL, V22, P1891, DOI 10.1002/eji.1830220732
   Bhardwaj RS, 1997, J MATER SCI-MATER M, V8, P737, DOI 10.1023/A:1018552326808
   CARVETH HJ, 1989, BIOCHEM BIOPH RES CO, V162, P387, DOI 10.1016/0006-291X(89)92009-3
   CHIGNIER E, 1993, J BIOMED MATER RES, V27, P1087, DOI 10.1002/jbm.820270814
   DEFIFE KM, 1995, J BIOMED MATER RES, V29, P431, DOI 10.1002/jbm.820290403
   DONNELLY RP, 1993, J IMMUNOL, V151, P5603
   EIERMAN DF, 1989, J IMMUNOL, V142, P1970
   Feinstein DL, 1996, J BIOL CHEM, V271, P17724, DOI 10.1074/jbc.271.30.17724
   FINCATO G, 1991, BLOOD, V77, P579
   FOUQUERAY B, 1992, EUR J IMMUNOL, V22, P2983, DOI 10.1002/eji.1830221133
   GIRIDHAR G, 1993, BIOMATERIALS, V14, P609, DOI 10.1016/0142-9612(93)90180-A
   Grigoriadis G, 1996, EMBO J, V15, P7099, DOI 10.1002/j.1460-2075.1996.tb01101.x
   HASKILL S, 1991, CELL, V65, P1281, DOI 10.1016/0092-8674(91)90022-Q
   Hauptmann S, 1996, J MATER SCI-MATER M, V7, P345, DOI 10.1007/BF00154546
   HENSOLD JO, 1988, MOL CELL BIOL, V8, P2219, DOI 10.1128/MCB.8.5.2219
   HORBETT TA, 1988, J BIOMED MATER RES, V22, P383, DOI 10.1002/jbm.820220503
   HOWARD M, 1992, IMMUNOL TODAY, V13, P198, DOI 10.1016/0167-5699(92)90153-X
   Hunt JA, 1996, J BIOMED MATER RES, V31, P139, DOI 10.1002/(SICI)1097-4636(199605)31:1<139::AID-JBM15>3.0.CO;2-I
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   Jackson JR, 1997, FASEB J, V11, P457
   JOHNSTON RB, 1988, NEW ENGL J MED, V318, P747, DOI 10.1056/NEJM198803243181205
   KANTENGWA S, 1993, INFECT IMMUN, V61, P1281
   KAPLAN SS, 1992, J BIOMED MATER RES, V26, P1039, DOI 10.1002/jbm.820260806
   KAPUR R, 1996, J BIOMED MATER RES, V32, P32
   Kato S, 1998, BIOMATERIALS, V19, P821, DOI 10.1016/S0142-9612(97)00240-8
   LEE MT, 1987, J IMMUNOL, V138, P3019
   Lentsch AB, 1997, J CLIN INVEST, V100, P2443, DOI 10.1172/JCI119786
   Lim F, 1996, J MATER SCI-MATER M, V7, P69, DOI 10.1007/BF00058717
   MALEFYT RD, 1991, J EXP MED, V174, P1209
   MANTOVANI A, 1989, IMMUNOL TODAY, V10, P370, DOI 10.1016/0167-5699(89)90270-3
   MARTINET Y, 1987, NEW ENGL J MED, V317, P202, DOI 10.1056/NEJM198707233170404
   MASURE S, 1991, EUR J BIOCHEM, V198, P391, DOI 10.1111/j.1432-1033.1991.tb16027.x
   NABIOULLIN R, 1994, J LEUKOCYTE BIOL, V55, P437
   PALABRICA T, 1992, NATURE, V359, P848, DOI 10.1038/359848a0
   POLLA BS, 1993, CLIN EXP ALLERGY, V23, P548, DOI 10.1111/j.1365-2222.1993.tb00893.x
   Rhodes NP, 1997, J BIOMED MATER RES, V37, P481, DOI 10.1002/(SICI)1097-4636(19971215)37:4<481::AID-JBM6>3.0.CO;2-H
   SAMPSONJOHANNES A, 1988, J IMMUNOL, V141, P3680
   SCHENK H, 1994, P NATL ACAD SCI USA, V91, P1672, DOI 10.1073/pnas.91.5.1672
   SCHRODER JM, 1989, J EXP MED, V170, P847, DOI 10.1084/jem.170.3.847
   SINGH MK, 1984, NATURE, V309, P631, DOI 10.1038/309631a0
   SPORN SA, 1990, J IMMUNOL, V144, P4431
   STEIN M, 1992, CLIN EXP ALLERGY, V22, P19, DOI 10.1111/j.1365-2222.1992.tb00110.x
   SUNDERKOTTER C, 1994, J LEUKOCYTE BIOL, V55, P410
   SUNDERKOTTER C, 1991, PHARMACOL THERAPEUT, V51, P195, DOI 10.1016/0163-7258(91)90077-Y
   Tang LP, 1996, J CLIN INVEST, V97, P1329, DOI 10.1172/JCI118549
   Teshima S, 1996, BIOCHEM J, V315, P497, DOI 10.1042/bj3150497
   WANG P, 1994, J IMMUNOL, V153, P811
   WANIDWORANUN C, 1993, J IMMUNOL, V151, P6853
   Watanabe N, 1997, EUR J IMMUNOL, V27, P2830, DOI 10.1002/eji.1830271113
   WATANABE N, 1988, CANCER RES, V48, P650
   WATANABE N, 1988, CANCER RES, V48, P2179
   WATANABE N, 1988, J BIOL CHEM, V263, P10262
   WEBER B, 1989, MOL CELL BIOL, V9, P769, DOI 10.1128/MCB.9.2.769
   WERB Z, 1984, BASIC CLIN IMMUNOL, P104
   WHELAN J, 1991, NUCLEIC ACIDS RES, V19, P2645, DOI 10.1093/nar/19.10.2645
   Wong HR, 1997, BIOCHEM BIOPH RES CO, V231, P257, DOI 10.1006/bbrc.1997.6076
   WRIGHT DG, 1979, J IMMUNOL, V123, P285
   YAMAUCHI N, 1989, CANCER RES, V49, P1671
   YOSHIMURA T, 1987, P NATL ACAD SCI USA, V84, P9233, DOI 10.1073/pnas.84.24.9233
NR 66
TC 9
Z9 9
U1 0
U2 1
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD FEB
PY 2001
VL 12
IS 2
BP 97
EP 106
DI 10.1023/A:1008974524580
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 397JB
UT WOS:000166691600001
PM 15348314
DA 2018-10-20
ER

PT J
AU Brunel, G
   Brocard, D
   Duffort, JF
   Jacquet, E
   Justumus, P
   Simonet, T
   Benque, E
AF Brunel, G
   Brocard, D
   Duffort, JF
   Jacquet, E
   Justumus, P
   Simonet, T
   Benque, E
TI Bioabsorbable materials for guided bone regeneration prior to implant
   placement and 7-year follow-up: Report of 14 cases
SO JOURNAL OF PERIODONTOLOGY
LA English
DT Article
DE titanium; bone regeneration; collagen, therapeutic use; dental implants;
   hydroxyapatite, therapeutic use; follow-up studies; membranes, barrier;
   membranes, bioabsorbable
ID PROGRESSIVE PERIODONTITIS PATIENTS; COLLAGEN MEMBRANE; TISSUE
   REGENERATION; BIORESORBABLE BARRIER; HISTOLOGIC EVALUATION; RIDGE
   AUGMENTATION; INTRABONY DEFECTS; CHRONIC ADULT; HYDROXYAPATITE;
   BIOCOMPATIBILITY
AB Background: The purpose of the present study was to evaluate the efficacy of a guided bone regeneration (GBR) procedure prior to implant placement and the long-term outcome of the inserted implants.
   Methods: Prior to dental implant placement GBR procedure was performed on 14 patients (mean age 48 years) using a synthetic hydroxyapatite (HA) spacer under a collagen membrane, After a mean healing period of 8 months, bone biopsies were obtained during the placement of 14 implants. The specimens were processed for histology without demineralization in order to assess bone quality and quantity of the regenerated bone.
   Results: Both the bone density and the resorption degree of HA particles were relatively varied between samples. The different phenotypes of osteoclasts and multinucleated giant cells and the individual host response could partially explain the unpredictable results in terms of bone remodeling and biomaterial resorption. However, the presence of HA particles in the regenerated bone had no influence on the osseointegration of implants presenting a success rate of 86% after a 7-year observation period.
   Conclusions: These results confirm the possibility of regenerating bone by means of bioabsorbable materials, assuring at the same time the long-term success for implants inserted in regenerated sites.
C1 Univ Toulouse 3, Fac Odontol, Dept Oral Biol, F-31062 Toulouse, France.
   Toulouse Grp, Toulouse, France.
   Univ Toulouse 3, Fac Odontol, Dept Periodontol, F-31062 Toulouse, France.
RP Brunel, G (reprint author), Fac Chirurg Dent, 3 Chemin Maraichers, F-31062 Toulouse, France.
CR Albrektsson T, 1986, Int J Oral Maxillofac Implants, V1, P11
   BAENA RRY, 1998, MINERVA STOMATOL, V47, P673
   Benque E, 1997, J CLIN PERIODONTOL, V24, P544, DOI 10.1111/j.1600-051X.1997.tb00227.x
   Benque E, 1999, INT J ORAL MAX IMPL, V14, P258
   Benque E, 1997, J CLIN PERIODONTOL, V24, P550, DOI 10.1111/j.1600-051X.1997.tb00228.x
   BENQUE EP, 1985, J BIOL BUCCALE, V13, P271
   Brunel G, 1996, J PERIODONTOL, V67, P1342, DOI 10.1902/jop.1996.67.12.1342
   Buser D, 1996, CLIN ORAL IMPLAN RES, V7, P175, DOI 10.1034/j.1600-0501.1996.070212.x
   Buser D A, 1997, Ann Periodontol, V2, P329, DOI 10.1902/annals.1997.2.1.329
   Cosci F, 1994, Pract Periodontics Aesthet Dent, V6, P35
   CUTLER S J, 1958, J Chronic Dis, V8, P699, DOI 10.1016/0021-9681(58)90126-7
   DAHLIN C, 1988, PLAST RECONSTR SURG, V81, P672, DOI 10.1097/00006534-198805000-00004
   DERSOT JM, 1995, ANAT REC, V242, P166, DOI 10.1002/ar.1092420205
   Fugazzotto PA, 1998, INT J ORAL MAX IMPL, V13, P358
   Hammerle CHF, 1998, PERIODONTOL 2000, V17, P151, DOI 10.1111/j.1600-0757.1998.tb00132.x
   Hermann JS, 1996, CURR OPIN PERIODONT, V3, P168
   Hurzeler MB, 1998, INT J ORAL MAX SURG, V27, P315, DOI 10.1016/S0901-5027(05)80623-X
   LUNDGREN D, 1994, CLIN ORAL IMPLAN RES, V5, P177, DOI 10.1034/j.1600-0501.1994.050309.x
   MARKS SC, 1991, J BONE MINER RES, V6, P395
   Mayfield L, 1997, CLIN ORAL IMPLAN RES, V8, P10, DOI 10.1111/j.1600-0501.1997.tb00002.x
   Mayfield L, 1998, CLIN ORAL IMPLAN RES, V9, P292, DOI 10.1034/j.1600-0501.1998.090502.x
   Nevins M, 1998, Int J Periodontics Restorative Dent, V18, P34
   Nevins M, 1997, CURR OPIN PERIODONT, V4, P109
   OGILVIE A, 1987, J PERIODONTAL RES, V22, P270, DOI 10.1111/j.1600-0765.1987.tb01585.x
   Palmer RM, 1998, CLIN ORAL IMPLAN RES, V9, P283, DOI 10.1034/j.1600-0501.1998.090501.x
   Parodi R, 1998, Int J Periodontics Restorative Dent, V18, P266
   Parodi R, 1997, INT J PERIODONT REST, V17, P283
   ROMINGER JW, 1994, J ORAL MAXIL SURG, V52, P106, DOI 10.1016/0278-2391(94)90388-3
   SEIBERT J, 1990, J PERIODONTOL, V61, P157, DOI 10.1902/jop.1990.61.3.157
   SHANAMAN RH, 1992, INT J PERIODONT REST, V12, P463
   Simion M, 1994, Int J Periodontics Restorative Dent, V14, P198
   Zahedi S, 1998, J PERIODONTOL, V69, P1238, DOI 10.1902/jop.1998.69.11.1238
NR 32
TC 54
Z9 57
U1 0
U2 2
PU AMER ACAD PERIODONTOLOGY
PI CHICAGO
PA 737 NORTH MICHIGAN AVENUE, SUITE 800, CHICAGO, IL 60611-2690 USA
SN 0022-3492
J9 J PERIODONTOL
JI J. Periodont.
PD FEB
PY 2001
VL 72
IS 2
BP 257
EP 264
DI 10.1902/jop.2001.72.2.257
PG 8
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 411HA
UT WOS:000167491100019
PM 11288801
DA 2018-10-20
ER

PT J
AU Estrada, LE
   Dodge, GR
   Richardson, DW
   Farole, A
   Jimenez, SA
AF Estrada, LE
   Dodge, GR
   Richardson, DW
   Farole, A
   Jimenez, SA
TI Characterization of a biomaterial with cartilage-like properties
   expressing type X collagen generated in vitro using neonatal porcine
   articular and growth plate chondrocytes
SO OSTEOARTHRITIS AND CARTILAGE
LA English
DT Article
DE cartilage; osteoarthritis; bioengineering; cartilage repair; type II
   collagen; type X collagen; calcification; chondrocyte
ID BIOCHEMICAL-CHARACTERIZATION; OSTEOCHONDRAL DEFECTS;
   EXTRACELLULAR-MATRIX; REPAIR; BONE; TRANSPLANTATION; IMPLANTS; CULTURE;
   MODEL; LOSE
AB Objective: The availability of cartilage with or without the potential to ossify and suitable for surgical restoration and resurfacing of joints is an important clinical problem in arthritis-related pathology, trauma and reconstructive surgery. Here, we designed experiments to generate a biomaterial with cartilage-like properties by culturing neonatal porcine articular and growth plate chondrocytes on a hydrogel substrate and to examine the biochemical and histological characteristics of the resulting tissue.
   Design: Neonatal porcine epiphyseal and growth plate chondrocytes were cultured on poly(2-hydroxyethyl methacrylate) (polyHEMA)coated dishes to prevent their adherence to plastic. We previously described that this procedure allows the maintenance of the chondrocyte-specific phenotype for greater than or equal to8 months. Chondrocytes were isolated by successive enzymatic digestions and cultured at high density (>2.0 x 10(7) cells/ml) in DMEM with 10% FBS, 50 mug/ml ascorbic acid, glutamine, vitamins, and antibiotics for up to 10 weeks on 60 mm plastic culture dishes coated with polyHEMA. The tissues produced during culture were studied histologically and biochemically and were examined for cellular proliferation employing H-3-thymidine incorporation and for their collagen production employing biosynthetic labeling with C-14-proline and Western blot with specific antibodies. The expression of relevant collagen genes was examined employing RT-PCR.
   Results: Within 24 h of culture, isolated chondrocytes organized into well-formed clusters and in 2 weeks formed structures with gross appearance and consistence similar to those of natural cartilage. The wet weight of the tissue formed in vitro increased six-fold during the 10-week period of study. Cell proliferation measured by the incorporation of H-3-thymidine increased during the first 3 weeks and reached a plateau in subsequent weeks. Histological examination showed that the cultures contained rounded chondrocytes embedded in an abundant cartilaginous extracellular matrix. The cartilage formed contained large amounts of collagen and sulfated proteoglycans as examined by staining with Masson's Trichrome and Alcian blue, respectively. Deposition of calcium in the deeper layers of the tissue was demonstrated with the von Kossa stain. Western analyses with specific antibodies showed that type II collagen was present from the first week and progressively increased in the cultures, whereas type X collagen was first detected at 4 weeks and increased with length of culture. When chondrocytes isolated from the growth plate were included, small amounts of type I collagen were detected in the medium of cultured biomaterial as expected. Type III collagen was not detected by Western blot over the 10-week period, High levels of type II and type X collagen gene expression were demonstrated by RT-PCR.
   Conclusion: These studies demonstrate the production in vitro of cartilage-like tissue with similar morphological, histochemical and biochemical characteristics to those of natural growth plate cartilage. The cartilage generated in vitro has the potential to be used in reconstructive surgery and in joint resurfacing and restoration of skeletal defects. (C) 2001 OsteoArthritis Research Society International.
C1 Thomas Jefferson Univ, Jefferson Med Coll, Dept Med, Div Rheumatol, Philadelphia, PA 19107 USA.
   Thomas Jefferson Univ, Jefferson Med Coll, Dept Oral & Maxillofacial Surg, Philadelphia, PA 19107 USA.
   Univ Penn, Sch Vet Med, Philadelphia, PA 19104 USA.
RP Jimenez, SA (reprint author), Thomas Jefferson Univ, Jefferson Med Coll, Dept Med, Div Rheumatol, 233 S 10th St,Room 509, Philadelphia, PA 19107 USA.
FU NIAMS NIH HHS [AR42417, AR39740]
CR BADER DL, 1992, BIOCHIM BIOPHYS ACTA, V1116, P147, DOI 10.1016/0304-4165(92)90111-7
   BENYA PD, 1978, CELL, V15, P1313, DOI 10.1016/0092-8674(78)90056-9
   BENYA PD, 1982, CELL, V30, P373
   Brittberg M, 1996, CLIN ORTHOP RELAT R, P270
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   BRUCKNER P, 1994, MICROSC RES TECHNIQ, V28, P378, DOI 10.1002/jemt.1070280504
   Buckwalter JA, 1998, ARTHRITIS RHEUM-US, V41, P1331, DOI 10.1002/1529-0131(199808)41:8<1331::AID-ART2>3.0.CO;2-J
   BURGESON RE, 1992, CLIN ORTHOP RELAT R, P250
   DUPOIRIEUX L, 1994, INT J ORAL MAX SURG, V23, P395, DOI 10.1016/S0901-5027(05)80028-1
   Ferraz MB, 1997, ARTHRITIS RHEUM, V40, P1587, DOI 10.1002/art.1780400907
   Freed LE, 1998, EXP CELL RES, V240, P58, DOI 10.1006/excr.1998.4010
   HEINEGARD D, 1989, FASEB J, V3, P2042
   Hunziker EB, 1999, OSTEOARTHR CARTILAGE, V7, P15, DOI 10.1053/joca.1998.0159
   ITAY S, 1987, CLIN ORTHOP RELAT R, P284
   JIMENEZ SA, 1978, BIOCHEM J, V173, P337, DOI 10.1042/bj1730337
   Kandel R A, 1997, In Vitro Cell Dev Biol Anim, V33, P174
   KRAMER JS, 1983, ARTHRITIS RHEUM, V26, P901, DOI 10.1002/art.1780260712
   MAYNE R, 1976, P NATL ACAD SCI USA, V73, P1674, DOI 10.1073/pnas.73.5.1674
   Meijer HJA, 1997, J ORAL MAXIL SURG, V55, P138, DOI 10.1016/S0278-2391(97)90229-9
   MENDLER M, 1989, J CELL BIOL, V108, P191, DOI 10.1083/jcb.108.1.191
   Mow VC, 1999, OSTEOARTHR CARTILAGE, V7, P41, DOI 10.1053/joca.1998.0161
   NOGUCHI T, 1994, CLIN ORTHOP RELAT R, P251
   PALETTA GA, 1992, AM J SPORT MED, V20, P725, DOI 10.1177/036354659202000614
   REGINATO A, 1986, J BIOL CHEM, V261, P2897
   REGINATO AM, 1994, ARTHRITIS RHEUM, V37, P1338, DOI 10.1002/art.1780370912
   REGINATO AM, 1991, BIOCHEM J, V273, P333, DOI 10.1042/bj2730333
   REMINGTON MC, 1984, BIOCHEM J, V224, P227, DOI 10.1042/bj2240227
   ROBINSON D, 1990, CALCIFIED TISSUE INT, V46, P246, DOI 10.1007/BF02555003
   SCHMID TM, 1983, J BIOL CHEM, V258, P9504
   Setton LA, 1999, OSTEOARTHR CARTILAGE, V7, P2, DOI 10.1053/joca.1998.0170
   Shortkroff S, 1996, BIOMATERIALS, V17, P147, DOI 10.1016/0142-9612(96)85759-0
   THOMAS JT, 1994, ANN RHEUM DIS, V53, P488, DOI 10.1136/ard.53.8.488
   TRELSTAD RL, 1993, TXB RHEUMATOLOGY, P35
   Tyler JA, 1998, OSTEOARTHRITIS, P94
   VACANTI CA, 1994, CLIN PLAST SURG, V21, P445
   Vacanti CA, 2000, ORTHOP CLIN N AM, V31, P351, DOI 10.1016/S0030-5898(05)70155-3
   VONDERMARK K, 1977, NATURE, V267, P531, DOI 10.1038/267531a0
   Vunjak-Novakovic G, 1998, BIOTECHNOL PROGR, V14, P193, DOI 10.1021/bp970120j
   WAKITANI S, 1994, J BONE JOINT SURG AM, V76A, P579, DOI 10.2106/00004623-199404000-00013
   WARDALE RJ, 1993, J CELL SCI, V105, P975
   Woo SL, 1988, INJURY REPAIR MUSCUL, P465
   YAMADA Y, 1991, J CRAN GENET DEV BIO, V11, P350
NR 42
TC 23
Z9 24
U1 0
U2 3
PU W B SAUNDERS CO LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 1063-4584
J9 OSTEOARTHR CARTILAGE
JI Osteoarthritis Cartilage
PD FEB
PY 2001
VL 9
IS 2
BP 169
EP 177
DI 10.1053/joca.2000.0373
PG 9
WC Orthopedics; Rheumatology
SC Orthopedics; Rheumatology
GA 409ZK
UT WOS:000167415400011
PM 11237664
OA Bronze
DA 2018-10-20
ER

PT J
AU Hallab, NJ
   Bundy, KJ
   O'Connor, K
   Moses, RL
   Jacobs, JJ
AF Hallab, NJ
   Bundy, KJ
   O'Connor, K
   Moses, RL
   Jacobs, JJ
TI Evaluation of metallic and polymeric biomaterial surface energy and
   surface roughness characteristics for directed cell adhesion
SO TISSUE ENGINEERING
LA English
DT Article
ID JET IMPINGEMENT; FIBROBLASTS; PROTEINS; GROWTH
AB Directed cell adhesion remains an important goal of implant and tissue engineering technology. In this study, surface energy and surface roughness were investigated to ascertain which of these properties show more overall influence on biomaterial-cell adhesion and colonization. Jet impingement was used to quantify cellular adhesion strength. Cellular proliferation and extracellular matrix secretion were used to characterize colonization of 3T3MC fibroblasts on: HS25 (a cobalt based implant alloy, ASTM F75), 316L stainless steel, Ti-6Al-4V (a titanium implant alloy), commercially pure tantalum (Ta), polytetrafluoroethylene (PTFE), silicone rubber (SR), and high-density polyethylene (HDPE). The metals exhibited a nearly five-fold greater adhesion strength than the polymeric materials tested. Generally, surface energy was proportional to cellular adhesion strength. Only polymeric materials demonstrated significant increased adhesion strength associated with increased surface roughness. Cellular adhesion on metals demonstrated a linear correlation with surface energy. Less than half as much cellular proliferation was detected on polymeric materials compared to the metals. However the polymers tested demonstrated greater than twice the amount of secreted extracellular matrix (ECM) proteins on a per tell basis than the metallic materials. Thus, surface energy may be a more important determinant of cell adhesion and proliferation, and may be more useful than surface roughness for directing cell adhesion and cell colonization onto engineered tissue scaffoldings.
C1 Rush Presbyterian St Lukes Med Ctr, Dept Orthoped Surg, Chicago, IL 60612 USA.
   Tulane Univ, Dept Biomed Engn, New Orleans, LA 70118 USA.
   Tulane Univ, Dept Chem Engn, New Orleans, LA 70118 USA.
   Louisiana State Univ, Sch Med, Dept Anat, New Orleans, LA USA.
RP Hallab, NJ (reprint author), Rush Med Coll, Dept Orthoped Surg, 1653 W Congress Pkwy, Chicago, IL 60612 USA.
RI O'Connor, Kim/H-3145-2012
CR BAGNALL RD, 1978, J BIOMED MATER RES, V12, P707, DOI 10.1002/jbm.820120511
   BAGNALL RD, 1980, J BIOMED MATER RES, V18, P1
   BRASH JL, 1986, J BIOMED MATER RES, V20, P1263, DOI 10.1002/jbm.820200904
   BUNDY K, 1993, T 39 ORTH RES SOC SA
   BUNDY K, 1991, T 17 ANN SOC BIOM SC
   BUNDY K, 1992, T 17 SOC BIOM SCOTTS
   BUNDY KJ, 1993, BIOMATERIALS, V14, P529, DOI 10.1016/0142-9612(93)90242-T
   DESHPANDE MD, 1982, J FLUID MECH, V114, P213, DOI 10.1017/S0022112082000111
   Gregonis DE, 1985, CONTACT ANGLE INTERF
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Hallab N., 1995, Proceedings of the 1995 Fourteenth Southern Biomedical Engineering Conference (Cat. No.95TH0703-9), P81, DOI 10.1109/SBEC.1995.514438
   HALLAB N, 1994, T 20 ANN SOC BIOM M
   Hallab NJ, 1995, J LONG-TERM EFF MED, V5, P209
   KLEINMAN HK, 1981, J CELL BIOL, V88, P473, DOI 10.1083/jcb.88.3.473
   MERRIL CR, 1986, PROTEIN STAINING DET, P323
   MOSES RL, 1989, EMSA B, V19, P60
   Richards RG, 1995, CELL BIOL INT, V19, P1015, DOI 10.1006/cbir.1995.1044
   RICHARDS RG, 1993, T 10 EUR C BIOM DAV
   SCHAKENRAAD JM, 1986, J BIOMED MATER RES, V20, P773, DOI 10.1002/jbm.820200609
   SUNG KLP, 1994, J BIOMECH ENG-T ASME, V116, P237, DOI 10.1115/1.2895725
   VAISHNAV RN, 1983, J BIOMECH ENG-T ASME, V105, P77, DOI 10.1115/1.3138389
   VANDIJK LJ, 1988, BIOFOULING, V1, P19
NR 22
TC 286
Z9 304
U1 3
U2 64
PU MARY ANN LIEBERT INC PUBL
PI LARCHMONT
PA 2 MADISON AVENUE, LARCHMONT, NY 10538 USA
SN 1076-3279
J9 TISSUE ENG
JI Tissue Eng.
PD FEB
PY 2001
VL 7
IS 1
BP 55
EP 71
DI 10.1089/107632700300003297
PG 17
WC Cell & Tissue Engineering
SC Cell Biology
GA 406UW
UT WOS:000167235200006
PM 11224924
DA 2018-10-20
ER

PT J
AU van Osch, GJVM
   van der Veen, SW
   Marijnissen, WJCM
   Verhaar, JAN
AF van Osch, GJVM
   van der Veen, SW
   Marijnissen, WJCM
   Verhaar, JAN
TI Monoclonal antibody 11-fibrau: A useful marker to characterize
   chondrocyte differentiation stage
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE 11-fibrau; cartilage; chondrocyte; differentiation; dedifferentiation;
   tissue-engineering; alginate culture; monolayer culture;
   immunohistochemistry
ID GROWTH-FACTOR-BETA; ARTICULAR CHONDROCYTES; EXPRESSION; COLLAGEN;
   CARTILAGE; CULTURE
AB The aim of this study was to determine the feasibility of discriminating between differentiated and dedifferentiated chondrocytes by using the Mab 11-fibrau. Mab 11-fibrau did not bind to differentiated chondrocytes in cartilage of human knee joint, auricle, or nasal septum. During monolayer culture, when cells dedifferentiate, the number of 11-fibrau positive cells gradually increased and reached up to 100% after 4 passages, When differentiated chondrocytes were cultured in alginate, most (90-95%) of the cells remained 11-fibrau negative, in accordance with previous studies demonstrating that differentiated chondrocytes cultured in alginate keep their phenotype. Dedifferentiated (11-fibrau positive) cells were subjected to different redifferentiation regimes. As a well-known fact, cultures in alginate in medium where FCS was replaced by IGF1 and TGF beta2 results in increased collagen type II formation, indicative for redifferentiation. However, the cells remained 11-fibrau positive, suggesting they are not (yet) fully redifferentiated. On the other hand, when dedifferentiated cells (after 4 passages in monolayer culture) were seeded in a biomaterial and implanted subcutaneously in a nude mouse, the newly formed cartilage matrix contained collagen type II and the 11-fibrau staining on the cells had disappeared. Our results indicate that 11-fibrau may be a reliable and sensitive marker of chondrocyte phenotype. (C) 2001 Academic Press.
C1 Erasmus Univ, Med Ctr, Dept Otorhinolaryngol, Rotterdam, Netherlands.
   Erasmus Univ, Med Ctr, Dept Orthopaed, Rotterdam, Netherlands.
RP van Osch, GJVM (reprint author), Erasmus Univ, Med Ctr, Dept Otorhinolaryngol, Rotterdam, Netherlands.
OI Verhaar, Jan/0000-0003-3016-9600
FU NICHD NIH HHS [N01-HD-6-2915]
CR ADAM M, 1983, CLIN CHIM ACTA, V133, P25, DOI 10.1016/0009-8981(83)90017-7
   Aigner T, 1997, OSTEOARTHR CARTILAGE, V5, P183, DOI 10.1016/S1063-4584(97)80013-1
   BUJIA J, 1996, IN VITRO CELL DEV-AN, V32, P366
   Elder SH, 2000, J ORTHOPAED RES, V18, P78, DOI 10.1002/jor.1100180112
   ELIMA K, 1989, FEBS LETT, V258, P195, DOI 10.1016/0014-5793(89)81651-5
   FARELL CM, 1995, J BIOL CHEM, V270, P3400
   HAUSELMANN HJ, 1994, J CELL SCI, V107, P17
   Lafeber FPJG, 1997, J RHEUMATOL, V24, P536
   Marijnissen WJCM, 2000, BIOMATERIALS, V21, P571, DOI 10.1016/S0142-9612(99)00218-5
   Martin I, 1999, EXP CELL RES, V253, P681, DOI 10.1006/excr.1999.4708
   MOLLENHAUER J, 1988, J RHEUMATOL, V15, P1811
   VANDERKRAAN P, 1992, J RHEUMATOL, V19, P140
   VANDERMARK K, 1977, NATURE, V267, P531
   VANOSCH GJV, 1998, T ORTHOP RES SOC, V23, P441
   VANOSCH GJV, 2001, IN PRESS AM J RHINOL
   VANOSCH GJV, 2001, IN PRESS PLAST RECON
   Wu QQ, 2000, EXP CELL RES, V256, P383, DOI 10.1006/excr.2000.4847
   Yaeger PC, 1997, EXP CELL RES, V237, P318, DOI 10.1006/excr.1997.3781
NR 18
TC 13
Z9 13
U1 0
U2 0
PU ACADEMIC PRESS INC
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD JAN 26
PY 2001
VL 280
IS 3
BP 806
EP 812
DI 10.1006/bbrc.2000.4168
PG 7
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 397LN
UT WOS:000166697300033
PM 11162592
DA 2018-10-20
ER

PT B
AU Raileanu, M
   Arsene, M
   Stanciu, L
   Bordeianu, L
   Zaharescu, M
AF Raileanu, M
   Arsene, M
   Stanciu, L
   Bordeianu, L
   Zaharescu, M
GP IMT-BUCHAREST
   IMT-BUCHAREST
TI Enzymes entrapment in sol-gel silica matrix for biomedical application
SO 2001 INTERNATIONAL SEMICONDUCTOR CONFERENCE, VOL 1 & 2, PROCEEDINGS
LA English
DT Proceedings Paper
CT International Semiconductor Conference
CY OCT 09-13, 2001
CL SINAIA, ROMANIA
SP Natl Inst Res & Dev Microtechnol, Romanian Acad, Electrochem Soc Inc, IEEE Electr Devices Soc, Natl Agcy Sci Technol & Innovat, IEEE Romanian Sect Elect Devices Chapter
ID ORGANIC-CHEMISTRY; GLUCOSE-OXIDASE
AB The immobilization of glucose oxidase by sol-gel method was performed in SiO2 matrices obtained from different precursors (tetraethylorthosilicate or sodium silicate solution). The enzymatic system was glucose oxidase-peroxidase and the chromogens were p-hidroxybenzensulphonate and 4-aminoantipyrine. An one step procedure was proposed which simplifies the experiments and improve the homogeneity of the biomaterial.
C1 Romanian Acad, Inst Phys Chem IG Murgulescu, Bucharest 77208, Romania.
RP Raileanu, M (reprint author), Romanian Acad, Inst Phys Chem IG Murgulescu, 202 Splauil Independentei, Bucharest 77208, Romania.
RI Zaharescu, Maria/C-4185-2012
CR ARSENE M, 1999, P 13 C GLASS CER VAR, P345
   AVNIR D, 1995, ACCOUNTS CHEM RES, V28, P328, DOI 10.1021/ar00056a002
   Avnir D., 1992, SPIE SOL GEL OPTICS, V1758, P456
   BRAUN S, 1992, J NON-CRYST SOLIDS, V147, P739, DOI 10.1016/S0022-3093(05)80708-2
   DAVE BC, 1994, ANAL CHEM, V66, pA1120, DOI 10.1021/ac00094a001
   DAVE BC, 1995, ACS SYM SER, V585, P351
   Georgi U, 1998, J SOL-GEL SCI TECHN, V13, P295, DOI 10.1023/A:1008611924361
   Lin J, 1997, TRAC-TREND ANAL CHEM, V16, P200, DOI 10.1016/S0165-9936(97)00021-6
   Liu ZJ, 1999, ANAL CHIM ACTA, V392, P135, DOI 10.1016/S0003-2670(99)00247-0
   Pandey PC, 1999, SENSOR ACTUAT B-CHEM, V60, P83, DOI 10.1016/S0925-4005(99)00246-4
   RAPPAPORT Z, 1998, CHEM ORGANIC SILICON
   Reetz MT, 1997, ADV MATER, V9, P943, DOI 10.1002/adma.19970091203
   Zink JI, 1994, J SOL-GEL SCI TECHN, V2, P791, DOI 10.1007/BF00486352
   ZINK JI, 1994, NEW J CHEM, V18, P1109
NR 14
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 0-7803-6666-2
PY 2001
BP 281
EP 284
PG 4
WC Engineering, Electrical & Electronic; Instruments & Instrumentation;
   Materials Science, Multidisciplinary; Optics
SC Engineering; Instruments & Instrumentation; Materials Science; Optics
GA BU24V
UT WOS:000175459600057
DA 2018-10-20
ER

PT B
AU Li, H
   Yang, SX
   Shi, J
AF Li, H
   Yang, SX
   Shi, J
BE Zhang, L
   Gu, F
TI Modeling of supercritical carbon dioxide extraction by artificial neural
   networks
SO 8TH INTERNATIONAL CONFERENCE ON NEURAL INFORMATION PROCESSING, VOLS 1-3,
   PROCEEDING
LA English
DT Proceedings Paper
CT 8th International Conference on Neural Information Processing (ICONIP
   2001)
CY NOV 14-18, 2001
CL SHANGHAI, PEOPLES R CHINA
SP Asia-Pacific Neural Network Assembly, China Neural Network Council, Fundan Univ, Shanghai Assoc Sci & Technol, IEEE Beijing Sect, IEEE NN Council INNS, Fudan Univ, Ctr Brain Sci Res, Shanghai Soc Biophys
DE supercritical carbon dioxide; artificial neural network;
   back-propagation; hybrid neural network
AB Supercritical carbon dioxide possesses specific characteristics that make it attractive as solvent. In particular, the solubility and hence the yield of biomaterial, can be controlled by pressure and temperature. The experiments to obtain high-pressure phase-equilibrium data for supercritical carbon dioxide are very difficult and costly to conduct. Therefore, it would be extremely useful to develop a model to extend and complement the experimentally obtained data for supercritical carbon dioxide-solute systems at high pressures. In this paper, an artificial neural network that consider the system as a black box is designed for the mass transfer modeling of supercritical carbon dioxide extraction. The proposed neural network assumes a three-layer structure with a fast back-propagation learning algorithm. The model predictions are compared to a conventional model with a Peng-Robinson equation of state in literature. In addition, a hybrid model using both neural network and Peng-Robinson state equation is developed for supercritical carbon dioxide extraction, where the neural network is used to generate the non-linear binary interaction parameter of the Peng-Robinson state equation. Various temperatures, pressures, and solubility in literature are used to train the proposed models. Generally, the results using the proposed neural network models are better than those using the conventional model. The effectiveness of the proposed neural network approaches proaches are demonstrated by simulation and comparison studies.
C1 Univ Guelph, Sch Engn, Guelph, ON N1G 2W1, Canada.
RP Yang, SX (reprint author), Univ Guelph, Sch Engn, Guelph, ON N1G 2W1, Canada.
CR CLIFFORD T, 1998, FUNDAMENTALS SUPERCR
   CYGNAROWICZPROVOST M, 1992, J SUPERCRIT FLUID, V5, P24, DOI 10.1016/0896-8446(92)90037-K
   GOPALAKRISHNAN N, 1991, J AGR FOOD CHEM, V39, P1976, DOI 10.1021/jf00011a018
   KARAYLANNIS NB, 1993, ARTIFICIAL NEURAL NE
   SCHMITT WJ, 1986, J CHEM ENG DATA, V31, P204, DOI 10.1021/je00044a021
   Sovava H., 1994, CHEM ENG SCI, V49, P409, DOI 10.1016/0009-2509(94)87012-8
   Stuart G., 1997, Ciencia e Tecnologia de Alimentos, V17, P501, DOI 10.1590/S0101-20611997000400030
   THOMPSON ML, 1991, AICHE J, V40, P1328
NR 8
TC 0
Z9 0
U1 0
U2 0
PU FUDAN UNIV PRESS
PI SHANGHAI
PA 579 GUOQUAN RD, SHANGHAI 200433, PEOPLES R CHINA
BN 7-309-03012-5
PY 2001
BP 337
EP 342
PG 6
WC Computer Science, Artificial Intelligence; Computer Science, Hardware &
   Architecture; Robotics
SC Computer Science; Robotics
GA BU46F
UT WOS:000176058200063
DA 2018-10-20
ER

PT J
AU Kuzay, TM
   Kazmierczak, M
   Hsieh, BJ
AF Kuzay, TM
   Kazmierczak, M
   Hsieh, BJ
TI X-ray beam/biomaterial thermal interactions in third-generation
   synchrotron sources
SO ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
LA English
DT Article
ID RADIATION-DAMAGE; CRYSTALLOGRAPHY; CRYOCRYSTALLOGRAPHY; CRYSTALS
AB Third-generation synchrotron sources generate strong X-ray beams. The beam's interaction with biomaterials gives rise to concerns related to thermal damage and radiation damage. Of the two issues, the thermal interaction is conducive to rigorous analysis from first principles, although this has not been performed to date in a comprehensive manner. In this study, the interaction of the X-ray beam emanating from a third-generation synchrotron with a typical frozen biocrystal is theoretically studied, focusing specifically on the resulting unsteady (time-dependent) and steady heat-transfer phenomena. A unique regime map is developed to explain and to identify, on the basis of Fourier and Biot numbers as governing parameters, the applicable mathematical models that predict the subsequent thermal behavior. Depending on the values of these parameters, some simplified but realistic 'generic' solutions are generated that are suitable for that particular domain of applicability. Classical heat-transfer theory was used to describe the third-generation X-ray beam and biomaterial thermal interaction. Besides the generalized approach presented, numerous illustrative cases were solved and the resulting temperature levels are explicitly presented. Overall, the resulting thermal behavior of the system, i.e. peak and local temperature distribution, during both early transient development and for sustained long-time steady-state conditions, depends on a number of factors including the amount of energy absorbed, convective heat-transfer film coefficient and gas temperature, the sample size and shape, and the thermophysical properties of the sample and cooling gas. Results of the analysis revealed the strong influence that convection has on the transient and final steady-state temperature of the sample and the impact of internal heat conduction. The characteristic timescales of the important and dominant thermal processes with respect to the two types of thermal models are clearly identified.
C1 Argonne Natl Lab, Adv Photon Source, Argonne, IL 60439 USA.
RP Kazmierczak, M (reprint author), Argonne Natl Lab, Adv Photon Source, 9700 S Cass Ave, Argonne, IL 60439 USA.
CR ANFINRUD PA, 1999, COMMUNICATION
   BEJAN A, 1993, HEAT TRANSFER, P153
   Blake C. F. F., 1962, BIOL EFFECTS IONIZIN, P183
   Garman E, 1999, ACTA CRYSTALLOGR D, V55, P1641, DOI 10.1107/S0907444999008653
   Garman EF, 1997, J APPL CRYSTALLOGR, V30, P211, DOI 10.1107/S0021889897002677
   GONZALEZ A, 1994, ACTA CRYSTALLOGR D, V50, P874, DOI 10.1107/S0907444994006311
   HELLIWELL JR, 1992, MACROMOLECULAR CRYST
   HOPE H, 1989, ACTA CRYSTALLOGR B, V45, P190, DOI 10.1107/S0108768188013710
   KUZAY TM, 2001, UNPUB J SYNCHROTRON
   LOCK GSH, 1990, GROWTH DECAY ICE, P302
   NAVE C, 1995, RADIAT PHYS CHEM, V45, P483, DOI 10.1016/0969-806X(95)92800-E
   OZISIK MN, 1994, J HEAT TRANS-T ASME, V116, P526, DOI 10.1115/1.2910903
   OZISIK MN, 1993, HEAT CONDUCTION
   Ren Z, 1999, J SYNCHROTRON RADIAT, V6, P891, DOI 10.1107/S0909049599006366
   Srajer V, 1996, SCIENCE, V274, P1726, DOI 10.1126/science.274.5293.1726
   TENG TY, 1990, J APPL CRYSTALLOGR, V23, P387, DOI 10.1107/S0021889890005568
NR 16
TC 40
Z9 40
U1 2
U2 9
PU MUNKSGAARD INT PUBL LTD
PI COPENHAGEN
PA 35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK
SN 0907-4449
J9 ACTA CRYSTALLOGR D
JI Acta Crystallogr. Sect. D-Biol. Crystallogr.
PD JAN
PY 2001
VL 57
BP 69
EP 81
DI 10.1107/S0907444900013299
PN 1
PG 13
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Biophysics; Crystallography
SC Biochemistry & Molecular Biology; Biophysics; Crystallography
GA 388BN
UT WOS:000166157700009
PM 11134929
OA Bronze
DA 2018-10-20
ER

PT J
AU Letic-Gavrilovic, A
   Fini, M
   Giavaresi, G
   Giardino, R
   Abe, K
AF Letic-Gavrilovic, A
   Fini, M
   Giavaresi, G
   Giardino, R
   Abe, K
TI Evaluation of composite collagen/hydroxy-apatite implantation and nerve
   growth factor (NGF) delivery on new bone ingrowth
SO ACTA VETERINARIA-BEOGRAD
LA English
DT Article
DE bone ingrowth; collagen/hydroxy apatite implants; nerve growth factor
   (NGF)
ID MORPHOGENETIC PROTEINS; REGENERATION; METABOLISM; CELLS; CGRP
AB In this study, a bio-artificial bioresorbable composite consisting of a polymer of collagen/hydroxy-apatite (Col/Hap) enriched with neurotropin - nerve growth factor (NGF), was implanted into the femurs of 73 male Wistar rats, weighing 100-125 g. Implants were left in place for different times, Controls were as follows: a) contralateral femur without any implants; and b) contralateral femur implanted with composite without NGF factor. The rats were euthanized after 1, 10 and 30 days and the implant sites and explants were examined clinically, histologically, by scanning electron microscopy and histomorphometrically.
   The results show stimulated periosteal and endocortical woven and lamellar bone formation, which yielded increases in bone mass and decreases in bone marrow. The NGF treatment had greater effects in the femur shafts of older male rats than in younger ones. Additionally, we found that NGF increased remodeling activity in the intracortical region and induced an increase of intracortical cavity number and area by the end of the study. Since no similar studies appear to have been carried out, it is difficult to correlate our findings with other studies where neurogenic factors are delivered by complex polymer composites. We believe that this proposed system has great advantages in tissue engineering and is very suitable as a biomaterial for filling irregular defects in orthopaedic and maxillo-facial surgery, bone replacement and fixation, and as a drug delivery device.
C1 Univ Belgrade, Fac Stomatol, Dept Biochem, Belgrade, Yugoslavia.
   Orthoped Inst Rizzoli, Dept Expt Surg, Bologna, Italy.
   Fukuoka Dent Coll, Dept Oral Biochem, Fukuoka, Japan.
RP Letic-Gavrilovic, A (reprint author), Univ Belgrade, Fac Stomatol, Dept Biochem, Belgrade, Yugoslavia.
RI Fini, Milena/J-4808-2016
OI Fini, Milena/0000-0002-3732-3570; Giavaresi,
   Gianluca/0000-0001-7843-5969
CR Akopian A, 2000, PEPTIDES, V21, P559, DOI 10.1016/S0196-9781(00)00185-6
   Aloe L, 1997, ALLERGY, V52, P883, DOI 10.1111/j.1398-9995.1997.tb01247.x
   Auffray I, 1996, BLOOD, V88, P1608
   Bakos D, 1999, BIOMATERIALS, V20, P191, DOI 10.1016/S0142-9612(98)00163-X
   BJURHOLM A, 1988, PEPTIDES, V9, P165, DOI 10.1016/0196-9781(88)90023-X
   Du C, 1998, J BIOMED MATER RES, V42, P540, DOI 10.1002/(SICI)1097-4636(19981215)42:4<540::AID-JBM9>3.3.CO;2-U
   Esposito M, 1998, EUR J ORAL SCI, V106, P527, DOI 10.1046/j.0909-8836..t01-2-.x
   Gao TJ, 1997, INT ORTHOP, V21, P194, DOI 10.1007/s002640050149
   Gross KA, 1998, INT J ORAL MAX IMPL, V13, P601
   HORISAKA Y, 1994, J BIOMED MATER RES, V28, P97, DOI 10.1002/jbm.820280113
   Kataoka K, 2001, ADV DRUG DELIVER REV, V47, P113, DOI 10.1016/S0169-409X(00)00124-1
   Kjaer I, 1998, CRIT REV ORAL BIOL M, V9, P224, DOI 10.1177/10454411980090020501
   KOUTSOUKOS P, 1980, J AM CHEM SOC, V102, P1553, DOI 10.1021/ja00525a015
   Kreuter J, 2001, ADV DRUG DELIVER REV, V47, P65, DOI 10.1016/S0169-409X(00)00122-8
   Kundu B, 1999, PEPTIDES, V20, P523, DOI 10.1016/S0196-9781(99)00034-0
   LERNER UH, 1994, ORAL SURG ORAL MED O, V78, P481, DOI 10.1016/0030-4220(94)90043-4
   Lerner UH, 1997, ACTA PHYSIOL SCAND, V161, P81, DOI 10.1046/j.1365-201X.1997.d01-1933.x
   Letic-Gavrilovic A, 2000, Dent Mater J, V19, P99
   Lind M, 1996, ACTA ORTHOP SCAND, V67, P407, DOI 10.3109/17453679609002342
   Lind M, 1998, Acta Orthop Scand Suppl, V283, P2
   Lundberg P, 1999, REGUL PEPTIDES, V85, P47, DOI 10.1016/S0167-0115(99)00069-5
   Lundberg P, 2001, ENDOCRINOLOGY, V142, P339, DOI 10.1210/en.142.1.339
   Park YJ, 1998, J CONTROL RELEASE, V51, P201, DOI 10.1016/S0168-3659(97)00169-7
   Pietrzak WS, 1996, BONE, V19, pS109, DOI 10.1016/S8756-3282(96)00139-1
   Reddi AH, 1998, NAT BIOTECHNOL, V16, P247, DOI 10.1038/nbt0398-247
   Ripamonti U, 1997, CRIT REV ORAL BIOL M, V8, P154, DOI 10.1177/10454411970080020401
   SANDHU HS, 1987, ANAT RECORD, V219, P32, DOI 10.1002/ar.1092190107
   Shikinami Y, 1999, BIOMATERIALS, V20, P859, DOI 10.1016/S0142-9612(98)00241-5
   TANAKA E, 1990, J DENT RES, V60, P60
   YADA M, 1994, BIOCHEM BIOPH RES CO, V205, P1187, DOI 10.1006/bbrc.1994.2791
   YANKNER BA, 1982, ANNU REV BIOCHEM, V51, P845, DOI 10.1146/annurev.bi.51.070182.004213
   Yao W, 1999, BONE, V25, P697, DOI 10.1016/S8756-3282(99)00220-3
NR 32
TC 0
Z9 0
U1 1
U2 2
PU VETERINARY FACULTY
PI BELGRADE
PA BULEVAR JNA 18, 11000 BELGRADE, YUGOSLAVIA
SN 0567-8315
J9 ACTA VET-BEOGRAD
JI Acta Vet.-Beogr.
PY 2001
VL 51
IS 5-6
BP 299
EP 310
PG 12
WC Veterinary Sciences
SC Veterinary Sciences
GA 514RC
UT WOS:000173454000004
DA 2018-10-20
ER

PT J
AU Mansur, HS
   Orefice, RL
   Lobato, ZP
   Vasconcelos, WL
   Mansur, ES
   Machado, LJC
AF Mansur, HS
   Orefice, RL
   Lobato, ZP
   Vasconcelos, WL
   Mansur, ES
   Machado, LJC
TI Adsorption/desorption behavior of bovine serum albumin and porcine
   insulin on chemically patterned porous gel networks
SO ADSORPTION-JOURNAL OF THE INTERNATIONAL ADSORPTION SOCIETY
LA English
DT Article
DE protein adsorption; adsorption kinetics; sol-gel process; porous glass;
   surface engineering
AB Adsorption/desorption of proteins onto a biomaterial surface plays a major role on the biocompatibility of the implanted material. By modifying the biomaterial surface with specially designed functional groups one may achieve the most specific behavior of the developed material used in a biological system. Based on that, porous gel matrixes with functionalized surfaces offer unlimited possibilities to control the protein-substrate interaction behavior. In the present work, we have functionalized the surface of porous glass with several chemical groups during the synthesis of the silica matrix. The porous glass matrixes were obtained using tetraethoxysilane (TEOS)/ethanol and functionalized with 3-mercaptopropyltrimethoxysilane (MPTMS) and 3-aminopropyltriethoxysilane (APTES). In vitro tests of the kinetics of protein adsorption and desorption from the gel matrix were monitored by UV-visible spectroscopy. The bioactivity of the incorporated protein was verified by in vivo experiments with adult male rats, where they presented an acute hypoglycemic peak.
C1 Univ Fed Minas Gerais, Dept Met & Mat Engn, BR-30160030 Belo Horizonte, MG, Brazil.
   Univ Fed Minas Gerais, Dept Vet Med, BR-30160030 Belo Horizonte, MG, Brazil.
   Univ Fed Minas Gerais, Sch Med, Dept Internal Med, Belo Horizonte, MG, Brazil.
EM hmansur@demet.ufmg.br
RI Orefice, Rodrigo/N-8055-2018
OI Orefice, Rodrigo/0000-0002-6046-4056; Lobato, Zelia/0000-0002-9399-3691;
   Mansur, Herman/0000-0002-3032-495X
CR Copeland R. A., 1994, METHODS PROTEIN ANAL
   DAVE BC, 1994, ANAL CHEM, V66, pA1120, DOI 10.1021/ac00094a001
   ELLERBY LM, 1992, SCIENCE, V255, P1115
   GILL I, 1998, J AM CHEM SOC, V120, P8598
   HENCH LL, 1990, CHEM REV, V90, P33, DOI 10.1021/cr00099a003
   JANOWSKI F, 1991, J CHEM TECHNOL BIOT, V51, P263
   LIVAGE J, 1994, SPIE, V2288, P503
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   LU CF, 1994, J COLLOID INTERF SCI, V168, P161
   MALMSTEN M, 1998, BIOPOLYMERS INTERFAC, P143
   MANSUR HS, 1999, J INT FED MED BIO S2, V37, P372
   MANSUR HS, 1999, ACTA MICROSC SA, V8, P17
   MCDONAGH C, 1998, ANAL CHEM, V70, P50
   Ratner B. D., 1996, BIOMATERIALS SCI INT
   YAMAGUCHI N, 1992, CAN J PHYSIOL PHARM, V70, P167, DOI 10.1139/y92-024
   ZHENG L, 1997, ANAL CHEM, V69, P3949
   ZUSMAN R, 1992, ANAL BIOCHEM, V201, P103, DOI 10.1016/0003-2697(92)90180-F
NR 17
TC 12
Z9 13
U1 0
U2 6
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0929-5607
EI 1572-8757
J9 ADSORPTION
JI Adsorpt.-J. Int. Adsorpt. Soc.
PY 2001
VL 7
IS 2
BP 105
EP 116
DI 10.1023/A:1011687706161
PG 12
WC Chemistry, Physical; Engineering, Chemical
SC Chemistry; Engineering
GA 467VQ
UT WOS:000170724800002
DA 2018-10-20
ER

PT J
AU Anderson, JM
AF Anderson, JM
TI Biological responses to materials
SO ANNUAL REVIEW OF MATERIALS RESEARCH
LA English
DT Review
DE biocompatibility; inflammation; foreign body reaction; in vivo studies;
   toxicity
ID GIANT-CELL FORMATION; GROWTH FACTOR-BETA; HUMAN MACROPHAGE FUSION;
   ENDOTHELIAL-CELLS; MONOCYTE/MACROPHAGE ADHESION; MODIFIED SURFACES;
   MESSENGER-RNA; IN-VITRO; INFLAMMATION; TISSUE
AB All materials intended for application in humans as biomaterials, medical devices, or prostheses undergo tissue responses when implanted into living tissue. This review first describes fundamental aspects of tissue responses to materials, which are commonly described as the tissue response continuum. These actions involve fundamental aspects of tissue responses including injury, inflammatory and wound healing responses, foreign body reactions, and fibrous encapsulation of the biomaterial, medical device, or prosthesis. The second part of this review describes the in vivo evaluation of tissue responses to biomaterials, medical devices, and prostheses to determine intended performance characteristics and safety or biocompatibility considerations. While fundamental aspects of tissue responses to materials are important from research and development perspectives, the in vivo evaluation of tissue responses to these materials is important for performance, safety, and regulatory reasons.
C1 Inst Pathol, Cleveland, OH 44106 USA.
RP Anderson, JM (reprint author), Inst Pathol, 2085 Adelbert Rd, Cleveland, OH 44106 USA.
CR ANDERSON D, 1988, BRIT VET J S, V1, P7
   ANDERSON JM, 1993, CARDIOVASC PATHOL, V2, pS33
   *ASS ADV MED INSTR, 1997, AAMI STAND REC PRA S, V4
   *ASTM, 1999, AM SOC TEST MAT ANN
   BROADLEY KN, 1989, LAB INVEST, V61, P571
   Burgess TL, 1999, J CELL BIOL, V145, P527, DOI 10.1083/jcb.145.3.527
   BUTCHER EC, 1991, CELL, V67, P1033, DOI 10.1016/0092-8674(91)90279-8
   CHAMBERS TJ, 1982, IMMUNOBIOLOGY, V161, P283, DOI 10.1016/S0171-2985(82)80084-3
   Chapekar MS, 1996, J BIOMED MATER RES, V33, P199, DOI 10.1002/(SICI)1097-4636(199623)33:3<199::AID-JBM10>3.0.CO;2-C
   CLARK RAF, 1982, J INVEST DERMATOL, V79, P264, DOI 10.1111/1523-1747.ep12500075
   Clark RAF, 1988, MOL CELLULAR BIOL WO
   Cleland JL, 1997, J CONTROL RELEASE, V49, P193, DOI 10.1016/S0168-3659(97)00075-8
   COTRAN RS, 1990, J AM SOC NEPHROL, V1, P225
   Cotran RS, 1999, PATHOLOGIC BASIS DIS, P50
   DeFife KM, 1999, J HISTOCHEM CYTOCHEM, V47, P65, DOI 10.1177/002215549904700107
   DeFife KM, 1999, J BIOMED MATER RES, V44, P298, DOI 10.1002/(SICI)1097-4636(19990305)44:3<298::AID-JBM8>3.0.CO;2-N
   DeFife KM, 1999, J BIOMED MATER RES, V45, P148, DOI 10.1002/(SICI)1097-4636(199905)45:2<148::AID-JBM10>3.0.CO;2-U
   DeFife KM, 1997, J IMMUNOL, V158, P3385
   DeFife KM, 1999, FASEB J, V13, P823
   DVORAK HF, 1987, LAB INVEST, V57, P673
   *FDA, 1995, G951 FDA
   FONG Y, 1990, SURG GYNECOL OBSTET, V170, P363
   GALLIN JI, 1999, INFLAMMATION BASIC P
   GOLDEN MA, 1991, J CLIN INVEST, V87, P406, DOI 10.1172/JCI115011
   Greenfield EM, 1999, LIFE SCI, V65, P1087, DOI 10.1016/S0024-3205(99)00156-3
   Greisler H, 1988, ASAIO Trans, V34, P1051
   HENSON PM, 1980, AM J PATHOL, V101, P494
   HENSON PM, 1987, J CLIN INVEST, V79, P669, DOI 10.1172/JCI112869
   HENSON PM, 1971, J IMMUNOL, V107, P1547
   Honma T, 1996, VIRCHOWS ARCH, V428, P165
   Hunt TK, 1984, SOFT HARD TISSUE REP
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   IGNOTZ RA, 1987, J BIOL CHEM, V262, P6443
   *ISO, 1993, 10993 ISO
   Jenney CR, 1999, J BIOMED MATER RES, V46, P11, DOI 10.1002/(SICI)1097-4636(199907)46:1<11::AID-JBM2>3.3.CO;2-P
   Jenney CR, 1999, J BIOMED MATER RES, V44, P206, DOI 10.1002/(SICI)1097-4636(199902)44:2<206::AID-JBM11>3.0.CO;2-D
   Jenney CR, 1998, J BIOMED MATER RES, V41, P171, DOI 10.1002/(SICI)1097-4636(199808)41:2<171::AID-JBM1>3.0.CO;2-F
   Jimi E, 1999, EXP CELL RES, V247, P84, DOI 10.1006/excr.1998.4320
   JOHNSTON RB, 1988, NEW ENGL J MED, V318, P747, DOI 10.1056/NEJM198803243181205
   JUTILA MA, 1992, APMIS, V100, P191, DOI 10.1111/j.1699-0463.1992.tb00861.x
   KAO WYJ, 1995, J BIOMED MATER RES, V29, P1267, DOI 10.1002/jbm.820291014
   KOVACS EJ, 1991, IMMUNOL TODAY, V12, P17, DOI 10.1016/0167-5699(91)90107-5
   LANGONE JJ, 1998, IMMUNOTOXICITY TESTI
   LEHRER RI, 1988, ANN INTERN MED, V109, P127, DOI 10.7326/0003-4819-109-2-127
   LUM L, 1999, J BIOL CHEM, V75, P783
   Maciag T, 1990, Important Adv Oncol, P85
   MADRI JA, 1988, J CELL BIOL, V106, P1375, DOI 10.1083/jcb.106.4.1375
   MALECH HL, 1987, NEW ENGL J MED, V317, P687, DOI 10.1056/NEJM198709103171107
   MARCHANT R, 1983, J BIOMED MATER RES, V17, P301, DOI 10.1002/jbm.820170209
   McNally AK, 1996, AM J PATHOL, V149, P975
   MCNALLY AK, 1995, AM J PATHOL, V147, P1487
   Merkel KD, 1999, AM J PATHOL, V154, P203, DOI 10.1016/S0002-9440(10)65266-2
   Most J, 1997, BLOOD, V89, P662
   MULLER G, 1987, P NATL ACAD SCI USA, V84, P5600, DOI 10.1073/pnas.84.16.5600
   MUSTOE TA, 1987, SCIENCE, V237, P1333, DOI 10.1126/science.2442813
   PATY PB, 1990, ARCH SURG-CHICAGO, V125, P65
   POBER JS, 1990, TRANSPLANTATION, V50, P537, DOI 10.1097/00007890-199010000-00001
   RAE T, 1986, CRIT REV BIOCOMPAT, V2, P97
   RICHES DWH, 1989, MOL CELLULAR BIOL WO, P213
   Roodman GD, 1996, ENDOCR REV, V17, P308, DOI 10.1210/er.17.4.308
   SALTHOUSE TN, 1976, J BIOMED MATER RES, V10, P197, DOI 10.1002/jbm.820100204
   SPECTOR M, 1989, CRIT REV BIOCOMPAT, V5, P269
   SPILIZEWSKI K L, 1985, Journal of Controlled Release, V2, P197, DOI 10.1016/0168-3659(85)90045-8
   SPORN MB, 1988, NATURE, V332, P217, DOI 10.1038/332217a0
   SPORN MB, 1990, PEPTIDE GROWTH FACTO, V1
   Takahashi N, 1999, BIOCHEM BIOPH RES CO, V256, P449, DOI 10.1006/bbrc.1999.0252
   Tang LP, 1998, J BIOMAT SCI-POLYM E, V9, P1257
   TANG LP, 1993, J EXP MED, V178, P2147, DOI 10.1084/jem.178.6.2147
   THOMPSON JA, 1988, SCIENCE, V241, P1349, DOI 10.1126/science.2457952
   WAHL SM, 1987, P NATL ACAD SCI USA, V84, P5788, DOI 10.1073/pnas.84.16.5788
   WAHL SM, 1989, J CELL BIOCHEM, V40, P193, DOI 10.1002/jcb.240400208
   WEISS SJ, 1989, NEW ENGL J MED, V320, P365
   WEISSMANN G, 1980, NEW ENGL J MED, V303, P27
   WILLIAMS GT, 1983, J CLIN PATHOL, V36, P723, DOI 10.1136/jcp.36.7.723
   Wokalek H, 1991, J Biomater Appl, V5, P337, DOI 10.1177/088532829100500405
   ZIATS NP, 1988, BIOMATERIALS, V9, P5, DOI 10.1016/0142-9612(88)90063-4
NR 76
TC 721
Z9 735
U1 11
U2 280
PU ANNUAL REVIEWS
PI PALO ALTO
PA 4139 EL CAMINO WAY, PO BOX 10139, PALO ALTO, CA 94303-0139 USA
SN 1531-7331
J9 ANNU REV MATER RES
JI Ann. Rev. Mater. Res.
PY 2001
VL 31
BP 81
EP 110
DI 10.1146/annurev.matsci.31.1.81
PG 30
WC Materials Science, Multidisciplinary
SC Materials Science
GA 486FX
UT WOS:000171808700005
DA 2018-10-20
ER

EF